protein_ID,ASCA_PC1_loadings,ASCA_PC2_loadings,ASCA_PC_threshold_pass,ClusterColor,SimpleClusterColor,UniprotID,Protein_names,Protein_fams,Gene_names,GO_terms,GO_bp_IDs,sig_bp_GO,sig_bp_GOslim
CHOYP_BRAFLDRAFT_284508.1.1.m.4587,-0.0369303755280097,-0.0145540511666833,Yes,purple,purple,Q9NR33,DNA polymerase epsilon subunit 4 (EC 2.7.7.7) (DNA polymerase II subunit 4) (DNA polymerase epsilon subunit p12),,POLE4,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; G1/S transition of mitotic cell cycle [GO:0000082]; histone H3 acetylation [GO:0043966],GO:0000082; GO:0003677; GO:0003887; GO:0005634; GO:0005654; GO:0005671; GO:0008622; GO:0043966; GO:0046982,GO:0043966,cellular protein modification process; chromosome organization
CHOYP_LOC100372607.1.1.m.49009,-0.0380506572658657,-0.00951569698469211,Yes,purple,purple,Q32KV4,Cytoplasmic dynein 2 light intermediate chain 1,Dynein light intermediate chain family,DYNC2LI1,apical part of cell [GO:0045177]; axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; intraciliary transport particle [GO:0030990]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein heavy chain binding [GO:0045504]; determination of left/right symmetry [GO:0007368]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cilium assembly [GO:1902017],GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0005930; GO:0007368; GO:0008569; GO:0030990; GO:0031514; GO:0035721; GO:0035735; GO:0035869; GO:0036064; GO:0045177; GO:0045504; GO:1902017,GO:0035721; GO:0035735; GO:1902017,transport; cellular component assembly; cytoskeleton-dependent intracellular transport
CHOYP_THTR.1.1.m.25924,-0.0251193703958107,0.0365030535052163,Yes,purple,purple,Q95KV7,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic-interferon-induced mortality 19 protein) (GRIM-19) (NADH-ubiquinone oxidoreductase B16.6 subunit),Complex I NDUFA13 subunit family,NDUFA13 GRIM19,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial respirasome [GO:0005746]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic signaling pathway [GO:0097190]; cellular response to interferon-beta [GO:0035458]; cellular response to retinoic acid [GO:0071300]; extrinsic apoptotic signaling pathway [GO:0097191]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of protein catabolic process [GO:0045732]; protein import into mitochondrial inner membrane [GO:0045039]; reactive oxygen species metabolic process [GO:0072593],GO:0005654; GO:0005737; GO:0005739; GO:0005746; GO:0005747; GO:0008137; GO:0016021; GO:0030308; GO:0032981; GO:0035458; GO:0043280; GO:0045039; GO:0045732; GO:0045892; GO:0071300; GO:0072593; GO:0097190; GO:0097191; GO:2001243,GO:0032981; GO:0043280; GO:0071300; GO:2001243,mitochondrion organization; signal transduction; cell death; cellular component assembly; protein-containing complex assembly
CHOYP_LAMC1.1.1.m.36098,-0.0379645198255789,0.0169221899901412,Yes,purple,purple,P11047,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),,LAMC1 LAMB2,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular protein metabolic process [GO:0044267]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; protein-containing complex assembly [GO:0065003]; substrate adhesion-dependent cell spreading [GO:0034446],GO:0005201; GO:0005576; GO:0005604; GO:0005606; GO:0005615; GO:0005788; GO:0007155; GO:0007492; GO:0016477; GO:0022617; GO:0030198; GO:0031581; GO:0034446; GO:0043259; GO:0043260; GO:0043687; GO:0044267; GO:0050679; GO:0062023; GO:0065003; GO:0070062,GO:0007492; GO:0022617; GO:0031581,cellular component assembly; extracellular matrix organization; cell junction organization; anatomical structure development
CHOYP_ATS6.3.3.m.56109,-0.040906660951862,0.00963476359526082,Yes,purple,purple,Q69Z28,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),,Adamts16 Kiaa2029,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0046872; GO:0048232; GO:1902017,GO:0001658; GO:0003073; GO:1902017,circulatory system process; cellular component assembly; anatomical structure development
CHOYP_EXOS3.1.1.m.10596,-0.0355083395624582,0.00668733875600459,Yes,purple,purple,Q9NQT5,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),RRP40 family,EXOSC3 RRP40 CGI-102,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; isotype switching [GO:0045190]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of isotype switching [GO:0045830]; regulation of mRNA stability [GO:0043488]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],GO:0000175; GO:0000176; GO:0000177; GO:0000178; GO:0000467; GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006364; GO:0034427; GO:0034475; GO:0035327; GO:0043488; GO:0043928; GO:0045006; GO:0045190; GO:0045830; GO:0071034; GO:0071035; GO:0071038; GO:0071049; GO:0071051,GO:0000467; GO:0034427; GO:0034475; GO:0043928; GO:0071035; GO:0071038; GO:0071051,tRNA metabolic process; catabolic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process; ribosome biogenesis
CHOYP_CLEC10A.3.3.m.27236,-0.0365287340214608,0.0202706520840853,Yes,purple,purple,P82596,Perlucin,,,carbohydrate binding [GO:0030246],GO:0030246,NA,NA
CHOYP_LOC100377801.1.1.m.10929,-0.0360737446962291,0.0189753310036775,Yes,purple,purple,Q1RML7,Protein MAK16 homolog,MAK16 family,MAK16,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687],GO:0005730; GO:0030687,NA,NA
CHOYP_XPF.1.1.m.14801,-0.0164352711112702,0.0356226152302634,Yes,purple,purple,Q6GQN4,Protein FAM32A-like,FAM32 family,fam32al fam32a zgc:91831,nucleolus [GO:0005730]; apoptotic process [GO:0006915]; cell cycle [GO:0007049],GO:0005730; GO:0006915; GO:0007049,NA,NA
CHOYP_BRAFLDRAFT_260197.1.1.m.8081,-0.0274276129756982,0.0449569581909191,Yes,purple,purple,O43402,ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B),EMC8/EMC9 family,EMC8 C16orf2 C16orf4 COX4AL COX4NB FAM158B NOC4,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ER membrane protein complex [GO:0072546]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634],GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0016020; GO:0072546,NA,NA
CHOYP_LOC752782.1.1.m.53937,-0.0617429395605915,-0.00246247039826684,Yes,purple,purple,O17320,Actin,Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_BRAFLDRAFT_89746.1.2.m.29425,-0.0399898478024049,0.0256198387743231,Yes,purple,purple,Q9R172,Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain],NOTCH family,Notch3,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; Notch signaling pathway [GO:0007219]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355]; tissue regeneration [GO:0042246]; wound healing [GO:0042060],GO:0005509; GO:0005634; GO:0005886; GO:0006355; GO:0007219; GO:0007275; GO:0016021; GO:0030154; GO:0038023; GO:0042060; GO:0042246; GO:0050793,NA,NA
CHOYP_CNDP2.4.4.m.56870,-0.0393125470120912,0.0200636506528252,Yes,purple,purple,Q5R432,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2),Peptidase M20A family,CNDP2,cytoplasm [GO:0005737]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237],GO:0004180; GO:0005737; GO:0008237; GO:0046872; GO:0102008; GO:0103046,NA,NA
CHOYP_ADAMTS16.1.1.m.28149,-0.0367435716520092,0.00034078016469003,Yes,purple,purple,Q8TE56,A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAM-TS 17) (ADAM-TS17) (ADAMTS-17) (EC 3.4.24.-),,ADAMTS17,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; nucleic acid binding [GO:0003676],GO:0003676; GO:0004222; GO:0005576; GO:0046872,NA,NA
CHOYP_DSIM_GD24875.1.1.m.66201,-0.0389182938220335,0.0127123697232495,Yes,purple,purple,Q3T149,Heat shock protein beta-1 (HspB1) (Heat shock 27 kDa protein) (HSP 27),Small heat shock protein (HSP20) family,HSPB1 HSP27,axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; identical protein binding [GO:0042802]; protein binding involved in protein folding [GO:0044183]; protein homodimerization activity [GO:0042803]; anterograde axonal protein transport [GO:0099641]; chaperone-mediated protein folding [GO:0061077]; regulation of protein phosphorylation [GO:0001932],GO:0001932; GO:0005634; GO:0005737; GO:0005819; GO:0042802; GO:0042803; GO:0044183; GO:0061077; GO:0099641; GO:1904115,NA,NA
CHOYP_BRAFLDRAFT_127065.4.7.m.28277,-0.0359455909081227,0.00585251863345422,Yes,purple,purple,P82198,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3),,Tgfbi,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023,NA,NA
CHOYP_LOC100536597.1.1.m.52329,-0.0397591085614844,-0.0111396905335011,Yes,purple,purple,Q14657,EKC/KEOPS complex subunit LAGE3 (L antigen family member 3) (Protein ESO-3) (Protein ITBA2),CTAG/PCC1 family,LAGE3 DXS9879E ESO3 ITBA2,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA processing [GO:0008033],GO:0000408; GO:0005634; GO:0005654; GO:0005737; GO:0008033; GO:0016604,NA,NA
CHOYP_contig_001129.m.1188,-0.0454089572741155,-0.0108445493787626,Yes,purple,purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004705.m.5404,-0.0377631566880015,0.0243843111631147,Yes,purple,purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024166.m.27453,-0.0370537958938461,0.00286451800100867,Yes,purple,purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100881430.1.1.m.4201,-0.0354470285980367,0.0235029605942097,Yes,purple,purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100933241.16.45.m.30626,-0.0358154869199824,0.00753945101722503,Yes,purple,purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PEAR1.8.16.m.41400,-0.0524145802828939,0.0251827169601704,Yes,purple,purple,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.9.23.m.25523,-0.0247622428760211,0.0415279637033401,Yes,green,green,P55210,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],Peptidase C14A family,CASP7 MCH3,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],GO:0004197; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0008233; GO:0008234; GO:0072734; GO:0097153; GO:0097194; GO:0097200,GO:0072734,NA
CHOYP_TF2AA.1.1.m.50726,-0.0050322973032403,0.0444175799090909,Yes,green,green,P52655,Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit) (TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)],TFIIA subunit 1 family,GTF2A1 TF2A1,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor TFIIA complex [GO:0005672]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; RNA polymerase II repressing transcription factor binding [GO:0001103]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],GO:0001103; GO:0003677; GO:0003713; GO:0005654; GO:0005669; GO:0005672; GO:0005829; GO:0006366; GO:0006367; GO:0008134; GO:0017025; GO:0042795; GO:0046982,GO:0042795,biosynthetic process; cellular nitrogen compound metabolic process
CHOYP_ISCW_ISCW000704.1.1.m.38250,-0.0249380235137192,0.0449649415687062,Yes,green,green,Q08E52,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),Protein kinase superfamily; STE Ser/Thr protein kinase family; STE20 subfamily,PAK1,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],GO:0001726; GO:0001934; GO:0004674; GO:0005518; GO:0005524; GO:0005737; GO:0005829; GO:0005884; GO:0005886; GO:0005911; GO:0005925; GO:0006468; GO:0006887; GO:0006915; GO:0008284; GO:0016477; GO:0023014; GO:0030335; GO:0031098; GO:0031116; GO:0031532; GO:0032147; GO:0032587; GO:0032991; GO:0033138; GO:0033148; GO:0042060; GO:0043408; GO:0043507; GO:0046777; GO:0048012; GO:0048365; GO:0048754; GO:0050770; GO:0051496; GO:0060244; GO:0071437,GO:0031116; GO:0043507; GO:0048012,cellular protein modification process; response to stress; cytoskeleton organization; signal transduction; cellular component assembly; protein-containing complex assembly
CHOYP_LOC100373864.2.2.m.55132,0.00130505864109162,0.0500626838431417,Yes,green,green,P12955,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase),Peptidase M24B family; Eukaryotic-type prolidase subfamily,PEPD PRD,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],GO:0004177; GO:0004181; GO:0005634; GO:0005654; GO:0006508; GO:0006520; GO:0030145; GO:0030574; GO:0070062; GO:0102009,GO:0030574,catabolic process
CHOYP_ADA17.3.3.m.54971,0.0118935522524983,0.0467224091842838,Yes,green,green,P27169,Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1),Paraoxonase family,PON1 PON,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; spherical high-density lipoprotein particle [GO:0034366]; acyl-L-homoserine-lactone lactonohydrolase activity [GO:0102007]; aryldialkylphosphatase activity [GO:0004063]; arylesterase activity [GO:0004064]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]; aromatic compound catabolic process [GO:0019439]; carboxylic acid catabolic process [GO:0046395]; cholesterol metabolic process [GO:0008203]; lipoxygenase pathway [GO:0019372]; organophosphate catabolic process [GO:0046434]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of binding [GO:0051099]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transporter activity [GO:0032411]; response to fatty acid [GO:0070542]; response to fluoride [GO:1902617]; response to nutrient levels [GO:0031667]; response to toxic substance [GO:0009636],GO:0004063; GO:0004064; GO:0005509; GO:0005543; GO:0005576; GO:0005615; GO:0008203; GO:0009636; GO:0010875; GO:0019372; GO:0019439; GO:0031667; GO:0032411; GO:0034364; GO:0034366; GO:0042803; GO:0043231; GO:0046395; GO:0046434; GO:0046470; GO:0051099; GO:0070062; GO:0070542; GO:0072562; GO:0102007; GO:1902617,GO:0010875; GO:0046470,lipid metabolic process; transport
CHOYP_G6PD.1.2.m.38380,0.00490712256397749,0.0430038860919972,Yes,green,green,P05370,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),Glucose-6-phosphate dehydrogenase family,G6pdx G6pd,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],GO:0004345; GO:0005536; GO:0005634; GO:0005829; GO:0006006; GO:0006098; GO:0006695; GO:0006739; GO:0006740; GO:0006749; GO:0009051; GO:0009898; GO:0010041; GO:0010734; GO:0014070; GO:0019322; GO:0030246; GO:0032094; GO:0034599; GO:0042803; GO:0043231; GO:0043249; GO:0043523; GO:0045471; GO:0046390; GO:0050661; GO:0051156; GO:0061052; GO:1904879; GO:2000378,GO:0006740; GO:0032094; GO:0043523; GO:0061052,cell death; cell differentiation; cellular nitrogen compound metabolic process; growth; small molecule metabolic process; anatomical structure development; cofactor metabolic process
CHOYP_MP2K5.1.1.m.45311,0.004145759367507,0.036266190437164,Yes,green,green,Q13163,Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5),Protein kinase superfamily; STE Ser/Thr protein kinase family; MAP kinase kinase subfamily,MAP2K5 MEK5 MKK5 PRKMK5,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular response to growth factor stimulus [GO:0071363]; cellular response to laminar fluid shear stress [GO:0071499]; ERK5 cascade [GO:0070375]; heart development [GO:0007507]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000342]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],GO:0000122; GO:0000187; GO:0004672; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005819; GO:0005829; GO:0007165; GO:0007507; GO:0023014; GO:0030307; GO:0031098; GO:0032088; GO:0032147; GO:0034115; GO:0043154; GO:0045415; GO:0045944; GO:0046872; GO:0050679; GO:0051247; GO:0060761; GO:0070375; GO:0071363; GO:0071499; GO:0090051; GO:2000342; GO:2001240,GO:0000187; GO:0090051,cellular protein modification process; signal transduction; locomotion; anatomical structure formation involved in morphogenesis; anatomical structure development; cell motility
CHOYP_MP2K4.1.1.m.10635,-0.017883362709884,0.0393609270306585,Yes,green,green,P47809,Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (C-JUN N-terminal kinase kinase 1) (JNK kinase 1) (JNKK 1) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1),Protein kinase superfamily; STE Ser/Thr protein kinase family; MAP kinase kinase subfamily,Map2k4 Jnkk1 Mek4 Mkk4 Prkmk4 Sek1 Serk1 Skk1,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; nucleus [GO:0005634]; perikaryon [GO:0043204]; ATP binding [GO:0005524]; JUN kinase kinase activity [GO:0008545]; MAP kinase kinase activity [GO:0004708]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell growth involved in cardiac muscle cell development [GO:0061049]; cellular response to mechanical stimulus [GO:0071260]; cellular response to sorbitol [GO:0072709]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA replication [GO:0045740]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; protein phosphorylation [GO:0006468]; response to wounding [GO:0009611]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],GO:0000165; GO:0000187; GO:0001934; GO:0004674; GO:0004708; GO:0004713; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006468; GO:0006915; GO:0007254; GO:0007257; GO:0008545; GO:0009611; GO:0023014; GO:0030424; GO:0031098; GO:0031435; GO:0032147; GO:0032839; GO:0034393; GO:0043065; GO:0043204; GO:0043525; GO:0045740; GO:0051770; GO:0061049; GO:0071260; GO:0072709; GO:2000672,GO:0000187; GO:0007257; GO:0061049,cellular protein modification process; response to stress; signal transduction; cell differentiation; growth; anatomical structure development
CHOYP_FABP6.2.2.m.59518,-0.031781345210701,0.0451785003793744,Yes,green,green,O01812,Fatty acid-binding protein homolog 6,Calycin superfamily; Fatty-acid binding protein (FABP) family,lbp-6 W02D3.5,lipid binding [GO:0008289],GO:0008289,NA,NA
CHOYP_CRE_20365.1.3.m.20889,0.0153364630420989,0.0460602373931308,Yes,green,green,Q21828,Probable mitochondrial pyruvate carrier 1 (MPC1),Mitochondrial pyruvate carrier (MPC) (TC 2.A.105) family,mpc-1 R07E5.13,integral component of mitochondrial inner membrane [GO:0031305]; pyruvate transmembrane transporter activity [GO:0050833]; mitochondrial pyruvate transmembrane transport [GO:0006850],GO:0006850; GO:0031305; GO:0050833,NA,NA
CHOYP_GKAP1.1.1.m.18792,0.00332438428188884,0.0399020775354997,Yes,green,green,Q6NWC9,G kinase-anchoring protein 1,GKAP1 family,gkap1 zgc:85804,Golgi apparatus [GO:0005794]; signal transduction [GO:0007165],GO:0005794; GO:0007165,NA,NA
CHOYP_AAEL_AAEL001706.1.1.m.43821,-0.0307006334714702,0.0459058513255713,Yes,green,green,Q5ZLH0,NTF2-related export protein 2,,NXT2 RCJMB04_6d20,cytoplasm [GO:0005737]; nuclear pore central transport channel [GO:0044613]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606],GO:0005634; GO:0005737; GO:0006606; GO:0006913; GO:0008565; GO:0044613; GO:0048471; GO:0051028,NA,NA
CHOYP_LOC100329062.2.2.m.39235,-0.00734724237941224,0.0503603101046168,Yes,green,green,Q9CS74,Protein ecdysoneless homolog,ECD family,Ecd,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; RNA splicing [GO:0008380],GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0008283; GO:0008380; GO:0035035; GO:0045944; GO:2000045,NA,NA
CHOYP_LOC100030437.1.3.m.5994,0.00343376790580819,0.0583531884294407,Yes,green,green,A2AX52,Collagen alpha-4(VI) chain,Type VI collagen family,Col6a4 Dvwa,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0031012; GO:0032991; GO:0062023; GO:0070208,NA,NA
CHOYP_USP2.1.1.m.44411,0.0170780542570764,0.0483400152294342,Yes,green,green,H2A0M5,Uncharacterized shell protein 2 (Prism uncharacterized shell protein 10) (PUSP10),,,extracellular region [GO:0005576],GO:0005576,NA,NA
CHOYP_ACT.6.27.m.15622,0.0125436876931048,0.0443967544041218,Yes,green,green,Q92193,Actin (Fragment),Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_TEMPT.3.3.m.40304,0.00647457678543767,0.0490452389604664,Yes,green,green,Q7Z0T3,Temptin,,,extracellular region [GO:0005576]; pheromone activity [GO:0005186],GO:0005186; GO:0005576,NA,NA
CHOYP_CALM.42.50.m.56135,-0.0123683164599326,0.0484095453841768,Yes,green,green,P0DP35,Calmodulin-2 B,Calmodulin family,calm2-b,calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]; calcium-mediated signaling [GO:0019722],GO:0005102; GO:0005509; GO:0019722,NA,NA
CHOYP_AMY.2.3.m.15473,0.00468359576361476,0.0444259700288674,Yes,green,green,P91778,Alpha-amylase (EC 3.2.1.1) (1;4-alpha-D-glucan glucanohydrolase),Glycosyl hydrolase 13 family,,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],GO:0004556; GO:0005975; GO:0046872; GO:0103025,NA,NA
CHOYP_LOC100744506.1.1.m.44043,0.0286555249729011,0.0353124349741876,Yes,green,green,O46037,Vinculin,Vinculin/alpha-catenin family,Vinc CG3299,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],GO:0003779; GO:0005198; GO:0005737; GO:0005925; GO:0007016; GO:0007155; GO:0015629; GO:0051015; GO:0098592,NA,NA
CHOYP_RLA1.5.12.m.15482,-0.000459858580785249,0.0721329884481604,Yes,green,green,O01359,60S acidic ribosomal protein P1 (Ribosomal protein RPL-21),Eukaryotic ribosomal protein P1/P2 family,rpl-21,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],GO:0003735; GO:0005840; GO:0006414,NA,NA
CHOYP_DVIR_GJ20612.1.1.m.14542,-0.00575877890874308,0.0519525985855958,Yes,green,green,Q291A0,39S ribosomal protein L41; mitochondrial (L41mt) (MRP-L41),Mitochondrion-specific ribosomal protein mL41 family,mRpL41 GA11937,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],GO:0003735; GO:0005762; GO:0006412; GO:1990904,NA,NA
CHOYP_DANA_GF10776.1.1.m.18533,-0.015020497550365,0.0356938987618031,Yes,green,green,Q2TBS2,39S ribosomal protein L21; mitochondrial (L21mt) (MRP-L21),Bacterial ribosomal protein bL21 family,MRPL21,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],GO:0003735; GO:0005743; GO:0005762,NA,NA
CHOYP_LOC100472408.1.1.m.17281,-0.00223486438249556,0.0383319395338436,Yes,green,green,Q562D6,tRNA (adenine(37)-N6)-methyltransferase (EC 2.1.1.-) (tRNA methyltransferase O),,Trmo,RNA binding [GO:0003723]; tRNA (adenine-N6-)-methyltransferase activity [GO:0016430]; tRNA methylation [GO:0030488],GO:0003723; GO:0016430; GO:0030488,NA,NA
CHOYP_ROA3.2.2.m.11068,-0.0179724236506739,0.0396989461712854,Yes,green,green,P51989,Heterogeneous nuclear ribonucleoprotein A2 homolog 1 (hnRNP A2(A)),,,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],GO:0003723; GO:0005634; GO:0006397; GO:0006406,NA,NA
CHOYP_BRAFLDRAFT_104488.3.3.m.2973,-0.0122358266967297,0.0452205422455686,Yes,green,green,Q9Y535,DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9),Eukaryotic RPB7/RPC8 RNA polymerase subunit family,POLR3H KIAA1665 RPC8,centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; nucleobase-containing compound metabolic process [GO:0006139]; transcription by RNA polymerase III [GO:0006383]; transcription initiation from RNA polymerase III promoter [GO:0006384],GO:0003677; GO:0003899; GO:0005654; GO:0005666; GO:0005813; GO:0005829; GO:0006139; GO:0006383; GO:0006384; GO:0043231; GO:0045087; GO:0051607,NA,NA
CHOYP_RL8.10.10.m.65636,-0.0195882792500831,0.062163785651213,Yes,green,green,Q6PBF0,60S ribosomal protein L8,Universal ribosomal protein uL2 family,rpl8 TTpA008p15.1,cytosolic large ribosomal subunit [GO:0022625]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0019843; GO:0022625,NA,NA
CHOYP_LOC100377856.1.2.m.13657,0.00861639002172384,0.0424516217020191,Yes,green,green,Q9Z221,Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein) (Outer dense fiber protein 3),,Pmfbp1 Odf3,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],GO:0001520; GO:0007010; GO:0007283; GO:0097224,NA,NA
CHOYP_LOC100883123.1.1.m.704,-0.0136767128817035,0.0370774390470585,Yes,green,green,P62501,TSC22 domain family protein 1 (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein),TSC-22/Dip/Bun family,Tsc22d1 Tgfb1i4 Tsc22,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000978; GO:0001228; GO:0005634; GO:0005737; GO:0045944,NA,NA
CHOYP_ALPHATUB84D.1.1.m.16562,0.00686324397953807,0.054192436808341,Yes,green,green,P06605,Tubulin alpha-3 chain,Tubulin family,alphaTub84D TubA84D CG2512,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],GO:0000226; GO:0000278; GO:0000281; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017; GO:0017022; GO:0048471,NA,NA
CHOYP_LOC100313569.1.1.m.15201,-0.0185285661718552,0.0356807150770757,Yes,green,green,Q13948,Protein CASP,CASP family,CUX1 CUTL1,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],GO:0000139; GO:0000981; GO:0005654; GO:0005794; GO:0006891; GO:0030173,NA,NA
CHOYP_DPSE_GA10259.1.1.m.36297,0.0184837894796233,0.0373768240139708,Yes,green,green,Q6NW29,RWD domain-containing protein 4 (Protein FAM28A),,RWDD4 FAM28A RWDD4A,,,NA,NA
CHOYP_BM8F.1.2.m.3009,0.00676862689344012,0.0413826173444894,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.4.5.m.44543,0.00539590522901027,0.0428766517778114,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003670.m.4147,0.0274972000402872,0.0447786012945075,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003956.m.4511,-0.00529414349108224,0.0617841464479622,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029222.m.33159,0.0221035121962594,0.0474429553940146,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038478.m.43530,0.0108488785300528,0.043588765740767,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039363.m.44567,-0.00566084952467713,0.0389215566186646,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039460.m.44676,-0.0206227736463705,0.0363473211925328,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FABP2.1.2.m.5800,0.00445609247738896,0.0439085781401213,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.1.2.m.5157,-0.0283635505355464,0.042074078748358,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375293.2.2.m.58888,-0.0143918097468304,0.0373971384570037,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC656741.1.1.m.19820,0.00396167296975002,0.04262094030506,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PITG_07096.1.1.m.4922,0.00331517923053911,0.035798069697291,Yes,green,green,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_F10A1.4.4.m.44752,-0.00874435638812965,-0.0395292158361826,Yes,gray50,gray,Q5ZLF0,Hsc70-interacting protein (Hip) (Protein FAM10A1) (Protein ST13 homolog),FAM10 family,ST13 FAM10A1 RCJMB04_6h13,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],GO:0005737; GO:0046983; GO:0051085,GO:0051085,protein folding
CHOYP_NEMVEDRAFT_V1G165338.1.1.m.60296,0.00223904648407144,-0.0563985689552337,Yes,gray50,gray,P60517,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein),ATG8 family,Gabarap,actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cell body [GO:0044297]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; protein transport [GO:0015031],GO:0000045; GO:0000139; GO:0000226; GO:0000421; GO:0000422; GO:0005764; GO:0005776; GO:0005790; GO:0005829; GO:0005874; GO:0005875; GO:0005886; GO:0005930; GO:0006995; GO:0008017; GO:0008625; GO:0015031; GO:0015629; GO:0031410; GO:0031625; GO:0044297; GO:0048471; GO:0048487; GO:0050811; GO:0097225,GO:0008625,signal transduction; cell death
CHOYP_BRAFLDRAFT_118250.1.1.m.11178,-0.00327865586444666,-0.0637591232356256,Yes,gray50,gray,O95295,SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein),SNAPIN family,SNAPIN BLOC1S7 SNAP25BP SNAPAP,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; cell junction [GO:0030054]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; SNARE binding [GO:0000149]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; autophagosome maturation [GO:0097352]; cellular protein-containing complex localization [GO:0034629]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; lysosomal lumen acidification [GO:0007042]; lysosome localization [GO:0032418]; melanosome organization [GO:0032438]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; neurotransmitter secretion [GO:0007269]; positive regulation of late endosome to lysosome transport [GO:1902824]; protein maturation [GO:0051604]; regulation of protein binding [GO:0043393]; regulation of synaptic vesicle exocytosis [GO:2000300]; retrograde axonal transport [GO:0008090]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle transport [GO:0048489]; terminal button organization [GO:0072553]; viral process [GO:0016032],GO:0000139; GO:0000149; GO:0005765; GO:0006886; GO:0007042; GO:0007269; GO:0008021; GO:0008089; GO:0008090; GO:0008333; GO:0010977; GO:0016032; GO:0016079; GO:0016188; GO:0030054; GO:0030141; GO:0030672; GO:0031083; GO:0031175; GO:0031629; GO:0032418; GO:0032438; GO:0034629; GO:0043393; GO:0045202; GO:0048471; GO:0048489; GO:0048490; GO:0051604; GO:0072553; GO:0097352; GO:0099078; GO:1902774; GO:1902824; GO:1904115; GO:2000300,GO:0008090; GO:0031629; GO:0032418; GO:0032438; GO:0034629; GO:0048490; GO:0072553; GO:0097352; GO:2000300,transport; autophagy; cell-cell signaling; catabolic process; vesicle-mediated transport; cytoskeleton-dependent intracellular transport; pigmentation; membrane organization
CHOYP_RHO1.3.3.m.44338,-0.00042967189569093,-0.0399191295941395,Yes,gray50,gray,P48148,Ras-like GTP-binding protein Rho1,Small GTPase superfamily; Rho family,Rho1 CG8416,apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell division site [GO:0032153]; cell hair [GO:0070451]; cell-cell contact zone [GO:0044291]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; actin cytoskeleton organization [GO:0030036]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin-mediated cell contraction [GO:0070252]; adherens junction maintenance [GO:0034334]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; cell migration [GO:0016477]; cellular protein localization [GO:0034613]; cellularization [GO:0007349]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dendrite self-avoidance [GO:0070593]; determination of left/right symmetry [GO:0007368]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; establishment of planar polarity of embryonic epithelium [GO:0042249]; establishment of protein localization [GO:0045184]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; gastrulation involving germ band extension [GO:0010004]; germ-band extension [GO:0007377]; glial cell migration [GO:0008347]; hemocyte migration [GO:0035099]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing hair organization [GO:0035317]; lumen formation; open tracheal system [GO:0035149]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; melanization defense response [GO:0035006]; mitotic actomyosin contractile ring assembly [GO:1903475]; mitotic cytokinesis [GO:0000281]; motor neuron axon guidance [GO:0008045]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; neuroblast proliferation [GO:0007405]; neuron projection morphogenesis [GO:0048812]; open tracheal system development [GO:0007424]; peripheral nervous system development [GO:0007422]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of wound healing [GO:0090303]; posterior midgut invagination [GO:0007374]; protein localization involved in establishment of planar polarity [GO:0090251]; protein localization to adherens junction [GO:0071896]; pseudocleavage involved in syncytial blastoderm formation [GO:0030589]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of embryonic cell shape [GO:0016476]; regulation of filopodium assembly [GO:0051489]; regulation of locomotor rhythm [GO:1904059]; regulation of Malpighian tubule size [GO:0035298]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; response to wounding [GO:0009611]; Rho protein signal transduction [GO:0007266]; salivary gland morphogenesis [GO:0007435]; spiracle morphogenesis; open tracheal system [GO:0035277]; tracheal pit formation in open tracheal system [GO:0035202]; ventral furrow formation [GO:0007370]; visual perception [GO:0007601]; wound healing [GO:0042060],GO:0000281; GO:0001745; GO:0003779; GO:0003924; GO:0005525; GO:0005737; GO:0005829; GO:0005856; GO:0005886; GO:0005938; GO:0006897; GO:0007015; GO:0007266; GO:0007298; GO:0007349; GO:0007368; GO:0007370; GO:0007374; GO:0007377; GO:0007391; GO:0007395; GO:0007405; GO:0007411; GO:0007422; GO:0007424; GO:0007435; GO:0007480; GO:0007601; GO:0008045; GO:0008347; GO:0008360; GO:0009611; GO:0010004; GO:0016476; GO:0016477; GO:0019900; GO:0019901; GO:0030036; GO:0030334; GO:0030589; GO:0030866; GO:0030950; GO:0031532; GO:0032153; GO:0032456; GO:0032956; GO:0034334; GO:0034613; GO:0035006; GO:0035099; GO:0035149; GO:0035159; GO:0035202; GO:0035277; GO:0035298; GO:0035317; GO:0042060; GO:0042249; GO:0043231; GO:0044291; GO:0045179; GO:0045184; GO:0045199; GO:0046663; GO:0048812; GO:0048813; GO:0050770; GO:0051017; GO:0051489; GO:0051493; GO:0070252; GO:0070451; GO:0070593; GO:0071896; GO:0071902; GO:0090090; GO:0090251; GO:0090254; GO:0090303; GO:1901739; GO:1903475; GO:1904059,GO:0007298; GO:0007349; GO:0007395; GO:0007435; GO:0034334; GO:0035006; GO:0035159; GO:0035277; GO:0035317; GO:0042249; GO:0045199; GO:0070593; GO:0090303; GO:1901739,reproduction; immune system process; response to stress; embryo development; secondary metabolic process; cell differentiation; cell junction organization; locomotion; anatomical structure formation involved in morphogenesis; anatomical structure development; cell motility
CHOYP_FLNA.6.6.m.37383,-0.0249641727248384,-0.0369214003106253,Yes,gray50,gray,Q80X90,Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin),Filamin family,Flnb,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],GO:0001725; GO:0003334; GO:0003382; GO:0003779; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0005903; GO:0005925; GO:0005938; GO:0007519; GO:0030018; GO:0030036; GO:0042802; GO:0043005; GO:0043025; GO:0045335; GO:0071346,GO:0003334,cell differentiation; anatomical structure development
CHOYP_BRAFLDRAFT_275787.2.2.m.62313,-0.00269295924853754,-0.0458553394560597,Yes,gray50,gray,Q5E951,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),TBCB family,TBCB CKAP1,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],GO:0005737; GO:0005829; GO:0005874; GO:0007399; GO:0030154,NA,NA
CHOYP_LYRM4.2.3.m.7011,0.000184578455017071,-0.0474647217652497,Yes,gray50,gray,Q6DCS1,LYR motif-containing protein 4,Complex I LYR family,lyrm4 isd11,mitochondrion [GO:0005739]; nucleus [GO:0005634],GO:0005634; GO:0005739,NA,NA
CHOYP_LOC100708991.3.5.m.40072,0.00873478548950716,-0.0463460590615398,Yes,gray50,gray,A6NMZ7,Collagen alpha-6(VI) chain,Type VI collagen family,COL6A6,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0031012; GO:0062023,NA,NA
CHOYP_PAN2.1.1.m.44691,-0.0158730150669564,-0.0861656996415937,Yes,gray50,gray,Q25381,Actin; muscle (LPM) (Fragment),Actin family,,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],GO:0005524; GO:0005737; GO:0005856,NA,NA
CHOYP_ISCW_ISCW010532.2.4.m.35454,0.0268350074838076,-0.0457302577402048,Yes,gray50,gray,Q9NL98,Peroxiredoxin (EC 1.11.1.15) (AsPrx) (Thioredoxin peroxidase),Peroxiredoxin family; AhpC/Prx1 subfamily,,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005623; GO:0006979; GO:0008379; GO:0016209; GO:0045454,NA,NA
CHOYP_TMO_0856.1.3.m.5045,0.0068509407758223,-0.0367849612621742,Yes,gray50,gray,Q9X6U2,D-beta-hydroxybutyrate dehydrogenase (BDH) (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (3-HBDH),Short-chain dehydrogenases/reductases (SDR) family,hbdH1 H16_A1334,3-hydroxybutyrate dehydrogenase activity [GO:0003858],GO:0003858,NA,NA
CHOYP_NEMVEDRAFT_V1G165649.1.1.m.2893,0.0270535986788631,-0.0405206178161923,Yes,gray50,gray,Q6DF67,Isochorismatase domain-containing protein 2,Isochorismatase family,isoc2,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],GO:0003824; GO:0005737,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22689,0.00629766241259544,-0.0592483937963257,Yes,gray50,gray,P62278,40S ribosomal protein S13,Universal ribosomal protein uS15 family,Rps13,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],GO:0003735; GO:0005730; GO:0006412; GO:0022627; GO:0045202; GO:0070181; GO:1990932,NA,NA
CHOYP_LOC100748395.6.7.m.57994,0.0302547095234897,-0.0449509632527559,Yes,gray50,gray,P51989,Heterogeneous nuclear ribonucleoprotein A2 homolog 1 (hnRNP A2(A)),,,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],GO:0003723; GO:0005634; GO:0006397; GO:0006406,NA,NA
CHOYP_LOC100227090.1.1.m.1313,0.0246672495402289,-0.0370632975574057,Yes,gray50,gray,Q8QZZ7,EKC/KEOPS complex subunit Tprkb (PRPK-binding protein) (TP53RK-binding protein),CGI121/TPRKB family,Tprkb,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; tRNA threonylcarbamoyladenosine modification [GO:0002949],GO:0000408; GO:0002949; GO:0005634; GO:0005737; GO:0005829; GO:0019901,NA,NA
CHOYP_DDX41.1.1.m.16719,-0.00474710298892564,-0.0420038682873997,Yes,gray50,gray,Q91VN6,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41),DEAD box helicase family; DDX41 subfamily,Ddx41,catalytic step 2 spliceosome [GO:0071013]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to interferon-beta [GO:0035458]; defense response to virus [GO:0051607]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944],GO:0000398; GO:0003677; GO:0003723; GO:0004386; GO:0005524; GO:0005634; GO:0005783; GO:0008283; GO:0030154; GO:0035458; GO:0045944; GO:0046872; GO:0051607; GO:0071013,NA,NA
CHOYP_OTU5B.1.1.m.6212,-0.00411252524789873,-0.0368741343625564,Yes,gray50,gray,Q6DHK1,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase),NnrE/AIBP family,naxe aibp apoa1bp si:dkeyp-84f11.6 zgc:92263,extracellular region [GO:0005576]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],GO:0000166; GO:0005576; GO:0005739; GO:0046872; GO:0052856; GO:0052857,NA,NA
CHOYP_SYYC.2.2.m.58390,0.0332419066325147,-0.0498813482944555,Yes,gray50,gray,Q6TGS6,Tyrosine--tRNA ligase; cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS),Class-I aminoacyl-tRNA synthetase family,yars,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],GO:0000049; GO:0004831; GO:0005524; GO:0006418; GO:0006437; GO:0006974; GO:0017101; GO:0017102,NA,NA
CHOYP_TPM.15.19.m.50851,-0.00496426124455945,-0.0453662553422853,Yes,gray50,gray,Q25145,Tropomyosin,Tropomyosin family,,,,NA,NA
CHOYP_BRAFLDRAFT_63471.1.1.m.25619,0.00114746721798108,-0.035548498716171,Yes,gray50,gray,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008975.m.10444,-0.0101318462267756,-0.0448377762889503,Yes,gray50,gray,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035889.m.40603,-0.0146916450650406,-0.0414750414086198,Yes,gray50,gray,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_268110.13.13.m.65590,0.024148880008251,-0.0368648862411168,Yes,gray50,gray,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC494408.1.1.m.29208,-0.046327575358633,-0.0211080117453247,Yes,darkslategray1,light blue,Q9ET66,Peptidase inhibitor 16 (PI-16) (Cysteine-rich protease inhibitor) (CD antigen CD364),CRISP family,Pi16 Cripi,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],GO:0005615; GO:0030414; GO:0061052,GO:0061052,cell differentiation; growth; anatomical structure development
CHOYP_LOC664138.1.1.m.26660,-0.0475875109759108,-0.0205152576049977,Yes,darkslategray1,light blue,Q9VRN5,Protein lin-28 homolog,Lin-28 family,lin-28 CG17334,cytosol [GO:0005829]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; zinc ion binding [GO:0008270]; negative regulation of pre-miRNA processing [GO:2000632]; oogenesis [GO:0048477]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of stem cell proliferation [GO:2000648]; regulation of transcription; DNA-templated [GO:0006355]; symmetric stem cell division [GO:0098724],GO:0003677; GO:0003729; GO:0005829; GO:0006355; GO:0008270; GO:0046628; GO:0048477; GO:0098724; GO:2000632; GO:2000648,GO:0046628; GO:2000648,signal transduction; cell proliferation
CHOYP_CNOT1.1.1.m.12106,-0.00961709306895342,-0.0475107303069603,Yes,darkslategray1,light blue,O54879,High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4),HMGB family,Hmgb3 Hmg2a Hmg4,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],GO:0000400; GO:0000790; GO:0003677; GO:0003723; GO:0005634; GO:0005737; GO:0006310; GO:0006338; GO:0006357; GO:0008134; GO:0008301; GO:0032392; GO:0045087; GO:0045089; GO:0045578; GO:0045638; GO:0045944,GO:0045638,immune system process; cell differentiation; anatomical structure development
CHOYP_VOLCADRAFT_89567.1.1.m.27272,-0.0505330074307289,0.000909000649671939,Yes,darkslategray1,light blue,Q9Y5Z4,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),HEBP family,HEBP2 C6orf34 SOUL,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],GO:0005576; GO:0005737; GO:0005739; GO:0010917; GO:0010940; GO:0020037; GO:0035578; GO:0035794; GO:0043312; GO:0070062,GO:0035794,transport; mitochondrion organization; membrane organization
CHOYP_PHUM_PHUM184790.1.1.m.41715,-0.0376366679346238,-0.019596287441721,Yes,darkslategray1,light blue,Q92626,Peroxidasin homolog (EC 1.11.1.7) (Melanoma-associated antigen MG50) (Vascular peroxidase 1) (p53-responsive gene 2 protein),Peroxidase family; XPO subfamily,PXDN KIAA0230 MG50 PRG2 VPO VPO1,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0020037; GO:0030198; GO:0042744; GO:0046872; GO:0055114; GO:0062023; GO:0070062,GO:0030198,extracellular matrix organization
CHOYP_BRAFLDRAFT_127065.5.7.m.28848,-0.0445295432238924,0.00529448058352249,Yes,darkslategray1,light blue,P82198,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3),,Tgfbi,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],GO:0001525; GO:0002062; GO:0005178; GO:0005201; GO:0005518; GO:0005604; GO:0005615; GO:0005802; GO:0007155; GO:0008283; GO:0030198; GO:0031012; GO:0050839; GO:0050840; GO:0062023,GO:0030198,extracellular matrix organization
CHOYP_CYTA.1.1.m.10540,-0.039063337565365,-0.0248598115993259,Yes,darkslategray1,light blue,P01040,Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A; N-terminally processed],Cystatin family,CSTA STF1 STFA,cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; protease binding [GO:0002020]; protein binding; bridging [GO:0030674]; structural molecule activity [GO:0005198]; cell-cell adhesion [GO:0098609]; cornification [GO:0070268]; keratinocyte differentiation [GO:0030216]; negative regulation of peptidase activity [GO:0010466]; negative regulation of proteolysis [GO:0045861]; peptide cross-linking [GO:0018149],GO:0001533; GO:0002020; GO:0004869; GO:0005198; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0010466; GO:0018149; GO:0030216; GO:0030674; GO:0045861; GO:0070268; GO:0098609,GO:0018149,cellular protein modification process
CHOYP_LOC101067698.2.2.m.27457,-0.0481360358615132,-0.0203987079903456,Yes,darkslategray1,light blue,Q5R1U3,Cystatin-A3 (VSA745),Cystatin family,cpiC DDB_G0277001,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; hyperosmotic response [GO:0006972]; proteolysis [GO:0006508],GO:0004869; GO:0005829; GO:0006508; GO:0006972,GO:0006972,response to stress
CHOYP_LOC100372473.3.5.m.39839,-0.0360902058057691,0.0214380502962844,Yes,darkslategray1,light blue,Q6B9X6,Alpha-protein kinase vwkA (EC 2.7.11.1) (von Willebrand factor A alpha-kinase) (vWF kinase),Protein kinase superfamily; Alpha-type protein kinase family; ALPK subfamily,vwkA DDB_G0268144,contractile vacuolar membrane [GO:0031164]; contractile vacuole [GO:0000331]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; contractile vacuole discharge [GO:0070177]; contractile vacuole organization [GO:0033298]; hypotonic response [GO:0006971]; mitotic cytokinesis [GO:0000281]; myosin II filament organization [GO:0031038]; peptidyl-serine modification [GO:0018209]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of sorocarp development [GO:0031156]; sorocarp morphogenesis [GO:0031288],GO:0000281; GO:0000331; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0006971; GO:0018107; GO:0018209; GO:0031038; GO:0031156; GO:0031164; GO:0031288; GO:0033298; GO:0048471; GO:0070177,GO:0006971; GO:0031038; GO:0031156,response to stress; cytoskeleton organization; anatomical structure development
CHOYP_ARGI.1.2.m.3263,-0.0184843926025253,-0.03944223996047,Yes,darkslategray1,light blue,P49900,Arginase; hepatic (EC 3.5.3.1),Arginase family,,arginase activity [GO:0004053]; metal ion binding [GO:0046872]; arginine metabolic process [GO:0006525]; urea cycle [GO:0000050],GO:0000050; GO:0004053; GO:0006525; GO:0046872,GO:0006525,cellular amino acid metabolic process; small molecule metabolic process
CHOYP_TXND3.2.4.m.21415,-0.0128642420874573,-0.0360794084072834,Yes,darkslategray1,light blue,P90666,Thioredoxin domain-containing protein 3 homolog (Intermediate chain 1) (NME/NM23 family member 8),NDK family,NME8 IC1,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],GO:0004550; GO:0005623; GO:0006183; GO:0006228; GO:0006241; GO:0007275; GO:0007283; GO:0030154; GO:0045454,GO:0006183; GO:0006228; GO:0006241,biosynthetic process; cellular nitrogen compound metabolic process; small molecule metabolic process
CHOYP_contig_026700.m.30399,-0.0428762018204137,0.00777259987558961,Yes,darkslategray1,light blue,P35555,Fibrillin-1 [Cleaved into: Asprosin],Fibrillin family,FBN1 FBN,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],GO:0001501; GO:0001527; GO:0001656; GO:0005178; GO:0005179; GO:0005201; GO:0005509; GO:0005576; GO:0005604; GO:0005615; GO:0005788; GO:0006006; GO:0007507; GO:0008201; GO:0010737; GO:0030023; GO:0030198; GO:0031012; GO:0033627; GO:0034199; GO:0035582; GO:0035583; GO:0042593; GO:0042802; GO:0043010; GO:0043687; GO:0044267; GO:0044877; GO:0045671; GO:0048048; GO:0048050; GO:0062023; GO:0071560; GO:1990314; GO:2001205,GO:0006006; GO:0030198; GO:0034199; GO:0035582; GO:0035583; GO:0048050; GO:1990314; GO:2001205,immune system process; carbohydrate metabolic process; cellular protein modification process; signal transduction; biosynthetic process; cell differentiation; extracellular matrix organization; cellular nitrogen compound metabolic process; small molecule metabolic process; anatomical structure development
CHOYP_BRAFLDRAFT_281651.5.8.m.25278,-0.0526609781808504,-0.0214059821132185,Yes,darkslategray1,light blue,Q6RY07,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14),Glycosyl hydrolase 18 family; Chitinase class II subfamily,Chia,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],GO:0000272; GO:0002376; GO:0002532; GO:0004568; GO:0005576; GO:0005615; GO:0005737; GO:0006032; GO:0006915; GO:0008061; GO:0090197,GO:0002532; GO:0006032; GO:0090197,transport; response to stress; catabolic process
CHOYP_LOC100370738.1.1.m.30463,-0.0407385095929977,-0.0166604348875075,Yes,darkslategray1,light blue,P51910,Apolipoprotein D (Apo-D) (ApoD),Calycin superfamily; Lipocalin family,Apod,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],GO:0000302; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0006869; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0071638; GO:1900016; GO:2000098; GO:2000405,GO:0000302; GO:0006006; GO:0010642; GO:0014012; GO:0042246; GO:0042308; GO:0048662; GO:0051895; GO:0071638; GO:1900016,carbohydrate metabolic process; transport; nucleocytoplasmic transport; response to stress; cell adhesion; signal transduction; cell proliferation; cellular component assembly; cell differentiation; cell junction organization; growth; small molecule metabolic process; anatomical structure development
CHOYP_LOC577063.1.1.m.30814,-0.0364712263970825,-0.0114270953574515,Yes,darkslategray1,light blue,P05090,Apolipoprotein D (Apo-D) (ApoD),Calycin superfamily; Lipocalin family,APOD,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],GO:0000302; GO:0001525; GO:0005319; GO:0005576; GO:0005615; GO:0005737; GO:0005783; GO:0006006; GO:0006629; GO:0007420; GO:0007568; GO:0010642; GO:0014012; GO:0015485; GO:0022626; GO:0030425; GO:0042246; GO:0042308; GO:0042493; GO:0043025; GO:0048471; GO:0048662; GO:0048678; GO:0051895; GO:0060588; GO:0070062; GO:0071638; GO:1900016; GO:2000098; GO:2000405,GO:0000302; GO:0006006; GO:0010642; GO:0014012; GO:0042246; GO:0042308; GO:0048662; GO:0051895; GO:0071638; GO:1900016,carbohydrate metabolic process; transport; nucleocytoplasmic transport; response to stress; cell adhesion; signal transduction; cell proliferation; cellular component assembly; cell differentiation; cell junction organization; growth; small molecule metabolic process; anatomical structure development
CHOYP_CO5A2.1.1.m.28030,-0.040776879984502,-0.0178679602950957,Yes,darkslategray1,light blue,Q5UNS9,Collagen-like protein 7,,MIMI_L669,virion [GO:0019012],GO:0019012,NA,NA
CHOYP_LOC100377195.1.2.m.28624,-0.0369831885336824,0.0115166591740896,Yes,darkslategray1,light blue,P08472,Mesenchyme-specific cell surface glycoprotein (MSP130),,,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],GO:0005886; GO:0031225,NA,NA
CHOYP_LOC581183.1.1.m.49767,-0.0398232133085418,-0.0185996853578902,Yes,darkslategray1,light blue,Q7ZU45,Tetratricopeptide repeat protein 25 (TPR repeat protein 25),,ttc25,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],GO:0005737; GO:0005856; GO:0032474; GO:0042995; GO:0060271; GO:0061371,NA,NA
CHOYP_LOC100749506.1.1.m.8951,-0.0466854651304682,-0.0216091881297334,Yes,darkslategray1,light blue,O35125,Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7),,Lrrc23 Lrpb7,cytoplasm [GO:0005737]; cytosol [GO:0005829],GO:0005737; GO:0005829,NA,NA
CHOYP_BRAFLDRAFT_129759.2.2.m.30082,-0.0443657204911396,-0.0204336215724451,Yes,darkslategray1,light blue,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_BRAFLDRAFT_201924.1.1.m.30855,-0.0477843888484935,-0.0220482788409078,Yes,darkslategray1,light blue,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_LOC100372505.2.2.m.26614,-0.040528112948515,-0.018108296670117,Yes,darkslategray1,light blue,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_LOC100485485.1.1.m.27961,-0.0438553443225044,-0.0279094328705715,Yes,darkslategray1,light blue,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_YBOXH.2.4.m.3352,-0.04219124482523,0.0190214500999903,Yes,darkslategray1,light blue,P86854,Perlucin-like protein,,,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],GO:0005576; GO:0030246,NA,NA
CHOYP_LOC101064693.1.2.m.30288,-0.0360279464936776,-0.0116308202891996,Yes,darkslategray1,light blue,A8TX70,Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4),Type VI collagen family,COL6A5 COL29A1 VWA4,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0062023,NA,NA
CHOYP_NRP.1.4.m.29956,-0.0354909504022708,-0.0161845791826413,Yes,darkslategray1,light blue,H2A0M0,Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1),,,extracellular region [GO:0005576],GO:0005576,NA,NA
CHOYP_ACA1_091870.1.1.m.43726,-0.0315796921238855,0.0398694557491614,Yes,darkslategray1,light blue,Q6R520,Calmodulin (CaM),Calmodulin family,calm,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],GO:0005509; GO:0019722,NA,NA
CHOYP_MLRA.3.3.m.62296,-0.0142925052081113,-0.0561848588755786,Yes,darkslategray1,light blue,P04113,Myosin regulatory light chain A; smooth adductor muscle,,,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],GO:0005509; GO:0016459,NA,NA
CHOYP_LOC592209.1.1.m.48009,-0.0355398642130744,-0.00432411059840409,Yes,darkslategray1,light blue,Q8IVU9,Ciliary-associated calcium-binding coiled-coil protein 1,,CABCOCO1 C10orf107,centrosome [GO:0005813]; cytoplasm [GO:0005737]; sperm flagellum [GO:0036126]; calcium ion binding [GO:0005509],GO:0005509; GO:0005737; GO:0005813; GO:0036126,NA,NA
CHOYP_CALM.49.50.m.63320,0.00331933397588247,-0.0421365050414662,Yes,darkslategray1,light blue,P02595,Calmodulin (CaM),Calmodulin family,,calcium ion binding [GO:0005509],GO:0005509,NA,NA
CHOYP_PRP6.2.2.m.34365,-0.0631193484922676,0.0262337314434703,Yes,darkslategray1,light blue,P30568,Glutathione S-transferase A (GST-A) (EC 2.5.1.18) (GST class-theta),GST superfamily; Theta family,,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],GO:0004364; GO:0005737,NA,NA
CHOYP_LOC100533291.4.7.m.29195,-0.0387626266983625,-0.0145445453801507,Yes,darkslategray1,light blue,P18445,60S ribosomal protein L27a,Universal ribosomal protein uL15 family,Rpl27a,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],GO:0003735; GO:0006412; GO:0022625,NA,NA
CHOYP_MSI2H.3.3.m.35858,-0.0489890136688613,0.0183007067073323,Yes,darkslategray1,light blue,Q9VVE5,RNA-binding protein Musashi homolog Rbp6,Musashi family,Rbp6 RRM6 CG32169,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],GO:0003723; GO:0003727; GO:0005737; GO:0005844; GO:0008266; GO:0048864; GO:1990904,NA,NA
CHOYP_BRAFLDRAFT_125073.1.1.m.1752,-0.00700028997914517,-0.046725175880577,Yes,darkslategray1,light blue,Q99P31,Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-interacting protein 1),,Hspbp1 Hspbp,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; adenyl-nucleotide exchange factor activity [GO:0000774]; ubiquitin protein ligase binding [GO:0031625]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398],GO:0000774; GO:0005737; GO:0005783; GO:0031398; GO:0031625; GO:0032436,NA,NA
CHOYP_RFOX2.1.2.m.24118,-0.0352304624894945,-0.00787984664213326,Yes,darkslategray1,light blue,O43251,RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity),,RBFOX2 FOX2 HRNBP2 RBM9 RTA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; dendrite morphogenesis [GO:0048813]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intracellular estrogen receptor signaling pathway [GO:0030520]; mRNA processing [GO:0006397]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of cell proliferation [GO:0042127]; regulation of definitive erythrocyte differentiation [GO:0010724]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380],GO:0000381; GO:0003714; GO:0003723; GO:0003729; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006397; GO:0007399; GO:0008134; GO:0008380; GO:0008543; GO:0010724; GO:0016070; GO:0021942; GO:0030520; GO:0042127; GO:0045892; GO:0048813; GO:0050885,NA,NA
CHOYP_TBA1A.2.4.m.19573,-0.0351949175820444,-0.00593776807628648,Yes,darkslategray1,light blue,P09645,Tubulin alpha-8 chain (Fragment),Tubulin family,,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],GO:0000226; GO:0000278; GO:0003924; GO:0005200; GO:0005525; GO:0005737; GO:0005874; GO:0007017,NA,NA
CHOYP_LOC100373444.44.79.m.39021,-0.00473290450517164,-0.0414916040002312,Yes,darkslategray1,light blue,O70277,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22),TRIM/RBCC family,Trim3 Berp Rnf22,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],GO:0000209; GO:0005737; GO:0005769; GO:0005794; GO:0008270; GO:0015031; GO:0030425; GO:0043161; GO:0061630; GO:0098794; GO:0098978,NA,NA
CHOYP_U728.1.1.m.63184,-0.0347029597468468,0.0364467869690198,Yes,darkslategray1,light blue,B6LS00,UPF0728 protein,UPF0728 family,BRAFLDRAFT_270831,,,NA,NA
CHOYP_LOC576665.1.2.m.10867,-0.0375178140210052,-0.0172382323339702,Yes,darkslategray1,light blue,A6QQL5,Uncharacterized protein C2orf73 homolog,,,,,NA,NA
CHOYP_LOC100368360.1.1.m.9672,-0.0434976893020351,-0.00281034076277926,Yes,darkslategray1,light blue,Q4KKZ1,Uncharacterized protein C1orf158 homolog,,,,,NA,NA
CHOYP_BRAFLDRAFT_151236.1.1.m.30653,-0.0521058591435042,-0.0197508262370754,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84494.2.5.m.30751,-0.0402520526367712,-0.0142437530289623,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11254.1.1.m.9107,-0.0444157500011776,-0.0282660736611259,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COCA1.3.6.m.49360,-0.039732882219762,-0.025285908164623,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007998.m.9259,-0.0482163236611029,-0.0197376675172125,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008002.m.9263,-0.0543233446188463,-0.0230728961984247,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008503.m.9899,-0.039920588941914,-0.0254053642592494,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023945.m.27245,-0.0463295994818714,-0.0190703975999535,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024012.m.27306,-0.0494653310699132,-0.0019482740504983,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024418.m.27769,-0.0437115934160523,-0.0115087156285532,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024582.m.27943,-0.0402501611011714,-0.0186222214415043,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025149.m.28635,-0.048687699574399,-0.00872210696918633,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025272.m.28780,-0.0366441279789815,0.00283063305014207,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025679.m.29295,-0.0447806250482168,-0.0194454797672753,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025702.m.29329,-0.0473965468007217,-0.0191272622204407,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026129.m.29781,-0.0480860787422976,-0.0185490993436836,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026328.m.29985,-0.0358060544425788,-0.0227868846605401,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026477.m.30166,-0.0486314138512083,-0.023632366472393,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026494.m.30182,-0.0445865469445033,-0.0192181802345389,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026723.m.30427,-0.0477651304299316,-0.0186795560567036,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026959.m.30676,-0.0420501515440337,-0.0177866333835997,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026975.m.30698,-0.0431358281758361,-0.00424650335290865,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027304.m.31034,-0.0525666380832899,-0.0206461989013497,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031126.m.35509,-0.0424476685428748,-0.0173073754893285,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040577.m.46077,-0.0298468116815244,0.0437471603188086,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048277.m.57151,-0.0452143031019702,0.0213458752220513,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048805.m.57897,-0.0401278745596701,0.00275657085206168,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.1.15.m.3193,-0.0396458002727958,-0.00788590519262186,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DDB_G0275195.1.1.m.47584,-0.0362037300058993,-0.00110073039892641,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175722.1.3.m.11427,-0.0512345556400202,-0.0218416524079778,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100183353.1.1.m.54920,-0.0478925176904935,0.00696576426718667,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100184451.1.8.m.30146,-0.0419018828594429,-0.00779993658198205,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367089.1.4.m.1412,-0.0342579616123643,-0.037551280677006,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370323.1.1.m.62024,-0.0118925811221773,-0.0417071420442404,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533367.1.1.m.49626,-0.0485996664966578,0.00386291074113998,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100555907.1.1.m.27452,-0.0542848988067674,-0.0215852628093042,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899149.2.2.m.29105,-0.0400708667192507,-0.00851812121643888,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101033229.1.1.m.38291,-0.0390712171351915,-0.015991215880273,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.3.8.m.3846,-0.0300073356889791,0.03681232837403,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RCOM_1886900.1.1.m.11248,-0.0511209105006822,-0.0208368951106213,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SIP.1.1.m.5725,-0.0452743739974857,0.0253689476290606,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SVIL.1.1.m.1136,-0.0367562630792551,0.00210112048278641,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.3.6.m.29936,-0.0536641547442032,-0.0224723236092165,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_09282.1.1.m.18814,-0.036083406071127,-0.00689421820029541,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.15.22.m.47579,-0.0262952693448872,0.0358419608269382,Yes,darkslategray1,light blue,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100486063.9.9.m.65186,0.0431647066682631,0.0216391921676681,Yes,black,black,A2AX52,Collagen alpha-4(VI) chain,Type VI collagen family,Col6a4 Dvwa,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],GO:0005576; GO:0005581; GO:0007155; GO:0030020; GO:0030198; GO:0031012; GO:0032991; GO:0062023; GO:0070208,GO:0070208,cellular component assembly; protein-containing complex assembly
CHOYP_FABP7.1.2.m.22674,0.00930874455442554,-0.0459911321632199,Yes,black,black,Q09139,Fatty acid-binding protein; brain (Brain-type fatty acid-binding protein) (B-FABP) (Fatty acid-binding protein 7),Calycin superfamily; Fatty-acid binding protein (FABP) family,FABP7,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],GO:0005737; GO:0005911; GO:0008289; GO:0021846; GO:0022008; GO:0042995; GO:0043025; GO:0060134; GO:0071944,GO:0021846; GO:0022008; GO:0060134,cell proliferation; cell differentiation; anatomical structure development; nervous system process
CHOYP_ADA.1.1.m.5625,0.0364382652060006,0.0162170392783055,Yes,black,black,Q6DG22,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Metallo-dependent hydrolases superfamily; Adenosine and AMP deaminases family,ada,cell junction [GO:0030054]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; adenosine deaminase activity [GO:0004000]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168],GO:0004000; GO:0005764; GO:0005829; GO:0005886; GO:0006154; GO:0008270; GO:0009117; GO:0009168; GO:0030054; GO:0043103; GO:0046103; GO:0060205,GO:0009117; GO:0009168,biosynthetic process; cellular nitrogen compound metabolic process; small molecule metabolic process
CHOYP_LOC101069006.1.2.m.5484,0.0391611482893958,-0.00993433699710443,Yes,black,black,Q60648,Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3),,Gm2a,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],GO:0004563; GO:0005319; GO:0005739; GO:0005764; GO:0006689; GO:0007611; GO:0008047; GO:0009313; GO:0009898; GO:0016004; GO:0016323; GO:0016324; GO:0019915; GO:0032428; GO:0050877; GO:0050885; GO:0051345,GO:0006689; GO:0009313; GO:0050885,carbohydrate metabolic process; lipid metabolic process; catabolic process; cellular nitrogen compound metabolic process; nervous system process
CHOYP_ALF.3.3.m.66837,0.040551175525444,-0.0090713549137205,Yes,black,black,P53442,Fructose-bisphosphate aldolase (EC 4.1.2.13),Class I fructose-bisphosphate aldolase family,,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],GO:0004332; GO:0006096,GO:0006096,carbohydrate metabolic process; generation of precursor metabolites and energy; catabolic process; biosynthetic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process; small molecule metabolic process; cofactor metabolic process
CHOYP_LOC657694.1.1.m.34526,-0.00967830790901024,-0.0351430237521811,Yes,black,black,Q9NFT7,Hexokinase type 2 (EC 2.7.1.1),Hexokinase family,Hex-t2 Hex CG32849,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005829; GO:0006000; GO:0006006; GO:0006013; GO:0006096; GO:0008865; GO:0019158,GO:0006000; GO:0006013; GO:0006096,carbohydrate metabolic process; generation of precursor metabolites and energy; catabolic process; biosynthetic process; cellular nitrogen compound metabolic process; nucleobase-containing compound catabolic process; small molecule metabolic process; cofactor metabolic process
CHOYP_CO6A3.2.5.m.39533,0.0172325884109404,-0.0376417209356296,Yes,black,black,P15989,Collagen alpha-3(VI) chain,Type VI collagen family,COL6A3,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],GO:0003429; GO:0004867; GO:0005581; GO:0005615; GO:0007155; GO:0031012,GO:0003429,cell morphogenesis; cell differentiation; growth; anatomical structure development
CHOYP_LOC100373842.4.4.m.40731,0.0466596075256216,0.0141624315612898,Yes,black,black,Q9WV92,Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (DAL1P) (mDAL-1) [Cleaved into: Band 4.1-like protein 3; N-terminally processed],,Epb41l3 Dal1 Epb4.1l3 Kiaa0987,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],GO:0001558; GO:0002175; GO:0003779; GO:0005200; GO:0005737; GO:0005856; GO:0005886; GO:0005911; GO:0006915; GO:0007016; GO:0008360; GO:0014069; GO:0030865; GO:0030866; GO:0030913; GO:0031032; GO:0033270; GO:0043217; GO:0044224; GO:0048812; GO:0071205; GO:0072659,GO:0002175; GO:0007016; GO:0030913; GO:0043217; GO:0071205,plasma membrane organization; cytoskeleton organization; cellular component assembly; cell junction organization; anatomical structure formation involved in morphogenesis; anatomical structure development; membrane organization
CHOYP_SYWC.5.5.m.54889,0.0449387098440127,-0.00517789642851103,Yes,black,black,Q9NQC3,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),,RTN4 KIAA0886 NOGO My043 SP1507,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],GO:0001825; GO:0003723; GO:0005622; GO:0005635; GO:0005783; GO:0005789; GO:0005886; GO:0006915; GO:0007413; GO:0010634; GO:0014069; GO:0021801; GO:0030176; GO:0030308; GO:0030334; GO:0030517; GO:0031625; GO:0033601; GO:0042981; GO:0042995; GO:0043025; GO:0045296; GO:0050771; GO:0050821; GO:0051292; GO:0051897; GO:0060317; GO:0071782; GO:0071786; GO:0071787; GO:0098826; GO:1905552; GO:1905580; GO:1990809; GO:2000172,GO:0001825; GO:0007413; GO:0021801; GO:0030517; GO:0051292; GO:0051897; GO:0060317,cell morphogenesis; signal transduction; embryo development; cellular component assembly; cell differentiation; growth; locomotion; anatomical structure formation involved in morphogenesis; anatomical structure development; cell motility; protein-containing complex assembly
CHOYP_LOC100459096.3.3.m.45135,0.0425992309973315,-0.00531173123301924,Yes,black,black,F1QYJ6,Sulfotransferase 6B1 (EC 2.8.2.-) (Thyroxine sulfotransferase) (EC 2.8.2.n2),Sulfotransferase 1 family,sult6b1,sulfotransferase activity [GO:0008146]; cellular response to xenobiotic stimulus [GO:0071466],GO:0008146; GO:0071466,NA,NA
CHOYP_LOC101156833.1.1.m.38739,0.0505592286012165,0.0195303383502404,Yes,black,black,O13008,Fatty acid-binding protein; heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP),Calycin superfamily; Fatty-acid binding protein (FABP) family,fabp3,cytoplasm [GO:0005737]; lipid binding [GO:0008289],GO:0005737; GO:0008289,NA,NA
CHOYP_GLIPR1L1.1.1.m.41745,0.0502932477612842,0.0239477033720557,Yes,black,black,Q7T141,Peptidase inhibitor 15-A,CRISP family,pi15a pi15 si:rp71-1m12.1,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; multicellular organism development [GO:0007275],GO:0005615; GO:0007275; GO:0030414,NA,NA
CHOYP_LOC100206475.1.16.m.4004,0.040706919101062,0.00638043753178973,Yes,black,black,Q02079,Laccase-3 (EC 1.10.3.2) (Benzenediol:oxygen oxidoreductase 3) (Diphenol oxidase 3) (Urishiol oxidase 3),Multicopper oxidase family,LCC3,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; hydroquinone:oxygen oxidoreductase activity [GO:0052716]; lignin catabolic process [GO:0046274],GO:0005507; GO:0005576; GO:0046274; GO:0052716,NA,NA
CHOYP_LOC100402577.1.1.m.44548,0.0389996266533255,0.0142028512830325,Yes,black,black,P0DMW7,PI-actitoxin-Aeq3b (PI-AITX-Aeq3b) (Kunitz-type proteinase inhibitor AEPI-II),Venom Kunitz-type family; Sea anemone type 2 potassium channel toxin subfamily,,extracellular region [GO:0005576]; nematocyst [GO:0042151]; serine-type endopeptidase inhibitor activity [GO:0004867]; toxin activity [GO:0090729],GO:0004867; GO:0005576; GO:0042151; GO:0090729,NA,NA
CHOYP_CPVL.1.2.m.2978,0.0275374819901077,-0.0433237345990333,Yes,black,black,Q9H3G5,Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase; vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP),Peptidase S10 family,CPVL VLP PSEC0124 UNQ197/PRO223,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],GO:0004185; GO:0051603; GO:0070062,NA,NA
CHOYP_LOC100375029.6.10.m.36981,0.0373395593945075,-0.0093386384933557,Yes,black,black,O17389,Thymosin beta (Tetrathymosin beta),Thymosin beta family,tth-1 F08F1.8,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],GO:0003785; GO:0005829; GO:0005856; GO:0005938; GO:0007015; GO:0030054,NA,NA
CHOYP_RS26.14.15.m.57342,0.0240415463443721,-0.0436470091761477,Yes,black,black,P27085,40S ribosomal protein S26,Eukaryotic ribosomal protein eS26 family,RPS26,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],GO:0002181; GO:0003735; GO:0022627; GO:0042788; GO:0098556,NA,NA
CHOYP_BRAFLDRAFT_67261.1.2.m.16694,0.0464009508126258,0.019325450882008,Yes,black,black,P86179,L-rhamnose-binding lectin CSL3,,,cell [GO:0005623]; cortical granule [GO:0060473]; cytoplasm [GO:0005737]; female germ cell nucleus [GO:0001674]; NLS-dependent protein nuclear import complex [GO:0042564]; galactose binding [GO:0005534]; melibiose binding [GO:1903777]; protein homodimerization activity [GO:0042803]; rhamnose binding [GO:0033296],GO:0001674; GO:0005534; GO:0005623; GO:0005737; GO:0033296; GO:0042564; GO:0042803; GO:0060473; GO:1903777,NA,NA
CHOYP_TPM.17.19.m.63919,0.0513642883066059,0.00543896171022282,Yes,black,black,Q25145,Tropomyosin,Tropomyosin family,,,,NA,NA
CHOYP_BRAFLDRAFT_67226.1.1.m.38034,0.0376042240165985,-0.00261648370619499,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4263,0.0516159376761911,-0.0125226191060244,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CELE_F01D5.5.1.1.m.4265,0.0466155875456483,-0.012134161021814,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004853.m.5555,0.0381017575371913,-0.000146625079461447,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016370.m.19270,0.0419955713796611,-0.00461527211808791,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016567.m.19514,0.04277194077846,0.0232174221796527,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033899.m.38537,0.0474136892947599,0.00928461091656076,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039058.m.44237,0.040118825844818,-0.00272625537554331,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042697.m.49175,0.0362373340186719,-0.0285702059695679,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044803.m.51967,0.014396452201453,-0.0404389044923747,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047190.m.55575,0.0391067878319499,0.0200201563418609,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048495.m.57473,0.0433395623938118,0.0163589847721031,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048721.m.57810,0.0470861676267609,0.0209217661756744,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053683.m.64287,0.044192167711192,0.00752133078159713,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRIM1.2.3.m.5811,0.0523155333776769,-0.0176925295968009,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178400.1.1.m.4321,0.0453233299441675,0.0159895640071552,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181159.1.1.m.6127,0.0404567276184678,-0.0123936475930596,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100535716.2.3.m.39162,0.0389783032840083,-0.00630699000975642,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169658.1.3.m.18820,0.0393838992693783,0.0182216362488642,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWAP.1.1.m.44818,0.037436306489104,0.0165003866819597,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SCE4070.1.1.m.29642,0.0384230842364494,0.0180944667082094,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TENX.1.2.m.12929,0.0448820062412756,0.0100360122652971,Yes,black,black,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_14332.1.2.m.5643,0.000977652442586088,0.00123946358856016,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_14332.2.2.m.61737,-0.00172299453508539,-0.00657938031625213,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_1433E.1.2.m.3638,0.00070970295173485,0.000650918645986543,No,NA,NA,P92177,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; germline ring canal [GO:0045172]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; transcription factor binding [GO:0008134]; axon guidance [GO:0007411]; cytoplasmic sequestering of transcription factor [GO:0042994]; determination of adult lifespan [GO:0008340]; DNA damage checkpoint [GO:0000077]; germarium-derived oocyte fate determination [GO:0007294]; imaginal disc development [GO:0007444]; mitotic cell cycle checkpoint [GO:0007093]; oocyte microtubule cytoskeleton polarization [GO:0008103]; pole cell migration [GO:0007280]; positive regulation of growth [GO:0045927]; positive regulation of hippo signaling [GO:0035332]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of growth [GO:0040008]; regulation of mitotic nuclear division [GO:0007088]; response to radiation [GO:0009314]; response to UV [GO:0009411]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_1433G.2.2.m.63450,0.00203581606079291,-0.000351223840862956,No,NA,NA,P68252,NA,NA,NA,cytoplasm [GO:0005737]; insulin-like growth factor receptor binding [GO:0005159]; protein domain specific binding [GO:0019904]; regulation of neuron differentiation [GO:0045664]; regulation of synaptic plasticity [GO:0048167],NA,NA,NA
CHOYP_1433G.2.2.m.63451,0.00183539224811939,-0.00140659603534708,No,NA,NA,Q4R979,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cap-independent translational initiation [GO:0002190]; cell differentiation [GO:0030154]; circadian regulation of translation [GO:0097167]; entrainment of circadian clock by photoperiod [GO:0043153]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA mediated inhibition of translation [GO:0035278]; mRNA processing [GO:0006397]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; positive regulation of muscle cell differentiation [GO:0051149]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_1433Z.1.1.m.17045,0.000560274856304999,0.0047345019275284,No,NA,NA,Q2F637,NA,NA,NA,cytoplasm [GO:0005737]; protein domain specific binding [GO:0019904],NA,NA,NA
CHOYP_2A5D.2.3.m.32240,0.00606503938560519,-0.00169336006402991,No,NA,NA,Q14738,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_2A5D.3.3.m.37716,-0.000767879420522325,-0.00111837672064575,No,NA,NA,Q14738,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; nervous system development [GO:0007399]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_2AAA.1.1.m.13306,0.0011526652067535,-0.000243069497203562,No,NA,NA,P54612,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_2AAA.1.1.m.13307,0.00347148487317613,-0.00775665020230494,No,NA,NA,P54612,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lateral plasma membrane [GO:0016328]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase regulator activity [GO:0019888]; chromosome segregation [GO:0007059]; protein dephosphorylation [GO:0006470]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_3BP2.2.3.m.19302,-0.00204073892601515,0.00743273636094717,No,NA,NA,Q06649,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_41.2.3.m.31169,-0.00216960763781058,-0.023628313375359,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_4EBP1.1.1.m.12045,0.00235063374194167,0.00113383160506656,No,NA,NA,Q13541,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic initiation factor 4E binding [GO:0008190]; translation repressor activity [GO:0030371]; cellular response to dexamethasone stimulus [GO:0071549]; G1/S transition of mitotic cell cycle [GO:0000082]; insulin receptor signaling pathway [GO:0008286]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; negative regulation of translational initiation [GO:0045947]; positive regulation of mitotic cell cycle [GO:0045931]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_4ET.1.1.m.1941,-0.0128366977755703,0.0155555229007962,No,NA,NA,Q9NRA8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; PML body [GO:0016605]; mRNA binding [GO:0003729]; protein transporter activity [GO:0008565]; RNA binding [GO:0003723]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of translation [GO:0017148]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_5HTR.1.1.m.64867,0.00449302985310361,0.0121420209971083,No,NA,NA,Q25414,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_5NT3.1.1.m.24925,-0.00179541200378568,0.00291650763423751,No,NA,NA,Q5ZKF6,NA,NA,NA,cytoplasm [GO:0005737]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; dephosphorylation [GO:0016311]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_A1CF.1.2.m.8145,-7.60692070422719e-05,0.00588134715453751,No,NA,NA,Q5R9H4,NA,NA,NA,apolipoprotein B mRNA editing enzyme complex [GO:0030895]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; single-stranded RNA binding [GO:0003727]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_A2M.2.3.m.54214,-0.0171857036852869,-0.000635213174703111,No,NA,NA,P20742,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_A4.2.3.m.7550,-0.00804653395618578,0.0204505621435576,No,NA,NA,Q10651,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; heparin binding [GO:0008201]; transition metal ion binding [GO:0046914]; body morphogenesis [GO:0010171]; cell differentiation [GO:0030154]; ecdysis; collagen and cuticulin-based cuticle [GO:0042395]; nematode larval development [GO:0002119]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_A4.3.3.m.22262,0.000399196739804398,-0.00667340721006398,No,NA,NA,Q8CH02,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_AACS.1.1.m.66267,-0.00230501749735325,0.00107251289875368,No,NA,NA,Q28BL6,NA,NA,NA,cytosol [GO:0005829]; acetoacetate-CoA ligase activity [GO:0030729]; ATP binding [GO:0005524]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_AADAT.1.1.m.12672,0.00299522944798257,-0.00114320358387101,No,NA,NA,Q8N5Z0,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2-aminoadipate transaminase activity [GO:0047536]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; 2-oxoglutarate metabolic process [GO:0006103]; alpha-amino acid metabolic process [GO:1901605]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536]; kynurenine metabolic process [GO:0070189]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine catabolic process [GO:0006554]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_AAEL_AAEL000057.1.1.m.36013,0.00287449747909163,-0.000776771320274528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL001424.1.1.m.40785,-0.0248571394831722,-0.00380525525375392,No,NA,NA,Q2KI92,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane peptidase complex [GO:0042720]; serine-type peptidase activity [GO:0008236]; blood circulation [GO:0008015]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum vasculature development [GO:0061300]; mitochondrial respiratory chain complex assembly [GO:0033108]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; respiratory electron transport chain [GO:0022904]; signal peptide processing [GO:0006465]; spermatogenesis [GO:0007283]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_AAEL_AAEL001503.1.1.m.10649,-0.000430770242195839,-0.00646287123148078,No,NA,NA,P48763,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; potassium:proton antiporter activity [GO:0015386]; sodium:proton antiporter activity [GO:0015385]; potassium ion transmembrane transport [GO:0071805]; protein localization [GO:0008104]; regulation of intracellular pH [GO:0051453]; sodium ion import across plasma membrane [GO:0098719],NA,NA,NA
CHOYP_AAEL_AAEL002456.1.1.m.35591,0.0071750614245512,0.0108050893012693,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_AAEL_AAEL002467.1.2.m.47358,0.0167070864338593,-0.0235823131446777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL003539.1.1.m.16619,-0.000380309636206293,-0.00593189980755125,No,NA,NA,Q8BHJ5,NA,NA,NA,histone deacetylase complex [GO:0000118]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; beta-catenin binding [GO:0008013]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein N-terminus binding [GO:0047485]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; adipose tissue development [GO:0060612]; blastocyst hatching [GO:0001835]; fat pad development [GO:0060613]; histone deacetylation [GO:0016575]; lipid catabolic process [GO:0016042]; multicellular organism growth [GO:0035264]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of triglyceride metabolic process [GO:0090207]; response to dietary excess [GO:0002021]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_AAEL_AAEL003853.1.2.m.39529,0.00541535276400275,-0.00115092258095287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL004399.1.1.m.3003,-0.00490092372716104,0.00106765254726154,No,NA,NA,P47799,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; follicle-stimulating hormone receptor activity [GO:0004963]; G protein-coupled peptide receptor activity [GO:0008528]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_AAEL_AAEL004839.1.1.m.13815,-0.0105456513362262,0.00165215803627577,No,NA,NA,Q7TQK0,NA,NA,NA,cyclin/CDK positive transcription elongation factor complex [GO:0008024]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; 7SK snRNA binding [GO:0097322]; chromatin binding [GO:0003682]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase binding [GO:0070063]; transcription coactivator binding [GO:0001223]; cell cycle [GO:0007049]; cell division [GO:0051301]; early viral transcription [GO:0019085]; late viral transcription [GO:0019086]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle tissue development [GO:0007519]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAEL_AAEL005197.1.1.m.59507,-0.000539707883022483,-0.0024967719062859,No,NA,NA,Q9HB90,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; positive regulation of TOR signaling [GO:0032008]; regulation of autophagy [GO:0010506]; regulation of macroautophagy [GO:0016241]; regulation of TOR signaling [GO:0032006]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200]; RNA splicing [GO:0008380]; small GTPase mediated signal transduction [GO:0007264]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAEL_AAEL006854.1.1.m.13363,-0.00170530788118004,6.63013688966932e-05,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_AAEL_AAEL006988.1.1.m.49733,-0.00152323865467586,-0.00104082604048799,No,NA,NA,Q91857,NA,NA,NA,MLL1 complex [GO:0071339]; SAGA complex [GO:0000124]; SLIK (SAGA-like) complex [GO:0046695]; transcription factor TFIID complex [GO:0005669]; protein heterodimerization activity [GO:0046982]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_AAEL_AAEL007173.1.1.m.41471,0.0259019095020654,-0.0262623837177658,No,NA,NA,O43399,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AAEL_AAEL007437.1.1.m.29443,0.00433891680103474,0.0120890878937155,No,NA,NA,P86948,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_AAEL_AAEL007549.1.1.m.13827,-0.0129121496364578,-0.00821726015519087,No,NA,NA,Q9D9G2,NA,NA,NA,lysosome [GO:0005764],NA,NA,NA
CHOYP_AAEL_AAEL007787.1.1.m.13188,-0.012232268229631,0.00886361061621558,No,NA,NA,P13195,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5-aminolevulinate synthase activity [GO:0003870]; pyridoxal phosphate binding [GO:0030170]; cellular response to insulin stimulus [GO:0032869]; cellular response to organic cyclic compound [GO:0071407]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to cAMP [GO:0051591]; response to cobalt ion [GO:0032025]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to gonadotropin [GO:0034698]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to nickel cation [GO:0010045]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to platinum ion [GO:0070541],NA,NA,NA
CHOYP_AAEL_AAEL008069.1.2.m.58164,0.00566041758347929,0.00773701376152273,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60920,0.0153747845383687,-3.33344717685576e-05,No,NA,NA,P46531,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AAEL_AAEL008069.2.2.m.60921,0.0146905549827638,0.0184645215539331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL008257.2.3.m.36861,0.00416160577734534,-0.00704066349329465,No,NA,NA,P48809,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P granule [GO:0043186]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; axon guidance [GO:0007411]; negative regulation of oskar mRNA translation [GO:0007319]; pole plasm oskar mRNA localization [GO:0045451]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; regulation of mRNA splicing; via spliceosome [GO:0048024]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_AAEL_AAEL009169.1.1.m.24699,-0.00342756939873892,-0.00044571902491485,No,NA,NA,Q3TZZ7,NA,NA,NA,endoplasmic reticulum-plasma membrane contact site [GO:0140268]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; integral component of plasma membrane [GO:0005887]; intrinsic component of endoplasmic reticulum membrane [GO:0031227]; organelle membrane contact site [GO:0044232]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endoplasmic reticulum-plasma membrane tethering [GO:0061817]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_AAEL_AAEL009187.1.1.m.25730,0.00041971621432251,0.0044979143575507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL009387.1.1.m.66163,-0.00116235689698661,-0.00188234275082209,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_AAEL_AAEL009414.1.1.m.639,-0.0008545139242965,-0.00102289211358115,No,NA,NA,Q5BK63,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; NADH dehydrogenase activity [GO:0003954]; protein-containing complex binding [GO:0044877]; circadian rhythm [GO:0007623]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to glucose [GO:0009749]; ubiquinone-6 biosynthetic process [GO:1901006],NA,NA,NA
CHOYP_AAEL_AAEL010339.1.1.m.63259,-0.0191222163721963,-0.0156302879276524,No,NA,NA,Q8R035,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; aminoacyl-tRNA hydrolase activity [GO:0004045]; translation release factor activity; codon nonspecific [GO:0016150]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_AAEL_AAEL010626.1.1.m.52019,0.00586779328997207,-0.0106528766453952,No,NA,NA,P56719,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_AAEL_AAEL010939.1.1.m.64870,-0.00496371345125912,-0.0122608535741957,No,NA,NA,Q66HY8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_AAEL_AAEL011273.1.1.m.12717,-0.00129810107525146,0.000848228606190024,No,NA,NA,Q9NWZ5,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CTP salvage [GO:0044211]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; viral process [GO:0016032],NA,NA,NA
CHOYP_AAEL_AAEL011391.1.1.m.10090,0.000508679238733641,0.0029302202906527,No,NA,NA,Q58DQ5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; translation [GO:0006412],NA,NA,NA
CHOYP_AAEL_AAEL011527.1.1.m.20909,0.000557208748820449,0.000790330492964386,No,NA,NA,Q99L45,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2 complex [GO:0005850]; metal ion binding [GO:0046872]; translation initiation factor activity [GO:0003743]; in utero embryonic development [GO:0001701]; male germ cell proliferation [GO:0002176]; male gonad development [GO:0008584],NA,NA,NA
CHOYP_AAEL_AAEL011814.1.1.m.48797,-0.00382867793807539,0.00866953899744633,No,NA,NA,P82924,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AAEL_AAEL011979.1.1.m.59057,0.00130543229033116,0.00311771213655229,No,NA,NA,Q91WQ9,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_AAEL_AAEL012012.1.1.m.11873,0.0138995681820087,0.00791750810663809,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL012950.1.1.m.1373,-0.00482077074694443,0.00454646673158723,No,NA,NA,P91929,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_AAEL_AAEL013229.1.2.m.30359,0,0,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_AAEL_AAEL013229.2.2.m.57593,-0.00778263676126487,-0.000696578877090774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AAEL_AAEL014931.1.1.m.24932,0.00350273374742128,0.0109006007858788,No,NA,NA,Q6IDD9,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AAEL_AAEL015271.1.1.m.56223,-0.00744269714331748,-0.0116285695781439,No,NA,NA,P15153,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; nuclear envelope [GO:0005635]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; protein kinase regulator activity [GO:0019887]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell projection assembly [GO:0030031]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte aggregation [GO:0071593]; neuron projection morphogenesis [GO:0048812]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rac protein signal transduction [GO:0016601]; regulation of cell-substrate adhesion [GO:0010810]; regulation of hydrogen peroxide metabolic process [GO:0010310]; regulation of mast cell chemotaxis [GO:0060753]; regulation of mast cell degranulation [GO:0043304]; regulation of neutrophil migration [GO:1902622]; regulation of respiratory burst [GO:0060263]; regulation of small GTPase mediated signal transduction [GO:0051056]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AAK1.1.1.m.14768,-0.00802850353661043,0.00945131538572788,No,NA,NA,Q2M2I8,NA,NA,NA,cell leading edge [GO:0031252]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; nucleus [GO:0005634]; terminal bouton [GO:0043195]; AP-2 adaptor complex binding [GO:0035612]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; positive regulation of Notch signaling pathway [GO:0045747]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of clathrin-dependent endocytosis [GO:2000369]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_AAK1.1.1.m.14769,-0.00571852894109932,-0.0215162975402396,No,NA,NA,Q9UBL3,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nuclear euchromatin [GO:0005719]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; beta-catenin binding [GO:0008013]; euchromatin binding [GO:1990188]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; hemopoiesis [GO:0030097]; histone H3-K4 methylation [GO:0051568]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355]; response to estrogen [GO:0043627]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_AAKG2.1.1.m.55638,0.0106425008135631,-0.0118834051778936,No,NA,NA,Q9UGJ0,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; cAMP-dependent protein kinase inhibitor activity [GO:0004862]; cAMP-dependent protein kinase regulator activity [GO:0008603]; phosphorylase kinase regulator activity [GO:0008607]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; ATP biosynthetic process [GO:0006754]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; glycogen metabolic process [GO:0005977]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein kinase activity [GO:0045860]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; regulation of fatty acid oxidation [GO:0046320]; regulation of glucose import [GO:0046324]; regulation of glycolytic process [GO:0006110]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_AAMP.1.1.m.13698,0.0217940799616876,-0.0111005134334116,No,NA,NA,Q13685,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; positive regulation of endothelial cell migration [GO:0010595]; ribosomal large subunit biogenesis [GO:0042273]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_AASI_1435.2.35.m.17918,0.00604817924627315,-0.00187276723045558,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_AASI_1435.28.35.m.60443,0.00769147418022098,-0.0100281390524203,No,NA,NA,O70511,NA,NA,NA,axon initial segment [GO:0043194]; cell surface [GO:0009986]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; cellular response to magnesium ion [GO:0071286]; magnesium ion homeostasis [GO:0010960]; membrane assembly [GO:0071709]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AASI_1435.35.35.m.65339,-0.00284842625809869,-0.0122600929897782,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_AATF.1.1.m.34004,0.000134783524393238,0.00367994048325808,No,NA,NA,Q5ZIM6,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; leucine zipper domain binding [GO:0043522]; cell adhesion [GO:0007155]; cellular response to DNA damage stimulus [GO:0006974]; embryonic cleavage [GO:0040016]; negative regulation of amyloid precursor protein biosynthetic process [GO:0042985]; negative regulation of apoptotic process [GO:0043066]; negative regulation of superoxide anion generation [GO:0032929]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_AATM.1.1.m.32176,0.0010977201991004,0.00159942436126896,No,NA,NA,Q28F67,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; biosynthetic process [GO:0009058]; glutamate metabolic process [GO:0006536],NA,NA,NA
CHOYP_ABCA1.1.3.m.6501,0.00161881645415383,0.00514825969474245,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCA1.3.3.m.56453,-0.00118694634821801,0.00585481233975445,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCA3.2.6.m.4295,-0.00497205131052454,-0.00316420118058252,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABCA3.5.6.m.54787,-0.00499280332890863,0.00221152674674769,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABCA4.1.1.m.31461,0.000589916328318014,0.00151854291324805,No,NA,NA,P41233,NA,NA,NA,cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; lysosome organization [GO:0007040]; peptide secretion [GO:0002790]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; phospholipid transport [GO:0015914]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_ABCB6.2.3.m.11344,0.00155602708577343,-0.0021649447007545,No,NA,NA,O94760,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; catalytic activity [GO:0003824]; dimethylargininase activity [GO:0016403]; metal ion binding [GO:0046872]; arginine catabolic process [GO:0006527]; arginine metabolic process [GO:0006525]; citrulline metabolic process [GO:0000052]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of vascular permeability [GO:0043116]; nitric oxide mediated signal transduction [GO:0007263]; positive regulation of angiogenesis [GO:0045766]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ABCB6.3.3.m.53101,0.00238555285833955,-0.00064464451850647,No,NA,NA,Q08D64,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626],NA,NA,NA
CHOYP_ABCE1.1.2.m.7437,0.00183374048217923,-0.00419319379620473,No,NA,NA,P61222,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415],NA,NA,NA
CHOYP_ABCE1.2.2.m.42246,-0.00487217261387878,-0.00186581432117811,No,NA,NA,P61222,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; endoribonuclease inhibitor activity [GO:0060698]; iron ion binding [GO:0005506]; ribosomal small subunit binding [GO:0043024]; negative regulation of endoribonuclease activity [GO:0060702]; ribosomal subunit export from nucleus [GO:0000054]; translational initiation [GO:0006413]; translational termination [GO:0006415],NA,NA,NA
CHOYP_ABCF2.1.2.m.28360,-0.00561419490753224,0.00707373555186731,No,NA,NA,Q99LE6,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_ABCF2.1.2.m.28362,2.92083440666224e-05,0.00475066964190231,No,NA,NA,P79781,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_ABCG8.1.1.m.3707,0.00334236979211298,0.00394725274040513,No,NA,NA,Q9H222,NA,NA,NA,apical plasma membrane [GO:0016324]; ATP-binding cassette (ABC) transporter complex [GO:0043190]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cholesterol transporter activity [GO:0017127]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; excretion [GO:0007588]; intestinal cholesterol absorption [GO:0030299]; negative regulation of intestinal cholesterol absorption [GO:0045796]; negative regulation of intestinal phytosterol absorption [GO:0010949]; response to drug [GO:0042493]; response to ionizing radiation [GO:0010212]; response to nutrient [GO:0007584]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ABHD2.2.2.m.32276,-0.00162832950888015,0.00118701337487143,No,NA,NA,Q9QXM0,NA,NA,NA,acrosomal membrane [GO:0002080]; acrosomal vesicle [GO:0001669]; integral component of membrane [GO:0016021]; sperm flagellum [GO:0036126]; sperm plasma membrane [GO:0097524]; acylglycerol lipase activity [GO:0047372]; hormone binding [GO:0042562]; lipase activity [GO:0016298]; short-chain carboxylesterase activity [GO:0034338]; steroid hormone receptor activity [GO:0003707]; acrosome reaction [GO:0007340]; acylglycerol catabolic process [GO:0046464]; cellular lipid metabolic process [GO:0044255]; medium-chain fatty acid biosynthetic process [GO:0051792]; medium-chain fatty acid catabolic process [GO:0051793]; negative regulation of cell migration [GO:0030336]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; sperm capacitation [GO:0048240]; steroid hormone mediated signaling pathway [GO:0043401],NA,NA,NA
CHOYP_ABI2.2.2.m.65629,-0.00206176587543418,-0.00361622517813794,No,NA,NA,Q9QZM5,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein tyrosine kinase activator activity [GO:0030296]; SH3 domain binding [GO:0017124]; transcription factor binding [GO:0008134]; actin polymerization or depolymerization [GO:0008154]; postsynapse to nucleus signaling pathway [GO:0099527],NA,NA,NA
CHOYP_ABL1.1.1.m.55647,0.00231082719148131,-0.0137004347886949,No,NA,NA,P00522,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; axon [GO:0030424]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; muscle tendon junction [GO:0005927]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; axis elongation [GO:0003401]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; branchiomotor neuron axon guidance [GO:0021785]; cell differentiation [GO:0030154]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; compound eye development [GO:0048749]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; dendrite morphogenesis [GO:0048813]; dorsal closure [GO:0007391]; epithelial cell morphogenesis [GO:0003382]; learning or memory [GO:0007611]; morphogenesis of an epithelium [GO:0002009]; motor neuron axon guidance [GO:0008045]; negative regulation of neuron projection development [GO:0010977]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; neuron migration [GO:0001764]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; photoreceptor cell axon guidance [GO:0072499]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein export from nucleus [GO:0046827]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ventral cord development [GO:0007419]; ventral furrow formation [GO:0007370],NA,NA,NA
CHOYP_ACA1_060860.1.1.m.52568,0.00216396426859508,0.00605909050884323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACA1_394750.1.2.m.54181,0.021248705528143,-0.0154470743827707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACAA2.1.1.m.30666,-7.05917659357567e-05,0.000331907021276716,No,NA,NA,Q3T0R7,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029],NA,NA,NA
CHOYP_ACAC.1.2.m.16888,-0.0015859408032912,-0.000664837825118493,No,NA,NA,P11029,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression; epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810],NA,NA,NA
CHOYP_ACAC.2.2.m.58115,-0.0137453690758624,-0.00874751894963808,No,NA,NA,P11029,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; acetyl-CoA carboxylase activity [GO:0003989]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; DBD domain binding [GO:0050692]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; sterol response element binding [GO:0032810]; thyroid hormone receptor binding [GO:0046966]; fatty acid biosynthetic process [GO:0006633]; malonyl-CoA biosynthetic process [GO:2001295]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of biological quality [GO:0065008]; regulation of gene expression; epigenetic [GO:0040029]; response to carbohydrate [GO:0009743]; response to fatty acid [GO:0070542]; response to thyroid hormone [GO:0097066]; transport [GO:0006810],NA,NA,NA
CHOYP_ACAD8.1.1.m.9135,-9.92476385214668e-05,-0.00207387868323825,No,NA,NA,Q9D7B6,NA,NA,NA,mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; lipid metabolic process [GO:0006629]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_ACADL.1.1.m.5508,-0.000157781737165321,0.000776540536255059,No,NA,NA,P51174,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; palmitoyl-CoA oxidase activity [GO:0016401]; carnitine catabolic process [GO:0042413]; carnitine metabolic process; CoA-linked [GO:0019254]; cellular lipid catabolic process [GO:0044242]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty acid catabolic process [GO:0009062]; long-chain fatty acid catabolic process [GO:0042758]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; oxidation-reduction process [GO:0055114]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ACBD5.1.2.m.16744,-0.00556080027292649,0.0188478298931338,No,NA,NA,Q5T8D3,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; autophagy of peroxisome [GO:0030242]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_ACBP.1.4.m.15501,-0.000189420580077167,0.000946251555068048,No,NA,NA,Q9PRL8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_ACDOPBH.1.9.m.8787,-0.00400110118046153,-0.00224721834557917,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.5.9.m.42992,0.0137904451787908,0.0121223697390554,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.8.9.m.52946,-0.000100735879212512,0.0133652271190591,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_ACDOPBH.9.9.m.63296,-0.00275297389328116,0.00373737337375753,No,NA,NA,Q98ST7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_ACE.2.4.m.5302,0.015148300702752,-0.000130829780996908,No,NA,NA,Q10751,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; exopeptidase activity [GO:0008238]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; positive regulation of blood pressure [GO:0045777]; positive regulation of systemic arterial blood pressure [GO:0003084]; primitive erythrocyte differentiation [GO:0060319]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ACE.4.4.m.17563,-0.00921620706022992,-0.00586517142305918,No,NA,NA,P09470,NA,NA,NA,basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; dipeptidyl-peptidase activity [GO:0008239]; drug binding [GO:0008144]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidase activity [GO:0008233]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ regeneration [GO:0031100]; arachidonic acid secretion [GO:0050482]; bradykinin catabolic process [GO:0010815]; cell proliferation in bone marrow [GO:0071838]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; heart contraction [GO:0060047]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; peptide metabolic process [GO:0006518]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood pressure [GO:0045777]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; response to lipopolysaccharide [GO:0032496]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_ACH5.1.1.m.3951,0.00362046420388435,-0.000978352835622114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACH7.2.2.m.66217,-0.0145606610317514,-0.00439103304889074,No,NA,NA,Q27218,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; inorganic cation transmembrane transport [GO:0098662]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of locomotion [GO:0040012]; regulation of membrane potential [GO:0042391]; regulation of oviposition [GO:0046662]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ACIN1A.2.2.m.51408,-0.000477913150893502,0.00857183180744091,No,NA,NA,Q9JIX8,NA,NA,NA,ASAP complex [GO:0061574]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; apoptotic chromosome condensation [GO:0030263]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; positive regulation of monocyte differentiation [GO:0045657]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ACL6B.1.1.m.62588,-0.00316593100853664,0.00257519418437302,No,NA,NA,O94805,NA,NA,NA,nBAF complex [GO:0071565]; nucleolus [GO:0005730]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; structural constituent of cytoskeleton [GO:0005200]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_ACLA_093460.1.1.m.41459,0.00318378362501215,-0.00725864562166006,No,NA,NA,O36022,NA,NA,NA,alpha-1;6-mannosyltransferase complex [GO:0000136]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; cell wall mannoprotein biosynthetic process [GO:0000032]; mannosylation [GO:0097502]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_ACLY.1.1.m.65081,0.000572039246540592,0.000553919807202482,No,NA,NA,Q91V92,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_ACO13.1.1.m.30659,0.00706073299516164,0.0214561585718843,No,NA,NA,Q5R833,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; spindle [GO:0005819]; acyl-CoA hydrolase activity [GO:0047617],NA,NA,NA
CHOYP_ACON.1.1.m.61060,0.00032222391974215,-5.30076934364795e-05,No,NA,NA,Q99798,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron ion binding [GO:0005506]; citrate metabolic process [GO:0006101]; generation of precursor metabolites and energy [GO:0006091]; isocitrate metabolic process [GO:0006102]; liver development [GO:0001889]; response to isolation stress [GO:0035900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ACOX1.3.3.m.26948,0.00864380397107238,0.00773553805230885,No,NA,NA,Q9R0H0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]; cholesterol homeostasis [GO:0042632]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; peroxisome fission [GO:0016559]; prostaglandin metabolic process [GO:0006693]; spermatogenesis [GO:0007283]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ACOX3.1.1.m.60111,-0.0027956538351575,-0.00659027314512997,No,NA,NA,O15254,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; pristanoyl-CoA oxidase activity [GO:0016402]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ACSA.1.1.m.61294,0.0020658581087299,4.78587336342408e-05,No,NA,NA,Q9VP61,NA,NA,NA,cytoplasm [GO:0005737]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; short-chain fatty acid-CoA ligase activity [GO:0031955]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; behavioral response to ethanol [GO:0048149]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_ACSF2.2.4.m.30204,-0.0140217237387193,-0.00892339037490284,No,NA,NA,Q0P4F7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_ACSF3.1.1.m.14825,-0.0175002409036263,-0.0111371101119814,No,NA,NA,Q58DN7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; malonyl-CoA synthetase activity [GO:0090409]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; fatty acid biosynthetic process [GO:0006633]; malonate catabolic process [GO:0090410],NA,NA,NA
CHOYP_ACSL1.1.1.m.685,0.000483156482667147,0.00217496387334436,No,NA,NA,Q9JID6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; peroxisomal membrane [GO:0005778]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_ACSL1.1.1.m.686,-0.00243099367585635,-0.00684486559179801,No,NA,NA,Q54TR1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_ACSL4.1.1.m.24576,-0.00242957898224461,0.00508325165968949,No,NA,NA,Q9QUJ7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; arachidonate-CoA ligase activity [GO:0047676]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; dendritic spine development [GO:0060996]; embryonic process involved in female pregnancy [GO:0060136]; fatty acid transport [GO:0015908]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; negative regulation of prostaglandin secretion [GO:0032307]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; regulation of fatty acid metabolic process [GO:0019217]; response to interleukin-15 [GO:0070672]; response to nutrient [GO:0007584]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_ACSM3.1.1.m.23686,0.0191007959161806,-0.0260973931310689,No,NA,NA,Q3UNX5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA ligase activity [GO:0003996]; ATP binding [GO:0005524]; butyrate-CoA ligase activity [GO:0047760]; fatty acid ligase activity [GO:0015645]; fatty-acyl-CoA synthase activity [GO:0004321]; metal ion binding [GO:0046872]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_ACSS3.1.1.m.64144,-0.0109313963307106,0.0176858284525073,No,NA,NA,Q5REB8,NA,NA,NA,mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.13.27.m.39351,0.0132453705263573,0.0156424418480616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ACT.19.27.m.53936,0.00159387165136044,0.000430548850154656,No,NA,NA,Q5R9Z1,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ACT.22.27.m.58204,0.0132973253580772,0.0157037991677597,No,NA,NA,P10994,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.23.27.m.58454,0.0207488769969432,0.0034773488832601,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.4.27.m.14034,-0.00815964113333742,0.0063999692866272,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT.5.27.m.15585,-0.0332825759380049,-0.0211809491693987,No,NA,NA,Q26065,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT1.3.7.m.25836,-0.0279079662776368,-0.00486623509668644,No,NA,NA,P53470,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT1.4.7.m.29125,-0.000782550315323168,0.0139704252295857,No,NA,NA,P02578,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3.1.3.m.23292,0.00969132025200572,-0.017594423333227,No,NA,NA,P41340,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3.3.3.m.66907,0.00234211313491591,0.000686290300917301,No,NA,NA,Q25010,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3A.1.1.m.25941,-0.0232381928426678,0.0131247492896619,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACT3A.1.1.m.25943,0.00105447521798966,0.00119532050766926,No,NA,NA,P52503,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; cardiovascular system development [GO:0072358]; fatty acid metabolic process [GO:0006631]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrion morphogenesis [GO:0070584]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; muscle contraction [GO:0006936]; reproductive system development [GO:0061458]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_ACT5.3.3.m.41147,-0.00130283989120627,0.0023928205436744,No,NA,NA,P53505,NA,NA,NA,cytoskeleton [GO:0005856]; dense body [GO:0097433]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTC.2.6.m.15315,-0.0115204881115124,0.00264123100311653,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTC.3.6.m.21571,-0.000422265563184819,-0.00970864357667134,No,NA,NA,P17126,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_ACTN.1.2.m.15252,0.00132215009195907,-0.000697739288071166,No,NA,NA,L7UZ85,NA,NA,NA,actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; IgE binding [GO:0019863]; actin filament bundle assembly [GO:0051017],NA,NA,NA
CHOYP_ACTN.2.2.m.63975,0.00496456025782177,0.0058630179487725,No,NA,NA,P18091,NA,NA,NA,focal adhesion [GO:0005925]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; cytoskeletal anchoring at plasma membrane [GO:0007016]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_ACTP1.1.1.m.30455,0.0061043052986922,0.0191856495140703,No,NA,NA,Q5UCA8,NA,NA,NA,extrinsic component of membrane [GO:0019898]; pore complex [GO:0046930]; channel activity [GO:0015267]; cation transport [GO:0006812]; hemolysis in other organism involved in symbiotic interaction [GO:0052331]; pore complex assembly [GO:0046931],NA,NA,NA
CHOYP_ACTZ.1.1.m.12877,0.00330696455752518,-0.00275428797806696,No,NA,NA,P85515,NA,NA,NA,cell cortex region [GO:0099738]; centriole [GO:0005814]; centrosome [GO:0005813]; COPI-coated vesicle [GO:0030137]; dynactin complex [GO:0005869]; manchette [GO:0002177]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ADA17.1.3.m.798,-0.00034429445791342,-0.0232890449290573,No,NA,NA,Q568K2,NA,NA,NA,nucleus [GO:0005634]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; ubiquitin protein ligase activity [GO:0061630]; defense response to Gram-positive bacterium [GO:0050830]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein dephosphorylation [GO:0035308]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ADAL.1.1.m.57556,-0.00410223712961647,-0.00728306466085185,No,NA,NA,Q4V9P6,NA,NA,NA,adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ADAMTS12.1.2.m.29930,-0.0174520598263543,-0.0102401461770872,No,NA,NA,Q9UKP5,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976],NA,NA,NA
CHOYP_ADAMTS18.1.2.m.4932,0.00184245649228465,0.00364491547272423,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ADAR.2.3.m.45677,-0.0132646292347959,-0.0084415773014826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ADD.2.5.m.15081,-0.0104516774089581,0.0297810496876483,No,NA,NA,Q02645,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation; actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724],NA,NA,NA
CHOYP_ADD.3.5.m.17639,0.0331298527172854,-0.000963892386113786,No,NA,NA,Q02645,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; female germline ring canal inner rim [GO:0035183]; fusome [GO:0045169]; germline ring canal [GO:0045172]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; spectrosome [GO:0045170]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; structural molecule activity [GO:0005198]; actin filament bundle assembly [GO:0051017]; actin filament bundle organization [GO:0061572]; adult somatic muscle development [GO:0007527]; axon guidance [GO:0007411]; barbed-end actin filament capping [GO:0051016]; centrosome cycle [GO:0007098]; cystoblast division [GO:0007282]; female germ-line cyst formation [GO:0048135]; female germline ring canal formation; actin assembly [GO:0008302]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived oocyte fate determination [GO:0007294]; meiotic spindle organization [GO:0000212]; oogenesis [GO:0048477]; ovarian fusome organization [GO:0030723]; photoreceptor cell axon guidance [GO:0072499]; sarcomere organization [GO:0045214]; testicular fusome organization [GO:0030724],NA,NA,NA
CHOYP_ADHX.1.1.m.60159,0.00233296275095847,0.000957602428154269,No,NA,NA,P81431,NA,NA,NA,cytoplasm [GO:0005737]; alcohol dehydrogenase (NAD) activity [GO:0004022]; S-(hydroxymethyl)glutathione dehydrogenase activity [GO:0051903]; zinc ion binding [GO:0008270]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_AFG32.1.1.m.59372,0.00445186036644865,-0.000692738506921123,No,NA,NA,Q9Y4W6,NA,NA,NA,m-AAA complex [GO:0005745]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]; axonogenesis [GO:0007409]; calcium import into the mitochondrion [GO:0036444]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial fusion [GO:0008053]; mitochondrial protein processing [GO:0034982]; muscle fiber development [GO:0048747]; myelination [GO:0042552]; nerve development [GO:0021675]; neuromuscular junction development [GO:0007528]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of multicellular organism growth [GO:0040014]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_AFG32.1.1.m.59373,0.00756379902502295,0.00439098359458478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AFUA_1G01020.33.50.m.43179,-0.00374367147061875,0.0060964723371446,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AFUA_1G01020.7.50.m.19296,-0.0115447998540162,-0.00734708212892786,No,NA,NA,Q8Q0U0,NA,NA,NA,,NA,NA,NA
CHOYP_AFURIN2.1.1.m.59865,-0.00217051101370282,-0.0024529532959025,No,NA,NA,Q92824,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; serine-type endopeptidase activity [GO:0004252]; anterior/posterior pattern specification [GO:0009952]; cardiac septum development [GO:0003279]; cell-cell signaling [GO:0007267]; coronary vasculature development [GO:0060976]; cytokine biosynthetic process [GO:0042089]; determination of left/right symmetry [GO:0007368]; embryo implantation [GO:0007566]; embryonic digestive tract development [GO:0048566]; embryonic skeletal system development [GO:0048706]; heart development [GO:0007507]; kidney development [GO:0001822]; limb morphogenesis [GO:0035108]; peptide biosynthetic process [GO:0043043]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485]; regulation of lipoprotein lipase activity [GO:0051004]; renin secretion into blood stream [GO:0002001]; respiratory tube development [GO:0030323]; signal peptide processing [GO:0006465]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_AGAP_AGAP000232.1.1.m.1999,-0.00172833084511122,-0.0188689252775037,No,NA,NA,Q9Z2H2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; negative regulation of signal transduction [GO:0009968]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_AGAP_AGAP000991.1.1.m.5123,0.000118734317081371,0.00317476492299749,No,NA,NA,Q9JJL8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; serine-tRNA ligase activity [GO:0004828]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_AGAP_AGAP002199.1.1.m.25337,-0.0242279110526401,0.0106827440420115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37286,0.00454303430487172,0.0031688774162002,No,NA,NA,Q9XZ71,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_AGAP_AGAP002350.1.1.m.37287,0.00821634441249198,-0.000682580562358605,No,NA,NA,P53683,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777],NA,NA,NA
CHOYP_AGAP_AGAP002739.1.5.m.19925,0.00184908452231315,0.00420747081001448,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_AGAP_AGAP002739.3.5.m.47030,0.0166152842711545,-0.00567356122337099,No,NA,NA,A2RUV0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AGAP_AGAP002739.4.5.m.55695,-0.00239988571116952,-0.00393400145416244,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_AGAP_AGAP002739.5.5.m.60925,0.00206145435590941,0.00285088801288738,No,NA,NA,P46531,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; regulation of transcription; DNA-templated [GO:0006355]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; transcription initiation from RNA polymerase II promoter [GO:0006367]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_AGAP_AGAP004136.1.3.m.24172,-0.00550869750401946,0.00834260538065529,No,NA,NA,Q8BGS1,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44418,-0.00115360250843776,-0.00904736093094599,No,NA,NA,Q8BGS1,NA,NA,NA,cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904]; actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of protein binding [GO:0032091]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein binding [GO:0032092]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration; cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826],NA,NA,NA
CHOYP_AGAP_AGAP004136.3.3.m.44420,0.00276882061593897,-0.00289955679755983,No,NA,NA,P62864,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_AGAP_AGAP004179.1.1.m.33303,-0.0036329752547615,-0.0177234405146607,No,NA,NA,Q86XE3,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; mitochondrial calcium ion transmembrane transport [GO:0006851],NA,NA,NA
CHOYP_AGAP_AGAP004481.1.1.m.8676,-0.0198719337564462,0.00476052698732336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP004499.1.1.m.13546,0.0110663281089174,-0.00624935802458958,No,NA,NA,Q96JP0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_AGAP_AGAP004861.2.2.m.54567,-0.00355415967294571,0.0161702097331043,No,NA,NA,P28648,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; epithelial cell differentiation [GO:0030855]; negative regulation of epithelial cell migration [GO:0010633]; pigment granule maturation [GO:0048757]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_AGAP_AGAP004868.1.1.m.60336,-0.00720273856646429,0.000435398365679274,No,NA,NA,O43399,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_AGAP_AGAP004885.1.1.m.29831,-0.0104228783781484,-0.01191765927422,No,NA,NA,B1AR13,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein maturation by [2Fe-2S] cluster transfer [GO:0106034],NA,NA,NA
CHOYP_AGAP_AGAP005057.1.1.m.62428,0.012534349491665,0.023147222926983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP005942.1.3.m.3157,0.000369017405963101,0.00199778949748314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP006478.1.1.m.44472,-0.00392565441040678,0.00139967236548716,No,NA,NA,Q80TB8,NA,NA,NA,oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_AGAP_AGAP006590.1.1.m.42108,-0.00381436502196096,0.00162747927558717,No,NA,NA,P91620,NA,NA,NA,cell junction [GO:0030054]; synapse [GO:0045202]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; actin cytoskeleton organization [GO:0030036]; intracellular signal transduction [GO:0035556]; positive regulation of filopodium assembly [GO:0051491]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of synapse structure or activity [GO:0050803],NA,NA,NA
CHOYP_AGAP_AGAP006810.1.2.m.12514,-0.00395505329917586,0.00536928843684539,No,NA,NA,Q68ER9,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; NuA3a histone acetyltransferase complex [GO:1990467]; NuA3b histone acetyltransferase complex [GO:1990468]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleolus [GO:0005730]; histone H2A acetylation [GO:0043968]; histone H3-K14 acetylation [GO:0044154]; histone H3-K23 acetylation [GO:0043972]; histone H4-K12 acetylation [GO:0043983]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_AGAP_AGAP007120.1.1.m.57542,0.00213489153484737,-0.00250830992575671,No,NA,NA,Q01768,NA,NA,NA,cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamellipodium [GO:0030027]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; drug binding [GO:0008144]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; G-quadruplex DNA binding [GO:0051880]; GDP binding [GO:0019003]; intermediate filament binding [GO:0019215]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; protein histidine kinase activity [GO:0004673]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to fatty acid [GO:0071398]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of apoptotic process [GO:0043066]; negative regulation of myeloid leukocyte differentiation [GO:0002762]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; regulation of epidermis development [GO:0045682]; response to growth hormone [GO:0060416]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_AGAP_AGAP007340.1.2.m.2953,-0.0155109675774484,-0.000699276202699263,No,NA,NA,P11167,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; cell-cell junction [GO:0005911]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; melanosome [GO:0042470]; midbody [GO:0030496]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; Z disc [GO:0030018]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein self-association [GO:0043621]; xenobiotic transmembrane transporter activity [GO:0042910]; cellular hyperosmotic response [GO:0071474]; cellular response to glucose starvation [GO:0042149]; cellular response to mechanical stimulus [GO:0071260]; cerebral cortex development [GO:0021987]; dehydroascorbic acid transport [GO:0070837]; female pregnancy [GO:0007565]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to osmotic stress [GO:0006970]; response to Thyroglobulin triiodothyronine [GO:1904016]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_AGAP_AGAP007368.1.1.m.8474,0.0113222141414562,0.018200058422765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP007681.1.1.m.36727,-0.0106013821116184,-0.00674669340647865,No,NA,NA,P55040,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium channel regulator activity [GO:0005246]; calmodulin binding [GO:0005516]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; cell surface receptor signaling pathway [GO:0007166]; chromosome organization [GO:0051276]; immune response [GO:0006955]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGAP_AGAP008046.1.1.m.58394,0.00202655644308158,-0.00407864628614721,No,NA,NA,Q4V920,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; cytoskeletal protein binding [GO:0008092]; phospholipid binding [GO:0005543]; actin filament organization [GO:0007015]; auditory receptor cell stereocilium organization [GO:0060088]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; neuron projection morphogenesis [GO:0048812]; plasma membrane tubulation [GO:0097320]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_AGAP_AGAP008287.1.1.m.58727,0.00149660876635829,0.00106938645425462,No,NA,NA,Q8AVR4,NA,NA,NA,Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62503,0.00215299183708001,-0.000581799888152072,No,NA,NA,Q8NDA2,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_AGAP_AGAP010186.1.1.m.62505,0.00617477164108533,0.0219860913584903,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP010490.1.1.m.51445,-0.0076882896099867,-0.0100409459244751,No,NA,NA,Q8TDJ6,NA,NA,NA,cell junction [GO:0030054]; extracellular space [GO:0005615]; RAVE complex [GO:0043291]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; Rab GTPase binding [GO:0017137]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_AGAP_AGAP011617.1.2.m.29071,0.0100092674657642,0.00940599689774422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGAP_AGAP013102.1.1.m.50186,0.00429117714024689,-0.00115959862793645,No,NA,NA,Q29RU1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_AGO2.1.1.m.17145,0.0041544547919257,-0.00754234040638235,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_AGPS.1.1.m.62910,-0.00388602606866528,-0.00232211818347394,No,NA,NA,P97275,NA,NA,NA,nucleolus [GO:0005730]; peroxisome [GO:0005777]; alkylglycerone-phosphate synthase activity [GO:0008609]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; ether lipid biosynthetic process [GO:0008611],NA,NA,NA
CHOYP_AGRIN.2.5.m.5339,-0.00235467210184089,0.00307197830934146,No,NA,NA,P25304,NA,NA,NA,axonal growth cone [GO:0044295]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; sialic acid binding [GO:0033691]; transforming growth factor beta binding [GO:0050431]; chemical synaptic transmission [GO:0007268]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotetramerization [GO:0051290]; receptor clustering [GO:0043113]; regulation of axon guidance [GO:1902667]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of protein phosphorylation [GO:0001932]; regulation of synapse organization [GO:0050807]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_AGRIN.3.5.m.5652,-0.0014960499219818,0.00267594856263988,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGRIN.4.5.m.27580,-0.0102301313321673,-0.00651043032686301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AGSA.1.1.m.5200,0.00339633922764572,0.0101605184790818,No,NA,NA,P15287,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; metal ion binding [GO:0046872]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_AHCTF1.1.1.m.17461,0.00268457335468023,0.000183159605872649,No,NA,NA,Q8CJF7,NA,NA,NA,chromatin [GO:0000785]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; cell cycle [GO:0007049]; cell division [GO:0051301]; hemopoiesis [GO:0030097]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_AIFM1.1.1.m.1582,0.00461088371476848,-0.00174594890761193,No,NA,NA,O95831,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; NAD(P)H oxidase activity [GO:0016174]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; protein dimerization activity [GO:0046983]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; cellular response to aldosterone [GO:1904045]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitric oxide [GO:0071732]; cellular response to oxygen-glucose deprivation [GO:0090650]; chromosome condensation [GO:0030261]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mitochondrial respiratory chain complex I assembly [GO:0032981]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; regulation of apoptotic DNA fragmentation [GO:1902510]; response to ischemia [GO:0002931]; response to L-glutamate [GO:1902065],NA,NA,NA
CHOYP_AIMP1.1.1.m.16360,-0.000598678556660575,-6.70436681373951e-05,No,NA,NA,O54873,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; tRNA binding [GO:0000049]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],NA,NA,NA
CHOYP_AJL2.1.1.m.26431,-0.000100295772925227,0.0133068356052107,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_AK5.1.2.m.7331,-0.0148584811802776,0.0176979340732359,No,NA,NA,A4IFD0,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_AKD1.2.3.m.49697,-0.0173279010922356,-0.0174246303421105,No,NA,NA,Q5TCS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKD1.3.3.m.63103,-0.00931275702132719,0.00418289222121949,No,NA,NA,Q5TCS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; nucleoside monophosphate kinase activity [GO:0050145]; AMP phosphorylation [GO:0006756]; ATP generation from ADP [GO:0006757]; CDP phosphorylation [GO:0061508]; CMP phosphorylation [GO:0061566]; dADP phosphorylation [GO:0006174]; dAMP phosphorylation [GO:0061565]; dCDP phosphorylation [GO:0061570]; dCMP phosphorylation [GO:0061567]; dGDP phosphorylation [GO:0006186]; GDP phosphorylation [GO:0061568]; nucleobase-containing small molecule interconversion [GO:0015949]; TDP phosphorylation [GO:0061571]; UDP phosphorylation [GO:0061569],NA,NA,NA
CHOYP_AKP13.1.5.m.12951,-0.00310926267061308,0.00196284546938855,No,NA,NA,Q12802,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; cAMP-dependent protein kinase activity [GO:0004691]; guanyl-nucleotide exchange factor activity [GO:0005085]; MAP-kinase scaffold activity [GO:0005078]; metal ion binding [GO:0046872]; protein kinase A binding [GO:0051018]; protein-containing complex scaffold activity [GO:0032947]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0086023]; adrenergic receptor signaling pathway [GO:0071875]; bone development [GO:0060348]; cardiac muscle cell differentiation [GO:0055007]; cell growth involved in cardiac muscle cell development [GO:0061049]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; nuclear export [GO:0051168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of Rho protein signal transduction [GO:0035025]; regulation of glucocorticoid mediated signaling pathway [GO:1900169]; regulation of sarcomere organization [GO:0060297]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_AKT1.2.2.m.51125,-0.000845604746255584,0.0073645147854857,No,NA,NA,Q8INB9,NA,NA,NA,cell cortex [GO:0005938]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; chitin-based embryonic cuticle biosynthetic process [GO:0008362]; cholesterol homeostasis [GO:0042632]; circadian rhythm [GO:0007623]; dendrite regeneration [GO:0031104]; epithelial cell migration; open tracheal system [GO:0007427]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; long-term synaptic depression [GO:0060292]; multicellular organism growth [GO:0035264]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neuron death [GO:1901215]; negative regulation of peptide hormone secretion [GO:0090278]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of triglyceride catabolic process [GO:0010897]; oogenesis [GO:0048477]; open tracheal system development [GO:0007424]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of lipid storage [GO:0010884]; positive regulation of organ growth [GO:0046622]; positive regulation of TORC1 signaling [GO:1904263]; protein phosphorylation [GO:0006468]; regulation of dendrite development [GO:0050773]; regulation of hemocyte proliferation [GO:0035206]; regulation of multicellular organism growth [GO:0040014]; response to oxidative stress [GO:0006979]; somatic muscle development [GO:0007525]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_AL1A1.1.1.m.24832,0.000889230739991971,-0.001023956260815,No,NA,NA,Q8MI17,NA,NA,NA,cytosol [GO:0005829]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; retinal dehydrogenase activity [GO:0001758]; oxidation-reduction process [GO:0055114]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_AL4A1.1.1.m.28988,-0.00154248934110126,-0.00252449079690248,No,NA,NA,Q7SY23,NA,NA,NA,mitochondrial matrix [GO:0005759]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; identical protein binding [GO:0042802]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_AL8A1.1.1.m.13904,0.00330357796423408,0.00520637741675167,No,NA,NA,Q66I21,NA,NA,NA,cytoplasm [GO:0005737]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; liver development [GO:0001889],NA,NA,NA
CHOYP_ALAT2.1.1.m.15163,0.00100623871997234,-0.00109036978086311,No,NA,NA,Q6GM82,NA,NA,NA,L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_ALDH2.3.3.m.25044,0.00191815771866882,-0.000461975168613349,No,NA,NA,P20000,NA,NA,NA,mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_ALDR.1.1.m.50075,0.00306637370917444,0.00308189354092198,No,NA,NA,P82125,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; 1;5-anhydro-D-fructose reductase activity [GO:0050571]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ALF.1.3.m.25601,0.000169265791236191,0.00127951419888173,No,NA,NA,P53442,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALF.2.3.m.40474,0.000652743259234061,0.00164794594822218,No,NA,NA,Q9GP32,NA,NA,NA,fructose-bisphosphate aldolase activity [GO:0004332]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ALG1.1.1.m.40067,-6.88494090436954e-05,0.00913465982602644,No,NA,NA,Q921Q3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; chitobiosyldiphosphodolichol beta-mannosyltransferase activity [GO:0004578]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_ALKB8.1.2.m.27789,0.00321526908017764,0.0115847152766663,No,NA,NA,Q95K79,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; tRNA (uracil) methyltransferase activity [GO:0016300]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; oxidation-reduction process [GO:0055114]; tRNA methylation [GO:0030488]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ALS2.1.3.m.33568,0.00412044556690154,-0.00442409941596485,No,NA,NA,Q96Q42,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; cell death [GO:0008219]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Rac protein signal transduction [GO:0035022]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of Rho protein signal transduction [GO:0035023]; response to oxidative stress [GO:0006979]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_ALS2.2.3.m.37861,0.00500615712439462,-0.00996065907124389,No,NA,NA,P06144,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_AMACR.1.1.m.21950,-0.00625788732856521,0.0101345726810358,No,NA,NA,O09174,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; alpha-methylacyl-CoA racemase activity [GO:0008111]; signaling receptor binding [GO:0005102]; bile acid biosynthetic process [GO:0006699]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; isoprenoid catabolic process [GO:0008300],NA,NA,NA
CHOYP_AMDHD2.2.2.m.52160,-0.0118506557349905,0.0240544720775263,No,NA,NA,Q6P0U0,NA,NA,NA,metal ion binding [GO:0046872]; N-acetylgalactosamine-6-phosphate deacetylase activity [GO:0047419]; N-acetylglucosamine-6-phosphate deacetylase activity [GO:0008448]; carbohydrate metabolic process [GO:0005975]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_AMO.1.5.m.28337,-0.00318787833001377,0.00432778952915239,No,NA,NA,H2A0M3,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMO.5.5.m.66428,-0.000875457270126725,-0.0230158868533187,No,NA,NA,H2A0M3,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],NA,NA,NA
CHOYP_AMPD2.1.2.m.1295,-0.0118357721436193,0.0263952592790685,No,NA,NA,Q01433,NA,NA,NA,cytosol [GO:0005829]; AMP deaminase activity [GO:0003876]; metal ion binding [GO:0046872]; cyclic purine nucleotide metabolic process [GO:0052652]; energy homeostasis [GO:0097009]; IMP biosynthetic process [GO:0006188]; IMP salvage [GO:0032264]; purine-containing compound salvage [GO:0043101],NA,NA,NA
CHOYP_AMPL.1.1.m.27061,-0.00356699105941755,0.0055589461020849,No,NA,NA,P00727,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; disordered domain specific binding [GO:0097718]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_AMRP.1.1.m.36070,-0.0166053157617868,0.0291278423210184,No,NA,NA,P30533,NA,NA,NA,cell surface [GO:0009986]; cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; rough endoplasmic reticulum lumen [GO:0048237]; amyloid-beta binding [GO:0001540]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]; very-low-density lipoprotein particle receptor binding [GO:0070326]; amyloid-beta clearance by transcytosis [GO:0150093]; extracellular negative regulation of signal transduction [GO:1900116]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of cell death [GO:0060548]; negative regulation of protein binding [GO:0032091]; negative regulation of receptor internalization [GO:0002091]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; positive regulation of amyloid-beta clearance [GO:1900223]; regulation of receptor-mediated endocytosis [GO:0048259],NA,NA,NA
CHOYP_AMY.3.3.m.64271,0.00414482148644419,0.00306985944691803,No,NA,NA,P91778,NA,NA,NA,alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_AN13B.1.1.m.15287,0.000548970133643323,0.00572258590821903,No,NA,NA,Q6PD24,NA,NA,NA,late endosome [GO:0005770]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_ANGP4.3.7.m.24608,0.0276842417201697,0.0122537652661925,No,NA,NA,P57756,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_ANGP4.4.7.m.33574,0.02049246086653,-0.000711867751239041,No,NA,NA,Q24K15,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_ANK.2.3.m.19487,-0.00625670151140313,0.0159547444794261,No,NA,NA,G5E8K5,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; dendrite [GO:0030425]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; lysosome [GO:0005764]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; synapse [GO:0045202]; T-tubule [GO:0030315]; Z disc [GO:0030018]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; ion channel binding [GO:0044325]; protein binding; bridging [GO:0030674]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cellular response to magnesium ion [GO:0071286]; establishment of protein localization [GO:0045184]; Golgi to plasma membrane protein transport [GO:0043001]; magnesium ion homeostasis [GO:0010960]; maintenance of protein location in plasma membrane [GO:0072660]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; neuromuscular junction development [GO:0007528]; neuronal action potential [GO:0019228]; plasma membrane organization [GO:0007009]; positive regulation of action potential [GO:0045760]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell communication by electrical coupling [GO:0010650]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900827]; positive regulation of membrane potential [GO:0045838]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765]; protein localization to axon [GO:0099612]; protein localization to plasma membrane [GO:0072659]; regulation of potassium ion transport [GO:0043266]; signal transduction [GO:0007165]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_ANK3.3.9.m.6798,0.00159037721647466,-0.00223938762129312,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANK3.7.9.m.43272,-0.00698092497635156,-0.0172533050582572,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_ANKK1.1.1.m.56194,0.0221961184182269,0.00179266360917541,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_ANKMY2.1.1.m.18238,0.000305384390566131,-0.00385932736622383,No,NA,NA,Q0VCS9,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANKRD27.1.1.m.12550,-4.61834872814229e-05,0.00612743742836892,No,NA,NA,Q5REW9,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ANKRD5.1.2.m.11711,-0.0135094043768136,-0.0188621537126257,No,NA,NA,Q9D2J7,NA,NA,NA,,NA,NA,NA
CHOYP_ANKY2.2.2.m.44213,-0.00470159176842942,-0.00448438152069383,No,NA,NA,Q0VCS9,NA,NA,NA,cilium [GO:0005929]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ANLN.1.1.m.6530,0.00522496610046872,-0.00749464151382965,No,NA,NA,Q801E2,NA,NA,NA,bleb [GO:0032059]; cell cortex region [GO:0099738]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of bleb assembly [GO:1904172],NA,NA,NA
CHOYP_ANM12.1.1.m.53881,-9.2143545215984e-07,0.0172158866900734,No,NA,NA,A2XYY8,NA,NA,NA,methyltransferase activity [GO:0008168]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_ANM3.1.1.m.376,0.00282795576869337,-0.000764194420800151,No,NA,NA,O60678,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; histone-arginine N-methyltransferase activity [GO:0008469]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; nucleic acid binding [GO:0003676]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; ribosome binding [GO:0043022]; histone arginine methylation [GO:0034969]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; protein methylation [GO:0006479]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ANM5.1.1.m.1529,-0.000269467463636144,0.000143192337584736,No,NA,NA,O14744,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; methyltransferase activity [GO:0008168]; protein heterodimerization activity [GO:0046982]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; ribonucleoprotein complex binding [GO:0043021]; transcription corepressor activity [GO:0003714]; cell proliferation [GO:0008283]; circadian regulation of gene expression [GO:0032922]; DNA-templated transcription; termination [GO:0006353]; endothelial cell activation [GO:0042118]; Golgi ribbon formation [GO:0090161]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; liver regeneration [GO:0097421]; negative regulation of cell differentiation [GO:0045596]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine N-methylation [GO:0035246]; positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:1904992]; positive regulation of oligodendrocyte differentiation [GO:0048714]; regulation of DNA methylation [GO:0044030]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of mitotic nuclear division [GO:0007088]; regulation of signal transduction by p53 class mediator [GO:1901796]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ANR11.1.1.m.56842,-0.0060317062435228,0.000187630895529038,No,NA,NA,Q6UB98,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ANR17.1.2.m.772,-0.00275205947431623,0.00348622770074875,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_ANR31.1.1.m.61075,-0.00422590220175008,-0.00837499269298832,No,NA,NA,Q8N7Z5,NA,NA,NA,,NA,NA,NA
CHOYP_ANR40.1.1.m.1429,-0.00792290327173824,-0.0122782724181087,No,NA,NA,Q5SUE8,NA,NA,NA,,NA,NA,NA
CHOYP_ANS1B.1.1.m.46724,-0.000424328122168314,0.00138192982446816,No,NA,NA,A5PMU4,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; regulation of synaptic plasticity by receptor localization to synapse [GO:1900383],NA,NA,NA
CHOYP_ANT_25430.1.2.m.613,-0.0196007678934456,0.0272467349926794,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ANT_25430.2.2.m.5862,-0.00282398663742507,-0.00149732333593921,No,NA,NA,P55906,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_ANXA4.1.2.m.19913,-0.0246181242271196,-0.0156669134886625,No,NA,NA,P08132,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; chondroitin sulfate binding [GO:0035374]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; epithelial cell differentiation [GO:0030855]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_ANXA7.1.4.m.4514,-0.00931715775542667,-0.00433954151726353,No,NA,NA,Q07076,NA,NA,NA,chromaffin granule membrane [GO:0042584]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_AOF.1.1.m.7109,0.00361952868773214,-0.0107172553974176,No,NA,NA,Q6NSN2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584]; cellular biogenic amine catabolic process [GO:0042402]; neurotransmitter catabolic process [GO:0042135],NA,NA,NA
CHOYP_AP1G1.1.1.m.13111,-2.41286678790172e-05,0.00151539300223789,No,NA,NA,P22892,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; microtubule cytoskeleton [GO:0015630]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; collagen binding [GO:0005518]; GTP-dependent protein binding [GO:0030742]; kinesin binding [GO:0019894]; protein C-terminus binding [GO:0008022]; Rab GTPase binding [GO:0017137]; endosome to melanosome transport [GO:0035646]; Golgi to lysosome transport [GO:0090160]; intracellular protein transport [GO:0006886]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP1M1.1.1.m.56248,0.000929433862630476,0.00380240152877285,No,NA,NA,Q9BXS5,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; neutrophil degranulation [GO:0043312]; regulation of defense response to virus by virus [GO:0050690],NA,NA,NA
CHOYP_AP2A2.1.1.m.62726,-0.000411797981448386,0.00100425431710906,No,NA,NA,P17427,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; cytoplasmic vesicle [GO:0031410]; membrane coat [GO:0030117]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]; clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; phosphatidylinositol binding [GO:0035091]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; regulation of hematopoietic stem cell differentiation [GO:1902036]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_AP2M1.1.1.m.25996,0.0033182366307187,0.00107275256410304,No,NA,NA,Q5ZMP6,NA,NA,NA,clathrin adaptor complex [GO:0030131]; clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP2S1.1.1.m.61530,-0.0094003134649975,-0.0283386585129872,No,NA,NA,P62744,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; plasma membrane [GO:0005886]; protein transporter activity [GO:0008565]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_AP3M2.1.1.m.43706,-0.000930122009392451,0.00117009205390903,No,NA,NA,Q5R478,NA,NA,NA,axon cytoplasm [GO:1904115]; clathrin adaptor complex [GO:0030131]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Rab GTPase binding [GO:0017137]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_APBP2.1.1.m.62244,0.00351749529982046,0.00415407145981924,No,NA,NA,A5HK05,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_API5.1.1.m.17066,0.001526061844562,-0.000589657252176739,No,NA,NA,Q9BZZ5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; fibroblast growth factor binding [GO:0017134]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; negative regulation of fibroblast apoptotic process [GO:2000270],NA,NA,NA
CHOYP_APLA.1.2.m.191,0.00211028955681173,0.00730747092425014,No,NA,NA,O88444,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; adenylate cyclase activity [GO:0004016]; ATP binding [GO:0005524]; calcium- and calmodulin-responsive adenylate cyclase activity [GO:0008294]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; axonogenesis [GO:0007409]; brain development [GO:0007420]; cAMP biosynthetic process [GO:0006171]; cAMP-mediated signaling [GO:0019933]; cellular response to calcium ion [GO:0071277]; cellular response to forskolin [GO:1904322]; circadian rhythm [GO:0007623]; long-term memory [GO:0007616]; modulation of chemical synaptic transmission [GO:0050804]; neuroinflammatory response [GO:0150076]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of long-term synaptic potentiation [GO:1900273]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to lithium ion [GO:0010226],NA,NA,NA
CHOYP_APLP.1.2.m.5955,-0.0101036625994161,-0.00135227778834849,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APLP.2.2.m.55987,-0.0101035326119755,-0.00135203534810412,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_APN.1.3.m.316,-0.00218196375732407,0.00296218328442175,No,NA,NA,O57579,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_APPBP2.1.1.m.9093,-0.011347962464472,-0.0114123932003228,No,NA,NA,Q92624,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; nucleus [GO:0005634]; microtubule motor activity [GO:0003777]; intracellular protein transport [GO:0006886]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_AQR.1.1.m.9127,-0.00392992791494687,0.00407223709508996,No,NA,NA,O60306,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ARALYDRAFT_472154.1.1.m.29819,0.00494513591316293,-0.00606540004423192,No,NA,NA,Q9FSG7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ARB_02478.1.1.m.29725,0.0291760612873318,-0.00365511656723873,No,NA,NA,D4B1Z7,NA,NA,NA,extracellular region [GO:0005576]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ARC1A.1.1.m.56262,0.000495035847498772,-0.000632032378068674,No,NA,NA,Q92747,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_ARC1A.1.1.m.56263,0.00377044764673964,-0.00216433724358166,No,NA,NA,Q1JP79,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARF2.1.3.m.10738,0.000440570284468064,0.00197943530973332,No,NA,NA,P84082,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF4.1.2.m.8401,-0.00345453279583162,0.00578083405758123,No,NA,NA,P51644,NA,NA,NA,Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARF6.1.2.m.3974,0.00216070820960785,-0.0036698946948079,No,NA,NA,P62332,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; filopodium membrane [GO:0031527]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; ruffle [GO:0001726]; GTP binding [GO:0005525]; protein N-terminus binding [GO:0047485]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; cellular response to nerve growth factor stimulus [GO:1990090]; cortical actin cytoskeleton organization [GO:0030866]; endocytic recycling [GO:0032456]; establishment of epithelial cell polarity [GO:0090162]; hepatocyte apoptotic process [GO:0097284]; intracellular protein transport [GO:0006886]; liver development [GO:0001889]; maintenance of postsynaptic density structure [GO:0099562]; myeloid cell apoptotic process [GO:0033028]; negative regulation of dendrite development [GO:2000171]; negative regulation of protein localization to cell surface [GO:2000009]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to cell surface [GO:0034394]; protein localization to endosome [GO:0036010]; regulation of dendritic spine development [GO:0060998]; regulation of filopodium assembly [GO:0051489]; regulation of presynapse assembly [GO:1905606]; regulation of Rac protein signal transduction [GO:0035020]; ruffle assembly [GO:0097178]; synaptic vesicle endocytosis [GO:0048488]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ARH.2.2.m.25884,-0.0149204117503944,0.00870362930943872,No,NA,NA,Q801G1,NA,NA,NA,cytoplasm [GO:0005737]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_ARHG7.3.5.m.37182,0.0132904689926886,0.00291092163921106,No,NA,NA,O55043,NA,NA,NA,cell cortex [GO:0005938]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein kinase binding [GO:0019901]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; astrocyte cell migration [GO:0043615]; lamellipodium assembly [GO:0030032]; positive regulation of apoptotic process [GO:0043065]; postsynaptic actin cytoskeleton organization [GO:0098974]; presynaptic actin cytoskeleton organization [GO:0099140]; regulation of Rho protein signal transduction [GO:0035023]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_ARHGAP12B.1.2.m.36731,0.00774153928382026,0.00289957266481448,No,NA,NA,Q8C0D4,NA,NA,NA,cytoplasm [GO:0005737]; phagocytic cup [GO:0001891]; GTPase activator activity [GO:0005096]; actin filament organization [GO:0007015]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; phagocytosis; engulfment [GO:0006911]; regulation of GTPase activity [GO:0043087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGAP8.1.1.m.25503,-0.0137710556885709,0.0125461591339703,No,NA,NA,P85298,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ARHGEF3.1.1.m.13898,0.00384408593768552,0.00453976660143567,No,NA,NA,Q9N0A8,NA,NA,NA,cytoplasm [GO:0005737]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_ARI2.1.1.m.34963,0.00535614737683368,0.00820152296725921,No,NA,NA,O76924,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARI4B.1.1.m.56056,-0.0106721643546562,-0.00398079180387458,No,NA,NA,Q9JKB5,NA,NA,NA,nucleus [GO:0005634]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ARID3A.1.1.m.55743,-0.00369028026409996,0.0156711754116451,No,NA,NA,Q5XGD9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ARIP4.3.3.m.33366,0.00961638559143441,-0.0094695441157282,No,NA,NA,A4IHD2,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_ARL6.1.2.m.29833,0.00717913644948952,0.0242612238130414,No,NA,NA,Q5M9P8,NA,NA,NA,axoneme [GO:0005930]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular protein transport [GO:0006886]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pectoral fin development [GO:0033339]; protein localization to cilium [GO:0061512]; regulation of Notch signaling pathway [GO:0008593]; response to stimulus [GO:0050896]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ARL6IP1.1.1.m.13877,0.020903774796894,-0.0279595008081064,No,NA,NA,Q9JKW0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; identical protein binding [GO:0042802]; apoptotic process [GO:0006915]; cotranslational protein targeting to membrane [GO:0006613]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of L-glutamate import across plasma membrane [GO:0002038],NA,NA,NA
CHOYP_ARL8A.1.1.m.12151,-0.00576884716316112,-0.00108880900318066,No,NA,NA,Q6P8C8,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059],NA,NA,NA
CHOYP_ARMC6.1.1.m.28786,-0.0114156634420864,-0.000707866838340819,No,NA,NA,Q8BNU0,NA,NA,NA,cytosol [GO:0005829]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_ARMC9.1.1.m.57265,-0.00253556718836606,-0.00124515581021311,No,NA,NA,Q5R629,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_ARNT.1.1.m.19078,-0.0106067937859205,0.00729249055544669,No,NA,NA,O15945,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; myosin binding [GO:0017022]; protein heterodimerization activity [GO:0046982]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; insulin receptor signaling pathway [GO:0008286]; limb development [GO:0060173]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of R7 cell differentiation [GO:0045676]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ARP2.1.1.m.43520,0.0001945356670454,0.00036189855621229,No,NA,NA,Q5BL41,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; ATP binding [GO:0005524]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ARP3.1.1.m.6867,-2.9415267334885e-07,0.0017628596908608,No,NA,NA,Q5R8R1,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; structural constituent of cytoskeleton [GO:0005200]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; asymmetric cell division [GO:0008356]; cellular response to interferon-gamma [GO:0071346]; cilium assembly [GO:0060271]; establishment or maintenance of cell polarity [GO:0007163]; meiotic chromosome movement towards spindle pole [GO:0016344]; meiotic cytokinesis [GO:0033206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spindle localization [GO:0051653],NA,NA,NA
CHOYP_ARP6.1.1.m.17920,-0.00623716454357414,0.0184339764932232,No,NA,NA,Q9GZN1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; chromatin remodeling [GO:0006338],NA,NA,NA
CHOYP_ARP8.1.1.m.10729,-0.0113876997697696,0.00445754063906985,No,NA,NA,D2I1E3,NA,NA,NA,centrosome [GO:0005813]; Ino80 complex [GO:0031011]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_ARPC2.1.1.m.50573,0.00232130340629289,-0.000886909035707972,No,NA,NA,Q3MHR7,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell junction [GO:0030054]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; synapse [GO:0045202]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARPC4.2.2.m.35677,0.000417534776454398,-0.00114345468934556,No,NA,NA,P59999,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; protein binding; bridging [GO:0030674]; structural constituent of cytoskeleton [GO:0005200]; actin filament polymerization [GO:0030041]; Arp2/3 complex-mediated actin nucleation [GO:0034314],NA,NA,NA
CHOYP_ARRB.1.2.m.25932,0.00130034414151501,-0.000946155358220625,No,NA,NA,Q4R562,NA,NA,NA,clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ARRD.6.1.1.m.9470,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ARRD3.2.2.m.64983,0.00743273526781592,-0.00254509570917748,No,NA,NA,Q7TPQ9,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-3 adrenergic receptor binding [GO:0031699]; fat pad development [GO:0060613]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of heat generation [GO:0031651]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; skin development [GO:0043588]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_ASB3.1.1.m.51103,0.0273008519385286,0.00991120732623055,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_ASCC1.1.1.m.39863,0.00421213493067818,0.00497442299392157,No,NA,NA,Q9D8Z1,NA,NA,NA,neuromuscular junction [GO:0031594]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; RNA binding [GO:0003723]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC2.1.1.m.34978,-0.000703897977062299,0.014457752374186,No,NA,NA,Q9H1I8,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA dealkylation involved in DNA repair [GO:0006307]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ASCC3.1.1.m.51755,0.000690992728384495,0.00921672523311368,No,NA,NA,F1NTD6,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent helicase activity [GO:0008026]; nucleic acid binding [GO:0003676]; cell proliferation [GO:0008283]; DNA dealkylation involved in DNA repair [GO:0006307]; DNA duplex unwinding [GO:0032508],NA,NA,NA
CHOYP_ASGR2.3.4.m.47793,0.00410989812623609,0.0147771127995221,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_ASK1.1.2.m.586,-0.0126823361809366,0.015354523461481,No,NA,NA,Q6ZN16,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; activation of MAPKK activity [GO:0000186],NA,NA,NA
CHOYP_ASM.1.1.m.21521,-0.00456619414395535,0.00360966161406887,No,NA,NA,Q04519,NA,NA,NA,endosome [GO:0005768]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; acid sphingomyelin phosphodiesterase activity [GO:0061750]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; zinc ion binding [GO:0008270]; ceramide biosynthetic process [GO:0046513]; negative regulation of MAP kinase activity [GO:0043407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein dephosphorylation [GO:0035307]; response to cocaine [GO:0042220]; sphingomyelin catabolic process [GO:0006685]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_ASMTL.1.1.m.20115,0.00089022241998856,0.0124022928283338,No,NA,NA,O95671,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_ASNA.1.1.m.52208,-0.00492096730653769,0.0022536377434372,No,NA,NA,B0WEV5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; protein insertion into ER membrane [GO:0045048],NA,NA,NA
CHOYP_ASPH.1.2.m.35319,-0.00517271808415049,0.013851849682151,No,NA,NA,Q8BSY0,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; calcium ion binding [GO:0005509]; peptide-aspartate beta-dioxygenase activity [GO:0004597]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of store-operated calcium channel activity [GO:0032237]; calcium ion transmembrane transport [GO:0070588]; cellular response to calcium ion [GO:0071277]; face morphogenesis [GO:0060325]; limb morphogenesis [GO:0035108]; negative regulation of cell proliferation [GO:0008285]; pattern specification process [GO:0007389]; peptidyl-aspartic acid hydroxylation [GO:0042264]; positive regulation of calcium ion transport into cytosol [GO:0010524]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of protein depolymerization [GO:1901879]; regulation of protein stability [GO:0031647]; response to ATP [GO:0033198]; roof of mouth development [GO:0060021],NA,NA,NA
CHOYP_ASPM.1.4.m.6650,0.00155940831037816,-0.00274548915189516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ASSY.2.4.m.43713,0.00103581724358244,0.0150003987154086,No,NA,NA,Q66I24,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_ASUN.1.1.m.6333,0.014543482970131,-0.0223426164228621,No,NA,NA,Q9NVM9,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cell division [GO:0051301]; centrosome localization [GO:0051642]; flagellated sperm motility [GO:0030317]; mitotic spindle organization [GO:0007052]; protein localization to nuclear envelope [GO:0090435]; regulation of fertilization [GO:0080154]; regulation of mitotic cell cycle [GO:0007346]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_AT1.1.1.m.66793,-0.00316862013790832,0.0113988015181332,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_AT10A.1.1.m.56662,0.00583662556676577,0.0068929046443333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_AT1A.1.1.m.18017,0.000938706786154495,0.00185972033304885,No,NA,NA,Q6RWA9,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; sodium:potassium-exchanging ATPase activity [GO:0005391],NA,NA,NA
CHOYP_AT5F1.1.1.m.12896,0.0119741427935175,-0.0160437703949276,No,NA,NA,P24539,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ATC1.1.1.m.5160,0.00424308061784561,-0.00041009143324681,No,NA,NA,Q7PPA5,NA,NA,NA,integral component of membrane [GO:0016021]; sarcoplasmic reticulum membrane [GO:0033017]; ATP binding [GO:0005524]; calcium-transporting ATPase activity [GO:0005388]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; calcium ion transmembrane transport [GO:0070588]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATC1.1.1.m.5161,-0.00698611637990429,-0.0226825200717679,No,NA,NA,P35224,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ATE1.1.3.m.6901,-0.0238198394727482,0.00798800684461658,No,NA,NA,Q9Z2A5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; arginyltransferase activity [GO:0004057]; proteasomal protein catabolic process [GO:0010498]; protein arginylation [GO:0016598],NA,NA,NA
CHOYP_ATG2A.1.1.m.57169,-0.00147755746160503,0.00677066623854163,No,NA,NA,Q96BY7,NA,NA,NA,extrinsic component of membrane [GO:0019898]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422],NA,NA,NA
CHOYP_ATG3.1.1.m.25570,-0.000964096436131693,-0.00208362364719231,No,NA,NA,Q5I0S6,NA,NA,NA,cytoplasmic ubiquitin ligase complex [GO:0000153]; cytosol [GO:0005829]; Atg12 transferase activity [GO:0019777]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ATG7.1.1.m.34175,-0.00482907388400955,0.0197939780005871,No,NA,NA,Q9D906,NA,NA,NA,axon [GO:0030424]; axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; Atg12 activating enzyme activity [GO:0019778]; Atg8 activating enzyme activity [GO:0019779]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; adult walking behavior [GO:0007628]; amino acid homeostasis [GO:0080144]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; cardiac muscle cell development [GO:0055013]; cellular homeostasis [GO:0019725]; cellular response to hyperoxia [GO:0071455]; cellular response to nitrogen starvation [GO:0006995]; cellular response to reactive oxygen species [GO:0034614]; cellular response to starvation [GO:0009267]; cellular sphingolipid homeostasis [GO:0090156]; central nervous system neuron axonogenesis [GO:0021955]; cerebellar Purkinje cell layer development [GO:0021680]; cerebral cortex development [GO:0021987]; defense response to virus [GO:0051607]; late nucleophagy [GO:0044805]; liver development [GO:0001889]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of mitochondrial DNA replication [GO:0090298]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of phagocytosis [GO:0050765]; negative regulation of sphingolipid biosynthetic process [GO:0090155]; negative stranded viral RNA replication [GO:0039689]; nervous system process [GO:0050877]; neuron projection development [GO:0031175]; organelle organization [GO:0006996]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mucus secretion [GO:0070257]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein modification process [GO:0031401]; post-embryonic development [GO:0009791]; protein catabolic process [GO:0030163]; protein lipidation [GO:0006497]; protein modification by small protein conjugation [GO:0032446]; protein transport [GO:0015031]; pyramidal neuron development [GO:0021860]; regulation of cell development [GO:0060284]; regulation of circadian rhythm [GO:0042752]; regulation of hemopoiesis [GO:1903706]; regulation of neuron death [GO:1901214]; regulation of protein ubiquitination [GO:0031396]; response to starvation [GO:0042594]; suppression by virus of host autophagy [GO:0039521],NA,NA,NA
CHOYP_ATIC.1.1.m.17816,-0.00120459182584883,0.000522158245767536,No,NA,NA,P31335,NA,NA,NA,cytosol [GO:0005829]; IMP cyclohydrolase activity [GO:0003937]; phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO:0004643]; protein homodimerization activity [GO:0042803]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_ATP13A.1.1.m.10161,-0.010380087965064,0.00717555421759561,No,NA,NA,Q9EPE9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; cation transport [GO:0006812]; cellular calcium ion homeostasis [GO:0006874],NA,NA,NA
CHOYP_ATP2B3.1.1.m.6573,0.00905627135618229,0.00756686544471144,No,NA,NA,Q16720,NA,NA,NA,extracellular vesicle [GO:1903561]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; ATP binding [GO:0005524]; calcium ion transmembrane transporter activity [GO:0015085]; calcium-transporting ATPase activity [GO:0005388]; calcium-transporting ATPase activity involved in regulation of presynaptic cytosolic calcium ion concentration [GO:1905056]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; calcium ion export across plasma membrane [GO:1990034]; cellular calcium ion homeostasis [GO:0006874]; ion transmembrane transport [GO:0034220]; regulation of cardiac conduction [GO:1903779]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_ATP5B.1.1.m.22321,-0.00290720238898552,0.000791203012509197,No,NA,NA,Q05825,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5C1.1.1.m.16222,4.35173593528396e-06,0.000822404293254153,No,NA,NA,O01666,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ATP5H.1.1.m.22927,0.000901224923513704,0.00076537352839569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATP6AP1.1.1.m.18150,-0.0128596095727015,0.0237649141946929,No,NA,NA,Q15904,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; Rab GTPase binding [GO:0017137]; transporter activity [GO:0005215]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; establishment of organelle localization [GO:0051656]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; pH reduction [GO:0045851]; positive regulation of bone resorption [GO:0045780]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoclast development [GO:2001206]; proton transmembrane transport [GO:1902600]; regulation of cellular pH [GO:0030641]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_ATP7A.1.1.m.23099,0.000274758598462397,0.0062474368260577,No,NA,NA,P70705,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; membrane raft [GO:0045121]; microvillus [GO:0005902]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]; trans-Golgi network transport vesicle [GO:0030140]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; copper-dependent protein binding [GO:0032767]; copper-exporting ATPase activity [GO:0004008]; copper-transporting ATPase activity [GO:0043682]; cuprous ion binding [GO:1903136]; Rac GTPase binding [GO:0048365]; cellular copper ion homeostasis [GO:0006878]; cellular response to amino acid stimulus [GO:0071230]; cellular response to antibiotic [GO:0071236]; cellular response to cadmium ion [GO:0071276]; cellular response to cobalt ion [GO:0071279]; cellular response to copper ion [GO:0071280]; cellular response to hypoxia [GO:0071456]; cellular response to iron ion [GO:0071281]; cellular response to lead ion [GO:0071284]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; copper ion export [GO:0060003]; in utero embryonic development [GO:0001701]; lactation [GO:0007595]; liver development [GO:0001889]; negative regulation of iron ion transmembrane transport [GO:0034760]; positive regulation of cell size [GO:0045793]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of response to wounding [GO:1903036]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytochrome-c oxidase activity [GO:1904959]; regulation of gene expression [GO:0010468]; response to copper ion [GO:0046688]; response to iron(III) ion [GO:0010041]; response to lead ion [GO:0010288]; response to manganese ion [GO:0010042]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_ATPA.1.1.m.50245,-0.000383860616918859,1.41485620542042e-05,No,NA,NA,P80021,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; plasma membrane [GO:0005886]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP biosynthetic process [GO:0006754]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; electron transport chain [GO:0022900]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ATPB.1.1.m.21960,-0.000823279120590264,-0.000917702579784711,No,NA,NA,Q25117,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_ATRIP.1.1.m.15992,0.0062488199224033,0.0170090313861171,No,NA,NA,Q8WXE1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; DNA damage checkpoint [GO:0000077]; DNA replication [GO:0006260]; interstrand cross-link repair [GO:0036297],NA,NA,NA
CHOYP_ATRP.1.1.m.22451,-0.0196653664639074,0.0108251807575007,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ATRX.1.1.m.14705,-0.000268393957848926,-0.00872911285745095,No,NA,NA,Q7YQM4,NA,NA,NA,condensed nuclear chromosome; centromeric region [GO:0000780]; nuclear chromosome; telomeric region [GO:0000784]; nuclear pericentric heterochromatin [GO:0031618]; nuclear subtelomeric heterochromatin [GO:1990707]; PML body [GO:0016605]; telomeric heterochromatin [GO:0031933]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; DNA binding [GO:0003677]; DNA translocase activity [GO:0015616]; helicase activity [GO:0004386]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cellular response to hydroxyurea [GO:0072711]; chromatin remodeling [GO:0006338]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; DNA replication-independent nucleosome assembly [GO:0006336]; forebrain development [GO:0030900]; meiotic spindle organization [GO:0000212]; multicellular organism growth [GO:0035264]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901581]; nucleosome assembly [GO:0006334]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomeric RNA transcription from RNA pol II promoter [GO:1901582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic forelimb morphogenesis [GO:0035128]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of histone H3-K9 trimethylation [GO:1900112]; replication fork processing [GO:0031297]; seminiferous tubule development [GO:0072520]; Sertoli cell development [GO:0060009]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ATS10.1.1.m.43473,-0.00305034931379129,0.0136004099512754,No,NA,NA,Q8TE60,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; eye development [GO:0001654]; negative regulation of platelet aggregation [GO:0090331],NA,NA,NA
CHOYP_ATS16.2.4.m.14579,-0.0139644855908278,-0.00782603748668578,No,NA,NA,Q8TE57,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS2.1.2.m.39791,0.00893947236820372,0.000630399760394202,No,NA,NA,Q69Z28,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; branching involved in ureteric bud morphogenesis [GO:0001658]; male gamete generation [GO:0048232]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],NA,NA,NA
CHOYP_ATS20.2.2.m.52571,0.00367363379308705,0.0096475988680621,No,NA,NA,O15072,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573],NA,NA,NA
CHOYP_ATXN10.1.1.m.33209,0.00594908640561066,-0.0108004628827117,No,NA,NA,Q5FVB0,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_AUHM.1.2.m.28847,0.00638058190659968,-0.00172421547340352,No,NA,NA,F1LU71,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730]; fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_AUHM.2.2.m.44102,0.00192273584152823,-0.00241242601934334,No,NA,NA,Q3TLP5,NA,NA,NA,mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_B3GT2.1.1.m.35771,0.00785076573405467,0.0144433945704064,No,NA,NA,Q9MYM7,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity [GO:0047275]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BACH1.3.17.m.6935,0.01356408375198,-0.00933263649665735,No,NA,NA,G5ED84,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BACH1.8.17.m.18006,-0.0131311381077575,-0.00318642859472989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BACOIKO003_21.1.1.m.44123,0.00668683913086019,0.0051711625416652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAG1.2.2.m.60616,0.0117735430563008,-0.00194255902951532,No,NA,NA,Q99933,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of apoptotic process [GO:0043066]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_BAG3.1.1.m.15160,-0.00732512617768334,-0.00466103313688379,No,NA,NA,O95429,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to tumor necrosis factor [GO:0071356]; negative regulation of apoptotic process [GO:0043066]; negative regulation of phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:2001145]; negative regulation of protein targeting to mitochondrion [GO:1903215]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion [GO:0045785]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; regulation of cellular response to heat [GO:1900034]; ruffle assembly [GO:0097178]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BAG6A.1.1.m.25802,-0.00323339821405219,0.00464735112823762,No,NA,NA,A3KPW9,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; brain development [GO:0007420]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; proteasomal protein catabolic process [GO:0010498]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of embryonic development [GO:0045995]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BAI1.1.2.m.4434,0.00202751247745197,-0.00237571616874529,No,NA,NA,Q9HAR2,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; G protein-coupled receptor signaling pathway [GO:0007186]; locomotion involved in locomotory behavior [GO:0031987]; neuron migration [GO:0001764]; positive regulation of synapse assembly [GO:0051965]; response to cocaine [GO:0042220]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_BAP18.1.1.m.48944,-0.021862228215825,0.0163817097684739,No,NA,NA,Q9DCT6,NA,NA,NA,cytosol [GO:0005829]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; NURF complex [GO:0016589]; DNA binding [GO:0003677]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_BAP31.1.1.m.62939,0.000176710868183579,0.000858184958459956,No,NA,NA,Q5R8H3,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BARBAKC583_0145.1.1.m.10555,0.00189121122254577,-0.00416515990206355,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BAT1.4.4.m.32273,0.0040983118560618,0.0137862114346723,No,NA,NA,P82251,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-amino acid transmembrane transporter activity [GO:0015179]; L-cystine transmembrane transporter activity [GO:0015184]; neutral amino acid transmembrane transporter activity [GO:0015175]; peptide antigen binding [GO:0042605]; L-cystine transport [GO:0015811]; leukocyte migration [GO:0050900]; neutral amino acid transport [GO:0015804]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_BAX.1.1.m.30787,-0.00333404053928857,0.00405401906954492,No,NA,NA,O02703,NA,NA,NA,BAX complex [GO:0097144]; Bcl-2 family protein complex [GO:0097136]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial outer membrane [GO:0005741]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; pore complex [GO:0046930]; BH3 domain binding [GO:0051434]; channel activity [GO:0015267]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; lipid binding [GO:0008289]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic mitochondrial changes [GO:0008637]; apoptotic process involved in blood vessel morphogenesis [GO:1902262]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; apoptotic signaling pathway [GO:0097190]; B cell apoptotic process [GO:0001783]; B cell homeostasis [GO:0001782]; B cell homeostatic proliferation [GO:0002358]; B cell negative selection [GO:0002352]; B cell receptor apoptotic signaling pathway [GO:1990117]; blood vessel remodeling [GO:0001974]; cellular response to organic substance [GO:0071310]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; development of secondary sexual characteristics [GO:0045136]; ectopic germ cell programmed cell death [GO:0035234]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; fertilization [GO:0009566]; germ cell development [GO:0007281]; glycosphingolipid metabolic process [GO:0006687]; homeostasis of number of cells within a tissue [GO:0048873]; hypothalamus development [GO:0021854]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of protein binding [GO:0032091]; neuron apoptotic process [GO:0051402]; neuron migration [GO:0001764]; odontogenesis of dentin-containing tooth [GO:0042475]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of developmental pigmentation [GO:0048087]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein homooligomerization [GO:0051260]; protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:0001844]; regulation of cell cycle [GO:0051726]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of nitrogen utilization [GO:0006808]; regulation of protein heterodimerization activity [GO:0043497]; regulation of protein homodimerization activity [GO:0043496]; release of cytochrome c from mitochondria [GO:0001836]; release of matrix enzymes from mitochondria [GO:0032976]; response to axon injury [GO:0048678]; response to gamma radiation [GO:0010332]; response to salt stress [GO:0009651]; response to toxic substance [GO:0009636]; retina development in camera-type eye [GO:0060041]; retinal cell programmed cell death [GO:0046666]; Sertoli cell proliferation [GO:0060011]; spermatid differentiation [GO:0048515]; T cell homeostatic proliferation [GO:0001777]; thymocyte apoptotic process [GO:0070242]; vagina development [GO:0060068],NA,NA,NA
CHOYP_BAZ1A.1.1.m.9485,-0.00311550917596866,-0.00356275297069781,No,NA,NA,Q9NRL2,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BAZ1B.1.1.m.24480,-0.00735927287776188,0.00475390312503178,No,NA,NA,Q9UIG0,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; pericentric heterochromatin [GO:0005721]; ATP binding [GO:0005524]; histone binding [GO:0042393]; histone kinase activity [GO:0035173]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; chromatin assembly or disassembly [GO:0006333]; chromatin remodeling [GO:0006338]; histone phosphorylation [GO:0016572]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BBOV_II003210.5.13.m.30678,-0.0169104231457321,-0.0145161820444872,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BBS4.1.1.m.50943,-0.00356575333295038,-0.021157437738388,No,NA,NA,Q96RK4,NA,NA,NA,BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytosol [GO:0005829]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; microtubule motor activity [GO:0003777]; RNA polymerase II repressing transcription factor binding [GO:0001103]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; face development [GO:0060324]; fat cell differentiation [GO:0045444]; fat pad development [GO:0060613]; heart looping [GO:0001947]; hippocampus development [GO:0021766]; intracellular transport [GO:0046907]; maintenance of protein location in nucleus [GO:0051457]; melanosome transport [GO:0032402]; microtubule anchoring at centrosome [GO:0034454]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of gene expression [GO:0010629]; negative regulation of GTPase activity [GO:0034260]; negative regulation of systemic arterial blood pressure [GO:0003085]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell outer segment organization [GO:0035845]; positive regulation of cilium assembly [GO:0045724]; positive regulation of multicellular organism growth [GO:0040018]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to organelle [GO:0033365]; protein localization to photoreceptor outer segment [GO:1903546]; protein transport [GO:0015031]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; regulation of cytokinesis [GO:0032465]; regulation of lipid metabolic process [GO:0019216]; regulation of non-motile cilium assembly [GO:1902855]; regulation of stress fiber assembly [GO:0051492]; retina homeostasis [GO:0001895]; retinal rod cell development [GO:0046548]; sensory perception of smell [GO:0007608]; sensory processing [GO:0050893]; social behavior [GO:0035176]; spermatid development [GO:0007286]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BBS5.1.1.m.56560,0,0,No,NA,NA,Q7ZWB7,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; phosphatidylinositol-3-phosphate binding [GO:0032266]; compound eye development [GO:0048749]; compound eye photoreceptor development [GO:0042051]; gastrulation [GO:0007369]; heart looping [GO:0001947]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; pigment granule aggregation in cell center [GO:0051877]; pronephros formation [GO:0072116],NA,NA,NA
CHOYP_BCAS0157.2.2.m.53484,0.0071891565336066,0.00319846353945766,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BCAS3.1.1.m.6968,0.000591562553847176,0.0242974211582253,No,NA,NA,Q9H6U6,NA,NA,NA,cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; histone acetyltransferase binding [GO:0035035]; histone binding [GO:0042393]; nuclear hormone receptor binding [GO:0035257]; transcription factor binding [GO:0008134]; activation of GTPase activity [GO:0090630]; angiogenesis [GO:0001525]; cellular response to estrogen stimulus [GO:0071391]; Golgi organization [GO:0007030]; microtubule organizing center organization [GO:0031023]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of catalytic activity [GO:0043085]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of establishment of cell polarity [GO:2000114]; response to starvation [GO:0042594]; tube formation [GO:0035148],NA,NA,NA
CHOYP_BCAT1.1.1.m.54127,0.00218344328843576,0.00044241421187308,No,NA,NA,Q5EA40,NA,NA,NA,mitochondrion [GO:0005739]; branched-chain-amino-acid transaminase activity [GO:0004084]; L-isoleucine transaminase activity [GO:0052656]; L-leucine transaminase activity [GO:0052654]; L-valine transaminase activity [GO:0052655]; cellular response to leukemia inhibitory factor [GO:1990830]; isoleucine catabolic process [GO:0006550]; leucine biosynthetic process [GO:0009098]; regulation of hormone levels [GO:0010817]; valine biosynthetic process [GO:0009099],NA,NA,NA
CHOYP_BCKD.2.2.m.60038,-0.00344213914032885,-0.00358326409307567,No,NA,NA,O14874,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity [GO:0047323]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; branched-chain amino acid catabolic process [GO:0009083]; cellular amino acid catabolic process [GO:0009063]; phosphorylation [GO:0016310],NA,NA,NA
CHOYP_BCL3.1.2.m.56007,0.00727852083215941,-0.00944521106234339,No,NA,NA,P20749,NA,NA,NA,Bcl3-Bcl10 complex [GO:0032996]; Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein binding; bridging [GO:0030674]; transcription factor binding [GO:0008134]; antimicrobial humoral response [GO:0019730]; cellular response to DNA damage stimulus [GO:0006974]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; maintenance of protein location in nucleus [GO:0051457]; marginal zone B cell differentiation [GO:0002315]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-8 biosynthetic process [GO:0045415]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor biosynthetic process [GO:0042536]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 biosynthetic process [GO:0045082]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translation [GO:0045727]; protein import into nucleus; translocation [GO:0000060]; regulation of apoptotic process [GO:0042981]; regulation of DNA binding [GO:0051101]; regulation of NIK/NF-kappaB signaling [GO:1901222]; response to UV-C [GO:0010225]; response to virus [GO:0009615]; spleen development [GO:0048536]; T-helper 1 type immune response [GO:0042088]; T-helper 2 cell differentiation [GO:0045064]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BCL3.2.2.m.57485,-6.05755471512551e-05,0.00803691745053272,No,NA,NA,Q9WTK5,NA,NA,NA,Bcl3/NF-kappaB2 complex [GO:0033257]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; aging [GO:0007568]; extracellular matrix organization [GO:0030198]; follicular dendritic cell differentiation [GO:0002268]; germinal center formation [GO:0002467]; lymph node development [GO:0048535]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; rhythmic process [GO:0048511]; spleen development [GO:0048536],NA,NA,NA
CHOYP_BCL7A.1.1.m.29528,0.00234555401966693,-0.00234506673002953,No,NA,NA,Q9CXE2,NA,NA,NA,,NA,NA,NA
CHOYP_BDH2.1.2.m.30737,0.00229110470413759,-0.00183027015426432,No,NA,NA,D4A1J4,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDH2.2.2.m.57286,0.0207792364316796,0.014711536755585,No,NA,NA,D4A1J4,NA,NA,NA,cytoplasm [GO:0005737]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; heme metabolic process [GO:0042168]; iron ion homeostasis [GO:0055072]; siderophore biosynthetic process [GO:0019290],NA,NA,NA
CHOYP_BDHB.1.1.m.9128,-0.0140306297413494,-0.0089290581329923,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BET1L.1.1.m.8210,-0.0193138744153207,0.0311527985374273,No,NA,NA,Q5RBX2,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BGAL.2.2.m.41942,-0.00296291634160703,0.00370625580078939,No,NA,NA,O19015,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BH13620.1.1.m.41020,-0.0104783447905633,-0.00666839275907497,No,NA,NA,P24928,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA-directed 5'-3' RNA polymerase activity [GO:0003968]; ubiquitin protein ligase binding [GO:0031625]; 7-methylguanosine mRNA capping [GO:0006370]; DNA-templated transcription; termination [GO:0006353]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of RNA splicing [GO:0033120]; regulation of gene silencing by miRNA [GO:0060964]; regulation of transcription; DNA-templated [GO:0006355]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BICD2.1.1.m.9177,-0.0112547122279127,0.0269907157090234,No,NA,NA,Q8BR07,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; host cell viral assembly compartment [GO:0072517]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; cytoskeletal adaptor activity [GO:0008093]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; dynein intermediate chain binding [GO:0045505]; protein kinase binding [GO:0019901]; proteinase activated receptor binding [GO:0031871]; Rab GTPase binding [GO:0017137]; microtubule anchoring at microtubule organizing center [GO:0072393]; minus-end-directed organelle transport along microtubule [GO:0072385]; negative regulation of phospholipase C activity [GO:1900275]; negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900737]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein localization to organelle [GO:0033365]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of proteinase activated receptor activity [GO:1900276]; stress granule assembly [GO:0034063]; viral process [GO:0016032],NA,NA,NA
CHOYP_BICRD.1.1.m.11088,0.00515346196476412,-0.0259446091010805,No,NA,NA,Q8SWR2,NA,NA,NA,,NA,NA,NA
CHOYP_BIG1.1.3.m.6444,0.00279573091967307,-0.00451251120635997,No,NA,NA,G3X9K3,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG1.3.3.m.34442,-0.00325104545808972,0.00542585112087516,No,NA,NA,Q9Y6D6,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; small nuclear ribonucleoprotein complex [GO:0030532]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; myosin binding [GO:0017022]; protein kinase A regulatory subunit binding [GO:0034237]; endomembrane system organization [GO:0010256]; exocytosis [GO:0006887]; Golgi organization [GO:0007030]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of GTPase activity [GO:0034260]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein glycosylation in Golgi [GO:0090284]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of wound healing [GO:0090303]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of establishment of cell polarity [GO:2000114]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BIG3.1.1.m.51447,-0.00269119659239507,0.00365350594588334,No,NA,NA,Q5TH69,NA,NA,NA,integral component of membrane [GO:0016021]; transport vesicle membrane [GO:0030658]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; negative regulation of phosphatase activity [GO:0010923]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_BIG3.1.1.m.51448,-0.000861043588810245,-0.00420338447236083,No,NA,NA,Q9Z2W1,NA,NA,NA,cytoplasm [GO:0005737]; Golgi membrane [GO:0000139]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; Golgi localization [GO:0051645]; Golgi reassembly [GO:0090168]; intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:0036481]; positive regulation of axonogenesis [GO:0050772]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; response to hydrogen peroxide [GO:0042542]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_BIR7B.2.2.m.60973,-0.0205887192351529,-0.026183878689926,No,NA,NA,P41436,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BIRA.1.1.m.18343,-0.0148145575271477,0.012283328740111,No,NA,NA,P0CI75,NA,NA,NA,ATP binding [GO:0005524]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; DNA binding [GO:0003677]; protein biotinylation [GO:0009305]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BIRC6.1.2.m.51516,0.00138331449181357,0.00408514634484535,No,NA,NA,Q9NR09,NA,NA,NA,endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465]; spongiotrophoblast layer development [GO:0060712]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BIRC7.3.5.m.22702,0.00524601030304887,-0.00997560143347285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BL1S2.1.1.m.11618,0.0152075774922927,-0.000285051528087061,No,NA,NA,Q66KB9,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; BORC complex [GO:0099078]; gamma-tubulin complex [GO:0000930]; lysosomal membrane [GO:0005765]; gamma-tubulin binding [GO:0043015]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; endosomal transport [GO:0016197]; lysosome localization [GO:0032418]; negative regulation of lymphoid progenitor cell differentiation [GO:1905457]; negative regulation of Notch signaling pathway [GO:0045746]; neuron projection development [GO:0031175]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of myeloid progenitor cell differentiation [GO:1905455],NA,NA,NA
CHOYP_BLIMP.1.1.1.m.55502,0.00724657281506952,-0.00941233420364001,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BLMH.1.1.m.66065,-0.000941967918080157,0.00143912171894771,No,NA,NA,Q13867,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; carboxypeptidase activity [GO:0004180]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; identical protein binding [GO:0042802]; homocysteine catabolic process [GO:0043418]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; response to drug [GO:0042493]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BLOC1S4.1.1.m.22903,-0.00121131045453822,-0.0102111069396559,No,NA,NA,Q8VED2,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; melanosome organization [GO:0032438]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_BLVRA.1.1.m.17904,-0.00840242339864667,-0.00209372324158052,No,NA,NA,Q9CY64,NA,NA,NA,cytosol [GO:0005829]; biliverdin reductase activity [GO:0004074]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BM1_00205.2.4.m.5170,-0.0165015901279097,0.0336816782872753,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_05690.1.1.m.23253,-0.00902493667729995,0.0260978594647907,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BM1_24035.1.1.m.40152,0.0016196500729208,0.00106081059318823,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BM1_57400.5.7.m.58033,0.00359481068643565,0.00337329750697068,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_BM8F.2.2.m.35731,0.0287390621553474,0.0210217841422944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BMS1.1.1.m.17619,-0.00692856013674187,0.00476855194647985,No,NA,NA,Q14692,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U3 snoRNA binding [GO:0034511]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BN6_64710.1.1.m.52168,-0.0145640099331566,-0.00926849997041724,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_BOP1.1.1.m.66373,-0.0148965930079616,0.00715497879688589,No,NA,NA,A0JMQ0,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_BPHL.1.1.m.55822,-0.00836451527525633,-0.0163568747633525,No,NA,NA,Q8R164,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BPTF.1.1.m.25244,-0.000902640592247193,-0.00603646742623049,No,NA,NA,Q9W0T1,NA,NA,NA,NURF complex [GO:0016589]; DNA binding [GO:0003677]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; nuclear receptor binding [GO:0016922]; chromatin organization [GO:0006325]; chromatin remodeling [GO:0006338]; ecdysone receptor-mediated signaling pathway [GO:0035076]; hemopoiesis [GO:0030097]; negative regulation of innate immune response [GO:0045824]; negative regulation of JAK-STAT cascade [GO:0046426]; nucleosome mobilization [GO:0042766]; positive regulation of Notch signaling pathway [GO:0045747]; pupariation [GO:0035073]; regulation of gene expression [GO:0010468]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatid differentiation [GO:0048515]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAF.2.3.m.21192,-0.0109189998244402,0.0139569041834767,No,NA,NA,P15056,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein heterodimerization activity [GO:0046982]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; animal organ morphogenesis [GO:0009887]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; CD4-positive; alpha-beta T cell differentiation [GO:0043367]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nerve growth factor stimulus [GO:1990090]; establishment of protein localization to membrane [GO:0090150]; face development [GO:0060324]; head morphogenesis [GO:0060323]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of synaptic vesicle exocytosis [GO:2000301]; positive regulation of axon regeneration [GO:0048680]; positive regulation of axonogenesis [GO:0050772]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein heterooligomerization [GO:0051291]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of T cell differentiation [GO:0045580]; response to cAMP [GO:0051591]; response to peptide hormone [GO:0043434]; somatic stem cell population maintenance [GO:0035019]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trehalose metabolism in response to stress [GO:0070413]; visual learning [GO:0008542],NA,NA,NA
CHOYP_BRAFLDRAFT_100614.1.1.m.31700,0.00287279419941677,0.00339269604549026,No,NA,NA,Q92636,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; sphingomyelin phosphodiesterase activator activity [GO:0016230]; ceramide metabolic process [GO:0006672]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ceramide biosynthetic process [GO:2000304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_100695.1.1.m.47761,-0.0202204542678826,-0.00208524512659003,No,NA,NA,Q2T9T0,NA,NA,NA,phosphatase binding [GO:0019902],NA,NA,NA
CHOYP_BRAFLDRAFT_101346.1.1.m.1028,0.00014764344146803,4.69520043811974e-05,No,NA,NA,Q6PDY2,NA,NA,NA,mitochondrion [GO:0005739]; cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_102226.1.1.m.48829,0.00536428422868387,-0.00973876470336267,No,NA,NA,O14975,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_102424.4.6.m.51652,-0.00225212370621217,0.00289148942915943,No,NA,NA,P28799,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_103544.1.1.m.38439,0.0234942260808511,0.0120950714992464,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_104092.10.11.m.53767,-0.0017452361709888,-0.00128101684886711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_104160.1.1.m.29524,-0.000147636564836288,-0.000772207093136665,No,NA,NA,Q91Z53,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_BRAFLDRAFT_104267.1.1.m.52332,0.0128998427808185,0.00314006916096405,No,NA,NA,Q5ZK69,NA,NA,NA,proteasome complex [GO:0000502],NA,NA,NA
CHOYP_BRAFLDRAFT_104472.1.1.m.16220,-0.00147645166837442,0.00136788703161289,No,NA,NA,Q6P963,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_BRAFLDRAFT_105037.1.1.m.17483,-0.012613972463185,-0.00268815853078042,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_105238.1.1.m.18657,-0.00124835559059424,0.00188307111256042,No,NA,NA,Q9H269,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; autophagosome maturation [GO:0097352]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; regulation of SNARE complex assembly [GO:0035542]; regulation of vacuole fusion; non-autophagic [GO:0032889]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.10.14.m.46985,-0.00742020995048257,5.28970083240687e-05,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62780,-0.0105344264483194,0.000651806897105609,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_106560.13.14.m.62781,-0.0349512936714177,0.00228546803658677,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_106560.4.14.m.5053,-0.00470728691984113,0.0157014272386071,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_107506.1.1.m.15759,0.00619654530288958,0.0285998464014082,No,NA,NA,Q29M42,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_108193.2.2.m.37878,0.00233616649423202,-0.00190862444860622,No,NA,NA,Q86VX2,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; NF-kappaB binding [GO:0051059]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of transcription; DNA-templated [GO:0045892]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.2.5.m.31493,-0.0132374014091414,0.00285733301339846,No,NA,NA,Q39565,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.3.5.m.34514,-0.00248910464163601,-0.00303792545753781,No,NA,NA,Q39565,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_108792.4.5.m.45892,-0.00767337744125466,0.0101414644513347,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_109077.1.1.m.7494,0,0,No,NA,NA,Q6CEJ6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_109340.1.1.m.30107,0.011014921210635,-0.0165964236910053,No,NA,NA,Q60769,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; nucleus [GO:0005634]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; kinase binding [GO:0019900]; Lys63-specific deubiquitinase activity [GO:0061578]; protease binding [GO:0002020]; protein self-association [GO:0043621]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; B-1 B cell homeostasis [GO:0001922]; cell migration [GO:0016477]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cytoskeleton organization [GO:0007010]; establishment of protein localization to vacuole [GO:0072666]; inflammatory response [GO:0006954]; marginal zone B cell differentiation [GO:0002315]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell activation [GO:0050869]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of cell death [GO:0060548]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of granuloma formation [GO:0002632]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070429]; negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070433]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; negative regulation of toll-like receptor 5 signaling pathway [GO:0034148]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein K11-linked deubiquitination [GO:0035871]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked deubiquitination [GO:0070536]; regulation of germinal center formation [GO:0002634]; regulation of immunoglobulin production [GO:0002637]; regulation of innate immune response [GO:0045088]; response to molecule of bacterial origin [GO:0002237]; response to muramyl dipeptide [GO:0032495]; response to wounding [GO:0009611]; tolerance induction to lipopolysaccharide [GO:0072573],NA,NA,NA
CHOYP_BRAFLDRAFT_109688.1.1.m.59704,-0.0144251897489711,-0.00720817115470809,No,NA,NA,P50174,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_BRAFLDRAFT_113534.1.1.m.10828,0.00110425089537381,-0.001556511322993,No,NA,NA,Q03161,NA,NA,NA,carbohydrate binding [GO:0030246]; glucose-6-phosphate 1-epimerase activity [GO:0047938]; cellular carbohydrate metabolic process [GO:0044262],NA,NA,NA
CHOYP_BRAFLDRAFT_113552.1.1.m.29171,0.00329345361177436,-0.00202004732261833,No,NA,NA,Q1W374,NA,NA,NA,cytoplasm [GO:0005737]; phosphomannomutase activity [GO:0004615]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_BRAFLDRAFT_113596.1.1.m.53557,0.00491806532035291,4.19678018977098e-05,No,NA,NA,A4IGP0,NA,NA,NA,cytosol [GO:0005829]; intracellular [GO:0005622]; nucleus [GO:0005634]; Hsp70 protein binding [GO:0030544]; protein transporter activity [GO:0008565]; cellular response to heat [GO:0034605]; protein import into nucleus [GO:0006606]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_113696.1.1.m.54166,0.00461291478520805,-0.00410309119499977,No,NA,NA,P20695,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; glial cell proliferation [GO:0014009]; muscle cell differentiation [GO:0042692]; neuroblast proliferation [GO:0007405]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53398,0.00120679592432083,-0.00403072357585171,No,NA,NA,Q9D8W5,NA,NA,NA,cytoplasm [GO:0005737]; nuclear proteasome complex [GO:0031595]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_113849.1.1.m.53400,0.00107097723252492,-0.00141416430056105,No,NA,NA,Q7ZUB2,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_113892.1.1.m.44055,0.00203734922196667,0.000968306371764288,No,NA,NA,P48508,NA,NA,NA,glutamate-cysteine ligase complex [GO:0017109]; enzyme regulator activity [GO:0030234]; glutamate-cysteine ligase activity [GO:0004357]; glutamate-cysteine ligase catalytic subunit binding [GO:0035226]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; hepatic stellate cell activation [GO:0035733]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of glutamate-cysteine ligase activity [GO:0035229]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to human chorionic gonadotropin [GO:0044752]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_114006.1.1.m.49056,-0.00907872045131913,-0.00986606504027916,No,NA,NA,Q6GNT9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_114106.1.1.m.28307,-0.00531593436744253,0.0041850181101383,No,NA,NA,P54921,NA,NA,NA,glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; SNARE complex [GO:0031201]; synaptobrevin 2-SNAP-25-syntaxin-1a complex [GO:0070044]; terminal bouton [GO:0043195]; vacuolar membrane [GO:0005774]; protein-containing complex binding [GO:0044877]; SNARE binding [GO:0000149]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; apical protein localization [GO:0045176]; brain development [GO:0007420]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; neuron differentiation [GO:0030182]; positive regulation of ATPase activity [GO:0032781]; protein-containing complex disassembly [GO:0032984]; regulation of synaptic vesicle priming [GO:0010807]; SNARE complex disassembly [GO:0035494]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_114158.1.1.m.24733,0.0111489617475346,-0.00326249901146563,No,NA,NA,Q5R9J9,NA,NA,NA,dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; synaptic vesicle [GO:0008021]; TRAPP complex [GO:0030008]; dendrite development [GO:0016358]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114204.1.1.m.15168,-0.0221964833089147,0.000792661915403963,No,NA,NA,A6QP05,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_114350.1.1.m.14176,-0.0333126981640779,0.00877809037536751,No,NA,NA,A6H791,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA (adenine-N1-)-methyltransferase activity [GO:0061953]; tRNA (adenine-N1-)-methyltransferase activity [GO:0016429]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_BRAFLDRAFT_114379.1.1.m.57424,-0.0026833683339052,-0.00357305696022378,No,NA,NA,Q9CRB6,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_BRAFLDRAFT_114488.1.1.m.6260,-0.0124056696909354,0.00682363585791859,No,NA,NA,Q9UNX4,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_114510.1.1.m.52252,-0.00386182805834994,0.00453440453806155,No,NA,NA,Q0VFM0,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_114633.1.1.m.49577,0.00937737127563367,0.0120178444548064,No,NA,NA,Q62348,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697],NA,NA,NA
CHOYP_BRAFLDRAFT_114709.1.1.m.17347,0.0240730420505933,0.00600568342115046,No,NA,NA,Q8IW92,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_114843.2.2.m.57232,0.000236920582536013,0.00546473101714314,No,NA,NA,Q7TP17,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2AF [GO:0089701]; metal ion binding [GO:0046872]; pre-mRNA 3'-splice site binding [GO:0030628]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_114859.1.1.m.37271,-0.0129938003991455,-0.00500445840669301,No,NA,NA,Q15119,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial pyruvate dehydrogenase complex [GO:0005967]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740]; cellular response to nutrient [GO:0031670]; cellular response to reactive oxygen species [GO:0034614]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular ketone metabolic process [GO:0010565]; regulation of gluconeogenesis [GO:0006111]; regulation of glucose metabolic process [GO:0010906]; regulation of pH [GO:0006885],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.1.5.m.6859,0.00214822988776668,-0.0028516842357149,No,NA,NA,Q3SZQ6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35626,-0.000100452579168263,0.0133276400203625,No,NA,NA,Q3SZQ6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_114866.4.5.m.35627,-0.000260355648743607,0.00179101554137849,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_114978.1.1.m.43775,0.00538163818024366,-0.0013749700377464,No,NA,NA,Q5IFJ8,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_BRAFLDRAFT_115029.1.2.m.8365,0.0284566048350437,0.00866177859670445,No,NA,NA,Q95NI4,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_115040.1.1.m.28389,0.00523628222750424,0.000282478251924647,No,NA,NA,Q8VC30,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; FAD-AMP lyase (cyclizing) activity [GO:0034012]; glycerone kinase activity [GO:0004371]; metal ion binding [GO:0046872]; triokinase activity [GO:0050354]; carbohydrate phosphorylation [GO:0046835]; cellular carbohydrate metabolic process [GO:0044262]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; glycerol catabolic process [GO:0019563]; glycolytic process through fructose-1-phosphate [GO:0061625]; negative regulation of MDA-5 signaling pathway [GO:0039534]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_BRAFLDRAFT_115113.1.2.m.31023,-0.000469657824189696,-0.000571426892835605,No,NA,NA,Q99417,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_115208.1.1.m.52467,0.00617446959434436,-0.00294016711646795,No,NA,NA,A4IIL4,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_115265.1.1.m.5158,-0.0179352504662246,-0.0040515409505313,No,NA,NA,Q5R792,NA,NA,NA,autophagosome [GO:0005776]; axoneme [GO:0005930]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; phagophore assembly site membrane [GO:0034045]; aggrephagy [GO:0035973]; antigen processing and presentation of endogenous antigen [GO:0019883]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of host cells involved in interaction with symbiont [GO:0075044]; autophagy of mitochondrion [GO:0000422]; blood vessel remodeling [GO:0001974]; cellular homeostasis [GO:0019725]; cellular response to nitrosative stress [GO:0071500]; cellular response to starvation [GO:0009267]; heart contraction [GO:0060047]; negative regulation of apoptotic process [GO:0043066]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative stranded viral RNA replication [GO:0039689]; negative thymic T cell selection [GO:0045060]; otolith development [GO:0048840]; positive regulation of mucus secretion [GO:0070257]; protein lipidation involved in autophagosome assembly [GO:0061739]; regulation of cilium assembly [GO:1902017]; regulation of cytokine secretion involved in immune response [GO:0002739]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to drug [GO:0042493]; response to fungus [GO:0009620]; vasodilation [GO:0042311]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_BRAFLDRAFT_115608.1.1.m.25984,0.00120639507138241,0.000753267358563821,No,NA,NA,Q4R502,NA,NA,NA,mitochondrion [GO:0005739]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_115611.1.1.m.33392,0.0068026478860226,0.0162376430741034,No,NA,NA,Q9DCN1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ diphosphatase activity [GO:0000210]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_BRAFLDRAFT_115639.1.1.m.11373,-0.0032372295952541,0.00133480337628131,No,NA,NA,Q9D287,NA,NA,NA,centrosome [GO:0005813]; DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_115687.1.1.m.4876,0.00239323273523838,0.000460761663492145,No,NA,NA,O57476,NA,NA,NA,cytoplasm [GO:0005737]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_115743.1.1.m.61177,-0.000400914040509748,0.000420551738166125,No,NA,NA,Q9WTP6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm mitochondrial sheath [GO:0097226]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060],NA,NA,NA
CHOYP_BRAFLDRAFT_115771.2.2.m.30817,-0.0028807269267368,-0.00233138381454325,No,NA,NA,Q0MQI9,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_BRAFLDRAFT_115951.1.1.m.22622,0.00575771104558983,-0.00268141400635514,No,NA,NA,P17276,NA,NA,NA,iron ion binding [GO:0005506]; phenylalanine 4-monooxygenase activity [GO:0004505]; tryptophan 5-monooxygenase activity [GO:0004510]; eye pigment biosynthetic process [GO:0006726]; L-phenylalanine catabolic process [GO:0006559]; long-term memory [GO:0007616]; serotonin biosynthetic process [GO:0042427]; tyrosine biosynthetic process [GO:0006571],NA,NA,NA
CHOYP_BRAFLDRAFT_116041.1.1.m.3962,-0.00464370161144822,0.00206531133272914,No,NA,NA,Q5I0D1,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_116053.1.1.m.63017,-0.0298965091591766,-0.00742706999386351,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_116088.2.2.m.27531,-0.00171590645776271,-0.00501782191703404,No,NA,NA,Q9H0A8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_116394.1.1.m.57079,0.00568406299870251,-0.00383029288609645,No,NA,NA,Q6NRT5,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_BRAFLDRAFT_116913.1.1.m.43886,0.000941249374139725,-0.00556019024996694,No,NA,NA,Q4QQQ7,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; brain development [GO:0007420]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_116988.1.3.m.3947,-0.00729444110705379,0.0136861490723349,No,NA,NA,P56941,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of lysosomal membrane [GO:1905103]; integral component of plasma membrane [GO:0005887]; late endosome membrane [GO:0031902]; lysosome [GO:0005764]; nuclear envelope [GO:0005635]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]; bile acid metabolic process [GO:0008206]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; lysosomal transport [GO:0007041]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_BRAFLDRAFT_117028.1.1.m.26596,-0.0166873394329998,0.022218876756076,No,NA,NA,Q96LR7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117068.1.1.m.36193,0.00258143726973831,0.00204428259639809,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117083.3.3.m.59001,-0.0163469098062027,-0.0013644775610647,No,NA,NA,Q0VB26,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117106.1.1.m.49365,0.000746802270599413,0.00145269578163613,No,NA,NA,Q0V8F1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117157.1.3.m.7944,-0.00529745566547933,-0.00212779697186808,No,NA,NA,Q502W6,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_117158.2.2.m.42430,0.0130311148500591,0.00515947135204842,No,NA,NA,Q9JKR5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; recycling endosome membrane [GO:0055038]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_117187.2.4.m.3553,0.00586583617823729,0.00692740162502405,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117216.1.1.m.25201,-0.0275238836775578,-0.0137938775070299,No,NA,NA,Q9JMD3,NA,NA,NA,cytosol [GO:0005829]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; microvillus [GO:0005902]; motile cilium [GO:0031514]; lipid binding [GO:0008289]; phospholipid transporter activity [GO:0005548]; bile acid secretion [GO:0032782]; phospholipid transport [GO:0015914]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360],NA,NA,NA
CHOYP_BRAFLDRAFT_117231.1.1.m.4966,0.00198476041006639,-0.000536338951545395,No,NA,NA,P36956,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; enzyme activator activity [GO:0008047]; nuclear receptor activity [GO:0004879]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sterol response element binding [GO:0032810]; aging [GO:0007568]; cellular response to fatty acid [GO:0071398]; cellular response to starvation [GO:0009267]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; insulin receptor signaling pathway [GO:0008286]; lipid biosynthetic process [GO:0008610]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of insulin secretion [GO:0046676]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid metabolic process [GO:0019217]; regulation of heart rate by chemical signal [GO:0003062]; regulation of protein stability [GO:0031647]; regulation of protein targeting to mitochondrion [GO:1903214]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cAMP [GO:0051591]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucose [GO:0009749]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_117263.1.1.m.28027,0.00241713308480672,0.000126271488742588,No,NA,NA,Q53T59,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; phosphatidylinositol binding [GO:0035091]; negative regulation of autophagy [GO:0010507]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_117275.1.1.m.9900,0.00112467994966768,-0.00229879351333266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117282.2.6.m.13259,-0.00612778250785968,-0.00110061895908764,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117283.2.2.m.37544,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117284.5.7.m.53216,-0.00396536915223717,-0.00055924414009587,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117292.1.1.m.19637,0.00304050603647393,-0.0211378078370238,No,NA,NA,P53352,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; mitotic cytokinesis [GO:0000281]; mitotic sister chromatid segregation [GO:0000070]; regulation of mitotic cytokinesis [GO:1902412],NA,NA,NA
CHOYP_BRAFLDRAFT_117315.1.2.m.7247,-0.00686529615367286,0.00282712992246312,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.1.2.m.12413,0.0053211890561477,0.00866566119264899,No,NA,NA,O43247,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117365.2.2.m.31681,-0.0139845787977266,-0.00645030881299655,No,NA,NA,O43247,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117560.1.1.m.18467,-0.0243448402693874,0.0160826525520582,No,NA,NA,Q3U829,NA,NA,NA,AP-5 adaptor complex [GO:0044599]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-strand break repair via homologous recombination [GO:0000724]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_117612.1.1.m.28286,0.00258214332841785,0.00148509313848477,No,NA,NA,P38024,NA,NA,NA,cytosol [GO:0005829]; 5-amino-4-imidazole carboxylate lyase activity [GO:0043727]; ATP binding [GO:0005524]; phosphoribosylaminoimidazole carboxylase activity [GO:0004638]; phosphoribosylaminoimidazolesuccinocarboxamide synthase activity [GO:0004639]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_BRAFLDRAFT_117629.2.2.m.31330,-0.00144768304199647,0.00835838084566434,No,NA,NA,Q8CE72,NA,NA,NA,ciliary transition zone [GO:0035869]; integral component of membrane [GO:0016021]; cardiac septum development [GO:0003279]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; coronary vasculature development [GO:0060976]; embryonic digit morphogenesis [GO:0042733]; establishment of planar polarity [GO:0001736]; heart development [GO:0007507]; kidney development [GO:0001822]; protein localization to ciliary transition zone [GO:1904491]; roof of mouth development [GO:0060021]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_BRAFLDRAFT_117631.1.1.m.45793,-0.0148726329926151,0.00755926394934764,No,NA,NA,Q99P25,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_117675.1.1.m.33772,-0.00117891264429664,-0.00112383304031362,No,NA,NA,Q4V847,NA,NA,NA,nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_BRAFLDRAFT_117737.1.1.m.4255,-0.00207190155261685,0.00142880771288725,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117750.1.1.m.12162,-0.00037465042238403,0.00415117876670338,No,NA,NA,Q7L0X2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27127,-0.000467667072239861,0.00368589013763388,No,NA,NA,Q86IV5,NA,NA,NA,extracellular region [GO:0005576]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; glucose homeostasis [GO:0042593]; multicellular organism development [GO:0007275]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of cAMP-mediated signaling [GO:0043949]; regulation of glucose-6-phosphatase activity [GO:0032114]; regulation of glycolytic process [GO:0006110]; response to UV-C [GO:0010225],NA,NA,NA
CHOYP_BRAFLDRAFT_117811.1.1.m.27128,0.0291234954591218,0.00707255345744472,No,NA,NA,Q6P823,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; nucleosomal DNA binding [GO:0031492]; protein heterodimerization activity [GO:0046982]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_BRAFLDRAFT_117821.1.1.m.16201,-0.00844507756223463,-0.0168891199526055,No,NA,NA,O88384,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; regulation of protein localization to plasma membrane [GO:1903076]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_BRAFLDRAFT_117849.1.3.m.2806,-0.000626980734831514,0.00909408000259829,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.2.3.m.4489,0.00671869091073754,0.00793460112400615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117849.3.3.m.5503,0.00311400482713407,0.00652826313840407,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117858.2.3.m.48274,0.000476664450087578,0.000519998392149513,No,NA,NA,Q8K2Z2,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA 5'-splice site recognition [GO:0000395],NA,NA,NA
CHOYP_BRAFLDRAFT_117858.3.3.m.61651,-0.0158267956802398,0.00126735151339145,No,NA,NA,Q5PPV2,NA,NA,NA,motile cilium [GO:0031514]; cell projection organization [GO:0030030],NA,NA,NA
CHOYP_BRAFLDRAFT_117875.1.1.m.48427,0.010805236741724,-0.00589010854890569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_117937.1.1.m.18686,-0.000894630476389609,0.00188784699028762,No,NA,NA,Q6DBY2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleus [GO:0005634]; H4 histone acetyltransferase activity [GO:0010485]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptidyl-lysine acetyltransferase activity [GO:0052858]; establishment of mitotic sister chromatid cohesion [GO:0034087]; histone acetylation [GO:0016573]; mitotic sister chromatid cohesion [GO:0007064]; mitotic sister chromatid cohesion; centromeric [GO:0071962]; N-terminal protein amino acid acetylation [GO:0006474]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_117940.1.1.m.59223,0,0,No,NA,NA,Q00808,NA,NA,NA,GTP binding [GO:0005525],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.1.3.m.22767,-0.0029303913946226,0.000713364794249862,No,NA,NA,Q4R8T1,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_117976.2.3.m.49156,-0.00762664151701842,0.00164497851979341,No,NA,NA,Q5THR3,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_118043.1.1.m.26278,0.00380984783036779,0.0115107685830642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118054.1.1.m.18488,-0.0128273770874696,-0.00816331111427457,No,NA,NA,Q888A4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on NAD(P)H; oxygen as acceptor [GO:0050664],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.2.6.m.3049,-0.00148265925030499,0.00746210066020977,No,NA,NA,Q6PGL7,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; retromer complex binding [GO:1905394]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118099.6.6.m.45150,0.0122711896339094,-0.0209378116538167,No,NA,NA,Q80X08,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; WASH complex [GO:0071203]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_118103.1.1.m.41767,0.0238006826252818,-0.00971146286681784,No,NA,NA,O14523,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; insulin binding [GO:0043559]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid transporter activity [GO:0005548]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774],NA,NA,NA
CHOYP_BRAFLDRAFT_118108.1.1.m.58962,0.00688805521154952,0.00670261894151154,No,NA,NA,Q90ZE4,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; aspartic-type endopeptidase activity [GO:0004190]; endopeptidase activity [GO:0004175]; amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; brain development [GO:0007420]; calcium ion transport [GO:0006816]; melanocyte differentiation [GO:0030318]; membrane protein ectodomain proteolysis [GO:0006509]; neurogenesis [GO:0022008]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; protein processing [GO:0016485]; somite development [GO:0061053],NA,NA,NA
CHOYP_BRAFLDRAFT_118210.1.1.m.51280,0.00237377844888444,-0.000641462736770908,No,NA,NA,B9FAF3,NA,NA,NA,kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_118260.1.1.m.13621,-0.000770045970372896,-0.00049548919990087,No,NA,NA,Q5R6L5,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265],NA,NA,NA
CHOYP_BRAFLDRAFT_118294.2.2.m.15439,-0.000823154224705554,0.00384402967874118,No,NA,NA,Q9R064,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; cell differentiation [GO:0030154]; establishment of protein localization to plasma membrane [GO:0061951]; Golgi organization [GO:0007030]; organelle organization [GO:0006996]; response to endoplasmic reticulum stress [GO:0034976]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_118310.1.1.m.8287,-0.00144841785694272,0.00252258619706223,No,NA,NA,P46461,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; neuromuscular junction [GO:0031594]; neuromuscular junction of somatic muscle [GO:0098527]; presynaptic cytosol [GO:0099523]; terminal bouton [GO:0043195]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; autophagy [GO:0006914]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle docking [GO:0048211]; neuromuscular synaptic transmission [GO:0007274]; neuron cellular homeostasis [GO:0070050]; neurotransmitter secretion [GO:0007269]; regulation of neuromuscular synaptic transmission [GO:1900073]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; SNARE complex disassembly [GO:0035494]; synaptic vesicle cycle [GO:0099504]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_BRAFLDRAFT_118365.1.1.m.44334,-0.0146899992212457,-0.00934867924235446,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.1.3.m.29148,-0.00822652555379897,-0.00460374384409124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.2.3.m.29362,-0.000156179613906719,0.000550563382291128,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118423.3.3.m.30322,-0.00792567560337215,0.00230682344440272,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118430.2.2.m.44188,-0.0088213264215502,-0.00561387035936045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118500.1.1.m.46374,-0.00735584817090215,0.0097319012971942,No,NA,NA,O75131,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.3.8.m.35521,0.00654027172365009,-0.000520660622528748,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.6.8.m.55199,0.00501405064708851,-0.00910292172842582,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118535.8.8.m.61819,-0.000209357266553507,-0.000108735220744759,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_118545.2.2.m.54585,-4.58870637257419e-05,0.00608810915550234,No,NA,NA,A0JPH4,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sterol binding [GO:0032934]; cholesterol metabolic process [GO:0008203]; SREBP signaling pathway [GO:0032933],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.2.5.m.17419,0.00378168897188399,0.000361628860471855,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_118602.3.5.m.19626,0.0332580855088073,-0.0287416311486793,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118602.4.5.m.26803,-0.00267140305109356,0.00316414416434123,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118619.2.2.m.4663,-0.0101759703037941,0.00282132364414978,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118645.1.1.m.30629,-0.000214322235296413,0.0142296205044221,No,NA,NA,M4YFG7,NA,NA,NA,FMN binding [GO:0010181]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_118680.1.1.m.14225,-0.000758045465198278,-0.0107737040278783,No,NA,NA,Q9CZT4,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_118709.2.4.m.41225,0.00818947119498794,-0.00156236501143659,No,NA,NA,O15050,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118709.3.4.m.52468,0.00566335901235295,-0.0102817297705916,No,NA,NA,Q8BV79,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_118718.1.1.m.14739,-0.00455313282653095,0.0119233367022714,No,NA,NA,O75594,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan receptor activity [GO:0016019]; zinc ion binding [GO:0008270]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antimicrobial humoral response [GO:0019730]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; growth of symbiont in host [GO:0044117]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; neutrophil degranulation [GO:0043312]; peptidoglycan catabolic process [GO:0009253]; positive regulation of cytolysis in other organism [GO:0051714],NA,NA,NA
CHOYP_BRAFLDRAFT_118735.1.1.m.6990,0.0040694253304711,0.0183035776034758,No,NA,NA,Q5RKZ7,NA,NA,NA,molybdopterin synthase complex [GO:0019008]; 4 iron; 4 sulfur cluster binding [GO:0051539]; cyclic pyranopterin monophosphate synthase activity [GO:0061799]; GTP 3';8'-cyclase activity [GO:0061798]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_BRAFLDRAFT_118736.1.1.m.17458,0.00139663202763083,0.00092445187896779,No,NA,NA,Q8IYD8,NA,NA,NA,FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; nuclease activity [GO:0004518]; interstrand cross-link repair [GO:0036297]; positive regulation of protein monoubiquitination [GO:1902527]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712],NA,NA,NA
CHOYP_BRAFLDRAFT_118756.1.2.m.16721,0.0157955596786347,0.00961062580620066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_118772.1.1.m.59465,-0.000761186952765464,-0.0142841791397881,No,NA,NA,A2RT91,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_118789.2.3.m.59829,-0.00216192002167076,0.000690531419601865,No,NA,NA,P52758,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; peroxisome [GO:0005777]; deaminase activity [GO:0019239]; endoribonuclease activity; producing 3'-phosphomonoesters [GO:0016892]; long-chain fatty acid binding [GO:0036041]; platinum binding [GO:1904012]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]; xenon atom binding [GO:1904013]; brain development [GO:0007420]; G1 to G0 transition [GO:0070314]; kidney development [GO:0001822]; L-threonine catabolic process to glycine [GO:0019518]; lung development [GO:0030324]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of translation [GO:0017148]; organonitrogen compound catabolic process [GO:1901565]; response to lipid [GO:0033993]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_118790.1.1.m.29970,0.00721120986654216,0.00812583615555128,No,NA,NA,Q9C6B9,NA,NA,NA,cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; phosphatidylcholine biosynthetic process [GO:0006656],NA,NA,NA
CHOYP_BRAFLDRAFT_118793.1.1.m.20795,0.00197908584986692,0.0174257865764553,No,NA,NA,A4IFB6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; mRNA catabolic process [GO:0006402]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_118803.1.1.m.14069,0.00692344515935648,-0.010852180889535,No,NA,NA,Q9HCD5,NA,NA,NA,actin cytoskeleton [GO:0015629]; extracellular space [GO:0005615]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; glucose homeostasis [GO:0042593]; negative regulation of insulin receptor signaling pathway [GO:0046627],NA,NA,NA
CHOYP_BRAFLDRAFT_118819.1.2.m.29565,-0.0090364955444624,-0.00575080345803996,No,NA,NA,O75460,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; Ire1 complex [GO:1990332]; IRE1-RACK1-PP2A complex [GO:1990630]; IRE1-TRAF2-ASK1 complex [GO:1990604]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; endoribonuclease activity [GO:0004521]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; unfolded protein binding [GO:0051082]; activation of JUN kinase activity [GO:0007257]; cell cycle arrest [GO:0007050]; cellular response to glucose stimulus [GO:0071333]; cellular response to unfolded protein [GO:0034620]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell proliferation [GO:0001935]; insulin metabolic process [GO:1901142]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; IRE1-mediated unfolded protein response [GO:0036498]; mRNA catabolic process [GO:0006402]; mRNA cleavage [GO:0006379]; mRNA cleavage involved in mRNA processing [GO:0098787]; mRNA splicing; via endonucleolytic cleavage and ligation [GO:0070054]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine trans-autophosphorylation [GO:1990579]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of RNA splicing [GO:0033120]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of macroautophagy [GO:0016241]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_118867.1.1.m.27944,0.0154573643868741,-0.00903165041144981,No,NA,NA,P26221,NA,NA,NA,cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_BRAFLDRAFT_118961.1.1.m.8363,-0.0146949530886393,-0.00369559946192846,No,NA,NA,Q5RF36,NA,NA,NA,CIA complex [GO:0097361]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_119035.1.3.m.6973,-0.0167430517780068,0.00749274920521221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119036.1.1.m.18576,-0.004546562649267,0.00593006489386055,No,NA,NA,Q8R3P7,NA,NA,NA,centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intracellular membrane-bounded organelle [GO:0043231]; intraciliary transport particle B [GO:0030992]; nucleoplasm [GO:0005654]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; floor plate formation [GO:0021508]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; neural tube closure [GO:0001843]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_119209.1.1.m.4850,-0.0216406988174252,0.00419569680415463,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119350.1.1.m.50169,0.00256735037837551,0.00365558903525565,No,NA,NA,Q5ZKD7,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; P-body [GO:0000932]; ATP binding [GO:0005524]; ATP-dependent 5'-3' RNA helicase activity [GO:0032575]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; gene silencing by miRNA [GO:0035195]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; negative regulation of transposition; RNA-mediated [GO:0010526]; positive regulation of mRNA catabolic process [GO:0061014]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of neuron projection arborization [GO:0150011],NA,NA,NA
CHOYP_BRAFLDRAFT_119363.1.1.m.41627,0.0169267718040755,-0.0176537642198537,No,NA,NA,Q6KAR6,NA,NA,NA,exocyst [GO:0000145]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; presynaptic membrane [GO:0042734]; secretory granule membrane [GO:0030667]; SNARE binding [GO:0000149]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_119367.1.1.m.59963,0.00226419841017837,-0.000611851080486432,No,NA,NA,Q3UWM4,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone demethylase activity (H3-K27 specific) [GO:0071558]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K9 specific) [GO:0032454]; histone demethylase activity (H4-K20 specific) [GO:0035575]; iron ion binding [GO:0005506]; methylated histone binding [GO:0035064]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; zinc ion binding [GO:0008270]; histone H3-K27 demethylation [GO:0071557]; histone H3-K36 demethylation [GO:0070544]; histone H3-K9 demethylation [GO:0033169]; histone H4-K20 demethylation [GO:0035574]; midbrain development [GO:0030901]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_119424.1.1.m.15350,-0.00994736399100266,-0.00633047788895286,No,NA,NA,Q6DJK9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119484.2.3.m.60445,0.014605012103153,0.00184264369208602,No,NA,NA,B5DF93,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nuclear speck [GO:0016607]; P-body [GO:0000932]; PML body [GO:0016605]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290],NA,NA,NA
CHOYP_BRAFLDRAFT_119491.1.1.m.58761,-0.00324358126003917,-0.0161675763480614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_119549.1.1.m.56597,-0.0111111718235746,-0.00707112232075916,No,NA,NA,Q5BK43,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_119616.1.1.m.31670,0.0021205822851361,0.000931805056686844,No,NA,NA,P30841,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_BRAFLDRAFT_119617.1.1.m.50138,-0.0141014804983133,-0.0024873639370527,No,NA,NA,Q2YDR3,NA,NA,NA,integral component of membrane [GO:0016021]; 3'-nucleotidase activity [GO:0008254]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; metal ion binding [GO:0046872]; inositol biosynthetic process [GO:0006021]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_119774.4.4.m.33349,-0.00570692037422993,-0.00176180553387367,No,NA,NA,Q80ZA4,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_119799.1.1.m.23765,-0.00116875354321066,-0.00288702246752214,No,NA,NA,P30044,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; antioxidant activity [GO:0016209]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; peroxynitrite reductase activity [GO:0072541]; protein dimerization activity [GO:0046983]; RNA polymerase III regulatory region DNA binding [GO:0001016]; signaling receptor binding [GO:0005102]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; hydrogen peroxide catabolic process [GO:0042744]; inflammatory response [GO:0006954]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of transcription by RNA polymerase III [GO:0016480]; positive regulation of collagen biosynthetic process [GO:0032967]; reactive nitrogen species metabolic process [GO:2001057]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_119901.1.1.m.7089,-0.00305184882212147,0.00917987650224753,No,NA,NA,P49916,NA,NA,NA,cytoplasm [GO:0005737]; DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270]; base-excision repair; DNA ligation [GO:0006288]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]; nucleotide-excision repair; DNA gap filling [GO:0006297]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45319,-0.0123905469919928,0.000195591953424951,No,NA,NA,B0DOB4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; non-motile cilium [GO:0097730]; negative regulation of canonical Wnt signaling pathway [GO:0090090],NA,NA,NA
CHOYP_BRAFLDRAFT_119906.1.1.m.45320,-0.0025587703952921,-0.00555335890714356,No,NA,NA,Q9CR41,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein N-terminus binding [GO:0047485]; negative regulation of apoptotic process [GO:0043066]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_BRAFLDRAFT_119955.1.1.m.16485,0.0039976138702457,-0.00660781726354987,No,NA,NA,Q6NU94,NA,NA,NA,nucleus [GO:0005634]; tRNA (guanine-N7-)-methyltransferase activity [GO:0008176]; tRNA binding [GO:0000049]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_BRAFLDRAFT_119982.1.1.m.62398,-0.0088345257619115,0.0083311296345602,No,NA,NA,O95243,NA,NA,NA,chromatin [GO:0000785]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; endodeoxyribonuclease activity [GO:0004520]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; satellite DNA binding [GO:0003696]; depyrimidination [GO:0045008]; DNA repair [GO:0006281]; response to estradiol [GO:0032355]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_BRAFLDRAFT_120041.1.1.m.6386,-0.0150791026820324,-0.00959630372430294,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120058.1.1.m.9895,-0.0104263473266881,-0.00117896158596009,No,NA,NA,Q8WWB3,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_BRAFLDRAFT_120093.2.2.m.51468,0.000638255983463853,-0.00260052360072435,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120139.4.5.m.50713,-0.00774374065477542,-0.00492809743738954,No,NA,NA,Q60997,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular matrix [GO:0031012]; extrinsic component of membrane [GO:0019898]; integral component of membrane [GO:0016021]; phagocytic vesicle membrane [GO:0030670]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; extracellular matrix structural constituent [GO:0005201]; scavenger receptor activity [GO:0005044]; zymogen binding [GO:0035375]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inner cell mass cell proliferation [GO:0001833]; positive regulation of epithelial cell differentiation [GO:0030858]; protein transport [GO:0015031]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_120431.1.1.m.49038,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120433.1.1.m.66614,-0.0109312787741614,-0.000994501461719305,No,NA,NA,Q5BJ68,NA,NA,NA,integral component of membrane [GO:0016021]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; FAD binding [GO:0071949]; response to yeast [GO:0001878]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_BRAFLDRAFT_120586.1.1.m.41856,0.0181557497912344,0.0108800072363426,No,NA,NA,Q9ULC5,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467]; long-chain fatty acid metabolic process [GO:0001676]; long-chain fatty-acyl-CoA biosynthetic process [GO:0035338]; regulation of extrinsic apoptotic signaling pathway [GO:2001236],NA,NA,NA
CHOYP_BRAFLDRAFT_120588.1.1.m.22993,-0.0139488989726368,-0.00887704487353475,No,NA,NA,Q9JMB1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_120607.1.3.m.8455,-0.00890697424099746,0.0010809781294465,No,NA,NA,Q6Q759,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; motile cilium [GO:0031514]; axonemal central apparatus assembly [GO:1904158]; epithelial cilium movement [GO:0003351],NA,NA,NA
CHOYP_BRAFLDRAFT_120767.1.1.m.16005,-0.0032760458382716,0.00444748368920148,No,NA,NA,Q8K1J5,NA,NA,NA,nucleus [GO:0005634]; damaged DNA binding [GO:0003684]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; protein processing [GO:0016485]; protein ubiquitination [GO:0016567]; regulation of cell cycle arrest [GO:0071156],NA,NA,NA
CHOYP_BRAFLDRAFT_120826.1.1.m.56321,-0.00584038095846353,-0.00226532696538769,No,NA,NA,A1A4L0,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; early endosome membrane [GO:0031901]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; transferrin receptor binding [GO:1990459]; endocytic recycling [GO:0032456]; positive regulation of histamine secretion by mast cell [GO:1903595]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_120908.1.1.m.5866,0.00155478505357627,-0.00251217577404783,No,NA,NA,Q865F7,NA,NA,NA,cytoplasm [GO:0005737]; lipid binding [GO:0008289]; hibernation [GO:0042750],NA,NA,NA
CHOYP_BRAFLDRAFT_120923.3.3.m.58916,0.00303007370257934,-0.000159029243644556,No,NA,NA,Q3B8G0,NA,NA,NA,zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_120970.1.1.m.63798,0.00486500434580476,0.0234978025879881,No,NA,NA,O75131,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; protein serine/threonine kinase activity [GO:0004674]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; transporter activity [GO:0005215]; cellular response to calcium ion [GO:0071277]; cellular response to growth factor stimulus [GO:0071363]; ERBB2 signaling pathway [GO:0038128]; glycerophospholipid biosynthetic process [GO:0046474]; lipid metabolic process [GO:0006629]; neutrophil degranulation [GO:0043312]; positive regulation of cell migration [GO:0030335]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_120990.1.18.m.2376,-0.00971252636666321,-0.0014690228110021,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120990.10.18.m.51025,0.00271588451569059,-0.00073390956725862,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_120993.1.2.m.41307,0.00502192732366722,-0.0090384845918455,No,NA,NA,Q60431,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_BRAFLDRAFT_121045.1.1.m.55827,-0.0147256612846763,-0.00104055171909104,No,NA,NA,Q5XM24,NA,NA,NA,extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; chemorepellent activity [GO:0045499]; peptidase activity [GO:0008233]; signaling receptor binding [GO:0005102]; cell cycle [GO:0007049]; negative chemotaxis [GO:0050919]; negative regulation of asexual reproduction [GO:1903665]; protein localization to plasma membrane [GO:0072659]; regulation of aggregate size involved in sorocarp development [GO:0031157]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_BRAFLDRAFT_121105.1.1.m.41883,-0.00643022582614086,0.00442070969918047,No,NA,NA,Q32NR4,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121138.1.1.m.787,-0.00113449922194255,0.00715061882918739,No,NA,NA,Q95KU9,NA,NA,NA,cytoplasm [GO:0005737]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cellular response to DNA damage stimulus [GO:0006974]; establishment of vesicle localization [GO:0051650]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_121151.1.1.m.59381,-0.00640713526387857,-0.0115366463860442,No,NA,NA,Q9Y5X3,NA,NA,NA,brush border [GO:0005903]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of endosome membrane [GO:0031313]; macropinocytic cup [GO:0070685]; phagocytic cup [GO:0001891]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; ruffle [GO:0001726]; tubular endosome [GO:0097422]; cadherin binding [GO:0045296]; D1 dopamine receptor binding [GO:0031748]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; protein heterodimerization activity [GO:0046982]; epidermal growth factor catabolic process [GO:0007174]; intracellular protein transport [GO:0006886]; negative regulation of blood pressure [GO:0045776]; pinocytosis [GO:0006907]; positive regulation of renal sodium excretion [GO:0035815]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_121259.1.1.m.2411,0.00270246775434063,0.00744468262114008,No,NA,NA,Q8BUV8,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; clathrin heavy chain binding [GO:0032050]; clathrin-dependent endocytosis [GO:0072583],NA,NA,NA
CHOYP_BRAFLDRAFT_121459.1.1.m.21810,-0.00390439162964596,0.0165927436704536,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_121480.1.1.m.48790,0.0095530462184486,0.00471556081999955,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_121507.1.2.m.30603,-0.00795046179411126,0.00588497290856084,No,NA,NA,Q5TYW6,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; cilium movement involved in cell motility [GO:0060294]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37267,0.000729116642534306,-0.00269627490841867,No,NA,NA,V5YMB3,NA,NA,NA,dipeptidyl-peptidase activity [GO:0008239]; endopeptidase activity [GO:0004175]; serine-type peptidase activity [GO:0008236]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_121562.1.1.m.37268,0.00374947173729283,-0.0018378988252138,No,NA,NA,Q5R9R4,NA,NA,NA,postsynaptic density [GO:0014069]; ribosome [GO:0005840]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_121667.1.2.m.12193,-0.033182160990732,-0.0119743539557569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121824.1.1.m.37419,-0.0110415244116496,-0.00490032131701832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121887.1.1.m.59668,-0.0103818303067318,0.0137019729627478,No,NA,NA,Q99973,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_121902.1.1.m.64757,0.00943548390664144,0.00331880211897291,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_121927.1.1.m.47211,-0.0209129729608322,0.0093160171124836,No,NA,NA,Q6ZTR5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122018.1.1.m.21774,-0.0108617864619728,0.0187623155405215,No,NA,NA,O08658,NA,NA,NA,nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_BRAFLDRAFT_122339.1.1.m.58748,-0.013147813501788,-0.0204936288427927,No,NA,NA,Q9CQ46,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_122376.1.1.m.49446,-0.00899396391316395,-0.00572373643287033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122381.3.4.m.23140,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_122389.1.1.m.15498,-0.000668434740208473,0.00669908599717277,No,NA,NA,Q11118,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; cell cycle [GO:0007049]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457],NA,NA,NA
CHOYP_BRAFLDRAFT_122422.1.2.m.52874,-0.00110282471537387,-0.00123863468660464,No,NA,NA,P51610,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; Set1C/COMPASS complex [GO:0048188]; activating transcription factor binding [GO:0033613]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; protein binding; bridging [GO:0030674]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription coactivator activity [GO:0003713]; blastocyst hatching [GO:0001835]; cell cycle [GO:0007049]; cellular response to organic cyclic compound [GO:0071407]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; mitochondrion organization [GO:0007005]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle [GO:0045787]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of protein complex assembly [GO:0043254]; regulation of transcription; DNA-templated [GO:0006355]; release from viral latency [GO:0019046],NA,NA,NA
CHOYP_BRAFLDRAFT_122572.1.1.m.29320,-0.0282293271065356,-0.00648242903290915,No,NA,NA,Q5PQ44,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122634.2.2.m.43678,0.0173622370790554,-0.00980199482622469,No,NA,NA,Q9Y6R7,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_122687.1.1.m.47713,0.00353845537886513,-0.012720134611984,No,NA,NA,Q5XIA2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_122791.1.6.m.8640,0.000188440596555882,0.0181982804139978,No,NA,NA,Q9UIF8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_122807.1.1.m.3729,0.00117474884894179,-5.64613871056979e-06,No,NA,NA,Q99MD6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein disulfide oxidoreductase activity [GO:0015035]; thioredoxin-disulfide reductase activity [GO:0004791]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_122887.1.1.m.62170,0.00409561012316067,-0.00113346495290113,No,NA,NA,Q3ULZ2,NA,NA,NA,cilium [GO:0005929]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; actin binding [GO:0003779]; microtubule binding [GO:0008017]; cilium assembly [GO:0060271]; Golgi ribbon formation [GO:0090161]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_BRAFLDRAFT_122922.1.1.m.17746,0.00346790882451116,0.00409551110811503,No,NA,NA,Q9UHB4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; cell death [GO:0008219]; cellular response to menadione [GO:0036245]; iron-sulfur cluster assembly [GO:0016226]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_122927.1.1.m.51870,-0.0337619822613483,0.0079141690543214,No,NA,NA,Q66J69,NA,NA,NA,chromosome [GO:0005694]; MLL1 complex [GO:0071339]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; histone H2A-K119 monoubiquitination [GO:0036353]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_BRAFLDRAFT_122970.1.1.m.52022,-0.0154206666524464,-0.00265582701618563,No,NA,NA,Q5VVH5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_123087.1.2.m.6329,-0.00502648030473011,-0.00233472676707499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123087.2.2.m.27308,0.001010470721964,0.0065654785652637,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_123202.1.1.m.17267,-0.0108044821612501,0.0189448167144867,No,NA,NA,P08836,NA,NA,NA,cytoplasm [GO:0005737]; dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384],NA,NA,NA
CHOYP_BRAFLDRAFT_123291.1.1.m.11923,-0.0187166479367842,-0.0348491538221913,No,NA,NA,B6CZ61,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_123298.1.1.m.483,-0.01209625059684,0.020278608876763,No,NA,NA,P24386,NA,NA,NA,cytosol [GO:0005829]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; post-translational protein modification [GO:0043687]; protein geranylgeranylation [GO:0018344]; protein targeting to membrane [GO:0006612]; regulation of apoptotic process [GO:0042981]; small GTPase mediated signal transduction [GO:0007264]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123304.1.1.m.29231,0.00667135662595219,-0.0066214152516829,No,NA,NA,Q6GQJ2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_BRAFLDRAFT_123389.1.1.m.57156,0.000498270514266109,0.00525053823658959,No,NA,NA,Q05AL1,NA,NA,NA,cytoplasm [GO:0005737]; GID complex [GO:0034657]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_123397.1.1.m.42218,-0.0136609071065019,0.000658082571498635,No,NA,NA,Q8WXR4,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; motor activity [GO:0003774]; protein serine/threonine kinase activity [GO:0004674]; cochlea morphogenesis [GO:0090103]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.1.2.m.28822,-0.00241851404919372,0.0137913447382028,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123537.2.2.m.50531,-0.0295024072907337,0.0131856077293457,No,NA,NA,Q9UIF3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_BRAFLDRAFT_123540.1.1.m.10582,-0.0119329786290994,0.00520987498350314,No,NA,NA,Q4R5Y0,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BRAFLDRAFT_123636.1.1.m.16162,0.00344685324881725,-0.00701355275726848,No,NA,NA,Q8C0J2,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytosol [GO:0005829]; phagophore assembly site membrane [GO:0034045]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; autophagosome assembly [GO:0000045]; negative stranded viral RNA replication [GO:0039689]; positive regulation of autophagy [GO:0010508]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; protein transport [GO:0015031]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_BRAFLDRAFT_123642.2.2.m.55471,0.000867335553685448,-0.00561427484147357,No,NA,NA,Q8N6T3,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein transport [GO:0015031]; regulation of ARF protein signal transduction [GO:0032012]; regulation of endocytosis [GO:0030100]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_BRAFLDRAFT_123736.1.1.m.48671,-0.000220801536900606,0.00523150822847786,No,NA,NA,A0A0R4IVV0,NA,NA,NA,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phospholipid transporter activity [GO:0005548]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; long-chain fatty acid transport [GO:0015909]; medium-chain fatty acid transport [GO:0001579]; sprouting angiogenesis [GO:0002040],NA,NA,NA
CHOYP_BRAFLDRAFT_123741.1.1.m.31088,0.00325499563537499,0.00261296609912602,No,NA,NA,Q7RTY7,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_123768.1.1.m.7223,-0.0102928123560198,-0.0166171202693112,No,NA,NA,Q6ZMT9,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_123909.1.1.m.24337,-0.00199915209123883,-0.00209058006538527,No,NA,NA,Q3UYG8,NA,NA,NA,centrosome [GO:0005813]; nucleolus [GO:0005730]; nucleus [GO:0005634]; deacetylase activity [GO:0019213]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; protein de-ADP-ribosylation [GO:0051725]; purine nucleoside metabolic process [GO:0042278]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_123969.1.1.m.15145,-0.00588207801933945,0.0111397061529265,No,NA,NA,Q9QXT0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; negative regulation of gene expression [GO:0010629]; positive regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045716]; regulation of low-density lipoprotein particle clearance [GO:0010988],NA,NA,NA
CHOYP_BRAFLDRAFT_123986.1.1.m.47284,-0.005188924166632,0.00635952499870839,No,NA,NA,Q7ZY18,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_BRAFLDRAFT_124020.1.1.m.22574,0.00154549556903993,-0.000575592315905964,No,NA,NA,Q9HBK9,NA,NA,NA,cytosol [GO:0005829]; arsenite methyltransferase activity [GO:0030791]; methylarsonite methyltransferase activity [GO:0030792]; arsonoacetate metabolic process [GO:0018872]; methylation [GO:0032259]; toxin metabolic process [GO:0009404],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.1.2.m.22812,0.00120987887225488,0.00059432965520907,No,NA,NA,B4JG34,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124027.2.2.m.50286,-0.0162053178067538,-0.0027446980053086,No,NA,NA,B4JG34,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; dorsal/ventral pattern formation [GO:0009953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.1.6.m.5120,-0.00137381626524276,-0.0270318583727921,No,NA,NA,Q66IM5,NA,NA,NA,N-acyltransferase activity [GO:0016410]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.3.6.m.38212,0.0208508269083906,-0.000820735412422651,No,NA,NA,P35543,NA,NA,NA,high-density lipoprotein particle [GO:0034364]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_124064.5.6.m.41252,0.0261196247757263,0.0116027542245962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124069.1.1.m.14145,-0.00131510880104678,-0.00340555939803823,No,NA,NA,Q4R6V2,NA,NA,NA,cell body [GO:0044297]; centrosome [GO:0005813]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; G-protein beta-subunit binding [GO:0031681]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to virus [GO:0009615]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_BRAFLDRAFT_124130.2.3.m.30247,0.00316490642151926,-0.000855248111181413,No,NA,NA,Q4R8M9,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_124233.1.1.m.26105,0.000214662618510598,0.00452664509742829,No,NA,NA,O43837,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124240.1.1.m.8573,-0.00568067829707149,0.00386423568181409,No,NA,NA,Q76NI1,NA,NA,NA,dendrite [GO:0030425]; guanyl-nucleotide exchange factor complex [GO:0032045]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; cerebellar granule cell differentiation [GO:0021707]; positive regulation of protein phosphorylation [GO:0001934]; regulation of dendrite development [GO:0050773]; regulation of dendrite morphogenesis [GO:0048814]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_BRAFLDRAFT_124260.1.1.m.8355,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124275.1.1.m.8900,0.00239750903437033,-0.00178911133512198,No,NA,NA,P13086,NA,NA,NA,mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; succinate-CoA ligase complex (GDP-forming) [GO:0045244]; cofactor binding [GO:0048037]; GDP binding [GO:0019003]; nucleoside diphosphate kinase activity [GO:0004550]; protein heterodimerization activity [GO:0046982]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; nucleoside triphosphate biosynthetic process [GO:0009142]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_124284.1.1.m.33673,-0.00495134089608566,-0.00204823975287374,No,NA,NA,Q3TNA1,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; xylulokinase activity [GO:0004856]; D-xylose metabolic process [GO:0042732]; phosphorylation [GO:0016310]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.1.4.m.1812,0.000981548281061088,-0.00146886111876925,No,NA,NA,Q96I24,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124476.3.4.m.48503,0.00155273484814643,0.00162178094973657,No,NA,NA,Q96I24,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_124523.1.1.m.18960,-0.0024697954195533,-0.0228225920560438,No,NA,NA,Q9CRA8,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_BRAFLDRAFT_124526.1.1.m.25228,0,0,No,NA,NA,Q9BRS2,NA,NA,NA,cytosol [GO:0005829]; methyltransferase complex [GO:0034708]; nucleoplasm [GO:0005654]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; maturation of SSU-rRNA [GO:0030490]; positive regulation of rRNA processing [GO:2000234]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_BRAFLDRAFT_124536.1.2.m.10835,-0.00187886495044269,0.00352101794365249,No,NA,NA,Q9ESB5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_BRAFLDRAFT_124611.1.1.m.34341,0.000793648200711628,0.01624881990772,No,NA,NA,Q6P9B9,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_BRAFLDRAFT_124637.1.1.m.26435,-0.000880280544666407,-0.00409037152578305,No,NA,NA,Q68FK8,NA,NA,NA,actin cytoskeleton [GO:0015629]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; transcription coactivator activity [GO:0003713]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to tumor necrosis factor [GO:0071356]; DNA duplex unwinding [GO:0032508]; DNA replication [GO:0006260]; DNA-templated transcription; termination [GO:0006353]; G-quadruplex DNA unwinding [GO:0044806]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cytoplasmic translation [GO:2000765]; regulation of mRNA processing [GO:0050684]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_BRAFLDRAFT_124675.1.1.m.61945,0.00503103078510179,-0.0186147958885833,No,NA,NA,Q99JG7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; CD40 signaling pathway [GO:0023035]; cellular response to lipopolysaccharide [GO:0071222]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; negative regulation of endothelial cell apoptotic process [GO:2000352]; positive regulation of B cell activation [GO:0050871]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage activation [GO:0043032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 9 signaling pathway [GO:0034162],NA,NA,NA
CHOYP_BRAFLDRAFT_124686.1.1.m.18409,0.00216517525450387,-0.00147391850274457,No,NA,NA,P00504,NA,NA,NA,cytosol [GO:0005829]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; L-cysteine:2-oxoglutarate aminotransferase activity [GO:0047801]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; aspartate biosynthetic process [GO:0006532]; aspartate metabolic process [GO:0006531]; cellular amino acid metabolic process [GO:0006520]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glycerol biosynthetic process [GO:0006114],NA,NA,NA
CHOYP_BRAFLDRAFT_124878.1.1.m.55561,0.00107621177005232,-0.00316169791593797,No,NA,NA,P35570,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; insulin receptor complex [GO:0005899]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; insulin receptor binding [GO:0005158]; insulin-like growth factor receptor binding [GO:0005159]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; aging [GO:0007568]; cellular response to angiotensin [GO:1904385]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to radiation [GO:0071478]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of insulin secretion [GO:0046676]; negative regulation of somatostatin secretion [GO:0090275]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphorylation [GO:0042327]; protein heterooligomerization [GO:0051291]; response to activity [GO:0014823]; response to caffeine [GO:0031000]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_124950.1.1.m.8139,0.00217087768861004,-0.0231853310989385,No,NA,NA,Q8C156,NA,NA,NA,chromosome [GO:0005694]; condensin complex [GO:0000796]; cytosol [GO:0005829]; nuclear condensin complex [GO:0000799]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA topoisomerase (ATP-hydrolyzing) activator activity [GO:0072587]; DNA topoisomerase binding [GO:0044547]; cell division [GO:0051301]; female meiosis chromosome separation [GO:0051309]; female meiotic nuclear division [GO:0007143]; meiotic chromosome condensation [GO:0010032]; meiotic chromosome segregation [GO:0045132]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_BRAFLDRAFT_124962.1.1.m.57433,-0.00754539216942689,0.0167310922069185,No,NA,NA,O97490,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3843,0.0042833207831838,0.00378067522308094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_124972.1.5.m.3844,-0.00146191172525641,0.00128851649993863,No,NA,NA,Q8HXX6,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_124972.2.5.m.4101,-0.00404331926497092,0.000211272867397239,No,NA,NA,Q8HXX6,NA,NA,NA,lysosome [GO:0005764]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; ganglioside catabolic process [GO:0006689],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.1.3.m.2939,6.24979625124896e-05,0.00100548740290638,No,NA,NA,Q58EK5,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125037.2.3.m.13981,0.00141061558761404,-0.000381188621788964,No,NA,NA,A9CPT4,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125104.1.1.m.31139,-0.01552935404023,-0.00988284257722109,No,NA,NA,P51909,NA,NA,NA,cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BRAFLDRAFT_125119.1.1.m.57550,-0.00198015728784233,-0.00315324924983669,No,NA,NA,Q5F201,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_125234.2.2.m.19033,-0.000304148668541569,-0.000456608423070048,No,NA,NA,Q5T6F2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_125263.1.9.m.7394,-0.00924928600080231,-0.00746755148141908,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125265.2.4.m.18968,-0.0036107049582427,0.00490180913243131,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125270.1.1.m.2429,0.00278930036998634,-0.000753748627993649,No,NA,NA,Q5TZ24,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; copper ion binding [GO:0005507]; dopamine beta-monooxygenase activity [GO:0004500]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced ascorbate as one donor; and incorporation of one atom of oxygen [GO:0016715]; dopamine catabolic process [GO:0042420]; norepinephrine biosynthetic process [GO:0042421]; octopamine biosynthetic process [GO:0006589],NA,NA,NA
CHOYP_BRAFLDRAFT_125327.1.1.m.29699,0.00108827137811989,-0.000766941245337088,No,NA,NA,Q91YN5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; UDP-N-acetylglucosamine diphosphorylase activity [GO:0003977]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_BRAFLDRAFT_125356.3.3.m.35009,4.86623557978751e-05,0.0103807403456135,No,NA,NA,Q3V0L5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125389.1.1.m.62938,-0.00134273341118808,0.00865062556401619,No,NA,NA,Q5RFR0,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125403.1.1.m.30476,-0.0073285536030759,0.00245545744956255,No,NA,NA,Q75J93,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_125405.1.1.m.5741,0.0130495256522621,0.00711149394947499,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125481.1.1.m.4369,-0.00345177957161402,-0.00235245578634416,No,NA,NA,Q9YGY3,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nucleus [GO:0005634]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_125501.1.1.m.30916,0.00216760131157685,0.00273469496209742,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125516.1.1.m.13150,-7.35043704778178e-05,0.00975226119391888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125550.1.5.m.9080,-0.0140696535263849,-0.00895389277345925,No,NA,NA,P11678,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; defense response to bacterium [GO:0042742]; defense response to nematode [GO:0002215]; eosinophil migration [GO:0072677]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-5 production [GO:0032714]; neutrophil degranulation [GO:0043312]; positive regulation of interleukin-4 production [GO:0032753]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_BRAFLDRAFT_125634.1.1.m.14767,0.00367763135895945,0.00246781261113439,No,NA,NA,Q9UI14,NA,NA,NA,cell junction [GO:0030054]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; protein C-terminus binding [GO:0008022],NA,NA,NA
CHOYP_BRAFLDRAFT_125658.1.1.m.27104,0.0196108183593072,-0.0150840425780724,No,NA,NA,O00471,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exocyst [GO:0000145]; midbody [GO:0030496]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; epithelial cell apoptotic process [GO:1904019]; establishment of planar polarity [GO:0001736]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; homeostasis of number of cells within a tissue [GO:0048873]; non-motile cilium assembly [GO:1905515]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_BRAFLDRAFT_125670.1.1.m.9555,-0.0105894801132374,-0.0044348097620903,No,NA,NA,Q96N23,NA,NA,NA,axoneme [GO:0005930]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_125701.1.3.m.18477,0.00142603643068796,-0.00235359238477087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125724.1.1.m.30781,-0.0121117545489275,-0.00082986482308014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125729.1.1.m.50316,-0.00569779965274496,-0.00916360425002848,No,NA,NA,Q8BN59,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; mRNA 5'-UTR binding [GO:0048027]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_BRAFLDRAFT_125731.1.1.m.6261,-0.00814571123774957,0.0097039597769049,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125735.1.3.m.26333,0.00141156963079471,-0.019113589814408,No,NA,NA,P62313,NA,NA,NA,cytoplasm [GO:0005737]; Lsm2-8 complex [GO:0120115]; nucleolus [GO:0005730]; nucleus [GO:0005634]; P-body [GO:0000932]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_BRAFLDRAFT_125780.1.1.m.60450,0.000635621077060282,0.00155319875883957,No,NA,NA,Q9YH58,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; folic acid binding [GO:0005542]; formimidoyltetrahydrofolate cyclodeaminase activity [GO:0030412]; glutamate formimidoyltransferase activity [GO:0030409]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_BRAFLDRAFT_125840.1.1.m.58396,-0.00231641000302453,-0.00430676619588669,No,NA,NA,Q5RB02,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_BRAFLDRAFT_125862.1.1.m.27159,-0.0242252173662728,0.00772033210725303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.1.3.m.7081,-0.00265570799251366,0.000348695499358649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125880.3.3.m.26918,-0.0227838672969302,0.0307617468979467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_125998.1.1.m.63211,-0.020137774497788,0.00251431384606463,No,NA,NA,Q8NA69,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_125999.1.1.m.24819,0.00467361251071859,0.0176101003767371,No,NA,NA,Q7ZTY7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126058.1.1.m.1201,0,0,No,NA,NA,Q503Y4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; hydrolase activity [GO:0016787]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_126152.2.2.m.42694,0.0107579299045392,0.000537825374644751,No,NA,NA,Q7ZUN8,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; transferase activity [GO:0016740]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_126227.1.1.m.24340,0.00452722840478795,-0.0261859540599933,No,NA,NA,O94903,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; pyridoxal phosphate binding [GO:0030170],NA,NA,NA
CHOYP_BRAFLDRAFT_126338.1.1.m.59058,-0.00426744214598149,-0.00392825653005075,No,NA,NA,Q922C1,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126352.2.2.m.64882,-0.00230137524829059,-0.01545905248363,No,NA,NA,Q9NXG6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; regulation of erythrocyte differentiation [GO:0045646],NA,NA,NA
CHOYP_BRAFLDRAFT_126371.3.3.m.66053,-0.00229439793297854,-0.00230508778774367,No,NA,NA,Q5XJN2,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; protein-disulfide reductase activity [GO:0047134]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126378.2.2.m.11826,-0.030766752061955,-0.0195798850649547,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126379.1.3.m.5102,0,0,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126411.1.1.m.49664,-0.000490314107576912,0.00127785028302791,No,NA,NA,Q96J94,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; dense body [GO:0097433]; nucleus [GO:0005634]; P granule [GO:0043186]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA cap binding complex binding [GO:0140262]; piRNA binding [GO:0034584]; polysome binding [GO:1905538]; protein kinase binding [GO:0019901]; single-stranded RNA binding [GO:0003727]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA metabolic process [GO:0034587]; regulation of translation [GO:0006417]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_BRAFLDRAFT_126506.1.1.m.60629,0.00456179580413432,0.00953246817039355,No,NA,NA,O02373,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NAD binding [GO:0051287]; UDP-glucose 6-dehydrogenase activity [GO:0003979]; chondroitin sulfate biosynthetic process [GO:0030206]; epithelial cell migration; open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process; polysaccharide chain biosynthetic process [GO:0015014]; mesoderm migration involved in gastrulation [GO:0007509]; segment polarity determination [GO:0007367]; UDP-glucuronate biosynthetic process [GO:0006065]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.2.6.m.5075,0.0169598007444765,0.0152838625597665,No,NA,NA,P54316,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_BRAFLDRAFT_126555.6.6.m.54234,-0.00929594137272549,-0.00591591414270839,No,NA,NA,Q6P8U6,NA,NA,NA,extracellular space [GO:0005615]; lipase activity [GO:0016298]; metal ion binding [GO:0046872]; triglyceride lipase activity [GO:0004806]; intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_BRAFLDRAFT_126596.1.1.m.64385,-0.00971989169623728,0.00722794723013622,No,NA,NA,Q8WV41,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; membrane [GO:0016020]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; cleavage furrow formation [GO:0036089]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; intracellular protein transport [GO:0006886]; macropinocytosis [GO:0044351]; mitotic cytokinesis [GO:0000281]; negative regulation of endocytosis [GO:0045806]; negative regulation of protein localization to cell surface [GO:2000009]; plasma membrane tubulation [GO:0097320]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein localization to cell surface [GO:2000010]; protein import [GO:0017038],NA,NA,NA
CHOYP_BRAFLDRAFT_126603.1.1.m.31078,-0.0105164665416827,0.00232066183092633,No,NA,NA,B2RY50,NA,NA,NA,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; heart development [GO:0007507]; outer dynein arm assembly [GO:0036158]; regulation of cilium beat frequency [GO:0003356]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_126700.1.2.m.17811,-0.0009196202323637,-0.000980381106178525,No,NA,NA,G3V9R8,NA,NA,NA,nucleoplasmic periphery of the nuclear pore complex [GO:1990826]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; deaminase binding [GO:1990827]; enzyme inhibitor activity [GO:0004857]; mRNA binding [GO:0003729]; N6-methyladenosine-containing RNA binding [GO:1990247]; protein domain specific binding [GO:0019904]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA modification [GO:0090367],NA,NA,NA
CHOYP_BRAFLDRAFT_126750.1.1.m.40768,0.00696351906975667,0.0347698864078852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126756.1.1.m.29611,-0.012859857742263,0.0119377036518847,No,NA,NA,Q6ZMY6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_126767.1.3.m.6394,0.00560420369451302,-0.00262507760802066,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_126822.1.1.m.14626,-0.00907900149783632,-0.000252163928478271,No,NA,NA,O35815,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; nuclear inclusion body [GO:0042405]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; RNA polymerase II regulatory region DNA binding [GO:0001012]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; actin cytoskeleton organization [GO:0030036]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; exploration behavior [GO:0035640]; histone H3 deacetylation [GO:0070932]; intermediate filament cytoskeleton organization [GO:0045104]; microtubule cytoskeleton organization [GO:0000226]; monoubiquitinated protein deubiquitination [GO:0035520]; positive regulation of ERAD pathway [GO:1904294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of cell-substrate adhesion [GO:0010810],NA,NA,NA
CHOYP_BRAFLDRAFT_126826.1.1.m.14796,0.014098589227959,-0.00619364524897966,No,NA,NA,Q0P4V4,NA,NA,NA,cytoplasm [GO:0005737]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.1.3.m.24519,-0.0141600137973628,-0.00119852153633402,No,NA,NA,P38552,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_BRAFLDRAFT_126856.2.3.m.30577,-0.00171945269590148,0.000257568478265859,No,NA,NA,Q3MHZ8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; immune system process [GO:0002376],NA,NA,NA
CHOYP_BRAFLDRAFT_126923.1.1.m.5580,-0.0136719345986559,0.00941791813870153,No,NA,NA,Q95LS7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_BRAFLDRAFT_126943.1.3.m.6839,0.00567253304391181,0.00671766639805045,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127028.1.1.m.18415,-0.000219821059912743,0.00174340822283866,No,NA,NA,Q9JLJ2,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; amine binding [GO:0043176]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein homodimerization activity [GO:0042803]; carnitine biosynthetic process [GO:0045329]; carnitine metabolic process [GO:0009437]; cellular aldehyde metabolic process [GO:0006081]; neurotransmitter biosynthetic process [GO:0042136]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.1.7.m.4586,-0.00810132994847848,0.00683675961002832,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.2.7.m.5835,-0.00195048736644977,-0.0107453313943797,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.3.7.m.15669,-0.00103963872307916,-0.0022676206862451,No,NA,NA,Q15063,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.6.7.m.30727,-0.0207833094287407,-0.00540391919839755,No,NA,NA,Q62009,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; neuron projection extension [GO:1990138]; positive regulation of chemokine (C-C motif) ligand 2 secretion [GO:1904209]; positive regulation of smooth muscle cell migration [GO:0014911]; regulation of Notch signaling pathway [GO:0008593]; regulation of systemic arterial blood pressure [GO:0003073]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to muscle activity [GO:0014850]; tissue development [GO:0009888],NA,NA,NA
CHOYP_BRAFLDRAFT_127065.7.7.m.57708,0.00387514338299375,-0.0045070827748117,No,NA,NA,P10675,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.1.2.m.2218,0.000838709145436941,3.34057924368046e-05,No,NA,NA,O08585,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843]; postsynaptic endocytic zone cytoplasmic component [GO:0099631]; presynaptic endocytic zone membrane [GO:0098835]; spindle [GO:0005819]; synaptic vesicle membrane [GO:0030672]; clathrin heavy chain binding [GO:0032050]; GTPase binding [GO:0051020]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; cell cycle [GO:0007049]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_127100.2.2.m.42594,0.00355888480619302,0.00323992774900408,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_127105.1.1.m.21922,0.00170452272434136,-0.000439862084459841,No,NA,NA,Q3ZC89,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_127252.1.1.m.16242,0.0022645850838504,0.00837199341424684,No,NA,NA,Q8CHI8,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_BRAFLDRAFT_127356.1.2.m.8691,0.000212038152927299,0.00511636079571061,No,NA,NA,Q5ZIQ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_127466.1.1.m.62415,-0.00947974316951188,0.00847295968151635,No,NA,NA,A6PWD2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_127486.1.1.m.57687,0,0,No,NA,NA,P58340,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein domain specific binding [GO:0019904]; cell cycle arrest [GO:0007050]; myeloid progenitor cell differentiation [GO:0002318]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_127497.1.1.m.35445,-0.00693744461207669,0.00865111627449998,No,NA,NA,Q6DEJ5,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA ligase activity [GO:0004812]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; regulation of translational fidelity [GO:0006450]; translation [GO:0006412]; tRNA aminoacylation [GO:0043039],NA,NA,NA
CHOYP_BRAFLDRAFT_127510.1.1.m.48935,-0.0159943213493924,-0.0101787466250071,No,NA,NA,P00920,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; arylesterase activity [GO:0004064]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; angiotensin-activated signaling pathway [GO:0038166]; carbon dioxide transport [GO:0015670]; cellular response to fluid shear stress [GO:0071498]; kidney development [GO:0001822]; morphogenesis of an epithelium [GO:0002009]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of bone resorption [GO:0045780]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of dipeptide transmembrane transport [GO:2001150]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of synaptic transmission; GABAergic [GO:0032230]; regulation of anion transport [GO:0044070]; regulation of chloride transport [GO:2001225]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to steroid hormone [GO:0048545]; response to zinc ion [GO:0010043]; secretion [GO:0046903],NA,NA,NA
CHOYP_BRAFLDRAFT_127851.1.1.m.10499,-0.00268326007869141,0.00454593806205402,No,NA,NA,P49020,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPI-coated vesicle membrane [GO:0030663]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; Golgi organization [GO:0007030]; negative regulation of GTPase activity [GO:0034260]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_128029.1.1.m.63515,-0.018353900125104,-0.00662199049959119,No,NA,NA,Q2TBS4,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; cell projection organization [GO:0030030]; positive regulation of kinase activity [GO:0033674]; regulation of cell projection organization [GO:0031344],NA,NA,NA
CHOYP_BRAFLDRAFT_128033.2.2.m.54293,0.012341198360618,0.00518552955535295,No,NA,NA,Q70LM4,NA,NA,NA,isomerase activity [GO:0016853]; ligase activity [GO:0016874]; oxidoreductase activity [GO:0016491]; phosphopantetheine binding [GO:0031177]; antibiotic biosynthetic process [GO:0017000],NA,NA,NA
CHOYP_BRAFLDRAFT_128100.1.1.m.10153,-0.00373328677710071,0.0189754484655498,No,NA,NA,P70279,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; granular component [GO:0001652]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal small subunit biogenesis [GO:0042274]; ribosome assembly [GO:0042255]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_128129.1.1.m.63237,-0.0188167413969809,-0.0174859221009697,No,NA,NA,Q96J01,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_BRAFLDRAFT_128345.1.1.m.9897,-0.00808729396966775,-0.00514673391893073,No,NA,NA,D6REC4,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_BRAFLDRAFT_128432.1.1.m.8945,0.00836758668021279,0.0185971665939043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128459.1.3.m.21899,-0.0194240692238995,-0.021166656603408,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128460.1.2.m.7232,-0.0073810469101816,-0.00875285889131033,No,NA,NA,Q7Z4L5,NA,NA,NA,ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; nuclear chromatin [GO:0000790]; forebrain dorsal/ventral pattern formation [GO:0021798]; intraciliary retrograde transport [GO:0035721]; intraciliary transport involved in cilium assembly [GO:0035735]; protein localization to cilium [GO:0061512]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357]; smoothened signaling pathway [GO:0007224]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_128562.2.4.m.33663,-0.00890881672265433,0.000761131945364753,No,NA,NA,Q99973,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_128749.1.1.m.56605,-0.000965403815830644,0.00148579232011686,No,NA,NA,Q8HXW6,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane raft [GO:0045121]; nucleus [GO:0005634]; synaptic vesicle [GO:0008021]; palmitoyl-(protein) hydrolase activity [GO:0008474]; palmitoyl-CoA hydrolase activity [GO:0016290]; cofactor metabolic process [GO:0051186]; cofactor transport [GO:0051181]; lipid catabolic process [GO:0016042]; lysosomal lumen acidification [GO:0007042]; membrane raft organization [GO:0031579]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; positive regulation of pinocytosis [GO:0048549]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein depalmitoylation [GO:0002084]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_128799.1.1.m.29183,-0.00770455274549807,-0.0224139344475082,No,NA,NA,A8MXQ7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_128825.1.1.m.10785,-0.00622024007549946,-0.0107695139120821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128828.1.2.m.7356,-0.0141975515586361,0.0199364749935244,No,NA,NA,Q2T9S4,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_BRAFLDRAFT_128878.1.1.m.42339,-0.000901839287939977,0.00118121822411331,No,NA,NA,Q9EPB1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; vesicle [GO:0031982]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_128887.2.2.m.46965,-0.00378509974182733,-0.0181886530263874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_128944.1.2.m.19981,-0.0111636923423225,0.0144019438326641,No,NA,NA,Q6NVM2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; katanin complex [GO:0008352]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule severing [GO:0051013],NA,NA,NA
CHOYP_BRAFLDRAFT_129004.15.15.m.60150,-0.00624945807346544,0.0117479267078283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129034.1.1.m.17626,-0.00483723160847966,0.00656691320624298,No,NA,NA,Q6DF94,NA,NA,NA,centriole [GO:0005814]; spindle [GO:0005819]; cell division [GO:0051301]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_BRAFLDRAFT_129048.1.1.m.1769,0.00951063944793499,-0.00463658512480292,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129063.1.1.m.15419,0.00666487215400301,-0.00135016053497976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129074.1.1.m.25032,-0.00253598214110652,0.0143141148824178,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_BRAFLDRAFT_129108.1.2.m.2456,0.0104694385820726,0.0065896676254834,No,NA,NA,A6QLI0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_129234.1.1.m.10468,-0.000416298103859933,0.0024917070737008,No,NA,NA,Q80Y14,NA,NA,NA,dendrite [GO:0030425]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; hemopoiesis [GO:0030097]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_BRAFLDRAFT_129259.1.1.m.9267,0.0032752024452062,0.00171531304128705,No,NA,NA,Q03460,NA,NA,NA,amyloplast [GO:0009501]; 3 iron; 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; glutamine metabolic process [GO:0006541]; L-glutamate biosynthetic process [GO:0097054],NA,NA,NA
CHOYP_BRAFLDRAFT_129513.1.1.m.51276,0.00192476073019634,0.00127155227871923,No,NA,NA,O89000,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; dihydropyrimidine dehydrogenase (NADP+) activity [GO:0017113]; dihydrouracil dehydrogenase (NAD+) activity [GO:0004159]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; NADH dehydrogenase activity [GO:0003954]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; uracil binding [GO:0002058]; aging [GO:0007568]; beta-alanine biosynthetic process [GO:0019483]; circadian rhythm [GO:0007623]; pyrimidine nucleobase catabolic process [GO:0006208]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; thymidine catabolic process [GO:0006214]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.1.2.m.24564,-0.00124674048699352,0.000709734052512996,No,NA,NA,Q8WUM4,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129885.2.2.m.34895,-0.000305332250575865,-0.0107618717943483,No,NA,NA,Q8WUM4,NA,NA,NA,actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871]; actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_BRAFLDRAFT_129914.1.3.m.8213,0.00385122132861606,0.00454819331456326,No,NA,NA,Q8IYJ2,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_BRAFLDRAFT_129932.1.1.m.30332,-0.0163968370254285,0.000549736230994394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_129967.1.4.m.4020,-0.00410309355527311,-0.00261119861014991,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.3.4.m.41916,-0.00233688324461689,-0.000609419161038844,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_129967.4.4.m.64315,0.0114771435971614,-0.00598921052693292,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_130097.1.1.m.12458,-0.00573489726288064,0.00301263507702845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130131.1.1.m.11020,0.0179486773501947,0.0237602095391664,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_130395.1.1.m.38394,-6.48472586478556e-05,0.00860367077403054,No,NA,NA,Q6IR74,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_130685.1.1.m.63499,-0.0136004562625285,-0.00865529679294752,No,NA,NA,Q9ULJ6,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; artery morphogenesis [GO:0048844]; cell aging [GO:0007569]; developmental growth [GO:0048589]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription by RNA polymerase II [GO:0045944]; vasculogenesis [GO:0001570]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_BRAFLDRAFT_130809.1.1.m.5127,0.0034591086958544,-0.00356956973002978,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_130974.1.1.m.28374,0.000168934299673025,0.00198995724691984,No,NA,NA,Q27245,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_BRAFLDRAFT_131134.3.3.m.16643,-0.00568345982810839,0.0120667793899225,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131151.3.4.m.57848,-0.00381334938923442,-0.0154325680594648,No,NA,NA,Q8TEU7,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131151.4.4.m.58019,-0.00218234520397545,0.00320905422387933,No,NA,NA,Q8TEU7,NA,NA,NA,apical plasma membrane [GO:0016324]; centrosome [GO:0005813]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; plasma membrane [GO:0005886]; GTP-dependent protein binding [GO:0030742]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidic acid binding [GO:0070300]; Ras GTPase binding [GO:0017016]; microvillus assembly [GO:0030033]; positive regulation of GTPase activity [GO:0043547]; protein localization to plasma membrane [GO:0072659]; Ras protein signal transduction [GO:0007265]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_BRAFLDRAFT_131216.1.1.m.8822,0.00208604747647989,-0.000563709609852464,No,NA,NA,Q6P9I7,NA,NA,NA,chromosome; telomeric region [GO:0000781]; PML body [GO:0016605]; Smc5-Smc6 complex [GO:0030915]; ATP binding [GO:0005524]; cellular senescence [GO:0090398]; double-strand break repair via homologous recombination [GO:0000724]; telomere maintenance via recombination [GO:0000722],NA,NA,NA
CHOYP_BRAFLDRAFT_131227.1.1.m.24973,0.00894841927867827,-0.00477458259729486,No,NA,NA,Q5ZIT5,NA,NA,NA,cilium [GO:0005929]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; endoplasmic reticulum tubular network organization [GO:0071786]; endosomal transport [GO:0016197]; establishment of neuroblast polarity [GO:0045200]; establishment of protein localization to endoplasmic reticulum membrane [GO:0097051]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi to plasma membrane transport [GO:0006893]; intracellular protein transport [GO:0006886]; polarized epithelial cell differentiation [GO:0030859]; protein localization to basolateral plasma membrane [GO:1903361]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_131414.1.1.m.9300,-0.00785879956449888,-0.00374370726857201,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_131608.1.1.m.44249,-0.00337117514543467,-0.0128419833540794,No,NA,NA,Q8R3V6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_131621.1.1.m.56341,0.0038836963236609,0.00327990264377043,No,NA,NA,P46425,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_131834.1.1.m.29489,8.22768409999965e-05,0.00142516800523808,No,NA,NA,Q561R0,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; integrin activation [GO:0033622]; positive regulation of cell proliferation [GO:0008284]; positive regulation of immunoglobulin biosynthetic process [GO:0002642]; regulation of B cell proliferation [GO:0030888]; regulation of cell proliferation [GO:0042127]; regulation of insulin receptor signaling pathway [GO:0046626],NA,NA,NA
CHOYP_BRAFLDRAFT_132233.1.4.m.13687,0.00444937217230071,0.00361788857419738,No,NA,NA,Q6AYN9,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_BRAFLDRAFT_132336.1.1.m.26677,-0.00833796650637903,0.0126346365772504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_132957.1.1.m.51287,-0.0162271485442913,-0.00257754624318054,No,NA,NA,Q9GZQ3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_BRAFLDRAFT_133135.1.1.m.18788,-0.00990985080543863,-0.00630660459026066,No,NA,NA,Q8WYH8,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; DNA replication [GO:0006260]; histone H3 acetylation [GO:0043966]; negative regulation of cell proliferation [GO:0008285]; negative regulation of growth [GO:0045926]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of transcription; DNA-templated [GO:0045893]; protein acetylation [GO:0006473]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_BRAFLDRAFT_136434.1.1.m.33244,-0.00496961583367208,-0.00707300459762855,No,NA,NA,O35737,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_140951.1.1.m.40225,0.0156439611920883,0.0139505783080872,No,NA,NA,Q9FMR5,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vacuole [GO:0005773]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; protein transport [GO:0015031]; response to salt stress [GO:0009651]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_150340.1.4.m.7435,0.0207110961367368,-0.0108321666311988,No,NA,NA,Q19QU3,NA,NA,NA,nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_153908.1.2.m.1377,-0.0041109886782894,0.000858818414569483,No,NA,NA,Q6ZT07,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_BRAFLDRAFT_154839.1.1.m.13878,0.00110574744836034,0.0105699601547379,No,NA,NA,Q7SXE4,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein homodimerization activity [GO:0042803]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; retrograde transport; vesicle recycling within Golgi [GO:0000301],NA,NA,NA
CHOYP_BRAFLDRAFT_161161.1.1.m.39447,-0.00399968502858119,0.00542987943536932,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_165799.1.1.m.33332,-0.0263742682131401,-0.0167845191863504,No,NA,NA,Q80XI3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_194931.1.1.m.46966,-0.00973281458635454,0.00993065872993387,No,NA,NA,Q14790,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type peptidase activity [GO:0008234]; death effector domain binding [GO:0035877]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity [GO:0097202]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; B cell activation [GO:0042113]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; death-inducing signaling complex assembly [GO:0071550]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; macrophage differentiation [GO:0030225]; natural killer cell activation [GO:0030101]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of neuron death [GO:1901216]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of proteolysis [GO:0045862]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to cobalt ion [GO:0032025]; response to cold [GO:0009409]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process [GO:0039650]; syncytiotrophoblast cell differentiation involved in labyrinthine layer development [GO:0060715]; T cell activation [GO:0042110]; toll-like receptor 3 signaling pathway [GO:0034138]; TRAIL-activated apoptotic signaling pathway [GO:0036462]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_BRAFLDRAFT_199108.1.2.m.24078,0.0123294113638645,-0.00619707358366282,No,NA,NA,O97902,NA,NA,NA,cell projection membrane [GO:0031253]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; podosome [GO:0002102]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cilium assembly [GO:0060271]; positive regulation of membrane tubulation [GO:1903527]; positive regulation of podosome assembly [GO:0071803],NA,NA,NA
CHOYP_BRAFLDRAFT_199346.1.3.m.11369,0.00568572646035371,-0.0103223374833465,No,NA,NA,Q96QF0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; Golgi to plasma membrane transport [GO:0006893]; protein localization to organelle [GO:0033365]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_BRAFLDRAFT_200206.1.1.m.35419,-0.000287924297838197,-0.00783774862286213,No,NA,NA,Q96AB6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; adult locomotory behavior [GO:0008344]; memory [GO:0007613]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_200527.1.1.m.601,0.00327043266187329,-0.000736084285883374,No,NA,NA,Q8JIS3,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; carbonyl reductase (NADPH) activity [GO:0004090]; erythrulose reductase activity [GO:0047880]; identical protein binding [GO:0042802]; L-xylulose reductase (NAD+) activity [GO:0044105]; L-xylulose reductase (NADP+) activity [GO:0050038]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; protein homotetramerization [GO:0051289]; xylulose metabolic process [GO:0005997],NA,NA,NA
CHOYP_BRAFLDRAFT_202318.1.1.m.4330,-0.00673307824478764,0.00579263650123919,No,NA,NA,Q5R7H0,NA,NA,NA,mitochondrion [GO:0005739]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_BRAFLDRAFT_202721.1.2.m.18687,-0.00587224065797108,-0.00532512840231781,No,NA,NA,Q9C005,NA,NA,NA,Golgi apparatus [GO:0005794]; histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; trans-Golgi network [GO:0005802]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; endosomal transport [GO:0016197]; histone H3-K4 methylation [GO:0051568]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_BRAFLDRAFT_202783.1.2.m.21505,0.00247237573702168,0.0113616464493217,No,NA,NA,C3ZQF9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide Y receptor activity [GO:0004983]; cellular response to peptide [GO:1901653],NA,NA,NA
CHOYP_BRAFLDRAFT_203026.1.1.m.61263,0.000938202965753756,-0.000957442604324893,No,NA,NA,P97379,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; mRNA transport [GO:0051028]; small GTPase mediated signal transduction [GO:0007264]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_BRAFLDRAFT_203057.1.1.m.47437,-0.00798392691380075,0.00122208824830355,No,NA,NA,Q5ZLS8,NA,NA,NA,integrator complex [GO:0032039]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_BRAFLDRAFT_203393.1.2.m.16760,-0.0029273095267602,0.0193763939500082,No,NA,NA,Q15291,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; MLL3/4 complex [GO:0044666]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; methylated histone binding [GO:0035064]; transcription regulatory region DNA binding [GO:0044212]; beta-catenin-TCF complex assembly [GO:1904837]; cellular response to DNA damage stimulus [GO:0006974]; histone H3-K4 methylation [GO:0051568]; post-translational protein modification [GO:0043687]; regulation of megakaryocyte differentiation [GO:0045652]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.1.2.m.10,-0.0169544732164547,-0.00292830911901089,No,NA,NA,Q9Y6F1,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_203655.2.2.m.20185,-0.00798251558958975,-0.0102612765429576,No,NA,NA,Q9Y6F1,NA,NA,NA,centriole [GO:0005814]; nucleolus [GO:0005730]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; catalytic activity [GO:0003824]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; negative regulation of telomerase RNA reverse transcriptase activity [GO:1905662]; positive regulation of DNA ligation [GO:0051106]; protein ADP-ribosylation [GO:0006471]; protein localization to site of double-strand break [GO:1990166]; protein poly-ADP-ribosylation [GO:0070212]; regulation of mitotic spindle organization [GO:0060236]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_204357.1.1.m.62329,-0.0127443800765935,-0.00811049202142991,No,NA,NA,P17141,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_204501.1.1.m.910,-0.00179006725618969,-0.00186293280647775,No,NA,NA,Q91YR5,NA,NA,NA,methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.1.2.m.27864,-0.0318960296399241,0.00175753441551648,No,NA,NA,Q503Q1,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204736.2.2.m.63327,0.00131563976161578,0.00476539795569902,No,NA,NA,Q503Q1,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial outer membrane [GO:0005741]; cellular response to DNA damage stimulus [GO:0006974]; mitochondrial protein catabolic process [GO:0035694]; mitophagy by induced vacuole formation [GO:0035695]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_BRAFLDRAFT_204871.1.1.m.66069,0.00618839323572653,0.0035378008520388,No,NA,NA,Q4PM12,NA,NA,NA,cytosol [GO:0005829]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.1.2.m.1690,-0.000172187032551476,0.00119185754963594,No,NA,NA,P48147,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_204923.2.2.m.63877,-0.0113345770158888,0.00375208527136117,No,NA,NA,Q9XTA2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endopeptidase activity [GO:0004175]; oligopeptidase activity [GO:0070012]; serine-type endopeptidase activity [GO:0004252]; serine-type exopeptidase activity [GO:0070008],NA,NA,NA
CHOYP_BRAFLDRAFT_205095.2.2.m.62915,-0.00590487213084105,0.00570425517156924,No,NA,NA,Q99L04,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_205939.3.3.m.64021,0.0181687342822992,-0.00936119804187015,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_206799.1.23.m.3242,0.00352820169081795,-0.000953420869388808,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60959,-0.00521783506937579,0.00567419835505928,No,NA,NA,P50429,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.11.11.m.60961,0.000761467189610903,0.000736402495569789,No,NA,NA,Q9Y2V2,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; P granule [GO:0043186]; P-body [GO:0000932]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; mRNA 3'-UTR binding [GO:0003730]; phosphatase binding [GO:0019902]; intracellular signal transduction [GO:0035556]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.5.11.m.19273,0.00145488236591367,-0.00376759980065718,No,NA,NA,Q9Y383,NA,NA,NA,nuclear speck [GO:0016607]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376],NA,NA,NA
CHOYP_BRAFLDRAFT_206907.6.11.m.30690,0.0184850888468849,-0.00504651515287323,No,NA,NA,P50429,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; anterior head development [GO:0097065]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_208090.1.1.m.45354,-0.00277756349774613,-0.00293699594526474,No,NA,NA,Q61371,NA,NA,NA,acrosomal membrane [GO:0002080]; axonemal basal plate [GO:0097541]; axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; kinocilium [GO:0060091]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; outer acrosomal membrane [GO:0002081]; photoreceptor connecting cilium [GO:0032391]; sperm flagellum [GO:0036126]; trans-Golgi network [GO:0005802]; kinesin binding [GO:0019894]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; brain development [GO:0007420]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum morphogenesis [GO:0060411]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; cytoplasmic microtubule organization [GO:0031122]; determination of left/right symmetry [GO:0007368]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endothelial cell morphogenesis [GO:0001886]; epidermal stem cell homeostasis [GO:0036334]; epidermis development [GO:0008544]; eye development [GO:0001654]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; heart formation [GO:0060914]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; limb development [GO:0060173]; liver development [GO:0001889]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; negative regulation of epithelial cell proliferation [GO:0050680]; nervous system development [GO:0007399]; neural precursor cell proliferation [GO:0061351]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; pancreas development [GO:0031016]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; primary palate development [GO:1903929]; protein localization [GO:0008104]; regulation of autophagosome assembly [GO:2000785]; regulation of cilium assembly [GO:1902017]; regulation of fat cell differentiation [GO:0045598]; regulation of feeding behavior [GO:0060259]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of protein processing [GO:0070613]; regulation of smoothened signaling pathway [GO:0008589]; response to fluid shear stress [GO:0034405]; smoothened signaling pathway [GO:0007224]; sperm axoneme assembly [GO:0007288]; spermatid nucleus elongation [GO:0007290]; spinal cord dorsal/ventral patterning [GO:0021513]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_BRAFLDRAFT_208117.3.3.m.56788,0.0184495281419567,-0.000951955213530767,No,NA,NA,P55196,NA,NA,NA,cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; tight junction [GO:0070160]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; protein C-terminus binding [GO:0008022]; Ras GTPase binding [GO:0017016]; adherens junction organization [GO:0034332]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell signaling [GO:0007267]; establishment of endothelial intestinal barrier [GO:0090557]; establishment of protein localization to plasma membrane [GO:0061951]; negative regulation of cell migration [GO:0030336]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of GTPase activity [GO:0043547]; regulation of protein localization [GO:0032880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_208160.1.2.m.4498,-0.0219527098955478,0.0167680305820973,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.18.21.m.59194,0.00384260547914716,0.00453801821798739,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.2.21.m.9816,0.00085126315354053,0.000102602597734722,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208197.5.21.m.21756,-0.0099205727770152,-0.00296639253736978,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.10.20.m.53518,-0.00129643751933186,-0.0147133880337766,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.15.20.m.61604,0.00594457734219966,0.00345784570671179,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208293.6.20.m.36168,0.00234221211264724,-0.000172551276506863,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.1.32.m.14239,0.00364122844982912,-0.0129466033373069,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.11.32.m.42955,0.00418819029275012,-0.00534855125030179,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.18.32.m.58763,-0.00498144162246142,0.00402888926363306,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.22.32.m.59131,0.00346158262907586,-0.0006003484825193,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.25.32.m.60144,0.00883962261507437,0.00749015956412503,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.27.32.m.61232,0.00657626291978029,-0.011939090934207,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.28.32.m.61328,-0.00855469335950243,-0.00470195173888148,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.29.32.m.61624,0.000794236339038767,-0.0116541445132634,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.30.32.m.61782,0.00457675785054279,-0.0104132649917983,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.4.32.m.22687,0.00710424633022144,0.000795159133107473,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208436.8.32.m.36574,-0.000789587867289255,-0.0145252887532524,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61941,-0.00100333034370671,-0.00340670848186584,No,NA,NA,Q26619,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603]; cGMP-mediated signaling [GO:0019934],NA,NA,NA
CHOYP_BRAFLDRAFT_208819.1.1.m.61942,-0.00241020426622211,0.00314464406374591,No,NA,NA,C9JJ37,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_209304.2.2.m.63768,-0.00326408130405344,0.00443124091562288,No,NA,NA,Q9QYI4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; nuclear membrane [GO:0031965]; Hsp70 protein binding [GO:0030544]; cellular protein-containing complex assembly [GO:0034622]; cellular response to misfolded protein [GO:0071218]; chaperone cofactor-dependent protein refolding [GO:0051085]; ERAD pathway [GO:0036503]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_209933.1.1.m.29283,0.00873198458175637,-0.0132084019784202,No,NA,NA,Q8N2R8,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_210874.1.1.m.28596,-0.0078868446602591,0.00938587543380084,No,NA,NA,P20351,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; compound eye pigmentation [GO:0048072]; kynurenine metabolic process [GO:0070189]; ommochrome biosynthetic process [GO:0006727]; positive regulation of neuron death [GO:1901216]; protein homotetramerization [GO:0051289]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to acetyl-CoA [GO:0019442]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_BRAFLDRAFT_211853.1.1.m.18681,0.00028284203056583,-0.00445006339596736,No,NA,NA,Q1JQA5,NA,NA,NA,extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; growth factor activity [GO:0008083]; metal ion binding [GO:0046872]; negative regulation of appetite [GO:0032099]; positive regulation of MAPK cascade [GO:0043410],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.1.11.m.20083,0.00912113380631674,-0.00273589727850717,No,NA,NA,Q32KR8,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.4.11.m.42448,0.00558019001617781,0.00404761743031229,No,NA,NA,P54922,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212086.9.11.m.60590,0.00816895959708813,0.0122841750098603,No,NA,NA,Q32KR8,NA,NA,NA,cell [GO:0005623]; ADP-ribosylarginine hydrolase activity [GO:0003875]; GTPase activator activity [GO:0005096]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular protein modification process [GO:0006464]; intracellular protein transport [GO:0006886]; protein de-ADP-ribosylation [GO:0051725],NA,NA,NA
CHOYP_BRAFLDRAFT_212438.1.1.m.29117,0.00886719314657079,-0.0107181944561825,No,NA,NA,Q08DF7,NA,NA,NA,mitochondrial matrix [GO:0005759]; exonuclease activity [GO:0004527]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; cellular response to dsRNA [GO:0071359]; cellular response to interferon-alpha [GO:0035457]; cellular response to interferon-gamma [GO:0071346]; mitochondrial mRNA catabolic process [GO:0000958]; mRNA processing [GO:0006397]; negative regulation of cell death [GO:0060548]; negative regulation of oxidative phosphorylation [GO:0090324]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of viral genome replication [GO:0045070]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_BRAFLDRAFT_214346.1.1.m.56462,-0.014554004491287,0.027585910039039,No,NA,NA,Q00988,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; electron transporter; transferring electrons within CoQH2-cytochrome c reductase complex activity [GO:0045153]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.1.2.m.42797,-0.00112515898597199,-0.0268086814230734,No,NA,NA,O14841,NA,NA,NA,cytosol [GO:0005829]; 5-oxoprolinase (ATP-hydrolyzing) activity [GO:0017168]; ATP binding [GO:0005524]; glutathione biosynthetic process [GO:0006750]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_214348.2.2.m.59996,-0.000882365077174218,-0.00600010641859337,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_214790.1.1.m.15955,0.00284159721303532,-0.000767880728688407,No,NA,NA,Q4QR86,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_BRAFLDRAFT_215087.1.1.m.66618,0.00560645262951566,-0.0118930753443404,No,NA,NA,Q5ZL74,NA,NA,NA,apical part of cell [GO:0045177]; azurophil granule membrane [GO:0035577]; cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; pseudopodium [GO:0031143]; SNARE complex [GO:0031201]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; calcium ion regulated exocytosis [GO:0017156]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosome to lysosome transport [GO:0008333]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; Golgi to plasma membrane protein transport [GO:0043001]; natural killer cell degranulation [GO:0043320]; neutrophil degranulation [GO:0043312]; phagocytosis; engulfment [GO:0006911]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of histamine secretion by mast cell [GO:1903595]; regulation of protein targeting to vacuolar membrane [GO:1900483]; SNARE complex assembly [GO:0035493]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_215208.1.1.m.40012,-8.19992075102409e-05,0.0108793216530648,No,NA,NA,Q0UI56,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_215283.1.1.m.1467,0.00312808611402876,-0.00953239373783188,No,NA,NA,Q68EZ3,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H2A-R3 specific) [GO:0070612]; histone methyltransferase activity (H3-R2 specific) [GO:0070611]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; DNA repair [GO:0006281]; histone H3-R2 methylation [GO:0034970]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; peptidyl-arginine N-methylation [GO:0035246],NA,NA,NA
CHOYP_BRAFLDRAFT_215361.1.1.m.55455,0.000178804920420807,-0.00148705668184203,No,NA,NA,Q3SZH7,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270]; cellular lipid metabolic process [GO:0044255]; cellular protein metabolic process [GO:0044267]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171],NA,NA,NA
CHOYP_BRAFLDRAFT_215413.1.1.m.2004,0.00880447108243045,-0.0103434932478819,No,NA,NA,Q3KRG3,NA,NA,NA,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60401,-0.00595369327189145,0.00181339882522513,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_215789.1.1.m.60405,0.000565121795278462,0.0025714761545463,No,NA,NA,Q9H0Z9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cell cycle [GO:0007049]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; mRNA processing [GO:0006397]; negative regulation of cell proliferation [GO:0008285]; regulation of myotube differentiation [GO:0010830]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_216204.1.1.m.30654,-0.000269839122658142,0.00370821303313614,No,NA,NA,P26697,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_BRAFLDRAFT_216893.1.1.m.18940,-0.00751251901179463,0.00568662322246383,No,NA,NA,Q9NRL2,NA,NA,NA,ACF complex [GO:0016590]; CHRAC [GO:0008623]; metal ion binding [GO:0046872]; chromatin remodeling [GO:0006338]; DNA-dependent DNA replication [GO:0006261]; histone acetylation [GO:0016573]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_BRAFLDRAFT_217332.2.2.m.51240,-0.0108755184563857,-0.0172663196999821,No,NA,NA,P70665,NA,NA,NA,lysosome [GO:0005764]; sialate O-acetylesterase activity [GO:0001681]; carbohydrate metabolic process [GO:0005975]; regulation of immune system process [GO:0002682],NA,NA,NA
CHOYP_BRAFLDRAFT_217424.2.2.m.44576,-0.00310749431691808,0.0174679306988508,No,NA,NA,O08590,NA,NA,NA,cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; aliphatic-amine oxidase activity [GO:0052595]; aminoacetone:oxygen oxidoreductase(deaminating) activity [GO:0052594]; copper ion binding [GO:0005507]; phenethylamine:oxygen oxidoreductase (deaminating) activity [GO:0052596]; primary amine oxidase activity [GO:0008131]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; tryptamine:oxygen oxidoreductase (deaminating) activity [GO:0052593]; aging [GO:0007568]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; eating behavior [GO:0042755]; leukocyte migration involved in inflammatory response [GO:0002523]; negative regulation of primary amine oxidase activity [GO:1902283]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of leukocyte migration [GO:0002687]; regulation of blood pressure [GO:0008217]; response to antibiotic [GO:0046677]; response to immobilization stress [GO:0035902],NA,NA,NA
CHOYP_BRAFLDRAFT_217516.1.1.m.18628,-0.000301008990507537,0.000678198897880156,No,NA,NA,P56518,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; Sin3-type complex [GO:0070822]; histone deacetylase activity [GO:0004407]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; transcription factor binding [GO:0008134]; chromatin organization [GO:0006325]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_218889.2.2.m.58058,-0.00128558209070626,0.00295908981548628,No,NA,NA,P28749,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription factor binding [GO:0008134]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of cellular senescence [GO:2000773]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell division [GO:0051302]; regulation of lipid kinase activity [GO:0043550]; regulation of mitotic cell cycle [GO:0007346]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40577,-0.00469243776779809,0.00338992152691843,No,NA,NA,Q5RC46,NA,NA,NA,extracellular space [GO:0005615]; adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; heparin binding [GO:0008201]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]; adenosine catabolic process [GO:0006154],NA,NA,NA
CHOYP_BRAFLDRAFT_219059.1.1.m.40578,-0.00187124663578641,-0.0032653311037805,No,NA,NA,Q91V57,NA,NA,NA,ephrin receptor binding [GO:0046875]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; regulation of axonogenesis [GO:0050770]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_BRAFLDRAFT_219160.1.1.m.58567,-0.00663559347956583,0.00275446053847447,No,NA,NA,Q7ZXF1,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_220284.1.1.m.29545,-0.00343353075974674,-0.00351141095653889,No,NA,NA,A2TJ54,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; mannose binding [GO:0005537]; glycosylation [GO:0070085]; positive regulation of GTP binding [GO:1904426]; retrograde transport; endosome to Golgi [GO:0042147]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_BRAFLDRAFT_220356.5.6.m.38505,0.00749948731530641,-0.0129355926505252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221105.1.2.m.172,0.026734005918485,-0.019996486929398,No,NA,NA,Q9D2Z4,NA,NA,NA,cysteine-type peptidase activity [GO:0008234]; NEDD8-specific protease activity [GO:0019784],NA,NA,NA
CHOYP_BRAFLDRAFT_221105.2.2.m.18318,-0.0075338659132198,0.0157803082383777,No,NA,NA,Q8N0U4,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_221115.1.1.m.28512,-0.0013527915427951,0.000481755680482561,No,NA,NA,Q2M389,NA,NA,NA,early endosome [GO:0005769]; endosome [GO:0005768]; nucleoplasm [GO:0005654]; WASH complex [GO:0071203]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_221294.2.2.m.52722,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_221898.1.2.m.28353,-0.00971589170097473,-0.0148288938524739,No,NA,NA,Q68CZ1,NA,NA,NA,axonemal microtubule [GO:0005879]; axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; plasma membrane [GO:0005886]; thromboxane A2 receptor binding [GO:0031870]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; ciliary basal body-plasma membrane docking [GO:0097711]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_BRAFLDRAFT_223290.2.2.m.30918,-0.0109634239770622,0.0180245986474159,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.1.2.m.30136,0.00327939329471022,-0.00529469794276445,No,NA,NA,Q13148,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_223429.2.2.m.38659,0.00142848585100338,-0.00204496804079695,No,NA,NA,Q28F51,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; double-stranded DNA binding [GO:0003690]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_223476.1.1.m.30983,-0.00255961177967835,0.00778741505365497,No,NA,NA,O35125,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829],NA,NA,NA
CHOYP_BRAFLDRAFT_223573.1.1.m.4526,0.00430910581749309,-0.00116444346860742,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_223623.1.1.m.11202,-0.017296047531141,0.0254049194704643,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_223894.1.1.m.7024,-0.000208555761934978,0.0151624017111205,No,NA,NA,Q9H9Y6,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase I complex [GO:0005736]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; embryo implantation [GO:0007566]; nucleologenesis [GO:0017126]; positive regulation of gene expression; epigenetic [GO:0045815]; rRNA transcription [GO:0009303]; termination of RNA polymerase I transcription [GO:0006363]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.1.3.m.26136,-0.0048030129851417,0.00652045879849795,No,NA,NA,Q64516,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; histone binding [GO:0042393]; glucose homeostasis [GO:0042593]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; regulation of fatty acid metabolic process [GO:0019217]; response to ethanol [GO:0045471]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224325.3.3.m.52906,0.0156535257822848,0.0153206083508105,No,NA,NA,Q0IID9,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.18.18.m.65591,0.0120998438461772,-0.00778822190024135,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_224574.3.18.m.20799,-0.00432703402314881,0.00587428082225103,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_BRAFLDRAFT_224716.1.2.m.41344,-0.0012225517622168,0.00869287290721148,No,NA,NA,Q6NSW5,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_225253.1.1.m.9264,-0.00205900974377357,0.00568808580291523,No,NA,NA,O75694,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; transporter activity [GO:0005215]; atrial cardiac muscle cell action potential [GO:0086014]; mRNA export from nucleus [GO:0006406]; nuclear envelope organization [GO:0006998]; protein import into nucleus [GO:0006606]; protein localization to nuclear inner membrane [GO:0036228]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_225290.1.1.m.5737,-0.0057369176172063,-0.00161496450679618,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_226345.1.1.m.55555,0.00492849498095412,0.00624154005585102,No,NA,NA,Q9BXB4,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; fat cell differentiation [GO:0045444]; positive regulation of sequestering of triglyceride [GO:0010890],NA,NA,NA
CHOYP_BRAFLDRAFT_226416.1.1.m.56984,-0.00551115208339653,-0.0303748966827578,No,NA,NA,Q9H939,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; actin filament polymerization [GO:0030041]; cell migration [GO:0016477],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.1.3.m.1062,-0.014881353741453,0.0294527256715421,No,NA,NA,Q5H8C4,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226506.3.3.m.53203,0.000902917320100509,-0.00547873575409066,No,NA,NA,Q5H8C4,NA,NA,NA,dense core granule [GO:0031045]; extrinsic component of membrane [GO:0019898]; autophagy [GO:0006914]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623]; social behavior [GO:0035176],NA,NA,NA
CHOYP_BRAFLDRAFT_226942.1.1.m.49751,0.00599642091565708,-0.00776538167758032,No,NA,NA,Q9UHJ3,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of muscle organ development [GO:0048635]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_227287.1.1.m.14669,-0.0123344797695879,-0.00784963247788446,No,NA,NA,Q498J9,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_227771.1.2.m.60606,0.0306054208161245,0.00943814131842568,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_BRAFLDRAFT_228853.1.1.m.9833,-0.000735587636844122,-0.000616850240490398,No,NA,NA,Q6TH15,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_230143.1.1.m.15015,-0.00875936021063248,-0.00825286414632216,No,NA,NA,Q1RMU2,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; Lys48-specific deubiquitinase activity [GO:1990380]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; CD4-positive or CD8-positive; alpha-beta T cell lineage commitment [GO:0043369]; homeostasis of number of cells [GO:0048872]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of B cell differentiation [GO:0045577]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of protein binding [GO:0043393]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ripoptosome assembly involved in necroptotic process [GO:1901026]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BRAFLDRAFT_230181.1.1.m.61583,-0.0014010811590079,0.00187463160636466,No,NA,NA,Q8NCC3,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; calcium-independent phospholipase A2 activity [GO:0047499]; lysophospholipase activity [GO:0004622]; O-acyltransferase activity [GO:0008374]; phospholipid binding [GO:0005543]; ceramide metabolic process [GO:0006672]; fatty acid catabolic process [GO:0009062]; glycerophospholipid metabolic process [GO:0006650]; phosphatidylcholine catabolic process [GO:0034638]; phosphatidylethanolamine catabolic process [GO:0046338]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_BRAFLDRAFT_232705.1.2.m.13912,-0.0252269162431843,0.00085770863301895,No,NA,NA,A7SG73,NA,NA,NA,cytoplasm [GO:0005737]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; quinolinate catabolic process [GO:0034213],NA,NA,NA
CHOYP_BRAFLDRAFT_233674.1.1.m.66738,0.00141540420281285,0.00481999839231723,No,NA,NA,A5PLK2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein histidine phosphatase activity [GO:0101006]; dephosphorylation [GO:0016311]; phosphate-containing compound metabolic process [GO:0006796]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_234513.1.1.m.9581,0.00416255501325842,-0.00112484125551777,No,NA,NA,Q95KG9,NA,NA,NA,Mon1-Ccz1 complex [GO:0035658]; guanyl-nucleotide exchange factor activity [GO:0005085],NA,NA,NA
CHOYP_BRAFLDRAFT_234854.2.2.m.58013,0.0046551883773076,0.0054976577166266,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_BRAFLDRAFT_235412.2.2.m.58139,-7.36979260585691e-05,0.00977794136187035,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.2.6.m.17168,-0.00421412242754938,-0.0197155074360807,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_236936.3.6.m.29228,-0.00942491250272669,0.0188912190504108,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_237339.1.1.m.15256,-8.40993808851171e-05,0.0111579641225013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_238139.1.1.m.12224,0,0,No,NA,NA,Q6DGP2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_239751.2.3.m.36889,-0.0100603823292278,-0.0230768519717165,No,NA,NA,Q28J59,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_240825.1.1.m.43452,-0.000725533897113809,0.0169663252014915,No,NA,NA,Q63186,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; hippocampus development [GO:0021766]; myelination [GO:0042552]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_BRAFLDRAFT_240864.1.1.m.24434,0.0035622635833431,-0.016263513910167,No,NA,NA,Q5RID7,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; phosphatidylinositol binding [GO:0035091]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_BRAFLDRAFT_240914.2.3.m.29586,0.0167166142960163,0.0101388989202966,No,NA,NA,Q96P44,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_BRAFLDRAFT_241287.1.1.m.5544,0.00030545346476983,-0.00128577964347702,No,NA,NA,F1NUK7,NA,NA,NA,axon terminus [GO:0043679]; axonal growth cone [GO:0044295]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; synaptic membrane [GO:0097060]; chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560],NA,NA,NA
CHOYP_BRAFLDRAFT_241400.1.1.m.44544,0.00432881270256949,-0.00558319949196943,No,NA,NA,Q498J9,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_241420.1.1.m.61408,0.000234471216138367,0.00533820656663356,No,NA,NA,Q8CG72,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; cellular response to superoxide [GO:0071451],NA,NA,NA
CHOYP_BRAFLDRAFT_241726.22.22.m.52736,-0.0134288525926433,-0.00854608864103375,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_241726.4.22.m.3766,0.0089677114024576,-0.0162807240543301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_244533.1.2.m.40480,0.00819747928549563,0.0316153089701853,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_244533.2.2.m.53951,-0.00393020232409636,0.00160119701591159,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_BRAFLDRAFT_245349.1.1.m.45479,-0.021181768187754,0.0225251381548151,No,NA,NA,Q6PBA8,NA,NA,NA,motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium organization [GO:0044782]; meiotic cell cycle [GO:0051321],NA,NA,NA
CHOYP_BRAFLDRAFT_246447.1.1.m.30255,-0.0165634233676425,-0.025669275802925,No,NA,NA,P50430,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_BRAFLDRAFT_246510.1.1.m.27433,-0.0210893337788719,-0.0134211999581648,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_246978.1.1.m.6916,-0.0101107753130806,0.000256233232790678,No,NA,NA,Q32KU3,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_247007.1.1.m.15096,-0.0144827964635897,-0.0092168159188591,No,NA,NA,O14618,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; copper ion binding [GO:0005507]; protein disulfide oxidoreductase activity [GO:0015035]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; metal ion transport [GO:0030001]; positive regulation of oxidoreductase activity [GO:0051353]; protein maturation by copper ion transfer [GO:0015680]; removal of superoxide radicals [GO:0019430]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_BRAFLDRAFT_247063.1.1.m.17671,0.00235228721613352,-0.000635655191848816,No,NA,NA,Q80UM7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_BRAFLDRAFT_249141.1.1.m.6974,-0.0200394299608689,-0.00108052040429987,No,NA,NA,Q7ZVC9,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_249506.2.2.m.60314,7.19040149583716e-05,0.00125439492287544,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_BRAFLDRAFT_251578.1.1.m.15566,-0.000609855005106215,-0.000641706354790254,No,NA,NA,Q9V535,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; establishment of pole plasm mRNA localization [GO:0046595]; germarium-derived oocyte fate determination [GO:0007294]; microtubule cytoskeleton organization [GO:0000226]; mRNA splicing; via spliceosome [GO:0000398]; mRNA transport [GO:0051028]; negative regulation of transposition; DNA-mediated [GO:0000335]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte dorsal/ventral axis specification [GO:0007310]; oocyte nucleus localization involved in oocyte dorsal/ventral axis specification [GO:0051663]; pole plasm oskar mRNA localization [GO:0045451]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of pole plasm oskar mRNA localization [GO:0007317]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_251779.1.2.m.6830,0.00585666351897678,-0.00191948439843077,No,NA,NA,Q8CGS6,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; identical protein binding [GO:0042802]; single-stranded DNA-dependent ATPase activity [GO:0043142]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; protein homooligomerization [GO:0051260]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_BRAFLDRAFT_251802.1.1.m.66483,0.00244208878550903,0.000611059832381664,No,NA,NA,Q2HJF4,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; biosynthetic process [GO:0009058]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512],NA,NA,NA
CHOYP_BRAFLDRAFT_255736.1.1.m.62027,-0.00393899077038697,-0.0199806370715019,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_258021.1.1.m.6099,-0.0252586106809054,0.00100633622271344,No,NA,NA,Q2VLG6,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953],NA,NA,NA
CHOYP_BRAFLDRAFT_259692.1.1.m.44099,0.00032666805902673,0.00403489372953287,No,NA,NA,Q3T0V9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribose-phosphate aldolase activity [GO:0004139]; carbohydrate catabolic process [GO:0016052]; deoxyribonucleoside catabolic process [GO:0046121]; deoxyribonucleotide catabolic process [GO:0009264]; deoxyribose phosphate catabolic process [GO:0046386],NA,NA,NA
CHOYP_BRAFLDRAFT_259734.1.1.m.23051,-0.0236454486519635,0.0260283993855721,No,NA,NA,Q5R5M0,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743],NA,NA,NA
CHOYP_BRAFLDRAFT_259980.1.1.m.17608,-0.0147398482426396,-0.0118908724752219,No,NA,NA,Q8CF89,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; kinase activator activity [GO:0019209]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activator activity [GO:0030295]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; activation of MAPKKK activity [GO:0000185]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; positive regulation of MAP kinase activity [GO:0043406]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_260828.1.1.m.16250,0.000937947977139689,0.00667006204592239,No,NA,NA,Q9D2V5,NA,NA,NA,spliceosomal complex [GO:0005681]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_BRAFLDRAFT_260946.1.2.m.54464,-0.0118012967038868,-0.00751031609102676,No,NA,NA,O69060,NA,NA,NA,dioxygenase activity [GO:0051213],NA,NA,NA
CHOYP_BRAFLDRAFT_261406.1.1.m.46291,-0.024792687769785,-0.00614219339711551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_261932.1.1.m.23690,-0.00346759052202278,-0.00827541967464069,No,NA,NA,Q9Y5Z4,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_BRAFLDRAFT_261940.2.2.m.53422,-0.00251697033783346,0.0034169804320028,No,NA,NA,F1NZI4,NA,NA,NA,cell wall [GO:0005618]; cytosol [GO:0005829]; alpha;alpha-trehalase activity [GO:0004555]; protein-glucosylgalactosylhydroxylysine glucosidase activity [GO:0047402]; carbohydrate metabolic process [GO:0005975]; trehalose catabolic process [GO:0005993],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65564,-0.00615425744169087,0.0148113987847118,No,NA,NA,Q99JW2,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aminoacylase activity [GO:0004046]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; cellular amino acid metabolic process [GO:0006520],NA,NA,NA
CHOYP_BRAFLDRAFT_262219.2.2.m.65565,-0.0170780158213313,-0.0137053663596934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59010,-0.0146771818575362,-0.00784485939427099,No,NA,NA,O95995,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; Rab GTPase binding [GO:0017137]; axoneme assembly [GO:0035082]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cilium movement involved in cell motility [GO:0060294]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; negative regulation of cell proliferation [GO:0008285]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of microtubule binding [GO:1904526],NA,NA,NA
CHOYP_BRAFLDRAFT_263599.1.1.m.59011,0.0113108913034236,-0.0103069978417328,No,NA,NA,Q60631,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_BRAFLDRAFT_263840.1.1.m.51673,-0.0118638530849601,-0.00244704655739279,No,NA,NA,A2BFC9,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.1.2.m.5174,0.00187120604938885,0.00338592630925134,No,NA,NA,Q58DU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; synapse [GO:0045202]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; ubiquitin protein ligase binding [GO:0031625]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_BRAFLDRAFT_264234.2.2.m.7063,0.000253476454951154,-0.00295360136428607,No,NA,NA,P27085,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_BRAFLDRAFT_264304.1.1.m.35625,0.00365339007430697,-0.000987250346239326,No,NA,NA,Q6DF57,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_BRAFLDRAFT_264316.1.1.m.29655,-0.0186086571177124,0.0306567138043528,No,NA,NA,Q08C33,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_264461.1.1.m.51481,-0.0178045460529622,-0.00771622167779483,No,NA,NA,Q3V0Q6,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.1.3.m.58969,-0.0184688777633184,0.00614608946553257,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265162.3.3.m.64003,-0.0031674613125146,0.021896917851967,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.3.7.m.10791,0.0107095065392317,0.00660729722964285,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.6.7.m.52336,0.00462157228748955,0.00350695065067784,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265208.7.7.m.62510,0,0,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_BRAFLDRAFT_265613.1.2.m.14785,0.00171909056326036,-0.000947690035089393,No,NA,NA,Q8BMB3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; ubiquitin protein ligase binding [GO:0031625]; in utero embryonic development [GO:0001701]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_BRAFLDRAFT_265991.1.1.m.58765,-0.00101483311537139,0.00604160400312325,No,NA,NA,Q9NXS2,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_BRAFLDRAFT_266349.1.1.m.9217,-0.000608036391220446,0.00268748279368792,No,NA,NA,Q3ULD5,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; coenzyme A metabolic process [GO:0015936]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24880,0.000229203085244722,-0.000382381556291444,No,NA,NA,Q2KI24,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_BRAFLDRAFT_266781.1.2.m.24881,0.0032087311853007,-0.000811318107937002,No,NA,NA,P62494,NA,NA,NA,axon [GO:0030424]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; kinetochore microtubule [GO:0005828]; multivesicular body [GO:0005771]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; postsynaptic recycling endosome [GO:0098837]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; Schaffer collateral - CA1 synapse [GO:0098685]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; myosin V binding [GO:0031489]; amyloid-beta clearance by transcytosis [GO:0150093]; astral microtubule organization [GO:0030953]; establishment of protein localization to organelle [GO:0072594]; exocytosis [GO:0006887]; exosomal secretion [GO:1990182]; intracellular cholesterol transport [GO:0032367]; intracellular protein transport [GO:0006886]; melanosome transport [GO:0032402]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; multivesicular body assembly [GO:0036258]; neuron projection development [GO:0031175]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of axon extension [GO:0045773]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; Rab protein signal transduction [GO:0032482]; regulation of cytokinesis [GO:0032465]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multivesicular body size [GO:0010796]; regulation of protein transport [GO:0051223]; regulation of vesicle-mediated transport [GO:0060627]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_BRAFLDRAFT_268308.1.1.m.17043,0.0048970978067082,0.00578334652951158,No,NA,NA,P00378,NA,NA,NA,mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; drug binding [GO:0008144]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_BRAFLDRAFT_268354.1.1.m.57510,-0.0181364191078197,0.0239591876842781,No,NA,NA,Q3ZBL4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_268591.1.1.m.59744,-0.00748293129588273,-0.00154495033431212,No,NA,NA,Q54728,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35239,0.00147306060632993,-0.000455719518984367,No,NA,NA,Q6GN02,NA,NA,NA,mitochondrion [GO:0005739]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_268929.1.1.m.35240,-0.00128044632576094,-0.00112361937391052,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_269194.1.1.m.53515,0.00037542530383981,0.0114929190076406,No,NA,NA,Q2PZI1,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_BRAFLDRAFT_269209.1.1.m.4681,0.00501910027853117,-0.00181522882560982,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_BRAFLDRAFT_270293.1.3.m.8709,-0.0175162206819007,0.026734898896759,No,NA,NA,P02720,NA,NA,NA,cytoplasm [GO:0005737]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phospholipid transporter activity [GO:0005548]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_BRAFLDRAFT_270300.1.1.m.59680,0.000339453315912633,0.00034080241647673,No,NA,NA,Q99L13,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyrate dehydrogenase activity [GO:0008442]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_BRAFLDRAFT_270517.1.1.m.27028,-0.0190847099603532,-0.00909439630388756,No,NA,NA,B0CM26,NA,NA,NA,cytoplasm [GO:0005737]; non-motile cilium [GO:0097730]; sperm midpiece [GO:0097225]; cell differentiation [GO:0030154]; olfactory behavior [GO:0042048]; positive regulation of fertilization [GO:1905516]; positive regulation of flagellated sperm motility [GO:1902093]; response to odorant [GO:1990834]; sensory perception of smell [GO:0007608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_270672.1.1.m.25768,0.0015294915307367,0.011589799611601,No,NA,NA,Q9Y617,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_BRAFLDRAFT_271463.1.1.m.62869,-0.00505039997689645,0.00242242703681476,No,NA,NA,Q5JVL4,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; neuronal cell body [GO:0043025]; spindle pole [GO:0000922]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; protein C-terminus binding [GO:0008022]; cerebral cortex cell migration [GO:0021795]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; regulation of cell division [GO:0051302],NA,NA,NA
CHOYP_BRAFLDRAFT_272416.1.1.m.56641,0.000928306424766851,-9.40976531058035e-05,No,NA,NA,P43487,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; intracellular transport [GO:0046907]; positive regulation of mitotic centrosome separation [GO:0046604]; signal transduction [GO:0007165]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_273508.1.4.m.5528,0.00205765181713822,-0.00137669299810174,No,NA,NA,Q9DFQ7,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_BRAFLDRAFT_273832.1.1.m.56325,-0.00089442970812189,0.00288346528039712,No,NA,NA,Q0MQI4,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; respirasome [GO:0070469]; 4 iron; 4 sulfur cluster binding [GO:0051539]; FMN binding [GO:0010181]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_BRAFLDRAFT_274539.3.3.m.49552,-0.0292388323649433,-0.0146066103586285,No,NA,NA,Q86TN4,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; regulation of protein kinase activity [GO:0045859]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_BRAFLDRAFT_274974.1.1.m.56783,0.00343236983483683,0.00178738005061493,No,NA,NA,Q6DED0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_BRAFLDRAFT_275083.2.2.m.66604,-0.00302191499918659,2.0785855406524e-05,No,NA,NA,Q8AVY1,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_275293.1.1.m.16192,-0.00114006029182794,0.000835890035655466,No,NA,NA,A4QNM5,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_BRAFLDRAFT_275517.1.1.m.9720,0.00330580657656604,-0.0153485268732668,No,NA,NA,Q2HJ56,NA,NA,NA,chromosome [GO:0005694]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; H4K20me3 modified histone binding [GO:1990889]; histone H4-K20 trimethylation [GO:0034773]; negative regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033140]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_275527.1.1.m.12579,0.000897399558572753,0.000571115467935656,No,NA,NA,Q7ZX96,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_275580.2.2.m.40924,-0.00664765929153547,-0.0273360550294344,No,NA,NA,Q8QZR1,NA,NA,NA,mitochondrion [GO:0005739]; amino acid binding [GO:0016597]; L-tyrosine:2-oxoglutarate aminotransferase activity [GO:0004838]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; glutamate metabolic process [GO:0006536]; L-phenylalanine catabolic process [GO:0006559]; response to glucocorticoid [GO:0051384]; response to mercury ion [GO:0046689]; response to organic cyclic compound [GO:0014070]; response to oxidative stress [GO:0006979]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_275667.1.1.m.17353,-0.00541748167818525,0.00219868631945282,No,NA,NA,Q9P2H3,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; bone morphogenesis [GO:0060349]; chondrocyte differentiation [GO:0002062]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; non-motile cilium assembly [GO:1905515]; osteoblast differentiation [GO:0001649]; positive regulation of smoothened signaling pathway [GO:0045880]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_275724.1.1.m.54178,0.000124466847638518,0.000591988728911692,No,NA,NA,Q93008,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; growth cone [GO:0030426]; membrane [GO:0016020]; co-SMAD binding [GO:0070410]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitinyl hydrolase activity [GO:0101005]; axon extension [GO:0048675]; BMP signaling pathway [GO:0030509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular protein metabolic process [GO:0044267]; chromosome segregation [GO:0007059]; female gamete generation [GO:0007292]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron migration [GO:0001764]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO:0071947]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; regulation of circadian rhythm [GO:0042752]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_275787.1.2.m.15360,-0.00161232337829372,0.0059846324447778,No,NA,NA,Q5E951,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_275793.1.1.m.9519,-8.75257928332193e-05,0.0116125665367338,No,NA,NA,Q9H3N1,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_BRAFLDRAFT_275870.1.1.m.12895,-0.0011728862724085,0.00196520794898703,No,NA,NA,P36993,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; magnesium ion binding [GO:0000287]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; manganese ion binding [GO:0030145]; protein serine/threonine phosphatase activity [GO:0004722]; N-terminal protein myristoylation [GO:0006499]; negative regulation of defense response to virus [GO:0050687]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; peptidyl-threonine dephosphorylation [GO:0035970]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_276131.1.1.m.46672,0.00465052388277344,-0.00337320400710376,No,NA,NA,O93327,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_BRAFLDRAFT_276226.1.2.m.21725,0.00933970515609419,-0.00540631788784728,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_276226.2.2.m.64449,0.000127634059562727,-0.000459152935451942,No,NA,NA,Q5R806,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_BRAFLDRAFT_276229.1.1.m.37508,-0.00903844317941461,-0.0109809094884507,No,NA,NA,Q5ZL12,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_276474.1.1.m.6793,-0.00432155627872888,0.0137402844987635,No,NA,NA,A1L259,NA,NA,NA,peroxisome [GO:0005777]; 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity [GO:0051997]; carboxy-lyase activity [GO:0016831]; allantoin biosynthetic process [GO:0019428]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_BRAFLDRAFT_276592.1.1.m.8046,-0.00450462926896791,-0.0237254033121372,No,NA,NA,Q8NI36,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; regulation of axon extension [GO:0030516]; response to stimulus [GO:0050896]; retina homeostasis [GO:0001895]; rRNA processing [GO:0006364]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_276662.1.1.m.52846,-0.00325626265611362,0.00136780317009107,No,NA,NA,P60522,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_276868.1.1.m.27780,-0.000860869947004639,0.00211028528134151,No,NA,NA,Q3U487,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; syntaxin binding [GO:0019905]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_276908.1.1.m.28793,-0.00116536927005353,0.00238297264253726,No,NA,NA,O54774,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic endosome [GO:0098830]; terminal bouton [GO:0043195]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; antigen processing and presentation [GO:0019882]; antigen processing and presentation; exogenous lipid antigen via MHC class Ib [GO:0048007]; endosome to melanosome transport [GO:0035646]; Golgi to vacuole transport [GO:0006896]; intracellular protein transport [GO:0006886]; neurotransmitter receptor transport; postsynaptic endosome to lysosome [GO:0098943]; positive regulation of NK T cell differentiation [GO:0051138]; protein localization to membrane [GO:0072657]; protein localization to organelle [GO:0033365]; protein targeting to vacuole [GO:0006623]; regulation of sequestering of zinc ion [GO:0061088]; synaptic vesicle budding from endosome [GO:0016182]; synaptic vesicle membrane organization [GO:0048499]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.1.2.m.3095,-0.00297107365926645,0.0129647792974718,No,NA,NA,Q32LQ6,NA,NA,NA,integral component of membrane [GO:0016021]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_BRAFLDRAFT_277055.2.2.m.18714,-0.0187492851492183,-0.003333580295031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_277091.1.3.m.1103,0.000482759985577949,-0.0206439971975257,No,NA,NA,P02434,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_277269.1.1.m.51636,0.00346860668753541,0.00961229113185419,No,NA,NA,A6H611,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.2.3.m.57496,0.00197191750284874,-0.0185365497798919,No,NA,NA,O43432,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_BRAFLDRAFT_277494.3.3.m.62602,0.00112526220524879,0.000252191135770855,No,NA,NA,Q80XI3,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA binding [GO:0003729]; RNA cap binding [GO:0000339]; translation initiation factor activity [GO:0003743]; positive regulation of meiosis I [GO:0060903]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of translation [GO:0045727]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRAFLDRAFT_277528.1.1.m.10120,-0.00269787523064931,-0.000570144431403175,No,NA,NA,Q9H0C1,NA,NA,NA,intracellular [GO:0005622]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_277744.1.2.m.5416,-0.00781439701964652,-0.00162705696190263,No,NA,NA,P98073,NA,NA,NA,brush border [GO:0005903]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12736,-0.000103919759101766,0.00147783683476966,No,NA,NA,P07953,NA,NA,NA,6-phosphofructo-2-kinase/fructose-2;6-biphosphatase complex [GO:0043540]; cytosol [GO:0005829]; 6-phosphofructo-2-kinase activity [GO:0003873]; ATP binding [GO:0005524]; fructose-2;6-bisphosphate 2-phosphatase activity [GO:0004331]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; animal organ regeneration [GO:0031100]; carbohydrate phosphorylation [GO:0046835]; fructose 2;6-bisphosphate metabolic process [GO:0006003]; fructose metabolic process [GO:0006000]; positive regulation of glucokinase activity [GO:0033133]; response to cAMP [GO:0051591]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to insulin [GO:0032868]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_BRAFLDRAFT_277775.1.1.m.12737,0.00453322743130223,-0.0157950867582165,No,NA,NA,Q567B1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport; ER to cytosol [GO:1904265]; endoplasmic reticulum unfolded protein response [GO:0030968]; macroautophagy [GO:0016236]; protein deubiquitination [GO:0016579]; protein K11-linked deubiquitination [GO:0035871]; protein K27-linked deubiquitination [GO:1990167]; protein K29-linked deubiquitination [GO:0035523]; protein K33-linked deubiquitination [GO:1990168]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_BRAFLDRAFT_277797.1.1.m.26394,0.0124740829931176,-0.00371388173262556,No,NA,NA,O75884,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_BRAFLDRAFT_277920.1.1.m.28845,-0.000983133306238136,-0.0174910059083436,No,NA,NA,Q5E9N0,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; snoRNA binding [GO:0030515]; cell proliferation [GO:0008283]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_BRAFLDRAFT_278091.1.1.m.7340,-0.0158083176942129,-0.0041078595701731,No,NA,NA,O15067,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylformylglycinamidine synthase activity [GO:0004642]; 'de novo' IMP biosynthetic process [GO:0006189]; anterior head development [GO:0097065]; glutamine metabolic process [GO:0006541]; purine ribonucleoside monophosphate biosynthetic process [GO:0009168]; response to drug [GO:0042493],NA,NA,NA
CHOYP_BRAFLDRAFT_278625.1.2.m.53120,0.00256379551890071,0.00669847371067899,No,NA,NA,Q9H3P7,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; protein kinase A regulatory subunit binding [GO:0034237]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_BRAFLDRAFT_278777.1.1.m.1970,0.00704853731779472,-0.0127964968884051,No,NA,NA,Q04281,NA,NA,NA,nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_278832.1.1.m.13624,0.0053118261845064,-0.0231491975454393,No,NA,NA,P07872,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyl-CoA oxidase activity [GO:0003997]; FAD binding [GO:0071949]; fatty acid binding [GO:0005504]; flavin adenine dinucleotide binding [GO:0050660]; palmitoyl-CoA oxidase activity [GO:0016401]; protein homodimerization activity [GO:0042803]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid oxidation [GO:0019395]; generation of precursor metabolites and energy [GO:0006091]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; prostaglandin metabolic process [GO:0006693]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.1.5.m.13792,0.0040128575735446,0.00774985043513104,No,NA,NA,Q9FLK4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.2.5.m.16457,-0.010225460929125,0.0230793249952364,No,NA,NA,Q9FWW9,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.3.5.m.38481,-0.0191789750858458,0.00135607557689526,No,NA,NA,Q9FLK4,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.4.5.m.39356,0.024737469172276,-0.000452997853481284,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_BRAFLDRAFT_278918.5.5.m.48881,-0.0332886423610515,-0.0153439940691353,No,NA,NA,Q9C8U0,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; monooxygenase activity [GO:0004497]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_BRAFLDRAFT_278938.1.1.m.38684,-0.00793244970103627,-0.01225909766335,No,NA,NA,Q5R605,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; gene silencing [GO:0016458]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell cycle [GO:0045786]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; vacuolar transport [GO:0007034]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_279143.1.1.m.50630,-0.000165870443804123,0.0220070164782545,No,NA,NA,Q5PQR5,NA,NA,NA,fibrillar center [GO:0001650]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA primary transcript binding [GO:0042134]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_279226.1.1.m.24471,-0.00237789893325886,-9.73221990664872e-05,No,NA,NA,Q91642,NA,NA,NA,cytoplasm [GO:0005737]; dipeptidase activity [GO:0016805]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_279360.1.1.m.11115,-0.00021707372579304,0.00611627174007569,No,NA,NA,O35345,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; maternal process involved in female pregnancy [GO:0060135]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_BRAFLDRAFT_279625.1.1.m.51890,0.00497725039549897,0.00313593242480512,No,NA,NA,P41636,NA,NA,NA,4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698],NA,NA,NA
CHOYP_BRAFLDRAFT_279668.1.1.m.21404,0.0100153027347803,0.00539781426300747,No,NA,NA,Q9CQP2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; ion channel binding [GO:0044325]; transcription factor binding [GO:0008134]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; regulation of transcription; DNA-templated [GO:0006355]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_279789.3.3.m.48128,0.000393070668506609,0.000456527955160433,No,NA,NA,Q26481,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_BRAFLDRAFT_279923.1.1.m.65663,-0.00020968467753351,0.00132010038323825,No,NA,NA,P84169,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; meiosis I [GO:0007127]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_279937.1.1.m.49979,0.00838916658567765,0.00354764053039322,No,NA,NA,Q9QXN5,NA,NA,NA,cytoplasm [GO:0005737]; inclusion body [GO:0016234]; aldo-keto reductase (NADP) activity [GO:0004033]; ferric iron binding [GO:0008199]; inositol oxygenase activity [GO:0050113]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen [GO:0016701]; inositol catabolic process [GO:0019310],NA,NA,NA
CHOYP_BRAFLDRAFT_279949.1.1.m.54415,-0.00875434126385565,-0.0055712411703555,No,NA,NA,Q9NXB0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; MKS complex [GO:0036038]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac septum morphogenesis [GO:0060411]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; common bile duct development [GO:0061009]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial structure maintenance [GO:0010669]; head development [GO:0060322]; inner ear receptor cell stereocilium organization [GO:0060122]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:1901620]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003271],NA,NA,NA
CHOYP_BRAFLDRAFT_279978.1.1.m.30960,-0.0121417311156216,0.00522107008273931,No,NA,NA,Q9D3W1,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280249.1.1.m.26508,0.00125494257031527,-0.00251773369964057,No,NA,NA,Q5PPV3,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_280343.1.1.m.41317,-0.0138097050932025,0.00057409602556195,No,NA,NA,Q9CQC8,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network transport vesicle [GO:0030140]; CD4 receptor binding [GO:0042609],NA,NA,NA
CHOYP_BRAFLDRAFT_280861.1.2.m.5389,-0.00255911861599784,0.00128638109147096,No,NA,NA,P12815,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein membrane anchor [GO:0043495]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_BRAFLDRAFT_281070.1.1.m.1319,0.00190964303618738,-0.00690444866509102,No,NA,NA,Q9Y2Q3,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein disulfide oxidoreductase activity [GO:0015035]; signaling receptor binding [GO:0005102]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_281217.1.1.m.15677,-0.000230780285019314,0.00456078816267387,No,NA,NA,P40112,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_BRAFLDRAFT_281480.1.1.m.22697,-0.00815451953430175,0.00287425538893907,No,NA,NA,Q8IXY8,NA,NA,NA,cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_BRAFLDRAFT_281490.1.1.m.53995,0.00331093975033677,-0.000442688042753822,No,NA,NA,Q8NFH3,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore outer ring [GO:0031080]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; mRNA export from nucleus [GO:0006406]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_281651.2.8.m.5909,-0.00820597492566432,0.00467858623943702,No,NA,NA,Q6RY07,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; apoptotic process [GO:0006915]; chitin catabolic process [GO:0006032]; immune system process [GO:0002376]; polysaccharide catabolic process [GO:0000272]; positive regulation of chemokine secretion [GO:0090197]; production of molecular mediator involved in inflammatory response [GO:0002532],NA,NA,NA
CHOYP_BRAFLDRAFT_281658.1.1.m.6266,-0.00200539545604926,0.00378326614965309,No,NA,NA,O93257,NA,NA,NA,Ku70:Ku80 complex [GO:0043564]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; 5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair via nonhomologous end joining [GO:0006303]; negative regulation of transcription; DNA-templated [GO:0045892]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_BRAFLDRAFT_281754.1.1.m.27604,-0.0018948685034189,-0.000355584666166135,No,NA,NA,Q92506,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial matrix [GO:0005759]; plasma membrane [GO:0005886]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity [GO:0047025]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; NADH binding [GO:0070404]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_BRAFLDRAFT_282065.1.2.m.590,0.00801921612093638,0.00431167642558434,No,NA,NA,Q6PBY7,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_282105.1.2.m.43460,0.00833935104274417,0.00188626649090182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_282135.1.1.m.55919,-0.00584528471355674,-0.00142405972373125,No,NA,NA,Q9HAB8,NA,NA,NA,cytosol [GO:0005829]; phosphopantothenate--cysteine ligase activity [GO:0004632]; coenzyme A biosynthetic process [GO:0015937]; coenzyme biosynthetic process [GO:0009108],NA,NA,NA
CHOYP_BRAFLDRAFT_282200.1.1.m.18115,-0.00108983740457685,-0.0260091150879709,No,NA,NA,P79101,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; 5'-3' exonuclease activity [GO:0008409]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snoRNA 3'-end processing [GO:0031126]; snoRNA splicing [GO:0034247]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_BRAFLDRAFT_282752.2.2.m.17526,0.00492597250766473,0.00581744680852558,No,NA,NA,Q8VDT1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_BRAFLDRAFT_283093.1.1.m.15039,-0.0225654446977979,0.020793307738749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_283789.1.1.m.40987,-0.00267034049543111,-0.00188141336385306,No,NA,NA,E2RQ08,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; rough endoplasmic reticulum [GO:0005791]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_BRAFLDRAFT_283981.1.1.m.7732,-0.0129403624889033,0.020692644946092,No,NA,NA,Q9YHY6,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_BRAFLDRAFT_284130.1.1.m.27065,-0.00723471546040421,0.00278274674357625,No,NA,NA,P90893,NA,NA,NA,membrane raft [GO:0045121]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; innate immune response [GO:0045087]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_BRAFLDRAFT_284242.1.1.m.13711,0.000160058300061625,0.004317584755365,No,NA,NA,Q9D4P0,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; protein localization to Golgi membrane [GO:1903292]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_284412.1.1.m.37396,0,0,No,NA,NA,Q05932,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; tetrahydrofolylpolyglutamate synthase activity [GO:0004326]; animal organ regeneration [GO:0031100]; brain development [GO:0007420]; cell proliferation [GO:0008283]; folic acid metabolic process [GO:0046655]; folic acid-containing compound metabolic process [GO:0006760]; glutamate metabolic process [GO:0006536]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; one-carbon metabolic process [GO:0006730]; tetrahydrofolylpolyglutamate biosynthetic process [GO:0046901],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.1.3.m.284,0.000494958319656641,4.89965025428561e-05,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.2.3.m.15867,-0.00133396000344082,0.00613189592556908,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284587.3.3.m.26954,0.00569107305992075,-0.000190322161052204,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_BRAFLDRAFT_284774.2.3.m.15260,-0.00491248149356709,-0.00836470025586485,No,NA,NA,P80895,NA,NA,NA,cytoplasm [GO:0005737]; protein-L-isoaspartate (D-aspartate) O-methyltransferase activity [GO:0004719],NA,NA,NA
CHOYP_BRAFLDRAFT_284784.1.1.m.12397,-0.00411650407584178,0.00558847025885841,No,NA,NA,Q6P632,NA,NA,NA,cytoplasm [GO:0005737]; NatB complex [GO:0031416]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_BRAFLDRAFT_284846.2.2.m.60100,-0.00418871291873711,-0.000750057270675267,No,NA,NA,Q8VHE0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; Sec62/Sec63 complex [GO:0031207]; protein transporter activity [GO:0008565]; liver development [GO:0001889]; multicellular organism aging [GO:0010259]; nitrogen compound metabolic process [GO:0006807]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; posttranslational protein targeting to membrane; translocation [GO:0031204]; renal system development [GO:0072001]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8607,-0.00646481351863148,-0.0131264689949626,No,NA,NA,Q99J62,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_BRAFLDRAFT_284971.1.1.m.8608,-0.00653853796036674,0.00240174234134608,No,NA,NA,P41900,NA,NA,NA,nucleus [GO:0005634]; transcription factor TFIIF complex [GO:0005674]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; TFIIF-class transcription factor complex binding [GO:0001096]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_BRAFLDRAFT_285193.1.1.m.63396,-0.00303075455003351,-0.007015872456349,No,NA,NA,Q9CWZ7,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; SNARE complex [GO:0031201]; synapse [GO:0045202]; vacuolar membrane [GO:0005774]; soluble NSF attachment protein activity [GO:0005483]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_285264.1.1.m.52913,-0.00203452427084983,0.00466746036807169,No,NA,NA,O95861,NA,NA,NA,cytosol [GO:0005829]; 3'(2');5'-bisphosphate nucleotidase activity [GO:0008441]; metal ion binding [GO:0046872]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; nervous system development [GO:0007399]; nucleobase-containing compound metabolic process [GO:0006139]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_BRAFLDRAFT_285738.1.1.m.21025,0.00267843933085882,-0.00174010303456337,No,NA,NA,O95394,NA,NA,NA,cytosol [GO:0005829]; magnesium ion binding [GO:0000287]; phosphoacetylglucosamine mutase activity [GO:0004610]; phosphoglucomutase activity [GO:0004614]; carbohydrate metabolic process [GO:0005975]; glucosamine metabolic process [GO:0006041]; glucose 1-phosphate metabolic process [GO:0019255]; hemopoiesis [GO:0030097]; protein N-linked glycosylation [GO:0006487]; protein O-linked glycosylation [GO:0006493]; spermatogenesis [GO:0007283]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_BRAFLDRAFT_285971.1.1.m.18286,-0.00062655961035165,0.00558183534066375,No,NA,NA,Q6GPV5,NA,NA,NA,metal ion binding [GO:0046872]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_286243.1.1.m.11085,0.00741185949357562,-0.000614224592887367,No,NA,NA,Q9HD45,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_BRAFLDRAFT_287019.1.1.m.36911,-0.00311288906925639,0.00229556789670041,No,NA,NA,Q4QQW8,NA,NA,NA,lysosomal lumen [GO:0043202]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_BRAFLDRAFT_287353.1.1.m.46293,0.00208777716729086,-0.000581696066001988,No,NA,NA,A6QR56,NA,NA,NA,oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620],NA,NA,NA
CHOYP_BRAFLDRAFT_287356.1.1.m.25008,-0.0223190839619251,-0.0108846338404933,No,NA,NA,Q7ZWY2,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_287444.3.5.m.17688,-0.000218272207003348,-0.00897040037302567,No,NA,NA,Q6RVV4,NA,NA,NA,chloroplast inner membrane [GO:0009706]; calmodulin binding [GO:0005516]; oxidoreductase activity [GO:0016491]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_287716.1.1.m.51443,-0.00933145202105174,-0.00947696360518498,No,NA,NA,P51464,NA,NA,NA,argininosuccinate lyase activity [GO:0004056]; arginine biosynthetic process via ornithine [GO:0042450]; urea cycle [GO:0000050],NA,NA,NA
CHOYP_BRAFLDRAFT_287844.1.1.m.63253,-0.0214254508930687,-0.0191386073548386,No,NA,NA,Q6P2Y2,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_BRAFLDRAFT_290492.1.1.m.21887,0.00348580693813045,-0.000941964596333323,No,NA,NA,Q9BPW9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; organelle membrane [GO:0031090]; alcohol dehydrogenase (NAD) activity [GO:0004022]; racemase and epimerase activity [GO:0016854]; retinol dehydrogenase activity [GO:0004745]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_BRAFLDRAFT_291364.1.1.m.47990,-0.0132865173765312,-0.00845550686085239,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_BRAFLDRAFT_57028.1.1.m.55583,-0.00298128981879368,0.00144271763229915,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_BRAFLDRAFT_57175.1.1.m.7616,0.00781946050848338,0.00860168623587867,No,NA,NA,P60027,NA,NA,NA,core TFIIH complex portion of holo TFIIH complex [GO:0000438]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; ATPase activator activity [GO:0001671]; DNA-dependent ATPase activity [GO:0008094]; double-stranded DNA binding [GO:0003690]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; nucleotide-excision repair [GO:0006289]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.3.5.m.23440,-0.00194121428655883,0.00305988084107439,No,NA,NA,O43805,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; G2/M transition of mitotic cell cycle [GO:0000086]; intraciliary transport [GO:0042073]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_BRAFLDRAFT_57176.5.5.m.54727,-0.00081178739274899,-0.000103719982111553,No,NA,NA,Q86UP9,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_57258.1.3.m.43523,0.00263933698852821,-0.00150814642332889,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_57258.2.3.m.48328,0.00259826115159221,0.00628400479586755,No,NA,NA,Q53FA7,NA,NA,NA,cytosol [GO:0005829]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; protein homodimerization activity [GO:0042803]; quinone binding [GO:0048038]; NADP metabolic process [GO:0006739]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_BRAFLDRAFT_57395.1.1.m.9938,-0.000234029409739878,-0.00205526349590865,No,NA,NA,O75521,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; fatty-acyl-CoA binding [GO:0000062]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid catabolic process [GO:0009062]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_BRAFLDRAFT_57407.1.1.m.28838,-0.020867881223115,0.0207784319876066,No,NA,NA,O88741,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; cellular response to vitamin D [GO:0071305]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_BRAFLDRAFT_57459.1.1.m.61613,-0.0169916727493734,0.000395336178899435,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_BRAFLDRAFT_57552.1.1.m.8199,-0.0032847105998681,0.0197846735020531,No,NA,NA,Q9R1C7,NA,NA,NA,cytosol [GO:0005829]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.3.10.m.31620,-0.00808357340057584,-0.0243657419548593,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.6.10.m.45495,0.00497005728631073,0.00586950979800424,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_57788.8.10.m.49717,0.00894457948277238,-0.0162387284565303,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_BRAFLDRAFT_58035.2.2.m.65814,0.0147160904246045,0.00604967417829953,No,NA,NA,Q6DQX6,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial respiratory chain complex I assembly [GO:0032981]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_BRAFLDRAFT_58194.1.1.m.27050,0.00354838840572103,0.000795399290447651,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_BRAFLDRAFT_58684.1.1.m.13006,-0.00131291791922438,0.00490573333137119,No,NA,NA,Q13367,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; clathrin-coated vesicle membrane [GO:0030665]; COPI-coated vesicle [GO:0030137]; Golgi apparatus [GO:0005794]; transporter activity [GO:0005215]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; post-Golgi vesicle-mediated transport [GO:0006892],NA,NA,NA
CHOYP_BRAFLDRAFT_59014.1.1.m.59709,-0.00530293885012305,0.00159924504588362,No,NA,NA,Q99NB1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetate-CoA ligase activity [GO:0003987]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; acetate biosynthetic process [GO:0019413]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA biosynthetic process from acetate [GO:0019427]; propionate biosynthetic process [GO:0019542],NA,NA,NA
CHOYP_BRAFLDRAFT_59154.3.3.m.53255,-0.00630266025683274,-0.0154882156927059,No,NA,NA,P61025,NA,NA,NA,cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; SCF ubiquitin ligase complex [GO:0019005]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; histone binding [GO:0042393]; protein kinase binding [GO:0019901]; ubiquitin binding [GO:0043130]; cell division [GO:0051301]; cell proliferation [GO:0008283]; mitotic cell cycle phase transition [GO:0044772]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; regulation of mitotic cell cycle [GO:0007346]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_BRAFLDRAFT_59647.1.1.m.25700,0.00333961327409548,-0.0112670945283986,No,NA,NA,Q4QRK0,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; protein initiator methionine removal [GO:0070084],NA,NA,NA
CHOYP_BRAFLDRAFT_59863.1.1.m.24545,-0.00407650814915042,-0.00192107592782645,No,NA,NA,O70439,NA,NA,NA,azurophil granule [GO:0042582]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endomembrane system [GO:0012505]; endosome [GO:0005768]; immunological synapse [GO:0001772]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; tertiary granule [GO:0070820]; vesicle [GO:0031982]; chloride channel inhibitor activity [GO:0019869]; protein-containing complex binding [GO:0044877]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; intracellular protein transport [GO:0006886]; organelle assembly [GO:0070925]; organelle localization [GO:0051640]; positive regulation of receptor localization to synapse [GO:1902685]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; regulation of protein localization to plasma membrane [GO:1903076]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22201,0.00440884640769227,-0.00119139622487092,No,NA,NA,Q3SX11,NA,NA,NA,nucleolus [GO:0005730]; preribosome; large subunit precursor [GO:0030687]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.1.3.m.22202,1.7905308555734e-05,0.00426671548636441,No,NA,NA,Q8NC51,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_BRAFLDRAFT_60200.2.3.m.33251,0.00668036626551338,0.00836250740708748,No,NA,NA,Q63340,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_BRAFLDRAFT_60329.1.1.m.18239,0.00117904325142655,0.000484072858852306,No,NA,NA,Q6GM65,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; synapse [GO:0045202]; cellular response to lipopolysaccharide [GO:0071222]; macroautophagy [GO:0016236]; negative regulation of protein K63-linked ubiquitination [GO:1900045]; positive regulation of dendrite extension [GO:1903861]; positive regulation of neuron migration [GO:2001224]; positive regulation of phospholipase A2 activity [GO:0032430]; positive regulation of synaptic vesicle recycling [GO:1903423]; prostaglandin metabolic process [GO:0006693]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_BRAFLDRAFT_60331.1.1.m.34512,-0.0211184211460007,0.0191188801778062,No,NA,NA,Q8BS45,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; intraciliary transport particle B binding [GO:0120170]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; manchette assembly [GO:1905198]; photoreceptor cell differentiation [GO:0046530]; photoreceptor cell morphogenesis [GO:0008594]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.5.14.m.37733,-0.00343286448492574,-0.0163439587460707,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61250.8.14.m.44214,-0.00649802706333215,-0.00683486742311233,No,NA,NA,Q6NT55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; icosanoid metabolic process [GO:0006690],NA,NA,NA
CHOYP_BRAFLDRAFT_61507.1.1.m.52347,-0.00376482499287861,-0.026783831699978,No,NA,NA,Q9WTP7,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleoside triphosphate adenylate kinase activity [GO:0046899]; ADP biosynthetic process [GO:0006172]; AMP metabolic process [GO:0046033]; AMP phosphorylation [GO:0006756]; ATP metabolic process [GO:0046034]; dATP metabolic process [GO:0046060]; GTP metabolic process [GO:0046039]; ITP metabolic process [GO:0046041]; protein homooligomerization [GO:0051260]; UTP metabolic process [GO:0046051],NA,NA,NA
CHOYP_BRAFLDRAFT_61845.1.1.m.37831,-0.0030753585032017,-0.00143200095989105,No,NA,NA,P56597,NA,NA,NA,sperm flagellum [GO:0036126]; nucleoside diphosphate kinase activity [GO:0004550]; cilium assembly [GO:0060271]; CTP biosynthetic process [GO:0006241]; epithelial cilium movement [GO:0003351]; GTP biosynthetic process [GO:0006183]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; nucleoside metabolic process [GO:0009116]; spermatid development [GO:0007286]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_BRAFLDRAFT_62156.1.1.m.47958,0.00298368361155429,0.00839578280232523,No,NA,NA,Q10725,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_BRAFLDRAFT_63199.1.5.m.9045,0.000197727481875919,-0.000691794119029393,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63199.2.5.m.21288,0.00334357060524255,-0.00867733462587035,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63281.1.2.m.28725,0.0025033780941433,-0.00833570746928702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63281.2.2.m.46528,-0.0036111010580196,0.00488603793072595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_63397.6.8.m.48804,0.00429153082192978,-0.00135425760115631,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_63459.2.3.m.27933,-0.0271003325747054,-0.0063207607287298,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_63652.1.1.m.8021,0.00352735480061052,0.0118826279794169,No,NA,NA,Q4R9E0,NA,NA,NA,integral component of membrane [GO:0016021]; apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_BRAFLDRAFT_63676.1.1.m.37146,0.00420708738701383,0.00496846197470447,No,NA,NA,Q6P3R8,NA,NA,NA,ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of cysteine-type endopeptidase activity [GO:2001056]; positive regulation of striated muscle cell differentiation [GO:0051155],NA,NA,NA
CHOYP_BRAFLDRAFT_63907.1.1.m.14584,-4.56843918389221e-05,0.00219504413453459,No,NA,NA,Q9P2J5,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; negative regulation of autophagy [GO:0010507]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TORC1 signaling [GO:1904263]; protein targeting to lysosome [GO:0006622]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_BRAFLDRAFT_64071.9.35.m.13313,-4.36891613602365e-05,0.00579650040070577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_64737.1.1.m.40499,-0.00191580619082545,0.0176158362729243,No,NA,NA,Q9C0B0,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; metal ion binding [GO:0046872]; mRNA CDS binding [GO:1990715]; polysome binding [GO:1905538]; RNA binding [GO:0003723]; cell morphogenesis involved in neuron differentiation [GO:0048667]; negative regulation of cytoplasmic translation [GO:2000766]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_BRAFLDRAFT_64948.1.1.m.17321,-0.00773749723823348,0.0195673414647497,No,NA,NA,B9EJR8,NA,NA,NA,cytoplasm [GO:0005737]; dynein intermediate chain binding [GO:0045505]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_BRAFLDRAFT_64962.1.1.m.59737,0.00213821256807596,0.00296805639940728,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65137.1.1.m.64534,-0.00391795714038336,0.00531892755384604,No,NA,NA,A2AIW0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; early endosome [GO:0005769]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome [GO:0055037]; retromer complex [GO:0030904]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein transport [GO:0015031]; regulation of cytokinesis [GO:0032465]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_BRAFLDRAFT_65518.1.1.m.29803,0.00417174315136115,0.0122653462842383,No,NA,NA,Q6P3Z3,NA,NA,NA,DNA binding [GO:0003677]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_BRAFLDRAFT_65562.1.1.m.14267,0.000759040549230889,0.0115488930674159,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_65681.1.1.m.445,-0.00251540151582511,0.00341485063570634,No,NA,NA,Q9P0W8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor cell maintenance [GO:0045494]; protein localization to photoreceptor connecting cilium [GO:1903621]; protein localization to photoreceptor outer segment [GO:1903546]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_65711.1.1.m.18159,0.0138385166125081,-0.0105248747701346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_65861.1.1.m.24624,-0.0177956698048434,0.0233963042192986,No,NA,NA,Q8NDI1,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_65994.1.1.m.40535,0.0045220444015336,0.00534041810643071,No,NA,NA,O00462,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_BRAFLDRAFT_66204.1.3.m.2589,0.00676656541668509,0.020161477653003,No,NA,NA,Q9Y6R7,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_BRAFLDRAFT_66627.1.1.m.40620,0.00172868985551288,0.00159979500986591,No,NA,NA,P49696,NA,NA,NA,cytoplasm [GO:0005737]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; valine-tRNA ligase activity [GO:0004832]; valyl-tRNA aminoacylation [GO:0006438],NA,NA,NA
CHOYP_BRAFLDRAFT_66688.1.2.m.2447,0.00181065749972048,0.00654067584697601,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_66688.2.2.m.10883,-0.0159271503075141,-0.00340319392917853,No,NA,NA,O43345,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_66705.1.1.m.47148,-0.00989361901402811,-0.00629627471827494,No,NA,NA,P31944,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_BRAFLDRAFT_67258.9.18.m.34120,-0.0202711773203801,-0.0108499462287852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67264.4.6.m.42082,-0.00527522555111043,-0.00151487618436987,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67459.2.2.m.56116,-0.00111795670303867,-0.00387975099818486,No,NA,NA,Q8BK67,NA,NA,NA,chromosome; centromeric core domain [GO:0034506]; early endosome membrane [GO:0031901]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle midzone [GO:1990023]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; small GTPase binding [GO:0031267]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome passenger complex localization to kinetochore [GO:0072356]; establishment of protein localization [GO:0045184]; focal adhesion assembly [GO:0048041]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of GTPase activity [GO:0034260]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of attachment of spindle microtubules to kinetochore [GO:0051987]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; regulation of cell migration [GO:0030334]; regulation of fibroblast migration [GO:0010762]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_BRAFLDRAFT_67483.1.1.m.55096,0.0049083131004746,0.00203827432547655,No,NA,NA,Q9JJP6,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; metal ion binding [GO:0046872]; p53 binding [GO:0002039]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; WW domain binding [GO:0050699]; aging [GO:0007568]; cell proliferation [GO:0008283]; chromatin remodeling [GO:0006338]; cloacal septation [GO:0060197]; cranial skeletal system development [GO:1904888]; ectoderm and mesoderm interaction [GO:0007499]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epidermal cell division [GO:0010481]; epithelial cell development [GO:0002064]; establishment of planar polarity [GO:0001736]; establishment of skin barrier [GO:0061436]; female genitalia morphogenesis [GO:0048807]; hair follicle morphogenesis [GO:0031069]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; multicellular organism aging [GO:0010259]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of keratinocyte differentiation [GO:0045617]; negative regulation of mesoderm development [GO:2000381]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron apoptotic process [GO:0051402]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of fibroblast apoptotic process [GO:2000271]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of somatic stem cell population maintenance [GO:1904674]; post-anal tail morphogenesis [GO:0036342]; prostatic bud formation [GO:0060513]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of epidermal cell division [GO:0010482]; replicative cell aging [GO:0001302]; skeletal system development [GO:0001501]; skin morphogenesis [GO:0043589]; spermatogenesis [GO:0007283]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; sympathetic nervous system development [GO:0048485],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.1.2.m.16093,0.00701697512372648,-0.00104643900496082,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_67520.2.2.m.34594,-0.0156416169696284,0.00930570134636017,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_67662.1.1.m.3006,-0.0203429137019508,-0.00329140677217355,No,NA,NA,O81884,NA,NA,NA,cytosol [GO:0005829]; L-galactose dehydrogenase activity [GO:0010349]; oxidoreductase activity [GO:0016491]; galactose metabolic process [GO:0006012]; L-ascorbic acid biosynthetic process [GO:0019853],NA,NA,NA
CHOYP_BRAFLDRAFT_67696.3.3.m.54584,-0.0111725656281845,-0.00711019318646325,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67741.2.2.m.37743,0.00384618080071529,0.00454224058078246,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_67911.1.1.m.4174,-0.00356380065239412,0.00483813293694653,No,NA,NA,Q8L970,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_BRAFLDRAFT_67999.1.1.m.44535,0.00962527570070477,-0.0116815955286816,No,NA,NA,Q92485,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_BRAFLDRAFT_68004.1.1.m.24323,0.00187363576065984,0.000919400616761099,No,NA,NA,O93610,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_BRAFLDRAFT_68242.2.3.m.26345,0.00511213914044046,0.0154414314381971,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_68488.1.1.m.58466,-0.00779676246633168,-0.0133159528822755,No,NA,NA,Q32L27,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936],NA,NA,NA
CHOYP_BRAFLDRAFT_68592.1.1.m.53611,0.0145684428641911,-0.000306041124524926,No,NA,NA,O13016,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; protein tyrosine phosphatase activity [GO:0004725]; actin cytoskeleton reorganization [GO:0031532]; endoplasmic reticulum unfolded protein response [GO:0030968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; regulation of endocytosis [GO:0030100]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_BRAFLDRAFT_68766.4.4.m.38248,0.00641235632693778,0.00757282786114403,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_68867.1.1.m.4095,0.00527573600887236,-0.00166168014212264,No,NA,NA,O14975,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of peroxisomal membrane [GO:0005779]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; enzyme binding [GO:0019899]; fatty acid transmembrane transporter activity [GO:0015245]; long-chain fatty acid transporter activity [GO:0005324]; long-chain fatty acid-CoA ligase activity [GO:0004467]; phytanate-CoA ligase activity [GO:0050197]; pristanate-CoA ligase activity [GO:0070251]; signaling receptor binding [GO:0005102]; very long-chain fatty acid-CoA ligase activity [GO:0031957]; bile acid biosynthetic process [GO:0006699]; fatty acid alpha-oxidation [GO:0001561]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import [GO:0044539]; long-chain fatty acid metabolic process [GO:0001676]; methyl-branched fatty acid metabolic process [GO:0097089]; neutrophil degranulation [GO:0043312]; protein targeting to peroxisome [GO:0006625]; very long-chain fatty acid catabolic process [GO:0042760],NA,NA,NA
CHOYP_BRAFLDRAFT_68915.2.7.m.3908,0.0113455161472422,-0.015394980263006,No,NA,NA,O08762,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic cleft [GO:0043083]; terminal bouton [GO:0043195]; peptidase activity [GO:0008233]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887]; proteolysis [GO:0006508]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.1.3.m.16606,0.00508368627276533,0.00299305398481714,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_68917.2.3.m.28554,0,0,No,NA,NA,A1L4H1,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; intracellular [GO:0005622]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; scavenger receptor activity [GO:0005044]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterial lipoprotein [GO:0042494]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; negative regulation of interleukin-8 secretion [GO:2000483],NA,NA,NA
CHOYP_BRAFLDRAFT_68934.1.2.m.57609,-0.00748428529027519,-0.00164915972339247,No,NA,NA,Q5XI68,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; negative cofactor 2 complex [GO:0017054]; core promoter binding [GO:0001047]; protein heterodimerization activity [GO:0046982]; TBP-class protein binding [GO:0017025]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045898]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_BRAFLDRAFT_68997.1.1.m.56357,-0.015221976784643,0.00961519172075496,No,NA,NA,P39429,NA,NA,NA,CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IRE1-TRAF2-ASK1 complex [GO:1990604]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; ubiquitin ligase complex [GO:0000151]; vesicle membrane [GO:0012506]; CD40 receptor binding [GO:0005174]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; sphingolipid binding [GO:0046625]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; cellular protein-containing complex assembly [GO:0034622]; cellular response to nitric oxide [GO:0071732]; negative regulation of apoptotic process [GO:0043066]; negative regulation of glial cell apoptotic process [GO:0034351]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein heterooligomerization [GO:0051291]; protein homotrimerization [GO:0070207]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of immunoglobulin secretion [GO:0051023]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_BRAFLDRAFT_69005.1.1.m.26462,0.00151919415293801,-0.000173678039729046,No,NA,NA,Q2HJH1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; metalloaminopeptidase activity [GO:0070006]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_69120.3.3.m.40386,0.0205316381866581,-0.0171525108493675,No,NA,NA,G8HTB6,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_69134.2.13.m.10914,0.00820804384885736,-0.0158353901907689,No,NA,NA,Q86Z23,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_BRAFLDRAFT_69505.3.4.m.52485,-0.00834145442628617,0.00786986242988394,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_69729.1.1.m.683,-0.00559593454607565,-0.0112096451111137,No,NA,NA,B2ZZS9,NA,NA,NA,nucleolus [GO:0005730]; eye development [GO:0001654]; head development [GO:0060322]; liver development [GO:0001889]; pharynx development [GO:0060465]; rRNA processing [GO:0006364]; spleen development [GO:0048536]; thymus development [GO:0048538],NA,NA,NA
CHOYP_BRAFLDRAFT_69798.11.22.m.42042,-0.0123284023675557,-0.00186528382630882,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70742.1.1.m.8525,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_70868.1.1.m.55081,-0.0011732204153742,-0.00108789882907243,No,NA,NA,Q9H1J1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; structural constituent of nuclear pore [GO:0017056]; telomeric DNA binding [GO:0042162]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_BRAFLDRAFT_70886.1.1.m.53762,0.00152736408733669,0.00102143433649125,No,NA,NA,Q96P53,NA,NA,NA,early endosome [GO:0005769]; vesicle [GO:0031982]; metal ion binding [GO:0046872]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_BRAFLDRAFT_70987.2.2.m.58284,-5.34474394782613e-05,0.00709118908916409,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_BRAFLDRAFT_71030.1.1.m.31477,-0.0213715403192484,0.000536397865579408,No,NA,NA,A2A3L6,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_71616.2.3.m.27171,-0.03089426278769,-0.0171870916053318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_71629.1.1.m.65970,0.00490933347916148,0.0057977965439103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72035.1.1.m.48832,-0.00345886328386716,-0.00576487173279426,No,NA,NA,Q5R630,NA,NA,NA,clathrin-coated vesicle membrane [GO:0030665]; plasma membrane [GO:0005886]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_72273.1.2.m.34499,0.0142149565876891,0.00425633461111808,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72357.1.1.m.59063,0.00382352515115541,-0.00784557465342637,No,NA,NA,Q5VYX0,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; epinephrine binding [GO:0051379]; monoamine oxidase activity [GO:0097621]; NADH binding [GO:0070404]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; negative regulation of blood pressure [GO:0045776]; negative regulation of heart rate [GO:0010459]; oxidation-reduction process [GO:0055114]; response to epinephrine [GO:0071871]; response to ischemia [GO:0002931]; response to salt [GO:1902074],NA,NA,NA
CHOYP_BRAFLDRAFT_72541.1.2.m.13652,-0.00959454789753561,-0.00610594659799175,No,NA,NA,Q5ZL00,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_BRAFLDRAFT_72611.1.1.m.61108,-0.00177131225597518,0.00841754725448644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_72748.1.1.m.27724,0.00286804879661634,-0.00241145967424732,No,NA,NA,Q00285,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_BRAFLDRAFT_73177.1.1.m.61488,0.0224468066591661,-0.00109740141929922,No,NA,NA,Q86VP3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_73486.1.1.m.16417,0.00234007643702349,-0.00768344856216852,No,NA,NA,Q93099,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; homogentisate 1;2-dioxygenase activity [GO:0004411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cellular amino acid metabolic process [GO:0006520]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_BRAFLDRAFT_73991.2.2.m.60726,0.03459240546379,0.0146280637048771,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.1.5.m.2740,0.00591453005745283,-0.000816839622846301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74063.2.5.m.9454,-0.00164852801634208,0.00223800332041179,No,NA,NA,Q9IBG7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_74063.4.5.m.43367,0.00439344906915791,0.0280825907091108,No,NA,NA,Q3U492,NA,NA,NA,extracellular space [GO:0005615]; hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of BMP signaling pathway [GO:0030513],NA,NA,NA
CHOYP_BRAFLDRAFT_74469.3.3.m.53818,-0.00698059835526328,-0.00217918670559456,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74594.1.3.m.1187,0.00384748824315199,0.00264180748515163,No,NA,NA,Q6GMV2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.2.3.m.1285,0.00262750700736958,0.00254125378354918,No,NA,NA,Q6GPQ4,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74594.3.3.m.1992,-0.00495176584460391,0.00672240222323625,No,NA,NA,Q5ZIZ2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_BRAFLDRAFT_74861.1.1.m.16599,-0.010105362793776,-0.00643102793702013,No,NA,NA,Q96IG2,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; SCF ubiquitin ligase complex [GO:0019005]; Schaffer collateral - CA1 synapse [GO:0098685]; ubiquitin-protein transferase activity [GO:0004842]; behavioral fear response [GO:0001662]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at presynapse; modulating synaptic transmission [GO:0099575]; regulation of synaptic vesicle exocytosis [GO:2000300]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.1.9.m.3545,-0.0024847112836618,-0.00918162073776482,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74874.3.9.m.37096,-0.026008663843147,0.0215253557847561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74874.5.9.m.47033,0.00922959484104994,-0.0183267902109691,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_74879.1.6.m.21111,0.00075686086093168,0.00490667413157795,No,NA,NA,Q2EMV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_74879.3.6.m.24658,0.00452743643879785,-0.0103843596614069,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_75094.1.2.m.24898,-0.00164393862638379,0.00223177287126959,No,NA,NA,Q7Z7G8,NA,NA,NA,protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_75616.1.2.m.9949,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_75632.1.1.m.60676,0.00447480065268471,-0.0178348227816083,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_BRAFLDRAFT_75707.1.1.m.8533,-0.00550278388340111,-0.00350195807985565,No,NA,NA,Q7Z5J8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_75823.1.2.m.2870,-0.014750618314962,0.0126061294464173,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76126.1.1.m.8736,-0.00194057232283669,-0.00818633237919183,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76176.1.1.m.55550,-0.0117822253080467,0.00251474487745712,No,NA,NA,Q8NE28,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_BRAFLDRAFT_76402.1.5.m.22765,0.00264780307315333,0.00412911424746631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_76662.3.3.m.61577,-0.0120683419260994,-0.0145540308415323,No,NA,NA,Q6ZV70,NA,NA,NA,plasma membrane [GO:0005886]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_BRAFLDRAFT_76728.1.1.m.17486,0.00206352350339842,-0.00176537250526496,No,NA,NA,Q6P8G1,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; transferase activity [GO:0016740]; immune response [GO:0006955]; positive regulation of transcription; DNA-templated [GO:0045893]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_BRAFLDRAFT_76825.1.1.m.2818,-0.0323577246891665,-0.0205923761176196,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_BRAFLDRAFT_76885.1.1.m.20259,-0.00122520502680205,-0.00100347803975929,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_76943.1.1.m.58001,-7.75624607204702e-05,0.0102906721174816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_77063.1.1.m.8252,-0.00645567146560998,0.00172260096712401,No,NA,NA,Q8D3M4,NA,NA,NA,2-aminoethylphosphonate-pyruvate transaminase activity [GO:0047304]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_BRAFLDRAFT_77132.1.2.m.5217,-0.000721489071050727,0.0015769030391269,No,NA,NA,Q9UNH7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular [GO:0005622]; nucleus [GO:0005634]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; tubular endosome [GO:0097422]; dynactin binding [GO:0034452]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; intracellular protein transport [GO:0006886]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of macroautophagy [GO:0016241]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_77225.1.2.m.29845,-0.00134165875832346,0.0252296409616299,No,NA,NA,P04988,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; hyperosmotic response [GO:0006972]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_BRAFLDRAFT_77483.1.1.m.56627,-0.00954610878650894,0.0152776554434299,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_78229.1.1.m.52210,0.0119955857366194,-0.00985597117299705,No,NA,NA,Q9P2K2,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_BRAFLDRAFT_79044.2.2.m.62650,0.000591024244582531,-0.00190149093911255,No,NA,NA,B0BNE5,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],NA,NA,NA
CHOYP_BRAFLDRAFT_79377.5.30.m.21330,-0.014582289716969,-0.00224860240845279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_79602.1.1.m.42298,0.000446133168435275,-0.0153236047569283,No,NA,NA,Q8IVI9,NA,NA,NA,cytoskeleton [GO:0005856]; endocytic vesicle membrane [GO:0030666]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; endocytosis [GO:0006897]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nitric-oxide synthase activity [GO:0050999],NA,NA,NA
CHOYP_BRAFLDRAFT_79734.1.1.m.15409,-0.0180563437199098,0.00840919729847374,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80039.1.1.m.2568,0.00403665082700585,-0.000226355869180027,No,NA,NA,Q6PDL0,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; kinetochore [GO:0000776]; late endosome [GO:0005770]; lysosome [GO:0005764]; microtubule [GO:0005874]; ATP binding [GO:0005524]; dynein heavy chain binding [GO:0045504]; microtubule motor activity [GO:0003777]; cellular response to nerve growth factor stimulus [GO:1990090]; centrosome localization [GO:0051642]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based movement [GO:0007018]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_BRAFLDRAFT_80064.1.1.m.40175,-0.0158991595467113,-0.0214802445681356,No,NA,NA,Q13546,NA,NA,NA,cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; endosome membrane [GO:0010008]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; receptor complex [GO:0043235]; ripoptosome [GO:0097342]; ATP binding [GO:0005524]; death domain binding [GO:0070513]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; JUN kinase kinase kinase activity [GO:0004706]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of JUN kinase activity [GO:0007257]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular protein catabolic process [GO:0044257]; cellular response to growth factor stimulus [GO:0071363]; cellular response to tumor necrosis factor [GO:0071356]; death-inducing signaling complex assembly [GO:0071550]; extrinsic apoptotic signaling pathway [GO:0097191]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; MAPK cascade [GO:0000165]; MyD88-independent toll-like receptor signaling pathway [GO:0002756]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; peptidyl-serine autophosphorylation [GO:0036289]; positive regulation of apoptotic process [GO:0043065]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of hydrogen peroxide-induced cell death [GO:1905206]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of necroptotic process [GO:0060545]; positive regulation of necrotic cell death [GO:0010940]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein autophosphorylation [GO:0046777]; protein deubiquitination [GO:0016579]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; regulation of ATP:ADP antiporter activity [GO:0070926]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; response to tumor necrosis factor [GO:0034612]; ripoptosome assembly [GO:0097343]; ripoptosome assembly involved in necroptotic process [GO:1901026]; T cell apoptotic process [GO:0070231]; toll-like receptor 3 signaling pathway [GO:0034138]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; viral process [GO:0016032],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.1.3.m.18963,0.00235831535638266,-0.00590137773894009,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_BRAFLDRAFT_80311.3.3.m.30251,-0.00141706472589043,0.0015969042384157,No,NA,NA,P98092,NA,NA,NA,carbohydrate binding [GO:0030246]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_80394.4.9.m.33604,0.00506361721904398,0.00662508042770377,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80432.2.2.m.18322,-0.0235446840754162,-0.00502920927581993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_80496.1.10.m.12618,0.00175155701046723,0.00991695863368832,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.3.10.m.22837,0.00244097985950464,0.00698960952539005,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.6.10.m.29014,-3.64955926849246e-05,0.00753020267697832,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80496.8.10.m.49028,0.00110408194603517,0.00665265764260399,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_BRAFLDRAFT_80577.2.6.m.24330,0.00480415551826458,0.005673584077845,No,NA,NA,Q5BIM1,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_80919.1.1.m.62047,-0.00876113698066059,0.00116132370990348,No,NA,NA,Q8C0R9,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_BRAFLDRAFT_80934.1.2.m.23714,-0.00385813887778705,0.00226140363475705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_81321.3.10.m.34305,-0.00696687040145782,-0.00223727857454536,No,NA,NA,P41241,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; transferase activity [GO:0016740]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; intracellular signal transduction [GO:0035556]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368]; regulation of T cell activation [GO:0050863],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.5.10.m.45062,0.00393131786497258,-0.00202110706336608,No,NA,NA,O22558,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; chloroplast organization [GO:0009658],NA,NA,NA
CHOYP_BRAFLDRAFT_81321.6.10.m.48025,0.0101740850691212,-0.00408642620905682,No,NA,NA,P32577,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_BRAFLDRAFT_81322.1.2.m.17860,0.0105658213199862,-0.000894487976624292,No,NA,NA,B2IZD3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.2.3.m.30348,-0.0204046783373614,-0.0076291690739723,No,NA,NA,A0A1P8AWH8,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81364.3.3.m.30607,-0.00619516428580402,-0.0023857396975179,No,NA,NA,O80596,NA,NA,NA,endo-1;4-beta-xylanase activity [GO:0031176]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_BRAFLDRAFT_81509.1.1.m.31565,0.00240101655990509,-0.00139862798802117,No,NA,NA,Q9BDK2,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to interferon-gamma [GO:0071346]; inflammatory response [GO:0006954]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_BRAFLDRAFT_81532.1.1.m.58865,0.0181713160044593,-0.0195533613914448,No,NA,NA,Q05609,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_BRAFLDRAFT_81609.1.1.m.94,0.00434332903367562,0.00088368131740472,No,NA,NA,Q9Y6N5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; FAD binding [GO:0071949]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221],NA,NA,NA
CHOYP_BRAFLDRAFT_81733.1.1.m.213,-0.00645341867441995,0.00713360167414417,No,NA,NA,A4IHY1,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; proteasome binding [GO:0070628]; proteasome assembly [GO:0043248]; proteasome core complex assembly [GO:0080129],NA,NA,NA
CHOYP_BRAFLDRAFT_82353.1.1.m.13454,0.00045305254116651,3.85707869682179e-05,No,NA,NA,Q9D4D4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transketolase activity [GO:0004802],NA,NA,NA
CHOYP_BRAFLDRAFT_82426.1.20.m.8067,-6.39226728150324e-05,0.00848100048273666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_82868.3.5.m.48837,-0.00974897618802996,0.00685263519028935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_83096.1.1.m.27011,-0.00195776301370212,7.45576922025693e-05,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_83552.1.1.m.55255,-0.00189209852463268,0.00163189060824478,No,NA,NA,Q704S8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carnitine O-acetyltransferase activity [GO:0004092]; carnitine metabolic process; CoA-linked [GO:0019254]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_BRAFLDRAFT_84054.1.2.m.8523,-0.0104609303896678,0.0102499006383569,No,NA,NA,Q4R918,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; microtubule binding [GO:0008017]; establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_BRAFLDRAFT_84207.2.2.m.36438,-6.92497403891545e-05,0.00918777416221693,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84237.1.1.m.1879,-0.0110195669908059,0.00828802057176027,No,NA,NA,Q9BQG0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; NLS-dependent protein nuclear import complex [GO:0042564]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; E-box binding [GO:0070888]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cellular response to glucose starvation [GO:0042149]; circadian regulation of gene expression [GO:0032922]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of anoikis [GO:2000210]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of gene expression; epigenetic [GO:0045815]; regulation of transcription; DNA-templated [GO:0006355]; respiratory electron transport chain [GO:0022904]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_BRAFLDRAFT_84245.2.2.m.53621,-0.00288299054160103,0.00391388095371018,No,NA,NA,Q9NQG7,NA,NA,NA,BLOC-3 complex [GO:0031085]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; platelet dense granule [GO:0042827]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; blood coagulation [GO:0007596]; hemostasis [GO:0007599]; lysosome organization [GO:0007040]; melanocyte differentiation [GO:0030318]; melanosome assembly [GO:1903232]; positive regulation of eye pigmentation [GO:0048075]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein stabilization [GO:0050821]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_BRAFLDRAFT_84494.3.5.m.41159,0.0133990441971526,-0.017408208764358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84664.1.7.m.3969,0.00793324723179925,-0.0144026723474069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_84838.3.6.m.42355,0.000775955906524209,-0.0007602589526207,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_84941.1.1.m.53224,0.0236383346503131,0.0151112082265243,No,NA,NA,Q3SZE9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; photoreceptor connecting cilium [GO:0032391]; GTPase activity [GO:0003924]; tubulin binding [GO:0015631]; cell morphogenesis [GO:0000902]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_BRAFLDRAFT_85170.1.1.m.8699,0.00592572681529999,-0.00771111961547349,No,NA,NA,Q69Z89,NA,NA,NA,microtubule [GO:0005874]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_BRAFLDRAFT_85206.1.1.m.49234,-0.0051690121338031,0.00284951573216789,No,NA,NA,F5H4B4,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_85506.1.1.m.54726,0.00488714860855768,-0.00425642449925623,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.15.23.m.46769,0.007574164620662,0.00894489356795178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85511.17.23.m.55470,-0.00892839264772182,0.0130369588858443,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_85511.3.23.m.14160,0.0317939899646601,-0.00432161555866415,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.10.10.m.45430,0.0020124746969901,-0.000543828143447904,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.3.10.m.26597,-5.79700010255235e-05,0.00769122417806793,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_BRAFLDRAFT_85664.6.10.m.30553,-0.0019681280212366,0.00662369286161424,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_85822.1.1.m.10102,0.00200215063890933,-0.0060085182762633,No,NA,NA,Q9CWK3,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ribonucleoprotein complex binding [GO:0043021]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BRAFLDRAFT_85896.1.1.m.38692,-0.0109096077031758,-0.00460158374569152,No,NA,NA,C0HBB2,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764],NA,NA,NA
CHOYP_BRAFLDRAFT_85994.3.10.m.7126,0.00368466712092109,0.019819541087159,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_85994.7.10.m.36866,0.0137396011692372,-0.00592619852676236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86052.1.1.m.25460,-0.00746456172204171,0.0138428047926177,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_BRAFLDRAFT_86765.1.1.m.54066,-0.0330678874193937,0.00377265460098541,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27107,0.00176572087202031,0.00298739559481466,No,NA,NA,E9PV24,NA,NA,NA,blood microparticle [GO:0072562]; cell cortex [GO:0005938]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adaptive immune response [GO:0002250]; blood coagulation [GO:0007596]; blood coagulation; common pathway [GO:0072377]; blood coagulation; fibrin clot formation [GO:0072378]; cell-matrix adhesion [GO:0007160]; cellular protein-containing complex assembly [GO:0034622]; fibrinolysis [GO:0042730]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; plasminogen activation [GO:0031639]; platelet aggregation [GO:0070527]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of exocytosis [GO:0045921]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of protein secretion [GO:0050714]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vasoconstriction [GO:0045907]; protein polymerization [GO:0051258]; protein-containing complex assembly [GO:0065003]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_BRAFLDRAFT_86801.1.1.m.27108,-0.00188322097481343,0.00501025514974557,No,NA,NA,Q20758,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_86827.2.4.m.9197,-0.00130795800174143,0.00246366705565519,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.3.4.m.27276,-0.0161639026518362,-0.00338689584107344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86827.4.4.m.61859,-0.0200218331899877,0.0220155475516266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_86846.1.3.m.13594,-0.00472567604210765,-0.0048882328612978,No,NA,NA,P10040,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86846.3.3.m.53453,0.00807598066997042,-0.00463588160408639,No,NA,NA,P10040,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; spindle [GO:0005819]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; protein kinase C binding [GO:0005080]; spectrin binding [GO:0030507]; adherens junction organization [GO:0034332]; amnioserosa maintenance [GO:0046665]; apical constriction [GO:0003383]; apical protein localization [GO:0045176]; assembly of apicomedial cortex actomyosin [GO:0106036]; cell division [GO:0051301]; cell morphogenesis involved in Malpighian tubule morphogenesis [GO:0061336]; centrosome localization [GO:0051642]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; liquid clearance; open tracheal system [GO:0035002]; maintenance of apical/basal cell polarity [GO:0035090]; Malpighian tubule morphogenesis [GO:0007443]; membrane organization [GO:0061024]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of organ growth [GO:0046621]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; nervous system development [GO:0007399]; nuclear chromosome segregation [GO:0098813]; open tracheal system development [GO:0007424]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cell proliferation [GO:0008284]; positive regulation of hippo signaling [GO:0035332]; protein stabilization [GO:0050821]; regulation of imaginal disc growth [GO:0045570]; regulation of intracellular protein transport [GO:0033157]; regulation of protein localization [GO:0032880]; rhabdomere development [GO:0042052]; rhabdomere morphogenesis [GO:0061541]; salivary gland morphogenesis [GO:0007435]; tube morphogenesis [GO:0035239]; zonula adherens assembly [GO:0045186]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_BRAFLDRAFT_86890.2.4.m.23914,-0.0144370838658477,-0.00918772453449701,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_87283.1.1.m.46768,-0.00418291511766802,0.005678628345737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87294.6.6.m.64622,-0.00506564283434163,0.00687699897781069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87336.4.9.m.23926,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87429.1.1.m.43808,-0.00676061781099722,0.0110881059288789,No,NA,NA,Q1RLX4,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi organization [GO:0007030]; lipid homeostasis [GO:0055088]; liver development [GO:0001889]; protein N-linked glycosylation [GO:0006487]; protein secretion [GO:0009306]; regulation of response to endoplasmic reticulum stress [GO:1905897]; retina development in camera-type eye [GO:0060041]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_BRAFLDRAFT_87630.1.1.m.30352,0.00567607335080938,0.0106929733875665,No,NA,NA,O43174,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; oxidation-reduction process [GO:0055114]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_BRAFLDRAFT_87634.1.1.m.39992,-0.00355616668295495,0.00482776923746225,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_87662.1.1.m.5474,0.000586163068041882,0.00118647491545497,No,NA,NA,P17560,NA,NA,NA,N-acylglucosamine 2-epimerase activity [GO:0050121]; peptidase inhibitor activity [GO:0030414]; N-acetylglucosamine metabolic process [GO:0006044]; N-acetylmannosamine metabolic process [GO:0006051]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_BRAFLDRAFT_87806.1.1.m.28308,0.010745482356564,-0.00344322421481492,No,NA,NA,Q6EV69,NA,NA,NA,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; angiogenesis [GO:0001525]; fucose metabolic process [GO:0006004]; heart development [GO:0007507]; nervous system development [GO:0007399]; Notch signaling pathway [GO:0007219]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_BRAFLDRAFT_88012.1.1.m.12815,-0.0185952193689813,-0.00556864529073796,No,NA,NA,P82861,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; NADPH-adrenodoxin reductase activity [GO:0015039]; cholesterol metabolic process [GO:0008203],NA,NA,NA
CHOYP_BRAFLDRAFT_88018.1.1.m.50147,-0.0179690527354602,0.0238434724468089,No,NA,NA,O35474,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_BRAFLDRAFT_88218.8.8.m.64733,0.00292252278275264,-0.00309805692864288,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_BRAFLDRAFT_88219.1.5.m.37187,0.0104892819052764,0.018196806412676,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.10.22.m.35410,0.00420812433382136,-0.00400655071232962,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88223.5.22.m.23899,-6.90011696000577e-05,0.00915479479997375,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88223.9.22.m.34933,0.00871350445131978,-0.00268589220957971,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_BRAFLDRAFT_88224.2.11.m.3212,-0.00100210780161339,-0.0243727109032512,No,NA,NA,O75382,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_88506.1.1.m.64174,-0.0113024732624888,0.00517217332047207,No,NA,NA,Q3SX22,NA,NA,NA,,NA,NA,NA
CHOYP_BRAFLDRAFT_88543.1.2.m.54473,-0.00889561714406442,0.00208929863751086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88566.3.11.m.5108,0.00280263939108996,0.00254947401923927,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_BRAFLDRAFT_88570.1.2.m.55232,-0.0019717584256779,0.00260159462346167,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_88583.1.1.m.56300,0.00263841664813376,0.0113605987220415,No,NA,NA,Q5SSH7,NA,NA,NA,calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_88596.1.2.m.24206,0.00479717234525997,0.013352806319009,No,NA,NA,Q95LU3,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_89105.1.1.m.2234,-0.0129226078563137,-0.00822391574049121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89330.1.1.m.23864,0.00694574005895705,0.0225657792433666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89362.1.1.m.49683,0.0210718468361545,0.0118466827896742,No,NA,NA,A2VDN6,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_BRAFLDRAFT_89535.1.1.m.6232,-0.00663386479073407,-0.00204306829068142,No,NA,NA,Q8C4B4,NA,NA,NA,ciliary transition zone [GO:0035869]; lipid binding [GO:0008289]; cilium assembly [GO:0060271]; lipoprotein transport [GO:0042953]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_BRAFLDRAFT_89536.1.1.m.26678,-0.00303228523154039,-0.00308060247143885,No,NA,NA,Q96QT6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; Sin3-type complex [GO:0070822]; transcriptional repressor complex [GO:0017053]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BRAFLDRAFT_89744.1.1.m.29497,-0.00370554429097874,-0.01814777075789,No,NA,NA,O88280,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; brain development [GO:0007420]; cell differentiation [GO:0030154]; spinal cord development [GO:0021510],NA,NA,NA
CHOYP_BRAFLDRAFT_89869.1.3.m.28871,-0.00257364489813128,-0.000610808846126707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89869.3.3.m.37644,0.00345904935620106,0.00408504830395491,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89870.1.1.m.15447,0.00513793129392675,-0.00346345404503585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89920.1.1.m.13963,-0.00384199212378345,0.0211531179929695,No,NA,NA,O15213,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59629,-0.00276087785317041,0.0123826072717101,No,NA,NA,Q7TQE6,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; synapse [GO:0045202]; brain development [GO:0007420]; neuronal signal transduction [GO:0023041],NA,NA,NA
CHOYP_BRAFLDRAFT_89952.1.1.m.59630,0.00189949554929492,-0.00437731670270182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.1.3.m.5717,0.00545095520874495,0.00422387487869596,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_89961.3.3.m.49198,0.0160199410896764,0.0175382204899155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90098.1.4.m.3841,-0.00484391004162416,0.00643828441832701,No,NA,NA,Q5M8Z0,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; amino-acid betaine catabolic process [GO:0006579]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90098.4.4.m.28113,0.00386089050763701,-0.00110812264276466,No,NA,NA,Q5RF32,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_BRAFLDRAFT_90187.1.1.m.30393,-0.00734913539852794,-0.000224612691538044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90196.2.2.m.42787,-0.00432889302746226,-0.00890644088170077,No,NA,NA,B0JZG0,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; L-ascorbate:sodium symporter activity [GO:0008520]; sodium-dependent L-ascorbate transmembrane transporter activity [GO:0070890]; L-ascorbic acid metabolic process [GO:0019852]; response to oxidative stress [GO:0006979]; transepithelial L-ascorbic acid transport [GO:0070904],NA,NA,NA
CHOYP_BRAFLDRAFT_90332.3.4.m.18933,0.00842431984377305,0.00773925868726964,No,NA,NA,Q8C6K9,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_BRAFLDRAFT_90405.1.1.m.44167,-1.71125159989417e-05,0.00345164210301376,No,NA,NA,Q3SZJ4,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_BRAFLDRAFT_90471.1.2.m.30257,-0.00229445564300538,0.000300767102755657,No,NA,NA,Q9JLQ0,NA,NA,NA,cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; filamentous actin [GO:0031941]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; vascular endothelial growth factor receptor binding [GO:0005172]; actin filament organization [GO:0007015]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of transforming growth factor beta1 production [GO:0032911]; positive regulation of protein localization to nucleus [GO:1900182]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of receptor-mediated endocytosis [GO:0048259]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_BRAFLDRAFT_90679.1.1.m.33411,-0.00205356820568874,0.00278787646765101,No,NA,NA,O18783,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_BRAFLDRAFT_90706.2.2.m.29119,-0.0143826197776978,-0.00915306372324218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_90929.1.1.m.54454,-0.00420676270098103,-0.00921634609276427,No,NA,NA,E9QAM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_BRAFLDRAFT_90953.1.1.m.48786,-0.000592412708487606,-0.0032039924119782,No,NA,NA,P51570,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; galactitol metabolic process [GO:0019402]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_BRAFLDRAFT_91062.1.1.m.77,-0.00493421461216681,-0.003140121999147,No,NA,NA,Q6XZF7,NA,NA,NA,cell junction [GO:0030054]; cytoskeleton [GO:0005856]; Golgi stack [GO:0005795]; synapse [GO:0045202]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; aging [GO:0007568]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_BRAFLDRAFT_91068.1.1.m.9955,-0.00101942645295379,-0.0109198361086683,No,NA,NA,Q58DT5,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; kinocilium [GO:0060091]; stereocilium [GO:0032420]; positive regulation of GTPase activity [GO:0043547],NA,NA,NA
CHOYP_BRAFLDRAFT_91316.1.1.m.46558,0.0113173910433985,-0.0134726293424797,No,NA,NA,Q3UIR3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.1.10.m.20278,0.00432560550883848,0.00510842882764335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.10.10.m.59301,-0.00151645831905005,-0.00325676447158268,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91321.5.10.m.37054,0.00500587479435746,0.00269363806104362,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91321.7.10.m.56158,-0.00690823425482273,0.0142523572250209,No,NA,NA,Q2EMV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_BRAFLDRAFT_91394.1.1.m.16068,-0.00909080645523858,0.00472328320784362,No,NA,NA,Q9CQF9,NA,NA,NA,lysosome [GO:0005764]; plasma membrane [GO:0005886]; very-low-density lipoprotein particle [GO:0034361]; chloride-transporting ATPase activity [GO:0008555]; prenylcysteine oxidase activity [GO:0001735]; chloride transport [GO:0006821]; prenylated protein catabolic process [GO:0030327]; prenylcysteine catabolic process [GO:0030328],NA,NA,NA
CHOYP_BRAFLDRAFT_91441.1.1.m.47971,0.00195649719130076,0.0022185996417539,No,NA,NA,P08472,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.1.11.m.28449,-0.00547329232519333,-0.00340470507558537,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.4.11.m.45350,-0.0103657239795578,-0.0130798587265339,No,NA,NA,P27473,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.6.11.m.49144,0.0215946922921788,-0.0183256751148637,No,NA,NA,Q8BV66,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_BRAFLDRAFT_91636.8.11.m.58992,0.00118365346128042,0.00878183067814255,No,NA,NA,Q8TCB0,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617]; response to virus [GO:0009615],NA,NA,NA
CHOYP_BRAFLDRAFT_91695.1.1.m.31423,-0.0143347137772669,0.010192471267464,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_91870.3.3.m.62762,0.00506551458803706,0.00598224241565776,No,NA,NA,P17178,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen [GO:0016705]; vitamin D3 25-hydroxylase activity [GO:0030343]; cholesterol metabolic process [GO:0008203]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_BRAFLDRAFT_92024.1.1.m.49813,-0.000764994747115309,-0.000538096597323402,No,NA,NA,O08746,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; axon guidance [GO:0007411]; dendrite regeneration [GO:0031104]; glial cell migration [GO:0008347]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_BRAFLDRAFT_92063.1.2.m.677,-0.0034694023933125,-0.00396122059587782,No,NA,NA,Q5ZKI4,NA,NA,NA,early endosome [GO:0005769]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92084.1.1.m.10643,-6.26521397738005e-05,0.00831243132156896,No,NA,NA,Q8VCY6,NA,NA,NA,nucleolus [GO:0005730]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_BRAFLDRAFT_92365.3.3.m.51160,-4.3934479036007e-05,0.00582904815309173,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_BRAFLDRAFT_92367.1.4.m.29492,0.0157677651296532,-0.00910588472864309,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_BRAFLDRAFT_92398.1.2.m.15178,0.00481241078405262,-0.000401636814868866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_92410.1.1.m.36946,0.006684074837172,0.00789372043164049,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_BRAFLDRAFT_92601.1.1.m.56157,0.00157234470182078,0.00226554799198481,No,NA,NA,Q5R7R6,NA,NA,NA,Golgi membrane [GO:0000139]; protein transport [GO:0015031],NA,NA,NA
CHOYP_BRAFLDRAFT_92908.1.1.m.36182,-0.00133342036711892,0.00633311173183211,No,NA,NA,Q80YA7,NA,NA,NA,cytosol [GO:0005829]; aminopeptidase activity [GO:0004177]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_BRAFLDRAFT_93030.1.1.m.29276,0.00840291188966043,-0.00291565322625801,No,NA,NA,Q62261,NA,NA,NA,axolemma [GO:0030673]; cortical cytoskeleton [GO:0030863]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; common-partner SMAD protein phosphorylation [GO:0007182]; Golgi to plasma membrane protein transport [GO:0043001]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_BRAFLDRAFT_93247.1.1.m.7558,-0.00971381589873039,-0.00618184845954081,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93411.1.3.m.13317,0.0128306782268751,0.00888789094882466,No,NA,NA,O95049,NA,NA,NA,bicellular tight junction [GO:0005923]; nucleus [GO:0005634]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_BRAFLDRAFT_93411.3.3.m.54402,0.00212434547460084,-0.00264028011690673,No,NA,NA,O97758,NA,NA,NA,bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; gap junction [GO:0005921]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; bicellular tight junction assembly [GO:0070830]; cellular response to calcium ion [GO:0071277],NA,NA,NA
CHOYP_BRAFLDRAFT_93856.2.6.m.20593,-0.000936747874847606,0.0283914371269282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_93876.1.1.m.8885,0.0147621287564566,-0.0183080342135827,No,NA,NA,Q9NPF5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471],NA,NA,NA
CHOYP_BRAFLDRAFT_94906.1.1.m.59345,0.00189009909664287,-0.00178276957599901,No,NA,NA,P90994,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein deglycase activity [GO:0036524]; cellular response to glyoxal [GO:0036471]; cellular response to methylglyoxal [GO:0097238]; glycolate biosynthetic process [GO:0046295]; glyoxal metabolic process [GO:1903189]; guanine deglycation; glyoxal removal [GO:0106046]; lactate biosynthetic process [GO:0019249]; methylglyoxal metabolic process [GO:0009438]; negative regulation of neuron death [GO:1901215]; protein deglycation; glyoxal removal [GO:0036529]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_BRAFLDRAFT_95073.3.9.m.27326,-5.13230295357536e-05,0.00680933101041838,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95739.1.2.m.53575,-0.00199873178611775,0.00271343181893241,No,NA,NA,P70193,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hair cycle process [GO:0022405]; innervation [GO:0060384]; otolith morphogenesis [GO:0032474]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_BRAFLDRAFT_95739.2.2.m.57592,-0.00343437578308399,0.00466242874242357,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_95868.1.2.m.56034,-0.00372373530465629,0.0314510175246747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96254.1.1.m.47860,-0.00314055350378737,-0.000769612719999248,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_96598.1.1.m.54770,0.00442984051868419,0.00523152769277507,No,NA,NA,Q62283,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_BRAFLDRAFT_97410.1.3.m.34739,0.000329454707034538,-0.0178900200930853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_97676.1.1.m.62102,-0.0186943698762314,0.00436910865022797,No,NA,NA,Q8N1B4,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network membrane [GO:0032588]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; ectodermal cell differentiation [GO:0010668]; embryonic ectodermal digestive tract development [GO:0048611]; endocytic recycling [GO:0032456]; Golgi to vacuole transport [GO:0006896]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_BRAFLDRAFT_97881.1.1.m.46581,-0.00309609086728863,-0.00343644098966864,No,NA,NA,O75182,NA,NA,NA,autosome [GO:0030849]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Sin3 complex [GO:0016580]; X chromosome [GO:0000805]; XY body [GO:0001741]; Y chromosome [GO:0000806]; chromatin binding [GO:0003682]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_BRAFLDRAFT_98499.1.1.m.5718,-0.00418714029882571,-0.00713631405195573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.3.7.m.46571,-0.00897112337968856,0.00326111971558687,No,NA,NA,Q8N2S1,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; glycosaminoglycan binding [GO:0005539]; integrin binding [GO:0005178]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta-activated receptor activity [GO:0005024]; growth hormone secretion [GO:0030252]; multicellular organism development [GO:0007275]; protein folding [GO:0006457]; regulation of cell differentiation [GO:0045595]; regulation of cell growth [GO:0001558]; regulation of proteolysis [GO:0030162]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.4.7.m.53694,0.0347493645011325,0.00265846682312951,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.5.7.m.58200,0.00471210455093436,0.000154573281358346,No,NA,NA,P98133,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; negative regulation of osteoclast development [GO:2001205]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59350,-0.0044166739868535,-0.0134635143090093,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98740.6.7.m.59351,0.0142561865842831,-0.00581089512300414,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98740.7.7.m.65348,0.026353963552108,0.0249944302504701,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_BRAFLDRAFT_98895.2.2.m.39575,-0.015149209719723,0.0152103259036413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_98992.1.1.m.62815,8.83210682062523e-05,0.00039260990605477,No,NA,NA,P08503,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; isomerase activity [GO:0016853]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; medium-chain fatty acid catabolic process [GO:0051793]; protein homotetramerization [GO:0051289]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; response to hormone [GO:0009725]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_BRAFLDRAFT_99018.1.1.m.14650,-0.0119853702222086,0.023755655428528,No,NA,NA,P55567,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_BRAFLDRAFT_99073.1.1.m.18282,0.00861903514227847,-0.0163420693000603,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99083.1.1.m.11705,0.000155694241976861,-0.00146129203053188,No,NA,NA,Q9DAK2,NA,NA,NA,cell body [GO:0044297]; cilium [GO:0005929]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; sperm midpiece [GO:0097225]; vesicle [GO:0031982]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; ubiquitin protein ligase binding [GO:0031625]; cellular response to unfolded protein [GO:0034620]; negative regulation of cell death [GO:0060548]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_BRAFLDRAFT_99539.1.1.m.55866,0.00414750585324894,0.00489809771609193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99630.3.9.m.20020,0.0191456483952654,-0.0062480323763369,No,NA,NA,P18460,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.5.9.m.36500,0.00259334034940536,-0.000700794633420722,No,NA,NA,P18460,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; positive regulation of cell proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_BRAFLDRAFT_99630.9.9.m.62562,-0.00753814974150237,-0.0047972598876807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_BRAFLDRAFT_99641.1.1.m.63666,-0.0170938899219971,-0.00742839123631085,No,NA,NA,Q2T9I5,NA,NA,NA,metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_BRAFLDRAFT_99974.1.1.m.25083,0.019915042622341,0.0117584546593472,No,NA,NA,Q9HAY6,NA,NA,NA,cytosol [GO:0005829]; beta-carotene 15;15'-monooxygenase activity [GO:0003834]; carotenoid dioxygenase activity [GO:0010436]; metal ion binding [GO:0046872]; retinal isomerase activity [GO:0004744]; beta-carotene metabolic process [GO:1901810]; carotene catabolic process [GO:0016121]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572]; vitamin A biosynthetic process [GO:0035238],NA,NA,NA
CHOYP_BRAP.1.1.m.47862,-0.00886482624284828,-0.0153806339047955,No,NA,NA,Q7Z569,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; ubiquitin ligase complex [GO:0000151]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; MAPK cascade [GO:0000165]; negative regulation of signal transduction [GO:0009968]; protein ubiquitination [GO:0016567]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_BRCA2.1.2.m.17660,-0.0165186834491013,0.00994504520815108,No,NA,NA,Q6AZL2,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; chromatin binding [GO:0003682]; cellular response to DNA damage stimulus [GO:0006974]; centrosome cycle [GO:0007098]; DNA replication [GO:0006260]; regulation of cell cycle [GO:0051726]; response to UV [GO:0009411]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_BRCC3.1.1.m.66615,0.000146095834883224,0.0126482585673125,No,NA,NA,B5X8M4,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; polyubiquitin modification-dependent protein binding [GO:0031593]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; cell cycle [GO:0007049]; cell division [GO:0051301]; double-strand break repair [GO:0006302]; histone H2A K63-linked deubiquitination [GO:0070537]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_BRD4.1.1.m.55245,0.00721486995972094,-0.010485205710873,No,NA,NA,Q91Y44,NA,NA,NA,nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; cell differentiation [GO:0030154]; chromatin remodeling [GO:0006338]; histone displacement [GO:0001207]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; mRNA processing [GO:0006397]; positive regulation of transcription involved in meiotic cell cycle [GO:0051039]; regulation of RNA splicing [GO:0043484]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_BRD8.1.1.m.244,-0.000777288227544915,0.000219614442909418,No,NA,NA,Q8R3B7,NA,NA,NA,mitochondrion [GO:0005739]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; Swr1 complex [GO:0000812]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_BRX1.1.1.m.30421,-0.00414595091849404,-0.00317758934715551,No,NA,NA,Q3SZZ0,NA,NA,NA,nucleolus [GO:0005730]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_BT3L4.1.1.m.2144,-0.000388003153834412,-0.00191823547162431,No,NA,NA,Q5M8V0,NA,NA,NA,,NA,NA,NA
CHOYP_BTAF1.2.2.m.55086,-0.00398447724965326,0.00500286340643685,No,NA,NA,O14981,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; negative regulation of chromatin binding [GO:0035562]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_BTKL.1.1.m.55270,0.00171007439738107,0.00482483095964312,No,NA,NA,Q14BI2,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; neuron projection [GO:0043005]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_BTKL.1.1.m.55271,0.00585971120453846,0.00174183836061873,No,NA,NA,P42680,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipid binding [GO:0005543]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; cytokine-mediated signaling pathway [GO:0019221]; Fc-epsilon receptor signaling pathway [GO:0038095]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein phosphorylation [GO:0006468]; regulation of platelet activation [GO:0010543]; T cell receptor signaling pathway [GO:0050852]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_BTRC.1.1.m.816,-0.00722055778344669,-0.00309074936818432,No,NA,NA,Q9Y297,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; SCF ubiquitin ligase complex [GO:0019005]; small-subunit processome [GO:0032040]; beta-catenin binding [GO:0008013]; ligase activity [GO:0016874]; protein dimerization activity [GO:0046983]; protein phosphorylated amino acid binding [GO:0045309]; snoRNA binding [GO:0030515]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cellular response to organic cyclic compound [GO:0071407]; G2/M transition of mitotic cell cycle [GO:0000086]; interleukin-1-mediated signaling pathway [GO:0070498]; mammary gland epithelial cell proliferation [GO:0033598]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of smoothened signaling pathway [GO:0045879]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of proteolysis [GO:0045862]; positive regulation of transcription; DNA-templated [GO:0045893]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; protein destabilization [GO:0031648]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of proteasomal protein catabolic process [GO:0061136]; rhythmic process [GO:0048511]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; signal transduction [GO:0007165]; stress-activated MAPK cascade [GO:0051403]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_BTZ.1.1.m.45914,0.00287261498402348,0.00178748934997998,No,NA,NA,A5D7H5,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_BUCC.1.2.m.10972,-0.0112156762415829,-0.00332702219569179,No,NA,NA,P20481,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_BUD31.3.3.m.64519,0.00528079198866225,-0.000259449904330245,No,NA,NA,Q962X9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_BUP1.1.1.m.13641,-0.00264190078935802,-0.00169462174323981,No,NA,NA,Q9UBR1,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; beta-ureidopropionase activity [GO:0003837]; metal ion binding [GO:0046872]; beta-alanine biosynthetic process via 3-ureidopropionate [GO:0033396]; beta-alanine metabolic process [GO:0019482]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_BZW1.1.1.m.44089,0.000138793191645057,0.000478155582208103,No,NA,NA,Q5ZLT7,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_C10.1.2.m.23678,-0.0152197472272118,-0.033736695933473,No,NA,NA,O35127,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; camera-type eye morphogenesis [GO:0048593]; cognition [GO:0050890]; corpus callosum morphogenesis [GO:0021540]; post-embryonic development [GO:0009791]; psychomotor behavior [GO:0036343]; regulation of skeletal muscle contraction [GO:0014819]; third ventricle development [GO:0021678],NA,NA,NA
CHOYP_C102A.1.1.m.23591,-0.00536664961475052,-0.0335069831822485,No,NA,NA,A0JNH6,NA,NA,NA,myosin complex [GO:0016459]; motor activity [GO:0003774],NA,NA,NA
CHOYP_C124A.1.1.m.61913,-0.0315390279183236,-0.0125311501182087,No,NA,NA,Q68EY7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_C19L1.1.1.m.13954,0.00219846131909082,-0.00230543783687239,No,NA,NA,Q5RGJ5,NA,NA,NA,,NA,NA,NA
CHOYP_C1QL2.19.32.m.29743,-0.0109805759570233,0.0147327625294982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL2.32.32.m.64434,0.0257996863637123,-0.0326649103088353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4.7.10.m.49245,0.0108743241225363,0.019268837346168,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QL4L.3.7.m.5967,-0.0108541417748075,0.0221769065831679,No,NA,NA,Q5RJ80,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_C1QL4L.3.7.m.5968,-0.00906133198268965,-0.0126142514173088,No,NA,NA,Q86Z23,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1QL4L.6.7.m.26358,0.00829854303755778,0.00585725369473739,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT3.4.8.m.22821,0.0047260976589602,0.00558139975408274,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_C1QT4.2.5.m.28767,0.0200845061087938,0.00366900766695317,No,NA,NA,Q8R066,NA,NA,NA,extracellular space [GO:0005615]; cytokine activity [GO:0005125]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor secretion [GO:1904469],NA,NA,NA
CHOYP_C1QT4.3.5.m.46406,0.0126215177100033,0.0117234465274778,No,NA,NA,Q4ZJM9,NA,NA,NA,collagen trimer [GO:0005581]; extracellular space [GO:0005615]; identical protein binding [GO:0042802]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147],NA,NA,NA
CHOYP_C1TC.1.1.m.28294,0.00399571621925704,0.000353964766461732,No,NA,NA,P27653,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; formate-tetrahydrofolate ligase activity [GO:0004329]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO:0004486]; 10-formyltetrahydrofolate biosynthetic process [GO:0009257]; histidine biosynthetic process [GO:0000105]; methionine biosynthetic process [GO:0009086]; nucleotide metabolic process [GO:0009117]; one-carbon metabolic process [GO:0006730]; purine nucleobase biosynthetic process [GO:0009113]; purine nucleotide biosynthetic process [GO:0006164]; response to nitrogen dioxide [GO:0035713]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_C2CD5.1.1.m.9675,0.00257479859513805,0.0167046663659522,No,NA,NA,Q28BX9,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to insulin stimulus [GO:0032869]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; intracellular protein transmembrane transport [GO:0065002]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of vesicle fusion [GO:0031340],NA,NA,NA
CHOYP_C2D1.1.1.m.8807,0.0198362798066167,0.0162275958760882,No,NA,NA,Q9VKJ9,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; phospholipid binding [GO:0005543]; compound eye development [GO:0048749]; endosomal transport [GO:0016197]; female germ-line stem cell asymmetric division [GO:0048132]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; multivesicular body organization [GO:0036257]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of protein catabolic process [GO:0045732]; regulation of endocytosis [GO:0030100]; regulation of Notch signaling pathway [GO:0008593]; sensory organ development [GO:0007423]; sensory organ precursor cell division [GO:0045035]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_C3ORF38.1.1.m.59043,-0.0129585213140336,0.00269095111475132,No,NA,NA,Q5JPI3,NA,NA,NA,nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_C43BP.1.1.m.62099,-0.00726935536202325,-0.00288399401604726,No,NA,NA,Q6VVX2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intermembrane ceramide transfer activity [GO:0120017]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ER to Golgi ceramide transport [GO:0035621],NA,NA,NA
CHOYP_CA050.1.2.m.10226,-0.00597182854941959,0.00380729079299656,No,NA,NA,Q5PQ76,NA,NA,NA,,NA,NA,NA
CHOYP_CA14.1.1.m.30677,-0.00650468892394975,0.0234783212224783,No,NA,NA,Q9ULX7,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_CA2.1.1.m.27846,-0.00480335522625806,0.00305629872040569,No,NA,NA,Q8UWA5,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAB32.1.1.m.52444,0.000971549251830052,0.00699170098950205,No,NA,NA,P41044,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuron projection [GO:0043005]; nucleus [GO:0005634]; synapse [GO:0045202]; type II terminal bouton [GO:0061175]; type III terminal bouton [GO:0097467]; calcium ion binding [GO:0005509]; negative regulation of response to wounding [GO:1903035]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of presynaptic cytosolic calcium ion concentration [GO:0099509],NA,NA,NA
CHOYP_CAD1.2.2.m.61448,0,0,No,NA,NA,Q6X862,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_CAD89.1.1.m.14552,0.00741143837440641,-0.0201128651596617,No,NA,NA,Q9VAF5,NA,NA,NA,apical plasma membrane [GO:0016324]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; apical protein localization [GO:0045176]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-mediated signaling [GO:0019722]; cell-cell adhesion mediated by cadherin [GO:0044331]; chorion-containing eggshell formation [GO:0007304]; follicle cell microvillus organization [GO:0032529]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; mucosal immune response [GO:0002385]; positive regulation of clathrin-dependent endocytosis [GO:2000370]; regulation of follicle cell microvillus length [GO:0032533]; tube morphogenesis [GO:0035239]; vitelline membrane formation involved in chorion-containing eggshell formation [GO:0007305],NA,NA,NA
CHOYP_CADM3.4.4.m.45272,-0.00497099762687897,-0.0009606488305894,No,NA,NA,Q7ZXX1,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60661,0.00654328026908513,0.00114214291356906,No,NA,NA,Q7ZXX1,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CADM4.1.1.m.60662,0.00144279171798744,-0.00710622858339054,No,NA,NA,Q0P5A1,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; midbody [GO:0030496]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cytoskeleton-dependent cytokinesis [GO:0061640]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_CADN.2.3.m.19237,0.00155594354817329,-0.000267680472350085,No,NA,NA,O15943,NA,NA,NA,axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_CAH1.1.2.m.24247,0.0146493891138313,0.0110712609566851,No,NA,NA,P83299,NA,NA,NA,cytoplasm [GO:0005737]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAH2.1.1.m.42306,0.00610084364592332,0.00094686202950503,No,NA,NA,Q8UWA5,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CAHD1.5.6.m.53893,-5.57980981866076e-05,0.00740306493481168,No,NA,NA,Q5VU97,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_CAL6303_3579.1.1.m.59031,-0.00316620235777209,0.00681846898811561,No,NA,NA,P28034,NA,NA,NA,caffeoyl-CoA O-methyltransferase activity [GO:0042409]; metal ion binding [GO:0046872]; lignin biosynthetic process [GO:0009809],NA,NA,NA
CHOYP_CAL7507_4591.1.1.m.49532,-0.00163817975881454,-0.0256036029536467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CALCR.1.6.m.856,0,0,No,NA,NA,O08893,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcitonin receptor activity [GO:0004948]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_CALM.11.50.m.28106,0.0263280956525024,-0.00700175756829103,No,NA,NA,Q8STF0,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.15.50.m.30007,0.00177743656853885,0.000980316692876054,No,NA,NA,Q9LIK5,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.22.50.m.31010,0.0278979172670646,-0.0137284004142594,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.31.50.m.48469,-0.0139640475737008,-0.00888668540585778,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CALM.32.50.m.48894,0,0,No,NA,NA,O16305,NA,NA,NA,cell periphery [GO:0071944]; centrosome [GO:0005813]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; apoptotic cell clearance [GO:0043277]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; embryo development ending in birth or egg hatching [GO:0009792]; establishment of meiotic spindle orientation [GO:0051296]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CALM.35.50.m.49987,-0.000433069671024193,-0.000876989896957222,No,NA,NA,P23286,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.37.50.m.52385,0.00148377886265423,0.00412254861982141,No,NA,NA,P02594,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALM.44.50.m.56751,0.00123685766210742,0.00290180781094985,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.45.50.m.57163,-0.000116909811715936,0.000526750469801952,No,NA,NA,O96102,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.50.50.m.67046,0.000715199267969664,0.00322310702785586,No,NA,NA,Q95NR9,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALM.7.50.m.12029,0.00524973272857305,0.0163818854657756,No,NA,NA,Q7T3T2,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CALMB.1.1.m.41570,0.00460321612709776,-0.00835705880400906,No,NA,NA,P05932,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALRL.2.3.m.42463,-0.0013141176239421,-0.0014866198707826,No,NA,NA,O42602,NA,NA,NA,integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; corticotrophin-releasing factor receptor activity [GO:0015056]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; corticotropin secretion [GO:0051458]; regulation of corticosterone secretion [GO:2000852],NA,NA,NA
CHOYP_CALUB.1.2.m.57842,-0.000461052940606481,-0.00246581118448171,No,NA,NA,B5X4E0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALUB.2.2.m.58007,0.00230470512280774,-0.00378663181518462,No,NA,NA,Q6XLQ7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CALX.1.1.m.12010,-0.000787202882438111,0.00166273243378125,No,NA,NA,Q5R440,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; clathrin-dependent endocytosis [GO:0072583]; protein folding [GO:0006457]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CAMK4.1.1.m.30431,-0.00504079829367208,-0.00101094580211092,No,NA,NA,Q16566,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fibrillar center [GO:0001650]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ATP binding [GO:0005524]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; adaptive immune response [GO:0002250]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; myeloid dendritic cell differentiation [GO:0043011]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of osteoclast differentiation [GO:0045670]; regulation of T cell differentiation in thymus [GO:0033081]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42242,-0.00836617864899848,-0.00532421544043408,No,NA,NA,O15484,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CAN5.1.1.m.42243,-0.00826272304594863,-0.00505575729350389,No,NA,NA,P80404,NA,NA,NA,4-aminobutyrate transaminase complex [GO:0032144]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; (S)-3-amino-2-methylpropionate transaminase activity [GO:0047298]; 4-aminobutyrate transaminase activity [GO:0003867]; 4-aminobutyrate:2-oxoglutarate transaminase activity [GO:0034386]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; succinate-semialdehyde dehydrogenase binding [GO:0032145]; aging [GO:0007568]; behavioral response to cocaine [GO:0048148]; cerebellum development [GO:0021549]; copulation [GO:0007620]; exploration behavior [GO:0035640]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; gamma-aminobutyric acid catabolic process [GO:0009450]; locomotory behavior [GO:0007626]; negative regulation of blood pressure [GO:0045776]; negative regulation of dopamine secretion [GO:0033602]; negative regulation of gamma-aminobutyric acid secretion [GO:0014053]; negative regulation of platelet aggregation [GO:0090331]; neurotransmitter catabolic process [GO:0042135]; positive regulation of aspartate secretion [GO:1904450]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of heat generation [GO:0031652]; positive regulation of inhibitory postsynaptic potential [GO:0097151]; positive regulation of insulin secretion [GO:0032024]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of uterine smooth muscle contraction [GO:0070474]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to nicotine [GO:0035094],NA,NA,NA
CHOYP_CAN8.1.2.m.21091,0.00234043001708131,-0.000632451037999478,No,NA,NA,O35920,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CAOG_00801.1.2.m.1579,-0.00200362203008438,-4.08358816735125e-05,No,NA,NA,Q9D9B4,NA,NA,NA,melanocyte differentiation [GO:0030318],NA,NA,NA
CHOYP_CAOG_01182.1.1.m.8019,-0.0106546674715185,-0.00678060407798495,No,NA,NA,Q717B4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of proteolysis [GO:0030162]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CAOG_01521.1.1.m.28103,0.00238909108186881,-0.00047788604222664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_02976.1.2.m.41292,-9.97654038874463e-05,0.00319496033561275,No,NA,NA,O83041,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_02976.2.2.m.56777,-0.00850587803833213,-0.02681725852083,No,NA,NA,O83041,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177],NA,NA,NA
CHOYP_CAOG_03463.1.1.m.16746,0.0079994295188575,0.00381015103929884,No,NA,NA,Q6P1C6,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_CAOG_04006.1.1.m.5403,-0.00108292159085125,-0.00441661414965709,No,NA,NA,Q5JI69,NA,NA,NA,cytoplasm [GO:0005737]; amino acid binding [GO:0016597]; L-threonine 3-dehydrogenase activity [GO:0008743]; NAD+ binding [GO:0070403]; zinc ion binding [GO:0008270]; L-threonine catabolic process to glycine [GO:0019518]; protein homotetramerization [GO:0051289]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_CAOG_04643.2.2.m.50992,-0.00949544104254989,0.0137486599379761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_04686.2.2.m.28117,0.0154233211000398,0.0286263473206077,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAOG_05733.1.2.m.29878,-0.00398980958945781,0.00541647276873729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CAP.1.2.m.22123,0.0144243963949819,0.016438392472405,No,NA,NA,P40122,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010],NA,NA,NA
CHOYP_CAPLA.1.2.m.51979,2.03008153245564e-05,-0.000279482716561675,No,NA,NA,P12370,NA,NA,NA,cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cAMP-dependent protein kinase activity [GO:0004691]; protein serine/threonine kinase activity [GO:0004674]; anesthesia-resistant memory [GO:0007615]; anterior/posterior pattern specification; imaginal disc [GO:0007448]; behavioral response to ethanol [GO:0048149]; cAMP-mediated signaling [GO:0019933]; cellular response to ethanol [GO:0071361]; compound eye development [GO:0048749]; imaginal disc-derived wing morphogenesis [GO:0007476]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of nucleocytoplasmic transport [GO:0046823]; negative regulation of smoothened signaling pathway [GO:0045879]; olfactory learning [GO:0008355]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte microtubule cytoskeleton polarization [GO:0008103]; oogenesis [GO:0048477]; positive regulation of gene expression [GO:0010628]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of smoothened signaling pathway [GO:0045880]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of apoptotic process [GO:0042981]; regulation of bicoid mRNA localization [GO:0008359]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; regulation of pole plasm oskar mRNA localization [GO:0007317]; rhythmic behavior [GO:0007622]; sprouting of injured axon [GO:0048682]; thermosensory behavior [GO:0040040],NA,NA,NA
CHOYP_CAPSLB.1.1.m.58887,-0.000259102794909497,0.0014932582749959,No,NA,NA,Q6P8Y1,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CAPZB.1.1.m.5762,-0.00085926592883514,-0.000829214832422318,No,NA,NA,Q5XI32,NA,NA,NA,actin filament [GO:0005884]; dendritic spine [GO:0043197]; F-actin capping protein complex [GO:0008290]; neuronal cell body [GO:0043025]; sarcomere [GO:0030017]; WASH complex [GO:0071203]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; cytoskeleton organization [GO:0007010]; negative regulation of filopodium assembly [GO:0051490]; regulation of cell morphogenesis [GO:0022604]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_CARNS1.1.6.m.2227,0.00883353558496913,0.00626744812312596,No,NA,NA,A5YM72,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.2.6.m.3531,-0.00710262372858089,0.0129252616307058,No,NA,NA,Q9BT30,NA,NA,NA,mitochondrial matrix [GO:0005759]; dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872]; cellular response to DNA damage stimulus [GO:0006974]; fatty acid metabolic process [GO:0006631]; regulation of lipid storage [GO:0010883]; regulation of mitochondrial membrane permeability involved in programmed necrotic cell death [GO:1902445],NA,NA,NA
CHOYP_CARNS1.4.6.m.40244,-0.029354458897242,-0.0108410392868834,No,NA,NA,A5YM72,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; carnosine synthase activity [GO:0047730]; FMN binding [GO:0010181]; homocarnosine synthase activity [GO:0102102]; metal ion binding [GO:0046872]; carnosine biosynthetic process [GO:0035499]; histidine catabolic process [GO:0006548],NA,NA,NA
CHOYP_CARNS1.5.6.m.63614,-0.00230681262297755,-0.00961096744575283,No,NA,NA,Q80TZ9,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleus [GO:0005634]; PML body [GO:0016605]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; branching morphogenesis of a nerve [GO:0048755]; cerebellar granule cell precursor proliferation [GO:0021930]; cerebellar Purkinje cell layer maturation [GO:0021691]; cerebellum development [GO:0021549]; chromatin remodeling [GO:0006338]; dendrite morphogenesis [GO:0048813]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CASP10.4.7.m.45631,-0.00430402090826684,0.00225148770923809,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP10.5.7.m.49889,-0.000339967475636031,-0.00256452837136408,No,NA,NA,Q92851,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ripoptosome [GO:0097342]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; death effector domain binding [GO:0035877]; ubiquitin protein ligase binding [GO:0031625]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; execution phase of apoptosis [GO:0097194]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_CASP2.5.5.m.35953,0.0080966288965336,0.00076645516613147,No,NA,NA,P29594,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; aging [GO:0007568]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; brain development [GO:0007420]; cellular response to mechanical stimulus [GO:0071260]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; luteolysis [GO:0001554]; negative regulation of apoptotic process [GO:0043066]; neural retina development [GO:0003407]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485],NA,NA,NA
CHOYP_CASP3.1.3.m.23354,-0.0195678647627925,-0.0110256714498982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP3.2.3.m.24896,0.00443930708309576,0.00524270746181318,No,NA,NA,P70677,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; death receptor binding [GO:0005123]; peptidase activity [GO:0008233]; phospholipase A2 activator activity [GO:0016005]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CASP7.11.23.m.26574,-0.00554064887283011,-0.00862082409806671,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.16.23.m.50828,-0.00323689840083969,-0.0109104318873677,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.17.23.m.52767,-0.00364277244185685,0.00724788255045514,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.18.23.m.52787,-0.000277946140295732,0.00607202336078346,No,NA,NA,Q60431,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_CASP7.2.23.m.5415,-0.00383324030730835,0.00520391795022563,No,NA,NA,P55214,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity [GO:0004197]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_CASP7.21.23.m.63852,-0.0143240508207401,-0.00911579058361091,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.22.23.m.66704,0.000980439794728751,0.00103182145986156,No,NA,NA,P97864,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; aspartic-type endopeptidase activity [GO:0004190]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; heart development [GO:0007507]; leukocyte apoptotic process [GO:0071887]; neuron apoptotic process [GO:0051402]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]; striated muscle cell differentiation [GO:0051146],NA,NA,NA
CHOYP_CASP7.5.23.m.12847,0.012444509629454,0.0129408147817783,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CASP7.8.23.m.23670,0.0104379763769295,0.0123269815791605,No,NA,NA,O89094,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cornification [GO:0070268]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630],NA,NA,NA
CHOYP_CAT.1.1.m.57038,0.00130751961338954,0.00353103746084,No,NA,NA,P00432,NA,NA,NA,peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; aminoacylase activity [GO:0004046]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; oxidation-reduction process [GO:0055114]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; response to hydrogen peroxide [GO:0042542]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.1.3.m.11120,-0.00481559287921054,-0.0137242308551773,No,NA,NA,Q9PWF7,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATA.2.3.m.18454,0.00182080563002572,0.00604765378922998,No,NA,NA,P04040,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; aminoacylase activity [GO:0004046]; antioxidant activity [GO:0016209]; catalase activity [GO:0004096]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NADP binding [GO:0050661]; oxidoreductase activity; acting on peroxide as acceptor [GO:0016684]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; aerobic respiration [GO:0009060]; aging [GO:0007568]; cellular response to growth factor stimulus [GO:0071363]; cellular response to oxidative stress [GO:0034599]; cholesterol metabolic process [GO:0008203]; hemoglobin metabolic process [GO:0020027]; hydrogen peroxide catabolic process [GO:0042744]; negative regulation of apoptotic process [GO:0043066]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; positive regulation of cell division [GO:0051781]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein homotetramerization [GO:0051289]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; response to activity [GO:0014823]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to L-ascorbic acid [GO:0033591]; response to lead ion [GO:0010288]; response to light intensity [GO:0009642]; response to ozone [GO:0010193]; response to phenylpropanoid [GO:0080184]; response to reactive oxygen species [GO:0000302]; response to vitamin A [GO:0033189]; response to vitamin E [GO:0033197]; triglyceride metabolic process [GO:0006641]; ureteric bud development [GO:0001657]; UV protection [GO:0009650],NA,NA,NA
CHOYP_CATA.3.3.m.21642,0.022338828308912,0.0222933035432211,No,NA,NA,Q9PWF7,NA,NA,NA,peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_CATB.1.2.m.5440,-0.00256825105207125,-0.00366558696196663,No,NA,NA,A1E295,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of catalytic activity [GO:0050790],NA,NA,NA
CHOYP_CATL1.1.1.m.56906,-0.0131165226142376,-0.00612783376900769,No,NA,NA,P25782,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_CATS.1.1.m.45218,-0.00113260423063906,-0.00562709349947839,No,NA,NA,O60911,NA,NA,NA,apical part of cell [GO:0045177]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; secretory granule [GO:0030141]; aminopeptidase activity [GO:0004177]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagic cell death [GO:0048102]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; extracellular matrix disassembly [GO:0022617]; multicellular organism aging [GO:0010259]; nerve development [GO:0021675]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of keratinocyte differentiation [GO:0045616]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to odorant [GO:1990834]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CB044.1.1.m.53539,-0.00153435934513322,-0.00498660185207023,No,NA,NA,Q5RFV8,NA,NA,NA,,NA,NA,NA
CHOYP_CBG09799.1.1.m.44038,-0.00949085869614492,3.72845193837567e-06,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG11292.1.1.m.12957,-0.0142644813187624,0.0200583743106415,No,NA,NA,Q8ISH7,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide hormone activity [GO:0005184]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_CBG18730.1.1.m.2611,0.00441088570590349,-0.0127479889514173,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_CBG20816.1.1.m.49333,0.00297308047408785,-0.000803411261250935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBG22657.2.2.m.28802,-0.0102002524786827,0.00745712888858544,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBLN3.1.2.m.29253,-0.0129904922072331,0.0182952594701226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBP.2.4.m.11401,0.00173653865125225,-0.000193478578120107,No,NA,NA,Q6JHU9,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; nuclear body [GO:0016604]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; acetyltransferase activity [GO:0016407]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; histone acetyltransferase activity [GO:0004402]; MRF binding [GO:0043426]; peroxisome proliferator activated receptor binding [GO:0042975]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell proliferation [GO:0008283]; cellular response to UV [GO:0034644]; histone acetylation [GO:0016573]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein destabilization [GO:0031648]; regulation of transcription; DNA-templated [GO:0006355]; response to interleukin-1 [GO:0070555]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_CBPC1.1.1.m.30713,-0.0012977156621296,-0.00761777949961871,No,NA,NA,Q5REG1,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; U6 snRNA binding [GO:0017070]; U6atac snRNA binding [GO:0030624]; mRNA splicing; via spliceosome [GO:0000398]; nucleosome assembly [GO:0006334]; positive regulation of histone deubiquitination [GO:1903586]; spliceosomal snRNP assembly [GO:0000387]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_CBPQ.1.1.m.58629,-0.00554072768332818,0.00152059227465486,No,NA,NA,Q6GQ29,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallodipeptidase activity [GO:0070573]; protein homodimerization activity [GO:0042803]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CBR.GLY.5.1.1.m.26441,0.0264182740401534,0.00456691943634639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44681,-0.0198722645991445,0.0158952941039123,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LET.2.2.2.m.44682,0.00850802701191668,-0.00846755572985941,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBR.LIN.24.1.1.m.5076,-0.0162314170518017,-0.00386112512100107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CBS.2.2.m.65898,-0.00138933337326332,0.00230371214419926,No,NA,NA,Q91WT9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; carbon monoxide binding [GO:0070025]; cystathionine beta-synthase activity [GO:0004122]; cysteine synthase activity [GO:0004124]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; modified amino acid binding [GO:0072341]; nitric oxide binding [GO:0070026]; nitrite reductase (NO-forming) activity [GO:0050421]; oxygen binding [GO:0019825]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; S-adenosyl-L-methionine binding [GO:1904047]; ubiquitin protein ligase binding [GO:0031625]; blood vessel remodeling [GO:0001974]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hypoxia [GO:0071456]; cerebellum morphogenesis [GO:0021587]; cysteine biosynthetic process [GO:0019344]; cysteine biosynthetic process from serine [GO:0006535]; cysteine biosynthetic process via cystathionine [GO:0019343]; endochondral ossification [GO:0001958]; homocysteine catabolic process [GO:0043418]; homocysteine metabolic process [GO:0050667]; hydrogen sulfide biosynthetic process [GO:0070814]; L-serine metabolic process [GO:0006563]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of apoptotic process [GO:0043066]; regulation of blood vessel size [GO:0050880]; regulation of JUN kinase activity [GO:0043506]; regulation of nitric oxide mediated signal transduction [GO:0010749]; response to folic acid [GO:0051593]; superoxide metabolic process [GO:0006801]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_CBWD1.1.1.m.6825,-0.0113652174013091,-0.00231807254809634,No,NA,NA,Q8IUF1,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_CBX1.1.4.m.5390,0.00147674807586529,0.00405529878285302,No,NA,NA,Q61686,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CBX1.3.4.m.27106,0.0277799391522264,-0.0288236718975776,No,NA,NA,Q61686,NA,NA,NA,chromocenter [GO:0010369]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear chromosome; telomeric region [GO:0000784]; nuclear heterochromatin [GO:0005720]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein binding; bridging [GO:0030674]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; repressing transcription factor binding [GO:0070491]; ribonucleoprotein complex binding [GO:0043021]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_CC136.1.1.m.64302,-0.00563466319792241,0.0309440798904719,No,NA,NA,Q01844,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CC171.1.1.m.55237,-0.00452832054407884,0.000834964987830989,No,NA,NA,E9Q1U1,NA,NA,NA,,NA,NA,NA
CHOYP_CC1G_13336.1.3.m.23079,-0.00375687675315582,0.00495281386320432,No,NA,NA,O94581,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrial respiratory chain complex IV assembly [GO:0033617],NA,NA,NA
CHOYP_CCAR1.1.1.m.25430,-0.0062164206727844,-0.00837706671412024,No,NA,NA,Q641G3,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; cell cycle [GO:0007049]; regulation of transcription; DNA-templated [GO:0006355]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_CCBL1.1.1.m.30637,-0.0176296332919879,-0.0181318063644592,No,NA,NA,Q7T3E5,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_CCD22.1.1.m.6639,0.0016874088876157,-0.00159078230671769,No,NA,NA,A7RNG8,NA,NA,NA,cullin family protein binding [GO:0097602]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060],NA,NA,NA
CHOYP_CCD43.1.1.m.63636,-0.0108610137204878,-0.00197857804051881,No,NA,NA,Q6PFL6,NA,NA,NA,,NA,NA,NA
CHOYP_CCD53.1.1.m.6684,0.0125374753533742,-0.00957148822745963,No,NA,NA,Q5RGJ6,NA,NA,NA,WASH complex [GO:0071203]; actin filament polymerization [GO:0030041]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_CCD73.1.2.m.21485,-0.00412442624526636,0.0147562703617967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CCDC146.1.1.m.11347,0,0,No,NA,NA,Q8IYE0,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_CCDC150.1.1.m.58800,-0.00885661490962525,-0.00141367781530452,No,NA,NA,Q8NCX0,NA,NA,NA,,NA,NA,NA
CHOYP_CCDC6.1.1.m.13918,0.0112092715294775,-0.00427105789065789,No,NA,NA,Q16204,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; SH3 domain binding [GO:0017124]; structural constituent of cytoskeleton [GO:0005200],NA,NA,NA
CHOYP_CCHCR1.1.1.m.59142,-0.00508290217459265,-0.0231422835019433,No,NA,NA,Q566U4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; arylformamidase activity [GO:0004061]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_CCHL.2.2.m.66608,-8.16230173859007e-05,0.010829410275996,No,NA,NA,Q5F339,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; holocytochrome-c synthase activity [GO:0004408]; metal ion binding [GO:0046872]; cytochrome c-heme linkage [GO:0018063],NA,NA,NA
CHOYP_CCKAR.4.6.m.43964,0.00446090947931801,0.00526821933601956,No,NA,NA,P70031,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_CCNB.2.2.m.16936,-0.0093850426985585,-0.00597261800652321,No,NA,NA,Q5XIK8,NA,NA,NA,phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_CCNL1.1.2.m.9018,-0.00989373324704123,0.0126736311869437,No,NA,NA,Q6GN15,NA,NA,NA,nuclear speck [GO:0016607]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of transcription; DNA-templated [GO:0006355]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CD033.1.1.m.25350,0.00415227406780975,-0.00933264425973656,No,NA,NA,Q8BGN2,NA,NA,NA,,NA,NA,NA
CHOYP_CD109.1.2.m.7033,-0.000961907794833523,0.000636329701241973,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_CD11B.1.1.m.51509,-0.00624564089809998,0.0128144787281306,No,NA,NA,P21127,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; mitotic cell cycle [GO:0000278]; protein phosphorylation [GO:0006468]; regulation of cell growth [GO:0001558]; regulation of mRNA processing [GO:0050684]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_CD36_40650.1.1.m.47015,0.00204883656001794,0.000390933586214718,No,NA,NA,O35601,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; immune response [GO:0006955]; integrin-mediated signaling pathway [GO:0007229]; protein localization to plasma membrane [GO:0072659]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_CDC14A.1.1.m.18068,0.0191094614838947,0.0110512589713971,No,NA,NA,Q9UNH5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinociliary basal body [GO:1902636]; kinocilium [GO:0060091]; mitotic spindle [GO:0072686]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; stereocilium tip [GO:0032426]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; cell division [GO:0051301]; cell proliferation [GO:0008283]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; positive regulation of cytokinesis [GO:0032467]; regulation of exit from mitosis [GO:0007096]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_CDC23.1.1.m.6463,-0.00592352276350219,-0.00629579610413173,No,NA,NA,A1A4R8,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cell division [GO:0051301]; mitotic metaphase plate congression [GO:0007080]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic metaphase/anaphase transition [GO:0030071],NA,NA,NA
CHOYP_CDC42.1.11.m.324,0.000986616240879139,-0.000173715721293194,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60002,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CDC42.11.11.m.60004,-0.00208009372341768,0.000716541011958233,No,NA,NA,Q29HY3,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; rhabdomere [GO:0016028]; GTP binding [GO:0005525]; GTPase activating protein binding [GO:0032794]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; axon extension [GO:0048675]; branching involved in open tracheal system development [GO:0060446]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; establishment of neuroblast polarity [GO:0045200]; exocyst localization [GO:0051601]; hemocyte migration [GO:0035099]; imaginal disc-derived wing hair outgrowth [GO:0035318]; maintenance of cell polarity [GO:0030011]; maintenance of protein location [GO:0045185]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; nephrocyte filtration [GO:0097206]; neuromuscular synaptic transmission [GO:0007274]; ommatidial rotation [GO:0016318]; phagocytosis [GO:0006909]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of wound healing [GO:0090303]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of cell shape [GO:0008360]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; Rho protein signal transduction [GO:0007266]; sensory perception of touch [GO:0050975]; spermatid development [GO:0007286]; wound healing [GO:0042060],NA,NA,NA
CHOYP_CDC5L.1.1.m.25107,-0.00370381901410231,-0.000819926619461606,No,NA,NA,O08837,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-DNA complex [GO:0032993]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; leucine zipper domain binding [GO:0043522]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor binding [GO:0001222]; WD40-repeat domain binding [GO:0071987]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-2 [GO:0071352]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to prolactin [GO:1990646]; cellular response to wortmannin [GO:1904568]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; mRNA splicing; via spliceosome [GO:0000398]; regulation of transcription; DNA-templated [GO:0006355]; signal transduction involved in DNA damage checkpoint [GO:0072422],NA,NA,NA
CHOYP_CDC73.1.1.m.36157,-0.0138361561550795,0.00141069832845483,No,NA,NA,Q5ZLM0,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II complex binding [GO:0000993]; cell cycle [GO:0007049]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone modification [GO:0016570]; mRNA polyadenylation [GO:0006378]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; positive regulation of Wnt signaling pathway [GO:0030177]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; regulation of cell growth [GO:0001558]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK13.1.1.m.59965,-0.00460206757918577,-0.00328281576298919,No,NA,NA,Q9NYV4,NA,NA,NA,chromosome [GO:0005694]; cyclin K-CDK12 complex [GO:0002944]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; fibrillar center [GO:0001650]; nuclear chromatin [GO:0000790]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; mRNA processing [GO:0006397]; negative regulation of stem cell differentiation [GO:2000737]; phosphorylation of RNA polymerase II C-terminal domain [GO:0070816]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of MAP kinase activity [GO:0043405]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_CDK5.1.1.m.25495,-0.0157383079935669,-0.00474144868814188,No,NA,NA,P49615,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; membrane [GO:0016020]; microtubule [GO:0005874]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; protein kinase 5 complex [GO:0016533]; Schaffer collateral - CA1 synapse [GO:0098685]; acetylcholine receptor activator activity [GO:0030549]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; Hsp90 protein binding [GO:0051879]; kinase activity [GO:0016301]; p53 binding [GO:0002039]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axonogenesis [GO:0007409]; behavioral response to cocaine [GO:0048148]; calcium ion import [GO:0070509]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; central nervous system neuron development [GO:0021954]; cerebellar cortex development [GO:0021695]; cerebellar cortex formation [GO:0021697]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; corpus callosum development [GO:0022038]; cortical actin cytoskeleton organization [GO:0030866]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; exocytosis [GO:0006887]; forebrain development [GO:0030900]; hippocampus development [GO:0021766]; histone phosphorylation [GO:0016572]; intracellular protein transport [GO:0006886]; layer formation in cerebral cortex [GO:0021819]; mitochondrion organization [GO:0007005]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; negative regulation of cell cycle [GO:0045786]; negative regulation of neuron death [GO:1901215]; negative regulation of protein export from nucleus [GO:0046826]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of proteolysis [GO:0045861]; negative regulation of synaptic plasticity [GO:0031914]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuron migration [GO:0001764]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; nucleocytoplasmic transport [GO:0006913]; oligodendrocyte differentiation [GO:0048709]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of glial cell apoptotic process [GO:0034352]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; protein autophosphorylation [GO:0046777]; protein localization to synapse [GO:0035418]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; receptor clustering [GO:0043113]; regulated exocytosis [GO:0045055]; regulation of cell migration [GO:0030334]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of postsynaptic membrane potential [GO:0060078]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission; glutamatergic [GO:0051966]; response to cocaine [GO:0042220]; response to wounding [GO:0009611]; rhythmic process [GO:0048511]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; serine phosphorylation of STAT protein [GO:0042501]; skeletal muscle tissue development [GO:0007519]; synapse assembly [GO:0007416]; synapse pruning [GO:0098883]; synaptic transmission; dopaminergic [GO:0001963]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle transport [GO:0048489]; telencephalon development [GO:0021537]; visual learning [GO:0008542],NA,NA,NA
CHOYP_CDO1.1.4.m.26663,0.0269326594521151,-0.0148856013797642,No,NA,NA,Q6NWZ9,NA,NA,NA,cysteine dioxygenase activity [GO:0017172]; iron ion binding [GO:0005506]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CDPK5.1.1.m.6214,0.00311110030961172,-0.000511522496997735,No,NA,NA,P04630,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_CDPKM.1.1.m.58179,0.00443611958230751,0.00752012860495335,No,NA,NA,P23286,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CE112.1.2.m.11508,-0.000281565629897357,-0.0204600067133862,No,NA,NA,Q8N8E3,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; inhibitory synapse [GO:0060077]; plasma membrane [GO:0005886]; receptor localization to synapse [GO:0097120],NA,NA,NA
CHOYP_CE120.1.2.m.19214,-0.0153252700128681,0.000436127271196205,No,NA,NA,Q8N960,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; protein C-terminus binding [GO:0008022]; astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],NA,NA,NA
CHOYP_CEBPZ.1.1.m.12869,-0.00371921276984117,0.00185356777785318,No,NA,NA,P53569,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_CECR2.2.3.m.13613,-0.00194531186589353,-0.00116997739118196,No,NA,NA,Q9BXF3,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CECR2.3.3.m.59311,-0.00405249411139661,-0.000704014152309197,No,NA,NA,Q9BXF3,NA,NA,NA,CERF complex [GO:0090537]; nucleus [GO:0005634]; apoptotic DNA fragmentation [GO:0006309]; ATP-dependent chromatin remodeling [GO:0043044]; cytoskeleton organization [GO:0007010]; cytoskeleton-dependent cytokinesis [GO:0061640]; execution phase of apoptosis [GO:0097194]; neural tube development [GO:0021915]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CED1.20.29.m.45054,-0.0102749934095948,-0.00653898044219654,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.22.29.m.48193,-0.00318651473463124,0.00798104510307098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CED1.26.29.m.53629,0,0,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CED1.9.29.m.29470,-0.012463758155137,-0.00793190492332608,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CEG1A.1.6.m.815,0.0129780334173313,0.0136368796780896,No,NA,NA,Q6NRL1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CEL.2.3.m.27351,-0.0133148896727653,0.00154181992950652,No,NA,NA,P07882,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; zymogen granule [GO:0042588]; carboxylic ester hydrolase activity [GO:0052689]; glycosphingolipid binding [GO:0043208]; lysophospholipase activity [GO:0004622]; neurexin family protein binding [GO:0042043]; protein-containing complex binding [GO:0044877]; retinyl-palmitate esterase activity [GO:0050253]; signaling receptor activity [GO:0038023]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804]; neuron cell-cell adhesion [GO:0007158]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_CELA1.1.3.m.14531,0.00357215939627434,0.0100634703762144,No,NA,NA,P00773,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CELA1.2.3.m.27287,-0.0069193652633719,-0.0103598999997596,No,NA,NA,Q7SIG3,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CELE_Y64G10A.7.3.4.m.53262,-7.74318951538775e-05,0.0102733492086522,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_CELF2.2.4.m.22506,0.00160184633712133,-0.00253439860211802,No,NA,NA,Q6P0B1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELF4.1.1.m.22429,-0.005730337868293,0.0121290272161759,No,NA,NA,Q6DGV1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splice site selection [GO:0006376]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_CELR2.3.8.m.29505,-0.0267151644175588,-0.0170014646893453,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CENPJ.1.1.m.49318,0.0018174218518271,-0.000491119293583667,No,NA,NA,Q569L8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; tubulin binding [GO:0015631]; astral microtubule nucleation [GO:0030954]; cell division [GO:0051301]; centriole assembly [GO:0098534]; centriole elongation [GO:0061511]; centriole replication [GO:0007099]; centrosome duplication [GO:0051298]; microtubule polymerization [GO:0046785]; mitotic spindle pole body duplication [GO:1903087]; motile cilium assembly [GO:0044458]; non-motile cilium assembly [GO:1905515]; positive regulation of centriole elongation [GO:1903724]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of non-motile cilium assembly [GO:1902857]; regulation of centriole replication [GO:0046599]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_CENTRIN.1.1.m.59526,0.0309545576660927,-0.0147488511170358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CEP164.1.1.m.40330,-0.000690756393566769,-0.0132329663431497,No,NA,NA,Q9UPV0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; DNA repair [GO:0006281]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP192.1.2.m.7869,0.00501156614111255,-0.00298741985583509,No,NA,NA,Q8TEP8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; pericentriolar material [GO:0000242]; phosphatase binding [GO:0019902]; centrosome duplication [GO:0051298]; centrosome-templated microtubule nucleation [GO:0090222]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic spindle assembly [GO:0090307]; negative regulation of phosphatase activity [GO:0010923]; protein localization to centrosome [GO:0071539]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CEP290.1.1.m.58767,-0.00257726865874641,0.00354304525740923,No,NA,NA,O15078,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; eye photoreceptor cell development [GO:0042462]; G2/M transition of mitotic cell cycle [GO:0000086]; hindbrain development [GO:0030902]; neutrophil degranulation [GO:0043312]; otic vesicle formation [GO:0030916]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephros development [GO:0048793]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_CEP350.1.1.m.4119,0.00121191577004805,0.00170126642484955,No,NA,NA,E9Q309,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; centrosome [GO:0005813]; nucleus [GO:0005634]; spindle [GO:0005819]; microtubule binding [GO:0008017]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_CEP63.2.2.m.35716,0.00180862611287906,0.0015424858082133,No,NA,NA,Q86X83,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CEP76.1.1.m.6264,-0.000310398585411678,-0.00739556400301159,No,NA,NA,Q28DH9,NA,NA,NA,centriole [GO:0005814]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_CEP89.1.2.m.14339,-0.0106398129234009,0.00668478248469255,No,NA,NA,Q9CZX2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition fiber [GO:0097539]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; chemical synaptic transmission [GO:0007268]; cilium assembly [GO:0060271]; mitochondrion organization [GO:0007005]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_CERS6.1.1.m.5214,0.0131826218614355,0.0159442783402887,No,NA,NA,Q9D6K9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; sphingosine N-acyltransferase activity [GO:0050291]; ceramide biosynthetic process [GO:0046513]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_CETN1.1.3.m.15199,-0.000893675350196212,0.00109893288899745,No,NA,NA,Q9R1K9,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; XPC complex [GO:0071942]; calcium ion binding [GO:0005509]; G-protein beta/gamma-subunit complex binding [GO:0031683]; heterotrimeric G-protein binding [GO:0032795]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; centriole replication [GO:0007099]; microtubule cytoskeleton organization [GO:0000226]; mitotic cytokinesis [GO:0000281]; nucleotide-excision repair [GO:0006289]; regulation of centrosome duplication [GO:0010824]; regulation of cytokinesis [GO:0032465]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CF106.1.1.m.14354,-7.91285401624267e-05,0.0104984531741603,No,NA,NA,Q3TT38,NA,NA,NA,autophagosome [GO:0005776]; phagophore assembly site [GO:0000407]; ubiquitin binding [GO:0043130]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_CG057.1.1.m.45912,-0.00345348910326252,-0.016716010117835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG14207.1.1.m.41523,0.00274764802991345,-0.00468378945801511,No,NA,NA,Q9EPF3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CG17147.1.1.m.28107,-0.00407200993876737,-0.00394939580279164,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CG34417.1.2.m.18203,-0.000179892788035606,-0.00783090316020541,No,NA,NA,A8MU46,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_CG42749.1.1.m.30138,0.00307621371814919,0.00459690300959822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGD4_750.1.1.m.29180,0.00476282749360311,-0.00270771952348397,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CGL.1.2.m.31960,0.00168480278577822,-0.00331567731826676,No,NA,NA,Q60HG7,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; cystathionine gamma-lyase activity [GO:0004123]; L-cysteine desulfhydrase activity [GO:0080146]; L-cystine L-cysteine-lyase (deaminating) [GO:0044540]; pyridoxal phosphate binding [GO:0030170]; cysteine biosynthetic process [GO:0019344]; hydrogen sulfide biosynthetic process [GO:0070814]; negative regulation of apoptotic process [GO:0043066]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein sulfhydration [GO:0044524]; protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine [GO:0018272],NA,NA,NA
CHOYP_CH60.1.1.m.26967,-0.000318364786932313,-0.000435792974855766,No,NA,NA,O02649,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; 'de novo' protein folding [GO:0006458]; apoptotic mitochondrial changes [GO:0008637]; cellular response to heat [GO:0034605]; mitochondrion organization [GO:0007005]; protein import into mitochondrial intermembrane space [GO:0045041]; protein refolding [GO:0042026]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_CHCHD1.1.1.m.25210,0.0142057369538085,-0.0175878794010982,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHD2.1.1.m.36132,-0.00247777058729462,0.00642963593457119,No,NA,NA,B6ZLK2,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386],NA,NA,NA
CHOYP_CHD5.2.2.m.28708,-0.00133664192349416,0.00018063656984537,No,NA,NA,D3ZD32,NA,NA,NA,heterochromatin [GO:0000792]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; H3K27me3 modified histone binding [GO:0061628]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cerebral cortex neuron differentiation [GO:0021895]; histone H3-K27 trimethylation [GO:0098532]; histone H4 acetylation [GO:0043967]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; regulation of transcription involved in cell fate commitment [GO:0060850]; spermatogenesis; exchange of chromosomal proteins [GO:0035093]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_CHD7.2.2.m.14418,-0.00877080989508922,-0.00143366678745634,No,NA,NA,Q8BYH8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_CHER.1.1.m.63350,-0.000104520090056414,-0.00114807088741994,No,NA,NA,Q9VEN1,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_CHERP.1.1.m.22401,-0.00688366352185167,0.000799596061469979,No,NA,NA,Q8CGZ0,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017]; ion channel binding [GO:0044325]; RNA binding [GO:0003723]; cellular calcium ion homeostasis [GO:0006874]; negative regulation of cell proliferation [GO:0008285]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_CHGG_10233.1.1.m.39238,0.00232359777280783,-0.00056981275578037,No,NA,NA,Q4I963,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_CHI1.1.1.m.40259,0.00380214424512903,0.0044902345414968,No,NA,NA,H2A0L4,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_CHKA.1.1.m.25454,-0.00820148212847753,0.00353300616653802,No,NA,NA,Q9Y259,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; choline kinase activity [GO:0004103]; ethanolamine kinase activity [GO:0004305]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_CHL1.2.2.m.65829,0.00677882364259601,0.00452991330316157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHM2A.1.1.m.59752,-0.000433020863144158,-0.00494941378408811,No,NA,NA,Q7ZW25,NA,NA,NA,ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nuclear envelope [GO:0005635]; endosome transport via multivesicular body sorting pathway [GO:0032509]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031],NA,NA,NA
CHOYP_CHM4B.1.1.m.19057,-0.000279103819612502,-0.000794029288782341,No,NA,NA,Q5XGW6,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; exit from mitosis [GO:0010458]; membrane fission [GO:0090148]; mitotic cytokinesis [GO:0000281]; nuclear envelope reassembly [GO:0031468]; protein transport [GO:0015031]; vacuolar transport [GO:0007034],NA,NA,NA
CHOYP_CHMP3.1.1.m.65684,-0.0119344590169065,0.00818648743751295,No,NA,NA,Q8CGS4,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; ESCRT III complex [GO:0000815]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; multivesicular body [GO:0005771]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; positive regulation of cytokinesis [GO:0032467]; protein transport [GO:0015031]; regulation of endosome size [GO:0051036],NA,NA,NA
CHOYP_CHMP5.1.1.m.66827,-0.00555800821423194,-0.00345092720624011,No,NA,NA,Q4QQV8,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; endosome to lysosome transport [GO:0008333]; lysosome organization [GO:0007040]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body sorting pathway [GO:0071985]; nucleus organization [GO:0006997]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; regulation of receptor recycling [GO:0001919]; viral budding [GO:0046755],NA,NA,NA
CHOYP_CHMP7.1.1.m.15221,0.0178444523523249,-0.00816319306295427,No,NA,NA,Q7T0X5,NA,NA,NA,ESCRT III complex [GO:0000815]; nuclear envelope [GO:0005635]; protein transporter activity [GO:0008565]; exit from mitosis [GO:0010458]; late endosome to vacuole transport [GO:0045324]; nuclear envelope reassembly [GO:0031468],NA,NA,NA
CHOYP_CHRD1.1.1.m.42143,6.67766713478658e-05,2.00165412722331e-06,No,NA,NA,Q7T3F7,NA,NA,NA,metal ion binding [GO:0046872]; regulation of centrosome duplication [GO:0010824],NA,NA,NA
CHOYP_CHRO_0413.1.2.m.16023,-0.0223642190931739,-0.0107773231681862,No,NA,NA,A6QLH5,NA,NA,NA,3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; DNA catabolic process; exonucleolytic [GO:0000738]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467],NA,NA,NA
CHOYP_CHS.2.1.1.m.37794,0.00419947894970334,0.0101963035532375,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CHS1.1.4.m.4755,-0.00608612615865775,-0.00403763134295161,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHS2.1.1.m.63783,0.0025058942309844,-0.000677164194586524,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_CHSS2.1.1.m.19314,0.00405498612638747,0.00478883429878327,No,NA,NA,Q6IQX7,NA,NA,NA,cytosol [GO:0005829]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; mitochondrial matrix [GO:0005759]; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity [GO:0047238]; metal ion binding [GO:0046872]; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO:0050510]; transferase activity; transferring glycosyl groups [GO:0016757]; chondroitin sulfate biosynthetic process [GO:0030206],NA,NA,NA
CHOYP_CHTOP.1.1.m.35404,-0.000895029465879557,0.00039962156251551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CI064.1.1.m.9517,-0.0248381309538506,0.00181409889368266,No,NA,NA,Q1JP73,NA,NA,NA,tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_CIAO1.1.1.m.48324,-0.000127747608813206,-0.00306214836913064,No,NA,NA,A7RWD2,NA,NA,NA,CIA complex [GO:0097361]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_CIC.1.2.m.57436,-0.00371787177928665,0.00473689590404209,No,NA,NA,Q96RK0,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; brain development [GO:0007420]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; social behavior [GO:0035176],NA,NA,NA
CHOYP_CIR1.1.2.m.16126,-0.00543787937218551,-0.00239130402867014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CIR1A.1.1.m.11568,0.00637572475552013,-0.00712594771846622,No,NA,NA,Q969X6,NA,NA,NA,90S preribosome [GO:0030686]; chromosome [GO:0005694]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; RNA binding [GO:0003723]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of transcription; DNA-templated [GO:0006355]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_CISD2.1.1.m.26823,-0.0163275996302247,0.0257580348266704,No,NA,NA,C1C524,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; autophagy of mitochondrion [GO:0000422]; multicellular organism aging [GO:0010259]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_CISY.1.1.m.36666,-0.00138019733470894,0.000643998508283348,No,NA,NA,Q7ZVY5,NA,NA,NA,mitochondrial matrix [GO:0005759]; citrate (Si)-synthase activity [GO:0004108]; carbohydrate metabolic process [GO:0005975]; response to activity [GO:0014823]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CKAP5.1.1.m.10679,-0.00354026576965709,-0.00259959769971012,No,NA,NA,Q14008,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; microtubule plus-end binding [GO:0051010]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; centrosome duplication [GO:0051298]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment or maintenance of microtubule cytoskeleton polarity [GO:0030951]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule depolymerization [GO:0007019]; microtubule polymerization [GO:0046785]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; RNA transport [GO:0050658]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CKLF4.1.1.m.55295,0.007008635626846,0.012374900673651,No,NA,NA,Q8IZR5,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_CLAP1.4.6.m.39950,-0.00371846421674383,-0.0147280308866643,No,NA,NA,A1A5G0,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; kinetochore microtubule [GO:0005828]; microtubule organizing center [GO:0005815]; kinetochore binding [GO:0043515]; microtubule plus-end binding [GO:0051010]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule anchoring [GO:0034453]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023],NA,NA,NA
CHOYP_CLAP1.6.6.m.57823,0.000497443037630296,-0.00775805225096718,No,NA,NA,Q7Z460,NA,NA,NA,basal cortex [GO:0045180]; cell cortex [GO:0005938]; centrosomal corona [GO:0031592]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cortical microtubule cytoskeleton [GO:0030981]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; spindle microtubule [GO:0005876]; dystroglycan binding [GO:0002162]; kinetochore binding [GO:0043515]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of epithelial cell polarity [GO:0090162]; establishment of mitotic spindle localization [GO:0040001]; establishment of spindle orientation [GO:0051294]; establishment or maintenance of cell polarity [GO:0007163]; exit from mitosis [GO:0010458]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi organization [GO:0007030]; microtubule anchoring [GO:0034453]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exocytosis [GO:0045921]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of microtubule polymerization [GO:0031116]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_CLASR.1.2.m.27688,0,0,No,NA,NA,Q5HZB6,NA,NA,NA,nucleoplasm [GO:0005654]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CLC10.2.5.m.4673,-0.0194364879566739,0.0254500607668541,No,NA,NA,Q66S03,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],NA,NA,NA
CHOYP_CLCN3.1.1.m.21245,-0.00747657546998628,0.00248360647549099,No,NA,NA,P51791,NA,NA,NA,apical plasma membrane [GO:0016324]; axon terminus [GO:0043679]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inhibitory synapse [GO:0060077]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of synaptic vesicle membrane [GO:0030285]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; membrane [GO:0016020]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]; specific granule [GO:0042581]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; chloride channel activity [GO:0005254]; chloride ion binding [GO:0031404]; ion channel activity [GO:0005216]; PDZ domain binding [GO:0030165]; protein heterodimerization activity [GO:0046982]; solute:proton antiporter activity [GO:0015299]; voltage-gated chloride channel activity [GO:0005247]; voltage-gated ion channel activity [GO:0005244]; adult locomotory behavior [GO:0008344]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; ion transport [GO:0006811]; negative regulation of cell volume [GO:0045794]; neuron cellular homeostasis [GO:0070050]; phagocytosis; engulfment [GO:0006911]; photoreceptor cell maintenance [GO:0045494]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; synaptic transmission; GABAergic [GO:0051932]; synaptic transmission; glutamatergic [GO:0035249]; synaptic vesicle lumen acidification [GO:0097401],NA,NA,NA
CHOYP_CLCN7.2.3.m.47039,0.00397828168619874,0.00469824832817923,No,NA,NA,O70496,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLCN7.3.3.m.51894,0.00492675630635078,-0.00894444037133551,No,NA,NA,O70496,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; antiporter activity [GO:0015297]; ATP binding [GO:0005524]; voltage-gated chloride channel activity [GO:0005247]; chloride transmembrane transport [GO:1902476]; response to pH [GO:0009268],NA,NA,NA
CHOYP_CLEC17A.1.1.m.28486,0.00550453564777533,-0.00228372871012161,No,NA,NA,Q6ZS10,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; fucose binding [GO:0042806]; mannose binding [GO:0005537]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CLH1.2.2.m.22327,0.00154056061155083,0.00137205802385021,No,NA,NA,P49951,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; melanosome [GO:0042470]; membrane coat [GO:0030117]; mitochondrion [GO:0005739]; spindle [GO:0005819]; arrestin family protein binding [GO:1990763]; clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; protein domain specific binding [GO:0019904]; structural molecule activity [GO:0005198]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_CLK2.1.1.m.3081,-0.00179503132552664,0.0121027788879235,No,NA,NA,P49760,NA,NA,NA,nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; negative regulation of gluconeogenesis [GO:0045721]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484]; response to ionizing radiation [GO:0010212]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_CLK2.1.1.m.3082,-0.000765110217064938,0.0019450316189422,No,NA,NA,Q91ZA3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_CLP1.1.1.m.11641,0.00134798890768898,0.0155764175464712,No,NA,NA,Q5ZJL4,NA,NA,NA,cytosol [GO:0005829]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; tRNA-intron endonuclease complex [GO:0000214]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity [GO:0051736]; polydeoxyribonucleotide kinase activity [GO:0051733]; cerebellar cortex development [GO:0021695]; mRNA polyadenylation [GO:0006378]; siRNA loading onto RISC involved in RNA interference [GO:0035087]; targeting of mRNA for destruction involved in RNA interference [GO:0030423]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CLPB.1.3.m.14233,-0.00227779146487558,-0.00646257938221903,No,NA,NA,Q60649,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cellular response to heat [GO:0034605],NA,NA,NA
CHOYP_CLPT1.1.1.m.50172,0,0,No,NA,NA,Q2NL17,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CLPX.1.2.m.12748,-0.00874692789416084,0.0154436180838316,No,NA,NA,Q5U2U0,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLPX.2.2.m.49273,-0.0056431884435943,-0.000554682718473196,No,NA,NA,Q9JHS4,NA,NA,NA,cytosol [GO:0005829]; endopeptidase Clp complex [GO:0009368]; mitochondrial endopeptidase Clp complex [GO:0009841]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; peptidase activator activity [GO:0016504]; unfolded protein binding [GO:0051082]; ATP metabolic process [GO:0046034]; protein catabolic process [GO:0030163]; protein folding [GO:0006457]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CLSTN1.1.1.m.55323,0.0120579056800808,-0.0123616485111577,No,NA,NA,O94985,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; integral component of postsynaptic density membrane [GO:0099061]; integral component of spine apparatus membrane [GO:0099065]; nucleus [GO:0005634]; postsynaptic endosome [GO:0098845]; postsynaptic membrane [GO:0045211]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; kinesin binding [GO:0019894]; X11-like protein binding [GO:0042988]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurotransmitter receptor transport to postsynaptic membrane [GO:0098969]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; regulation of cell growth [GO:0001558]; regulation of synapse maturation [GO:0090128]; vesicle-mediated transport in synapse [GO:0099003],NA,NA,NA
CHOYP_CLU.1.1.m.8566,-0.000277324406041363,0.0024929333661053,No,NA,NA,Q17N71,NA,NA,NA,cytoplasm [GO:0005737]; intracellular distribution of mitochondria [GO:0048312],NA,NA,NA
CHOYP_CML1.1.1.m.30763,-0.0136067280326099,-0.00865928813194558,No,NA,NA,P0DH96,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CML8.1.1.m.37436,-0.0311489047000959,0.00500507754603749,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_CN166.1.1.m.14529,-0.00098041195563375,0.00335490665818783,No,NA,NA,Q5R8I2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; tRNA-splicing ligase complex [GO:0072669]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_CNA1.1.1.m.65403,-0.00394152073213047,0.00914331888785408,No,NA,NA,P63329,NA,NA,NA,calcineurin complex [GO:0005955]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; sarcolemma [GO:0042383]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; Z disc [GO:0030018]; calcium-dependent protein serine/threonine phosphatase activity [GO:0004723]; calmodulin binding [GO:0005516]; calmodulin-dependent protein phosphatase activity [GO:0033192]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; brain development [GO:0007420]; calcineurin-mediated signaling [GO:0097720]; calcineurin-NFAT signaling cascade [GO:0033173]; calcium ion transport [GO:0006816]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to drug [GO:0035690]; cellular response to glucose stimulus [GO:0071333]; excitatory postsynaptic potential [GO:0060079]; G1/S transition of mitotic cell cycle [GO:0000082]; multicellular organismal response to stress [GO:0033555]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of chromatin binding [GO:0035562]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of insulin secretion [GO:0046676]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy in response to stress [GO:1903244]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endocytosis [GO:0045807]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein dephosphorylation [GO:0006470]; protein import into nucleus [GO:0006606]; response to amphetamine [GO:0001975]; response to calcium ion [GO:0051592]; skeletal muscle fiber development [GO:0048741]; transition between fast and slow fiber [GO:0014883],NA,NA,NA
CHOYP_CNDP2.1.4.m.11722,0.0116801859962297,-0.00109995237196786,No,NA,NA,Q96KP4,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; glutathione biosynthetic process [GO:0006750],NA,NA,NA
CHOYP_CNDP2.3.4.m.30467,0.00351739320804751,-0.00173071965765835,No,NA,NA,Q9D1A2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; alanylglutamate dipeptidase activity [GO:0103046]; carboxypeptidase activity [GO:0004180]; cytosolic dipeptidase activity [GO:0102008]; dipeptidase activity [GO:0016805]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CNE_1C34780.3.3.m.30615,-0.00105169673971605,0.0103969669872044,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CNOT1.1.1.m.12104,-0.00686630239897406,0.00300410360067027,No,NA,NA,Q6ZQ08,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; armadillo repeat domain binding [GO:0070016]; estrogen receptor binding [GO:0030331]; protein domain specific binding [GO:0019904]; protein-containing complex scaffold activity [GO:0032947]; retinoic acid receptor binding [GO:0042974]; gene silencing by miRNA [GO:0035195]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; regulation of stem cell population maintenance [GO:2000036]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT2.1.2.m.47530,-0.00418024631027165,0.00156479594708331,No,NA,NA,Q9NZN8,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; RNA polymerase II transcription corepressor binding [GO:0001226]; transcription coregulator activity [GO:0003712]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT3.1.1.m.62322,0.00722777643428004,0.00168221270366487,No,NA,NA,Q8K0V4,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; nucleus [GO:0005634]; P-body [GO:0000932]; gene silencing by RNA [GO:0031047]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of translation [GO:0017148]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of stem cell population maintenance [GO:2000036]; regulation of transcription; DNA-templated [GO:0006355]; trophectodermal cell differentiation [GO:0001829],NA,NA,NA
CHOYP_CNOT7.1.2.m.7497,-0.00179652809519468,0.00336209575409986,No,NA,NA,Q60809,NA,NA,NA,CCR4-NOT complex [GO:0030014]; CCR4-NOT core complex [GO:0030015]; cytoplasm [GO:0005737]; host cell PML body [GO:0075341]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cytoplasmic mRNA processing body assembly [GO:0033962]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; defense response to virus [GO:0051607]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; gene silencing by RNA [GO:0031047]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation [GO:0017148]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cell proliferation [GO:0008284]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral genome replication [GO:0045070]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509],NA,NA,NA
CHOYP_CNOT7.2.2.m.35718,-0.00736789205603794,0.017356984345988,No,NA,NA,Q8CHS8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ESCRT I complex [GO:0000813]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; endosome transport via multivesicular body sorting pathway [GO:0032509]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_CNTN5.4.5.m.44639,-0.00508017350722119,-0.00041536811950955,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTN6.1.2.m.781,-0.00558822290932976,-0.00196701033340011,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_CNTRL.1.1.m.8381,-0.0110834637776656,0.00698458177890499,No,NA,NA,A2AL36,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; cytoskeletal protein binding [GO:0008092]; aorta development [GO:0035904]; cardiac septum development [GO:0003279]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; mitotic cell cycle [GO:0000278]; regulation of cytoskeleton organization [GO:0051493]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_CNTROB.1.1.m.11584,-0.00158106369016644,0.00214641531918058,No,NA,NA,Q8CB62,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; protein domain specific binding [GO:0019904]; centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_CO1A1.1.1.m.32133,0.0152077988692593,0.00748702964864103,No,NA,NA,Q30D77,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; extracellular matrix organization [GO:0030198]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_CO2A1.1.1.m.62996,0.0117296795284582,0.00420991406504126,No,NA,NA,P02466,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_CO4A1.1.2.m.36472,0.00119606411001374,-0.0202579962459564,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CO4A2.1.2.m.14631,-0.012309557929332,-0.00169616065482586,No,NA,NA,P08120,NA,NA,NA,basement membrane [GO:0005604]; collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cardiac muscle cell development [GO:0055013]; dorsal closure [GO:0007391]; extracellular matrix organization [GO:0030198]; intestinal epithelial structure maintenance [GO:0060729]; oviduct morphogenesis [GO:0035848]; post-embryonic digestive tract morphogenesis [GO:0048621],NA,NA,NA
CHOYP_CO6A3.3.5.m.39796,0.00806757665405063,-0.0146465450767917,No,NA,NA,P12111,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_CO6A5.1.6.m.5838,0.00251835014844543,0.000204589579984062,No,NA,NA,A8TX70,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_CO6A5.1.6.m.5840,3.12537611820442e-05,0.00285059090480164,No,NA,NA,P27080,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857],NA,NA,NA
CHOYP_CO9A1.1.1.m.62338,-0.00426490123618512,-0.00123182985131427,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_COG2.1.2.m.12604,0.0186614239951802,0.00951568283348328,No,NA,NA,Q14746,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; protein-containing complex binding [GO:0044877]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_COG3.1.1.m.35921,0.00473850612347184,-0.00712943043239149,No,NA,NA,Q96JB2,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COG5.1.1.m.13833,-0.00312063678967001,0.00120508805760981,No,NA,NA,Q9UP83,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG6.1.1.m.57008,0.00739678160342377,-0.0122661533437147,No,NA,NA,Q9Y2V7,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; glycosylation [GO:0070085]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COG8.1.1.m.10907,-0.00228677715245736,0.00315352545460669,No,NA,NA,Q96MW5,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; membrane [GO:0016020]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_COIL.1.1.m.18070,-0.00790615775846415,-0.00867632785886542,No,NA,NA,Q09003,NA,NA,NA,sphere organelle [GO:0071601],NA,NA,NA
CHOYP_COL4A4.1.1.m.30919,-0.0210555845424294,-0.00433258099203484,No,NA,NA,Q5UQ13,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_COL6A6.1.2.m.39071,0.00248345153808434,0.0154529933702085,No,NA,NA,A3DC27,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cellulose binding [GO:0030248]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_contig_000003.m.1,0.00761001713154904,-0.0138158537231161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000121.m.127,-0.00366091816880171,0.00496997742004644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000189.m.198,-0.017116816164689,0.0100045734554942,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000227.m.218,-0.0150849217481944,0.00799133187060208,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_000437.m.416,0.00635091406568191,-0.0344672116830367,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001114.m.1165,-0.00416287849593322,0.00429490526398613,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001251.m.1283,0.00633483611139671,0.00748127848083509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001305.m.1337,0.00242353884875973,-0.00782163101193946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001317.m.1351,-0.0284892051275773,0.011376109156832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001413.m.1466,0.00392309145518285,-0.00106013136256536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001477.m.1562,0.0122462603524061,0.018815218988136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001544.m.1660,0.00212842409100567,-6.47965615105899e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001740.m.1863,0.0108988591487107,-0.00709032551111221,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_001932.m.2147,-0.00175841786809498,-0.00741727190730559,No,NA,NA,Q09575,NA,NA,NA,nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_002228.m.2410,-0.00813682273548503,-0.00228456168210489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002245.m.2431,0.00460420373286196,-0.00517183816265462,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002279.m.2484,0.00446026659444527,0.00866644860150143,No,NA,NA,Q5RA22,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_contig_002305.m.2519,-0.000127561900670887,0.0169243946400531,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002327.m.2549,0.00272436850722511,0.0039049944723933,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_002369.m.2605,-8.19218931670191e-05,0.000838588404975168,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002417.m.2661,0.0201893096010279,0.0043706921610604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002558.m.2814,-0.0228388842682502,-0.00960886541790241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002568.m.2819,-0.0123235764361959,-0.0152778977987901,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002597.m.2856,0.00453417079980194,-0.00122526245513541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002691.m.2966,0.00420856673081372,-0.00113727493578832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002715.m.2994,0.0136041097930773,-0.0268048619490827,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002718.m.2999,0.00763003312110176,0.0109001916969854,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002734.m.3017,-0.0215609546896517,-0.0211787524854571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002762.m.3056,-9.90461291071542e-05,0.0131410379412894,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002806.m.3116,0.00422458517646859,0.00498912641391144,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002826.m.3144,0.00458182452899427,0.000572705667478143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002896.m.3210,-7.19896919233414e-05,0.00955129979812637,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002989.m.3291,0.00444243572082342,0.00524640230248382,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_002999.m.3300,-0.000435894894849297,0.00100172317334186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003050.m.3358,-0.00112623437560195,0.00124934969980919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003161.m.3509,0.00607146480482359,-0.0110226387376628,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003213.m.3589,-0.00988088091200059,-0.00628816822158845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003275.m.3667,0.0113585898321809,-0.013940919437835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003319.m.3735,0.0139142884628724,-0.0180485173862466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003356.m.3782,-6.99006680850774e-05,0.00927413660390228,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003460.m.3916,0.0192994693777204,0.00143540038690895,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003549.m.4007,-0.000269062998974412,0.00500026184716222,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003595.m.4058,0.0100885818109858,-0.0122896212067661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003695.m.4176,0.00324966689555137,-0.000878152812194342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003840.m.4375,0.0105808216991178,0.00055456753325521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_003882.m.4416,-0.00797073611464416,-0.00209335368479023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004011.m.4571,-8.21216777539829e-05,0.0108955705073535,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004045.m.4615,-0.005667564097599,0.00970063519375813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004193.m.4802,0.00467596511795488,0.00552219451283933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004202.m.4814,-0.00331491744602309,0.00450025488044311,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004338.m.4955,-0.00439362262862944,0.0192765057127494,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004401.m.5025,0.0217511324025669,-0.0263423453352551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004461.m.5117,-7.21153261968997e-05,0.00956796844303396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004474.m.5130,-0.0213421906119541,0.00678877719373298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004504.m.5173,-0.00082024808481112,0.00870791273431205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004513.m.5183,0.00350018062548834,-0.000945848777198817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004572.m.5255,0.0336225122142522,0.00760426220451739,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004594.m.5279,0.0152363786833543,0.019970318930911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004609.m.5296,0.00711382230418325,-0.00261279292237599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004652.m.5338,0.00621185032830929,0.00733603543487763,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004751.m.5446,-9.57199779461617e-05,0.012699737720886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004756.m.5453,-0.00738301259329056,-0.00264906512681027,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004795.m.5507,0.00332625983886868,-0.000223720682942323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004820.m.5529,-0.00194311059916076,0.0269484975537929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004869.m.5573,-0.0128152128154514,0.00533803496997091,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004890.m.5604,-0.0256558211965458,-0.00304734007605551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004925.m.5642,0.0301359325632039,-0.0010272289930879,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004972.m.5699,-0.00139868046844659,0.00126499366404992,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004987.m.5716,-0.00564870198205557,0.0348676895832088,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_004993.m.5721,0.0149563004041234,0.0131189981974039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005029.m.5761,-0.00347583432769897,0.00706308739784328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005134.m.5869,0.0183647606062294,0.00651605174400458,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005396.m.6126,0.0186369368385553,0.0158546830024824,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005454.m.6186,0.00608548268614696,0.00718679850035266,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005583.m.6332,0.0020271740055344,0.000749448120280455,No,NA,NA,P21399,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cellular iron ion homeostasis [GO:0006879]; citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; post-embryonic development [GO:0009791]; regulation of translation [GO:0006417]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_contig_005590.m.6345,-0.00867999278222684,-0.000950954785120083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005659.m.6448,0.00366325406840704,-0.000989915879180658,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005830.m.6680,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005858.m.6708,0.012942960030349,0.00216476697999438,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005908.m.6759,-0.0172638789024591,-0.0109866899178946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_005913.m.6764,-6.44400595707564e-05,0.00854964525511275,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006063.m.6910,-0.00162245441417009,-0.00684227125788403,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006084.m.6928,-0.0245625688727143,0.0213841194947614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006214.m.7057,0.0103348641090503,-0.0311069989516443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006293.m.7131,-0.0149234063342751,-0.00949721895292433,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006299.m.7138,-8.86015702342432e-05,0.0117552963109378,No,NA,NA,Q96EY1,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_contig_006359.m.7206,0.00796810982329493,0.00999121969592976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006364.m.7211,-0.0224833431688158,-0.0143083440928335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006560.m.7472,-0.0343663932254174,0.0227288761540413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006640.m.7557,-0.0132075206385334,-0.00379316043639766,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006758.m.7690,-0.00139554392909602,0.0120756474411634,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_006775.m.7711,-0.00304691601100974,0.00413642236107479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007032.m.8066,0.00597618290882806,0.0215531242984528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007082.m.8119,0.0156617938685262,0.00218966938298274,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007115.m.8183,-0.0135851830664267,0.0247476197300927,No,NA,NA,Q58DT4,NA,NA,NA,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; negative regulation of hydrogen peroxide-induced cell death [GO:1903206]; proline biosynthetic process [GO:0006561]; regulation of mitochondrial membrane potential [GO:0051881],NA,NA,NA
CHOYP_contig_007164.m.8244,0.00116442781253017,-0.00170696876211387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007754.m.8963,-0.00530939735589889,0.00720791445101023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_007858.m.9121,-0.00607613959123275,0.00892860830712179,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008016.m.9273,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008030.m.9291,0.00579687710399354,-0.0105241295433659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008101.m.9378,0.0122674569343253,-0.00423576073195622,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008102.m.9380,0.0122850522255074,-0.00424649027455896,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008114.m.9394,-0.0131998395059715,-0.00840034527799119,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008181.m.9453,0.0130844133955197,0.0255122267277898,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008261.m.9575,-0.0245392785467352,-0.0156167362922953,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008262.m.9576,-0.00727774711597994,0.00213267889628446,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008307.m.9640,-0.0338934814096293,-0.0215697279035294,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008452.m.9831,-0.0152438142627799,-0.008515609590901,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008795.m.10231,-0.00222643621510979,0.000674065447165886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008923.m.10388,-0.0137035057186661,-0.00872087721245745,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_008926.m.10391,0.00262395482106485,0.00786120716809738,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009176.m.10652,0.0215595651764819,-0.0233360134053917,No,NA,NA,Q9NR12,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; ruffle [GO:0001726]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; axon guidance [GO:0007411]; ossification [GO:0001503]; positive regulation of osteoblast differentiation [GO:0045669]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_contig_009196.m.10701,-0.0326944608855557,-0.0177654880528737,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009315.m.10833,-0.00611714663496459,-0.00499525693911023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009651.m.11212,-0.00852483494868709,-0.0122498243009143,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009697.m.11280,0.00448074997460481,-0.00121082662236104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009806.m.11429,0.00823881817826186,-0.0149574310851842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009817.m.11438,0.0043532117003648,-0.00976218932388608,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009870.m.11509,0.000508255961311337,-0.000888559490876615,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_009887.m.11524,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010011.m.11666,0.00593557926094582,-9.69203941187103e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010154.m.11827,-0.00549687782550286,0.0248872775241292,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010181.m.11866,-0.0330083780967121,-0.0267617646556045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010226.m.11916,-0.00073135993438114,0.0171451660337264,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010233.m.11921,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010276.m.11960,-0.00207146794813375,-0.00096891056569634,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010354.m.12065,-0.0216419848391557,-0.0141606874605513,No,NA,NA,Q9CRB3,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; hydroxyisourate hydrolase activity [GO:0033971]; purine nucleobase metabolic process [GO:0006144]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_contig_010487.m.12180,-0.0188583872200274,-0.0120014310751749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010532.m.12231,-0.0127985945581705,-0.0318335791982782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010639.m.12333,0.0214582329799498,0.0204755478792327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010659.m.12347,-0.020033466923943,-0.00328676327710039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010674.m.12365,-0.0186047329357394,-0.0118400061147958,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010687.m.12382,-0.0279377396742956,0.00860057786414883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_010861.m.12544,-0.00454872369483313,-0.0182108946213071,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011170.m.12887,-0.00326706596495847,0.00443529282189899,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011268.m.13012,0.00870815325452949,0.0092892570066848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_011571.m.13308,-0.00769680789672539,-0.00731019863497139,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012045.m.13814,-0.00912171487026668,-0.00247017120967505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012068.m.13831,-0.000797548653918707,-0.00489344348699545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012079.m.13839,-0.00133572783355247,9.10520893103728e-05,No,NA,NA,P74897,NA,NA,NA,,NA,NA,NA
CHOYP_contig_012255.m.14080,0.000906832401377039,-0.00575671367145545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012395.m.14264,-0.00208584251673642,0.000819599629872676,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012437.m.14312,-0.0137907650520417,-0.00877640883681929,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012819.m.14744,-0.0125335582385149,-0.00797632552408733,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_012962.m.14885,0.00641625968222221,0.00505430215241933,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013437.m.15402,0.0163278077144347,-0.0105522588333151,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013551.m.15499,-0.0136386465314593,0.0269626430463164,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013622.m.15553,-0.00591236102794253,0.00426977417024335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013738.m.15666,0.0230837459193272,0.0146168239876438,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013751.m.15674,-0.00379378299507068,-0.00495769423984196,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013806.m.15731,0.0036061427112795,0.0075838559649558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_013837.m.15768,0.0122917945496688,-0.0083924636948111,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014109.m.16087,0.00770429052405026,-0.0139870054272797,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014152.m.16145,0.00292349875789167,0.00352602987044859,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014205.m.16198,-0.0104779244576217,0.019569722223487,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014279.m.16311,0.00787293824510705,-0.0102298125496122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014296.m.16345,2.28188494941175e-05,0.00719555061672401,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014354.m.16426,-0.0138782366413754,-0.00810457857398689,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014357.m.16429,-0.0238586274673748,-0.0244881590890722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014469.m.16593,-0.0122713299154343,-0.00780944406658558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014479.m.16604,0.02048597556698,0.0184717538781808,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014529.m.16671,0.0112060413219693,-0.00648182697364256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014863.m.17135,0.00597964983264608,0.00706181262296949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014867.m.17143,0.00302054195536025,0.00898739413062303,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014877.m.17157,0.00951205579958452,0.0112334931970709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014947.m.17245,0.00303635186626577,0.00312414917493607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_014958.m.17266,0.0131451988799196,0.00862807072866938,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015023.m.17360,0.00525912048632674,0.00621088600093245,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015209.m.17650,-0.00438428111355457,0.000111290921281831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015341.m.17864,-0.00136959937723388,9.21947270772384e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015391.m.17937,-0.000247631020210562,-0.00265004573337239,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015430.m.17979,-0.0180066419529404,-0.00191715663328912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015439.m.17989,-0.0173469865448708,0.00300697214183584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015543.m.18138,0.0164969801107839,0.00867678681480509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015692.m.18358,0.0303064839168718,0.0157617498178169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015712.m.18387,0.000669139306512703,0.00573054673055238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015857.m.18578,0.0105429148806992,-0.00532149532654314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015918.m.18639,-0.0164103249892149,-0.0104434903144913,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015923.m.18643,-0.0183516074847621,0.0046634913035236,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_015931.m.18654,0.00536894476066257,0.00634058564364047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016010.m.18750,-0.0057171216708967,-0.00363836211872817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016017.m.18760,-0.00995021722306974,-0.0089090030751533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016020.m.18768,-0.024046072611006,-0.00357555765440354,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016120.m.18916,-0.0184964326339328,-0.00520403203173564,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016292.m.19158,0.00855205991953577,0.00787542849004941,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016375.m.19279,0.0180724931638868,0.00666029129939347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016405.m.19312,0.0139049813770392,0.0336013167986218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016540.m.19484,0.00816821122190435,-0.0106116165733968,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016554.m.19499,0.000180271496941448,0.00319285245959154,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016559.m.19503,-0.0334550164006344,0.0114229523831429,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016589.m.19530,-0.000745610834658113,-0.00191136909094172,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016628.m.19586,-0.00486200145716339,-0.020940568031498,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016637.m.19603,0.024656541611324,-0.00284692320051569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016752.m.19715,0.00924994063953287,0.00497267269746421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016762.m.19724,-0.017246080108224,-0.0109753628091795,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_016854.m.19834,0.00995328597315511,0.00321692822964515,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017060.m.20058,-0.000769733446961762,-0.00865247108545631,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017672.m.20677,-0.0064709265005134,-0.00687550289472989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_017941.m.21005,0.0103640938294609,0.0130031828935348,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_018098.m.21196,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018118.m.21239,0.00684961722162302,-0.0124353609140979,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018645.m.21889,0.0229394629882285,0.0149918043437709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018676.m.21920,-0.0124326088669912,-0.00399495273702009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018822.m.22082,-0.0101258438864139,0.0177471001895249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018956.m.22217,0.0274499019612538,0.0215996038032823,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_018978.m.22243,0.00411268877266045,0.00485697963960317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019122.m.22406,-4.49014824027355e-06,0.00434572364033614,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019189.m.22478,-0.00402600751816147,0.00546561423544441,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019238.m.22546,0.0104075255816035,0.00201275439212198,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019263.m.22580,0.0124818249592557,-0.00413004698233283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019436.m.22745,0.00137626804551573,-0.00208255625746489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_019571.m.22867,0.0226605813480805,0.00298159499087146,No,NA,NA,A0MSJ1,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; bone mineralization [GO:0030282]; extracellular matrix organization [GO:0030198]; notochord morphogenesis [GO:0048570]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_contig_019914.m.23170,0.0036786435834426,-0.000994074565698738,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020023.m.23276,0.000943667487661881,-0.00440456457654365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020370.m.23576,0.00385375596506214,-0.00104139493277383,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020390.m.23600,-0.00224761552936078,0.00176736388695011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020392.m.23606,-0.00759929563398075,-0.0245897809134141,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_020442.m.23651,0.00395697601850686,-0.00106928793938672,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021278.m.24464,-0.00999918685677378,0.0026055313492428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021455.m.24647,-0.00904829866764629,-0.00575831493649836,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021478.m.24670,0.00592911895390938,-0.0107642123214896,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021494.m.24691,0.00313303064346904,-0.000846634365515973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021632.m.24849,-0.0034677943392449,0.0146996726468476,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021664.m.24884,0.00542981128335907,0.00641246744112428,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021811.m.25040,-0.0142057997127536,0.00478344931986115,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_021858.m.25098,0.0100188674369751,0.0165159015028121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022142.m.25369,-0.00261793513379663,0.00625289912971463,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022641.m.25871,0.0044204331659305,-0.00802521951759067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022643.m.25874,-0.0269827248451706,0.0319956061434191,No,NA,NA,Q96HC4,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell-cell adherens junction [GO:0005913]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; actinin binding [GO:0042805]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_022826.m.26063,0.00471574900127257,0.00556917825557787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022851.m.26077,-0.0135474844001906,-0.00862158563051598,No,NA,NA,Q9VT65,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_contig_022855.m.26082,0.0107594293699288,-0.00627549584232434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_022863.m.26088,0.0222471969614109,0.00825396002237483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023043.m.26235,-0.00719787541352368,-0.00757405353401285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023172.m.26349,-0.0123923611983644,-0.00788646807627833,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023259.m.26467,0.00510755424717729,0.0060318901716118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023399.m.26635,0.00670369991474135,0.0213631690755543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023445.m.26685,-0.00771981876268293,0.00735801595989211,No,NA,NA,Q66HG4,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_contig_023474.m.26716,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023538.m.26787,-0.00724935276810709,-0.00370145857440649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023655.m.26913,-0.0231751545679988,-0.0147486111595473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023660.m.26915,0.00373375230581897,0.0193591613297178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023673.m.26924,0.00915569569135145,0.00103986438327031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023675.m.26925,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023710.m.26965,-0.00392848915757554,0.00405250901282111,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023723.m.26983,0.00360130237984436,0.0107193613661735,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023724.m.26984,-0.00968940349817079,0.00356300834229688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023752.m.27015,0.00668617877828363,-0.00237294445910398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023763.m.27021,-0.00392083535269277,-0.0116506532304708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023792.m.27044,-0.00639631373142275,-0.00801100595119413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023811.m.27063,0.00797442699970023,-0.000407693772128624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023814.m.27068,-0.00445334028509483,0.00548878738990887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023887.m.27194,-0.00466208185825825,0.00193034094677781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023888.m.27197,-0.0172798343586762,-0.0109968439308454,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023897.m.27203,-0.0270134574202291,-0.0171393638428644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023932.m.27233,0.0190360843988039,-0.027609377401835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_023964.m.27264,0.0135183532729891,-0.0175070547840352,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024035.m.27331,0.00125360997629725,-0.000544775355532642,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024046.m.27342,0.00811189444208704,0.00957993865369488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024156.m.27442,-0.0119365349256531,-0.0075963813615253,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024175.m.27461,0.00175242265916366,-0.0049001085425155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024218.m.27505,0.00290553946846797,0.0053536847932131,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024219.m.27509,-0.0207765486467523,-0.00188101388364207,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024342.m.27673,0.0175132862916388,-0.0147754473767877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024357.m.27696,-0.00979943951970514,-0.00597627157842641,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024372.m.27722,-0.0279253855868097,-0.0177716464540434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024424.m.27774,-0.0109551561464565,-0.0186834042057286,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_contig_024498.m.27853,-0.0191937236721683,-0.0122148383655442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024504.m.27855,-0.0330451125084152,-0.0210298280289828,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024602.m.27966,-0.0132297811696211,-0.00119125913484711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024605.m.27976,0.00454980479251398,-0.00122948720650445,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024653.m.28033,-0.0107725667322084,0.0103299541813922,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024662.m.28044,-0.0143593453134073,-0.00913825191162037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024665.m.28048,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024679.m.28057,0.0193987954141705,-0.00147041892256288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024697.m.28081,-0.00310892320414325,0.00602502753097411,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024706.m.28101,-0.00217858619824615,-0.0129300520757152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024730.m.28114,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024739.m.28119,-0.0194131148609374,-0.012354458376513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024742.m.28122,-0.00327197213451684,-0.00100923580554391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024846.m.28258,0.00329331644364837,0.0228900334452048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024858.m.28270,0.0230965207534766,0.0128248709611817,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_024935.m.28365,-8.0438087939929e-05,0.0106721986520017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025014.m.28472,-0.0143433000549389,-0.00912804074873856,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025032.m.28479,-7.09592157263334e-05,-0.00574885645623595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025058.m.28495,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025076.m.28535,-0.0257500523500886,0.022293464797996,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025167.m.28650,0.0161973236169659,0.0192440009582853,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025192.m.28699,-0.00465968299869806,0.00632587734013292,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025210.m.28720,-0.00462053420779222,-0.00125491952993874,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025311.m.28826,-0.0195131471255621,-0.012418118662792,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025377.m.28903,-0.0152784500011865,0.0321900073232645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025391.m.28934,-0.0159713885646939,-0.0101641522574342,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025398.m.28945,-0.00255530684841436,0.0080285813226016,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025411.m.28960,-0.0183183586737928,-0.0116577582414036,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025422.m.28978,-0.00856088749655006,0.0244884291956887,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025639.m.29255,0.00647090532906697,-0.0117478160610032,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_contig_025684.m.29301,-0.0125572521142927,0.00213583033490643,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025725.m.29348,0.0119789890804774,-0.015413319744718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025759.m.29400,-0.0242029086586806,-0.0121080064280082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025810.m.29463,-0.0205867641921143,0.0166152867526425,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025827.m.29484,-0.0326841771408714,-0.0208001296520416,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025861.m.29521,-0.0130234269575967,-0.0082880767676773,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025862.m.29523,-0.0261717373064745,-0.00732672635746782,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025865.m.29527,-0.0209381969330086,-0.00457484270918318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025897.m.29562,3.50185860383004e-05,0.000797176166787722,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_025962.m.29619,-0.0320674091784183,0.0263523230675983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026106.m.29754,-0.0194059677883488,-0.01234990999716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026140.m.29796,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026147.m.29805,-0.00399039181506716,0.0169657365215709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026238.m.29873,-0.00526918983117071,0.00869125191340357,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026389.m.30064,-0.0168356862039478,-0.0107141891415494,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026398.m.30077,-0.0177465009974584,-0.0112938294278067,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026567.m.30260,0.00787172254065644,-0.000186246752169749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026627.m.30320,-0.0204711092843712,0.0148948183951835,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026644.m.30335,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026676.m.30376,-0.0144122605402827,-0.00917192703138346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026679.m.30379,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026684.m.30387,-0.00479322640314592,0.00752922267593296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026696.m.30395,-0.0296474948573014,-0.0312272607141051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026816.m.30541,0.013001085301298,0.00313019646485846,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026852.m.30581,0.00418370752678731,-0.00113055726883157,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026871.m.30597,0.00621365285724924,-0.0112807786734251,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026910.m.30632,0.0130171465043287,-0.0168968107418593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026915.m.30635,-0.031427849341888,-0.0200006057419952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_026949.m.30663,-0.003467491096475,0.00289984269624493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027060.m.30790,0.00203927277299013,-0.00162412731352709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027196.m.30937,0.00706862460677316,0.0182521970314753,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027213.m.30953,-0.0276634758803144,-0.0053055096711583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027260.m.31007,0.00129253572511705,-0.000277791552587137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027327.m.31055,-0.0207827614525805,-0.0132260980864822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027342.m.31071,-0.012141178137778,-0.00772661579656287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027379.m.31113,-0.019487142641134,-0.0124015694730936,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027593.m.31285,0.0139146820116353,0.00499406545348226,No,NA,NA,O42350,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_contig_027703.m.31406,-0.0145662098445666,-0.00926989998860814,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027730.m.31434,0.0013078444771136,0.00629157740953482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_027976.m.31727,-0.00160347514934218,-0.0262903116485709,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028013.m.31792,0.00259003172074151,0.00356817501920602,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028016.m.31798,-0.00211875365045685,0.00712301643526268,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028143.m.32002,-8.16488478746805e-05,0.0108328373602865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028227.m.32131,0.0149507748330804,-0.0229505948505481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028345.m.32285,0.0221699533524723,0.00359559360752666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028370.m.32304,0.00640085383491887,0.00631946426384387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028488.m.32431,0.0010189678006839,0.0203012047235844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028566.m.32498,0.00837231932791701,-0.0151998001000786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_028737.m.32661,0.00945731593058102,-0.0171695925582767,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029139.m.33073,0.00557097938682511,0.0065791833396999,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029279.m.33207,0.00474469209734249,0.0220939206288851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029445.m.33401,0.00522171640088403,0.00110665697993632,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_029710.m.33698,-0.00975579567861563,0.00399432010591064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030340.m.34527,-0.00849436310191567,-0.00540579170984916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030366.m.34550,9.1901833323474e-05,0.0209414183381946,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030528.m.34754,-0.0111166664372916,-0.00707461907936533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030621.m.34884,0.0318085959477723,-0.00526885358741016,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_contig_030692.m.34979,0.00464323009920658,0.00471545630096069,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030744.m.35041,0.0102785851643591,-0.0133177486972152,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030748.m.35048,-0.00495675340139187,0.00897038158694719,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030819.m.35130,-0.0126803981848854,-0.00806977410348526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030869.m.35200,-0.0216123868538296,0.0246640507172317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030888.m.35216,-0.00502061706421435,0.00156696278718144,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_030959.m.35312,0.00630811158859878,0.0037095771047496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031003.m.35364,-0.0181827599657161,-0.011571463558307,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031244.m.35665,-0.0109101185467488,-0.00694317251168431,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031272.m.35693,0.00722201975951797,-0.00935533398378568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031279.m.35700,0.00373981932889497,-0.00101060599942218,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031433.m.35919,0.00424979998195612,0.00501890445052915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031485.m.35969,-0.00653373112249399,-0.00517113198202327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031486.m.35972,0.00389161529379377,0.00459589754828384,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031630.m.36105,-0.0164359436299719,-0.0104597939542298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031802.m.36287,0.00496639556383134,-0.00901640475375114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_031987.m.36469,-9.04412983213541e-05,0.0119993839578989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032098.m.36603,0.0153569497431021,-0.00786492731877883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032567.m.37185,-0.0136535796190434,-0.00291816350480653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032576.m.37192,-0.0066615291879622,0.00896600721586008,No,NA,NA,Q8CI51,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Z disc [GO:0030018]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; protein kinase C binding [GO:0005080]; protein N-terminus binding [GO:0047485]; cell growth involved in cardiac muscle cell development [GO:0061049]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of synapse assembly [GO:0051963],NA,NA,NA
CHOYP_contig_032616.m.37244,0.0108824052775515,-0.0200811221306554,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032666.m.37309,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032690.m.37333,0.00313712655886349,-0.000847741198843126,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_032916.m.37612,0.00561230629245082,-0.00328786861914913,No,NA,NA,P49446,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein homodimerization activity [GO:0042803]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of mast cell activation [GO:0033003]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185],NA,NA,NA
CHOYP_contig_032947.m.37658,-0.0133048657651862,0.0156656809119678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033072.m.37776,0.00701176921538922,-0.0127297450380834,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033090.m.37804,0.0183354769697287,0.00258552327269049,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033147.m.37856,-0.0111659811628399,-0.00710600284897159,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033179.m.37880,-0.0249509262526225,0.0109794893216977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033285.m.37973,0.0249021030948642,0.0162349090138015,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033346.m.38026,-0.0141814933693527,-0.00902506737344892,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033356.m.38032,0.0111033002703257,0.0115432564184368,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033663.m.38288,0.00410092172426689,-0.00110818618046168,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033740.m.38360,0.02845874825627,-0.0254056496912467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033822.m.38452,0.0322724075118477,-0.0263953808182682,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_033976.m.38613,-0.00720102168716375,0.00805171459293226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034345.m.39015,0.00600495416499077,0.00709169638850238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034390.m.39050,0.000144142968705546,0.00320818932316753,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034410.m.39066,0.0097835379910777,0.00857949365697988,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034686.m.39375,-0.00348923217116704,-0.0170148486323049,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034695.m.39383,0.00819778520630987,-0.00241698601774633,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034750.m.39458,0.0307052017638824,0.00844392157567489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034847.m.39553,0.0037784036183542,-0.000157818970493801,No,NA,NA,P95896,NA,NA,NA,amidase activity [GO:0004040]; indoleacetamide hydrolase activity [GO:0043864],NA,NA,NA
CHOYP_contig_034890.m.39584,0.028527485830439,-0.0240460401214114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034934.m.39632,0.00152997466173022,0.0166615414020732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_034987.m.39710,0.0153702581015491,-0.00618297323353171,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035123.m.39896,-0.0036379397432845,0.00493878244362167,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035291.m.40069,0.0162173102456113,0.000323987368001387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035372.m.40130,0.010227691259665,0.0341997943925117,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035380.m.40136,0.0285924405393609,-0.0187618254012581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035493.m.40257,0.0117488963139535,0.0079967962137585,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035545.m.40311,0.00897639961754313,0.0151776745181355,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035578.m.40341,-0.00909155264408655,-0.0306094072834309,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035697.m.40446,0.00445763032989383,0.0150109652190473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035767.m.40509,-0.00756330530865262,0.0143878515519625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_035951.m.40680,0.0293643318123346,0.00396593053475322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036103.m.40829,0.0163614836133906,-0.0105710247745483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036280.m.40985,-0.0176613329694161,0.00140702372169217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036283.m.40992,-1.98462842966312e-05,0.0317613473842061,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036657.m.41264,-0.0194471707568373,0.00135257193247696,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036790.m.41410,0.0181139121885097,0.0141699396198643,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036886.m.41498,0.00840929469780811,-0.00121934847139349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036899.m.41515,-0.0222962646173307,0.0101001782123272,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036935.m.41573,-0.00654646209018201,-0.000895642757777532,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_036974.m.41637,0.0096802641943794,-0.0133559737902504,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037000.m.41674,0.0107891654460179,0.0214468845665486,No,NA,NA,A0A1I9LN01,NA,NA,NA,integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; de-etiolation [GO:0009704]; response to far red light [GO:0010218]; seed germination [GO:0009845],NA,NA,NA
CHOYP_contig_037038.m.41727,0.000957810613422453,0.0240905138031581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037467.m.42206,-0.0174544500242824,0.00182450420249003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037561.m.42354,-0.00893487167975298,-0.0056861302813959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037644.m.42447,-0.000408260539564712,0.0176820765512921,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037727.m.42549,0.00344131668576505,-0.000929942059413187,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037785.m.42603,-0.0015941129941278,0.0204881857434727,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037938.m.42800,-0.000617504273260489,-0.0128040133703209,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037956.m.42826,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_037959.m.42830,0.00151099408146787,0.0116449298870126,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038058.m.42964,0.00263604452204975,0.00740651744616195,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038126.m.43051,0.00648515817860045,0.00765880497509478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038160.m.43103,-0.0294922508056829,-0.0300270610854254,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038218.m.43194,-0.0238871183589453,0.0159931951097193,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038370.m.43386,0.00427645177081277,0.00341666513578861,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038408.m.43447,0.00370749077454704,0.0104454642995606,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038486.m.43547,0.00263116001165966,-0.0214242082690404,No,NA,NA,Q9BXM0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; T-tubule [GO:0030315]; axon ensheathment [GO:0008366]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_contig_038513.m.43619,0.0344944050427701,0.0143214040079496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038550.m.43669,-0.00244568537616007,0.0138681259573323,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038579.m.43695,0.0161372349296011,0.0123816417535132,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038691.m.43809,-0.00724210069424206,-0.0184987718466811,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038703.m.43817,-0.00513197638673134,0.000532657548534037,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038765.m.43871,0.00463770239706365,-0.00125323964978598,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038766.m.43872,0.0148590012160582,-0.0269762582296418,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038806.m.43911,0.00332363116562737,0.000858368571033481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038817.m.43926,-0.00965055044730695,-0.00614158648242477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038859.m.43982,-0.030036134246596,0.0154565241902789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038869.m.43996,0.00959816540604344,0.0078916118705875,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038921.m.44081,-0.00214367461048133,0.00640589409532532,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_038946.m.44119,-0.00972693044992663,-0.0192149232945322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039068.m.44246,0.00547823227546251,-0.00148037483015163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039097.m.44266,-0.00388357717574163,0.00527225411289684,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039100.m.44268,-0.000203002905077439,0.0337484553723363,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039169.m.44357,0.00765532936094185,0.0198238367966002,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039208.m.44410,0.00741050894990063,0.0136254057706114,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039283.m.44494,-0.0311446155925615,-0.0198203564830821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039285.m.44499,0.00543208043140835,0.000349182553351452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039330.m.44540,0.0175925946340102,0.0116032202735999,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039366.m.44569,0.0158310266102156,0.0144846787814495,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039465.m.44679,-9.15442894000617e-05,0.0121457243322765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039575.m.44801,-0.00159771508548534,0.00784662755171865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039595.m.44817,0.00809681655739572,0.00956213205976032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039638.m.44850,-9.36876375728011e-05,0.0124300950584551,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039715.m.44911,0.0152555210188021,0.0131246238760656,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039741.m.44927,-0.0045089739807216,0.00653031481476711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_039966.m.45203,0.00341331920167096,0.00316410191967029,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040048.m.45313,0.00339197849258005,-0.000916609470416663,No,NA,NA,P04323,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_contig_040238.m.45604,0.0139893396383921,-0.00485364888580478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040334.m.45722,-5.62989956036937e-05,0.00746952196874076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040433.m.45856,-0.014694266060472,0.022178187160446,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040481.m.45927,0.0106398432244511,-0.0138130657808869,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040503.m.45959,-0.000104892660845997,0.0139167320153301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040623.m.46145,-0.0304023742511764,0.0253588412367227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040750.m.46306,-0.00163078569737041,-0.000582433253758573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040887.m.46494,0.00369993639051819,0.0135480576472899,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040962.m.46595,0.00320037486216764,0.00163647000392512,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_040975.m.46616,-0.00201837249584143,-0.000253417942757154,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_contig_040978.m.46621,-0.0184620291470615,-0.0117491897759434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041025.m.46710,0.000150489264831652,0.00284649411508087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041068.m.46778,0.0177881896790588,-0.0188535800455625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041073.m.46786,0.00384069109403742,0.00453575737842127,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041193.m.46961,0.0179219556620455,-0.018501761333018,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041218.m.46991,-0.00447281683878185,0.0292366163274841,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041288.m.47081,-0.0155397114107316,0.0316738688771584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041298.m.47095,0.0287207460569662,0.00633170832549466,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041336.m.47149,-0.0126489867364776,-0.00804978393525726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041380.m.47215,0.00358894503329014,0.00423845175696796,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041554.m.47492,0.00677905822415052,0.0235595754883507,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041605.m.47590,0.0145084918084414,0.00188678507261491,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041673.m.47688,-0.0124232069815946,-0.00854134110522057,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041706.m.47739,-0.0125516286688427,-0.00798782550134135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041712.m.47757,0.00293950175601251,0.00212390214691321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041717.m.47768,0.00656192906878028,-0.0119130680770594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041765.m.47848,0.00206572696333152,-0.000558218426805086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041782.m.47874,0.0129303272102684,-0.00604494350770646,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041876.m.48001,-0.00880356283740243,0.00120194806457255,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041950.m.48134,-0.00458998916109855,0.008562820945559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_041958.m.48141,0.00504666884318724,0.00564451185363356,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042054.m.48295,-0.00692028391980268,0.00342399940480121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042130.m.48414,-0.00929196766704239,-0.0059133852862207,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042244.m.48592,-0.0104364649604965,-0.00722532277433339,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042249.m.48611,-0.0150598409100152,-0.00958404558013861,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042362.m.48774,-0.0097303584667135,-0.00619237610897018,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042378.m.48796,-9.82187270539006e-05,0.0130312615989675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042449.m.48875,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042540.m.49007,0.00450350773181747,-0.00121697641836718,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042557.m.49033,0.0319165770692493,0.0147700335476299,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042616.m.49103,0.00333042064409119,0.00393314110398902,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042690.m.49166,-0.00876527130414998,0.0116929706130805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042766.m.49278,-0.0118607764129426,-0.00754816883104514,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042815.m.49366,0.0034172259625783,-0.000923432057928665,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042864.m.49442,-0.00875493742990665,-0.00557162056895873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_042901.m.49495,0.00903635994034165,-0.0164053542806905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043041.m.49677,-0.0190528179590276,-0.0121251663175252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043053.m.49693,0.011492957082323,-0.0225432498053007,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043057.m.49706,0.00627971317122562,-0.00397696247058164,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043072.m.49721,-0.000598053021213802,0.00148759724747095,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043212.m.49892,0.00265232172976135,0.00313232373058818,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043231.m.49931,0.00468436989881015,-0.00542138897956339,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043238.m.49940,0.00566480807361395,0.00355376278038009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043280.m.49983,-0.0035006499261867,-0.0067546161860183,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043301.m.50018,0.00390086168969902,-0.00876057640918605,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043488.m.50266,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043510.m.50295,0.00797500635109907,0.0300717213589625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043576.m.50359,0.0251536443804768,-0.0140838260426998,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043813.m.50619,-0.000381689833496057,-0.00138639074037391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043818.m.50622,0.00102644989231122,-0.00165363709176782,No,NA,NA,Q5TZA2,NA,NA,NA,actin cytoskeleton [GO:0015629]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; kinesin binding [GO:0019894]; structural molecule activity [GO:0005198]; centriole-centriole cohesion [GO:0010457]; centrosome cycle [GO:0007098]; ciliary basal body organization [GO:0032053]; epithelial structure maintenance [GO:0010669]; establishment of organelle localization [GO:0051656]; photoreceptor cell maintenance [GO:0045494]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization [GO:0008104]; protein localization to organelle [GO:0033365],NA,NA,NA
CHOYP_contig_043845.m.50665,-0.014487827367422,-0.00922001757363926,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043862.m.50684,0.00391789109593168,0.0046793314450178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043874.m.50696,0.0130051218175813,0.00218367891384661,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043898.m.50728,-0.00363830595000633,0.00493927959735597,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_043909.m.50738,-0.0124097190957092,-0.00789751459930085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044078.m.50900,-0.00193746794202859,0.0193085202686372,No,NA,NA,Q01484,NA,NA,NA,A band [GO:0031672]; apical plasma membrane [GO:0016324]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; intercalated disc [GO:0014704]; lysosome [GO:0005764]; M band [GO:0031430]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; recycling endosome [GO:0055037]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; phosphorylation-dependent protein binding [GO:0140031]; protein binding; bridging [GO:0030674]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; atrial cardiac muscle cell action potential [GO:0086014]; atrial cardiac muscle cell to AV node cell communication [GO:0086066]; atrial septum development [GO:0003283]; cellular calcium ion homeostasis [GO:0006874]; cellular protein localization [GO:0034613]; endocytosis [GO:0006897]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; membrane depolarization during SA node cell action potential [GO:0086046]; paranodal junction assembly [GO:0030913]; positive regulation of calcium ion transmembrane transporter activity [GO:1901021]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cation channel activity [GO:2001259]; positive regulation of gene expression [GO:0010628]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; positive regulation of potassium ion transport [GO:0043268]; protein localization to cell surface [GO:0034394]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to M-band [GO:0036309]; protein localization to organelle [GO:0033365]; protein localization to plasma membrane [GO:0072659]; protein localization to T-tubule [GO:0036371]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of atrial cardiac muscle cell action potential [GO:0098910]; regulation of calcium ion transmembrane transporter activity [GO:1901019]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of heart rate [GO:0002027]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of protein stability [GO:0031647]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of SA node cell action potential [GO:0098907]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to methylmercury [GO:0051597]; SA node cell action potential [GO:0086015]; SA node cell to atrial cardiac muscle cell communication [GO:0086070]; sarcoplasmic reticulum calcium ion transport [GO:0070296]; T-tubule organization [GO:0033292]; ventricular cardiac muscle cell action potential [GO:0086005],NA,NA,NA
CHOYP_contig_044225.m.51129,0.00403864311511389,-0.00109135672146632,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044310.m.51269,-0.00898536353270124,-0.00571826317197377,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044503.m.51534,-0.00352275439237412,-0.000694340990305536,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044612.m.51675,-0.00600271578419118,-0.00131176959029395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044629.m.51700,-0.0107294363148356,0.00385185925588877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044640.m.51719,0.0179150278387599,-0.0325244214023836,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044678.m.51771,0.00756256977830741,-0.0137297138786711,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044692.m.51797,-0.0278186181330028,-0.0136587440074442,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044795.m.51952,-0.00303392735432859,0.00411878926264277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_044824.m.51993,0.00584168252502699,-0.00760793967807006,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045072.m.52344,0.00436178679956042,-0.00662578947199409,No,NA,NA,Q3ZBG9,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleolus [GO:0005730]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; CD4 receptor binding [GO:0042609]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; epidermal growth factor receptor binding [GO:0005154]; phospholipid scramblase activity [GO:0017128]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; plasma membrane phospholipid scrambling [GO:0017121]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of innate immune response [GO:0045089]; response to interferon-beta [GO:0035456],NA,NA,NA
CHOYP_contig_045193.m.52491,-0.00595388513027441,-0.0182852927179478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045205.m.52522,-0.00120712571895217,-0.00340249639029347,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045248.m.52574,-0.00200898419824052,0.00418325668027511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045427.m.52825,-0.0101030290848506,0.00360683921348009,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045550.m.53021,0.0131087741622404,0.0134967541188851,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045552.m.53024,0.0141462737105089,-0.00722635936498048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045655.m.53199,0.00165937437469969,0.00683795176122716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_045662.m.53210,-0.00344127166923669,0.00120284967902697,No,NA,NA,Q14686,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; nuclear receptor transcription coactivator activity [GO:0030374]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; brain development [GO:0007420]; cellular response to DNA damage stimulus [GO:0006974]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA-templated transcription; initiation [GO:0006352]; glucocorticoid receptor signaling pathway [GO:0042921]; heart development [GO:0007507]; intracellular estrogen receptor signaling pathway [GO:0030520]; myeloid cell differentiation [GO:0030099]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of lipid metabolic process [GO:0019216]; response to hormone [GO:0009725],NA,NA,NA
CHOYP_contig_045946.m.53656,0.0101021835245186,0.0179354379133866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046319.m.54200,-0.00694072952271257,-0.00165968030384547,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046503.m.54505,0.00168130092326816,-0.00590093133146103,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046530.m.54559,-0.0130872970181133,-0.00832872351652771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046551.m.54588,-0.000609902391892831,0.00460669292913627,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046706.m.54827,-0.00606275599225427,-0.00126193639895787,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046854.m.55054,0.00963407687530072,-0.00550639753521444,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_046883.m.55107,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047016.m.55305,-0.00207340745227112,-0.00361702251760129,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047066.m.55375,-8.97941066883612e-05,0.0119135172018621,No,NA,NA,Q6MG82,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_contig_047135.m.55497,0.00942170479996456,-0.0171049411701121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047214.m.55631,0.0107148050813508,-0.010214129427488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047294.m.55755,-7.6336969971518e-05,0.0101280789846267,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047333.m.55799,-0.0103650128695078,-0.00659626860427346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047394.m.55871,0.0038689759862407,0.0045691611084708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047449.m.55959,-0.032577661635311,-0.00204173733834288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047498.m.56019,0.00466462154155893,0.00550879804093471,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047569.m.56118,0.0140378713494951,0.0233563096639619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047668.m.56271,0.00860497208311667,0.00578031543635232,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047685.m.56291,-0.0295236030054821,-0.0126321619242161,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047707.m.56320,-0.0143172291211941,-0.0228110380934462,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047731.m.56360,-0.0262571656868188,-0.0116486448152653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047828.m.56501,0.00457085948730051,0.00539806746692973,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047907.m.56621,-0.0116342181300008,-0.00740398769903673,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047908.m.56622,0.00479086349137726,0.0116217560794877,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047916.m.56635,0.00489698648102821,-0.00618724158427622,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_047982.m.56715,0.00329296521129391,-0.00975298658501821,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048122.m.56947,0.00585327085157029,-0.0106265114111003,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048134.m.56964,0.00705011368515364,0.00832600289458031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048148.m.56980,-0.00396577878956785,0.00538384911332304,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048267.m.57131,-0.000809634467645147,-0.0262607308499949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048274.m.57147,0.0125842567036668,-0.00813350213119107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048369.m.57273,-0.0189147241722495,-0.00491608880454386,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048457.m.57397,-0.00335296787780121,-0.0158199795344492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048541.m.57541,0.00688384027713947,0.00274501466583774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048603.m.57625,0.00354840016227901,-0.00182281583194706,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048626.m.57669,-0.00273342163826938,0.00371082968678096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048667.m.57735,0.00620270142119435,0.00484918472895024,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048706.m.57793,-0.00235302158638681,0.00833432984970144,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048781.m.57879,0.00570465387856442,0.00673704947560305,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048887.m.57987,-0.0100437429506538,-0.0114191221422021,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048930.m.58050,-0.00339163159172324,-0.016826206851772,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048973.m.58107,-0.029762791694796,0.00839986455133052,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_048994.m.58122,0.00817006076377166,0.00440613942323175,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049099.m.58219,0.00899283750463994,-0.0163263400557638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049136.m.58269,-0.0164315001396539,-0.0161599394772016,No,NA,NA,Q8N7X0,NA,NA,NA,calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; heme binding [GO:0020037]; oxygen binding [GO:0019825],NA,NA,NA
CHOYP_contig_049345.m.58557,0.0207926212313395,0.0127850796074935,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049353.m.58568,-0.00023982299616197,0.00390340606080771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049367.m.58596,-0.00428634113941386,-0.0208106259023977,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049413.m.58667,-0.00900758315240863,-0.002482914260285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049548.m.58834,-0.00474911745321228,0.0182626943240552,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049586.m.58876,0.00343111380605082,-0.0284886914523366,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_049619.m.58908,-0.0336792429875681,-0.021433387100574,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050044.m.59512,-0.0150439422363162,-0.00957392770344219,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050158.m.59641,0.00570416138098865,0.0067364678486358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050222.m.59713,-7.85111946632007e-05,0.0104165462818732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050253.m.59761,-0.0151000759027804,0.00460515963836858,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050301.m.59822,0.0038799309418466,-0.00104846815911092,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050355.m.59899,0.00582557959310964,-0.0105762384130652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050388.m.59942,-0.00353277009369307,-0.0167857351548503,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050483.m.60085,0.000119303773048136,0.00278861427515803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050507.m.60115,0.00315103352068462,-0.000851499257137969,No,NA,NA,Q6H236,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_contig_050515.m.60136,0.00864215823528793,-0.0156896879424576,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050645.m.60289,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050710.m.60376,0.00478111453493567,0.0115386207829726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050842.m.60581,0.00349291959773203,-0.00094388664010952,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050863.m.60613,-0.00341008887616699,-0.016998722614496,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_050942.m.60734,0.00440365160524131,-0.0269830273144079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051171.m.61058,0.00850496231339178,-0.00521426690593638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61184,0.0046020317351649,0.00543488108973641,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051254.m.61185,-0.0157226122585778,-0.0100058316303226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051311.m.61287,0.0012774925624079,0.00446000091596666,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051346.m.61337,0.00973081340227641,-0.00639204538706272,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051433.m.61487,0.00344491364952261,-0.000930914061756993,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051499.m.61590,0.0232819490022648,1.01037881072118e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051534.m.61634,0.0219207138440435,-0.00772708350889643,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051787.m.61994,0.00216969013933445,-0.00282085012597744,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051794.m.62013,0.00619901897980463,-0.0112542111234864,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_051943.m.62221,-0.00718174947673089,0.0337465826036545,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052015.m.62309,-0.0117558657631745,-0.000615315572060452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052081.m.62393,-0.0178617275872364,-0.00869290595676328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052083.m.62396,0.00304380577462407,0.00538573401053372,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052147.m.62461,0.00806763320798536,-0.00408732073217083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052383.m.62773,0.0013605668841681,0.0284309760139916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052396.m.62799,-0.00326613378282118,0.0036201839269581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052416.m.62821,-0.0233553477919437,0.00574796036299734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052441.m.62852,-0.005626074291855,0.0108894872384934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052658.m.63135,-5.47203506916738e-05,0.00726007377655305,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052729.m.63227,0.00764098820629627,0.00902381050351677,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052748.m.63243,-0.000189848308542136,-0.0210172482604365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_052993.m.63573,0.00625184898288273,-0.00801189538893461,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053017.m.63597,0.0194191231766903,-0.0171878322781124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053024.m.63605,0.0117327368958575,0.0295743361623247,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053133.m.63737,0.00527448577734634,-0.00957573717703841,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053329.m.63915,0.00342225951187226,-0.00890584158412447,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053371.m.63972,-0.0115561312683403,0.0033683022556205,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053582.m.64175,0.00225424878540191,-0.00243036478305478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053627.m.64220,-5.88126015929654e-05,0.00780301699749385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053687.m.64290,0.00213748260145504,-0.00388932849152529,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053787.m.64362,0.0237066999757061,0.0218741010629146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053912.m.64506,0.0162058155844768,0.00286451148128649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053977.m.64571,0.00549579894239999,0.00329142247739917,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053989.m.64582,0.011875374706331,-0.016198478460888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_053995.m.64585,0.0168134301097716,0.00218651197156509,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054223.m.64734,-0.0147221518894194,-0.00936914112101179,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054409.m.64895,0.00625546294723197,0.00138247757990432,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054622.m.65176,-0.0213552610870604,0.00420513725290537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054868.m.65463,-0.00575847642837966,-0.00292981575390704,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_054901.m.65508,0.00616422277643914,-0.0152082299297108,No,NA,NA,A8XZB0,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_contig_055102.m.65741,-0.00907674368844374,0.00152215471363155,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055225.m.65857,0.00432541318564027,0.0104485051967775,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055303.m.65981,-0.00691398092295308,-0.00728746117270734,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055335.m.66005,0.00835816062173914,0.015401047231219,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055359.m.66029,-0.0136067280326099,-0.00865928813194558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055404.m.66082,-0.0111577553887925,0.00228521232107285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055406.m.66084,-0.0306888502775644,0.0119836453278774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055822.m.66445,-0.00295768165017249,0.0266714018703039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055842.m.66464,0.000185602901843217,0.00374507972109558,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_055984.m.66583,0.0116547398295359,-0.00249688275952943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056008.m.66602,-0.00217471250019877,0.00624624616416625,No,NA,NA,P51958,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_contig_056033.m.66621,-0.00190544892018792,-0.000234481536348995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_contig_056499.m.66997,-0.0137295754333223,0.0225882905577296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COPA.1.1.m.31888,0.000329490434336751,0.00138977311487709,No,NA,NA,Q27954,NA,NA,NA,COPI vesicle coat [GO:0030126]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; hormone activity [GO:0005179]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPA.1.1.m.31889,0.0029883897665151,-0.000807548269328934,No,NA,NA,Q9JLR1,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784]; protein transmembrane transporter activity [GO:0008320]; ribosome binding [GO:0043022]; signal sequence binding [GO:0005048]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_COPB.1.1.m.16988,0.00102393444916984,0.000372714977707735,No,NA,NA,P23514,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPB2.1.1.m.11046,-0.000116270238276005,0.00321938011190725,No,NA,NA,P35606,NA,NA,NA,COPI vesicle coat [GO:0030126]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; transport vesicle [GO:0030133]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_COPD.1.1.m.37389,0.00085618747117232,-0.000138109720631578,No,NA,NA,Q5ZL57,NA,NA,NA,COPI vesicle coat [GO:0030126]; COPI-coated vesicle [GO:0030137]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi localization [GO:0051645]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPD.1.1.m.37390,-0.00165440918533043,-0.000333219294378247,No,NA,NA,Q9DCM4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_COPE.1.1.m.48265,0.00371244398129091,-0.000810685442086117,No,NA,NA,Q5ZIK9,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; structural molecule activity [GO:0005198]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_COPG2.1.1.m.60836,0.00117113240699479,0.000268868604099704,No,NA,NA,Q9I8E6,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_COQ4.1.1.m.6843,-0.0082330055006054,-0.00112793057229059,No,NA,NA,Q16FT5,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_COQ9.1.2.m.4620,-0.00664844537306088,0.00402045141375453,No,NA,NA,O75208,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_CORIN.2.2.m.40858,0.0109750133264959,0.00404755301620069,No,NA,NA,Q9Y5Q5,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell surface [GO:0009986]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; female pregnancy [GO:0007565]; peptide hormone processing [GO:0016486]; regulation of blood pressure [GO:0008217]; regulation of cardiac conduction [GO:1903779]; regulation of renal sodium excretion [GO:0035813]; regulation of systemic arterial blood pressure by atrial natriuretic peptide [GO:0003050],NA,NA,NA
CHOYP_COX1.5.15.m.24406,0.00118220025160502,-0.0035398673354609,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_COX1.6.15.m.25748,-0.000920675623993009,-0.000640875840847194,No,NA,NA,Q9BYJ9,NA,NA,NA,cytoplasm [GO:0005737]; N6-methyladenosine-containing RNA binding [GO:1990247]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948],NA,NA,NA
CHOYP_COX5B.1.3.m.20245,-0.00337026572275316,0.00457539441454446,No,NA,NA,Q710D6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_COX5B.3.3.m.38557,-0.00157739754413938,0.00460605239656296,No,NA,NA,P00428,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; respiratory chain complex IV [GO:0045277]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_CP080.1.1.m.24911,-0.00463690561184542,0.00264557181868829,No,NA,NA,Q8BTU1,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; microtubule [GO:0005874]; nucleus [GO:0005634]; cilium assembly [GO:0060271]; positive regulation of cell motility [GO:2000147]; positive regulation of feeding behavior [GO:2000253]; protein polyglutamylation [GO:0018095]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296],NA,NA,NA
CHOYP_CP096.1.1.m.35853,-0.00283033854553394,-0.00171906718857981,No,NA,NA,Q9H0J4,NA,NA,NA,,NA,NA,NA
CHOYP_CP2BA.1.1.m.38084,0.0149378166417748,0.0126069120934911,No,NA,NA,O46658,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; arachidonic acid metabolic process [GO:0019369]; exogenous drug catabolic process [GO:0042738]; organic acid metabolic process [GO:0006082]; oxidation-reduction process [GO:0055114]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_CP3AB.4.4.m.47872,-0.0168991150625835,-0.00803392227534981,No,NA,NA,Q64459,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; testosterone 6-beta-hydroxylase activity [GO:0050649]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_CP3AO.1.1.m.63459,0.00295845663310768,-0.00663009638794072,No,NA,NA,P51538,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; organelle membrane [GO:0031090]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; steroid hydroxylase activity [GO:0008395]; female pregnancy [GO:0007565]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to zinc ion [GO:0010043]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_CP4F2.1.1.m.7803,-0.0146244162823212,0.00077117822724048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPE.1.1.m.53041,-0.0118658790706801,0.00721449571078805,No,NA,NA,P37892,NA,NA,NA,extracellular region [GO:0005576]; transport vesicle membrane [GO:0030658]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_CPIB.2.3.m.44557,0.00906548627044663,-0.0164582326263323,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIB.3.3.m.46138,-0.0064254018138227,0.0033499222530119,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_CPIPJ_CPIJ000723.1.1.m.7190,-0.016856256936245,-0.0107272803048048,No,NA,NA,P27393,NA,NA,NA,basement membrane [GO:0005604]; collagen trimer [GO:0005581]; extracellular matrix structural constituent [GO:0005201],NA,NA,NA
CHOYP_CPIPJ_CPIJ001623.1.1.m.19531,0.00245949642760912,-0.00184375605361317,No,NA,NA,Q9UMY4,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; enzyme binding [GO:0019899]; phosphatidylinositol binding [GO:0035091]; negative regulation of early endosome to late endosome transport [GO:2000642]; negative regulation of gene expression [GO:0010629]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein processing [GO:0010955]; negative regulation of protein transport [GO:0051224]; protein transport [GO:0015031]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_CPIPJ_CPIJ003599.1.1.m.61267,-0.00769224951098228,-0.00489532860058471,No,NA,NA,Q9NRH2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; myeloid cell differentiation [GO:0030099]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_CPIPJ_CPIJ003871.1.1.m.147,0.00165380638719146,-0.000163568491012015,No,NA,NA,P49024,NA,NA,NA,cell [GO:0005623]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; metal ion binding [GO:0046872]; vinculin binding [GO:0017166]; cell-matrix adhesion [GO:0007160]; response to muscle stretch [GO:0035994],NA,NA,NA
CHOYP_CPIPJ_CPIJ004440.1.1.m.62518,0.00139147990315606,0.0106885639809005,No,NA,NA,Q9HC07,NA,NA,NA,early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; cellular calcium ion homeostasis [GO:0006874]; Golgi calcium ion transport [GO:0032472]; protein N-linked glycosylation [GO:0006487]; regulation of lysosomal lumen pH [GO:0035751],NA,NA,NA
CHOYP_CPIPJ_CPIJ004536.3.3.m.52790,0.0112996836295908,0.00861958768294409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ004840.1.1.m.3309,-0.00940198824859324,-0.00658503058747096,No,NA,NA,Q5EA45,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity [GO:0016491]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ005489.1.1.m.43655,0.00360496083510151,-0.00821822562452211,No,NA,NA,P13668,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; neuron projection [GO:0043005]; tubulin binding [GO:0015631]; axonogenesis [GO:0007409]; brain development [GO:0007420]; establishment of skin barrier [GO:0061436]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; microtubule depolymerization [GO:0007019]; mitotic cytokinesis [GO:0000281]; mitotic spindle organization [GO:0007052]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; neuron projection development [GO:0031175]; positive regulation of cellular component movement [GO:0051272]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule polymerization or depolymerization [GO:0031110]; response to virus [GO:0009615],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.1.4.m.5854,0.00763640900108575,-0.0141987864965878,No,NA,NA,P48166,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.3.4.m.30316,0.00440940003742692,0.00715030187662559,No,NA,NA,Q6GL69,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_CPIPJ_CPIJ007723.4.4.m.64973,-0.0303669865172997,0.01721530719868,No,NA,NA,Q4V886,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA polymerase II complex binding [GO:0000993]; cellular response to lipopolysaccharide [GO:0071222]; endodermal cell fate commitment [GO:0001711]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; mRNA polyadenylation [GO:0006378]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome positioning [GO:0016584]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of histone methylation [GO:0031062]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein localization to nucleus [GO:0034504]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CPIPJ_CPIJ007907.1.1.m.45771,-6.08271009382396e-05,0.000767583782478279,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ008112.1.1.m.51524,0.00113186930288593,0.0010872951654934,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CPIPJ_CPIJ008190.1.1.m.21761,0.0292747318128185,-0.0294525732610669,No,NA,NA,Q7ZUH5,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_CPIPJ_CPIJ008492.1.1.m.6934,-0.00852087653295801,-0.0170176349736971,No,NA,NA,P83565,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761],NA,NA,NA
CHOYP_CPIPJ_CPIJ011304.2.2.m.43130,-0.00784284959140889,-2.81117848032291e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ011346.2.2.m.44999,0.0208102991805705,-0.00664183936829804,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CPIPJ_CPIJ012408.1.1.m.10724,-0.00286925092450468,-9.40199752776185e-05,No,NA,NA,Q6PV61,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_CPIPJ_CPIJ015079.1.1.m.39675,-0.0135697393649992,0.0193117450163494,No,NA,NA,P42029,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; protein-containing complex binding [GO:0044877]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_CPIPJ_CPIJ016910.1.1.m.62713,-0.00370355795295563,0.00760866732571943,No,NA,NA,P07686,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_CPNE8.2.2.m.58380,0.000461520340182351,0.00195450971630977,No,NA,NA,Q78ZA7,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; nucleosome binding [GO:0031491]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_CPSF1.1.1.m.27767,-0.0155521852903552,-0.00349446466989215,No,NA,NA,Q10569,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF2.1.1.m.13908,-0.00278118350222216,-0.0102750765004632,No,NA,NA,O35218,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA 3'-end processing by stem-loop binding and cleavage [GO:0006398]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_CPSF5.1.2.m.59012,-0.000882572701463651,-0.00115473822408866,No,NA,NA,Q7T3C6,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; AU-rich element binding [GO:0017091]; hydrolase activity [GO:0016787]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; positive regulation of mRNA cleavage [GO:0031439]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of pro-B cell differentiation [GO:2000975]; positive regulation of stem cell differentiation [GO:2000738]; posttranscriptional regulation of gene expression [GO:0010608]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_CPT1A.1.1.m.53985,-0.0208939902518513,0.0153355495320531,No,NA,NA,Q9R0P6,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; serine-type peptidase activity [GO:0008236]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_CPT2.1.1.m.16349,-0.00189460891261833,-0.00433778366647215,No,NA,NA,P23786,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; carnitine O-palmitoyltransferase activity [GO:0004095]; carnitine shuttle [GO:0006853]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_CPVL.2.2.m.62669,-0.00370267432611775,-0.000156295063939616,No,NA,NA,Q9H3G5,NA,NA,NA,extracellular exosome [GO:0070062]; serine-type carboxypeptidase activity [GO:0004185]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CRADD.1.2.m.27800,0.000701032535291105,-0.00685011287192616,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_01395.2.2.m.44269,-0.0200373821065973,0.0239055460865161,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_CRE_02254.1.1.m.12455,0.00867257549456144,0.0336574051235136,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_CRE_06881.1.1.m.62783,0.0044351255727032,0.00523776920561094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_13958.1.1.m.31239,0.00441902286231438,0.00368373332391348,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE_16884.1.1.m.28203,-0.015728465344361,-0.0072664600424539,No,NA,NA,Q19673,NA,NA,NA,copper ion binding [GO:0005507]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; another compound as one donor; and incorporation of one atom of oxygen [GO:0016716]; melanin biosynthetic process [GO:0042438],NA,NA,NA
CHOYP_CRE_18961.1.1.m.30942,-0.0219915190676735,0.0100859009713936,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_CRE_21950.1.1.m.55,-0.00987494183672455,-0.00628438860874329,No,NA,NA,Q9VZW5,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; peptide receptor activity [GO:0001653]; adult locomotory behavior [GO:0008344]; behavioral defense response [GO:0002209]; G protein-coupled receptor signaling pathway [GO:0007186]; larval locomotory behavior [GO:0008345]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204],NA,NA,NA
CHOYP_CRE_25145.1.1.m.8177,-0.0269633072618942,0.00859565265563952,No,NA,NA,Q9D9T0,NA,NA,NA,Set1C/COMPASS complex [GO:0048188]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_CRE_29942.1.1.m.48587,0.0102806115700233,0.00555052934883488,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_CRE.DIG.1.1.1.m.26794,0.00338698951339951,0.00364793660901353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.GST.7.1.1.m.30139,-0.0336524841027156,0.0110180829184592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.HIM.4.1.1.m.55343,-0.00766989715677839,-0.00486630816238296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.1.3.m.20277,0.00687436993429947,0.00168296340922816,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRE.UNC.89.3.3.m.61234,-0.0068004425995215,-0.00432778488354327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CREM.1.1.m.12267,-0.000945053446277816,-0.00404773118664526,No,NA,NA,P79145,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; glycosphingolipid metabolic process [GO:0006687]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRI9333_2800.1.1.m.5332,0.00096433619818051,-0.000810908023750535,No,NA,NA,Q9BXB1,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_CRIM1.1.3.m.5078,0.00536684988253636,0.00628579550611162,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CRLF3.1.2.m.8760,0.0018390394590401,-0.00178437517490101,No,NA,NA,Q568M3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_CRNL1.1.1.m.2792,-0.00648299699271213,-0.0121845937994715,No,NA,NA,Q9BZJ0,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_CRYAB.1.5.m.2659,-0.0325777515919988,0.0332942998769056,No,NA,NA,Q91312,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYAB.5.5.m.49919,-0.0148363646849956,0.0239052663522533,No,NA,NA,Q91312,NA,NA,NA,metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_CRYM.1.1.m.8544,0.00645082927869919,0.00359881498789356,No,NA,NA,O54983,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; hormone binding [GO:0042562]; NADP binding [GO:0050661]; oxidoreductase activity; acting on the CH-NH2 group of donors; NAD or NADP as acceptor [GO:0016639]; protein homodimerization activity [GO:0042803]; thiomorpholine-carboxylate dehydrogenase activity [GO:0047127]; thyroid hormone binding [GO:0070324]; transcription corepressor activity [GO:0003714]; mitochondrial transport [GO:0006839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; sensory perception of sound [GO:0007605]; thyroid hormone metabolic process [GO:0042403]; thyroid hormone transport [GO:0070327],NA,NA,NA
CHOYP_CRYZ.2.2.m.65927,0.00576740723243647,0.00239309845494646,No,NA,NA,Q08257,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mRNA 3'-UTR binding [GO:0003730]; NADPH binding [GO:0070402]; NADPH:quinone reductase activity [GO:0003960]; zinc ion binding [GO:0008270]; protein homotetramerization [GO:0051289]; visual perception [GO:0007601]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_CS066.1.3.m.44165,-0.0145716657012005,-0.0320746390804613,No,NA,NA,Q32L09,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; negative regulation of viral genome replication [GO:0045071]; response to interferon-gamma [GO:0034341]; response to type I interferon [GO:0034340]; response to type III interferon [GO:0034342],NA,NA,NA
CHOYP_CS081.1.1.m.48577,-0.00351985838663079,0.0150543380452664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CSAD.1.1.m.40056,0.00494227398146348,0.00340588441205778,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_CSK.1.1.m.55145,0.00262875113884308,-0.000379784638812368,No,NA,NA,P32577,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; proline-rich region binding [GO:0070064]; protein kinase A catalytic subunit binding [GO:0034236]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; adherens junction organization [GO:0034332]; brain development [GO:0007420]; cellular response to peptide hormone stimulus [GO:0071375]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of kinase activity [GO:0033673]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of phagocytosis [GO:0050765]; oligodendrocyte differentiation [GO:0048709]; positive regulation of MAP kinase activity [GO:0043406]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of Fc receptor mediated stimulatory signaling pathway [GO:0060368],NA,NA,NA
CHOYP_CSK21.1.2.m.19313,-0.00847660871151709,0.00782729802903834,No,NA,NA,P21868,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; rhythmic process [GO:0048511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSK2B.1.1.m.37285,-0.00281292450538511,0.00754554562785604,No,NA,NA,P28021,NA,NA,NA,protein kinase CK2 complex [GO:0005956]; metal ion binding [GO:0046872]; protein kinase regulator activity [GO:0019887]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_CSKI2.1.1.m.29327,9.9520730376116e-05,0.00189711896614343,No,NA,NA,Q8VHK2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; protein domain specific binding [GO:0019904]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_CSKP.1.2.m.20832,0.000911539490401918,0.00262690776835469,No,NA,NA,O14936,NA,NA,NA,actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; guanylate kinase activity [GO:0004385]; neurexin family protein binding [GO:0042043]; protein serine/threonine kinase activity [GO:0004674]; calcium ion import [GO:0070509]; cell adhesion [GO:0007155]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of wound healing [GO:0061045]; neurotransmitter secretion [GO:0007269]; positive regulation of calcium ion import [GO:0090280]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_CSN2.1.1.m.28636,0.00569477720207928,-0.0123513808998506,No,NA,NA,Q6IR75,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_CSN3.1.1.m.10996,-0.00230253337341474,-0.00107141272942621,No,NA,NA,Q6P2U9,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CSN4.1.1.m.18561,-0.0015982476328561,-0.00138454842944183,No,NA,NA,O88544,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; synaptic vesicle [GO:0008021]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSN5.1.1.m.52330,0.0010218473904089,-0.00178007642993056,No,NA,NA,Q6PC30,NA,NA,NA,cell junction [GO:0030054]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; NEDD8-specific protease activity [GO:0019784]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; protein deneddylation [GO:0000338]; vestibular receptor cell development [GO:0060118],NA,NA,NA
CHOYP_CSN8.1.1.m.14798,-0.00478979631230429,0.0107399805096326,No,NA,NA,Q6GQA6,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; COP9 signalosome assembly [GO:0010387]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_CSPA_C15740.1.1.m.59258,-0.0149133425565866,0.00854247304634831,No,NA,NA,Q27237,NA,NA,NA,cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; patched binding [GO:0005113]; unfolded protein binding [GO:0051082]; mitochondrion organization [GO:0007005]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein folding [GO:0006457]; response to heat [GO:0009408],NA,NA,NA
CHOYP_CSPP1.11.14.m.54546,-0.00661420030948574,0.00768663558170552,No,NA,NA,Q1MSJ5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; spindle [GO:0005819]; spindle pole [GO:0000922]; positive regulation of cell division [GO:0051781]; positive regulation of cytokinesis [GO:0032467],NA,NA,NA
CHOYP_CSTA.1.3.m.6422,-0.0172006983740578,-0.0109464819855802,No,NA,NA,P80416,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_CSTF3.1.1.m.10636,-0.00351565570362379,0.00197057329069982,No,NA,NA,Q12996,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; RNA 3'-end processing [GO:0031123]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_CTBL1.1.1.m.22983,0.00245602229192461,-0.000901816556272031,No,NA,NA,O62703,NA,NA,NA,nucleus [GO:0005634]; Prp19 complex [GO:0000974]; spliceosomal complex [GO:0005681]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_CTBS.1.1.m.54468,0.00306537133222144,-0.000828350887130988,No,NA,NA,Q8R242,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_CTK2.3.3.m.51999,0.0038007713254149,0.00746181301563177,No,NA,NA,P20480,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; meiotic spindle [GO:0072687]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein homodimerization activity [GO:0042803]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; distributive segregation [GO:0032837]; meiotic spindle organization [GO:0000212]; microtubule bundle formation [GO:0001578]; microtubule-based movement [GO:0007018]; minus-end directed microtubule sliding [GO:0031534]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle elongation [GO:0000022]; mitotic spindle organization [GO:0007052]; mRNA transport [GO:0051028]; regulation of mitotic spindle assembly [GO:1901673]; regulation of mitotic spindle elongation [GO:0032888]; spindle assembly involved in female meiosis [GO:0007056]; spindle assembly involved in meiosis [GO:0090306]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_CTL2.1.2.m.3858,0.000998665843363327,0.000518082511746333,No,NA,NA,Q642H9,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; brain development [GO:0007420]; chordate embryonic development [GO:0043009]; translation [GO:0006412],NA,NA,NA
CHOYP_CTND2.1.1.m.12206,0.000201545692065928,-0.000719030842726859,No,NA,NA,P98203,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell junction assembly [GO:0007043]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_CTR1.2.4.m.39987,0.00921345408707591,-0.0127888691078401,No,NA,NA,Q05609,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cellular response to iron ion [GO:0071281]; ethylene-activated signaling pathway [GO:0009873]; gibberellin biosynthetic process [GO:0009686]; negative regulation of ethylene-activated signaling pathway [GO:0010105]; protein autophosphorylation [GO:0046777]; regulation of post-embryonic root development [GO:2000069]; regulation of stem cell division [GO:2000035]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; response to ethylene [GO:0009723]; response to fructose [GO:0009750]; response to hypoxia [GO:0001666]; response to sucrose [GO:0009744]; sugar mediated signaling pathway [GO:0010182],NA,NA,NA
CHOYP_CTR9.1.1.m.18832,-0.00686659761633544,0.0106497010982021,No,NA,NA,Q4QR29,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; transcriptionally active chromatin [GO:0035327]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_CTRA.1.2.m.26705,-0.00933648006358904,-0.0059417128655048,No,NA,NA,P80646,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_CTRL.1.1.m.48654,0.00193407599908131,0.000702345941097742,No,NA,NA,P35003,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_CTSL2.1.2.m.2936,-0.00269295278241406,-0.0101353646829714,No,NA,NA,Q9GL24,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_CTTN.1.1.m.22042,0.000164083540991947,-0.00021822347747561,No,NA,NA,Q14247,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; actin cytoskeleton reorganization [GO:0031532]; actin filament polymerization [GO:0030041]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; membrane organization [GO:0061024]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of axon extension [GO:0030516]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_CTU2.1.1.m.43200,-0.000138140971797157,0.0183279828095968,No,NA,NA,Q6DC53,NA,NA,NA,cytosol [GO:0005829]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; tRNA binding [GO:0000049]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_CTXA.1.2.m.31637,0.00139399222772124,0.00925090388628713,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CUL1.1.1.m.13087,0.00116515972454656,-0.0021246857607597,No,NA,NA,Q9WTX6,NA,NA,NA,cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUL2.1.1.m.59278,-0.0109116476875978,0.0116597604038869,No,NA,NA,Q9D4H8,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_CUL3B.1.1.m.61643,-0.00344688045545223,0.00285708734684112,No,NA,NA,Q6GPF3,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; polar microtubule [GO:0005827]; ubiquitin protein ligase binding [GO:0031625]; cell migration [GO:0016477]; COPII vesicle coating [GO:0048208]; embryonic cleavage [GO:0040016]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; integrin-mediated signaling pathway [GO:0007229]; mitotic metaphase plate congression [GO:0007080]; negative regulation of Rho protein signal transduction [GO:0035024]; positive regulation of mitotic metaphase/anaphase transition [GO:0045842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; stem cell division [GO:0017145]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_CUL3B.1.1.m.61644,-0.0171593690487641,-0.021517493364816,No,NA,NA,A3RLT6,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_CUL4B.1.1.m.6652,0.00428892476085801,-0.00529908235849302,No,NA,NA,Q13619,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; nucleoplasm [GO:0005654]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin protein ligase binding [GO:0031625]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; G1/S transition of mitotic cell cycle [GO:0000082]; global genome nucleotide-excision repair [GO:0070911]; hemopoiesis [GO:0030097]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; negative regulation of granulocyte differentiation [GO:0030853]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; regulation of DNA damage checkpoint [GO:2000001]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein metabolic process [GO:0051246]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; somatic stem cell population maintenance [GO:0035019]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_CUX1.1.2.m.10448,0.00329612971281229,-0.00489568979137181,No,NA,NA,Q13948,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of Golgi membrane [GO:0030173]; nucleoplasm [GO:0005654]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_CWC22.1.1.m.29270,-0.0036204033630843,0.00524302209175785,No,NA,NA,Q9VJ87,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_CX6A2.1.1.m.47963,-0.000992741358723545,0.00189055947694464,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYB5.1.2.m.2195,-0.000550901105433069,0.00376139856462908,No,NA,NA,P56395,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; organelle membrane [GO:0031090]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; stearoyl-CoA 9-desaturase activity [GO:0004768]; fatty acid metabolic process [GO:0006631]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_CYC.1.5.m.5663,0.00640681679477908,-0.00332097622135937,No,NA,NA,Q6QLW4,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_CYH1.1.1.m.66676,0.0133665249894335,0.0145493333019886,No,NA,NA,Q15438,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; lipid binding [GO:0008289]; establishment of epithelial cell polarity [GO:0090162]; regulation of ARF protein signal transduction [GO:0032012]; regulation of cell adhesion [GO:0030155]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_CYIIB.2.2.m.64544,0.00118870876802089,0.000367345920128969,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_CYIIB.2.2.m.64545,0.00672759957575358,0.0149891361179245,No,NA,NA,Q11212,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_CYPL.1.1.m.25000,0.00476591899986275,-0.00361348007039381,No,NA,NA,Q9D0W5,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_CYT5.1.1.m.29960,0.0109739643791986,-0.0199230414340516,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYT5.1.1.m.29962,0.0025494487959581,-0.00999525778716169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_CYTB.1.6.m.7874,-0.0181737308320731,-0.019239220053733,No,NA,NA,Q6DRC3,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; motile cilium assembly [GO:0044458]; pronephros development [GO:0048793]; pronephros morphogenesis [GO:0072114]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_CZH5ORF51.1.1.m.25147,-0.00347569555268729,0.0047185235012958,No,NA,NA,A8Y5U1,NA,NA,NA,,NA,NA,NA
CHOYP_D39U1.1.1.m.29364,0.000337301896449768,-0.00402583861046759,No,NA,NA,Q17QH8,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_DAB2.1.1.m.22396,0.000750087514661779,0.000409892287874031,No,NA,NA,P98081,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; presynapse [GO:0098793]; sevenless binding [GO:0005118]; SH3 domain binding [GO:0017124]; cellularization [GO:0007349]; clathrin-dependent endocytosis [GO:0072583]; compound eye photoreceptor development [GO:0042051]; dorsal closure [GO:0007391]; motor neuron axon guidance [GO:0008045]; positive regulation of sevenless signaling pathway [GO:0045874]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_DANA_GF10165.1.1.m.59230,-0.00317293583923018,0.000727508532182483,No,NA,NA,Q68FA2,NA,NA,NA,,NA,NA,NA
CHOYP_DANA_GF14191.1.1.m.11942,0.00399235711884059,-6.39162384222901e-06,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF15280.1.2.m.4538,0.0209200613135786,-0.0203430752940268,No,NA,NA,Q5ZHW4,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44177,0.00441616525965017,-0.00434818532971753,No,NA,NA,Q66KY3,NA,NA,NA,response to metal ion [GO:0010038],NA,NA,NA
CHOYP_DANA_GF15955.1.1.m.44178,0.0145808188611678,-0.00427677013430912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF16638.1.1.m.10255,-0.00162285504818241,0.00472608274592059,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DANA_GF18010.1.1.m.6864,0.00059587269516644,0.00137198118359932,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DANA_GF20914.1.1.m.14747,-0.00368977720791224,-0.000870255535277476,No,NA,NA,O76902,NA,NA,NA,apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; metal ion binding [GO:0046872]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_DANA_GF24303.1.1.m.33639,-0.0129978317048416,-0.000661835489409143,No,NA,NA,P17671,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; heme binding [GO:0020037]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; antimicrobial humoral response [GO:0019730]; cell differentiation [GO:0030154]; ecdysis; chitin-based cuticle [GO:0018990]; hormone-mediated signaling pathway [GO:0009755]; molting cycle; chitin-based cuticle [GO:0007591]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oogenesis [GO:0048477]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of ecdysteroid metabolic process [GO:0007553]; regulation of gene expression [GO:0010468]; response to ecdysone [GO:0035075]; response to lipid [GO:0033993],NA,NA,NA
CHOYP_DAR1.2.4.m.29583,-0.0155716071695806,-0.00408591713357185,No,NA,NA,Q9GZT4,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; D-serine ammonia-lyase activity [GO:0008721]; glycine binding [GO:0016594]; L-serine ammonia-lyase activity [GO:0003941]; magnesium ion binding [GO:0000287]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine racemase activity [GO:0030378]; threonine racemase activity [GO:0018114]; aging [GO:0007568]; brain development [GO:0007420]; D-serine biosynthetic process [GO:0070179]; D-serine metabolic process [GO:0070178]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; pyruvate biosynthetic process [GO:0042866]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; serine family amino acid metabolic process [GO:0009069],NA,NA,NA
CHOYP_DARS2.1.1.m.43847,0.00386588676781571,-0.00953804731019291,No,NA,NA,A6QPU5,NA,NA,NA,mitochondrial matrix [GO:0005759]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; mitochondrial asparaginyl-tRNA aminoacylation [GO:0070145],NA,NA,NA
CHOYP_DBP2.2.2.m.55820,0.00814296743533091,-0.00764769054368185,No,NA,NA,Q59LU0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DBT.1.1.m.4866,-0.0083279959160331,0.00557354436002734,No,NA,NA,P11181,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; acetyltransferase activity [GO:0016407]; dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity [GO:0043754]; lipoic acid binding [GO:0031405]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_DC1I2.1.3.m.25743,-0.00786071904454225,0.00678694523465014,No,NA,NA,O88487,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; protein-containing complex binding [GO:0044877]; microtubule-based movement [GO:0007018]; negative regulation of neuron projection development [GO:0010977],NA,NA,NA
CHOYP_DC1I2.2.3.m.54049,0.00503653262737008,-0.00136101496940756,No,NA,NA,Q0III3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; microtubule [GO:0005874]; vesicle [GO:0031982]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DCA15.1.1.m.11376,-0.0078426901141136,-0.00499106862905708,No,NA,NA,A2BDA5,NA,NA,NA,protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCAF7.1.1.m.51583,0.00893964992797253,0.0105574965881152,No,NA,NA,P61963,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; multicellular organism development [GO:0007275]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DCDC2.3.7.m.36589,0.0117299326973831,0.0129673122511706,No,NA,NA,Q5DU00,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605]; visual learning [GO:0008542],NA,NA,NA
CHOYP_DCDC2.7.7.m.46807,-0.0214728478372607,0.0201297475935628,No,NA,NA,Q9UHG0,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinocilium [GO:0060091]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; kinesin binding [GO:0019894]; cellular defense response [GO:0006968]; cilium assembly [GO:0060271]; dendrite morphogenesis [GO:0048813]; intracellular signal transduction [GO:0035556]; neuron migration [GO:0001764]; positive regulation of smoothened signaling pathway [GO:0045880]; regulation of cilium assembly [GO:1902017]; regulation of Wnt signaling pathway [GO:0030111]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_DCNL4.1.2.m.36826,0.0148000252739389,-0.00493594345100672,No,NA,NA,Q8CCA0,NA,NA,NA,nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_DCTN1.2.2.m.40900,-0.00146844107535784,0.000417269974349297,No,NA,NA,Q14203,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; intermediate filament cytoskeleton [GO:0045111]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; spindle [GO:0005819]; spindle pole [GO:0000922]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; tau protein binding [GO:0048156]; tubulin binding [GO:0015631]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; centriole-centriole cohesion [GO:0010457]; ciliary basal body-plasma membrane docking [GO:0097711]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; IRE1-mediated unfolded protein response [GO:0036498]; maintenance of synapse structure [GO:0099558]; microtubule anchoring at centrosome [GO:0034454]; mitotic cell cycle [GO:0000278]; motor behavior [GO:0061744]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; neuromuscular process [GO:0050905]; neuron cellular homeostasis [GO:0070050]; neuron projection maintenance [GO:1990535]; non-motile cilium assembly [GO:1905515]; nuclear envelope disassembly [GO:0051081]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuromuscular junction development [GO:1904398]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport; endosome to Golgi [GO:0042147]; transport along microtubule [GO:0010970]; ventral spinal cord development [GO:0021517],NA,NA,NA
CHOYP_DCTN2.1.1.m.1084,-0.00191361146377794,0.00254513420359666,No,NA,NA,Q99KJ8,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; dynein complex [GO:0030286]; growth cone [GO:0030426]; kinetochore [GO:0000776]; membrane [GO:0016020]; microtubule [GO:0005874]; vesicle [GO:0031982]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein kinase binding [GO:0019901]; spectrin binding [GO:0030507]; cell proliferation [GO:0008283]; melanosome transport [GO:0032402]; mitotic cell cycle [GO:0000278]; mitotic spindle organization [GO:0007052]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_DCTN4.1.1.m.29541,0.00363087433721156,-0.000749694790746645,No,NA,NA,Q9UJW0,NA,NA,NA,cell cortex [GO:0005938]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dynactin complex [GO:0005869]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleus [GO:0005634]; sarcomere [GO:0030017]; spindle pole [GO:0000922]; stress fiber [GO:0001725]; protein N-terminus binding [GO:0047485]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; nuclear migration [GO:0007097],NA,NA,NA
CHOYP_DCUP.1.1.m.7527,-0.00223870520133584,0.00564634795787784,No,NA,NA,P06132,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; uroporphyrinogen decarboxylase activity [GO:0004853]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_DD19A.1.1.m.57641,-0.00130970308388122,-0.00299329436638735,No,NA,NA,Q3ZBV2,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DDB1.1.1.m.59135,-0.00170528954853243,-0.00040058052116069,No,NA,NA,Q805F9,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cullin family protein binding [GO:0097602]; damaged DNA binding [GO:0003684]; protein binding; bridging [GO:0030674]; protein-containing complex binding [GO:0044877]; WD40-repeat domain binding [GO:0071987]; DNA repair [GO:0006281]; histone H2A monoubiquitination [GO:0035518]; interaction with symbiont [GO:0051702]; negative regulation of apoptotic process [GO:0043066]; positive regulation by virus of viral protein levels in host cell [GO:0046726]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral genome replication [GO:0045070]; positive regulation of viral release from host cell [GO:1902188]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of mitotic cell cycle phase transition [GO:1901990]; UV-damage excision repair [GO:0070914]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DDX1.1.1.m.46908,-0.00831476942218346,0.00701789157292024,No,NA,NA,Q90WU3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA/RNA helicase activity [GO:0033677]; exonuclease activity [GO:0004527]; nuclease activity [GO:0004518]; poly(A) binding [GO:0008143]; transcription coregulator activity [GO:0003712]; DNA duplex unwinding [GO:0032508]; double-strand break repair [GO:0006302]; mRNA processing [GO:0006397]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DDX10.1.1.m.17783,0.0170792584484299,0.0120494743595098,No,NA,NA,Q9D7V9,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; transcription factor binding [GO:0008134]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_DDX18.1.2.m.12567,-0.0101932574001763,-0.0108486527037665,No,NA,NA,Q9NVP1,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX18.2.2.m.51768,-0.00984455082986723,-0.0043588649609016,No,NA,NA,Q9NVP1,NA,NA,NA,chromosome [GO:0005694]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cellular response to estradiol stimulus [GO:0071392],NA,NA,NA
CHOYP_DDX21.1.2.m.3695,-0.00489255654453695,-0.00548118794268671,No,NA,NA,Q99MJ9,NA,NA,NA,nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX23.1.1.m.20195,-0.00662962197895505,-0.016739015460241,No,NA,NA,Q9BUQ8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_DDX23.1.1.m.20196,-0.0113069526624666,0.024908384577659,No,NA,NA,Q6DF67,NA,NA,NA,cytoplasm [GO:0005737]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_DDX24.1.1.m.6330,-0.0131433674964954,0.00376665197068032,No,NA,NA,Q9GZR7,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_DDX3Y.1.1.m.3679,-0.00129099327849232,-0.00124486394736969,No,NA,NA,P24346,NA,NA,NA,ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX42.2.2.m.54450,-0.0010460952295427,0.00758266714935116,No,NA,NA,Q7ZY47,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_DDX46.1.1.m.52473,-0.000604524806718264,0.000914240314375654,No,NA,NA,Q4TVV3,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; brain development [GO:0007420]; definitive hemopoiesis [GO:0060216]; digestive tract morphogenesis [GO:0048546]; exocrine pancreas development [GO:0031017]; liver morphogenesis [GO:0072576]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of hematopoietic stem cell differentiation [GO:1902038]; positive regulation of lymphocyte differentiation [GO:0045621],NA,NA,NA
CHOYP_DDX47.1.1.m.11144,-0.0021782675674347,-0.000571020651963457,No,NA,NA,Q9CWX9,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DDX58.1.9.m.822,-0.0187424899632471,-0.00841730136258224,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.7.9.m.58168,-0.0142209772299356,0.000657045826662424,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_DDX58.9.9.m.62757,-0.00267597748086805,-0.0137234743157192,No,NA,NA,O95786,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; negative regulation of type I interferon production [GO:0032480]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; regulation of cell migration [GO:0030334]; regulation of type III interferon production [GO:0034344]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529]; viral process [GO:0016032],NA,NA,NA
CHOYP_DDX58.9.9.m.62758,-0.00517150479362221,-0.00819713035102373,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DECR2.1.2.m.29687,-0.000837114171909675,0.00244255677254438,No,NA,NA,Q6NV34,NA,NA,NA,peroxisome [GO:0005777]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_DEK.1.1.m.40646,0.000782911910224079,0.00903998065280862,No,NA,NA,Q6AXS3,NA,NA,NA,contractile fiber [GO:0043292]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; chromatin organization [GO:0006325]; regulation of double-strand break repair [GO:2000779]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032],NA,NA,NA
CHOYP_DENND4A.1.1.m.342,-0.00197967477051245,-0.00358229427089915,No,NA,NA,Q7Z401,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; DNA binding [GO:0003677]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_DEP1A.1.1.m.50111,0.0159046662994266,-0.00866842516071893,No,NA,NA,Q803Q4,NA,NA,NA,GTPase activator activity [GO:0005096]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44727,-0.00113087167165091,0.0207263308155273,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DERE_GG18317.1.1.m.44730,-0.0202625031330374,-0.012895006976175,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_00978.1.1.m.17875,0.00529647586397517,0.0152364514492747,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFA_05420.1.1.m.25051,-0.000319371005556651,-0.00153856550954314,No,NA,NA,O42646,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_DFA_06569.1.1.m.9782,-0.0345584094834372,-0.0251216845721263,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DFER_5601.1.1.m.49215,0.0144713437891602,0.0275725536137075,No,NA,NA,Q8J0I9,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; glucan endo-1;6-beta-glucosidase activity [GO:0046557]; glucosylceramidase activity [GO:0004348]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; polysaccharide metabolic process [GO:0005976]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_DFPA.1.1.m.29402,-0.00667463000709443,0.00911124565376262,No,NA,NA,Q7SIG4,NA,NA,NA,calcium ion binding [GO:0005509]; diisopropyl-fluorophosphatase activity [GO:0047862],NA,NA,NA
CHOYP_DGKD.2.2.m.9520,0.00277421226736923,0.00906003258246877,No,NA,NA,Q16760,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; diacylglycerol binding [GO:0019992]; diacylglycerol kinase activity [GO:0004143]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; diacylglycerol metabolic process [GO:0046339]; endocytosis [GO:0006897]; epidermal growth factor receptor signaling pathway [GO:0007173]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; multicellular organism development [GO:0007275]; platelet activation [GO:0030168]; protein homooligomerization [GO:0051260]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein transport [GO:0015031]; response to organic substance [GO:0010033]; second-messenger-mediated signaling [GO:0019932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DGKZA.1.2.m.29620,0.00213890262242881,0.00647970089070783,No,NA,NA,O08560,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0090216]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_DGRI_GH10893.1.1.m.27211,-0.0193432992166826,0.0297875400799259,No,NA,NA,Q6DGW9,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium channel activity [GO:0005262]; calcium ion transmembrane transport [GO:0070588]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; ER overload response [GO:0006983],NA,NA,NA
CHOYP_DGRI_GH12278.1.1.m.5056,-0.0111251944468745,-0.01667790708032,No,NA,NA,Q9Y2S2,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640],NA,NA,NA
CHOYP_DGRI_GH13197.1.1.m.35578,0.00455170638034607,-0.00826354375481346,No,NA,NA,O17482,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_DGRI_GH14833.1.1.m.14206,-0.0115911812431842,0.0101535390433201,No,NA,NA,Q9VUJ0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleotide binding [GO:0000166]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH14972.1.1.m.64210,0.00673525099144313,0.00795415815330337,No,NA,NA,P31396,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_DGRI_GH15313.1.1.m.5763,0.0016088267133106,0.000793383248799187,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_DGRI_GH15575.1.1.m.49170,-0.00168509723506328,0.00131343286957651,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DGRI_GH19122.1.1.m.1378,-0.00448238335883786,0.00219783967982803,No,NA,NA,Q2TBK2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DGRI_GH20300.1.1.m.57587,0.00397815097128588,-0.00541580136349898,No,NA,NA,Q63ZH8,NA,NA,NA,,NA,NA,NA
CHOYP_DGRI_GH22804.1.1.m.12160,-0.0101941390986123,-0.00406876274729254,No,NA,NA,Q9HCB6,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954],NA,NA,NA
CHOYP_DGRI_GH22876.2.3.m.54068,0,0,No,NA,NA,Q761V0,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine transmembrane transporter activity [GO:0015187]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; glycine import across plasma membrane [GO:1903804]; glycine transport [GO:0015816]; neurotransmitter reuptake [GO:0098810]; neurotransmitter uptake [GO:0001504]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_DGRI_GH23100.1.1.m.44142,-0.00472263568832301,-0.00593536567771802,No,NA,NA,O60500,NA,NA,NA,cell projection [GO:0042995]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; slit diaphragm [GO:0036057]; myosin binding [GO:0017022]; cell adhesion [GO:0007155]; excretion [GO:0007588]; glomerular basement membrane development [GO:0032836]; glomerular visceral epithelial cell development [GO:0072015]; JNK cascade [GO:0007254]; myoblast fusion [GO:0007520]; positive regulation of actin filament polymerization [GO:0030838]; protein localization to synapse [GO:0035418]; regulation of excretion [GO:0044062]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_DGRI_GH24618.1.2.m.1995,0.00241508174143321,-0.000652624066122612,No,NA,NA,Q7KVW5,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; photoreceptor activity [GO:0009881]; small conductance calcium-activated potassium channel activity [GO:0016286]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of membrane potential in photoreceptor cell [GO:0016057],NA,NA,NA
CHOYP_DHB12.1.1.m.62534,0.00680998442468282,-0.0123634082606809,No,NA,NA,Q28IU1,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; 3-oxo-arachidoyl-CoA reductase activity [GO:0102339]; 3-oxo-behenoyl-CoA reductase activity [GO:0102340]; 3-oxo-cerotoyl-CoA reductase activity [GO:0102342]; 3-oxo-lignoceroyl-CoA reductase activity [GO:0102341]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; estrogen biosynthetic process [GO:0006703]; fatty acid biosynthetic process [GO:0006633],NA,NA,NA
CHOYP_DHB14.1.1.m.13441,0.0146159505878211,-0.0228234923808111,No,NA,NA,Q9MYP6,NA,NA,NA,cytosol [GO:0005829]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; identical protein binding [GO:0042802]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; steroid catabolic process [GO:0006706],NA,NA,NA
CHOYP_DHB4.1.2.m.13985,0.00447904339004759,0.00126968901292651,No,NA,NA,P51659,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; isomerase activity [GO:0016853]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; alpha-linolenic acid metabolic process [GO:0036109]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; protein targeting to peroxisome [GO:0006625]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111],NA,NA,NA
CHOYP_DHB4.2.2.m.19618,-0.00081311588406359,0.0164590798250073,No,NA,NA,P97852,NA,NA,NA,peroxisome [GO:0005777]; 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxyacyl-CoA dehydratase activity [GO:0018812]; 3alpha;7alpha;12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity [GO:0033989]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; isomerase activity [GO:0016853]; protein homodimerization activity [GO:0042803]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; aging [GO:0007568]; cellular response to organic cyclic compound [GO:0071407]; cholesterol metabolic process [GO:0008203]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_DHC6.1.1.m.22887,-0.0201647194034112,-0.0128327776520186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHE4.1.1.m.48536,-0.00154538186613369,-0.00030057279135973,No,NA,NA,P00367,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; glutamate dehydrogenase (NAD+) activity [GO:0004352]; glutamate dehydrogenase [NAD(P)+] activity [GO:0004353]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; leucine binding [GO:0070728]; NAD+ binding [GO:0070403]; cellular amino acid biosynthetic process [GO:0008652]; glutamate biosynthetic process [GO:0006537]; glutamate catabolic process [GO:0006538]; glutamine metabolic process [GO:0006541]; positive regulation of insulin secretion [GO:0032024]; substantia nigra development [GO:0021762]; tricarboxylic acid metabolic process [GO:0072350],NA,NA,NA
CHOYP_DHPS.1.1.m.55870,-0.0105710575670223,0.0178410644044232,No,NA,NA,P49366,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; deoxyhypusine synthase activity [GO:0034038]; identical protein binding [GO:0042802]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612]; positive regulation of cell proliferation [GO:0008284]; spermidine metabolic process [GO:0008216]; translation [GO:0006412],NA,NA,NA
CHOYP_DHR.1.1.1.m.43819,0.00661649415847633,-0.0120121300482216,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DHR11.2.2.m.36445,-0.0144827964635897,-0.0092168159188591,No,NA,NA,Q71R50,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_DHSAB.1.1.m.25026,-0.00143483118545924,0.000717389186819532,No,NA,NA,Q801S2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; flavin adenine dinucleotide binding [GO:0050660]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; electron transport chain [GO:0022900]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSB.1.1.m.3993,-0.00386588040352418,0.00224703640081362,No,NA,NA,P21912,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 3 iron; 4 sulfur cluster binding [GO:0051538]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (ubiquinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]; aerobic respiration [GO:0009060]; respiratory electron transport chain [GO:0022904]; succinate metabolic process [GO:0006105]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_DHSO.1.2.m.5409,-0.0185411789835019,0.00354440035243299,No,NA,NA,P27867,NA,NA,NA,extracellular exosome [GO:0070062]; mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; identical protein binding [GO:0042802]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; flagellated sperm motility [GO:0030317]; fructose biosynthetic process [GO:0046370]; L-xylitol catabolic process [GO:0051160]; response to cadmium ion [GO:0046686]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient levels [GO:0031667]; response to osmotic stress [GO:0006970]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHSO.2.2.m.29745,0.00776984431319256,0.00346160254128806,No,NA,NA,P0DMQ6,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_DHTK1.1.1.m.8425,0.0126998534325456,-0.0062356677995817,No,NA,NA,Q5EAR5,NA,NA,NA,tRNA 2'-phosphotransferase activity [GO:0000215]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_DHX15.2.2.m.62441,-0.00185527793925878,-0.000643162487281873,No,NA,NA,O43143,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to alkaloid [GO:0043279]; response to toxic substance [GO:0009636]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_DHX57.2.2.m.45703,0.00782999996931591,-0.0142152287383947,No,NA,NA,Q9R0X0,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; skeletal muscle cell differentiation [GO:0035914],NA,NA,NA
CHOYP_DHX8.2.3.m.55112,-0.0155061624844581,0.0168028062949689,No,NA,NA,Q14562,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; spliceosomal complex disassembly [GO:0000390],NA,NA,NA
CHOYP_DHX8.2.3.m.55114,-0.000580856703622495,-0.000520729553224305,No,NA,NA,P38542,NA,NA,NA,nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nucleocytoplasmic transport [GO:0006913]; protein transport [GO:0015031],NA,NA,NA
CHOYP_DI3L2.1.1.m.61980,0.00553162596915371,-0.0155925960658825,No,NA,NA,Q0V9R3,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_DIAP2.1.1.m.25706,0.0109433381190649,0.0073419812666254,No,NA,NA,Q9Z207,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DIAPH1.1.1.m.55416,0.0208782501079342,0.00787298888576816,No,NA,NA,O70566,NA,NA,NA,actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin filament polymerization [GO:0030041]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_DICER.1.3.m.9936,-0.00210527226519113,0.00285806869714182,No,NA,NA,Q9VCU9,NA,NA,NA,cytoplasm [GO:0005737]; micro-ribonucleoprotein complex [GO:0035068]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; bidentate ribonuclease III activity [GO:0016443]; deoxyribonuclease I activity [GO:0004530]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; pre-miRNA binding [GO:0070883]; ribonuclease III activity [GO:0004525]; single-stranded RNA binding [GO:0003727]; apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; mitotic cell cycle; embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; production of siRNA involved in RNA interference [GO:0030422]; response to starvation [GO:0042594]; RNA interference [GO:0016246]; segment polarity determination [GO:0007367]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_DICPUDRAFT_147269.1.1.m.34818,-0.00615067622700381,0.0110229693117789,No,NA,NA,Q54P70,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_DICPUDRAFT_81027.1.1.m.5425,0.00419403100453661,-7.55037614591538e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DICPUDRAFT_93011.1.1.m.30650,-0.0321406189419892,-0.0204542105560384,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_DIS3.1.1.m.6724,-0.000834588600976806,-0.0135516006998028,No,NA,NA,Q9CSH3,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; endonuclease activity [GO:0004519]; guanyl-nucleotide exchange factor activity [GO:0005085]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_DJC13.1.1.m.46117,-0.000858897375741749,0.00238298197266579,No,NA,NA,O75165,NA,NA,NA,azurophil granule membrane [GO:0035577]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; endosome organization [GO:0007032]; neutrophil degranulation [GO:0043312]; osteoblast differentiation [GO:0001649]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of early endosome to recycling endosome transport [GO:1902954],NA,NA,NA
CHOYP_DKC1.1.1.m.10978,0.000924412235261288,0.00193971031528183,No,NA,NA,Q9ESX5,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; box H/ACA snoRNA metabolic process [GO:0033979]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of cell proliferation [GO:0008284]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA pseudouridine synthesis [GO:0031118]; scaRNA localization to Cajal body [GO:0090666]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; snRNA pseudouridine synthesis [GO:0031120]; telomerase RNA stabilization [GO:0090669]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_DLAT.1.1.m.64812,0.000144667665726064,-0.000107619588634717,No,NA,NA,Q19749,NA,NA,NA,mitochondrial matrix [GO:0005759]; pyruvate dehydrogenase complex [GO:0045254]; dihydrolipoyllysine-residue acetyltransferase activity [GO:0004742]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_DLDH.1.1.m.31018,-0.000475782018127703,-0.00130752374357091,No,NA,NA,P09623,NA,NA,NA,acrosomal vesicle [GO:0001669]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyl dehydrogenase activity [GO:0004148]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; cell redox homeostasis [GO:0045454]; histone succinylation [GO:0106077],NA,NA,NA
CHOYP_DLGP1.3.3.m.44296,0.00289706322446508,0.00125917602917433,No,NA,NA,O14490,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_DLL1.1.1.m.4589,0.00283944492036799,-0.000767299117735891,No,NA,NA,P78504,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198]; angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; glomerular visceral epithelial cell development [GO:0072015]; hemopoiesis [GO:0030097]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell proliferation [GO:0042127]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],NA,NA,NA
CHOYP_DLL4.1.1.m.40197,0.0170644517402119,0.00731724858999203,No,NA,NA,D3ZHH1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; Notch binding [GO:0005112]; blood vessel lumenization [GO:0072554]; blood vessel remodeling [GO:0001974]; branching involved in blood vessel morphogenesis [GO:0001569]; cardiac atrium morphogenesis [GO:0003209]; dorsal aorta morphogenesis [GO:0035912]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; pericardium morphogenesis [GO:0003344]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of neural retina development [GO:0061074]; regulation of neurogenesis [GO:0050767]; T cell differentiation [GO:0030217]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DLP.1.1.m.31353,0.000166250466856742,0.00251603754052856,No,NA,NA,Q5GN48,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; actin filament binding [GO:0051015]; dystroglycan binding [GO:0002162]; zinc ion binding [GO:0008270]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639],NA,NA,NA
CHOYP_DLP1.1.1.m.40279,-0.0135149997315375,0.00747393031760114,No,NA,NA,Q86YH6,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; transferase complex [GO:1990234]; protein heterodimerization activity [GO:0046982]; trans-hexaprenyltranstransferase activity [GO:0000010]; trans-octaprenyltranstransferase activity [GO:0050347]; isoprenoid biosynthetic process [GO:0008299]; protein heterotetramerization [GO:0051290]; regulation of body fluid levels [GO:0050878]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_DMBT1.11.34.m.22620,0.00748632225580261,-0.00487617254212361,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_DMBT1.13.34.m.27666,0.00499159391606053,0.00213603427320658,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_DMBT1.15.34.m.29008,-0.0236859088371299,0.0222245943121369,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_DMBT1.3.34.m.3602,0.00229135144941611,-0.000280104393744531,No,NA,NA,Q86VB7,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; acute-phase response [GO:0006953]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_DMOJ_GI11203.1.1.m.24977,-0.00412494443625592,0.000637324581130234,No,NA,NA,Q9VXK0,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_DMOJ_GI12418.1.1.m.49398,-0.00724039512403689,-0.00762827250613322,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.1.3.m.5732,0.00727281112338793,-0.0132036620811294,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI12939.2.3.m.20888,0.0046855911185337,0.00553356257188939,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17052.1.1.m.4566,-0.00226227158119879,0.00307120731962467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI17690.1.1.m.48369,-0.00525359567988435,0.0148626577672645,No,NA,NA,B7YZV4,NA,NA,NA,extracellular space [GO:0005615]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; calcium- and calmodulin-regulated 3';5'-cyclic-GMP phosphodiesterase activity [GO:0048101]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; male mating behavior [GO:0060179]; multicellular organism reproduction [GO:0032504]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8902,-0.0031913270875927,0.0257980772746413,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18492.1.1.m.8903,0.0231158712506081,-0.00498734201762121,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_DMOJ_GI18925.1.1.m.37775,-0.00427175517485609,-0.000851397731184672,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_DMOJ_GI19977.1.1.m.66449,0.00660185401250187,0.00779661975287557,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.1.2.m.12269,-0.0119369700444571,-0.00759665827005807,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DMOJ_GI23261.2.2.m.30988,-0.0265610994845075,-0.0169034181462584,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAH12.2.3.m.32353,-0.000330278376650978,0.00455007084134847,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH12.3.3.m.63246,-0.0138782323462891,0.00438577510128446,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH5.1.2.m.56799,0.0120917112863306,-0.00960361793192435,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH5.2.2.m.61452,-0.00796032370946922,0.0013996949543273,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNAH6.2.3.m.21512,-0.0148991486637633,0.00254937988211539,No,NA,NA,Q9C0G6,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.1.2.m.19685,-0.0101514419224119,0.000536867698344002,No,NA,NA,Q63170,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAH7.2.2.m.46648,-0.00907983880894172,0.00410581449538264,No,NA,NA,Q8WXX0,NA,NA,NA,axonemal dynein complex [GO:0005858]; cilium [GO:0005929]; cytosol [GO:0005829]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; calcium ion binding [GO:0005509]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DNAJ.11.1.1.m.18882,0.00262614496456931,0.000982926664834752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DNAJB6B.1.2.m.1265,0.00555836696964297,0.00656428839946833,No,NA,NA,O35723,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_DNAL1.1.1.m.11822,1.85893106543998e-05,-0.00542360693883908,No,NA,NA,Q05A62,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; alpha-tubulin binding [GO:0043014]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DNER.1.1.m.28378,-0.0060778791487754,0.00825118747220513,No,NA,NA,Q07008,NA,NA,NA,acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoskeleton [GO:0005856]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle [GO:0001726]; calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; Notch binding [GO:0005112]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transmembrane signaling receptor activity [GO:0004888]; animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; auditory receptor cell fate commitment [GO:0009912]; axonogenesis [GO:0007409]; brain development [GO:0007420]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell proliferation [GO:0060038]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac vascular smooth muscle cell development [GO:0060948]; cell cycle arrest [GO:0007050]; cell differentiation in spinal cord [GO:0021515]; cell fate specification [GO:0001708]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart looping [GO:0001947]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; interleukin-4 secretion [GO:0072602]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of growth rate [GO:0045967]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell differentiation [GO:0045687]; positive regulation of JAK-STAT cascade [GO:0046427]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; pulmonary valve morphogenesis [GO:0003184]; regulation of cardioblast proliferation [GO:0003264]; regulation of cell proliferation [GO:0042127]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003256]; response to corticosteroid [GO:0031960]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; tissue regeneration [GO:0042246]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_DNJA2.2.2.m.51791,0.0038577853320202,-0.00217429617401166,No,NA,NA,Q2HJ94,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026]; response to heat [GO:0009408],NA,NA,NA
CHOYP_DNJA3.1.1.m.15026,-0.0234304468571949,0.00913604545324794,No,NA,NA,Q96EY1,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_DNJC2.1.1.m.8941,-0.00152195599468629,0.00163273843552953,No,NA,NA,Q7TQ20,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; ubiquitin modification-dependent histone binding [GO:0061649]; chromatin organization [GO:0006325]; negative regulation of cell growth [GO:0030308]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_DNJC3.1.1.m.52309,-0.00469669422761838,-0.00031782731323473,No,NA,NA,Q27968,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; chaperone binding [GO:0051087]; misfolded protein binding [GO:0051787]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; unfolded protein binding [GO:0051082]; cellular response to cold [GO:0070417]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of translation initiation in response to endoplasmic reticulum stress [GO:0036494]; protein folding in endoplasmic reticulum [GO:0034975]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_DNJC5.1.1.m.52453,-0.00370911497457107,0.00503540828338378,No,NA,NA,P56101,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_DNJC7.1.1.m.8987,-0.00518671653926154,-0.00339287115327755,No,NA,NA,Q99615,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATPase activator activity [GO:0001671]; heat shock protein binding [GO:0031072]; chaperone cofactor-dependent protein refolding [GO:0051085]; protein folding [GO:0006457]; regulation of cellular response to heat [GO:1900034],NA,NA,NA
CHOYP_DNJC9.1.1.m.12688,-0.0062871835205217,0.0260692595378456,No,NA,NA,Q91WN1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; heat shock protein binding [GO:0031072]; positive regulation of ATPase activity [GO:0032781]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DNLI1.1.2.m.19123,0,0,No,NA,NA,P51892,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DNMT1.1.1.m.54990,-0.0040381899668207,0.000340251910687828,No,NA,NA,Q92072,NA,NA,NA,nucleus [GO:0005634]; DNA (cytosine-5-)-methyltransferase activity [GO:0003886]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; zinc ion binding [GO:0008270]; DNA methylation on cytosine within a CG sequence [GO:0010424]; maintenance of DNA methylation [GO:0010216]; positive regulation of methylation-dependent chromatin silencing [GO:0090309]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_DNPH1.1.1.m.28418,-0.00135590869286269,-0.000583484429742696,No,NA,NA,Q80VJ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; deoxyribonucleoside 5'-monophosphate N-glycosidase activity [GO:0070694]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; deoxyribonucleoside monophosphate catabolic process [GO:0009159]; epithelial cell differentiation [GO:0030855]; nucleoside metabolic process [GO:0009116]; nucleotide metabolic process [GO:0009117]; positive regulation of cell growth [GO:0030307],NA,NA,NA
CHOYP_DOCK1.2.2.m.61345,-0.000424380935532624,-0.00154569602088809,No,NA,NA,Q14185,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor complex [GO:0032045]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; phagocytosis; engulfment [GO:0006911]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_DOCK3.1.2.m.49353,-0.00155218412951528,0.00653524872836476,No,NA,NA,Q8N1I0,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; PDZ domain binding [GO:0030165]; Rac GTPase binding [GO:0048365]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; cell chemotaxis [GO:0060326]; negative regulation of vascular smooth muscle contraction [GO:1904694]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK7.1.3.m.1197,0.0108897475495565,0.0170191170293309,No,NA,NA,Q96N67,NA,NA,NA,axon [GO:0030424]; basal part of cell [GO:0045178]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; neuron projection [GO:0043005]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rac GTPase binding [GO:0048365]; activation of GTPase activity [GO:0090630]; axonogenesis [GO:0007409]; establishment of neuroblast polarity [GO:0045200]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of cold-induced thermogenesis [GO:0120163]; neuron projection development [GO:0031175]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of neurogenesis [GO:0050767]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOCK9.1.2.m.7649,-0.00328460142194647,0.0109846310171031,No,NA,NA,Q9BZ29,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; membrane [GO:0016020]; cadherin binding [GO:0045296]; guanyl-nucleotide exchange factor activity [GO:0005085]; blood coagulation [GO:0007596]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_DOME.2.2.m.62360,-0.00143182299536094,0.00346132817644463,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DP13A.2.3.m.10746,-0.00456700188280151,-0.00431053447983798,No,NA,NA,Q9UKG1,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; vesicle membrane [GO:0012506]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; insulin receptor signaling pathway [GO:0008286]; regulation of glucose import [GO:0046324]; regulation of protein localization to plasma membrane [GO:1903076]; signal transduction [GO:0007165]; signaling [GO:0023052],NA,NA,NA
CHOYP_DPER_GL17438.1.1.m.11680,0.00794379468773884,-0.000468432462704193,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_DPER_GL17448.1.1.m.54836,-0.00345113575733964,-0.000629114962791519,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_DPER_GL24378.1.1.m.64285,0.00702500722568234,-0.00232183000773557,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.1.2.m.885,0.00398643964106734,0.00366082212260845,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPER_GL26275.2.2.m.17886,-0.000222816739406091,0.00283680524168852,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPF2.1.2.m.6678,-5.19930527333637e-05,-0.003184837186841,No,NA,NA,Q61103,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; H3K9me3 modified histone binding [GO:0062072]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; apoptotic process [GO:0006915]; negative regulation of myeloid progenitor cell differentiation [GO:1905454]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_DPOLB.1.1.m.15375,0.000115106279969082,0.00244960505683207,No,NA,NA,O57383,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; lyase activity [GO:0016829]; metal ion binding [GO:0046872]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_DPOLZ.1.1.m.49299,-0.00124147502913695,0.00168539764558073,No,NA,NA,Q61493,NA,NA,NA,nucleolus [GO:0005730]; zeta DNA polymerase complex [GO:0016035]; 4 iron; 4 sulfur cluster binding [GO:0051539]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; error-prone translesion synthesis [GO:0042276]; nucleic acid phosphodiester bond hydrolysis [GO:0090305],NA,NA,NA
CHOYP_DPSE_GA10675.1.1.m.23860,0.0130068334217576,-0.0183489905971147,No,NA,NA,Q23023,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagophore assembly site [GO:0000407]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; apoptotic cell clearance [GO:0043277]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; dauer larval development [GO:0040024]; determination of adult lifespan [GO:0008340]; embryo development ending in birth or egg hatching [GO:0009792]; nematode male tail tip morphogenesis [GO:0045138]; programmed cell death [GO:0012501]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of cell size [GO:0008361]; regulation of multicellular organism growth [GO:0040014]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_DPSE_GA15574.1.1.m.62967,-0.000766637593253328,0.000686312450340902,No,NA,NA,Q9NFT7,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucose binding [GO:0005536]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; cellular glucose homeostasis [GO:0001678]; fructose metabolic process [GO:0006000]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_DPSE_GA16367.1.1.m.22618,-0.000514858326399894,0.000216113231796596,No,NA,NA,B5X4E0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_DPSE_GA17283.3.3.m.59446,-4.22599662344846e-05,0.0140402042153275,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DPSE_GA19599.1.1.m.64309,-0.00117813537765663,0.0037943360384715,No,NA,NA,P58365,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; stereocilium [GO:0032420]; calcium ion binding [GO:0005509]; protein N-terminus binding [GO:0047485]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_DPSE_GA25136.1.1.m.66680,0,0,No,NA,NA,Q8MRC9,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; multicellular organism reproduction [GO:0032504]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_DPSE_GA27121.1.1.m.6089,0.00735336186505864,0.00430865279613676,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA28568.3.9.m.19206,-0.00460103360382679,-0.0127826128268557,No,NA,NA,Q8TCU4,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922]; alpha-actinin binding [GO:0051393]; ciliary basal body-plasma membrane docking [GO:0097711]; endosomal transport [GO:0016197]; G2/M transition of mitotic cell cycle [GO:0000086]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of centriole replication [GO:0046599]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of stress fiber assembly [GO:0051492],NA,NA,NA
CHOYP_DPSE_GA28568.5.9.m.33670,-0.00473247575521203,0.00271800137536837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DPSE_GA30097.1.1.m.24050,-0.00131824979511217,0.00112910375540663,No,NA,NA,Q5R8Z6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_DPSE_GA30464.1.1.m.65390,-0.00451463701410217,0.00469514067821813,No,NA,NA,Q3T094,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; hydrolase activity; acting on ester bonds [GO:0016788]; iron ion binding [GO:0005506]; sulfur dioxygenase activity [GO:0050313]; glutathione metabolic process [GO:0006749]; hydrogen sulfide metabolic process [GO:0070813],NA,NA,NA
CHOYP_DPY19L3.1.1.m.7532,-0.000116441261016595,0.0103316815979552,No,NA,NA,Q71B07,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; mannosyltransferase activity [GO:0000030]; protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan [GO:0018406],NA,NA,NA
CHOYP_DRE2.2.2.m.41479,-0.00316278696711888,-0.00186891357548128,No,NA,NA,Q5EAC7,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial intermembrane space [GO:0005758]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; apoptotic process [GO:0006915]; hemopoiesis [GO:0030097]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_DRG1.1.1.m.28901,-0.00379079340434869,0.00219176680455947,No,NA,NA,P32234,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_DRG2.1.1.m.14009,-0.00173254121277162,0.00667123090019168,No,NA,NA,P55039,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; cytoplasmic translation [GO:0002181]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_DRPR.1.2.m.58255,-0.00264189037066822,0.00358656896522681,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DRPR.2.2.m.62931,-0.00721069335554756,0.00209385903872237,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_DS.1.1.m.62106,-0.000900960283784734,0.00457388810415628,No,NA,NA,Q24292,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of hippo signaling [GO:0035331]; peptide cross-linking [GO:0018149]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_DSCAM.3.3.m.65848,-0.000703838860226651,-0.0157761872316689,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSEC_GM10209.1.1.m.49171,0.00658843987504531,-0.0119611979846677,No,NA,NA,P27701,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_DSEC_GM12928.1.1.m.11933,0.00525928233694656,0.0308652606973719,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSEC_GM16292.1.1.m.12184,-0.00996842936756663,0.00964727716868543,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DSEC_GM19691.1.1.m.30070,0.0006671760421719,0.00121256547022451,No,NA,NA,P19803,NA,NA,NA,cytosol [GO:0005829]; immunological synapse [GO:0001772]; membrane [GO:0016020]; nucleus [GO:0005634]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; Rho GDP-dissociation inhibitor activity [GO:0005094]; regulation of protein localization [GO:0032880]; Rho protein signal transduction [GO:0007266]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_DSEC_GM21767.1.1.m.63020,0.0227645172993579,0.0131489483509161,No,NA,NA,O16011,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DSIM_GD11682.1.1.m.30804,0.00218289279521025,-0.0063223692237131,No,NA,NA,Q8WTC1,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; regulation of growth [GO:0040008]; translation [GO:0006412],NA,NA,NA
CHOYP_DSIM_GD13062.1.1.m.3175,0.0018691416296961,-0.00913933538337385,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_DSIM_GD13354.1.1.m.6235,-0.00587500634525201,-0.00507384247584165,No,NA,NA,O75489,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_DSIM_GD25210.1.1.m.29275,0,0,No,NA,NA,Q5XIS2,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; plasma membrane [GO:0005886]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; ceramide 1-phosphate transport [GO:1902389]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009]; negative regulation of autophagy [GO:0010507]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226],NA,NA,NA
CHOYP_DSPP.5.8.m.37255,0.00234343016301024,-0.00425445669606493,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_DSPP.6.8.m.47723,-0.00248723709037896,0.000184003566570495,No,NA,NA,Q80WT5,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; trans-Golgi network membrane [GO:0032588]; clathrin binding [GO:0030276]; protein transporter activity [GO:0008565]; intracellular transport [GO:0046907],NA,NA,NA
CHOYP_DSPP.8.8.m.65419,0.00604422349142096,0.00108627443767607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DSRAD.1.4.m.4228,-0.0131334230031576,-0.00629947599778705,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.2.4.m.5410,0.0051453936058647,0.00607657748078582,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_DSRAD.3.4.m.24850,0.00908335442854555,-0.017678685237413,No,NA,NA,Q99MU3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; left-handed Z-DNA binding [GO:0003692]; metal ion binding [GO:0046872]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; definitive hemopoiesis [GO:0060216]; erythrocyte differentiation [GO:0030218]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell homeostasis [GO:0061484]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of RNA interference [GO:1900369]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; negative regulation of viral genome replication [GO:0045071]; osteoblast differentiation [GO:0001649]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; somatic diversification of immune receptors via somatic mutation [GO:0002566],NA,NA,NA
CHOYP_DTNBP1.1.1.m.66644,0.00823816518034392,-0.00429152260764083,No,NA,NA,Q96EV8,NA,NA,NA,axon [GO:0030424]; axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome membrane [GO:0033162]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle membrane [GO:0030672]; actin cytoskeleton reorganization [GO:0031532]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; dendrite morphogenesis [GO:0048813]; melanosome organization [GO:0032438]; negative regulation of protein binding [GO:0032091]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; neuron projection development [GO:0031175]; neuron projection morphogenesis [GO:0048812]; platelet dense granule organization [GO:0060155]; positive regulation of gene expression [GO:0010628]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dopamine receptor signaling pathway [GO:0060159]; regulation of dopamine secretion [GO:0014059]; regulation of JUN kinase activity [GO:0043506]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_DTX3.3.3.m.64703,0.000517633926420339,0.00264146548612264,No,NA,NA,Q5REG4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_DTX3L.2.4.m.51200,0.00586304638225213,0.00692410694773442,No,NA,NA,Q3UIR3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_DUOX1.1.4.m.14284,-0.00984239887237678,0.00392638213987439,No,NA,NA,Q58EK5,NA,NA,NA,cytoplasm [GO:0005737]; P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; piRNA binding [GO:0034584]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; P granule organization [GO:0030719]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_DUOX1.1.4.m.14285,-0.00302323643418042,-0.000785305811267461,No,NA,NA,Q8HZK2,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.2.4.m.33964,-0.00225182901398745,0.000188496426650179,No,NA,NA,Q8HZK2,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; oxidation-reduction process [GO:0055114]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590],NA,NA,NA
CHOYP_DUOX1.3.4.m.34160,-0.000106034109044419,0.0128654389383716,No,NA,NA,Q9VQH2,NA,NA,NA,endomembrane system [GO:0012505]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; heme binding [GO:0020037]; NAD(P)H oxidase activity [GO:0016174]; peroxidase activity [GO:0004601]; adult chitin-based cuticle development [GO:0008365]; adult chitin-containing cuticle pigmentation [GO:0048085]; cuticle development [GO:0042335]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; hydrogen peroxide biosynthetic process [GO:0050665]; hydrogen peroxide catabolic process [GO:0042744]; imaginal disc-derived wing morphogenesis [GO:0007476]; mucosal immune response [GO:0002385]; negative regulation of apoptotic process [GO:0043066]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591]; response to oxidative stress [GO:0006979]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_DUOX1.4.4.m.44613,-0.00255296338350071,0.00653659889629897,No,NA,NA,Q01105,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_DVIR_GJ11008.1.1.m.11917,-0.000656253942100804,0.00143012455720156,No,NA,NA,P20073,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; RNA binding [GO:0003723]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; membrane fusion [GO:0061025]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to organic cyclic compound [GO:0014070]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_DVIR_GJ11267.1.1.m.29991,-0.0045552178845025,-0.00136507441888518,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_DVIR_GJ13593.1.1.m.18124,-0.0269348259827653,0.00713249923047608,No,NA,NA,P37193,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; positive regulation of ecdysteroid biosynthetic process [GO:0045998],NA,NA,NA
CHOYP_DVIR_GJ14588.1.1.m.25420,-0.00781902708846951,-0.0227210169357463,No,NA,NA,Q8IZ73,NA,NA,NA,pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; enzyme-directed rRNA pseudouridine synthesis [GO:0000455],NA,NA,NA
CHOYP_DVIR_GJ17679.2.3.m.46443,0.00183586746182745,0.00474905651973428,No,NA,NA,A2RU49,NA,NA,NA,mitochondrial matrix [GO:0005759]; hydroxylysine kinase activity [GO:0047992]; lysine catabolic process [GO:0006554],NA,NA,NA
CHOYP_DVIR_GJ21252.1.1.m.10086,-4.51485677624165e-05,-0.00115813051446779,No,NA,NA,P80311,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_DVIR_GJ22204.1.1.m.17270,0.0026372167020623,0.00357152401335328,No,NA,NA,Q642M9,NA,NA,NA,D-xylose 1-dehydrogenase (NADP+) activity [GO:0047837]; trans-1;2-dihydrobenzene-1;2-diol dehydrogenase activity [GO:0047115],NA,NA,NA
CHOYP_DVIR_GJ23521.1.1.m.2757,-0.00218471276205302,0.000388485245797657,No,NA,NA,P0C1H5,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_DVL.2.2.m.40553,-0.00526058792186032,0.0162770346271607,No,NA,NA,Q6DKE2,NA,NA,NA,cytoplasm [GO:0005737]; beta-catenin binding [GO:0008013]; ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; multicellular organism development [GO:0007275]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_DWIL_GK10341.1.1.m.21304,-0.0231057326086906,-0.0003072733403449,No,NA,NA,Q3ZBX6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK10525.1.1.m.56074,0.00296502638044017,-0.00127493391048817,No,NA,NA,P15330,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; subsynaptic reticulum [GO:0071212]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; high mobility group box 1 binding [GO:0070379]; identical protein binding [GO:0042802]; repressing transcription factor binding [GO:0070491]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; defense response [GO:0006952]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; ectodermal cell fate specification [GO:0001715]; gastrulation involving germ band extension [GO:0010004]; germ cell migration [GO:0008354]; heart development [GO:0007507]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; immune response [GO:0006955]; inflammatory response [GO:0006954]; melanization defense response [GO:0035006]; mesoderm development [GO:0007498]; mesodermal cell fate specification [GO:0007501]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; NIK/NF-kappaB signaling [GO:0038061]; peripheral nervous system neuron development [GO:0048935]; plasmatocyte differentiation [GO:0042387]; positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria [GO:0006964]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of hemocyte proliferation [GO:0035206]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; Toll signaling pathway [GO:0008063]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_DWIL_GK11849.1.1.m.12344,-0.00820745319344975,-0.014559329144594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK12566.1.1.m.26720,-0.021898156242036,-0.0139359325771561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DWIL_GK15715.1.1.m.52399,-0.0137715824212597,-0.0016382329322002,No,NA,NA,Q924N4,NA,NA,NA,axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; integral component of plasma membrane [GO:0005887]; potassium ion transmembrane transporter activity [GO:0015079]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901]; cell volume homeostasis [GO:0006884]; cellular hypotonic response [GO:0071476]; cellular hypotonic salinity response [GO:0071477]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; ion transport [GO:0006811]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573],NA,NA,NA
CHOYP_DWIL_GK17319.1.1.m.58968,-0.00183364102912675,-0.00679967016908635,No,NA,NA,Q90879,NA,NA,NA,nucleus [GO:0005634]; ubiquitin conjugating enzyme activity [GO:0061631]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_DWIL_GK23042.1.1.m.38792,0.00188019725251296,0.023332777703371,No,NA,NA,Q92539,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634]; phosphatidate phosphatase activity [GO:0008195]; transcription coactivator activity [GO:0003713]; cellular response to insulin stimulus [GO:0032869]; fatty acid catabolic process [GO:0009062]; lipid metabolic process [GO:0006629]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of transcription by RNA polymerase II [GO:0045944]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_DWIL_GK24328.1.1.m.16490,0.0183892814419818,-0.00288201362936267,No,NA,NA,Q32PI6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_DWIL_GK25045.1.2.m.9225,0.00217027067253334,-0.000959520461053784,No,NA,NA,Q8WQA4,NA,NA,NA,apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; chloride channel complex [GO:0034707]; integral component of plasma membrane [GO:0005887]; lysosome [GO:0005764]; nucleus [GO:0005634]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; epithelial cell development [GO:0002064]; regulation of ion transmembrane transport [GO:0034765]; regulation of tube size [GO:0035150],NA,NA,NA
CHOYP_DWIL_GK25256.1.1.m.7275,-0.00726645109074024,0.0214460997547849,No,NA,NA,Q8MV48,NA,NA,NA,endomembrane system [GO:0012505]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; oligosaccharide biosynthetic process [GO:0009312]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_DX39B.2.3.m.18241,-0.000587640008230328,0.00182998965120681,No,NA,NA,Q5RE47,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_DYAK_GE11656.1.2.m.34706,0.00353515929194515,-0.000955301011936448,No,NA,NA,O16011,NA,NA,NA,cytoplasm [GO:0005737]; H zone [GO:0031673]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; compound eye photoreceptor cell differentiation [GO:0001751]; eye development [GO:0001654]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of female receptivity [GO:0045924]; regulation of gene expression [GO:0010468]; response to stimulus [GO:0050896]; rhabdomere development [GO:0042052]; visual perception [GO:0007601],NA,NA,NA
CHOYP_DYAK_GE21870.1.1.m.28467,-0.00963950962734999,-0.00613456013185826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25081.2.3.m.43232,0.00904457524155811,0.0109373416232358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYAK_GE25484.1.1.m.6273,0.00819406482165351,-0.0148761821447638,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_DYH1.1.1.m.46156,-0.011246920189894,-0.000740482385802935,No,NA,NA,E9Q8T7,NA,NA,NA,axoneme [GO:0005930]; dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; epithelial cilium movement [GO:0003351]; flagellated sperm motility [GO:0030317]; inner dynein arm assembly [GO:0036159]; microtubule-based movement [GO:0007018]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_DYH2.1.1.m.28905,-0.0133672255129555,0.00324706934949883,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYH8.2.2.m.45091,0.00209244068119159,-0.00410549198801776,No,NA,NA,Q91XQ0,NA,NA,NA,dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157]; sperm principal piece [GO:0097228]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_DYHC.1.3.m.10664,-0.00571204357543383,0.0014677015128228,No,NA,NA,P23098,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_DYHC1.1.1.m.2432,-0.000645187703498708,0.00178192113840903,No,NA,NA,Q14204,NA,NA,NA,azurophil granule lumen [GO:0035578]; centrosome [GO:0005813]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; filopodium [GO:0030175]; membrane [GO:0016020]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; RNA binding [GO:0003723]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; cytoplasmic mRNA processing body assembly [GO:0033962]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of spindle localization [GO:0051293]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule-based movement [GO:0007018]; minus-end-directed vesicle transport along microtubule [GO:0072382]; mitotic spindle organization [GO:0007052]; neutrophil degranulation [GO:0043312]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_DYHC2.2.2.m.31941,-0.0120295131810913,0.0159126649428091,No,NA,NA,Q27802,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_DYN1.2.3.m.30771,-0.00152181358937029,-0.00112619615622141,No,NA,NA,P21575,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendritic spine [GO:0043197]; dendritic spine head [GO:0044327]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; membrane coat [GO:0030117]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic endocytic zone membrane [GO:0098844]; postsynaptic membrane [GO:0045211]; presynaptic endocytic zone membrane [GO:0098835]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; varicosity [GO:0043196]; D2 dopamine receptor binding [GO:0031749]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; nitric-oxide synthase binding [GO:0050998]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; clathrin-dependent endocytosis [GO:0072583]; endosome organization [GO:0007032]; G protein-coupled receptor internalization [GO:0002031]; modulation of chemical synaptic transmission [GO:0050804]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of synapse structure or activity [GO:0050803]; regulation of synaptic vesicle endocytosis [GO:1900242]; response to amyloid-beta [GO:1904645]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_DYNLL2.2.2.m.37356,-9.09709791093141e-05,0.00024497454929953,No,NA,NA,Q78P75,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; glutamatergic synapse [GO:0098978]; microtubule [GO:0005874]; myosin V complex [GO:0031475]; postsynaptic density [GO:0014069]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; motor activity [GO:0003774]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; microtubule-based process [GO:0007017]; positive regulation of ATP-dependent microtubule motor activity; plus-end-directed [GO:2000582],NA,NA,NA
CHOYP_E_R_.1.1.m.63122,-0.00629601070940112,-0.010382520621674,No,NA,NA,Q93104,NA,NA,NA,cell cycle [GO:0007049]; positive regulation of Notch signaling pathway [GO:0045747]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_E2F4.1.1.m.25398,-0.00316175546505991,-0.0017738638819658,No,NA,NA,Q6DE14,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; protein dimerization activity [GO:0046983]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; motile cilium assembly [GO:0044458]; multi-ciliated epithelial cell differentiation [GO:1903251]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_E41L3.2.2.m.57999,-0.00993609209942025,0.00923413684687055,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_EATER.1.1.m.30042,0.0027197167737733,-0.0124237909790674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EBNA1BP2.1.1.m.63216,-0.0165503928948291,-0.00867278678007131,No,NA,NA,Q9D903,NA,NA,NA,nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ECD.1.1.m.61798,0.0019441643873752,0.00809427059017112,No,NA,NA,O95905,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ECH1.1.1.m.29110,0.00075034909175171,0.00139229194179808,No,NA,NA,Q62651,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; delta3;5-delta2;4-dienoyl-CoA isomerase activity [GO:0051750]; signaling receptor binding [GO:0005102]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHM.1.1.m.38462,0.000608383110888619,8.75797359199272e-05,No,NA,NA,Q8BH95,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_ECHVI_0367.2.2.m.16808,0.00695569857634873,0.0025171235223102,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECM29.1.1.m.48083,-0.00143403870668549,0.0055861499385891,No,NA,NA,Q6PDI5,NA,NA,NA,centrosome [GO:0005813]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; late endosome [GO:0005770]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein-containing complex scaffold activity [GO:0032947]; proteasome assembly [GO:0043248]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ECMB.1.3.m.2566,-0.00497698598005343,0.00804703203883855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ECR.1.1.m.28368,0.00318696798765542,-0.0133292996169526,No,NA,NA,P49880,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; ecdysone binding [GO:0035100]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; ecdysone receptor-mediated signaling pathway [GO:0035076],NA,NA,NA
CHOYP_EDEM1.1.1.m.12175,0.00540428220885871,-0.0110503241013788,No,NA,NA,Q925U4,NA,NA,NA,aggresome [GO:0016235]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of endoplasmic reticulum membrane [GO:0030176]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; misfolded protein binding [GO:0051787]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; positive regulation of retrograde protein transport; ER to cytosol [GO:1904154]; response to unfolded protein [GO:0006986]; trimming of terminal mannose on C branch [GO:0036510]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent glycoprotein ERAD pathway [GO:0097466],NA,NA,NA
CHOYP_EDI_002780.1.1.m.31041,-0.0168419298858677,-0.0107181626053108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDI_048910.1.2.m.31504,0.00822103442978906,-0.0128648044657385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EDRF1.2.2.m.45353,-0.00157157721966789,0.0153243913279796,No,NA,NA,Q5R9R1,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_EEA1.1.1.m.9573,0.00591443222071661,-0.00427906565930159,No,NA,NA,Q8BL66,NA,NA,NA,axonal spine [GO:0044308]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extrinsic component of plasma membrane [GO:0019897]; recycling endosome [GO:0055037]; serine-pyruvate aminotransferase complex [GO:0005969]; 1-phosphatidylinositol binding [GO:0005545]; GTP-dependent protein binding [GO:0030742]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; endocytosis [GO:0006897]; vesicle fusion [GO:0006906]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_EEF1A.2.3.m.20692,0.00075743529652402,-0.00262604910849781,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF1A.3.3.m.37430,-0.00104951960862242,0.00137094821655912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EEF2.1.2.m.44023,0.00368961077913476,-0.000997038215219906,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EEF2.1.2.m.44025,-0.00376168224406833,0.00285328325699818,No,NA,NA,Q8WZA0,NA,NA,NA,beta-catenin binding [GO:0008013]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_EF.1A.6.9.m.43621,4.27162116462087e-06,0.0038017376133595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF.1A.9.9.m.63037,-0.00733312631017842,0.0012509914899281,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EF1A.2.4.m.50858,0.00120484832444467,-0.00069318334240517,No,NA,NA,Q92005,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A.3.4.m.63413,0.0016662961933667,-0.00760609435992031,No,NA,NA,Q5RKI1,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_EF1A.3.4.m.63416,-0.00177960254939087,0.000614638019558129,No,NA,NA,P54353,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; positive regulation of protein ubiquitination [GO:0031398]; regulation of locomotor rhythm [GO:1904059],NA,NA,NA
CHOYP_EF1A.4.4.m.65743,-0.0116386804167117,0.0155959252167795,No,NA,NA,Q92630,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; cellular response to DNA damage stimulus [GO:0006974]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_EF1A2.1.3.m.30022,-0.000523929854750256,-0.0178082914911722,No,NA,NA,Q92005,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF1A2.2.3.m.37043,-0.00461100014237064,0.00625978662585458,No,NA,NA,P27634,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.1.7.m.26504,0.00134581949884254,0.00104823475461182,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.2.7.m.30853,-0.00277076945708699,0.0284159838247727,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1B.3.7.m.35082,-0.00366091816880171,0.00496997742004644,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.1.3.m.12909,-0.00257196601542198,0.00171793151912378,No,NA,NA,P63100,NA,NA,NA,cytosol [GO:0005829]; sarcolemma [GO:0042383]; calcium ion binding [GO:0005509]; phosphoprotein phosphatase activity [GO:0004721]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_EF1G.2.3.m.50676,0.00207154172229562,-3.8226985884139e-05,No,NA,NA,P29694,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF1G.3.3.m.63510,0.00304564091279052,-0.000295435778136814,No,NA,NA,P12261,NA,NA,NA,translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EF2.1.5.m.1541,-0.0084321961387248,0.00680064652596768,No,NA,NA,P24156,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; cellular response to hypoxia [GO:0071456]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_EF2.4.5.m.30185,-0.00321580137938895,-0.0213170504384896,No,NA,NA,Q05086,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; brain development [GO:0007420]; positive regulation of protein ubiquitination [GO:0031398]; progesterone receptor signaling pathway [GO:0050847]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_EF2.4.5.m.30186,0.00243032550467151,-0.00101811029775851,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39855,-0.0109483504293413,0.0154307531012119,No,NA,NA,P29691,NA,NA,NA,cytosol [GO:0005829]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of gene expression [GO:0010629]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_EF2.5.5.m.39856,-0.00111625836343605,0.000143353871348913,No,NA,NA,Q7QC84,NA,NA,NA,mitochondrion [GO:0005739]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating) activity [GO:0004491]; thymine catabolic process [GO:0006210]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573],NA,NA,NA
CHOYP_EFCAB1.1.1.m.43342,0.00141067838376906,0.000979357689729829,No,NA,NA,Q3KQ77,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFCAB7.1.1.m.17862,-0.0136798201578771,0.00939368813539898,No,NA,NA,Q6DCF6,NA,NA,NA,ciliary membrane [GO:0060170]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFGM.1.1.m.16632,-0.00183791913384079,0.0032094386849037,No,NA,NA,Q7Q1K8,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125],NA,NA,NA
CHOYP_EFHD2.1.1.m.22844,-0.000625555264798524,-0.00265903148040274,No,NA,NA,Q4FZY0,NA,NA,NA,membrane raft [GO:0045121]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EFTS.2.2.m.66393,3.22503671890569e-05,0.00216882374525914,No,NA,NA,Q17PI0,NA,NA,NA,mitochondrion [GO:0005739]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_EGF1.1.2.m.46366,0.0093338287928537,-0.00540262767270069,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_EGFR.1.3.m.30285,0.000328450261278062,0.0125969440417957,No,NA,NA,P0CY46,NA,NA,NA,integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; multicellular organism development [GO:0007275]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_EGFR.2.3.m.61781,0.00352736404584669,-0.000953194513792753,No,NA,NA,Q01279,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body; internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; synapse [GO:0045202]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor-activated receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase activity [GO:0016301]; nitric-oxide synthase regulator activity [GO:0030235]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; activation of MAPKK activity [GO:0000186]; astrocyte activation [GO:0048143]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to cadmium ion [GO:0071276]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; cellular response to reactive oxygen species [GO:0034614]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis development [GO:0008544]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; magnesium ion homeostasis [GO:0010960]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neuron projection morphogenesis [GO:0048812]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphorylation [GO:0042327]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of vasoconstriction [GO:0045907]; protein autophosphorylation [GO:0046777]; receptor-mediated endocytosis [GO:0006898]; regulation of cell proliferation [GO:0042127]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of JNK cascade [GO:0046328]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to osmotic stress [GO:0006970]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060],NA,NA,NA
CHOYP_EHHADH.1.1.m.26459,-0.0134234129963874,0.0159018912963703,No,NA,NA,Q6NYL3,NA,NA,NA,peroxisome [GO:0005777]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_EHI_072050.2.8.m.16931,-0.0108144209298581,0.00592408467931469,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.5.8.m.47580,-0.00346809917727397,-0.0195702875446185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_072050.7.8.m.61373,-0.00241761617511085,0.0112056991934487,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHI_153670.1.2.m.21885,-0.00148871998034878,0.014628235706242,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EHMT2.1.1.m.263,0.00176928212980754,-0.003944483710026,No,NA,NA,Q9H9B1,NA,NA,NA,chromosome [GO:0005694]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; C2H2 zinc finger domain binding [GO:0070742]; histone methyltransferase activity (H3-K27 specific) [GO:0046976]; histone methyltransferase activity (H3-K9 specific) [GO:0046974]; histone-lysine N-methyltransferase activity [GO:0018024]; methyltransferase activity [GO:0008168]; p53 binding [GO:0002039]; protein-lysine N-methyltransferase activity [GO:0016279]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; histone methylation [GO:0016571]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; positive regulation of cold-induced thermogenesis [GO:0120162]; regulation of embryonic development [GO:0045995]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_EIF1A.1.1.m.30303,0.00421291577274374,-0.0117716162166426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF1A.1.1.m.30304,-0.00254968575860944,-0.00362796078785027,No,NA,NA,Q0V9J5,NA,NA,NA,nucleus [GO:0005634]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_EIF1B.1.3.m.29107,-0.00100860488484052,-0.0018887956931203,No,NA,NA,P42678,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_EIF2A.1.1.m.12752,0.00184778365652225,-0.00224999971296445,No,NA,NA,Q5ZKC1,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; eukaryotic translation initiation factor 2 complex [GO:0005850]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; tRNA binding [GO:0000049]; regulation of translation [GO:0006417]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_EIF3B.1.1.m.12232,0.00109055932011842,0.000973678469631919,No,NA,NA,P55884,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF3C.1.1.m.7991,0.00109626931657776,0.00127579113427052,No,NA,NA,Q6PFQ2,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3E.1.1.m.27167,-0.00107174184395573,0.00296357418137676,No,NA,NA,Q641X8,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; nucleus [GO:0005634]; PML body [GO:0016605]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3G.1.1.m.29464,0.000514452822650707,-0.00333002694128118,No,NA,NA,Q6DRC4,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3I.1.1.m.56504,0.00277958923670817,-0.000949151578865663,No,NA,NA,B5FZ19,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3K.1.1.m.59650,-0.00127454630051003,-0.000877380561992575,No,NA,NA,Q28C65,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; nucleus [GO:0005634]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; regulation of translational initiation [GO:0006446]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_EIF3L.1.1.m.7542,-0.00324353961344496,0.0045844197339659,No,NA,NA,Q5F428,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],NA,NA,NA
CHOYP_EIF4BB.1.1.m.51065,-0.00200764355966143,0.00148594150986265,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIF4BB.1.1.m.51066,0.00196188180285782,0.000607594419285462,No,NA,NA,Q8BGD9,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; postsynapse [GO:0098794]; ribosomal small subunit binding [GO:0043024]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_EIF4H.3.3.m.57962,0.000740378006707828,0.00148500669442666,No,NA,NA,Q15056,NA,NA,NA,cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; cadherin binding [GO:0045296]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA strand annealing activity [GO:0033592]; RNA strand-exchange activity [GO:0034057]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cytoplasmic translation [GO:0002181]; developmental growth [GO:0048589]; eukaryotic translation initiation factor 4F complex assembly [GO:0097010]; formation of translation preinitiation complex [GO:0001731]; regulation of translational initiation [GO:0006446]; sexual reproduction [GO:0019953]; translational initiation [GO:0006413]; viral process [GO:0016032],NA,NA,NA
CHOYP_EIF5A.1.3.m.22684,-0.00148258588462518,-0.00247657205119462,No,NA,NA,P10160,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear pore [GO:0005643]; ribosome binding [GO:0043022]; translation elongation factor activity [GO:0003746]; mRNA transport [GO:0051028]; positive regulation of translation [GO:0045727]; positive regulation of translational elongation [GO:0045901]; positive regulation of translational termination [GO:0045905]; protein transport [GO:0015031]; translational frameshifting [GO:0006452],NA,NA,NA
CHOYP_EIN_155680.4.6.m.52358,0.00281585025733698,0.0033254467148045,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_155680.6.6.m.56323,0.00372320911571543,-0.00675942138290905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EIN_201030.1.3.m.20334,0.0169931605131633,0.00784160880518172,No,NA,NA,Q6NZL8,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_ELDP2.1.2.m.39081,0.00821204792285876,0.00631159521862503,No,NA,NA,B3A0R6,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELDP2.2.2.m.40194,0.00397603166267241,0.0032408908174383,No,NA,NA,P86954,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_ELMO1.1.1.m.59285,0.00133966626579307,0.000521658157534645,No,NA,NA,Q96JJ3,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; cell chemotaxis [GO:0060326]; cell-cell adhesion [GO:0098609]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_ELOB.1.1.m.56270,0.00133694476677529,-0.00017018874437883,No,NA,NA,P62870,NA,NA,NA,elongin complex [GO:0070449]; transcription factor complex [GO:0005667]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ubiquitination [GO:0016567]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ELOC.1.1.m.1299,-0.000957484167832169,-0.00110424290106995,No,NA,NA,P83941,NA,NA,NA,elongin complex [GO:0070449]; VCB complex [GO:0030891]; protein-containing complex binding [GO:0044877]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_ELOV4.3.3.m.64203,-7.75640395002171e-05,0.0102908815835629,No,NA,NA,Q9JLJ4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; 3-oxo-arachidoyl-CoA synthase activity [GO:0102336]; 3-oxo-cerotoyl-CoA synthase activity [GO:0102337]; 3-oxo-lignoceronyl-CoA synthase activity [GO:0102338]; fatty acid elongase activity [GO:0009922]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; very-long-chain 3-ketoacyl-CoA synthase activity [GO:0102756]; fatty acid elongation; monounsaturated fatty acid [GO:0034625]; fatty acid elongation; polyunsaturated fatty acid [GO:0034626]; fatty acid elongation; saturated fatty acid [GO:0019367]; sphingolipid biosynthetic process [GO:0030148]; unsaturated fatty acid biosynthetic process [GO:0006636]; very long-chain fatty acid biosynthetic process [GO:0042761]; very long-chain fatty acid metabolic process [GO:0000038],NA,NA,NA
CHOYP_ELP1.2.2.m.29114,-0.00256174795852723,4.08311751048226e-05,No,NA,NA,O95163,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Elongator holoenzyme complex [GO:0033588]; nucleolus [GO:0005730]; transcription elongation factor complex [GO:0008023]; phosphorylase kinase regulator activity [GO:0008607]; immune response [GO:0006955]; positive regulation of cell migration [GO:0030335]; protein phosphorylation [GO:0006468]; protein-containing complex assembly [GO:0065003]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_ELP2.1.1.m.18394,0.00240104690091523,-0.000648831451351409,No,NA,NA,Q05AM5,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; proteasome complex [GO:0000502]; transcription elongation factor complex [GO:0008023]; endopeptidase activator activity [GO:0061133]; proteasome assembly [GO:0043248]; transcription elongation from RNA polymerase II promoter [GO:0006368]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_EMAL1.1.1.m.58030,-0.000298048982583946,-0.00133495990000107,No,NA,NA,O00423,NA,NA,NA,cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; brain development [GO:0007420]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neuroblast proliferation [GO:0007405],NA,NA,NA
CHOYP_EMAL6.1.1.m.6370,-0.00425264796210113,-0.00143799988142832,No,NA,NA,Q6ZMW3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_EMC2.2.2.m.21018,-0.0147873541589965,0.0154662421562853,No,NA,NA,Q6TGY8,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; ER membrane protein complex [GO:0072546]; nucleus [GO:0005634]; protein folding in endoplasmic reticulum [GO:0034975],NA,NA,NA
CHOYP_ENGASE.1.1.m.54655,0.0139605790008679,-0.00254797102183739,No,NA,NA,Q8BX80,NA,NA,NA,cytosol [GO:0005829]; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity [GO:0033925]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_ENO.1.2.m.7680,0.00353080648929036,0.00658133486117282,No,NA,NA,Q5ZK62,NA,NA,NA,endosome membrane [GO:0010008]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456],NA,NA,NA
CHOYP_ENO.1.2.m.7681,0.00189064459263313,-0.000846514552994644,No,NA,NA,O02654,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_ENOPH.1.4.m.8576,0.00620368636764262,0.00244721214890193,No,NA,NA,Q69ZR9,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_ENOPH.3.4.m.51956,-0.00237974929201143,0.000128730993470967,No,NA,NA,Q0VD27,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; 2;3-diketo-5-methylthiopentyl-1-phosphate enolase activity [GO:0043715]; 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity [GO:0043716]; acireductone synthase activity [GO:0043874]; magnesium ion binding [GO:0000287]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_ENOX2.1.1.m.7197,-0.00903573385125368,0.00887025373276791,No,NA,NA,Q8TC92,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_ENPEP.1.1.m.12765,-0.00923835592862001,-0.00587926690822848,No,NA,NA,P50123,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; angiotensin maturation [GO:0002003]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],NA,NA,NA
CHOYP_ENPL.3.4.m.39476,-0.00276664196096845,0.00806079443178867,No,NA,NA,Q66HD0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPL.4.4.m.47194,0.00496154426235244,-0.012278446833836,No,NA,NA,Q66HD0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]; smooth endoplasmic reticulum [GO:0005790]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; cellular response to manganese ion [GO:0071287]; protein folding [GO:0006457]; response to hypoxia [GO:0001666]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ENPP3.1.1.m.13519,0.00164219200008423,0.00338743438401796,No,NA,NA,J3SBP3,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleic acid binding [GO:0003676]; phosphodiesterase I activity [GO:0004528]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; toxin activity [GO:0090729]; immune response [GO:0006955],NA,NA,NA
CHOYP_ENS.1.3.m.25925,0.00900079806903652,-0.00515802062405046,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ENTPD4.1.1.m.15533,2.70194764675449e-05,0.00291749651123346,No,NA,NA,Q28CF8,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_EP15R.1.1.m.14260,0.000493800007250932,0.000376506779525902,No,NA,NA,Q9UBC2,NA,NA,NA,clathrin coat of coated pit [GO:0030132]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_EPDR2.1.1.m.33988,0.0196287632092879,-0.00279667969987432,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_EPN2.1.1.m.23660,-0.00198502699022863,-0.00170833301458141,No,NA,NA,Q9Z1Z3,NA,NA,NA,clathrin coat of endocytic vesicle [GO:0030128]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_EPN4.1.3.m.10807,-0.0146506343603297,0.0190746741986864,No,NA,NA,A7Z035,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPN4.2.3.m.66030,-0.00392861881920586,-0.00178295016858027,No,NA,NA,A7Z035,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; Golgi-associated vesicle [GO:0005798]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; clathrin binding [GO:0030276]; lipid binding [GO:0008289]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_EPRS.1.1.m.35443,-0.00118354031648093,-0.0163362389462303,No,NA,NA,Q8CGC7,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; long-chain fatty acid import [GO:0044539]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_EPS.8.1.1.m.17522,0.00702457640907344,-0.00801589670779517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ER.1.2.m.14189,-0.0130838653738565,-0.00832653962659365,No,NA,NA,P81559,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; estrogen receptor activity [GO:0030284]; sequence-specific DNA binding [GO:0043565]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ERD22.1.1.m.12383,-0.0152633501318526,0.00693331613401873,No,NA,NA,Q6PEH1,NA,NA,NA,cis-Golgi network [GO:0005801]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; ER retention sequence binding [GO:0046923]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein retention in ER lumen [GO:0006621]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ERF1.1.1.m.37539,0.000797220987786309,-0.00161815289526006,No,NA,NA,Q9GR88,NA,NA,NA,cytoplasm [GO:0005737]; translation release factor activity [GO:0003747],NA,NA,NA
CHOYP_ERF1.1.1.m.37540,-0.00277474611715169,0.00445846180026148,No,NA,NA,P81004,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; pore complex [GO:0046930]; nucleotide binding [GO:0000166]; porin activity [GO:0015288]; voltage-gated anion channel activity [GO:0008308],NA,NA,NA
CHOYP_ERF3A.1.1.m.57282,-0.000352767251551221,0.000995137457969212,No,NA,NA,Q8R050,NA,NA,NA,cytosol [GO:0005829]; translation release factor complex [GO:0018444]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation release factor activity [GO:0003747]; cytoplasmic translational termination [GO:0002184]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; protein methylation [GO:0006479]; translation [GO:0006412],NA,NA,NA
CHOYP_ERGI1.1.1.m.9684,-0.0167791718334036,0.0317564053835938,No,NA,NA,Q969X5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ERL2B.1.1.m.187,-0.019432489403637,0.0202067526871491,No,NA,NA,Q6DKC0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; ubiquitin protein ligase binding [GO:0031625]; cholesterol metabolic process [GO:0008203]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_ERP44.1.1.m.3853,-0.000681989564430912,0.00475351468620339,No,NA,NA,Q3T0L2,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; glycoprotein metabolic process [GO:0009100]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_ERR3.1.1.m.25316,0.00620600152886345,-0.0078891165875862,No,NA,NA,P62510,NA,NA,NA,nucleus [GO:0005634]; AF-2 domain binding [GO:0050682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid binding [GO:0005496]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription; DNA-templated [GO:0006355]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_ES1.1.1.m.66406,-0.00205983918489198,0.00221841169228886,No,NA,NA,Q9D172,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_ESF1.1.1.m.15088,0.0109264940305496,-0.0126663210484677,No,NA,NA,Q3V1V3,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EST1A.1.1.m.59161,-0.00335370925223664,0.0115110571130225,No,NA,NA,P61406,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; DNA polymerase binding [GO:0070182]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; negative regulation of telomere capping [GO:1904354]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_ETFD.1.1.m.6881,-0.00132157619917712,0.00225457906863321,No,NA,NA,Q921G7,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; membrane [GO:0016020]; mitochondrial electron transfer flavoprotein complex [GO:0017133]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; electron-transferring-flavoprotein dehydrogenase activity [GO:0004174]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; oxidizing metal ions with flavin as acceptor [GO:0043783]; quinone binding [GO:0048038]; ubiquinone binding [GO:0048039]; electron transport chain [GO:0022900]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; respiratory electron transport chain [GO:0022904]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_EVI1.1.1.m.62064,-0.00446277753114869,0.0027402536186745,No,NA,NA,Q03112,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_EVL.1.1.m.57134,-0.000598279774452998,0.00123614144322551,No,NA,NA,P70460,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium [GO:0030175]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_EXC6B.1.1.m.38489,0.00961967937301558,-0.0174643605636414,No,NA,NA,Q9Y2D4,NA,NA,NA,exocyst [GO:0000145]; membrane [GO:0016020]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_EXOC1.1.2.m.60,0.00250285684977284,-0.0138349150777152,No,NA,NA,Q9NV70,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTP-Rho binding [GO:0017049]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; defense response to virus [GO:0051607]; exocyst localization [GO:0051601]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of protein secretion [GO:0050714]; protein transport [GO:0015031]; regulation of macroautophagy [GO:0016241]; viral process [GO:0016032],NA,NA,NA
CHOYP_EXOC2.1.3.m.360,-0.000105508682930728,0.0139984633223595,No,NA,NA,Q96KP1,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; Ral GTPase binding [GO:0017160]; exocyst assembly [GO:0001927]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031]; regulation of entry of bacterium into host cell [GO:2000535],NA,NA,NA
CHOYP_EXOC4.1.2.m.4421,0.0118761695452295,0.0096407904950775,No,NA,NA,Q62824,NA,NA,NA,cell leading edge [GO:0031252]; dendritic shaft [GO:0043198]; exocyst [GO:0000145]; Flemming body [GO:0090543]; growth cone [GO:0030426]; growth cone membrane [GO:0032584]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; chemical synaptic transmission [GO:0007268]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; Golgi to transport vesicle transport [GO:0055108]; membrane biogenesis [GO:0044091]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcium-mediated signaling [GO:0050850]; protein targeting to membrane [GO:0006612]; regulation of protein transport [GO:0051223]; vesicle docking involved in exocytosis [GO:0006904]; vesicle targeting [GO:0006903]; vesicle tethering involved in exocytosis [GO:0090522],NA,NA,NA
CHOYP_EXOS7.1.1.m.3323,-0.00104880607540202,0.00101212079166287,No,NA,NA,Q15024,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 3'-5'-exoribonuclease activity [GO:0000175]; AU-rich element binding [GO:0017091]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOS9.1.1.m.12468,0.0222756965684465,-0.00407260546137769,No,NA,NA,Q5XJQ5,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; nuclear exosome (RNase complex) [GO:0000176]; AU-rich element binding [GO:0017091]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; rRNA catabolic process [GO:0016075]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_EXOSC10.1.1.m.39774,-0.00740750332517493,-0.00228979081567623,No,NA,NA,Q01780,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; membrane [GO:0016020]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; 3'-5'-exoribonuclease activity [GO:0000175]; exoribonuclease activity [GO:0004532]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; CUT catabolic process [GO:0071034]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; negative regulation of telomere maintenance via telomerase [GO:0032211]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_EXOSC2.1.1.m.9530,-0.0090752588325714,6.63087457278179e-05,No,NA,NA,Q2KID0,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; CUT catabolic process [GO:0071034]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription [GO:0071049]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_EZH2.1.1.m.47916,-0.00710290200299409,0.0110344787737764,No,NA,NA,Q28D84,NA,NA,NA,ESC/E(Z) complex [GO:0035098]; histone-lysine N-methyltransferase activity [GO:0018024]; promoter-specific chromatin binding [GO:1990841]; negative regulation of gene expression; epigenetic [GO:0045814]; rhythmic process [GO:0048511],NA,NA,NA
CHOYP_F10A1.2.4.m.11805,0.00624998888628008,0.00454751841284137,No,NA,NA,Q5ZLF0,NA,NA,NA,cytoplasm [GO:0005737]; protein dimerization activity [GO:0046983]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_F172A.2.2.m.58797,-0.00728149615447583,-0.00175069160594627,No,NA,NA,Q3TNH5,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; chromatin silencing by small RNA [GO:0031048]; mRNA processing [GO:0006397]; neural crest cell development [GO:0014032]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_F179B.1.1.m.45817,0.000208354558647357,0.00488639454777397,No,NA,NA,Q8BMI3,NA,NA,NA,early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; ubiquitin binding [GO:0043130]; endocytic recycling [GO:0032456]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein localization to cell surface [GO:0034394]; protein localization to lysosome [GO:0061462]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_F188B.1.1.m.8460,0.00889892955176003,-0.0110326124179334,No,NA,NA,Q3UQI9,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459],NA,NA,NA
CHOYP_F48E3.8.1.1.m.46349,-7.46851037670331e-05,0.00990891608888559,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_F91A1.1.1.m.52980,-0.00238304089496377,0.0339099935709905,No,NA,NA,Q3UVG3,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_FA13A.1.2.m.296,0.004321464544792,-0.00116778314971368,No,NA,NA,Q8HYW0,NA,NA,NA,,NA,NA,NA
CHOYP_FA13A.1.2.m.297,-0.0124819314544848,-0.0079434703661705,No,NA,NA,Q6TH47,NA,NA,NA,cleavage furrow [GO:0032154]; endosome [GO:0005768]; membrane [GO:0016020]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536],NA,NA,NA
CHOYP_FA49B.1.1.m.294,0.00174155890983188,-0.00155255585735652,No,NA,NA,Q9NUQ9,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; MHC class Ib protein binding; via antigen binding groove [GO:0023030]; platelet degranulation [GO:0002576]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of memory T cell activation [GO:2000568]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated cytotoxicity [GO:0001916],NA,NA,NA
CHOYP_FA63B.1.1.m.52872,-0.00541066315751251,0.0070903796441724,No,NA,NA,Q2KI23,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; cysteine-type carboxypeptidase activity [GO:0016807]; K11-linked polyubiquitin modification-dependent protein binding [GO:0071795]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; K6-linked polyubiquitin modification-dependent protein binding [GO:0071796]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; Lys48-specific deubiquitinase activity [GO:1990380]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_FA65A.1.1.m.24019,0.00218563190611864,-0.000590620167072268,No,NA,NA,Q96MK2,NA,NA,NA,,NA,NA,NA
CHOYP_FAAA.1.1.m.7653,-0.000981018403223489,0.00194249360336752,No,NA,NA,A5PKH3,NA,NA,NA,cytosol [GO:0005829]; fumarylacetoacetase activity [GO:0004334]; metal ion binding [GO:0046872]; homogentisate catabolic process [GO:1902000]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_FABP.1.2.m.51611,0.00490149829056853,0.00350831897419465,No,NA,NA,O01814,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_FABP6.1.2.m.49858,0.0329520359385009,-0.0185349345744872,No,NA,NA,O01812,NA,NA,NA,lipid binding [GO:0008289],NA,NA,NA
CHOYP_FABP7.2.2.m.29096,0.018405772342532,-0.000233016702237837,No,NA,NA,Q09139,NA,NA,NA,cell periphery [GO:0071944]; cell projection [GO:0042995]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; lipid binding [GO:0008289]; cell proliferation in forebrain [GO:0021846]; neurogenesis [GO:0022008]; prepulse inhibition [GO:0060134],NA,NA,NA
CHOYP_FACE1.1.1.m.13875,0.00301956383670986,0.00845433779533731,No,NA,NA,Q80W54,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; protein-containing complex [GO:0032991]; double-stranded DNA binding [GO:0003690]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; adult walking behavior [GO:0007628]; bone mineralization [GO:0030282]; CAAX-box protein processing [GO:0071586]; calcium ion import into sarcoplasmic reticulum [GO:1990036]; CAMKK-AMPK signaling cascade [GO:0061762]; cardiac conduction [GO:0061337]; cardiac muscle fiber development [GO:0048739]; cardiac ventricle development [GO:0003231]; cellular lipid metabolic process [GO:0044255]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; chromatin organization [GO:0006325]; chromosome organization [GO:0051276]; determination of adult lifespan [GO:0008340]; DNA repair [GO:0006281]; epidermis development [GO:0008544]; growth plate cartilage development [GO:0003417]; hair follicle development [GO:0001942]; heart morphogenesis [GO:0003007]; histone H2A phosphorylation [GO:1990164]; histone H2B acetylation [GO:0043969]; histone H2B-K5 acetylation [GO:0043979]; hypomethylation of CpG island [GO:0044029]; inflammatory cell apoptotic process [GO:0006925]; kidney morphogenesis [GO:0060993]; liver development [GO:0001889]; maintenance of rDNA [GO:0043007]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; neuromuscular process [GO:0050905]; nuclear envelope organization [GO:0006998]; nucleus organization [GO:0006997]; positive regulation of gene expression [GO:0010628]; prenylated protein catabolic process [GO:0030327]; protein processing [GO:0016485]; regulation of autophagy [GO:0010506]; regulation of blood circulation [GO:1903522]; regulation of bone mineralization [GO:0030500]; regulation of cell shape [GO:0008360]; regulation of cellular senescence [GO:2000772]; regulation of defense response to virus [GO:0050688]; regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043516]; regulation of DNA methylation [GO:0044030]; regulation of fibroblast proliferation [GO:0048145]; regulation of glucose metabolic process [GO:0010906]; regulation of heart contraction [GO:0008016]; regulation of histone H4 acetylation [GO:0090239]; regulation of histone H4-K16 acetylation [GO:2000618]; regulation of hormone metabolic process [GO:0032350]; regulation of lipid metabolic process [GO:0019216]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle DNA replication [GO:1903463]; regulation of multicellular organism growth [GO:0040014]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of stress-activated protein kinase signaling cascade [GO:0070302]; regulation of termination of RNA polymerase I transcription [GO:2000730]; regulation of TOR signaling [GO:0032006]; regulation of transcription; DNA-templated [GO:0006355]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; response to DNA damage checkpoint signaling [GO:0072423]; thymus development [GO:0048538]; ventricular cardiac muscle tissue development [GO:0003229],NA,NA,NA
CHOYP_FAF1.1.1.m.35621,0.00488102883042328,-0.00113285928067149,No,NA,NA,Q9UNN5,NA,NA,NA,CD95 death-inducing signaling complex [GO:0031265]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; heat shock protein binding [GO:0031072]; NF-kappaB binding [GO:0051059]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell death [GO:0010942]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of DNA replication [GO:0045740]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of protein complex assembly [GO:0031334]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_FAF1.1.1.m.35623,0.00791835124467293,0.00935136911654123,No,NA,NA,Q92193,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_FAF2.1.1.m.54271,0.0253907641005007,0.00164946710220441,No,NA,NA,P30568,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_FAIM1.1.1.m.36651,-0.00230282027423167,0.0146531928375515,No,NA,NA,Q0IIF6,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_FAM122B.1.1.m.7361,-0.000975538050588129,0.00819421356052624,No,NA,NA,Q5ZLN7,NA,NA,NA,protein serine/threonine phosphatase inhibitor activity [GO:0004865]; positive regulation of cell growth [GO:0030307]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436],NA,NA,NA
CHOYP_FAM193A.1.1.m.66343,-0.00323484030919654,0.00296152067001286,No,NA,NA,P78312,NA,NA,NA,,NA,NA,NA
CHOYP_FAM50.1.1.m.17123,-0.00411925693638775,-0.011284400827837,No,NA,NA,Q9VAY7,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_FANCJ.1.1.m.17513,0.00188931137294207,0.00135883145515886,No,NA,NA,Q3YK19,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; chiasma assembly [GO:0051026]; DNA repair [GO:0006281]; double-strand break repair involved in meiotic recombination [GO:1990918]; meiotic DNA double-strand break processing involved in reciprocal meiotic recombination [GO:0010705]; nucleotide-excision repair [GO:0006289]; regulation of transcription by RNA polymerase II [GO:0006357]; seminiferous tubule development [GO:0072520]; spermatid development [GO:0007286]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_FARP2.1.1.m.9404,-0.0130553078820257,0.000782126667480651,No,NA,NA,Q91VS8,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; cytoskeletal protein binding [GO:0008092]; Rac guanyl-nucleotide exchange factor activity [GO:0030676]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; hair cycle process [GO:0022405]; neuron remodeling [GO:0016322]; osteoclast differentiation [GO:0030316]; podosome assembly [GO:0071800]; Rac protein signal transduction [GO:0016601]; regulation of integrin activation [GO:0033623]; regulation of Rho protein signal transduction [GO:0035023]; semaphorin-plexin signaling pathway [GO:0071526],NA,NA,NA
CHOYP_FAS2.1.1.m.41201,0.00633646005338321,-0.00101867745382109,No,NA,NA,P13596,NA,NA,NA,glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; cytoskeletal protein binding [GO:0008092]; fibroblast growth factor receptor binding [GO:0005104]; heparin binding [GO:0008201]; LRR domain binding [GO:0030275]; phosphatase binding [GO:0019902]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; axonal fasciculation [GO:0007413]; calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules [GO:0016338]; cell adhesion [GO:0007155]; cellular response to inorganic substance [GO:0071241]; cellular response to molecule of bacterial origin [GO:0071219]; learning or memory [GO:0007611]; modulation of chemical synaptic transmission [GO:0050804]; multicellular organismal response to stress [GO:0033555]; negative regulation of cell death [GO:0060548]; neuron development [GO:0048666]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to cocaine [GO:0042220]; response to drug [GO:0042493]; response to inorganic substance [GO:0010035]; response to lead ion [GO:0010288]; thalamus development [GO:0021794],NA,NA,NA
CHOYP_FASN.3.4.m.60278,-0.0103635519569104,0.00181947262572739,No,NA,NA,P12276,NA,NA,NA,cell [GO:0005623]; (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activity [GO:0008659]; 3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity [GO:0047451]; 3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; enoyl-[acyl-carrier-protein] reductase (NADPH; A-specific) activity [GO:0047117]; fatty acid synthase activity [GO:0004312]; myristoyl-[acyl-carrier-protein] hydrolase activity [GO:0016295]; oleoyl-[acyl-carrier-protein] hydrolase activity [GO:0004320]; palmitoyl-[acyl-carrier-protein] hydrolase activity [GO:0016296]; phosphopantetheine binding [GO:0031177]; single-stranded DNA binding [GO:0003697]; fatty acid biosynthetic process [GO:0006633]; lactate metabolic process [GO:0006089]; positive regulation of appetite [GO:0032100],NA,NA,NA
CHOYP_FAT1.2.4.m.36735,0.00773875059722144,-0.0100506091074694,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FAT1.4.4.m.63315,0.00195944216784215,0.00790514185981477,No,NA,NA,Q6V0I7,NA,NA,NA,apical part of cell [GO:0045177]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_FAT4.8.10.m.44748,-0.000443801744322639,0.00336472988587804,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_FBLN2.1.1.m.25187,0.00257599082549618,0.00653745222403011,No,NA,NA,P37889,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_FBX22.1.1.m.35385,-0.0241687941977102,-0.00876223388832897,No,NA,NA,Q5RE08,NA,NA,NA,Z disc [GO:0030018],NA,NA,NA
CHOYP_FBX42.1.1.m.11569,-0.0137400129013265,-0.00330233949413639,No,NA,NA,Q6PDJ6,NA,NA,NA,,NA,NA,NA
CHOYP_FBX9.1.1.m.49865,0.0069631729516387,-0.00809229377185145,No,NA,NA,Q3ZBT2,NA,NA,NA,cytoplasm [GO:0005737]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; fat cell differentiation [GO:0045444]; innate immune response [GO:0045087]; protein ubiquitination [GO:0016567]; regulation of TOR signaling [GO:0032006]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_FCHO2.1.1.m.46242,-0.00492071153662937,-0.00988382919889031,No,NA,NA,Q3UQN2,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886]; presynaptic endocytic zone membrane [GO:0098835]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; tubulin binding [GO:0015631]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; plasma membrane tubulation [GO:0097320]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_FCL.1.1.m.13504,0.000186688199233161,0.000826522788099893,No,NA,NA,Q8K3X2,NA,NA,NA,coenzyme binding [GO:0050662]; GDP-L-fucose synthase activity [GO:0050577]; GDP-mannose 3;5-epimerase activity [GO:0047918]; identical protein binding [GO:0042802]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; T cell mediated cytotoxicity [GO:0001913],NA,NA,NA
CHOYP_FEN1.1.1.m.66181,0.0038104645994928,0.014000362007821,No,NA,NA,A7RRJ0,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; 5'-3' exonuclease activity [GO:0008409]; 5'-flap endonuclease activity [GO:0017108]; DNA binding [GO:0003677]; flap endonuclease activity [GO:0048256]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; apoptotic DNA fragmentation [GO:0006309]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication; removal of RNA primer [GO:0043137]; positive regulation of sister chromatid cohesion [GO:0045876],NA,NA,NA
CHOYP_FGD1.1.2.m.11030,0.0156803998916644,0.000532935250319063,No,NA,NA,P98174,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; small GTPase binding [GO:0031267]; actin cytoskeleton organization [GO:0030036]; animal organ morphogenesis [GO:0009887]; cytoskeleton organization [GO:0007010]; filopodium assembly [GO:0046847]; G protein-coupled receptor signaling pathway [GO:0007186]; multicellular organism development [GO:0007275]; positive regulation of apoptotic process [GO:0043065]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_FGFR2.1.3.m.20151,-0.0046630588576149,0.00921677525716171,No,NA,NA,Q03142,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; heparin binding [GO:0008201]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; alveolar secondary septum development [GO:0061144]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; lung development [GO:0030324]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; organ induction [GO:0001759]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of parathyroid hormone secretion [GO:2000830]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; regulation of phosphate transport [GO:0010966]; regulation of phosphorus metabolic process [GO:0051174]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vitamin D3 metabolic process [GO:0070640],NA,NA,NA
CHOYP_FGFR2.2.3.m.53947,0,0,No,NA,NA,Q8JG38,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor-activated receptor activity [GO:0005007]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; apoptotic process [GO:0006915]; cell proliferation in midbrain [GO:0033278]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; digestive tract development [GO:0048565]; midbrain development [GO:0030901]; positive regulation of cell proliferation [GO:0008284]; regulation of hematopoietic stem cell differentiation [GO:1902036]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FGL1.1.6.m.30450,0.00859956724813843,-0.004895734273416,No,NA,NA,Q9R045,NA,NA,NA,extracellular space [GO:0005615],NA,NA,NA
CHOYP_FHOD3.2.2.m.44837,-0.00721162321604623,-0.0110415220935974,No,NA,NA,Q2V2M9,NA,NA,NA,striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; negative regulation of actin filament polymerization [GO:0030837]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FIBP.1.1.m.36402,0.0066535611733975,-0.0120794245690158,No,NA,NA,Q9JI19,NA,NA,NA,endomembrane system [GO:0012505]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134],NA,NA,NA
CHOYP_FKBP12.1.1.m.32709,-0.0149796769942912,-0.000158006002944625,No,NA,NA,Q9Z2I2,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; Z disc [GO:0030018]; calcium channel inhibitor activity [GO:0019855]; cyclic nucleotide binding [GO:0030551]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; signaling receptor binding [GO:0005102]; chaperone-mediated protein folding [GO:0061077]; insulin secretion [GO:0030073]; negative regulation of heart rate [GO:0010459]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; neuronal action potential propagation [GO:0019227]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of sequestering of calcium ion [GO:0051284]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to redox state [GO:0051775]; response to vitamin E [GO:0033197]; smooth muscle contraction [GO:0006939]; T cell proliferation [GO:0042098],NA,NA,NA
CHOYP_FKBP13.1.1.m.43694,0.00577864144024173,0.00520621019461127,No,NA,NA,Q9Y680,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP14.1.1.m.7244,-0.0116751751229724,-0.00615945929992623,No,NA,NA,P59024,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_FKBP1AA.1.1.m.26101,0.00104116761377921,0.000175381481342727,No,NA,NA,O42123,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic side of membrane [GO:0098562]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of organelle membrane [GO:0031312]; membrane [GO:0016020]; ryanodine receptor complex [GO:1990425]; sarcoplasmic reticulum membrane [GO:0033017]; terminal cisterna [GO:0014802]; Z disc [GO:0030018]; activin binding [GO:0048185]; calcium channel inhibitor activity [GO:0019855]; drug binding [GO:0008144]; FK506 binding [GO:0005528]; ion channel binding [GO:0044325]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; amyloid fibril formation [GO:1990000]; cytokine-mediated signaling pathway [GO:0019221]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; muscle contraction [GO:0006936]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of release of sequestered calcium ion into cytosol [GO:0051280]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein binding [GO:0032092]; positive regulation of protein ubiquitination [GO:0031398]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of immune response [GO:0050776]; regulation of protein localization [GO:0032880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; release of sequestered calcium ion into cytosol [GO:0051209]; response to caffeine [GO:0031000]; SMAD protein complex assembly [GO:0007183]; supramolecular fiber organization [GO:0097435]; T cell proliferation [GO:0042098]; ventricular cardiac muscle tissue morphogenesis [GO:0055010],NA,NA,NA
CHOYP_FKBP4.1.1.m.15147,0.000836739579372985,-0.00064026380014723,No,NA,NA,Q9TRY0,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_FL2D.1.1.m.62439,-0.00415739278479036,-0.00730063254407777,No,NA,NA,Q7SXL7,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cell cycle [GO:0007049]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_FLELI_3104.1.1.m.46432,0.00344538600488958,0.00474452135553613,No,NA,NA,Q30NT6,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphotransferase activity; alcohol group as acceptor [GO:0016773]; 1;6-anhydro-N-acetyl-beta-muramic acid catabolic process [GO:0097175]; amino sugar metabolic process [GO:0006040]; carbohydrate metabolic process [GO:0005975]; peptidoglycan turnover [GO:0009254],NA,NA,NA
CHOYP_FLNA.1.6.m.11089,-0.00224210868153763,0.0210761255448372,No,NA,NA,Q80X90,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; identical protein binding [GO:0042802]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_FLNA.2.6.m.11845,0.0114567239496,0.00015481708090254,No,NA,NA,Q9VEN1,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical cortex [GO:0045179]; cytosol [GO:0005829]; female germline ring canal [GO:0035324]; female germline ring canal inner rim [GO:0035183]; female germline ring canal outer rim [GO:0035182]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; behavioral response to ethanol [GO:0048149]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; determination of adult lifespan [GO:0008340]; female germline ring canal formation [GO:0007301]; female germline ring canal formation; actin assembly [GO:0008302]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; germline ring canal formation [GO:0030725]; long-term memory [GO:0007616]; mitotic cell cycle [GO:0000278]; motor neuron axon guidance [GO:0008045]; negative regulation of lamellocyte differentiation [GO:0035204]; positive regulation of cytoskeleton organization [GO:0051495]; protein localization [GO:0008104]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_FLNC.2.5.m.37450,-4.76702141083118e-05,0.00515883232602625,No,NA,NA,P21333,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.3.5.m.38669,-0.00843055022985311,-0.0234389224095105,No,NA,NA,P21333,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; apical dendrite [GO:0097440]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Myb complex [GO:0031523]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; mu-type opioid receptor binding [GO:0031852]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; Rac GTPase binding [GO:0048365]; Ral GTPase binding [GO:0017160]; Rho GTPase binding [GO:0017048]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transcription factor binding [GO:0008134]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; cell junction assembly [GO:0034329]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; defense response to virus [GO:0051607]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; semaphorin-plexin signaling pathway [GO:0071526]; wound healing; spreading of cells [GO:0044319],NA,NA,NA
CHOYP_FLNC.5.5.m.40834,0.0142648672218308,-0.025897618298314,No,NA,NA,D3ZHA0,NA,NA,NA,costamere [GO:0043034]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_FLOT1.1.2.m.21435,-8.05868466630956e-05,0.0106919353549183,No,NA,NA,O61491,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FLOT1.2.2.m.59727,-0.0001571261112109,-0.000572838424051732,No,NA,NA,O61491,NA,NA,NA,cytoplasm [GO:0005737]; flotillin complex [GO:0016600]; structural molecule activity [GO:0005198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FMRF.1.4.m.26285,-0.00664140383443591,-0.00928333290379998,No,NA,NA,P08021,NA,NA,NA,extracellular region [GO:0005576]; neuropeptide signaling pathway [GO:0007218],NA,NA,NA
CHOYP_FMRF.2.4.m.37051,0.0137705702503648,-0.00337826138423947,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRF.4.4.m.62077,-0.00830780595190577,-0.00420961987887395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FMRP.1.2.m.37742,-0.00238599369962111,-0.000586932135014845,No,NA,NA,Q5XI81,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; polysome [GO:0005844]; postsynaptic density [GO:0014069]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA strand annealing activity [GO:0033592]; translation regulator activity [GO:0045182]; cell differentiation [GO:0030154]; muscle organ development [GO:0007517]; negative regulation of translation [GO:0017148]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of translation [GO:0045727]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_FND2.1.4.m.8542,-0.00501191402912193,0.00517282720141698,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.3.4.m.40482,0.00793157052323282,0.00540023900461501,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FND2.4.4.m.44570,0.0148997724783625,-8.58396441503797e-05,No,NA,NA,H2A0L8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_FNTA.1.1.m.40996,0.0013292993190004,0.00368999933159195,No,NA,NA,P49354,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; protein farnesyltransferase complex [GO:0005965]; acetylcholine receptor regulator activity [GO:0030548]; alpha-tubulin binding [GO:0043014]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; microtubule binding [GO:0008017]; protein farnesyltransferase activity [GO:0004660]; protein geranylgeranyltransferase activity [GO:0004661]; Rab geranylgeranyltransferase activity [GO:0004663]; receptor tyrosine kinase binding [GO:0030971]; neurotransmitter receptor metabolic process [GO:0045213]; positive regulation of deacetylase activity [GO:0090045]; positive regulation of tubulin deacetylation [GO:0090044]; protein farnesylation [GO:0018343]; protein geranylgeranylation [GO:0018344]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_FNTB.1.1.m.45546,0.00441939870861051,0.00513143319860884,No,NA,NA,P49355,NA,NA,NA,protein farnesyltransferase complex [GO:0005965]; farnesyltranstransferase activity [GO:0004311]; protein farnesyltransferase activity [GO:0004660]; zinc ion binding [GO:0008270]; negative regulation of cell proliferation [GO:0008285]; positive regulation of fibroblast proliferation [GO:0048146]; protein farnesylation [GO:0018343]; protein prenylation [GO:0018342]; wound healing [GO:0042060],NA,NA,NA
CHOYP_FOCAD.2.2.m.52366,-0.0130458058058913,0.00172755537108264,No,NA,NA,Q5VW36,NA,NA,NA,focal adhesion [GO:0005925]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_FOXF1.1.1.m.4194,-0.01010802125326,-0.00643271977407335,No,NA,NA,Q61080,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; animal organ morphogenesis [GO:0009887]; blood vessel development [GO:0001568]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; cellular response to organic cyclic compound [GO:0071407]; detection of wounding [GO:0014822]; determination of left/right symmetry [GO:0007368]; digestive tract development [GO:0048565]; ductus arteriosus closure [GO:0097070]; embryonic digestive tract development [GO:0048566]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic ectodermal digestive tract morphogenesis [GO:0048613]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion development [GO:0003197]; epithelial cell differentiation involved in mammary gland alveolus development [GO:0061030]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; extracellular matrix organization [GO:0030198]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; lateral mesodermal cell differentiation [GO:0048371]; lung alveolus development [GO:0048286]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; lung morphogenesis [GO:0060425]; lung vasculature development [GO:0060426]; mesenchyme migration [GO:0090131]; mesoderm development [GO:0007498]; midgut development [GO:0007494]; morphogenesis of a branching structure [GO:0001763]; negative regulation of inflammatory response [GO:0050728]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system development [GO:0072001]; respiratory tube development [GO:0030323]; right lung morphogenesis [GO:0060461]; smooth muscle cell differentiation [GO:0051145]; smoothened signaling pathway [GO:0007224]; somitogenesis [GO:0001756]; trachea development [GO:0060438]; ureter development [GO:0072189]; vasculogenesis [GO:0001570]; venous blood vessel development [GO:0060841],NA,NA,NA
CHOYP_FOXK2.1.1.m.56318,-0.000285438546551291,-0.00158084693895703,No,NA,NA,Q7ZX03,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; magnesium ion binding [GO:0000287]; sequence-specific DNA binding [GO:0043565]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_FOXN2_3.1.1.m.8518,0.00688706340981683,-0.005296610637784,No,NA,NA,Q33BP8,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_FREM1.1.1.m.55119,-0.0013026229804674,0.0075280276308026,No,NA,NA,Q5H8C1,NA,NA,NA,basement membrane [GO:0005604]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; cell communication [GO:0007154]; cell-matrix adhesion [GO:0007160]; craniofacial suture morphogenesis [GO:0097094],NA,NA,NA
CHOYP_FREM2.1.1.m.31430,-0.00307596978808654,-0.00195753958015224,No,NA,NA,Q9GV77,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell communication [GO:0007154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_FRIS.10.11.m.66055,-0.00892104486973951,-0.0115274430394873,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.6.11.m.44036,0.000245962348943299,0.00542081169964474,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRIS.9.11.m.53958,-0.003511790227503,-0.00599161923168271,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FRIY.1.1.m.5052,0.00138996309466539,0.00564927382569146,No,NA,NA,P42578,NA,NA,NA,cell [GO:0005623]; extracellular region [GO:0005576]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_FRM4B.1.1.m.2249,-0.0166768418933073,0.0163471017082757,No,NA,NA,Q8BIE6,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; protein binding; bridging [GO:0030674]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_FRRS1.2.3.m.41025,0.0349554663241389,0.0193384086496362,No,NA,NA,A4QP81,NA,NA,NA,integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_FUCL1.1.1.m.28893,0,0,No,NA,NA,Q9I931,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_FUCO.1.2.m.58756,-0.00772016818034544,0.0329518742410297,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO.2.2.m.58905,-0.00426649930531297,0.0044057402858463,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_FUCO2.1.1.m.64139,-0.0206573110232582,0.0181537017580258,No,NA,NA,Q9BTY2,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; cellular protein metabolic process [GO:0044267]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; regulation of entry of bacterium into host cell [GO:2000535]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_FUK.1.1.m.17020,9.58425942817588e-05,0.0054677008308742,No,NA,NA,Q8N0W3,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; fucokinase activity [GO:0050201]; carbohydrate phosphorylation [GO:0046835]; GDP-L-fucose salvage [GO:0042352]; response to dopamine [GO:1903350],NA,NA,NA
CHOYP_FUMH.2.2.m.55401,-0.00418784817399934,0.0049956321809921,No,NA,NA,O17214,NA,NA,NA,mitochondrion [GO:0005739]; tricarboxylic acid cycle enzyme complex [GO:0045239]; fumarate hydratase activity [GO:0004333]; fumarate metabolic process [GO:0006106]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_FUT2.4.5.m.54048,0.00330470031041457,-0.000893024412755293,No,NA,NA,Q28113,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactoside 2-alpha-L-fucosyltransferase activity [GO:0008107]; carbohydrate metabolic process [GO:0005975]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_FUT8.1.1.m.9231,-0.00561853850642074,0.0156451553932422,No,NA,NA,Q659X0,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->6)-fucosyltransferase activity [GO:0046921]; glycoprotein 6-alpha-L-fucosyltransferase activity [GO:0008424]; SH3 domain binding [GO:0017124]; GDP-L-fucose metabolic process [GO:0046368]; N-glycan fucosylation [GO:0036071]; protein glycosylation in Golgi [GO:0033578]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_FUTSC.1.4.m.10187,-0.00686212790995937,-0.00436704126283665,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.3.4.m.18545,-0.00738963306359548,0.000927379484362569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FUTSC.4.4.m.59503,-0.0178219150937726,0.0212064533996203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_FYN.1.1.m.44312,0.00190229633223527,-0.00109206751724377,No,NA,NA,Q9CPW4,NA,NA,NA,Arp2/3 protein complex [GO:0005885]; cytoplasm [GO:0005737]; endosome [GO:0005768]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; neuron projection [GO:0043005]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; actin filament network formation [GO:0051639]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell migration [GO:0016477]; lamellipodium organization [GO:0097581]; maintenance of cell polarity [GO:0030011]; microtubule organizing center localization [GO:0061842]; orbitofrontal cortex development [GO:0021769]; smooth muscle cell migration [GO:0014909],NA,NA,NA
CHOYP_FYNA.1.1.m.63901,-7.16171310676734e-05,0.00950186993767734,No,NA,NA,P00523,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; connexin binding [GO:0071253]; growth factor receptor binding [GO:0070851]; heme binding [GO:0020037]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; bone resorption [GO:0045453]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; progesterone receptor signaling pathway [GO:0050847]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_FYV1.1.1.m.41923,0.00144420718450256,-0.0032902073895814,No,NA,NA,Q9Z1T6,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; late endosome membrane [GO:0031902]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; vesicle membrane [GO:0012506]; 1-phosphatidylinositol-3-phosphate 5-kinase activity [GO:0000285]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; 1-phosphatidylinositol-5-kinase activity [GO:0052810]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556]; myelin assembly [GO:0032288]; protein localization to nucleus [GO:0034504]; regulation of autophagosome assembly [GO:2000785]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_FZD7A.1.1.m.29589,0.0103235984450838,0.00809153157326623,No,NA,NA,Q9I9M5,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; Wnt-activated receptor activity [GO:0042813]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_G6PD.2.2.m.46923,-0.000557192946630618,-0.00190997479673351,No,NA,NA,P05370,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; carbohydrate binding [GO:0030246]; glucose binding [GO:0005536]; glucose-6-phosphate dehydrogenase activity [GO:0004345]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cellular response to oxidative stress [GO:0034599]; cholesterol biosynthetic process [GO:0006695]; erythrocyte maturation [GO:0043249]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glutathione metabolic process [GO:0006749]; NADP metabolic process [GO:0006739]; NADPH regeneration [GO:0006740]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of protein glutathionylation [GO:0010734]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051]; positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904879]; regulation of neuron apoptotic process [GO:0043523]; response to ethanol [GO:0045471]; response to food [GO:0032094]; response to iron(III) ion [GO:0010041]; response to organic cyclic compound [GO:0014070]; ribose phosphate biosynthetic process [GO:0046390],NA,NA,NA
CHOYP_GABPA.1.1.m.15077,-0.00449696389584488,-0.0129494566118762,No,NA,NA,Q06546,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; blastocyst formation [GO:0001825]; cell differentiation [GO:0030154]; cellular response to dopamine [GO:1903351]; mitochondrion organization [GO:0007005]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_GACZ.1.1.m.42619,-0.0137469576057344,0.0183253298497135,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GADL1.1.1.m.14433,-0.00345059943150327,-0.00750027821529157,No,NA,NA,Q9Y600,NA,NA,NA,cytoplasm [GO:0005737]; aspartate 1-decarboxylase activity [GO:0004068]; pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; L-cysteine catabolic process to hypotaurine [GO:0019449]; L-cysteine catabolic process to taurine [GO:0019452]; taurine biosynthetic process [GO:0042412],NA,NA,NA
CHOYP_GAK.1.1.m.7017,-0.00483692071075153,-0.00715139222058484,No,NA,NA,O14976,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; presynapse [GO:0098793]; vesicle [GO:0031982]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; cyclin binding [GO:0030332]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; chaperone cofactor-dependent protein refolding [GO:0051085]; clathrin coat disassembly [GO:0072318]; clathrin-coated pit assembly [GO:1905224]; clathrin-dependent endocytosis [GO:0072583]; endoplasmic reticulum organization [GO:0007029]; Golgi organization [GO:0007030]; Golgi to lysosome transport [GO:0090160]; membrane organization [GO:0061024]; negative regulation of neuron projection development [GO:0010977]; protein localization to Golgi apparatus [GO:0034067]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis [GO:0006898]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_GALK2.1.2.m.5222,0.00191451287106415,-0.00477212896170816,No,NA,NA,Q5XIG6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; galactokinase activity [GO:0004335]; galactose binding [GO:0005534]; N-acetylgalactosamine kinase activity [GO:0033858]; galactose catabolic process via UDP-galactose [GO:0033499],NA,NA,NA
CHOYP_GALNS.1.1.m.66165,-0.0239299435751409,-0.00966148297887879,No,NA,NA,Q32KH5,NA,NA,NA,lysosome [GO:0005764]; metal ion binding [GO:0046872]; N-acetylgalactosamine-6-sulfatase activity [GO:0043890],NA,NA,NA
CHOYP_GALT1.1.1.m.33853,0.00554077844900359,-0.00149727659268682,No,NA,NA,Q29121,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_GALT2.1.1.m.54493,0.0107572222778781,-0.0157769224422949,No,NA,NA,Q10471,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; integral component of Golgi membrane [GO:0030173]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; immunoglobulin biosynthetic process [GO:0002378]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GAR1.1.2.m.9449,-0.00147261239005414,-0.00298126065063199,No,NA,NA,Q9CY66,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; box H/ACA telomerase RNP complex [GO:0090661]; Cajal body [GO:0015030]; dense fibrillar component [GO:0001651]; fibrillar center [GO:0001650]; nuclear chromosome; telomeric region [GO:0000784]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; snoRNA binding [GO:0030515]; telomerase RNA binding [GO:0070034]; snoRNA guided rRNA pseudouridine synthesis [GO:0000454]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_GATA1.1.2.m.16576,0.00793386145340796,-0.0103560542239741,No,NA,NA,P52168,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; protein heterodimerization activity [GO:0046982]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor binding [GO:0001085]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; blastoderm segmentation [GO:0007350]; cardioblast cell fate determination [GO:0007510]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cell differentiation [GO:0030154]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; digestive tract development [GO:0048565]; dorsal closure [GO:0007391]; ectoderm development [GO:0007398]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart contraction [GO:0060047]; heart development [GO:0007507]; lymph gland development [GO:0048542]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; pattern specification process [GO:0007389]; pericardial nephrocyte differentiation [GO:0061320]; pigment metabolic process [GO:0042440]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_GATAD1.1.1.m.50020,0.0297699958745657,0.0164149120324561,No,NA,NA,Q1L8G7,NA,NA,NA,I band [GO:0031674]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_GATC.1.2.m.2975,-0.000222529057541084,0.0295242511196282,No,NA,NA,C3XVM1,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543]; regulation of translational fidelity [GO:0006450],NA,NA,NA
CHOYP_GBB.2.2.m.35274,0.00160963452477082,-0.00300115206348097,No,NA,NA,Q17902,NA,NA,NA,nuclear envelope [GO:0005635]; 3'-5' exonuclease activity [GO:0008408]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_GBLP.3.7.m.20931,0.000400725752200485,0.000752541345343886,No,NA,NA,O42249,NA,NA,NA,ribosome [GO:0005840]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of gastrulation [GO:2000543]; regulation of cell division [GO:0051302]; regulation of establishment of cell polarity [GO:2000114]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_GBLP.6.7.m.57427,0.00187556047493042,-0.000307038073601512,No,NA,NA,Q9W2N0,NA,NA,NA,actin cortical patch [GO:0030479]; apical plasma membrane [GO:0016324]; dynactin complex [GO:0005869]; F-actin capping protein complex [GO:0008290]; WASH complex [GO:0071203]; actin filament binding [GO:0051015]; protein heterodimerization activity [GO:0046982]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; barbed-end actin filament capping [GO:0051016]; cell morphogenesis [GO:0000902]; germarium-derived oocyte fate determination [GO:0007294]; microtubule-based movement [GO:0007018]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of JNK cascade [GO:0046329]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_GCC2.1.1.m.17251,-0.000379265215301213,0.0032316832845118,No,NA,NA,Q8CHG3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; identical protein binding [GO:0042802]; Golgi ribbon formation [GO:0090161]; late endosome to Golgi transport [GO:0034499]; microtubule anchoring [GO:0034453]; microtubule organizing center organization [GO:0031023]; protein localization to Golgi apparatus [GO:0034067]; protein targeting to lysosome [GO:0006622]; recycling endosome to Golgi transport [GO:0071955]; regulation of protein exit from endoplasmic reticulum [GO:0070861]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_GCKR.1.1.m.51743,-0.013078160202603,0.0228390653894765,No,NA,NA,Q91754,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; fructose-6-phosphate binding [GO:0070095]; carbohydrate derivative metabolic process [GO:1901135]; carbohydrate metabolic process [GO:0005975]; negative regulation of glucokinase activity [GO:0033132],NA,NA,NA
CHOYP_GCN1L.1.1.m.1352,0.000546833748053573,0.000705866363644691,No,NA,NA,E9PVA8,NA,NA,NA,cytosol [GO:0005829]; polysome [GO:0005844]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; ribosome binding [GO:0043022]; cellular response to amino acid starvation [GO:0034198]; cellular response to leucine starvation [GO:1990253]; positive regulation of kinase activity [GO:0033674]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_GCP2.1.1.m.23103,0.00282344629206032,0.0033344174364011,No,NA,NA,Q921G8,NA,NA,NA,centrosome [GO:0005813]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin complex [GO:0000930]; gamma-tubulin small complex [GO:0008275]; microtubule [GO:0005874]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; structural constituent of cytoskeleton [GO:0005200]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic cell cycle [GO:0000278]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_GCSP.1.1.m.46644,-0.00283523796550075,-0.0013881599228281,No,NA,NA,P23378,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; glycine binding [GO:0016594]; glycine dehydrogenase (decarboxylating) activity [GO:0004375]; lyase activity [GO:0016829]; protein homodimerization activity [GO:0042803]; pyridoxal binding [GO:0070280]; pyridoxal phosphate binding [GO:0030170]; cellular response to leukemia inhibitory factor [GO:1990830]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464]; response to lipoic acid [GO:1903442]; response to methylamine [GO:0036255],NA,NA,NA
CHOYP_GCST.1.1.m.16047,0.000310508920045263,-0.00538162916521626,No,NA,NA,P48728,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aminomethyltransferase activity [GO:0004047]; transaminase activity [GO:0008483]; glycine catabolic process [GO:0006546]; glycine decarboxylation via glycine cleavage system [GO:0019464],NA,NA,NA
CHOYP_GCY.2.4.m.33243,0.000105412005050943,0.00215231085176755,No,NA,NA,P18293,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_GD1L1.1.1.m.11963,0.00412952962442948,-0.00081263926431535,No,NA,NA,A6QQZ0,NA,NA,NA,cytosol [GO:0005829]; integral component of mitochondrial outer membrane [GO:0031307]; mitochondrion [GO:0005739]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053]; mitochondrion organization [GO:0007005]; protein targeting to mitochondrion [GO:0006626]; response to retinoic acid [GO:0032526],NA,NA,NA
CHOYP_GDAP2.1.1.m.57049,-0.00944730605577707,-0.00601224225336093,No,NA,NA,A7T167,NA,NA,NA,,NA,NA,NA
CHOYP_GDE.1.1.m.54948,0.00120536475886203,-0.00312580671295911,No,NA,NA,P35573,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; inclusion body [GO:0016234]; isoamylase complex [GO:0043033]; nucleus [GO:0005634]; sarcoplasmic reticulum [GO:0016529]; secretory granule lumen [GO:0034774]; 4-alpha-glucanotransferase activity [GO:0004134]; amylo-alpha-1;6-glucosidase activity [GO:0004135]; beta-maltose 4-alpha-glucanotransferase activity [GO:0102500]; glycogen debranching enzyme activity [GO:0004133]; polysaccharide binding [GO:0030247]; polyubiquitin modification-dependent protein binding [GO:0031593]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_GDS1B.1.1.m.52257,0.000953141594355029,0.000622241081966878,No,NA,NA,Q5PPZ9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; GTPase activator activity [GO:0005096]; Ral GTPase binding [GO:0017160]; positive regulation of GTPase activity [GO:0043547]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_GEK.1.1.m.4939,0.00416950039622065,0.00271448057956056,No,NA,NA,O54874,NA,NA,NA,actomyosin [GO:0042641]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_GELS2.2.2.m.30443,0.00294485357883139,-0.00230856985687071,No,NA,NA,Q8MPM1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_GEMIN5.2.2.m.59078,0.0105411675904807,0.0126299302659711,No,NA,NA,Q8BX17,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; SMN complex [GO:0032797]; SMN-Gemin2 complex [GO:0034718]; SMN-Sm protein complex [GO:0034719]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; RNA 7-methylguanosine cap binding [GO:0000340]; snRNA binding [GO:0017069]; U1 snRNA binding [GO:0030619]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622]; regulation of translation [GO:0006417]; spliceosomal snRNP assembly [GO:0000387]; translation [GO:0006412],NA,NA,NA
CHOYP_GEPH.1.2.m.49093,-0.00325919352715096,-0.000625544201058962,No,NA,NA,Q9NQX3,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdenum incorporation into molybdenum-molybdopterin complex [GO:0018315]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038],NA,NA,NA
CHOYP_GFM2.1.1.m.18396,-0.0204304323645134,0.00177803033952368,No,NA,NA,A6QNM2,NA,NA,NA,mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translation [GO:0032543]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_GGPPS.1.1.m.12124,0.00239206467779475,-0.00572699250429973,No,NA,NA,O95749,NA,NA,NA,cytosol [GO:0005829]; dimethylallyltranstransferase activity [GO:0004161]; farnesyltranstransferase activity [GO:0004311]; geranyltranstransferase activity [GO:0004337]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384]; geranylgeranyl diphosphate biosynthetic process [GO:0033386]; isoprenoid metabolic process [GO:0006720]; regulation of cholesterol biosynthetic process [GO:0045540],NA,NA,NA
CHOYP_GIGA2.1.1.m.44916,0.0196982051083578,0.0124128699836998,No,NA,NA,P86785,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA3.1.1.m.42774,0.0277227870030685,0.0122924343805038,No,NA,NA,P86786,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.1.3.m.10521,0.00897501003536814,-0.0162939745954166,No,NA,NA,P86787,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA4.2.3.m.41265,-0.00972010956921003,0.0137116656335532,No,NA,NA,P86787,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.3.4.m.17227,0.00350018062548834,-0.000945848777198817,No,NA,NA,P86788,NA,NA,NA,,NA,NA,NA
CHOYP_GIGA5.4.4.m.39598,-9.04412983213541e-05,0.0119993839578989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GIGA6.1.1.m.38687,0.00818758479253885,0.00478802042251357,No,NA,NA,P86789,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GIMA4.4.7.m.42250,0.012405678176334,0.02285477316085,No,NA,NA,Q8K3K9,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_GINS3.1.1.m.18574,-0.0286319692200677,0.0121928199591163,No,NA,NA,Q9CY94,NA,NA,NA,nucleoplasm [GO:0005654]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_GIPC1.1.1.m.60630,-0.000394753426574775,0.00145013942150212,No,NA,NA,Q9Z254,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic vesicle [GO:0008021]; vesicle membrane [GO:0012506]; actin binding [GO:0003779]; myosin binding [GO:0017022]; PDZ domain binding [GO:0030165]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular response to interleukin-7 [GO:0098761]; chemical synaptic transmission [GO:0007268]; endothelial cell migration [GO:0043542]; glutamate secretion [GO:0014047]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of cytokinesis [GO:0032467]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein targeting [GO:0006605]; regulation of protein stability [GO:0031647]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GIT1.1.2.m.26059,0.00216779869746392,-0.0010137392568868,No,NA,NA,Q9Y2X7,NA,NA,NA,calyx of Held [GO:0044305]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ephrin receptor signaling pathway [GO:0048013]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; regulation of cytokinesis [GO:0032465]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic vesicle exocytosis [GO:2000300],NA,NA,NA
CHOYP_GLB1L2.1.1.m.5029,0.0339741973024946,0.00449588095765745,No,NA,NA,Q3UPY5,NA,NA,NA,extracellular region [GO:0005576]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_GLCM.2.3.m.40511,-0.00392121380197801,-0.0276494915650576,No,NA,NA,P17439,NA,NA,NA,extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; glucosylceramidase activity [GO:0004348]; hydrolase activity [GO:0016787]; scavenger receptor binding [GO:0005124]; signaling receptor binding [GO:0005102]; autophagosome organization [GO:1905037]; beta-glucoside catabolic process [GO:1901805]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glucosylceramide catabolic process [GO:0006680]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; positive regulation of neuronal action potential [GO:1904457]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein complex disassembly [GO:0043243]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein lipidation [GO:1903061]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of proteolysis involved in cellular protein catabolic process [GO:1903052]; regulation of cellular protein metabolic process [GO:0032268]; regulation of protein metabolic process [GO:0051246]; regulation of water loss via skin [GO:0033561]; response to dexamethasone [GO:0071548]; response to estrogen [GO:0043627]; response to pH [GO:0009268]; response to testosterone [GO:0033574]; response to thyroid hormone [GO:0097066]; skin morphogenesis [GO:0043589]; sphingosine biosynthetic process [GO:0046512]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_GLMN.1.1.m.17085,-0.00262280491156029,0.00356065898952016,No,NA,NA,Q8BZM1,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytoplasm [GO:0005737]; hepatocyte growth factor receptor binding [GO:0005171]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase inhibitor activity [GO:0055105]; cell surface receptor signaling pathway [GO:0007166]; circulatory system development [GO:0072359]; muscle cell differentiation [GO:0042692]; negative regulation of cell proliferation [GO:0008285]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of phosphorylation [GO:0042327]; regulation of gene expression; epigenetic [GO:0040029]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_GLNA.1.5.m.1591,-0.003923156300715,0.00532598581307501,No,NA,NA,P20478,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4133,0.00749660457891444,0.000437198328113211,No,NA,NA,P20478,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; glutamate catabolic process [GO:0006538]; glutamine biosynthetic process [GO:0006542]; neurotransmitter receptor metabolic process [GO:0045213]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_GLNA2.1.4.m.4134,0.0185270047454993,0.00700486886920144,No,NA,NA,Q86UP9,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_GLO1.1.1.m.32382,-0.00621698320834573,0.0126067907106321,No,NA,NA,Q6P7Q4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; lactoylglutathione lyase activity [GO:0004462]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; glutathione metabolic process [GO:0006749]; methylglyoxal metabolic process [GO:0009438]; negative regulation of apoptotic process [GO:0043066]; osteoclast differentiation [GO:0030316]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GLOD5.1.1.m.25831,0.00587127502684609,0.00693382476531403,No,NA,NA,Q502D1,NA,NA,NA,,NA,NA,NA
CHOYP_GLRX2.1.1.m.19246,-0.0139409628717035,-0.0320307951272108,No,NA,NA,Q5RC53,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_GLRX3.1.1.m.63529,0.000783472615635886,-0.00162351904140144,No,NA,NA,Q28ID3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; electron transfer activity [GO:0009055]; glutathione disulfide oxidoreductase activity [GO:0015038]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein disulfide oxidoreductase activity [GO:0015035]; [2Fe-2S] cluster assembly [GO:0044571]; cell redox homeostasis [GO:0045454]; cellular iron ion homeostasis [GO:0006879]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_GLT13.2.2.m.10604,-0.00659303778694036,0.00684430668653674,No,NA,NA,O08912,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; carbohydrate binding [GO:0030246]; manganese ion binding [GO:0030145]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_GM2A.2.3.m.19346,0.00314504539881404,-5.38189223106737e-05,No,NA,NA,Q60648,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; beta-N-acetylgalactosaminidase activity [GO:0032428]; beta-N-acetylhexosaminidase activity [GO:0004563]; enzyme activator activity [GO:0008047]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; ganglioside catabolic process [GO:0006689]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; nervous system process [GO:0050877]; neuromuscular process controlling balance [GO:0050885]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_GMCLL.1.1.m.15031,0.00523680277755202,-0.00101085318643253,No,NA,NA,Q96IK5,NA,NA,NA,nuclear matrix [GO:0016363]; identical protein binding [GO:0042802]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_GMDS.1.1.m.28602,-0.000553908682796179,-0.000604577958248356,No,NA,NA,Q8K0C9,NA,NA,NA,cytoplasm [GO:0005737]; GDP-mannose 4;6-dehydratase activity [GO:0008446]; identical protein binding [GO:0042802]; NADP+ binding [GO:0070401]; 'de novo' GDP-L-fucose biosynthetic process [GO:0042351]; GDP-mannose metabolic process [GO:0019673]; Notch signaling pathway [GO:0007219],NA,NA,NA
CHOYP_GMEB1.1.1.m.8284,-0.0137814977697152,0.0132190137504464,No,NA,NA,O88873,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_GMFB.2.2.m.54955,-0.0023594692583955,0.00435142483075442,No,NA,NA,Q5R6P6,NA,NA,NA,actin binding [GO:0003779]; Arp2/3 complex binding [GO:0071933]; growth factor activity [GO:0008083]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316],NA,NA,NA
CHOYP_GMPAA.1.1.m.1432,0.000315636230959427,0.00360569460407621,No,NA,NA,Q6GMK8,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298],NA,NA,NA
CHOYP_GMPR2.1.1.m.63274,0.000804269838501242,0.00217809071486971,No,NA,NA,Q9P2T1,NA,NA,NA,cytosol [GO:0005829]; GMP reductase complex [GO:1902560]; GMP reductase activity [GO:0003920]; metal ion binding [GO:0046872]; GMP metabolic process [GO:0046037]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleotide interconversion [GO:0015951]; purine-containing compound salvage [GO:0043101],NA,NA,NA
CHOYP_GNA1.1.1.m.39198,-0.00357988458693485,-0.00197438206749189,No,NA,NA,Q9VAI0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; glucosamine 6-phosphate N-acetyltransferase activity [GO:0004343]; monosaccharide binding [GO:0048029]; N-acetylglucosamine biosynthetic process [GO:0006045]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GNAI.1.1.m.26096,0.00232555250181814,-0.0132810092974063,No,NA,NA,P30682,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAO.1.1.m.37355,0.00410484769792753,-0.00675157604892553,No,NA,NA,P30683,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188],NA,NA,NA
CHOYP_GNAQ.1.1.m.20698,-0.018715175500343,0.0215001109763121,No,NA,NA,O15975,NA,NA,NA,G protein-coupled receptor binding [GO:0001664]; G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNAS.3.3.m.55756,-0.00734595782043519,0.00529592502480298,No,NA,NA,P30684,NA,NA,NA,G-protein beta/gamma-subunit complex binding [GO:0031683]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_GNBPB3.1.1.m.55379,0.00460375363938507,0.00215019257740962,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_GNPI2.1.1.m.55897,-0.00407173980669858,0.00271976068492593,No,NA,NA,A4IHW6,NA,NA,NA,cytoplasm [GO:0005737]; glucosamine-6-phosphate deaminase activity [GO:0004342]; identical protein binding [GO:0042802]; carbohydrate metabolic process [GO:0005975]; glucosamine catabolic process [GO:0006043]; N-acetylglucosamine catabolic process [GO:0006046]; N-acetylneuraminate catabolic process [GO:0019262]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048],NA,NA,NA
CHOYP_GOGB1.1.2.m.26408,-0.00319161956057283,-0.00864557805554549,No,NA,NA,Q27421,NA,NA,NA,,NA,NA,NA
CHOYP_GOGB1.2.2.m.66418,0.00375094407768372,0.00129384160797658,No,NA,NA,Q27421,NA,NA,NA,,NA,NA,NA
CHOYP_GOLGA4.1.3.m.4761,-0.00731515211731734,0.00109494531798722,No,NA,NA,Q91VW5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773],NA,NA,NA
CHOYP_GOLGA4.3.3.m.55461,-0.00293751347659022,0.00801764382393961,No,NA,NA,Q13439,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; trans-Golgi network [GO:0005802]; GTPase binding [GO:0051020]; Golgi to plasma membrane protein transport [GO:0043001]; positive regulation of axon extension [GO:0045773]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_GOLI4.2.4.m.15493,0.0140802100034239,-0.00709095894575405,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLI4.3.4.m.29146,0.000816967732325779,0.0141233807117996,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_GOLP3.1.1.m.52389,-0.000933229243268474,-0.00408371313849256,No,NA,NA,Q9VQ93,NA,NA,NA,cleavage furrow [GO:0032154]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; Rab GTPase binding [GO:0017137]; actomyosin contractile ring assembly [GO:0000915]; cleavage furrow formation [GO:0036089]; Golgi organization [GO:0007030]; Golgi to plasma membrane protein transport [GO:0043001]; Golgi vesicle budding [GO:0048194]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; meiosis II cytokinesis [GO:0007111]; mitotic cytokinesis [GO:0000281]; mitotic spindle assembly [GO:0090307]; retrograde transport; vesicle recycling within Golgi [GO:0000301]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle assembly [GO:0051225]; spindle assembly involved in male meiosis [GO:0007053],NA,NA,NA
CHOYP_GOPC.1.1.m.45489,0.000424276971498537,-0.0109334131493875,No,NA,NA,Q8BH60,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; trans-Golgi network transport vesicle [GO:0030140]; frizzled binding [GO:0005109]; GTPase regulator activity [GO:0030695]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; cytoplasmic sequestering of CFTR protein [GO:0043004]; negative regulation of anion channel activity [GO:0010360]; negative regulation of protein localization to cell surface [GO:2000009]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_GPAT4.1.1.m.56178,0.00605850748080951,-0.010999114941313,No,NA,NA,Q5R6J7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; glycerol-3-phosphate O-acyltransferase activity [GO:0004366]; sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity [GO:0102420]; acyl-CoA metabolic process [GO:0006637]; CDP-diacylglycerol biosynthetic process [GO:0016024]; diacylglycerol metabolic process [GO:0046339]; fatty acid metabolic process [GO:0006631]; glandular epithelial cell maturation [GO:0002071]; lactation [GO:0007595]; lipid biosynthetic process [GO:0008610]; phosphatidylcholine biosynthetic process [GO:0006656]; regulation of multicellular organism growth [GO:0040014]; triglyceride biosynthetic process [GO:0019432],NA,NA,NA
CHOYP_GPC6.1.1.m.64926,-0.0166994363261946,0.0104402954883259,No,NA,NA,Q9R087,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; synapse [GO:0045202]; cell migration [GO:0016477]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_GPCP1.1.1.m.11490,-0.00478121952644523,-0.0038578197415651,No,NA,NA,Q9NPB8,NA,NA,NA,cytosol [GO:0005829]; glycerophosphocholine phosphodiesterase activity [GO:0047389]; starch binding [GO:2001070]; glycerophospholipid catabolic process [GO:0046475]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_GPDA.1.2.m.6967,-0.000187223078185581,-0.00187939846765829,No,NA,NA,O35077,NA,NA,NA,cytosol [GO:0005829]; glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO:0047952]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; cellular response to cAMP [GO:0071320]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerol-3-phosphate metabolic process [GO:0006072]; glycerolipid metabolic process [GO:0046486]; glycerophosphate shuttle [GO:0006127]; NADH metabolic process [GO:0006734]; NADH oxidation [GO:0006116]; positive regulation of glycolytic process [GO:0045821],NA,NA,NA
CHOYP_GPDA.2.2.m.30755,0.000215288203488112,0.000366868321892034,No,NA,NA,Q27928,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; carbohydrate metabolic process [GO:0005975]; glycerol-3-phosphate catabolic process [GO:0046168]; glycerophospholipid metabolic process [GO:0006650],NA,NA,NA
CHOYP_GPM6A.1.1.m.41817,0.00757043077571631,-0.0313147188870747,No,NA,NA,P35803,NA,NA,NA,integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; extracellular matrix assembly [GO:0085029]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of serotonin uptake [GO:0051612]; neuron projection development [GO:0031175]; ossification [GO:0001503]; positive regulation of bone mineralization [GO:0030501]; protein transport [GO:0015031]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_GPMA.1.1.m.35689,0.00062676372628497,-0.00153343905569682,No,NA,NA,Q54NE6,NA,NA,NA,cytosol [GO:0005829]; phagocytic vesicle [GO:0045335]; bisphosphoglycerate mutase activity [GO:0004082]; hydrolase activity [GO:0016787]; phosphoglycerate mutase activity [GO:0004619]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_GPN3.1.2.m.6649,-5.98329758771058e-05,0.000816202106798485,No,NA,NA,O15145,NA,NA,NA,actin cytoskeleton [GO:0015629]; Arp2/3 protein complex [GO:0005885]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; focal adhesion [GO:0005925]; growth cone leading edge [GO:0061850]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actin polymerization-dependent cell motility [GO:0070358]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cellular response to nerve growth factor stimulus [GO:1990090]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_GPR98.4.5.m.21296,0.00901004664514447,0.00485850025855586,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GPSM2.1.1.m.58301,-0.0231877034502314,-0.00225167945699594,No,NA,NA,P81274,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; mitotic spindle pole [GO:0097431]; protein-containing complex [GO:0032991]; dynein complex binding [GO:0070840]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; identical protein binding [GO:0042802]; nucleotide binding [GO:0000166]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein self-association [GO:0043621]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; G protein-coupled receptor signaling pathway [GO:0007186]; maintenance of centrosome location [GO:0051661]; mitotic spindle organization [GO:0007052]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of spindle assembly [GO:1905832]; Ran protein signal transduction [GO:0031291]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_GPSM2.1.1.m.58302,-0.000163595930214899,0.000583615676402888,No,NA,NA,O42387,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_GPX1.1.4.m.11300,0.0163577462239269,-0.000940241634306589,No,NA,NA,Q8MJ14,NA,NA,NA,cytoplasm [GO:0005737]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX3.1.2.m.24838,-0.0143195171337431,0.0196760688045264,No,NA,NA,G9JJU2,NA,NA,NA,glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_GPX4.A.1.1.m.257,-0.000430649454757583,-0.00141324733898654,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GR101.3.3.m.43507,-0.00752969352024226,-0.00479187836934483,No,NA,NA,P46023,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_GRAP1.1.1.m.45768,0.0128436401563076,-5.64640250943315e-05,No,NA,NA,Q8VD04,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of postsynaptic early endosome membrane [GO:0098998]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; regulation of modification of synaptic structure [GO:1905244]; regulation of neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0099152]; regulation of recycling endosome localization within postsynapse [GO:0099158],NA,NA,NA
CHOYP_GRDN.1.5.m.12675,-0.00650425249286558,-0.00413929023080835,No,NA,NA,Q3V6T2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; dynein light intermediate chain binding [GO:0051959]; microtubule binding [GO:0008017]; phosphatidylinositol binding [GO:0035091]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; activation of protein kinase B activity [GO:0032148]; cell migration [GO:0016477]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; DNA replication [GO:0006260]; lamellipodium assembly [GO:0030032]; membrane organization [GO:0061024]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell proliferation [GO:0042127]; regulation of DNA replication [GO:0006275]; regulation of neuron projection development [GO:0010975]; regulation of protein phosphorylation [GO:0001932]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_GRIA3.1.1.m.44173,0.000257662815876194,0.00427787868791482,No,NA,NA,Q91756,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_GRK5.1.1.m.6617,-0.00159127009320271,-0.00185738242458654,No,NA,NA,P43249,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; lipid binding [GO:0008289]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; fat cell differentiation [GO:0045444]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell proliferation [GO:0008284]; protein autophosphorylation [GO:0046777]; regulation of cell cycle [GO:0051726]; tachykinin receptor signaling pathway [GO:0007217]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GRM1.2.2.m.65835,0.00162255039838695,0.00138807369518769,No,NA,NA,Q14416,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; chemical synaptic transmission [GO:0007268]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; glutamate homeostasis [GO:0090461]; glutamate secretion [GO:0014047]; negative regulation of adenylate cyclase activity [GO:0007194]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_GRP75.1.1.m.11678,-0.000144151318059876,0.000477951859844734,No,NA,NA,Q3ZCH0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; erythrocyte differentiation [GO:0030218]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of hemopoiesis [GO:1903707]; protein export from nucleus [GO:0006611]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_GRP78.2.5.m.33058,0.000165427422697999,0.00180884281678685,No,NA,NA,Q16956,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_GSH1.1.1.m.8927,-0.0153215591400905,-0.0201008095484925,No,NA,NA,P19468,NA,NA,NA,cytosol [GO:0005829]; glutamate-cysteine ligase complex [GO:0017109]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; coenzyme binding [GO:0050662]; glutamate binding [GO:0016595]; glutamate-cysteine ligase activity [GO:0004357]; magnesium ion binding [GO:0000287]; protein heterodimerization activity [GO:0046982]; aging [GO:0007568]; apoptotic mitochondrial changes [GO:0008637]; cell redox homeostasis [GO:0045454]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucose stimulus [GO:0071333]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to insulin stimulus [GO:0032869]; cellular response to mechanical stimulus [GO:0071260]; cellular response to thyroxine stimulus [GO:0097069]; cysteine metabolic process [GO:0006534]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; L-ascorbic acid metabolic process [GO:0019852]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of hepatic stellate cell activation [GO:2000490]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; regulation of blood vessel size [GO:0050880]; regulation of mitochondrial depolarization [GO:0051900]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to human chorionic gonadotropin [GO:0044752]; response to interleukin-1 [GO:0070555]; response to nitrosative stress [GO:0051409]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410],NA,NA,NA
CHOYP_GSHB.1.1.m.27512,-0.000848389888755304,0.00206838828427967,No,NA,NA,Q5EAC2,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; glutathione binding [GO:0043295]; glutathione synthase activity [GO:0004363]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_GSK3B.1.1.m.62139,-0.00266383551686083,0.00263644431101119,No,NA,NA,Q9WV60,NA,NA,NA,axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; cell body [GO:0044297]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; membrane [GO:0016020]; membrane raft [GO:0045121]; membrane-bounded organelle [GO:0043227]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; Schaffer collateral - CA1 synapse [GO:0098685]; Wnt signalosome [GO:1990909]; ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; dynein complex binding [GO:0070840]; integrin binding [GO:0005178]; ionotropic glutamate receptor binding [GO:0035255]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II transcription factor binding [GO:0001085]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interleukin-3 [GO:0036016]; cellular response to mechanical stimulus [GO:0071260]; circadian rhythm [GO:0007623]; cytoskeleton organization [GO:0007010]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; establishment or maintenance of cell polarity [GO:0007163]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fat cell differentiation [GO:0045444]; glycogen metabolic process [GO:0005977]; hepatic stellate cell activation [GO:0035733]; hepatocyte apoptotic process [GO:0097284]; hippocampus development [GO:0021766]; hypermethylation of CpG island [GO:0044027]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; maintenance of cell polarity [GO:0030011]; myoblast fusion [GO:0007520]; myotube differentiation [GO:0014902]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of dendrite development [GO:2000171]; negative regulation of dendrite morphogenesis [GO:0050774]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron maturation [GO:0014043]; negative regulation of neuron migration [GO:2001223]; negative regulation of neuron projection development [GO:0010977]; negative regulation of nitric-oxide synthase activity [GO:0051001]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein binding [GO:0032091]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein localization to centrosome [GO:1904780]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of TOR signaling [GO:0032007]; neuron projection development [GO:0031175]; neuron projection retraction [GO:0106028]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of axon extension [GO:0045773]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein complex assembly [GO:0031334]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; protein export from nucleus [GO:0006611]; protein localization to microtubule [GO:0035372]; protein phosphorylation [GO:0006468]; re-entry into mitotic cell cycle [GO:0000320]; regulation of apoptotic process [GO:0042981]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of dendrite morphogenesis [GO:0048814]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of neuron projection development [GO:0010975]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of osteoblast differentiation [GO:0045667]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to zinc ion [GO:0010043]; superior temporal gyrus development [GO:0071109]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_GSLG1.3.3.m.66468,0.00101602502920715,0.00089104992483279,No,NA,NA,Q61543,NA,NA,NA,extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; fibroblast growth factor binding [GO:0017134]; bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330],NA,NA,NA
CHOYP_GSPATT00009499001.1.1.m.34366,-0.00586207142661888,-0.00127321531677353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GSPATT00037947001.1.1.m.24620,-0.00124176945944413,-0.0135088995446356,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_GST7.1.1.m.59335,-0.00826755861246864,0.000752925282353809,No,NA,NA,P46088,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTO1.1.2.m.14745,0.0175352646198578,0.00414581176841579,No,NA,NA,P78417,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTO1.2.2.m.26202,0.000737567732757013,0.00142762539539143,No,NA,NA,Q9VSL3,NA,NA,NA,cytoplasm [GO:0005737]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; pyrimidodiazepine synthase activity [GO:0004734]; transferase activity; transferring sulfur-containing groups [GO:0016782]; eye pigment biosynthetic process [GO:0006726]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114]; pteridine biosynthetic process [GO:0006728],NA,NA,NA
CHOYP_GSTO2.1.1.m.36486,0.000880103113679491,-0.00426801010833628,No,NA,NA,P78417,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione dehydrogenase (ascorbate) activity [GO:0045174]; glutathione transferase activity [GO:0004364]; methylarsonate reductase activity [GO:0050610]; oxidoreductase activity [GO:0016491]; cellular response to arsenic-containing substance [GO:0071243]; glutathione derivative biosynthetic process [GO:1901687]; interleukin-12-mediated signaling pathway [GO:0035722]; L-ascorbic acid metabolic process [GO:0019852]; methylation [GO:0032259]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; oxidation-reduction process [GO:0055114]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014810]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; xenobiotic catabolic process [GO:0042178],NA,NA,NA
CHOYP_GSTP1.1.2.m.29677,-0.00891552810547424,-0.0206159031621896,No,NA,NA,P19157,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; TRAF2-GSTP1 complex [GO:0097057]; dinitrosyl-iron complex binding [GO:0035731]; drug binding [GO:0008144]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; JUN kinase binding [GO:0008432]; kinase regulator activity [GO:0019207]; protein kinase binding [GO:0019901]; S-nitrosoglutathione binding [GO:0035730]; animal organ regeneration [GO:0031100]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; common myeloid progenitor cell proliferation [GO:0035726]; glutathione metabolic process [GO:0006749]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of neutrophil aggregation [GO:2000429]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of peroxidase activity [GO:2000469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of tumor necrosis factor production [GO:0032720]; oligodendrocyte development [GO:0014003]; positive regulation of superoxide anion generation [GO:0032930]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of stress-activated MAPK cascade [GO:0032872]; response to amino acid [GO:0043200]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to L-ascorbic acid [GO:0033591]; response to nutrient levels [GO:0031667]; response to reactive oxygen species [GO:0000302]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_GSTP1.2.2.m.30099,-0.00185255265599337,0.0063348059571363,No,NA,NA,P81942,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_GSTS8.1.1.m.12434,-0.00901581918832428,0.0171536212799714,No,NA,NA,O73888,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_GSTUL.1.1.m.35986,0.000604509031931837,0.0209189390721489,No,NA,NA,Q9ZRW8,NA,NA,NA,chloroplast [GO:0009507]; chloroplast stroma [GO:0009570]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; peroxidase activity [GO:0004601]; cellular response to water deprivation [GO:0042631]; glutathione metabolic process [GO:0006749]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979]; toxin catabolic process [GO:0009407],NA,NA,NA
CHOYP_GSTZ1.1.1.m.56540,-7.60764047445216e-05,0.00302118739288119,No,NA,NA,Q9VHD2,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; glutathione transferase activity [GO:0004364]; maleylacetoacetate isomerase activity [GO:0016034]; glutathione metabolic process [GO:0006749]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_GTPB1.1.1.m.66453,-0.0036196590098127,0.0026450050239341,No,NA,NA,O08582,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; GTP metabolic process [GO:0046039]; positive regulation of mRNA catabolic process [GO:0061014]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_GTR1.1.1.m.25509,0.00975682428001764,0.0115225584756749,No,NA,NA,P27674,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cortical actin cytoskeleton [GO:0030864]; cytosol [GO:0005829]; female pronucleus [GO:0001939]; integral component of plasma membrane [GO:0005887]; melanosome [GO:0042470]; membrane raft [GO:0045121]; midbody [GO:0030496]; D-glucose transmembrane transporter activity [GO:0055056]; dehydroascorbic acid transmembrane transporter activity [GO:0033300]; glucose transmembrane transporter activity [GO:0005355]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; cellular response to glucose starvation [GO:0042149]; glucose import [GO:0046323]; glucose transmembrane transport [GO:1904659]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_GUAA.1.1.m.18809,-0.00192516539032602,-0.00413360325531168,No,NA,NA,Q5RA96,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; GMP synthase (glutamine-hydrolyzing) activity [GO:0003922]; pyrophosphatase activity [GO:0016462]; glutamine metabolic process [GO:0006541]; GMP biosynthetic process [GO:0006177],NA,NA,NA
CHOYP_GUAD.1.1.m.33511,0.00129428383044946,-0.002440420375745,No,NA,NA,Q5RAV9,NA,NA,NA,guanine deaminase activity [GO:0008892]; zinc ion binding [GO:0008270]; guanine catabolic process [GO:0006147],NA,NA,NA
CHOYP_GUK1.1.1.m.48140,-0.00155701586968822,-0.00128548500042906,No,NA,NA,P15454,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; GDP biosynthetic process [GO:0046711]; purine nucleotide metabolic process [GO:0006163],NA,NA,NA
CHOYP_GULP1.1.1.m.44407,-0.0114755923559924,0.000760992019884041,No,NA,NA,Q32PV0,NA,NA,NA,cytoplasm [GO:0005737]; apoptotic process [GO:0006915]; phagocytosis [GO:0006909],NA,NA,NA
CHOYP_GUN.1.2.m.26883,-0.0261636052956724,-0.0245306463056503,No,NA,NA,P82186,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GUN.2.2.m.46462,0.0120554939546727,0.00385774259155039,No,NA,NA,P82186,NA,NA,NA,cellulase activity [GO:0008810]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_GZF1.1.2.m.7747,0.00227225602135682,0.000147380614221436,No,NA,NA,P18737,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_H2AV.1.7.m.12182,-0.00369754337983632,-0.00188515338839445,No,NA,NA,Q5BJ65,NA,NA,NA,nuclear chromatin [GO:0000790]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_H2BL3.1.1.m.16594,0.0132332385810493,-0.0123569340381778,No,NA,NA,P0C1H5,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_H3.1.2.m.3829,-0.00784742949830609,-0.00177168523659062,No,NA,NA,P84239,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982],NA,NA,NA
CHOYP_HAAF.11.13.m.44366,0.00775132842617855,0.0091541194646422,No,NA,NA,Q01528,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HAAF.3.13.m.8849,-0.0198484215017855,-0.00337026900024862,No,NA,NA,Q01528,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_HACE1.1.2.m.24806,-0.0167597413432806,0.000725750016754871,No,NA,NA,Q28BK1,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; Rab GTPase binding [GO:0017137]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of cell migration [GO:0030334]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HACL1.1.1.m.6578,0.0047902119293372,0.0118729736468218,No,NA,NA,Q9UJ83,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carbon-carbon lyase activity [GO:0016830]; cofactor binding [GO:0048037]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; signaling receptor binding [GO:0005102]; thiamine pyrophosphate binding [GO:0030976]; fatty acid alpha-oxidation [GO:0001561]; protein complex oligomerization [GO:0051259]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_HAND1.1.1.m.10874,-9.3546219943553e-05,0.0124113323420494,No,NA,NA,P57102,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983]; cardiac muscle cell differentiation [GO:0055007]; cardioblast differentiation [GO:0010002]; cardiocyte differentiation [GO:0035051]; cardiogenic plate morphogenesis [GO:0003142]; determination of intestine left/right asymmetry [GO:0071908]; embryonic heart tube formation [GO:0003144]; embryonic pectoral fin morphogenesis [GO:0035118]; embryonic viscerocranium morphogenesis [GO:0048703]; heart contraction [GO:0060047]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; noradrenergic neuron differentiation [GO:0003357]; polarized epithelial cell differentiation [GO:0030859]; proepicardium development [GO:0003342]; sympathetic nervous system development [GO:0048485]; thyroid gland development [GO:0030878],NA,NA,NA
CHOYP_HBS1L.1.2.m.14311,-0.0147270645207568,0.0211509727741686,No,NA,NA,Q9Y450,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; signal transduction [GO:0007165]; translation [GO:0006412],NA,NA,NA
CHOYP_HBX5.1.1.m.11081,0.00228446919322367,0.00269789934812169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HD.1.1.m.56119,0.00311458782685341,0.00598123905348207,No,NA,NA,P42859,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; postsynaptic density [GO:0014069]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; beta-tubulin binding [GO:0048487]; diazepam binding [GO:0050809]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; signaling receptor binding [GO:0005102]; transcription factor binding [GO:0008134]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; associative learning [GO:0008306]; axo-dendritic transport [GO:0008088]; brain development [GO:0007420]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; citrulline metabolic process [GO:0000052]; determination of adult lifespan [GO:0008340]; dopamine receptor signaling pathway [GO:0007212]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endosomal transport [GO:0016197]; establishment of mitotic spindle orientation [GO:0000132]; gastrulation [GO:0007369]; Golgi organization [GO:0007030]; grooming behavior [GO:0007625]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; iron ion homeostasis [GO:0055072]; L-glutamate import [GO:0051938]; lactate biosynthetic process from pyruvate [GO:0019244]; learning [GO:0007612]; learning or memory [GO:0007611]; locomotory behavior [GO:0007626]; mitochondrial transport [GO:0006839]; mitochondrion organization [GO:0007005]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; neural plate formation [GO:0021990]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; olfactory lobe development [GO:0021988]; paraxial mesoderm formation [GO:0048341]; peptide hormone secretion [GO:0030072]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of motile cilium assembly [GO:1905505]; positive regulation of non-motile cilium assembly [GO:1902857]; postsynapse to nucleus signaling pathway [GO:0099527]; protein destabilization [GO:0031648]; protein localization to centrosome [GO:0071539]; protein localization to nucleus [GO:0034504]; quinolinate biosynthetic process [GO:0019805]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gene expression [GO:0010468]; regulation of intracellular mRNA localization [GO:1904580]; regulation of mitochondrial membrane permeability [GO:0046902]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein localization to nucleus [GO:1900180]; regulation of synaptic plasticity [GO:0048167]; response to calcium ion [GO:0051592]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; social behavior [GO:0035176]; spermatogenesis [GO:0007283]; striatum development [GO:0021756]; urea cycle [GO:0000050]; vesicle transport along microtubule [GO:0047496]; visual learning [GO:0008542]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HEAT1.1.1.m.11228,0.00381975191083322,0.00504456025419651,No,NA,NA,Q7SY48,NA,NA,NA,90S preribosome [GO:0030686]; small-subunit processome [GO:0032040]; t-UTP complex [GO:0034455]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase I [GO:0045943]; regulation of RNA stability [GO:0043487],NA,NA,NA
CHOYP_HEATR3.1.1.m.33423,-0.00717912734995024,-0.0171344394091229,No,NA,NA,Q7Z4Q2,NA,NA,NA,cell [GO:0005623]; unfolded protein binding [GO:0051082]; protein import into nucleus [GO:0006606]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_HECD1.1.1.m.27759,-0.00119224824606587,-0.00869599944983343,No,NA,NA,Q9ULT8,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; protein K63-linked ubiquitination [GO:0070534],NA,NA,NA
CHOYP_HELZ.2.2.m.43303,-0.00460514423303425,0.0101804476466821,No,NA,NA,Q6NYU2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P granule [GO:0043186]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; posttranscriptional gene silencing by RNA [GO:0035194],NA,NA,NA
CHOYP_HEM2.1.1.m.6789,0.000126818591921154,-0.0145719810204898,No,NA,NA,Q58DK5,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; zinc ion binding [GO:0008270]; cellular response to interleukin-4 [GO:0071353]; heme biosynthetic process [GO:0006783]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM3.1.1.m.28414,-0.000501904321182528,-0.00774911808738213,No,NA,NA,Q2KIN5,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HEM6.1.1.m.17205,0.00713995267400828,0.0135479747380659,No,NA,NA,Q9V3D2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; coproporphyrinogen oxidase activity [GO:0004109]; protein homodimerization activity [GO:0042803]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process from glutamate [GO:0019353],NA,NA,NA
CHOYP_HERC1.2.2.m.51367,0.000601508502399118,-0.000162544777639732,No,NA,NA,Q15751,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ubiquitin-protein transferase activity [GO:0004842]; cerebellar Purkinje cell differentiation [GO:0021702]; negative regulation of autophagy [GO:0010507]; neuromuscular process controlling balance [GO:0050885]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_HERC2.1.1.m.65153,-0.00201001953502203,0.00263097191974289,No,NA,NA,O95714,NA,NA,NA,centriole [GO:0005814]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; SUMO binding [GO:0032183]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair via nonhomologous end joining [GO:0006303]; intracellular protein transport [GO:0006886]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_HES1.2.3.m.27001,0.00481009621569581,0.00568059988868398,No,NA,NA,Q90Z12,NA,NA,NA,nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; BMP signaling pathway [GO:0030509]; cell proliferation [GO:0008283]; floor plate development [GO:0033504]; lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neural crest formation [GO:0014029]; prechordal plate formation [GO:0021501],NA,NA,NA
CHOYP_HEX.1.1.m.43068,0.00165964570749336,0.000605469204495899,No,NA,NA,H2A0L6,NA,NA,NA,extracellular region [GO:0005576]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; carbohydrate metabolic process [GO:0005975]; chitin catabolic process [GO:0006032],NA,NA,NA
CHOYP_HGFAC.1.1.m.5902,0.00339544979662992,-0.000917547515918358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HHEX.2.2.m.19527,-0.022634703203127,-0.0144046692450392,No,NA,NA,O88271,NA,NA,NA,basement membrane [GO:0005604]; condensed chromosome kinetochore [GO:0000777]; cell adhesion [GO:0007155]; multicellular organism development [GO:0007275]; negative regulation of fibroblast apoptotic process [GO:2000270]; regulation of cell proliferation [GO:0042127]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_HIF1N.1.1.m.53726,0.00791421866336361,-0.0265251795980207,No,NA,NA,Q9NWT6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; ankyrin repeat binding [GO:0071532]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; hypoxia-inducible factor-asparagine oxygenase activity [GO:0102113]; iron ion binding [GO:0005506]; NF-kappaB binding [GO:0051059]; Notch binding [GO:0005112]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; oxygen sensor activity [GO:0019826]; peptidyl-asparagine 3-dioxygenase activity [GO:0036140]; peptidyl-histidine dioxygenase activity [GO:0036139]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; oxidation-reduction process [GO:0055114]; peptidyl-asparagine hydroxylation [GO:0042265]; peptidyl-aspartic acid hydroxylation [GO:0042264]; peptidyl-histidine hydroxylation [GO:0036138]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of vasculogenesis [GO:2001214]; regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061418],NA,NA,NA
CHOYP_HINT1.1.1.m.53526,-0.000999983891706611,0.00160488644386714,No,NA,NA,P80912,NA,NA,NA,cytoplasm [GO:0005737]; histone deacetylase complex [GO:0000118]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; purine ribonucleotide catabolic process [GO:0009154]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_HIP1.1.1.m.31791,-0.00174553533453124,-0.0114709019649048,No,NA,NA,O00291,NA,NA,NA,actin cortical patch [GO:0030479]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; presynapse [GO:0098793]; actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]; actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane organization [GO:0061024]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_HIRA.1.1.m.19212,-0.00251178921097802,-0.0140949983829483,No,NA,NA,O42611,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_HMBS.1.1.m.31422,-0.000787360037493939,-0.00245478328997294,No,NA,NA,Q2KIN5,NA,NA,NA,cytoplasm [GO:0005737]; hydroxymethylbilane synthase activity [GO:0004418]; heme biosynthetic process [GO:0006783]; peptidyl-pyrromethane cofactor linkage [GO:0018160]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_HMCN1.19.44.m.39500,-0.000733274263168991,0.0150436764919527,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.23.44.m.42684,0.0131429244520505,0.0115706523747316,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.28.44.m.47379,0.0331013284095094,0.00355140435770772,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_HMCN1.32.44.m.58935,0.0130917842281163,-0.00811960977934993,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN1.33.44.m.58938,0.0189408017762979,-0.00320049107818549,No,NA,NA,P98160,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_HMCN1.39.44.m.61047,-0.0107975133430107,-0.00687151083798962,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN1.5.44.m.7236,0.00341640741817766,-0.0278032651373762,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HMCN2.10.12.m.49343,-0.0111518183559784,-0.00709698967364558,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_HMCN2.11.12.m.51619,0.00457031568201082,-0.00829732861826976,No,NA,NA,Q9W6R5,NA,NA,NA,extracellular region [GO:0005576]; plasma membrane [GO:0005886]; lipid binding [GO:0008289]; cell adhesion [GO:0007155]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.3.12.m.26811,-7.13951312007994e-05,-0.00239575671588216,No,NA,NA,Q5UNS9,NA,NA,NA,virion [GO:0019012],NA,NA,NA
CHOYP_HMCN2.6.12.m.33452,-0.0139028900404031,0.0256735850406988,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_HMCN2.8.12.m.39297,0.00112507113628199,0.0163362909959056,No,NA,NA,A2AJ76,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_HMCN2.9.12.m.44986,0.0106205190752369,0.0183353093650567,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HN1L.2.2.m.9837,-0.00167706967508006,-0.00856413999507943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HNRPR.1.2.m.44125,0.00168974069200283,-0.00188815500472886,No,NA,NA,O43390,NA,NA,NA,axon terminus [GO:0043679]; catalytic step 2 spliceosome [GO:0071013]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; circadian rhythm [GO:0007623]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of catalytic activity [GO:0043086]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_HNRPR.1.2.m.44126,0.00402940781539952,-0.00108886107970478,No,NA,NA,P07291,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_HOIL1.2.3.m.54310,0.00709725560203239,0.0167377451626456,No,NA,NA,A9JTG5,NA,NA,NA,LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin-protein transferase activity [GO:0004842]; embryonic cranial skeleton morphogenesis [GO:0048701]; otic vesicle morphogenesis [GO:0071600]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein linear polyubiquitination [GO:0097039],NA,NA,NA
CHOYP_HOOK3.1.1.m.14456,-0.0102591668656428,0.0102965887392768,No,NA,NA,Q86VS8,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; FHF complex [GO:0070695]; microtubule [GO:0005874]; pericentriolar material [GO:0000242]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton-dependent intracellular transport [GO:0030705]; early endosome to late endosome transport [GO:0045022]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; Golgi localization [GO:0051645]; interkinetic nuclear migration [GO:0022027]; lysosome organization [GO:0007040]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuronal stem cell population maintenance [GO:0097150]; protein localization to centrosome [GO:0071539]; protein transport [GO:0015031],NA,NA,NA
CHOYP_HOW.5.5.m.58452,0.00386988215005056,0.000936615452637959,No,NA,NA,O01367,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; single-stranded RNA binding [GO:0003727]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon ensheathment [GO:0008366]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; germ-line stem cell population maintenance [GO:0030718]; glial cell migration [GO:0008347]; mesoderm development [GO:0007498]; mesodermal cell migration [GO:0008078]; muscle attachment [GO:0016203]; muscle cell fate determination [GO:0007521]; muscle organ development [GO:0007517]; oenocyte development [GO:0007438]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of embryonic development [GO:0045995]; regulation of heart contraction [GO:0008016]; regulation of translation [GO:0006417]; sarcomere organization [GO:0045214]; somatic muscle development [GO:0007525]; spermatogonial cell division [GO:0007284],NA,NA,NA
CHOYP_HPGD.1.3.m.50258,0.00671139613963657,0.00144396309948056,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_HPRT.1.1.m.61881,0.000687963559167956,0.00109722083205272,No,NA,NA,P47959,NA,NA,NA,cytoplasm [GO:0005737]; guanine phosphoribosyltransferase activity [GO:0052657]; hypoxanthine phosphoribosyltransferase activity [GO:0004422]; magnesium ion binding [GO:0000287]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; GMP catabolic process [GO:0046038]; guanine salvage [GO:0006178]; hypoxanthine metabolic process [GO:0046100]; hypoxanthine salvage [GO:0043103]; IMP metabolic process [GO:0046040]; IMP salvage [GO:0032264]; positive regulation of dopamine metabolic process [GO:0045964]; protein homotetramerization [GO:0051289]; purine nucleotide biosynthetic process [GO:0006164]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_HS12A.10.33.m.38139,0.00436843297523334,-0.0140512618000057,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.12.33.m.39763,0.00609388558219866,0.0196525020454019,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.14.33.m.41988,0.00432027103931774,-0.00021743684248244,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.20.33.m.55554,-0.00509109262997517,0.0168960920752018,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.24.33.m.60051,0.022615577180761,0.0177491746888913,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12A.25.33.m.60352,0.000972312961766729,0.0130876884249678,No,NA,NA,Q9CZJ2,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.10.14.m.59859,-0.00537640872564062,-0.00197596913985069,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.2.14.m.19896,0.0133709344468968,-0.00198033844827284,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40600,0.00221712321479139,-0.00701030733680986,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HS12B.7.14.m.40601,0.00019978116847334,-0.000359229004477412,No,NA,NA,Q5EAE6,NA,NA,NA,death domain binding [GO:0070513]; apoptotic signaling pathway [GO:0097190]; autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; negative regulation of autophagy [GO:0010507],NA,NA,NA
CHOYP_HS74L.1.1.m.24610,0.000325698260071598,-0.00019935842655116,No,NA,NA,O95757,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HS90A.1.3.m.7725,0.00516020439029757,9.80274329797813e-05,No,NA,NA,O14562,NA,NA,NA,cadherin binding [GO:0045296]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_HS90A.3.3.m.28299,-0.00860698169530744,0.0139473416440307,No,NA,NA,Q90474,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HS90A.3.3.m.28300,0.00071681954720603,0.00475147068171337,No,NA,NA,P24539,NA,NA,NA,membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proton transmembrane transporter activity [GO:0015078]; transmembrane transporter activity [GO:0022857]; ATP biosynthetic process [GO:0006754]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; ATP synthesis coupled proton transport [GO:0015986]; cristae formation [GO:0042407]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_HSC70.1.1.m.335,0.0106587491360296,-0.00140908277719692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSF1.2.2.m.38636,-0.0164305063534306,-0.00730895812744253,No,NA,NA,P38529,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; heat shock protein binding [GO:0031072]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; cellular response to cadmium ion [GO:0071276]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of cell cycle G2/M phase transition [GO:1902751]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of mRNA polyadenylation [GO:1900365]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to heat stress [GO:0061408]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to heat [GO:0009408]; response to light stimulus [GO:0009416],NA,NA,NA
CHOYP_HSP21.4.1.1.m.8171,-0.00338097055777167,-0.00162556036915503,No,NA,NA,P12812,NA,NA,NA,,NA,NA,NA
CHOYP_HSP70.1.1.m.61727,-0.0219596398820351,-0.0139750606138801,No,NA,NA,P41827,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34782,0.00255384290391716,-0.00033834568681994,No,NA,NA,Q9U639,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSP7D.2.3.m.34785,-0.00867017620219094,0.00518261086633816,No,NA,NA,Q3T022,NA,NA,NA,ASAP complex [GO:0061574]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_HSP7D.3.3.m.41778,0.000113488059744244,-0.00245621447072997,No,NA,NA,O18373,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; selenide; water dikinase activity [GO:0004756]; cell cycle [GO:0007049]; cell proliferation [GO:0008283]; glutamine metabolic process [GO:0006541]; imaginal disc development [GO:0007444]; mitochondrion organization [GO:0007005]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of cell proliferation [GO:0008284]; selenium compound metabolic process [GO:0001887]; selenocysteine biosynthetic process [GO:0016260]; tRNA seleno-modification [GO:0070329],NA,NA,NA
CHOYP_HSP7E.1.1.m.13730,6.56195705751162e-05,-3.94761142951281e-05,No,NA,NA,Q2YDD0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; polysome [GO:0005844]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; cytoplasmic translation [GO:0002181]; protein refolding [GO:0042026]; regulation of translational fidelity [GO:0006450]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_HSP90AA1.1.1.m.14867,0.00161690912053845,-0.000762309972209015,No,NA,NA,Q90474,NA,NA,NA,A band [GO:0031672]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; melanosome [GO:0042470]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Z disc [GO:0030018]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; disordered domain specific binding [GO:0097718]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; myofibril assembly [GO:0030239]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to metal ion [GO:0010038]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; skeletal myofibril assembly [GO:0014866]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_HSPA12A.10.27.m.35252,0.0178236767579219,-0.0176897018645186,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.15.27.m.45635,0.00862502713944908,-0.0221638385375209,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.16.27.m.48207,0.00530603385354039,0.00514136217643432,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.2.27.m.15188,0.0103513727363515,0.00852854242231924,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HSPA12A.21.27.m.57005,0.000117937818115379,-3.28470731600958e-06,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.5.27.m.21251,0.00845892975267232,0.0099897784278448,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12A.9.27.m.34375,0.00954775664123667,-0.00966342713332189,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPA12B.1.1.m.36165,0.00289960217584442,-0.000783555326377717,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_HSPG2.1.4.m.1496,-0.00842040499107885,0.00546821305032066,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_HTF4.1.5.m.16262,0.00286401940864492,-0.00365008638757193,No,NA,NA,Q99081,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; cAMP response element binding [GO:0035497]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; enhancer binding [GO:0035326]; HMG box domain binding [GO:0071837]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; immune response [GO:0006955]; muscle organ development [GO:0007517]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_HTR2B.1.1.m.121,0.000143135214350055,-0.0135276321229546,No,NA,NA,P41595,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synapse [GO:0045202]; drug binding [GO:0008144]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; neurotransmitter receptor activity [GO:0030594]; serotonin binding [GO:0051378]; activation of phospholipase C activity [GO:0007202]; behavior [GO:0007610]; calcium-mediated signaling [GO:0019722]; cardiac muscle hypertrophy [GO:0003300]; cellular calcium ion homeostasis [GO:0006874]; cellular response to temperature stimulus [GO:0071502]; cGMP-mediated signaling [GO:0019934]; chemical synaptic transmission [GO:0007268]; embryonic morphogenesis [GO:0048598]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor internalization [GO:0002031]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; heart morphogenesis [GO:0003007]; intestine smooth muscle contraction [GO:0014827]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cell death [GO:0060548]; neural crest cell differentiation [GO:0014033]; neural crest cell migration [GO:0001755]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphorylation [GO:0016310]; positive regulation of cell division [GO:0051781]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phosphatidylinositol biosynthetic process [GO:0010513]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of behavior [GO:0050795]; release of sequestered calcium ion into cytosol [GO:0051209]; response to drug [GO:0042493]; serotonin receptor signaling pathway [GO:0007210]; vasoconstriction [GO:0042310],NA,NA,NA
CHOYP_HTR5B.1.1.m.39330,-0.00644784022508109,0.0167495617353833,No,NA,NA,A1A5F2,NA,NA,NA,cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytosis [GO:0006897]; protein localization [GO:0008104]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_HTT.1.1.m.33803,0.0161860238486167,-0.00251651378228354,No,NA,NA,P42858,NA,NA,NA,autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; profilin binding [GO:0005522]; apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy of mitochondrion [GO:1903599]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of phosphoprotein phosphatase activity [GO:0043666]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297],NA,NA,NA
CHOYP_HUTH.1.1.m.30350,-0.00161985923400218,0.00241765748773132,No,NA,NA,P21213,NA,NA,NA,cytosol [GO:0005829]; histidine ammonia-lyase activity [GO:0004397]; histidine catabolic process [GO:0006548]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557]; histidine metabolic process [GO:0006547],NA,NA,NA
CHOYP_HUWE1.1.2.m.566,-0.00164184079376077,0.0027116112087719,No,NA,NA,Q7Z6Z7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; base-excision repair [GO:0006284]; cell differentiation [GO:0030154]; histone ubiquitination [GO:0016574]; neutrophil degranulation [GO:0043312]; positive regulation of protein targeting to mitochondrion [GO:1903955]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_HVCN1.1.4.m.8888,0.00431843610737503,0.00509996194895134,No,NA,NA,Q5F4C0,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; voltage-gated proton channel activity [GO:0030171]; cellular response to pH [GO:0071467]; cellular response to zinc ion [GO:0071294]; proton transmembrane transport [GO:1902600]; regulation of ion transmembrane transport [GO:0034765]; response to pH [GO:0009268]; response to zinc ion [GO:0010043],NA,NA,NA
CHOYP_HVCN1.2.4.m.29334,0.00628555360574454,-0.0114113132315768,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_HX1.1.1.m.23716,0.0096987055897075,0.00366616949394978,No,NA,NA,Q8IWF2,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_HXD3.1.1.m.40287,0.00844773500949117,0.00997655772413805,No,NA,NA,P50901,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_HYI.1.1.m.10528,-0.00372458247294842,0.0077709836397828,No,NA,NA,Q7T3H9,NA,NA,NA,hydroxypyruvate isomerase activity [GO:0008903]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857],NA,NA,NA
CHOYP_HYOU1.1.3.m.163,-0.0101262484116029,-0.00191736191712763,No,NA,NA,Q7ZUW2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_HYOU1.2.3.m.12568,0.00104036191618239,0.00266045973708697,No,NA,NA,Q7ZUW2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; ATP binding [GO:0005524]; cellular response to hypoxia [GO:0071456]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298],NA,NA,NA
CHOYP_IARS.1.1.m.27559,0.000165505207975342,0.000662614368716986,No,NA,NA,P41252,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; isoleucine-tRNA ligase activity [GO:0004822]; tRNA binding [GO:0000049]; isoleucyl-tRNA aminoacylation [GO:0006428]; osteoblast differentiation [GO:0001649]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_IDE.1.3.m.8450,-0.000941707551186792,0.00217937928915617,No,NA,NA,P35559,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; amyloid-beta binding [GO:0001540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; beta-endorphin binding [GO:0031626]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ubiquitin-dependent protein binding [GO:0140036]; zinc ion binding [GO:0008270]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; negative regulation of proteolysis [GO:0045861]; peptide catabolic process [GO:0043171]; positive regulation of protein oligomerization [GO:0032461]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992],NA,NA,NA
CHOYP_IDHC.1.1.m.7041,0.000443391321066141,7.60958253957252e-05,No,NA,NA,Q9Z2K9,NA,NA,NA,cytosol [GO:0005829]; isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_IDLC.1.1.m.63624,-0.00346740713569556,0.00165103809416287,No,NA,NA,Q26630,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; filopodium [GO:0030175]; dynein heavy chain binding [GO:0045504]; motor activity [GO:0003774]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_IF122.2.2.m.59794,-0.010498706199463,-0.00041406713970892,No,NA,NA,A8WGF4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; multicellular organism development [GO:0007275]; negative regulation of smoothened signaling pathway [GO:0045879]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_IF2A.1.1.m.13279,-0.000315606811498782,-0.00121973211465029,No,NA,NA,P68101,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 2 complex [GO:0005850]; eukaryotic translation initiation factor 2B complex [GO:0005851]; glial limiting end-foot [GO:0097451]; multi-eIF complex [GO:0043614]; nucleus [GO:0005634]; synapse [GO:0045202]; translation initiation ternary complex [GO:0044207]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; aging [GO:0007568]; cellular response to amino acid starvation [GO:0034198]; cellular response to heat [GO:0034605]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; negative regulation of guanyl-nucleotide exchange factor activity [GO:1905098]; negative regulation of translational initiation in response to stress [GO:0032057]; positive regulation of neuron death [GO:1901216]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; protein autophosphorylation [GO:0046777]; response to endoplasmic reticulum stress [GO:0034976]; response to manganese-induced endoplasmic reticulum stress [GO:1990737]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_IF2H.1.1.m.18253,0.000929476484849471,0.000128251949278726,No,NA,NA,C9WPN6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2 complex [GO:0005850]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731],NA,NA,NA
CHOYP_IF4A3.1.1.m.30424,-0.00309757963894792,0.000341323760062291,No,NA,NA,Q7ZVA6,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IF4E.1.1.m.56823,0.000904511770954153,0.0040579882718688,No,NA,NA,P48597,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; protein-containing complex [GO:0032991]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_IF4G2.1.1.m.62766,-0.00648538877087236,0.00360400159866627,No,NA,NA,Q62448,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; postsynaptic density [GO:0014069]; mRNA binding [GO:0003729]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; cellular macromolecule biosynthetic process [GO:0034645]; negative regulation of autophagy [GO:0010507]; positive regulation of axon extension [GO:0045773]; positive regulation of cell growth [GO:0030307]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of translation [GO:0045727]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_IF6.1.1.m.22685,-0.000120055085020049,-0.00100329531905061,No,NA,NA,O55135,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament [GO:0005882]; lamin filament [GO:0005638]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; translation initiation factor activity [GO:0003743]; assembly of large subunit precursor of preribosome [GO:1902626]; gene silencing by miRNA [GO:0035195]; mature ribosome assembly [GO:0042256]; miRNA mediated inhibition of translation [GO:0035278]; positive regulation of translation [GO:0045727]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of glycolytic process [GO:0006110]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to insulin [GO:0032868]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal subunit export from nucleus [GO:0000054],NA,NA,NA
CHOYP_IFIH1.10.14.m.60393,-0.00221017989810796,0.014280907011752,No,NA,NA,Q8R5F7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein sumoylation [GO:0016925]; response to virus [GO:0009615],NA,NA,NA
CHOYP_IFIH1.3.14.m.24387,-0.00297735102227155,0.00104904783290188,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.7.14.m.46974,-0.00535482777757417,-0.0050772808900132,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFIH1.9.14.m.54678,-0.00146241713532909,0.00344123073934139,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_IFT140.1.1.m.61053,-0.00284121210830703,0.000114824150408408,No,NA,NA,E9PY46,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; non-motile cilium [GO:0097730]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; intraciliary retrograde transport [GO:0035721]; intraciliary transport [GO:0042073]; limb morphogenesis [GO:0035108]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; photoreceptor cell outer segment organization [GO:0035845]; protein localization to cilium [GO:0061512]; regulation of cilium assembly [GO:1902017]; regulation of smoothened signaling pathway [GO:0008589]; renal system development [GO:0072001]; retina development in camera-type eye [GO:0060041]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_IFT57.1.1.m.13249,-0.00968517126812292,0.00277707624065695,No,NA,NA,Q5EA95,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; photoreceptor connecting cilium [GO:0032391]; DNA binding [GO:0003677]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; heart looping [GO:0001947]; intraciliary transport [GO:0042073]; left/right pattern formation [GO:0060972]; motile cilium assembly [GO:0044458]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; regulation of apoptotic process [GO:0042981]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_IKBZ.1.1.m.23083,0.00294019200337755,-0.000649250728174094,No,NA,NA,G5EDE9,NA,NA,NA,transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_IKZF.1.1.m.55498,-6.11512185334406e-05,0.00811329519031122,No,NA,NA,A4IFJ6,NA,NA,NA,nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein domain specific binding [GO:0019904]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_IMA2.1.2.m.35753,0.000626386622944857,-0.00714983360934791,No,NA,NA,F4KF65,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nuclear import signal receptor activity [GO:0061608]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; NLS-bearing protein import into nucleus [GO:0006607],NA,NA,NA
CHOYP_IMA2.2.2.m.49279,-0.0169635461270205,0.0118765060304216,No,NA,NA,P52170,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IMDH3.1.1.m.51789,-0.000785160518127145,0.00108885246936337,No,NA,NA,B0UXP9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; IMP dehydrogenase activity [GO:0003938]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; circadian rhythm [GO:0007623]; GMP biosynthetic process [GO:0006177]; GTP biosynthetic process [GO:0006183],NA,NA,NA
CHOYP_IMG5_109580.1.1.m.27791,-0.0141141268698596,-0.00898219549946471,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMG5_163910.1.1.m.46747,-0.0127940053106583,-0.0082284131144447,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IMSP5.2.2.m.17779,0.0281673381428794,0.0246655796688286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_INF2.3.5.m.13728,0.00493868678771743,0.00290347768145209,No,NA,NA,Q27J81,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_INO1A.1.1.m.91,-0.00735507355794373,-0.000186201741841676,No,NA,NA,Q6DDT1,NA,NA,NA,cytoplasm [GO:0005737]; inositol-3-phosphate synthase activity [GO:0004512]; inositol biosynthetic process [GO:0006021]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_INO80.1.2.m.1270,-0.0112869547786238,-0.00121238147783894,No,NA,NA,Q9ULG1,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; intermediate filament cytoskeleton [GO:0045111]; microtubule [GO:0005874]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-dependent ATPase activity [GO:0008094]; histone binding [GO:0042393]; ATP-dependent chromatin remodeling [GO:0043044]; cell division [GO:0051301]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; chromatin remodeling [GO:0006338]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; mitotic sister chromatid segregation [GO:0000070]; nucleosome mobilization [GO:0042766]; positive regulation of cell growth [GO:0030307]; positive regulation of nuclear cell cycle DNA replication [GO:0010571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; spindle assembly [GO:0051225]; transcription; DNA-templated [GO:0006351]; UV-damage excision repair [GO:0070914],NA,NA,NA
CHOYP_INSI2.1.1.m.59456,0.000931665389377584,-8.93409445519404e-05,No,NA,NA,P49230,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779],NA,NA,NA
CHOYP_INT11.1.1.m.29494,-0.0116088327421595,0.0173327413495172,No,NA,NA,Q5ZIH0,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; hydrolase activity [GO:0016787]; regulation of RNA splicing [GO:0043484]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT2.1.1.m.52909,0.00232531340504997,-0.000628366097667794,No,NA,NA,Q9H0H0,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; intracellular [GO:0005622]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INT6.1.1.m.13005,-0.00610347766711267,-0.0027062094126365,No,NA,NA,Q6PCM2,NA,NA,NA,actin cytoskeleton [GO:0015629]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA 3'-end processing [GO:0034472]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_INT7.1.1.m.14480,0.00489503833113271,0.00937948581864777,No,NA,NA,Q5ZL91,NA,NA,NA,chromosome [GO:0005694]; integrator complex [GO:0032039]; cellular response to DNA damage stimulus [GO:0006974]; snRNA 3'-end processing [GO:0034472],NA,NA,NA
CHOYP_INT9.1.1.m.11703,-0.00605854254146178,-0.00215632653821085,No,NA,NA,Q9NV88,NA,NA,NA,cytosol [GO:0005829]; integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; snRNA processing [GO:0016180]; snRNA transcription by RNA polymerase II [GO:0042795],NA,NA,NA
CHOYP_INVS.2.6.m.8331,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_IP6K1.1.1.m.54347,-0.0105502189768576,-0.00671413331381233,No,NA,NA,Q9ESM0,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; ATP binding [GO:0005524]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol phosphate biosynthetic process [GO:0032958]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_IPO11.1.1.m.10815,0.0110244277838124,0.00689509013231762,No,NA,NA,Q9UI26,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_IPO5.1.1.m.25693,0.000310943577329318,0.00222733646722449,No,NA,NA,O00410,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTPase inhibitor activity [GO:0005095]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of protein import into nucleus [GO:0042307]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_IPO7.1.1.m.16806,-0.000528102523631178,0.00536036712052132,No,NA,NA,Q9EPL8,NA,NA,NA,cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; SMAD binding [GO:0046332]; innate immune response [GO:0045087]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_IPO9.1.4.m.24013,-0.00209004914212065,0.00534190720577691,No,NA,NA,Q91YE6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; histone binding [GO:0042393]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_IQCA1.1.3.m.4290,-0.0225713043881674,0.00446569058849351,No,NA,NA,Q86XH1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_IQGA1.1.1.m.47731,0.00228488166537369,0.00155383662595728,No,NA,NA,P46940,NA,NA,NA,actin filament [GO:0005884]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; focal adhesion [GO:0005925]; growth cone [GO:0030426]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; secretory granule membrane [GO:0030667]; slit diaphragm [GO:0036057]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; GTPase activator activity [GO:0005096]; GTPase inhibitor activity [GO:0005095]; mitogen-activated protein kinase binding [GO:0051019]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein serine/threonine kinase activator activity [GO:0043539]; protein-containing complex binding [GO:0044877]; protein-containing complex scaffold activity [GO:0032947]; Rac GTPase binding [GO:0048365]; S100 protein binding [GO:0044548]; small GTPase binding [GO:0031267]; cell migration [GO:0016477]; cellular response to calcium ion [GO:0071277]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of dephosphorylation [GO:0035305]; neuron projection extension [GO:1990138]; neutrophil degranulation [GO:0043312]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of dendrite development [GO:1900006]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; regulation of cytokine production [GO:0001817]; regulation of mitotic cell cycle [GO:0007346]; response to angiotensin [GO:1990776]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_IRAK4.1.1.m.23405,-0.00666821981173912,-0.0145351954303139,No,NA,NA,Q8R4K2,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; interleukin-1 receptor binding [GO:0005149]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; neutrophil mediated immunity [GO:0002446]; neutrophil migration [GO:1990266]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of smooth muscle cell proliferation [GO:0048661],NA,NA,NA
CHOYP_IRF1.1.3.m.52606,-0.0202118272876604,0.0262553488869413,No,NA,NA,Q8R4E0,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_IRF5.1.1.m.58123,0.00829253460027347,0.00539718584234674,No,NA,NA,Q90871,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; myeloid cell differentiation [GO:0030099]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phagocytosis [GO:0006909]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_IRO.4.4.m.24034,-0.000165533159828301,0.0305079982502902,No,NA,NA,P54269,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; compound eye morphogenesis [GO:0001745]; equator specification [GO:0045317]; imaginal disc-derived wing vein specification [GO:0007474]; muscle cell fate commitment [GO:0042693]; negative regulation of growth [GO:0045926]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCA1.1.2.m.17578,0.00165841389859856,0.0132248181961091,No,NA,NA,Q80W96,NA,NA,NA,mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; endocrine process [GO:0050886]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_ISCU.1.1.m.37414,0.000225521283970202,0.00111521709420636,No,NA,NA,Q9D7P6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ferrous iron binding [GO:0008198]; iron-sulfur transferase activity [GO:0036455]; protein-containing complex scaffold activity [GO:0032947]; cellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_ISCW_ISCW000210.4.4.m.38490,0.0269210226280754,-0.0167730291674912,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW000642.1.1.m.4065,0.0065871387363227,0.00163184418019891,No,NA,NA,Q8WVN8,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_ISCW_ISCW001190.1.1.m.26579,-0.00974518915834449,-0.0315294834100791,No,NA,NA,Q7ZV80,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW001487.2.2.m.61505,0.00195291510972558,0.00140958409418159,No,NA,NA,Q96DR7,NA,NA,NA,cytosol [GO:0005829]; ruffle [GO:0001726]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endothelial cell morphogenesis [GO:0001886]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_ISCW_ISCW001592.1.2.m.20852,-0.00204518444685039,0.00324548522754095,No,NA,NA,O75439,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial processing peptidase complex [GO:0017087]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; aerobic respiration [GO:0009060]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_ISCW_ISCW003477.1.1.m.37800,5.17139855951917e-05,0.00272298109660906,No,NA,NA,Q28619,NA,NA,NA,apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; filopodium [GO:0030175]; membrane [GO:0016020]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; ruffle [GO:0001726]; sperm midpiece [GO:0097225]; chloride channel regulator activity [GO:0017081]; protein-containing complex scaffold activity [GO:0032947]; bile acid secretion [GO:0032782]; glutathione transport [GO:0034635]; negative regulation of cell motility [GO:2000146]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase B signaling [GO:0051898]; regulation of protein kinase activity [GO:0045859]; renal absorption [GO:0070293]; renal phosphate ion absorption [GO:0097291]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_ISCW_ISCW003928.1.1.m.18079,-0.00396816908592472,-0.0287172065619078,No,NA,NA,Q6P5H6,NA,NA,NA,adherens junction [GO:0005912]; cytoskeleton [GO:0005856]; cytoskeletal protein binding [GO:0008092]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; actomyosin structure organization [GO:0031032]; negative regulation of cell motility [GO:2000146]; positive regulation of cell adhesion [GO:0045785]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_ISCW_ISCW004420.1.8.m.5439,-0.0113583211268725,0.0176718084151349,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW004725.1.1.m.9722,-0.00104150244393497,-0.00523346721286779,No,NA,NA,Q09506,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW005083.2.2.m.40343,0.00427142952566884,0.00313273459888632,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW005292.1.1.m.11066,-0.00062886618208007,-0.000639175289940327,No,NA,NA,Q9QXD6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; AMP binding [GO:0016208]; fructose 1;6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; cellular response to drug [GO:0035690]; cellular response to magnesium ion [GO:0071286]; dephosphorylation [GO:0016311]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein homotetramerization [GO:0051289]; regulation of gluconeogenesis [GO:0006111]; sucrose biosynthetic process [GO:0005986],NA,NA,NA
CHOYP_ISCW_ISCW005596.1.1.m.60561,0.000513460113456048,-0.00146809110493999,No,NA,NA,O94812,NA,NA,NA,cytosol [GO:0005829]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission; GABAergic [GO:0032228]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW005651.1.1.m.49000,-0.0051818456180066,0.00292652163862044,No,NA,NA,P42669,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; DNA replication factor A complex [GO:0005662]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; double-stranded telomeric DNA binding [GO:0003691]; purine-rich negative regulatory element binding [GO:0032422]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; SMAD binding [GO:0046332]; transcription factor binding [GO:0008134]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; DNA unwinding involved in DNA replication [GO:0006268]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_ISCW_ISCW005791.1.1.m.53514,0.00137424149943319,-0.00209636122719494,No,NA,NA,P23880,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; positive regulation of establishment of cell polarity regulating cell shape [GO:2000784]; regulation of cell cycle [GO:0051726]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_ISCW_ISCW005878.1.1.m.39374,0.0105594160448485,-0.0137197625926979,No,NA,NA,Q9D773,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW006091.2.2.m.61313,-0.00472280700722221,0.00194468141038351,No,NA,NA,Q503Y7,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; spindle [GO:0005819]; DNA binding [GO:0003677]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_ISCW_ISCW006277.2.2.m.66212,-0.0030688025668862,0.0135987811809765,No,NA,NA,Q5M8V0,NA,NA,NA,,NA,NA,NA
CHOYP_ISCW_ISCW006831.1.1.m.23820,-0.00412784402825731,0.00818156056811537,No,NA,NA,Q9NTZ6,NA,NA,NA,nucleoplasm [GO:0005654]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ISCW_ISCW007151.1.2.m.41781,0.0131127474149934,0.00503168947551507,No,NA,NA,Q6BEA0,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; axon guidance [GO:0007411]; axonal defasciculation [GO:0007414]; morphogenesis of a branching structure [GO:0001763]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_ISCW_ISCW007151.2.2.m.41979,0.00301333241805488,-0.0054706525868879,No,NA,NA,Q9HCM2,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; anterior commissure morphogenesis [GO:0021960]; chemorepulsion of branchiomotor axon [GO:0021793]; facial nerve structural organization [GO:0021612]; glossopharyngeal nerve morphogenesis [GO:0021615]; negative regulation of cell adhesion [GO:0007162]; positive regulation of axonogenesis [GO:0050772]; postganglionic parasympathetic fiber development [GO:0021784]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of negative chemotaxis [GO:0050923]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sympathetic nervous system development [GO:0048485]; trigeminal nerve structural organization [GO:0021637]; vagus nerve morphogenesis [GO:0021644],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53689,0,0,No,NA,NA,Q99MK9,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; cell cycle arrest [GO:0007050]; cellular response to DNA damage stimulus [GO:0006974]; negative regulation of cell cycle arrest [GO:0071157]; positive regulation of protein ubiquitination [GO:0031398]; protein stabilization [GO:0050821]; Ras protein signal transduction [GO:0007265]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_ISCW_ISCW007158.2.2.m.53690,-0.00666354268705454,-0.0226063911715004,No,NA,NA,Q9QXV3,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606]; regulation of cell death [GO:0010941],NA,NA,NA
CHOYP_ISCW_ISCW007303.1.1.m.42263,0.00561035838712021,0.00662568892600457,No,NA,NA,P41095,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_ISCW_ISCW008174.1.2.m.8360,-0.00978007290294394,-0.0094751349557424,No,NA,NA,O08740,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; LRR domain binding [GO:0030275]; protein dimerization activity [GO:0046983]; RNA polymerase II activity [GO:0001055]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_ISCW_ISCW008219.1.2.m.46822,0.00186285459902413,-0.00156331236813742,No,NA,NA,P08228,NA,NA,NA,axon cytoplasm [GO:1904115]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; protein phosphatase 2B binding [GO:0030346]; Rac GTPase binding [GO:0048365]; superoxide dismutase activity [GO:0004784]; superoxide dismutase copper chaperone activity [GO:0016532]; zinc ion binding [GO:0008270]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; anterograde axonal transport [GO:0008089]; auditory receptor cell stereocilium organization [GO:0060088]; cell aging [GO:0007569]; cellular iron ion homeostasis [GO:0006879]; cellular response to ATP [GO:0071318]; cellular response to cadmium ion [GO:0071276]; cellular response to potassium ion [GO:0035865]; embryo implantation [GO:0007566]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide biosynthetic process [GO:0050665]; locomotory behavior [GO:0007626]; muscle cell cellular homeostasis [GO:0046716]; myeloid cell homeostasis [GO:0002262]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of neuron apoptotic process [GO:0043524]; neurofilament cytoskeleton organization [GO:0060052]; ovarian follicle development [GO:0001541]; peripheral nervous system myelin maintenance [GO:0032287]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cytokine production [GO:0001819]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of superoxide anion generation [GO:0032930]; reactive oxygen species metabolic process [GO:0072593]; regulation of blood pressure [GO:0008217]; regulation of GTPase activity [GO:0043087]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of multicellular organism growth [GO:0040014]; regulation of protein kinase activity [GO:0045859]; relaxation of vascular smooth muscle [GO:0060087]; removal of superoxide radicals [GO:0019430]; response to amphetamine [GO:0001975]; response to antipsychotic drug [GO:0097332]; response to axon injury [GO:0048678]; response to carbon monoxide [GO:0034465]; response to copper ion [GO:0046688]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to nutrient levels [GO:0031667]; response to organic substance [GO:0010033]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302]; response to superoxide [GO:0000303]; retina homeostasis [GO:0001895]; retrograde axonal transport [GO:0008090]; sensory perception of sound [GO:0007605]; spermatogenesis [GO:0007283]; superoxide anion generation [GO:0042554]; superoxide metabolic process [GO:0006801]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_ISCW_ISCW008316.1.3.m.11997,0.0202671757188419,-0.0113061916349789,No,NA,NA,Q8MQI6,NA,NA,NA,transcription elongation factor complex [GO:0008023]; metal ion binding [GO:0046872]; RNA polymerase II complex binding [GO:0000993]; chromatin-mediated maintenance of transcription [GO:0048096]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_ISCW_ISCW008555.1.1.m.40873,0.000177375269978584,0.000365817000267653,No,NA,NA,Q8AXV0,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; podosome [GO:0002102]; presynapse [GO:0098793]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_ISCW_ISCW008596.2.2.m.44077,-0.000669728636496087,0.00523071996521025,No,NA,NA,Q3SZ76,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_ISCW_ISCW008669.1.1.m.20227,0.00161337114555011,0.0244242544057217,No,NA,NA,Q8BK35,NA,NA,NA,cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; rDNA heterochromatin [GO:0033553]; 5S rRNA binding [GO:0008097]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; DNA repair [GO:0006281]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; protein localization to nucleolus [GO:1902570]; protein localization to nucleoplasm [GO:1990173]; protein stabilization [GO:0050821]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of protein phosphorylation [GO:0001932]; regulation of RIG-I signaling pathway [GO:0039535]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_ISCW_ISCW009103.1.1.m.24140,0.00434618517979173,-0.0236355739342447,No,NA,NA,O70133,NA,NA,NA,actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; micro-ribonucleoprotein complex [GO:0035068]; nuclear body [GO:0016604]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; polysomal ribosome [GO:0042788]; polysome [GO:0005844]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RISC-loading complex [GO:0070578]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; ATP-dependent 3'-5' DNA/RNA helicase activity [GO:0033681]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA replication origin binding [GO:0003688]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; importin-alpha family protein binding [GO:0061676]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; nucleoside-triphosphatase activity [GO:0017111]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; polysome binding [GO:1905538]; promoter-specific chromatin binding [GO:1990841]; regulatory region RNA binding [GO:0001069]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825]; single-stranded DNA binding [GO:0003697]; single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity [GO:1990518]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; triplex DNA binding [GO:0045142]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; circadian rhythm [GO:0007623]; CRD-mediated mRNA stabilization [GO:0070934]; DNA duplex unwinding [GO:0032508]; DNA-templated transcription; termination [GO:0006353]; DNA-templated viral transcription [GO:0039695]; G-quadruplex DNA unwinding [GO:0044806]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mRNA transport [GO:0051028]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of inflammatory response [GO:0050729]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of polysome binding [GO:1905698]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of RNA export from nucleus [GO:0046833]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; positive regulation of viral transcription [GO:0050434]; positive regulation of viral translation [GO:1904973]; protein localization to cytoplasmic stress granule [GO:1903608]; pyroptosis [GO:0070269]; regulation of cytoplasmic translation [GO:2000765]; regulation of defense response to virus by host [GO:0050691]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA secondary structure unwinding [GO:0010501]; small RNA loading onto RISC [GO:0070922]; targeting of mRNA for destruction involved in RNA interference [GO:0030423],NA,NA,NA
CHOYP_ISCW_ISCW009328.2.2.m.65633,0.0192189439189773,0.00675934261192994,No,NA,NA,Q1L673,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; calcitriol binding [GO:1902098]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear receptor transcription coactivator activity [GO:0030374]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; vitamin D binding [GO:0005499]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner ear receptor cell development [GO:0060119]; multicellular organism development [GO:0007275]; otic vesicle development [GO:0071599]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ISCW_ISCW010143.1.3.m.17397,-0.00513822760629237,-0.0262742582808908,No,NA,NA,Q9UBB5,NA,NA,NA,cytosol [GO:0005829]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; C2H2 zinc finger domain binding [GO:0070742]; chromatin binding [GO:0003682]; methyl-CpG binding [GO:0008327]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; satellite DNA binding [GO:0003696]; siRNA binding [GO:0035197]; aging [GO:0007568]; ATP-dependent chromatin remodeling [GO:0043044]; cellular protein-containing complex assembly [GO:0034622]; cellular response to organic cyclic compound [GO:0071407]; chromatin silencing at rDNA [GO:0000183]; embryonic organ development [GO:0048568]; heart development [GO:0007507]; maternal behavior [GO:0042711]; methylation-dependent chromatin silencing [GO:0006346]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of cell proliferation [GO:0042127]; regulation of DNA methylation [GO:0044030]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_ISCW_ISCW010143.3.3.m.61542,0.00100685298356832,0.00163558567733973,No,NA,NA,P41236,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; generation of precursor metabolites and energy [GO:0006091]; glycogen metabolic process [GO:0005977]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of signal transduction [GO:0009966],NA,NA,NA
CHOYP_ISCW_ISCW010532.1.4.m.11493,-0.00265498224903707,0.00543138901485078,No,NA,NA,Q9NL98,NA,NA,NA,cell [GO:0005623]; antioxidant activity [GO:0016209]; peroxidase activity [GO:0004601]; thioredoxin peroxidase activity [GO:0008379]; cell redox homeostasis [GO:0045454]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_ISCW_ISCW011108.1.1.m.13934,-0.000669239145617757,0.00253049109751691,No,NA,NA,P62944,NA,NA,NA,AP-2 adaptor complex [GO:0030122]; AP-type membrane coat adaptor complex [GO:0030119]; clathrin coat [GO:0030118]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; cargo receptor activity [GO:0038024]; clathrin binding [GO:0030276]; protein-containing complex binding [GO:0044877]; aorta development [GO:0035904]; clathrin coat assembly [GO:0048268]; coronary vasculature development [GO:0060976]; negative regulation of neuron death [GO:1901215]; positive regulation of endocytosis [GO:0045807]; positive regulation of protein localization to membrane [GO:1905477]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_ISCW_ISCW011328.1.1.m.8861,-0.00641721417085918,-0.00675912493005928,No,NA,NA,Q6AXX4,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; brain development [GO:0007420]; chromatin organization [GO:0006325]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_ISCW_ISCW011341.1.1.m.18728,-0.00303128268483431,-0.000688736162063381,No,NA,NA,B4NYV0,NA,NA,NA,nucleoplasm [GO:0005654]; conversion of ds siRNA to ss siRNA involved in RNA interference [GO:0033168]; defense response to Gram-negative bacterium [GO:0050829]; mRNA processing [GO:0006397]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; RNA interference [GO:0016246],NA,NA,NA
CHOYP_ISCW_ISCW012010.1.1.m.27251,-0.000209817973377145,0.000126680661503506,No,NA,NA,P38117,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_ISCW_ISCW012036.1.1.m.27987,0.00228686824065491,0.000532434115598915,No,NA,NA,Q24297,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; small nucleolar ribonucleoprotein complex [GO:0005732]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_ISCW_ISCW012228.1.2.m.57884,-0.0340118437635162,0.0216836074237647,No,NA,NA,Q3T100,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629],NA,NA,NA
CHOYP_ISCW_ISCW012232.1.1.m.38746,0.00893677199993894,0.011605984654732,No,NA,NA,A8WHP3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3690,0.000847389069506516,0.00557328419807157,No,NA,NA,P53563,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; postsynapse [GO:0098794]; presynapse [GO:0098793]; synaptic vesicle membrane [GO:0030672]; BH domain binding [GO:0051400]; clathrin binding [GO:0030276]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; GTPase binding [GO:0051020]; MDM2/MDM4 family protein binding [GO:0097371]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; aging [GO:0007568]; apoptotic process [GO:0006915]; cellular response to astaxanthin [GO:1905218]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to drug [GO:0035690]; cellular response to erythropoietin [GO:0036018]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-1 [GO:0071347]; cellular response to prolactin [GO:1990646]; cellular response to thapsigargin [GO:1904579]; cellular response to tumor necrosis factor [GO:0071356]; cerebral cortex development [GO:0021987]; endocytosis [GO:0006897]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; regulation of apoptotic process [GO:0042981]; regulation of cytokinesis [GO:0032465]; regulation of long-term synaptic depression [GO:1900452]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to erythropoietin [GO:0036017]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to ischemia [GO:0002931]; response to lead ion [GO:0010288]; response to lipopolysaccharide [GO:0032496]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; synaptic vesicle recycling via endosome [GO:0036466],NA,NA,NA
CHOYP_ISCW_ISCW012366.1.1.m.3691,-0.00318626733172461,0.00910747209466696,No,NA,NA,O75489,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nuclear body [GO:0016604]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; NADH dehydrogenase activity [GO:0003954]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981]; negative regulation of cell growth [GO:0030308]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; reactive oxygen species metabolic process [GO:0072593]; substantia nigra development [GO:0021762],NA,NA,NA
CHOYP_ISCW_ISCW012442.1.1.m.8441,0.0274976370615443,0.0195881180528203,No,NA,NA,Q5RBX7,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_ISCW_ISCW012623.1.1.m.26452,-0.00389096200992135,0.00180105465679692,No,NA,NA,P49256,NA,NA,NA,COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; exocytic vesicle [GO:0070382]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; perinuclear region of cytoplasm [GO:0048471]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_ISCW_ISCW012957.1.2.m.51659,0.0237412358426058,-0.00229249735793413,No,NA,NA,Q9Y5K3,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; choline-phosphate cytidylyltransferase activity [GO:0004105]; phosphatidylcholine binding [GO:0031210]; ovarian follicle development [GO:0001541]; phosphatidylcholine biosynthetic process [GO:0006656]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ISCW_ISCW013289.2.2.m.18741,-0.00115283164779146,0.00200236052503444,No,NA,NA,O22703,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to cold [GO:0009409]; response to water deprivation [GO:0009414],NA,NA,NA
CHOYP_ISCW_ISCW013378.2.3.m.11858,-0.000294272304285354,-0.00313236747830909,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013378.3.3.m.20296,-0.0108885466734538,-0.00431116529581791,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_ISCW_ISCW013556.1.1.m.26406,-0.00383082438636083,0.00520063815209736,No,NA,NA,Q7T0M6,NA,NA,NA,nucleus [GO:0005634]; chromatin assembly or disassembly [GO:0006333],NA,NA,NA
CHOYP_ISCW_ISCW013767.1.1.m.29335,0.00127612830035789,-6.04836428339201e-05,No,NA,NA,O08807,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; smooth endoplasmic reticulum [GO:0005790]; protein homodimerization activity [GO:0042803]; thioredoxin peroxidase activity [GO:0008379]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; hydrogen peroxide catabolic process [GO:0042744]; male gonad development [GO:0008584]; negative regulation of male germ cell proliferation [GO:2000255]; oxidation-reduction process [GO:0055114]; protein maturation by protein folding [GO:0022417]; reactive oxygen species metabolic process [GO:0072593]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_ISCW_ISCW013795.1.1.m.12153,-0.0114282323414432,0.0204841104269533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW013810.2.2.m.19882,0.00987271032873577,-0.0128077357360648,No,NA,NA,P36241,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15838,0.00116527257376623,-0.00337678691905558,No,NA,NA,Q5ZML3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014398.1.3.m.15839,-0.00046241398106781,0.0100136698330364,No,NA,NA,Q5ZML3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ISCW_ISCW014481.1.1.m.61217,-0.000536626161528844,-0.00138333601987864,No,NA,NA,P56524,NA,NA,NA,A band [GO:0031672]; actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; Z disc [GO:0030018]; activating transcription factor binding [GO:0033613]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; potassium ion binding [GO:0030955]; promoter-specific chromatin binding [GO:1990841]; protein deacetylase activity [GO:0033558]; protein kinase binding [GO:0019901]; repressing transcription factor binding [GO:0070491]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor binding [GO:0001085]; SUMO transferase activity [GO:0019789]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; zinc ion binding [GO:0008270]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cellular response to mechanical stimulus [GO:0071260]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to tumor necrosis factor [GO:0071356]; chromatin remodeling [GO:0006338]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; histone H4 deacetylation [GO:0070933]; inflammatory response [GO:0006954]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of glycolytic process [GO:0045820]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; osteoblast development [GO:0002076]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein deacetylation [GO:0006476]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of gene expression; epigenetic [GO:0040029]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle fiber development [GO:0048742]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to drug [GO:0042493]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW014579.2.2.m.5327,-0.000266078347698988,0.00157009784910092,No,NA,NA,Q8VHF0,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; establishment of cell polarity [GO:0030010]; intracellular signal transduction [GO:0035556]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of hippo signaling [GO:0035331]; peptidyl-serine autophosphorylation [GO:0036289]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of protein binding [GO:0032092]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW014726.5.5.m.47210,-0.00720294732375176,-0.011363466929474,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ISCW_ISCW014880.1.1.m.27977,-0.00460041723044182,0.012686781471174,No,NA,NA,Q7L7X3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; beta-tubulin binding [GO:0048487]; kinase activity [GO:0016301]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transferase activity [GO:0016740]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; execution phase of apoptosis [GO:0097194]; microtubule cytoskeleton organization [GO:0000226]; mitotic G2 DNA damage checkpoint [GO:0007095]; negative regulation of microtubule depolymerization [GO:0007026]; neuron cellular homeostasis [GO:0070050]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein acetylation [GO:1901985]; positive regulation of stress-activated MAPK cascade [GO:0032874]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cytoskeleton organization [GO:0051493]; regulation of microtubule cytoskeleton organization [GO:0070507]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW015061.1.1.m.51,-0.00314846080410997,0.00149932279666323,No,NA,NA,O08662,NA,NA,NA,cytoplasm [GO:0005737]; Golgi-associated vesicle membrane [GO:0030660]; membrane [GO:0016020]; plasma membrane [GO:0005886]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_ISCW_ISCW015295.1.1.m.22192,-0.00598839775589787,-0.000342725508163165,No,NA,NA,O88986,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; glycine C-acetyltransferase activity [GO:0008890]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058]; L-threonine catabolic process to glycine [GO:0019518],NA,NA,NA
CHOYP_ISCW_ISCW016148.3.6.m.54385,-0.00761985103423979,-0.00890326674901153,No,NA,NA,P31674,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW016212.1.2.m.2539,-0.0192225666254067,-0.00107536021880054,No,NA,NA,Q9W5U2,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016212.2.2.m.46221,-0.00785958892342141,-0.00604383077373907,No,NA,NA,Q9W5U2,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_ISCW_ISCW016254.2.5.m.38599,-0.00955008217340316,-0.0143075368361475,No,NA,NA,Q9W141,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex; coupling factor F(o) [GO:0000276]; mitochondrion [GO:0005739]; ATP biosynthetic process [GO:0006754]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_ISCW_ISCW016289.1.1.m.12312,-0.00494571781966301,0.00202885581800234,No,NA,NA,P57721,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; C-rich single-stranded DNA binding [GO:1990829]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; mRNA metabolic process [GO:0016071],NA,NA,NA
CHOYP_ISCW_ISCW016328.1.1.m.10256,0.00580838126102211,-0.0105450151403319,No,NA,NA,Q9R1C6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; modulation of chemical synaptic transmission [GO:0050804]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205],NA,NA,NA
CHOYP_ISCW_ISCW017188.1.1.m.23179,-0.00232704063967841,-0.00595869359408235,No,NA,NA,Q8WVM7,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; regulation of mitotic spindle assembly [GO:1901673],NA,NA,NA
CHOYP_ISCW_ISCW017350.1.1.m.11950,0.00185882087192851,-0.00730415442750121,No,NA,NA,Q24537,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; single-stranded DNA binding [GO:0003697]; TBP-class protein binding [GO:0017025]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; developmental process [GO:0032502]; DNA recombination [GO:0006310]; DNA unwinding involved in DNA replication [GO:0006268]; leg disc development [GO:0035218]; negative regulation of antimicrobial humoral response [GO:0008348]; negative regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of DNA binding [GO:0043388]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; segment specification [GO:0007379],NA,NA,NA
CHOYP_ISCW_ISCW017474.1.1.m.18280,-0.000141917995226462,0.0188291029304641,No,NA,NA,Q4PJX1,NA,NA,NA,integral component of membrane [GO:0016021]; protein localization [GO:0008104],NA,NA,NA
CHOYP_ISCW_ISCW017519.1.2.m.935,8.45271794794555e-05,0.00576607690258764,No,NA,NA,Q5R5V4,NA,NA,NA,focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; sarcomere [GO:0030017]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_ISCW_ISCW017526.2.2.m.57044,0.0133485497166962,-0.00213196206611923,No,NA,NA,Q9VZZ9,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; anterior/posterior axis specification; embryo [GO:0008595]; antimicrobial humoral response [GO:0019730]; photoreceptor cell development [GO:0042461]; R7 cell fate commitment [GO:0007465]; regulation of Ras protein signal transduction [GO:0046578]; sevenless signaling pathway [GO:0045500]; torso signaling pathway [GO:0008293],NA,NA,NA
CHOYP_ISCW_ISCW017652.1.1.m.49306,-0.0106269893355858,0.0245747602654274,No,NA,NA,Q32PI8,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; mitochondrial ribosome binding [GO:0097177]; rRNA binding [GO:0019843]; tRNA binding [GO:0000049]; cell proliferation [GO:0008283]; positive regulation of mitochondrial translation [GO:0070131],NA,NA,NA
CHOYP_ISCW_ISCW017655.1.1.m.22914,0.00152039835952932,-0.00113389718122993,No,NA,NA,Q95WA0,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW017707.1.1.m.58329,0.00397305760505764,0.00119086975557299,No,NA,NA,Q9Y2H1,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],NA,NA,NA
CHOYP_ISCW_ISCW017709.1.1.m.30040,-0.0118958998548313,0.00561931152357474,No,NA,NA,Q04757,NA,NA,NA,membrane [GO:0016020],NA,NA,NA
CHOYP_ISCW_ISCW017872.2.2.m.60293,0.00157547596578287,-0.00921080307386175,No,NA,NA,P70365,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; aryl hydrocarbon receptor binding [GO:0017162]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase activity [GO:0004402]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; progesterone receptor binding [GO:0033142]; protein dimerization activity [GO:0046983]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region DNA binding [GO:0001012]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; cellular response to hormone stimulus [GO:0032870]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; estrous cycle [GO:0044849]; hippocampus development [GO:0021766]; histone H4 acetylation [GO:0043967]; hypothalamus development [GO:0021854]; labyrinthine layer morphogenesis [GO:0060713]; lactation [GO:0007595]; male gonad development [GO:0008584]; male mating behavior [GO:0060179]; positive regulation of apoptotic process [GO:0043065]; positive regulation of female receptivity [GO:0045925]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by galactose [GO:0000435]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cellular response to drug [GO:2001038]; regulation of RNA biosynthetic process [GO:2001141]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to retinoic acid [GO:0032526]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_ISCW_ISCW018108.1.1.m.43365,-0.0176724605738161,-0.00625765779408093,No,NA,NA,Q9C0D3,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_ISCW_ISCW018298.1.1.m.741,0.00573258909069009,0.0195206041068335,No,NA,NA,Q12893,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; negative regulation of cell proliferation [GO:0008285]; protein glycosylation [GO:0006486]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_ISCW_ISCW018425.1.1.m.35608,0.00333505167028002,-2.46853079074451e-05,No,NA,NA,P81623,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; activation of MAPK activity [GO:0000187]; negative regulation of gene expression [GO:0010629]; negative regulation of protein secretion [GO:0050709]; positive regulation of gene expression [GO:0010628]; protein secretion [GO:0009306]; regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902235],NA,NA,NA
CHOYP_ISCW_ISCW018501.2.2.m.61797,-0.0113997680380092,0.0188891841100449,No,NA,NA,Q5F452,NA,NA,NA,nuclear envelope [GO:0005635]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_ISCW_ISCW018536.1.1.m.56336,0.000443812788859782,0.00164866740927175,No,NA,NA,Q8C0E2,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; late endosome [GO:0005770]; phagocytic vesicle [GO:0045335]; retromer complex [GO:0030904]; protein transporter activity [GO:0008565]; cellular response to interferon-gamma [GO:0071346]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_ISCW_ISCW018656.1.1.m.51893,-0.0163515331129009,0.00832735542134158,No,NA,NA,Q6PGW3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_ISCW_ISCW019027.2.2.m.66984,0.00841574694440651,-0.00242575176212103,No,NA,NA,Q2PFW9,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_ISCW_ISCW019130.1.2.m.10722,0.000132412723472432,0.00172777094794629,No,NA,NA,Q3SZ90,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; GAIT complex [GO:0097452]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_ISCW_ISCW019177.2.4.m.56600,-0.029212907594349,0.00253890911681281,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019177.4.4.m.63940,-0.0132021588508125,-0.00840182130332274,No,NA,NA,Q9CYL5,NA,NA,NA,extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; protein homodimerization activity [GO:0042803]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_ISCW_ISCW019590.1.1.m.30707,-0.000141102118615549,-0.000140379028679502,No,NA,NA,Q7KRY7,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_ISCW_ISCW019991.1.5.m.8713,-0.00654292384652379,0.00940835774853885,No,NA,NA,Q6DFR2,NA,NA,NA,cytoplasm [GO:0005737]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; phosphotyrosine residue binding [GO:0001784]; receptor tyrosine kinase binding [GO:0030971]; SH3 domain binding [GO:0017124]; ubiquitin protein ligase activity [GO:0061630]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_ISCW_ISCW020028.1.1.m.57937,0.00385968595891965,0.00475388741916971,No,NA,NA,Q9I7F7,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; dorsal closure; amnioserosa morphology change [GO:0046664]; head involution [GO:0008258]; myosin filament assembly [GO:0031034]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_ISCW_ISCW020302.1.1.m.37564,0.000813552297355187,0.00228618329628869,No,NA,NA,Q17QJ7,NA,NA,NA,mitochondrion [GO:0005739]; pyrroline-5-carboxylate reductase activity [GO:0004735]; cellular response to oxidative stress [GO:0034599]; L-proline biosynthetic process [GO:0055129]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_ISCW_ISCW020550.2.2.m.18099,0.000648788727632528,0.000929788791484158,No,NA,NA,O35796,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; presynaptic active zone [GO:0048786]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; protein kinase C binding [GO:0005080]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; immune response [GO:0006955]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_ISCW_ISCW021350.1.1.m.10332,-0.000173844527025204,-8.99219314257111e-05,No,NA,NA,Q01105,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; histone binding [GO:0042393]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; DNA replication [GO:0006260]; negative regulation of histone acetylation [GO:0035067]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; regulation of mRNA stability [GO:0043488]; viral process [GO:0016032],NA,NA,NA
CHOYP_ISCW_ISCW021457.1.1.m.31134,-0.00766000553992403,0.00579665197762812,No,NA,NA,Q5XIH7,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; cellular response to hypoxia [GO:0071456]; cellular response to retinoic acid [GO:0071300]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription; DNA-templated [GO:0045892]; response to wounding [GO:0009611],NA,NA,NA
CHOYP_ISCW_ISCW021476.1.1.m.29578,-0.0102432604731485,0.00286992668035783,No,NA,NA,Q66KE3,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_ISCW_ISCW021545.1.1.m.25379,-0.0039016786882104,-0.01833643303208,No,NA,NA,P35555,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein-containing complex binding [GO:0044877]; activation of protein kinase A activity [GO:0034199]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular protein metabolic process [GO:0044267]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; post-translational protein modification [GO:0043687]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13969,-0.00142428012451564,-0.0158608042147458,No,NA,NA,Q5RE70,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_ISCW_ISCW021591.1.1.m.13970,0.00157463744693405,0.00287143027104435,No,NA,NA,Q2KJG3,NA,NA,NA,cytoplasm [GO:0005737]; asparagine-tRNA ligase activity [GO:0004816]; ATP binding [GO:0005524]; nucleic acid binding [GO:0003676]; asparaginyl-tRNA aminoacylation [GO:0006421],NA,NA,NA
CHOYP_ISCW_ISCW021601.2.2.m.20304,-6.27263280997668e-05,0.0013446876957194,No,NA,NA,Q6INR1,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732],NA,NA,NA
CHOYP_ISCW_ISCW022021.1.1.m.53168,0.00600508600205387,-0.00228213360451266,No,NA,NA,A2AVA0,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_ISCW_ISCW022029.1.1.m.9014,-0.000132478064889659,0.000492052406211796,No,NA,NA,P61258,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; nuclear body [GO:0016604]; nuclear replication fork [GO:0043596]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]; cellular response to UV [GO:0034644]; DNA replication [GO:0006260]; epithelial cell differentiation [GO:0030855]; mismatch repair [GO:0006298]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_ISCW_ISCW022189.1.1.m.8227,-0.000300986056890144,-0.00114163656239469,No,NA,NA,Q9XZ71,NA,NA,NA,troponin complex [GO:0005861]; regulation of muscle contraction [GO:0006937],NA,NA,NA
CHOYP_ISCW_ISCW022609.1.1.m.26988,-0.0114313924319057,-0.00727490992544127,No,NA,NA,P97521,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; carnitine transmembrane transport [GO:1902603],NA,NA,NA
CHOYP_ISCW_ISCW022842.1.1.m.5648,0.0123522422104657,0.00779526533828299,No,NA,NA,Q8VI63,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection terminus [GO:0044306]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; actin cytoskeleton organization [GO:0030036]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein phosphorylation [GO:0001934],NA,NA,NA
CHOYP_ISCW_ISCW022925.1.2.m.61535,0.00178786362909281,0.00722629584357059,No,NA,NA,Q9UEW8,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_ISCW_ISCW023153.1.1.m.10480,0.000160940156011072,0.0008699237012265,No,NA,NA,Q96GG9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin-like protein binding [GO:0032182]; positive regulation of protein neddylation [GO:2000436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; post-translational protein modification [GO:0043687]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_ISCW_ISCW023180.1.2.m.31255,-0.0163192581996812,0.0248188037264188,No,NA,NA,Q8WXF0,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; RS domain binding [GO:0050733]; unfolded protein binding [GO:0051082]; mRNA 5'-splice site recognition [GO:0000395]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_ISCW_ISCW023297.1.1.m.11833,-0.00700526791408651,0.0161379563417367,No,NA,NA,Q9DCD2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; blastocyst development [GO:0001824]; cerebral cortex development [GO:0021987]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; mRNA splicing; via spliceosome [GO:0000398]; transcription; DNA-templated [GO:0006351]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_ISCW_ISCW023591.1.1.m.9921,0.00978438596580933,0.00738993699425511,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_ISCW_ISCW023973.1.2.m.6506,0.00114530214332593,0.000415120364242171,No,NA,NA,Q28F07,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; identical protein binding [GO:0042802]; N-methyltransferase activity [GO:0008170]; protein methyltransferase activity [GO:0008276]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; S-adenosyl-L-methionine binding [GO:1904047]; transcription coactivator activity [GO:0003713]; histone arginine methylation [GO:0034969]; histone H4-R3 methylation [GO:0043985]; histone methylation [GO:0016571]; metamorphosis [GO:0007552]; negative regulation of megakaryocyte differentiation [GO:0045653]; neurogenesis [GO:0022008]; peptidyl-arginine methylation [GO:0018216]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; protein homooligomerization [GO:0051260]; protein methylation [GO:0006479]; regulation of histone modification [GO:0031056]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ISL1.1.1.m.10993,0.00643757357743029,-0.0116873028457257,No,NA,NA,P61374,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enhancer sequence-specific DNA binding [GO:0001158]; estrogen receptor binding [GO:0030331]; metal ion binding [GO:0046872]; nuclear receptor binding [GO:0016922]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; atrial septum morphogenesis [GO:0060413]; axon regeneration [GO:0031103]; cardiac cell fate determination [GO:0060913]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac right ventricle morphogenesis [GO:0003215]; cellular response to glucocorticoid stimulus [GO:0071385]; endocardial cushion morphogenesis [GO:0003203]; heart development [GO:0007507]; innervation [GO:0060384]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of protein homodimerization activity [GO:0090074]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell migration [GO:0001755]; outflow tract septum morphogenesis [GO:0003148]; pancreas development [GO:0031016]; peripheral nervous system neuron axonogenesis [GO:0048936]; pharyngeal system development [GO:0060037]; pituitary gland development [GO:0021983]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of histone acetylation [GO:0035066]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of transcription; DNA-templated [GO:0006355]; retinal ganglion cell axon guidance [GO:0031290]; secondary heart field specification [GO:0003139]; sensory system development [GO:0048880]; spinal cord motor neuron cell fate specification [GO:0021520]; trigeminal nerve development [GO:0021559]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; visceral motor neuron differentiation [GO:0021524],NA,NA,NA
CHOYP_ISY1.1.1.m.53545,-0.00425937448490592,-0.00670770584490124,No,NA,NA,Q6AYB3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; post-mRNA release spliceosomal complex [GO:0071014]; post-spliceosomal complex [GO:0071020]; Prp19 complex [GO:0000974]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; mRNA 3'-splice site recognition [GO:0000389],NA,NA,NA
CHOYP_ITA5.1.1.m.55930,0.00235447731878578,-0.00166624472094732,No,NA,NA,P26009,NA,NA,NA,integrin complex [GO:0008305]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; integrin-mediated signaling pathway [GO:0007229]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_ITA7.1.1.m.1060,-0.00563221264895065,-0.00653604910965836,No,NA,NA,P23229,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; cell-cell adherens junction [GO:0005913]; external side of plasma membrane [GO:0009897]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; integrin alpha6-beta4 complex [GO:0034676]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; insulin-like growth factor I binding [GO:0031994]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; neuregulin binding [GO:0038132]; protein-containing complex binding [GO:0044877]; amelogenesis [GO:0097186]; brown fat cell differentiation [GO:0050873]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to extracellular stimulus [GO:0031668]; cellular response to organic cyclic compound [GO:0071407]; digestive tract development [GO:0048565]; ectodermal cell differentiation [GO:0010668]; extracellular matrix organization [GO:0030198]; filopodium assembly [GO:0046847]; hemidesmosome assembly [GO:0031581]; integrin-mediated signaling pathway [GO:0007229]; leukocyte migration [GO:0050900]; nail development [GO:0035878]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; renal system development [GO:0072001]; skin development [GO:0043588],NA,NA,NA
CHOYP_ITB1.2.4.m.24270,-5.50416801113345e-05,0.00730270645824877,No,NA,NA,O54890,NA,NA,NA,alpha9-beta1 integrin-ADAM8 complex [GO:0071133]; alphav-beta3 integrin-HMGB1 complex [GO:0035868]; alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; alphav-beta3 integrin-PKCalpha complex [GO:0035866]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alpha9-beta1 complex [GO:0034679]; integrin alphav-beta3 complex [GO:0034683]; integrin complex [GO:0008305]; lamellipodium membrane [GO:0031258]; melanosome [GO:0042470]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; cell adhesion molecule binding [GO:0050839]; enzyme binding [GO:0019899]; extracellular matrix binding [GO:0050840]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein disulfide isomerase activity [GO:0003756]; protein kinase C binding [GO:0005080]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of protein kinase activity [GO:0032147]; apolipoprotein A-I-mediated signaling pathway [GO:0038027]; apoptotic cell clearance [GO:0043277]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell projection morphogenesis [GO:0048858]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; cell-substrate junction assembly [GO:0007044]; cellular response to drug [GO:0035690]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryo implantation [GO:0007566]; heterotypic cell-cell adhesion [GO:0034113]; integrin-mediated signaling pathway [GO:0007229]; negative chemotaxis [GO:0050919]; negative regulation of cell death [GO:0060548]; negative regulation of lipid storage [GO:0010888]; negative regulation of lipid transport [GO:0032369]; negative regulation of lipoprotein metabolic process [GO:0050748]; negative regulation of low-density lipoprotein particle receptor biosynthetic process [GO:0045715]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway [GO:1900731]; positive regulation of angiogenesis [GO:0045766]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell migration [GO:0030334]; regulation of extracellular matrix organization [GO:1903053]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein tyrosine kinase activity [GO:0061097]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; response to activity [GO:0014823]; response to radiation [GO:0009314]; smooth muscle cell migration [GO:0014909]; substrate adhesion-dependent cell spreading [GO:0034446]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_ITB1.3.4.m.28565,-0.00929013284633509,-0.0157312597637523,No,NA,NA,P11584,NA,NA,NA,apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; cell surface [GO:0009986]; costamere [GO:0043034]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; muscle tendon junction [GO:0005927]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; actin filament organization [GO:0007015]; apposition of dorsal and ventral imaginal disc-derived wing surfaces [GO:0007475]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; calcium-dependent cell-matrix adhesion [GO:0016340]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cell-substrate adhesion [GO:0031589]; central nervous system development [GO:0007417]; central nervous system morphogenesis [GO:0021551]; determination of adult lifespan [GO:0008340]; dorsal closure [GO:0007391]; dorsal trunk growth; open tracheal system [GO:0035001]; flight behavior [GO:0007629]; germ-band extension [GO:0007377]; germ-line stem cell population maintenance [GO:0030718]; hemocyte migration [GO:0035099]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; integrin-mediated signaling pathway [GO:0007229]; larval heart development [GO:0007508]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; midgut development [GO:0007494]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; negative regulation of cell migration [GO:0030336]; pericardium morphogenesis [GO:0003344]; positive regulation of synapse maturation [GO:0090129]; regulation of cell shape [GO:0008360]; regulation of stress fiber assembly [GO:0051492]; salivary gland development [GO:0007431]; sarcomere organization [GO:0045214]; sensory perception of smell [GO:0007608]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration; cell extension [GO:0006930]; ventral cord development [GO:0007419]; visual perception [GO:0007601],NA,NA,NA
CHOYP_ITB1B.1.1.m.59423,0.0072825545352755,-0.00242165789645745,No,NA,NA,B0FYY4,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_ITF2.1.1.m.1446,0.00573887693881398,0.0262828694369587,No,NA,NA,Q62655,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_ITIH3.1.3.m.21736,-0.0155761740571994,-0.00991263872044587,No,NA,NA,Q8N801,NA,NA,NA,cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; germinal vesicle [GO:0042585]; male pronucleus [GO:0001940]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; C-5 methylation of cytosine [GO:0090116]; chromatin organization [GO:0006325]; DNA demethylation of male pronucleus [GO:0044727]; positive regulation of DNA demethylation [GO:1901537],NA,NA,NA
CHOYP_ITPA.1.1.m.13655,-0.0052160737144378,-0.00781436589388471,No,NA,NA,A7RWC9,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; nucleotide binding [GO:0000166]; deoxyribonucleoside triphosphate catabolic process [GO:0009204]; nucleoside triphosphate catabolic process [GO:0009143]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_ITSN1.4.4.m.35131,-0.0033286007632116,-0.00116233074553132,No,NA,NA,O42287,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; endomembrane system [GO:0012505]; membrane [GO:0016020]; neuron projection [GO:0043005]; nuclear envelope [GO:0005635]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; endocytosis [GO:0006897]; intracellular signal transduction [GO:0035556]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_IVBI.2.2.m.67049,-0.0137585722379501,-0.00875592140939888,No,NA,NA,Q90W98,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_IVD.1.2.m.5213,6.76662768651871e-05,-0.000922532231566145,No,NA,NA,Q9JHI5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; flavin adenine dinucleotide binding [GO:0050660]; isovaleryl-CoA dehydrogenase activity [GO:0008470]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IVD.2.2.m.14522,-0.00319949831334588,-0.00243688146297724,No,NA,NA,P34275,NA,NA,NA,plasma membrane [GO:0005886]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; leucine catabolic process [GO:0006552],NA,NA,NA
CHOYP_IWS1.1.1.m.13972,-0.00268574942909755,0.0125598162420735,No,NA,NA,Q3SWT4,NA,NA,NA,nucleus [GO:0005634]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; regulation of histone H3-K36 trimethylation [GO:2001253]; regulation of histone H4 acetylation [GO:0090239]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_IWS1.1.1.m.13973,0.0035711178985001,-0.000965018054477653,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_JIP3.1.1.m.25162,-0.00224538118757435,0.00898212839640557,No,NA,NA,Q58A65,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; perinuclear region of cytoplasm [GO:0048471]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; mitogen-activated protein kinase p38 binding [GO:0048273]; receptor signaling complex scaffold activity [GO:0030159]; activation of JUN kinase activity [GO:0007257]; activation of MAPK activity [GO:0000187]; negative regulation of protein homodimerization activity [GO:0090074]; positive regulation of cell migration [GO:0030335]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; protein homooligomerization [GO:0051260]; retrograde transport; endosome to Golgi [GO:0042147]; striated muscle cell differentiation [GO:0051146]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_JNK.1.1.m.1540,-0.00257637559754485,0.00297121305273256,No,NA,NA,P92208,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; JUN kinase activity [GO:0004705]; MAP kinase activity [GO:0004707]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; antibacterial humoral response [GO:0019731]; axon extension [GO:0048675]; axon guidance [GO:0007411]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to cadmium ion [GO:0071276]; cellular response to organic substance [GO:0071310]; cellular response to oxidative stress [GO:0034599]; cellular response to reactive oxygen species [GO:0034614]; chorion micropyle formation [GO:0046844]; collateral sprouting of injured axon [GO:0048674]; determination of digestive tract left/right asymmetry [GO:0071907]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; embryonic anterior midgut (ectodermal) morphogenesis [GO:0048615]; engulfment of apoptotic cell [GO:0043652]; establishment of planar polarity [GO:0001736]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; intracellular signal transduction [GO:0035556]; JNK cascade [GO:0007254]; JUN phosphorylation [GO:0007258]; long-term memory [GO:0007616]; MAPK cascade [GO:0000165]; melanization defense response [GO:0035006]; mushroom body development [GO:0016319]; negative regulation of JUN kinase activity [GO:0043508]; neuron development [GO:0048666]; neuron projection morphogenesis [GO:0048812]; ovarian follicle cell development [GO:0030707]; positive regulation of autophagy [GO:0010508]; positive regulation of border follicle cell migration [GO:1903688]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron remodeling [GO:1904801]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; wound healing [GO:0042060]; wound healing; spreading of epidermal cells [GO:0035313],NA,NA,NA
CHOYP_K0020.1.1.m.1673,-0.00309023062127171,-0.003381315937291,No,NA,NA,Q562C7,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of protein ADP-ribosylation [GO:0010835],NA,NA,NA
CHOYP_K11G12.5.1.1.m.55605,-8.56748810269367e-05,0.0113669950793573,No,NA,NA,Q9UBX3,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antiporter activity [GO:0015297]; dicarboxylic acid transmembrane transporter activity [GO:0005310]; malate transmembrane transporter activity [GO:0015140]; oxaloacetate transmembrane transporter activity [GO:0015131]; succinate transmembrane transporter activity [GO:0015141]; sulfate transmembrane transporter activity [GO:0015116]; thiosulfate transmembrane transporter activity [GO:0015117]; dicarboxylic acid transport [GO:0006835]; gluconeogenesis [GO:0006094]; ion transport [GO:0006811]; malate transmembrane transport [GO:0071423]; mitochondrial transport [GO:0006839]; oxaloacetate transport [GO:0015729]; phosphate ion transmembrane transport [GO:0035435]; succinate transmembrane transport [GO:0071422]; sulfate transport [GO:0008272]; sulfide oxidation; using sulfide:quinone oxidoreductase [GO:0070221]; thiosulfate transport [GO:0015709],NA,NA,NA
CHOYP_K1239.3.3.m.45453,-0.00271631948663802,-0.000436247569618697,No,NA,NA,Q9ULI1,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_K1468.1.1.m.24917,-0.00198855445482735,0.011467482323286,No,NA,NA,Q6P6Y1,NA,NA,NA,recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_K1609.1.1.m.17775,0.0145298004026385,0.00775300750551183,No,NA,NA,Q5ZJX5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020],NA,NA,NA
CHOYP_K6PF.1.1.m.46882,6.82687790280636e-05,2.20858786463189e-05,No,NA,NA,P52034,NA,NA,NA,6-phosphofructokinase complex [GO:0005945]; 6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; canonical glycolysis [GO:0061621]; fructose 1;6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose catabolic process [GO:0006007]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; myoblast fusion [GO:0007520]; protein complex oligomerization [GO:0051259]; response to sucrose [GO:0009744]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_KAL1.1.1.m.60996,0.00236028182484442,0.0152022108951966,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KALRN.1.2.m.891,0.00723461531034201,5.42701106984994e-05,No,NA,NA,O60229,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; adult locomotory behavior [GO:0008344]; ephrin receptor signaling pathway [GO:0048013]; G protein-coupled receptor signaling pathway [GO:0007186]; habituation [GO:0046959]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; maternal behavior [GO:0042711]; maternal process involved in parturition [GO:0060137]; memory [GO:0007613]; negative regulation of growth hormone secretion [GO:0060125]; nervous system development [GO:0007399]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of dendritic spine morphogenesis [GO:0061003]; protein phosphorylation [GO:0006468]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_KAPR.1.3.m.8246,0.00249846315034827,-0.0183306479526036,No,NA,NA,P31319,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KAPR.2.3.m.56519,-0.0026696304072426,0.00821578294546735,No,NA,NA,P31319,NA,NA,NA,cAMP-dependent protein kinase complex [GO:0005952]; cAMP binding [GO:0030552]; cAMP-dependent protein kinase regulator activity [GO:0008603],NA,NA,NA
CHOYP_KARG.11.11.m.50800,-0.000247531517083993,0.00427857030125102,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.2.11.m.2196,0.00103289649985121,0.000231136175854606,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.3.11.m.2494,-0.0238166590809017,-0.0154887487607882,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.4.11.m.5401,0.0102360749645578,-0.00483269603360788,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KARG.9.11.m.50527,-0.0135829013277311,-0.00864412487577657,No,NA,NA,O15990,NA,NA,NA,arginine kinase activity [GO:0004054]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_KAT3.1.1.m.49207,0.00110719657640916,0.000595833211140074,No,NA,NA,Q6YP21,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; cellular amino acid metabolic process [GO:0006520]; kynurenine metabolic process [GO:0070189],NA,NA,NA
CHOYP_KAT5.1.1.m.9015,-0.0126161416411067,-0.00206420713883765,No,NA,NA,Q99MK2,NA,NA,NA,cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; Piccolo NuA4 histone acetyltransferase complex [GO:0032777]; protein-containing complex [GO:0032991]; Swr1 complex [GO:0000812]; chromatin binding [GO:0003682]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to X-ray [GO:0071481]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; histone acetylation [GO:0016573]; histone H4 acetylation [GO:0043967]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; response to heat [GO:0009408],NA,NA,NA
CHOYP_KAT6B.1.2.m.10955,0,0,No,NA,NA,Q8WML3,NA,NA,NA,MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleosome [GO:0000786]; acetyltransferase activity [GO:0016407]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H3 acetylation [GO:0043966]; negative regulation of transcription; DNA-templated [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_KAT8.1.1.m.28310,0.000165242644010981,-0.00716136074597834,No,NA,NA,Q9H7Z6,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; MLL1 complex [GO:0071339]; MSL complex [GO:0072487]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; acetyltransferase activity [GO:0016407]; enzyme binding [GO:0019899]; histone acetyltransferase activity [GO:0004402]; histone acetyltransferase activity (H4-K16 specific) [GO:0046972]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription factor binding [GO:0008134]; histone acetylation [GO:0016573]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; myeloid cell differentiation [GO:0030099]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_KBP.1.1.m.16212,-0.00275961119660846,-0.000268692020461828,No,NA,NA,Q0IIZ5,NA,NA,NA,cytoskeleton [GO:0005856]; mitochondrion [GO:0005739]; cell differentiation [GO:0030154]; mitochondrial transport [GO:0006839]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KC1A.1.2.m.14719,0,0,No,NA,NA,Q8BK63,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell morphogenesis [GO:0000902]; Golgi organization [GO:0007030]; intermediate filament cytoskeleton organization [GO:0045104]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein phosphorylation [GO:0006468]; regulation of GTP binding [GO:1904424]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1A.2.2.m.64030,-0.00218448528269313,-0.00323797725722359,No,NA,NA,P67963,NA,NA,NA,ciliary basal body [GO:0036064]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; intermediate filament cytoskeleton organization [GO:0045104]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.1.3.m.12297,0.00365102755717537,0.0102812133538447,No,NA,NA,Q06486,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle microtubule [GO:0005876]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cellular response to nerve growth factor stimulus [GO:1990090]; circadian regulation of gene expression [GO:0032922]; Golgi organization [GO:0007030]; microtubule nucleation [GO:0007020]; non-motile cilium assembly [GO:1905515]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein phosphorylation [GO:0001934]; protein localization to centrosome [GO:0071539]; protein localization to cilium [GO:0061512]; protein localization to Golgi apparatus [GO:0034067]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KC1D.3.3.m.61498,0.0125550903723345,-0.00679389384129036,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_KC1G3.1.2.m.18974,-7.21625306704365e-05,0.00957423134076995,No,NA,NA,Q62762,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; peptide binding [GO:0042277]; phosphoprotein binding [GO:0051219]; protein serine/threonine kinase activity [GO:0004674]; endocytosis [GO:0006897]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_KCIP4.1.1.m.46682,0.00376909750218636,0.0035935219708662,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCMF1.1.1.m.62675,-0.00191834943701751,0.00444371078768891,No,NA,NA,Q9P0J7,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleic acid binding [GO:0003676]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_KCP.10.13.m.44423,0.00624039441027028,-0.00127303909768858,No,NA,NA,Q3U515,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cellular response to virus [GO:0098586],NA,NA,NA
CHOYP_KCP.3.13.m.17018,0.00551868929243367,0.00284436849282594,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.6.13.m.26127,0.00201981835791667,-0.000103683516678774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.7.13.m.40006,-0.00616233149606584,0.0160872596152093,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCP.8.13.m.40457,0.0217793834553443,0.015446382723266,No,NA,NA,Q6ZWJ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_KCP.9.13.m.43409,0.0257231134474634,0.0158819005592213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KCY.1.1.m.29973,0.0012042958949114,-0.00203166649609852,No,NA,NA,Q7ZWE9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_KDEL1.1.1.m.62729,-0.00140751641987161,-0.00226541651396787,No,NA,NA,Q6UW63,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; protein O-linked glycosylation via serine [GO:0018242],NA,NA,NA
CHOYP_KDM1A.1.1.m.60229,-0.00297272216177012,0.00579996820921275,No,NA,NA,O60341,NA,NA,NA,DNA repair complex [GO:1990391]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription factor complex [GO:0005667]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; histone deacetylase activity [GO:0004407]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-K4 specific) [GO:0032453]; histone demethylase activity (H3-K9 specific) [GO:0032454]; MRF binding [GO:0043426]; nuclear receptor transcription coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; telomeric DNA binding [GO:0042162]; telomeric repeat-containing RNA binding [GO:0061752]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; alternative mRNA splicing; via spliceosome [GO:0000380]; blood coagulation [GO:0007596]; cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; guanine metabolic process [GO:0046098]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of histone ubiquitination [GO:0033184]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of cellular protein localization [GO:1903827]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992],NA,NA,NA
CHOYP_KDM1A.1.1.m.60230,0.00195650437809452,-0.0109001344838681,No,NA,NA,Q9C0D0,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; nucleus [GO:0005634]; synapse [GO:0045202]; actin binding [GO:0003779]; protein phosphatase 1 binding [GO:0008157]; protein phosphatase inhibitor activity [GO:0004864]; actin cytoskeleton reorganization [GO:0031532]; actomyosin structure organization [GO:0031032]; cell motility [GO:0048870]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_KDM1B.1.1.m.15843,-0.017750885038166,-0.0066921491615687,No,NA,NA,Q8NB78,NA,NA,NA,nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; FAD binding [GO:0071949]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-monomethyl-K4 specific) [GO:0034649]; oxidoreductase activity [GO:0016491]; zinc ion binding [GO:0008270]; DNA methylation involved in gamete generation [GO:0043046]; histone H3-K4 demethylation [GO:0034720]; multicellular organism development [GO:0007275]; protein deubiquitination [GO:0016579]; regulation of DNA methylation [GO:0044030]; regulation of gene expression by genetic imprinting [GO:0006349],NA,NA,NA
CHOYP_KDM2B.1.1.m.58689,0.000104506800503203,0.00413982621172511,No,NA,NA,Q8N9M1,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_KDM5A.1.1.m.51935,-0.0105206266024671,0.00566938119012712,No,NA,NA,P29375,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; core promoter sequence-specific DNA binding [GO:0001046]; dioxygenase activity [GO:0051213]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; histone binding [GO:0042393]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-dimethyl-K4 specific) [GO:0034648]; histone demethylase activity (H3-trimethyl-K4 specific) [GO:0034647]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; histone H3-K4 demethylation [GO:0034720]; histone H3-K9 demethylation [GO:0033169]; male gonad development [GO:0008584]; negative regulation of histone deacetylase activity [GO:1901726]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of DNA-binding transcription factor activity [GO:0051090]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_KHDR1.1.1.m.8878,-0.0014628970733903,-0.000887969252591489,No,NA,NA,Q0VFL3,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_KI11A.1.1.m.14576,-2.79498955679171e-05,0.00234995252687253,No,NA,NA,P52732,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein kinase binding [GO:0019901]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of mitotic centrosome separation [GO:0046602]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KI16B.1.3.m.42636,-0.00597817244925719,-0.00620548389299134,No,NA,NA,Q96L93,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; phagocytic vesicle [GO:0045335]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; Rab GTPase binding [GO:0017137]; cellular response to interferon-gamma [GO:0071346]; early endosome to late endosome transport [GO:0045022]; endoderm development [GO:0007492]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; formation of primary germ layer [GO:0001704]; Golgi to endosome transport [GO:0006895]; microtubule-based movement [GO:0007018]; receptor catabolic process [GO:0032801]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_KI21A.1.2.m.43900,0.00117520964012168,0.0154287873674388,No,NA,NA,Q9QXL2,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIAA1143.1.1.m.1249,0.0103540320028638,-0.00274472159412076,No,NA,NA,Q8K039,NA,NA,NA,,NA,NA,NA
CHOYP_KIF2A.2.2.m.62686,0.000531990409162943,-0.00550119006821278,No,NA,NA,Q5ZKV8,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cell differentiation [GO:0030154]; cell division [GO:0051301]; microtubule-based movement [GO:0007018]; mitotic spindle organization [GO:0007052]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_KIF2A.2.2.m.62687,0.00086454911290159,0.000659644862524164,No,NA,NA,P49432,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; pyruvate dehydrogenase activity [GO:0004738]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glucose metabolic process [GO:0006006]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_KIF2A.2.2.m.62688,-0.0016279584329825,-0.000823368121217202,No,NA,NA,Q8VEM8,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; inorganic phosphate transmembrane transporter activity [GO:0005315]; protein-containing complex binding [GO:0044877]; symporter activity [GO:0015293]; phosphate ion transmembrane transport [GO:0035435],NA,NA,NA
CHOYP_KIF3A.1.1.m.51746,-0.00536702371172802,-0.0157889516709822,No,NA,NA,Q4R628,NA,NA,NA,centriole [GO:0005814]; cilium [GO:0005929]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; centriole-centriole cohesion [GO:0010457]; cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.1.9.m.1032,0.000512875316363525,0.000261231948844302,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KINH.6.9.m.42394,-0.00179081187803913,-0.00738826084347433,No,NA,NA,P21613,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_KIZ.1.1.m.57618,0,0,No,NA,NA,Q2M2Z5,NA,NA,NA,cell projection [GO:0042995]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; protein kinase binding [GO:0019901]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_KLC.2.3.m.40314,-0.00069336814901478,-0.00103265301570658,No,NA,NA,P46825,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule motor activity [GO:0003777],NA,NA,NA
CHOYP_KLH26.1.2.m.8792,-0.0146214104928054,-0.00930502954488528,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLH36.1.2.m.12244,0.000720024590319151,-0.00296749367380023,No,NA,NA,Q6ZPT1,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; midbody [GO:0030496]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein ubiquitination [GO:0016567]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_KLHDB.3.5.m.46662,0.0072172631597118,0.0144655692094073,No,NA,NA,O94889,NA,NA,NA,,NA,NA,NA
CHOYP_KLHL24.1.4.m.8833,0.00842667349841214,-0.0109440603065979,No,NA,NA,Q6TFL4,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; desmosome [GO:0030057]; perikaryon [GO:0043204]; intermediate filament organization [GO:0045109]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of kainate selective glutamate receptor activity [GO:2000312],NA,NA,NA
CHOYP_KLHL24.2.4.m.18433,-0.00396865347027388,0.00324343972024691,No,NA,NA,Q8WZ60,NA,NA,NA,B cell receptor signaling pathway [GO:0050853]; germinal center formation [GO:0002467]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_KLHL7.1.1.m.9444,0.00523820122835982,0.00618618089543156,No,NA,NA,F1LZ52,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin binding [GO:0003779]; distal tubule morphogenesis [GO:0072156]; ion homeostasis [GO:0050801]; protein K48-linked ubiquitination [GO:0070936]; protein ubiquitination [GO:0016567]; renal sodium ion absorption [GO:0070294]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_KLLA0E01035G.1.1.m.13451,0.00422044635998335,0.00498423857811543,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KMO.1.2.m.17496,0.00409043214643938,0.0262833764590243,No,NA,NA,Q1RLY6,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; kynurenine 3-monooxygenase activity [GO:0004502]; NAD(P)H oxidase activity [GO:0016174]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; glomerular visceral epithelial cell development [GO:0072015]; kynurenine metabolic process [GO:0070189]; NAD metabolic process [GO:0019674]; quinolinate biosynthetic process [GO:0019805]; response to yeast [GO:0001878]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_KNOP1.1.1.m.11909,0.00299578056663311,0.00908707946539299,No,NA,NA,A5D7J3,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_KPC1.1.2.m.30648,-0.0292568281315038,0.0301783488096017,No,NA,NA,Q16974,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC1.2.2.m.37402,0.00212747030196443,0.0039656541992481,No,NA,NA,Q16974,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; protein kinase C activity [GO:0004697]; zinc ion binding [GO:0008270]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPC2.1.3.m.22368,-0.00439464602382746,-0.00829508704427163,No,NA,NA,Q16975,NA,NA,NA,membrane [GO:0016020]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_KPCD3.1.1.m.10808,0.00682462503953385,0.0214513724722928,No,NA,NA,O94806,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase D signaling [GO:0089700]; protein phosphorylation [GO:0006468]; sphingolipid biosynthetic process [GO:0030148],NA,NA,NA
CHOYP_KPOL_1058P4.2.2.m.61989,0.00830070129224102,-0.00580521984755939,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_KPRB.1.1.m.17501,-0.0016846576124321,0.0046581929557957,No,NA,NA,O08618,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; bone development [GO:0060348]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164],NA,NA,NA
CHOYP_KPYK.2.4.m.19753,0.0288733954905952,-0.00238051160624244,No,NA,NA,P00548,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_KPYK.3.4.m.47446,0.00851041008077433,-0.00538450492810053,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYK.4.4.m.48513,0.00648869094160629,-0.0117801055311807,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KPYM.1.1.m.33498,0.00211545205098706,0.000555709582320435,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_KRP95.1.1.m.13582,-0.0183888132909905,-0.00892816873020529,No,NA,NA,O15066,NA,NA,NA,axon cytoplasm [GO:1904115]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; kinesin II complex [GO:0016939]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; plus-end kinesin complex [GO:0005873]; spindle [GO:0005819]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; intraciliary transport particle B binding [GO:0120170]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; Rho GTPase binding [GO:0017048]; anterograde axonal transport [GO:0008089]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; determination of left/right symmetry [GO:0007368]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule-based movement [GO:0007018]; mitotic centrosome separation [GO:0007100]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of cytokinesis [GO:0032467]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_KS6A1.1.1.m.38386,0.00127059133298767,-9.06708579116121e-05,No,NA,NA,P51812,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosomal protein S6 kinase activity [GO:0004711]; cell cycle [GO:0007049]; central nervous system development [GO:0007417]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription in response to stress [GO:0043620]; regulation of translation in response to stress [GO:0043555]; response to lipopolysaccharide [GO:0032496]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_KS6A1.1.1.m.38387,0.000657669691192442,-0.00240826038527747,No,NA,NA,Q07598,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869]; positive regulation of intracellular cholesterol transport [GO:0032385],NA,NA,NA
CHOYP_KS6A5.1.1.m.51330,-0.0212904693114179,0.0187622051960543,No,NA,NA,Q5F3L1,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; histone H2A-S1 phosphorylation [GO:0043990]; histone H3-S10 phosphorylation [GO:0043987]; histone H3-S28 phosphorylation [GO:0043988]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_KS6B1.1.1.m.8274,-0.0103958627170248,-0.0100151457217661,No,NA,NA,P67999,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; synapse [GO:0045202]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; PDZ domain binding [GO:0030165]; peptide binding [GO:0042277]; protein kinase activity [GO:0004672]; protein phosphatase 2A binding [GO:0051721]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; ribosomal protein S6 kinase activity [GO:0004711]; aging [GO:0007568]; apoptotic process [GO:0006915]; behavioral fear response [GO:0001662]; cell migration [GO:0016477]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to interferon-gamma [GO:0071346]; G1/S transition of mitotic cell cycle [GO:0000082]; germ cell development [GO:0007281]; intracellular signal transduction [GO:0035556]; long-chain fatty acid import [GO:0044539]; long-term memory [GO:0007616]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of translational initiation [GO:0045948]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; regulation of glucose import [GO:0046324]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to electrical stimulus involved in regulation of muscle adaptation [GO:0014878]; response to ethanol [GO:0045471]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to insulin [GO:0032868]; response to leucine [GO:0043201]; response to lipopolysaccharide [GO:0032496]; response to mechanical stimulus [GO:0009612]; response to nutrient [GO:0007584]; response to organic cyclic compound [GO:0014070]; response to organic substance [GO:0010033]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to testosterone [GO:0033574]; response to toxic substance [GO:0009636]; response to tumor necrosis factor [GO:0034612]; response to wounding [GO:0009611]; skeletal muscle atrophy [GO:0014732]; skeletal muscle contraction [GO:0003009]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_KSR2.1.1.m.9852,-0.00589943507047163,-0.00381727248078064,No,NA,NA,Q9D0F6,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_KTNA1.1.2.m.16373,0.00331188939150609,-0.0211670806201931,No,NA,NA,O61577,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; isomerase activity [GO:0016853]; microtubule binding [GO:0008017]; microtubule-severing ATPase activity [GO:0008568]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoplasmic microtubule organization [GO:0031122],NA,NA,NA
CHOYP_KTNA1.2.2.m.63437,-0.00261480967230361,0.00427415425589273,No,NA,NA,O08623,NA,NA,NA,aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; SH2 domain binding [GO:0042169]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cell differentiation [GO:0030154]; endosome organization [GO:0007032]; immune system process [GO:0002376]; macroautophagy [GO:0016236]; mitochondrion organization [GO:0007005]; mitophagy [GO:0000423]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; protein heterooligomerization [GO:0051291]; protein localization to perinuclear region of cytoplasm [GO:1905719]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of protein complex stability [GO:0061635]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; selective autophagy [GO:0061912],NA,NA,NA
CHOYP_L1CAM.2.2.m.49542,0.0034970176497969,-0.0137008002380885,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LA.1.1.m.65962,-0.00126251757525072,0.000927469252422282,No,NA,NA,P10881,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409],NA,NA,NA
CHOYP_LACB2.1.1.m.31957,-0.0132822407941436,0.00950722842696729,No,NA,NA,Q0V9A9,NA,NA,NA,mitochondrial matrix [GO:0005759]; endoribonuclease activity [GO:0004521]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502],NA,NA,NA
CHOYP_LACBIDRAFT_295117.3.10.m.29879,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LACH.1.1.m.62529,5.56427498415064e-07,0.0113418683083944,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LAMA2.1.1.m.10439,-0.000752136764264716,0.00419810616192121,No,NA,NA,Q60675,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]; extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; positive regulation of synaptic transmission; cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; Schwann cell differentiation [GO:0014037],NA,NA,NA
CHOYP_LAMP1.2.3.m.16422,0.00166165358922057,0.00324196543092496,No,NA,NA,P05300,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAMP1.3.3.m.16600,-0.00705962541567244,-0.00168669800856203,No,NA,NA,P05300,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LAR.1.2.m.30133,-0.00520156567198189,0.004182447182093,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LARP4.1.1.m.14987,-0.00319071431724188,-0.00207224230723184,No,NA,NA,Q6A0A2,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleolus [GO:0005730]; polysomal ribosome [GO:0042788]; RNA binding [GO:0003723]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_LARP7.1.1.m.35019,0.00891457026041257,-0.00637187632024987,No,NA,NA,Q7ZWE3,NA,NA,NA,nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; cardiac muscle tissue regeneration [GO:0061026]; regulation of cardiac muscle cell proliferation [GO:0060043]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LC7L3.1.1.m.20705,-0.0013947240435516,0.000589216151544619,No,NA,NA,Q5SUF2,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; mRNA splice site selection [GO:0006376]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LCAZH_2403.1.1.m.47655,0.00244312775909086,-0.000660202901144331,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LCP2.12.14.m.40093,0.00991530138663911,0.00154372782453331,No,NA,NA,Q13094,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; Fc-epsilon receptor signaling pathway [GO:0038095]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; platelet activation [GO:0030168]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LCP2.3.14.m.8968,-0.018526972696019,-0.00392701952026745,No,NA,NA,Q60787,NA,NA,NA,cell-cell junction [GO:0005911]; cytosol [GO:0005829]; plasma membrane raft [GO:0044853]; TCR signalosome [GO:0036398]; cytokine secretion [GO:0050663]; intracellular signal transduction [GO:0035556]; mast cell activation [GO:0045576]; positive regulation of protein kinase activity [GO:0045860]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LDB3.1.1.m.371,-0.00891706760876775,-0.0129243830714408,No,NA,NA,Q5E9E1,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LDBPK_300810.1.1.m.29406,0.00683091120312468,0.00328633092584647,No,NA,NA,Q54I71,NA,NA,NA,adherens junction [GO:0005912]; basal cortex [GO:0045180]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; alpha-catenin binding [GO:0045294]; cell adhesion [GO:0007155]; cell motility [GO:0048870]; cellular protein localization [GO:0034613]; centrosome localization [GO:0051642]; culmination involved in sorocarp development [GO:0031154]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of bipolar cell polarity [GO:0061245]; Golgi localization [GO:0051645]; multicellular organism development [GO:0007275]; positive regulation of cytoskeleton organization [GO:0051495]; protein secretion [GO:0009306]; regulation of gene expression [GO:0010468]; sorocarp spore cell differentiation [GO:0044671]; sorocarp stalk development [GO:0031150]; sorocarp stalk morphogenesis [GO:0036360],NA,NA,NA
CHOYP_LDLR.6.7.m.57984,0.00525244867857053,-0.000278857856128372,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LECG.3.4.m.29627,-0.0135605255615666,-0.0086298849934237,No,NA,NA,Q66S03,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; toxin activity [GO:0090729]; inflammatory response [GO:0006954],NA,NA,NA
CHOYP_LEG4.1.1.m.22079,-0.00908952994207165,0.0203135492178612,No,NA,NA,P38486,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; spliceosomal complex [GO:0005681]; carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LEMD3.1.1.m.56975,0.0135347640067459,0.0105378477155628,No,NA,NA,Q9Y2U8,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of nuclear inner membrane [GO:0005639]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nuclear membrane [GO:0031965]; DNA binding [GO:0003677]; angiogenesis [GO:0001525]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; nuclear envelope organization [GO:0006998]; regulation of intracellular signal transduction [GO:1902531],NA,NA,NA
CHOYP_LEO1.1.1.m.41626,-0.0206018461635091,0.0246417585360513,No,NA,NA,Q6NYV9,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleus [GO:0005634]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; embryonic cranial skeleton morphogenesis [GO:0048701]; glial cell development [GO:0021782]; heart development [GO:0007507]; histone modification [GO:0016570]; melanocyte differentiation [GO:0030318]; neural crest cell development [GO:0014032]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; spinal cord oligodendrocyte cell differentiation [GO:0021529]; transcription elongation from RNA polymerase II promoter [GO:0006368]; xanthophore differentiation [GO:0050936],NA,NA,NA
CHOYP_LGR4.1.2.m.27343,0.0029281314728169,0.00116421732608304,No,NA,NA,Q9BXB1,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor activity [GO:0004930]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone remodeling [GO:0046849]; canonical Wnt signaling pathway involved in metanephric kidney development [GO:0061290]; cell differentiation involved in metanephros development [GO:0072202]; circadian regulation of gene expression [GO:0032922]; digestive tract development [GO:0048565]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; hair follicle development [GO:0001942]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; intestinal stem cell homeostasis [GO:0036335]; male genitalia development [GO:0030539]; metanephric glomerulus development [GO:0072224]; metanephric nephron tubule morphogenesis [GO:0072282]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of cytokine secretion [GO:0050710]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transcription; DNA-templated [GO:0045892]; osteoblast differentiation [GO:0001649]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription; DNA-templated [GO:0045893]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LIAS.1.1.m.21693,-0.0242816902346487,-0.00971073374404299,No,NA,NA,Q6GQ48,NA,NA,NA,mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; lipoate synthase activity [GO:0016992]; metal ion binding [GO:0046872]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_LIG4.1.1.m.6295,-0.00774031315428604,-0.00490114372762768,No,NA,NA,Q8BTF7,NA,NA,NA,condensed chromosome [GO:0000793]; cytoplasmic ribonucleoprotein granule [GO:0036464]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; ligase activity [GO:0016874]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cellular response to ionizing radiation [GO:0071479]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; chromosome organization [GO:0051276]; DNA biosynthetic process [GO:0071897]; DNA ligation [GO:0006266]; DNA ligation involved in DNA recombination [GO:0051102]; DNA ligation involved in DNA repair [GO:0051103]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair [GO:0006302]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; in utero embryonic development [GO:0001701]; isotype switching [GO:0045190]; negative regulation of neuron apoptotic process [GO:0043524]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair; DNA gap filling [GO:0006297]; positive regulation of chromosome organization [GO:2001252]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neurogenesis [GO:0050769]; pro-B cell differentiation [GO:0002328]; response to gamma radiation [GO:0010332]; response to ionizing radiation [GO:0010212]; response to X-ray [GO:0010165]; single strand break repair [GO:0000012]; somatic stem cell population maintenance [GO:0035019]; T cell differentiation in thymus [GO:0033077]; T cell receptor V(D)J recombination [GO:0033153]; V(D)J recombination [GO:0033151],NA,NA,NA
CHOYP_LIGO2.1.2.m.3525,0.00130364590279245,0.00323325114106085,No,NA,NA,Q80X72,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of cell migration [GO:0030335]; receptor-mediated virion attachment to host cell [GO:0046813],NA,NA,NA
CHOYP_LIN9.1.1.m.12005,0.00673650814626654,-0.000723371415772045,No,NA,NA,Q5TKA1,NA,NA,NA,nucleoplasm [GO:0005654]; transcriptional repressor complex [GO:0017053]; DNA binding [GO:0003677]; cell cycle [GO:0007049]; DNA biosynthetic process [GO:0071897]; regulation of cell cycle [GO:0051726]; reproduction [GO:0000003]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LINJ_09_0950.1.1.m.64023,0.00838342791793637,-0.00683467025373077,No,NA,NA,P0CH27,NA,NA,NA,nucleus [GO:0005634]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LIPA1.1.1.m.10892,-0.00188134612007912,-0.00104200317661154,No,NA,NA,Q13136,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; cell-matrix adhesion [GO:0007160]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LIPB1.1.1.m.35961,-0.0165337505235679,0.00983593000454421,No,NA,NA,Q8ND30,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; intracellular [GO:0005622]; presynapse [GO:0098793]; identical protein binding [GO:0042802],NA,NA,NA
CHOYP_LIPR1.2.3.m.4679,-0.0137268417476179,-0.00245835814892038,No,NA,NA,P54316,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LIS1.1.1.m.56212,0.00123413274928007,0.00577847751551683,No,NA,NA,C3XVT5,NA,NA,NA,axon cytoplasm [GO:1904115]; cytoplasmic microtubule [GO:0005881]; kinetochore [GO:0000776]; microtubule associated complex [GO:0005875]; microtubule organizing center [GO:0005815]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; dynein complex binding [GO:0070840]; microtubule plus-end binding [GO:0051010]; brain morphogenesis [GO:0048854]; cell division [GO:0051301]; establishment of mitotic spindle orientation [GO:0000132]; microtubule organizing center organization [GO:0031023]; microtubule sliding [GO:0051012]; nuclear migration [GO:0007097]; regulation of microtubule motor activity [GO:2000574]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_LMBL3.1.1.m.14251,-0.0023499583367438,0.00026488953182364,No,NA,NA,E1C2V1,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; methylated histone binding [GO:0035064]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325],NA,NA,NA
CHOYP_LMNB2.1.1.m.55999,4.13734768398089e-05,-0.0019437936507303,No,NA,NA,P08928,NA,NA,NA,cytoplasm [GO:0005737]; lamin filament [GO:0005638]; nuclear envelope [GO:0005635]; nuclear inner membrane [GO:0005637]; nuclear lamina [GO:0005652]; nucleus [GO:0005634]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; adult locomotory behavior [GO:0008344]; cell aging [GO:0007569]; central nervous system development [GO:0007417]; chitin-based cuticle development [GO:0040003]; chromatin silencing [GO:0006342]; compound eye morphogenesis [GO:0001745]; digestive tract morphogenesis [GO:0048546]; gonad morphogenesis [GO:0035262]; heterochromatin maintenance involved in chromatin silencing [GO:0070870]; male meiosis cytokinesis [GO:0007112]; meiosis I cytokinesis [GO:0007110]; mitotic nuclear envelope reassembly [GO:0007084]; negative regulation of cell proliferation [GO:0008285]; negative regulation of immune response [GO:0050777]; nuclear envelope organization [GO:0006998]; nuclear membrane organization [GO:0071763]; nuclear migration [GO:0007097]; nuclear pore distribution [GO:0031081]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cytokinesis; actomyosin contractile ring assembly [GO:2000433]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of spindle assembly [GO:1905832]; protein localization to nuclear envelope [GO:0090435]; spermatocyte division [GO:0048137]; spermatogenesis [GO:0007283]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_LMO7.1.1.m.27803,0.00315661455650715,-0.00264000976862969,No,NA,NA,Q9UPQ0,NA,NA,NA,cytoplasm [GO:0005737]; stress fiber [GO:0001725]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin II head/neck binding [GO:0032034]; actomyosin structure organization [GO:0031032]; negative regulation of cell migration [GO:0030336]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; regulation of focal adhesion assembly [GO:0051893],NA,NA,NA
CHOYP_LNTL.1.1.2.m.10782,-0.000732225379664628,-0.0061933643239233,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_00377.2.4.m.54574,0.00235577181455818,-0.000636596829870293,No,NA,NA,Q20930,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; gonad morphogenesis [GO:0035262]; protein autoprocessing [GO:0016540]; protein localization [GO:0008104]; regulation of cell migration [GO:0030334]; regulation of distal tip cell migration [GO:1903354]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOAG_00625.1.1.m.34418,0.00893982163558821,-0.0162300906677321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOAG_01021.1.4.m.1826,-0.00868249595103207,-0.00409565800768717,No,NA,NA,O01761,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; ATP binding [GO:0005524]; MATH domain binding [GO:0090736]; phosphatase binding [GO:0019902]; protein kinase activity [GO:0004672]; Rho GTPase binding [GO:0017048]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; cellular protein localization [GO:0034613]; myosin filament assembly [GO:0031034]; pharyngeal gland morphogenesis [GO:1905905]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion [GO:0040017]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; regulation of Rho protein signal transduction [GO:0035023]; regulation of skeletal muscle contraction by calcium ion signaling [GO:0014722]; sarcomere organization [GO:0045214]; skeletal muscle myosin thick filament assembly [GO:0030241]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOAG_05095.2.2.m.58023,0.0103526440212153,0.0058315386190533,No,NA,NA,Q9NJV4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOAG_05718.1.1.m.48540,-0.00429009272706094,-0.0014375430583301,No,NA,NA,Q5R957,NA,NA,NA,chloride channel complex [GO:0034707]; cytoplasmic vesicle membrane [GO:0030659]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; chloride channel activity [GO:0005254]; voltage-gated ion channel activity [GO:0005244]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOAG_05814.1.1.m.56611,-0.0128720109897011,-0.00819171601947658,No,NA,NA,Q9JLY7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; MAP kinase tyrosine/serine/threonine phosphatase activity [GO:0017017]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100005182.1.1.m.53007,-0.000474760087798866,-0.00845143103093975,No,NA,NA,Q9NUV9,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC100005318.1.1.m.30043,0.0141747387732547,-0.00726846080227568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100007585.5.7.m.51610,4.68434104409535e-05,-0.00230253610859238,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100008030.1.1.m.10817,-0.00211111954671813,-0.00690884305991031,No,NA,NA,Q6ZSB9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100013725.1.2.m.12740,-0.00604908787090156,-0.00124201261252093,No,NA,NA,P07607,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; cofactor binding [GO:0048037]; drug binding [GO:0008144]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; nucleotide binding [GO:0000166]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; aging [GO:0007568]; cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; dUMP metabolic process [GO:0046078]; immortalization of host cell by virus [GO:0019088]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; negative regulation of translation [GO:0017148]; regulation of translation [GO:0006417]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to vitamin A [GO:0033189]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860],NA,NA,NA
CHOYP_LOC100017222.1.1.m.19930,0.00201045109959076,-0.00447751392364165,No,NA,NA,Q6PGE4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100017224.1.1.m.26828,-0.000891289735572591,-0.00114813286889463,No,NA,NA,Q4VBV9,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; asparagine metabolic process [GO:0006528]; glutamine metabolic process [GO:0006541]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100023660.1.1.m.30865,0.00605850748080951,-0.010999114941313,No,NA,NA,Q91766,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; hepatocyte differentiation [GO:0070365]; lipid homeostasis [GO:0055088]; regulation of insulin secretion [GO:0050796]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100024134.1.1.m.61877,0.0105711875690335,0.00296995784441722,No,NA,NA,Q91ZW6,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; trimethyllysine dioxygenase activity [GO:0050353]; carnitine biosynthetic process [GO:0045329],NA,NA,NA
CHOYP_LOC100024935.1.1.m.2615,-0.000109547329550739,0.00345631985511353,No,NA,NA,Q95108,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; glycerol ether metabolic process [GO:0006662],NA,NA,NA
CHOYP_LOC100027252.1.1.m.30045,-0.00190596149647145,0.00316544831364382,No,NA,NA,Q08623,NA,NA,NA,cytosol [GO:0005829]; hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; pseudouridine 5'-phosphatase activity [GO:1990738]; nucleotide metabolic process [GO:0009117]; pyrimidine nucleoside salvage [GO:0043097],NA,NA,NA
CHOYP_LOC100027962.1.1.m.48278,0.00356687525502196,0.00165772797545303,No,NA,NA,Q8R146,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; identical protein binding [GO:0042802]; omega peptidase activity [GO:0008242]; serine-type endopeptidase activity [GO:0004252]; amyloid-beta metabolic process [GO:0050435]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100028654.1.1.m.62088,0.00206339286867243,0.0013918837033003,No,NA,NA,A3KPN8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100030710.2.4.m.13432,0.0056997800319721,0.00831344733152546,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100030710.4.4.m.20819,0.00246307649680085,0.00499865895094052,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100049762.1.1.m.1777,4.34642386719896e-08,0.00461499868342976,No,NA,NA,Q1HQF8,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100061302.1.1.m.47172,0.00512893952530495,-0.00138598595255625,No,NA,NA,Q96PY6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100068494.1.1.m.8733,0.000394516451841665,0.00661848011017817,No,NA,NA,A5PKG7,NA,NA,NA,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cullin family protein binding [GO:0097602]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100072802.1.1.m.27280,-0.00582877088518533,0.00021506516229487,No,NA,NA,Q3T0B6,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; adrenergic receptor binding [GO:0031690]; complement component C1q binding [GO:0001849]; hyaluronic acid binding [GO:0005540]; kininogen binding [GO:0030984]; mitochondrial ribosome binding [GO:0097177]; mRNA binding [GO:0003729]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; translation activator activity [GO:0008494]; apoptotic process [GO:0006915]; complement activation; classical pathway [GO:0006958]; innate immune response [GO:0045087]; mature ribosome assembly [GO:0042256]; mRNA processing [GO:0006397]; negative regulation of defense response to virus [GO:0050687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of transcription by RNA polymerase II [GO:0000122]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of mitochondrial translation [GO:0070131]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of trophoblast cell migration [GO:1901165]; regulation of complement activation [GO:0030449]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100079978.1.1.m.18519,0.00293054947520309,0.00881682462702344,No,NA,NA,Q9WU56,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; nuclear receptor transcription coactivator activity [GO:0030374]; pseudouridine synthase activity [GO:0009982]; steroid receptor RNA activator RNA binding [GO:0002153]; tRNA binding [GO:0000049]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_LOC100080726.1.1.m.59048,0.00551395668693428,0.00115069700065727,No,NA,NA,A0JPN4,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; rough endoplasmic reticulum membrane [GO:0030867]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; endoribonuclease activity [GO:0004521]; exoribonuclease activity [GO:0004532]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; nuclease activity [GO:0004518]; ribosome binding [GO:0043022]; RNA stem-loop binding [GO:0035613]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cellular response to chemokine [GO:1990869]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to glucose starvation [GO:0042149]; cellular response to interleukin-1 [GO:0071347]; cellular response to ionomycin [GO:1904637]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to sodium arsenite [GO:1903936]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response-activating signal transduction [GO:0002757]; inflammatory response [GO:0006954]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma secretion [GO:1902714]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of interleukin-6 secretion [GO:1900165]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of tumor necrosis factor secretion [GO:1904468]; nervous system development [GO:0007399]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy [GO:0010508]; positive regulation of cell death [GO:0010942]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of lipid storage [GO:0010884]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein deubiquitination [GO:1903003]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259]; protein deubiquitination [GO:0016579]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100081619.1.1.m.33744,-0.0134662751266342,-0.0335669468441064,No,NA,NA,O70480,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of presynaptic endosome membrane [GO:0099067]; integral component of synaptic vesicle membrane [GO:0030285]; phagocytic vesicle [GO:0045335]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network [GO:0005802]; cellular response to interferon-gamma [GO:0071346]; Golgi ribbon formation [GO:0090161]; Golgi to plasma membrane protein transport [GO:0043001]; microtubule cytoskeleton organization [GO:0000226]; regulation of Golgi to plasma membrane protein transport [GO:0042996]; regulation of synaptic vesicle endocytosis [GO:1900242]; SNARE complex assembly [GO:0035493]; synaptic vesicle to endosome fusion [GO:0016189]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100081920.1.4.m.1772,-0.0125292568973046,0.0165136702087383,No,NA,NA,Q28024,NA,NA,NA,heterotrimeric G-protein complex [GO:0005834]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; phosphate ion binding [GO:0042301]; cerebral cortex development [GO:0021987]; G protein-coupled receptor signaling pathway [GO:0007186]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100083076.1.1.m.35327,0.00183706993383021,-0.00421768806338168,No,NA,NA,A2RT67,NA,NA,NA,cytoplasm [GO:0005737]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; cellular protein catabolic process [GO:0044257]; endosome to lysosome transport [GO:0008333],NA,NA,NA
CHOYP_LOC100089326.1.1.m.19184,-0.00596165433990077,0.00612538309913032,No,NA,NA,P70581,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; protein-containing complex [GO:0032991]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_LOC100113561.1.1.m.37903,-0.00125442375865636,0.00364485853108128,No,NA,NA,P31478,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_LOC100113671.1.1.m.18491,-0.0317301064705756,-0.011699090332481,No,NA,NA,Q8R3G1,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA binding [GO:0003729]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of protein dephosphorylation [GO:0035308]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100114159.1.1.m.53867,0.00788084953552548,-0.00768317620211723,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100114171.1.1.m.50280,0.00138654362929301,-0.00259565256923708,No,NA,NA,O42254,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; translation regulator activity [GO:0045182]; CRD-mediated mRNA stabilization [GO:0070934]; mRNA transport [GO:0051028]; negative regulation of translation [GO:0017148]; neuronal stem cell population maintenance [GO:0097150]; pallium cell proliferation in forebrain [GO:0022013]; positive regulation of neuron projection development [GO:0010976]; regulation of mRNA stability involved in response to stress [GO:0010610],NA,NA,NA
CHOYP_LOC100114247.1.1.m.30717,0.00152869163351572,8.45368063919937e-05,No,NA,NA,Q99MN1,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; amino acid binding [GO:0016597]; ATP adenylyltransferase activity [GO:0003877]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; tRNA binding [GO:0000049]; activation of MAPK activity [GO:0000187]; basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; negative regulation of cell proliferation [GO:0008285]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of cytokine secretion involved in immune response [GO:0002741]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of metallopeptidase activity [GO:1905050]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of transcription; DNA-templated [GO:0045893]; response to X-ray [GO:0010165]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100114310.1.2.m.39843,0.000214892558063719,0.00047725496013366,No,NA,NA,Q01082,NA,NA,NA,axolemma [GO:0030673]; cuticular plate [GO:0032437]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; M band [GO:0031430]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; spectrin [GO:0008091]; spectrin-associated cytoskeleton [GO:0014731]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; GTPase binding [GO:0051020]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; common-partner SMAD protein phosphorylation [GO:0007182]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi to plasma membrane protein transport [GO:0043001]; MAPK cascade [GO:0000165]; membrane assembly [GO:0071709]; mitotic cytokinesis [GO:0000281]; plasma membrane organization [GO:0007009]; positive regulation of interleukin-2 secretion [GO:1900042]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of SMAD protein signal transduction [GO:0060390],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64227,0.00150067426134265,0.000540318018246078,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100114310.2.2.m.64228,0.00202308188525575,-0.00587826623104276,No,NA,NA,P36241,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100114433.2.4.m.6343,0.00141831292130086,0.00324047488257173,No,NA,NA,O14974,NA,NA,NA,A band [GO:0031672]; actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; PTW/PP1 phosphatase complex [GO:0072357]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; enzyme inhibitor activity [GO:0004857]; phosphatase regulator activity [GO:0019208]; protein kinase binding [GO:0019901]; cellular response to drug [GO:0035690]; centrosome cycle [GO:0007098]; mitotic cell cycle [GO:0000278]; negative regulation of catalytic activity [GO:0043086]; positive regulation of myosin-light-chain-phosphatase activity [GO:0035508]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein dephosphorylation [GO:0006470]; regulation of cell adhesion [GO:0030155]; regulation of myosin-light-chain-phosphatase activity [GO:0035507]; regulation of nucleocytoplasmic transport [GO:0046822]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100114636.1.1.m.11052,0.000417428019447198,0.000800225334422799,No,NA,NA,O43396,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; disulfide oxidoreductase activity [GO:0015036]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100114736.1.1.m.18266,0.000542093412205252,-0.000503404632398591,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC100115002.1.1.m.45844,0.00119110841713933,0.00447163992657589,No,NA,NA,Q9CX00,NA,NA,NA,centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; identical protein binding [GO:0042802]; MIT domain binding [GO:0090541]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; abscission [GO:0009838]; cell division [GO:0051301]; cytoskeleton-dependent cytokinesis [GO:0061640]; establishment of protein localization [GO:0045184]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of proteolysis [GO:0045862]; protein localization [GO:0008104]; protein transport [GO:0015031]; viral capsid secondary envelopment [GO:0046745]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_LOC100115298.1.1.m.39207,0.00253128564210912,7.02716324725201e-06,No,NA,NA,P35604,NA,NA,NA,COPI vesicle coat [GO:0030126]; Golgi membrane [GO:0000139]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100115467.1.1.m.51329,0.00351831480518041,-0.00175120112784659,No,NA,NA,P62323,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; histone pre-mRNA DCP binding [GO:0071208]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100115577.1.1.m.21791,0.000502437693824692,-0.00104163465567563,No,NA,NA,P12613,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; ovarian follicle cell development [GO:0030707]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100115776.1.1.m.24729,-0.00267430242390266,0.00108064225822894,No,NA,NA,Q921I2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100115939.1.1.m.28155,-0.0126356587823275,0.0104022672351116,No,NA,NA,Q8CHI8,NA,NA,NA,NuA4 histone acetyltransferase complex [GO:0035267]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; protein antigen binding [GO:1990405]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967],NA,NA,NA
CHOYP_LOC100116049.1.1.m.54372,-0.00433062831326184,-0.00205090133564877,No,NA,NA,Q7K556,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; phosphatidic acid binding [GO:0070300]; phosphatidylinositol binding [GO:0035091]; photoreceptor cell maintenance [GO:0045494]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100116717.2.2.m.30034,-0.0051918624502859,0.00428546457653508,No,NA,NA,Q9EPR2,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; arachidonic acid secretion [GO:0050482]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_LOC100116719.1.1.m.58,0.00686874726656798,-0.00414589213618766,No,NA,NA,A4FV97,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; maturation of LSU-rRNA [GO:0000470]; regulation of apoptotic process [GO:0042981]; regulation of cellular senescence [GO:2000772]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11654,-0.00179400466359676,0.00274668430750533,No,NA,NA,O88665,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577]; p53 binding [GO:0002039]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100116878.1.1.m.11655,-0.00106945720796843,0.00110981604783478,No,NA,NA,Q6NWC6,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; mRNA cleavage factor complex [GO:0005849]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; perichromatin fibrils [GO:0005726]; mRNA binding [GO:0003729]; messenger ribonucleoprotein complex assembly [GO:1990120]; mRNA alternative polyadenylation [GO:0110104]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_LOC100117365.1.1.m.37817,0.0174690156594554,0.018796149977538,No,NA,NA,Q5RA42,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100117425.1.1.m.1256,0.00464409651576466,-0.00843127643850353,No,NA,NA,O77633,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; postsynaptic density [GO:0014069]; tetraspanin-enriched microdomain [GO:0097197]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch signaling pathway [GO:0007219]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to tumor necrosis factor [GO:0034612],NA,NA,NA
CHOYP_LOC100117775.2.2.m.59969,-0.00849494000029823,0.015872865278961,No,NA,NA,Q9Y2E4,NA,NA,NA,catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100117917.1.1.m.21225,0.00234241196662381,-0.0177343181853576,No,NA,NA,Q9DC48,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62637,-0.000335430244514261,-0.00492751897040944,No,NA,NA,P53356,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100118048.1.1.m.62638,0.00466462154155893,0.00550879804093471,No,NA,NA,P53013,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; translation factor activity; RNA binding [GO:0008135]; translation [GO:0006412]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100118063.2.4.m.29108,-0.0116515238235002,-0.0146475218047058,No,NA,NA,P18172,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100118098.1.1.m.14795,-0.0011202468648033,0.00223278762248932,No,NA,NA,Q5ZL33,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; signaling receptor binding [GO:0005102]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100118291.1.1.m.54817,0.00288216425008859,0.00142410910635486,No,NA,NA,Q5M824,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; Shc-EGFR complex [GO:0070435]; epidermal growth factor receptor binding [GO:0005154]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; actin cytoskeleton organization [GO:0030036]; activation of MAPK activity [GO:0000187]; aging [GO:0007568]; angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of cell proliferation [GO:0008284]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of vasoconstriction [GO:0045907]; regulation of growth [GO:0040008]; regulation of smooth muscle contraction [GO:0006940]; response to endothelin [GO:1990839]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to nicotine [GO:0035094]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100118354.1.4.m.27048,-0.00376920688732334,0.00871172198849649,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118354.2.4.m.44636,-0.00690168903187478,0.000824904392553789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100118464.1.1.m.33259,-6.71075192017942e-05,0.00413729282391686,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100118502.1.1.m.57420,0.0099269584219656,-0.0267427731023411,No,NA,NA,Q9DCR2,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; axon cytoplasm [GO:1904115]; cytoplasmic vesicle membrane [GO:0030659]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; intracellular protein transport [GO:0006886]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100118811.1.1.m.57633,-0.00551205059771055,0.00228286565496491,No,NA,NA,P97526,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; GTPase activator activity [GO:0005096]; microtubule binding [GO:0008017]; phosphatidylcholine binding [GO:0031210]; phosphatidylethanolamine binding [GO:0008429]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; brain development [GO:0007420]; camera-type eye morphogenesis [GO:0048593]; cell communication [GO:0007154]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to nerve growth factor stimulus [GO:1990090]; cerebral cortex development [GO:0021987]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; forebrain astrocyte development [GO:0021897]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; liver development [GO:0001889]; MAPK cascade [GO:0000165]; metanephros development [GO:0001656]; myelination in peripheral nervous system [GO:0022011]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of protein kinase activity [GO:0006469]; osteoblast differentiation [GO:0001649]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; pigmentation [GO:0043473]; positive regulation of adenylate cyclase activity [GO:0045762]; positive regulation of apoptotic process [GO:0043065]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron projection development [GO:0010976]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of bone resorption [GO:0045124]; regulation of cell-matrix adhesion [GO:0001952]; regulation of glial cell differentiation [GO:0045685]; regulation of GTPase activity [GO:0043087]; regulation of neuron differentiation [GO:0045664]; response to hypoxia [GO:0001666]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; smooth muscle tissue development [GO:0048745]; spinal cord development [GO:0021510]; sympathetic nervous system development [GO:0048485]; visual learning [GO:0008542]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100119008.1.1.m.43229,0.0111428291777242,0.000357480328912105,No,NA,NA,H3ZPL1,NA,NA,NA,L-phenylalanine:2-oxoglutarate aminotransferase activity [GO:0080130]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC100119086.1.1.m.55425,0.00904498098374329,-0.0200983131348612,No,NA,NA,P16591,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nucleus [GO:0005634]; ATP binding [GO:0005524]; epidermal growth factor receptor binding [GO:0005154]; lipid binding [GO:0008289]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase 1 binding [GO:0008157]; protein tyrosine kinase activity [GO:0004713]; actin cytoskeleton reorganization [GO:0031532]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cell-cell adhesion mediated by cadherin [GO:0044331]; cellular response to insulin stimulus [GO:0032869]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to reactive oxygen species [GO:0034614]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; diapedesis [GO:0050904]; extracellular matrix-cell signaling [GO:0035426]; Fc-epsilon receptor signaling pathway [GO:0038095]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular signal transduction [GO:0035556]; Kit signaling pathway [GO:0038109]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of mast cell activation involved in immune response [GO:0033007]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cell proliferation [GO:0042127]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of fibroblast migration [GO:0010762]; regulation of lamellipodium assembly [GO:0010591]; regulation of mast cell degranulation [GO:0043304]; regulation of protein phosphorylation [GO:0001932]; response to lipopolysaccharide [GO:0032496]; response to platelet-derived growth factor [GO:0036119]; substrate adhesion-dependent cell spreading [GO:0034446]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100119236.1.1.m.22785,-0.009044554708408,-0.0182884947942404,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100119310.1.1.m.22031,0.0006106174421191,-0.011754688842855,No,NA,NA,Q28727,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; microvillus [GO:0005902]; bile acid:sodium symporter activity [GO:0008508]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100119310.1.1.m.22032,0.00200433301241682,-0.00201455597418162,No,NA,NA,P62248,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100119577.1.1.m.47861,-0.00925956792273174,-0.00146315672687867,No,NA,NA,Q60676,NA,NA,NA,cell periphery [GO:0071944]; chaperone complex [GO:0101031]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; proximal dendrite [GO:1990635]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; G-protein alpha-subunit binding [GO:0001965]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722]; RNA binding [GO:0003723]; cellular response to cadmium ion [GO:0071276]; cellular response to hydrogen peroxide [GO:0070301]; histone dephosphorylation [GO:0016576]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of glucocorticoid receptor signaling pathway [GO:2000324]; protein complex oligomerization [GO:0051259]; protein dephosphorylation [GO:0006470]; protein heterooligomerization [GO:0051291]; response to arachidonic acid [GO:1904550]; response to lead ion [GO:0010288]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100119750.1.1.m.7019,0.0020792254991532,-0.00194336953404714,No,NA,NA,Q80YR4,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; ribosome binding [GO:0043022]; ubiquitin protein ligase activity [GO:0061630]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567]; rescue of stalled ribosome [GO:0072344],NA,NA,NA
CHOYP_LOC100120123.1.1.m.12979,-0.00713591379965849,0.00425607093391342,No,NA,NA,P54886,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; delta1-pyrroline-5-carboxylate synthetase activity [GO:0017084]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cellular amino acid biosynthetic process [GO:0008652]; citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; proline biosynthetic process [GO:0006561],NA,NA,NA
CHOYP_LOC100120260.1.1.m.41887,0.00654431634131452,0.0141243497312244,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100120260.1.1.m.41888,-0.0021467989287088,-0.0187843471557836,No,NA,NA,Q62685,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; nuclear receptor transcription coactivator activity [GO:0030374]; protein heterodimerization activity [GO:0046982]; retinoid X receptor binding [GO:0046965]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; cellular response to lipopolysaccharide [GO:0071222]; cholesterol homeostasis [GO:0042632]; insulin receptor signaling pathway [GO:0008286]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; multicellular organism development [GO:0007275]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of inflammatory response [GO:0050728]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of nuclear receptor transcription coactivator activity [GO:2000325],NA,NA,NA
CHOYP_LOC100120440.1.1.m.15371,-0.000800369092539177,0.00116465555467573,No,NA,NA,Q7TN29,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100120677.1.1.m.16799,0.00266839166978456,-0.0007210756438037,No,NA,NA,A0JMK9,NA,NA,NA,CAF-1 complex [GO:0033186]; nucleus [GO:0005634]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100120994.1.1.m.54109,0.00316690753324041,0.002207042859222,No,NA,NA,Q9TUP7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; G protein-coupled receptor activity [GO:0004930]; orexin receptor activity [GO:0016499]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC100121360.1.1.m.56328,-4.9003021941854e-05,0.00650152183008658,No,NA,NA,Q99315,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100121363.1.1.m.46369,-0.0081276023528668,-0.0223970318032928,No,NA,NA,P97570,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; ATP-dependent protein binding [GO:0043008]; calcium-independent phospholipase A2 activity [GO:0047499]; calmodulin binding [GO:0005516]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein kinase binding [GO:0019901]; serine hydrolase activity [GO:0017171]; antibacterial humoral response [GO:0019731]; cardiolipin biosynthetic process [GO:0032049]; chemotaxis [GO:0006935]; lipid catabolic process [GO:0016042]; maternal process involved in female pregnancy [GO:0060135]; memory [GO:0007613]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of store-operated calcium channel activity [GO:1901339]; response to endoplasmic reticulum stress [GO:0034976]; urinary bladder smooth muscle contraction [GO:0014832],NA,NA,NA
CHOYP_LOC100121425.1.1.m.10532,-0.00827892447193094,-0.00253847241933226,No,NA,NA,Q01617,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; snRNA stem-loop binding [GO:0035614]; chemical synaptic transmission [GO:0007268]; dormancy process [GO:0022611]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; regulation of hemocyte proliferation [GO:0035206],NA,NA,NA
CHOYP_LOC100121687.1.1.m.57141,-0.00456645995049719,-0.000592061659034685,No,NA,NA,Q14202,NA,NA,NA,nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; cytoskeleton organization [GO:0007010]; multicellular organism development [GO:0007275]; regulation of cell morphogenesis [GO:0022604]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100121788.1.1.m.28436,0.0048089497929753,0.000883406068872501,No,NA,NA,Q96HN2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_LOC100121969.1.1.m.52130,-0.00230225257825525,0.00312548459200265,No,NA,NA,Q5RAY1,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_LOC100121991.1.1.m.13778,-0.014580873127012,-0.00927923166536028,No,NA,NA,Q9NG98,NA,NA,NA,chromosome [GO:0005694]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; zinc ion binding [GO:0008270]; developmental growth [GO:0048589]; DNA topological change [GO:0006265]; double-strand break repair via homologous recombination [GO:0000724]; mitochondrial genome maintenance [GO:0000002]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100121999.3.4.m.54805,0.0122390080715374,-0.0035586330602656,No,NA,NA,O61122,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; spindle [GO:0005819]; actin binding [GO:0003779]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; hippo signaling [GO:0035329]; hyperosmotic response [GO:0006972]; positive regulation of cell division [GO:0051781]; positive regulation of mitotic cytokinetic process [GO:1903438]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of sorocarp development [GO:0031156]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100122037.1.1.m.12516,-0.00154143358600499,0.00248620784703327,No,NA,NA,A2BHJ4,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100122067.1.1.m.49811,-0.00531285900365963,0.000242008231635836,No,NA,NA,Q9BYD6,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100122208.1.1.m.58545,-7.4269583037959e-05,0.00985378648699823,No,NA,NA,Q8CC21,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; mitochondrial respiratory chain complex III assembly [GO:0034551]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_LOC100122211.1.1.m.56146,0.00132467962631019,-0.00325392969821078,No,NA,NA,Q920Q8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleus [GO:0005634]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein ubiquitination [GO:0031397]; response to virus [GO:0009615]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100122269.1.1.m.8408,0.00409471873173084,0.00571368455279678,No,NA,NA,Q9KPS0,NA,NA,NA,DNA binding [GO:0003677]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100122293.2.2.m.61265,0.00441251381330279,-0.00119934037703869,No,NA,NA,Q96RU3,NA,NA,NA,cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; endocytosis [GO:0006897]; membrane organization [GO:0061024],NA,NA,NA
CHOYP_LOC100122438.2.2.m.60108,-0.00327750614701704,0.00444946617041425,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100122904.1.1.m.45984,0.00274598364662036,0.00324293604490054,No,NA,NA,Q3TLI0,NA,NA,NA,cytosol [GO:0005829]; TRAPP complex [GO:0030008]; TRAPPII protein complex [GO:1990071]; early endosome to Golgi transport [GO:0034498]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100123075.1.1.m.8128,0.0109174877727045,-0.00773775306927617,No,NA,NA,Q5RBH9,NA,NA,NA,cell cortex [GO:0005938]; endomembrane system [GO:0012505]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100123216.1.1.m.28671,0.00218514316270823,-0.0016581494906841,No,NA,NA,Q5RBL1,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; ATP binding [GO:0005524]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; protein dimerization activity [GO:0046983]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; glycyl-tRNA aminoacylation [GO:0006426]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_LOC100123238.1.1.m.27155,0.000253881789567502,-0.0129355255922898,No,NA,NA,Q8C1Z8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA (guanine(9)-N(1))-methyltransferase activity [GO:0052905]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA binding [GO:0000049]; magnesium ion homeostasis [GO:0010960]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100123307.1.1.m.13647,-0.0115942039132623,-0.00184285284152801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100123521.1.2.m.20656,0.00660217044078675,-0.00835464097175019,No,NA,NA,Q9UDR5,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123521.2.2.m.52492,-0.00123657917377467,-0.00307610946833847,No,NA,NA,Q9UDR5,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; saccharopine dehydrogenase (NAD+; L-glutamate-forming) activity [GO:0047131]; saccharopine dehydrogenase (NADP+; L-lysine-forming) activity [GO:0047130]; saccharopine dehydrogenase activity [GO:0004753]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; lysine catabolic process [GO:0006554]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100123553.1.1.m.34041,-0.00772958894058638,-0.000349280472302838,No,NA,NA,Q8I8U7,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100123595.1.2.m.63353,0.0150113283910716,-0.0094847695612039,No,NA,NA,O88874,NA,NA,NA,cyclin K-CDK12 complex [GO:0002944]; cyclin K-CDK13 complex [GO:0002945]; cyclin/CDK positive transcription elongation factor complex [GO:0008024]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; protein kinase binding [GO:0019901]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; in utero embryonic development [GO:0001701]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues [GO:2001165]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100123629.1.1.m.841,0.00260196358906288,-0.0089927164111465,No,NA,NA,P50464,NA,NA,NA,adherens junction [GO:0005912]; basal plasma membrane [GO:0009925]; M band [GO:0031430]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; cell-cell junction organization [GO:0045216]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; sensory perception of mechanical stimulus [GO:0050954],NA,NA,NA
CHOYP_LOC100123667.1.1.m.22353,0.00356289224617433,-0.000962795248278073,No,NA,NA,P97376,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; striated muscle dense body [GO:0055120]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; muscle organ development [GO:0007517]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100123810.2.2.m.52182,-0.00618841935970643,-0.0039382948044953,No,NA,NA,Q7TSH8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100123890.1.1.m.11450,0.000817498644388467,-0.00100004708679854,No,NA,NA,B4JSC2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; glucose homeostasis [GO:0042593]; multicellular organism aging [GO:0010259]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; regulation of lipid metabolic process [GO:0019216]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100123907.1.1.m.2987,-0.0239280644505476,0.00903512001643932,No,NA,NA,Q7ZWE9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; uridylate kinase activity [GO:0009041]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine nucleotide biosynthetic process [GO:0006221],NA,NA,NA
CHOYP_LOC100136190.1.1.m.9460,-0.0259349282117236,0.0112673138009222,No,NA,NA,Q67ER4,NA,NA,NA,nuclear speck [GO:0016607]; U2-type spliceosomal complex [GO:0005684]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; DNA repair [GO:0006281]; isopeptide cross-linking via N6-glycyl-L-lysine [GO:0018276]; mRNA processing [GO:0006397]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; protein ubiquitination [GO:0016567]; snoRNA splicing [GO:0034247],NA,NA,NA
CHOYP_LOC100142119.1.2.m.2339,0.00578249439133688,0.025932719974057,No,NA,NA,Q8R003,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100142249.1.1.m.55762,0.0130153508253468,0.0122166288851447,No,NA,NA,P58283,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic endocytic zone [GO:0098843]; Schaffer collateral - CA1 synapse [GO:0098685]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; apoptotic process [GO:0006915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process; modulating synaptic transmission [GO:0099546]; protein K48-linked ubiquitination [GO:0070936]; regulation of defense response to virus by host [GO:0050691]; regulation of interferon-beta production [GO:0032648],NA,NA,NA
CHOYP_LOC100145215.1.1.m.6904,-8.7469884584471e-05,0.0116051488574701,No,NA,NA,P28285,NA,NA,NA,dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; G protein-coupled amine receptor activity [GO:0008227]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled serotonin receptor activity [GO:0004993]; Gi/o-coupled serotonin receptor activity [GO:0001586]; neurotransmitter receptor activity [GO:0030594]; adenylate cyclase-inhibiting serotonin receptor signaling pathway [GO:0007198]; anesthesia-resistant memory [GO:0007615]; chemical synaptic transmission [GO:0007268]; G protein-coupled receptor signaling pathway; coupled to cyclic nucleotide second messenger [GO:0007187]; inter-male aggressive behavior [GO:0002121]; male courtship behavior [GO:0008049]; phospholipase C-activating serotonin receptor signaling pathway [GO:0007208]; regulation of circadian sleep/wake cycle; sleep [GO:0045187]; serotonin receptor signaling pathway [GO:0007210],NA,NA,NA
CHOYP_LOC100146233.1.1.m.36400,-5.70787538879634e-05,0.00300047721305419,No,NA,NA,Q0VH32,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein dimerization activity [GO:0046983],NA,NA,NA
CHOYP_LOC100148223.1.1.m.10633,-0.00751272520678069,-0.00478107977654391,No,NA,NA,B7Z6K7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100150876.1.1.m.61100,-0.00212272506785719,0.000697388082622807,No,NA,NA,Q96NN9,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; execution phase of apoptosis [GO:0097194],NA,NA,NA
CHOYP_LOC100158931.1.1.m.8283,0.00266398129758649,0.00314609338024166,No,NA,NA,Q5RDQ2,NA,NA,NA,bicellular tight junction [GO:0005923]; endomembrane system [GO:0012505]; plasma membrane [GO:0005886]; bicellular tight junction assembly [GO:0070830]; establishment of epithelial cell polarity [GO:0090162],NA,NA,NA
CHOYP_LOC100160077.1.1.m.62645,0.00401215816656128,0.000164801827924854,No,NA,NA,Q62829,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; GTPase binding [GO:0051020]; MAP kinase kinase activity [GO:0004708]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; axonogenesis [GO:0007409]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; dendrite development [GO:0016358]; dendritic spine morphogenesis [GO:0060997]; intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron apoptotic process [GO:0043525]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; regulation of neuron projection development [GO:0010975]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100160385.1.2.m.40193,0.00338748554217845,-0.000915395346890458,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100160412.2.2.m.56352,0.00256470070396493,0.00150802604978743,No,NA,NA,O35115,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC100161158.1.1.m.14383,-0.00512606391271152,0.00463309232733742,No,NA,NA,Q6NYU7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; GTP binding [GO:0005525]; uridine kinase activity [GO:0004849],NA,NA,NA
CHOYP_LOC100161360.1.1.m.65809,-0.000813657735394736,-0.00239799518879745,No,NA,NA,P23128,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; messenger ribonucleoprotein complex [GO:1990124]; neuronal cell body [GO:0043025]; neuronal ribonucleoprotein granule [GO:0071598]; P granule [GO:0043186]; P-body [GO:0000932]; postsynapse [GO:0098794]; sensory dendrite [GO:0071683]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; gene silencing by miRNA [GO:0035195]; habituation [GO:0046959]; messenger ribonucleoprotein complex assembly [GO:1990120]; negative regulation of cytoplasmic translation [GO:2000766]; ovarian follicle cell development [GO:0030707]; pole cell formation [GO:0007279]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of posttranscriptional gene silencing [GO:0060148]; regulation of defense response to virus [GO:0050688]; regulation of neuron projection arborization [GO:0150011]; regulation of olfactory learning [GO:0090328],NA,NA,NA
CHOYP_LOC100162380.1.1.m.23942,0.00365503646054448,-0.000987695246824802,No,NA,NA,Q5RH71,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100162439.1.1.m.19182,-0.00638960713163325,-0.00406633020592048,No,NA,NA,Q17RP2,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100164363.1.1.m.61731,0.00337307071686306,-0.000970182167091937,No,NA,NA,P18155,NA,NA,NA,mitochondrion [GO:0005739]; magnesium ion binding [GO:0000287]; methenyltetrahydrofolate cyclohydrolase activity [GO:0004477]; methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO:0004487]; methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO:0004488]; phosphate ion binding [GO:0042301]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100164899.1.1.m.59665,0.00283202214077152,0.00102698042658179,No,NA,NA,Q8BGT5,NA,NA,NA,mitochondrion [GO:0005739]; L-alanine:2-oxoglutarate aminotransferase activity [GO:0004021]; pyridoxal phosphate binding [GO:0030170]; 2-oxoglutarate metabolic process [GO:0006103]; biosynthetic process [GO:0009058]; L-alanine catabolic process [GO:0042853]; L-alanine metabolic process [GO:0042851],NA,NA,NA
CHOYP_LOC100165317.1.1.m.8504,0.00497068185651314,-0.00902418644355323,No,NA,NA,P27398,NA,NA,NA,cytoplasm [GO:0005737]; intracellular [GO:0005622]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; nervous system development [GO:0007399]; proteolysis [GO:0006508]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165581.1.1.m.18008,-0.00681238173577852,0.00258644468523931,No,NA,NA,Q5R4B2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741],NA,NA,NA
CHOYP_LOC100165685.1.1.m.13583,0.000852821019432963,0.0208571946145315,No,NA,NA,O14639,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; animal organ morphogenesis [GO:0009887]; cilium assembly [GO:0060271]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100165703.1.1.m.48642,0.00443848255404693,-0.0201573043884525,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100166052.1.1.m.46867,0.00101616304022959,0.00120006240922522,No,NA,NA,A2AAE1,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; presynapse [GO:0098793]; adipose tissue development [GO:0060612]; fat cell differentiation [GO:0045444]; lipid metabolic process [GO:0006629]; lipid storage [GO:0019915]; nucleus localization [GO:0051647]; regulation of cell growth [GO:0001558]; spermatogenesis [GO:0007283]; synaptic vesicle endocytosis [GO:0048488],NA,NA,NA
CHOYP_LOC100166353.1.1.m.4625,0.000331626857975877,-0.0164276854300185,No,NA,NA,Q2NL00,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],NA,NA,NA
CHOYP_LOC100166368.1.1.m.44709,0.00194520523860769,0.0014540061327215,No,NA,NA,Q63598,NA,NA,NA,actin filament [GO:0005884]; actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; inner ear auditory receptor cell differentiation [GO:0042491],NA,NA,NA
CHOYP_LOC100167728.1.2.m.2289,0.000927984588222463,-0.000277429796463895,No,NA,NA,Q3U1T9,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; protein transport [GO:0015031]; regulation of immune response [GO:0050776]; T cell receptor signaling pathway [GO:0050852]; T-helper 2 cell cytokine production [GO:0035745],NA,NA,NA
CHOYP_LOC100168017.1.1.m.40316,0.0112060413219693,-0.00648182697364256,No,NA,NA,Q26474,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100168209.1.1.m.26697,-0.00536237195848496,0.00267557820625633,No,NA,NA,Q5XI42,NA,NA,NA,plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; cellular aldehyde metabolic process [GO:0006081]; ethanol catabolic process [GO:0006068],NA,NA,NA
CHOYP_LOC100168368.1.1.m.18551,-0.007138070742159,-0.00156777689311417,No,NA,NA,P41778,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; adrenal gland development [GO:0030325]; animal organ morphogenesis [GO:0009887]; anterior/posterior pattern specification [GO:0009952]; branching involved in ureteric bud morphogenesis [GO:0001658]; embryonic hemopoiesis [GO:0035162]; embryonic limb morphogenesis [GO:0030326]; embryonic organ development [GO:0048568]; embryonic skeletal system development [GO:0048706]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of cell proliferation [GO:0008284]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proximal/distal pattern formation [GO:0009954]; regulation of cell proliferation [GO:0042127]; regulation of ossification [GO:0030278]; sex differentiation [GO:0007548]; spleen development [GO:0048536]; steroid biosynthetic process [GO:0006694]; thymus development [GO:0048538]; urogenital system development [GO:0001655],NA,NA,NA
CHOYP_LOC100168569.1.2.m.11752,0.00486029505230113,0.00835657591284801,No,NA,NA,Q13188,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; protein dimerization activity [GO:0046983]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cell differentiation involved in embryonic placenta development [GO:0060706]; central nervous system development [GO:0007417]; endocardium development [GO:0003157]; hepatocyte apoptotic process [GO:0097284]; hippo signaling [GO:0035329]; intracellular signal transduction [GO:0035556]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of organ growth [GO:0046621]; neural tube formation [GO:0001841]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; primitive hemopoiesis [GO:0060215]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell differentiation involved in embryonic placenta development [GO:0060800]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100168620.4.4.m.40081,-0.0284492855786797,-0.0181050551156301,No,NA,NA,Q0Q028,NA,NA,NA,extracellular region [GO:0005576]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100168796.1.1.m.4672,0.000693106182368979,0.00136657231050299,No,NA,NA,Q60899,NA,NA,NA,synapse [GO:0045202]; RNA binding [GO:0003723]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_LOC100168945.1.1.m.37004,0.000142730243382262,0.00106463121798975,No,NA,NA,P50395,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; myelin sheath [GO:0043209]; secretory granule lumen [GO:0034774]; synapse [GO:0045202]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GDP-dissociation inhibitor activity [GO:0005093]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; neutrophil degranulation [GO:0043312]; protein transport [GO:0015031]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100169229.1.1.m.25981,0.00852135872170747,0.00703009598553188,No,NA,NA,Q7Z6B7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; negative regulation of cell migration [GO:0030336]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100169297.1.1.m.48433,-0.00824044774117056,-0.00628421421461657,No,NA,NA,G5ECP4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100169460.1.1.m.41302,-0.00490176564155616,0.00490252870423407,No,NA,NA,Q9UJZ1,NA,NA,NA,cytoskeleton [GO:0005856]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; cardiolipin binding [GO:1901612]; GTPase binding [GO:0051020]; signaling receptor binding [GO:0005102]; CD4-positive; alpha-beta T cell activation [GO:0035710]; cellular calcium ion homeostasis [GO:0006874]; interleukin-2 production [GO:0032623]; lipid localization [GO:0010876]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; mitochondrial calcium ion transmembrane transport [GO:0006851]; mitochondrial protein processing [GO:0034982]; mitochondrion organization [GO:0007005]; positive regulation of cardiolipin metabolic process [GO:1900210]; positive regulation of mitochondrial DNA replication [GO:0090297]; positive regulation of mitochondrial membrane potential [GO:0010918]; protein complex oligomerization [GO:0051259]; stress-induced mitochondrial fusion [GO:1990046]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100174996.1.1.m.27300,-0.0015147172393321,-0.00410987298574607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.11.11.m.63958,-0.0150953173949778,-0.00960662272759563,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175021.7.11.m.58378,-0.0150953173949778,-0.00960662272759563,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100175702.1.1.m.56240,0,0,No,NA,NA,A2RSX4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100175867.1.1.m.48982,0.0326477994177476,0.0189356501996918,No,NA,NA,P05099,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100175959.1.7.m.1896,0.0017608481306757,-0.00512197505027213,No,NA,NA,P90703,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100175959.4.7.m.28172,0.00290242055679168,-0.00133241590265344,No,NA,NA,O61463,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100176099.1.1.m.40368,-0.0127371642108751,-0.00810589986229902,No,NA,NA,Q9P0M2,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC100176232.1.1.m.24645,-0.00419576629421148,-0.0152491468111956,No,NA,NA,Q5SSL4,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density; intracellular component [GO:0099092]; Schaffer collateral - CA1 synapse [GO:0098685]; GTPase activator activity [GO:0005096]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; brain development [GO:0007420]; inner ear morphogenesis [GO:0042472]; intracellular signal transduction [GO:0035556]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of blood vessel remodeling [GO:0060313]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular extravasation [GO:0002692]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neutrophil degranulation [GO:0043314]; neuromuscular process controlling balance [GO:0050885]; positive regulation of phagocytosis [GO:0050766]; regulation of Rho protein signal transduction [GO:0035023]; regulation of vascular permeability [GO:0043114]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC100176461.1.1.m.63236,0.0044530236659973,0.0250232738757375,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100176721.6.6.m.66056,-6.71066651355716e-05,0.00890343964584313,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100176799.1.1.m.3132,0.00653000863321658,0.00448256721846909,No,NA,NA,Q60HE9,NA,NA,NA,lysosome [GO:0005764]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013],NA,NA,NA
CHOYP_LOC100177459.1.2.m.48730,-0.0274972148522233,-0.0087412570469039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100177679.1.1.m.54177,0.0203394629645978,0.00539409152966429,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100177909.1.1.m.29356,-0.00547010486991274,0.00156326373586283,No,NA,NA,Q8K3A0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; [2Fe-2S] cluster assembly [GO:0044571]; iron-sulfur cluster assembly [GO:0016226]; protein complex oligomerization [GO:0051259]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC100178034.1.2.m.13282,-0.0100728919726414,0.0184638207967886,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100178081.1.1.m.56365,-0.000465847157293209,0.0050658542870237,No,NA,NA,O18334,NA,NA,NA,cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; synapse [GO:0045202]; vesicle [GO:0031982]; actin binding [GO:0003779]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; axon guidance [GO:0007411]; compound eye morphogenesis [GO:0001745]; defense response to fungus [GO:0050832]; exocytosis [GO:0006887]; germarium-derived egg chamber formation [GO:0007293]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; oocyte microtubule cytoskeleton polarization [GO:0008103]; phototransduction [GO:0007602]; pole plasm oskar mRNA localization [GO:0045451]; R7 cell development [GO:0045467]; Rab protein signal transduction [GO:0032482]; regulation of postsynaptic membrane potential [GO:0060078]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100178700.1.1.m.37554,-0.0102286098261413,-0.00300967152500469,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100178916.1.1.m.26391,-0.00410015893488409,-0.0188184570337365,No,NA,NA,Q3KQ80,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100179134.1.1.m.23870,0.00303996294412543,-0.000821484814952827,No,NA,NA,Q6NXK5,NA,NA,NA,fibrillar center [GO:0001650]; intercellular bridge [GO:0045171]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; polynucleotide 5'-phosphatase activity [GO:0004651]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; RNA binding [GO:0003723]; polynucleotide 5' dephosphorylation [GO:0098507]; protein dephosphorylation [GO:0006470]; RNA metabolic process [GO:0016070],NA,NA,NA
CHOYP_LOC100179300.1.2.m.22734,-0.0012183398478515,0.00571033803486043,No,NA,NA,Q6P8Y1,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100179357.5.6.m.45322,-0.00988126621889652,0.0179195736746166,No,NA,NA,Q5RHP9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179448.1.1.m.8298,0.00133411029428184,0.00194733648678366,No,NA,NA,P23403,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100179516.1.2.m.45110,0.00992259764853175,0.00786285450028048,No,NA,NA,Q6IMH0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100179516.2.2.m.49937,-0.034264544378,0.0174135479028122,No,NA,NA,Q6IMH0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100180023.1.7.m.11060,0.00264096054779242,-0.00206789485754014,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.4.7.m.33650,0.00360935763323877,0.00112078970803839,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180023.5.7.m.56825,0.00110078523136954,-0.00654611195228836,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180543.1.1.m.4746,0.00689744892779815,-0.00905729050445064,No,NA,NA,Q90XD2,NA,NA,NA,mitochondrion [GO:0005739]; agmatinase activity [GO:0008783]; metal ion binding [GO:0046872]; putrescine biosynthetic process from arginine [GO:0033388]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100180636.1.1.m.66440,-0.0191384202675855,0.0314062173930579,No,NA,NA,Q8CEQ0,NA,NA,NA,ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; heart development [GO:0007507]; protein phosphorylation [GO:0006468]; regulation of cilium assembly [GO:1902017],NA,NA,NA
CHOYP_LOC100180716.1.2.m.860,0.00138068135565061,-0.00248110370795665,No,NA,NA,Q9IA76,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100180855.2.4.m.46097,-0.00263797895534892,-0.00217731980860805,No,NA,NA,Q8LGG8,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100180855.4.4.m.66721,-0.00925035271104208,0.0171152603250848,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100180883.1.1.m.46611,-0.0194233005964663,0.0138059669915619,No,NA,NA,Q9CQ66,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; dynein intermediate chain binding [GO:0045505]; cilium assembly [GO:0060271]; regulation of cilium assembly [GO:1902017]; regulation of intraciliary retrograde transport [GO:1905799],NA,NA,NA
CHOYP_LOC100181095.1.1.m.8314,-0.00949899547465242,0.00872844969272205,No,NA,NA,Q9C093,NA,NA,NA,Golgi apparatus [GO:0005794]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100181343.1.1.m.59214,0.00114905524850188,-0.0030910649809054,No,NA,NA,Q9VRV7,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; precatalytic spliceosome [GO:0071011]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; mRNA binding [GO:0003729]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100181350.1.1.m.2782,0.00579417025383171,0.00557992148185563,No,NA,NA,P47989,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100181355.1.1.m.48652,0.00329907497472218,-0.0150484264374092,No,NA,NA,Q9BXF9,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_LOC100181607.1.2.m.36709,0.00414431207843944,-0.00445678598819145,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181826.1.1.m.16288,0.000968089942371363,0.00245931782862036,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100181873.1.2.m.45633,-0.0184657391126024,-0.0199993221161258,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100182131.1.1.m.26023,-0.00585919642024148,0.0111074768676118,No,NA,NA,Q3T0C9,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; endocytosis [GO:0006897]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of sprouting angiogenesis [GO:1903671]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100182237.2.2.m.33734,0.00299306620857595,0.00185110028477595,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC100182352.2.2.m.64092,0.00300814692903099,0.00722396262429293,No,NA,NA,D3YXS5,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100182585.1.2.m.2597,-0.00308704935988241,-0.00378144332732339,No,NA,NA,Q95M12,NA,NA,NA,lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of ERBB signaling pathway [GO:1901185]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; receptor catabolic process [GO:0032801]; renal system process [GO:0003014]; vacuolar protein processing [GO:0006624],NA,NA,NA
CHOYP_LOC100182585.2.2.m.24665,-0.00704872752898945,0.00538127938502323,No,NA,NA,Q2PFW9,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100183535.2.2.m.10350,-0.00213707823086104,0.0060795762640301,No,NA,NA,Q9LGZ2,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_LOC100183583.1.2.m.3863,0.00205827243359653,-0.00568219747257173,No,NA,NA,Q9BXW7,NA,NA,NA,mitochondrion [GO:0005739]; glycerophospholipid biosynthetic process [GO:0046474],NA,NA,NA
CHOYP_LOC100183682.1.1.m.61630,0.00557238539625586,0.000797432659152734,No,NA,NA,Q8CGC6,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100183847.1.2.m.12797,-0.000948513379038474,-0.00166615003964836,No,NA,NA,P33316,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; peroxisome proliferator activated receptor binding [GO:0042975]; pyrimidine deoxyribonucleotide binding [GO:0032556]; receptor inhibitor activity [GO:0030547]; RNA binding [GO:0003723]; DNA replication [GO:0006260]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; liver development [GO:0001889]; nucleobase-containing compound metabolic process [GO:0006139]; nucleobase-containing small molecule interconversion [GO:0015949]; protein homotrimerization [GO:0070207]; regulation of protein heterodimerization activity [GO:0043497]; response to organic cyclic compound [GO:0014070],NA,NA,NA
CHOYP_LOC100184284.2.2.m.21644,-5.32573363051769e-05,0.00706596697263334,No,NA,NA,Q5RJI4,NA,NA,NA,extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; bone mineralization [GO:0030282]; cell differentiation [GO:0030154]; embryonic digestive tract development [GO:0048566]; limb morphogenesis [GO:0035108]; lung alveolus development [GO:0048286]; multicellular organism growth [GO:0035264]; negative regulation of Golgi to plasma membrane protein transport [GO:0042997]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of chondrocyte differentiation [GO:0032332]; protein transport [GO:0015031]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100184874.1.1.m.41851,-0.00598317137950024,0.0179444574254754,No,NA,NA,Q2L6K8,NA,NA,NA,extracellular region [GO:0005576]; signaling receptor binding [GO:0005102],NA,NA,NA
CHOYP_LOC100185060.2.2.m.18100,-0.00899782457130811,-0.0015087104242882,No,NA,NA,Q91ZT9,NA,NA,NA,cytoplasm [GO:0005737]; intracellular signal transduction [GO:0035556]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100185271.1.1.m.19210,-0.0256075215631884,0.000592106709285444,No,NA,NA,B9EJX3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185431.1.1.m.43063,-0.0104583263282552,-0.0068695302154279,No,NA,NA,B1WB06,NA,NA,NA,extracellular region [GO:0005576]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100185443.1.1.m.60976,-0.028808628791876,0.012896045246507,No,NA,NA,A7RR34,NA,NA,NA,apical plasma membrane [GO:0016324]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100185472.1.1.m.66178,-0.011552777766146,-0.0115075152681157,No,NA,NA,Q810N6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185473.1.1.m.5316,-0.0101451869297269,-0.00645637191883395,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100185549.1.6.m.31232,-0.00207054096117365,-0.00365441850841371,No,NA,NA,Q8LGG8,NA,NA,NA,plasma membrane [GO:0005886]; AMP binding [GO:0016208],NA,NA,NA
CHOYP_LOC100185549.5.6.m.62694,-0.00319864653564646,0.000186597560756402,No,NA,NA,Q57951,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100185846.1.1.m.37884,-0.000275556437281353,-0.00471018418038841,No,NA,NA,Q6TGV7,NA,NA,NA,regulation of actin filament-based process [GO:0032970],NA,NA,NA
CHOYP_LOC100186070.1.1.m.3415,-0.0146461061065126,0.0230722729183549,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7875,-0.00826013234569796,0.0168860194229386,No,NA,NA,Q52KB5,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100186203.1.1.m.7876,0.00153640285151533,-0.000458997701019249,No,NA,NA,Q3SYZ4,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; aspartate-tRNA ligase activity [GO:0004815]; ATP binding [GO:0005524]; RNA binding [GO:0003723]; aspartyl-tRNA aminoacylation [GO:0006422],NA,NA,NA
CHOYP_LOC100186276.4.5.m.12980,-5.32380599724461e-05,0.00706340946713501,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186299.6.6.m.52749,0.00383880247400988,0.00292175699364277,No,NA,NA,Q70FJ1,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; dendritic branch [GO:0044307]; extrinsic component of postsynaptic density membrane [GO:0099147]; Golgi apparatus [GO:0005794]; Golgi stack [GO:0005795]; neuronal cell body [GO:0043025]; pericentriolar material [GO:0000242]; synaptic membrane [GO:0097060]; potassium channel regulator activity [GO:0015459]; protein kinase A regulatory subunit binding [GO:0034237]; protein-containing complex scaffold activity [GO:0032947]; maintenance of centrosome location [GO:0051661]; microtubule nucleation [GO:0007020]; negative regulation of adenylate cyclase activity [GO:0007194]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of potassium ion transmembrane transporter activity [GO:1901018]; regulation of Golgi organization [GO:1903358]; regulation of ventricular cardiac muscle cell membrane repolarization [GO:0060307]; Sertoli cell development [GO:0060009]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100186360.1.2.m.50759,0.00136751490078843,0.0262881866095079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100186361.3.3.m.66600,0.000826734699478671,-0.000146067710694024,No,NA,NA,P47911,NA,NA,NA,A band [GO:0031672]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; tRNA binding [GO:0000049]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_LOC100186692.1.1.m.7600,-0.00209830792959866,-0.00284343186734752,No,NA,NA,Q6ZWJ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC100186733.1.1.m.7066,0.00081742788817814,-0.00217397409968649,No,NA,NA,Q5XIA9,NA,NA,NA,cellularization cleavage furrow [GO:0110070]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; midbody [GO:0030496]; mitotic cytokinetic process [GO:1902410]; mitotic nuclear division [GO:0140014]; nuclear chromosome segregation [GO:0098813],NA,NA,NA
CHOYP_LOC100186936.1.2.m.12235,0.0033976345802564,-0.00616834647727899,No,NA,NA,Q6IE24,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100187037.1.1.m.55673,-6.54659492111983e-05,0.00868575612395879,No,NA,NA,Q0VAA2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100187348.1.1.m.29904,-0.0127536732105372,-0.00811640614893173,No,NA,NA,Q4R6F0,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100197130.2.2.m.39076,0.00338706430898236,0.00231896168873892,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100197511.1.1.m.22053,-0.00956932775329331,0.00963550200927596,No,NA,NA,Q5R546,NA,NA,NA,mitochondrial proton-transporting ATP synthase complex [GO:0005753]; plasma membrane [GO:0005886]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; ATP binding [GO:0005524]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP synthesis coupled proton transport [GO:0015986],NA,NA,NA
CHOYP_LOC100197876.1.1.m.45271,-0.00153561357947809,0.00208471330524738,No,NA,NA,P18293,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; hormone binding [GO:0042562]; natriuretic peptide receptor activity [GO:0016941]; peptide hormone binding [GO:0017046]; peptide receptor activity [GO:0001653]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; dopamine metabolic process [GO:0042417]; intracellular signal transduction [GO:0035556]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of cGMP-mediated signaling [GO:0010753]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood vessel size [GO:0050880]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100198049.1.1.m.13866,-0.00677428179437424,0.0173729521924823,No,NA,NA,Q9CWP8,NA,NA,NA,cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA biosynthetic process [GO:0071897]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; positive regulation of endothelial cell proliferation [GO:0001938],NA,NA,NA
CHOYP_LOC100199222.1.1.m.17588,-0.000883086102312178,0.0147027001982076,No,NA,NA,P0AF48,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100199246.1.1.m.43478,-0.0148467775103888,0.0042805710172983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199379.1.2.m.59875,0,0,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC100199379.2.2.m.63866,0.0157470717502653,0.00984446113341353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199505.1.2.m.19947,-0.000159894296536438,0.000956218402110746,No,NA,NA,P04114,NA,NA,NA,chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; cholesterol transporter activity [GO:0017127]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]; artery morphogenesis [GO:0048844]; cellular protein metabolic process [GO:0044267]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; chylomicron assembly [GO:0034378]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; leukocyte migration [GO:0050900]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; membrane organization [GO:0061024]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; post-translational protein modification [GO:0043687]; receptor-mediated endocytosis [GO:0006898]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; retinoid metabolic process [GO:0001523]; spermatogenesis [GO:0007283]; toll-like receptor signaling pathway [GO:0002224]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100199505.2.2.m.25542,-0.00203241534397002,0.0027591598342099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199663.1.1.m.22109,-0.0180546882088233,0.00759245090839583,No,NA,NA,P27659,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; cellular response to interleukin-4 [GO:0071353]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100199980.1.2.m.51259,-0.00205309020119078,-0.00196685741697205,No,NA,NA,Q5AF03,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100199980.2.2.m.62743,0.00825234339707078,0.0115387463348605,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100199980.2.2.m.62746,0.0094111515209444,0.00516677793345304,No,NA,NA,Q5AF03,NA,NA,NA,fungal biofilm matrix [GO:0062040]; hyphal cell wall [GO:0030446]; yeast-form cell wall [GO:0030445]; glyoxalase III activity [GO:0019172]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243],NA,NA,NA
CHOYP_LOC100200137.1.1.m.23041,0.00309627803295153,-0.000836702760425736,No,NA,NA,P19208,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; heat shock protein binding [GO:0031072]; misfolded protein binding [GO:0051787]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; cellular response to heat [GO:0034605]; cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein refolding [GO:0042026]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100200424.1.1.m.16669,0.00465754614847841,-0.00125860199819566,No,NA,NA,Q1RMG8,NA,NA,NA,RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100201155.1.1.m.58066,-0.0146213397915017,0.0149965243094436,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100202203.1.1.m.27309,-0.00956326890625939,0.00561165423757629,No,NA,NA,P29145,NA,NA,NA,serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100202812.1.1.m.31203,0.00307098029679041,-0.000829866589560824,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100204502.1.2.m.26864,-0.000787739318708556,0.00124446885882468,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100205674.1.1.m.5810,-0.0249361455730096,0.0122900626837925,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100206557.1.1.m.11857,0,0,No,NA,NA,P61315,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; galactose 3-O-sulfotransferase activity [GO:0050694]; galactosylceramide sulfotransferase activity [GO:0001733]; glycolipid biosynthetic process [GO:0009247],NA,NA,NA
CHOYP_LOC100207121.5.9.m.48175,-0.00157025386543018,0.0119284017358464,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100207216.2.2.m.28185,-0.0118351293994698,-0.00753184713498027,No,NA,NA,Q5EB30,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100208023.1.8.m.8628,0.00384277359242498,-0.0006212850824784,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_LOC100208023.8.8.m.49917,-0.00321424309782415,0.0115853976358035,No,NA,NA,Q05909,NA,NA,NA,extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100208544.1.1.m.54499,0.000318634021304144,0.00108492274731738,No,NA,NA,P26779,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100210536.1.1.m.18414,-0.00423643632051034,-0.00241513857573642,No,NA,NA,Q9CX34,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; positive regulation by host of symbiont catalytic activity [GO:0043947]; protein stabilization [GO:0050821]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_LOC100210677.7.8.m.42871,0.0198275310688542,0.00427713339709905,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100210677.8.8.m.43132,0.0183201791637697,-0.00325291212641004,No,NA,NA,Q700K0,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100211409.1.1.m.4742,0.00387976959459309,0.00203737104082387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100211409.1.1.m.4743,-0.00304576379912264,-0.000305885582465317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100212224.1.1.m.37724,0.00205823189193388,-0.00101658854984537,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100212386.1.2.m.33906,0.00521520703397563,-0.00677054140299587,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100212698.1.1.m.5807,-0.0237184772969022,-0.00892314831210454,No,NA,NA,P38571,NA,NA,NA,fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; lipase activity [GO:0016298]; sterol esterase activity [GO:0004771]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cellular lipid metabolic process [GO:0044255]; cytokine production [GO:0001816]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle clearance [GO:0034383]; lung development [GO:0030324]; sterol metabolic process [GO:0016125]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100213495.2.2.m.51531,0.00559448535882293,0.00660694328792682,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213558.1.1.m.45753,0.00252987146557571,-0.00222840902504856,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100213744.7.19.m.33062,-0.00627469325350981,0.00208396935692461,No,NA,NA,Q5BIM1,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100213744.9.19.m.37687,-6.41096005890127e-05,0.00850580130021731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100215454.1.1.m.40627,0.0304898373484563,6.89025935604518e-05,No,NA,NA,P43143,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; drug binding [GO:0008144]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of dopamine secretion [GO:0033603]; protein heterooligomerization [GO:0051291]; regulation of membrane potential [GO:0042391]; response to nicotine [GO:0035094]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100217869.1.2.m.29774,-0.00119770950615855,0.0113783340733624,No,NA,NA,Q5U317,NA,NA,NA,mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100218754.1.1.m.60778,0.000443827640739701,0.00244298262839857,No,NA,NA,Q14678,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; beta-catenin binding [GO:0008013]; actin cytoskeleton organization [GO:0030036]; cell proliferation [GO:0008283]; glomerular visceral epithelial cell migration [GO:0090521]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell migration [GO:0030336]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of neuron projection development [GO:0010977]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of ruffle assembly [GO:1900028]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of establishment of cell polarity [GO:2000114]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100222629.1.1.m.9927,0.0200117986814182,-0.0061827140277716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100222774.1.1.m.56990,-0.0114250023567851,-0.00952382273266101,No,NA,NA,Q9V9A7,NA,NA,NA,methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; leucine catabolic process [GO:0006552]; leucine metabolic process [GO:0006551]; regulation of eclosion [GO:0007563],NA,NA,NA
CHOYP_LOC100222774.1.1.m.56992,-0.000294895165978983,-9.31713010854173e-05,No,NA,NA,P61354,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; response to aldosterone [GO:1904044]; rRNA processing [GO:0006364]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100232142.1.1.m.19194,-0.00111845425617468,-0.00529943146063237,No,NA,NA,Q96PE7,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_LOC100232691.1.1.m.15025,-0.00116270880881155,-5.26105737982769e-05,No,NA,NA,Q924T2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial ribosome assembly [GO:0061668]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100261610.1.1.m.6374,0,0,No,NA,NA,P24044,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722],NA,NA,NA
CHOYP_LOC100313559.1.1.m.47009,-0.0061880744556486,0.00679774494174779,No,NA,NA,Q8VBW5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100313573.1.1.m.62977,-0.0131510331503316,-0.0212703084726499,No,NA,NA,O15182,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; half bridge of spindle pole body [GO:0005825]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription export complex 2 [GO:0070390]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; calcium-mediated signaling [GO:0019722]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; microtubule nucleation [GO:0007020]; mitotic spindle pole body duplication [GO:1903087]; spindle pole body duplication [GO:0030474],NA,NA,NA
CHOYP_LOC100313589.1.1.m.31479,-0.0107402703044556,0.0258575592545793,No,NA,NA,Q9JLM8,NA,NA,NA,postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; brain development [GO:0007420]; central nervous system projection neuron axonogenesis [GO:0021952]; dendrite morphogenesis [GO:0048813]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; negative regulation of protein localization to nucleus [GO:1900181]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100313617.1.1.m.18024,-0.0121010262507648,-0.007701063234782,No,NA,NA,O75496,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; animal organ morphogenesis [GO:0009887]; DNA replication preinitiation complex assembly [GO:0071163]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-dependent DNA replication [GO:2000104]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of chromatin binding [GO:0035563]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC100313636.2.3.m.26350,-0.00507157981044273,-0.00145155088843063,No,NA,NA,O88801,NA,NA,NA,apical part of cell [GO:0045177]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; G protein-coupled glutamate receptor binding [GO:0035256]; GKAP/Homer scaffold activity [GO:0030160]; glutamate receptor binding [GO:0035254]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; behavioral response to cocaine [GO:0048148]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; chemical homeostasis within a tissue [GO:0048875]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of interleukin-2 production [GO:0032703]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of store-operated calcium entry [GO:2001256]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100313649.1.1.m.49801,-0.00507879014663434,0.007399167839422,No,NA,NA,Q9D5E4,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100313653.1.1.m.61188,-0.00158137487403177,0.00131046718896432,No,NA,NA,Q27433,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_LOC100313655.1.1.m.52035,-0.00366066746260694,-0.00156854067259402,No,NA,NA,O88368,NA,NA,NA,nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; protein dimerization activity [GO:0046983]; bone remodeling [GO:0046849]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway involved in negative regulation of apoptotic process [GO:0044336]; cell fate commitment [GO:0045165]; melanocyte differentiation [GO:0030318]; negative regulation of cell migration [GO:0030336]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoclast differentiation [GO:0030316]; positive regulation of DNA-templated transcription; initiation [GO:2000144]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cell proliferation [GO:0042127]; regulation of osteoclast differentiation [GO:0045670]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100313661.1.1.m.17706,0.00261797653551632,0.0103187515624815,No,NA,NA,A6QLT2,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; phosphatidylinositol-3;5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; protein tyrosine phosphatase activity [GO:0004725]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100313664.1.1.m.37913,-0.0235377163437276,0.0208837694160217,No,NA,NA,D3ZSZ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; SH2 domain binding [GO:0042169]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; intracellular signal transduction [GO:0035556]; negative regulation of Wnt signaling pathway [GO:0030178]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein stabilization [GO:0050821]; regulation of gene expression [GO:0010468]; regulation of transcription; DNA-templated [GO:0006355]; serine phosphorylation of STAT protein [GO:0042501]; transforming growth factor beta receptor signaling pathway [GO:0007179]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100313668.2.6.m.31487,0.000822301641487381,0.0122753855415892,No,NA,NA,Q24746,NA,NA,NA,nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; mesoderm development [GO:0007498]; nervous system development [GO:0007399]; peripheral nervous system development [GO:0007422]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360],NA,NA,NA
CHOYP_LOC100313676.1.2.m.2193,-0.0159957050278269,0.00552858074590204,No,NA,NA,Q03017,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; transcription factor binding [GO:0008134]; antifungal humoral response [GO:0019732]; antimicrobial humoral response [GO:0019730]; defense response [GO:0006952]; dorsal appendage formation [GO:0046843]; dorsal/ventral axis specification [GO:0009950]; hemopoiesis [GO:0030097]; innate immune response [GO:0045087]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of antifungal peptide biosynthetic process [GO:0006967]; response to fungus [GO:0009620]; Toll signaling pathway [GO:0008063],NA,NA,NA
CHOYP_LOC100313691.1.1.m.290,-0.00235253881289523,-0.00548742083038834,No,NA,NA,Q21086,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; germ cell development [GO:0007281]; nematode larval development [GO:0002119]; regulation of cell proliferation [GO:0042127]; regulation of multicellular organism growth [GO:0040014],NA,NA,NA
CHOYP_LOC100329062.1.2.m.10150,-0.00343547354903608,0.00414172013255395,No,NA,NA,O88951,NA,NA,NA,basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; MPP7-DLG1-LIN7 complex [GO:0097025]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; L27 domain binding [GO:0097016]; PDZ domain binding [GO:0030165]; protein domain specific binding [GO:0019904]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100329078.1.3.m.26927,-0.000928120833799954,0.00117189440827657,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329078.2.3.m.30776,0.00179467668181413,-8.68425537749078e-05,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC100329955.1.1.m.11340,-0.00319202116484969,0.00433341374543915,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.1.2.m.48676,0.0160544062491521,-0.0103778405878871,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100330792.2.2.m.53521,0.0308458197510722,-0.00466897375587789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100331324.2.3.m.40325,-0.000330734522651143,-0.00514067673699606,No,NA,NA,P55210,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; cysteine-type peptidase activity [GO:0008234]; peptidase activity [GO:0008233]; apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; execution phase of apoptosis [GO:0097194]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100332237.1.1.m.18128,-0.00389160920947904,0.00528315821522073,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100346427.1.1.m.44592,0.0174404411635619,-0.00100229968729474,No,NA,NA,Q9UH65,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; actin filament bundle assembly [GO:0051017]; isotype switching [GO:0045190]; negative regulation of actin filament depolymerization [GO:0030835]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of mast cell chemotaxis [GO:0060754]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100353582.2.2.m.63483,0.0137343262682687,0.0181878476530523,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100358262.2.3.m.28381,-0.0101244643506434,-0.0132145645693987,No,NA,NA,P35244,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nucleoplasm [GO:0005654]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; single-stranded DNA binding [GO:0003697]; base-excision repair [GO:0006284]; DNA damage response; detection of DNA damage [GO:0042769]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; regulation of cell proliferation [GO:0042127]; regulation of cellular response to heat [GO:1900034]; regulation of mitotic cell cycle [GO:0007346]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_LOC100366344.1.1.m.7458,-0.0162619831205785,0.0220547206997182,No,NA,NA,Q8BJ64,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100366380.1.4.m.16838,0.0107581030082835,-0.0159559826887157,No,NA,NA,P28799,NA,NA,NA,azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosome [GO:0005764]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100366404.1.2.m.22137,-0.0016051789119399,-0.0055335195288729,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366408.1.1.m.37601,0.00531743971111853,0.00558558712824441,No,NA,NA,Q38SD2,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; bone resorption [GO:0045453]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; osteoclast development [GO:0036035]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731],NA,NA,NA
CHOYP_LOC100366424.1.1.m.29609,0.000170932773032313,-0.00643079425799866,No,NA,NA,Q9GKS9,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3739,-0.00493683865963085,0.00829904706237984,No,NA,NA,Q7RTY7,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],NA,NA,NA
CHOYP_LOC100366428.1.1.m.3740,-0.00226806177431437,5.92859975606139e-05,No,NA,NA,Q504A5,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100366442.1.4.m.6288,-0.00503113212802284,0.000424421060683,No,NA,NA,Q5ZKK5,NA,NA,NA,centriole [GO:0005814]; microtubule [GO:0005874]; sperm flagellum [GO:0036126]; spindle pole [GO:0000922]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366451.1.1.m.10500,-0.00981694754357925,0.000418248680070147,No,NA,NA,B2RW38,NA,NA,NA,cilium [GO:0005929],NA,NA,NA
CHOYP_LOC100366451.1.1.m.10501,0.000847797470203958,0.00182661537975531,No,NA,NA,Q9VZI3,NA,NA,NA,cytoplasm [GO:0005737]; cell adhesion molecule binding [GO:0050839]; cardiac muscle tissue development [GO:0048738]; cell-matrix adhesion [GO:0007160]; defense response to Gram-negative bacterium [GO:0050829]; integrin-mediated signaling pathway [GO:0007229],NA,NA,NA
CHOYP_LOC100366455.1.3.m.13543,-0.00176524642681695,-0.00517230248288878,No,NA,NA,P16152,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; oxidoreductase activity; acting on NAD(P)H; quinone or similar compound as acceptor [GO:0016655]; prostaglandin-E2 9-reductase activity [GO:0050221]; cyclooxygenase pathway [GO:0019371]; drug metabolic process [GO:0017144]; epithelial cell differentiation [GO:0030855]; oxidation-reduction process [GO:0055114]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366455.2.3.m.25037,0.000202985788888153,0.00463401172972618,No,NA,NA,Q9CXS4,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; carbon-sulfur lyase activity [GO:0016846]; ameboidal-type cell migration [GO:0001667]; cell cycle [GO:0007049]; cell division [GO:0051301]; centromere complex assembly [GO:0034508]; pericentric heterochromatin assembly [GO:0031508]; positive regulation of cytokinesis [GO:0032467]; regulation of chromosome organization [GO:0033044],NA,NA,NA
CHOYP_LOC100366455.3.3.m.28840,-0.0261807092427398,0.00808199080011653,No,NA,NA,Q5RCU5,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100366470.2.2.m.64705,0.00417049576004538,-0.00446560241282561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366482.1.1.m.9777,-0.00377405933262455,-0.00109757731142995,No,NA,NA,Q8T773,NA,NA,NA,cell [GO:0005623]; electron transfer activity [GO:0009055]; malate dehydrogenase activity [GO:0016615]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein disulfide oxidoreductase activity [GO:0015035]; carbohydrate metabolic process [GO:0005975]; cell redox homeostasis [GO:0045454]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100366486.1.1.m.15010,0.00884768751217742,-0.0160628227693887,No,NA,NA,Q6P9T8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366488.1.1.m.56518,-0.000599791712455854,-0.00558391218526266,No,NA,NA,Q7ZYG4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366489.1.1.m.21907,0.00269105181611074,0.00976748645418884,No,NA,NA,A8MWY0,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100366518.5.6.m.43397,-0.00205540966995738,-0.00443981536904582,No,NA,NA,P07207,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_LOC100366536.3.3.m.51739,0.00987350264405632,0.0233692149053703,No,NA,NA,Q13426,NA,NA,NA,cytosol [GO:0005829]; DNA ligase IV complex [GO:0032807]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; nonhomologous end joining complex [GO:0070419]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; cellular response to lithium ion [GO:0071285]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; positive regulation of ligase activity [GO:0051351]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC100366575.1.1.m.29959,-0.0182042215629032,0.0116826951900263,No,NA,NA,Q9D3N2,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; beta-tubulin binding [GO:0048487]; calcium ion binding [GO:0005509]; calcium-dependent outer dynein arm binding [GO:0120152]; dynein heavy chain binding [GO:0045504]; cell chemotaxis [GO:0060326]; negative regulation of ATP-dependent microtubule motor activity; minus-end-directed [GO:2000578]; regulation of flagellated sperm motility [GO:1901317],NA,NA,NA
CHOYP_LOC100366577.1.2.m.17884,-0.00927198027350159,-0.0107598251141748,No,NA,NA,Q9NRG9,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; fertilization [GO:0009566]; learning [GO:0007612]; mRNA export from nucleus [GO:0006406]; nucleocytoplasmic transport [GO:0006913]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100366606.1.2.m.47289,-0.0105545812757029,-0.00671690947002922,No,NA,NA,Q9Y238,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100366708.1.1.m.19335,0.00313178742786407,-0.00113677484947363,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57449,-0.000719180321827083,-0.00356216568104323,No,NA,NA,Q0V9S9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100366728.1.1.m.57452,0.00897463820889429,-0.0162932995509214,No,NA,NA,P18700,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC100366734.1.1.m.47271,-0.0112104774641293,0.0122095706336926,No,NA,NA,O35594,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; tubulin binding [GO:0015631]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; multicellular organism development [GO:0007275]; regulation of smoothened signaling pathway [GO:0008589]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366735.1.1.m.52023,-0.00705824304178674,-0.00153852187338141,No,NA,NA,Q86YS6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network membrane [GO:0032588]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cellular response to interferon-gamma [GO:0071346]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; phagosome maturation [GO:0090382]; Rab protein signal transduction [GO:0032482]; retrograde transport; plasma membrane to Golgi [GO:0035526]; toxin transport [GO:1901998]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_LOC100366754.1.1.m.49522,0.00183891879713969,-0.00110409608606792,No,NA,NA,Q9HBI1,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; Z disc [GO:0030018]; actin binding [GO:0003779]; actin cytoskeleton reorganization [GO:0031532]; cell projection assembly [GO:0030031]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of cell polarity regulating cell shape [GO:0071963]; lamellipodium assembly [GO:0030032]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53708,-0.00472764654117166,0.00233142554144946,No,NA,NA,Q9BYB0,NA,NA,NA,cell junction [GO:0030054]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; actin binding [GO:0003779]; GKAP/Homer scaffold activity [GO:0030160]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; zinc ion binding [GO:0008270]; adult behavior [GO:0030534]; AMPA glutamate receptor clustering [GO:0097113]; axon guidance [GO:0007411]; brain morphogenesis [GO:0048854]; dendritic spine morphogenesis [GO:0060997]; guanylate kinase-associated protein clustering [GO:0097117]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; MAPK cascade [GO:0000165]; memory [GO:0007613]; negative regulation of actin filament bundle assembly [GO:0032232]; negative regulation of cell volume [GO:0045794]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of long-term neuronal synaptic plasticity [GO:0048170]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of synapse structural plasticity [GO:0051835]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; regulation of AMPA receptor activity [GO:2000311]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of long-term synaptic depression [GO:1900452]; regulation of long-term synaptic potentiation [GO:1900271]; social behavior [GO:0035176]; striatal medium spiny neuron differentiation [GO:0021773]; synapse assembly [GO:0007416]; synaptic growth at neuromuscular junction [GO:0051124]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100366763.1.1.m.53709,0.00450213713451819,0.0053169081362096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366766.1.1.m.56292,0.00171584733358688,-0.0041125016899397,No,NA,NA,P59083,NA,NA,NA,cytosol [GO:0005829]; calcium channel inhibitor activity [GO:0019855]; ion channel binding [GO:0044325]; protein histidine phosphatase activity [GO:0101006]; negative regulation of ATP citrate synthase activity [GO:2000984]; negative regulation of lyase activity [GO:0051350]; negative regulation of T cell receptor signaling pathway [GO:0050860]; peptidyl-histidine dephosphorylation [GO:0035971]; positive regulation of cell motility [GO:2000147]; regulation of actin cytoskeleton reorganization [GO:2000249],NA,NA,NA
CHOYP_LOC100366770.1.1.m.55784,0.00211117891201051,0.00913817189371909,No,NA,NA,Q6P3V7,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100366787.1.1.m.65795,-0.00191946414011661,0.000415710551217534,No,NA,NA,A8Y5T1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366797.1.3.m.20765,0.00275151351668088,0.00991055608030449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366797.2.3.m.54046,-4.00316242383822e-05,0.00531123323758464,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366799.1.2.m.37253,3.88347410861642e-05,0.000884432524234154,No,NA,NA,Q3ZBD7,NA,NA,NA,ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; intramolecular transferase activity [GO:0016866]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin secretion [GO:0051024],NA,NA,NA
CHOYP_LOC100366813.1.6.m.2829,0.00198088657310033,0.00263653757179639,No,NA,NA,O57592,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366813.4.6.m.31116,0.00187062921543429,-0.00129285036832373,No,NA,NA,O57592,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100366857.1.1.m.38884,0.00674222267763114,0.0253483609718976,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366862.1.1.m.62455,-0.00349166354304732,0.00162468578776364,No,NA,NA,A5D6U8,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100366892.2.3.m.51427,0.00870750800790304,-0.0158083293178556,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100366906.1.1.m.61901,-0.00722087084793538,-0.00132348406730339,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_LOC100366918.1.1.m.31506,-0.00827636003157741,8.92017199548432e-05,No,NA,NA,P11717,NA,NA,NA,cell surface [GO:0009986]; clathrin coat [GO:0030118]; clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle [GO:0030133]; enzyme binding [GO:0019899]; G-protein alpha-subunit binding [GO:0001965]; identical protein binding [GO:0042802]; insulin-like growth factor binding [GO:0005520]; insulin-like growth factor II binding [GO:0031995]; insulin-like growth factor-activated receptor activity [GO:0005010]; kringle domain binding [GO:0036143]; mannose binding [GO:0005537]; phosphoprotein binding [GO:0051219]; retinoic acid binding [GO:0001972]; signaling receptor activity [GO:0038023]; animal organ regeneration [GO:0031100]; G protein-coupled receptor signaling pathway [GO:0007186]; liver development [GO:0001889]; lysosomal transport [GO:0007041]; membrane organization [GO:0061024]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; post-embryonic development [GO:0009791]; post-Golgi vesicle-mediated transport [GO:0006892]; receptor-mediated endocytosis [GO:0006898]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100366927.1.1.m.6140,-0.00192569854333407,-0.0163862514930168,No,NA,NA,P44121,NA,NA,NA,ATP binding [GO:0005524]; DNA ligase (ATP) activity [GO:0003910]; metal ion binding [GO:0046872]; DNA ligation involved in DNA repair [GO:0051103]; DNA recombination [GO:0006310]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_LOC100366932.1.1.m.36598,-0.00579086194367962,0.0051231251635523,No,NA,NA,Q86UY6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; H2A histone acetyltransferase activity [GO:0043998]; H4 histone acetyltransferase activity [GO:0010485]; peptide-serine-N-acetyltransferase activity [GO:1990189]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; lipid metabolic process [GO:0006629]; N-terminal protein amino acid acetylation [GO:0006474]; regulation of chromatin silencing at rDNA [GO:0061187],NA,NA,NA
CHOYP_LOC100366957.1.1.m.10938,0,0,No,NA,NA,Q9BGT1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100366965.1.2.m.40982,-0.00363906731548228,-0.0129972196457149,No,NA,NA,Q8C079,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; Rho GTPase binding [GO:0017048]; cortical actin cytoskeleton organization [GO:0030866]; regulation of cell morphogenesis [GO:0022604],NA,NA,NA
CHOYP_LOC100366987.2.2.m.61972,-0.00186030761698727,0.00353510373186343,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367001.1.1.m.55663,0.00574563262969125,-0.0104310960916876,No,NA,NA,Q15650,NA,NA,NA,activating signal cointegrator 1 complex [GO:0099053]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; neuromuscular junction [GO:0031594]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; nuclear receptor binding [GO:0016922]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; transcription coactivator activity [GO:0003713]; ubiquitin-like protein ligase binding [GO:0044389]; zinc ion binding [GO:0008270]; intracellular estrogen receptor signaling pathway [GO:0030520]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of myoblast differentiation [GO:0045661]; regulation of transcription; DNA-templated [GO:0006355]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100367006.2.2.m.17211,0.000110141134188344,0.0175638739480959,No,NA,NA,Q80U87,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; SH3 domain binding [GO:0017124]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; cellular response to nerve growth factor stimulus [GO:1990090]; endosome organization [GO:0007032]; mitotic cytokinesis [GO:0000281]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; Ras protein signal transduction [GO:0007265]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of protein localization [GO:0032880]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367014.1.1.m.18505,0.00956464635809757,-0.00266510172660811,No,NA,NA,Q08CA1,NA,NA,NA,cytoplasm [GO:0005737]; GDP-D-glucose phosphorylase activity [GO:0080048]; guanyl-nucleotide exchange factor activity [GO:0005085]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; nucleotidyltransferase activity [GO:0016779]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_LOC100367051.1.1.m.13013,-0.00407123444924021,0.00235833457503022,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100367053.1.1.m.18595,-0.0104864355079783,-0.000477476244706067,No,NA,NA,Q9UKZ1,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytosol [GO:0005829]; nucleus [GO:0005634]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; gene silencing by RNA [GO:0031047]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367064.1.1.m.52280,-0.0139224579094108,0.0184883139275004,No,NA,NA,Q08E40,NA,NA,NA,integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; zinc ion transmembrane transporter activity [GO:0005385]; cellular zinc ion homeostasis [GO:0006882]; regulation of microtubule polymerization [GO:0031113]; regulation of neuron projection development [GO:0010975]; signal transduction [GO:0007165]; zinc ion import across plasma membrane [GO:0071578],NA,NA,NA
CHOYP_LOC100367069.1.1.m.14484,-0.000889175258979741,-0.0014872055060871,No,NA,NA,Q9UHX1,NA,NA,NA,cell junction [GO:0030054]; nucleoplasm [GO:0005654]; cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100367071.1.1.m.27695,-0.0033813334177781,0.0143249652130185,No,NA,NA,Q02337,NA,NA,NA,matrix side of mitochondrial inner membrane [GO:0099617]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; 3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100367084.12.22.m.48659,-0.00550047280884489,-0.00350048731771292,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.3.22.m.29143,0.00205600369842231,0.00632460436050482,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100367084.6.22.m.31842,0.00154490109974528,-0.000417476402630884,No,NA,NA,Q9ULL1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100367089.1.4.m.1384,0.0130360919736539,0.0163562064599577,No,NA,NA,Q9I7U4,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; sarcomere [GO:0030017]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; actin binding [GO:0003779]; structural constituent of muscle [GO:0008307]; cell division [GO:0051301]; locomotion [GO:0040011]; mesoderm development [GO:0007498]; mitotic chromosome condensation [GO:0007076]; muscle attachment [GO:0016203]; muscle organ development [GO:0007517]; myoblast fusion [GO:0007520]; regulation of hemocyte proliferation [GO:0035206]; sarcomere organization [GO:0045214]; sister chromatid cohesion [GO:0007062]; skeletal muscle tissue development [GO:0007519]; somatic muscle development [GO:0007525]; visceral muscle development [GO:0007522],NA,NA,NA
CHOYP_LOC100367089.2.4.m.1910,0.0077228009633149,-0.00897499821626287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367093.1.1.m.63664,-0.0013665046866572,0.00676364184495139,No,NA,NA,Q90511,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; central nervous system development [GO:0007417]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100367137.1.1.m.23977,-0.00558544377348245,-0.0116396953521846,No,NA,NA,O08663,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aminopeptidase activity [GO:0004177]; metal ion binding [GO:0046872]; metalloaminopeptidase activity [GO:0070006]; metalloexopeptidase activity [GO:0008235]; N-terminal protein amino acid modification [GO:0031365]; peptidyl-methionine modification [GO:0018206]; protein initiator methionine removal [GO:0070084]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100367144.1.1.m.34153,0.00132106446653294,0.0053384442919633,No,NA,NA,P49746,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_LOC100367166.1.1.m.1262,-0.0095747791766787,-0.0093716269493342,No,NA,NA,Q8BT14,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; regulation of megakaryocyte differentiation [GO:0045652]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100367201.2.2.m.61573,-0.00148224423542897,-0.000828189981411998,No,NA,NA,P56812,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; acetyltransferase activator activity [GO:0010698]; beta-tubulin binding [GO:0048487]; DNA binding [GO:0003677]; heparin binding [GO:0008201]; apoptotic process [GO:0006915]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of cell proliferation [GO:0008285]; negative regulation of chaperone-mediated protein folding [GO:1903645]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into mitochondrial outer membrane [GO:1903638]; positive regulation of release of cytochrome c from mitochondria [GO:0090200],NA,NA,NA
CHOYP_LOC100367205.1.1.m.24472,-0.0271267987012521,0.0147304176754102,No,NA,NA,Q7Z4T9,NA,NA,NA,axoneme [GO:0005930]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100367232.4.5.m.45036,0.012232929849144,-0.0239837694559091,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367237.1.2.m.43812,-0.0117883055790102,0.00544828155552717,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367237.2.2.m.47349,0.00251835277581037,-0.0105427306577324,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100367242.1.2.m.48297,0.00343265425720031,-0.000927601223798627,No,NA,NA,Q69Z37,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367266.1.1.m.10803,0.00373583882923134,-0.001009530354722,No,NA,NA,Q5R6Q2,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100367291.1.1.m.51818,0.0123112674102563,-0.00802124962455656,No,NA,NA,O35963,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; presynapse [GO:0098793]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; autophagosome assembly [GO:0000045]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891]; intracellular protein transport [GO:0006886]; negative regulation of constitutive secretory pathway [GO:1903434]; protein localization to Golgi apparatus [GO:0034067]; Rab protein signal transduction [GO:0032482]; regulation of Golgi organization [GO:1903358]; regulation of retrograde vesicle-mediated transport; Golgi to ER [GO:2000156]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_LOC100367312.7.13.m.37565,-0.000458997000991739,0.00151897292246432,No,NA,NA,Q90Z10,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; structural constituent of ribosome [GO:0003735]; regulation of cell cycle [GO:0051726]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100367326.1.1.m.56733,0.00462219227601636,0.0149558531575208,No,NA,NA,P27447,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100367352.1.1.m.27863,-0.0161585812124043,-0.00286492010273363,No,NA,NA,Q4G0U5,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; calmodulin binding [GO:0005516]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100367353.1.1.m.32092,0.00019288060981113,-0.000700333479304615,No,NA,NA,Q6BWA5,NA,NA,NA,cytoplasm [GO:0005737]; inorganic diphosphatase activity [GO:0004427]; magnesium ion binding [GO:0000287]; phosphate-containing compound metabolic process [GO:0006796],NA,NA,NA
CHOYP_LOC100367356.1.1.m.29181,-0.0118911310299,0.000720162878046295,No,NA,NA,A4D263,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367378.1.1.m.25783,-0.00137131662608255,-0.00305973049331951,No,NA,NA,Q9UBV8,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100367394.1.2.m.34992,-0.00481512503853505,-0.000676917641807762,No,NA,NA,Q8N4P6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367405.1.2.m.10570,-0.00978854043591723,-0.0062294029705501,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367414.1.7.m.21233,-0.00638646282758912,-0.022044353764552,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100367421.1.1.m.66338,-0.000340344858623544,-0.00170592862470096,No,NA,NA,Q5R514,NA,NA,NA,orotate phosphoribosyltransferase activity [GO:0004588]; orotidine-5'-phosphate decarboxylase activity [GO:0004590]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205],NA,NA,NA
CHOYP_LOC100367423.1.1.m.23397,0.00537940301719851,-0.00976621260091377,No,NA,NA,H2MTR9,NA,NA,NA,adherens junction [GO:0005912]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; cell adhesion [GO:0007155]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_LOC100367436.1.1.m.20579,0,0,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC100367460.1.1.m.62925,0.000536175351590579,-0.00204298323028994,No,NA,NA,Q8YTC2,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100367470.1.1.m.51904,0.0151278788819792,0.014511986117075,No,NA,NA,Q4QQY7,NA,NA,NA,mitochondrial outer membrane [GO:0005741]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_LOC100367535.1.2.m.4730,0.0169855550023553,-0.0166025659979932,No,NA,NA,Q8R238,NA,NA,NA,mitochondrion [GO:0005739]; identical protein binding [GO:0042802]; L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100367548.1.1.m.48434,0.0125130641485818,0.00436558042374177,No,NA,NA,Q5ZKF4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_LOC100367581.3.3.m.56472,-0.00895164842277822,0.00575739264424288,No,NA,NA,Q69Z37,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; common myeloid progenitor cell proliferation [GO:0035726]; endosomal vesicle fusion [GO:0034058]; hematopoietic progenitor cell differentiation [GO:0002244]; regulation of protein catabolic process [GO:0042176]; spleen development [GO:0048536]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC100367604.1.1.m.52334,-0.00522946160530253,0.00454406060200851,No,NA,NA,Q9Y366,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary base [GO:0097546]; ciliary tip [GO:0097542]; cilium [GO:0005929]; dendrite terminus [GO:0044292]; intraciliary transport particle B [GO:0030992]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; protein C-terminus binding [GO:0008022]; cilium assembly [GO:0060271]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; intraciliary anterograde transport [GO:0035720]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; negative regulation of epithelial cell proliferation [GO:0050680]; neural tube formation [GO:0001841]; non-motile cilium assembly [GO:1905515]; regulation of protein processing [GO:0070613]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100367612.1.1.m.37487,-0.00271300868912921,-0.00134608695318772,No,NA,NA,Q5XI13,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA replication origin binding [GO:0003688]; histone binding [GO:0042393]; DNA replication [GO:0006260]; nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100367637.1.1.m.55661,-0.0159189835473286,-0.0194575567918445,No,NA,NA,Q96C86,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; exoribonuclease activity [GO:0004532]; m7G(5')pppN diphosphatase activity [GO:0050072]; RNA 7-methylguanosine cap binding [GO:0000340]; cellular response to menadione [GO:0036245]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of programmed cell death [GO:0043069]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288],NA,NA,NA
CHOYP_LOC100367640.1.1.m.22070,0.000235294003415313,0.0223318110765099,No,NA,NA,Q0IHY5,NA,NA,NA,ER membrane protein complex [GO:0072546]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367645.1.1.m.29695,-0.00108336972977569,0.00433490516311954,No,NA,NA,P21839,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; mitochondrion [GO:0005739]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; branched-chain amino acid catabolic process [GO:0009083]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100367659.1.1.m.9232,0.0044587077425926,0.00584848361771614,No,NA,NA,A1L258,NA,NA,NA,extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; mitochondrion [GO:0005739]; (R)-2-hydroxyglutarate dehydrogenase activity [GO:0051990]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; FAD binding [GO:0071949]; lactate oxidation [GO:0019516]; respiratory electron transport chain [GO:0022904],NA,NA,NA
CHOYP_LOC100367705.1.1.m.9297,-0.0181190498131305,-0.00607337231066643,No,NA,NA,Q04859,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; cytoplasm [GO:0005737]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; motile cilium [GO:0031514]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; transcription coactivator activity [GO:0003713]; cilium assembly [GO:0060271]; intracellular signal transduction [GO:0035556]; intraciliary transport [GO:0042073]; negative regulation of non-motile cilium assembly [GO:1902856]; photoreceptor cell maintenance [GO:0045494]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC100367718.1.1.m.8839,-0.00284041591158649,0.00468759968932476,No,NA,NA,P84817,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of mitochondrial outer membrane [GO:0031307]; integral component of peroxisomal membrane [GO:0005779]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; apoptotic process [GO:0006915]; autophagy of mitochondrion [GO:0000422]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to glucose stimulus [GO:0071333]; cellular response to lipid [GO:0071396]; cellular response to peptide [GO:1901653]; cellular response to thapsigargin [GO:1904579]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial fusion [GO:0008053]; mitochondrion morphogenesis [GO:0070584]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peroxisome fission [GO:0016559]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein targeting to membrane [GO:0090314]; protein homooligomerization [GO:0051260]; protein targeting to mitochondrion [GO:0006626]; release of cytochrome c from mitochondria [GO:0001836]; response to flavonoid [GO:1905395]; response to fluoride [GO:1902617]; response to hypobaric hypoxia [GO:1990910]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667],NA,NA,NA
CHOYP_LOC100367726.1.2.m.47322,9.14438110774017e-05,0.00186725425287417,No,NA,NA,P11498,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; pyruvate carboxylase activity [GO:0004736]; biotin metabolic process [GO:0006768]; gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791]; pyruvate metabolic process [GO:0006090]; viral RNA genome packaging [GO:0019074],NA,NA,NA
CHOYP_LOC100367736.2.2.m.66862,-0.0162302906321162,-0.0103289168940458,No,NA,NA,P20072,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100367739.1.1.m.22741,-0.00138376144720316,-0.00315486435452587,No,NA,NA,Q9UL16,NA,NA,NA,cilium [GO:0005929]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367787.1.1.m.52250,-0.00640501748150874,0.000956972446478683,No,NA,NA,A8MV24,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100367809.2.2.m.44174,0.0062537473003578,-0.0113535694374302,No,NA,NA,Q1HG43,NA,NA,NA,cell leading edge [GO:0031252]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; cellular protein localization [GO:0034613]; hydrogen peroxide metabolic process [GO:0042743]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of neuron differentiation [GO:0045666]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of inflammatory response [GO:0050727]; regulation of thyroid hormone generation [GO:2000609],NA,NA,NA
CHOYP_LOC100367837.1.1.m.56015,-0.00209834289046584,-0.000499406569421718,No,NA,NA,Q5BJQ6,NA,NA,NA,mRNA cleavage stimulating factor complex [GO:0005848]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100367880.1.1.m.12770,-0.00437377632752622,0.00593773708830375,No,NA,NA,Q9BXW4,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; microtubule [GO:0005874]; organelle membrane [GO:0031090]; microtubule binding [GO:0008017]; ubiquitin protein ligase binding [GO:0031625]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100367908.2.2.m.55212,0.0160191767564027,-0.0180280017995554,No,NA,NA,Q5R7A7,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100367949.2.3.m.55056,-0.0151124349464215,-0.00772912388212834,No,NA,NA,Q5R6Z6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367949.3.3.m.63228,-0.0018353233185674,-0.00159094859435863,No,NA,NA,Q5R6Z6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; nucleus [GO:0005634]; P-body [GO:0000932]; epidermal growth factor receptor binding [GO:0005154]; kinase binding [GO:0019900]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; cytokine-mediated signaling pathway [GO:0019221]; gene silencing by RNA [GO:0031047]; mRNA catabolic process [GO:0006402]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of nuclear receptor transcription coactivator activity [GO:2000327]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100367951.1.1.m.38662,0.00236668321843648,-0.0090205514642082,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100367954.1.2.m.66390,0.0111951896864411,-0.0340515238219084,No,NA,NA,Q9Y426,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100367954.2.2.m.66596,0.0112272161436138,-0.00746239279150539,No,NA,NA,E9Q3C1,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100367956.2.2.m.62044,0.00342089617289265,-0.000924423853584183,No,NA,NA,Q92113,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100367974.1.3.m.19352,-0.00566489060419945,-0.00116567346522677,No,NA,NA,Q5R7A7,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC100368004.1.1.m.62584,-0.0280993115076099,0.0129629547818295,No,NA,NA,Q5FVB2,NA,NA,NA,metal ion binding [GO:0046872]; transcription coregulator activity [GO:0003712]; embryonic camera-type eye development [GO:0031076]; forebrain development [GO:0030900]; gastrulation [GO:0007369]; mesoderm development [GO:0007498]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100368022.1.1.m.55588,-0.0066051531807723,0.00228629580078704,No,NA,NA,Q16959,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100368023.1.1.m.14890,-0.0168935070311603,-0.0213065444095852,No,NA,NA,Q9BSF4,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; TIM22 mitochondrial import inner membrane insertion complex [GO:0042721]; protein import into mitochondrial inner membrane [GO:0045039],NA,NA,NA
CHOYP_LOC100368053.1.1.m.25224,-0.0170520940129272,0.00596181429855429,No,NA,NA,A1L271,NA,NA,NA,membrane [GO:0016020]; heart contraction [GO:0060047]; optokinetic behavior [GO:0007634]; signal transduction [GO:0007165]; swimming behavior [GO:0036269],NA,NA,NA
CHOYP_LOC100368071.1.1.m.6755,-0.0130759370877433,-0.00487357470521344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368072.1.1.m.52449,-0.00945807024662886,0.00129351415422554,No,NA,NA,Q9P2G1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100368104.1.1.m.22554,-0.00925496272606198,-0.000387926218381994,No,NA,NA,Q8K1N2,NA,NA,NA,basal cortex [GO:0045180]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; establishment of protein localization [GO:0045184]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100368109.1.1.m.18734,0.00552194194074025,0.0236351466514926,No,NA,NA,A6QQM4,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100368117.1.1.m.27153,-0.00597002838289708,-0.0127790216554944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368128.1.1.m.9893,-0.00983986370448819,-0.00626206497197793,No,NA,NA,Q3UPW2,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; anatomical structure morphogenesis [GO:0009653]; blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; epithelial cell differentiation [GO:0030855]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100368178.1.3.m.36490,-0.00671350451355418,-0.00105074656171041,No,NA,NA,Q9BYK8,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of lipid metabolic process [GO:0019216],NA,NA,NA
CHOYP_LOC100368194.1.1.m.59989,0.000235478554461831,-0.00448381526814205,No,NA,NA,Q9CRB9,NA,NA,NA,cytoplasm [GO:0005737]; MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; phosphatase binding [GO:0019902]; protein-containing complex scaffold activity [GO:0032947]; cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; mitochondrial fusion [GO:0008053]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100368219.2.5.m.38385,-0.0268164093551271,-0.0170658967176921,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368219.4.5.m.58416,0.0163042235197158,-0.0296000341817274,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368228.3.3.m.54183,-0.00395941498681969,-0.00849437183943891,No,NA,NA,Q9W391,NA,NA,NA,phosphorylase kinase complex [GO:0005964]; plasma membrane [GO:0005886]; calmodulin binding [GO:0005516]; catalytic activity [GO:0003824]; glycogen metabolic process [GO:0005977]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100368238.1.1.m.7505,0.0216956456024116,0.00668049146340564,No,NA,NA,Q13231,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100368251.3.6.m.40053,-0.00926299156465344,-0.00589494496618746,No,NA,NA,Q5K651,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_LOC100368259.1.1.m.39485,0.00215891662392766,0.0026159994997096,No,NA,NA,Q9VFC8,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; glycogen (starch) synthase activity [GO:0004373]; cellular response to starvation [GO:0009267]; cellular response to sucrose stimulus [GO:0071329]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977]; glycophagy [GO:0061723]; positive regulation of glycogen catabolic process [GO:0045819]; response to sucrose [GO:0009744],NA,NA,NA
CHOYP_LOC100368376.1.2.m.11023,0.0104110386485983,0.0168778974420298,No,NA,NA,Q3EC11,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein targeting to membrane [GO:0006612],NA,NA,NA
CHOYP_LOC100368394.1.2.m.22888,-0.00816944335809135,0.000130496320429367,No,NA,NA,Q5T0N1,NA,NA,NA,cilium [GO:0005929]; extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100368410.2.2.m.44510,-0.00992733400532753,-0.00631773085551293,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368416.1.1.m.58347,-0.00433168246012514,0.005493026299337,No,NA,NA,Q8VHI3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; fucosyltransferase activity [GO:0008417]; peptide-O-fucosyltransferase activity [GO:0046922]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; mesoderm formation [GO:0001707]; protein O-linked fucosylation [GO:0036066]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of secretion [GO:0051046],NA,NA,NA
CHOYP_LOC100368486.1.1.m.18263,-0.00106069027510273,0.000983025375936061,No,NA,NA,O95433,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; ATPase activator activity [GO:0001671]; cadherin binding [GO:0045296]; chaperone binding [GO:0051087]; Hsp90 protein binding [GO:0051879]; positive regulation of ATPase activity [GO:0032781],NA,NA,NA
CHOYP_LOC100368495.1.1.m.9879,0.0148352104445732,0.0327681276615711,No,NA,NA,Q9BVG4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368521.3.3.m.41435,-0.00314027224357302,0.00426316061264625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100368525.1.1.m.62480,-0.00249920233149107,-0.0110692885158945,No,NA,NA,Q3UGF1,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; intraciliary transport particle A [GO:0030991]; motile cilium [GO:0031514]; non-motile cilium [GO:0097730]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; cell morphogenesis [GO:0000902]; ciliary receptor clustering involved in smoothened signaling pathway [GO:0060830]; cilium assembly [GO:0060271]; digestive system development [GO:0055123]; ear morphogenesis [GO:0042471]; embryonic camera-type eye development [GO:0031076]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic limb morphogenesis [GO:0030326]; gonad development [GO:0008406]; in utero embryonic development [GO:0001701]; intraciliary retrograde transport [GO:0035721]; myotome development [GO:0061055]; nervous system process [GO:0050877]; protein localization to cilium [GO:0061512]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],NA,NA,NA
CHOYP_LOC100368576.1.1.m.45391,-0.0145139106757366,-0.0132870482792024,No,NA,NA,Q6DMN8,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100368627.1.1.m.13820,-0.00167566505429967,-0.000692322211260861,No,NA,NA,Q15061,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; positive regulation of rRNA processing [GO:2000234]; positive regulation of transcription by RNA polymerase I [GO:0045943]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368636.1.1.m.6631,-0.0100034982027515,-0.0103147108761293,No,NA,NA,Q3UY96,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082],NA,NA,NA
CHOYP_LOC100368639.1.1.m.56563,-4.00356001510015e-05,0.000961878451358695,No,NA,NA,Q5PPY6,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100368658.1.1.m.16577,-0.000667732713857698,0.00135357420252543,No,NA,NA,P49139,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; cellular response to DNA damage stimulus [GO:0006974]; inflammatory response [GO:0006954]; macropinocytosis [GO:0044351]; regulation of interleukin-6 production [GO:0032675]; regulation of tumor necrosis factor production [GO:0032680]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496]; toll-like receptor signaling pathway [GO:0002224],NA,NA,NA
CHOYP_LOC100368659.1.2.m.15836,0.0102401154832731,0.0018329239378996,No,NA,NA,P78316,NA,NA,NA,90S preribosome [GO:0030686]; membrane [GO:0016020]; Noc4p-Nop14p complex [GO:0030692]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100368661.1.1.m.60830,0.00152415829907289,-0.0109126176993033,No,NA,NA,Q5F464,NA,NA,NA,cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100368695.1.1.m.26746,0.00064564281178642,-0.000317921158184033,No,NA,NA,O43301,NA,NA,NA,extracellular exosome [GO:0070062]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100368715.1.3.m.31823,0.00457261094937823,-0.00830149563624824,No,NA,NA,Q5REG4,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100368803.1.1.m.12857,-0.00659325476742526,0.0123365478251487,No,NA,NA,Q5JTW2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium organization [GO:0044782]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_LOC100368820.1.1.m.12090,0.0203257196911131,0.00622329234049241,No,NA,NA,Q4T2X8,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; ribosome assembly [GO:0042255],NA,NA,NA
CHOYP_LOC100368844.1.1.m.45290,-0.0106963646518432,-0.0247815752787416,No,NA,NA,B0WYR6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48100,0.00419681020875807,-0.00761923592885254,No,NA,NA,Q9D2K4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368865.1.1.m.48101,-0.00326588795202792,0.00160899459131223,No,NA,NA,Q5GIS3,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100368866.1.1.m.6804,0.000494625818946247,0.000169155047789198,No,NA,NA,Q24439,NA,NA,NA,mitochondrial proton-transporting ATP synthase; central stalk [GO:0005756]; mitochondrion [GO:0005739]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; mitochondrial ATP synthesis coupled proton transport [GO:0042776]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC100368885.1.1.m.7807,-0.0073536809136875,-0.00162219029861483,No,NA,NA,A0A0R4IFG5,NA,NA,NA,axoneme [GO:0005930]; ciliary base [GO:0097546]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287],NA,NA,NA
CHOYP_LOC100368907.1.1.m.22004,0.0129356816281257,-0.00312577118604658,No,NA,NA,B5X7E4,NA,NA,NA,cilium [GO:0005929]; intraciliary transport particle A [GO:0030991]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721],NA,NA,NA
CHOYP_LOC100368913.1.1.m.25628,-0.0147089350318341,0.00804086826959317,No,NA,NA,B0G143,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; transmembrane transporter activity [GO:0022857]; mitochondrial transport [GO:0006839],NA,NA,NA
CHOYP_LOC100368918.1.2.m.6229,0.000466080046337494,-0.00398371630092867,No,NA,NA,Q49AM3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100368924.1.1.m.5031,-0.00843484161275778,-0.0237444445101496,No,NA,NA,Q642C0,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100368926.5.5.m.55016,-0.000745290761262197,-0.00881893507151362,No,NA,NA,O00370,NA,NA,NA,metal ion binding [GO:0046872]; RNA-directed DNA polymerase activity [GO:0003964]; type II site-specific deoxyribonuclease activity [GO:0009036]; DNA recombination [GO:0006310]; nucleic acid phosphodiester bond hydrolysis [GO:0090305]; reverse transcription involved in RNA-mediated transposition [GO:0032199]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_LOC100368938.2.2.m.53945,-0.00486202865066492,-0.00424276728124341,No,NA,NA,Q5M7G4,NA,NA,NA,cytosol [GO:0005829]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100368976.1.1.m.1873,0.00284764978351716,0.0121641975118455,No,NA,NA,A0JNH9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; 3'-5' exonuclease activity [GO:0008408]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; endodeoxyribonuclease activity [GO:0004520]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; single strand break repair [GO:0000012],NA,NA,NA
CHOYP_LOC100368987.1.1.m.6182,0.00180925547308813,-0.0105857708416303,No,NA,NA,Q62165,NA,NA,NA,basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; contractile ring [GO:0070938]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dystroglycan complex [GO:0016011]; dystrophin-associated glycoprotein complex [GO:0016010]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; membrane [GO:0016020]; membrane raft [GO:0045121]; node of Ranvier [GO:0033268]; nuclear periphery [GO:0034399]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; synapse [GO:0045202]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; calcium ion binding [GO:0005509]; dystroglycan binding [GO:0002162]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; SH2 domain binding [GO:0042169]; structural constituent of muscle [GO:0008307]; tubulin binding [GO:0015631]; vinculin binding [GO:0017166]; aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; axon regeneration [GO:0031103]; basement membrane organization [GO:0071711]; branching involved in salivary gland morphogenesis [GO:0060445]; calcium-dependent cell-matrix adhesion [GO:0016340]; cellular response to cholesterol [GO:0071397]; cellular response to mechanical stimulus [GO:0071260]; commissural neuron axon guidance [GO:0071679]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; membrane protein ectodomain proteolysis [GO:0006509]; microtubule anchoring [GO:0034453]; modulation by virus of host morphology or physiology [GO:0019048]; morphogenesis of an epithelial sheet [GO:0002011]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell migration [GO:0030336]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase B signaling [GO:0051898]; nerve maturation [GO:0021682]; positive regulation of basement membrane assembly involved in embryonic body morphogenesis [GO:1904261]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein kinase activity [GO:0045860]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gastrulation [GO:0010470]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by trans-synaptic protein complex [GO:0098942]; Schwann cell development [GO:0014044]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100369014.8.9.m.53287,0.0142760421919463,-0.00630364872831798,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369014.9.9.m.53367,0.00424217408796272,-0.0113911895569098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369017.1.1.m.27033,0.000665964569981774,-0.00231259056479767,No,NA,NA,Q3V3N7,NA,NA,NA,axoneme [GO:0005930]; BBSome [GO:0034464]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; motile cilium [GO:0031514]; patched binding [GO:0005113]; phosphoprotein binding [GO:0051219]; RNA polymerase II repressing transcription factor binding [GO:0001103]; signaling receptor binding [GO:0005102]; smoothened binding [GO:0005119]; adult behavior [GO:0030534]; brain morphogenesis [GO:0048854]; cartilage development [GO:0051216]; cellular lipid metabolic process [GO:0044255]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; dendrite development [GO:0016358]; fat cell differentiation [GO:0045444]; fertilization [GO:0009566]; Golgi to plasma membrane protein transport [GO:0043001]; hippocampus development [GO:0021766]; hormone metabolic process [GO:0042445]; intraciliary retrograde transport [GO:0035721]; microtubule cytoskeleton organization [GO:0000226]; neural precursor cell proliferation [GO:0061351]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; olfactory behavior [GO:0042048]; photoreceptor cell maintenance [GO:0045494]; photoreceptor cell morphogenesis [GO:0008594]; protein localization [GO:0008104]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency involved in ciliary motility [GO:0060296]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; striatum development [GO:0021756]; ventricular system development [GO:0021591]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100369022.1.1.m.62978,-0.0221709079716253,0.0301947148874645,No,NA,NA,Q8N0W5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369031.1.1.m.19197,-0.000239739331171529,-0.000919742581113821,No,NA,NA,Q9JK25,NA,NA,NA,cytoplasmic microtubule [GO:0005881]; cytoplasmic vesicle membrane [GO:0030659]; microtubule plus-end [GO:0035371]; ruffle [GO:0001726]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; positive regulation of dendrite development [GO:1900006],NA,NA,NA
CHOYP_LOC100369186.2.9.m.27904,0.0105973814230862,0.00085582389745286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369194.1.1.m.42345,-0.000430215496306593,-0.0149611260678081,No,NA,NA,Q5EAJ7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100369232.1.1.m.58420,-0.00195323064845253,0.0152930819928541,No,NA,NA,O93327,NA,NA,NA,condensed chromosome [GO:0000793]; nuclear chromatin [GO:0000790]; nucleolus [GO:0005730]; nucleosome [GO:0000786]; pericentric heterochromatin [GO:0005721]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; nucleosomal DNA binding [GO:0031492]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine/threonine kinase inhibitor activity [GO:0030291]; rDNA binding [GO:0000182]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; chromatin organization [GO:0006325]; dosage compensation [GO:0007549]; establishment of protein localization to chromatin [GO:0071169]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of histone H3-K27 methylation [GO:0061086]; negative regulation of histone H3-K4 methylation [GO:0051572]; negative regulation of histone phosphorylation [GO:0033128]; negative regulation of protein localization to chromosome; telomeric region [GO:1904815]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901837]; nucleosome assembly [GO:0006334]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of maintenance of mitotic sister chromatid cohesion [GO:0034184]; regulation of lipid metabolic process [GO:0019216]; regulation of response to oxidative stress [GO:1902882],NA,NA,NA
CHOYP_LOC100369237.3.3.m.48902,-7.12919266285705e-05,0.00606945420425611,No,NA,NA,Q3UHR0,NA,NA,NA,chromatin binding [GO:0003682],NA,NA,NA
CHOYP_LOC100369255.1.3.m.17623,-0.0154010003459654,0.00540967912814226,No,NA,NA,Q9P1Z9,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100369259.1.1.m.7509,0.00386414518747496,-0.00104420239740684,No,NA,NA,P23919,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside monophosphate kinase activity [GO:0050145]; thymidylate kinase activity [GO:0004798]; uridylate kinase activity [GO:0009041]; cell proliferation [GO:0008283]; cellular response to growth factor stimulus [GO:0071363]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; myoblast differentiation [GO:0045445]; nucleobase-containing small molecule interconversion [GO:0015949]; response to cadmium ion [GO:0046686]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_LOC100369270.1.1.m.27019,0.000973742047814369,-0.0204905793471393,No,NA,NA,Q9VFR0,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; mitotic spindle pole [GO:0097431]; nuclear cyclin-dependent protein kinase holoenzyme complex [GO:0019908]; kinase regulator activity [GO:0019207]; protein kinase regulator activity [GO:0019887]; tubulin binding [GO:0015631]; cellular response to DNA damage stimulus [GO:0006974]; establishment of mitotic spindle orientation [GO:0000132]; microtubule anchoring [GO:0034453]; mitotic spindle assembly [GO:0090307]; mitotic spindle organization [GO:0007052]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of protein kinase activity [GO:0045859]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100369290.1.1.m.66929,0.0168647000991392,0.00303264233565121,No,NA,NA,A4IF78,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100369294.2.6.m.22959,-6.61526313133294e-05,0.00877686231497352,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369294.3.6.m.24633,0.0041169470887985,0.00132183014643554,No,NA,NA,Q28298,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; protein transport [GO:0015031]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100369302.1.3.m.6808,-0.00925553652098282,-0.000475885460004923,No,NA,NA,Q008S8,NA,NA,NA,Rho guanyl-nucleotide exchange factor activity [GO:0005089]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_LOC100369330.1.1.m.48177,-0.00440410435299776,0.0059789097108094,No,NA,NA,Q3T0W7,NA,NA,NA,Atg12-Atg5-Atg16 complex [GO:0034274]; phagophore assembly site membrane [GO:0034045]; Atg8 ligase activity [GO:0019776]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; C-terminal protein lipidation [GO:0006501]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100369333.14.32.m.32582,-0.00906410240143444,-0.00576837239366985,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100369333.22.32.m.39414,0.00292768302287015,-0.000791143573289485,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369333.28.32.m.53859,0.00561647622361721,0.00663291393352324,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369340.1.1.m.51639,0.00200199207726403,-0.00432527734232911,No,NA,NA,Q80ZX8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; axonemal dynein complex assembly [GO:0070286]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC100369350.2.6.m.42373,0.00167588789046263,-0.000452872774728655,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC100369378.1.1.m.5391,0.00295884648794051,-0.00100088931694421,No,NA,NA,P02640,NA,NA,NA,actin filament bundle [GO:0032432]; cytoplasm [GO:0005737]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; ruffle [GO:0001726]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; lysophosphatidic acid binding [GO:0035727]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein homodimerization activity [GO:0042803]; actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; epidermal growth factor receptor signaling pathway [GO:0007173]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell migration [GO:0010634]; regulation of actin nucleation [GO:0051125]; regulation of cell shape [GO:0008360]; regulation of lamellipodium morphogenesis [GO:2000392]; regulation of wound healing [GO:0061041]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100369384.1.1.m.47986,-0.0174055003482487,-0.0250622223454688,No,NA,NA,Q9WTR0,NA,NA,NA,extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; metalloaminopeptidase activity [GO:0070006]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; bone development [GO:0060348]; chondrocyte proliferation [GO:0035988]; collagen catabolic process [GO:0030574]; craniofacial suture morphogenesis [GO:0097094]; embryonic cranial skeleton morphogenesis [GO:0048701]; endochondral ossification [GO:0001958]; ossification [GO:0001503]; protein processing [GO:0016485]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100369402.2.2.m.29002,4.92096178245452e-05,0.00132091693994049,No,NA,NA,P45842,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100369411.1.1.m.1071,0.00241938843186224,-0.00880539053498742,No,NA,NA,Q920N2,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin-[acetyl-CoA-carboxylase] ligase activity [GO:0004077]; biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity [GO:0004078]; biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity [GO:0004079]; biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity [GO:0004080]; biotin-protein ligase activity [GO:0018271]; enzyme binding [GO:0019899]; protein homodimerization activity [GO:0042803]; cell proliferation [GO:0008283]; histone biotinylation [GO:0071110]; histone modification [GO:0016570]; protein biotinylation [GO:0009305]; response to biotin [GO:0070781],NA,NA,NA
CHOYP_LOC100369421.1.2.m.17340,-0.0112942706757873,-0.00648568227240595,No,NA,NA,Q2TA16,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC100369444.1.1.m.18613,-0.00973140636644871,0.0219250227430274,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369488.1.1.m.10559,-8.25752771233371e-05,0.0109557522285025,No,NA,NA,Q6P0I8,NA,NA,NA,cytoplasmic exosome (RNase complex) [GO:0000177]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],NA,NA,NA
CHOYP_LOC100369524.1.1.m.8159,-0.00255477150444778,0.00462538699563547,No,NA,NA,P48818,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of fatty acid oxidation [GO:0046322]; regulation of cholesterol metabolic process [GO:0090181]; response to cold [GO:0009409]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100369566.1.1.m.41492,-0.0135699490501237,0.0099281630112902,No,NA,NA,A1A5Q4,NA,NA,NA,motile cilium [GO:0031514]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100369570.1.1.m.25302,-0.00774199503020469,0.00672589830926133,No,NA,NA,Q8CIG9,NA,NA,NA,SCF ubiquitin ligase complex [GO:0019005]; ubiquitin-protein transferase activity [GO:0004842]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100369596.1.1.m.7021,0.00128625515274147,-0.00199439045182132,No,NA,NA,Q8IZH2,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; synapse [GO:0045202]; 5'-3' exoribonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; regulation of mRNA stability [GO:0043488]; response to testosterone [GO:0033574]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; rRNA catabolic process [GO:0016075],NA,NA,NA
CHOYP_LOC100369608.1.3.m.11971,0.00292869462427169,0.001587680089504,No,NA,NA,Q8IVV2,NA,NA,NA,stereocilium [GO:0032420]; catalase activity [GO:0004096]; heme binding [GO:0020037]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100369620.1.1.m.13590,-0.0140391859112166,0.0217750108811782,No,NA,NA,Q5E9Z7,NA,NA,NA,RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100369657.2.2.m.45309,0.0135160715186878,0.0132628765983626,No,NA,NA,P19891,NA,NA,NA,cytosol [GO:0005829]; asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; cellular response to glucose starvation [GO:0042149]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]; negative regulation of apoptotic process [GO:0043066]; positive regulation of mitotic cell cycle [GO:0045931],NA,NA,NA
CHOYP_LOC100369686.2.2.m.30008,0.00682100231947391,-0.0123834110570136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369689.1.1.m.28663,-0.0259722865048306,-0.0165286990194682,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369695.1.1.m.26973,-0.0271784548714236,-0.0227219706949445,No,NA,NA,Q504A5,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119],NA,NA,NA
CHOYP_LOC100369712.1.1.m.64282,-0.0252656484516941,0.0235562707875692,No,NA,NA,O15116,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; Lsm1-7-Pat1 complex [GO:1990726]; messenger ribonucleoprotein complex [GO:1990124]; mRNA cap binding complex [GO:0005845]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; mRNA binding [GO:0003729]; pre-mRNA binding [GO:0036002]; RNA binding [GO:0003723]; RNA cap binding [GO:0000339]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; histone mRNA catabolic process [GO:0071044]; mRNA processing [GO:0006397]; negative regulation of neuron differentiation [GO:0045665]; RNA metabolic process [GO:0016070]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100369721.1.1.m.17704,0.00440145898148247,-0.0027217426789129,No,NA,NA,Q5FW48,NA,NA,NA,aspartate dehydrogenase activity [GO:0033735]; NADP binding [GO:0050661]; NAD biosynthetic process [GO:0009435]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_LOC100369745.1.1.m.18815,-0.00208839123387698,0.00600380925398723,No,NA,NA,Q5RKI1,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; translation initiation factor activity [GO:0003743]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of RNA-directed 5'-3' RNA polymerase activity [GO:1900260],NA,NA,NA
CHOYP_LOC100369754.6.10.m.53352,0.00284662588886901,0.00857829044408825,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369791.1.2.m.8271,-0.00570530245891856,-0.00363084040140084,No,NA,NA,Q14315,NA,NA,NA,costamere [GO:0043034]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ankyrin binding [GO:0030506]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; cell junction assembly [GO:0034329]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC100369816.1.1.m.23060,-0.0135722841303814,-0.000208382268888499,No,NA,NA,Q6AXP4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369839.2.4.m.27857,-0.025622318069254,-0.0227876265636771,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369879.3.3.m.59095,0.00208708560531913,-0.000563990141915871,No,NA,NA,P32018,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100369901.1.2.m.9586,-0.0142306321673821,-0.00173949055402125,No,NA,NA,Q8N6D5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100369929.1.5.m.32680,-0.00376551360297317,0.00511197375050314,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100369935.1.1.m.40124,-0.0100766872365769,0.00690357305863087,No,NA,NA,Q96M32,NA,NA,NA,cytosol [GO:0005829]; motile cilium [GO:0031514]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; cell projection organization [GO:0030030]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22656,-0.00569102910079011,-0.00928870245255933,No,NA,NA,Q00420,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100369954.1.1.m.22658,-8.86300400428358e-06,-0.00346989345313086,No,NA,NA,B0BNA5,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; actin binding [GO:0003779]; enzyme binding [GO:0019899]; defense response to fungus [GO:0050832],NA,NA,NA
CHOYP_LOC100369985.1.1.m.35628,-0.0158673202528704,-0.0046348848545749,No,NA,NA,A6NNX1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370026.1.1.m.42957,-0.00414175254849906,0.00030614122160482,No,NA,NA,Q8JFY9,NA,NA,NA,nucleus [GO:0005634]; endoribonuclease activity [GO:0004521]; manganese ion binding [GO:0030145]; RNA binding [GO:0003723]; snoRNA processing [GO:0043144],NA,NA,NA
CHOYP_LOC100370040.1.2.m.55411,0.0171780743414383,0.0116824942876341,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370040.2.2.m.55789,0.00582452288398096,0.021062950629095,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370046.1.1.m.18329,-0.0208349911870465,0.00548073445788657,No,NA,NA,Q9UET6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; tRNA (cytosine-2'-O-)-methyltransferase activity [GO:0052666]; tRNA (guanosine-2'-O-)-methyltransferase activity [GO:0009020]; tRNA methyltransferase activity [GO:0008175]; cytoplasmic translation [GO:0002181]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400]; tRNA nucleoside ribose methylation [GO:0002128],NA,NA,NA
CHOYP_LOC100370061.1.1.m.41505,-0.0211327077795431,-0.0102493442023021,No,NA,NA,Q9DBB5,NA,NA,NA,eukaryotic translation initiation factor 4F complex [GO:0016281]; mRNA cap binding complex [GO:0005845]; RNA 7-methylguanosine cap binding [GO:0000340]; translation initiation factor activity [GO:0003743]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100370071.1.1.m.46123,-0.00744055370850411,-0.0153055794385616,No,NA,NA,Q17GZ9,NA,NA,NA,nucleus [GO:0005634]; chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100370080.1.1.m.14971,-0.000125153743215576,-0.00438329719550563,No,NA,NA,P36404,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; lateral plasma membrane [GO:0016328]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; nucleolus [GO:0005730]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase inhibitor activity [GO:0005095]; bicellular tight junction assembly [GO:0070830]; centrosome cycle [GO:0007098]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of GTPase activity [GO:0034260]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of microtubule polymerization [GO:0031116]; regulation of insulin secretion [GO:0050796]; regulation of microtubule polymerization [GO:0031113]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_LOC100370113.2.2.m.56346,0.00693070046231645,0.000952010609615628,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370122.2.2.m.59310,-0.011860243837388,-0.00754782990127684,No,NA,NA,Q6P2C0,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; electron transport chain [GO:0022900],NA,NA,NA
CHOYP_LOC100370136.1.1.m.2170,-0.00510826247422937,0.0237920637544225,No,NA,NA,Q9BZE4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of collagen binding [GO:0033342]; negative regulation of DNA replication [GO:0008156]; negative regulation of protein ubiquitination [GO:0031397]; osteoblast differentiation [GO:0001649]; protein stabilization [GO:0050821]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_LOC100370139.3.4.m.58156,0.00237378643366381,-0.00473549776212868,No,NA,NA,Q32P85,NA,NA,NA,cytoplasmic dynein complex [GO:0005868]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; dynein intermediate chain binding [GO:0045505]; motor activity [GO:0003774]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100370154.1.2.m.27385,-0.00134824233819668,0.00239799718042786,No,NA,NA,Q13637,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; membrane [GO:0016020]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; trans-Golgi network [GO:0005802]; AP-1 adaptor complex binding [GO:0035650]; AP-3 adaptor complex binding [GO:0035651]; BLOC-2 complex binding [GO:0036461]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; antigen processing and presentation [GO:0019882]; endosome to melanosome transport [GO:0035646]; intracellular protein transport [GO:0006886]; melanosome assembly [GO:1903232]; mitochondrion organization [GO:0007005]; phagosome maturation [GO:0090382]; protein localization to membrane [GO:0072657]; Rab protein signal transduction [GO:0032482]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100370167.1.1.m.15539,0.00202831936069261,-0.0158947567551528,No,NA,NA,O04469,NA,NA,NA,peroxisome [GO:0005777]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062],NA,NA,NA
CHOYP_LOC100370187.1.1.m.8872,0.00268861952443185,-0.000726541787877572,No,NA,NA,Q07553,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; signaling receptor activity [GO:0038023]; cGMP-mediated signaling [GO:0019934]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370194.1.1.m.52469,-0.00571251640089788,0.00824149225474831,No,NA,NA,A4IIK1,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; inflammatory response [GO:0006954]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100370201.1.1.m.974,-0.0219986145004589,0.022597991781303,No,NA,NA,Q8BFY6,NA,NA,NA,COPII vesicle coat [GO:0030127]; Cul3-RING ubiquitin ligase complex [GO:0031463]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi membrane [GO:0000139]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; molecular adaptor activity [GO:0060090]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; positive regulation of protein monoubiquitination [GO:1902527]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100370218.1.1.m.36701,-0.00205504672941033,-0.00148745961169515,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370236.1.3.m.7766,0.00368509599851959,0.00435200357337384,No,NA,NA,Q9JKL7,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45834,-0.000669874128004744,0.00230308318389284,No,NA,NA,P41824,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100370246.2.2.m.45836,0.000164115422579669,-0.000461815068370713,No,NA,NA,Q13442,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell proliferation [GO:0008283]; neutrophil degranulation [GO:0043312]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100370269.1.1.m.55713,0.000579188011261815,-0.0130124321439309,No,NA,NA,Q640Q5,NA,NA,NA,P-body [GO:0000932]; PAN complex [GO:0031251]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606]; protein targeting [GO:0006605],NA,NA,NA
CHOYP_LOC100370330.1.1.m.10944,0.000663948943509292,-0.0038717883979836,No,NA,NA,Q9NRY5,NA,NA,NA,purine nucleotide binding [GO:0017076],NA,NA,NA
CHOYP_LOC100370334.1.1.m.48934,-0.012556299981147,-0.000995933885162649,No,NA,NA,Q54RV9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; actin cytoskeleton organization [GO:0030036]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; cell death [GO:0008219]; cell motility [GO:0048870]; cellular calcium ion homeostasis [GO:0006874]; ceramide metabolic process [GO:0006672]; chemotaxis [GO:0006935]; locomotion [GO:0040011]; negative regulation of aggregate size involved in sorocarp development [GO:0031158]; negative regulation of lateral pseudopodium assembly [GO:0031276]; positive phototaxis [GO:0046956]; regulation of actin filament polymerization [GO:0030833]; sorocarp development [GO:0030587]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_LOC100370358.1.1.m.39703,-0.00937463424995206,0.00160043225676237,No,NA,NA,D3ZY60,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; trans-Golgi network [GO:0005802]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; ceramide binding [GO:0097001]; glycolipid binding [GO:0051861]; glycolipid transporter activity [GO:0017089]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; ceramide transport [GO:0035627]; ER to Golgi ceramide transport [GO:0035621]; intermembrane lipid transfer [GO:0120009]; lipid transport [GO:0006869]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100370401.1.1.m.15416,-0.000541828800854805,-0.000425300269179911,No,NA,NA,P70195,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100370403.1.1.m.11269,-5.04954829478847e-05,0.00669953549183131,No,NA,NA,C6KFA3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; G protein-coupled receptor activity [GO:0004930]; laminin binding [GO:0043236]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell surface receptor signaling pathway [GO:0007166]; ear development [GO:0043583]; G protein-coupled receptor signaling pathway [GO:0007186]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; mitochondrion organization [GO:0007005]; myelination [GO:0042552]; myelination in peripheral nervous system [GO:0022011]; myelination of posterior lateral line nerve axons [GO:0048932]; ossification [GO:0001503]; peripheral nervous system myelin formation [GO:0032290]; regulation of sprouting angiogenesis [GO:1903670]; Schwann cell differentiation [GO:0014037]; semicircular canal fusion [GO:0060879],NA,NA,NA
CHOYP_LOC100370410.1.1.m.24212,-0.00255846250481351,-0.00975694470556926,No,NA,NA,Q96AT9,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; ribulose-phosphate 3-epimerase activity [GO:0004750]; carbohydrate metabolic process [GO:0005975]; cellular carbohydrate metabolic process [GO:0044262]; pentose catabolic process [GO:0019323]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_LOC100370453.1.1.m.48521,-0.0164836465020232,-0.00175377845478386,No,NA,NA,Q0VFN8,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule binding [GO:0008017]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_LOC100370463.1.1.m.30276,-0.0115447998540162,-0.00734708212892786,No,NA,NA,A6NJI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370478.2.2.m.16291,0.00267198058472967,0.000811117277315778,No,NA,NA,P0DMQ6,NA,NA,NA,mitochondrial membrane [GO:0031966]; motile cilium [GO:0031514]; protein-containing complex [GO:0032991]; L-iditol 2-dehydrogenase activity [GO:0003939]; NAD binding [GO:0051287]; zinc ion binding [GO:0008270]; fructose biosynthetic process [GO:0046370]; fructose metabolic process [GO:0006000]; NADH oxidation [GO:0006116]; NADH regeneration [GO:0006735]; sorbitol biosynthetic process [GO:0006061]; sorbitol catabolic process [GO:0006062],NA,NA,NA
CHOYP_LOC100370504.1.2.m.17506,-0.016499614468224,-0.0105003139185229,No,NA,NA,Q95J53,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100370516.1.1.m.29182,0.003444142905827,-0.000941547641897766,No,NA,NA,B1H1E4,NA,NA,NA,cytoplasm [GO:0005737]; Lewy body [GO:0097413]; nuclear body [GO:0016604]; ubiquitin ligase complex [GO:0000151]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370520.1.1.m.12258,0.00112876574459884,-0.000538531811519742,No,NA,NA,Q8R059,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; UDP-glucose 4-epimerase activity [GO:0003978]; UDP-N-acetylglucosamine 4-epimerase activity [GO:0003974]; galactose catabolic process [GO:0019388]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10588,-0.0184630975801883,0.0152515125185262,No,NA,NA,Q494V2,NA,NA,NA,axonemal outer doublet [GO:0097545]; motile cilium [GO:0031514]; dynein complex binding [GO:0070840]; cilium movement [GO:0003341]; inner dynein arm assembly [GO:0036159]; regulation of microtubule motor activity [GO:2000574],NA,NA,NA
CHOYP_LOC100370537.1.1.m.10589,-0.00769877148893501,0.00144166307707488,No,NA,NA,Q3SZ21,NA,NA,NA,nucleolar ribonuclease P complex [GO:0005655]; ribonuclease P activity [GO:0004526]; RNA binding [GO:0003723]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_LOC100370551.1.1.m.64375,-0.00534685781725144,-0.00100115384765787,No,NA,NA,Q568D2,NA,NA,NA,motile cilium [GO:0031514]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100370552.2.2.m.59438,0.000590560119605935,-0.00065117712788673,No,NA,NA,Q6AYD3,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell differentiation [GO:0045597]; regulation of translation [GO:0006417]; ribosomal large subunit export from nucleus [GO:0000055]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100370583.1.1.m.56859,-0.00917547420686409,0.0115353506878105,No,NA,NA,Q05655,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium-independent protein kinase C activity [GO:0004699]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; insulin receptor substrate binding [GO:0043560]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; B cell proliferation [GO:0042100]; cell chemotaxis [GO:0060326]; cell cycle [GO:0007049]; cellular response to angiotensin [GO:1904385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hydroperoxide [GO:0071447]; cellular senescence [GO:0090398]; defense response to bacterium [GO:0042742]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; histone phosphorylation [GO:0016572]; immunoglobulin mediated immune response [GO:0016064]; interferon-gamma-mediated signaling pathway [GO:0060333]; interleukin-10 production [GO:0032613]; interleukin-12 production [GO:0032615]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of filopodium assembly [GO:0051490]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein binding [GO:0032091]; neutrophil activation [GO:0042119]; neutrophil degranulation [GO:0043312]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; platelet activation [GO:0030168]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of glucosylceramide catabolic process [GO:2000753]; positive regulation of phospholipid scramblase activity [GO:1900163]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of response to DNA damage stimulus [GO:2001022]; positive regulation of sphingomyelin catabolic process [GO:2000755]; positive regulation of superoxide anion generation [GO:0032930]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of mRNA stability [GO:0043488]; regulation of signaling receptor activity [GO:0010469]; signal transduction [GO:0007165]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; termination of signal transduction [GO:0023021],NA,NA,NA
CHOYP_LOC100370588.15.19.m.60881,0.0118970602948526,-0.0149440076161285,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370600.1.1.m.29572,-0.0300309073904053,0.0282460731847365,No,NA,NA,Q5ZID0,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],NA,NA,NA
CHOYP_LOC100370603.1.1.m.51092,0.0245715357512704,0.006812511716843,No,NA,NA,P40237,NA,NA,NA,integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_LOC100370625.2.3.m.26929,-0.00238927820980417,-0.00301622824254999,No,NA,NA,Q7Z2W4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of RIG-I signaling pathway [GO:1900246]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100370637.1.2.m.12891,-0.00127834493540489,-0.000955085014889452,No,NA,NA,Q4R5S7,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; pi-body [GO:0071546]; piP-body [GO:0071547]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; helicase activity [GO:0004386]; nucleic acid binding [GO:0003676]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; multicellular organism development [GO:0007275]; negative regulation of transposition [GO:0010529]; piRNA biosynthetic process [GO:1990511]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100370662.1.3.m.5814,-0.00187168306928582,0.018484092435116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370665.1.1.m.29815,0.000657568711190195,-0.00162641949557021,No,NA,NA,F6P3G4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; lid subcomplex [GO:0008541]; structural molecule activity [GO:0005198]; proteasome assembly [GO:0043248]; stem cell differentiation [GO:0048863]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100370672.1.1.m.54509,-0.00284243205372183,-0.00650843871128523,No,NA,NA,Q505F5,NA,NA,NA,phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100370673.1.1.m.13161,-0.00899685234268123,-0.00661922883494583,No,NA,NA,Q9WV04,NA,NA,NA,cytosol [GO:0005829]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; podosome [GO:0002102]; vesicle [GO:0031982]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; protein dimerization activity [GO:0046983]; extracellular matrix disassembly [GO:0022617]; microtubule-based movement [GO:0007018]; organelle disassembly [GO:1903008]; regulation of podosome assembly [GO:0071801],NA,NA,NA
CHOYP_LOC100370684.1.2.m.61027,-0.00306245995777659,0.0041575244619379,No,NA,NA,Q6DCG4,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; ammonium transmembrane transporter activity [GO:0008519],NA,NA,NA
CHOYP_LOC100370705.1.2.m.30943,0.0100033099133774,-0.00615411672857619,No,NA,NA,O15018,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370705.2.2.m.55449,-0.00337268000880604,0.000966507261701968,No,NA,NA,O15018,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; nucleus [GO:0005634]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100370716.1.1.m.35654,-0.00181456435793639,0.0148964929741024,No,NA,NA,Q9H0E3,NA,NA,NA,nuclear speck [GO:0016607]; Sin3-type complex [GO:0070822]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100370747.1.1.m.28315,0.000653167170888825,-0.000177523781485882,No,NA,NA,P19623,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100370750.2.2.m.52391,-0.00690473967242008,0.000986605037668193,No,NA,NA,Q9MBF8,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100370790.1.1.m.9845,0.00226439884792089,-0.000840927140385814,No,NA,NA,Q9Z336,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasmic dynein complex [GO:0005868]; cytoplasmic microtubule [GO:0005881]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; lamellipodium [GO:0030027]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; secretory vesicle [GO:0099503]; spindle [GO:0005819]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; protein C-terminus binding [GO:0008022]; axon development [GO:0061564]; cell division [GO:0051301]; dendrite development [GO:0016358]; establishment of mitotic spindle orientation [GO:0000132]; intracellular protein transport [GO:0006886]; intracellular transport of viral protein in host cell [GO:0019060]; negative regulation of cell death [GO:0060548]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of neurogenesis [GO:0050768]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Rac protein signal transduction [GO:0035022]; regulation of cytoskeleton organization [GO:0051493]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100370821.2.2.m.45409,-0.0026079621019186,0.00255089704374203,No,NA,NA,A5D6U8,NA,NA,NA,extracellular region [GO:0005576]; acid phosphatase activity [GO:0003993]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370838.1.1.m.18679,-0.0160957975951741,0.00321454757662185,No,NA,NA,Q8N9H8,NA,NA,NA,3'-5' exonuclease activity [GO:0008408]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100370844.1.2.m.30341,-0.00707302513214068,-0.00450125573443616,No,NA,NA,A6NI56,NA,NA,NA,early endosome [GO:0005769],NA,NA,NA
CHOYP_LOC100370879.1.1.m.53699,0.00060881200165722,0.0163268117167943,No,NA,NA,P49754,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein self-association [GO:0043621]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; Golgi vesicle transport [GO:0048193]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; regulated exocytosis [GO:0045055]; regulation of SNARE complex assembly [GO:0035542]; vacuole fusion; non-autophagic [GO:0042144],NA,NA,NA
CHOYP_LOC100370896.4.4.m.56380,-0.00143658905931821,-0.0041829299806979,No,NA,NA,Q54QQ1,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein serine/threonine kinase activity [GO:0004674]; Ras GTPase binding [GO:0017016]; actin filament organization [GO:0007015]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-substrate adhesion [GO:0031589]; cellular response to nutrient [GO:0031670]; chemotaxis [GO:0006935]; mitotic cytokinesis [GO:0000281]; phagocytosis [GO:0006909]; positive regulation of gene expression [GO:0010628]; positive regulation of STAT cascade [GO:1904894]; protein phosphorylation [GO:0006468]; regulation of filopodium assembly [GO:0051489]; regulation of sorocarp development [GO:0031156]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100370897.5.5.m.39218,0.0046690887279508,-0.00537505153453519,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370900.1.1.m.20012,-0.0089889199376262,0.00298300026463842,No,NA,NA,Q5W041,NA,NA,NA,extracellular exosome [GO:0070062],NA,NA,NA
CHOYP_LOC100370907.1.3.m.3187,0.000608958069396764,0.00948148202789296,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100370907.3.3.m.36832,-0.01003630374328,-0.00638707892775568,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100370909.1.1.m.30849,-0.00441745806561428,0.00635352390482506,No,NA,NA,Q9JID1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell aging [GO:0007569]; cellular response to lipopolysaccharide [GO:0071222]; epithelial to mesenchymal transition involved in cardiac fibroblast development [GO:0060940]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of myofibroblast differentiation [GO:1904761]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular smooth muscle cell differentiation [GO:1905064]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of inflammatory response [GO:0050729]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of protein metabolic process [GO:0051246],NA,NA,NA
CHOYP_LOC100370910.1.1.m.13897,0.0144057836164698,-0.0149649967680423,No,NA,NA,Q5R7X9,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; 3'-5' exonuclease activity [GO:0008408]; exodeoxyribonuclease III activity [GO:0008853]; cellular response to ionizing radiation [GO:0071479]; DNA damage checkpoint [GO:0000077]; DNA repair [GO:0006281]; meiotic recombination checkpoint [GO:0051598],NA,NA,NA
CHOYP_LOC100370913.1.1.m.19909,0.000691650790755647,-0.00232481778807224,No,NA,NA,O15084,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; nucleoplasm [GO:0005654]; COPII vesicle coating [GO:0048208],NA,NA,NA
CHOYP_LOC100370941.1.1.m.59883,-0.00398200002238812,-0.00767336573873464,No,NA,NA,Q6ZNA5,NA,NA,NA,integral component of membrane [GO:0016021]; ferric-chelate reductase activity [GO:0000293]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100370957.1.1.m.22435,-0.00616687098540593,0.0076613831920972,No,NA,NA,Q8N0Z6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signal transduction by p53 class mediator [GO:1901796],NA,NA,NA
CHOYP_LOC100370976.1.2.m.17764,-0.00622842530951487,-0.0170473317770306,No,NA,NA,Q6IQY5,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; cilium assembly [GO:0060271]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100370989.2.2.m.37995,-0.00124126335539838,0.00886351071703897,No,NA,NA,P62489,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; translation initiation factor binding [GO:0031369]; apoptotic process [GO:0006915]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of translational initiation [GO:0045948]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100371005.1.2.m.2526,0.00425687965637768,0.00373281204153129,No,NA,NA,P14618,NA,NA,NA,cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; pyruvate kinase complex [GO:1902912]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; potassium ion binding [GO:0030955]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; thyroid hormone binding [GO:0070324]; animal organ regeneration [GO:0031100]; canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; liver development [GO:0001889]; neutrophil degranulation [GO:0043312]; positive regulation of sprouting angiogenesis [GO:1903672]; programmed cell death [GO:0012501]; protein homotetramerization [GO:0051289]; response to gravity [GO:0009629]; response to hypoxia [GO:0001666]; response to muscle inactivity [GO:0014870]; response to nutrient [GO:0007584]; skeletal muscle tissue regeneration [GO:0043403],NA,NA,NA
CHOYP_LOC100371022.1.1.m.51315,0.000402928228065911,-0.00816431380638521,No,NA,NA,Q8K2K6,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; acrosome assembly [GO:0001675]; intermediate filament organization [GO:0045109]; multicellular organism development [GO:0007275]; spermatid nucleus differentiation [GO:0007289],NA,NA,NA
CHOYP_LOC100371039.1.1.m.18908,-0.0110515519327371,0.0100333130816562,No,NA,NA,Q64261,NA,NA,NA,centrosome [GO:0005813]; cyclin D2-CDK6 complex [GO:0097132]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726]; ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; kinase activity [GO:0016301]; cell cycle [GO:0007049]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; gliogenesis [GO:0042063]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; hemopoiesis [GO:0030097]; negative regulation of cell cycle [GO:0045786]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of erythrocyte differentiation [GO:0045646]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100371043.3.5.m.24649,0.00346936982132996,-0.000937522817896747,No,NA,NA,Q92113,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371058.3.3.m.36497,-0.0253270816309361,0.00829129504276675,No,NA,NA,Q58DA1,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; microtubule binding [GO:0008017]; cell migration [GO:0016477]; cilium-dependent cell motility [GO:0060285]; negative regulation of microtubule depolymerization [GO:0007026],NA,NA,NA
CHOYP_LOC100371059.1.1.m.25395,-0.0308448737275258,0.0210473130615761,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371074.1.1.m.36435,-0.0268537546666261,0.0170793592941626,No,NA,NA,Q5R573,NA,NA,NA,GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC100371085.1.1.m.44789,0.000193437874893112,0.00294177446324503,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100371099.1.1.m.20282,-0.0138410721766823,0.0165489388184993,No,NA,NA,Q5M7F8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371127.1.1.m.23427,-0.0020541756679633,0.0027887011443165,No,NA,NA,Q96S38,NA,NA,NA,early endosome [GO:0005769]; membrane [GO:0016020]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein serine/threonine kinase activity [GO:0004674]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100371143.1.1.m.27046,0,0,No,NA,NA,Q66IC8,NA,NA,NA,cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100371148.1.1.m.47147,-0.0216927271450755,0.0143584431854779,No,NA,NA,Q8TDX7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein phosphorylation [GO:0006468]; regulation of mitotic cell cycle [GO:0007346]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC100371168.1.1.m.54022,-0.0275590261632638,0.0306895525014267,No,NA,NA,H3BNL1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371176.1.1.m.33995,-0.00399825702149824,0.00619671790693661,No,NA,NA,Q58CP0,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100371209.1.1.m.49090,-0.0100422659721843,-0.000179779671897268,No,NA,NA,A5PLI4,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100371218.2.3.m.38221,0.0021671326039553,0.01970062545838,No,NA,NA,Q8TEW0,NA,NA,NA,adherens junction [GO:0005912]; apical junction complex [GO:0043296]; apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; internode region of axon [GO:0033269]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein phosphatase binding [GO:0019903]; asymmetric cell division [GO:0008356]; axonogenesis [GO:0007409]; bicellular tight junction assembly [GO:0070830]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; establishment of cell polarity [GO:0030010]; establishment of centrosome localization [GO:0051660]; establishment of epithelial cell polarity [GO:0090162]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule cytoskeleton organization [GO:0000226]; myelination in peripheral nervous system [GO:0022011]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; positive regulation of myelination [GO:0031643]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein localization [GO:0008104]; protein targeting to membrane [GO:0006612]; protein-containing complex assembly [GO:0065003]; regulation of cellular localization [GO:0060341]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100371228.1.4.m.6670,0.00332928010125928,-0.000899666574289748,No,NA,NA,P14381,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371232.1.1.m.25817,-0.00117049676218635,-6.92962673864944e-05,No,NA,NA,Q6P8E9,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; RNA binding [GO:0003723]; U4atac snRNA binding [GO:0030622]; maturation of LSU-rRNA [GO:0000470]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371236.1.1.m.62865,0.000891913656819762,0.00103912131229909,No,NA,NA,P35623,NA,NA,NA,cytosol [GO:0005829]; glycine hydroxymethyltransferase activity [GO:0004372]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine metabolic process [GO:0006563]; protein homotetramerization [GO:0051289]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_LOC100371248.1.2.m.10238,0.0161303395367132,-0.000571539327606979,No,NA,NA,Q5RF32,NA,NA,NA,cytoplasm [GO:0005737]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; zinc ion binding [GO:0008270]; methionine biosynthetic process [GO:0009086],NA,NA,NA
CHOYP_LOC100371248.2.2.m.48460,0.00390156746935134,0.00101775204040925,No,NA,NA,Q9H2M3,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; betaine-homocysteine S-methyltransferase activity [GO:0047150]; S-methylmethionine-homocysteine S-methyltransferase activity [GO:0061627]; zinc ion binding [GO:0008270]; L-methionine salvage [GO:0071267]; S-adenosylmethionine metabolic process [GO:0046500]; S-methylmethionine metabolic process [GO:0033477]; sulfur amino acid metabolic process [GO:0000096],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63117,0.00352434417030252,-0.00070158426463261,No,NA,NA,Q8XBI9,NA,NA,NA,cytoplasm [GO:0005737]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601],NA,NA,NA
CHOYP_LOC100371249.1.1.m.63118,0.00447920315788876,0.00528982369979788,No,NA,NA,Q7JQD3,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100371254.1.1.m.1838,-0.00115254318061959,0.000397099210698992,No,NA,NA,Q6PAM1,NA,NA,NA,cytoplasm [GO:0005737]; syntaxin binding [GO:0019905]; B cell activation [GO:0042113]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100371275.1.1.m.46896,0.0021454906388185,0.00492030097004463,No,NA,NA,Q93034,NA,NA,NA,Cul5-RING ubiquitin ligase complex [GO:0031466]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; calcium channel activity [GO:0005262]; signaling receptor activity [GO:0038023]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle arrest [GO:0007050]; cell proliferation [GO:0008283]; ERBB2 signaling pathway [GO:0038128]; G1/S transition of mitotic cell cycle [GO:0000082]; intrinsic apoptotic signaling pathway [GO:0097193]; negative regulation of cell proliferation [GO:0008285]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371304.1.1.m.47915,-0.00958143433051551,0.00523955870729103,No,NA,NA,Q8TBZ9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371319.1.1.m.10776,0.000216488455564283,0.00480182741402719,No,NA,NA,Q23445,NA,NA,NA,COPII vesicle coat [GO:0030127]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; embryo development ending in birth or egg hatching [GO:0009792]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; membrane organization [GO:0061024]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; regulation of COPII vesicle coating [GO:0003400]; vesicle organization [GO:0016050],NA,NA,NA
CHOYP_LOC100371319.1.1.m.10777,0.000762792174522167,0.000522566574683034,No,NA,NA,Q9CQV5,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100371332.1.6.m.7760,-0.0148352763610425,-4.84934969976505e-05,No,NA,NA,Q28864,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; blood coagulation [GO:0007596],NA,NA,NA
CHOYP_LOC100371339.1.1.m.4513,-0.0326952662804919,0.00184073804463391,No,NA,NA,P51910,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; cholesterol binding [GO:0015485]; aging [GO:0007568]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to drug [GO:0042493]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_LOC100371354.1.1.m.47130,0.000540724185215795,-0.0137964827933982,No,NA,NA,Q92576,NA,NA,NA,metal ion binding [GO:0046872]; multicellular organism development [GO:0007275]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100371361.1.1.m.9282,0.00345107256169513,0.00902725162060167,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371374.1.1.m.46502,-0.00722434801281832,-0.00459755724216111,No,NA,NA,B0SJT4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_LOC100371390.1.1.m.8047,0.0015471171706541,-0.00180865012301967,No,NA,NA,Q99700,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; trans-Golgi network [GO:0005802]; epidermal growth factor receptor binding [GO:0005154]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cytoplasmic mRNA processing body assembly [GO:0033962]; negative regulation of receptor internalization [GO:0002091]; regulation of cytoplasmic mRNA processing body assembly [GO:0010603]; regulation of translation [GO:0006417]; RNA metabolic process [GO:0016070]; RNA transport [GO:0050658]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_LOC100371429.1.1.m.13499,0.00129399788796494,0.00152817821696475,No,NA,NA,P09849,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100371430.1.1.m.61181,-0.0142175063240141,-0.0279856631755023,No,NA,NA,Q01460,NA,NA,NA,lysosome [GO:0005764]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; chitin catabolic process [GO:0006032]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_LOC100371435.1.1.m.6503,0,0,No,NA,NA,E5RJM6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371443.1.1.m.15017,-0.00830732945458074,-0.0103229551701907,No,NA,NA,Q66I67,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; Golgi apparatus [GO:0005794]; intraciliary transport particle B [GO:0030992]; cell differentiation [GO:0030154]; centrosome localization [GO:0051642]; intraciliary transport [GO:0042073]; protein localization to cilium [GO:0061512]; regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000583]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371457.1.1.m.12814,-0.00343309264298918,0.000954731618100686,No,NA,NA,O75832,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_LOC100371468.2.2.m.53875,0.000172051024897179,0.00180515169307897,No,NA,NA,Q15058,NA,NA,NA,cytosol [GO:0005829]; Flemming body [GO:0090543]; kinesin complex [GO:0005871]; membrane [GO:0016020]; microtubule [GO:0005874]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle midzone [GO:0051233]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; tubulin binding [GO:0015631]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebellar granular layer structural organization [GO:0021685]; cerebellar Purkinje cell layer structural organization [GO:0021693]; cerebral cortex development [GO:0021987]; establishment of protein localization [GO:0045184]; hippocampus development [GO:0021766]; microtubule-based movement [GO:0007018]; mitotic metaphase plate congression [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of integrin activation [GO:0033624]; negative regulation of neuron apoptotic process [GO:0043524]; olfactory bulb development [GO:0021772]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytokinesis [GO:0032467]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of cell maturation [GO:1903429]; regulation of cell migration [GO:0030334]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of myelination [GO:0031641]; regulation of neuron apoptotic process [GO:0043523]; regulation of Rap protein signal transduction [GO:0032487]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371500.1.7.m.4423,-0.000250145620367093,-0.00414045560521682,No,NA,NA,Q8R151,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100371503.1.1.m.62767,0.00682100231947391,-0.0123834110570136,No,NA,NA,Q91W67,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371557.1.1.m.57537,0.00153415343302722,-0.000403299108397894,No,NA,NA,Q9VXK6,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; translation initiation factor activity [GO:0003743]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100371571.1.1.m.2417,-4.99432606694681e-05,0.00350608999901204,No,NA,NA,Q3TLD5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; phosphatase inhibitor activity [GO:0019212]; phosphoprotein binding [GO:0051219]; protein phosphatase inhibitor activity [GO:0004864]; RNA polymerase II complex binding [GO:0000993]; transcription corepressor activity [GO:0003714]; cellular response to growth factor stimulus [GO:0071363]; cellular response to steroid hormone stimulus [GO:0071383]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cell growth [GO:0001558]; regulation of transcription by RNA polymerase II [GO:0006357]; response to virus [GO:0009615],NA,NA,NA
CHOYP_LOC100371575.1.1.m.10551,-0.0234430555876154,0.0241400623270127,No,NA,NA,P43307,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cotranslational protein targeting to membrane [GO:0006613]; IRE1-mediated unfolded protein response [GO:0036498]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_LOC100371590.1.1.m.64405,-0.0230963886451888,0.0232181257731693,No,NA,NA,Q2YDN4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100371597.1.1.m.3330,0.000899540942901681,0.00978177907700395,No,NA,NA,A7RX26,NA,NA,NA,cytoplasm [GO:0005737]; imidazolonepropionase activity [GO:0050480]; metal ion binding [GO:0046872]; histidine catabolic process to glutamate and formamide [GO:0019556]; histidine catabolic process to glutamate and formate [GO:0019557],NA,NA,NA
CHOYP_LOC100371628.1.1.m.35401,-0.0322901603652362,0.0196561355341067,No,NA,NA,Q9CPW7,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100371637.1.1.m.7833,-0.0013188324765894,-0.000956227326507406,No,NA,NA,Q9D024,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; rough endoplasmic reticulum [GO:0005791]; calcium ion binding [GO:0005509]; calcium ion homeostasis [GO:0055074]; endoplasmic reticulum organization [GO:0007029]; ER overload response [GO:0006983]; post-embryonic development [GO:0009791]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100371650.1.1.m.4398,0.00835811857568471,0.00106432927062697,No,NA,NA,Q6IQ20,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane-bounded organelle [GO:0043227]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; photoreceptor outer segment membrane [GO:0042622]; identical protein binding [GO:0042802]; N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity [GO:0102200]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; zinc ion binding [GO:0008270]; aging [GO:0007568]; host-mediated regulation of intestinal microbiota composition [GO:0048874]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; negative regulation of eating behavior [GO:1903999]; phospholipid catabolic process [GO:0009395]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of inflammatory response [GO:0050729]; response to isolation stress [GO:0035900]; retinoid metabolic process [GO:0001523]; temperature homeostasis [GO:0001659],NA,NA,NA
CHOYP_LOC100371654.1.1.m.14188,-0.0119060415936475,-0.00757697548030931,No,NA,NA,Q9R0M5,NA,NA,NA,ATP binding [GO:0005524]; kinase activity [GO:0016301]; thiamine binding [GO:0030975]; thiamine diphosphokinase activity [GO:0004788]; thiamine diphosphate biosynthetic process [GO:0009229]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100371677.1.1.m.122,0.0016276049943724,-0.00192537196393551,No,NA,NA,O46037,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytoplasmic side of apical plasma membrane [GO:0098592]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_LOC100371695.1.1.m.10063,0.000294409859115794,0.000580614712819349,No,NA,NA,Q9SF85,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; plasmodesma [GO:0009506]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; response to cadmium ion [GO:0046686]; response to trehalose-6-phosphate [GO:0080094]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100371721.1.1.m.23143,-0.00638244740133556,-0.0164030534658879,No,NA,NA,Q16629,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100371750.2.2.m.64949,-0.000641248653553852,0.00510209625839788,No,NA,NA,P07942,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-10 complex [GO:0043259]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; perinuclear region of cytoplasm [GO:0048471]; extracellular matrix structural constituent [GO:0005201]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cellular protein metabolic process [GO:0044267]; endodermal cell differentiation [GO:0035987]; extracellular matrix organization [GO:0030198]; neuron projection development [GO:0031175]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; post-translational protein modification [GO:0043687]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100371756.1.1.m.24048,-0.0205525958792199,0.00171814006307205,No,NA,NA,Q26626,NA,NA,NA,kinesin II complex [GO:0016939]; kinesin binding [GO:0019894]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100371761.1.1.m.57462,0.0114847993716123,-0.0228620988065963,No,NA,NA,Q6P2W7,NA,NA,NA,late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; Ragulator complex [GO:0071986]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; cholesterol homeostasis [GO:0042632]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558]; regulation of cholesterol efflux [GO:0010874]; regulation of cholesterol esterification [GO:0010872]; regulation of cholesterol import [GO:0060620]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100371830.5.6.m.55811,-0.00281862804946602,0.00382650393028067,No,NA,NA,O73853,NA,NA,NA,membrane [GO:0016020]; 17-alpha-hydroxyprogesterone aldolase activity [GO:0047442]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100371831.1.1.m.11775,-0.00026911811678009,-0.0144863772772421,No,NA,NA,O88327,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100371845.3.3.m.62472,-0.00418417128850504,-0.000824902770394885,No,NA,NA,P57103,NA,NA,NA,cell junction [GO:0030054]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; intrinsic component of plasma membrane [GO:0031226]; microtubule [GO:0005874]; mitochondrial outer membrane [GO:0005741]; neuromuscular junction [GO:0031594]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; calcium:sodium antiporter activity [GO:0005432]; calmodulin binding [GO:0005516]; ion antiporter activity involved in regulation of postsynaptic membrane potential [GO:0099580]; metal ion binding [GO:0046872]; calcium ion export across plasma membrane [GO:1990034]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; cell communication [GO:0007154]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to hypoxia [GO:0071456]; hematopoietic progenitor cell differentiation [GO:0002244]; ion transport [GO:0006811]; learning [GO:0007612]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; myelination [GO:0042552]; oligodendrocyte differentiation [GO:0048709]; regulation of cardiac conduction [GO:1903779]; regulation of skeletal muscle contraction [GO:0014819]; sodium ion transmembrane transport [GO:0035725]; telencephalon development [GO:0021537],NA,NA,NA
CHOYP_LOC100371875.1.1.m.29467,-0.00198062486639186,0.00135548417894624,No,NA,NA,P85971,NA,NA,NA,cytoplasm [GO:0005737]; 6-phosphogluconolactonase activity [GO:0017057]; monosaccharide binding [GO:0048029]; carbohydrate metabolic process [GO:0005975]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_LOC100371881.1.2.m.3634,0.0167609948339117,0.0160389194314328,No,NA,NA,E9PVX6,NA,NA,NA,chromosome; centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; cell proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088],NA,NA,NA
CHOYP_LOC100371885.1.1.m.9427,0.000973721522066268,0.000286516716340858,No,NA,NA,O61492,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; flotillin complex [GO:0016600]; plasma membrane [GO:0005886]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; melanotic encapsulation of foreign target [GO:0035011]; positive regulation of Wnt protein secretion [GO:0061357]; positive regulation of Wnt signaling pathway by establishment of Wnt protein localization to extracellular region [GO:0035593],NA,NA,NA
CHOYP_LOC100371909.1.1.m.30745,-0.00697191803486573,0.00147408051719517,No,NA,NA,Q9D180,NA,NA,NA,cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC100371965.3.4.m.28742,-0.01117962811822,-0.002076434393417,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100371977.1.1.m.21628,-0.00184263920800212,0.00898267108771317,No,NA,NA,Q5U312,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100371983.1.3.m.2863,0.0013074154964804,-0.00321260498327769,No,NA,NA,P9WK87,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371983.2.3.m.48879,0.0252806704088369,0.012118089559637,No,NA,NA,P9WK87,NA,NA,NA,methyl indole-3-acetate esterase activity [GO:0080030]; short-chain carboxylesterase activity [GO:0034338]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_LOC100371994.1.1.m.50098,0.00155772435398667,0.0112020615649195,No,NA,NA,Q29RI9,NA,NA,NA,methionine adenosyltransferase complex [GO:0048269]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_LOC100372012.1.1.m.36569,-0.00313167351003686,-0.00333361411473923,No,NA,NA,O14513,NA,NA,NA,microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019],NA,NA,NA
CHOYP_LOC100372020.1.1.m.59998,0.00332193952475085,0.00392312512022898,No,NA,NA,Q8BVV7,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle pole [GO:0000922],NA,NA,NA
CHOYP_LOC100372028.1.1.m.22341,-0.000176717169220192,-0.0113151713169493,No,NA,NA,Q62717,NA,NA,NA,cell junction [GO:0030054]; dense core granule [GO:0031045]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; glutamatergic synapse [GO:0098978]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; dense core granule exocytosis [GO:1990504]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulated exocytosis [GO:0045055]; synaptic vesicle exocytosis [GO:0016079],NA,NA,NA
CHOYP_LOC100372071.1.1.m.14107,0.0163616959188163,-0.0297043743225396,No,NA,NA,O14662,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; Golgi ribbon formation [GO:0090161]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372110.1.1.m.11437,-0.00518828060710032,-0.0279406091233496,No,NA,NA,O00400,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; acetyl-CoA transmembrane transporter activity [GO:0008521]; solute:proton symporter activity [GO:0015295]; BMP signaling pathway [GO:0030509]; SMAD protein signal transduction [GO:0060395]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100372131.1.2.m.36461,0.00132799459478397,-0.000365906303844789,No,NA,NA,Q14117,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; amino acid binding [GO:0016597]; dihydropyrimidinase activity [GO:0004157]; phosphoprotein binding [GO:0051219]; thymine binding [GO:0002059]; uracil binding [GO:0002058]; zinc ion binding [GO:0008270]; beta-alanine metabolic process [GO:0019482]; protein homotetramerization [GO:0051289]; pyrimidine nucleobase catabolic process [GO:0006208]; pyrimidine nucleoside catabolic process [GO:0046135]; thymine catabolic process [GO:0006210]; uracil catabolic process [GO:0006212],NA,NA,NA
CHOYP_LOC100372150.1.1.m.7059,0.00120647237979723,-0.000300977037661931,No,NA,NA,P28289,NA,NA,NA,actin filament [GO:0005884]; cortical cytoskeleton [GO:0030863]; cytosol [GO:0005829]; membrane [GO:0016020]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; tropomyosin binding [GO:0005523]; adult locomotory behavior [GO:0008344]; lens fiber cell development [GO:0070307]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; myofibril assembly [GO:0030239]; pointed-end actin filament capping [GO:0051694],NA,NA,NA
CHOYP_LOC100372183.1.1.m.31741,0.00113518518436637,-0.0114735604799579,No,NA,NA,Q6ZSB9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator binding [GO:0001223]; transcription factor binding [GO:0008134]; cell cycle arrest [GO:0007050]; negative regulation of cell proliferation [GO:0008285]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100372197.3.3.m.56377,0.00391028579467604,-0.00817530943213108,No,NA,NA,O35161,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; protein dimerization activity [GO:0046983]; transmembrane signaling receptor activity [GO:0004888]; anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell-cell signaling [GO:0007267]; central nervous system development [GO:0007417]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; G protein-coupled receptor signaling pathway [GO:0007186]; gastrulation with mouth forming second [GO:0001702]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; neural tube closure [GO:0001843]; neuron migration [GO:0001764]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of neurotransmitter secretion [GO:0046928]; Rho protein signal transduction [GO:0007266]; signal transduction [GO:0007165]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372208.1.1.m.18397,0.0084910591676394,-0.00590238548204649,No,NA,NA,Q9N5Y2,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; oxidoreductase activity [GO:0016491]; very-long-chain enoyl-CoA reductase activity [GO:0102758]; very long-chain fatty acid biosynthetic process [GO:0042761],NA,NA,NA
CHOYP_LOC100372219.1.1.m.11590,-0.018137060301068,0.00460823704252793,No,NA,NA,Q92125,NA,NA,NA,calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544],NA,NA,NA
CHOYP_LOC100372221.2.2.m.48004,0.00747999874721006,-0.0064168506352858,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100372236.1.4.m.16991,-0.00302455439323239,0.00410606474850201,No,NA,NA,Q6ITT3,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-1;3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity [GO:0008454]; metal ion binding [GO:0046872]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100372239.1.1.m.50390,-0.0104405139016703,-0.00826224883601359,No,NA,NA,Q0VFZ6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372241.1.1.m.9935,-0.00144424626116933,-0.00222761448902094,No,NA,NA,Q9Z265,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell division [GO:0051301]; cellular protein catabolic process [GO:0044257]; cellular response to bisphenol A [GO:1903926]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to gamma radiation [GO:0071480]; DNA damage checkpoint [GO:0000077]; DNA damage induced protein phosphorylation [GO:0006975]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mitotic DNA damage checkpoint [GO:0044773]; mitotic spindle assembly [GO:0090307]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of DNA damage checkpoint [GO:2000002]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of anoikis [GO:2000210]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of protein catabolic process [GO:0042176]; regulation of transcription; DNA-templated [GO:0006355]; replicative cell aging [GO:0001302]; response to gamma radiation [GO:0010332]; response to glycoside [GO:1903416]; signal transduction in response to DNA damage [GO:0042770]; signal transduction involved in intra-S DNA damage checkpoint [GO:0072428],NA,NA,NA
CHOYP_LOC100372245.1.1.m.60270,-0.00548843907740095,-0.00981013761676792,No,NA,NA,Q9NUJ3,NA,NA,NA,microtubule [GO:0005874],NA,NA,NA
CHOYP_LOC100372287.1.1.m.10381,-0.0184887920828802,0.0199477154001995,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372290.2.2.m.40459,0.0156883556880203,-0.00163764364001483,No,NA,NA,Q5E960,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; zinc ion transmembrane transporter activity [GO:0005385]; cell morphogenesis [GO:0000902]; embryonic cranial skeleton morphogenesis [GO:0048701]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; T cell homeostasis [GO:0043029]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100372298.1.1.m.19547,0.00412380475276905,0.00196541642388171,No,NA,NA,Q8VDC1,NA,NA,NA,autophagosome [GO:0005776]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; plus-end-directed vesicle transport along microtubule [GO:0072383]; positive regulation of autophagosome maturation [GO:1901098],NA,NA,NA
CHOYP_LOC100372311.1.1.m.6654,0.00400126075833336,0.00472538602122246,No,NA,NA,Q6ZUK4,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100372339.1.2.m.5168,0.00105849262962095,-0.00162510802962049,No,NA,NA,Q5ZMH1,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_LOC100372340.1.3.m.9116,-0.000778524132207216,-0.000345404993598495,No,NA,NA,Q921X9,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372340.3.3.m.59986,0.0176998586540212,0.00285206528656024,No,NA,NA,Q921X9,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC100372341.1.1.m.46956,-0.00258858829503659,0.00188158478833575,No,NA,NA,Q0V9R3,NA,NA,NA,cytoplasm [GO:0005737]; exosome (RNase complex) [GO:0000178]; P-body [GO:0000932]; 3'-5'-exoribonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell cycle [GO:0007049]; cell division [GO:0051301]; miRNA catabolic process [GO:0010587]; nuclear-transcribed mRNA catabolic process; exonucleolytic [GO:0000291]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_LOC100372342.1.1.m.63404,-0.00131469723566771,0.00371353765058548,No,NA,NA,P40423,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicomedial cortex [GO:0106037]; cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germline ring canal inner rim [GO:0035183]; midbody [GO:0030496]; myosin II complex [GO:0016460]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233]; calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048]; apical constriction involved in gastrulation [GO:0003384]; border follicle cell migration [GO:0007298]; cell elongation involved in imaginal disc-derived wing morphogenesis [GO:0090254]; compartment boundary maintenance [GO:0060289]; cytoskeleton-dependent cytoplasmic transport; nurse cell to oocyte [GO:0019749]; establishment of planar polarity [GO:0001736]; formation of a compartment boundary [GO:0060288]; imaginal disc-derived wing hair organization [GO:0035317]; mitotic cytokinesis [GO:0000281]; myosin II filament assembly [GO:0031036]; nuclear axial expansion [GO:0035191]; ovarian follicle cell development [GO:0030707]; ovarian nurse cell to oocyte transport [GO:0007300]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of tube length; open tracheal system [GO:0035159]; spiracle morphogenesis; open tracheal system [GO:0035277]; tube formation [GO:0035148]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100372388.1.1.m.26623,-0.00493275773252309,0.000640501372654103,No,NA,NA,Q3UVV9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.4.8.m.31087,-0.00898723481403693,-0.00571945405079658,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372392.6.8.m.56267,-0.0119589525658487,0.016928814272054,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372393.1.1.m.12043,0.000964484001528143,-0.00484199508259663,No,NA,NA,P49116,NA,NA,NA,nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; signaling receptor activity [GO:0038023]; steroid hormone receptor activity [GO:0003707]; transcription coactivator activity [GO:0003713]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; spermatogenesis [GO:0007283]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100372454.1.1.m.56045,0.015856451961077,0.0089949176954916,No,NA,NA,Q7ZYC4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; decanoate-CoA ligase activity [GO:0102391]; long-chain fatty acid-CoA ligase activity [GO:0004467],NA,NA,NA
CHOYP_LOC100372467.1.1.m.42336,-0.00078898066590983,-0.00153603306599212,No,NA,NA,Q8WXA3,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; SH3 domain binding [GO:0017124]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC100372473.1.5.m.7845,-0.00467214898435008,-0.0234248860062277,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372473.2.5.m.35440,-0.0045040089779533,0.0313198511393362,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372473.4.5.m.48798,0,0,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21010,-0.00638322326861606,0.0181620207110441,No,NA,NA,P23727,NA,NA,NA,cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex; class IA [GO:0005943]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transcription factor binding [GO:0008134]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; cellular glucose homeostasis [GO:0001678]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of glucose import [GO:0046326]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551]; regulation of stress fiber assembly [GO:0051492]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC100372481.1.1.m.21011,0.0153192667935871,-0.0121405291186738,No,NA,NA,Q5RC32,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_LOC100372482.1.1.m.61581,0.00270247957383016,-0.00504394895033811,No,NA,NA,Q63HQ0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; transport vesicle [GO:0030133]; AP-1 adaptor complex binding [GO:0035650]; kinesin binding [GO:0019894]; cellular protein localization [GO:0034613]; negative regulation of cell motility [GO:2000146]; negative regulation of receptor recycling [GO:0001920]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; protein transport [GO:0015031]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; vesicle targeting; trans-Golgi to endosome [GO:0048203],NA,NA,NA
CHOYP_LOC100372487.1.1.m.39712,0.00240978919273034,-0.00546173142727592,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10260,-0.0058376487737548,0.00657197348844449,No,NA,NA,Q5FWT1,NA,NA,NA,tRNA-splicing ligase complex [GO:0072669]; protein methyltransferase activity [GO:0008276]; lysosome localization [GO:0032418]; positive regulation of cell proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of ruffle assembly [GO:1900029]; protein methylation [GO:0006479],NA,NA,NA
CHOYP_LOC100372505.1.2.m.10261,-0.0026024976569731,0.0051114812133312,No,NA,NA,Q5RE15,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome regulatory particle [GO:0005838]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100372560.1.1.m.25500,0.0142494279988711,-0.017611307957414,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_LOC100372582.1.2.m.8558,-0.000565657552029323,0.000422658779640265,No,NA,NA,Q6IQ97,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100372601.1.1.m.13567,0.00267743264151389,0.00735679305751815,No,NA,NA,D2H8V8,NA,NA,NA,centrosome [GO:0005813]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; 5'-3' exonuclease activity [GO:0008409]; DNA repair [GO:0006281]; mitotic cell cycle checkpoint [GO:0007093]; protection from non-homologous end joining at telomere [GO:0031848]; telomere maintenance [GO:0000723]; telomeric 3' overhang formation [GO:0031860]; telomeric loop formation [GO:0031627],NA,NA,NA
CHOYP_LOC100372616.2.3.m.5692,0.00913223542796614,-0.0118360096787325,No,NA,NA,Q16820,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372626.1.2.m.8346,0.00808104428799331,-0.00222923105757463,No,NA,NA,Q5T9S5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372693.1.1.m.16279,0.000160575815156921,0.00110088271746128,No,NA,NA,P13804,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539],NA,NA,NA
CHOYP_LOC100372698.1.1.m.18674,-0.00250800662600673,0.00340481150515862,No,NA,NA,Q8BTK5,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_LOC100372703.1.1.m.29633,-0.01107362365073,-0.00170802595560979,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372716.5.10.m.31370,0.00437036032477405,-0.00126874296031134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372803.1.2.m.18615,-0.0281551234591858,0.00819286724566898,No,NA,NA,Q5RDU7,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100372845.1.3.m.7734,-0.00995375025754859,-0.00946727636250918,No,NA,NA,Q497Q6,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100372867.1.1.m.18083,-0.00494962569533834,0.0105146508720484,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100372879.1.3.m.18886,0.0156031750458262,0.0105915390979041,No,NA,NA,P18142,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100372881.1.1.m.4636,-0.0050325521584788,0.00544874641101792,No,NA,NA,Q29RK9,NA,NA,NA,metal ion binding [GO:0046872]; regulation of hippo signaling [GO:0035330],NA,NA,NA
CHOYP_LOC100372889.1.2.m.37506,-0.0295314270977629,-0.0132237833686669,No,NA,NA,P54001,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; mitochondrion [GO:0005739]; procollagen-proline 4-dioxygenase complex [GO:0016222]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen fibril organization [GO:0030199]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_LOC100372889.2.2.m.57965,0.000985980932489139,0.00320154925640879,No,NA,NA,Q7ZU45,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cilium assembly [GO:0060271]; determination of heart left/right asymmetry [GO:0061371]; otolith morphogenesis [GO:0032474],NA,NA,NA
CHOYP_LOC100372921.2.2.m.56247,-0.0103771625025607,-0.00660400060075709,No,NA,NA,Q69ZM6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; transcription factor binding [GO:0008134]; brain development [GO:0007420]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; regulation of DNA-binding transcription factor activity [GO:0051090],NA,NA,NA
CHOYP_LOC100372922.1.1.m.12888,-0.00250635695370533,0.0034025719483834,No,NA,NA,P54254,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; protein C-terminus binding [GO:0008022]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; adult locomotory behavior [GO:0008344]; brain development [GO:0007420]; excitatory postsynaptic potential [GO:0060079]; learning [GO:0007612]; lung alveolus development [GO:0048286]; memory [GO:0007613]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nuclear export [GO:0051168]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; social behavior [GO:0035176]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100372926.1.3.m.29881,0.000198680258387263,-0.00181017547588683,No,NA,NA,Q3T0K2,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372926.2.3.m.61794,0.000741516146415462,0.000849898329487987,No,NA,NA,Q3T0K2,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; pore complex assembly [GO:0046931]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100372942.1.1.m.31119,-0.00234210447752204,-0.000948626810816987,No,NA,NA,Q28XE2,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; nucleocytoplasmic transport [GO:0006913],NA,NA,NA
CHOYP_LOC100372945.2.2.m.47110,0.00208605042415077,-0.00188689793747532,No,NA,NA,Q810B6,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; intracellular membrane-bounded organelle [GO:0043231]; macropinosome [GO:0044354]; membrane [GO:0016020]; retromer complex [GO:0030904]; metal ion binding [GO:0046872]; phosphatidylinositol phosphate binding [GO:1901981]; Rab GTPase binding [GO:0017137]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; endosomal vesicle fusion [GO:0034058]; Golgi to lysosome transport [GO:0090160]; positive regulation of pinocytosis [GO:0048549]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100372955.1.1.m.18209,-0.0175873261199081,0.00215413234300911,No,NA,NA,Q14181,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protein heterodimerization activity [GO:0046982]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_LOC100372966.1.1.m.18755,0.00532403106093164,0.00628754371968489,No,NA,NA,Q08DB5,NA,NA,NA,cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; vesicle [GO:0031982]; protein N-terminus binding [GO:0047485]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; early endosome to Golgi transport [GO:0034498]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; intracellular protein transport [GO:0006886]; positive regulation of protein catabolic process [GO:0045732]; regulation of Golgi organization [GO:1903358]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100372967.1.1.m.16378,-0.00198016459041736,-0.00265672395824249,No,NA,NA,Q58EM4,NA,NA,NA,protein carboxyl O-methyltransferase activity [GO:0051998]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; regulation of response to DNA damage stimulus [GO:2001020],NA,NA,NA
CHOYP_LOC100372990.1.1.m.15018,-0.0116293395760436,0.0151190526751863,No,NA,NA,Q62186,NA,NA,NA,integral component of membrane [GO:0016021]; Sec61 translocon complex [GO:0005784],NA,NA,NA
CHOYP_LOC100373045.1.1.m.16825,-0.00126102404544889,-0.0017614893571826,No,NA,NA,P18288,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19986,-0.00149617911992019,0.00203117799947499,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373083.1.2.m.19987,0.00329040781647907,0.00201913506665116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373083.2.2.m.26841,-5.61659747714385e-05,0.00745187330524024,No,NA,NA,Q99758,NA,NA,NA,alveolar lamellar body [GO:0097208]; alveolar lamellar body membrane [GO:0097233]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lamellar body membrane [GO:0097232]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; transporter activity [GO:0005215]; cellular protein metabolic process [GO:0044267]; lipid transport [GO:0006869]; response to drug [GO:0042493]; response to glucocorticoid [GO:0051384]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC100373090.1.1.m.52283,0.0170056152499154,-0.0211489145853708,No,NA,NA,Q1LWJ6,NA,NA,NA,lamellipodium [GO:0030027]; directional locomotion [GO:0033058]; negative regulation of actin nucleation [GO:0051126]; negative regulation of cell migration [GO:0030336],NA,NA,NA
CHOYP_LOC100373100.3.4.m.51137,-0.00435006524938065,0.000252060386115963,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373100.4.4.m.65650,-0.00438044979849526,0.0014184381928149,No,NA,NA,Q9P2E3,NA,NA,NA,chromosome; centromeric region [GO:0000775]; nuclear RNA-directed RNA polymerase complex [GO:0031380]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; chromatin silencing at centromere [GO:0030702]; chromatin silencing by small RNA [GO:0031048],NA,NA,NA
CHOYP_LOC100373136.1.1.m.6977,-0.00420646277602806,-0.0019302757931015,No,NA,NA,Q5XJS5,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100373138.1.1.m.23491,-0.00139824270895836,0.00118655048004304,No,NA,NA,O75886,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; membrane organization [GO:0061024]; multivesicular body assembly [GO:0036258]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059],NA,NA,NA
CHOYP_LOC100373141.1.1.m.11194,-0.00398287057942106,0.00210991141070794,No,NA,NA,Q99K28,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC100373146.1.2.m.13310,-0.00463258268678076,-0.0219318398035679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373146.2.2.m.27802,-0.0152449585050563,-0.0102878074917629,No,NA,NA,Q6ZUG5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373169.1.1.m.15573,-0.0167535411486626,-0.00429509424073592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373170.1.1.m.10994,0.00284325058254498,0.00841464502439527,No,NA,NA,O57590,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100373178.1.1.m.61012,0.00383833538259869,-0.00103722785094938,No,NA,NA,A7E3W5,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; synaptic vesicle membrane [GO:0030672]; regulated exocytosis [GO:0045055]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_LOC100373186.1.1.m.58981,-0.0175275498871797,0.0071934586940117,No,NA,NA,Q6AXK4,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromatin organization [GO:0006325]; double-strand break repair [GO:0006302]; positive regulation of DNA repair [GO:0045739]; protein K63-linked deubiquitination [GO:0070536]; response to ionizing radiation [GO:0010212]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_LOC100373240.1.1.m.28382,-0.0152698663276995,-0.00971770523750823,No,NA,NA,Q9I931,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; fucose binding [GO:0042806]; regulation of cellular defense response [GO:0010185]; regulation of complement activation; lectin pathway [GO:0001868]; regulation of innate immune response [GO:0045088],NA,NA,NA
CHOYP_LOC100373287.1.1.m.36226,-0.00094296159698827,-0.0132491495297439,No,NA,NA,Q96DI7,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; U2-type catalytic step 2 spliceosome [GO:0071007]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100373289.1.2.m.7904,0.00759949903490425,-0.00785000863997662,No,NA,NA,Q9CPT5,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC100373317.1.1.m.16740,-0.0137276333359392,-0.0263742763260474,No,NA,NA,Q5HZP1,NA,NA,NA,nucleus [GO:0005634]; ribonuclease H2 complex [GO:0032299]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100373327.1.13.m.13252,-0.00383270327553758,-0.00243912290358063,No,NA,NA,E9PYK3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373327.2.13.m.16978,0.00131339152102539,0.00411187949631574,No,NA,NA,E9PYK3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell death [GO:0008219]; cellular protein modification process [GO:0006464]; inflammatory response [GO:0006954]; protein ADP-ribosylation [GO:0006471]; regulation of telomerase activity [GO:0051972],NA,NA,NA
CHOYP_LOC100373339.1.1.m.5653,-0.00292336186112004,-0.00750802519146925,No,NA,NA,Q5RKJ1,NA,NA,NA,actomyosin contractile ring [GO:0005826]; cytoplasm [GO:0005737]; GID complex [GO:0034657]; integral component of plasma membrane [GO:0005887]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; ubiquitin ligase complex [GO:0000151]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cytoskeleton organization [GO:0007010]; enucleate erythrocyte development [GO:0048822]; erythrocyte maturation [GO:0043249]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of myeloid cell apoptotic process [GO:0033033]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373351.1.3.m.49572,-0.0229865005458206,0.0116526074045933,No,NA,NA,Q6ZN84,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373351.2.3.m.58893,-0.00176641353196354,0.00911109209131715,No,NA,NA,Q6ZN84,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100373353.1.1.m.50175,0.000347985819176145,0.00113171380692634,No,NA,NA,Q0IIF7,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; innate immune response [GO:0045087]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100373374.1.1.m.7546,0.000533334516731872,-0.00582178550449882,No,NA,NA,Q3ZCL5,NA,NA,NA,cytoplasm [GO:0005737]; trans-Golgi network membrane [GO:0032588]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100373421.1.1.m.38932,-0.00885554906637575,-0.00563564956604933,No,NA,NA,A0JPP8,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_LOC100373427.1.1.m.49648,0.00629613509106329,0.0117964564487954,No,NA,NA,Q8NHP6,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; chemotaxis [GO:0006935]; neutrophil degranulation [GO:0043312]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neutrophil chemotaxis [GO:0090023],NA,NA,NA
CHOYP_LOC100373429.1.1.m.10007,-0.012460785608271,-0.0104828674327129,No,NA,NA,F1P4W9,NA,NA,NA,integral component of membrane [GO:0016021]; motile cilium [GO:0031514]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100373444.22.79.m.26109,-0.0028874694255582,0.00391996138247361,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.23.79.m.27899,-0.0104792791460775,-0.0109982103449465,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.59.79.m.54129,0.0256296432746237,-0.00536054771773493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.63.79.m.59147,0.0125057514340898,-0.00794900253051298,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.7.79.m.3209,0.00264286702483266,0.0113795547241681,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373444.72.79.m.60850,0.00562705600521054,-0.0102158222926295,No,NA,NA,A4IF63,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100373444.8.79.m.3255,0.0106386399588815,-0.00715551717248583,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373454.1.1.m.59681,0,0,No,NA,NA,Q32LJ3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100373457.1.1.m.27685,-0.000383500978137796,0.000167880110203432,No,NA,NA,A0MTA1,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; phosphodiesterase I activity [GO:0004528]; RNA binding [GO:0003723]; base-excision repair [GO:0006284]; DNA demethylation [GO:0080111]; heart contraction [GO:0060047]; heart looping [GO:0001947]; negative regulation of apoptotic process [GO:0043066]; oxidation-reduction process [GO:0055114]; positive regulation of gene expression [GO:0010628],NA,NA,NA
CHOYP_LOC100373461.1.2.m.30015,0.000663152662079305,0.00151487873971745,No,NA,NA,Q0VC16,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; lipoprotein transporter activity [GO:0042954]; cargo loading into COPII-coated vesicle [GO:0090110]; cargo loading into vesicle [GO:0035459]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; lipoprotein transport [GO:0042953]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein secretion [GO:0009306]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100373484.1.1.m.8540,-0.000777723780480258,-0.00288454031751401,No,NA,NA,Q96EQ0,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; TRC complex [GO:0072380]; protein-containing complex scaffold activity [GO:0032947]; positive regulation of chaperone-mediated protein folding [GO:1903646]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100373488.1.1.m.10129,-0.00226182897172741,0.000786388416332709,No,NA,NA,P10088,NA,NA,NA,dioxygenase activity [GO:0051213]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; 2;4-dichlorophenoxyacetic acid catabolic process [GO:0046300],NA,NA,NA
CHOYP_LOC100373492.1.1.m.24527,0.00487583173127069,0.0248947305272286,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373522.2.5.m.19698,0.00823947406745699,-0.0270330505570099,No,NA,NA,Q95230,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373522.5.5.m.54028,-0.00403721767515926,0.00374014356890441,No,NA,NA,Q95230,NA,NA,NA,membrane [GO:0016020]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100373569.1.1.m.280,0.0048002127078112,0.0176397876904151,No,NA,NA,Q96D46,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein binding; bridging [GO:0030674]; ribosomal large subunit binding [GO:0043023]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of RNA biosynthetic process [GO:1902680]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100373578.1.1.m.478,-0.00196399823718918,-0.00665077915701341,No,NA,NA,Q5U4F6,NA,NA,NA,axoneme [GO:0005930]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; cytoplasmic dynein complex [GO:0005868]; cytosol [GO:0005829]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373584.1.1.m.6647,-0.0180447472673739,0.00673820980990689,No,NA,NA,Q7ZYA5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; double-stranded RNA binding [GO:0003725]; enzyme activator activity [GO:0008047]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_LOC100373590.1.1.m.51920,-0.0153655241596444,0.0232571168768754,No,NA,NA,P47758,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_LOC100373606.1.1.m.29757,0.0112128527385501,0.023250361725013,No,NA,NA,Q6GM78,NA,NA,NA,cytoplasm [GO:0005737]; photoreceptor inner segment [GO:0001917]; asparaginase activity [GO:0004067]; beta-aspartyl-peptidase activity [GO:0008798]; asparagine catabolic process via L-aspartate [GO:0033345],NA,NA,NA
CHOYP_LOC100373653.3.3.m.56289,0.00348090285256009,0.012756054895069,No,NA,NA,P97411,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein domain specific binding [GO:0019904]; neurotransmitter transport [GO:0006836]; regulation of insulin secretion [GO:0050796]; regulation of neurotransmitter secretion [GO:0046928]; regulation of protein homodimerization activity [GO:0043496],NA,NA,NA
CHOYP_LOC100373656.1.1.m.57144,-0.00644809271692935,-0.00581280622305319,No,NA,NA,Q5F356,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO:0016309]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100373657.1.1.m.10366,-0.0148220737978729,0.0159061613976716,No,NA,NA,Q96B26,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AU-rich element binding [GO:0017091]; identical protein binding [GO:0042802]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear polyadenylation-dependent tRNA catabolic process [GO:0071038]; nuclear-transcribed mRNA catabolic process; exonucleolytic; 3'-5' [GO:0034427]; regulation of mRNA stability [GO:0043488]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476],NA,NA,NA
CHOYP_LOC100373670.1.1.m.2427,-0.000517327056956414,-0.00861101491324984,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373694.1.1.m.11753,-0.00146678221340361,7.74417761091495e-05,No,NA,NA,P0CB97,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; mitochondrial respiratory chain complex I assembly [GO:0032981]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100373728.1.1.m.59746,-0.014856583266239,-0.00823470106654075,No,NA,NA,Q8TC84,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100373809.1.2.m.35126,-0.0118599387843548,-0.00191960381672951,No,NA,NA,Q8C761,NA,NA,NA,ciliary base [GO:0097546]; cilium [GO:0005929]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; interphase microtubule organizing center [GO:0031021]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium assembly [GO:0060271]; embryonic skeletal system morphogenesis [GO:0048704]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100373842.2.4.m.5139,-0.00879735988871226,0.00599826675363134,No,NA,NA,Q9WV92,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; juxtaparanode region of axon [GO:0044224]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; structural constituent of cytoskeleton [GO:0005200]; actomyosin structure organization [GO:0031032]; apoptotic process [GO:0006915]; cortical actin cytoskeleton organization [GO:0030866]; cortical cytoskeleton organization [GO:0030865]; cytoskeletal anchoring at plasma membrane [GO:0007016]; myelin maintenance [GO:0043217]; neuron projection morphogenesis [GO:0048812]; paranodal junction assembly [GO:0030913]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; regulation of cell growth [GO:0001558]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100373864.1.2.m.16543,0.000664013953942578,-0.000541434676055633,No,NA,NA,P12955,NA,NA,NA,extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metallocarboxypeptidase activity [GO:0004181]; proline dipeptidase activity [GO:0102009]; cellular amino acid metabolic process [GO:0006520]; collagen catabolic process [GO:0030574]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100373888.8.9.m.60548,0.00791171692237889,-0.0143635844451824,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373888.9.9.m.66033,0.00588824615658418,0.0128079030415064,No,NA,NA,P29590,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endoplasmic reticulum membrane [GO:0042406]; heterochromatin [GO:0000792]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; cobalt ion binding [GO:0050897]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; SUMO binding [GO:0032183]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell cycle arrest [GO:0007050]; cell fate commitment [GO:0045165]; cellular response to interleukin-4 [GO:0071353]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular senescence [GO:0090398]; circadian regulation of gene expression [GO:0032922]; common-partner SMAD protein phosphorylation [GO:0007182]; defense response to virus [GO:0051607]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; entrainment of circadian clock by photoperiod [GO:0043153]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast migration [GO:0010761]; innate immune response [GO:0045087]; interferon-gamma-mediated signaling pathway [GO:0060333]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; maintenance of protein location in nucleus [GO:0051457]; myeloid cell differentiation [GO:0030099]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of interleukin-1 beta secretion [GO:0050713]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of translation in response to oxidative stress [GO:0032938]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of viral release from host cell [GO:1902187]; PML body organization [GO:0030578]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of protein localization to chromosome; telomeric region [GO:1904816]; positive regulation of telomere maintenance [GO:0032206]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; protein-containing complex assembly [GO:0065003]; regulation of calcium ion transport into cytosol [GO:0010522]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752]; regulation of double-strand break repair [GO:2000779]; regulation of protein phosphorylation [GO:0001932]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription; DNA-templated [GO:0006355]; response to cytokine [GO:0034097]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to UV [GO:0009411]; retinoic acid receptor signaling pathway [GO:0048384]; transforming growth factor beta receptor signaling pathway [GO:0007179]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100373892.1.2.m.44404,-0.000478678400732661,0.0105891153349021,No,NA,NA,Q9CZC8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373892.2.2.m.55838,-0.00268456359948811,-0.0105528902345426,No,NA,NA,Q8VCA8,NA,NA,NA,dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC100373898.1.1.m.24900,-0.00581550876463014,-0.00370097542231305,No,NA,NA,Q86VH2,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium assembly [GO:0060271]; epithelial cilium movement [GO:0003351]; microtubule-based movement [GO:0007018]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100373917.1.1.m.43876,-0.022881841135597,0.00820358750379464,No,NA,NA,Q5F457,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100373945.1.1.m.53450,-0.0267169175636195,-0.00427074900850132,No,NA,NA,Q5EA50,NA,NA,NA,endosome membrane [GO:0010008],NA,NA,NA
CHOYP_LOC100373956.1.1.m.10987,0.00141576095753475,-0.000626763580844073,No,NA,NA,A5D989,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_LOC100373985.1.1.m.9302,-0.00240585905179732,-0.0278363517904077,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100373990.1.1.m.6259,-0.0118050739222955,-0.0118866218395082,No,NA,NA,B4F7A7,NA,NA,NA,centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; nucleus [GO:0005634]; fibroblast growth factor binding [GO:0017134]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; fibroblast growth factor receptor signaling pathway [GO:0008543]; microtubule anchoring [GO:0034453]; protein homooligomerization [GO:0051260]; protein import into nucleus; translocation [GO:0000060]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100374036.1.1.m.65939,-0.0131667809590251,-0.00591806490431675,No,NA,NA,Q28IV8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100374062.1.1.m.22586,-0.021039431084745,-0.00392348186361927,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374077.1.1.m.5922,-0.00182262149247894,-0.00203743357149687,No,NA,NA,Q5T1M5,NA,NA,NA,actin filament [GO:0005884]; early endosome [GO:0005769]; growth cone [GO:0030426]; membrane [GO:0016020]; actin binding [GO:0003779]; endocytosis [GO:0006897]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100374096.1.1.m.8052,-0.0211094811613005,-0.00922825495135172,No,NA,NA,Q8TBP0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of receptor recycling [GO:0001919],NA,NA,NA
CHOYP_LOC100374116.1.1.m.37009,0.00653997983798134,-0.0118732196303593,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374155.1.1.m.56570,-0.0108261925084327,-0.0116036337565298,No,NA,NA,Q08BC4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374249.1.1.m.58296,-0.00640288079647835,-0.00519342984600978,No,NA,NA,Q4G0X9,NA,NA,NA,axoneme [GO:0005930]; cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of liver left/right asymmetry [GO:0071910]; determination of pancreatic left/right asymmetry [GO:0035469]; epithelial cilium movement [GO:0003351]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; flagellated sperm motility [GO:0030317]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159]; lung development [GO:0030324]; motile cilium assembly [GO:0044458]; protein localization to cilium [GO:0061512]; regulation of cilium beat frequency [GO:0003356],NA,NA,NA
CHOYP_LOC100374249.1.1.m.58297,-0.0157988306667425,0.0247348441540938,No,NA,NA,O14770,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; eye development [GO:0001654]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pancreas development [GO:0031016]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to growth factor [GO:0070848]; response to mechanical stimulus [GO:0009612]; transcription by RNA polymerase II [GO:0006366]; visual learning [GO:0008542],NA,NA,NA
CHOYP_LOC100374254.1.1.m.22199,-0.0264632544385809,0.00534598653691236,No,NA,NA,B0BLT0,NA,NA,NA,cell [GO:0005623]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; ribosomal large subunit binding [GO:0043023]; zinc ion binding [GO:0008270]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_LOC100374268.1.1.m.58983,0.000417372891341804,0.000893700189098418,No,NA,NA,Q6P877,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; endopeptidase activator activity [GO:0061133]; proteasome binding [GO:0070628]; ubiquitin binding [GO:0043130]; proteasome assembly [GO:0043248]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100374272.3.6.m.53440,0.00425499401217939,-0.00772486761183403,No,NA,NA,O00222,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; G protein-coupled receptor activity [GO:0004930]; glutamate receptor activity [GO:0008066]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of synaptic transmission; glutamatergic [GO:0051966]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100374272.5.6.m.57085,0.00153822490171995,0.00768989698907826,No,NA,NA,Q9QYS2,NA,NA,NA,astrocyte projection [GO:0097449]; axon [GO:0030424]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of presynaptic membrane [GO:0099056]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynaptic active zone [GO:0048786]; presynaptic membrane [GO:0042734]; calcium channel regulator activity [GO:0005246]; glutamate receptor activity [GO:0008066]; group II metabotropic glutamate receptor activity [GO:0001641]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; modulation of chemical synaptic transmission [GO:0050804]; regulation of sensory perception of pain [GO:0051930]; regulation of synaptic transmission; glutamatergic [GO:0051966]; sensory perception of pain [GO:0019233]; synaptic transmission; glutamatergic [GO:0035249],NA,NA,NA
CHOYP_LOC100374272.6.6.m.62213,0.00627844565411885,-0.00812991145918335,No,NA,NA,Q5RDQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutamate receptor activity [GO:0008066]; group III metabotropic glutamate receptor activity [GO:0001642]; adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO:0007196],NA,NA,NA
CHOYP_LOC100374274.2.3.m.27036,-0.00212401578315111,0.00288351446149329,No,NA,NA,Q54BA2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374277.1.3.m.16275,0.0245339435280441,0.00622612979916506,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374277.2.3.m.23204,0.00134987356213589,-0.000582578022213147,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374280.1.1.m.17385,0.0185999597310183,0.0108417937006437,No,NA,NA,A0A1D3PCM3,NA,NA,NA,mitochondrion [GO:0005739]; transferase activity; transferring acyl groups other than amino-acyl groups [GO:0016747]; cysteine biosynthetic process [GO:0019344],NA,NA,NA
CHOYP_LOC100374307.1.1.m.29504,0.0039574581040639,0.00400856749209944,No,NA,NA,Q5RDZ2,NA,NA,NA,cytosol [GO:0005829]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; L-gulonate 3-dehydrogenase activity [GO:0050104]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374320.1.1.m.54274,-0.00636617969183657,-0.0204165872986797,No,NA,NA,P21369,NA,NA,NA,metal ion binding [GO:0046872]; nicotinamidase activity [GO:0008936]; pyridine nucleotide salvage [GO:0019365],NA,NA,NA
CHOYP_LOC100374338.1.1.m.44584,0.00758606930879903,0.000551815776265062,No,NA,NA,P42620,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; oxidoreductase activity; acting on a sulfur group of donors; quinone or similar compound as acceptor [GO:0016672],NA,NA,NA
CHOYP_LOC100374345.1.2.m.11328,-0.0030708534592539,0.00168547075981647,No,NA,NA,Q8BHJ9,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; pre-mRNA 3'-splice site binding [GO:0030628]; second spliceosomal transesterification activity [GO:0000386]; zinc ion binding [GO:0008270]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to heat [GO:0034605]; intracellular protein transport [GO:0006886]; mRNA 3'-splice site recognition [GO:0000389]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC100374358.1.1.m.59032,0.00470638520064438,-0.0252478468132438,No,NA,NA,Q5ZLW3,NA,NA,NA,Golgi apparatus [GO:0005794]; enzyme binding [GO:0019899]; bone development [GO:0060348]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC100374370.1.1.m.56335,0.00244616904957107,0.00293793368497038,No,NA,NA,Q0P4F7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100374422.1.2.m.26376,-0.0146622611556479,0.00567019432258947,No,NA,NA,Q8IVF4,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100374446.1.1.m.29971,-0.00872195366473233,-4.27141570694657e-05,No,NA,NA,Q9H0I3,NA,NA,NA,centriolar satellite [GO:0034451]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100374467.1.1.m.31786,-0.0240447398592068,0.00400225442667405,No,NA,NA,Q4R7Y8,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100374491.1.1.m.6498,-0.00640793413039106,-0.00266604242535008,No,NA,NA,Q0V9R4,NA,NA,NA,axoneme [GO:0005930]; axonemal dynein complex assembly [GO:0070286]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100374495.1.1.m.55368,-0.00485265753332399,-0.0035454225600484,No,NA,NA,P80311,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA polymerase binding [GO:0070063]; unfolded protein binding [GO:0051082]; bone development [GO:0060348]; chaperone-mediated protein folding [GO:0061077]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of multicellular organism growth [GO:0040018]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100374522.1.1.m.66943,-0.0177698001851374,-0.00873949265699191,No,NA,NA,Q9DAM1,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100374527.1.1.m.55214,-0.00555522055319161,-0.00153775077022586,No,NA,NA,O97593,NA,NA,NA,kinetochore [GO:0000776]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; response to DNA damage checkpoint signaling [GO:0072423]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100374535.2.3.m.26026,0.00246694998680031,-0.00517725310916621,No,NA,NA,O44441,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780]; negative regulation of nucleotide metabolic process [GO:0045980],NA,NA,NA
CHOYP_LOC100374535.3.3.m.31001,-0.00101621029815889,-0.00589170817835921,No,NA,NA,A8XZB0,NA,NA,NA,mitochondrion [GO:0005739]; ATPase binding [GO:0051117]; ATPase inhibitor activity [GO:0042030]; heme biosynthetic process [GO:0006783]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_LOC100374537.1.1.m.27241,-0.00210933550669109,0.0270939752732758,No,NA,NA,Q19269,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100374573.1.1.m.24523,0.00148450504007056,-0.00455527421467682,No,NA,NA,P31689,NA,NA,NA,cytoplasmic side of endoplasmic reticulum membrane [GO:0098554]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; ATPase activator activity [GO:0001671]; C3HC4-type RING finger domain binding [GO:0055131]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; low-density lipoprotein particle receptor binding [GO:0050750]; metal ion binding [GO:0046872]; Tat protein binding [GO:0030957]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; androgen receptor signaling pathway [GO:0030521]; DNA damage response; detection of DNA damage [GO:0042769]; flagellated sperm motility [GO:0030317]; negative regulation of apoptotic process [GO:0043066]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway [GO:1905259]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of apoptotic process [GO:0043065]; protein folding [GO:0006457]; protein localization to mitochondrion [GO:0070585]; regulation of protein transport [GO:0051223]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21988,0.00102534295202076,0.00938565702223452,No,NA,NA,P34714,NA,NA,NA,basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100374633.1.2.m.21989,-0.00856214117974212,0.00622839146860437,No,NA,NA,Q9D0C1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100374651.1.4.m.28869,-0.00013259844004847,0.0175926222189622,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374651.3.4.m.52010,0.00269549440063518,-0.00072839957578799,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100374662.1.6.m.7038,-0.0306937030755986,-0.00059283763982724,No,NA,NA,Q496A3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374676.1.1.m.61638,0,0,No,NA,NA,Q9BZ19,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100374685.1.1.m.16061,-0.0120591089032269,-0.00879523688054415,No,NA,NA,Q5M8Z2,NA,NA,NA,cytosol [GO:0005829]; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [GO:0000506]; mitochondrion [GO:0005739]; GPI anchor biosynthetic process [GO:0006506],NA,NA,NA
CHOYP_LOC100374693.1.1.m.62043,0.0160535189560916,0.0122788216201451,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374703.1.1.m.28348,-0.00442390886881889,0.00286774852571187,No,NA,NA,Q8IV36,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extrinsic component of Golgi membrane [GO:0090498]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; intracellular protein transport [GO:0006886]; response to brefeldin A [GO:0031001],NA,NA,NA
CHOYP_LOC100374741.27.83.m.24541,0.00672468816504758,-9.84985358701486e-05,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100374741.30.83.m.32433,-0.00233978288998354,0.00152321244197085,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.38.83.m.33463,0.00590916368595963,-0.0107279838796565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.49.83.m.42424,0.0102912497826897,0.0222710656589989,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.54.83.m.47294,0.0110030862332124,-0.00533248377585146,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.61.83.m.53306,0.00613421734687299,-0.0145514697681692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374741.70.83.m.60164,0.00723144132916682,-0.0131285559393647,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.72.83.m.60196,0.0246044730185062,0.0260836269180958,No,NA,NA,Q9ESN6,NA,NA,NA,cytoplasm [GO:0005737]; myosin binding [GO:0017022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_LOC100374741.79.83.m.63217,0.00486819793199154,-0.00620114776557485,No,NA,NA,Q9BRZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_LOC100374742.1.2.m.209,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374747.1.1.m.54969,-6.49954378875516e-05,0.00176706822127542,No,NA,NA,Q9NZQ3,NA,NA,NA,cytosol [GO:0005829]; intermediate filament [GO:0005882]; nucleus [GO:0005634]; cytoskeletal protein binding [GO:0008092]; SH3 domain binding [GO:0017124]; cytoskeleton organization [GO:0007010]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of neuron projection development [GO:0010976]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100374754.1.1.m.32299,-0.00460484260373608,0.00868644658023141,No,NA,NA,Q8R0G9,NA,NA,NA,condensed chromosome outer kinetochore [GO:0000940]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; neural tube development [GO:0021915]; neurogenesis [GO:0022008]; nuclear pore distribution [GO:0031081]; nuclear pore organization [GO:0006999]; paraxial mesoderm development [GO:0048339]; protein import into nucleus [GO:0006606]; somite development [GO:0061053],NA,NA,NA
CHOYP_LOC100374772.1.4.m.30631,0.0014638116962886,-0.00238732782212712,No,NA,NA,Q9JIX0,NA,NA,NA,DUBm complex [GO:0071819]; mitochondrion [GO:0005739]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; SAGA complex [GO:0000124]; transcription export complex 2 [GO:0070390]; chromatin binding [GO:0003682]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coactivator activity [GO:0003713]; histone deubiquitination [GO:0016578]; negative regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061179]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100374785.2.3.m.34677,-0.00813826685779879,0.00893995084011741,No,NA,NA,Q8IYW2,NA,NA,NA,axoneme [GO:0005930]; axoneme assembly [GO:0035082]; cilium movement involved in cell motility [GO:0060294],NA,NA,NA
CHOYP_LOC100374808.1.1.m.29300,-0.00226247739304969,-0.0141990084668175,No,NA,NA,B1H283,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100374819.2.7.m.48237,0.00309141327529515,-0.000835388163959726,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100374839.1.1.m.63735,0.000860579448261332,0.00934041198351815,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374845.1.1.m.49323,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374849.1.4.m.16004,-0.00658104580312401,0.0100696062908731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374909.1.2.m.4076,-0.000125652147536372,0.0248821329872641,No,NA,NA,P91254,NA,NA,NA,glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374909.2.2.m.57748,0.000611425014305912,0.000345431886864984,No,NA,NA,P46088,NA,NA,NA,cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100374912.1.1.m.51922,0.0174538984893466,-0.0181531244576397,No,NA,NA,P52556,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; biliverdin reductase activity [GO:0004074]; riboflavin reductase (NADPH) activity [GO:0042602]; heme catabolic process [GO:0042167],NA,NA,NA
CHOYP_LOC100374960.1.1.m.25267,-0.0102474017188845,0.0214762820492215,No,NA,NA,Q8NHH9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; Golgi organization [GO:0007030]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100374962.1.1.m.28954,-0.00906427142722815,0.00437527707882731,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.12.16.m.47308,-0.00306327237049012,0.00415862737455595,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374974.15.16.m.58657,-0.00310430223485468,0.0142637355245391,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.1.16.m.21258,-6.67297573407551e-05,0.00885343305117158,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100374981.4.16.m.24874,0.0113979833897816,-0.0143019867491102,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100374995.1.3.m.34198,-0.00262572021976597,0.00336421840170914,No,NA,NA,Q1LUT1,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087],NA,NA,NA
CHOYP_LOC100374995.2.3.m.59062,-0.025846712709252,0.0220456107954268,No,NA,NA,Q7ZXT3,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932],NA,NA,NA
CHOYP_LOC100375012.1.1.m.11931,0,0,No,NA,NA,Q6NXP6,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100375022.1.1.m.3033,-0.00130323695123201,0.0013429830835934,No,NA,NA,P14685,NA,NA,NA,proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; enzyme regulator activity [GO:0030234]; regulation of protein catabolic process [GO:0042176]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100375029.3.10.m.11445,0.0163405637037626,0.0103263891154886,No,NA,NA,O17389,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375029.8.10.m.60484,0.00743511761332975,0.0127787585191422,No,NA,NA,O17389,NA,NA,NA,cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; actin monomer binding [GO:0003785]; actin filament organization [GO:0007015],NA,NA,NA
CHOYP_LOC100375065.1.1.m.7678,-0.0115944314422044,-0.00318622478959725,No,NA,NA,Q9BVG8,NA,NA,NA,centrosome [GO:0005813]; cytoplasmic vesicle membrane [GO:0030659]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; zonula adherens [GO:0005915]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; epithelial cell-cell adhesion [GO:0090136]; Golgi organization [GO:0007030]; microtubule-based movement [GO:0007018]; visual perception [GO:0007601]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC100375089.1.1.m.1341,0.00182740793507081,-0.00158732276628941,No,NA,NA,Q3MHN0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100375122.1.1.m.52296,-0.0104110124243836,0.00404481635219003,No,NA,NA,Q9D581,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100375141.1.1.m.12655,0.000902638583685357,-0.012901890367316,No,NA,NA,Q9X6U2,NA,NA,NA,3-hydroxybutyrate dehydrogenase activity [GO:0003858],NA,NA,NA
CHOYP_LOC100375168.1.1.m.23641,-0.00247666440551919,0.00447704003720954,No,NA,NA,Q59E55,NA,NA,NA,nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; cell proliferation [GO:0008283]; locomotory behavior [GO:0007626]; negative regulation of transcription; DNA-templated [GO:0045892]; neuroblast development [GO:0014019]; neuron development [GO:0048666]; regulation of transcription; DNA-templated [GO:0006355]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC100375191.1.2.m.9220,-0.0156809541235723,0.0207032166478496,No,NA,NA,Q86YF9,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; multicellular organism development [GO:0007275]; positive regulation of cilium assembly [GO:0045724]; protein localization to cilium [GO:0061512]; regulation of protein binding [GO:0043393]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375194.5.7.m.46447,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375204.2.2.m.21490,-0.00579358423824138,-0.0103009723027225,No,NA,NA,Q6NVL7,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100375204.2.2.m.21491,0.00455433924714722,-0.0102198999741983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375219.1.1.m.30268,-0.0156628228206381,-0.0106996265032311,No,NA,NA,Q9H4K1,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100375219.1.1.m.30269,-0.0217776190971812,0.023190356702729,No,NA,NA,Q9DAN9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100375230.1.1.m.52612,-0.0285988283759764,0.0108802302485702,No,NA,NA,Q96M69,NA,NA,NA,acrosomal vesicle [GO:0001669]; cell projection [GO:0042995]; cytosol [GO:0005829]; manchette [GO:0002177]; ATP binding [GO:0005524]; guanylate kinase activity [GO:0004385]; axoneme assembly [GO:0035082]; cell differentiation [GO:0030154]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375232.1.2.m.2686,0.00397443687637818,0.00469370770669073,No,NA,NA,Q9Y2F9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cerebral cortex development [GO:0021987]; dendrite morphogenesis [GO:0048813]; neurogenesis [GO:0022008],NA,NA,NA
CHOYP_LOC100375265.2.2.m.11396,-0.0295094898969862,-0.00268013471302885,No,NA,NA,Q9UBQ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; carboxylic acid binding [GO:0031406]; glycerate dehydrogenase activity [GO:0008465]; glyoxylate reductase (NADP) activity [GO:0030267]; hydroxypyruvate reductase activity [GO:0016618]; NAD binding [GO:0051287]; NADPH binding [GO:0070402]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; cellular nitrogen compound metabolic process [GO:0034641]; dicarboxylic acid metabolic process [GO:0043648]; excretion [GO:0007588]; glyoxylate metabolic process [GO:0046487]; oxidation-reduction process [GO:0055114]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LOC100375266.1.1.m.6535,-0.000942075751957123,-0.0140046909550348,No,NA,NA,Q9D5R3,NA,NA,NA,centriole [GO:0005814]; ciliary transition fiber [GO:0097539]; Golgi apparatus [GO:0005794]; cilium assembly [GO:0060271]; establishment of centrosome localization [GO:0051660]; protein localization to centrosome [GO:0071539]; vesicle docking [GO:0048278],NA,NA,NA
CHOYP_LOC100375314.1.1.m.19446,-0.00235652728779219,-0.00489237764709617,No,NA,NA,P18142,NA,NA,NA,cell cortex [GO:0005938]; esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689],NA,NA,NA
CHOYP_LOC100375322.1.1.m.22016,-0.020054053429925,-0.015499585123902,No,NA,NA,Q74FW6,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; pyridoxal phosphate binding [GO:0030170]; isoleucine biosynthetic process [GO:0009097]; L-serine catabolic process [GO:0006565]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC100375324.1.1.m.45919,-0.00820129946989654,-0.0087043913096455,No,NA,NA,Q96S44,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EKC/KEOPS complex [GO:0000408]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; p53 binding [GO:0002039]; protein serine/threonine kinase activity [GO:0004674]; protein phosphorylation [GO:0006468]; regulation of signal transduction by p53 class mediator [GO:1901796]; tRNA processing [GO:0008033]; tRNA threonylcarbamoyladenosine metabolic process [GO:0070525],NA,NA,NA
CHOYP_LOC100375342.2.3.m.30827,-0.00807663776056283,-0.0204887588725051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375342.3.3.m.40363,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375357.1.1.m.46425,-0.00396020700247428,-0.0232404592523876,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_LOC100375367.1.1.m.10761,0.000106645758971262,0.00220478547735691,No,NA,NA,O60231,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; ATPase activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375395.1.2.m.3613,-0.00247510662999594,0.00276168689016443,No,NA,NA,Q9LJN4,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; plant-type cell wall [GO:0009505]; alpha-L-arabinofuranosidase activity [GO:0046556]; xylan 1;4-beta-xylosidase activity [GO:0009044]; arabinan catabolic process [GO:0031222]; xylan catabolic process [GO:0045493],NA,NA,NA
CHOYP_LOC100375405.1.1.m.48387,-0.00174282931399555,-0.00279539538744272,No,NA,NA,Q9JI92,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; ephrin receptor binding [GO:0046875]; growth factor binding [GO:0019838]; interleukin-5 receptor binding [GO:0005137]; lipid binding [GO:0008289]; neurexin family protein binding [GO:0042043]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; syndecan binding [GO:0045545]; actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of receptor internalization [GO:0002091]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_LOC100375419.1.1.m.60972,0.00330248160683949,2.45841991188837e-05,No,NA,NA,O54786,NA,NA,NA,cytosol [GO:0005829]; lipid droplet [GO:0005811]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; deoxyribonuclease inhibitor activity [GO:0060703]; protein binding involved in protein folding [GO:0044183]; protein domain specific binding [GO:0019904]; apoptotic DNA fragmentation [GO:0006309]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic DNA fragmentation [GO:1902511]; negative regulation of deoxyribonuclease activity [GO:0032076]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process [GO:0043065]; thymocyte apoptotic process [GO:0070242],NA,NA,NA
CHOYP_LOC100375427.1.1.m.6282,0.00657982291830075,0.00473970853734122,No,NA,NA,Q9ULX7,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; bicarbonate transport [GO:0015701],NA,NA,NA
CHOYP_LOC100375467.1.1.m.42789,0.00389320828243222,-0.00026844803534987,No,NA,NA,Q04721,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; atrial septum morphogenesis [GO:0060413]; bone remodeling [GO:0046849]; cell cycle arrest [GO:0007050]; cell fate determination [GO:0001709]; hemopoiesis [GO:0030097]; marginal zone B cell differentiation [GO:0002315]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of growth rate [GO:0045967]; nervous system development [GO:0007399]; Notch signaling involved in heart development [GO:0061314]; Notch signaling pathway [GO:0007219]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Ras protein signal transduction [GO:0046579]; pulmonary valve morphogenesis [GO:0003184]; regulation of osteoclast development [GO:2001204]; regulation of transcription; DNA-templated [GO:0006355]; stem cell population maintenance [GO:0019827]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100375473.1.1.m.9062,-0.0173188854217865,0.00679866845418765,No,NA,NA,Q4R6T7,NA,NA,NA,cell projection organization [GO:0030030],NA,NA,NA
CHOYP_LOC100375476.1.1.m.33187,-0.00510510835473768,-0.0232418837678563,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375481.1.1.m.4496,0.00726180204582806,0.0182312075644274,No,NA,NA,Q9VY28,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100375491.1.1.m.11693,-0.00882327905470254,-0.00561511301027854,No,NA,NA,Q61909,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; transcription corepressor activity [GO:0003714]; fat cell differentiation [GO:0045444]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron projection development [GO:0010977]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA binding [GO:0051101]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100375514.2.6.m.12927,-0.00761176361313157,-0.0122180064504579,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27488,-0.0103069896612565,-0.00199777161746317,No,NA,NA,Q8VIG3,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC100375551.1.2.m.27489,-5.40374729925344e-05,-0.00030204832596668,No,NA,NA,Q9JJW6,NA,NA,NA,cytoplasm [GO:0005737]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100375551.2.2.m.63719,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375622.1.1.m.55637,0.0209593362633116,0.0043612981915272,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100375647.1.2.m.39652,0.00282741991929905,-0.00647523421808195,No,NA,NA,P78329,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; organelle membrane [GO:0031090]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; tocotrienol omega-hydroxylase activity [GO:0052872]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; drug metabolic process [GO:0017144]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; oxidation-reduction process [GO:0055114]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377],NA,NA,NA
CHOYP_LOC100375650.1.1.m.51555,0.00242220708532933,-0.0152257232008932,No,NA,NA,Q98SP7,NA,NA,NA,BBSome [GO:0034464]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; membrane [GO:0016020]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; intracellular transport [GO:0046907]; Kupffer's vesicle development [GO:0070121]; melanosome transport [GO:0032402]; non-motile cilium assembly [GO:1905515]; pigment granule aggregation in cell center [GO:0051877],NA,NA,NA
CHOYP_LOC100375678.1.1.m.51537,1.12343823143769e-05,0.0025261562996879,No,NA,NA,P70541,NA,NA,NA,cytoplasm [GO:0005737]; eukaryotic translation initiation factor 2B complex [GO:0005851]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleotidyltransferase activity [GO:0016779]; translation initiation factor activity [GO:0003743]; hippocampus development [GO:0021766]; oligodendrocyte development [GO:0014003]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100375699.1.2.m.19738,-0.0157274178903573,0.0146358699069642,No,NA,NA,Q9TU19,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cell differentiation [GO:0030154]; cell projection organization [GO:0030030]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100375733.1.1.m.66021,0.0107728105136653,0.0134249445372165,No,NA,NA,P54961,NA,NA,NA,hydroxymethylglutaryl-CoA synthase activity [GO:0004421]; isoprenoid biosynthetic process [GO:0008299]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC100375747.1.1.m.36999,-0.00611079996591439,0.00678671269397766,No,NA,NA,Q9P209,NA,NA,NA,centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; centriole replication [GO:0007099]; ciliary basal body-plasma membrane docking [GO:0097711]; G2/M transition of mitotic cell cycle [GO:0000086]; gamma-tubulin complex localization [GO:0033566]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of protein localization to centrosome [GO:1904779]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_LOC100375776.1.3.m.8907,0.0125629299541013,-0.0170016786062708,No,NA,NA,Q06852,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_LOC100375784.2.6.m.7640,-0.0225024899015656,0.0116512391254121,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.3.6.m.12285,0.00522316080927593,0.0152216238123704,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375784.4.6.m.27594,0.00690354647607219,-0.00257272359068682,No,NA,NA,Q4G0P3,NA,NA,NA,axonemal central pair projection [GO:1990718]; axonemal central apparatus assembly [GO:1904158]; cilium movement [GO:0003341]; epithelial cell development [GO:0002064]; trachea development [GO:0060438]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC100375791.1.1.m.18116,0.00444931131246081,0.0281148278569179,No,NA,NA,Q6AY40,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; nucleus [GO:0005634]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of glycolytic process [GO:0006110]; regulation of pyruvate kinase activity [GO:1903302],NA,NA,NA
CHOYP_LOC100375797.1.3.m.4166,0.0122387158519932,-0.0184608957554082,No,NA,NA,Q01262,NA,NA,NA,hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; cellular amino acid biosynthetic process [GO:0008652],NA,NA,NA
CHOYP_LOC100375820.1.1.m.62640,0.00306340423864286,0.00232678430221683,No,NA,NA,Q924T7,NA,NA,NA,CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; LUBAC complex [GO:0071797]; metal ion binding [GO:0046872]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; CD40 signaling pathway [GO:0023035]; negative regulation of necroptotic process [GO:0060546]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein linear polyubiquitination [GO:0097039]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100375831.1.1.m.24502,0.00534993437503525,0.00288065881578714,No,NA,NA,Q810J8,NA,NA,NA,autophagosome [GO:0005776]; endoplasmic reticulum [GO:0005783]; extrinsic component of omegasome membrane [GO:0097629]; Golgi stack [GO:0005795]; mitochondria-associated endoplasmic reticulum membrane [GO:0044233]; omegasome [GO:1990462]; perinuclear region of cytoplasm [GO:0048471]; phagophore assembly site [GO:0000407]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; cellular response to starvation [GO:0009267]; macroautophagy [GO:0016236]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC100375838.1.1.m.39473,0.00460806296565703,-0.00836585815510076,No,NA,NA,Q8K4L0,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; estrogen receptor binding [GO:0030331]; RNA binding [GO:0003723]; signaling receptor binding [GO:0005102]; transcription corepressor activity [GO:0003714]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100375877.1.1.m.16493,-0.00110613104518521,-0.0016026591255304,No,NA,NA,Q9H0A0,NA,NA,NA,membrane [GO:0016020]; midbody [GO:0030496]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; DNA polymerase binding [GO:0070182]; N-acetyltransferase activity [GO:0008080]; RNA binding [GO:0003723]; rRNA cytidine N-acetyltransferase activity [GO:1990883]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA acetylation involved in maturation of SSU-rRNA [GO:1904812]; rRNA modification [GO:0000154]; tRNA acetylation [GO:0051391],NA,NA,NA
CHOYP_LOC100375888.1.1.m.18951,0.000631664050562192,0.000159859413923185,No,NA,NA,Q8K370,NA,NA,NA,mitochondrion [GO:0005739]; flavin adenine dinucleotide binding [GO:0050660]; hydrolase activity [GO:0016787]; oxidoreductase activity; acting on the CH-CH group of donors [GO:0016627],NA,NA,NA
CHOYP_LOC100375890.1.1.m.10490,-0.000769303119684515,-0.000287557253514646,No,NA,NA,Q8CHP8,NA,NA,NA,cytoplasm [GO:0005737]; glycerol-1-phosphatase activity [GO:0000121]; glycerol-3-phosphatase activity [GO:0043136]; magnesium ion binding [GO:0000287]; nucleotide phosphatase activity; acting on free nucleotides [GO:0098519]; phosphatase activity [GO:0016791]; phosphoglycolate phosphatase activity [GO:0008967]; protein tyrosine phosphatase activity [GO:0004725]; dephosphorylation [GO:0016311]; glycerol biosynthetic process [GO:0006114]; glycerophospholipid metabolic process [GO:0006650]; negative regulation of gluconeogenesis [GO:0045721]; peptidyl-tyrosine dephosphorylation [GO:0035335],NA,NA,NA
CHOYP_LOC100375897.1.2.m.14439,-0.00715616736560682,0.00220356554920993,No,NA,NA,Q4KMD7,NA,NA,NA,nuclear speck [GO:0016607]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; mRNA 3'-UTR binding [GO:0003730]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; snRNA processing [GO:0016180],NA,NA,NA
CHOYP_LOC100375913.1.1.m.9170,-0.010358212519548,0.0105372317682754,No,NA,NA,Q0IHI3,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; actin filament polymerization [GO:0030041]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100375943.1.1.m.9395,0.000323705189107825,-0.0295494554884651,No,NA,NA,P57772,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC100375954.4.6.m.32949,-0.0224827880137096,-0.0143079907934943,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC100375955.1.1.m.9940,0.0152205214625162,-0.0284786335584756,No,NA,NA,Q5F415,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; embryonic brain development [GO:1990403]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC100376045.1.1.m.30010,0.00863175519854664,0.00485746939146442,No,NA,NA,Q96CN5,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC100376049.1.1.m.10489,0.0033565227540389,0.00613520662904529,No,NA,NA,Q5VWJ9,NA,NA,NA,phosphatidylinositol binding [GO:0035091]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376067.3.3.m.62990,-0.0142364753810233,-0.00989949185629429,No,NA,NA,O93310,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; nuclear chromosome [GO:0000228]; apoptotic process [GO:0006915]; cell division [GO:0051301]; DNA repair [GO:0006281]; protein localization to chromatin [GO:0071168]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_LOC100376096.1.1.m.62366,-0.0116563789438363,-0.00786657600546451,No,NA,NA,A1A4V9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376151.1.1.m.21094,-0.00292061919048045,-0.00347279263495731,No,NA,NA,Q7Z5K2,NA,NA,NA,chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome; centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; cell division [GO:0051301]; meiotic chromosome segregation [GO:0045132]; mitotic cell cycle [GO:0000278]; negative regulation of chromatin binding [GO:0035562]; negative regulation of DNA replication [GO:0008156]; negative regulation of sister chromatid cohesion [GO:0045875]; positive regulation of fibroblast proliferation [GO:0048146]; protein localization to chromatin [GO:0071168]; regulation of chromosome condensation [GO:0060623]; regulation of cohesin loading [GO:0071922]; response to toxic substance [GO:0009636]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100376162.1.1.m.48261,-0.0181739418232013,0.00383593587655031,No,NA,NA,P39098,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; glycoprotein metabolic process [GO:0009100]; lung alveolus development [GO:0048286]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585],NA,NA,NA
CHOYP_LOC100376187.1.2.m.22539,-0.00300594078403183,-0.00517933560864213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376187.1.2.m.22540,0.00206312996309078,0.000516007606206103,No,NA,NA,Q03049,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376187.2.2.m.55240,0.0104571129330091,-0.0184437660398977,No,NA,NA,Q03049,NA,NA,NA,aldehyde dehydrogenase (NADP+) activity [GO:0033721]; coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; response to furfural [GO:1901426],NA,NA,NA
CHOYP_LOC100376200.1.1.m.19157,0.00201026459323609,0.0178878130526265,No,NA,NA,B9EQ30,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_LOC100376214.9.11.m.53354,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376250.1.1.m.46061,-0.00786595565469292,0.0141219014115334,No,NA,NA,Q5E9X5,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; cytosol [GO:0005829]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; endosomal transport [GO:0016197]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100376265.3.4.m.22693,-0.0024839441989956,-0.00124492392813784,No,NA,NA,B5X3C1,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376265.4.4.m.28000,0.0170231474578607,-0.015111286429387,No,NA,NA,Q5SNX7,NA,NA,NA,lysosome [GO:0005764]; galactosylceramidase activity [GO:0004336]; galactosylceramide catabolic process [GO:0006683],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30521,-0.0138015080248413,-0.0087832456381901,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376272.3.4.m.30522,0.00155683566874559,6.16592654954512e-06,No,NA,NA,Q8HZM5,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC100376274.7.7.m.64553,-0.00341950261458472,0.00167268116987579,No,NA,NA,Q9MBF8,NA,NA,NA,axoneme [GO:0005930]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; inner dynein arm assembly [GO:0036159],NA,NA,NA
CHOYP_LOC100376289.1.1.m.60023,-0.00769750540864102,-0.00178785638409742,No,NA,NA,Q5RHH4,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; photoreceptor cell maintenance [GO:0045494]; pronephros development [GO:0048793]; regulation of TOR signaling [GO:0032006]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC100376296.1.1.m.36837,0.00409280534402612,0.00483349782189685,No,NA,NA,Q96MY1,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100376308.1.1.m.60595,0.0241286981737376,0.0074171729896875,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100376325.1.2.m.1959,0.00571206146838137,-0.0197494591216558,No,NA,NA,Q9NWU2,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; protein homodimerization activity [GO:0042803]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell proliferation [GO:0008284]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100376387.1.1.m.9565,0.0112882901789392,0.00580077115952458,No,NA,NA,O43818,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; U3 snoRNA binding [GO:0034511]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100376426.1.3.m.28097,-0.0341083012179353,-0.0152196552564784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376426.3.3.m.65900,0.0125288869832607,-0.0140238993006429,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376429.1.1.m.24844,-0.0187964465030083,0.00863145261810917,No,NA,NA,Q0VCN3,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; sperm flagellum [GO:0036126]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cell differentiation [GO:0030154]; intracellular protein transport [GO:0006886]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; Rab protein signal transduction [GO:0032482]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100376442.1.1.m.40651,-0.0124355570660141,-0.0103108279296878,No,NA,NA,A7S8T5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100376457.1.2.m.11537,0.00174619762148604,-0.000280773765165565,No,NA,NA,O73888,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; glutathione transferase activity [GO:0004364]; magnesium ion binding [GO:0000287]; prostaglandin-D synthase activity [GO:0004667]; protein homodimerization activity [GO:0042803]; negative regulation of male germ cell proliferation [GO:2000255]; prostaglandin biosynthetic process [GO:0001516]; prostaglandin metabolic process [GO:0006693],NA,NA,NA
CHOYP_LOC100376457.2.2.m.51737,0.00557356353048521,0.00147107019601751,No,NA,NA,P18426,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_LOC100376500.1.1.m.36606,0.000201303864496023,-0.00134299830317519,No,NA,NA,Q08E38,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; DNA replication factor A complex [GO:0005662]; lipid droplet [GO:0005811]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular protein localization [GO:0034613]; double-strand break repair via nonhomologous end joining [GO:0006303]; generation of catalytic spliceosome for first transesterification step [GO:0000349]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; signal transduction involved in DNA damage checkpoint [GO:0072422]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LOC100376608.2.4.m.47059,0.00565039212290223,-0.0102581886083579,No,NA,NA,Q9R1R2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100376608.3.4.m.51379,0.00352708574069193,0.00416539752376971,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376610.3.3.m.19687,-0.00461503302497438,0.000661827943582013,No,NA,NA,Q61656,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; androgen receptor binding [GO:0050681]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; MH2 domain binding [GO:0035500]; mRNA 3'-UTR binding [GO:0003730]; pre-mRNA binding [GO:0036002]; primary miRNA binding [GO:0070878]; promoter-specific chromatin binding [GO:1990841]; R-SMAD binding [GO:0070412]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; alternative mRNA splicing; via spliceosome [GO:0000380]; androgen receptor signaling pathway [GO:0030521]; BMP signaling pathway [GO:0030509]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; intracellular estrogen receptor signaling pathway [GO:0030520]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; mRNA transcription [GO:0009299]; myoblast differentiation [GO:0045445]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear-transcribed mRNA catabolic process [GO:0000956]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of transcription; DNA-templated [GO:0045893]; pri-miRNA transcription by RNA polymerase II [GO:0061614]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of osteoblast differentiation [GO:0045667]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of skeletal muscle cell differentiation [GO:2001014]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of viral genome replication [GO:0045069],NA,NA,NA
CHOYP_LOC100376688.1.8.m.12067,0.00175539763396486,-0.000524246872600415,No,NA,NA,P84175,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; Golgi apparatus [GO:0005794]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100376708.2.2.m.19660,0.0020765560493829,-0.000502191669640479,No,NA,NA,P28668,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; metal ion binding [GO:0046872]; proline-tRNA ligase activity [GO:0004827]; RNA binding [GO:0003723]; glutamyl-tRNA aminoacylation [GO:0006424]; prolyl-tRNA aminoacylation [GO:0006433],NA,NA,NA
CHOYP_LOC100376733.1.1.m.12140,0.00403747914658039,0.000546849326990089,No,NA,NA,Q803V5,NA,NA,NA,cytoplasm [GO:0005737]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; positive regulation of TOR signaling [GO:0032008]; regulation of actin cytoskeleton organization [GO:0032956]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376749.1.1.m.27252,0.007614115386402,-0.0231248195691594,No,NA,NA,Q5FW12,NA,NA,NA,cytosol [GO:0005829]; chordate embryonic development [GO:0043009]; negative regulation of apoptotic process [GO:0043066]; signal transduction [GO:0007165]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC100376759.2.2.m.59482,-0.00683792692780093,-0.0104967190718984,No,NA,NA,Q8WXX7,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; actin cytoskeleton reorganization [GO:0031532]; axon extension [GO:0048675]; dendrite extension [GO:0097484]; embryonic viscerocranium morphogenesis [GO:0048703]; forebrain neuron development [GO:0021884]; innate vocalization behavior [GO:0098582]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H4-K16 acetylation [GO:2000620]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of transcription by RNA polymerase II [GO:0045944]; righting reflex [GO:0060013],NA,NA,NA
CHOYP_LOC100376802.2.2.m.60631,-0.00280914144956856,0.00462535135465863,No,NA,NA,O76537,NA,NA,NA,N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; peptidoglycan catabolic process [GO:0009253],NA,NA,NA
CHOYP_LOC100376807.1.1.m.22568,-0.00994920322196062,0.00252178741854479,No,NA,NA,Q96DY2,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC100376827.1.1.m.60291,-0.00836430217738311,0.00102564371801327,No,NA,NA,Q5RBM1,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein N-linked glycosylation [GO:0006487],NA,NA,NA
CHOYP_LOC100376857.1.7.m.30171,-0.014341168704966,-0.000667106315851926,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376857.4.7.m.47467,0.00034045684103854,0.000977469383321215,No,NA,NA,Q40588,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC100376863.1.1.m.65235,0.00155464650900822,0.000941299502027395,No,NA,NA,Q04446,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 1;4-alpha-glucan branching enzyme activity [GO:0003844]; 1;4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis) [GO:0102752]; cation binding [GO:0043169]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; generation of precursor metabolites and energy [GO:0006091]; glycogen biosynthetic process [GO:0005978]; glycogen metabolic process [GO:0005977],NA,NA,NA
CHOYP_LOC100376864.2.4.m.20389,-0.00290886340902713,0.0204569198962625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100376880.1.1.m.475,-0.0167944865666904,-0.00131961114693407,No,NA,NA,P70531,NA,NA,NA,dendritic spine [GO:0043197]; postsynaptic density [GO:0014069]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; elongation factor-2 kinase activity [GO:0004686]; cellular response to anoxia [GO:0071454]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of endocytosis [GO:0045807]; positive regulation of synapse assembly [GO:0051965]; protein autophosphorylation [GO:0046777]; regulation of protein autophosphorylation [GO:0031952]; response to ischemia [GO:0002931]; response to prolactin [GO:1990637],NA,NA,NA
CHOYP_LOC100376902.1.1.m.20390,-0.00662574069380202,0.00575282027017271,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100376908.1.4.m.112,0.0128966014618895,0.0143260910841103,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_LOC100376932.1.1.m.12642,0.000859075971321346,0.000650616841517111,No,NA,NA,Q63569,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; P-body [GO:0000932]; perinuclear region of cytoplasm [GO:0048471]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_LOC100376984.1.1.m.15840,-0.00294287838400151,-6.62063183550399e-05,No,NA,NA,Q5U2Q3,NA,NA,NA,nuclear body [GO:0016604]; hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377001.1.2.m.10821,-0.000527579092793567,0.000778789889804885,No,NA,NA,A2T7G9,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154],NA,NA,NA
CHOYP_LOC100377001.2.2.m.52324,-0.003688902094047,0.00500796774656578,No,NA,NA,Q9Z2G9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; protein serine/threonine kinase activity [GO:0004674]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; import into nucleus [GO:0051170]; positive regulation of programmed cell death [GO:0043068]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autophosphorylation [GO:0046777]; regulation of angiogenesis [GO:0045765],NA,NA,NA
CHOYP_LOC100377024.2.2.m.63302,-0.0119055238424043,-0.000898339977368731,No,NA,NA,E9Q7R9,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; sperm axoneme assembly [GO:0007288]; sperm motility [GO:0097722],NA,NA,NA
CHOYP_LOC100377034.1.1.m.6251,0.00225472292124117,-0.000524894321401875,No,NA,NA,Q6GNL7,NA,NA,NA,cytoplasm [GO:0005737]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; hydroxymethyl-; formyl- and related transferase activity [GO:0016742]; oxidoreductase activity; acting on the aldehyde or oxo group of donors; NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],NA,NA,NA
CHOYP_LOC100377054.1.1.m.8489,0.00108045709331484,-0.000425763418770503,No,NA,NA,O35737,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100377058.1.1.m.22299,-0.00682785129990042,0.00395665936493699,No,NA,NA,M0R2J8,NA,NA,NA,intracellular signal transduction [GO:0035556],NA,NA,NA
CHOYP_LOC100377066.1.2.m.18381,0.0013876247921453,-0.00784859414363592,No,NA,NA,Q9EQ06,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; lipid droplet [GO:0005811]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; androgen catabolic process [GO:0006710]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100377077.1.1.m.9907,-0.0189566595923006,0.00861882123441479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377089.1.2.m.5892,0.00522842236399827,-0.000192790541427441,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100377100.1.1.m.51994,-0.000153649274018499,0.00495783260339751,No,NA,NA,Q86WU2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; D-lactate dehydrogenase (cytochrome) activity [GO:0004458]; D-lactate dehydrogenase activity [GO:0008720]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; lactate catabolic process [GO:1903457],NA,NA,NA
CHOYP_LOC100377119.1.1.m.44037,-0.0230438569866266,-0.00195415615287865,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377154.3.4.m.52896,-0.00793995701190513,-0.00143181449341851,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377160.2.2.m.55835,0.00429627199642012,-4.84476022873138e-05,No,NA,NA,P50867,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; cysteine synthase activity [GO:0004124]; L-cysteine desulfhydrase activity [GO:0080146]; pyridoxal phosphate binding [GO:0030170]; cellular amino acid biosynthetic process [GO:0008652]; cysteine biosynthetic process from serine [GO:0006535],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37698,-0.0314309856175587,0.00129891881886434,No,NA,NA,Q969V4,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100377173.1.2.m.37699,-0.0146858676067469,0.0103248715879644,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377184.1.1.m.16090,-0.00260844359951349,-0.00244278715591337,No,NA,NA,Q9DB15,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; mitochondrial transcription [GO:0006390]; positive regulation of transcription; DNA-templated [GO:0045893]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100377200.1.2.m.19811,0.00677345511241037,-0.00189132699330386,No,NA,NA,Q8R2K1,NA,NA,NA,fucose binding [GO:0042806]; L-fucose mutarotase activity [GO:0036373]; racemase and epimerase activity; acting on carbohydrates and derivatives [GO:0016857]; female mating behavior [GO:0060180]; fucose metabolic process [GO:0006004]; fucosylation [GO:0036065]; negative regulation of neuron differentiation [GO:0045665],NA,NA,NA
CHOYP_LOC100377220.1.1.m.36306,-6.52856544113638e-05,0.00866183534253505,No,NA,NA,Q6AX59,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100377233.1.1.m.30409,-0.00337865212344766,0.00549741338300288,No,NA,NA,P08962,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC100377235.1.2.m.30935,0.00769325915012157,0.00256025242835347,No,NA,NA,Q2KIR1,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; snRNA stem-loop binding [GO:0035614]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100377243.1.1.m.6500,-0.00696111612774733,-0.00191094694382819,No,NA,NA,Q8T880,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377244.1.2.m.31458,-0.0248125803347778,-0.003978982744041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377267.1.1.m.49876,0.00745670195258653,0.00510928339824441,No,NA,NA,A2BG43,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; ceramide 1-phosphate binding [GO:1902387]; ceramide 1-phosphate transporter activity [GO:1902388]; intermembrane lipid transfer activity [GO:0120013]; lipid binding [GO:0008289]; ceramide transport [GO:0035627]; intermembrane lipid transfer [GO:0120009],NA,NA,NA
CHOYP_LOC100377311.6.14.m.34688,-5.82890388579079e-05,0.00773355282127548,No,NA,NA,Q8C525,NA,NA,NA,protein-containing complex binding [GO:0044877],NA,NA,NA
CHOYP_LOC100377323.1.1.m.23683,-0.0164672281023413,-0.0165427720763755,No,NA,NA,D4GU72,NA,NA,NA,dTDP-glucose 4;6-dehydratase activity [GO:0008460]; nucleotide-sugar metabolic process [GO:0009225]; protein glycosylation [GO:0006486]; S-layer organization [GO:0045232],NA,NA,NA
CHOYP_LOC100377347.1.1.m.11235,-0.0077615325560227,-0.00717591874107245,No,NA,NA,Q80Y83,NA,NA,NA,axon terminus [GO:0043679]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; neuronal cell body [GO:0043025]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; gamma-tubulin binding [GO:0043015]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein domain specific binding [GO:0019904]; canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cerebellar cortex development [GO:0021695]; cerebral cortex cell migration [GO:0021795]; cerebral cortex radially oriented cell migration [GO:0021799]; forebrain ventricular zone progenitor cell division [GO:0021869]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of axonogenesis [GO:0050772]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microtubule cytoskeleton organization [GO:0070507],NA,NA,NA
CHOYP_LOC100377362.1.1.m.10266,-0.00120806935150792,0.00773279253589398,No,NA,NA,Q99LM2,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cyclin binding [GO:0030332]; MDM2/MDM4 family protein binding [GO:0097371]; mitogen-activated protein kinase binding [GO:0051019]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; ubiquitin-like protein ligase binding [GO:0044389]; apoptotic nuclear changes [GO:0030262]; cell proliferation [GO:0008283]; endoplasmic reticulum unfolded protein response [GO:0030968]; mitotic G2 DNA damage checkpoint [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ufmylation [GO:0071569]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of mitotic cell cycle [GO:0007346]; regulation of phosphatase activity [GO:0010921],NA,NA,NA
CHOYP_LOC100377364.1.2.m.4828,0.00271440071520909,0.00281926428435299,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100377364.2.2.m.52803,0.00526460501499173,0.00297924577674793,No,NA,NA,Q9NRC6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; photoreceptor connecting cilium [GO:0032391]; photoreceptor disc membrane [GO:0097381]; spectrin [GO:0008091]; actin binding [GO:0003779]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; kinesin binding [GO:0019894]; myosin tail binding [GO:0032029]; protein self-association [GO:0043621]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; spectrin binding [GO:0030507]; actin cytoskeleton organization [GO:0030036]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; lysosomal transport [GO:0007041]; MAPK cascade [GO:0000165]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100377378.1.1.m.64418,-0.00359573931092277,-5.47757940599044e-05,No,NA,NA,Q32TF8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377381.1.2.m.29868,-0.00221142036472071,-0.0118569157595474,No,NA,NA,Q99PW8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377381.2.2.m.49035,-0.00556627029752902,-0.000489961851836988,No,NA,NA,Q99PW8,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; dendrite cytoplasm [GO:0032839]; intraciliary transport particle B [GO:0030992]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; anterograde dendritic transport of neurotransmitter receptor complex [GO:0098971]; cell projection organization [GO:0030030]; intraciliary transport [GO:0042073]; microtubule-based movement [GO:0007018]; microtubule-based process [GO:0007017]; protein-containing complex localization [GO:0031503]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100377392.2.4.m.21904,0.0107331052610561,0.00919196947535445,No,NA,NA,P05539,NA,NA,NA,collagen trimer [GO:0005581]; collagen type II trimer [GO:0005585]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cartilage development [GO:0051216]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to mechanical stimulus [GO:0071260]; cellular response to nicotine [GO:0071316]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vitamin E [GO:0071306]; chondrocyte differentiation [GO:0002062]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; growth plate cartilage development [GO:0003417]; notochord development [GO:0030903]; response to fibroblast growth factor [GO:0071774]; response to mechanical stimulus [GO:0009612]; response to X-ray [GO:0010165]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100377392.3.4.m.26363,-0.0273622922984947,-0.0174132952753472,No,NA,NA,Q32KL8,NA,NA,NA,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377392.4.4.m.65974,-0.00488379972109256,-0.00211549848161632,No,NA,NA,Q32KL8,NA,NA,NA,cytosol [GO:0005829]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377398.1.1.m.44441,-0.00859982777389935,-0.00272484836407977,No,NA,NA,Q9N285,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; positive regulation of apoptotic process [GO:0043065],NA,NA,NA
CHOYP_LOC100377412.1.1.m.41404,-0.00361138237101696,-0.000787218458137212,No,NA,NA,Q80Y75,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; motile cilium [GO:0031514]; sperm connecting piece [GO:0097224]; sperm flagellum [GO:0036126]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; axonemal central apparatus assembly [GO:1904158]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC100377435.1.1.m.46017,-0.00498423007588486,-0.00537584475233717,No,NA,NA,Q2KHM9,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; centriole replication [GO:0007099]; protein localization to centrosome [GO:0071539],NA,NA,NA
CHOYP_LOC100377460.1.1.m.38781,0.00306583167785193,-0.00374135313923982,No,NA,NA,Q3ZBD3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; 4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; protein heterooligomerization [GO:0051291]; protein homotetramerization [GO:0051289]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_LOC100377487.1.1.m.27964,-0.000809579537903886,-0.0124956850370029,No,NA,NA,Q91V92,NA,NA,NA,citrate lyase complex [GO:0009346]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATP citrate synthase activity [GO:0003878]; cofactor binding [GO:0048037]; metal ion binding [GO:0046872]; acetyl-CoA biosynthetic process [GO:0006085]; acetyl-CoA metabolic process [GO:0006084]; citrate metabolic process [GO:0006101]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107],NA,NA,NA
CHOYP_LOC100377495.1.1.m.17707,-0.00465883746754949,-0.0049139787450519,No,NA,NA,Q03164,NA,NA,NA,cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; AT DNA binding [GO:0003680]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; identical protein binding [GO:0042802]; lysine-acetylated histone binding [GO:0070577]; protein homodimerization activity [GO:0042803]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; unmethylated CpG binding [GO:0045322]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; circadian regulation of gene expression [GO:0032922]; embryonic hemopoiesis [GO:0035162]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; negative regulation of DNA methylation [GO:1905642]; positive regulation of cellular response to drug [GO:2001040]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transporter activity [GO:0032411]; protein-containing complex assembly [GO:0065003]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of histone H3-K14 acetylation [GO:0071440]; regulation of histone H3-K9 acetylation [GO:2000615]; regulation of megakaryocyte differentiation [GO:0045652]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377501.1.1.m.13155,-0.0179880585873884,0.0267542642232254,No,NA,NA,Q7ZWS1,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; metal ion binding [GO:0046872]; tRNA dihydrouridine synthase activity [GO:0017150],NA,NA,NA
CHOYP_LOC100377541.2.4.m.15307,0.00863697938573421,0.00567673430167173,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100377560.1.1.m.66612,0.000458687771826424,0.000317052163682272,No,NA,NA,O75486,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; STAGA complex [GO:0030914]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; histone deubiquitination [GO:0016578]; histone H3 acetylation [GO:0043966]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100377596.1.1.m.7350,-0.00565629794529822,0.00600304298594285,No,NA,NA,Q571G4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC100377647.1.2.m.10110,-0.0162065402928416,-0.0103138022367589,No,NA,NA,Q5VZQ5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377677.1.2.m.23471,-0.0095061274745573,-0.00604967605907286,No,NA,NA,P15848,NA,NA,NA,azurophil granule lumen [GO:0035578]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; chondroitin sulfate catabolic process [GO:0030207]; colon epithelial cell migration [GO:0061580]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; neutrophil degranulation [GO:0043312]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377677.2.2.m.27049,-0.00104027125291838,0.00347186893866345,No,NA,NA,P50430,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; rough endoplasmic reticulum [GO:0005791]; arylsulfatase activity [GO:0004065]; metal ion binding [GO:0046872]; N-acetylgalactosamine-4-sulfatase activity [GO:0003943]; sulfuric ester hydrolase activity [GO:0008484]; autophagy [GO:0006914]; central nervous system development [GO:0007417]; colon epithelial cell migration [GO:0061580]; positive regulation of neuron projection development [GO:0010976]; regulation of epithelial cell migration [GO:0010632]; response to estrogen [GO:0043627]; response to methylmercury [GO:0051597]; response to nutrient [GO:0007584]; response to pH [GO:0009268],NA,NA,NA
CHOYP_LOC100377682.1.1.m.31441,-0.000863101444825064,0.00192619635789088,No,NA,NA,Q8TDX5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; aminocarboxymuconate-semialdehyde decarboxylase activity [GO:0001760]; hydrolase activity [GO:0016787]; zinc ion binding [GO:0008270]; negative regulation of quinolinate biosynthetic process [GO:1904985]; picolinic acid biosynthetic process [GO:1905004]; protein complex oligomerization [GO:0051259]; regulation of 'de novo' NAD biosynthetic process from tryptophan [GO:1905012]; secondary metabolic process [GO:0019748]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC100377736.1.1.m.251,-0.00281387224747864,-0.0163263033315166,No,NA,NA,P97478,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; 2-octoprenyl-3-methyl-6-methoxy-1;4-benzoquinone hydroxylase activity [GO:0008682]; chromatin binding [GO:0003682]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; age-dependent response to oxidative stress [GO:0001306]; cellular response to oxidative stress [GO:0034599]; determination of adult lifespan [GO:0008340]; in utero embryonic development [GO:0001701]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrion morphogenesis [GO:0070584]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube formation [GO:0001841]; neurogenesis [GO:0022008]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of reactive oxygen species metabolic process [GO:2000377]; respiratory electron transport chain [GO:0022904]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100377751.1.1.m.26359,-0.00988925410758609,0.00705859969250343,No,NA,NA,Q8TBY9,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1005,0.0173275708994186,0.00379828112835696,No,NA,NA,O75534,NA,NA,NA,CRD-mediated mRNA stability complex [GO:0070937]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; male gonad development [GO:0008584]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100377755.1.1.m.1006,-0.0116126888369221,-0.00491700600411956,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377759.10.15.m.45798,-0.00490295315026942,-0.00510851362221412,No,NA,NA,A6QPC8,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Smc5-Smc6 complex [GO:0030915]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of response to DNA damage stimulus [GO:2001022],NA,NA,NA
CHOYP_LOC100377759.15.15.m.64824,0.00432560550883848,0.00510842882764335,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377771.1.1.m.7044,-0.00372986479062065,3.34054349190468e-05,No,NA,NA,Q4R7V3,NA,NA,NA,cell projection [GO:0042995]; centriole [GO:0005814]; cell projection organization [GO:0030030]; microtubule anchoring [GO:0034453],NA,NA,NA
CHOYP_LOC100377780.8.11.m.53259,-0.0201521317259073,0.000987004905968205,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC100377783.1.1.m.14549,0.00184267789124728,-0.00107563958188336,No,NA,NA,P56399,NA,NA,NA,cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100377837.2.2.m.7996,-0.00740735923439569,0.0105922684726834,No,NA,NA,Q6P5B0,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730],NA,NA,NA
CHOYP_LOC100377856.2.2.m.43339,-0.00187064832135152,-0.00414773041269804,No,NA,NA,Q9Z221,NA,NA,NA,outer dense fiber [GO:0001520]; sperm connecting piece [GO:0097224]; cytoskeleton organization [GO:0007010]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100377864.1.1.m.33298,-0.00665912895337968,0.0163505351543039,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377872.1.1.m.30372,-0.00441169668341753,0.000241335402571107,No,NA,NA,Q16513,NA,NA,NA,apical junction complex [GO:0043296]; centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; midbody [GO:0030496]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; GTP-Rho binding [GO:0017049]; histone deacetylase binding [GO:0042826]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; apical junction assembly [GO:0043297]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell projection organization [GO:0030030]; epithelial cell migration [GO:0010631]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cytokinesis [GO:0032467]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of cell motility [GO:2000145]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100377901.1.1.m.7173,0.00526054470591512,-0.00393450466902478,No,NA,NA,Q62077,NA,NA,NA,cell projection [GO:0042995]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; Schaffer collateral - CA1 synapse [GO:0098685]; calcium ion binding [GO:0005509]; glutamate receptor binding [GO:0035254]; insulin receptor binding [GO:0005158]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; in utero embryonic development [GO:0001701]; inositol trisphosphate biosynthetic process [GO:0032959]; modulation of chemical synaptic transmission [GO:0050804]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein secretion [GO:0009306]; regulation of store-operated calcium channel activity [GO:1901339]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100377934.1.1.m.48699,0.00403629540119853,-0.00109072230211097,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100377974.1.1.m.6543,-0.00315285153926763,0.00428023797211718,No,NA,NA,Q96LI9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100377982.1.1.m.43510,-0.00359623637405385,0.00488216691881085,No,NA,NA,Q9QXE5,NA,NA,NA,endosome [GO:0005768]; lysosome [GO:0005764]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100378002.1.1.m.47564,-0.0048011886653416,0.00319704474884116,No,NA,NA,Q6DFB8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC100378011.2.2.m.52041,-0.00729134629337881,-0.0145221734086656,No,NA,NA,Q5UQ35,NA,NA,NA,metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842],NA,NA,NA
CHOYP_LOC100378054.4.4.m.63855,0.00134695487663059,-0.00181195170167853,No,NA,NA,Q9VXX8,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; metal ion binding [GO:0046872]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_LOC100378071.1.1.m.40488,-0.00641484859344134,-0.00109286835681894,No,NA,NA,Q16960,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motor activity [GO:0003774],NA,NA,NA
CHOYP_LOC100378083.1.3.m.26711,-0.0290009784178976,-0.0140335036859077,No,NA,NA,Q9BYX4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; ribonucleoprotein complex binding [GO:0043021]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; MDA-5 signaling pathway [GO:0039530]; negative regulation of type I interferon production [GO:0032480]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of tumor necrosis factor secretion [GO:1904469]; protein deubiquitination [GO:0016579]; protein sumoylation [GO:0016925]; regulation of type III interferon production [GO:0034344]; response to virus [GO:0009615]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378083.3.3.m.65631,0.00632525635448331,0.0216667733803536,No,NA,NA,Q6Q899,NA,NA,NA,actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; single-stranded RNA binding [GO:0003727]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; detection of virus [GO:0009597]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interferon-alpha secretion [GO:1902741]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interferon-beta secretion [GO:0035549]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-6 secretion [GO:2000778]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor secretion [GO:1904469]; regulation of cell migration [GO:0030334]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22676,0.0013913544137742,0.00159435956750859,No,NA,NA,Q7LBC6,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K9 specific) [GO:0032454]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; histone H3-K9 demethylation [GO:0033169]; response to cisplatin [GO:0072718],NA,NA,NA
CHOYP_LOC100378099.1.1.m.22677,0.0041719546712419,-0.00920255271846868,No,NA,NA,P81942,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364],NA,NA,NA
CHOYP_LOC100378116.1.3.m.22707,-0.0037356942039112,0.00507149162738979,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378116.3.3.m.60538,0.00733977734517897,-0.0026832250083118,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378195.1.1.m.46024,-0.00705477450132312,-0.00783209913308614,No,NA,NA,Q1LV46,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC100378204.1.1.m.40064,-0.00118560839079735,0.00498363667868161,No,NA,NA,Q7ZUX6,NA,NA,NA,cofactor binding [GO:0048037]; deoxyhypusine monooxygenase activity [GO:0019135]; iron ion binding [GO:0005506]; peptidyl-lysine modification to peptidyl-hypusine [GO:0008612],NA,NA,NA
CHOYP_LOC100378209.1.2.m.7335,-0.0098653034983873,0.0120729900874063,No,NA,NA,P25490,NA,NA,NA,cytoplasm [GO:0005737]; Ino80 complex [GO:0031011]; nuclear chromatin [GO:0000790]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; enhancer sequence-specific DNA binding [GO:0001158]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; anterior/posterior pattern specification [GO:0009952]; camera-type eye morphogenesis [GO:0048593]; cell differentiation [GO:0030154]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; cellular response to UV [GO:0034644]; chromosome organization [GO:0051276]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deubiquitination [GO:0016579]; regulation of transcription by RNA polymerase II [GO:0006357]; response to prostaglandin F [GO:0034696]; response to UV-C [GO:0010225]; RNA localization [GO:0006403]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100378221.1.1.m.29052,0.000144792109530081,-0.00091862979338053,No,NA,NA,Q8K4K5,NA,NA,NA,axon [GO:0030424]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; Golgi cis cisterna [GO:0000137]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; axonogenesis [GO:0007409]; cortical actin cytoskeleton organization [GO:0030866]; establishment of spindle orientation [GO:0051294]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100378252.1.1.m.16877,0.00159202188890475,1.67103331676984e-05,No,NA,NA,Q5ZIQ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100378255.1.1.m.63185,-0.0166039383161541,0.00995949030091163,No,NA,NA,Q8NHU2,NA,NA,NA,axoneme [GO:0005930]; motile cilium [GO:0031514]; cilium movement [GO:0003341]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378269.1.2.m.12226,-0.00612276863480405,-0.00127451900735316,No,NA,NA,Q2NL11,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378295.1.4.m.3278,0.00184207575946879,0.00217544408364234,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100378322.1.1.m.16268,-0.00291664519489174,-0.01189445410519,No,NA,NA,Q4V8C9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378331.1.1.m.47480,-0.00865667845809374,-0.00342586232614965,No,NA,NA,Q8TD57,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium movement [GO:0003341]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100378364.1.1.m.53053,0.00159571008265769,-0.00118316399860809,No,NA,NA,Q0V8S0,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; ESCRT-0 complex [GO:0033565]; lysosome [GO:0005764]; multivesicular body membrane [GO:0032585]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; ubiquitin-like protein ligase binding [GO:0044389]; membrane invagination [GO:0010324]; negative regulation of angiogenesis [GO:0016525]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of gene expression [GO:0010628]; protein localization to membrane [GO:0072657]; protein targeting to lysosome [GO:0006622]; regulation of MAP kinase activity [GO:0043405],NA,NA,NA
CHOYP_LOC100378410.1.1.m.18106,-0.0261416381087271,0.0245799864619932,No,NA,NA,Q8IZL8,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; cellular response to estrogen stimulus [GO:0071391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378414.1.1.m.34038,-0.00211292833023206,0.00887476276364118,No,NA,NA,B4PZ52,NA,NA,NA,mitochondrion [GO:0005739]; iron ion binding [GO:0005506]; iron-sulfur cluster binding [GO:0051536]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_LOC100378430.1.1.m.63142,-0.010365741491916,-0.00550736816080731,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100378445.1.1.m.7111,-0.000405017528800922,-0.0104596286038454,No,NA,NA,Q5SSI6,NA,NA,NA,nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100378487.1.1.m.64108,-0.0092110413068304,0.00175431686050843,No,NA,NA,Q7SXN4,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; messenger ribonucleoprotein complex [GO:1990124]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; ribosome binding [GO:0043022]; translation factor activity; RNA binding [GO:0008135]; translation repressor activity; mRNA regulatory element binding [GO:0000900]; cellular response to amino acid stimulus [GO:0071230]; cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; ionotropic glutamate receptor signaling pathway [GO:0035235]; negative regulation of cytoplasmic translation [GO:2000766]; negative regulation of neuron apoptotic process [GO:0043524]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_LOC100378510.1.1.m.9865,0.0124248001672653,-0.00126769891093943,No,NA,NA,Q14318,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; apoptotic process [GO:0006915]; camera-type eye development [GO:0043010]; cell fate specification [GO:0001708]; dorsal/ventral neural tube patterning [GO:0021904]; intracellular signal transduction [GO:0035556]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of BMP signaling pathway [GO:0030513]; smoothened signaling pathway [GO:0007224]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378526.1.1.m.16747,0.000737642012768336,-0.00422053489269536,No,NA,NA,Q5ZJU4,NA,NA,NA,cytosol [GO:0005829]; sulfur carrier activity [GO:0097163]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC100378553.1.1.m.7444,-0.00419700439364202,0.0113469750859935,No,NA,NA,Q8BMQ3,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; endochondral bone growth [GO:0003416]; mesenchyme development [GO:0060485]; roof of mouth development [GO:0060021]; tongue development [GO:0043586],NA,NA,NA
CHOYP_LOC100378570.1.1.m.25501,-0.00934974661810191,-0.00886153028858433,No,NA,NA,O15527,NA,NA,NA,mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; 8-oxo-7;8-dihydroguanine DNA N-glycosylase activity [GO:0034039]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; endonuclease activity [GO:0004519]; microtubule binding [GO:0008017]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; acute inflammatory response [GO:0002526]; aging [GO:0007568]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; cellular response to cadmium ion [GO:0071276]; cellular response to DNA damage stimulus [GO:0006974]; depurination [GO:0045007]; depyrimidination [GO:0045008]; negative regulation of apoptotic process [GO:0043066]; negative regulation of double-strand break repair via single-strand annealing [GO:1901291]; nucleotide-excision repair; DNA incision [GO:0033683]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to light stimulus [GO:0009416]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC100378584.1.3.m.38091,-0.00951866865596068,-0.00640090799186251,No,NA,NA,Q28I85,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378607.1.2.m.17330,-0.00453805662753532,-0.00121003111207706,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378615.1.2.m.25321,0.00295074859595551,-0.000797376549936264,No,NA,NA,Q9NRA2,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672]; carbohydrate:proton symporter activity [GO:0005351]; sialic acid transmembrane transporter activity [GO:0015136]; sialic acid:proton symporter activity [GO:0015538]; amino acid transport [GO:0006865]; anion transport [GO:0006820]; ion transport [GO:0006811]; response to bacterium [GO:0009617]; sialic acid transport [GO:0015739],NA,NA,NA
CHOYP_LOC100378618.1.1.m.48704,-0.010967383390924,0.00552140135561054,No,NA,NA,Q6ZU80,NA,NA,NA,centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; spindle pole [GO:0000922]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100378619.1.2.m.21468,0.00682874274897767,-0.00830523793567542,No,NA,NA,Q8N9Z9,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378619.2.2.m.36047,-0.0159387357328801,0.0134807748905099,No,NA,NA,Q8N9Z9,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; nuclear envelope [GO:0005635]; structural molecule activity [GO:0005198]; cell proliferation [GO:0008283],NA,NA,NA
CHOYP_LOC100378642.1.1.m.54868,0.00605519882167519,0.0208326106501293,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378644.2.2.m.58497,-0.00285177120046424,-0.00206311659023664,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378652.1.1.m.5656,-0.00700343396381107,-0.00455218982142845,No,NA,NA,Q8BKE9,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; intraciliary transport particle B [GO:0030992]; nucleus [GO:0005634]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; epidermis development [GO:0008544]; heart development [GO:0007507]; intraciliary transport [GO:0042073]; intraciliary transport involved in cilium assembly [GO:0035735]; keratinocyte development [GO:0003334]; negative regulation of epithelial cell proliferation [GO:0050680]; non-motile cilium assembly [GO:1905515]; Notch signaling pathway [GO:0007219]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5657,-0.00231312215801776,0.00671882783511785,No,NA,NA,O75197,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378652.1.1.m.5658,-0.00332826410184415,-0.000616685025893465,No,NA,NA,O75096,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; limb development [GO:0060173]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100378653.1.3.m.42107,-0.0087163949490562,-0.00554709222928705,No,NA,NA,P47967,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100378658.1.1.m.38454,-7.92794175547511e-05,0.0105184709734915,No,NA,NA,Q5EAD5,NA,NA,NA,CAAX-protein geranylgeranyltransferase complex [GO:0005953]; CAAX-protein geranylgeranyltransferase activity [GO:0004662]; protein geranylgeranyltransferase activity [GO:0004661]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344]; protein prenylation [GO:0018342],NA,NA,NA
CHOYP_LOC100378676.3.8.m.43012,0.00372742362631779,0.0178744053557162,No,NA,NA,Q6ZRF8,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; ion channel binding [GO:0044325]; zinc ion binding [GO:0008270]; cell-cell signaling involved in cardiac conduction [GO:0086019]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of gene expression [GO:0010628]; positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:1903954]; positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903762]; regulation of cardiac muscle contraction [GO:0055117]; regulation of heart looping [GO:1901207],NA,NA,NA
CHOYP_LOC100378691.2.2.m.40118,-0.00387798819130145,-0.00225867264110375,No,NA,NA,Q2KI56,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100378714.2.4.m.30802,0.00229490194660413,0.00036547004961133,No,NA,NA,Q8IT98,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100378719.1.1.m.7367,-4.41242172530162e-07,0.00309900138503512,No,NA,NA,Q6UUV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cAMP response element binding protein binding [GO:0008140]; energy homeostasis [GO:0097009]; entrainment of circadian clock by photoperiod [GO:0043153]; memory [GO:0007613]; negative regulation of membrane hyperpolarization [GO:1902631]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendrite development [GO:1900006]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse to nucleus signaling pathway [GO:0099527]; protein homotetramerization [GO:0051289]; rhythmic process [GO:0048511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100378760.1.1.m.37015,0.000533445809551079,-0.000693831780555862,No,NA,NA,P68037,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle phase transition [GO:0044770]; cell proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of transcription; DNA-templated [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100378816.1.1.m.10997,-0.0256766179306665,-0.011365980599042,No,NA,NA,Q4R642,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; sperm flagellum [GO:0036126]; flagellated sperm motility [GO:0030317],NA,NA,NA
CHOYP_LOC100378818.2.2.m.27217,0.011353447022646,0.00348505442527269,No,NA,NA,O95671,NA,NA,NA,cytosol [GO:0005829]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; O-methyltransferase activity [GO:0008171],NA,NA,NA
CHOYP_LOC100378821.1.1.m.8967,0.00108656986113629,0.0152623956015664,No,NA,NA,Q4R6F0,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100378839.1.1.m.21328,-0.00488361360510813,0.00360159675736434,No,NA,NA,Q86UC2,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC100378844.1.4.m.7322,-0.00968241076141372,0.00324329306297501,No,NA,NA,B5X5D0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378848.1.1.m.29949,0.00533885546013817,0.00401380847181792,No,NA,NA,Q96JC1,NA,NA,NA,AP-3 adaptor complex [GO:0030123]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; late endosome to lysosome transport [GO:1902774]; retrograde transport; endosome to plasma membrane [GO:1990126]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100378849.1.1.m.21445,-0.0114101079136613,-0.00282775316369109,No,NA,NA,Q8BJM3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378873.3.3.m.30410,-0.0316272683086511,0.00662979819032435,No,NA,NA,Q9H0J4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100378881.1.1.m.29212,-0.0024320616165705,-0.0011027727306354,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378892.1.1.m.41502,5.92438750115913e-05,-0.00248086962048991,No,NA,NA,Q7ZYB4,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],NA,NA,NA
CHOYP_LOC100378901.1.2.m.29418,-0.00318430870275467,0.000716330569885041,No,NA,NA,P31331,NA,NA,NA,extracellular region [GO:0005576]; hemoglobin complex [GO:0005833]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC100378967.1.1.m.62298,-0.00270149480645482,0.00433786500882467,No,NA,NA,B0BM24,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; photoreceptor connecting cilium [GO:0032391]; cilium organization [GO:0044782],NA,NA,NA
CHOYP_LOC100378969.2.2.m.31240,0.00618608721580412,-0.00127485263370581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100378993.1.1.m.13997,0.00426607712549321,-0.00555789464100897,No,NA,NA,Q13029,NA,NA,NA,Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; determination of adult lifespan [GO:0008340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100378999.1.1.m.36850,-0.0176311693920715,-0.0112204326788328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100379008.4.4.m.54023,-0.0067655201753893,0.00918018880237681,No,NA,NA,Q12912,NA,NA,NA,azurophil granule membrane [GO:0035577]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922]; neutrophil degranulation [GO:0043312]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],NA,NA,NA
CHOYP_LOC100379027.1.1.m.27022,-0.0104464624522677,0.00957480199816376,No,NA,NA,Q5RK00,NA,NA,NA,cell junction [GO:0030054]; mitochondrial large ribosomal subunit [GO:0005762]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC100379049.1.1.m.51860,-0.00353604995409475,0.0110719587298413,No,NA,NA,A6N6J5,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle A [GO:0030991]; phosphatidylinositol binding [GO:0035091]; cellular response to glucose stimulus [GO:0071333]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to paclitaxel [GO:1905705]; cellular response to tumor necrosis factor [GO:0071356]; cilium assembly [GO:0060271]; intraciliary retrograde transport [GO:0035721]; liver regeneration [GO:0097421]; negative regulation of blood vessel diameter [GO:0097756]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; protein localization to cilium [GO:0061512]; response to lipopolysaccharide [GO:0032496]; response to paclitaxel [GO:1901555]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_LOC100462678.2.2.m.28619,0.00497850063702482,0.0058794811779883,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100465916.1.1.m.44328,0.00470075951756212,-0.00127027948478273,No,NA,NA,Q5R8X6,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_LOC100471656.2.2.m.34266,7.38381960161138e-05,0.0135347468115811,No,NA,NA,Q6P360,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; endoplasmic reticulum unfolded protein response [GO:0030968]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100476601.1.1.m.9343,0.0132324003021095,0.000673495275730571,No,NA,NA,A6H619,NA,NA,NA,metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; mRNA processing [GO:0006397]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100485159.1.1.m.30340,-0.00319671565725927,0.00208309348764934,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485247.1.1.m.37690,0.0154986277815329,-0.00711355452373054,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485356.1.1.m.21339,0.0025852340298543,-0.000698604074345249,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485383.1.1.m.52650,-0.0275323388979783,-0.00705652992995562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100485536.1.1.m.48204,0.00108449954110306,-0.00823978783202472,No,NA,NA,A7SCH8,NA,NA,NA,cytoplasm [GO:0005737]; kynureninase activity [GO:0030429]; pyridoxal phosphate binding [GO:0030170]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; L-kynurenine catabolic process [GO:0097053]; quinolinate biosynthetic process [GO:0019805]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_LOC100485604.1.1.m.45268,-0.011043959821469,-0.00702834876853099,No,NA,NA,O43903,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule binding [GO:0008017]; antral ovarian follicle growth [GO:0001547]; apoptotic process [GO:0006915]; basement membrane organization [GO:0071711]; cell cycle arrest [GO:0007050]; initiation of primordial ovarian follicle growth [GO:0001544]; ovulation [GO:0030728]; regulation of cell shape [GO:0008360]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_LOC100486001.1.1.m.6209,0,0,No,NA,NA,Q8IX29,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100486063.2.9.m.5918,-0.00424601021398152,-0.00443568927005427,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486063.5.9.m.39538,0.00566640356242738,0.00363651338154034,No,NA,NA,P12111,NA,NA,NA,collagen type VI trimer [GO:0005589]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC100486063.6.9.m.44250,0.00197328645613689,-0.000533238361474463,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100486357.1.1.m.51050,-0.00163312996386413,0.0229074125213289,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100486738.1.2.m.63464,0.0200923252758345,-0.0198854323841807,No,NA,NA,Q99KF0,NA,NA,NA,cytoplasm [GO:0005737]; CARD domain binding [GO:0050700]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein phosphorylation [GO:0001934]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100487213.2.4.m.53374,-0.00172270355324724,0.00105896079770482,No,NA,NA,E7F568,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; auditory receptor cell stereocilium organization [GO:0060088]; cilium assembly [GO:0060271]; heart jogging [GO:0003146]; heart looping [GO:0001947],NA,NA,NA
CHOYP_LOC100488715.1.1.m.61241,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100488894.1.5.m.4048,-0.000191582116878307,-0.00304754141382243,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100489126.1.1.m.18822,0.00713416355355861,-0.00924172239981832,No,NA,NA,Q0V8M0,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447],NA,NA,NA
CHOYP_LOC100489926.1.3.m.3642,-0.00816183854376272,-0.00557769257761615,No,NA,NA,Q14676,NA,NA,NA,chromosome [GO:0005694]; focal adhesion [GO:0005925]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; FHA domain binding [GO:0070975]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; double-strand break repair via nonhomologous end joining [GO:0006303]; intra-S DNA damage checkpoint [GO:0031573],NA,NA,NA
CHOYP_LOC100489929.1.1.m.51437,0.0166408077578627,0.00942759392957402,No,NA,NA,O73746,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100490321.2.2.m.54266,0.00317196792631866,0.0037460125205725,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100490454.1.1.m.64455,0.00147008848664008,0.00137783700759384,No,NA,NA,Q9DBL7,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; dephospho-CoA kinase activity [GO:0004140]; pantetheine-phosphate adenylyltransferase activity [GO:0004595]; coenzyme A biosynthetic process [GO:0015937],NA,NA,NA
CHOYP_LOC100491753.1.3.m.45589,-0.00277362912047992,0.00376541443014022,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100491886.1.1.m.26703,-0.0289241156432442,-0.0184072357966079,No,NA,NA,P55113,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; pharyngeal pumping [GO:0043050]; pharynx development [GO:0060465],NA,NA,NA
CHOYP_LOC100492442.1.1.m.16466,-0.00624361468603178,0.000772099514101509,No,NA,NA,Q08379,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905]; asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; spindle assembly involved in meiosis [GO:0090306],NA,NA,NA
CHOYP_LOC100492576.1.1.m.7775,0.00135250843139842,0.000839910109752417,No,NA,NA,Q14697,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; glucosidase II complex [GO:0017177]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; carbohydrate binding [GO:0030246]; glucan 1;3-alpha-glucosidase activity [GO:0033919]; RNA binding [GO:0003723]; carbohydrate metabolic process [GO:0005975]; N-glycan processing [GO:0006491],NA,NA,NA
CHOYP_LOC100492683.1.1.m.63753,0.00562032420247422,0.0242577035446332,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100493179.5.15.m.32003,-0.00301939170594031,-0.00326106116167443,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493440.1.2.m.17291,0.00822454822266815,-0.0106788496106537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100493600.1.1.m.58682,-0.00354075407354624,-0.00103307667560462,No,NA,NA,Q3U5Q7,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; cytidylate kinase activity [GO:0004127]; nucleoside diphosphate kinase activity [GO:0004550]; thymidylate kinase activity [GO:0004798]; UMP kinase activity [GO:0033862]; uridylate kinase activity [GO:0009041]; cellular response to lipopolysaccharide [GO:0071222]; dTDP biosynthetic process [GO:0006233]; dTTP biosynthetic process [GO:0006235]; dUDP biosynthetic process [GO:0006227]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_LOC100495846.1.1.m.11305,-0.00243172509857103,0.00146349514386427,No,NA,NA,O88554,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; base-excision repair [GO:0006284]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of neuron death [GO:1901215]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_LOC100496973.2.8.m.19997,0.0115309342748027,-0.0209342105908127,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100496973.4.8.m.55256,-0.00707959436731348,-0.0115123576913677,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100497129.3.8.m.32060,0.00837268692721254,0.0106196704185224,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.6.8.m.41866,-0.022030004655404,-0.0140198405819577,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100497129.7.8.m.41875,0.012426531773998,0.00330417569165261,No,NA,NA,Q2PC93,NA,NA,NA,extracellular space [GO:0005615]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100498109.3.3.m.55841,-0.00892727852088639,-0.0056812980138368,No,NA,NA,Q96DM1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100502592.1.1.m.27996,-0.0119556338288284,-0.00760853585636072,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100524481.1.1.m.14740,0.0174523681090178,-0.0133751297757616,No,NA,NA,Q99PL6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of membrane [GO:0019898]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236],NA,NA,NA
CHOYP_LOC100533218.1.1.m.56993,-0.00908725069500874,0.0183229673657889,No,NA,NA,O55173,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; 3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; insulin receptor binding [GO:0005158]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; hyperosmotic response [GO:0006972]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; type B pancreatic cell development [GO:0003323],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13989,0.00534560912578571,-0.00132494122357831,No,NA,NA,Q9Z139,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; astrocyte development [GO:0014002]; inner ear development [GO:0048839]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100533220.2.2.m.13990,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533220.2.2.m.13991,-0.000100139781602998,0.0132861393104394,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533225.1.2.m.36896,-0.0125688387807485,0.0101813671222478,No,NA,NA,Q6QM28,NA,NA,NA,cell junction [GO:0030054]; cell projection [GO:0042995]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31982,0.00288174132797342,-0.00658373343641256,No,NA,NA,P04755,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533245.3.6.m.31983,0,0,No,NA,NA,P04755,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165]; synaptic transmission; cholinergic [GO:0007271],NA,NA,NA
CHOYP_LOC100533258.6.6.m.48142,0.00251580462329258,0.000528703437990055,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533258.6.6.m.48143,0.00307653167635056,0.000583266815621184,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533261.1.1.m.36141,-0.00276135354376522,0.0022749079382631,No,NA,NA,P06603,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_LOC100533283.1.1.m.54357,0.00238147804074783,-0.000466219241523393,No,NA,NA,Q5ZKI0,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection [GO:0043005]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683],NA,NA,NA
CHOYP_LOC100533284.1.2.m.25143,-0.00622950900119834,0.00881866036215755,No,NA,NA,F1M7Y5,NA,NA,NA,apical plasma membrane [GO:0016324]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; Schmidt-Lanterman incisure [GO:0043220]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase C activity [GO:0004697]; protein serine/threonine kinase activity [GO:0004674]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; cell-cell junction organization [GO:0045216]; cellular protein localization [GO:0034613]; cellular response to insulin stimulus [GO:0032869]; establishment of apical/basal cell polarity [GO:0035089]; eye photoreceptor cell development [GO:0042462]; Golgi vesicle budding [GO:0048194]; intracellular signal transduction [GO:0035556]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron apoptotic process [GO:0043524]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of glucose import [GO:0046326]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein phosphorylation [GO:0006468]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_LOC100533289.6.6.m.59221,-0.0128819820358166,-0.0022195618221508,No,NA,NA,P24524,NA,NA,NA,cell junction [GO:0030054]; dendrite [GO:0030425]; glycine-gated chloride channel complex [GO:0016935]; glycinergic synapse [GO:0098690]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; synapse [GO:0045202]; extracellularly glycine-gated chloride channel activity [GO:0016934]; glycine binding [GO:0016594]; glycine-gated chloride ion channel activity [GO:0022852]; metal ion binding [GO:0046872]; transmembrane signaling receptor activity [GO:0004888]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ethanol [GO:0071361]; cellular response to zinc ion [GO:0071294]; chemical synaptic transmission [GO:0007268]; chloride transmembrane transport [GO:1902476]; ion transmembrane transport [GO:0034220]; nervous system process [GO:0050877]; neuropeptide signaling pathway [GO:0007218]; regulation of membrane potential [GO:0042391]; response to amino acid [GO:0043200]; signal transduction [GO:0007165]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_LOC100533290.1.1.m.9001,-0.0013324903934554,-0.00530323730522698,No,NA,NA,Q9R152,NA,NA,NA,nucleolus [GO:0005730]; site of DNA damage [GO:0090734]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_LOC100533294.1.3.m.35108,7.09163870530915e-05,0.00225903803406244,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533294.2.3.m.36820,0.00914966980117914,-0.00382978515707906,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100533315.1.3.m.40003,-0.00404058263383737,-0.0192469474974437,No,NA,NA,Q38PU3,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; dendritic spine [GO:0043197]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; extracellularly glutamate-gated ion channel activity [GO:0005234]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100533316.2.2.m.47773,0.00410328600267752,-0.0110351575348862,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100533319.1.2.m.46,-0.00256136689271087,0.0208357728823203,No,NA,NA,P17972,NA,NA,NA,axon [GO:0030424]; dendrite membrane [GO:0032590]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; voltage-gated potassium channel complex [GO:0008076]; delayed rectifier potassium channel activity [GO:0005251]; voltage-gated cation channel activity [GO:0022843]; voltage-gated potassium channel activity [GO:0005249]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; protein homooligomerization [GO:0051260]; regulation of ion transmembrane transport [GO:0034765]; sleep [GO:0030431],NA,NA,NA
CHOYP_LOC100533325.1.1.m.55617,-0.00400185364582295,-0.00212132917851693,No,NA,NA,O75976,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; metallocarboxypeptidase activity [GO:0004181]; serine-type carboxypeptidase activity [GO:0004185]; zinc ion binding [GO:0008270]; peptide metabolic process [GO:0006518]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC100533330.1.2.m.2565,-0.0127889925335602,0.00265498965199717,No,NA,NA,P25228,NA,NA,NA,cell junction [GO:0030054]; endosome [GO:0005768]; plasma membrane [GO:0005886]; presynaptic active zone [GO:0048786]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; cytoskeletal matrix organization at active zone [GO:0048789]; intracellular protein transport [GO:0006886]; maintenance of presynaptic active zone structure [GO:0048790]; neurotransmitter secretion [GO:0007269]; protein localization to plasma membrane [GO:0072659]; protein secretion [GO:0009306]; Rab protein signal transduction [GO:0032482]; regulation of exocytosis [GO:0017157]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; regulation of synaptic vesicle fusion to presynaptic active zone membrane [GO:0031630]; vesicle docking involved in exocytosis [GO:0006904]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533341.1.1.m.1846,-0.00222236366224007,-0.00185797194462442,No,NA,NA,O35344,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; nuclear import signal receptor activity [GO:0061608]; protein C-terminus binding [GO:0008022]; protein transporter activity [GO:0008565]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100533349.3.5.m.52212,0.00996610301455703,0.00177296514518873,No,NA,NA,Q9VF87,NA,NA,NA,apical part of cell [GO:0045177]; cytoplasm [GO:0005737]; neuron projection [GO:0043005]; SCAR complex [GO:0031209]; synapse [GO:0045202]; RNA 7-methylguanosine cap binding [GO:0000340]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; centripetally migrating follicle cell migration [GO:0060269]; chaeta development [GO:0022416]; compound eye morphogenesis [GO:0001745]; cortical actin cytoskeleton organization [GO:0030866]; positive regulation of filopodium assembly [GO:0051491]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC100533356.6.6.m.63561,-0.00318296096261924,0.0139740684437655,No,NA,NA,O01393,NA,NA,NA,cell-cell junction [GO:0005911]; gap junction [GO:0005921]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; gap junction channel activity [GO:0005243]; gap junction hemi-channel activity [GO:0055077]; ion transmembrane transport [GO:0034220],NA,NA,NA
CHOYP_LOC100533357.1.2.m.56848,-0.00100351147630784,-0.00097053595885382,No,NA,NA,P34121,NA,NA,NA,actin cytoskeleton [GO:0015629]; phagocytic vesicle [GO:0045335]; actin filament binding [GO:0051015]; regulation of actin filament polymerization [GO:0030833]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100533383.1.2.m.10358,0.0194045860867207,0.00816465515312529,No,NA,NA,P35224,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cadherin binding [GO:0045296]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100533384.3.5.m.37350,0.0166971476292832,-0.0141812145640146,No,NA,NA,Q28FX0,NA,NA,NA,RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59082,-0.00227234596162082,-0.00120740274717329,No,NA,NA,Q28GD4,NA,NA,NA,cell cortex [GO:0005938]; RNA binding [GO:0003723]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533384.5.5.m.59083,-0.0151329222822783,0.0232068282046994,No,NA,NA,Q5RA42,NA,NA,NA,translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_LOC100533387.1.1.m.56131,-0.000148694837194235,0.00145923907525821,No,NA,NA,Q14974,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum tubular network [GO:0071782]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; specific granule lumen [GO:0035580]; enzyme binding [GO:0019899]; Hsp90 protein binding [GO:0051879]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; apoptotic DNA fragmentation [GO:0006309]; astral microtubule organization [GO:0030953]; establishment of mitotic spindle localization [GO:0040001]; establishment of protein localization [GO:0045184]; intracellular transport of virus [GO:0075733]; mitotic chromosome movement towards spindle pole [GO:0007079]; mitotic metaphase plate congression [GO:0007080]; mitotic spindle assembly [GO:0090307]; modulation by virus of host process [GO:0019054]; neutrophil degranulation [GO:0043312]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus [GO:0006606]; protein import into nucleus; translocation [GO:0000060]; Ran protein signal transduction [GO:0031291]; regulation of cholesterol biosynthetic process [GO:0045540]; ribosomal protein import into nucleus [GO:0006610],NA,NA,NA
CHOYP_LOC100533388.1.6.m.3716,0.0174554537331929,0.0206961573863931,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.2.6.m.5374,0.00404236291614479,-0.000678527515553571,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.4.6.m.45039,0.0176315669449188,-0.0113732190261959,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533388.6.6.m.45695,0.000980334197767275,0.000735948690814215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533400.1.4.m.12300,0.00567919222529632,-0.00397660487050615,No,NA,NA,P36975,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533400.3.4.m.28214,0.013222545746464,-0.0177742344158083,No,NA,NA,P36975,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; neuromuscular synaptic transmission [GO:0007274]; neurotransmitter secretion [GO:0007269]; regulation of short-term neuronal synaptic plasticity [GO:0048172]; synaptic vesicle docking [GO:0016081]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; vesicle fusion [GO:0006906]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100533411.1.1.m.37112,0.00103546822502306,0.0107409732359944,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533437.1.2.m.4596,6.51931894022384e-05,-0.0255059165631826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100533444.1.1.m.33578,0.00166878062527881,-0.0167291146683635,No,NA,NA,Q9XSC1,NA,NA,NA,extracellular space [GO:0005615]; Wnt-protein binding [GO:0017147]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; non-canonical Wnt signaling pathway [GO:0035567]; regulation of BMP signaling pathway [GO:0030510],NA,NA,NA
CHOYP_LOC100533447.1.3.m.37261,-0.00139309714413977,0.027695904942713,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44496,0.00461025553441376,0.000705321376185254,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC100533447.2.3.m.44497,-0.00583301674799408,-0.0169827882611112,No,NA,NA,O43639,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506]; cytoskeletal adaptor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3/SH2 adaptor activity [GO:0005070]; actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress [GO:1990441]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_LOC100533450.1.1.m.54334,-0.00386701627347164,0.00329276633403307,No,NA,NA,Q3L1C9,NA,NA,NA,neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; mRNA binding [GO:0003729]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC100533455.1.9.m.3607,-0.00840713701909221,0.00568187555398755,No,NA,NA,P42577,NA,NA,NA,cytoplasm [GO:0005737]; ferric iron binding [GO:0008199]; ferroxidase activity [GO:0004322]; cellular iron ion homeostasis [GO:0006879]; iron ion transport [GO:0006826],NA,NA,NA
CHOYP_LOC100533521.2.2.m.52097,0.00329469682844261,0.0050144879949609,No,NA,NA,C4N147,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; lipid binding [GO:0008289],NA,NA,NA
CHOYP_LOC100533524.1.1.m.33932,-0.0128901038787566,0.0156445316373264,No,NA,NA,E2RDZ6,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; NAD+ binding [GO:0070403]; NAD-dependent protein deacetylase activity [GO:0034979]; protein-glutaryllysine deglutarylase activity [GO:0061697]; protein-malonyllysine demalonylase activity [GO:0036054]; protein-succinyllysine desuccinylase activity [GO:0036055]; zinc ion binding [GO:0008270]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein demalonylation [GO:0036046]; protein desuccinylation [GO:0036048]; regulation of ketone biosynthetic process [GO:0010566],NA,NA,NA
CHOYP_LOC100533528.2.2.m.26125,0.0012453468140519,0.00138491067501403,No,NA,NA,Q7JQD3,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament capping [GO:0051693]; actin filament fragmentation [GO:0030043]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin nucleation [GO:0045010]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100533537.1.1.m.36,0.00266157250569215,-0.00510635616504218,No,NA,NA,Q921J2,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; spliceosomal complex [GO:0005681]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of TOR signaling [GO:0032008]; regulation of postsynapse organization [GO:0099175]; regulation of TOR signaling [GO:0032006]; regulation of type B pancreatic cell development [GO:2000074]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100535066.1.2.m.15640,-0.000679803236207615,-0.000393454322376119,No,NA,NA,O54891,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100537361.1.1.m.55516,-0.0145640725171007,0.000279827034528318,No,NA,NA,P10076,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100538313.1.1.m.64152,0.0137187329344233,0.00815883522749563,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100538996.1.1.m.14935,-0.0105050004127173,-0.0100478729822685,No,NA,NA,Q5R7P7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352],NA,NA,NA
CHOYP_LOC100539769.1.1.m.36990,0.00559593515368522,-0.000746856273130463,No,NA,NA,O60879,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; actin binding [GO:0003779]; Rho GTPase binding [GO:0017048]; signaling receptor binding [GO:0005102]; actin filament organization [GO:0007015]; female gamete generation [GO:0007292]; multicellular organism development [GO:0007275]; oogenesis [GO:0048477],NA,NA,NA
CHOYP_LOC100540539.1.1.m.14519,0.000553620802926727,0.0103060121470605,No,NA,NA,Q15643,NA,NA,NA,cilium [GO:0005929]; cis-Golgi network [GO:0005801]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; inner acrosomal membrane [GO:0002079]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; transport vesicle [GO:0030133]; transcription coactivator activity [GO:0003713]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; Golgi organization [GO:0007030]; inner ear receptor cell stereocilium organization [GO:0060122]; intraciliary transport involved in cilium assembly [GO:0035735]; protein glycosylation [GO:0006486]; transcription by RNA polymerase II [GO:0006366]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_LOC100541322.1.1.m.43256,0.00102644968789005,0.000422399222420595,No,NA,NA,Q60631,NA,NA,NA,cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; vesicle membrane [GO:0012506]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphoprotein binding [GO:0051219]; phosphotyrosine residue binding [GO:0001784]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH3 domain binding [GO:0017124]; SH3/SH2 adaptor activity [GO:0005070]; aging [GO:0007568]; anatomical structure formation involved in morphogenesis [GO:0048646]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cell differentiation [GO:0030154]; cellular response to ionizing radiation [GO:0071479]; insulin receptor signaling pathway [GO:0008286]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein heterooligomerization [GO:0051291]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_LOC100543236.1.2.m.20322,0.00545157588004028,0.00643817086990002,No,NA,NA,Q24K15,NA,NA,NA,extracellular region [GO:0005576]; receptor tyrosine kinase binding [GO:0030971]; angiogenesis [GO:0001525],NA,NA,NA
CHOYP_LOC100543709.1.1.m.32086,0.00736758280975905,-0.00748652665014007,No,NA,NA,O08688,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; synapse [GO:0045202]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100546924.1.2.m.34506,-0.0128238828529374,-0.00628642464018508,No,NA,NA,Q8BP86,NA,NA,NA,snRNA-activating protein complex [GO:0019185]; DNA binding [GO:0003677]; snRNA transcription by RNA polymerase II [GO:0042795]; snRNA transcription by RNA polymerase III [GO:0042796],NA,NA,NA
CHOYP_LOC100547490.1.1.m.5822,0.0202727695475563,0.0207569276901385,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100548534.1.1.m.26484,-0.0181410799879697,-0.0115449385233557,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100548534.1.1.m.26485,-0.0176654872582091,-0.0112422724841296,No,NA,NA,Q01177,NA,NA,NA,extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; proteolysis involved in cellular protein catabolic process [GO:0051603]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF; modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707],NA,NA,NA
CHOYP_LOC100549486.1.1.m.54965,-0.00837737207043162,-0.00533133890620334,No,NA,NA,P70610,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium ion-regulated exocytosis of neurotransmitter [GO:0048791]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of insulin secretion [GO:0032024]; positive regulation of vesicle fusion [GO:0031340]; protein localization [GO:0008104],NA,NA,NA
CHOYP_LOC100552087.1.1.m.26238,-0.0122788739541027,0.0181793849907279,No,NA,NA,Q15853,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; sequence-specific DNA binding [GO:0043565]; lactation [GO:0007595]; late viral transcription [GO:0019086]; lipid homeostasis [GO:0055088]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter by glucose [GO:0000432]; regulation of transcription from RNA polymerase II promoter by glucose [GO:0000430]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100552337.1.1.m.19614,-0.00331422863087276,0.00413630281218799,No,NA,NA,Q6ZQ58,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; polysome [GO:0005844]; TORC1 complex [GO:0031931]; eukaryotic initiation factor 4E binding [GO:0008190]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA cap binding [GO:0000339]; translation activator activity [GO:0008494]; translation initiation factor binding [GO:0031369]; cell proliferation [GO:0008283]; cellular response to rapamycin [GO:0072752]; mRNA stabilization [GO:0048255]; negative regulation of translation [GO:0017148]; positive regulation of macroautophagy [GO:0016239]; positive regulation of viral genome replication [GO:0045070]; response to amino acid starvation [GO:1990928]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100552374.1.1.m.21979,-0.0148351859596937,-0.0026037822902923,No,NA,NA,Q3T0Y3,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100552730.1.1.m.18699,-0.0098489998203518,-0.00626787917356116,No,NA,NA,O35375,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; heart development [GO:0007507]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_LOC100553519.1.1.m.20707,-0.00294163322976577,0.00364674211913504,No,NA,NA,Q8VDM6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC100553663.1.1.m.58460,-0.00925269687220878,-0.0169705855969326,No,NA,NA,Q6P7A9,NA,NA,NA,lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; alpha-1;4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; maltose alpha-glucosidase activity [GO:0032450]; glycogen catabolic process [GO:0005980],NA,NA,NA
CHOYP_LOC100553687.1.1.m.61663,-0.00205786455720845,0.00236203887781868,No,NA,NA,P0CB49,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_LOC100553809.1.1.m.45965,0.000710782195970809,-0.00597414207905327,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100554313.1.1.m.20949,-0.0190848009848551,0.0242590710832846,No,NA,NA,Q6P069,NA,NA,NA,axon [GO:0030424]; axon terminus [GO:0043679]; chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; dendritic spine neck [GO:0044326]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; T-tubule [GO:0030315]; vesicle [GO:0031982]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; repressing transcription factor binding [GO:0070491]; calcium ion transport [GO:0006816]; cytoplasmic sequestering of transcription factor [GO:0042994]; heart development [GO:0007507]; negative regulation of cardiac muscle contraction [GO:0055118]; negative regulation of heart rate [GO:0010459]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; negative regulation of transcription regulatory region DNA binding [GO:2000678]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of high voltage-gated calcium channel activity [GO:1901841]; regulation of relaxation of muscle [GO:1901077],NA,NA,NA
CHOYP_LOC100554450.1.1.m.66550,-0.0139454118496579,-0.000720311935073124,No,NA,NA,Q8R3Q6,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100554578.1.2.m.7421,0,0,No,NA,NA,O15484,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; proteolysis [GO:0006508]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100554670.1.1.m.4865,-0.000265499250515487,0.000750818049900009,No,NA,NA,Q8IZD4,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; P-body [GO:0000932]; enzyme activator activity [GO:0008047]; hydrolase activity [GO:0016787]; mRNA binding [GO:0003729]; deadenylation-dependent decapping of nuclear-transcribed mRNA [GO:0000290]; deadenylation-independent decapping of nuclear-transcribed mRNA [GO:0031087]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_LOC100555223.1.1.m.47612,0.0117164089544516,-0.0159863566467134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100555295.1.1.m.51356,-0.00206342527936835,0.0169823657399616,No,NA,NA,Q9DBU0,NA,NA,NA,autophagosome membrane [GO:0000421]; cytoplasmic vesicle [GO:0031410]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; autophagy [GO:0006914]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_LOC100555755.1.1.m.58711,0.00436552085009604,0.00515556781882706,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_LOC100556034.2.2.m.15378,0.0104172413395457,-0.0143076548045349,No,NA,NA,Q5TFE4,NA,NA,NA,5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100556517.1.1.m.22221,-0.013187132041999,-0.0310837170783927,No,NA,NA,P79942,NA,NA,NA,metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; circadian regulation of gene expression [GO:0032922]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100558815.1.1.m.30536,-0.00255573841402849,-0.00209833414306513,No,NA,NA,P23193,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; positive regulation of exoribonuclease activity [GO:1901919]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC100558843.1.1.m.14396,-0.0191886146095943,0.0175445417827956,No,NA,NA,Q5VWZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; palmitoyl-(protein) hydrolase activity [GO:0008474]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LOC100559879.1.1.m.8598,-0.0154645816775645,0.0163094108892539,No,NA,NA,Q9D8N6,NA,NA,NA,transcriptional repressor complex [GO:0017053],NA,NA,NA
CHOYP_LOC100559941.1.2.m.12240,-0.00189580177105729,0.00290298876740495,No,NA,NA,Q3TLH4,NA,NA,NA,cytosol [GO:0005829]; protein C-terminus binding [GO:0008022]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_LOC100560334.2.3.m.42997,0.0186166050215033,-0.00751434031800032,No,NA,NA,Q9DAG6,NA,NA,NA,acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; sperm connecting piece [GO:0097224]; binding of sperm to zona pellucida [GO:0007339],NA,NA,NA
CHOYP_LOC100560768.1.1.m.18804,-0.0175485264333816,0.0225165129470188,No,NA,NA,Q6PBT7,NA,NA,NA,integral component of membrane [GO:0016021]; PAM complex; Tim23 associated import motor [GO:0001405]; ATPase activator activity [GO:0001671]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100561086.1.1.m.13015,-0.0213034413330703,0.0157670966626463,No,NA,NA,Q7Z9I4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491]; cellular detoxification of aldehyde [GO:0110095],NA,NA,NA
CHOYP_LOC100561262.1.1.m.16846,-0.00170703178660422,0.000470078489931097,No,NA,NA,P47791,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; glutathione binding [GO:0043295]; glutathione-disulfide reductase activity [GO:0004362]; NADP binding [GO:0050661]; protein homodimerization activity [GO:0042803]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glutathione metabolic process [GO:0006749]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100561410.1.1.m.58687,-0.00806263290476611,0.00600678148223103,No,NA,NA,Q9P000,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; cholesterol homeostasis [GO:0042632]; neutrophil degranulation [GO:0043312]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC100561810.1.1.m.8656,-0.0243464677729371,0.0227420270270073,No,NA,NA,Q80UY1,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; carnosine N-methyltransferase activity [GO:0030735]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; carnosine metabolic process [GO:0035498],NA,NA,NA
CHOYP_LOC100561894.1.1.m.45814,-0.010372771243618,-0.00471266352172786,No,NA,NA,P20072,NA,NA,NA,chromaffin granule membrane [GO:0042584]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; autophagy [GO:0006914]; cell proliferation [GO:0008283]; cellular calcium ion homeostasis [GO:0006874]; cellular water homeostasis [GO:0009992]; epithelial cell differentiation [GO:0030855]; hemostasis [GO:0007599]; negative regulation of gene expression [GO:0010629]; regulation of cell shape [GO:0008360]; response to calcium ion [GO:0051592]; response to salt stress [GO:0009651]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC100562697.1.1.m.27375,-8.74457383715345e-05,-0.00397196293552466,No,NA,NA,Q3SZ45,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC100562954.1.1.m.27429,0.00740875646774826,0.016675270664035,No,NA,NA,O70309,NA,NA,NA,cell leading edge [GO:0031252]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of synaptic membrane [GO:0099699]; integrin alphav-beta5 complex [GO:0034684]; integrin complex [GO:0008305]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; integrin binding [GO:0005178]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; epithelial cell-cell adhesion [GO:0090136]; integrin-mediated signaling pathway [GO:0007229]; stress fiber assembly [GO:0043149]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC100563402.1.1.m.5257,-0.0121213510038911,-0.0116341791947985,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_LOC100563554.1.1.m.49953,0.00239155811248498,0.00698959823419596,No,NA,NA,Q1LY46,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; calcium ion binding [GO:0005509]; calcium:proton antiporter activity [GO:0015369]; ribosome binding [GO:0043022]; calcium export from the mitochondrion [GO:0099093]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; protein hexamerization [GO:0034214]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100563867.1.1.m.11836,0.0031375307912738,-7.58059581684443e-05,No,NA,NA,Q8BGB5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100563952.1.1.m.30232,0.00357113468206145,-0.00291531311742103,No,NA,NA,Q32PA9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100564140.2.2.m.10031,-0.00608227378087234,0.00825715352260127,No,NA,NA,Q92010,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC100564354.1.1.m.46361,0.00207459196712973,0.000198730793215724,No,NA,NA,Q9NQP4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC100564832.1.1.m.43026,-0.00324571015475082,-0.0290497081499112,No,NA,NA,Q95JD5,NA,NA,NA,cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100565366.1.1.m.49990,0.00237211461876001,0.00172815562501396,No,NA,NA,Q5SFM8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; positive regulation of RNA export from nucleus [GO:0046833],NA,NA,NA
CHOYP_LOC100565534.1.3.m.28075,-0.0346041160491843,0.0107662217405304,No,NA,NA,P02597,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-mediated signaling [GO:0019722]; spindle pole body organization [GO:0051300],NA,NA,NA
CHOYP_LOC100565534.2.3.m.29570,-0.000268031721208606,0.00220366267725976,No,NA,NA,Q40302,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100566943.1.2.m.35349,-0.00345515798613889,0.0167342130486621,No,NA,NA,P02693,NA,NA,NA,apical cortex [GO:0045179]; cytoplasm [GO:0005737]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; fatty acid binding [GO:0005504]; long-chain fatty acid binding [GO:0036041]; long-chain fatty acid transporter activity [GO:0005324]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; intestinal absorption [GO:0050892]; long-chain fatty acid transport [GO:0015909],NA,NA,NA
CHOYP_LOC100566968.1.1.m.15268,0.00574630329006988,0.00333998182245151,No,NA,NA,Q8AXY6,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; Wnt-protein binding [GO:0017147]; anatomical structure development [GO:0048856]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; regulation of synaptic growth at neuromuscular junction [GO:0008582]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100567114.1.1.m.39091,0.0173385846334129,0.0142854407782681,No,NA,NA,Q3T052,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100567407.1.1.m.8503,-0.00386692935356473,-0.00854345580240716,No,NA,NA,Q5RB75,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100567969.1.1.m.26460,-0.00142156274282809,-0.0105184819964586,No,NA,NA,P36876,NA,NA,NA,cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; protein phosphatase type 2A complex [GO:0000159]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; tau protein binding [GO:0048156]; mitotic cell cycle [GO:0000278]; peptidyl-serine dephosphorylation [GO:0070262]; response to morphine [GO:0043278],NA,NA,NA
CHOYP_LOC100568234.1.1.m.60837,0.00372641569292193,-0.00652904449510873,No,NA,NA,Q8R0F3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; cupric ion binding [GO:1903135]; Formylglycine-generating oxidase activity [GO:0120147]; protein homodimerization activity [GO:0042803]; post-translational protein modification [GO:0043687]; protein oxidation [GO:0018158],NA,NA,NA
CHOYP_LOC100571875.1.1.m.48861,-0.00542724699795972,0.0188267511650304,No,NA,NA,Q16595,NA,NA,NA,cytosol [GO:0005829]; L-cysteine desulfurase complex [GO:1990221]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; ferroxidase activity [GO:0004322]; iron chaperone activity [GO:0034986]; adult walking behavior [GO:0007628]; aerobic respiration [GO:0009060]; cellular iron ion homeostasis [GO:0006879]; cellular response to hydrogen peroxide [GO:0070301]; embryo development ending in birth or egg hatching [GO:0009792]; heme biosynthetic process [GO:0006783]; ion transport [GO:0006811]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of organ growth [GO:0046621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; oxidative phosphorylation [GO:0006119]; positive regulation of aconitate hydratase activity [GO:1904234]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell growth [GO:0030307]; positive regulation of cell proliferation [GO:0008284]; positive regulation of lyase activity [GO:0051349]; positive regulation of succinate dehydrogenase activity [GO:1904231]; proprioception [GO:0019230]; protein autoprocessing [GO:0016540]; regulation of ferrochelatase activity [GO:0010722]; response to iron ion [GO:0010039]; small molecule metabolic process [GO:0044281],NA,NA,NA
CHOYP_LOC100575377.1.10.m.10592,-0.0113247739421198,-0.00205309644401726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100576447.2.2.m.55515,0,0,No,NA,NA,Q9CR48,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; photoreceptor inner segment [GO:0001917]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; photoreceptor cell maintenance [GO:0045494]; regulation of autophagy [GO:0010506]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100577801.1.1.m.7007,0.00244007099844079,0.00288166107715137,No,NA,NA,Q9VPQ6,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II transcription factor binding [GO:0001085]; transcription factor binding [GO:0008134]; amnioserosa maintenance [GO:0046665]; chaeta development [GO:0022416]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; dorsal closure; leading edge cell fate determination [GO:0007393]; ectoderm development [GO:0007398]; germ-band shortening [GO:0007390]; head involution [GO:0008258]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; larval lymph gland hemopoiesis [GO:0035167]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; lymph gland plasmatocyte differentiation [GO:0035169]; negative regulation of cell fate specification [GO:0009996]; negative regulation of crystal cell differentiation [GO:0042690]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of transcription by RNA polymerase II [GO:0000122]; pigment metabolic process [GO:0042440]; regulation of antimicrobial peptide biosynthetic process [GO:0002805]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100617548.1.1.m.64248,-0.0143316779148261,-0.0091206444474599,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100618341.1.1.m.42477,-0.00365891229956313,-0.00609941477499533,No,NA,NA,O15394,NA,NA,NA,axon [GO:0030424]; integral component of membrane [GO:0016021]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; axonal fasciculation [GO:0007413]; neuron cell-cell adhesion [GO:0007158]; sensory perception of smell [GO:0007608],NA,NA,NA
CHOYP_LOC100619435.1.2.m.28884,-0.00390673353934874,0.00986024612718217,No,NA,NA,P97576,NA,NA,NA,mitochondrion [GO:0005739]; PAM complex; Tim23 associated import motor [GO:0001405]; adenyl-nucleotide exchange factor activity [GO:0000774]; ATPase activator activity [GO:0001671]; ATPase binding [GO:0051117]; chaperone binding [GO:0051087]; protein homodimerization activity [GO:0042803]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_LOC100631809.1.2.m.30895,-0.013113386095642,-0.0258348318320636,No,NA,NA,Q9QXT1,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; plasma membrane [GO:0005886]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325],NA,NA,NA
CHOYP_LOC100632370.1.1.m.25156,-0.0126310780328204,0.0167489155394553,No,NA,NA,Q9FKK7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; vacuolar membrane [GO:0005774]; vacuole [GO:0005773]; metal ion binding [GO:0046872]; xylose isomerase activity [GO:0009045]; D-xylose metabolic process [GO:0042732],NA,NA,NA
CHOYP_LOC100632618.1.3.m.23426,-0.00311878421899075,0.00423398896989132,No,NA,NA,Q9FE17,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632618.2.3.m.30752,-0.0123416941200801,-0.00785422367272916,No,NA,NA,B8ARK7,NA,NA,NA,nucleus [GO:0005634]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NAD+ binding [GO:0070403]; histone H3-K9 acetylation [GO:0043970],NA,NA,NA
CHOYP_LOC100632738.1.1.m.4911,0.0107812341133432,-0.0106815584905624,No,NA,NA,O14082,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100632832.1.1.m.45608,-0.0120347845187116,0.0125250481840103,No,NA,NA,Q9ET47,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; filamentous actin [GO:0031941]; microvillus [GO:0005902]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; actin filament binding [GO:0051015]; SH3 domain binding [GO:0017124]; actin filament bundle assembly [GO:0051017]; actin filament network formation [GO:0051639]; locomotory behavior [GO:0007626]; negative regulation of cytoskeleton organization [GO:0051494]; parallel actin filament bundle assembly [GO:0030046]; positive regulation of filopodium assembly [GO:0051491]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC100633041.1.1.m.35428,0.000160245550740719,0.00468112583194253,No,NA,NA,Q13423,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial respirasome [GO:0005746]; mitochondrion [GO:0005739]; NAD binding [GO:0051287]; NAD(P)+ transhydrogenase (B-specific) activity [GO:0003957]; NAD(P)+ transhydrogenase activity [GO:0008746]; NADP binding [GO:0050661]; cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; NADPH regeneration [GO:0006740]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein phosphorylation [GO:0001933]; oxidation-reduction process [GO:0055114]; oxygen homeostasis [GO:0032364]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of mitochondrial membrane potential [GO:0010918]; proton transmembrane transport [GO:1902600]; reactive oxygen species metabolic process [GO:0072593]; response to vitamin [GO:0033273]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100633059.1.1.m.20098,0.00679610482814513,-0.00882142869422546,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633075.1.4.m.4467,0.00265377320551276,-0.00606436728668844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100633077.1.4.m.4444,-0.00235627127398057,0.000151419149099759,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100633077.4.4.m.62658,0.0022189941094432,-0.000897560745809554,No,NA,NA,Q503L9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; protein-disulfide reductase activity [GO:0047134]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100634021.1.1.m.53536,-0.00619906247516603,-0.011843718320341,No,NA,NA,Q8IYJ1,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; calcium-dependent phospholipid binding [GO:0005544]; cellular response to calcium ion [GO:0071277]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC100634556.1.1.m.45015,-0.00418133643831158,0.0112397744243513,No,NA,NA,O19015,NA,NA,NA,lysosome [GO:0005764]; vacuole [GO:0005773]; beta-galactosidase activity [GO:0004565]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100634688.3.6.m.36725,0.00896659628705928,-0.0290352191302124,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634688.6.6.m.63689,-0.00234025617351428,0.00365113799062479,No,NA,NA,P10155,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_LOC100634891.1.1.m.11488,-0.00628727474733635,0.00495519101086559,No,NA,NA,F6PHZ6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; synaptonemal complex [GO:0000795]; Hsp90 protein binding [GO:0051879]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; piRNA metabolic process [GO:0034587]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100635182.1.1.m.5368,0.0128037841575404,0.00344302532063048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100635245.3.4.m.44747,0.0145747089918833,-0.00949962238037617,No,NA,NA,Q54GB3,NA,NA,NA,integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; transport vesicle membrane [GO:0030658]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; exocytosis [GO:0006887]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100635352.1.1.m.9481,0.00480878534176921,0.00567905178029952,No,NA,NA,Q2KI83,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_LOC100635487.1.1.m.21915,0.0166899093670315,0.00926696228758691,No,NA,NA,Q0P4P2,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100635694.1.1.m.24761,-0.00510636176828424,0.00399958192026675,No,NA,NA,P55008,NA,NA,NA,actin filament [GO:0005884]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; actin filament bundle assembly [GO:0051017]; actin filament polymerization [GO:0030041]; cellular response to extracellular stimulus [GO:0031668]; cellular response to hormone stimulus [GO:0032870]; cellular response to hydroperoxide [GO:0071447]; cellular response to interferon-gamma [GO:0071346]; cellular response to morphine [GO:0071315]; cerebellum development [GO:0021549]; inflammatory response [GO:0006954]; microglial cell activation [GO:0001774]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phagocytosis; engulfment [GO:0006911]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of muscle hyperplasia [GO:0014739]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; Rac protein signal transduction [GO:0016601]; response to axon injury [GO:0048678]; response to electrical stimulus [GO:0051602]; response to glucocorticoid [GO:0051384]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC100635715.2.9.m.8040,0.00316893969799,0.000612252757532386,No,NA,NA,O16277,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; chromosome condensation [GO:0030261]; negative regulation of chromatin silencing [GO:0031936]; negative regulation of DNA recombination [GO:0045910]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100636110.1.2.m.5041,0.00313204132610383,0.00249396825461569,No,NA,NA,Q04336,NA,NA,NA,mannosyl-oligosaccharide glucosidase activity [GO:0004573]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC100636340.1.4.m.5143,-0.00350262411918077,0.00377471552912388,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.3.4.m.44279,0.00534186046329056,0.0163912918182058,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636340.4.4.m.50991,0.00136857738664674,-0.00309888745164607,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100636433.3.4.m.27077,0.00583814358308307,0.00251949705366086,No,NA,NA,O42401,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100636493.1.1.m.65727,0.00151610148700446,0.00378879987664415,No,NA,NA,Q2PZL6,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_LOC100636568.1.1.m.16013,-0.0066138748202817,-0.00418459677033416,No,NA,NA,P10351,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; arginine metabolic process [GO:0006525]; compound eye pigmentation [GO:0048072]; determination of adult lifespan [GO:0008340]; glycerophospholipid metabolic process [GO:0006650]; purine nucleobase metabolic process [GO:0006144]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ethanol [GO:0045471]; tryptophan metabolic process [GO:0006568]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_LOC100636813.1.1.m.19517,-0.0137111069437386,-0.0111423050524289,No,NA,NA,Q66J85,NA,NA,NA,DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC100637812.1.1.m.1303,0.00815472329941659,-0.0303906623118505,No,NA,NA,Q8WWF8,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100637925.1.4.m.34491,0.00215563993490278,-0.00272912606089395,No,NA,NA,Q61555,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; microfibril [GO:0001527]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; bone trabecula formation [GO:0060346]; camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; embryonic limb morphogenesis [GO:0030326]; limb morphogenesis [GO:0035108]; positive regulation of bone mineralization [GO:0030501]; positive regulation of osteoblast differentiation [GO:0045669]; sequestering of TGFbeta in extracellular matrix [GO:0035583],NA,NA,NA
CHOYP_LOC100637925.3.4.m.48236,0.00956065602419055,0.00246718151131381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638337.1.1.m.19693,0.0130977173801573,-0.00603417726492736,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100638372.1.1.m.60468,4.68473940155822e-05,0.00218388418380325,No,NA,NA,Q75J93,NA,NA,NA,COPII vesicle coat [GO:0030127]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; zinc ion binding [GO:0008270]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100638431.10.10.m.59513,0,0,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.3.10.m.24462,-0.0190824683638111,-0.00652561870016808,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.4.10.m.48496,-0.0125682274688913,0.00734571599077756,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638431.8.10.m.58430,0.0101669543633155,0.00317101206726526,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_LOC100638860.2.2.m.44785,0.000122294460910153,-0.0023149913410771,No,NA,NA,O28987,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100638885.1.4.m.28187,-0.00944485035398969,-0.00273806940490141,No,NA,NA,Q95ND5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097199]; apoptotic process [GO:0006915]; erythrocyte differentiation [GO:0030218]; keratinocyte differentiation [GO:0030216]; neuron differentiation [GO:0030182]; positive regulation of amyloid-beta formation [GO:1902004]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100639369.1.1.m.23669,0.0135716958039828,0.00494602417214409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639574.1.1.m.40201,0.00645911829912912,-0.0117264169131911,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639626.1.1.m.61641,0.000533021043725762,-0.000643507512786169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100639879.1.1.m.38832,0.00889497079837251,-0.00954065097702238,No,NA,NA,Q8WZ64,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; metal ion binding [GO:0046872]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100640001.1.2.m.37241,0.003143289621559,0.000319900749571032,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640001.2.2.m.62667,0.00376699064148478,-0.00161679204366353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100640206.1.1.m.48266,-0.00214892335622859,0.00507643867963042,No,NA,NA,O35075,NA,NA,NA,endosome [GO:0005768]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC100640260.1.2.m.21931,-0.00864222816761065,-0.00549989267265471,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100640618.1.1.m.4378,0.017289631587246,0.0113562367611936,No,NA,NA,Q5U3U0,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100641267.1.2.m.49206,-0.00277492942490521,0.00281703649474104,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641267.2.2.m.57947,-0.00199684088125394,-0.00606336873909422,No,NA,NA,R9UTQ8,NA,NA,NA,iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; antibiotic biosynthetic process [GO:0017000]; antibiotic metabolic process [GO:0016999],NA,NA,NA
CHOYP_LOC100641892.1.1.m.56601,0.000469096080972651,-0.00506541629030254,No,NA,NA,P19623,NA,NA,NA,cytosol [GO:0005829]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; spermidine synthase activity [GO:0004766]; cellular response to leukemia inhibitory factor [GO:1990830]; polyamine biosynthetic process [GO:0006596]; polyamine metabolic process [GO:0006595]; spermidine biosynthetic process [GO:0008295],NA,NA,NA
CHOYP_LOC100641969.1.1.m.7196,0.00378739802564375,-0.00676857667149999,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100642024.1.2.m.38402,0.000800627505283125,-0.00277875653064441,No,NA,NA,Q8MPM1,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; actin filament binding [GO:0051015]; actin filament capping [GO:0051693],NA,NA,NA
CHOYP_LOC100642349.1.1.m.53035,0.00147247331836673,0.00304900377158976,No,NA,NA,Q6DKB0,NA,NA,NA,cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC100642494.1.1.m.58088,0.00281489932867501,0.00857266298764562,No,NA,NA,Q3V384,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC100642680.1.1.m.6611,-0.033714833495019,0.00779749742037581,No,NA,NA,Q8TCA0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100642881.1.1.m.14183,0.00098917812651982,-0.00131583494920165,No,NA,NA,Q8NCN5,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25638,0.00389283775521953,0.012369591436178,No,NA,NA,Q1LZ96,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; proton-transporting ATP synthase complex assembly [GO:0043461],NA,NA,NA
CHOYP_LOC100642891.1.1.m.25639,-0.0108139203381146,0.00985849230811591,No,NA,NA,Q9CPY6,NA,NA,NA,ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC100642984.1.1.m.28915,0.0061405957516091,0.0203956251517332,No,NA,NA,Q9UM13,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100643070.1.1.m.40176,-0.00215339486166298,0.00219300135391955,No,NA,NA,Q24498,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasmic vesicle membrane [GO:0030659]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasmic reticulum membrane [GO:0033017]; smooth endoplasmic reticulum [GO:0005790]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; calcium-induced calcium release activity [GO:0048763]; ryanodine-sensitive calcium-release channel activity [GO:0005219]; calcium ion transport [GO:0006816]; heart contraction [GO:0060047]; multicellular organism development [GO:0007275]; muscle contraction [GO:0006936]; regulation of hemocyte proliferation [GO:0035206]; release of sequestered calcium ion into cytosol [GO:0051209]; response to anesthetic [GO:0072347],NA,NA,NA
CHOYP_LOC100644321.3.7.m.24037,-0.0020406638057798,-0.00249444669414104,No,NA,NA,Q9NZN5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644321.6.7.m.56495,-0.00135754072278288,-0.000332383424881771,No,NA,NA,Q9NZN5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100644613.1.1.m.55011,0.0113632772671083,0.0075335748345808,No,NA,NA,A0R5M8,NA,NA,NA,dimethylhistidine N-methyltransferase activity [GO:0030745]; protein methyltransferase activity [GO:0008276]; ergothioneine biosynthesis from histidine via N-alpha;N-alpha;N-alpha-trimethyl-L-histidine [GO:0052704]; N-alpha;N-alpha;N-alpha-trimethyl-L-histidine biosynthesis from histidine [GO:0052707],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54959,0.00185917985280052,0.0182578579517072,No,NA,NA,Q9UBI9,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; negative regulation of mitotic cell cycle [GO:0045930]; respiratory tube development [GO:0030323],NA,NA,NA
CHOYP_LOC100644701.2.2.m.54960,-0.00773218333606785,-0.00656057392078398,No,NA,NA,Q5PQP2,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; secretory granule [GO:0030141]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC100645183.1.1.m.53488,-0.00461454570289669,-0.00131629485862854,No,NA,NA,Q6NTN5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatase regulator activity [GO:0019208]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_LOC100645380.1.1.m.14246,0.0291856671303394,0.00660382273785376,No,NA,NA,Q9DBG7,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; signal recognition particle receptor complex [GO:0005785]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal recognition particle binding [GO:0005047]; protein targeting [GO:0006605]; protein targeting to ER [GO:0045047]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_LOC100645450.1.1.m.39898,0.00594216148143361,-0.0134662784828487,No,NA,NA,O60502,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102167]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102571]; [protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity [GO:0102166]; beta-N-acetylglucosaminidase activity [GO:0016231]; hyalurononglucosaminidase activity [GO:0004415]; glycoprotein catabolic process [GO:0006516]; glycoprotein metabolic process [GO:0009100]; N-acetylglucosamine metabolic process [GO:0006044]; protein deglycosylation [GO:0006517]; protein O-linked glycosylation [GO:0006493]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100645706.1.1.m.62733,-0.00347373715131904,0.0159327932056342,No,NA,NA,A5D794,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; membrane [GO:0016020]; GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; endocytosis [GO:0006897]; regulation of protein transport [GO:0051223]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100646524.1.1.m.44445,0.000897241948737355,-0.0036536467981358,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100646535.1.1.m.61774,-0.000252238585765416,0.000738871774552759,No,NA,NA,Q9W4E2,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC100646574.1.1.m.55144,0.00129352681094451,0.000876501184606642,No,NA,NA,Q7SXN5,NA,NA,NA,cell junction [GO:0030054]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; synaptic vesicle membrane [GO:0030672]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; lipid binding [GO:0008289]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; apoptotic mitochondrial changes [GO:0008637]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; intracellular distribution of mitochondria [GO:0048312]; membrane fusion [GO:0061025]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; peroxisome fission [GO:0016559]; protein complex oligomerization [GO:0051259]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of mitochondrion organization [GO:0010821],NA,NA,NA
CHOYP_LOC100646810.1.1.m.25033,0.00227228041858555,0.00250553776593172,No,NA,NA,O95045,NA,NA,NA,cytosol [GO:0005829]; type III intermediate filament [GO:0045098]; identical protein binding [GO:0042802]; uridine phosphorylase activity [GO:0004850]; nucleoside metabolic process [GO:0009116]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine metabolic process [GO:0046108],NA,NA,NA
CHOYP_LOC100647135.1.2.m.21531,0.00166325229223829,0.00196425816916334,No,NA,NA,C9D7C2,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; calcium ion binding [GO:0005509]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100647521.2.2.m.59908,0.00368929453989238,-0.0256617445003734,No,NA,NA,P50416,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; carnitine O-palmitoyltransferase activity [GO:0004095]; identical protein binding [GO:0042802]; palmitoleoyltransferase activity [GO:1990698]; carnitine metabolic process [GO:0009437]; carnitine shuttle [GO:0006853]; cellular response to fatty acid [GO:0071398]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; glucose metabolic process [GO:0006006]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; protein homooligomerization [GO:0051260]; regulation of insulin secretion [GO:0050796]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to organic cyclic compound [GO:0014070]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_LOC100647948.1.1.m.9650,-0.00176389088726669,0.00523746328566148,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100648051.2.2.m.61174,-0.000816418784017321,0.00315064447469671,No,NA,NA,Q9V3J1,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC100648516.1.1.m.64902,0.0075784730405993,0.00285988435159622,No,NA,NA,P21783,NA,NA,NA,integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793],NA,NA,NA
CHOYP_LOC100649130.1.1.m.58207,0.00161607896926422,-0.000583138657123345,No,NA,NA,Q99323,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100649205.1.1.m.39938,0.000348439815273018,-0.0177534871083398,No,NA,NA,O43257,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Swr1 complex [GO:0000812]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; nucleosome binding [GO:0031491]; histone exchange [GO:0043486]; regulation of histone deacetylation [GO:0031063],NA,NA,NA
CHOYP_LOC100649375.1.1.m.21222,0.00723211868404441,0.00388357763471328,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100650469.1.2.m.42139,-0.0165428879071704,0.00458596515703264,No,NA,NA,Q9JM52,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; chemical synaptic transmission [GO:0007268]; dendrite morphogenesis [GO:0048813]; MAPK cascade [GO:0000165]; multicellular organism development [GO:0007275]; negative thymic T cell selection [GO:0045060]; neuron cellular homeostasis [GO:0070050]; neuron projection morphogenesis [GO:0048812]; positive regulation of JNK cascade [GO:0046330]; positive regulation of p38MAPK cascade [GO:1900745]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of AMPA receptor activity [GO:2000311]; regulation of cell migration [GO:0030334]; regulation of cell-cell adhesion [GO:0022407]; regulation of cell-matrix adhesion [GO:0001952]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100650552.1.1.m.44153,-0.00180129489784337,0.00710680125388415,No,NA,NA,Q9VHN6,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100650613.1.1.m.10270,0.000125007415557736,0.00257446713335525,No,NA,NA,Q9UJX6,NA,NA,NA,anaphase-promoting complex [GO:0005680]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin protein ligase binding [GO:0031625]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell cycle [GO:0007049]; cell division [GO:0051301]; positive regulation of axon extension [GO:0045773]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic plasticity [GO:0031915]; protein K11-linked ubiquitination [GO:0070979]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_LOC100650648.1.2.m.24726,0.00238633105135185,0.00538331080644011,No,NA,NA,W0LYS5,NA,NA,NA,ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; molting cycle process [GO:0022404]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC100650709.1.1.m.12958,-0.0164076361190276,-0.00282543972745905,No,NA,NA,Q9CQ90,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100651274.1.1.m.26220,-0.0114836527660611,-0.0180506807271133,No,NA,NA,O54941,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; N-acetyltransferase activity [GO:0008080]; nuclear receptor binding [GO:0016922]; protein N-terminus binding [GO:0047485]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; neurogenesis [GO:0022008]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_LOC100651327.1.1.m.34619,-0.00461313406999339,-0.0089980723684713,No,NA,NA,F1RD40,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; axon choice point recognition [GO:0016198]; axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; developmental pigmentation [GO:0048066]; habenula development [GO:0021986]; neuromuscular process [GO:0050905]; regulation of axon guidance [GO:1902667]; regulation of pteridine metabolic process [GO:0042068]; retinal ganglion cell axon guidance [GO:0031290],NA,NA,NA
CHOYP_LOC100651687.1.1.m.39884,-0.00567227983434298,-0.0036098248846368,No,NA,NA,Q76I76,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; actin binding [GO:0003779]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; actin cytoskeleton organization [GO:0030036]; protein dephosphorylation [GO:0006470]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of axonogenesis [GO:0050770]; regulation of lamellipodium assembly [GO:0010591],NA,NA,NA
CHOYP_LOC100653683.1.1.m.7478,-0.0223407818586742,-0.0110286176500953,No,NA,NA,Q9R0Z7,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100655005.1.1.m.51334,-0.0066815388135349,0.00458987292868135,No,NA,NA,Q6P4S8,NA,NA,NA,integral component of membrane [GO:0016021]; integrator complex [GO:0032039]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; blastocyst growth [GO:0001832]; inner cell mass cell proliferation [GO:0001833]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; snRNA processing [GO:0016180]; U2 snRNA 3'-end processing [GO:0034474],NA,NA,NA
CHOYP_LOC100656236.1.1.m.27240,0.00080396159254528,-0.0019428460889697,No,NA,NA,Q8HY12,NA,NA,NA,integral component of membrane [GO:0016021]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; adaptive immune response [GO:0002250]; endocytosis [GO:0006897]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100658481.1.1.m.8712,0.0110556799387857,0.0125343284075122,No,NA,NA,Q14978,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; mitotic cell cycle [GO:0000278]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC100659825.1.1.m.62706,-0.0025102310705423,0.0111665279633112,No,NA,NA,Q8K2L8,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; kinetochore [GO:0000776]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; TRAPP complex [GO:0030008]; endopeptidase activity [GO:0004175]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase plate congression [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; protein complex oligomerization [GO:0051259]; regulation of kinetochore assembly [GO:0090234],NA,NA,NA
CHOYP_LOC100668913.1.1.m.6819,-0.00547419881118208,-0.0215610372626543,No,NA,NA,Q9WVF8,NA,NA,NA,mitochondrion [GO:0005739]; cell maturation [GO:0048469]; chemokine (C-C motif) ligand 5 production [GO:0071609]; defense response to Gram-negative bacterium [GO:0050829]; inflammatory response [GO:0006954]; interleukin-15 production [GO:0032618]; natural killer cell differentiation [GO:0001779]; negative regulation of interleukin-17 production [GO:0032700]; neutrophil mediated killing of gram-negative bacterium [GO:0070945]; phagocytosis [GO:0006909]; positive regulation of interleukin-10 production [GO:0032733]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to defense-related host reactive oxygen species production [GO:0052567],NA,NA,NA
CHOYP_LOC100669963.1.1.m.57300,0.00267365465767225,0.014827208953871,No,NA,NA,Q5RJR8,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial nucleoid [GO:0042645]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090],NA,NA,NA
CHOYP_LOC100670231.1.1.m.6369,0.00228322461684259,-0.00795508968236036,No,NA,NA,Q8BHT6,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; fucose metabolic process [GO:0006004]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100672555.1.1.m.15827,-0.0220274850938457,-0.000246670165952393,No,NA,NA,B6D5P6,NA,NA,NA,axoneme [GO:0005930]; dynein complex binding [GO:0070840]; cilium assembly [GO:0060271]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC100677972.1.1.m.12181,0,0,No,NA,NA,Q60738,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of postsynaptic density membrane [GO:0099061]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; T-tubule [GO:0030315]; calcium channel inhibitor activity [GO:0019855]; zinc ion transmembrane transporter activity [GO:0005385]; cadmium ion transmembrane transport [GO:0070574]; calcium ion import [GO:0070509]; cellular calcium ion homeostasis [GO:0006874]; cellular zinc ion homeostasis [GO:0006882]; detoxification of cadmium ion [GO:0071585]; in utero embryonic development [GO:0001701]; negative regulation of calcium ion import [GO:0090281]; negative regulation of neurotransmitter secretion [GO:0046929]; negative regulation of zinc ion transmembrane import [GO:0071584]; zinc ion transport [GO:0006829],NA,NA,NA
CHOYP_LOC100678100.1.1.m.14602,-0.00668975518321583,0.00302391883263663,No,NA,NA,B4U7S7,NA,NA,NA,cytoplasm [GO:0005737]; DNA binding [GO:0003677]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100678410.1.1.m.16114,-0.0152904997552091,0.00852773590935339,No,NA,NA,Q3MII6,NA,NA,NA,autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; autophagy [GO:0006914]; intracellular protein transport [GO:0006886]; regulation of autophagosome maturation [GO:1901096],NA,NA,NA
CHOYP_LOC100679233.1.1.m.21455,-0.00156030943787573,-0.00130654895905837,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679608.1.3.m.1597,-0.00414662680972384,-0.016828845062826,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100679620.1.1.m.66367,-0.0052537480624625,-0.000544329115960658,No,NA,NA,Q6DFN1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100680210.1.1.m.5750,0.00434635625170219,-0.00333066221907314,No,NA,NA,Q02427,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcriptionally active chromatin [GO:0035327]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of gene expression [GO:0010468]; regulation of mRNA 3'-end processing [GO:0031440]; regulation of transcriptional start site selection at RNA polymerase II promoter [GO:0001178]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100681683.1.1.m.60729,-0.00505892776857909,0.00286157247498421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100689951.1.1.m.56514,0.000996670493932559,-2.02551617774668e-05,No,NA,NA,P11179,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; dihydrolipoyllysine-residue succinyltransferase activity [GO:0004149]; 2-oxoglutarate metabolic process [GO:0006103]; histone succinylation [GO:0106077]; L-lysine catabolic process to acetyl-CoA via saccharopine [GO:0033512]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC100690782.1.1.m.26094,-0.000123729839423475,0.000754427394694999,No,NA,NA,A2VDC2,NA,NA,NA,mitochondrion [GO:0005739]; 3-hydroxyisobutyryl-CoA hydrolase activity [GO:0003860]; valine catabolic process [GO:0006574],NA,NA,NA
CHOYP_LOC100690874.1.2.m.62880,0.0041694829994628,0.00978885537726873,No,NA,NA,O14832,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carboxylic acid binding [GO:0031406]; cofactor binding [GO:0048037]; ferrous iron binding [GO:0008198]; L-ascorbic acid binding [GO:0031418]; phytanoyl-CoA dioxygenase activity [GO:0048244]; 2-oxoglutarate metabolic process [GO:0006103]; fatty acid alpha-oxidation [GO:0001561]; isoprenoid metabolic process [GO:0006720]; methyl-branched fatty acid metabolic process [GO:0097089]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC100691034.1.2.m.10976,0.000248610484312928,0.000151007889944745,No,NA,NA,Q9D0S9,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; apoptotic process [GO:0006915]; lipid catabolic process [GO:0016042]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100691144.1.1.m.47006,0.00115403374059662,-0.000733669007306658,No,NA,NA,Q4QQW3,NA,NA,NA,mitochondrion [GO:0005739]; alcohol dehydrogenase (NAD) activity [GO:0004022]; hydroxyacid-oxoacid transhydrogenase activity [GO:0047988]; metal ion binding [GO:0046872]; glutamate catabolic process via 2-oxoglutarate [GO:0006539],NA,NA,NA
CHOYP_LOC100691455.1.1.m.3282,0.00272347300598872,-0.00171064780776064,No,NA,NA,Q505H4,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24964,0.0102085777148109,-0.00668540310122934,No,NA,NA,Q9Y305,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acetyl-CoA hydrolase activity [GO:0003986]; acyl-CoA hydrolase activity [GO:0047617]; carboxylic ester hydrolase activity [GO:0052689]; acyl-CoA metabolic process [GO:0006637],NA,NA,NA
CHOYP_LOC100691486.1.1.m.24965,-0.00116699717190771,0.0196008967488753,No,NA,NA,P62255,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100691601.2.2.m.40748,0.00369314822550044,0.00436151304629078,No,NA,NA,P31597,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; chloride transmembrane transporter activity [GO:0015108]; cysteine transmembrane transporter activity [GO:0033229]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; chloride transmembrane transport [GO:1902476]; cysteine transport [GO:0042883]; D-aspartate import across plasma membrane [GO:0070779]; L-aspartate import across plasma membrane [GO:0140009]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813],NA,NA,NA
CHOYP_LOC100691676.1.1.m.64226,0.00531819560576773,-0.0184442609536298,No,NA,NA,Q9UKK9,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular [GO:0005622]; nucleus [GO:0005634]; 8-oxo-dGDP phosphatase activity [GO:0044715]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; magnesium ion binding [GO:0000287]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; snoRNA binding [GO:0030515]; ATP generation from poly-ADP-D-ribose [GO:1990966]; chromatin remodeling [GO:0006338]; D-ribose catabolic process [GO:0019303]; nucleobase-containing small molecule catabolic process [GO:0034656]; nucleoside phosphate metabolic process [GO:0006753]; nucleotide metabolic process [GO:0009117]; ribonucleoside diphosphate catabolic process [GO:0009191]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_LOC100692139.1.1.m.27787,-0.00412582358177746,0.000511408252746709,No,NA,NA,O57478,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; 2 iron; 2 sulfur cluster binding [GO:0051537]; ferrochelatase activity [GO:0004325]; metal ion binding [GO:0046872]; heme biosynthetic process [GO:0006783],NA,NA,NA
CHOYP_LOC100692402.2.2.m.49856,0.00488057746926257,0.00576383643598196,No,NA,NA,Q14624,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55157,-0.00540053419301457,0.000971706048672317,No,NA,NA,P45954,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; flavin adenine dinucleotide binding [GO:0050660]; branched-chain amino acid catabolic process [GO:0009083]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_LOC100692418.1.1.m.55158,0.000120077491141477,0.00327927512262952,No,NA,NA,Q9D172,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC100692795.2.2.m.50682,0.027210307255271,-0.00290698254739287,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100692883.1.1.m.5437,-0.00615469671434826,0.0300663449426565,No,NA,NA,Q5IS41,NA,NA,NA,extracellular matrix [GO:0031012]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100692894.1.1.m.10137,0.00549893069491407,-0.00998321302057589,No,NA,NA,Q8WWT9,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; citrate transmembrane transporter activity [GO:0015137]; high-affinity sodium:dicarboxylate symporter activity [GO:0015362]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141]; citrate transport [GO:0015746],NA,NA,NA
CHOYP_LOC100693418.1.2.m.990,-0.0308627736395388,0.00869834853112084,No,NA,NA,P56389,NA,NA,NA,cytosol [GO:0005829]; cytidine deaminase activity [GO:0004126]; identical protein binding [GO:0042802]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cytidine deamination [GO:0009972]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC100693418.2.2.m.56971,-0.0150509635925368,0.00317294968865396,No,NA,NA,P32320,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; tertiary granule lumen [GO:1904724]; cytidine deaminase activity [GO:0004126]; nucleoside binding [GO:0001882]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; cell surface receptor signaling pathway [GO:0007166]; cytidine deamination [GO:0009972]; cytosine metabolic process [GO:0019858]; negative regulation of cell growth [GO:0030308]; negative regulation of nucleotide metabolic process [GO:0045980]; neutrophil degranulation [GO:0043312]; protein homotetramerization [GO:0051289]; pyrimidine nucleoside salvage [GO:0043097]; pyrimidine-containing compound salvage [GO:0008655],NA,NA,NA
CHOYP_LOC100693575.1.1.m.19082,-0.00568289637410031,-0.0232440884334849,No,NA,NA,Q8K4P0,NA,NA,NA,collagen trimer [GO:0005581]; fibrillar center [GO:0001650]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA polyadenylation [GO:0006378],NA,NA,NA
CHOYP_LOC100693708.1.1.m.7688,-0.00637227951644154,0.001484377173562,No,NA,NA,Q5RGU1,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; protein phosphorylation [GO:0006468]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100693867.1.1.m.27278,0.000461877765299774,0.00124143846878417,No,NA,NA,Q03249,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; UDP-glucose:hexose-1-phosphate uridylyltransferase activity [GO:0008108]; zinc ion binding [GO:0008270]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glycolytic process from galactose [GO:0061623]; UDP-glucose catabolic process [GO:0006258]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_LOC100694272.1.1.m.19247,-0.0117640975055274,-0.00283067989808216,No,NA,NA,P78318,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase regulator activity [GO:0019888]; B cell activation [GO:0042113]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of microtubule-based movement [GO:0060632]; response to interleukin-1 [GO:0070555]; response to tumor necrosis factor [GO:0034612]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100694623.1.1.m.14876,0.00760599004061113,-0.00326520899609778,No,NA,NA,Q80Z30,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cellular response to drug [GO:0035690]; negative regulation of protein kinase activity [GO:0006469]; peptidyl-threonine dephosphorylation [GO:0035970]; positive regulation of stress fiber assembly [GO:0051496],NA,NA,NA
CHOYP_LOC100694648.1.1.m.18881,0.000162549631835258,0.00474149465210521,No,NA,NA,Q8K268,NA,NA,NA,ATP binding [GO:0005524]; ATPase activity [GO:0016887]; defense response to virus [GO:0051607],NA,NA,NA
CHOYP_LOC100694901.3.3.m.66949,-0.00197197713245883,0.000318752048467376,No,NA,NA,Q3SZE2,NA,NA,NA,cytosol [GO:0005829]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082],NA,NA,NA
CHOYP_LOC100695151.2.2.m.30573,0.00141826420018973,0.00325757334217185,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100695307.1.1.m.51209,0.000128467530967905,0.00367379536031876,No,NA,NA,A9JS71,NA,NA,NA,mitochondrion [GO:0005739]; catalytic activity [GO:0003824],NA,NA,NA
CHOYP_LOC100695438.1.1.m.8594,0.00614777243425536,-0.00803034376464876,No,NA,NA,Q9QYE0,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; gland morphogenesis [GO:0022612]; multicellular organism growth [GO:0035264]; negative regulation of gene expression [GO:0010629]; organ growth [GO:0035265]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland growth [GO:0060736]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC100696358.1.1.m.27370,-0.000171009659586555,-0.0129989058938998,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696604.1.1.m.40638,-0.00633809334041889,-0.0120237026904919,No,NA,NA,Q5M9G3,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; P-body [GO:0000932]; postsynapse [GO:0098794]; RNA binding [GO:0003723]; negative regulation of translation [GO:0017148]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003],NA,NA,NA
CHOYP_LOC100696668.1.1.m.31105,-0.0307331546029094,-0.0195585037249529,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100696985.1.1.m.17599,0.0179968155491598,0.00852332814902461,No,NA,NA,O43719,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2 snRNP [GO:0005686]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; regulation of DNA-templated transcription; elongation [GO:0032784]; regulation of transcription by RNA polymerase II [GO:0006357]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC100697247.1.2.m.37588,0.0174045527290006,0.02999866519742,No,NA,NA,Q60438,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697247.2.2.m.56896,-0.00238616893175426,0.00245314207115647,No,NA,NA,Q4V7M2,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100697720.1.2.m.5790,0.000889561805263499,0.00934416328727033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697793.5.6.m.62286,0.00510520681507218,0.00602911791468449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100697862.1.1.m.27738,-0.0304385167853299,0.0101412770662441,No,NA,NA,O02467,NA,NA,NA,lysosome [GO:0005764]; N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity [GO:0003948]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC100698013.1.1.m.5420,-0.00273183721542016,0.000177397975459612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100698240.2.4.m.14964,-6.53042329582384e-05,0.00866430026864151,No,NA,NA,G5ED84,NA,NA,NA,cell junction [GO:0030054]; Cul3-RING ubiquitin ligase complex [GO:0031463]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC100698638.1.1.m.45171,-3.81442441999944e-05,0.00206049859749874,No,NA,NA,A2AJ88,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; mitochondrial membrane [GO:0031966]; nuclear membrane [GO:0031965]; carboxylic ester hydrolase activity [GO:0052689]; lysophospholipase activity [GO:0004622]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100699093.1.1.m.20134,0.00070560285031377,-0.000677005577515442,No,NA,NA,Q2KJC9,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; glycine betaine biosynthetic process from choline [GO:0019285],NA,NA,NA
CHOYP_LOC100699161.1.1.m.35139,0.0003495027231976,8.95856068736749e-05,No,NA,NA,Q5U247,NA,NA,NA,exocyst [GO:0000145]; growth cone [GO:0030426]; perinuclear region of cytoplasm [GO:0048471]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC100699383.1.1.m.63490,0.00470056100277142,-0.0073985931413532,No,NA,NA,Q95VY2,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100699837.1.1.m.54956,-0.00335966230327807,0.00456099945870645,No,NA,NA,Q5E9P6,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; fat cell differentiation [GO:0045444]; lipid catabolic process [GO:0016042]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; negative regulation of lipid catabolic process [GO:0050995],NA,NA,NA
CHOYP_LOC100699850.1.3.m.3523,-0.00130438730753006,-0.00593472518244094,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC100700188.1.1.m.30931,-0.0129915912239827,-0.00826781658539136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100700230.1.1.m.57851,-0.00315756427855836,0.00462541635625758,No,NA,NA,A4IGH4,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC100700626.2.2.m.17262,-3.99241300246852e-05,0.00189748364319827,No,NA,NA,Q13395,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; regulation of transcription by RNA polymerase II [GO:0006357]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_LOC100700757.1.1.m.23394,0.00279159611225783,-0.0313584304526719,No,NA,NA,Q8N0X4,NA,NA,NA,mitochondrion [GO:0005739]; (3S)-citramalyl-CoA lyase activity [GO:0047777]; magnesium ion binding [GO:0000287]; malate synthase activity [GO:0004474]; protein homotrimerization [GO:0070207]; regulation of cobalamin metabolic process [GO:0106064],NA,NA,NA
CHOYP_LOC100701105.1.1.m.56657,-0.00513900982933592,-0.0132093907820713,No,NA,NA,Q91XF0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; FMN binding [GO:0010181]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; pyridoxamine-phosphate oxidase activity [GO:0004733]; pyridoxal phosphate biosynthetic process [GO:0042823]; pyridoxine biosynthetic process [GO:0008615],NA,NA,NA
CHOYP_LOC100701406.1.1.m.23796,-0.012664892247794,0.00712308541219621,No,NA,NA,Q6UX04,NA,NA,NA,catalytic step 1 spliceosome [GO:0071012]; catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100701551.1.7.m.3948,0.00230513509640472,0.000602861773592573,No,NA,NA,Q9CQR2,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; synapse [GO:0045202]; protein N-terminus binding [GO:0047485]; ribosome binding [GO:0043022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000461],NA,NA,NA
CHOYP_LOC100701725.1.1.m.54512,0.00203489639109616,0.000279364376510439,No,NA,NA,Q8HXM1,NA,NA,NA,cleavage body [GO:0071920]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; pre-mRNA cleavage required for polyadenylation [GO:0098789],NA,NA,NA
CHOYP_LOC100702367.1.1.m.62543,0.00208793014592026,-0.011618149214011,No,NA,NA,Q5U3V9,NA,NA,NA,ESCRT II complex [GO:0000814]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_LOC100703090.1.1.m.46433,-0.0236940039797606,0.0238915360626618,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703202.1.1.m.10370,0.000696539320103782,0.00392467415100807,No,NA,NA,Q503I8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity [GO:0000224]; glycoprotein catabolic process [GO:0006516]; protein deglycosylation [GO:0006517]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],NA,NA,NA
CHOYP_LOC100703289.1.1.m.53585,0.000608217950718773,-0.00127099001376932,No,NA,NA,Q8CF97,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi stack [GO:0005795]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; endoplasmic reticulum membrane fusion [GO:0016320]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; mitotic cell cycle [GO:0000278]; protein K11-linked deubiquitination [GO:0035871]; protein K48-linked deubiquitination [GO:0071108]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC100703423.1.1.m.940,-0.000555674480521725,0.000602634882849186,No,NA,NA,P40939,NA,NA,NA,mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; enoyl-CoA hydratase activity [GO:0004300]; fatty-acyl-CoA binding [GO:0000062]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; NAD binding [GO:0051287]; protein-containing complex binding [GO:0044877]; fatty acid beta-oxidation [GO:0006635]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_LOC100703423.1.1.m.941,-0.00150346068445308,0.000616981786956565,No,NA,NA,O46629,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; acetyl-CoA C-acyltransferase activity [GO:0003988]; enoyl-CoA hydratase activity [GO:0004300]; long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO:0016509]; long-chain-enoyl-CoA hydratase activity [GO:0016508]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100703585.2.4.m.39510,0.0164709453947846,-0.0252337757218692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100703956.1.1.m.31550,0.00428249199152306,0.00505751287280993,No,NA,NA,Q8CGC6,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100704039.1.1.m.21695,0.00745895826185618,-0.00415550846002554,No,NA,NA,E9PTA2,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; cation channel activity [GO:0005261]; ligand-gated calcium channel activity [GO:0099604]; manganese ion transmembrane transporter activity [GO:0005384]; sodium channel activity [GO:0005272]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cellular response to calcium ion [GO:0071277]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to purine-containing compound [GO:0071415]; cellular response to temperature stimulus [GO:0071502]; dendritic cell chemotaxis [GO:0002407]; dendritic cell differentiation [GO:0097028]; estrous cycle [GO:0044849]; positive regulation of insulin secretion [GO:0032024]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of filopodium assembly [GO:0051489]; release of sequestered calcium ion into cytosol [GO:0051209]; response to heat [GO:0009408]; response to hydroperoxide [GO:0033194]; temperature homeostasis [GO:0001659]; zinc ion transmembrane transport [GO:0071577],NA,NA,NA
CHOYP_LOC100704264.1.1.m.49420,0.00559765871346844,0.00189776886777476,No,NA,NA,P52333,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activity [GO:0004713]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; cytokine-mediated signaling pathway [GO:0019221]; enzyme linked receptor protein signaling pathway [GO:0007167]; erythrocyte differentiation [GO:0030218]; innate immune response [GO:0045087]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-21-mediated signaling pathway [GO:0038114]; interleukin-4-mediated signaling pathway [GO:0035771]; interleukin-7-mediated signaling pathway [GO:0038111]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular signal transduction [GO:0035556]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; MAPK cascade [GO:0000165]; negative regulation of dendritic cell cytokine production [GO:0002731]; negative regulation of FasL biosynthetic process [GO:0045221]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of T cell activation [GO:0050868]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of thymocyte apoptotic process [GO:0070244]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; regulation of JAK-STAT cascade [GO:0046425]; regulation of T cell apoptotic process [GO:0070232]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to interleukin-9 [GO:0071104]; T cell homeostasis [GO:0043029]; tyrosine phosphorylation of STAT protein [GO:0007260],NA,NA,NA
CHOYP_LOC100704562.1.1.m.25340,-0.00193542901742572,-0.00131709067362742,No,NA,NA,Q8YWD8,NA,NA,NA,peptide-methionine (S)-S-oxide reductase activity [GO:0008113]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_LOC100704819.1.2.m.14210,0.0078148423706537,-0.00187623978076788,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100704819.2.2.m.49100,-0.00269237120645145,-0.00386862639492311,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC100705265.3.3.m.40296,0.00214131791576532,-0.00388752542701301,No,NA,NA,O70244,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LOC100705460.1.3.m.4908,-0.0164948865717639,0.00951469494461718,No,NA,NA,Q5RJ80,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; dorsal/ventral pattern formation [GO:0009953]; negative regulation of translation [GO:0017148]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification [GO:2000055]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC100705726.1.1.m.17900,-0.00077482023836605,-0.0181911750707001,No,NA,NA,Q8JZL3,NA,NA,NA,cytoplasm [GO:0005737]; magnesium ion binding [GO:0000287]; thiamin-triphosphatase activity [GO:0050333]; dephosphorylation [GO:0016311]; thiamine diphosphate metabolic process [GO:0042357]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC100705966.1.1.m.45957,-0.012039505217721,0.0104403501290698,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100706133.1.1.m.56708,-0.0177040384298802,-0.0140963212747219,No,NA,NA,Q28EW0,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC100706374.1.1.m.51988,0.000875213268869901,-0.0324349280963166,No,NA,NA,Q9UBS3,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; misfolded protein binding [GO:0051787]; B cell differentiation [GO:0030183]; immunoglobulin production [GO:0002377]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of IRE1-mediated unfolded protein response [GO:1903895]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_LOC100706747.1.1.m.14818,-0.0156652272637664,-0.0275309223600309,No,NA,NA,P23965,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dodecenoyl-CoA delta-isomerase activity [GO:0004165]; enoyl-CoA hydratase activity [GO:0004300]; identical protein binding [GO:0042802]; fatty acid beta-oxidation [GO:0006635],NA,NA,NA
CHOYP_LOC100707249.1.1.m.15336,-0.00727383704073704,-0.00765547317457134,No,NA,NA,P50219,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; anatomical structure morphogenesis [GO:0009653]; endocrine pancreas development [GO:0031018]; humoral immune response [GO:0006959]; neuron projection morphogenesis [GO:0048812]; regulation of transcription by RNA polymerase II [GO:0006357]; spinal cord motor neuron cell fate specification [GO:0021520],NA,NA,NA
CHOYP_LOC100707367.1.1.m.16292,0.0026339223846179,0.00723430516854308,No,NA,NA,Q9JLV6,NA,NA,NA,mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; double-stranded DNA binding [GO:0003690]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC100707656.1.1.m.10569,-0.012341965893367,-0.0151027315100549,No,NA,NA,Q8VXZ0,NA,NA,NA,chloroplast [GO:0009507]; 8-oxo-dGDP phosphatase activity [GO:0044715]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100707920.1.1.m.27511,0.00470330581379534,-0.0123124640359088,No,NA,NA,Q8C4J7,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; Pwp2p-containing subcomplex of 90S preribosome [GO:0034388]; small-subunit processome [GO:0032040]; snoRNA binding [GO:0030515]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462],NA,NA,NA
CHOYP_LOC100708024.1.2.m.7177,-0.00757684416181454,-0.00869931212955393,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100708054.1.1.m.57813,0.00059790340353436,-0.000653751224210892,No,NA,NA,P42566,NA,NA,NA,aggresome [GO:0016235]; AP-2 adaptor complex [GO:0030122]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; ciliary membrane [GO:0060170]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; identical protein binding [GO:0042802]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; epidermal growth factor receptor signaling pathway [GO:0007173]; Golgi to endosome transport [GO:0006895]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cell proliferation [GO:0042127]; vesicle organization [GO:0016050]; viral entry into host cell [GO:0046718],NA,NA,NA
CHOYP_LOC100708199.3.6.m.23799,-0.0128524357313172,-0.0081792583733623,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708199.6.6.m.57028,-0.00547030203312556,-0.00348128671052126,No,NA,NA,P10394,NA,NA,NA,aspartic-type endopeptidase activity [GO:0004190]; endonuclease activity [GO:0004519]; nucleic acid binding [GO:0003676]; RNA-directed DNA polymerase activity [GO:0003964]; DNA integration [GO:0015074],NA,NA,NA
CHOYP_LOC100708329.1.1.m.3319,-0.0115319196007005,0.0293664160459031,No,NA,NA,P47224,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; guanyl-nucleotide exchange factor activity [GO:0005085]; zinc ion binding [GO:0008270]; membrane fusion [GO:0061025]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_LOC100708602.1.1.m.65805,0,0,No,NA,NA,Q66IH2,NA,NA,NA,nucleus [GO:0005634]; cell cycle [GO:0007049]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC100708650.1.3.m.10354,0.00684350170659279,-0.0124242583029423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100708717.1.1.m.5825,-0.00360092594616758,5.76798489881051e-05,No,NA,NA,P07686,NA,NA,NA,acrosomal vesicle [GO:0001669]; azurophil granule [GO:0042582]; azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; acetylglucosaminyltransferase activity [GO:0008375]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; astrocyte cell migration [GO:0043615]; cellular calcium ion homeostasis [GO:0006874]; cellular protein metabolic process [GO:0044267]; chondroitin sulfate catabolic process [GO:0030207]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; hyaluronan catabolic process [GO:0030214]; keratan sulfate catabolic process [GO:0042340]; lipid storage [GO:0019915]; locomotory behavior [GO:0007626]; lysosome organization [GO:0007040]; male courtship behavior [GO:0008049]; myelination [GO:0042552]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; oogenesis [GO:0048477]; penetration of zona pellucida [GO:0007341]; phospholipid biosynthetic process [GO:0008654]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell shape [GO:0008360]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_LOC100708991.1.5.m.740,-0.0114262849162464,0.00232052122440966,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100708991.2.5.m.29236,-0.0135698196977509,-0.0160092070847078,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_LOC100708991.5.5.m.59991,0.0119955947681481,0.0149990798284558,No,NA,NA,A6NMZ7,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100709262.1.2.m.17960,-0.00153316964233919,0.0216669301989198,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC100709316.1.1.m.17221,-0.00527754961569276,0.00616037250520669,No,NA,NA,Q9TRY0,NA,NA,NA,axonal growth cone [GO:0044295]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; chaperone-mediated protein folding [GO:0061077]; negative regulation of microtubule polymerization or depolymerization [GO:0031111]; negative regulation of neuron projection development [GO:0010977]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100709493.2.2.m.59425,0.0251122717299223,-0.00428766202810187,No,NA,NA,A6NHC0,NA,NA,NA,cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709538.1.2.m.4299,-0.0263964122647807,0.0311658569519479,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100709617.1.1.m.10644,-0.00466101814982634,-0.022537424321895,No,NA,NA,Q76IC5,NA,NA,NA,cytosol [GO:0005829]; cysteine-type peptidase activity [GO:0008234]; pyroglutamyl-peptidase activity [GO:0016920]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100709948.1.1.m.9245,-0.00291155322412955,0.00840430858894201,No,NA,NA,Q5RHP9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100710392.2.2.m.14004,0.000171570455630269,0.00493324842430421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710565.1.1.m.5315,-0.00635482315601364,0.0144621591006416,No,NA,NA,O46640,NA,NA,NA,cytoplasm [GO:0005737]; amine sulfotransferase activity [GO:0047685],NA,NA,NA
CHOYP_LOC100710578.1.1.m.62426,-0.0226865018870424,0.00850726445757632,No,NA,NA,Q29448,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; hydroxymethylglutaryl-CoA lyase activity [GO:0004419]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; ketone body biosynthetic process [GO:0046951]; leucine catabolic process [GO:0006552]; lipid metabolic process [GO:0006629]; mitochondrion organization [GO:0007005]; protein tetramerization [GO:0051262],NA,NA,NA
CHOYP_LOC100710612.1.1.m.5449,-0.00441587285978224,0.00308933492605426,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100710670.1.2.m.7245,0.00219396217522447,-0.0031430410050098,No,NA,NA,Q4R4I6,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710670.2.2.m.45011,0.00206213957295366,-0.00196592730736446,No,NA,NA,Q4R4I6,NA,NA,NA,plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell morphogenesis [GO:0000902],NA,NA,NA
CHOYP_LOC100710965.1.1.m.15140,-0.00367415148177607,-0.0316231228046043,No,NA,NA,Q99ND9,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; androgen receptor signaling pathway [GO:0030521]; cell aging [GO:0007569]; cellular response to oxidative stress [GO:0034599]; cellular response to testosterone stimulus [GO:0071394]; cytoplasmic translation [GO:0002181]; positive regulation of androgen receptor activity [GO:2000825],NA,NA,NA
CHOYP_LOC100711334.1.1.m.16928,0.00236169266682116,-0.00181497864534408,No,NA,NA,P17078,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; mRNA binding [GO:0003729]; ribonucleoprotein complex binding [GO:0043021]; structural constituent of ribosome [GO:0003735]; cellular response to UV-B [GO:0071493]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100711559.1.1.m.10313,-3.57929018242683e-05,0.00437655743896332,No,NA,NA,Q6NW52,NA,NA,NA,mitochondrion [GO:0005739]; actin binding [GO:0003779]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; metal ion binding [GO:0046872]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; actin filament polymerization [GO:0030041]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_LOC100711617.1.1.m.9209,0.00372091032877772,-0.0139807012032594,No,NA,NA,Q9D7M8,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleotide binding [GO:0000166]; translation initiation factor binding [GO:0031369]; mRNA export from nucleus in response to heat stress [GO:0031990]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of translational initiation [GO:0045948]; recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex [GO:0034402]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100713637.1.1.m.16691,-0.00865024633322488,0.00164106865739184,No,NA,NA,Q5RL51,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100714922.1.1.m.39817,0.00264891709248145,-0.000715813056783339,No,NA,NA,Q9WTN5,NA,NA,NA,endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100717261.1.1.m.51839,0.00362496723180352,0.00131680273447951,No,NA,NA,Q8JG30,NA,NA,NA,cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100718468.1.1.m.11334,-0.00290193488440172,0.00035211954717153,No,NA,NA,Q96ER3,NA,NA,NA,extracellular space [GO:0005615]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC100720440.1.2.m.11473,-0.00515418314866842,0.0132750953531554,No,NA,NA,Q9Y4C0,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; social behavior [GO:0035176]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC100721364.1.1.m.15879,-0.000442328959371555,-0.0172206271081337,No,NA,NA,Q8IYB9,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100721584.1.1.m.52602,0.00203162180098727,-0.0079081933009641,No,NA,NA,Q2M385,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_LOC100723342.1.1.m.58414,-0.00188163196847255,0.00255445982809474,No,NA,NA,Q9UHB7,NA,NA,NA,ELL-EAF complex [GO:0032783]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; spermatid development [GO:0007286]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100725472.1.2.m.5970,0.00320892758660569,0.0158070843749468,No,NA,NA,Q95KI0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100726220.1.1.m.8701,-0.00822706196924291,-0.0142284379046235,No,NA,NA,Q6PEE2,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; RNA binding [GO:0003723]; translation activator activity [GO:0008494]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC100726448.1.1.m.26536,-0.00584689646212738,-0.00689481070737031,No,NA,NA,Q711G3,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC100727159.1.1.m.60272,0.00719342640736313,-0.0130595405101144,No,NA,NA,Q5SSZ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; limb development [GO:0060173]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of Wnt signaling pathway [GO:0030178]; protein ubiquitination [GO:0016567]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of Wnt signaling pathway; planar cell polarity pathway [GO:2000095]; stem cell proliferation [GO:0072089]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt receptor catabolic process [GO:0038018]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9365,-0.0104509306066983,-0.00665094644013478,No,NA,NA,Q5U2Z0,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100727208.1.1.m.9366,-0.000123788316749254,0.00171116359777566,No,NA,NA,Q6AXS5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; mRNA 3'-UTR binding [GO:0003730]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100728625.2.2.m.51928,-0.00720995151268032,-0.00102308235331282,No,NA,NA,Q9S9V0,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-dependent protein serine/threonine kinase activity [GO:0009931]; calmodulin binding [GO:0005516]; calmodulin-dependent protein kinase activity [GO:0004683]; abscisic acid-activated signaling pathway [GO:0009738]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105]; protein autophosphorylation [GO:0046777]; response to salicylic acid [GO:0009751],NA,NA,NA
CHOYP_LOC100729623.1.2.m.6310,0.00201873526363742,-0.00457816479117749,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100730443.1.1.m.57698,-0.00668513348603099,0.0125969213413827,No,NA,NA,Q4V348,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100740246.1.1.m.25108,-0.000722508202271696,-0.0102605819850565,No,NA,NA,A9C3P0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_LOC100740578.1.1.m.65702,-0.00977043962460638,0.0118386136599181,No,NA,NA,Q04870,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; promoter-specific chromatin binding [GO:1990841]; transferase activity [GO:0016740]; negative regulation of protein binding [GO:0032091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100740873.1.1.m.46472,-0.00190054012178167,-0.00120949904204661,No,NA,NA,Q14517,NA,NA,NA,apical plasma membrane [GO:0016324]; cell-cell junction [GO:0005911]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; actin filament organization [GO:0007015]; anatomical structure morphogenesis [GO:0009653]; camera-type eye morphogenesis [GO:0048593]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; epithelial cell morphogenesis [GO:0003382]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_LOC100741247.2.2.m.27816,-0.00842473344584949,0.00779467897478705,No,NA,NA,Q9Z1G4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; integral component of synaptic vesicle membrane [GO:0030285]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; ATPase binding [GO:0051117]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; regulation of macroautophagy [GO:0016241]; toxin transport [GO:1901998]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_LOC100741250.1.2.m.48951,0.0105766825110282,0.00644534072213485,No,NA,NA,P79098,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100741406.1.1.m.29038,0.000341668038022195,0.00218599169052631,No,NA,NA,Q6PD03,NA,NA,NA,centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; Z disc [GO:0030018]; kinase binding [GO:0019900]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase activator activity [GO:0072542]; negative regulation of lipid kinase activity [GO:0090219]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of protein dephosphorylation [GO:0035307]; protein dephosphorylation [GO:0006470]; regulation of protein autophosphorylation [GO:0031952]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100742152.1.2.m.4504,-0.000320011206941853,0.00364202284911089,No,NA,NA,Q5ZLR5,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; 2 iron; 2 sulfur cluster binding [GO:0051537]; metal ion binding [GO:0046872]; ubiquinol-cytochrome-c reductase activity [GO:0008121]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_LOC100742289.1.1.m.25180,0.00063868512982807,0.00303503014674292,No,NA,NA,Q91447,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],NA,NA,NA
CHOYP_LOC100743250.1.1.m.12309,0.0031457038535519,-0.000850059028852705,No,NA,NA,Q14642,NA,NA,NA,membrane [GO:0016020]; plasma membrane [GO:0005886]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; PH domain binding [GO:0042731]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; inositol phosphate-mediated signaling [GO:0048016]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_LOC100743251.1.1.m.16814,-0.00269986593557386,-0.00215834180024233,No,NA,NA,Q8BMF3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; malic enzyme activity [GO:0004470]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948]; malate metabolic process [GO:0006108]; oxidation-reduction process [GO:0055114]; pyruvate metabolic process [GO:0006090],NA,NA,NA
CHOYP_LOC100743492.1.1.m.58896,0.0229072435053739,0.0114052812992345,No,NA,NA,P49963,NA,NA,NA,signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; SRP-dependent cotranslational protein targeting to membrane; signal sequence recognition [GO:0006617]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC100743548.1.2.m.18991,0.0090272767797611,-0.000699664088796513,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100743601.1.1.m.37797,-0.00629811681457611,0.0046007507673993,No,NA,NA,Q00963,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; axon [GO:0030424]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; structural constituent of cytoskeleton [GO:0005200]; actin filament capping [GO:0051693]; axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuromuscular synaptic transmission [GO:0007274]; photoreceptor cell axon guidance [GO:0072499]; plasma membrane organization [GO:0007009]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_LOC100743901.1.1.m.4559,-0.000482583106318549,-0.00038854936983608,No,NA,NA,Q6DC04,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-R17 specific) [GO:0035642]; histone-arginine N-methyltransferase activity [GO:0008469]; lysine-acetylated histone binding [GO:0070577]; nuclear receptor transcription coactivator activity [GO:0030374]; protein-arginine N-methyltransferase activity [GO:0016274]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; histone arginine methylation [GO:0034969]; histone H3-R17 methylation [GO:0034971]; peptidyl-arginine methylation; to asymmetrical-dimethyl arginine [GO:0019919]; positive regulation of fat cell differentiation [GO:0045600]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of skeletal muscle fiber development [GO:0048742]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100744089.1.1.m.58530,-0.012329164350896,0.0188127558378942,No,NA,NA,Q7ZVK3,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glial cell projection [GO:0097386]; juxtaparanode region of axon [GO:0044224]; meiotic spindle [GO:0072687]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; myelin sheath [GO:0043209]; nuclear heterochromatin [GO:0005720]; nucleus [GO:0005634]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; Schmidt-Lanterman incisure [GO:0043220]; spindle [GO:0005819]; histone deacetylase activity [GO:0004407]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H4-K16 specific) [GO:0046970]; NAD-dependent protein deacetylase activity [GO:0034979]; transcription factor binding [GO:0008134]; tubulin deacetylase activity [GO:0042903]; zinc ion binding [GO:0008270]; cellular response to caloric restriction [GO:0061433]; cellular response to hypoxia [GO:0071456]; cellular response to oxidative stress [GO:0034599]; cilium assembly [GO:0060271]; histone H4 deacetylation [GO:0070933]; negative regulation of angiogenesis [GO:0016525]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285]; negative regulation of oligodendrocyte progenitor proliferation [GO:0070446]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061428]; positive regulation of DNA binding [GO:0043388]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia [GO:2000777]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein deacetylation [GO:0006476]; regulation of cell cycle [GO:0051726]; tubulin deacetylation [GO:0090042],NA,NA,NA
CHOYP_LOC100744356.1.1.m.49326,-0.00144004166956589,-0.00140492879444123,No,NA,NA,Q9P2K3,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcriptional repressor complex [GO:0017053]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212],NA,NA,NA
CHOYP_LOC100744369.1.1.m.56678,0.00178357874965496,0.0270246618850659,No,NA,NA,Q08509,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC100745330.1.1.m.65802,-0.00522866425272252,-0.00550941093077159,No,NA,NA,O35598,NA,NA,NA,cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle [GO:0005798]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; synaptic vesicle [GO:0008021]; tetraspanin-enriched microdomain [GO:0097197]; trans-Golgi network [GO:0005802]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; amyloid-beta formation [GO:0034205]; constitutive protein ectodomain proteolysis [GO:0051089]; in utero embryonic development [GO:0001701]; membrane protein ectodomain proteolysis [GO:0006509]; monocyte activation [GO:0042117]; negative regulation of cell adhesion [GO:0007162]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; nucleocytoplasmic transport [GO:0006913]; PMA-inducible membrane protein ectodomain proteolysis [GO:0051088]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of T cell chemotaxis [GO:0010820]; postsynapse organization [GO:0099173]; protein phosphorylation [GO:0006468]; protein processing [GO:0016485]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to antineoplastic agent [GO:0097327]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100745429.1.1.m.27818,-0.0017355801979765,-0.00433174327699683,No,NA,NA,O95758,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; anatomical structure morphogenesis [GO:0009653]; erythrocyte maturation [GO:0043249]; mRNA processing [GO:0006397]; negative regulation of RNA splicing [GO:0033119]; regulation of cell differentiation [GO:0045595]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100745778.1.1.m.27697,0.00164561363587458,-0.000412087003894901,No,NA,NA,Q7T3N8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100748006.1.2.m.19013,-0.00260983051749536,-0.00987072111907036,No,NA,NA,Q6P9H4,NA,NA,NA,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of sodium ion transport [GO:0010765],NA,NA,NA
CHOYP_LOC100748395.4.7.m.40663,0.000948519081513224,-0.00167687251651517,No,NA,NA,P51989,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_LOC100748436.1.1.m.33164,-0.00364235784202225,-0.0155308729940317,No,NA,NA,P13216,NA,NA,NA,mitochondrial matrix [GO:0005759]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100748625.1.1.m.24479,-0.000439459475538207,0.00187147140990708,No,NA,NA,Q9JIH2,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; Ran GTPase binding [GO:0008536]; mRNA transport [GO:0051028]; neural tube formation [GO:0001841]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_LOC100749296.1.1.m.45471,0.00037533959167786,-0.00878337097315121,No,NA,NA,A1A4S6,NA,NA,NA,cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; cytoskeleton organization [GO:0007010]; negative regulation of apoptotic process [GO:0043066]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100749463.1.1.m.6770,-0.000734832434639198,-0.00137690218008385,No,NA,NA,Q93009,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; Lys48-specific deubiquitinase activity [GO:1990380]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitinyl hydrolase activity [GO:0101005]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; maintenance of DNA methylation [GO:0010216]; monoubiquitinated protein deubiquitination [GO:0035520]; multicellular organism development [GO:0007275]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of DNA demethylation [GO:1901537]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of protein stability [GO:0031647]; regulation of telomere capping [GO:1904353]; transcription-coupled nucleotide-excision repair [GO:0006283]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100749506.1.1.m.8950,-5.72307078987127e-05,0.00759313777008076,No,NA,NA,Q9CWL2,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; negative regulation of amacrine cell differentiation [GO:1902870]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinal cone cell fate commitment [GO:0060226]; positive regulation of transcription; DNA-templated [GO:0045893]; retinal bipolar neuron differentiation [GO:0060040]; retinal rod cell fate commitment [GO:0060223],NA,NA,NA
CHOYP_LOC100749745.1.1.m.11523,0.00388826467445763,0.00459194055304416,No,NA,NA,P48545,NA,NA,NA,external side of plasma membrane [GO:0009897]; T-tubule [GO:0030315]; voltage-gated potassium channel complex [GO:0008076]; G-protein activated inward rectifier potassium channel activity [GO:0015467]; inward rectifier potassium channel activity [GO:0005242]; voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization [GO:0086089]; membrane repolarization during atrial cardiac muscle cell action potential [GO:0098914]; potassium ion import across plasma membrane [GO:1990573]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of ion transmembrane transport [GO:0034765],NA,NA,NA
CHOYP_LOC100752270.1.1.m.23081,-0.00829372723397257,-0.00424850688747867,No,NA,NA,Q5RCU5,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NADP+) activity [GO:0047021]; carbonyl reductase (NADPH) activity [GO:0004090]; prostaglandin-E2 9-reductase activity [GO:0050221]; drug metabolic process [GO:0017144]; vitamin K metabolic process [GO:0042373],NA,NA,NA
CHOYP_LOC100755189.1.1.m.33307,0.000574649903428057,-0.00120590871810349,No,NA,NA,Q9CQM5,NA,NA,NA,cytosol [GO:0005829]; peroxidase activity [GO:0004601]; protein-disulfide reductase activity [GO:0047134]; tumor necrosis factor-mediated signaling pathway [GO:0033209],NA,NA,NA
CHOYP_LOC100759507.1.1.m.30604,-0.00227921704718653,2.98342413437959e-05,No,NA,NA,P17900,NA,NA,NA,apical plasma membrane [GO:0016324]; azurophil granule lumen [GO:0035578]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; beta-N-acetylgalactosaminidase activity [GO:0032428]; lipid transporter activity [GO:0005319]; phospholipase activator activity [GO:0016004]; sphingolipid activator protein activity [GO:0030290]; ganglioside catabolic process [GO:0006689]; glycosphingolipid metabolic process [GO:0006687]; learning or memory [GO:0007611]; lipid storage [GO:0019915]; neuromuscular process controlling balance [GO:0050885]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313]; positive regulation of hydrolase activity [GO:0051345],NA,NA,NA
CHOYP_LOC100769755.1.1.m.59793,-0.00656440834311084,-0.0059124812575696,No,NA,NA,Q8IV20,NA,NA,NA,peroxisome [GO:0005777]; copper ion binding [GO:0005507],NA,NA,NA
CHOYP_LOC100770235.1.1.m.2514,0.00288427303299054,-0.000779412954147477,No,NA,NA,Q9R001,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; defense response to bacterium [GO:0042742]; negative regulation of cold-induced thermogenesis [GO:0120163]; tooth eruption [GO:0044691],NA,NA,NA
CHOYP_LOC100770313.1.1.m.3513,0.0130801859553514,0.0121859552382806,No,NA,NA,O00748,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; methyl indole-3-acetate esterase activity [GO:0080030]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC100808508.1.1.m.59055,-0.000585079294152508,-0.00495897064547422,No,NA,NA,Q93XW5,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; enzyme regulator activity [GO:0030234]; glucosinolate catabolic process [GO:0019762]; nitrile biosynthetic process [GO:0080028],NA,NA,NA
CHOYP_LOC100841619.1.1.m.40382,0.00171109989675218,-0.000462388064553745,No,NA,NA,P10447,NA,NA,NA,ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715],NA,NA,NA
CHOYP_LOC100862999.1.1.m.11759,0.00124932565109593,-0.000603185186892713,No,NA,NA,Q6PEC4,NA,NA,NA,Cul7-RING ubiquitin ligase complex [GO:0031467]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],NA,NA,NA
CHOYP_LOC100863242.1.1.m.9849,-0.0016917550498256,0.00247244872079037,No,NA,NA,Q767L0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC100863386.1.1.m.37224,-0.00516512916397715,0.013439704994216,No,NA,NA,P98156,NA,NA,NA,apical part of cell [GO:0045177]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; very-low-density lipoprotein particle [GO:0034361]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; glycoprotein transporter activity [GO:0034437]; reelin receptor activity [GO:0038025]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor activity [GO:0030229]; cellular response to hypoxia [GO:0071456]; cholesterol metabolic process [GO:0008203]; dendrite morphogenesis [GO:0048813]; glycoprotein transport [GO:0034436]; lipid transport [GO:0006869]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of dendrite development [GO:1900006]; positive regulation of protein kinase activity [GO:0045860]; receptor-mediated endocytosis [GO:0006898]; reelin-mediated signaling pathway [GO:0038026]; ventral spinal cord development [GO:0021517]; very-low-density lipoprotein particle clearance [GO:0034447],NA,NA,NA
CHOYP_LOC100863781.1.1.m.33751,0.00692968705171876,-0.0116847883939355,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC100863920.1.1.m.40408,-0.00156618594095335,0.000156641590831069,No,NA,NA,B0W6M9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100864134.1.1.m.41690,0.00486209966381802,-0.00882705736154477,No,NA,NA,Q2PFD7,NA,NA,NA,cell junction [GO:0030054]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; ARF protein signal transduction [GO:0032011]; regulation of ARF protein signal transduction [GO:0032012],NA,NA,NA
CHOYP_LOC100864501.1.1.m.7850,-0.0254443967547529,0.0192730539277998,No,NA,NA,M9PBE2,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; cadherin binding [GO:0045296]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; actin filament organization [GO:0007015]; chitin-based cuticle development [GO:0040003]; dorsal closure [GO:0007391]; epithelial cell migration; open tracheal system [GO:0007427]; epithelium development [GO:0060429]; head involution [GO:0008258]; midgut development [GO:0007494]; protein ubiquitination [GO:0016567]; segmentation [GO:0035282],NA,NA,NA
CHOYP_LOC100864577.1.1.m.8977,-0.00343078028257231,0.00742103985641005,No,NA,NA,Q9Y4K4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of JUN kinase activity [GO:0007257]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100865129.1.1.m.45329,0.00205873414771944,-0.000556328768297838,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100865286.1.1.m.17958,-0.00538831019537143,-0.00193029103130339,No,NA,NA,O02695,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; secretory granule membrane [GO:0030667]; synaptic vesicle membrane [GO:0030672]; protein tyrosine phosphatase activity [GO:0004725]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; lipid metabolic process [GO:0006629]; neurotransmitter secretion [GO:0007269],NA,NA,NA
CHOYP_LOC100865976.1.1.m.15403,-0.00265930023564574,4.11917505197439e-05,No,NA,NA,Q9W445,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; formation of translation preinitiation complex [GO:0001731]; positive regulation of translational initiation [GO:0045948]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_LOC100866180.1.1.m.49582,-0.00792261894048957,-0.00810612313310817,No,NA,NA,Q8IV50,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100867381.8.8.m.53059,0.00098427069057482,0.00750862407950712,No,NA,NA,Q62417,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-substrate adherens junction [GO:0005924]; centrosome [GO:0005813]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; insulin receptor complex [GO:0005899]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; synapse [GO:0045202]; insulin receptor binding [GO:0005158]; protein kinase binding [GO:0019901]; SH3/SH2 adaptor activity [GO:0005070]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; acetylcholine receptor signaling pathway [GO:0095500]; cellular response to insulin stimulus [GO:0032869]; focal adhesion assembly [GO:0048041]; insulin receptor signaling pathway [GO:0008286]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904393]; stress fiber assembly [GO:0043149],NA,NA,NA
CHOYP_LOC100867487.2.2.m.65146,0.00630760555007272,-0.00825829601056214,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC100867628.1.1.m.1331,-0.000754408674405207,-0.003615612913318,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100867962.1.1.m.19193,-0.0117295672024356,-0.00246291092424327,No,NA,NA,A2AV36,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; histone methyltransferase activity (H4-R3 specific) [GO:0044020]; histone-arginine N-methyltransferase activity [GO:0008469]; protein-arginine omega-N asymmetric methyltransferase activity [GO:0035242]; protein-arginine omega-N monomethyltransferase activity [GO:0035241]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; cell differentiation [GO:0030154]; DNA methylation involved in gamete generation [GO:0043046]; histone arginine methylation [GO:0034969]; peptidyl-arginine methylation [GO:0018216]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of transcription; DNA-templated [GO:0006355]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC100869188.1.1.m.18952,-0.0240972554251494,0.0154890640155,No,NA,NA,Q9CXW2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC100869625.1.1.m.52959,0.00093948483653354,0.00213553891083441,No,NA,NA,Q8VEG6,NA,NA,NA,CCR4-NOT complex [GO:0030014]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; gene silencing by RNA [GO:0031047]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_LOC100870649.1.2.m.13573,-0.0135035854844809,-0.00772569381498925,No,NA,NA,Q9UKI8,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; chromatin organization [GO:0006325]; intracellular protein transport [GO:0006886]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; regulation of chromatin assembly or disassembly [GO:0001672],NA,NA,NA
CHOYP_LOC100872239.1.1.m.53052,-0.00169100250119923,0.00215730185271485,No,NA,NA,Q9H9H4,NA,NA,NA,cytoplasm [GO:0005737]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; midbody [GO:0030496]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; endosomal transport [GO:0016197]; endosome transport via multivesicular body sorting pathway [GO:0032509]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral release from host cell [GO:1902188]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC100872507.1.1.m.21152,0.0173119425795046,0.00249266449915517,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_LOC100874620.1.1.m.23782,0.000288006347517417,-0.0119280962593802,No,NA,NA,Q01063,NA,NA,NA,apical plasma membrane [GO:0016324]; calcium channel complex [GO:0034704]; centrosome [GO:0005813]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; voltage-gated calcium channel complex [GO:0005891]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; ATPase binding [GO:0051117]; cAMP binding [GO:0030552]; drug binding [GO:0008144]; ion channel binding [GO:0044325]; metal ion binding [GO:0046872]; scaffold protein binding [GO:0097110]; aging [GO:0007568]; cAMP catabolic process [GO:0006198]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to lipopolysaccharide [GO:0071222]; establishment of endothelial barrier [GO:0061028]; leukocyte migration [GO:0050900]; multicellular organism growth [GO:0035264]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of heart contraction [GO:0045822]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of relaxation of cardiac muscle [GO:1901898]; neutrophil chemotaxis [GO:0030593]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-5 production [GO:0032754]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; smooth muscle contraction [GO:0006939]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC100875369.1.1.m.31446,0.00701734751651256,0.008854788687799,No,NA,NA,P20936,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; phosphotyrosine residue binding [GO:0001784]; potassium channel inhibitor activity [GO:0019870]; signaling receptor binding [GO:0005102]; blood vessel morphogenesis [GO:0048514]; ephrin receptor signaling pathway [GO:0048013]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; mitotic cytokinesis [GO:0000281]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of Ras protein signal transduction [GO:0046580]; regulation of actin filament polymerization [GO:0030833]; regulation of cell shape [GO:0008360]; regulation of RNA metabolic process [GO:0051252]; signal transduction [GO:0007165]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_LOC100875390.1.1.m.24780,-0.00139462393285208,0.00104083434536837,No,NA,NA,Q641Z6,NA,NA,NA,ciliary pocket membrane [GO:0020018]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; lipid droplet [GO:0005811]; myelin sheath [GO:0043209]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet dense tubular network membrane [GO:0031095]; recycling endosome membrane [GO:0055038]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; cellular response to nerve growth factor stimulus [GO:1990090]; cholesterol homeostasis [GO:0042632]; cilium assembly [GO:0060271]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; low-density lipoprotein particle clearance [GO:0034383]; neuron projection development [GO:0031175]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron projection development [GO:0010976]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_LOC100875404.1.1.m.8506,-0.00703286899070156,-0.0283611096576214,No,NA,NA,Q6AXY7,NA,NA,NA,precatalytic spliceosome [GO:0071011]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC100875479.1.2.m.42509,-0.00674247637957717,0.00419812219803011,No,NA,NA,Q7PHR1,NA,NA,NA,cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; synapse [GO:0045202]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; plus-end-directed [GO:0008574]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC100875585.1.1.m.8714,-0.00215209568854608,0.00559402630686378,No,NA,NA,Q00174,NA,NA,NA,axon [GO:0030424]; basement membrane [GO:0005604]; cell junction [GO:0030054]; presynaptic periactive zone [GO:0036062]; synaptic vesicle [GO:0008021]; signaling receptor binding [GO:0005102]; axon guidance [GO:0007411]; cell adhesion mediated by integrin [GO:0033627]; dorsal trunk growth; open tracheal system [GO:0035001]; female meiosis chromosome segregation [GO:0016321]; heart development [GO:0007507]; melanotic encapsulation of foreign target [GO:0035011]; mesoderm development [GO:0007498]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_LOC100875705.1.1.m.10980,-0.0100787621125614,0.00356280027998941,No,NA,NA,Q9V9W8,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]; transcription coactivator activity [GO:0003713]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; delamination [GO:0060232]; embryonic pattern specification [GO:0009880]; eye-antennal disc development [GO:0035214]; imaginal disc-derived wing expansion [GO:0048526]; positive regulation of transcription by RNA polymerase II [GO:0045944]; segment polarity determination [GO:0007367]; transcription; DNA-templated [GO:0006351]; wing disc morphogenesis [GO:0007472],NA,NA,NA
CHOYP_LOC100875978.1.1.m.34640,-0.0160763976825333,-0.0102309798008137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100875987.1.2.m.7720,-0.00666525470536568,0.0070377567803955,No,NA,NA,P42026,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; quinone binding [GO:0048038]; aerobic respiration [GO:0009060]; electron transport coupled proton transport [GO:0015990]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC100876012.1.1.m.8280,0.00707588834716268,-0.0233877295472403,No,NA,NA,Q16831,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; uridine phosphorylase activity [GO:0004850]; cellular response to glucose starvation [GO:0042149]; nucleobase-containing compound metabolic process [GO:0006139]; nucleotide catabolic process [GO:0009166]; pyrimidine nucleoside catabolic process [GO:0046135]; pyrimidine nucleoside salvage [GO:0043097]; UMP salvage [GO:0044206]; uridine catabolic process [GO:0006218],NA,NA,NA
CHOYP_LOC100876515.1.2.m.37063,0.0112029937810213,-0.00399196083736386,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876515.2.2.m.54514,0.000211515631952822,-0.000447678176851812,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100876659.1.1.m.19405,-0.0121922910461644,-0.00336429411168919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100876663.1.1.m.4368,-0.00817889766284063,0.00169622560983994,No,NA,NA,O01404,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; copper ion binding [GO:0005507]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; memory [GO:0007613]; multicellular organism reproduction [GO:0032504]; peptide amidation [GO:0001519]; regulation of imaginal disc-derived wing size [GO:0044719]; response to fungus [GO:0009620],NA,NA,NA
CHOYP_LOC100877311.1.1.m.25123,-9.88949011581192e-05,0.00280312938042156,No,NA,NA,Q9NX05,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC100877335.1.1.m.8851,-0.00113521990656722,-0.000853730813555317,No,NA,NA,Q61329,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; zinc ion binding [GO:0008270]; brain development [GO:0007420]; circadian regulation of gene expression [GO:0032922]; muscle organ development [GO:0007517]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cell adhesion [GO:0045785]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of locomotor rhythm [GO:1904059]; regulation of neuron differentiation [GO:0045664]; response to transforming growth factor beta [GO:0071559],NA,NA,NA
CHOYP_LOC100877393.1.1.m.26310,-0.00575013725297868,0.0114547213705714,No,NA,NA,Q5F499,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; cardiolipin binding [GO:1901612]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidic acid binding [GO:0070300]; apoptotic process [GO:0006915]; dynamin family protein polymerization involved in mitochondrial fission [GO:0003374]; GTP metabolic process [GO:0046039]; membrane fusion [GO:0061025]; membrane tubulation [GO:0097749]; mitochondrial fission [GO:0000266]; mitochondrial fusion [GO:0008053],NA,NA,NA
CHOYP_LOC100877438.2.2.m.37290,-0.00386552061634065,0.0134254495294316,No,NA,NA,Q7KRY7,NA,NA,NA,apicolateral plasma membrane [GO:0016327]; basolateral part of cell [GO:1990794]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; fusome [GO:0045169]; lateral plasma membrane [GO:0016328]; neuromuscular junction [GO:0031594]; postsynaptic density [GO:0014069]; septate junction [GO:0005918]; synapse [GO:0045202]; ionotropic glutamate receptor binding [GO:0035255]; anterior/posterior axis specification; follicular epithelium [GO:0030714]; basal protein localization [GO:0045175]; cell fate commitment involved in pattern specification [GO:0060581]; cell fate specification [GO:0001708]; cell morphogenesis [GO:0000902]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; compound eye development [GO:0048749]; dorsal closure [GO:0007391]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment or maintenance of apical/basal cell polarity [GO:0035088]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; establishment or maintenance of polarity of follicular epithelium [GO:0016334]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; Malpighian tubule development [GO:0072002]; memory [GO:0007613]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; morphogenesis of follicular epithelium [GO:0016333]; morphogenesis of larval imaginal disc epithelium [GO:0016335]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; olfactory behavior [GO:0042048]; ovarian follicle cell development [GO:0030707]; pole plasm protein localization [GO:0007318]; R3/R4 cell fate commitment [GO:0007464]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell cycle [GO:0051726]; regulation of endocytosis [GO:0030100]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of JAK-STAT cascade [GO:0046425]; regulation of Notch signaling pathway [GO:0008593]; regulation of synapse structure or activity [GO:0050803]; sensory perception of smell [GO:0007608]; septate junction assembly [GO:0019991]; stem cell differentiation [GO:0048863]; stem cell proliferation [GO:0072089]; wing disc morphogenesis [GO:0007472]; zonula adherens assembly [GO:0045186],NA,NA,NA
CHOYP_LOC100877549.1.1.m.8321,-0.0064352224162011,-0.0040953596604188,No,NA,NA,Q91WD2,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; ion channel activity [GO:0005216]; metal ion binding [GO:0046872]; calcium ion homeostasis [GO:0055074]; calcium ion import [GO:0070509]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; parathyroid hormone secretion [GO:0035898]; protein homotetramerization [GO:0051289]; response to calcium ion [GO:0051592],NA,NA,NA
CHOYP_LOC100877554.2.2.m.34916,0.00367830652335901,0.0287754692523217,No,NA,NA,P18172,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100877618.1.1.m.39871,0,0,No,NA,NA,Q86V88,NA,NA,NA,metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725],NA,NA,NA
CHOYP_LOC100877689.1.2.m.14376,0.00379334510549307,0.0102986018370663,No,NA,NA,Q9ERG0,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; metal ion binding [GO:0046872]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; intestinal cholesterol absorption [GO:0030299]; negative regulation of actin filament depolymerization [GO:0030835]; ruffle organization [GO:0031529],NA,NA,NA
CHOYP_LOC100877689.2.2.m.26187,0.00074800942349902,-0.000910657261732139,No,NA,NA,Q9BT23,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100877728.1.1.m.19879,-0.000934910797007364,-0.00180799224833814,No,NA,NA,Q5ZLS7,NA,NA,NA,nuclear speck [GO:0016607]; DNA binding [GO:0003677]; methylated histone binding [GO:0035064]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC100877749.1.1.m.65236,0.000126147900102574,0.00289389103007481,No,NA,NA,Q9UBN7,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_LOC100877947.1.1.m.51907,0.00221444449434159,0.000503682932832906,No,NA,NA,Q6PFX9,NA,NA,NA,chromosome; centromeric region [GO:0000775]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; mitotic spindle pole [GO:0097431]; nuclear body [GO:0016604]; nuclear chromosome; telomeric region [GO:0000784]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone binding [GO:0042393]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; mRNA transport [GO:0051028]; negative regulation of maintenance of mitotic sister chromatid cohesion; telomeric [GO:1904908]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of telomeric DNA binding [GO:1904743]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein ADP-ribosylation [GO:0006471]; protein auto-ADP-ribosylation [GO:0070213]; protein localization to chromosome; telomeric region [GO:0070198]; protein poly-ADP-ribosylation [GO:0070212]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; spindle assembly [GO:0051225]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC100877992.1.1.m.1507,-0.0182946840526419,0.0292889915156488,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100878123.1.1.m.55730,0.0183375919844805,0.010360960943883,No,NA,NA,A5PK45,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; procollagen galactosyltransferase activity [GO:0050211]; positive regulation of collagen fibril organization [GO:1904028],NA,NA,NA
CHOYP_LOC100878391.1.1.m.28644,0.00782272085545717,0.0109952595163257,No,NA,NA,O35094,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; cardiac muscle cell differentiation [GO:0055007]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]; response to 3;3';5-triiodo-L-thyronine [GO:1905242],NA,NA,NA
CHOYP_LOC100878601.1.1.m.15486,-0.00345048077996057,-0.0118284401193906,No,NA,NA,Q803E1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA 7-methylguanosine cap binding [GO:0000340]; 7-methylguanosine mRNA capping [GO:0006370]; mRNA transport [GO:0051028],NA,NA,NA
CHOYP_LOC100879052.1.1.m.53743,-0.0105799094447214,-0.00673302825427034,No,NA,NA,A1XBS5,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; cilium assembly [GO:0060271],NA,NA,NA
CHOYP_LOC100879129.1.1.m.44467,0.00391566579593851,0.00179879724319811,No,NA,NA,Q5DTY9,NA,NA,NA,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; protein homooligomerization [GO:0051260]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],NA,NA,NA
CHOYP_LOC100879250.1.1.m.24381,0.000719109936762657,-0.00157767130059222,No,NA,NA,Q589R5,NA,NA,NA,cytosol [GO:0005829]; methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242],NA,NA,NA
CHOYP_LOC100879339.1.1.m.20204,-0.0095896048297432,-0.00174299107497752,No,NA,NA,Q8TBG4,NA,NA,NA,mitochondrial matrix [GO:0005759]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC100879389.2.2.m.63959,-0.000347590406987498,-0.00272504230060391,No,NA,NA,Q92804,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of signal transduction by p53 class mediator [GO:1901796]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_LOC100879487.1.3.m.20887,-0.0175920725845969,-0.0111955515670659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879487.2.3.m.32793,-0.00729834409743191,-0.010283352760008,No,NA,NA,Q8K480,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; eye photoreceptor cell development [GO:0042462]; retina development in camera-type eye [GO:0060041]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33048,-0.0116765683949072,0.0149146449558132,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_LOC100879487.3.3.m.33049,0.00516546108761956,-0.00135225703906932,No,NA,NA,Q6NZL8,NA,NA,NA,cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; positive regulation of smoothened signaling pathway [GO:0045880]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_LOC100879690.1.1.m.18064,0.0023363688549764,0.0152284937458907,No,NA,NA,Q6AWC2,NA,NA,NA,cytosol [GO:0005829]; kinase binding [GO:0019900]; protein-containing complex scaffold activity [GO:0032947]; negative regulation of hippo signaling [GO:0035331]; negative regulation of organ growth [GO:0046621]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_LOC100879804.1.1.m.59833,-0.00761822661376462,0.0239013159436024,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100879890.1.1.m.4963,0.00392032212376179,0.00414822706000589,No,NA,NA,O00499,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; chaperone binding [GO:0051087]; clathrin binding [GO:0030276]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; RNA polymerase binding [GO:0070063]; tau protein binding [GO:0048156]; cell proliferation [GO:0008283]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; membrane organization [GO:0061024]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; regulation of cell cycle arrest [GO:0071156]; regulation of endocytosis [GO:0030100]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; T-tubule organization [GO:0033292]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC100879964.1.1.m.1780,-0.00800063523103724,0.00707624645472289,No,NA,NA,Q924I2,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine/threonine kinase activity [GO:0004674]; SH3 domain binding [GO:0017124]; activation of protein kinase activity [GO:0032147]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]; response to UV [GO:0009411]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC100879981.1.1.m.57826,-0.0121566278125781,0.0116243299376977,No,NA,NA,O75808,NA,NA,NA,cytoplasm [GO:0005737]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; metal ion binding [GO:0046872]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100880308.1.1.m.6158,-0.000801061105232804,0.00618396057217613,No,NA,NA,Q5EA98,NA,NA,NA,microfibril [GO:0001527]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC100880757.2.2.m.41249,0.00150068008307445,-0.00084128053826222,No,NA,NA,Q4PIN7,NA,NA,NA,nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC100880815.3.7.m.45911,-0.00734940412503976,-0.00467714264327967,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100880815.5.7.m.54594,0.00216538043763247,0.018640704852093,No,NA,NA,D3YXG0,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC100880948.1.1.m.25232,0.00138831472275308,-0.00493846073195726,No,NA,NA,P52632,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; protein dimerization activity [GO:0046983]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; liver development [GO:0001889]; luteinization [GO:0001553]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC100881280.1.1.m.39133,-0.00416554629847845,-0.00568261528132446,No,NA,NA,Q9EQW7,NA,NA,NA,centrosome [GO:0005813]; endosome membrane [GO:0010008]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cargo loading into vesicle [GO:0035459]; cell cycle [GO:0007049]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; microtubule-based movement [GO:0007018]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_LOC100881316.1.1.m.51540,0.00121476377518094,-0.0024419454592083,No,NA,NA,P47812,NA,NA,NA,ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; intracellular signal transduction [GO:0035556]; p38MAPK cascade [GO:0038066]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of myotube differentiation [GO:0010831]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC100881900.1.3.m.1852,0.00272127173597695,2.09219192672734e-05,No,NA,NA,P54357,NA,NA,NA,cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; myosin V complex [GO:0031475]; myosin VI complex [GO:0031476]; myosin VII complex [GO:0031477]; calcium ion binding [GO:0005509]; myosin binding [GO:0017022]; myosin heavy chain binding [GO:0032036]; actin filament-based movement [GO:0030048],NA,NA,NA
CHOYP_LOC100882263.1.1.m.48839,0.000245409512172098,0.00292691579909731,No,NA,NA,P34611,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100882621.1.2.m.25860,-0.0142003892044316,-0.00778571608891082,No,NA,NA,Q8IRG6,NA,NA,NA,cytosol [GO:0005829]; FACT complex [GO:0035101]; nucleolus [GO:0005730]; nucleus [GO:0005634]; polytene chromosome puff [GO:0005703]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication-independent nucleosome organization [GO:0034724]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of chromatin assembly or disassembly [GO:0001672]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_LOC100883412.1.1.m.25657,-0.018095881687969,0.0166673368629855,No,NA,NA,O15550,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; dioxygenase activity [GO:0051213]; histone demethylase activity [GO:0032452]; histone demethylase activity (H3-K27 specific) [GO:0071558]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; canonical Wnt signaling pathway [GO:0060070]; cardiovascular system development [GO:0072358]; chromatin remodeling [GO:0006338]; heart morphogenesis [GO:0003007]; histone H3-K4 methylation [GO:0051568]; in utero embryonic development [GO:0001701]; mesodermal cell differentiation [GO:0048333]; multicellular organism growth [GO:0035264]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; positive regulation of gene expression [GO:0010628]; respiratory system process [GO:0003016]; somite rostral/caudal axis specification [GO:0032525],NA,NA,NA
CHOYP_LOC100883571.1.1.m.42323,-0.00216536935949888,0.00135412913426398,No,NA,NA,Q9UPY6,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; postsynapse [GO:0098794]; actin binding [GO:0003779]; actin filament polymerization [GO:0030041]; cytoskeleton organization [GO:0007010]; lamellipodium assembly [GO:0030032]; modification of postsynaptic actin cytoskeleton [GO:0098885]; oligodendrocyte development [GO:0014003]; positive regulation of myelination [GO:0031643]; protein-containing complex assembly [GO:0065003]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC100883586.1.1.m.268,0.00842119372161452,-0.0028998480335544,No,NA,NA,Q641Z2,NA,NA,NA,cytoplasm [GO:0005737]; neuron projection terminus [GO:0044306]; protein tyrosine phosphatase activity [GO:0004725]; negative regulation of neuron projection development [GO:0010977]; positive regulation of protein localization to plasma membrane [GO:1903078],NA,NA,NA
CHOYP_LOC100883864.1.1.m.41791,-0.000775599174084499,0.000135033333562737,No,NA,NA,Q9WUB3,NA,NA,NA,cytoplasm [GO:0005737]; sarcoplasmic reticulum [GO:0016529]; Z disc [GO:0030018]; AMP binding [GO:0016208]; carbohydrate binding [GO:0030246]; drug binding [GO:0008144]; glycogen phosphorylase activity [GO:0008184]; linear malto-oligosaccharide phosphorylase activity [GO:0102250]; pyridoxal phosphate binding [GO:0030170]; SHG alpha-glucan phosphorylase activity [GO:0102499]; cellular calcium ion homeostasis [GO:0006874]; glycogen catabolic process [GO:0005980]; glycogen metabolic process [GO:0005977]; response to cAMP [GO:0051591]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC100888253.1.1.m.18761,0.00489657810559458,-0.00888965237282419,No,NA,NA,A2RRH5,NA,NA,NA,nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC100888299.1.3.m.3738,-0.00338958597424467,-0.00697404337891711,No,NA,NA,Q6MHJ5,NA,NA,NA,ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC100888300.1.2.m.10203,-0.00408921967160768,-0.00145841274790949,No,NA,NA,Q92805,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802],NA,NA,NA
CHOYP_LOC100888608.1.3.m.5445,0.00909541375804189,-0.00183787175326422,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100888702.1.1.m.56287,0.00216432805049107,-0.000584863256800775,No,NA,NA,P35448,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC100888889.1.1.m.14397,0.00520981451289166,-0.00945832762140277,No,NA,NA,Q5HY98,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100888910.1.1.m.64827,0.0133014493126347,-0.0172246528310548,No,NA,NA,Q7ZWI4,NA,NA,NA,cytoplasm [GO:0005737]; protein kinase A binding [GO:0051018]; regulation of canonical Wnt signaling pathway [GO:0060828],NA,NA,NA
CHOYP_LOC100888919.1.1.m.1193,0.00687237745218736,-0.00178376874036249,No,NA,NA,P25455,NA,NA,NA,cell [GO:0005623]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; entrainment of circadian clock by photoperiod [GO:0043153]; flight behavior [GO:0007629]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; neuron cellular homeostasis [GO:0070050]; regulation of neuromuscular synaptic transmission [GO:1900073],NA,NA,NA
CHOYP_LOC100888944.1.1.m.45112,0.00896115027954263,-0.0107284675327709,No,NA,NA,P53500,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100889245.1.2.m.999,-0.00716657096142071,-0.00456078806927347,No,NA,NA,A2ALS5,NA,NA,NA,axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; GTPase activator activity [GO:0005096]; protein homodimerization activity [GO:0042803]; Ras GTPase binding [GO:0017016]; cellular response to glial cell derived neurotrophic factor [GO:1990792]; negative regulation of GTP binding [GO:1904425]; negative regulation of microvillus assembly [GO:1903697]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of thyroid gland epithelial cell proliferation [GO:1904442]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phagocytosis [GO:0050766]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC100889318.1.1.m.61506,0.0023961618427731,0.00282980549389211,No,NA,NA,Q9VCX1,NA,NA,NA,apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GDP-dissociation inhibitor activity [GO:0005092]; GTPase activator activity [GO:0005096]; asymmetric neuroblast division [GO:0055059]; axon ensheathment in central nervous system [GO:0032291]; cell cycle [GO:0007049]; cortical actin cytoskeleton organization [GO:0030866]; cytoplasmic transport; nurse cell to oocyte [GO:0007303]; defense response to fungus [GO:0050832]; dorsal/ventral axis specification; ovarian follicular epithelium [GO:0008069]; embryonic axis specification [GO:0000578]; establishment of endothelial blood-brain barrier [GO:0014045]; establishment of glial blood-brain barrier [GO:0060857]; G protein-coupled receptor signaling pathway [GO:0007186]; glial cell differentiation [GO:0010001]; heart process [GO:0003015]; oocyte dorsal/ventral axis specification [GO:0007310]; regulation of asymmetric cell division [GO:0009786]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to starvation [GO:0042594]; septate junction assembly [GO:0019991]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_LOC100889336.1.1.m.18327,-0.021203371127129,0.0133179146718282,No,NA,NA,Q6ZV65,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC100889562.1.1.m.27158,-0.00792289087726573,0.00561680894254276,No,NA,NA,A9VFD6,NA,NA,NA,ATP binding [GO:0005524]; S-methyl-5-thioribose kinase activity [GO:0046522]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_LOC100889564.1.1.m.17148,0.00348385337145413,0.00540168478784605,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100889564.1.1.m.17149,-0.00849392233632399,0.0192612118241229,No,NA,NA,Q6DF46,NA,NA,NA,cell projection [GO:0042995]; extrinsic component of mitochondrial inner membrane [GO:0031314]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; oxidoreductase activity [GO:0016491]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; reduced flavin or flavoprotein as one donor; and incorporation of one atom of oxygen [GO:0016712]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC100889738.1.1.m.41184,-0.00528371731357282,-0.000847705873140433,No,NA,NA,Q6NXI6,NA,NA,NA,RNA polymerase II; holoenzyme [GO:0016591],NA,NA,NA
CHOYP_LOC100889837.1.2.m.2516,-0.00396511499224394,-0.0120809872993858,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889837.2.2.m.31074,0.0111148943872899,-0.00547722238551433,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC100889942.1.1.m.57041,-0.00314221604155317,-0.00789395051178391,No,NA,NA,Q96PN7,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding; bending [GO:0008301]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; nuclear receptor transcription coactivator activity [GO:0030374]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; cholesterol catabolic process [GO:0006707]; homeostatic process [GO:0042592]; multicellular organism development [GO:0007275]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of hormone biosynthetic process [GO:0046885]; steroid biosynthetic process [GO:0006694],NA,NA,NA
CHOYP_LOC100890015.1.1.m.8302,-0.00296709318203468,-0.00322479507359945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890099.1.1.m.11505,0.0211730309791886,0.000640986198010949,No,NA,NA,P53486,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100890106.1.1.m.40543,0.0165277490936869,0.0102717051912724,No,NA,NA,Q2M2T5,NA,NA,NA,Cul2-RING ubiquitin ligase complex [GO:0031462]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; recycling endosome [GO:0055037]; copper ion binding [GO:0005507]; copper ion homeostasis [GO:0055070]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of sodium ion transmembrane transport [GO:1902306]; positive regulation of protein ubiquitination [GO:0031398]; protein transport [GO:0015031]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434],NA,NA,NA
CHOYP_LOC100890342.1.1.m.10194,-0.0239739984830698,0.0069049513606985,No,NA,NA,O15259,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; membrane [GO:0016020]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; structural molecule activity [GO:0005198]; actin cytoskeleton organization [GO:0030036]; cell projection organization [GO:0030030]; cell-cell adhesion [GO:0098609]; ciliary basal body-plasma membrane docking [GO:0097711]; excretion [GO:0007588]; positive regulation of bicellular tight junction assembly [GO:1903348]; retina development in camera-type eye [GO:0060041]; signal transduction [GO:0007165]; spermatid differentiation [GO:0048515]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_LOC100890433.1.1.m.30609,-0.00362239385265616,-0.00930958403685346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890512.1.1.m.36422,-0.00573529784933664,0.000816506704676444,No,NA,NA,Q8IYX7,NA,NA,NA,axonemal microtubule [GO:0005879]; centriole [GO:0005814]; ciliary basal body [GO:0036064]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; microtubule binding [GO:0008017]; cell projection organization [GO:0030030]; cellular response to cold [GO:0070417]; cold acclimation [GO:0009631]; microtubule anchoring [GO:0034453]; positive regulation of cilium assembly [GO:0045724]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC100890512.1.1.m.36423,-0.000125650707873554,0.00100440660986427,No,NA,NA,Q29L80,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100890517.2.2.m.22207,-0.0148869926465658,0.0116300524795853,No,NA,NA,Q08E31,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; condensed nuclear chromosome; centromeric region [GO:0000780]; cytosol [GO:0005829]; nBAF complex [GO:0071565]; nucleus [GO:0005634]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_LOC100890554.1.1.m.28894,-0.0218628630342958,-0.00352682202603679,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890653.1.1.m.13755,-0.0182861787554641,0.00706008481647094,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100890753.1.3.m.50299,-0.01675888061825,0.00891086001769818,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890753.2.3.m.53551,0.00220308340860059,-0.000595336061492866,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC100890762.1.1.m.31399,-0.0225155508853922,0.0116757931352902,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891184.1.1.m.18226,0.000523578774286487,-0.012477066463073,No,NA,NA,O95477,NA,NA,NA,endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; external side of plasma membrane [GO:0009897]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; anion transmembrane transporter activity [GO:0008509]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein A-I receptor activity [GO:0034188]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ATPase binding [GO:0051117]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; high-density lipoprotein particle binding [GO:0008035]; lipid transporter activity [GO:0005319]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylserine-translocating ATPase activity [GO:0090556]; phospholipid binding [GO:0005543]; phospholipid transporter activity [GO:0005548]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267]; syntaxin binding [GO:0019905]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to cholesterol [GO:0071397]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to retinoic acid [GO:0071300]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; endosomal transport [GO:0016197]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; interleukin-1 beta secretion [GO:0050702]; intracellular cholesterol transport [GO:0032367]; lipid transport [GO:0006869]; lysosome organization [GO:0007040]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; phagocytosis; engulfment [GO:0006911]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; phospholipid translocation [GO:0045332]; platelet dense granule organization [GO:0060155]; positive regulation of cholesterol efflux [GO:0010875]; protein lipidation [GO:0006497]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of high-density lipoprotein particle assembly [GO:0090107]; regulation of lipid metabolic process [GO:0019216]; response to drug [GO:0042493]; response to laminar fluid shear stress [GO:0034616]; response to nutrient [GO:0007584]; reverse cholesterol transport [GO:0043691],NA,NA,NA
CHOYP_LOC100891282.1.1.m.41107,-0.0172704054513467,0.0129414459452197,No,NA,NA,O00115,NA,NA,NA,extracellular exosome [GO:0070062]; lysosome [GO:0005764]; deoxyribonuclease II activity [GO:0004531]; DNA binding [GO:0003677]; apoptotic DNA fragmentation [GO:0006309]; DNA metabolic process [GO:0006259]; erythrocyte differentiation [GO:0030218]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_LOC100891402.2.3.m.27268,-0.00609634388312726,-0.00502482768279575,No,NA,NA,P60897,NA,NA,NA,proteasome complex [GO:0000502]; proteasome regulatory particle; lid subcomplex [GO:0008541]; double-strand break repair via homologous recombination [GO:0000724]; mRNA export from nucleus [GO:0006406]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_LOC100891466.2.10.m.9752,0.00384174121522388,0.0045369975445276,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100891502.1.1.m.14627,-0.00407851136538442,-0.00310859961156092,No,NA,NA,Q3ZBD2,NA,NA,NA,cytoplasm [GO:0005737]; dynactin complex [GO:0005869]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100891594.2.2.m.54602,0.000256466657177355,0.000459562012466768,No,NA,NA,Q1MTN8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100891656.1.1.m.62466,-0.00249132215833604,0.00108070144722462,No,NA,NA,Q8YTC2,NA,NA,NA,ADP binding [GO:0043531]; sequence-specific DNA binding [GO:0043565],NA,NA,NA
CHOYP_LOC100891888.1.1.m.20756,-0.00176695325527791,-0.000208133221153278,No,NA,NA,P29218,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; identical protein binding [GO:0042802]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; inositol monophosphate phosphatase activity [GO:0052834]; lithium ion binding [GO:0031403]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; inositol biosynthetic process [GO:0006021]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; phosphate-containing compound metabolic process [GO:0006796]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100892150.1.1.m.10319,-0.00156102976322745,0.00211921772559049,No,NA,NA,A9CPT4,NA,NA,NA,P granule [GO:0043186]; pi-body [GO:0071546]; metal ion binding [GO:0046872]; DNA methylation involved in gamete generation [GO:0043046]; gene silencing by RNA [GO:0031047]; germ cell development [GO:0007281]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; piRNA metabolic process [GO:0034587]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC100892181.1.1.m.49777,-0.00855125835357857,0.0166876079982801,No,NA,NA,Q9ET66,NA,NA,NA,extracellular space [GO:0005615]; peptidase inhibitor activity [GO:0030414]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052],NA,NA,NA
CHOYP_LOC100892193.1.5.m.13369,-0.00843254034709939,0.000410738741073599,No,NA,NA,Q98943,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892193.2.5.m.28130,0.0189124922367429,-0.00657850866608012,No,NA,NA,Q98943,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:0097200]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; regulation of apoptotic process [GO:0042981],NA,NA,NA
CHOYP_LOC100892461.2.2.m.55369,0.00630245335540079,-0.00878309315232162,No,NA,NA,Q6PK81,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC100892516.1.1.m.38152,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892637.1.1.m.49164,-0.0116605225821147,-0.00649810900047913,No,NA,NA,Q2NKS3,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100892743.1.1.m.55850,0,0,No,NA,NA,O54926,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; CD27 receptor binding [GO:0005175]; tumor necrosis factor receptor binding [GO:0005164]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; activation-induced cell death of T cells [GO:0006924]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030],NA,NA,NA
CHOYP_LOC100892914.1.1.m.53491,0.00304678292203096,-0.00329375460819235,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100892925.1.2.m.44655,-0.00307798407929972,-0.0125330587039718,No,NA,NA,Q5F359,NA,NA,NA,endoplasmic reticulum [GO:0005783]; TRAPP complex [GO:0030008]; TRAPPI protein complex [GO:1990070]; TRAPPII protein complex [GO:1990071]; TRAPPIII protein complex [GO:1990072]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC100893261.2.3.m.49437,-7.31344534538448e-05,0.00970318210631615,No,NA,NA,D4AR77,NA,NA,NA,extracellular region [GO:0005576]; serine-type peptidase activity [GO:0008236],NA,NA,NA
CHOYP_LOC100893889.1.2.m.7738,0.00723568027418954,-0.00936731538220612,No,NA,NA,Q8IXR9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC100893889.2.2.m.64935,0.00183803266324176,-0.00140120749508889,No,NA,NA,P04113,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC100893981.1.1.m.56774,0.00247914101956097,0.00292780176699911,No,NA,NA,B0JZV4,NA,NA,NA,cytosol [GO:0005829]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; metallocarboxypeptidase activity [GO:0004181]; tubulin binding [GO:0015631]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; protein branching point deglutamylation [GO:0035611]; protein deglutamylation [GO:0035608],NA,NA,NA
CHOYP_LOC100897892.1.1.m.1462,-0.00496123232007375,-0.00209299638987884,No,NA,NA,P82147,NA,NA,NA,perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; multicellular organism development [GO:0007275]; protein refolding [GO:0042026]; regulation of translational initiation by eIF2 alpha phosphorylation [GO:0010998]; response to heat [GO:0009408]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_LOC100898095.9.19.m.32685,-6.97738227583297e-05,0.00925730728137856,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100898860.1.1.m.7386,0.00330468170767424,0.00206466022407709,No,NA,NA,O76387,NA,NA,NA,cytosol [GO:0005829]; aminoacyl-tRNA hydrolase activity [GO:0004045],NA,NA,NA
CHOYP_LOC100899149.1.2.m.6146,0,0,No,NA,NA,Q65YR7,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC100899229.1.1.m.12157,-0.00340791866066472,0.0188570100457704,No,NA,NA,Q9VRJ2,NA,NA,NA,integral component of endoplasmic reticulum membrane [GO:0030176]; adult locomotory behavior [GO:0008344]; lipid droplet organization [GO:0034389]; lipid storage [GO:0019915]; phospholipid biosynthetic process [GO:0008654]; regulation of dendrite development [GO:0050773]; sensory perception of sound [GO:0007605]; sequestering of triglyceride [GO:0030730],NA,NA,NA
CHOYP_LOC100899437.1.1.m.28953,-0.0304853745158879,0.0130941615626462,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899732.1.1.m.26595,0.00996831483960283,0.0225868935363675,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100899882.1.3.m.27725,-0.0109485464007351,-0.00696762790310259,No,NA,NA,Q96MM6,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC100900162.1.1.m.58237,-0.00767826824891013,0.0100914525536517,No,NA,NA,Q8AV57,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; camera-type eye photoreceptor cell differentiation [GO:0060219]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],NA,NA,NA
CHOYP_LOC100900174.1.1.m.14983,0.00431176070251252,-0.00782792655065516,No,NA,NA,A8K0R7,NA,NA,NA,metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_LOC100900429.1.1.m.13158,-0.00896898595036,-0.00847979305537292,No,NA,NA,Q91756,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; postsynaptic membrane [GO:0045211]; ionotropic glutamate receptor activity [GO:0004970],NA,NA,NA
CHOYP_LOC100900935.1.1.m.56691,-0.00021791839849219,-0.0130666324914492,No,NA,NA,Q6P5E8,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; vesicle membrane [GO:0012506]; activating transcription factor binding [GO:0033613]; ATP binding [GO:0005524]; diacylglycerol kinase activity [GO:0004143]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; NAD+ kinase activity [GO:0003951]; phospholipase binding [GO:0043274]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; cAMP-mediated signaling [GO:0019933]; diacylglycerol metabolic process [GO:0046339]; G protein-coupled receptor signaling pathway [GO:0007186]; glycerolipid metabolic process [GO:0046486]; lipid phosphorylation [GO:0046834]; negative regulation of gene expression [GO:0010629]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidic acid biosynthetic process [GO:0006654]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; protein kinase C signaling [GO:0070528]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of cholesterol metabolic process [GO:0090181]; regulation of cortisol biosynthetic process [GO:2000064]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of gluconeogenesis [GO:0006111]; regulation of progesterone biosynthetic process [GO:2000182]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of TORC1 signaling [GO:1903432]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ATP [GO:0033198]; response to cAMP [GO:0051591]; thrombin-activated receptor signaling pathway [GO:0070493],NA,NA,NA
CHOYP_LOC100900939.1.1.m.15284,0.00454980479251398,-0.00122948720650445,No,NA,NA,P11031,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; DNA helicase activity [GO:0003678]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; identical protein binding [GO:0042802]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; transcription coactivator activity [GO:0003713]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein homooligomerization [GO:0051260]; regulation of transcription by RNA polymerase II [GO:0006357]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7834,-0.00350720849478786,0.00807391985974065,No,NA,NA,Q9VA73,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; L-aspartate transmembrane transporter activity [GO:0015183]; L-glutamate transmembrane transporter activity [GO:0005313]; transmembrane transporter activity [GO:0022857]; aspartate transmembrane transport [GO:0015810]; L-glutamate transmembrane transport [GO:0015813]; malate-aspartate shuttle [GO:0043490]; mitochondrial transport [GO:0006839]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100901947.1.1.m.7835,-0.00525155277739349,-0.00725933756748281,No,NA,NA,O14929,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; H4 histone acetyltransferase activity [GO:0010485]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; chromatin silencing at telomere [GO:0006348]; DNA packaging [GO:0006323]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; histone H4 acetylation [GO:0043967]; internal protein amino acid acetylation [GO:0006475]; response to nutrient [GO:0007584],NA,NA,NA
CHOYP_LOC100902046.1.1.m.11187,-0.00810589563139739,-0.0167594096853501,No,NA,NA,P34611,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; negative regulation of ribosome biogenesis [GO:0090071]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; regulation of translation [GO:0006417]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC100902075.1.1.m.10103,0.00348609872280926,0.00411699291006115,No,NA,NA,Q96FN5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC100902565.1.1.m.19044,0.0128405458834443,0.0159598364467927,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC100902628.1.1.m.1200,0.0082224025612694,0.00971044589957441,No,NA,NA,O45947,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_LOC100902807.1.4.m.12152,0.00644684951780478,0.00891832838452088,No,NA,NA,Q9VN14,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902807.4.4.m.59166,-0.000486543666205007,0.0041785815316848,No,NA,NA,Q9VN14,NA,NA,NA,anchored component of membrane [GO:0031225]; axon [GO:0030424]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; cell-cell adhesion mediator activity [GO:0098632]; axon ensheathment [GO:0008366]; axon guidance [GO:0007411]; cell adhesion involved in heart morphogenesis [GO:0061343]; dendrite self-avoidance [GO:0070593]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nerve maturation [GO:0021682]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LOC100902912.1.1.m.9008,-0.0158652589358694,0.0135586095061188,No,NA,NA,Q1HCL7,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; NAD+ kinase activity [GO:0003951]; protein homodimerization activity [GO:0042803]; NAD metabolic process [GO:0019674]; NADP biosynthetic process [GO:0006741],NA,NA,NA
CHOYP_LOC100903522.1.3.m.2296,0.00153196266121654,0.000896972886849234,No,NA,NA,Q28DR4,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334],NA,NA,NA
CHOYP_LOC100903758.1.1.m.43697,-6.71934412536422e-05,0.00891495274857873,No,NA,NA,Q47944,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity; acting on CH-OH group of donors [GO:0016614],NA,NA,NA
CHOYP_LOC100903812.1.1.m.65786,0.00875356732676071,0.00343059807299572,No,NA,NA,Q15149,NA,NA,NA,brush border [GO:0005903]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; actin binding [GO:0003779]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; structural molecule activity [GO:0005198]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC100903999.1.1.m.16840,-0.00474852239418225,0.012120563903368,No,NA,NA,Q923M0,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC100904232.1.1.m.38777,0.00041105212222805,-0.00511187110061475,No,NA,NA,Q96L92,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; immunological synapse [GO:0001772]; nucleoplasm [GO:0005654]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3-phosphate binding [GO:0032266]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; establishment of natural killer cell polarity [GO:0001770]; intracellular protein transport [GO:0006886]; retrograde transport; endosome to plasma membrane [GO:1990126]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC100904451.3.11.m.13002,-0.0080514666170499,0.00699170308421256,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100904558.2.2.m.26621,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905188.1.1.m.2446,0.00990934914292657,-0.00618744047270522,No,NA,NA,Q9WYP5,NA,NA,NA,inositol 2-dehydrogenase activity [GO:0050112]; oxidoreductase activity [GO:0016491]; inositol metabolic process [GO:0006020]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC100905387.1.1.m.30579,-0.00877024321093635,-0.03107722832372,No,NA,NA,Q5TM62,NA,NA,NA,cell junction [GO:0030054]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC100905544.1.3.m.6504,-0.0166901380781897,-0.0106215626736004,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100905729.1.3.m.13789,-0.00469829667680674,0.00570238961959025,No,NA,NA,Q8WPI2,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC100906408.1.1.m.3002,0.0142473232407203,0.0067738804157842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907253.3.3.m.27327,0.0040614538604061,-0.00063382246532423,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907408.1.1.m.24444,-0.0122492455185659,-0.00779538961093353,No,NA,NA,Q9Z2P6,NA,NA,NA,autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; ciliary pocket membrane [GO:0020018]; cytoplasmic vesicle [GO:0031410]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; terminal bouton [GO:0043195]; SNAP receptor activity [GO:0005484]; syntaxin binding [GO:0019905]; autophagosome maturation [GO:0097352]; cilium assembly [GO:0060271]; exocytosis [GO:0006887]; protein transport [GO:0015031]; regulation of synaptic vesicle cycle [GO:0098693]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; synaptic vesicle priming [GO:0016082]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC100907708.1.1.m.16095,0.00212899011868819,0.000947856900008027,No,NA,NA,O13035,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; prostate gland growth [GO:0060736]; regulation of lipid metabolic process [GO:0019216]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_LOC100907797.3.4.m.54168,0.00214832255646955,0.00253711367255319,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100907841.1.1.m.39986,-3.6572904483781e-05,-0.0192201617852628,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC100907845.2.3.m.23111,0.00382096208452888,0.00705882332669846,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC100908241.1.1.m.52509,-0.0015968065820446,-0.0107057608969157,No,NA,NA,Q8CJG0,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; micro-ribonucleoprotein complex [GO:0035068]; mitochondrion [GO:0005739]; mRNA cap binding complex [GO:0005845]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; RISC complex [GO:0016442]; RISC-loading complex [GO:0070578]; core promoter binding [GO:0001047]; double-stranded RNA binding [GO:0003725]; endoribonuclease activity [GO:0004521]; endoribonuclease activity; cleaving miRNA-paired mRNA [GO:0090624]; endoribonuclease activity; cleaving siRNA-paired mRNA [GO:0070551]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; mRNA cap binding [GO:0098808]; protein C-terminus binding [GO:0008022]; RNA 7-methylguanosine cap binding [GO:0000340]; RNA binding [GO:0003723]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; siRNA binding [GO:0035197]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; mRNA cleavage involved in gene silencing by miRNA [GO:0035279]; mRNA cleavage involved in gene silencing by siRNA [GO:0090625]; negative regulation of translational initiation [GO:0045947]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA mediated inhibition of translation [GO:1905618]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; post-embryonic development [GO:0009791]; pre-miRNA processing [GO:0031054]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; RNA secondary structure unwinding [GO:0010501]; siRNA loading onto RISC involved in RNA interference [GO:0035087],NA,NA,NA
CHOYP_LOC100908688.1.5.m.30293,0.00135322896715477,0.00116280629846319,No,NA,NA,P35979,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit [GO:0015934]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC100909243.1.1.m.22728,0.00332124589376732,-0.00728336696815472,No,NA,NA,Q99M87,NA,NA,NA,actin filament [GO:0005884]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; IkappaB kinase complex binding [GO:0106137]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],NA,NA,NA
CHOYP_LOC100910862.2.2.m.45085,-0.00185735574882781,0.00637664293271353,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100914852.1.1.m.29079,-0.00963681728122397,0.00335641028287614,No,NA,NA,Q9W735,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cilium [GO:0005929]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; prominosome [GO:0071914]; cholesterol binding [GO:0015485],NA,NA,NA
CHOYP_LOC100918713.1.1.m.17833,0,0,No,NA,NA,Q4V348,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC100922782.1.1.m.5582,0.00564646727306786,-0.0102510631117579,No,NA,NA,Q8BK48,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; trans-permethrin hydrolase activity [GO:0102209],NA,NA,NA
CHOYP_LOC100927475.1.1.m.28390,-0.00882990134029703,-0.00254303591363305,No,NA,NA,Q8VCT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; lipid droplet [GO:0005811]; carboxylic ester hydrolase activity [GO:0052689]; fatty-acyl-ethyl-ester synthase activity [GO:0030339]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; acyl-CoA metabolic process [GO:0006637]; acylglycerol catabolic process [GO:0046464]; cholesterol biosynthetic process [GO:0006695]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; response to toxic substance [GO:0009636]; short-chain fatty acid catabolic process [GO:0019626]; very-low-density lipoprotein particle assembly [GO:0034379],NA,NA,NA
CHOYP_LOC100929680.1.2.m.17333,0.00203285644649369,-0.0200442261232456,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929680.2.2.m.28318,-0.00924897666746827,-0.0168743333439288,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_LOC100929997.1.1.m.23658,0.011899120911056,0.0268605423599543,No,NA,NA,Q9H2H8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_LOC100931580.2.2.m.44310,0.00146240293657964,-0.000844896321200435,No,NA,NA,P31944,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; keratin filament [GO:0045095]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type endopeptidase activity involved in apoptotic process [GO:0097153]; endopeptidase activity [GO:0004175]; apoptotic process [GO:0006915]; cornification [GO:0070268]; epidermis development [GO:0008544]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; keratinization [GO:0031424],NA,NA,NA
CHOYP_LOC100932567.1.1.m.26590,-0.00177242025376078,-0.00431800575164139,No,NA,NA,Q5T5Y3,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; spectrin binding [GO:0030507]; cytoplasmic microtubule organization [GO:0031122]; cytoskeleton organization [GO:0007010]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175]; regulation of cell morphogenesis [GO:0022604]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC100933589.3.3.m.59374,-0.00910199098997292,0.0089444684825741,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC100934353.1.1.m.11772,0.0119297885303977,-0.0216583235536203,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101020089.1.1.m.9396,0.00703230146276784,-0.00914089103067472,No,NA,NA,P10077,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101040300.1.2.m.6533,0.00192130560099228,-9.62599273087362e-05,No,NA,NA,P62248,NA,NA,NA,endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC101058182.1.1.m.57909,-0.00360797045861989,0.00489809683929777,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101060411.1.1.m.54761,0.00386265435082372,0.00456169541967048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061101.1.1.m.50165,0.011252196696852,0.0024721287772799,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101061332.1.1.m.25069,0.011727922471328,-0.00313346850323886,No,NA,NA,Q6PCL9,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_LOC101061667.1.1.m.8351,0.00788566649808408,0.00357479890774381,No,NA,NA,Q80V24,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101062323.1.1.m.15918,-0.0170367540365647,0.0258515896069264,No,NA,NA,P54106,NA,NA,NA,cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101062578.1.1.m.56255,-0.011217223731383,-0.0153251243528288,No,NA,NA,Q9R0D8,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; microtubule binding [GO:0008017],NA,NA,NA
CHOYP_LOC101063181.1.1.m.12864,-0.00331239507988843,-0.00297109040215848,No,NA,NA,Q9EP82,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527]; tRNA (guanine-N7)-methylation [GO:0106004]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_LOC101063699.1.1.m.18944,-0.00479638765282023,-0.0070801707921209,No,NA,NA,Q9UUI3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_LOC101063838.1.1.m.50540,-0.00490377009888735,-0.00969065962990074,No,NA,NA,Q5BJI9,NA,NA,NA,integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; signal peptidase complex [GO:0005787]; peptidase activity [GO:0008233]; protein targeting to ER [GO:0045047]; signal peptide processing [GO:0006465],NA,NA,NA
CHOYP_LOC101063890.1.1.m.7895,-0.00739033436553965,-0.0189227661398938,No,NA,NA,P50607,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; phosphatidylinositol binding [GO:0035091]; protein-containing complex binding [GO:0044877]; phagocytosis; recognition [GO:0006910]; photoreceptor cell maintenance [GO:0045494]; positive regulation of phagocytosis [GO:0050766]; protein localization to cilium [GO:0061512]; protein localization to photoreceptor outer segment [GO:1903546]; receptor localization to non-motile cilium [GO:0097500]; response to hormone [GO:0009725]; retina development in camera-type eye [GO:0060041]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_LOC101064182.1.1.m.8320,-0.0102328580357553,-0.00194441225591672,No,NA,NA,Q5E9S4,NA,NA,NA,mitochondrion [GO:0005739]; ethanolamine-phosphate phospho-lyase activity [GO:0050459]; pyridoxal phosphate binding [GO:0030170]; transaminase activity [GO:0008483],NA,NA,NA
CHOYP_LOC101064328.2.3.m.57090,-0.0296914967902655,-0.0132655533148861,No,NA,NA,Q9Z0T0,NA,NA,NA,cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; response to organic cyclic compound [GO:0014070]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_LOC101064384.1.1.m.19175,0.00396792449968989,-0.001072246531713,No,NA,NA,Q8NFH5,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear lamina [GO:0005652]; nuclear membrane [GO:0031965]; nuclear pore central transport channel [GO:0044613]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; phospholipid binding [GO:0005543]; single-stranded DNA binding [GO:0003697]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101064472.1.1.m.66819,0.007284058351678,0.0213133502166601,No,NA,NA,P13944,NA,NA,NA,collagen type XII trimer [GO:0005595]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101064793.1.1.m.27191,-0.00011297233468639,-0.000851614461562795,No,NA,NA,Q99471,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; transcription corepressor activity [GO:0003714]; unfolded protein binding [GO:0051082]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription; DNA-templated [GO:0045892]; protein folding [GO:0006457]; regulation of transcription; DNA-templated [GO:0006355]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC101065149.1.1.m.49591,0.00745416241090805,-0.0252350570929175,No,NA,NA,Q6P7S1,NA,NA,NA,lysosome [GO:0005764]; ceramidase activity [GO:0102121]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; N-acylsphingosine amidohydrolase activity [GO:0017040]; lipid metabolic process [GO:0006629]; lung development [GO:0030324]; response to organic substance [GO:0010033],NA,NA,NA
CHOYP_LOC101065571.1.2.m.36430,-0.0152972524095629,-0.00973513367240397,No,NA,NA,P24540,NA,NA,NA,acylphosphatase activity [GO:0003998],NA,NA,NA
CHOYP_LOC101065647.2.2.m.10863,-0.00346582737047432,0.00470512668647668,No,NA,NA,Q5SZD4,NA,NA,NA,mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],NA,NA,NA
CHOYP_LOC101065695.1.1.m.13611,0.00668853166953248,-0.000875570879452807,No,NA,NA,Q6NVR9,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; zinc ion binding [GO:0008270]; mitochondrion organization [GO:0007005],NA,NA,NA
CHOYP_LOC101066074.1.1.m.19291,0.00667903825492458,0.00185248833823215,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101066924.1.1.m.16031,-0.0184789195186322,-0.0198994012261328,No,NA,NA,A7YY46,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; hydroxyacylglutathione hydrolase activity [GO:0004416]; metal ion binding [GO:0046872]; methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione [GO:0019243]; negative regulation of neurotransmitter secretion [GO:0046929]; neuromuscular process controlling posture [GO:0050884]; regulation of dopamine metabolic process [GO:0042053]; regulation of synaptic transmission; dopaminergic [GO:0032225],NA,NA,NA
CHOYP_LOC101067075.1.2.m.30552,0,0,No,NA,NA,Q6AX44,NA,NA,NA,integral component of membrane [GO:0016021]; chitin binding [GO:0008061]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC101067281.1.2.m.14666,-0.0207527938456014,0.0112849445409437,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101067376.1.1.m.40668,0.00926520248432392,-0.00327048316850299,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_LOC101067777.1.1.m.52432,0.00321132810327898,-0.0167380633574953,No,NA,NA,Q4QQV2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; Ras protein signal transduction [GO:0007265]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101067833.2.3.m.25528,0.00476086579561977,-0.0254488175891654,No,NA,NA,Q8TDB6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; enzyme activator activity [GO:0008047]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; STAT family protein binding [GO:0097677]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-protein transferase activity [GO:0004842]; cellular response to DNA damage stimulus [GO:0006974]; defense response to virus [GO:0051607]; double-strand break repair [GO:0006302]; endosome to lysosome transport [GO:0008333]; histone H2A ubiquitination [GO:0033522]; histone H2B ubiquitination [GO:0033523]; histone monoubiquitination [GO:0010390]; innate immune response [GO:0045087]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; Notch signaling pathway [GO:0007219]; positive regulation of chromatin binding [GO:0035563]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC101067857.1.1.m.36995,0.000247743448658082,0.000780845107386291,No,NA,NA,Q63413,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; transcription export complex [GO:0000346]; U4 snRNP [GO:0005687]; U6 snRNP [GO:0005688]; ATP binding [GO:0005524]; ATP-dependent protein binding [GO:0043008]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of translation [GO:0045727]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; RNA secondary structure unwinding [GO:0010501]; spliceosomal complex assembly [GO:0000245]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_LOC101067905.1.1.m.42386,0.00318526226645946,-0.0177960175635378,No,NA,NA,P41214,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; signaling receptor activity [GO:0038023]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; intracellular protein transport [GO:0006886]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_LOC101068003.1.1.m.14900,-0.00573594588226493,-0.00159331320880852,No,NA,NA,Q9NZJ6,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 2-polyprenyl-6-methoxy-1;4-benzoquinone methyltransferase activity [GO:0008425]; 3-demethylubiquinone-10 3-O-methyltransferase activity [GO:0044596]; 3-demethylubiquinone-9 3-O-methyltransferase activity [GO:0008689]; decaprenyldihydroxybenzoate methyltransferase activity [GO:0044595]; hexaprenyldihydroxybenzoate methyltransferase activity [GO:0004395]; O-methyltransferase activity [GO:0008171]; glycerol metabolic process [GO:0006071]; regulation of ubiquinone biosynthetic process [GO:0010795]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC101068028.1.1.m.48693,0.0117866421499492,0.0286676371294581,No,NA,NA,Q9DCS2,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101068272.1.3.m.40396,0.0167254468359258,0.0150356197832903,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101068378.2.3.m.20090,-0.0165728245374982,-0.010546904625891,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC101068378.3.3.m.29759,0.00609720857205673,0.00523311660594717,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_LOC101068677.1.1.m.30685,0.0113710787489378,0.0139501227497462,No,NA,NA,Q00536,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; microtubule cytoskeleton [GO:0015630]; neuron projection [GO:0043005]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; protein serine/threonine kinase activity [GO:0004674]; exocytosis [GO:0006887]; growth hormone secretion [GO:0030252]; neuron projection development [GO:0031175]; protein phosphorylation [GO:0006468]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101069440.1.3.m.4206,-0.0036732803928352,0.00445170339228802,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.2.3.m.16645,-0.00321285056936402,0.00359411937415452,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069440.3.3.m.28439,0.0322663104092941,0.0248136787858826,No,NA,NA,Q9V0D5,NA,NA,NA,cytoplasm [GO:0005737]; L-malate dehydrogenase activity [GO:0030060]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC101069588.1.1.m.34189,0.00260874861958815,-0.00134740520697529,No,NA,NA,Q6B855,NA,NA,NA,metal ion binding [GO:0046872]; transketolase activity [GO:0004802]; regulation of growth [GO:0040008],NA,NA,NA
CHOYP_LOC101069759.1.1.m.40708,-0.000186384764061826,-0.000928194909676939,No,NA,NA,P28024,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; threonine-type endopeptidase activity [GO:0004298]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC101070424.1.1.m.64148,-0.00411179749966973,-0.0124548635388689,No,NA,NA,P85834,NA,NA,NA,mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC101070553.1.1.m.9549,-0.00253092856261033,0.00343592979354716,No,NA,NA,Q9JII1,NA,NA,NA,axoneme [GO:0005930]; cytoplasm [GO:0005737]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4;5-bisphosphate phosphatase activity [GO:0106019]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of translation [GO:0017148]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488],NA,NA,NA
CHOYP_LOC101070737.2.3.m.11531,-0.00483768270348293,0.00017140808750027,No,NA,NA,Q9CQZ5,NA,NA,NA,mitochondrial membrane [GO:0031966]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; oxidation-reduction process [GO:0055114]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101071050.1.1.m.38421,-0.00134965768003753,0.00352868267143698,No,NA,NA,Q9HCN4,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],NA,NA,NA
CHOYP_LOC101071230.1.1.m.22193,0.00461664463130299,0.00251186499396258,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101071441.1.1.m.64484,-0.00148405178839154,0.00530179275303461,No,NA,NA,P60899,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter [GO:0001193]; mRNA cleavage [GO:0006379]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_LOC101071891.1.2.m.31440,-0.0182502372175461,-0.00433754421016407,No,NA,NA,Q68EV6,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_LOC101071902.1.1.m.49967,-0.00214655618266734,0.00536962142023519,No,NA,NA,Q9CQE3,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC101072178.1.1.m.65566,0.0175324760533601,0.00110856554931047,No,NA,NA,Q6PCJ9,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_LOC101072591.1.1.m.1861,-0.00968454052586785,0.0115952771920786,No,NA,NA,Q32LJ2,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; GTP binding [GO:0005525]; gastrulation [GO:0007369]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_LOC101072646.1.1.m.8800,0.000627428402144095,0.00298526634874732,No,NA,NA,Q9D3D9,NA,NA,NA,mitochondrial envelope [GO:0005740]; mitochondrial inner membrane [GO:0005743]; mitochondrial proton-transporting ATP synthase complex [GO:0005753]; mitochondrial proton-transporting ATP synthase complex; catalytic core F(1) [GO:0000275]; mitochondrion [GO:0005739]; proton-transporting ATP synthase complex [GO:0045259]; proton-transporting ATP synthase complex; catalytic core F(1) [GO:0045261]; protein-containing complex binding [GO:0044877]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATP synthase activity; rotational mechanism [GO:0046933]; ATP metabolic process [GO:0046034]; ATP synthesis coupled proton transport [GO:0015986]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63778,-0.0187352728623059,-0.0138821113547284,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101072885.1.1.m.63779,-0.0198669770695757,-0.00346931790001105,No,NA,NA,Q25381,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC101073830.1.1.m.42117,-0.00738095223931441,0.000929732860884967,No,NA,NA,Q9DB91,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC101075536.1.1.m.42991,-0.0192397115710567,0.00734101137924937,No,NA,NA,Q9GLW9,NA,NA,NA,mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC101075808.1.1.m.17712,-0.00493759949388322,0.000855962398445757,No,NA,NA,Q5RE33,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101076145.1.1.m.26253,0.00662506920163014,-0.0120276978899011,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101076180.1.1.m.41749,0.000811120096498388,0.0138472791879354,No,NA,NA,Q3SYU1,NA,NA,NA,cytosol [GO:0005829]; Noc1p-Noc2p complex [GO:0030690]; Noc2p-Noc3p complex [GO:0030691]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; apoptotic process [GO:0006915]; cellular response to UV [GO:0034644]; chromatin assembly [GO:0031497]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of histone acetylation [GO:0035067]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC101076498.2.2.m.25096,0.00637292951513366,-0.0115699426751348,No,NA,NA,P70031,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930],NA,NA,NA
CHOYP_LOC101076790.1.1.m.45316,0.00470237989639767,0.00555338968664731,No,NA,NA,Q6Q4G4,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; carboxypeptidase activity [GO:0004180]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241],NA,NA,NA
CHOYP_LOC101077059.1.1.m.57292,-0.0183060021702735,0.00230987761814864,No,NA,NA,P54864,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; transcription regulatory region DNA binding [GO:0044212]; Ras protein signal transduction [GO:0007265],NA,NA,NA
CHOYP_LOC101077542.1.1.m.58180,-0.00538253202520571,-0.00449728501032069,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC101077597.2.3.m.25843,-0.0038975134413635,0.00529117366320275,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101077787.2.3.m.65668,-7.18527686804923e-05,0.00953313337864547,No,NA,NA,O95149,NA,NA,NA,cytosol [GO:0005829]; nuclear pore [GO:0005643]; nuclear import signal receptor activity [GO:0061608]; RNA cap binding [GO:0000339]; import into nucleus [GO:0051170]; protein import into nucleus [GO:0006606]; snRNA import into nucleus [GO:0061015]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC101078033.1.1.m.42470,-0.00744902224817623,-0.00765659906826641,No,NA,NA,P49816,NA,NA,NA,caveola [GO:0005901]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; GTPase activator activity [GO:0005096]; phosphatase binding [GO:0019902]; protein heterodimerization activity [GO:0046982]; protein N-terminus binding [GO:0047485]; aging [GO:0007568]; cell projection organization [GO:0030030]; establishment of cell polarity [GO:0030010]; establishment of protein localization [GO:0045184]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of pinocytosis [GO:0048550]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of TOR signaling [GO:0032007]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of neuron projection development [GO:0010976]; protein heterooligomerization [GO:0051291]; protein homooligomerization [GO:0051260]; protein localization to cell surface [GO:0034394]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC101078145.1.1.m.54616,0.00468025083138125,0.00552725583014382,No,NA,NA,Q9DDT2,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; identical protein binding [GO:0042802]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; cellular response to insulin stimulus [GO:0032869]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of inflammatory response [GO:0050727]; regulation of kinase activity [GO:0043549]; regulation of phosphorylation [GO:0042325]; toll-like receptor 2 signaling pathway [GO:0034134]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor 7 signaling pathway [GO:0034154]; toll-like receptor 9 signaling pathway [GO:0034162]; TOR signaling [GO:0031929],NA,NA,NA
CHOYP_LOC101078252.1.1.m.39219,-0.00320107244436088,0.0140528614532481,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101078542.1.1.m.44610,0.0019698484524498,-0.00112978611684116,No,NA,NA,Q01518,NA,NA,NA,azurophil granule lumen [GO:0035578]; cortical actin cytoskeleton [GO:0030864]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; adenylate cyclase binding [GO:0008179]; actin polymerization or depolymerization [GO:0008154]; activation of adenylate cyclase activity [GO:0007190]; ameboidal-type cell migration [GO:0001667]; cell morphogenesis [GO:0000902]; establishment or maintenance of cell polarity [GO:0007163]; neutrophil degranulation [GO:0043312]; receptor-mediated endocytosis [GO:0006898]; regulation of adenylate cyclase activity [GO:0045761]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101078914.1.1.m.34199,-0.0112635726370547,-0.00204253917464504,No,NA,NA,Q148G5,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; FAD binding [GO:0071949]; proline dehydrogenase activity [GO:0004657]; proline catabolic process to glutamate [GO:0010133],NA,NA,NA
CHOYP_LOC101079138.1.4.m.4320,-0.00386278321723048,-0.0085659196365505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101079642.1.1.m.56374,-0.00827486068999523,0.00706511445603623,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101107626.1.1.m.1051,-0.00683044916318308,-0.00722422601895254,No,NA,NA,Q5TYW1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; cellular response to zinc ion [GO:0071294]; negative regulation of transcription; DNA-templated [GO:0045892]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC101154772.1.1.m.55397,-0.0157611690012472,-0.0117827397710571,No,NA,NA,P49442,NA,NA,NA,inositol-1;4-bisphosphate 1-phosphatase activity [GO:0004441]; metal ion binding [GO:0046872]; inositol phosphate dephosphorylation [GO:0046855]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC101155522.1.1.m.45101,-0.00155966467519133,0.00325182626537075,No,NA,NA,Q9VU84,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cytoskeleton [GO:0005856]; growth cone [GO:0030426]; neuromuscular junction [GO:0031594]; type Ib terminal bouton [GO:0061176]; type Is terminal bouton [GO:0061177]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; chaeta development [GO:0022416]; positive regulation of synaptic growth at neuromuscular junction [GO:0045887]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_LOC101155562.1.1.m.51414,-0.00900905267985496,-0.000362717018883672,No,NA,NA,Q5TYQ8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; poly(A) binding [GO:0008143]; negative regulation of mRNA polyadenylation [GO:1900364]; regulation of mRNA stability [GO:0043488],NA,NA,NA
CHOYP_LOC101155629.1.1.m.30633,0.0139039372655572,0.00183039203729084,No,NA,NA,Q93425,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101156197.1.1.m.31571,0.0039224898795651,-0.00105996879965123,No,NA,NA,Q9EQ28,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA-dependent DNA replication [GO:0006261]; nucleotide-excision repair; DNA gap filling [GO:0006297],NA,NA,NA
CHOYP_LOC101156767.1.1.m.65605,-3.80443117835947e-05,0.00504756469642131,No,NA,NA,Q9QYP0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; BMP signaling pathway [GO:0030509]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_LOC101156914.1.1.m.30383,-0.00840228169785457,-0.0146246791767561,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101156984.2.2.m.22956,1.71682901496145e-05,-0.000674498951677284,No,NA,NA,P54985,NA,NA,NA,cytoplasm [GO:0005737]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC101157039.2.2.m.54697,0.0196041432106651,0.00847009234115823,No,NA,NA,Q27546,NA,NA,NA,inosine nucleosidase activity [GO:0047724]; metal ion binding [GO:0046872]; uridine nucleosidase activity [GO:0045437]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_LOC101157079.2.2.m.7067,-0.00666477453796963,-0.00424144606406627,No,NA,NA,Q9BZA8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; sperm head [GO:0061827]; sperm midpiece [GO:0097225]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of Wnt signaling pathway [GO:0030177]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101157371.3.3.m.51109,0.00529395813675635,-6.79598805730585e-06,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157864.1.2.m.9913,-0.000840210371145767,0.004931236594086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101157895.2.2.m.28009,0.00363855429526979,-0.000983241295003822,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101158638.1.2.m.5931,0.00460432879039247,-0.0103336610029382,No,NA,NA,Q2TAL6,NA,NA,NA,AMPA glutamate receptor complex [GO:0032281]; basement membrane [GO:0005604]; cell junction [GO:0030054]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666],NA,NA,NA
CHOYP_LOC101158638.2.2.m.27400,-0.00201800725094103,-0.00163959744551016,No,NA,NA,B0UZC8,NA,NA,NA,cell junction [GO:0030054]; extracellular region [GO:0005576]; synapse [GO:0045202]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC101158923.1.2.m.27410,-0.00305460613648139,0.00414686229668361,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC101159074.1.1.m.29872,0.00597383504702015,0.00705494551073344,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101159300.1.1.m.26609,0.00603933012819916,0.0186354963204974,No,NA,NA,Q99N92,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101159719.1.1.m.21443,-0.00715824403287859,0.0141819335854354,No,NA,NA,A4IGL7,NA,NA,NA,extracellular space [GO:0005615]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; peroxidase activity [GO:0004601]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC101160004.1.1.m.48946,0.0204805482017305,-0.00966989441991619,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101160053.1.1.m.18848,0.0098457395411794,0.00228434772677293,No,NA,NA,Q6AY09,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101160063.1.4.m.2465,0.00908069575870838,0.00711856199390769,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC101160163.2.2.m.44944,0.00173722893437157,-0.00285213360399178,No,NA,NA,Q05695,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic growth cone [GO:0044294]; endosome [GO:0005768]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]; axon guidance receptor activity [GO:0008046]; PDZ domain binding [GO:0030165]; axon development [GO:0061564]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to thyroxine stimulus [GO:0097069]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dopaminergic neuron differentiation [GO:0071542]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; modulation of chemical synaptic transmission [GO:0050804]; neuron differentiation [GO:0030182]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of ERK1 and ERK2 cascade [GO:0070372]; response to activity [GO:0014823]; response to thyroid hormone [GO:0097066]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_LOC101160363.1.1.m.194,-0.0127552389635815,-0.00215263770244656,No,NA,NA,Q9HAC7,NA,NA,NA,mitochondrion [GO:0005739]; succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369],NA,NA,NA
CHOYP_LOC101161108.1.1.m.52561,-0.00732471545025346,-0.00466143083158929,No,NA,NA,Q9NR21,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; cell differentiation [GO:0030154]; mRNA transport [GO:0051028]; nuclear envelope organization [GO:0006998]; protein transport [GO:0015031]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC101161976.1.1.m.43986,0.00197892452364464,-0.00326212622147683,No,NA,NA,Q9X248,NA,NA,NA,3-oxo-glutaryl-[acp] methyl ester reductase activity [GO:0102131]; 3-oxo-pimeloyl-[acp] methyl ester reductase activity [GO:0102132]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; fatty acid elongation [GO:0030497],NA,NA,NA
CHOYP_LOC101162206.1.1.m.53261,0.00492614612585359,-0.0052010259273452,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101162499.1.1.m.47400,-0.00920190098485023,-0.00585606707200189,No,NA,NA,O95428,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_LOC101162528.1.1.m.17841,0.00361681500239356,0.00427136547351066,No,NA,NA,Q5ZJL9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC101163682.1.1.m.10220,0.00910721955721128,0.00388621302029722,No,NA,NA,Q6DRD9,NA,NA,NA,mitochondrion [GO:0005739]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_LOC101164168.1.1.m.24728,-5.65381392751276e-05,0.0307578084537818,No,NA,NA,Q9UK41,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; endosomal transport [GO:0016197]; macroautophagy [GO:0016236]; multivesicular body assembly [GO:0036258]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702]; viral life cycle [GO:0019058],NA,NA,NA
CHOYP_LOC101164444.1.1.m.42364,-0.00572721973375462,0.00538162215428653,No,NA,NA,Q6P1J6,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phospholipid metabolic process [GO:0006644]; positive regulation of acrosome reaction [GO:2000344]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_LOC101164482.1.1.m.44586,-0.000154181440305624,0.000215141399380608,No,NA,NA,Q5SRX1,NA,NA,NA,cell [GO:0005623]; clathrin binding [GO:0030276]; protein kinase binding [GO:0019901]; intracellular protein transport [GO:0006886]; negative regulation of mitotic nuclear division [GO:0045839]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC101165304.1.1.m.54576,-0.00105046661432609,-0.00134101037176512,No,NA,NA,Q9QY36,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatA complex [GO:0031415]; nucleolus [GO:0005730]; nucleus [GO:0005634]; N-acetyltransferase activity [GO:0008080]; peptide alpha-N-acetyltransferase activity [GO:0004596]; peptide-glutamate-N-acetyltransferase activity [GO:1990190]; peptide-serine-N-acetyltransferase activity [GO:1990189]; ribosome binding [GO:0043022]; N-terminal peptidyl-glutamic acid acetylation [GO:0018002]; N-terminal peptidyl-serine acetylation [GO:0017198]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of maintenance of mitotic sister chromatid cohesion; centromeric [GO:2000719]; protein acetylation [GO:0006473],NA,NA,NA
CHOYP_LOC101165968.2.7.m.18121,-0.0170330989693642,-0.000337849161499218,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.3.7.m.49147,0.0115913884661789,-0.0185697010843521,No,NA,NA,P27473,NA,NA,NA,cytoplasm [GO:0005737]; immune response [GO:0006955]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC101165968.5.7.m.54243,-0.0208732989300792,-0.00541261905915367,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101165968.6.7.m.55758,-0.0112665902257077,-0.00717003020822869,No,NA,NA,Q53G44,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; defense response to virus [GO:0051607]; immune response [GO:0006955],NA,NA,NA
CHOYP_LOC101166328.1.1.m.14447,-0.0122570706672298,0.0147624923414466,No,NA,NA,Q9NXZ2,NA,NA,NA,intracellular [GO:0005622]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC101166335.1.1.m.5463,-0.00104123271675817,0.000159657946975249,No,NA,NA,Q9UM22,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC101167642.1.1.m.31028,-0.00464069750223497,-0.00197296463274155,No,NA,NA,Q71R50,NA,NA,NA,extracellular region [GO:0005576]; 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0072582]; 17-beta-ketosteroid reductase activity [GO:0072555]; 3-keto sterol reductase activity [GO:0000253]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; nucleotide binding [GO:0000166]; estrogen biosynthetic process [GO:0006703],NA,NA,NA
CHOYP_LOC101167938.1.1.m.27316,0.0185979344673175,-0.0233487945034217,No,NA,NA,Q01538,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; zinc ion binding [GO:0008270]; cell differentiation [GO:0030154]; nervous system development [GO:0007399]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC101168798.1.1.m.6128,0.008418111803145,-0.0109509883866361,No,NA,NA,Q9D0R4,NA,NA,NA,nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; positive regulation of neuron projection development [GO:0010976]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101168834.1.1.m.9567,-0.00595506445036868,-0.0184208135520545,No,NA,NA,Q96BK5,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome kinetochore [GO:0000777]; kinetochore [GO:0000776]; nuclear chromosome [GO:0000228]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; spindle [GO:0005819]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomerase RNA binding [GO:0070034]; mitotic metaphase plate congression [GO:0007080]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of telomerase activity [GO:0051974]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomeric DNA binding [GO:1904744]; protein localization to chromosome; telomeric region [GO:0070198]; protein localization to nucleolus [GO:1902570]; regulation of protein stability [GO:0031647]; regulation of telomerase activity [GO:0051972]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_LOC101168891.1.1.m.30839,-0.00541148886405741,-0.0115870980110426,No,NA,NA,Q6DRG1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; RNA binding [GO:0003723]; lens development in camera-type eye [GO:0002088],NA,NA,NA
CHOYP_LOC101169131.2.2.m.32499,0.0112124458046504,0.0186419518526251,No,NA,NA,O70277,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; postsynapse [GO:0098794]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC101169402.1.1.m.7122,0.0027063813986469,-0.0135436839175476,No,NA,NA,Q9BWU0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; mRNA binding [GO:0003729],NA,NA,NA
CHOYP_LOC101169524.1.1.m.4630,0.00372843286798639,0.00671430007274171,No,NA,NA,O00566,NA,NA,NA,chromosome [GO:0005694]; Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101169658.2.3.m.20752,0.0271779817036288,0.0074420997702537,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101169976.1.1.m.55723,-0.0061077208216254,0.00594812293977189,No,NA,NA,Q91XU0,NA,NA,NA,nuclear chromosome; telomeric region [GO:0000784]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; replisome [GO:0030894]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; enzyme activator activity [GO:0008047]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA recombination [GO:0006310]; DNA replication; Okazaki fragment processing [GO:0033567]; DNA strand renaturation [GO:0000733]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; innate immune response [GO:0045087]; regulation of DNA repair [GO:0006282]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_LOC101170942.1.1.m.47597,0.00215905400850234,-0.00380634439291235,No,NA,NA,P41105,NA,NA,NA,cell body [GO:0044297]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosolic large ribosomal subunit [GO:0022625]; dendrite [GO:0030425]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC101171340.1.1.m.29474,0.00345114927752564,0.00760477898889305,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_LOC101171379.1.1.m.27459,-0.00695798742500039,-0.0174392084889158,No,NA,NA,Q08BY0,NA,NA,NA,mitochondrion [GO:0005739]; protein-arginine omega-N symmetric methyltransferase activity [GO:0035243]; chordate embryonic development [GO:0043009]; mitochondrial respiratory chain complex I assembly [GO:0032981]; peptidyl-arginine methylation; to symmetrical-dimethyl arginine [GO:0019918],NA,NA,NA
CHOYP_LOC101173065.1.1.m.11998,0.00696936147863548,-0.00385320324273746,No,NA,NA,Q8IY37,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC101173335.2.4.m.33982,0.0178688815500166,0.0162943496127624,No,NA,NA,P15989,NA,NA,NA,collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; growth plate cartilage chondrocyte morphogenesis [GO:0003429],NA,NA,NA
CHOYP_LOC101173335.4.4.m.49816,0.0233454257096795,-0.0011550103029744,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_LOC101173404.1.1.m.27554,-0.00846852500338398,0.0125681907067191,No,NA,NA,Q9LZG0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; copper ion binding [GO:0005507]; kinase binding [GO:0019900]; adenosine salvage [GO:0006169]; AMP salvage [GO:0044209]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101173869.1.1.m.32090,0.00520257750764016,0.0237077659859099,No,NA,NA,Q8C5L6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; inositol bisphosphate phosphatase activity [GO:0016312]; inositol trisphosphate phosphatase activity [GO:0046030]; inositol-1;3;4;5-tetrakisphosphate 5-phosphatase activity [GO:0052659]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; inositol-polyphosphate 5-phosphatase activity [GO:0004445]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol trisphosphate phosphatase activity [GO:0034594]; phosphatidylinositol-3;4;5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; vasopressin receptor activity [GO:0005000]; cellular response to cAMP [GO:0071320]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; dephosphorylation [GO:0016311]; G protein-coupled receptor signaling pathway [GO:0007186]; glucose homeostasis [GO:0042593]; in utero embryonic development [GO:0001701]; inositol phosphate dephosphorylation [GO:0046855]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of dephosphorylation [GO:0035305]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045869]; negative regulation of stress fiber assembly [GO:0051497]; negative regulation of transcription; DNA-templated [GO:0045892]; neuromuscular junction development; skeletal muscle fiber [GO:0098529]; phosphatidylinositol dephosphorylation [GO:0046856]; positive regulation of renal water transport [GO:2001153]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of urine volume [GO:0035810]; protein localization to plasma membrane [GO:0072659]; regulation of glycogen biosynthetic process [GO:0005979]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC101174856.1.1.m.47585,-0.00742981855068087,0.000791955551597425,No,NA,NA,Q9Y6R4,NA,NA,NA,cytoplasm [GO:0005737]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; chorionic trophoblast cell differentiation [GO:0060718]; intracellular signal transduction [GO:0035556]; male germ-line sex determination [GO:0019100]; placenta development [GO:0001890]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of gene expression [GO:0010468]; response to UV-C [GO:0010225]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_LOC101175128.1.1.m.13811,-0.00737843981075278,-0.000968803287487867,No,NA,NA,Q99LC9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; photoreceptor cell cilium [GO:0097733]; photoreceptor outer segment [GO:0001750]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; peroxisome organization [GO:0007031]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix; translocation [GO:0016561]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_LOC101175542.1.1.m.39653,0.000986254068664884,0.016233417718435,No,NA,NA,Q15542,NA,NA,NA,actin cytoskeleton [GO:0015629]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFTC complex [GO:0033276]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; DNA-templated transcription; initiation [GO:0006352]; histone acetylation [GO:0016573]; regulation of signal transduction by p53 class mediator [GO:1901796]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription initiation from RNA polymerase II promoter [GO:0006367]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC101175582.1.1.m.59321,-0.000832967680581381,-0.00121547760611794,No,NA,NA,F1LQ48,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_LOC101175670.1.1.m.37,-0.00783362233770393,0.0188729932726507,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC101234062.1.1.m.27366,-0.00679479116844135,0.00262100375498254,No,NA,NA,Q2KIR8,NA,NA,NA,mitochondrion [GO:0005739]; coenzyme binding [GO:0050662]; identical protein binding [GO:0042802]; L-threonine 3-dehydrogenase activity [GO:0008743]; L-threonine catabolic process to glycine [GO:0019518]; threonine catabolic process [GO:0006567],NA,NA,NA
CHOYP_LOC101236385.3.6.m.4348,0.0085345508529037,-0.00482238214090618,No,NA,NA,B3EWZ3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101238350.1.1.m.23002,-0.0127306540746034,-0.00810175682764585,No,NA,NA,B3EWY8,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_LOC101242114.1.1.m.13149,0.00284796249773571,0.00292960520740207,No,NA,NA,Q8N7A1,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_LOC101242248.1.2.m.24785,0.00534051286310073,-0.00144315911138832,No,NA,NA,P0C6F1,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC101242430.1.2.m.23519,0.0040809188219217,0.00481946014507805,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101345275.1.1.m.1796,-0.00223427676722989,0.021474995954765,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC101384981.1.1.m.53468,0.00300405026915519,0.00354770608722544,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC101416772.1.1.m.30815,0.00273999959751524,-0.00115643899326556,No,NA,NA,Q9W6X3,NA,NA,NA,mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; metal ion binding [GO:0046872]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085],NA,NA,NA
CHOYP_LOC101439509.1.1.m.65851,-0.0134318346925143,0.00883372111411868,No,NA,NA,P20742,NA,NA,NA,blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; female pregnancy [GO:0007565],NA,NA,NA
CHOYP_LOC373223.1.1.m.48226,0.00120635976925617,-0.000934162810324222,No,NA,NA,Q17R14,NA,NA,NA,apical dendrite [GO:0097440]; axolemma [GO:0030673]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; brush border [GO:0005903]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endosome [GO:0005768]; myelin sheath [GO:0043209]; myosin complex [GO:0016459]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; smooth endoplasmic reticulum [GO:0005790]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; cellular localization [GO:0051641]; early endosome to recycling endosome transport [GO:0061502]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_LOC373229.2.3.m.43412,0.00040019111811422,0.00349590398416352,No,NA,NA,G5EBQ8,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; chitin synthase activity [GO:0004100]; chitin biosynthetic process [GO:0006031]; multicellular organism development [GO:0007275]; positive regulation of nematode larval development [GO:0061063],NA,NA,NA
CHOYP_LOC373274.1.1.m.29721,0.0154563849124958,0.0123393909644534,No,NA,NA,Q8N0N3,NA,NA,NA,extracellular region [GO:0005576]; (1->3)-beta-D-glucan binding [GO:0001872]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; carbohydrate metabolic process [GO:0005975]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC373275.4.7.m.47547,0.00208762032992801,-0.000993653204245382,No,NA,NA,Q5R481,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC373275.6.7.m.57854,-0.0164709240102007,0.0104978229792666,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC373275.7.7.m.63851,-0.000112102106495123,0.0148732519688591,No,NA,NA,P18700,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_LOC408431.1.1.m.18046,0.00767861312325879,-0.00994554521710853,No,NA,NA,Q9VY77,NA,NA,NA,adherens junction [GO:0005912]; apical cortex [GO:0045179]; apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; nucleus [GO:0005634]; P-body [GO:0000932]; transcription factor complex [GO:0005667]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; cytoskeleton organization [GO:0007010]; mitotic cell cycle [GO:0000278]; negative regulation of hippo signaling [GO:0035331]; ovarian follicle cell development [GO:0030707]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of imaginal disc growth [GO:0045572]; protein localization to centrosome [GO:0071539]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LOC408643.1.1.m.50154,-0.00814226993266678,0.0128979760192162,No,NA,NA,Q4J781,NA,NA,NA,alcohol dehydrogenase (NAD) activity [GO:0004022]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC409619.1.4.m.13984,0.00549313148947429,0.00624944043156457,No,NA,NA,P79098,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC410403.1.1.m.31535,-0.00486042002195278,-0.000979360784275406,No,NA,NA,Q5F3J5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome activator complex [GO:0008537]; endopeptidase activator activity [GO:0061133]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; p53 binding [GO:0002039]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of endopeptidase activity [GO:0010950]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of proteasomal protein catabolic process [GO:0061136],NA,NA,NA
CHOYP_LOC410511.1.2.m.10509,-0.00389653711432663,0.011750195588416,No,NA,NA,Q2KHT3,NA,NA,NA,cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; vesicle [GO:0031982]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; cellular response to starvation [GO:0009267]; endosomal transport [GO:0016197]; endosome to lysosome transport [GO:0008333]; negative regulation of autophagosome maturation [GO:1901097]; negative regulation of macroautophagy by TORC1 signaling [GO:1904766]; negative regulation of mitophagy [GO:1901525]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of TORC1 signaling [GO:1904263],NA,NA,NA
CHOYP_LOC411194.1.1.m.8502,-9.37878917032065e-05,0.0124433963691,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC412116.1.1.m.42829,-0.000956071594616295,0.00333918108979842,No,NA,NA,Q8BHN5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_LOC413005.1.1.m.63172,-0.00476688976765939,0.000717575501178823,No,NA,NA,Q6AYR2,NA,NA,NA,cytoplasm [GO:0005737]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC420515.1.1.m.15613,0.0037165361812998,0.00820829335871408,No,NA,NA,P22897,NA,NA,NA,cell surface [GO:0009986]; endosome membrane [GO:0010008]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; cargo receptor activity [GO:0038024]; mannose binding [GO:0005537]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_LOC496139.1.1.m.39321,-0.0134018286481657,-0.0039514988262917,No,NA,NA,Q9D187,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; chromosome segregation [GO:0007059]; iron-sulfur cluster assembly [GO:0016226]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC549476.1.1.m.42388,0.00164164995949342,-0.000919831230254351,No,NA,NA,P62264,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000462]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC551931.1.1.m.9934,0.00136658941518185,-0.00200195246047271,No,NA,NA,Q99447,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; ethanolamine-phosphate cytidylyltransferase activity [GO:0004306]; phosphatidylethanolamine biosynthetic process [GO:0006646]; phospholipid biosynthetic process [GO:0008654],NA,NA,NA
CHOYP_LOC552012.1.1.m.65224,0,0,No,NA,NA,Q9NRF2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; blood coagulation [GO:0007596]; intracellular signal transduction [GO:0035556]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278],NA,NA,NA
CHOYP_LOC552024.1.1.m.5290,0.0131116430800412,0.0195372342955387,No,NA,NA,O05389,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_LOC552081.1.1.m.51439,-0.00192285558703301,0.0223438249862582,No,NA,NA,A4IG32,NA,NA,NA,integral component of mitochondrial membrane [GO:0032592]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; uniplex complex [GO:1990246]; calcium ion binding [GO:0005509]; calcium ion import [GO:0070509]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of mitochondrial calcium ion concentration [GO:0051561],NA,NA,NA
CHOYP_LOC552559.1.2.m.39702,-0.00180358553567109,0.00174619114056761,No,NA,NA,Q9VU02,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; cytosol [GO:0005829]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; precatalytic spliceosome [GO:0071011]; small nuclear ribonucleoprotein complex [GO:0030532]; SMN-Sm protein complex [GO:0034719]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U4 snRNP [GO:0005687]; U5 snRNP [GO:0005682]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LOC552662.1.1.m.15078,0.00791675220947962,-0.0102846903208232,No,NA,NA,Q68ED3,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; TRAMP complex [GO:0031499]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; carbohydrate homeostasis [GO:0033500]; cell cycle [GO:0007049]; cell division [GO:0051301]; histone mRNA catabolic process [GO:0071044]; miRNA catabolic process [GO:0010587]; mRNA polyadenylation [GO:0006378]; ncRNA polyadenylation [GO:0043629]; ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process [GO:0043630]; negative regulation of telomere maintenance via telomerase [GO:0032211]; rRNA processing [GO:0006364]; snoRNA polyadenylation [GO:0071050],NA,NA,NA
CHOYP_LOC557305.1.1.m.18011,0.0079441047561878,-0.00546573791441607,No,NA,NA,Q86VP3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ion channel binding [GO:0044325]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; protein localization to phagophore assembly site [GO:0034497]; protein localization to plasma membrane [GO:0072659]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC558150.4.4.m.53050,0.00266177112675572,0.0024959045949168,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_LOC558213.1.1.m.27293,-0.00294569873549736,-0.00630711671388474,No,NA,NA,Q4VGL6,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; P-body [GO:0000932]; double-stranded RNA binding [GO:0003725]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; RNA stem-loop binding [GO:0035613]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; B cell homeostasis [GO:0001782]; cellular response to interleukin-1 [GO:0071347]; cytoplasmic mRNA processing body assembly [GO:0033962]; lymph node development [GO:0048535]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of germinal center formation [GO:0002635]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper cell differentiation [GO:0045623]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:0000288]; positive regulation of mRNA catabolic process [GO:0061014]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; posttranscriptional regulation of gene expression [GO:0010608]; protein polyubiquitination [GO:0000209]; regulation of gene expression [GO:0010468]; regulation of germinal center formation [GO:0002634]; regulation of miRNA metabolic process [GO:2000628]; regulation of mRNA stability [GO:0043488]; regulation of T cell receptor signaling pathway [GO:0050856]; spleen development [GO:0048536]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852]; T follicular helper cell differentiation [GO:0061470],NA,NA,NA
CHOYP_LOC559490.1.1.m.44696,-0.0114446762527874,0.00691537754933247,No,NA,NA,Q9CRB6,NA,NA,NA,microtubule [GO:0005874]; microtubule bundle [GO:0097427]; perinuclear region of cytoplasm [GO:0048471]; tubulin binding [GO:0015631]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; positive regulation of protein polymerization [GO:0032273],NA,NA,NA
CHOYP_LOC562156.1.2.m.16403,-0.0125919004920648,-0.0080134543902295,No,NA,NA,Q5G265,NA,NA,NA,axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]; exocytosis [GO:0006887],NA,NA,NA
CHOYP_LOC564392.1.1.m.29701,-0.00536986834842755,0.0215342483939624,No,NA,NA,Q92485,NA,NA,NA,anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685],NA,NA,NA
CHOYP_LOC565211.1.2.m.34982,-0.00209379789196106,0.00927334387044487,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC565211.2.2.m.55017,0.0021569130539265,-0.000582859512941826,No,NA,NA,Q9JHA8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC566621.1.1.m.45550,0.00920688359922971,-0.00600249095755174,No,NA,NA,Q5ZJL9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_LOC566887.1.1.m.45765,0.0028816492254571,0.00565319040618847,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC567383.1.1.m.16245,0.00174671140943398,0.00231304258042893,No,NA,NA,Q75NR7,NA,NA,NA,chromosome [GO:0005694]; chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; annealing helicase activity [GO:0036310]; ATP binding [GO:0005524]; ATP-dependent 3'-5' DNA helicase activity [GO:0043140]; bubble DNA binding [GO:0000405]; DNA binding [GO:0003677]; four-way junction helicase activity [GO:0009378]; oxidized purine DNA binding [GO:0032357]; single-stranded DNA binding [GO:0003697]; telomeric D-loop binding [GO:0061821]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284]; DNA duplex unwinding [GO:0032508]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA strand renaturation [GO:0000733]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of sister chromatid cohesion [GO:0045875]; pigmentation [GO:0043473]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; telomere maintenance [GO:0000723]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_LOC567820.1.1.m.51203,0.0064005440640422,-0.0116200764083124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC569612.1.1.m.18528,-0.0114951551127686,-0.00731548833814517,No,NA,NA,Q6P9H5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_LOC571721.1.3.m.36443,0.00231462887323454,0.00196833803409403,No,NA,NA,Q52M93,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC571721.2.3.m.53122,-0.016825184473428,0.0114492609057071,No,NA,NA,A6NNF4,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC574569.1.1.m.61069,0.0145009308702019,-0.0109233030040499,No,NA,NA,O54922,NA,NA,NA,cytosol [GO:0005829]; exocyst [GO:0000145]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC574602.1.1.m.44079,0,0,No,NA,NA,Q9UA35,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_LOC574740.1.1.m.29924,-0.021180473681983,0.0150537850753703,No,NA,NA,Q4V8G4,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; cilium movement [GO:0003341]; hematopoietic progenitor cell differentiation [GO:0002244]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC574855.1.9.m.547,0.0157608965345023,0.00453931618285104,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.4.9.m.22339,0.0110184365612101,-0.0072054346134569,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574855.6.9.m.46549,0.0209469474546015,-0.00941468840520124,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC574928.1.2.m.48221,0.00330496916598923,0.000626396420079248,No,NA,NA,Q9D5V6,NA,NA,NA,axon [GO:0030424]; cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; cell differentiation [GO:0030154]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of protein homodimerization activity [GO:0090073]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; TORC2 signaling [GO:0038203],NA,NA,NA
CHOYP_LOC574943.1.1.m.56446,0.0253321037189311,-0.00334408021629836,No,NA,NA,P23800,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; nucleosomal DNA binding [GO:0031492]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC575058.1.1.m.9531,0.00397209530313503,0.00318649196854168,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC575132.2.2.m.66125,0.000725846199066107,0.00449942637876151,No,NA,NA,Q9WVM7,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex scaffold activity [GO:0032947]; apoptotic process [GO:0006915]; negative regulation of cell proliferation [GO:0008285]; positive regulation of aminoacyl-tRNA ligase activity [GO:1903632]; positive regulation of protein ubiquitination [GO:0031398]; protein-containing complex assembly [GO:0065003]; translation [GO:0006412]; type II pneumocyte differentiation [GO:0060510],NA,NA,NA
CHOYP_LOC575161.4.5.m.42590,8.16746816439463e-05,0.00180313414693259,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575161.5.5.m.55590,-0.0056491178389597,0.0040056447483537,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC575203.2.6.m.6856,0.0011852840601237,-0.00193393914450684,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575203.6.6.m.30705,-0.000367919393860003,0.000109787469761451,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC575264.1.1.m.10111,-0.0163031222975622,-0.000388499363655001,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575405.1.1.m.18640,0.00230878403392799,0.000117741055282456,No,NA,NA,Q5YLG1,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_LOC575478.1.1.m.6923,-0.00266551394927888,0.0118497776716627,No,NA,NA,Q86U38,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC575509.2.2.m.63548,-0.00700467198894217,-0.00692698070216386,No,NA,NA,Q7T0Y4,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285],NA,NA,NA
CHOYP_LOC575600.1.1.m.27851,-0.0100161395213509,0.00149307712788162,No,NA,NA,Q9Y5X2,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC575625.1.2.m.50064,0.000376714751257086,-0.00304457572111265,No,NA,NA,O95405,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; 1-phosphatidylinositol binding [GO:0005545]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; serine-type peptidase activity [GO:0008236]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC575793.1.2.m.34690,-0.00414324513743517,-0.000160208401166134,No,NA,NA,Q3T042,NA,NA,NA,nucleus [GO:0005634]; preribosome; small subunit precursor [GO:0030688]; endoribonuclease activity [GO:0004521]; metal ion binding [GO:0046872]; cleavage involved in rRNA processing [GO:0000469]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_LOC575793.1.2.m.34691,0.00670994271187162,0.00792426972619715,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575893.1.1.m.62614,0.000354553518981648,0.00131915416716847,No,NA,NA,Q3T0Z7,NA,NA,NA,cytoplasm [GO:0005737]; 6;7-dihydropteridine reductase activity [GO:0004155]; NADH binding [GO:0070404]; NADPH binding [GO:0070402]; L-phenylalanine catabolic process [GO:0006559]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_LOC575944.1.5.m.22547,0.00502834547471115,0.00593834664901329,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC575944.3.5.m.24887,0.00924643885207947,0.0072536051466954,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC576041.1.1.m.28220,-0.00896458672571138,-0.00768830915477608,No,NA,NA,Q92051,NA,NA,NA,carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270]; carbon dioxide transport [GO:0015670]; hypotonic salinity response [GO:0042539],NA,NA,NA
CHOYP_LOC576200.3.4.m.38681,0.00111462869089242,-0.0151813143691999,No,NA,NA,A6X942,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC576326.1.1.m.49857,0.0069384462190119,0.0105346932927724,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC576341.1.2.m.9414,-0.00564930427504556,-0.000983560463656853,No,NA,NA,Q4AC94,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; brain development [GO:0007420]; centriole elongation [GO:0061511]; ciliary basal body-plasma membrane docking [GO:0097711]; embryonic digit morphogenesis [GO:0042733]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; neural plate axis specification [GO:0021997]; neural tube development [GO:0021915]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539]; protein processing [GO:0016485]; regulation of proteolysis [GO:0030162]; regulation of smoothened signaling pathway [GO:0008589],NA,NA,NA
CHOYP_LOC576498.1.1.m.10455,-0.0230754656343515,-0.00373372431755299,No,NA,NA,Q5FWU8,NA,NA,NA,apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cilium [GO:0005929]; metal ion binding [GO:0046872]; inner dynein arm assembly [GO:0036159]; motile cilium assembly [GO:0044458]; outer dynein arm assembly [GO:0036158]; positive regulation of motile cilium assembly [GO:1905505],NA,NA,NA
CHOYP_LOC576511.1.1.m.53180,-0.000626265227962802,-0.00174852586390798,No,NA,NA,Q5RG45,NA,NA,NA,centriole [GO:0005814]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457],NA,NA,NA
CHOYP_LOC576660.1.1.m.33760,-0.0143595691603798,-0.00892115745542365,No,NA,NA,A6QLU1,NA,NA,NA,glycerol-3-phosphate dehydrogenase complex [GO:0009331]; mitochondrion [GO:0005739]; calcium ion binding [GO:0005509]; glycerol-3-phosphate dehydrogenase (quinone) activity [GO:0004368]; glycerol-3-phosphate dehydrogenase [NAD+] activity [GO:0004367]; sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity [GO:0052591]; camera-type eye development [GO:0043010]; gluconeogenesis [GO:0006094]; glycerol catabolic process [GO:0019563]; glycerol-3-phosphate catabolic process [GO:0046168]; multicellular organism growth [GO:0035264],NA,NA,NA
CHOYP_LOC576665.1.2.m.10868,-0.0251292551790566,-0.015992195964756,No,NA,NA,Q96L03,NA,NA,NA,cytoplasm [GO:0005737]; calmodulin binding [GO:0005516],NA,NA,NA
CHOYP_LOC576698.1.1.m.32335,-0.0337674005956783,0.0227799443702588,No,NA,NA,Q3V096,NA,NA,NA,nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092],NA,NA,NA
CHOYP_LOC576797.1.1.m.8986,-0.000527069518373138,0.00362691473522741,No,NA,NA,O43822,NA,NA,NA,ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; photoreceptor connecting cilium [GO:0032391]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; DNA damage response; detection of DNA damage [GO:0042769]; motile cilium assembly [GO:0044458]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC577184.1.1.m.62005,0.0112868618628401,0.00456153064777946,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC577190.1.1.m.18117,-0.0157111488970765,-0.0122694953827313,No,NA,NA,C3XRY1,NA,NA,NA,nucleus [GO:0005634]; histone demethylase activity (H3-K36 specific) [GO:0051864]; histone demethylase activity (H3-K4 specific) [GO:0032453]; iron ion binding [GO:0005506]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; 2-oxoglutarate as one donor; and incorporation of one atom each of oxygen into both donors [GO:0016706]; histone H3-K36 demethylation [GO:0070544]; histone H3-K4 demethylation [GO:0034720]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_LOC577313.2.5.m.45484,-0.0154074134144024,-0.00598336476722752,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577338.1.1.m.9819,-0.022406409588572,-0.0155006944569054,No,NA,NA,Q6GPB8,NA,NA,NA,nucleus [GO:0005634]; RNA lariat debranching enzyme activity [GO:0008419]; mRNA processing [GO:0006397]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC577351.1.1.m.17664,-0.00844699899097366,-0.00261145943489181,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC577371.1.2.m.46335,-0.0235318785185407,0.0176051428625792,No,NA,NA,Q8TE73,NA,NA,NA,9+2 motile cilium [GO:0097729]; axoneme [GO:0005930]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; flagellated sperm motility [GO:0030317]; heart development [GO:0007507]; lateral ventricle development [GO:0021670]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577550.1.1.m.36506,-0.00111789568247947,0.00142234939821128,No,NA,NA,Q28IH8,NA,NA,NA,cytoplasm [GO:0005737]; motile cilium [GO:0031514]; nucleus [GO:0005634],NA,NA,NA
CHOYP_LOC577551.1.1.m.30278,0.00432311694561776,0.00211620351804312,No,NA,NA,Q8BHL8,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; proteasome binding [GO:0070628]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; negative regulation of proteasomal protein catabolic process [GO:1901799]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577573.1.1.m.13979,-0.00433218223809312,-0.0045052111646165,No,NA,NA,Q9NVE5,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC577730.2.5.m.11065,-0.033624325973358,0.0275825564339844,No,NA,NA,A7RT29,NA,NA,NA,lysosome [GO:0005764]; Ragulator complex [GO:0071986]; cellular response to amino acid stimulus [GO:0071230]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; positive regulation of TOR signaling [GO:0032008]; protein localization to lysosome [GO:0061462]; regulation of cell size [GO:0008361]; viral genome replication [GO:0019079],NA,NA,NA
CHOYP_LOC577805.1.4.m.9698,-0.0118455224363948,-0.00419143635447547,No,NA,NA,Q39575,NA,NA,NA,cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; motile cilium [GO:0031514]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cilium movement involved in cell motility [GO:0060294]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577805.3.4.m.46026,0,0,No,NA,NA,Q96JB1,NA,NA,NA,axonemal dynein complex [GO:0005858]; dynein complex [GO:0030286]; microtubule [GO:0005874]; outer dynein arm [GO:0036157]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; microtubule motor activity [GO:0003777]; cilium-dependent cell motility [GO:0060285]; microtubule-based movement [GO:0007018]; outer dynein arm assembly [GO:0036158],NA,NA,NA
CHOYP_LOC577905.1.2.m.2598,0.00209827216758417,9.66021381095873e-05,No,NA,NA,P40757,NA,NA,NA,mitochondrion [GO:0005739]; allantoinase activity [GO:0004038]; cobalt ion binding [GO:0050897]; zinc ion binding [GO:0008270]; allantoin catabolic process [GO:0000256],NA,NA,NA
CHOYP_LOC577931.3.3.m.35020,-0.00336801959755139,0.0144120353840854,No,NA,NA,P07589,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; disordered domain specific binding [GO:0097718]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_LOC578003.1.1.m.64329,-0.00309626295528946,0.00195753165217884,No,NA,NA,Q5M7D6,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888],NA,NA,NA
CHOYP_LOC578045.4.5.m.61073,0.00265259984403821,0.00799466997239648,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578045.5.5.m.65293,0.00648350018863313,-0.0161730168923803,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC578169.1.1.m.63470,-0.0246283963357815,-0.00748328855287136,No,NA,NA,Q5T1B0,NA,NA,NA,,NA,NA,NA
CHOYP_LOC578260.1.1.m.21677,-0.00536245302435049,0.0125461427012213,No,NA,NA,Q5R2J2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; microtubule cytoskeleton organization [GO:0000226]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC578280.1.1.m.42277,-0.00244086377216064,0.00331365992729045,No,NA,NA,O95490,NA,NA,NA,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; carbohydrate binding [GO:0030246]; G protein-coupled receptor activity [GO:0004930]; latrotoxin receptor activity [GO:0016524]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; brain development [GO:0007420]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_LOC578284.1.1.m.30567,-0.00085246875535093,-0.00478917507197187,No,NA,NA,Q5ZM33,NA,NA,NA,nucleosome [GO:0000786]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; heterochromatin organization [GO:0070828]; nucleosome assembly [GO:0006334]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC578349.1.1.m.51923,-0.00608744675313361,0.0184607042232391,No,NA,NA,Q9BUH6,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellular response to DNA damage stimulus [GO:0006974]; DNA ligation involved in DNA repair [GO:0051103]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC578371.1.1.m.56054,-0.0203779842880428,-0.0109454646657251,No,NA,NA,Q9P2S6,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC578464.1.1.m.46553,0.00759929257680059,0.0207326211972282,No,NA,NA,P49109,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; organelle membrane [GO:0031090]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661],NA,NA,NA
CHOYP_LOC578599.1.8.m.12749,-4.7392959632986e-05,0.00628790530534801,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578599.8.8.m.57682,0.00576617835636236,-0.00755701858991363,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578600.1.1.m.45849,0.00109673975352539,0.012667267391173,No,NA,NA,P83741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_LOC578627.1.1.m.61950,-0.00092182696779454,-0.00245242903679932,No,NA,NA,P51147,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; exocytic vesicle [GO:0070382]; lipid droplet [GO:0005811]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_LOC578656.8.15.m.42294,-0.0219525788124352,0.00622968255743309,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LOC578656.9.15.m.53454,-4.50222896430599e-05,0.00597337444417533,No,NA,NA,Q9JI18,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; receptor complex [GO:0043235]; calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]; low-density lipoprotein particle receptor binding [GO:0050750]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC578672.1.2.m.29847,-0.00375155810169067,-0.0105913620193498,No,NA,NA,Q9BUJ2,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; response to virus [GO:0009615]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578672.2.2.m.44884,-0.000959625810153265,0.00168749341435127,No,NA,NA,Q00839,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell surface [GO:0009986]; centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; CRD-mediated mRNA stability complex [GO:0070937]; cytoplasmic ribonucleoprotein granule [GO:0036464]; dendrite cytoplasm [GO:0032839]; inactive sex chromosome [GO:0098577]; kinetochore [GO:0000776]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; mitotic spindle midzone [GO:1990023]; nuclear chromosome [GO:0000228]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; telomerase holoenzyme complex [GO:0005697]; actin binding [GO:0003779]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(C) RNA binding [GO:0017130]; poly(G) binding [GO:0034046]; pre-mRNA binding [GO:0036002]; promoter-specific chromatin binding [GO:1990841]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; RNA polymerase II C-terminal domain binding [GO:0099122]; RNA polymerase II complex binding [GO:0000993]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; snRNA binding [GO:0017069]; telomerase RNA binding [GO:0070034]; TFIIH-class transcription factor complex binding [GO:0001097]; transcription corepressor activity [GO:0003714]; adaptive thermogenesis [GO:1990845]; cardiac muscle cell development [GO:0055013]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; circadian regulation of gene expression [GO:0032922]; CRD-mediated mRNA stabilization [GO:0070934]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; dosage compensation by inactivation of X chromosome [GO:0009048]; maintenance of protein location in nucleus [GO:0051457]; mRNA splicing; via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of kinase activity [GO:0033673]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; osteoblast differentiation [GO:0001649]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO:2000373]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to spindle microtubule [GO:1902889]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of chromatin organization [GO:1902275]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic spindle assembly [GO:1901673]; RNA localization to chromatin [GO:1990280]; RNA metabolic process [GO:0016070]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC578680.1.1.m.49370,-0.00743541712707256,-0.00209611164974472,No,NA,NA,Q8CDU5,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC578781.1.5.m.2353,-0.00390011538125201,-0.00448897962618615,No,NA,NA,O95425,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578781.2.5.m.8827,0.000797332976268653,-0.00339285905300762,No,NA,NA,O95425,NA,NA,NA,actin cytoskeleton [GO:0015629]; cleavage furrow [GO:0032154]; costamere [GO:0043034]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; microtubule minus-end [GO:0036449]; midbody [GO:0030496]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; podosome [GO:0002102]; actin filament binding [GO:0051015]; cytoskeleton organization [GO:0007010]; positive regulation of cytokinesis [GO:0032467]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_LOC578858.2.2.m.25157,-0.00785787035372734,-0.00339643050533288,No,NA,NA,Q6SP97,NA,NA,NA,acrosomal vesicle [GO:0001669]; sperm principal piece [GO:0097228]; calmodulin binding [GO:0005516]; SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_LOC578881.1.1.m.9743,0.0069179945962836,-0.00109847551071869,No,NA,NA,Q9HBU6,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ethanolamine kinase activity [GO:0004305]; phosphatidylethanolamine biosynthetic process [GO:0006646],NA,NA,NA
CHOYP_LOC578897.1.1.m.11932,-0.0153155471260262,-0.00974677638480098,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC578968.1.2.m.41294,-0.00611999519201336,0.00372027372355636,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578968.2.2.m.54316,-7.756640749825e-05,0.0102911957599199,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC578979.1.1.m.10409,-0.0222251585993617,-0.00896417994911496,No,NA,NA,Q4R6I5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC579012.1.1.m.10830,-0.0331308723591808,0.0127899356333515,No,NA,NA,Q8N865,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579123.1.1.m.65215,-0.00771489556405451,0.0101537678184703,No,NA,NA,Q9UNS1,NA,NA,NA,nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork protection complex [GO:0031298]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle phase transition [GO:0044770]; cell division [GO:0051301]; cellular response to bleomycin [GO:1904976]; cellular response to cisplatin [GO:0072719]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydroxyurea [GO:0072711]; circadian rhythm [GO:0007623]; detection of abiotic stimulus [GO:0009582]; DNA repair [GO:0006281]; DNA replication checkpoint [GO:0000076]; lung development [GO:0030324]; morphogenesis of an epithelium [GO:0002009]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of double-strand break repair [GO:2000781]; regulation of circadian rhythm [GO:0042752]; replication fork arrest [GO:0043111]; replication fork protection [GO:0048478],NA,NA,NA
CHOYP_LOC579332.1.1.m.41750,-0.00122062037373489,0.00749457469444618,No,NA,NA,Q92538,NA,NA,NA,cell leading edge [GO:0031252]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739]; peroxisome [GO:0005777]; trans-Golgi network [GO:0005802]; ARF guanyl-nucleotide exchange factor activity [GO:0005086]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; cell activation involved in immune response [GO:0002263]; cellular response to virus [GO:0098586]; COPI coating of Golgi vesicle [GO:0048205]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum-Golgi intermediate compartment organization [GO:0097111]; establishment of monopolar cell polarity [GO:0061162]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi to endosome transport [GO:0006895]; neutrophil chemotaxis [GO:0030593]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to endoplasmic reticulum tubular network [GO:1903420]; protein localization to Golgi apparatus [GO:0034067]; protein transport [GO:0015031]; reactive oxygen species biosynthetic process [GO:1903409]; regulation of ARF protein signal transduction [GO:0032012]; regulation of mitotic cell cycle [GO:0007346]; regulation of protein localization to cell surface [GO:2000008]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; viral process [GO:0016032],NA,NA,NA
CHOYP_LOC579381.1.1.m.10900,0.00262628300976512,-0.000709696681158503,No,NA,NA,Q8BUG5,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579644.1.1.m.16828,-0.00788226714312121,-0.00501625535262221,No,NA,NA,Q9Z0R0,NA,NA,NA,centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; histone kinase activity (H3-T3 specific) [GO:0072354]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore [GO:2000751]; intracellular signal transduction [GO:0035556]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; protein localization to chromosome; centromeric region [GO:0071459]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_LOC579656.3.5.m.41908,0.000565941858283553,-0.0114580951277274,No,NA,NA,Q9Y3Q0,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carboxypeptidase activity [GO:0004180]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; N-formylglutamate deformylase activity [GO:0050129]; serine-type peptidase activity [GO:0008236]; cellular amino acid biosynthetic process [GO:0008652]; neurotransmitter catabolic process [GO:0042135]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC579681.1.1.m.25827,0.000453619179296946,-0.00657931964635612,No,NA,NA,Q6IP50,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC579713.1.1.m.17440,-0.0256975249167513,0.0120250317303672,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC579737.1.1.m.14356,-0.00185126479299212,0.00111288703093572,No,NA,NA,Q64350,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; aging [GO:0007568]; astrocyte development [GO:0014002]; astrocyte differentiation [GO:0048708]; hippocampus development [GO:0021766]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; positive regulation of apoptotic process [GO:0043065]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to lithium ion [GO:0010226]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_LOC579832.2.2.m.47454,-0.0109705446872678,-0.00509983562793711,No,NA,NA,Q5SUV2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC579833.1.1.m.23271,0.0270978206606995,0.0142166202976198,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_LOC579914.1.1.m.13347,-0.00953188662979021,-0.000625031241916158,No,NA,NA,Q07DZ5,NA,NA,NA,cell cortex [GO:0005938]; dendritic spine [GO:0043197],NA,NA,NA
CHOYP_LOC579934.1.1.m.59523,-0.00373525384655341,0.00575839087585571,No,NA,NA,Q6NY77,NA,NA,NA,mitochondrion [GO:0005739]; 4-hydroxy-2-oxoglutarate aldolase activity [GO:0008700]; glyoxylate catabolic process [GO:0009436],NA,NA,NA
CHOYP_LOC579946.11.24.m.42367,0.00304783030119588,-0.00963874285294113,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.17.24.m.53406,-0.00609819808258744,-0.0005035148388692,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC579946.20.24.m.55163,-0.000743172624492363,0.00322603840928349,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_LOC579946.7.24.m.39737,0.0167605318229958,0.00860905631049816,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_LOC580197.1.1.m.4591,0.00273288800817024,0.0107374444463687,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC580207.1.1.m.49071,0.00436840835413367,-0.00227676406978628,No,NA,NA,Q3MHG0,NA,NA,NA,Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; Golgi organization [GO:0007030]; Golgi vesicle prefusion complex stabilization [GO:0048213]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC580355.1.1.m.29389,0.00273723953380591,0.00194325653514447,No,NA,NA,P07314,NA,NA,NA,extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; peptidyltransferase activity [GO:0000048]; transferase activity; transferring amino-acyl groups [GO:0016755]; aging [GO:0007568]; cellular amino acid metabolic process [GO:0006520]; cellular response to oxidative stress [GO:0034599]; cysteine biosynthetic process [GO:0019344]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; glutathione metabolic process [GO:0006749]; peptide modification [GO:0031179]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to tumor necrosis factor [GO:0034612]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],NA,NA,NA
CHOYP_LOC580466.1.2.m.18704,-0.00526326254752981,-0.0144552796751527,No,NA,NA,Q640V9,NA,NA,NA,nucleus [GO:0005634]; endodeoxyribonuclease activity; producing 5'-phosphomonoesters [GO:0016888]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC580666.1.2.m.21929,0.00961894598295884,-0.0135642376311094,No,NA,NA,B0C431,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC580669.1.1.m.7758,-0.0084726460964009,-0.00891442295684612,No,NA,NA,Q9Y7Y3,NA,NA,NA,90S preribosome [GO:0030686]; nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; ribosomal small subunit biogenesis [GO:0042274]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_LOC580670.1.6.m.4085,0.00608630918191785,0.000951678609395834,No,NA,NA,A2AJX4,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; cholesterol homeostasis [GO:0042632]; negative regulation of bile acid biosynthetic process [GO:0070858],NA,NA,NA
CHOYP_LOC580670.5.6.m.34028,0.00950168556710013,0.00725509853237579,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580670.6.6.m.40875,0.00379703983451591,0.0190464867046469,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_LOC580675.1.1.m.44042,0.00443884767688969,0.00524216491490226,No,NA,NA,Q5ZQU0,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_LOC580687.1.1.m.1044,0.00404564118408198,-0.00109269969535542,No,NA,NA,P82094,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; DNA binding [GO:0003677]; transcription coregulator activity [GO:0003712]; acrosome assembly [GO:0001675]; cellular response to organic cyclic compound [GO:0071407]; defense response to bacterium [GO:0042742]; flagellated sperm motility [GO:0030317]; Leydig cell differentiation [GO:0033327]; luteinizing hormone secretion [GO:0032275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; positive regulation of cytokine production [GO:0001819]; positive regulation of testosterone secretion [GO:2000845]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of transcription; DNA-templated [GO:0006355]; spermatid nucleus differentiation [GO:0007289]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC580832.1.1.m.66146,-0.0028063572159705,0.000496009351158601,No,NA,NA,Q92947,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; glutaryl-CoA dehydrogenase activity [GO:0004361]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; fatty-acyl-CoA biosynthetic process [GO:0046949]; lysine catabolic process [GO:0006554]; tryptophan metabolic process [GO:0006568],NA,NA,NA
CHOYP_LOC580840.1.1.m.45392,-0.0111331884737629,0.0125360453212502,No,NA,NA,Q32L77,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_LOC581113.2.2.m.57598,-0.00532442932224354,-0.000875373392930835,No,NA,NA,Q8AV28,NA,NA,NA,apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; social behavior [GO:0035176],NA,NA,NA
CHOYP_LOC581128.1.1.m.46711,-6.03522250596377e-05,0.0080072879828742,No,NA,NA,P83436,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; nucleolus [GO:0005730]; trans-Golgi network membrane [GO:0032588]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; protein glycosylation [GO:0006486]; protein localization to Golgi apparatus [GO:0034067]; protein localization to organelle [GO:0033365]; protein stabilization [GO:0050821]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_LOC581387.1.1.m.56997,-0.00427781768968414,0.000829187109384596,No,NA,NA,A8E5W8,NA,NA,NA,,NA,NA,NA
CHOYP_LOC581447.1.1.m.65782,0.0145563012180449,-0.0150611602179602,No,NA,NA,P23913,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear inner membrane [GO:0005637]; DNA binding [GO:0003677]; oxidoreductase activity; acting on the CH-CH group of donors; NAD or NADP as acceptor [GO:0016628]; sterol biosynthetic process [GO:0016126],NA,NA,NA
CHOYP_LOC581452.2.4.m.25348,0.00342868257315362,0.00404918591437607,No,NA,NA,Q20191,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581452.3.4.m.41000,-0.00946363940023064,-0.00167801762687426,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC581491.1.2.m.56125,-0.0118275425935154,0.0197293532116195,No,NA,NA,Q9Y283,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; calmodulin binding [GO:0005516]; multicellular organism development [GO:0007275]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LOC581508.1.1.m.26966,0.00128837771532918,0.011880268625118,No,NA,NA,Q96FN9,NA,NA,NA,cytoplasm [GO:0005737]; Ala-tRNA(Thr) hydrolase activity [GO:0106105]; aminoacyl-tRNA editing activity [GO:0002161]; D-tyrosyl-tRNA(Tyr) deacylase activity [GO:0051500]; tRNA binding [GO:0000049]; aminoacyl-tRNA metabolism involved in translational fidelity [GO:0106074]; tRNA metabolic process [GO:0006399],NA,NA,NA
CHOYP_LOC581594.2.3.m.34837,-0.00102451031456739,-0.00136194920265281,No,NA,NA,Q4FZG9,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; electron transport chain [GO:0022900]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_LOC581711.1.1.m.14276,0.0144125210212943,-0.00900167866772212,No,NA,NA,Q9CY21,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein heterodimerization activity [GO:0046982]; rRNA (guanine) methyltransferase activity [GO:0016435]; chromatin organization [GO:0006325]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476],NA,NA,NA
CHOYP_LOC581748.1.1.m.47690,0.00262438299146977,0.00945151208731708,No,NA,NA,P53753,NA,NA,NA,cell septum [GO:0030428]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fungal-type cell wall [GO:0009277]; glucan endo-1;3-beta-D-glucosidase activity [GO:0042973]; glucan endo-1;3-beta-glucanase activity; C-3 substituted reducing group [GO:0052861]; glucan endo-1;4-beta-glucanase activity; C-3 substituted reducing group [GO:0052862]; metabolic process [GO:0008152]; septum digestion after cytokinesis [GO:0000920],NA,NA,NA
CHOYP_LOC581773.1.1.m.56865,-0.00461250257433927,0.00203054792911474,No,NA,NA,Q9WV48,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; intracellular [GO:0005622]; ionotropic glutamate receptor complex [GO:0008328]; neuron projection [GO:0043005]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schaffer collateral - CA1 synapse [GO:0098685]; synapse [GO:0045202]; ankyrin repeat binding [GO:0071532]; GKAP/Homer scaffold activity [GO:0030160]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; scaffold protein binding [GO:0097110]; SH3 domain binding [GO:0017124]; somatostatin receptor binding [GO:0031877]; adult behavior [GO:0030534]; associative learning [GO:0008306]; brain morphogenesis [GO:0048854]; cytoskeletal anchoring at plasma membrane [GO:0007016]; dendritic spine morphogenesis [GO:0060997]; determination of affect [GO:0050894]; habituation [GO:0046959]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; negative regulation of actin filament bundle assembly [GO:0032232]; neuromuscular process controlling balance [GO:0050885]; olfactory behavior [GO:0042048]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density assembly [GO:0097107]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; regulation of AMPA receptor activity [GO:2000311]; righting reflex [GO:0060013]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; synaptic growth at neuromuscular junction [GO:0051124]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_LOC581886.1.3.m.23639,-0.0128451939376848,-0.016652501811568,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC581927.10.27.m.32671,-0.0141479434242953,0.00757753275691178,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC581927.9.27.m.31886,-0.012516751404495,-0.0079656296964045,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC582121.1.1.m.30176,-0.00578114736905171,-0.0189140281436942,No,NA,NA,P23034,NA,NA,NA,cytoplasm [GO:0005737]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; biosynthetic process [GO:0009058],NA,NA,NA
CHOYP_LOC582154.1.1.m.58922,0.00545992171662933,0.000268286979824159,No,NA,NA,P46952,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3-hydroxyanthranilate 3;4-dioxygenase activity [GO:0000334]; electron transfer activity [GO:0009055]; ferrous iron binding [GO:0008198]; 'de novo' NAD biosynthetic process from tryptophan [GO:0034354]; anthranilate metabolic process [GO:0043420]; NAD biosynthetic process [GO:0009435]; neuron cellular homeostasis [GO:0070050]; quinolinate biosynthetic process [GO:0019805]; quinolinate metabolic process [GO:0046874]; response to cadmium ion [GO:0046686]; response to zinc ion [GO:0010043]; tryptophan catabolic process [GO:0006569],NA,NA,NA
CHOYP_LOC582174.2.16.m.16430,-0.00470736595143209,0.00531358104042671,No,NA,NA,O95613,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; calmodulin binding [GO:0005516]; protein-containing complex scaffold activity [GO:0032947]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; positive regulation of intracellular protein transport [GO:0090316]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582178.1.1.m.42729,-0.000991765278309048,0.00137004835139989,No,NA,NA,Q91VD9,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; plasma membrane respiratory chain complex I [GO:0045272]; 2 iron; 2 sulfur cluster binding [GO:0051537]; 4 iron; 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; apoptotic mitochondrial changes [GO:0008637]; ATP metabolic process [GO:0046034]; ATP synthesis coupled electron transport [GO:0042773]; cellular respiration [GO:0045333]; reactive oxygen species metabolic process [GO:0072593]; regulation of mitochondrial membrane potential [GO:0051881],NA,NA,NA
CHOYP_LOC582352.1.1.m.30199,-0.0111279052524475,-0.00834178749740321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC582570.1.1.m.65944,-0.00153261472180622,0.00208064212577057,No,NA,NA,Q9P2F6,NA,NA,NA,cytosol [GO:0005829]; GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC582626.1.1.m.5567,-0.0214810142306505,0.0299818550442687,No,NA,NA,Q9H9J2,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; double-stranded RNA binding [GO:0003725]; ribonuclease III activity [GO:0004525]; RNA binding [GO:0003723]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; pre-miRNA processing [GO:0031054]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_LOC582726.1.1.m.29762,-0.000254607341939718,0.00182895132002168,No,NA,NA,P08183,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_LOC582782.1.4.m.8110,0.0127417716682588,0.0110764458377309,No,NA,NA,Q5UQP2,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582782.4.4.m.62807,0.0122582785611016,0.0104156293422175,No,NA,NA,Q5UQP2,NA,NA,NA,integral component of membrane [GO:0016021]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC582784.1.1.m.53921,-0.0164784297737075,0.00759223652560858,No,NA,NA,Q9BY77,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of translation [GO:0045727]; RNA export from nucleus [GO:0006405],NA,NA,NA
CHOYP_LOC582874.1.1.m.5135,0.000574348403697341,0.00155400039928064,No,NA,NA,O55096,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; dipeptidyl-peptidase activity [GO:0008239]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC583072.4.25.m.20255,0.00476999329989657,-0.00865983986007143,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC583138.1.1.m.8990,-0.00779020126338072,-0.002001288103271,No,NA,NA,A9UMP7,NA,NA,NA,phosphopyruvate hydratase complex [GO:0000015]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_LOC583253.1.1.m.11773,0.00281597112483278,0.00332558945620767,No,NA,NA,A9ZSZ2,NA,NA,NA,cytoplasm [GO:0005737]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; gene silencing by RNA [GO:0031047]; meiotic cell cycle [GO:0051321]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC583472.1.1.m.25642,-0.00125603011855912,-0.00108864741470511,No,NA,NA,P13010,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear chromosome; telomeric region [GO:0000784]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription regulatory region DNA binding [GO:0044212]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; brain development [GO:0007420]; cell proliferation [GO:0008283]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; establishment of integrated proviral latency [GO:0075713]; hematopoietic stem cell differentiation [GO:0060218]; innate immune response [GO:0045087]; negative regulation of t-circle formation [GO:1904430]; negative regulation of transcription; DNA-templated [GO:0045892]; neutrophil degranulation [GO:0043312]; positive regulation of catalytic activity [GO:0043085]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of type I interferon production [GO:0032481]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to drug [GO:0042493]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_LOC583843.1.1.m.11191,0.0088947527856046,0.00290976154268563,No,NA,NA,Q6DCY9,NA,NA,NA,cytoplasm [GO:0005737]; HAUS complex [GO:0070652]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_LOC583865.2.2.m.15485,-0.00111088559458757,0.0137838603654835,No,NA,NA,Q6NYV5,NA,NA,NA,histone deacetylase complex [GO:0000118]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; non-sequence-specific DNA binding; bending [GO:0044378]; nucleosome binding [GO:0031491]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylinositol-5-phosphate binding [GO:0010314]; zinc ion binding [GO:0008270]; heart looping [GO:0001947]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC583890.1.1.m.14405,0.00676091097067001,-0.00237567933141655,No,NA,NA,P12426,NA,NA,NA,cytoplasm [GO:0005737]; adenine binding [GO:0002055]; adenine phosphoribosyltransferase activity [GO:0003999]; AMP binding [GO:0016208]; adenine salvage [GO:0006168]; AMP salvage [GO:0044209]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_LOC583954.1.1.m.777,-0.0214073867609535,0.0103135928518157,No,NA,NA,Q8AVG9,NA,NA,NA,glutamyl-tRNA(Gln) amidotransferase complex [GO:0030956]; mitochondrion [GO:0005739]; amidase activity [GO:0004040]; ATP binding [GO:0005524]; glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity [GO:0050567]; glutaminyl-tRNAGln biosynthesis via transamidation [GO:0070681]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC584001.1.1.m.46452,-0.00425550948942989,0.0157563704799639,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584015.1.1.m.10227,-0.0100142731881558,0.0101369962324121,No,NA,NA,Q5BKR2,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC584052.1.1.m.6375,0.0108039430285313,-0.0139791664366489,No,NA,NA,Q6DJN2,NA,NA,NA,cytoplasm [GO:0005737]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122],NA,NA,NA
CHOYP_LOC584058.1.1.m.59244,0,0,No,NA,NA,P55265,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; DNA binding [GO:0003677]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; miRNA loading onto RISC involved in gene silencing by miRNA [GO:0035280]; mRNA processing [GO:0006397]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; positive regulation of viral genome replication [GO:0045070]; pre-miRNA processing [GO:0031054]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; response to interferon-alpha [GO:0035455]; response to virus [GO:0009615]; RNA processing [GO:0006396]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_LOC584062.1.1.m.62279,-0.0258427109609671,-0.018909837313547,No,NA,NA,O00625,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC584095.1.1.m.6815,-0.00421781623984332,0.00708164917176319,No,NA,NA,Q9DE46,NA,NA,NA,alpha DNA polymerase:primase complex [GO:0005658]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleoside binding [GO:0001882]; nucleotide binding [GO:0000166]; cell proliferation [GO:0008283]; DNA replication [GO:0006260]; DNA replication initiation [GO:0006270]; DNA replication; synthesis of RNA primer [GO:0006269]; DNA strand elongation involved in DNA replication [GO:0006271]; double-strand break repair via nonhomologous end joining [GO:0006303]; lagging strand elongation [GO:0006273]; leading strand elongation [GO:0006272],NA,NA,NA
CHOYP_LOC584238.1.1.m.30307,-0.00411465242327572,0.0173686530861278,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584270.1.1.m.49225,0.0130701618076516,-0.00319261294121944,No,NA,NA,Q9NX08,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC584281.1.1.m.34958,0.00106791240627298,0.000396214254266442,No,NA,NA,P51650,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; oxidation-reduction process [GO:0055114]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_LOC584318.1.1.m.35309,0.00922040327282238,-0.00090213350479699,No,NA,NA,Q6A098,NA,NA,NA,ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; ribonucleoprotein complex binding [GO:0043021]; selenocysteine insertion sequence binding [GO:0035368]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_LOC584333.1.1.m.42540,0.00440868378724186,-0.00800388872496647,No,NA,NA,P14133,NA,NA,NA,extracellular region [GO:0005576]; copper ion binding [GO:0005507]; L-ascorbate oxidase activity [GO:0008447],NA,NA,NA
CHOYP_LOC584364.2.2.m.57790,0.020394196815803,-0.0193387095147186,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC584368.1.2.m.10628,0.000325741206764414,-0.00219174472096062,No,NA,NA,P80513,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; sarcoplasmic reticulum lumen [GO:0033018]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC584392.1.1.m.24512,-0.0182778451675267,0.011618534600014,No,NA,NA,Q32KI9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; metal ion binding [GO:0046872]; sulfuric ester hydrolase activity [GO:0008484],NA,NA,NA
CHOYP_LOC584416.1.1.m.34286,-0.0102263352344884,-0.0065080144996708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584481.10.10.m.66365,0.00414401932701895,0.00738249242836885,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.5.10.m.52126,-0.00173491975356618,0.0159184301407313,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584481.8.10.m.61433,0.00340587224942188,-0.000920363960348939,No,NA,NA,O16025,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; arachidonate 8(R)-lipoxygenase activity [GO:0047677]; catalase activity [GO:0004096]; heme binding [GO:0020037]; hydroperoxide dehydratase activity [GO:0047987]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; oxylipin biosynthetic process [GO:0031408],NA,NA,NA
CHOYP_LOC584567.1.1.m.29825,0.000158880715562947,-0.0132210018841786,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC584665.1.1.m.28760,-0.0212248930445815,0.00756227672107493,No,NA,NA,Q6ZMT9,NA,NA,NA,signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC584905.1.1.m.51595,-0.00739882112298702,-0.00676630875503073,No,NA,NA,Q6P2D8,NA,NA,NA,cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; response to X-ray [GO:0010165],NA,NA,NA
CHOYP_LOC585032.1.2.m.1235,-0.000463438183853871,0.00397779197827802,No,NA,NA,Q15276,NA,NA,NA,early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; membrane fusion [GO:0061025]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC585158.1.2.m.18137,-0.00635515328916997,-0.0101122062356727,No,NA,NA,O14095,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454]; negative regulation of signal transduction [GO:0009968]; protein folding [GO:0006457]; response to pheromone [GO:0019236],NA,NA,NA
CHOYP_LOC585322.1.2.m.8217,-0.00747374831782607,-0.000352895607164634,No,NA,NA,Q4R8T1,NA,NA,NA,nucleus [GO:0005634]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC585438.1.1.m.44017,-0.00572775865787608,0.0089552760284432,No,NA,NA,Q9NVX2,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; hematopoietic stem cell homeostasis [GO:0061484]; inner cell mass cell differentiation [GO:0001826]; kidney development [GO:0001822]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of mitotic cell cycle [GO:0045930]; Notch signaling pathway [GO:0007219]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; ribosomal large subunit assembly [GO:0000027]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_LOC585494.1.1.m.64158,0.00424539701521308,-0.00770744443078519,No,NA,NA,Q99LG0,NA,NA,NA,nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; transcription coactivator activity [GO:0003713]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; histone deubiquitination [GO:0016578]; histone H2A K63-linked deubiquitination [GO:0070537]; mitotic cell cycle [GO:0000278]; mitotic nuclear division [GO:0140014]; monoubiquitinated histone H2A deubiquitination [GO:0035522]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of translational elongation [GO:0045901]; protein homotetramerization [GO:0051289]; regulation of cell cycle [GO:0051726]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC585591.1.1.m.62390,-0.02052051206469,0.0200789494609116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585638.1.1.m.10100,-0.0170477698988256,-0.0108491586814442,No,NA,NA,Q9NNW5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; RNA binding [GO:0003723]; cell cycle arrest [GO:0007050]; negative regulation of autophagy [GO:0010507]; negative regulation of cell proliferation [GO:0008285],NA,NA,NA
CHOYP_LOC585734.1.1.m.36212,0.00588959496277353,-0.0106924572031177,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC585839.1.1.m.51865,-0.00356839056721537,0.00484436409863048,No,NA,NA,Q5XIJ8,NA,NA,NA,axonemal dynein complex [GO:0005858]; axoneme [GO:0005930]; motile cilium [GO:0031514]; axonemal dynein complex assembly [GO:0070286]; cilium-dependent cell motility [GO:0060285]; regulation of cilium movement [GO:0003352],NA,NA,NA
CHOYP_LOC585963.1.2.m.36775,-2.13387557641041e-06,0.00028311394058886,No,NA,NA,Q27991,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; midbody [GO:0030496]; myosin II complex [GO:0016460]; myosin II filament [GO:0097513]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; polysome [GO:0005844]; spindle [GO:0005819]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; mRNA 5'-UTR binding [GO:0048027]; RNA stem-loop binding [GO:0035613]; actin filament-based movement [GO:0030048]; adult heart development [GO:0007512]; aorta development [GO:0035904]; axon guidance [GO:0007411]; cardiac myofibril assembly [GO:0055003]; cardiac septum development [GO:0003279]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; cerebellar Purkinje cell layer development [GO:0021680]; coronary vasculature development [GO:0060976]; exocytosis [GO:0006887]; fourth ventricle development [GO:0021592]; in utero embryonic development [GO:0001701]; lateral ventricle development [GO:0021670]; mitotic cytokinesis [GO:0000281]; neuromuscular process controlling balance [GO:0050885]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; plasma membrane repair [GO:0001778]; positive regulation of protein secretion [GO:0050714]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of cell shape [GO:0008360]; retina development in camera-type eye [GO:0060041]; substrate-dependent cell migration; cell extension [GO:0006930]; third ventricle development [GO:0021678]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_LOC585972.1.1.m.25356,-0.011633558367602,-0.0168191229222032,No,NA,NA,Q0P5A2,NA,NA,NA,extrinsic component of mitochondrial inner membrane [GO:0031314]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; 2-octaprenyl-6-methoxy-1;4-benzoquinone methylase activity [GO:0043333]; ubiquinone biosynthetic process [GO:0006744],NA,NA,NA
CHOYP_LOC586005.1.1.m.63556,0.000498077678578331,-0.000257115608276605,No,NA,NA,Q8WVM8,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi cisterna membrane [GO:0032580]; Golgi-associated vesicle [GO:0005798]; plasma membrane [GO:0005886]; protein N-terminus binding [GO:0047485]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; cell morphogenesis [GO:0000902]; COPII vesicle coating [GO:0048208]; negative regulation of autophagosome assembly [GO:1902902]; post-Golgi vesicle-mediated transport [GO:0006892]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of protein transport [GO:0051223]; response to hypoxia [GO:0001666]; response to toxic substance [GO:0009636]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; toxin transport [GO:1901998]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_LOC586039.1.1.m.27100,0.000710675652030534,-0.00187784932245825,No,NA,NA,P81799,NA,NA,NA,ATP binding [GO:0005524]; N-acetylglucosamine kinase activity [GO:0045127]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_LOC586044.1.1.m.60359,-0.00164637897998155,0.00223508583859597,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_LOC586122.3.4.m.63155,0.0245240882428583,0.00153276794581494,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586471.1.1.m.8913,-0.0081924156246328,-0.00521363308065923,No,NA,NA,Q13569,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; ATP binding [GO:0005524]; chloride ion binding [GO:0031404]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA N-glycosylase activity [GO:0019104]; double-stranded DNA binding [GO:0003690]; G/U mismatch-specific uracil-DNA glycosylase activity [GO:0043739]; magnesium ion binding [GO:0000287]; mismatched DNA binding [GO:0030983]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; protein self-association [GO:0043621]; pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO:0008263]; sodium ion binding [GO:0031402]; SUMO binding [GO:0032183]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; uracil DNA N-glycosylase activity [GO:0004844]; base-excision repair [GO:0006284]; base-excision repair; AP site formation [GO:0006285]; chromatin organization [GO:0006325]; depyrimidination [GO:0045008]; DNA demethylation [GO:0080111]; mismatch repair [GO:0006298]; negative regulation of chromatin binding [GO:0035562]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; oxidative DNA demethylation [GO:0035511]; regulation of DNA N-glycosylase activity [GO:1902544]; regulation of embryonic development [GO:0045995]; regulation of gene expression; epigenetic [GO:0040029],NA,NA,NA
CHOYP_LOC586494.1.1.m.50214,-0.0171741019550674,-0.0196219730693065,No,NA,NA,Q96T60,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity [GO:0046404]; damaged DNA binding [GO:0003684]; double-stranded DNA binding [GO:0003690]; endonuclease activity [GO:0004519]; nucleoside monophosphate kinase activity [GO:0050145]; polynucleotide 3'-phosphatase activity [GO:0046403]; purine nucleotide binding [GO:0017076]; dephosphorylation [GO:0016311]; DNA 3' dephosphorylation involved in DNA repair [GO:0098504]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA-dependent DNA replication [GO:0006261]; negative regulation of protein ADP-ribosylation [GO:0010836]; nucleotide phosphorylation [GO:0046939]; nucleotide-excision repair; DNA damage removal [GO:0000718]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; response to oxidative stress [GO:0006979]; response to radiation [GO:0009314],NA,NA,NA
CHOYP_LOC586604.1.1.m.30509,0.000686338151191893,0.0205105864533608,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC586661.1.1.m.56660,-0.0190837519396293,0.0103893423950219,No,NA,NA,Q9XGA0,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; ribose phosphate diphosphokinase activity [GO:0004749]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165],NA,NA,NA
CHOYP_LOC586678.1.1.m.35070,-0.00219898397236129,0.0134154014829282,No,NA,NA,Q8CAQ8,NA,NA,NA,MICOS complex [GO:0061617]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; cristae formation [GO:0042407]; mitochondrial calcium ion homeostasis [GO:0051560],NA,NA,NA
CHOYP_LOC586835.1.1.m.9967,0.00220037741995848,0.00432038834558108,No,NA,NA,Q96MU7,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; N6-methyladenosine-containing RNA binding [GO:1990247]; RNA binding [GO:0003723]; dosage compensation by inactivation of X chromosome [GO:0009048]; mRNA export from nucleus [GO:0006406]; mRNA splice site selection [GO:0006376]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing; via spliceosome [GO:0048024],NA,NA,NA
CHOYP_LOC586835.1.1.m.9969,-0.0174072526408006,-0.00277944013253724,No,NA,NA,Q28FE4,NA,NA,NA,,NA,NA,NA
CHOYP_LOC586953.1.1.m.19600,0.00611946536992525,-0.0111097829286164,No,NA,NA,Q28FY0,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; motile cilium [GO:0031514]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; cytoskeleton organization [GO:0007010]; epithelial cilium movement [GO:0003351]; motile cilium assembly [GO:0044458],NA,NA,NA
CHOYP_LOC587133.1.1.m.61281,0.00198571123645671,0.000236967627621696,No,NA,NA,P72745,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587136.1.3.m.7607,-0.00149552557345582,-0.000666708974812613,No,NA,NA,Q8BW94,NA,NA,NA,dynein complex [GO:0030286]; inner dynein arm [GO:0036156]; microtubule [GO:0005874]; ATP binding [GO:0005524]; ATP-dependent microtubule motor activity; minus-end-directed [GO:0008569]; dynein intermediate chain binding [GO:0045505]; dynein light chain binding [GO:0045503]; dynein light intermediate chain binding [GO:0051959]; cilium movement [GO:0003341]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_LOC587346.1.1.m.17791,0.014991754083891,0.0015199727980696,No,NA,NA,A1A5V9,NA,NA,NA,cytoplasm [GO:0005737]; Elongator holoenzyme complex [GO:0033588]; nucleus [GO:0005634]; positive regulation of cell migration [GO:0030335]; tRNA wobble uridine modification [GO:0002098],NA,NA,NA
CHOYP_LOC587439.1.1.m.45707,-0.0159868928697321,-0.0183878253227335,No,NA,NA,Q5HYI8,NA,NA,NA,cell [GO:0005623]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_LOC587610.1.3.m.16984,0.0195958520564871,0.0103159166620662,No,NA,NA,P00687,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587610.3.3.m.27175,0.011092307048117,0.00357666137097155,No,NA,NA,P00687,NA,NA,NA,extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; alpha-amylase activity (releasing maltohexaose) [GO:0103025]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_LOC587700.1.1.m.42534,-0.00103806900952485,0.00504817764426644,No,NA,NA,Q9D6R2,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; isocitrate dehydrogenase (NAD+) activity [GO:0004449]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287]; 2-oxoglutarate metabolic process [GO:0006103]; isocitrate metabolic process [GO:0006102]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_LOC587705.1.2.m.11702,0.00334333133731847,-0.00233560744212884,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587705.2.2.m.11817,0.00161092395896489,-0.00273347175266082,No,NA,NA,P77735,NA,NA,NA,cytosol [GO:0005829]; oxidoreductase activity [GO:0016491]; thiamine metabolic process [GO:0006772],NA,NA,NA
CHOYP_LOC587740.1.4.m.22830,0.0113707771777745,0.0134285953282064,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC587752.1.1.m.66173,0.00224008900516264,0.0134746107556978,No,NA,NA,P53369,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; 8-oxo-7;8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity [GO:0035539]; 8-oxo-7;8-dihydroguanosine triphosphate pyrophosphatase activity [GO:0008413]; ATP diphosphatase activity [GO:0047693]; GTP diphosphatase activity [GO:0036219]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; snoRNA binding [GO:0030515]; aging [GO:0007568]; dATP catabolic process [GO:0046061]; dGTP catabolic process [GO:0006203]; DNA protection [GO:0042262]; DNA repair [GO:0006281]; male gonad development [GO:0008584]; purine nucleotide catabolic process [GO:0006195]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC587791.2.3.m.33887,0,0,No,NA,NA,Q86TZ1,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587803.1.1.m.9452,-0.0129132657184902,0.00262973121153426,No,NA,NA,Q8BYR1,NA,NA,NA,protein C-terminal carboxyl O-methyltransferase activity [GO:0003880]; protein C-terminal leucine carboxyl O-methyltransferase activity [GO:0018423]; tRNA methyltransferase activity [GO:0008175]; C-terminal protein methylation [GO:0006481]; tRNA methylation [GO:0030488]; wybutosine biosynthetic process [GO:0031591],NA,NA,NA
CHOYP_LOC587840.1.1.m.10143,-0.00376774251838359,-0.00463951082996389,No,NA,NA,Q90744,NA,NA,NA,cytoplasm [GO:0005737]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; glycoside catabolic process [GO:0016139]; glycosylceramide catabolic process [GO:0046477]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC587946.1.1.m.5037,0.0035899647987874,0.00423965607378626,No,NA,NA,P46012,NA,NA,NA,,NA,NA,NA
CHOYP_LOC587966.1.1.m.10698,7.4617399698706e-05,-0.00923885320275605,No,NA,NA,Q9JK84,NA,NA,NA,apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell cortex [GO:0005938]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein kinase C binding [GO:0005080]; Rho GTPase binding [GO:0017048]; cell division [GO:0051301]; centrosome cycle [GO:0007098]; establishment or maintenance of cell polarity [GO:0007163]; regulation of cellular localization [GO:0060341],NA,NA,NA
CHOYP_LOC587972.1.2.m.3283,0.00690498543538455,0.0248934557012752,No,NA,NA,P09848,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; beta-glucosidase activity [GO:0008422]; glycosylceramidase activity [GO:0017042]; lactase activity [GO:0000016]; carbohydrate metabolic process [GO:0005975]; polysaccharide digestion [GO:0044245],NA,NA,NA
CHOYP_LOC588385.1.2.m.18390,-0.00356374490651813,0.00483805725764091,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC588440.1.1.m.4951,0.000388079360905712,-0.00109416766183969,No,NA,NA,Q6TUG0,NA,NA,NA,endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; nucleus [GO:0005634]; signaling receptor binding [GO:0005102]; unfolded protein binding [GO:0051082]; mRNA modification [GO:0016556]; negative regulation of neurogenesis [GO:0050768]; protein folding [GO:0006457]; protein maturation [GO:0051604],NA,NA,NA
CHOYP_LOC588549.1.2.m.1855,-0.001806243606952,0.00596727883032806,No,NA,NA,O75376,NA,NA,NA,cytosol [GO:0005829]; histone deacetylase complex [GO:0000118]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; nuclear hormone receptor binding [GO:0035257]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II regulatory region DNA binding [GO:0001012]; sequence-specific DNA binding [GO:0043565]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulatory region DNA binding [GO:0044212]; chromatin organization [GO:0006325]; circadian rhythm [GO:0007623]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of JNK cascade [GO:0046329]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of fatty acid transport [GO:2000191]; regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter [GO:0072362]; regulation of lipid metabolic process [GO:0019216]; regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter [GO:0072368]; spindle assembly [GO:0051225]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC588572.1.2.m.17892,-0.00689765397424422,0.00929164229021531,No,NA,NA,Q52KI8,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; spliceosomal complex [GO:0005681]; DNA binding [GO:0003677]; mRNA splicing; via spliceosome [GO:0000398]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_LOC588827.1.1.m.11601,-0.00349669649212218,-0.00812513359664436,No,NA,NA,Q8WV99,NA,NA,NA,anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; proteasome complex [GO:0000502]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; ubiquitin binding [GO:0043130]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein targeting to ER [GO:0045047]; regulation of insulin-like growth factor receptor signaling pathway [GO:0043567]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_LOC588883.2.3.m.14590,-0.00531444598720161,0.00514971987823643,No,NA,NA,E9QAT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588883.3.3.m.38321,-0.000194742454754523,0.00126481011783713,No,NA,NA,E9QAT4,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; organelle membrane [GO:0031090]; perinuclear region of cytoplasm [GO:0048471]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi to plasma membrane CFTR protein transport [GO:0043000]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to endoplasmic reticulum exit site [GO:0070973]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_LOC588932.3.3.m.35464,0.00933494765685915,0.00861838685391408,No,NA,NA,Q9UMZ2,NA,NA,NA,AP-1 adaptor complex [GO:0030121]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_LOC589108.1.2.m.9688,-0.00395062487234343,0.00226924712604591,No,NA,NA,Q4V7T8,NA,NA,NA,motile cilium [GO:0031514],NA,NA,NA
CHOYP_LOC589108.2.2.m.48073,0.00467545830335937,0.00183993550803746,No,NA,NA,Q969T9,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; chromatin DNA binding [GO:0031490]; estrogen receptor binding [GO:0030331]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coactivator activity [GO:0003713]; cellular response to estrogen stimulus [GO:0071391]; establishment of protein localization [GO:0045184]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of histone H3-K14 acetylation [GO:0071442]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; response to estrogen [GO:0043627]; response to progesterone [GO:0032570],NA,NA,NA
CHOYP_LOC589177.1.1.m.52878,-0.002455986337845,0.0025675852382166,No,NA,NA,Q5U2V4,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; hydrolase activity [GO:0016787]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC589201.1.1.m.59863,-0.00360528235650365,0.0024903309816336,No,NA,NA,F1N9Y5,NA,NA,NA,cytosol [GO:0005829]; early phagosome [GO:0032009]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; adaptive immune response [GO:0002250]; B cell receptor signaling pathway [GO:0050853]; blood vessel morphogenesis [GO:0048514]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to molecule of fungal origin [GO:0071226]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of mast cell degranulation [GO:0043306]; protein phosphorylation [GO:0006468]; regulation of arachidonic acid secretion [GO:0090237]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; serotonin secretion by platelet [GO:0002554],NA,NA,NA
CHOYP_LOC589390.1.1.m.11589,-0.00293901775395721,0.00398994219503792,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC589479.2.2.m.57247,-0.00616051611500572,4.75884514284129e-06,No,NA,NA,Q9JLI7,NA,NA,NA,axonemal central apparatus [GO:1990716]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; sperm principal piece [GO:0097228]; flagellated sperm motility [GO:0030317]; sperm axoneme assembly [GO:0007288]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_LOC589644.2.3.m.21781,-0.000507266020404866,0.0167704297611264,No,NA,NA,Q96RW7,NA,NA,NA,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; extracellular matrix structural constituent [GO:0005201]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; cell cycle [GO:0007049]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],NA,NA,NA
CHOYP_LOC589720.1.1.m.63687,-0.000354344736864814,0.00634790932894185,No,NA,NA,Q9UHV9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein binding involved in protein folding [GO:0044183]; unfolded protein binding [GO:0051082]; positive regulation of cytoskeleton organization [GO:0051495]; protein folding [GO:0006457],NA,NA,NA
CHOYP_LOC589750.3.5.m.42967,0,0,No,NA,NA,Q5F478,NA,NA,NA,,NA,NA,NA
CHOYP_LOC589839.1.1.m.29309,-0.00603495255906886,-0.00384062891140008,No,NA,NA,Q5XX13,NA,NA,NA,cytosol [GO:0005829]; ubiquitin-protein transferase activity [GO:0004842]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC589952.1.5.m.2235,-0.0221773736535958,0.0260285984261587,No,NA,NA,Q2TBI0,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.2.5.m.21623,-0.0105330630389816,0.013232660347055,No,NA,NA,Q2TBI0,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; lipopolysaccharide binding [GO:0001530]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipid transport [GO:0006869]; macrophage activation involved in immune response [GO:0002281]; positive regulation of tumor necrosis factor production [GO:0032760],NA,NA,NA
CHOYP_LOC589952.3.5.m.29284,-0.00859584020116336,-0.0104529148936917,No,NA,NA,Q61805,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC589952.4.5.m.31147,-0.0191338051513706,0.0127775371342933,No,NA,NA,Q61805,NA,NA,NA,cell surface [GO:0009986]; extracellular space [GO:0005615]; membrane [GO:0016020]; lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; signaling receptor binding [GO:0005102]; acute-phase response [GO:0006953]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of molecule of bacterial origin [GO:0032490]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; lipopolysaccharide transport [GO:0015920]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macromolecule localization [GO:0033036]; macrophage activation involved in immune response [GO:0002281]; negative regulation of growth of symbiont in host [GO:0044130]; negative regulation of tumor necrosis factor production [GO:0032720]; opsonization [GO:0008228]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytolysis [GO:0045919]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phagocytosis; engulfment [GO:0060100]; positive regulation of respiratory burst involved in inflammatory response [GO:0060265]; positive regulation of toll-like receptor 4 signaling pathway [GO:0034145]; positive regulation of tumor necrosis factor biosynthetic process [GO:0042535]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of membrane permeability [GO:0090559]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_LOC590125.6.7.m.53735,-0.00540566733553991,-0.00237557067464426,No,NA,NA,B3EWY9,NA,NA,NA,integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; ErbB-2 class receptor binding [GO:0005176]; extracellular matrix constituent; lubricant activity [GO:0030197]; cell-matrix adhesion [GO:0007160]; epithelial structure maintenance [GO:0010669]; regulation of signaling receptor activity [GO:0010469],NA,NA,NA
CHOYP_LOC590298.2.3.m.4191,0.0130394642539237,-0.00651956375328749,No,NA,NA,P80109,NA,NA,NA,cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intracellular membrane-bounded organelle [GO:0043231]; glycosylphosphatidylinositol phospholipase D activity [GO:0004621]; sodium channel regulator activity [GO:0017080]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to calcium ion [GO:0071277]; cellular response to cholesterol [GO:0071397]; cellular response to drug [GO:0035690]; cellular response to insulin stimulus [GO:0032869]; cellular response to pH [GO:0071467]; cellular response to triglyceride [GO:0071401]; chondrocyte differentiation [GO:0002062]; complement receptor mediated signaling pathway [GO:0002430]; GPI anchor release [GO:0006507]; insulin receptor signaling pathway [GO:0008286]; negative regulation of cell proliferation [GO:0008285]; negative regulation of triglyceride catabolic process [GO:0010897]; ossification [GO:0001503]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytolysis [GO:0045919]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of secretion [GO:0051047]; positive regulation of triglyceride biosynthetic process [GO:0010867]; regulation of cellular response to insulin stimulus [GO:1900076]; response to glucose [GO:0009749]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_LOC590567.1.1.m.29483,-0.0023362239522715,-0.0182375692992988,No,NA,NA,O02350,NA,NA,NA,extracellular space [GO:0005615]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270]; digestion [GO:0007586]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC590568.2.4.m.38593,0.00582436962198365,0.00342179447235517,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590633.1.1.m.32259,-0.014553928377193,-0.00730414352716096,No,NA,NA,Q3UMR0,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rab GTPase binding [GO:0017137]; SNARE binding [GO:0000149]; early endosome to late endosome transport [GO:0045022]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC590657.1.1.m.633,-0.00484857820659069,-0.00132472679459823,No,NA,NA,Q8BZ25,NA,NA,NA,ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674],NA,NA,NA
CHOYP_LOC590657.1.1.m.634,0.0146426571233973,-0.0160668627494406,No,NA,NA,Q6PIP5,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654],NA,NA,NA
CHOYP_LOC590729.1.1.m.35259,-0.0251255788519861,0.0194269733357964,No,NA,NA,Q2T9T9,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_LOC590756.2.6.m.28777,0.00622752136353767,-0.0031179561094288,No,NA,NA,Q86XZ4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC590756.3.6.m.40372,0.0107153788633765,-0.00313559316879449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC590756.4.6.m.48555,-0.0205481034426954,0.0158550046290371,No,NA,NA,A7MBP4,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; cilium assembly [GO:0060271]; determination of ventral identity [GO:0048264]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_LOC590931.1.1.m.7446,-0.0191183528866143,0.0110144469905284,No,NA,NA,Q6PGZ3,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; intraciliary transport particle B [GO:0030992]; microtubule binding [GO:0008017]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; pronephros development [GO:0048793]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113],NA,NA,NA
CHOYP_LOC590949.1.2.m.13540,-0.0102518375562289,0.00149115188941489,No,NA,NA,P27987,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; inositol-1;4;5-trisphosphate 3-kinase activity [GO:0008440]; cell surface receptor signaling pathway [GO:0007166]; cellular response to calcium ion [GO:0071277]; common myeloid progenitor cell proliferation [GO:0035726]; inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; inositol trisphosphate metabolic process [GO:0032957]; MAPK cascade [GO:0000165]; myeloid cell homeostasis [GO:0002262]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of neutrophil apoptotic process [GO:0033030]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of Ras protein signal transduction [GO:0046579]; positive thymic T cell selection [GO:0045059]; regulation of protein phosphorylation [GO:0001932]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC590969.1.1.m.15822,0.000731683610572902,0.00772842135924299,No,NA,NA,Q9Z160,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC590971.1.1.m.30661,0.00290404710181486,-0.00189492270811301,No,NA,NA,O43175,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; myelin sheath [GO:0043209]; electron transfer activity [GO:0009055]; L-malate dehydrogenase activity [GO:0030060]; NAD binding [GO:0051287]; phosphoglycerate dehydrogenase activity [GO:0004617]; brain development [GO:0007420]; cellular amino acid metabolic process [GO:0006520]; G1 to G0 transition [GO:0070314]; gamma-aminobutyric acid metabolic process [GO:0009448]; glial cell development [GO:0021782]; glutamine metabolic process [GO:0006541]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; neural tube development [GO:0021915]; neuron projection development [GO:0031175]; regulation of gene expression [GO:0010468]; spinal cord development [GO:0021510]; taurine metabolic process [GO:0019530]; threonine metabolic process [GO:0006566],NA,NA,NA
CHOYP_LOC590989.3.3.m.32047,0.00153099931279193,-0.00866689082744683,No,NA,NA,Q6J6I8,NA,NA,NA,BRCA1-A complex [GO:0070531]; BRCA1-BARD1 complex [GO:0031436]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA polymerase binding [GO:0070063]; transcription coactivator activity [GO:0003713]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; chordate embryonic development [GO:0043009]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of histone acetylation [GO:0035067]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of histone acetylation [GO:0035066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC591073.1.1.m.50375,-0.0197782218832012,-0.00903949101482169,No,NA,NA,Q5XHC1,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LOC591084.2.2.m.59355,0.00165350399259838,-0.00370373758426974,No,NA,NA,Q8BRH4,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; eyelid development in camera-type eye [GO:0061029]; histone methylation [GO:0016571]; multicellular organism growth [GO:0035264]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; single fertilization [GO:0007338],NA,NA,NA
CHOYP_LOC591177.1.1.m.1476,0.00748210375107668,-0.013242201644827,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC591426.1.1.m.19353,-0.00337913198671264,0.00478404172175629,No,NA,NA,Q9UGU0,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transcription regulatory region DNA binding [GO:0044212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC591426.1.1.m.19354,0.00503855856969202,-0.00643404798512679,No,NA,NA,Q9Y6D9,NA,NA,NA,centrosome [GO:0005813]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear pore nuclear basket [GO:0044615]; spindle [GO:0005819]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; kinetochore binding [GO:0043515]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of T cell proliferation [GO:0042130]; regulation of metaphase plate congression [GO:0090235]; thymus development [GO:0048538],NA,NA,NA
CHOYP_LOC591441.1.1.m.19965,0.0107215176029008,-0.00522258878856822,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_LOC591570.1.1.m.4767,-0.0028956089002019,-0.00323496286342571,No,NA,NA,Q2T9W3,NA,NA,NA,axoneme [GO:0005930]; cilium movement [GO:0003341]; outer dynein arm assembly [GO:0036158]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_LOC591690.1.1.m.30550,0.000848848396059013,-0.00166554098394329,No,NA,NA,Q4R4T9,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; intracellular transport [GO:0046907]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC591797.1.3.m.11526,-0.00841519029266776,-0.00869057478329938,No,NA,NA,Q60596,NA,NA,NA,ERCC4-ERCC1 complex [GO:0070522]; nuclear chromatin [GO:0000790]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; oxidized DNA binding [GO:0032356]; base-excision repair [GO:0006284]; cerebellum morphogenesis [GO:0021587]; DNA repair [GO:0006281]; double-strand break repair via nonhomologous end joining [GO:0006303]; hippocampus development [GO:0021766]; negative regulation of protection from non-homologous end joining at telomere [GO:1905765]; negative regulation of protein ADP-ribosylation [GO:0010836]; positive regulation of DNA ligase activity [GO:1904877]; positive regulation of single strand break repair [GO:1903518]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; response to drug [GO:0042493]; response to hydroperoxide [GO:0033194]; response to hypoxia [GO:0001666]; response to organic substance [GO:0010033]; single strand break repair [GO:0000012]; telomeric DNA-containing double minutes formation [GO:0061819]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC591797.1.3.m.11527,-0.00361801855067767,0.00286886252473091,No,NA,NA,P22232,NA,NA,NA,nucleolus [GO:0005730]; histone-glutamine methyltransferase activity [GO:1990259]; RNA binding [GO:0003723]; histone glutamine methylation [GO:1990258]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_LOC591898.1.2.m.28918,0.0192704324487071,-0.00974475685740705,No,NA,NA,P70684,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591898.2.2.m.29158,0.00269016469100063,0.0117469494501708,No,NA,NA,P70684,NA,NA,NA,cytoplasm [GO:0005737]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; prostaglandin metabolic process [GO:0006693]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_LOC591926.1.1.m.27235,-0.00626054928798835,0.0343902689289841,No,NA,NA,Q9H0U6,NA,NA,NA,extracellular space [GO:0005615]; mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; 5S rRNA binding [GO:0008097]; structural constituent of ribosome [GO:0003735]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126]; rRNA import into mitochondrion [GO:0035928]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC591968.1.1.m.37093,-0.000466945859065504,-0.000211731947384488,No,NA,NA,Q9DAZ9,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; midbody [GO:0030496]; metal ion binding [GO:0046872]; phosphatidylinositol-3-phosphate binding [GO:0032266]; abscission [GO:0009838]; cell division [GO:0051301]; mitotic cytokinesis checkpoint [GO:0044878]; negative regulation of cytokinesis [GO:0032466],NA,NA,NA
CHOYP_LOC592001.1.1.m.43470,-0.00119915239036793,0.0195254964747843,No,NA,NA,Q9UPU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_LOC592006.1.1.m.18498,0.00174045119025916,-0.00470906271276003,No,NA,NA,Q96AJ9,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; neuron projection terminus [GO:0044306]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagy [GO:0006914]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi ribbon formation [GO:0090161]; Golgi to vacuole transport [GO:0006896]; intra-Golgi vesicle-mediated transport [GO:0006891]; protein targeting to vacuole [GO:0006623]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion with Golgi apparatus [GO:0048280]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_LOC592013.1.1.m.20072,-0.00878712371293488,-0.0253596823286014,No,NA,NA,Q9HAS0,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; trans-Golgi network [GO:0005802]; intracellular protein transport [GO:0006886]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_LOC592142.4.9.m.49474,-0.0272009601750507,0.00284815094044156,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.5.9.m.53066,-0.010977341558817,-0.0225124024922104,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.6.9.m.54976,-0.00416730713682708,-0.0023436122220989,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592142.7.9.m.55467,-0.00402728184665159,-0.00249705964075206,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC592215.1.1.m.34856,-0.00231342032844187,0.00693430946636349,No,NA,NA,Q8R2E9,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide isomerase activity [GO:0003756]; protein disulfide oxidoreductase activity [GO:0015035]; 4-hydroxyproline metabolic process [GO:0019471]; cell redox homeostasis [GO:0045454]; extracellular matrix organization [GO:0030198]; glucose homeostasis [GO:0042593]; insulin processing [GO:0030070]; protein folding in endoplasmic reticulum [GO:0034975]; protein maturation by protein folding [GO:0022417],NA,NA,NA
CHOYP_LOC592357.1.1.m.27228,-0.00207513362529625,-8.49044853590172e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC592411.1.1.m.19664,-0.0159398898786814,0.0130088206365592,No,NA,NA,Q6NUB2,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC592528.1.2.m.17290,0.0192596987210865,-0.00725557239727297,No,NA,NA,O88545,NA,NA,NA,COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; protein deneddylation [GO:0000338],NA,NA,NA
CHOYP_LOC592585.1.1.m.51309,0.00525330912938081,-0.00293536813913541,No,NA,NA,P16444,NA,NA,NA,anchored component of membrane [GO:0031225]; apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; microvillus membrane [GO:0031528]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dipeptidase activity [GO:0016805]; dipeptidyl-peptidase activity [GO:0008239]; GPI anchor binding [GO:0034235]; metallodipeptidase activity [GO:0070573]; metalloexopeptidase activity [GO:0008235]; modified amino acid binding [GO:0072341]; zinc ion binding [GO:0008270]; antibiotic metabolic process [GO:0016999]; cellular lactam catabolic process [GO:0072340]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to nitric oxide [GO:0071732]; glutathione metabolic process [GO:0006749]; homocysteine metabolic process [GO:0050667]; leukotriene metabolic process [GO:0006691]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell migration [GO:0030336]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC592624.1.1.m.45639,-0.021995904299949,-0.0172653720869195,No,NA,NA,Q32PH2,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_LOC592709.1.1.m.22553,-0.0149335917565444,-0.0002572651824711,No,NA,NA,A6NCI4,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC592745.1.1.m.47718,0.0128510288781191,0.0130086269463932,No,NA,NA,Q10002,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; 3'-tyrosyl-DNA phosphodiesterase activity [GO:0017005]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO:0008311]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_LOC592825.1.1.m.43751,-0.00982827610067615,0.013868171147368,No,NA,NA,Q5RBB1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; SUMO-specific isopeptidase activity [GO:0070140]; protein desumoylation [GO:0016926],NA,NA,NA
CHOYP_LOC592857.1.1.m.62834,-0.0213985775736631,0.00907661625598575,No,NA,NA,B2RC85,NA,NA,NA,,NA,NA,NA
CHOYP_LOC592888.1.1.m.63240,0.00954927048456234,-0.0185806336436285,No,NA,NA,Q6DFB7,NA,NA,NA,centriole [GO:0005814]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_LOC592990.1.1.m.17663,0.000649002861584178,0.00141474190498416,No,NA,NA,Q99L04,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_LOC593134.1.1.m.29711,-0.0217102485998965,0.0167007251925575,No,NA,NA,O88630,NA,NA,NA,cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; regulation of vesicle targeting; to; from or within Golgi [GO:0048209]; retrograde transport; endosome to Golgi [GO:0042147]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_LOC593247.1.1.m.56872,0.0103413953664942,-0.0125392447460961,No,NA,NA,Q9HU55,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_LOC593338.1.2.m.31413,-0.0099147213616015,-0.00184450305721163,No,NA,NA,Q18297,NA,NA,NA,integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; non-motile cilium [GO:0097730]; plasma membrane [GO:0005886]; ion channel activity [GO:0005216]; response to stimulus [GO:0050896],NA,NA,NA
CHOYP_LOC593467.2.4.m.66724,0.0163840261392978,0.0038663494427506,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_LOC593522.1.2.m.5381,-0.00273125010972158,0.00012002140658253,No,NA,NA,P23246,NA,NA,NA,chromatin [GO:0000785]; dendrite cytoplasm [GO:0032839]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382]; RNA polymerase II transcription factor complex [GO:0090575]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; E-box binding [GO:0070888]; histone deacetylase binding [GO:0042826]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; dendritic transport of messenger ribonucleoprotein complex [GO:0098963]; double-strand break repair via homologous recombination [GO:0000724]; histone H3 deacetylation [GO:0070932]; innate immune response [GO:0045087]; mRNA processing [GO:0006397]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902177]; positive regulation of sister chromatid cohesion [GO:0045876]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of circadian rhythm [GO:0042752]; rhythmic process [GO:0048511]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC593522.2.2.m.33858,-0.00201192461079759,0.0084878947296047,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC593529.1.1.m.59343,-0.00582161933980315,0.0185070130368043,No,NA,NA,Q4KM30,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC593558.3.4.m.36843,1.78356762395802e-05,-9.59159661907111e-05,No,NA,NA,B6RSP1,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; zonula adherens [GO:0005915]; delta-catenin binding [GO:0070097]; cardiac muscle cell differentiation [GO:0055007]; epithelial cell-cell adhesion [GO:0090136]; regulation of heart contraction [GO:0008016]; zonula adherens maintenance [GO:0045218],NA,NA,NA
CHOYP_LOC593741.1.1.m.11514,-0.00224120567763317,-0.000255341778486936,No,NA,NA,Q567I9,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC594038.1.1.m.8864,0.0155754489879777,0.000273731655719514,No,NA,NA,B0WIW5,NA,NA,NA,,NA,NA,NA
CHOYP_LOC594130.1.1.m.48747,-0.00115024084417623,-0.00199787790553477,No,NA,NA,P32755,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; 4-hydroxyphenylpyruvate dioxygenase activity [GO:0003868]; metal ion binding [GO:0046872]; L-phenylalanine catabolic process [GO:0006559]; tyrosine catabolic process [GO:0006572],NA,NA,NA
CHOYP_LOC594151.1.2.m.7270,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594176.1.1.m.9662,-0.0160375339662798,-0.00883126796114642,No,NA,NA,Q14186,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription factor complex [GO:0090575]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein domain specific binding [GO:0019904]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; anoikis [GO:0043276]; cell proliferation [GO:0008283]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epidermis development [GO:0008544]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of G0 to G1 transition [GO:0070317]; positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway [GO:1900740]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA biosynthetic process [GO:2000278]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0000083],NA,NA,NA
CHOYP_LOC594315.1.1.m.28047,0.00152830145470719,0.000152213402728752,No,NA,NA,Q78PY7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dense body [GO:0097433]; melanosome [GO:0042470]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; RISC complex [GO:0016442]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; nuclease activity [GO:0004518]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; miRNA catabolic process [GO:0010587]; regulation of cell cycle process [GO:0010564]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_LOC594379.1.1.m.55370,-0.00100703348148251,0.00444493155880957,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC594407.1.1.m.38463,-0.00134882974219788,-0.00254708548647258,No,NA,NA,Q8BWQ6,NA,NA,NA,early endosome [GO:0005769]; integral component of membrane [GO:0016021]; Golgi to plasma membrane transport [GO:0006893]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC594533.1.1.m.58830,0.00497923086734178,-0.00903970702399925,No,NA,NA,Q8IYE1,NA,NA,NA,cell projection [GO:0042995]; centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; cellular response to DNA damage stimulus [GO:0006974]; cytoplasmic microtubule organization [GO:0031122]; non-motile cilium assembly [GO:1905515],NA,NA,NA
CHOYP_LOC594590.1.2.m.10772,-0.0189432319408999,0.0221779373908159,No,NA,NA,B5XGE7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888],NA,NA,NA
CHOYP_LOC594665.1.1.m.8448,0.00533312894720897,0.00111991489711574,No,NA,NA,P16435,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrion [GO:0005739]; cytochrome-b5 reductase activity; acting on NAD(P)H [GO:0004128]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; hydrolase activity [GO:0016787]; iron-cytochrome-c reductase activity [GO:0047726]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric oxide dioxygenase activity [GO:0008941]; oxidoreductase activity [GO:0016491]; carnitine metabolic process [GO:0009437]; cellular organofluorine metabolic process [GO:0090346]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to peptide hormone stimulus [GO:0071375]; demethylation [GO:0070988]; fatty acid oxidation [GO:0019395]; flavonoid metabolic process [GO:0009812]; internal peptidyl-lysine acetylation [GO:0018393]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of lipase activity [GO:0060192]; nitrate catabolic process [GO:0043602]; nitric oxide catabolic process [GO:0046210]; oxidation-reduction process [GO:0055114]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of steroid hormone biosynthetic process [GO:0090031]; regulation of growth plate cartilage chondrocyte proliferation [GO:0003420]; response to drug [GO:0042493]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC594665.1.1.m.8449,-0.000730421676613638,-2.92984754127999e-05,No,NA,NA,O77622,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cytosol [GO:0005829]; microtubule [GO:0005874]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; WD40-repeat domain binding [GO:0071987]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC594676.1.1.m.8936,0.00689688350747757,-0.00182926967241578,No,NA,NA,Q5BKR2,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; endosome membrane [GO:0010008]; integral component of membrane [GO:0016021]; intracellular vesicle [GO:0097708]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; plasma membrane [GO:0005886]; sperm principal piece [GO:0097228]; synaptic vesicle membrane [GO:0030672]; identical protein binding [GO:0042802]; lithium:proton antiporter activity [GO:0010348]; sodium:proton antiporter activity [GO:0015385]; clathrin-dependent endocytosis [GO:0072583]; flagellated sperm motility [GO:0030317]; positive regulation of osteoclast development [GO:2001206]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_LOC654860.3.3.m.63750,-0.00069365679919809,-0.00115618569856485,No,NA,NA,Q13492,NA,NA,NA,cell surface [GO:0009986]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; intrinsic component of membrane [GO:0031224]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; vesicle [GO:0031982]; 1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; Rab GTPase binding [GO:0017137]; tau protein binding [GO:0048156]; amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; cargo loading into vesicle [GO:0035459]; cell proliferation [GO:0008283]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; iron ion homeostasis [GO:0055072]; iron ion import across plasma membrane [GO:0098711]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; membrane organization [GO:0061024]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of gene expression [GO:0010629]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron death [GO:1901216]; positive regulation of transcription; DNA-templated [GO:0045893]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902959]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC654949.1.1.m.9313,-0.00688670748726709,0.007385925637677,No,NA,NA,O74503,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; RNA polymerase I upstream activating factor complex [GO:0000500]; RNA polymerase I general transcription initiation factor activity [GO:0001181]; transcription initiation from RNA polymerase I promoter [GO:0006361],NA,NA,NA
CHOYP_LOC654994.1.1.m.39461,-0.00643350130609316,0.00220380193422837,No,NA,NA,Q9VLN1,NA,NA,NA,histone methyltransferase complex [GO:0035097]; PTW/PP1 phosphatase complex [GO:0072357]; Set1C/COMPASS complex [GO:0048188]; chromatin binding [GO:0003682]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182],NA,NA,NA
CHOYP_LOC655520.2.2.m.14178,-0.00296252028115513,0.00464892377334205,No,NA,NA,Q9NQC3,NA,NA,NA,cell projection [GO:0042995]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; endoplasmic reticulum tubular network membrane [GO:0098826]; integral component of endoplasmic reticulum membrane [GO:0030176]; intracellular [GO:0005622]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; blastocyst formation [GO:0001825]; cardiac epithelial to mesenchymal transition [GO:0060317]; cerebral cortex radial glia guided migration [GO:0021801]; endoplasmic reticulum tubular network formation [GO:0071787]; endoplasmic reticulum tubular network membrane organization [GO:1990809]; endoplasmic reticulum tubular network organization [GO:0071786]; negative regulation of axon extension [GO:0030517]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cell growth [GO:0030308]; nuclear pore complex assembly [GO:0051292]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERBB3 signaling pathway [GO:1905580]; positive regulation of mammary gland epithelial cell proliferation [GO:0033601]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to endoplasmic reticulum [GO:1905552]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of branching morphogenesis of a nerve [GO:2000172]; regulation of cell migration [GO:0030334],NA,NA,NA
CHOYP_LOC655529.1.3.m.1225,-0.00160802995303824,-0.00592422473062129,No,NA,NA,Q8NI08,NA,NA,NA,intracellular [GO:0005622]; nucleus [GO:0005634]; nuclear hormone receptor binding [GO:0035257]; nuclear receptor transcription coactivator activity [GO:0030374]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of peptidyl-cysteine S-nitrosylation [GO:1902083]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC655570.1.2.m.9210,-0.0159223926671448,0.00202869547851607,No,NA,NA,Q49GP5,NA,NA,NA,endosome [GO:0005768]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; ATP binding [GO:0005524]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; pectoral fin development [GO:0033339]; phosphatidylinositol phosphorylation [GO:0046854],NA,NA,NA
CHOYP_LOC656201.1.1.m.8657,-0.00458490998048284,0.00401559968073767,No,NA,NA,Q13148,NA,NA,NA,cytoplasm [GO:0005737]; interchromatin granule [GO:0035061]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; identical protein binding [GO:0042802]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded RNA binding [GO:0003727]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA processing [GO:0006397]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of gene expression [GO:0010629]; negative regulation of protein phosphorylation [GO:0001933]; nuclear inner membrane organization [GO:0071765]; positive regulation of insulin secretion [GO:0032024]; positive regulation of protein import into nucleus [GO:0042307]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; response to endoplasmic reticulum stress [GO:0034976]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_LOC656402.1.1.m.62053,0.00319495498272745,0.000568038190079585,No,NA,NA,Q9R062,NA,NA,NA,glucose binding [GO:0005536]; glycogenin glucosyltransferase activity [GO:0008466]; manganese ion binding [GO:0030145]; protein homodimerization activity [GO:0042803]; UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity [GO:0102751]; glycogen biosynthetic process [GO:0005978],NA,NA,NA
CHOYP_LOC656459.1.1.m.34956,-0.0129003258283261,-0.0225517366711505,No,NA,NA,B7ZMP1,NA,NA,NA,mitochondrion [GO:0005739]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; glomerular filtration [GO:0003094]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC656615.1.1.m.66274,-2.81587041721138e-05,0.00373598244816778,No,NA,NA,Q6GPD0,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; GTPase activator activity [GO:0005096]; phosphatidylinositol binding [GO:0035091]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_LOC656702.1.1.m.14425,0.00431985873505675,-0.000510806146817972,No,NA,NA,Q13045,NA,NA,NA,brush border [GO:0005903]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; microtubule organizing center [GO:0005815]; nucleoplasm [GO:0005654]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036]; actin filament severing [GO:0051014]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC656867.1.1.m.28658,0.000133114308969398,-0.0015433112003701,No,NA,NA,Q6P799,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; serine-tRNA ligase activity [GO:0004828]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular endothelial growth factor production [GO:1904046]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; seryl-tRNA aminoacylation [GO:0006434],NA,NA,NA
CHOYP_LOC656899.1.1.m.15417,-0.000768257601919304,0.00140604614405273,No,NA,NA,Q6NSR8,NA,NA,NA,cytoplasm [GO:0005737]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloexopeptidase activity [GO:0008235],NA,NA,NA
CHOYP_LOC657235.1.1.m.1711,-0.00190548963622311,-0.0239484998183304,No,NA,NA,Q9V3J1,NA,NA,NA,plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; determination of adult lifespan [GO:0008340]; dsRNA transport [GO:0033227],NA,NA,NA
CHOYP_LOC657327.1.1.m.54811,-0.00458252311195677,0.000148494725576631,No,NA,NA,M9NDE3,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; tricellular tight junction [GO:0061689]; carbohydrate binding [GO:0030246]; scavenger receptor activity [GO:0005044]; cell-cell junction maintenance [GO:0045217]; establishment of endothelial intestinal barrier [GO:0090557]; liquid clearance; open tracheal system [GO:0035002]; regulation of tube length; open tracheal system [GO:0035159]; response to endoplasmic reticulum stress [GO:0034976]; tricellular tight junction assembly [GO:1904274],NA,NA,NA
CHOYP_LOC657378.1.1.m.14648,-0.0197197923036385,0.0250347605586613,No,NA,NA,Q08509,NA,NA,NA,brush border [GO:0005903]; cell cortex [GO:0005938]; cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ruffle membrane [GO:0032587]; stereocilium [GO:0032420]; stereocilium bundle [GO:0032421]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin binding [GO:0003779]; Rac GTPase binding [GO:0048365]; signaling adaptor activity [GO:0035591]; actin crosslink formation [GO:0051764]; actin cytoskeleton reorganization [GO:0031532]; actin filament bundle assembly [GO:0051017]; actin polymerization-dependent cell motility [GO:0070358]; adult locomotory behavior [GO:0008344]; barbed-end actin filament capping [GO:0051016]; behavioral response to ethanol [GO:0048149]; cellular response to leukemia inhibitory factor [GO:1990830]; dendritic cell migration [GO:0036336]; exit from mitosis [GO:0010458]; positive regulation of ruffle assembly [GO:1900029]; Rac protein signal transduction [GO:0016601]; regulation of actin filament length [GO:0030832]; regulation of cell shape [GO:0008360]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of Rho protein signal transduction [GO:0035023]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC657466.1.1.m.38710,-0.0147114191889429,-0.01651423797001,No,NA,NA,Q95KE5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_LOC657473.1.1.m.55374,-0.00468385176260923,0.0038046890453608,No,NA,NA,O55203,NA,NA,NA,cell leading edge [GO:0031252]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transcription factor complex [GO:0005667]; enzyme binding [GO:0019899]; LIM domain binding [GO:0030274]; RNA polymerase II activating transcription factor binding [GO:0001102]; transcription coregulator activity [GO:0003712]; epithelial structure maintenance [GO:0010669]; hair follicle development [GO:0001942]; multicellular organism development [GO:0007275]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of cellular component biogenesis [GO:0044089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of kinase activity [GO:0043549]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_LOC657674.1.1.m.21821,0.0110821856475756,0.00683088935604363,No,NA,NA,B0FYY4,NA,NA,NA,cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; invadopodium membrane [GO:0071438]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome [GO:0055037]; ruffle membrane [GO:0032587]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of protein localization to plasma membrane [GO:1903078]; receptor internalization [GO:0031623]; regulation of collagen catabolic process [GO:0010710],NA,NA,NA
CHOYP_LOC657811.1.1.m.29214,0.00592345198438596,-0.00320409238289731,No,NA,NA,Q08D57,NA,NA,NA,chromosome [GO:0005694]; nuclear speck [GO:0016607]; Set1C/COMPASS complex [GO:0048188]; histone-lysine N-methyltransferase activity [GO:0018024]; RNA binding [GO:0003723]; histone H3-K4 methylation [GO:0051568],NA,NA,NA
CHOYP_LOC658003.1.1.m.29101,0.00275221745101975,-0.00603604776740946,No,NA,NA,Q7ZWP1,NA,NA,NA,cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_LOC658092.1.2.m.22901,-0.000978488280911244,0.000962810129122517,No,NA,NA,Q58DA0,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome assembly [GO:0043248]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_LOC658092.2.2.m.60940,-0.00150424658759754,-0.00132798937213643,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_LOC658201.1.1.m.42880,0.0018304800837984,0.00858304700132425,No,NA,NA,P22488,NA,NA,NA,cytoplasm [GO:0005737]; intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_LOC658242.1.1.m.41709,-0.0041605668728834,0.000853747352081874,No,NA,NA,Q9UQ03,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; membrane [GO:0016020]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin cytoskeleton organization [GO:0030036],NA,NA,NA
CHOYP_LOC658248.1.1.m.11054,-0.0109675691389839,0.00684078661543057,No,NA,NA,Q5FWY5,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; aryl hydrocarbon receptor binding [GO:0017162]; GAF domain binding [GO:0036004]; transcription coregulator activity [GO:0003712]; unfolded protein binding [GO:0051082]; negative regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051344]; protein maturation by protein folding [GO:0022417]; protein targeting to mitochondrion [GO:0006626]; regulation of protein kinase A signaling [GO:0010738]; xenobiotic metabolic process [GO:0006805],NA,NA,NA
CHOYP_LOC658280.1.1.m.18469,-0.00248818454700327,0.00249094571315537,No,NA,NA,Q6TH22,NA,NA,NA,cytosol [GO:0005829]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; ubiquitin binding [GO:0043130]; protein processing [GO:0016485],NA,NA,NA
CHOYP_LOC658414.1.3.m.6219,-0.00830689372636225,0.0124280386585565,No,NA,NA,Q9HCD6,NA,NA,NA,glutamatergic synapse [GO:0098978]; postsynaptic density; intracellular component [GO:0099092]; in utero embryonic development [GO:0001701],NA,NA,NA
CHOYP_LOC658593.1.1.m.25202,-0.0163250473247141,0.0124164358073076,No,NA,NA,P56380,NA,NA,NA,mitochondrion [GO:0005739]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; GTP binding [GO:0005525]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_LOC658611.1.1.m.11239,0.00397002559573782,-0.00787243726719701,No,NA,NA,Q96PE2,NA,NA,NA,cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_LOC658640.1.2.m.36016,0.00484519429300496,0.020774509989971,No,NA,NA,A0A0F7YYX3,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658640.2.2.m.56941,-0.00306327915379262,0.0120068159816004,No,NA,NA,A0A0F7YYX3,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC658895.1.1.m.20262,-0.00014933620827712,0.000836262082369092,No,NA,NA,Q8BFR5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; synapse [GO:0045202]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation elongation factor activity [GO:0003746]; mitochondrial translational elongation [GO:0070125]; response to ethanol [GO:0045471]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_LOC659024.1.2.m.31136,-0.000406754911096557,0.000982226756537025,No,NA,NA,P70318,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; AU-rich element binding [GO:0017091]; DNA binding [GO:0003677]; apoptotic process [GO:0006915]; germ cell development [GO:0007281]; positive regulation of cell proliferation [GO:0008284]; stem cell division [GO:0017145],NA,NA,NA
CHOYP_LOC659206.1.6.m.3536,0.000808376378995295,0.000730935042930547,No,NA,NA,P62890,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; ribosome [GO:0005840]; RNA binding [GO:0003723]; selenocysteine insertion sequence binding [GO:0035368]; structural constituent of ribosome [GO:0003735]; liver regeneration [GO:0097421]; positive regulation of selenocysteine incorporation [GO:1904571]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC659206.6.6.m.43541,0.0184068473709264,0.00795182210626488,No,NA,NA,P02466,NA,NA,NA,collagen type I trimer [GO:0005584]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]; cellular response to organic substance [GO:0071310]; cellular response to retinoic acid [GO:0071300]; cellular response to thyroid hormone stimulus [GO:0097067]; extracellular matrix organization [GO:0030198]; response to norepinephrine [GO:0071873],NA,NA,NA
CHOYP_LOC659226.1.3.m.16864,-0.0013896020985302,0.00367425272349587,No,NA,NA,Q26636,NA,NA,NA,lysosome [GO:0005764]; cysteine-type peptidase activity [GO:0008234]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC659306.1.1.m.11580,-0.0024839365822856,-0.00155337032081257,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC659398.1.1.m.9611,-0.00342049095330657,0.00121746159426172,No,NA,NA,Q7ZVR8,NA,NA,NA,nucleus [GO:0005634]; mRNA binding [GO:0003729]; mRNA processing [GO:0006397]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_LOC659409.1.1.m.24437,-0.0200578378848994,-0.000406731805053948,No,NA,NA,Q96PX1,NA,NA,NA,cell body [GO:0044297]; cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; negative regulation of apoptotic process [GO:0043066]; positive regulation of dendrite extension [GO:1903861],NA,NA,NA
CHOYP_LOC659512.1.4.m.6122,-0.0048424320623453,0.00327012053604723,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.3.4.m.26463,0.00841726941633024,0.00318709892491744,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659512.4.4.m.31246,0.00255347218478378,0.000558418378520871,No,NA,NA,Q5R941,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; calcium ion binding [GO:0005509]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755],NA,NA,NA
CHOYP_LOC659617.1.1.m.23473,-0.000312153244698641,-0.0128675220078229,No,NA,NA,Q6PB03,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; N-acylphosphatidylethanolamine-specific phospholipase D activity [GO:0070290]; phospholipase D activity [GO:0004630]; lipid catabolic process [GO:0016042],NA,NA,NA
CHOYP_LOC659702.1.1.m.7231,-0.00685365435586943,-0.0121460193229629,No,NA,NA,P56377,NA,NA,NA,AP-type membrane coat adaptor complex [GO:0030119]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; trans-Golgi network membrane [GO:0032588]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; intracellular protein transport [GO:0006886]; regulation of defense response to virus by virus [GO:0050690]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_LOC659901.1.1.m.348,-0.0142570081668432,-0.00907312480416472,No,NA,NA,Q5C9Z4,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; RNA binding [GO:0003723]; hair follicle maturation [GO:0048820]; ribosomal small subunit biogenesis [GO:0042274],NA,NA,NA
CHOYP_LOC659964.1.1.m.25995,0,0,No,NA,NA,Q9V439,NA,NA,NA,chromatin [GO:0000785]; mediator complex [GO:0016592]; nucleolus [GO:0005730]; nucleus [GO:0005634]; transcription coregulator activity [GO:0003712]; mitotic cell cycle [GO:0000278]; negative regulation of neuroblast proliferation [GO:0007406]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription from RNA polymerase II promoter involved in spermatogenesis [GO:1902064],NA,NA,NA
CHOYP_LOC660067.1.1.m.20126,0.00465645645702794,0.0149093794964119,No,NA,NA,Q9DBE9,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; rRNA (guanine) methyltransferase activity [GO:0016435]; rRNA (uridine-2'-O-)-methyltransferase activity [GO:0008650]; enzyme-directed rRNA 2'-O-methylation [GO:0000453]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; rRNA methylation [GO:0031167],NA,NA,NA
CHOYP_LOC660183.1.1.m.8143,-0.00658989327929444,0.00911673430403977,No,NA,NA,Q62902,NA,NA,NA,COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; mannose binding [GO:0005537]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC660225.1.1.m.35196,0.00384618080071529,0.00454224058078246,No,NA,NA,C3YWU0,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; alpha-L-fucosidase activity [GO:0004560]; fucose metabolic process [GO:0006004]; glycoside catabolic process [GO:0016139],NA,NA,NA
CHOYP_LOC660225.1.1.m.35197,-0.00269452150494294,-0.0044102249095897,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660338.1.1.m.33595,0.00361894080141362,0.00484454352232824,No,NA,NA,Q91W90,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; isomerase activity [GO:0016853]; apoptotic cell clearance [GO:0043277]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_LOC660381.1.1.m.6379,-0.000626013042006249,-0.00354101380761761,No,NA,NA,Q9VRP9,NA,NA,NA,nucleus [GO:0005634]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; histone modification [GO:0016570]; histone monoubiquitination [GO:0010390]; histone ubiquitination [GO:0016574]; Notch signaling pathway [GO:0007219]; protein monoubiquitination [GO:0006513],NA,NA,NA
CHOYP_LOC660501.1.2.m.5218,-0.0217283755574935,-0.0125248005052958,No,NA,NA,Q9W436,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660501.2.2.m.19155,-0.00714941113110189,-0.00284607121675432,No,NA,NA,Q9W436,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_LOC660510.1.1.m.56258,0.0124587090506566,-0.00564116422933256,No,NA,NA,Q8BHR2,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; nucleic acid binding [GO:0003676]; oxidoreductase activity [GO:0016491]; ultradian rhythm [GO:0007624],NA,NA,NA
CHOYP_LOC660560.1.4.m.31035,0.00640413170315091,-0.0116265897047059,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC660560.1.4.m.31036,0.00243412476772215,-0.00129616992192596,No,NA,NA,P39872,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; structural constituent of ribosome [GO:0003735]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC660560.4.4.m.54542,0,0,No,NA,NA,Q5T0B9,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC660590.1.1.m.26950,0.00486462177376724,0.0186010930524058,No,NA,NA,Q2T9U5,NA,NA,NA,nucleolus [GO:0005730]; exonuclease activity [GO:0004527]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_LOC660684.1.1.m.28592,-0.00780420017853274,-0.00599355051251994,No,NA,NA,Q949P2,NA,NA,NA,apoplast [GO:0048046]; chloroplast [GO:0009507]; cytosol [GO:0005829]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508]; response to cadmium ion [GO:0046686],NA,NA,NA
CHOYP_LOC660898.1.1.m.38632,-0.00138207476247665,5.83756397031018e-05,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC661043.1.1.m.11553,-0.00209746879945487,0.00372748357103147,No,NA,NA,P14543,NA,NA,NA,basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin binding [GO:0043236]; laminin-1 binding [GO:0043237]; proteoglycan binding [GO:0043394]; basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; extracellular matrix organization [GO:0030198]; glomerular basement membrane development [GO:0032836]; positive regulation of cell-substrate adhesion [GO:0010811],NA,NA,NA
CHOYP_LOC661226.1.1.m.62936,0.00481919072559916,-0.00222164705713842,No,NA,NA,Q16658,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; growth cone [GO:0030426]; invadopodium [GO:0071437]; lamellipodium [GO:0030027]; microspike [GO:0044393]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; podosome [GO:0002102]; ruffle [GO:0001726]; stress fiber [GO:0001725]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; drug binding [GO:0008144]; protein binding; bridging [GO:0030674]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cell motility [GO:0048870]; cell proliferation [GO:0008283]; cell-cell junction assembly [GO:0007043]; cytokine-mediated signaling pathway [GO:0019221]; establishment of apical/basal cell polarity [GO:0035089]; establishment or maintenance of cell polarity [GO:0007163]; microspike assembly [GO:0030035]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of podosome assembly [GO:0071803]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of microvillus assembly [GO:0032534],NA,NA,NA
CHOYP_LOC661306.1.3.m.11419,0.00509250669755151,0.00380502695188986,No,NA,NA,Q9VX32,NA,NA,NA,cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activator activity [GO:0005096]; GTPase activity [GO:0003924]; semaphorin receptor binding [GO:0030215]; defasciculation of motor neuron axon [GO:0007415]; mushroom body development [GO:0016319]; negative regulation of cell size [GO:0045792]; regulation of axonogenesis [GO:0050770]; Rho protein signal transduction [GO:0007266],NA,NA,NA
CHOYP_LOC661626.1.1.m.53878,-0.00669796239524414,0.00876998800739473,No,NA,NA,Q8BH75,NA,NA,NA,endoplasmic reticulum tubular network [GO:0071782]; perinuclear region of cytoplasm [GO:0048471]; erythropoietin receptor binding [GO:0005128]; interleukin-3 receptor binding [GO:0005135]; protein domain specific binding [GO:0019904]; Ral GTPase binding [GO:0017160]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; autophagy [GO:0006914]; extrinsic apoptotic signaling pathway [GO:0097191]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of mitophagy [GO:1901525]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; proteasomal protein catabolic process [GO:0010498]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of lymphocyte differentiation [GO:0045619]; regulation of MAPK cascade [GO:0043408]; regulation of myeloid cell differentiation [GO:0045637]; regulation of protein kinase B signaling [GO:0051896]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_LOC661769.1.1.m.10866,0.0181861873374358,0.00655642832497372,No,NA,NA,Q3SYS1,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; ribosome [GO:0005840]; mRNA binding [GO:0003729]; structural constituent of ribosome [GO:0003735]; negative regulation of translation [GO:0017148]; translation [GO:0006412],NA,NA,NA
CHOYP_LOC661829.1.1.m.64858,-0.00506310497152459,0.00552559853153939,No,NA,NA,C0H906,NA,NA,NA,cytoplasm [GO:0005737]; nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; 7-methylguanosine mRNA capping [GO:0006370]; gene silencing by RNA [GO:0031047]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_LOC661955.1.1.m.37858,-0.0145270181651731,-0.0178134581481385,No,NA,NA,Q5R4R9,NA,NA,NA,membrane [GO:0016020]; mitochondrion [GO:0005739]; calmodulin binding [GO:0005516]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC662072.1.1.m.51458,-0.0127550891767471,0.0250475566185829,No,NA,NA,Q10131,NA,NA,NA,endoplasmic reticulum [GO:0005783]; calcium ion binding [GO:0005509]; calcium ion regulated exocytosis [GO:0017156],NA,NA,NA
CHOYP_LOC662115.2.2.m.15477,0.00330122177460708,0.000429294658443286,No,NA,NA,O60841,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743]; regulation of translational initiation [GO:0006446],NA,NA,NA
CHOYP_LOC662190.1.3.m.1532,0.00185510100817357,0.00143421364460219,No,NA,NA,Q9R050,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662190.3.3.m.62554,0.000824285010244308,0.00283369538286685,No,NA,NA,Q9R050,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; head development [GO:0060322]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC662211.1.1.m.23378,-0.00739182391465927,0.0101673978124216,No,NA,NA,Q13905,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; protein-containing complex [GO:0032991]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rap guanyl-nucleotide exchange factor activity [GO:0017034]; SH3 domain binding [GO:0017124]; activation of GTPase activity [GO:0090630]; activation of MAPKK activity [GO:0000186]; blood vessel development [GO:0001568]; cell-cell adhesion [GO:0098609]; cellular response to cAMP [GO:0071320]; cellular response to nerve growth factor stimulus [GO:1990090]; cytokine-mediated signaling pathway [GO:0019221]; establishment of endothelial barrier [GO:0061028]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Ras protein signal transduction [GO:0046580]; nerve growth factor signaling pathway [GO:0038180]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of GTPase activity [GO:0043547]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; Rap protein signal transduction [GO:0032486]; regulation of cell junction assembly [GO:1901888]; regulation of JNK cascade [GO:0046328]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_LOC662241.1.1.m.66905,-0.0043346440192634,0.0191036404550049,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC662320.1.2.m.18374,-0.00930653687466665,0.0171621121071877,No,NA,NA,Q66II8,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619]; hematopoietic stem cell differentiation [GO:0060218]; mRNA splicing; via spliceosome [GO:0000398]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_LOC662320.2.2.m.19454,-0.0140455823567992,0.00649820810327953,No,NA,NA,Q42404,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; mRNA binding [GO:0003729]; U1 snRNA binding [GO:0030619]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_LOC662357.1.1.m.64851,-0.00976945244849548,0.0109238587929455,No,NA,NA,Q961D9,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; canonical Wnt signaling pathway [GO:0060070]; chitin-based larval cuticle pattern formation [GO:0035293]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; leg disc pattern formation [GO:0035223]; segment polarity determination [GO:0007367]; sternite morphogenesis [GO:0007491]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_LOC662408.1.1.m.44393,-0.0104923901441224,-0.00371922074832766,No,NA,NA,Q9GKY8,NA,NA,NA,integral component of membrane [GO:0016021]; junctional membrane complex [GO:0030314]; plasma membrane [GO:0005886]; sarcoplasmic reticulum membrane [GO:0033017],NA,NA,NA
CHOYP_LOC662543.1.1.m.39811,0.00597039439485131,0.00795699065086528,No,NA,NA,Q14624,NA,NA,NA,blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097],NA,NA,NA
CHOYP_LOC662585.2.2.m.7262,0.00350299344037456,-0.00527676481146669,No,NA,NA,Q91ZU6,NA,NA,NA,actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cytoplasmic microtubule organization [GO:0031122]; hemidesmosome assembly [GO:0031581]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]; wound healing [GO:0042060],NA,NA,NA
CHOYP_LOC663138.1.1.m.7661,-0.00266592728370073,0.011638667973707,No,NA,NA,Q9Y2H2,NA,NA,NA,axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037]; inositol monophosphate 1-phosphatase activity [GO:0008934]; inositol monophosphate 3-phosphatase activity [GO:0052832]; inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803]; adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135]; regulation of protein kinase B signaling [GO:0051896],NA,NA,NA
CHOYP_LOC663155.1.1.m.62768,-0.0258625324997018,0.0030580988104843,No,NA,NA,Q2L969,NA,NA,NA,mitochondrial sorting and assembly machinery complex [GO:0001401]; nucleolus [GO:0005730]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LOC663249.1.1.m.25441,-0.0156388942959167,-0.00387155661390667,No,NA,NA,P06280,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-galactosidase activity [GO:0004557]; catalytic activity [GO:0003824]; galactoside binding [GO:0016936]; hydrolase activity [GO:0016787]; protein homodimerization activity [GO:0042803]; raffinose alpha-galactosidase activity [GO:0052692]; signaling receptor binding [GO:0005102]; glycoside catabolic process [GO:0016139]; glycosphingolipid catabolic process [GO:0046479]; glycosphingolipid metabolic process [GO:0006687]; glycosylceramide catabolic process [GO:0046477]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of nitric-oxide synthase activity [GO:0051001]; neutrophil degranulation [GO:0043312]; oligosaccharide metabolic process [GO:0009311],NA,NA,NA
CHOYP_LOC663261.1.1.m.21784,-0.000664841978129473,-0.00169453212410831,No,NA,NA,Q922K7,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723]; rRNA (cytosine-C5-)-methyltransferase activity [GO:0009383]; blastocyst formation [GO:0001825]; positive regulation of cell proliferation [GO:0008284]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_LOC663375.1.1.m.11969,-0.00685846344527829,0.00956748623648568,No,NA,NA,Q76IQ7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; RNA polymerase II transcription factor binding [GO:0001085]; female gonad development [GO:0008585]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to gonadotropin [GO:0034698],NA,NA,NA
CHOYP_LOC663422.1.1.m.57246,-0.00860560610755427,0.0170899507202261,No,NA,NA,P31396,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; metamorphosis [GO:0007552]; mushroom body development [GO:0016319]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of development; heterochronic [GO:0040034],NA,NA,NA
CHOYP_LOC663424.1.2.m.49957,-0.00509066569271044,-0.00441315930025112,No,NA,NA,D3ZSI8,NA,NA,NA,cytosol [GO:0005829]; lamellipodium [GO:0030027]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nuclear speck [GO:0016607]; ruffle membrane [GO:0032587]; 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO:0016308]; ATP binding [GO:0005524]; kinase binding [GO:0019900]; actin cytoskeleton reorganization [GO:0031532]; activation of GTPase activity [GO:0090630]; cell chemotaxis [GO:0060326]; fibroblast migration [GO:0010761]; focal adhesion assembly [GO:0048041]; phosphatidylinositol biosynthetic process [GO:0006661]; protein localization to plasma membrane [GO:0072659]; ruffle assembly [GO:0097178],NA,NA,NA
CHOYP_LOC663518.1.1.m.11968,-0.0044610183149835,0.00584875749734183,No,NA,NA,Q7KMJ6,NA,NA,NA,nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; RNA binding [GO:0003723]; cell differentiation [GO:0030154]; compound eye development [GO:0048749]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of stem cell differentiation [GO:2000737]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; sex differentiation [GO:0007548]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_LOC663776.1.1.m.66113,-0.00216630849158979,-0.0116189539794524,No,NA,NA,Q29RP8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; histone-lysine N-methyltransferase activity [GO:0018024]; histone H4-K20 trimethylation [GO:0034773]; muscle organ development [GO:0007517],NA,NA,NA
CHOYP_LOC663838.2.2.m.43318,-0.000262909411212721,0.000521757391118171,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC663855.2.5.m.747,0.0035851349571756,-0.000152110216463989,No,NA,NA,Q9DC07,NA,NA,NA,Z disc [GO:0030018]; actin filament binding [GO:0051015]; metal ion binding [GO:0046872]; cardiac muscle thin filament assembly [GO:0071691]; muscle fiber development [GO:0048747],NA,NA,NA
CHOYP_LOC663855.5.5.m.51311,-0.0206827095987591,0.0260600109183795,No,NA,NA,P34416,NA,NA,NA,cell junction [GO:0030054]; striated muscle dense body [GO:0055120]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC664087.1.1.m.19351,0.00871111599819765,0.00339186621700514,No,NA,NA,Q03112,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; hematopoietic stem cell proliferation [GO:0071425]; negative regulation of JNK cascade [GO:0046329]; negative regulation of programmed cell death [GO:0043069]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_LOC664527.1.1.m.16232,0.00116886321057267,0.00244253618274153,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC684934.1.1.m.1807,-0.00219576382722959,-0.00664559736833046,No,NA,NA,Q8VC31,NA,NA,NA,,NA,NA,NA
CHOYP_LOC689840.1.1.m.6512,-0.00971381589873039,-0.00618184845954081,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC720058.1.1.m.11127,-0.0040860794278996,-0.00146943934955432,No,NA,NA,A0JNB1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_LOC724172.1.1.m.24081,0.00688457925035672,0.010389464330118,No,NA,NA,Q9W4E2,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; protein kinase A binding [GO:0051018]; compound eye cone cell differentiation [GO:0042675]; eye photoreceptor cell development [GO:0042462]; mushroom body development [GO:0016319]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; short-term memory [GO:0007614],NA,NA,NA
CHOYP_LOC724467.1.1.m.38548,-0.00182960973050524,-0.00644582026123164,No,NA,NA,Q5R788,NA,NA,NA,mitochondrion [GO:0005739]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; structural molecule activity [GO:0005198]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_LOC725079.1.1.m.66349,-0.00389568897009405,0.00670271250520458,No,NA,NA,Q9DCD5,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; Golgi organization [GO:0007030],NA,NA,NA
CHOYP_LOC725565.1.1.m.19064,0.000592057563384223,0.00154940639344848,No,NA,NA,Q6P829,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_LOC725703.1.1.m.31182,-0.0335050067185938,-0.0024181018030187,No,NA,NA,P04570,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC726145.1.1.m.27163,-0.00395052457551419,-0.000899044802949385,No,NA,NA,P52486,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; proteasome binding [GO:0070628]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_LOC732900.1.1.m.62814,-0.00359879307403334,0.00478475203856577,No,NA,NA,Q641Y2,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; nucleoplasm [GO:0005654]; 4 iron; 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; NADH dehydrogenase activity [GO:0003954]; quinone binding [GO:0048038]; ubiquitin protein ligase binding [GO:0031625]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_LOC732961.1.1.m.29082,-0.0111100446081008,-0.0106843054068215,No,NA,NA,O18404,NA,NA,NA,cytosol [GO:0005829]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO:0047022]; acetoacetyl-CoA reductase activity [GO:0018454]; estradiol 17-beta-dehydrogenase activity [GO:0004303]; steroid dehydrogenase activity [GO:0016229]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)] activity [GO:0030283]; acyl-CoA metabolic process [GO:0006637]; androgen metabolic process [GO:0008209]; ecdysone metabolic process [GO:0008205]; estrogen metabolic process [GO:0008210]; fatty acid metabolic process [GO:0006631]; mitochondrial tRNA processing [GO:0090646]; RNA phosphodiester bond hydrolysis; endonucleolytic [GO:0090502]; steroid metabolic process [GO:0008202],NA,NA,NA
CHOYP_LOC751836.2.6.m.25437,0.00145708994151917,0.000996224355998283,No,NA,NA,P08962,NA,NA,NA,azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; plasma membrane [GO:0005886]; platelet dense granule membrane [GO:0031088]; cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cell-matrix adhesion [GO:0007160]; cellular protein localization [GO:0034613]; endosome to melanosome transport [GO:0035646]; neutrophil degranulation [GO:0043312]; pigment granule maturation [GO:0048757]; platelet degranulation [GO:0002576]; positive regulation of endocytosis [GO:0045807]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of potassium ion transmembrane transport [GO:1901379]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_LOC751836.5.6.m.43257,-0.00645954016850381,-0.00136388507234314,No,NA,NA,Q6AYR9,NA,NA,NA,cell junction [GO:0030054]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; vesicle [GO:0031982]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; positive regulation of endocytosis [GO:0045807]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_LOC752244.2.2.m.45622,-0.000158438346753758,0.00166135634431008,No,NA,NA,Q9UDY4,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATPase activator activity [GO:0001671]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone cofactor-dependent protein refolding [GO:0051085]; negative regulation of transcription by RNA polymerase II [GO:0000122]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_LOC752782.1.1.m.53938,0.0134737598184593,0.0100059943149567,No,NA,NA,Q93129,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_LOC752884.1.1.m.4412,0.00841589738953313,-0.00266386979705165,No,NA,NA,Q8NE09,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; negative regulation of signal transduction [GO:0009968],NA,NA,NA
CHOYP_LOC753176.3.3.m.54259,0.00378877774491339,0.00447444904860182,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_LOC753178.2.2.m.60569,-0.0159889871244015,0.00527676911616108,No,NA,NA,Q4R744,NA,NA,NA,,NA,NA,NA
CHOYP_LOC753709.10.44.m.22246,-0.00252491847700101,0.00342777064100848,No,NA,NA,Q8IWZ3,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723]; innate immune response [GO:0045087],NA,NA,NA
CHOYP_LOC753939.1.1.m.44379,-0.0033133126238857,0.00563940406803911,No,NA,NA,Q9H845,NA,NA,NA,dendrite [GO:0030425]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; long-chain-acyl-CoA dehydrogenase activity [GO:0004466]; medium-chain-acyl-CoA dehydrogenase activity [GO:0070991]; very-long-chain-acyl-CoA dehydrogenase activity [GO:0017099]; long-chain fatty acid metabolic process [GO:0001676]; medium-chain fatty acid metabolic process [GO:0051791]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_LOC754102.1.1.m.57575,0.00600769800464381,0.00179870161258625,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754102.1.1.m.57578,-0.00234642411090396,-0.00243722185541741,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_LOC754150.1.1.m.29730,0,0,No,NA,NA,Q9P0M2,NA,NA,NA,cytosol [GO:0005829]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; nucleotide binding [GO:0000166]; protein kinase A binding [GO:0051018]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; modulation of chemical synaptic transmission [GO:0050804]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_LOC754355.1.1.m.66745,-0.0313602745632202,-0.00990119141674566,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC754396.1.1.m.39126,0.000647745250629609,0.000527513622446392,No,NA,NA,Q6INX4,NA,NA,NA,mitochondrion [GO:0005739]; isomerase activity [GO:0016853]; L-fuconate dehydratase activity [GO:0050023]; magnesium ion binding [GO:0000287]; cellular carbohydrate catabolic process [GO:0044275],NA,NA,NA
CHOYP_LOC754557.1.2.m.5492,0.00384451416261866,0.00249575472452346,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754557.2.2.m.22904,-0.000251656487774161,0.00308764717255357,No,NA,NA,Q6TLF6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_LOC754728.5.6.m.42237,-0.00458432627851666,0.0063456149732601,No,NA,NA,Q99NH0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; blood vessel maturation [GO:0001955]; defense response to bacterium [GO:0042742]; endoderm development [GO:0007492]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell differentiation [GO:0051151]; positive regulation of cell cycle [GO:0045787]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of MDA-5 signaling pathway [GO:1900245]; positive regulation of RIG-I signaling pathway [GO:1900246]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_LOC754820.1.1.m.57329,0.0165646039054531,0.00785830077792135,No,NA,NA,Q6NV18,NA,NA,NA,DNA ligase IV complex [GO:0032807]; nonhomologous end joining complex [GO:0070419]; DNA end binding [GO:0045027]; double-strand break repair via nonhomologous end joining [GO:0006303],NA,NA,NA
CHOYP_LOC755229.1.1.m.5006,-0.0134313323153131,0.00130867912973843,No,NA,NA,P57756,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extrinsic component of external side of plasma membrane [GO:0031232]; carbohydrate binding [GO:0030246]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; sialic acid binding [GO:0033691]; signaling pattern recognition receptor activity [GO:0008329]; cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation; lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 secretion [GO:2000484]; protein localization to cell surface [GO:0034394]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_LOC755290.2.4.m.31794,-0.0151501770261115,-0.0115459220652105,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC755521.5.28.m.32618,0.00232635457124283,-0.00443473502986164,No,NA,NA,Q9ULJ7,NA,NA,NA,endosome [GO:0005768]; protein transport [GO:0015031]; retrograde transport; endosome to plasma membrane [GO:1990126],NA,NA,NA
CHOYP_LOC755594.2.6.m.51265,0.00378675422615883,-0.00847991910807038,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.4.6.m.53187,0.0113994261093067,-0.0110793067663004,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC755594.5.6.m.54446,0.00257196858024607,-0.00069501937097321,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_LOC756222.1.2.m.62,0.00652286150174016,0.0015780057664896,No,NA,NA,A8MU46,NA,NA,NA,contractile fiber [GO:0043292]; cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; I band [GO:0031674]; M band [GO:0031430]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; calmodulin binding [GO:0005516]; protein phosphatase 1 binding [GO:0008157]; tropomyosin binding [GO:0005523]; actin cytoskeleton organization [GO:0030036]; negative regulation of blood vessel diameter [GO:0097756]; positive regulation of vasoconstriction [GO:0045907],NA,NA,NA
CHOYP_LOC756760.1.1.m.1259,-0.000190900724092619,-0.00405178994705446,No,NA,NA,Q9BW91,NA,NA,NA,extracellular exosome [GO:0070062]; intracellular [GO:0005622]; mitochondrial matrix [GO:0005759]; adenosine-diphosphatase activity [GO:0043262]; ADP-ribose diphosphatase activity [GO:0047631]; ADP-sugar diphosphatase activity [GO:0019144]; ADP catabolic process [GO:0046032]; IDP catabolic process [GO:0046709]; nucleobase-containing small molecule catabolic process [GO:0034656],NA,NA,NA
CHOYP_LOC756946.1.1.m.49284,0.00354585136725655,0.00741535076530342,No,NA,NA,Q9C0I9,NA,NA,NA,,NA,NA,NA
CHOYP_LOC756958.1.2.m.17672,-0.00462142134354581,-0.00294106113512216,No,NA,NA,Q7Z591,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_LOC757096.1.1.m.9762,-0.0141627805329512,-0.0106786900773367,No,NA,NA,Q5THR3,NA,NA,NA,nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC762368.1.1.m.8991,0.00520595919061368,0.00614810387829539,No,NA,NA,Q08DU8,NA,NA,NA,axon cytoplasm [GO:1904115]; BLOC-1 complex [GO:0031083]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extrinsic component of membrane [GO:0019898]; transport vesicle [GO:0030133]; actin filament binding [GO:0051015]; protein homodimerization activity [GO:0042803]; anterograde axonal transport [GO:0008089]; anterograde synaptic vesicle transport [GO:0048490]; blood coagulation [GO:0007596]; endosome to melanosome transport [GO:0035646]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; membrane fusion [GO:0061025]; neuron projection development [GO:0031175]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of pigment cell differentiation [GO:0050942]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_LOC762575.1.1.m.54012,-0.00688809015910133,-0.00537529438949956,No,NA,NA,Q9D2U5,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; nucleus [GO:0005634]; polysome [GO:0005844]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_LOC762871.1.1.m.37896,0.00627921125560245,-0.00747840551525138,No,NA,NA,Q5R8Z8,NA,NA,NA,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; Golgi membrane [GO:0000139]; phagocytic vesicle [GO:0045335]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; defense response to bacterium [GO:0042742]; endocytic recycling [GO:0032456]; fibroblast growth factor receptor signaling pathway [GO:0008543]; Golgi to endosome transport [GO:0006895]; phagosome maturation [GO:0090382]; protein transport [GO:0015031]; regulation of embryonic development [GO:0045995]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_LOC762961.3.5.m.46330,0.00399769647223171,0.00472117669102939,No,NA,NA,O43614,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_LOC763087.1.1.m.9110,0.00258031837740476,0.0152351938999459,No,NA,NA,Q5EAN7,NA,NA,NA,chromosome; telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Mre11 complex [GO:0030870]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; shelterin complex [GO:0070187]; G-rich strand telomeric DNA binding [GO:0098505]; phosphatase binding [GO:0019902]; negative regulation of DNA recombination at telomere [GO:0048239]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of telomere maintenance [GO:0032205]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein acetylation [GO:1901985]; protein localization to chromosome; telomeric region [GO:0070198]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of transcription; DNA-templated [GO:0006355]; telomere maintenance [GO:0000723]; telomere maintenance via telomere lengthening [GO:0010833],NA,NA,NA
CHOYP_LOC763287.1.1.m.43472,0.0217711376950237,0.00971326369159115,No,NA,NA,P86880,NA,NA,NA,cytoplasm [GO:0005737]; perikaryon [GO:0043204]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxygen binding [GO:0019825]; oxygen carrier activity [GO:0005344],NA,NA,NA
CHOYP_LOC763308.3.3.m.63145,0.00434842955162838,-0.0012481471503039,No,NA,NA,O35186,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; lysosome [GO:0005764]; nucleoplasm [GO:0005654]; collagen binding [GO:0005518]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; fibronectin binding [GO:0001968]; proteoglycan binding [GO:0043394]; bone resorption [GO:0045453]; collagen catabolic process [GO:0030574]; intramembranous ossification [GO:0001957]; negative regulation of cartilage development [GO:0061037]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_LOC763340.1.1.m.60271,-0.00461416197134036,-0.00996306921275167,No,NA,NA,Q8VCM3,NA,NA,NA,endosome [GO:0005768]; focal adhesion [GO:0005925]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763378.1.1.m.7889,-0.00635099756325073,0.0118412979252108,No,NA,NA,Q9C0D2,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; microtubule binding [GO:0008017]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of protein acetylation [GO:1901985]; regulation of centriole replication [GO:0046599],NA,NA,NA
CHOYP_LOC763463.1.1.m.1366,-0.00148129077542098,-0.000683406121021947,No,NA,NA,Q6GLT8,NA,NA,NA,hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_LOC763793.3.7.m.24306,0.00642635622228412,-0.011666937932588,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_LOC763845.1.1.m.35345,-3.15638851109951e-05,0.00418776801836793,No,NA,NA,Q9ULI1,NA,NA,NA,unfolded protein binding [GO:0051082]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_LOC763960.1.2.m.17062,0.00182921670476018,0.00216025787083687,No,NA,NA,Q5JR59,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803],NA,NA,NA
CHOYP_LOC764565.1.1.m.3966,-0.00123615060683377,-0.0106180604064368,No,NA,NA,Q9GKX2,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; carbonyl reductase (NADPH) activity [GO:0004090],NA,NA,NA
CHOYP_LOC764722.1.3.m.16471,0.0178611074695889,0.00305407108127665,No,NA,NA,Q7YT83,NA,NA,NA,extracellular region [GO:0005576]; peptidase activity [GO:0008233],NA,NA,NA
CHOYP_LOC764722.3.3.m.43616,0.0330322080208779,0.00680268099836244,No,NA,NA,A1BQQ5,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_LOC764806.1.2.m.17636,7.33992237527763e-05,-0.00068724054794505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764850.1.8.m.5396,-2.59883776854839e-05,0.0252524792335922,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC764898.1.1.m.28118,-0.000431210145632898,0.000913286568111559,No,NA,NA,Q9Y547,NA,NA,NA,centrosome [GO:0005813]; ciliary tip [GO:0097542]; cilium [GO:0005929]; intraciliary transport particle B [GO:0030992]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; heart development [GO:0007507]; intraciliary transport involved in cilium assembly [GO:0035735]; kidney development [GO:0001822]; left/right axis specification [GO:0070986]; lung development [GO:0030324]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_LOC764949.1.1.m.44351,0.0144395014813263,0.00240224258241308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC769726.1.1.m.26365,-0.00366011014481328,-0.00064219447551588,No,NA,NA,G4V4G1,NA,NA,NA,extracellular region [GO:0005576]; insulin-like growth factor binding [GO:0005520]; serine-type endopeptidase inhibitor activity [GO:0004867]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LOC778718.1.1.m.29230,0.000543485272138016,0.00409929275542778,No,NA,NA,O54879,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA binding; bending [GO:0008301]; four-way junction DNA binding [GO:0000400]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; chromatin remodeling [GO:0006338]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; innate immune response [GO:0045087]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of myeloid cell differentiation [GO:0045638]; positive regulation of innate immune response [GO:0045089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_LOC794295.1.1.m.42748,0.00515689656782741,0.00609016218294451,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LOC797197.1.1.m.49426,-0.0130164102234847,0.0042852307351311,No,NA,NA,Q8IYF3,NA,NA,NA,central element [GO:0000801]; chiasma assembly [GO:0051026]; fertilization [GO:0009566]; male gonad development [GO:0008584]; male meiosis chromosome segregation [GO:0007060]; meiotic gene conversion [GO:0006311]; negative regulation of apoptotic process [GO:0043066]; reciprocal meiotic recombination [GO:0007131]; resolution of meiotic recombination intermediates [GO:0000712]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_LONM.1.1.m.7031,-0.00127721683625332,0.0017239121626581,No,NA,NA,Q8CGK3,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP-dependent peptidase activity [GO:0004176]; ATPase activity [GO:0016887]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; mitochondrial promoter sequence-specific DNA binding [GO:0001018]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727]; aging [GO:0007568]; cellular protein-containing complex assembly [GO:0034622]; cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrion organization [GO:0007005]; oxidation-dependent protein catabolic process [GO:0070407]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to aluminum ion [GO:0010044]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_LR16A.1.3.m.9037,-0.00111580329708702,-0.00818479473106292,No,NA,NA,Q6EDY6,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filamentous actin [GO:0031941]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; barbed-end actin filament uncapping [GO:0051638]; cell migration [GO:0016477]; establishment or maintenance of cell polarity [GO:0007163]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59538,0.00477198078719632,0.00401805140943915,No,NA,NA,Q5VZK9,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex binding [GO:0044877]; actin filament network formation [GO:0051639]; actin filament organization [GO:0007015]; barbed-end actin filament uncapping [GO:0051638]; blood coagulation [GO:0007596]; cell migration [GO:0016477]; lamellipodium assembly [GO:0030032]; macropinocytosis [GO:0044351]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; ruffle organization [GO:0031529]; urate metabolic process [GO:0046415],NA,NA,NA
CHOYP_LR16A.3.3.m.59539,-7.8048326376568e-05,0.0103551347984434,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_LRC40.1.2.m.20043,9.16168071984685e-05,-0.00354364709003988,No,NA,NA,Q7SXW3,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_LRCH2.2.2.m.56149,0.00601590396086068,-0.000412166995156713,No,NA,NA,Q96II8,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576],NA,NA,NA
CHOYP_LRIG1.1.3.m.954,0.00332658132518058,-0.000753634132430885,No,NA,NA,F7D3V9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; trans-Golgi network membrane [GO:0032588]; G protein-coupled peptide receptor activity [GO:0008528]; protein-hormone receptor activity [GO:0016500]; transmembrane signaling receptor activity [GO:0004888]; activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of canonical Wnt signaling pathway [GO:0090263],NA,NA,NA
CHOYP_LRP1.5.5.m.54869,0.0048439902605462,0.00726691982175358,No,NA,NA,Q91ZX7,NA,NA,NA,basolateral plasma membrane [GO:0016323]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome [GO:0005768]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; receptor complex [GO:0043235]; alpha-2 macroglobulin receptor activity [GO:0016964]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; clathrin heavy chain binding [GO:0032050]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; aorta morphogenesis [GO:0035909]; apoptotic cell clearance [GO:0043277]; astrocyte activation involved in immune response [GO:0002265]; cardiac septum development [GO:0003279]; cell proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; cholesterol metabolic process [GO:0008203]; coronary vasculature development [GO:0060976]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell death [GO:0010942]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipid transport [GO:0032370]; positive regulation of lysosomal protein catabolic process [GO:1905167]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein transport [GO:0051222]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; receptor-mediated endocytosis [GO:0006898]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cholesterol transport [GO:0032374]; regulation of phospholipase A2 activity [GO:0032429]; transcytosis [GO:0045056],NA,NA,NA
CHOYP_LRP12.1.2.m.30870,-0.00859914849310491,-0.00481001862094295,No,NA,NA,Q5R662,NA,NA,NA,clathrin-coated pit [GO:0005905]; integral component of plasma membrane [GO:0005887]; endocytosis [GO:0006897]; neuron migration [GO:0001764]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_LRP1B.1.2.m.7346,-0.0022326075291288,-0.0112770558181249,No,NA,NA,O75581,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation involved in somitogenesis [GO:0090245]; beta-catenin destruction complex disassembly [GO:1904886]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; canonical Wnt signaling pathway involved in regulation of cell proliferation [GO:0044340]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; gastrulation with mouth forming second [GO:0001702]; midbrain development [GO:0030901]; midbrain dopaminergic neuron differentiation [GO:1904948]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; response to peptide hormone [GO:0043434]; roof of mouth development [GO:0060021]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRP2.6.7.m.41365,0.00251089046599026,0.000688143670503697,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_LRP4.5.5.m.48010,0.00114610896051711,0.0102885532105939,No,NA,NA,Q9QYP1,NA,NA,NA,cell surface [GO:0009986]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]; apolipoprotein binding [GO:0034185]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; BMP signaling pathway [GO:0030509]; dendrite morphogenesis [GO:0048813]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; endocytosis [GO:0006897]; hair follicle development [GO:0001942]; kidney development [GO:0001822]; negative regulation of axonogenesis [GO:0050771]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; postsynaptic membrane assembly [GO:0097104]; presynaptic membrane assembly [GO:0097105]; protein heterotetramerization [GO:0051290]; proximal/distal pattern formation [GO:0009954]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP5.1.3.m.18025,-0.000899232861203792,0.00189265659001976,No,NA,NA,O75197,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; coreceptor activity involved in canonical Wnt signaling pathway [GO:1904928]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; adipose tissue development [GO:0060612]; anterior/posterior pattern specification [GO:0009952]; bone marrow development [GO:0048539]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; cholesterol homeostasis [GO:0042632]; endocytosis [GO:0006897]; gastrulation with mouth forming second [GO:0001702]; glucose catabolic process [GO:0006007]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; osteoblast development [GO:0002076]; positive regulation of cell proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of blood pressure [GO:0008217]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; retina morphogenesis in camera-type eye [GO:0060042]; retinal blood vessel morphogenesis [GO:0061304]; toxin transport [GO:1901998]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRP6.1.6.m.878,0.00495849368586596,-0.00900205903176125,No,NA,NA,O88572,NA,NA,NA,caveola [GO:0005901]; cell surface [GO:0009986]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202]; Wnt signalosome [GO:1990909]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]; apolipoprotein binding [GO:0034185]; coreceptor activity involved in Wnt signaling pathway [GO:0071936]; frizzled binding [GO:0005109]; identical protein binding [GO:0042802]; kinase inhibitor activity [GO:0019210]; low-density lipoprotein particle receptor activity [GO:0005041]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; toxin transmembrane transporter activity [GO:0019534]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]; anterior/posterior pattern specification [GO:0009952]; axis elongation [GO:0003401]; axis elongation involved in somitogenesis [GO:0090245]; bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; branching involved in mammary gland duct morphogenesis [GO:0060444]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development [GO:0061310]; canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation [GO:0061324]; cell migration involved in gastrulation [GO:0042074]; cell-cell adhesion [GO:0098609]; cellular response to cholesterol [GO:0071397]; cerebellum morphogenesis [GO:0021587]; cerebral cortex cell migration [GO:0021795]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; convergent extension [GO:0060026]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral axis specification [GO:0009950]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; external genitalia morphogenesis [GO:0035261]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; forebrain generation of neurons [GO:0021872]; forebrain radial glial cell differentiation [GO:0021861]; formation of radial glial scaffolds [GO:0021943]; gastrulation with mouth forming second [GO:0001702]; generation of neurons [GO:0048699]; heart looping [GO:0001947]; limb morphogenesis [GO:0035108]; mammary gland duct morphogenesis [GO:0060603]; mammary placode formation [GO:0060596]; midbrain development [GO:0030901]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:2000151]; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:2000162]; negative regulation of planar cell polarity pathway involved in neural tube closure [GO:2000168]; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis [GO:2000164]; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis [GO:2000166]; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis [GO:2000149]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; neural crest cell differentiation [GO:0014033]; neural crest formation [GO:0014029]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; odontogenesis of dentin-containing tooth [GO:0042475]; pericardium morphogenesis [GO:0003344]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; post-anal tail morphogenesis [GO:0036342]; primitive streak formation [GO:0090009]; protein localization to plasma membrane [GO:0072659]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of cell development [GO:0060284]; regulation of cell proliferation [GO:0042127]; regulation of transcription; DNA-templated [GO:0006355]; response to folic acid [GO:0051593]; retina morphogenesis in camera-type eye [GO:0060042]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; somitogenesis [GO:0001756]; thalamus development [GO:0021794]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in somitogenesis [GO:0090244],NA,NA,NA
CHOYP_LRRF2.2.2.m.40846,0.000851989794049188,-0.00840411081919711,No,NA,NA,Q2T9W6,NA,NA,NA,regulation of transcription; DNA-templated [GO:0006355]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_LRRX1.6.11.m.41895,0.0282482667604193,0.0122105693965896,No,NA,NA,Q7Z5L3,NA,NA,NA,collagen trimer [GO:0005581]; extracellular region [GO:0005576]; identical protein binding [GO:0042802]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_LS14A.2.3.m.10984,-0.00161560272357298,-0.00340557487257512,No,NA,NA,Q8ND56,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; P-body [GO:0000932]; double-stranded DNA binding [GO:0003690]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; cytoplasmic mRNA processing body assembly [GO:0033962]; multicellular organism development [GO:0007275]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; regulation of translation [GO:0006417]; RIG-I signaling pathway [GO:0039529],NA,NA,NA
CHOYP_LSAMP.1.1.m.36104,0.0142483060713624,-0.0258675518177263,No,NA,NA,Q24372,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; septate junction [GO:0005918]; protein homodimerization activity [GO:0042803]; cell adhesion involved in heart morphogenesis [GO:0061343]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; maintenance of epithelial integrity; open tracheal system [GO:0035160]; morphogenesis of embryonic epithelium [GO:0016331]; open tracheal system development [GO:0007424]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991],NA,NA,NA
CHOYP_LSDA.1.1.m.28040,0.00114898052089828,0.0315473871837414,No,NA,NA,Q5NAI7,NA,NA,NA,cytoplasm [GO:0005737]; flavin adenine dinucleotide binding [GO:0050660]; N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity [GO:0052903]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; thermospermine oxidase activity [GO:1990534]; regulation of timing of transition from vegetative to reproductive phase [GO:0048510]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_LSG1.1.1.m.14762,0.0129724325586543,-0.00542555893244744,No,NA,NA,Q6NY89,NA,NA,NA,Cajal body [GO:0015030]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; GTP binding [GO:0005525]; hydrolase activity [GO:0016787]; nuclear export [GO:0051168]; protein transport [GO:0015031],NA,NA,NA
CHOYP_LSM12.1.1.m.24998,0.00414928679510256,0.000853192392577965,No,NA,NA,Q5RAT5,NA,NA,NA,,NA,NA,NA
CHOYP_LSM2.1.2.m.54283,0.00186481307140657,-0.00215049116888052,No,NA,NA,O35900,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein kinase binding [GO:0019901]; Ral GTPase binding [GO:0017160]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_LSM3.1.1.m.9505,-0.00533525399049425,-0.00339221106726479,No,NA,NA,P62311,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; P-body [GO:0000932]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LSM4.1.3.m.2601,0.000605779426930455,0.00075665266411903,No,NA,NA,Q9QXA5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Lsm2-8 complex [GO:0120115]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; protein-containing complex [GO:0032991]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; U6 snRNA binding [GO:0017070]; cytoplasmic mRNA processing body assembly [GO:0033962]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_LSM7.1.1.m.3617,0.00570362880932405,-0.0204710396924422,No,NA,NA,Q9CQQ8,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleus [GO:0005634]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; mRNA catabolic process [GO:0006402]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process [GO:0000956],NA,NA,NA
CHOYP_LTN1.1.2.m.7693,0.00431527766489005,0.0160791703105948,No,NA,NA,Q6A009,NA,NA,NA,cytosol [GO:0005829]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_LTOR2.2.2.m.61709,-5.41210561143711e-05,0.00268113318761687,No,NA,NA,B5X7X4,NA,NA,NA,late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; Ragulator complex [GO:0071986]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein-containing complex scaffold activity [GO:0032947]; cellular protein localization [GO:0034613]; cellular response to amino acid stimulus [GO:0071230]; positive regulation of TOR signaling [GO:0032008]; regulation of cell growth [GO:0001558],NA,NA,NA
CHOYP_LTV1.1.1.m.19482,-0.0128400320531717,-0.0020081931532442,No,NA,NA,Q4V838,NA,NA,NA,,NA,NA,NA
CHOYP_LYAM3.2.4.m.3333,0.00274152286436533,-0.0192418921927146,No,NA,NA,P98109,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; oligosaccharide binding [GO:0070492]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; leukocyte tethering or rolling [GO:0050901],NA,NA,NA
CHOYP_LYPA2.1.1.m.45740,-0.00272767571678728,-0.0026302229641739,No,NA,NA,Q9QYL8,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; carboxylic ester hydrolase activity [GO:0052689]; palmitoyl-(protein) hydrolase activity [GO:0008474]; fatty acid metabolic process [GO:0006631]; protein depalmitoylation [GO:0002084],NA,NA,NA
CHOYP_LYS3.1.1.m.31221,0.00460475370312459,-0.00301868784502348,No,NA,NA,B3A003,NA,NA,NA,extracellular region [GO:0005576]; lysozyme activity [GO:0003796]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_M1I1L.1.1.m.4329,-0.0119306853093832,0.00204804930462021,No,NA,NA,Q9CQ20,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; lipid metabolic process [GO:0006629]; negative regulation of microtubule depolymerization [GO:0007026]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of ligase activity [GO:0051351]; protein polymerization [GO:0051258]; regulation of lipid biosynthetic process [GO:0046890],NA,NA,NA
CHOYP_M2OM.1.1.m.11786,-8.2042770962396e-05,0.0108851014748791,No,NA,NA,P22292,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; oxoglutarate:malate antiporter activity [GO:0015367],NA,NA,NA
CHOYP_M3K1.1.1.m.7202,0.0035567310007508,-0.000961130303787084,No,NA,NA,Q62925,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; ATP binding [GO:0005524]; JUN kinase binding [GO:0008432]; JUN kinase kinase kinase activity [GO:0004706]; MAP kinase kinase kinase activity [GO:0004709]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; protein serine/threonine kinase activity [GO:0004674]; sphingolipid binding [GO:0046625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of JNKK activity [GO:0007256]; activation of MAPKK activity [GO:0000186]; activation of protein kinase activity [GO:0032147]; MAPK cascade [GO:0000165]; negative regulation of actin filament bundle assembly [GO:0032232]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of viral transcription [GO:0050434]; protein autophosphorylation [GO:0046777]; protein complex oligomerization [GO:0051259]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; response to osmotic stress [GO:0006970]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_M3K7.1.4.m.7880,-0.00627516706117494,0.000369613069389948,No,NA,NA,P0C8E4,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; MAP kinase kinase kinase activity [GO:0004709]; activation of MAPKK activity [GO:0000186]; apoptotic process [GO:0006915]; I-kappaB phosphorylation [GO:0007252]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JUN kinase activity [GO:0043507]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_M3K7.2.4.m.17369,-0.00455794315343249,0.00315117651391519,No,NA,NA,Q3U3C9,NA,NA,NA,,NA,NA,NA
CHOYP_M6PR.1.1.m.51635,-0.00603837213098467,0.0171799138412049,No,NA,NA,Q6AY20,NA,NA,NA,integral component of membrane [GO:0016021]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; perinuclear region of cytoplasm [GO:0048471]; trans-Golgi network [GO:0005802]; mannose binding [GO:0005537]; protein domain specific binding [GO:0019904]; retromer complex binding [GO:1905394]; protein targeting to lysosome [GO:0006622]; secretion of lysosomal enzymes [GO:0033299],NA,NA,NA
CHOYP_MA1B1.1.1.m.22675,-0.0120640559486814,0.0197120185493025,No,NA,NA,B2GUY0,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; mannosyl-oligosaccharide 1;2-alpha-mannosidase activity [GO:0004571]; mannose trimming involved in glycoprotein ERAD pathway [GO:1904382]; N-glycan processing [GO:0006491]; protein glycosylation [GO:0006486]; trimming of terminal mannose on B branch [GO:0036509]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_MA2A1.1.1.m.19620,-0.00374639032181626,0.00781603129867809,No,NA,NA,P28494,NA,NA,NA,cis-Golgi network [GO:0005801]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; in utero embryonic development [GO:0001701]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mannose metabolic process [GO:0006013]; mitochondrion organization [GO:0007005]; N-glycan processing [GO:0006491]; positive regulation of neurogenesis [GO:0050769]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486]; respiratory gaseous exchange [GO:0007585]; retina morphogenesis in camera-type eye [GO:0060042]; vacuole organization [GO:0007033],NA,NA,NA
CHOYP_MA2A2.1.1.m.8261,-0.00308604245105556,0.00839466838418511,No,NA,NA,Q8BRK9,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; hydrolase activity; hydrolyzing N-glycosyl compounds [GO:0016799]; mannosidase activity [GO:0015923]; mannosyl-oligosaccharide 1;3-1;6-alpha-mannosidase activity [GO:0004572]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; N-glycan processing [GO:0006491]; protein deglycosylation [GO:0006517]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MA2C1.1.1.m.46709,0.00550229629863731,0.00649807037945579,No,NA,NA,Q91W89,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; mannose metabolic process [GO:0006013]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MABP1.1.2.m.21698,-0.0015200831076369,0.00733692848577753,No,NA,NA,Q6DFF9,NA,NA,NA,,NA,NA,NA
CHOYP_MABP1.1.2.m.21699,-8.187806061537e-05,0.000659218143578492,No,NA,NA,Q7L2H7,NA,NA,NA,cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; cytoplasmic translational initiation [GO:0002183]; formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_MAD1.1.1.m.48542,-0.0119223137589783,0.0145907220664728,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MAD2L1.1.1.m.10353,-0.0252758895185028,0.028403039111438,No,NA,NA,Q13257,NA,NA,NA,chromosome [GO:0005694]; condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; identical protein binding [GO:0042802]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; mitotic cell cycle checkpoint [GO:0007093]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; regulation of mitotic cell cycle phase transition [GO:1901990],NA,NA,NA
CHOYP_MAGI1.1.1.m.66921,-4.73738335581989e-05,0.00628536773546302,No,NA,NA,O88382,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extrinsic component of postsynaptic membrane [GO:0098890]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; slit diaphragm [GO:0036057]; synapse [GO:0045202]; beta-1 adrenergic receptor binding [GO:0031697]; kinesin binding [GO:0019894]; phosphatase binding [GO:0019902]; protein-containing complex binding [GO:0044877]; receptor signaling complex scaffold activity [GO:0030159]; SMAD binding [GO:0046332]; structural constituent of postsynaptic density [GO:0098919]; structural constituent of postsynaptic specialization [GO:0098879]; type II activin receptor binding [GO:0070699]; cellular response to nerve growth factor stimulus [GO:1990090]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; mitotic cell cycle arrest [GO:0071850]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase B signaling [GO:0051898]; nerve growth factor signaling pathway [GO:0038180]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of receptor internalization [GO:0002092]; protein heterooligomerization [GO:0051291]; receptor clustering [GO:0043113]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of synaptic membrane adhesion [GO:0099179]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395],NA,NA,NA
CHOYP_MALT1.1.1.m.53909,0.0101367186721526,-0.0131643961961197,No,NA,NA,Q9UDY8,NA,NA,NA,CBM complex [GO:0032449]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protease binding [GO:0002020]; protein self-association [GO:0043621]; ubiquitin-protein transferase activity [GO:0004842]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; B cell activation [GO:0042113]; B-1 B cell differentiation [GO:0001923]; defense response [GO:0006952]; Fc-epsilon receptor signaling pathway [GO:0038095]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of apoptotic process [GO:0043066]; nuclear export [GO:0051168]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T-helper 17 cell differentiation [GO:2000321]; protein complex oligomerization [GO:0051259]; proteolysis [GO:0006508]; regulation of apoptotic process [GO:0042981]; regulation of T cell receptor signaling pathway [GO:0050856]; response to fungus [GO:0009620]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_MAN2B1.1.1.m.38450,-0.00996230067993059,0.00390857341232138,No,NA,NA,Q29451,NA,NA,NA,lysosome [GO:0005764]; vacuolar membrane [GO:0005774]; alpha-mannosidase activity [GO:0004559]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; learning or memory [GO:0007611]; mannose metabolic process [GO:0006013]; protein deglycosylation [GO:0006517],NA,NA,NA
CHOYP_MANBA.2.2.m.47433,0.00284316347499666,0.00335770292221484,No,NA,NA,O00462,NA,NA,NA,azurophil granule membrane [GO:0035577]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; beta-mannosidase activity [GO:0004567]; mannose binding [GO:0005537]; cellular protein modification process [GO:0006464]; glycoprotein catabolic process [GO:0006516]; mannan catabolic process [GO:0046355]; neutrophil degranulation [GO:0043312]; oligosaccharide catabolic process [GO:0009313],NA,NA,NA
CHOYP_MANL.2.9.m.16934,-0.000626164282199869,-0.0184016073130306,No,NA,NA,P86856,NA,NA,NA,extracellular region [GO:0005576]; carbonate dehydratase activity [GO:0004089]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_MANL.5.9.m.42622,0.00288368188362409,-0.00665954896706486,No,NA,NA,Q90YP3,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_MARE3.1.1.m.30069,0.00240849282027357,-0.00244214129584146,No,NA,NA,Q9UPY8,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; microtubule organizing center [GO:0005815]; microtubule plus-end [GO:0035371]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle midzone [GO:0051233]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; microtubule plus-end binding [GO:0051010]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; cell division [GO:0051301]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of microtubule plus-end binding [GO:1903033]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription; DNA-templated [GO:0045893]; protein localization [GO:0008104]; protein localization to microtubule [GO:0035372]; protein localization to microtubule plus-end [GO:1904825]; regulation of microtubule polymerization or depolymerization [GO:0031110]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MARH5.1.1.m.45222,-8.62248780293024e-05,0.0114399664467479,No,NA,NA,Q5ZJ41,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; GTPase binding [GO:0051020]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of cell aging [GO:0090344]; positive regulation of mitochondrial fission [GO:0090141]; protein autoubiquitination [GO:0051865]; protein localization to mitochondrion [GO:0070585]; protein polyubiquitination [GO:0000209]; regulation of mitochondrial fission [GO:0090140],NA,NA,NA
CHOYP_MASP2.1.1.m.3029,0.0100333091597233,-0.0130570641242743,No,NA,NA,O70244,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi-associated vesicle [GO:0005798]; ionotropic glutamate receptor complex [GO:0008328]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; neuron projection membrane [GO:0032589]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; synapse [GO:0045202]; calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; channel regulator activity [GO:0016247]; cobalamin binding [GO:0031419]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023]; adult locomotory behavior [GO:0008344]; cholesterol metabolic process [GO:0008203]; cobalamin catabolic process [GO:0042366]; cobalamin transport [GO:0015889]; endocytic hemoglobin import [GO:0020028]; hyperosmotic response [GO:0006972]; in utero embryonic development [GO:0001701]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; protein homotrimerization [GO:0070207]; receptor-mediated endocytosis [GO:0006898]; regulation of locomotion [GO:0040012]; response to nutrient [GO:0007584]; thigmotaxis [GO:0001966]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_MAST4.1.1.m.25573,-0.0141509697072656,-0.00478031738404013,No,NA,NA,Q811L6,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cytoskeleton organization [GO:0007010]; intracellular signal transduction [GO:0035556]; peptidyl-serine phosphorylation [GO:0018105],NA,NA,NA
CHOYP_MATN1.2.5.m.45361,0.00214515587407461,-0.0011263598892847,No,NA,NA,A2AX52,NA,NA,NA,collagen trimer [GO:0005581]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]; protein heterotrimerization [GO:0070208],NA,NA,NA
CHOYP_MATN1.3.5.m.46206,0.00529270544769807,0.00174448951616162,No,NA,NA,P21941,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; protein-containing complex assembly [GO:0065003]; regulation of bone mineralization [GO:0030500],NA,NA,NA
CHOYP_MB21L.1.1.m.35723,-7.77245961851926e-05,0.010312183592112,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MBCDH18.1.1.m.34344,-0.00852713017581514,0.00686379420096016,No,NA,NA,Q2PZL6,NA,NA,NA,apical part of cell [GO:0045177]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],NA,NA,NA
CHOYP_MBLK1.1.1.m.51933,0.0124906257441156,0.00412298357948469,No,NA,NA,Q5BJS9,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; stereocilium tip [GO:0032426]; response to axon injury [GO:0048678],NA,NA,NA
CHOYP_MCA3.1.1.m.5766,0.00791148374469793,-0.00167971382443739,No,NA,NA,O43324,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; negative regulation of cell proliferation [GO:0008285]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043517]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_MCA3A.1.2.m.24375,0.00741739713198299,-0.00168059997166299,No,NA,NA,G3MWR8,NA,NA,NA,cell cortex [GO:0005938]; cell projection [GO:0042995]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; FAD binding [GO:0071949]; metal ion binding [GO:0046872]; oxidoreductase activity; acting on paired donors; with incorporation or reduction of molecular oxygen; NAD(P)H as one donor; and incorporation of one atom of oxygen [GO:0016709]; Rab GTPase binding [GO:0017137]; actin filament depolymerization [GO:0030042]; cytoskeleton organization [GO:0007010]; exocytosis [GO:0006887]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MCCA.1.1.m.18170,-0.00142529538926755,0.000740462957498805,No,NA,NA,Q96RQ3,NA,NA,NA,3-methylcrotonyl-CoA carboxylase complex; mitochondrial [GO:0002169]; cytosol [GO:0005829]; methylcrotonoyl-CoA carboxylase complex [GO:1905202]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin carboxylase activity [GO:0004075]; metal ion binding [GO:0046872]; methylcrotonoyl-CoA carboxylase activity [GO:0004485]; biotin metabolic process [GO:0006768]; leucine catabolic process [GO:0006552]; protein heterooligomerization [GO:0051291],NA,NA,NA
CHOYP_MCEE.1.1.m.62224,0.000443390321131998,-0.00608934853134319,No,NA,NA,Q96PE7,NA,NA,NA,mitochondrial matrix [GO:0005759]; metal ion binding [GO:0046872]; methylmalonyl-CoA epimerase activity [GO:0004493]; L-methylmalonyl-CoA metabolic process [GO:0046491]; short-chain fatty acid catabolic process [GO:0019626],NA,NA,NA
CHOYP_MCES.1.2.m.15348,-0.0113692800117525,0.00217248834840499,No,NA,NA,Q5U2U7,NA,NA,NA,fibrillar center [GO:0001650]; mRNA cap binding complex [GO:0005845]; mRNA cap methyltransferase complex [GO:0031533]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; mRNA (guanine-N7-)-methyltransferase activity [GO:0004482]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; cellular response to leukemia inhibitory factor [GO:1990830],NA,NA,NA
CHOYP_MCM2.1.1.m.14569,-0.00330273146576395,-0.000206793309122629,No,NA,NA,P55861,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; negative regulation of DNA helicase activity [GO:1905775]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM3.1.1.m.14853,-0.00526455335440261,0.00515584170817129,No,NA,NA,Q28BS0,NA,NA,NA,MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270],NA,NA,NA
CHOYP_MCM4.1.1.m.61253,-0.00384224672585183,0.00229192681399468,No,NA,NA,Q6GL41,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM4.1.1.m.61254,0.0022521305265251,0.00310083989826483,No,NA,NA,Q9XUY5,NA,NA,NA,sodium:potassium-exchanging ATPase complex [GO:0005890]; ATPase activator activity [GO:0001671]; cellular potassium ion homeostasis [GO:0030007]; cellular sodium ion homeostasis [GO:0006883]; establishment or maintenance of transmembrane electrochemical gradient [GO:0010248]; potassium ion import across plasma membrane [GO:1990573]; sodium ion export across plasma membrane [GO:0036376],NA,NA,NA
CHOYP_MCM5.1.1.m.48534,-0.00953172456928403,-0.00211877194845794,No,NA,NA,P55862,NA,NA,NA,chromatin [GO:0000785]; cytosol [GO:0005829]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA replication origin binding [GO:0003688]; helicase activity [GO:0004386]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCM7.1.1.m.50070,-0.00253696752403876,0.00244466548285161,No,NA,NA,Q6NX31,NA,NA,NA,chromatin [GO:0000785]; MCM complex [GO:0042555]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; metal ion binding [GO:0046872]; cell cycle [GO:0007049]; DNA replication initiation [GO:0006270]; DNA unwinding involved in DNA replication [GO:0006268]; regulation of DNA-dependent DNA replication initiation [GO:0030174],NA,NA,NA
CHOYP_MCMBP.1.2.m.3994,-0.00539846279725399,0.0137463363521153,No,NA,NA,Q7ZYP6,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MCMBP.2.2.m.18631,-0.00954826663704989,0.0123635780272609,No,NA,NA,Q7ZYP6,NA,NA,NA,nucleus [GO:0005634]; chromatin binding [GO:0003682]; cell division [GO:0051301]; DNA-dependent DNA replication [GO:0006261]; sister chromatid cohesion [GO:0007062],NA,NA,NA
CHOYP_MD27A.1.2.m.18338,-0.0170669043573316,-0.0107195434069745,No,NA,NA,Q5XHA1,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MDHC.1.1.m.57053,0.00237778453250182,-0.00203408247212339,No,NA,NA,Q5ZME2,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; L-malate dehydrogenase activity [GO:0030060]; carbohydrate metabolic process [GO:0005975]; malate metabolic process [GO:0006108]; NADH metabolic process [GO:0006734]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDHM.1.1.m.43603,0.000858883384727104,-0.000339233711467871,No,NA,NA,Q5NVR2,NA,NA,NA,mitochondrial matrix [GO:0005759]; L-malate dehydrogenase activity [GO:0030060]; protein homodimerization activity [GO:0042803]; aerobic respiration [GO:0009060]; carbohydrate metabolic process [GO:0005975]; internal protein amino acid acetylation [GO:0006475]; malate metabolic process [GO:0006108]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_MDM1.1.2.m.7535,-0.0128699011202692,0.0220788488526724,No,NA,NA,Q5RC32,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; microtubule [GO:0005874]; nucleus [GO:0005634]; microtubule binding [GO:0008017]; negative regulation of centriole replication [GO:0046600],NA,NA,NA
CHOYP_MDN1.2.8.m.1779,-0.014628628669826,-0.00261385352102989,No,NA,NA,Q9NU22,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.4.8.m.6155,0.00152963441808009,0.00921911474429135,No,NA,NA,Q9NU22,NA,NA,NA,cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; unfolded protein binding [GO:0051082]; protein-containing complex assembly [GO:0065003]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MDN1.6.8.m.52635,-0.0197070340166028,0.00930669939507475,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDN1.7.8.m.63476,0.0144695549765687,-0.00151852563369413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MDR1A.1.1.m.47026,0.00247818051163997,-0.000669675156060147,No,NA,NA,P06795,NA,NA,NA,apical plasma membrane [GO:0016324]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transporter activity [GO:0005215]; establishment of endothelial blood-brain barrier [GO:0014045]; response to drug [GO:0042493]; Sertoli cell barrier remodeling [GO:0061843],NA,NA,NA
CHOYP_MDR1B.1.2.m.12480,-0.0102040518056492,0.00564893297262103,No,NA,NA,P21440,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; bile acid secretion [GO:0032782]; cellular response to bile acid [GO:1903413]; lipid homeostasis [GO:0055088]; phospholipid translocation [GO:0045332]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of phospholipid translocation [GO:0061092]; positive regulation of phospholipid transport [GO:2001140]; response to fenofibrate [GO:1901557],NA,NA,NA
CHOYP_MDR3.3.3.m.66641,-0.0101255066604898,0.00728023707701332,No,NA,NA,P08183,NA,NA,NA,apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; ceramide-translocating ATPase activity [GO:0099038]; phosphatidylcholine-translocating ATPase activity [GO:0090554]; phosphatidylethanolamine-translocating ATPase activity [GO:0090555]; transporter activity [GO:0005215]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; ceramide translocation [GO:0099040]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; positive regulation of anion channel activity [GO:1901529]; regulation of chloride transport [GO:2001225]; regulation of response to osmotic stress [GO:0047484]; response to drug [GO:0042493]; stem cell proliferation [GO:0072089]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_ME3.1.1.m.58433,-0.0001749013528834,0.000773952295625425,No,NA,NA,P40927,NA,NA,NA,cytoplasm [GO:0005737]; malate dehydrogenase (decarboxylating) (NAD+) activity [GO:0004471]; malate dehydrogenase (decarboxylating) (NADP+) activity [GO:0004473]; metal ion binding [GO:0046872]; NAD binding [GO:0051287]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_MEC2.3.4.m.30735,-0.0101770316303137,0.00652980975319846,No,NA,NA,Q27433,NA,NA,NA,integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; neuron projection membrane [GO:0032589]; cholesterol binding [GO:0015485]; detection of mechanical stimulus involved in sensory perception of touch [GO:0050976]; mechanosensory behavior [GO:0007638]; positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO:1905789]; positive regulation of mechanosensory behavior [GO:1905792]; response to mechanical stimulus [GO:0009612],NA,NA,NA
CHOYP_MECR.1.1.m.6989,6.21877613206098e-05,0.00257240208759635,No,NA,NA,Q6GQN8,NA,NA,NA,mitochondrion [GO:0005739]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MED17.1.1.m.1678,0.00262118700149987,-0.000708319594172997,No,NA,NA,Q0VFR9,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED18.1.1.m.28719,0.00781850745429605,-0.0141943642772929,No,NA,NA,Q9BUE0,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_MED21.1.1.m.6955,-0.0237692255657519,0.00235363529504529,No,NA,NA,Q16RX1,NA,NA,NA,mediator complex [GO:0016592],NA,NA,NA
CHOYP_MED24.4.10.m.16708,-0.000617320749691071,0.000900269156508762,No,NA,NA,Q2PW47,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; enteric nervous system development [GO:0048484]; interstitial cell of Cajal differentiation [GO:0061453]; retinal cone cell development [GO:0046549]; thymus development [GO:0048538],NA,NA,NA
CHOYP_MED25.2.2.m.42845,0,0,No,NA,NA,A4IHD9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_MED4.1.1.m.12006,-0.0128181084405207,-0.00239098258868069,No,NA,NA,Q7QH62,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED7.1.1.m.48813,-0.0123769436768267,-0.00787665640362969,No,NA,NA,Q7PR68,NA,NA,NA,core mediator complex [GO:0070847]; mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MED8B.1.1.m.7004,-0.0201423667103758,-0.0238021021264256,No,NA,NA,Q5HZZ6,NA,NA,NA,mediator complex [GO:0016592]; transcription coregulator activity [GO:0003712]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_MEF2A.1.1.m.21731,0.00064195281959125,-0.00444149766299969,No,NA,NA,A2VDZ3,NA,NA,NA,cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; activating transcription factor binding [GO:0033613]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase binding [GO:0035035]; histone deacetylase binding [GO:0042826]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II transcription factor binding [GO:0001085]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cardiac conduction [GO:0061337]; cellular response to calcium ion [GO:0071277]; dendrite morphogenesis [GO:0048813]; ERK5 cascade [GO:0070375]; MAPK cascade [GO:0000165]; mitochondrial genome maintenance [GO:0000002]; mitochondrion distribution [GO:0048311]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of glucose import [GO:0046326]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription; DNA-templated [GO:0006351]; ventricular cardiac myofibril assembly [GO:0055005],NA,NA,NA
CHOYP_MEG10.11.91.m.21604,-0.0029417238589191,0.00399361594023975,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.19.91.m.24289,-0.0132612559543894,-0.00202371971786305,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEG10.22.91.m.28727,0.00970124565935708,-0.00562050443131055,No,NA,NA,Q8VIK5,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.47.91.m.45614,-8.8134932493668e-05,0.0116933847116758,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.50.91.m.46730,-0.00990233365662237,-0.00630182069530996,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.56.91.m.47515,0.00389309177412524,-0.00105202459189242,No,NA,NA,Q8VIK5,NA,NA,NA,integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; signaling receptor activity [GO:0038023]; negative regulation of Notch signaling pathway [GO:0045746]; phosphatidylinositol 3-kinase signaling [GO:0014065]; platelet aggregation [GO:0070527]; protein kinase B signaling [GO:0043491]; recognition of apoptotic cell [GO:0043654],NA,NA,NA
CHOYP_MEG10.58.91.m.48257,0.00588085519848288,-0.0129292103033035,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.61.91.m.50119,0.00856361267505933,0.00422344870589024,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEG10.67.91.m.52967,0,0,No,NA,NA,A6BM72,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG10.70.91.m.54892,0.00361976468594242,0.00662445304515191,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEG10.78.91.m.58715,-0.00230430824790444,0.0217386460094017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEG10.79.91.m.59237,0.00497557292294709,-0.00134454191614081,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEG10.80.91.m.60740,0.00450059449291192,-0.00352798352816243,No,NA,NA,Q9W0A0,NA,NA,NA,axon [GO:0030424]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; intrinsic component of membrane [GO:0031224]; phagocytic cup [GO:0001891]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; phosphatidylserine binding [GO:0001786]; apoptotic cell clearance [GO:0043277]; cell competition in a multicellular organism [GO:0035212]; defense response to bacterium [GO:0042742]; engulfment of apoptotic cell [GO:0043652]; larval locomotory behavior [GO:0008345]; neuron remodeling [GO:0016322]; phagocytosis [GO:0006909]; phagocytosis; engulfment [GO:0006911]; positive regulation of phagocytosis; engulfment [GO:0060100]; regulation of neuromuscular junction development [GO:1904396]; response to axon injury [GO:0048678]; salivary gland cell autophagic cell death [GO:0035071]; wing disc dorsal/ventral pattern formation [GO:0048190],NA,NA,NA
CHOYP_MEG10.83.91.m.61586,0.00435550210027718,-0.0087097215478837,No,NA,NA,P23469,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_MEG10.9.91.m.20215,-0.00265371574079906,0.00360262281287486,No,NA,NA,Q80T91,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842],NA,NA,NA
CHOYP_MEG11.15.25.m.46952,0.0037921778882165,0.0143357611578537,No,NA,NA,Q14162,NA,NA,NA,endocytic vesicle membrane [GO:0030666]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; transmembrane signaling receptor activity [GO:0004888]; cell adhesion [GO:0007155]; cholesterol catabolic process [GO:0006707]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_MEG11.8.25.m.39826,-7.789981028157e-05,0.0103354302864462,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF10.8.12.m.38635,0.0109910319410575,0.00699985770755974,No,NA,NA,Q06805,NA,NA,NA,integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]; ATP binding [GO:0005524]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; angiogenesis [GO:0001525]; positive regulation of angiogenesis [GO:0045766]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.1.59.m.1169,0,0,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.11.59.m.24279,-0.010473680840589,-0.0016983231250819,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.13.59.m.24300,-0.00664689705673791,-0.00182522003996379,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.15.59.m.24311,-0.0019444279966481,0.00263971025646015,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.3.59.m.2378,0.0132099676838107,-0.0239824665374268,No,NA,NA,A0JM12,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; myofibril assembly [GO:0030239]; phagocytosis [GO:0006909]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.32.59.m.41698,0.00699700149715108,-0.00908962026306483,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MEGF6.35.59.m.42904,-0.00243590676980838,0.00330693041610613,No,NA,NA,P22105,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; collagen fibril binding [GO:0098633]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_MEGF6.36.59.m.43203,0.0118848875843025,-0.00645351313243494,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.44.59.m.47511,-6.28750488341547e-05,0.00834200598991773,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_MEGF6.48.59.m.51016,0.00442811708149981,-0.00803916953264205,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.52.59.m.54262,-2.16866318336592e-06,-0.00845723438268104,No,NA,NA,O88281,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MEGF6.55.59.m.59497,0.0125508555480266,-0.0061133220875064,No,NA,NA,Q5ND28,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; low-density lipoprotein particle binding [GO:0030169]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; neuron remodeling [GO:0016322]; positive regulation of axon regeneration [GO:0048680]; positive regulation of neuron projection development [GO:0010976],NA,NA,NA
CHOYP_MEGF6.8.59.m.7292,0.00502965174328245,0.0022865406114511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEGF6A.1.2.m.17795,0.00638418035025614,-0.011590368370587,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MEP50.1.1.m.12931,-0.00296020584794772,0.0039671425488775,No,NA,NA,Q5RBZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; methyl-CpG binding [GO:0008327],NA,NA,NA
CHOYP_MERL.1.1.m.1067,0.00666598701607792,-0.00172696498384113,No,NA,NA,P35240,NA,NA,NA,adherens junction [GO:0005912]; apical part of cell [GO:0045177]; cell body [GO:0044297]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; filopodium membrane [GO:0031527]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; actin binding [GO:0003779]; actin cytoskeleton organization [GO:0030036]; cell-cell junction organization [GO:0045216]; ectoderm development [GO:0007398]; hippocampus development [GO:0021766]; lens fiber cell differentiation [GO:0070306]; mesoderm formation [GO:0001707]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell differentiation [GO:0045597]; positive regulation of stress fiber assembly [GO:0051496]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of gliogenesis [GO:0014013]; regulation of hippo signaling [GO:0035330]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein localization to nucleus [GO:1900180]; regulation of protein stability [GO:0031647]; regulation of stem cell proliferation [GO:0072091]; Schwann cell proliferation [GO:0014010],NA,NA,NA
CHOYP_MESD.1.1.m.52095,-0.0009038919667422,0.0173435074807173,No,NA,NA,A1L243,NA,NA,NA,endoplasmic reticulum [GO:0005783]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; protein folding [GO:0006457]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_MESH1.1.3.m.13824,-0.00237280597574894,-0.00613898426412247,No,NA,NA,Q9D114,NA,NA,NA,guanosine-3';5'-bis(diphosphate) 3'-diphosphatase activity [GO:0008893]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_MEST.2.2.m.55065,-0.014321213781377,0.00134524594891818,No,NA,NA,Q6GQN0,NA,NA,NA,centriole [GO:0005814]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; tubulin-glutamic acid ligase activity [GO:0070740]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; protein polyglutamylation [GO:0018095]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MET14.1.1.m.5073,-0.00269823776014671,-0.0154583607582474,No,NA,NA,Q6NZ22,NA,NA,NA,nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA splicing; via spliceosome [GO:0000398]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_MET14.1.1.m.5074,0.0196354004903412,-0.0164940031087179,No,NA,NA,Q9Y6G5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MET23.1.1.m.14359,-0.0122920982844349,-0.00782266100535115,No,NA,NA,Q6DJF8,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_METEV_0975.1.1.m.28991,-0.00586118499827697,0.00112425746194278,No,NA,NA,P82198,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; chondrocyte differentiation [GO:0002062]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_METH.1.1.m.18095,0.00307610747729199,0.00363252365023766,No,NA,NA,Q4JIJ3,NA,NA,NA,cytosol [GO:0005829]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558],NA,NA,NA
CHOYP_METK.1.2.m.3732,0.00114737645399665,-0.0002146068804788,No,NA,NA,Q2KJC6,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; methionine adenosyltransferase activity [GO:0004478]; methionine catabolic process [GO:0009087]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556],NA,NA,NA
CHOYP_METTL15.1.1.m.14094,-0.00965747423582145,-0.00614599276434413,No,NA,NA,A6NJ78,NA,NA,NA,rRNA (cytosine-N4-)-methyltransferase activity [GO:0071424]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_MF.CPA.1.1.m.3630,0.00345689483009938,0.00103908433840983,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MFAP4.3.3.m.62664,0.00803848710748356,0.00431361092480771,No,NA,NA,D8VNS8,NA,NA,NA,extracellular region [GO:0005576]; toxin activity [GO:0090729],NA,NA,NA
CHOYP_MGA.2.2.m.66484,-0.00514414777467277,0.00371309406977683,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MGC154513.1.1.m.20908,-0.00617173259827269,-0.00650479104849749,No,NA,NA,Q9H9L4,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_MGC78792.1.1.m.45233,-0.00146645245054622,0.00295040667812161,No,NA,NA,Q08288,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; erythrocyte development [GO:0048821]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of phagocytosis [GO:0050766]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MGC81574.1.1.m.8983,0.0117356979506116,-0.00764946642596061,No,NA,NA,Q91XN4,NA,NA,NA,integral component of membrane [GO:0016021]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_MGC82409.1.1.m.44657,-0.0010295286107689,0.000647884466579689,No,NA,NA,P05689,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_MGC89016.1.2.m.76,0.00188646286246984,-0.000668961750841234,No,NA,NA,Q03168,NA,NA,NA,lysosome [GO:0005764]; aspartic-type endopeptidase activity [GO:0004190],NA,NA,NA
CHOYP_MGN2.1.1.m.9330,0.00158688959173315,-0.000921910428193369,No,NA,NA,Q96A72,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; exon-exon junction complex [GO:0035145]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_MIB.2.3.m.30418,-0.000193481281363176,0.0186895102639669,No,NA,NA,Q8R412,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; nuclear inner membrane [GO:0005637]; aging [GO:0007568]; response to virus [GO:0009615],NA,NA,NA
CHOYP_MIB1.2.4.m.35815,0.00235951669232456,-0.00813851004974732,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MIB1.3.4.m.57545,-0.0091252741427368,-0.0162192799003432,No,NA,NA,Q86YT6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; blood vessel development [GO:0001568]; endocytosis [GO:0006897]; heart looping [GO:0001947]; in utero embryonic development [GO:0001701]; negative regulation of neuron differentiation [GO:0045665]; neural tube formation [GO:0001841]; Notch signaling pathway [GO:0007219]; positive regulation of endocytosis [GO:0045807]; protein ubiquitination [GO:0016567]; somitogenesis [GO:0001756],NA,NA,NA
CHOYP_MIB1.4.4.m.64019,0.00433274141667079,0.00511685615121863,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.2.6.m.23029,0.00422518089618898,-0.00480430940736205,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.4.6.m.43287,0.0120327524793777,0.0109202813462591,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MIB2.5.6.m.43978,-0.0109002214773936,0.00698867429632822,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_MICPUCDRAFT_54866.2.4.m.37897,0.0142149410956019,-0.00224654797029086,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUCDRAFT_54866.4.4.m.57185,-0.00540178321202244,0.00153153945698229,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MICPUN_58704.1.1.m.54967,-0.0283446286723597,-0.000529264424013897,No,NA,NA,Q9Y5Z4,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; negative regulation of mitochondrial membrane potential [GO:0010917]; neutrophil degranulation [GO:0043312]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of necrotic cell death [GO:0010940],NA,NA,NA
CHOYP_MIF.2.2.m.30795,-0.0105229869214001,0.0193098556029032,No,NA,NA,P80928,NA,NA,NA,cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular space [GO:0005615]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]; cell aging [GO:0007569]; cell proliferation [GO:0008283]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of cell aging [GO:0090344]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine secretion [GO:0050715]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207],NA,NA,NA
CHOYP_MINP1.1.1.m.13284,-0.00493789697317885,0.0248632520143343,No,NA,NA,Q9Z2L6,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; plasma membrane [GO:0005886]; acid phosphatase activity [GO:0003993]; bisphosphoglycerate 3-phosphatase activity [GO:0034417]; inositol hexakisphosphate 2-phosphatase activity [GO:0052826]; inositol phosphate phosphatase activity [GO:0052745]; inositol-1;3;4;5;6-pentakisphosphate 3-phosphatase activity [GO:0030351]; inositol-1;4;5;6-tetrakisphosphate 6-phosphatase activity [GO:0030352],NA,NA,NA
CHOYP_MINT.1.1.m.54605,-0.00455672368220552,-0.000655909735611939,No,NA,NA,Q8SX83,NA,NA,NA,nucleus [GO:0005634]; RNA binding [GO:0003723]; axon guidance [GO:0007411]; compound eye development [GO:0048749]; defense response to fungus [GO:0050832]; epidermal growth factor receptor signaling pathway [GO:0007173]; establishment of thoracic bristle planar orientation [GO:0048106]; glial cell fate determination [GO:0007403]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; maintenance of imaginal disc-derived wing hair orientation [GO:0035321]; neuroblast fate determination [GO:0007400]; peripheral nervous system development [GO:0007422]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_MK01.1.1.m.48878,0.000627992152548578,0.00470037855051703,No,NA,NA,P26696,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; mitotic spindle assembly checkpoint [GO:0007094]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein phosphorylation [GO:0006468]; regulation of protein stability [GO:0031647]; response to epidermal growth factor [GO:0070849],NA,NA,NA
CHOYP_ML12B.1.1.m.27220,0.0320248451681911,0.0230658955212483,No,NA,NA,Q09510,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; calcium ion binding [GO:0005509]; embryonic body morphogenesis [GO:0010172]; establishment of cell polarity [GO:0030010]; meiosis I cytokinesis [GO:0007110]; mitotic cytokinesis [GO:0000281]; nematode larval development [GO:0002119]; protein localization [GO:0008104],NA,NA,NA
CHOYP_MLE.1.9.m.15462,0.00106824652820905,-0.00553211509531382,No,NA,NA,P07291,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MLE.4.9.m.38686,0.0340600835123983,0.00650490876715455,No,NA,NA,P05945,NA,NA,NA,myosin complex [GO:0016459]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_MLL.1.1.m.33426,0.00256487216105981,-0.003396962180711,No,NA,NA,O08550,NA,NA,NA,histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; zinc ion binding [GO:0008270]; gene silencing [GO:0016458]; histone H3-K4 methylation [GO:0051568]; histone H3-K4 trimethylation [GO:0080182]; histone lysine methylation [GO:0034968]; memory [GO:0007613]; oocyte differentiation [GO:0009994]; ovarian follicle development [GO:0001541]; ovulation [GO:0030728]; regulation of histone H3-K4 methylation [GO:0051569]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_MLL3.2.3.m.25295,-0.000454072350035429,0.00186263871106582,No,NA,NA,Q8NEZ4,NA,NA,NA,histone methyltransferase complex [GO:0035097]; MLL3/4 complex [GO:0044666]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone methyltransferase activity (H3-K4 specific) [GO:0042800]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; transferase activity; transferring acyl groups [GO:0016746]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of megakaryocyte differentiation [GO:0045652],NA,NA,NA
CHOYP_MLP2.4.4.m.62619,0.000380514812131475,-0.000854982057724194,No,NA,NA,Q24400,NA,NA,NA,nucleus [GO:0005634]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; structural constituent of muscle [GO:0008307]; muscle organ development [GO:0007517]; muscle tissue development [GO:0060537]; regulation of establishment of planar polarity [GO:0090175]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_MMAC.1.1.m.8063,-0.00268161497824282,0.00285677159456303,No,NA,NA,Q5ZL21,NA,NA,NA,cytoplasm [GO:0005737]; cyanocobalamin reductase (cyanide-eliminating) activity [GO:0033787]; demethylase activity [GO:0032451]; FAD binding [GO:0071949]; glutathione binding [GO:0043295]; oxidoreductase activity [GO:0016491]; cobalamin biosynthetic process [GO:0009236]; cobalamin metabolic process [GO:0009235]; demethylation [GO:0070988]; glutathione metabolic process [GO:0006749]; oxidation-reduction process [GO:0055114],NA,NA,NA
CHOYP_MMS19.1.1.m.18650,-0.00415867728169213,-0.00783336904548928,No,NA,NA,Q0V9L1,NA,NA,NA,CIA complex [GO:0097361]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; spindle [GO:0005819]; cellular response to DNA damage stimulus [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; iron-sulfur cluster assembly [GO:0016226]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein maturation by iron-sulfur cluster transfer [GO:0097428],NA,NA,NA
CHOYP_MNB.1.1.m.14023,0.00148545195831373,-0.0148409336525958,No,NA,NA,Q63470,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendrite [GO:0030425]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; tau protein binding [GO:0048156]; amyloid-beta formation [GO:0034205]; circadian rhythm [GO:0007623]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of RNA splicing [GO:0033120]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_MO25.1.1.m.62210,-0.000928221151670689,0.00455800975842904,No,NA,NA,P91891,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; signal transduction by protein phosphorylation [GO:0023014],NA,NA,NA
CHOYP_MO4L1.1.1.m.8106,-0.00265933762337414,-0.00172763121405656,No,NA,NA,Q9Y0I1,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme regulator activity [GO:0030234]; methylated histone binding [GO:0035064]; chromatin silencing [GO:0006342]; chromosome organization [GO:0051276]; chromosome separation [GO:0051304]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone deacetylation [GO:0016575]; histone exchange [GO:0043486]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K36 methylation [GO:0000416],NA,NA,NA
CHOYP_MOB1.1.1.m.19452,-0.00733313173090085,0.0208823049730895,No,NA,NA,Q95RA8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; apoptotic process [GO:0006915]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; hippo signaling [GO:0035329]; multicellular organism development [GO:0007275]; ovarian follicle cell development [GO:0030707]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MON2.1.1.m.65761,-0.00150308017613357,-0.00581340337604847,No,NA,NA,Q7Z3U7,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MONBRDRAFT_34536.1.1.m.30219,0.000914341017228075,0.00732417627092416,No,NA,NA,A0KDV2,NA,NA,NA,L-rhamnonate dehydratase activity [GO:0050032]; magnesium ion binding [GO:0000287]; cellular amino acid catabolic process [GO:0009063],NA,NA,NA
CHOYP_MONBRDRAFT_34989.1.1.m.34385,-0.0107419663664068,0.0049650171559922,No,NA,NA,O18823,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; acyloxyacyl hydrolase activity [GO:0050528]; calcium ion binding [GO:0005509]; fatty acid metabolic process [GO:0006631]; lipopolysaccharide catabolic process [GO:0009104]; negative regulation of inflammatory response [GO:0050728],NA,NA,NA
CHOYP_MORC2.1.1.m.6240,0.00243095812449269,-0.00315868450375073,No,NA,NA,Q9Y6X9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; zinc ion binding [GO:0008270]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_MORC3.1.2.m.38178,-0.00666105448173148,0.00821977049404529,No,NA,NA,Q14149,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; PML body [GO:0016605]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cell aging [GO:0007569]; maintenance of protein location in nucleus [GO:0051457]; negative regulation of fibroblast proliferation [GO:0048147]; peptidyl-serine phosphorylation [GO:0018105]; post-embryonic development [GO:0009791]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; viral process [GO:0016032],NA,NA,NA
CHOYP_MP2K5.1.1.m.45312,0.00265300662995288,-0.00101564676516507,No,NA,NA,P26446,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; DNA binding [GO:0003677]; NAD binding [GO:0051287]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylase activity [GO:1990404]; zinc ion binding [GO:0008270]; ATP generation from poly-ADP-D-ribose [GO:1990966]; double-strand break repair [GO:0006302]; peptidyl-serine ADP-ribosylation [GO:0018312]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_MP2K6.1.1.m.38188,0.00681008194743243,0.000344196599625529,No,NA,NA,P52564,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; MAP kinase kinase activity [GO:0004708]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; cardiac muscle contraction [GO:0060048]; cell cycle arrest [GO:0007050]; cellular response to sorbitol [GO:0072709]; DNA damage induced protein phosphorylation [GO:0006975]; negative regulation of cold-induced thermogenesis [GO:0120163]; nucleotide-binding oligomerization domain containing signaling pathway [GO:0070423]; ovulation cycle process [GO:0022602]; positive regulation of apoptotic process [GO:0043065]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of prostaglandin secretion [GO:0032308]; response to drug [GO:0042493]; response to ischemia [GO:0002931]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_MPDZ.3.3.m.51236,-0.0071084873896202,0.0099219659285774,No,NA,NA,O75970,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; dendrite [GO:0030425]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; protein C-terminus binding [GO:0008022]; cell adhesion [GO:0007155]; viral process [GO:0016032],NA,NA,NA
CHOYP_MPEG1.4.5.m.49975,0.0035692913905043,0.00421524131043736,No,NA,NA,Q2KJC3,NA,NA,NA,integral component of membrane [GO:0016021]; defense response to bacterium [GO:0042742],NA,NA,NA
CHOYP_MPET_1013.1.2.m.36696,-0.0056256292652335,-0.00205001964144577,No,NA,NA,Q5I0S8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_MPHOSPH9.1.1.m.9795,-0.00956568011426982,-0.00335450154828281,No,NA,NA,A6H5Y1,NA,NA,NA,centriole [GO:0005814]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],NA,NA,NA
CHOYP_MPI.1.1.m.35645,0.000910181008270267,-8.11301379078888e-05,No,NA,NA,Q3SZI0,NA,NA,NA,cytoplasm [GO:0005737]; mannose-6-phosphate isomerase activity [GO:0004476]; zinc ion binding [GO:0008270]; carbohydrate metabolic process [GO:0005975]; cell wall mannoprotein biosynthetic process [GO:0000032]; GDP-mannose biosynthetic process [GO:0009298]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_MPP2.1.1.m.62101,-7.87221901670207e-05,-0.00289133910899255,No,NA,NA,D3ZAA9,NA,NA,NA,anchored component of postsynaptic density membrane [GO:0099031]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; dendritic shaft [GO:0043198]; dendritic spine membrane [GO:0032591]; glutamatergic synapse [GO:0098978]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; ion channel binding [GO:0044325]; PDZ domain binding [GO:0030165]; structural constituent of postsynaptic density [GO:0098919]; excitatory postsynaptic potential [GO:0060079]; long-term synaptic potentiation [GO:0060291]; protein homooligomerization [GO:0051260],NA,NA,NA
CHOYP_MPPA.2.2.m.18272,0.00147781325332255,0.0019944983858886,No,NA,NA,Q9DC61,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein processing involved in protein targeting to mitochondrion [GO:0006627]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_MPPA.2.2.m.18273,-0.0129121496364578,-0.00821726015519087,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MPST.1.1.m.11853,-0.0115425554787658,0.00409876225382544,No,NA,NA,P97532,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; synapse [GO:0045202]; 3-mercaptopyruvate sulfurtransferase activity [GO:0016784]; identical protein binding [GO:0042802]; thiosulfate sulfurtransferase activity [GO:0004792]; hydrogen sulfide biosynthetic process [GO:0070814]; kidney development [GO:0001822]; liver development [GO:0001889]; spinal cord development [GO:0021510]; transsulfuration [GO:0019346],NA,NA,NA
CHOYP_MROH1.1.1.m.24366,-0.00305932014742101,-0.00110134016258534,No,NA,NA,Q8NDA8,NA,NA,NA,,NA,NA,NA
CHOYP_MRP1.10.10.m.64931,-0.0146185943087677,-0.00930323733231545,No,NA,NA,Q8CG09,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRP1.4.10.m.27993,-0.00348478377964139,0.0104859833523806,No,NA,NA,Q5F364,NA,NA,NA,basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_MRP1.5.10.m.34368,-0.0108849695533087,0.00369445150549686,No,NA,NA,Q8CG09,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; drug transmembrane transporter activity [GO:0015238]; efflux transmembrane transporter activity [GO:0015562]; glutathione transmembrane transporter activity [GO:0034634]; lipid-transporting ATPase activity [GO:0034040]; long-chain fatty acid transporter activity [GO:0005324]; oxidoreductase activity [GO:0016491]; sphingolipid transporter activity [GO:0046624]; xenobiotic transmembrane transporting ATPase activity [GO:0008559]; cell chemotaxis [GO:0060326]; drug export [GO:0046618]; drug transmembrane transport [GO:0006855]; glutathione transmembrane transport [GO:0034775]; negative regulation of cell death [GO:0060548]; negative regulation of neuron death [GO:1901215]; phospholipid efflux [GO:0033700]; plasma membrane long-chain fatty acid transport [GO:0015911]; positive regulation of cell migration [GO:0030335]; positive regulation of drug transmembrane export [GO:1905701]; response to drug [GO:0042493]; response to oxidative stress [GO:0006979]; transmembrane transport [GO:0055085]; xenobiotic transport [GO:0042908],NA,NA,NA
CHOYP_MRPL42.1.1.m.61762,0.0162235433357725,0.0146216215061644,No,NA,NA,Q9CPV3,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],NA,NA,NA
CHOYP_MRPL45.1.1.m.11763,-0.00892183702549333,-0.0186745936805366,No,NA,NA,Q3T142,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739],NA,NA,NA
CHOYP_MRPL55.1.1.m.1120,-0.00011041495962462,0.0146494081777121,No,NA,NA,P0C2B8,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_MRPS28.1.1.m.29259,-0.00674612132565982,-0.0118718699374604,No,NA,NA,P82928,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763],NA,NA,NA
CHOYP_MRPS35.1.1.m.20118,-0.00559726762869119,-0.00128186060165434,No,NA,NA,Q2YDF6,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_MRRF.1.1.m.16730,0.00315092914165663,-0.0204592979894834,No,NA,NA,Q0VCQ4,NA,NA,NA,mitochondrion [GO:0005739]; ribosomal large subunit binding [GO:0043023]; translation [GO:0006412],NA,NA,NA
CHOYP_MRT4.1.1.m.1698,0.00369271572588785,-0.00532806038966282,No,NA,NA,Q9UKD2,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; nuclear-transcribed mRNA catabolic process [GO:0000956]; ribosomal large subunit assembly [GO:0000027]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_MSH2.1.1.m.18340,-0.00741577462717511,0.00230074592772493,No,NA,NA,Q5XXB5,NA,NA,NA,chromosome [GO:0005694]; MutSalpha complex [GO:0032301]; ATP binding [GO:0005524]; mismatched DNA binding [GO:0030983]; cell cycle [GO:0007049]; mismatch repair [GO:0006298],NA,NA,NA
CHOYP_MSMB.4.5.m.40217,0.0137451274301566,-0.00969550001092743,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MSRB3.1.4.m.4844,-0.0137018290006799,0.0266352724267874,No,NA,NA,Q5R930,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; protein repair [GO:0030091]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_MSRB3.2.4.m.17278,0,0,No,NA,NA,Q8BU85,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; L-methionine-(R)-S-oxide reductase activity [GO:0033745]; peptide-methionine (R)-S-oxide reductase activity [GO:0033743]; zinc ion binding [GO:0008270]; cellular response to oxidative stress [GO:0034599]; protein repair [GO:0030091],NA,NA,NA
CHOYP_MT.10.18.m.44063,-0.000301742046361411,0.000514515104819899,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTA1.1.1.m.12640,-0.00435544307481855,0.000224494541954386,No,NA,NA,Q13330,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; circadian regulation of gene expression [GO:0032922]; double-strand break repair [GO:0006302]; entrainment of circadian clock by photoperiod [GO:0043153]; histone deacetylation [GO:0016575]; locomotor rhythm [GO:0045475]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein autoubiquitination [GO:1902499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of gene expression; epigenetic [GO:0040029]; response to ionizing radiation [GO:0010212]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_MTAP.1.1.m.15433,-0.00107431777815254,0.0072679053843027,No,NA,NA,Q7ZV22,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; S-methyl-5-thioadenosine phosphorylase activity [GO:0017061]; L-methionine salvage from methylthioadenosine [GO:0019509]; purine ribonucleoside salvage [GO:0006166],NA,NA,NA
CHOYP_MTBP.1.1.m.17026,-0.00238903111687765,0.00324329311915667,No,NA,NA,Q6NRW0,NA,NA,NA,cell cycle arrest [GO:0007050]; regulation of protein ubiquitination [GO:0031396],NA,NA,NA
CHOYP_MTHR.1.1.m.54596,-0.00179299016442,0.0137196344727495,No,NA,NA,Q5I598,NA,NA,NA,cytosol [GO:0005829]; FAD binding [GO:0071949]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine biosynthetic process [GO:0009086]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999],NA,NA,NA
CHOYP_MTIF2.1.1.m.17935,-0.0102695417781921,-0.00173499132144918,No,NA,NA,P46198,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribosomal small subunit binding [GO:0043024]; translation factor activity; RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; mitochondrial translational initiation [GO:0070124]; ribosome disassembly [GO:0032790],NA,NA,NA
CHOYP_MTMR9.1.1.m.26430,0.0123605769935315,-0.0285497162043612,No,NA,NA,Q9Z2D0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex [GO:0032991]; enzyme regulator activity [GO:0030234]; protein phosphatase binding [GO:0019903]; negative regulation of autophagy [GO:0010507]; positive regulation of phosphatase activity [GO:0010922]; protein stabilization [GO:0050821]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],NA,NA,NA
CHOYP_MTNA.1.1.m.1717,-0.00499002780334712,-0.00386786860017963,No,NA,NA,Q16I17,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; S-methyl-5-thioribose-1-phosphate isomerase activity [GO:0046523]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284],NA,NA,NA
CHOYP_MTNB.1.1.m.16051,0.0257161541821196,-0.0261197156367375,No,NA,NA,Q96GX9,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; methylthioribulose 1-phosphate dehydratase activity [GO:0046570]; zinc ion binding [GO:0008270]; apoptotic process [GO:0006915]; L-methionine salvage from methylthioadenosine [GO:0019509]; L-methionine salvage from S-adenosylmethionine [GO:0019284]; negative regulation of apoptotic process [GO:0043066]; protein homotetramerization [GO:0051289]; pyroptosis [GO:0070269]; regulation of ERK1 and ERK2 cascade [GO:0070372],NA,NA,NA
CHOYP_MTND.2.3.m.41824,-0.00135384942717684,0.00364716302839173,No,NA,NA,C3ZAH2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acireductone dioxygenase [iron(II)-requiring] activity [GO:0010309]; iron ion binding [GO:0005506]; L-methionine salvage from methylthioadenosine [GO:0019509]; methionine metabolic process [GO:0006555],NA,NA,NA
CHOYP_MTOR.2.2.m.51573,-0.00975047262872078,0.00120812536081876,No,NA,NA,P42345,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; endoplasmic reticulum membrane [GO:0005789]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; TORC1 complex [GO:0031931]; TORC2 complex [GO:0031932]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phosphoprotein binding [GO:0051219]; protein domain specific binding [GO:0019904]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; ribosome binding [GO:0043022]; RNA polymerase III type 1 promoter DNA binding [GO:0001030]; RNA polymerase III type 2 promoter DNA binding [GO:0001031]; RNA polymerase III type 3 promoter DNA binding [GO:0001032]; TFIIIC-class transcription factor complex binding [GO:0001156]; translation regulator activity [GO:0045182]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; activation of protein kinase B activity [GO:0032148]; anoikis [GO:0043276]; brain development [GO:0007420]; cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cell aging [GO:0007569]; cell cycle arrest [GO:0007050]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to hypoxia [GO:0071456]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to nutrient levels [GO:0031669]; cellular response to starvation [GO:0009267]; energy reserve metabolic process [GO:0006112]; germ cell development [GO:0007281]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; long-term memory [GO:0007616]; maternal process involved in female pregnancy [GO:0060135]; mRNA stabilization [GO:0048255]; multicellular organism growth [GO:0035264]; negative regulation of autophagy [GO:0010507]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cell size [GO:0045792]; negative regulation of cholangiocyte apoptotic process [GO:1904193]; negative regulation of iodide transmembrane transport [GO:1904213]; negative regulation of macroautophagy [GO:0016242]; negative regulation of muscle atrophy [GO:0014736]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; phosphorylation [GO:0016310]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cholangiocyte proliferation [GO:1904056]; positive regulation of cytoplasmic translational initiation [GO:1904690]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of eating behavior [GO:1904000]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulosa cell proliferation [GO:1904197]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of myotube differentiation [GO:0010831]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron maturation [GO:0014042]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sensory perception of pain [GO:1904058]; positive regulation of skeletal muscle hypertrophy [GO:1904206]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase III [GO:0045945]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; positive regulation of translation [GO:0045727]; positive regulation of wound healing; spreading of epidermal cells [GO:1903691]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of brown fat cell differentiation [GO:0090335]; regulation of carbohydrate utilization [GO:0043610]; regulation of cell growth [GO:0001558]; regulation of cell size [GO:0008361]; regulation of cellular response to heat [GO:1900034]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of GTPase activity [GO:0043087]; regulation of macroautophagy [GO:0016241]; regulation of membrane permeability [GO:0090559]; regulation of myelination [GO:0031641]; regulation of osteoclast differentiation [GO:0045670]; regulation of response to food [GO:0032095]; regulation of translation at synapse; modulating synaptic transmission [GO:0099547]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to cocaine [GO:0042220]; response to insulin [GO:0032868]; response to morphine [GO:0043278]; response to nutrient [GO:0007584]; ruffle organization [GO:0031529]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; T-helper 1 cell lineage commitment [GO:0002296]; TOR signaling [GO:0031929]; TORC1 signaling [GO:0038202]; visual learning [GO:0008542]; voluntary musculoskeletal movement [GO:0050882]; wound healing [GO:0042060],NA,NA,NA
CHOYP_MTPN.2.2.m.58730,-0.00161318950103058,-0.00250836694907462,No,NA,NA,Q55FM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; negative regulation of barbed-end actin filament capping [GO:2000813],NA,NA,NA
CHOYP_MTR_027S0011.1.1.m.29241,-0.0021470098621298,-0.00330650608704165,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MTR_7G016900.1.1.m.39323,0.00778653043339137,-0.0083594995583377,No,NA,NA,Q9FMB4,NA,NA,NA,HAUS complex [GO:0070652]; phragmoplast [GO:0009524]; spindle microtubule [GO:0005876]; microtubule minus-end binding [GO:0051011]; cell division [GO:0051301]; spindle assembly [GO:0051225],NA,NA,NA
CHOYP_MTR1.1.1.m.59840,-0.0225451858585809,0.0128868460231232,No,NA,NA,Q803R5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; nucleic acid binding [GO:0003676]; 7-methylguanosine mRNA capping [GO:0006370]; cap1 mRNA methylation [GO:0097309]; mRNA methylation [GO:0080009],NA,NA,NA
CHOYP_MTSS1.1.1.1.m.41595,-0.00971085012672781,-0.00260238043585789,No,NA,NA,O43312,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; endocytic vesicle [GO:0030139]; ruffle [GO:0001726]; actin monomer binding [GO:0003785]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; cellular response to fluid shear stress [GO:0071498]; epithelial cell proliferation involved in renal tubule morphogenesis [GO:2001013]; glomerulus morphogenesis [GO:0072102]; microspike assembly [GO:0030035]; negative regulation of epithelial cell proliferation [GO:0050680]; nephron tubule epithelial cell differentiation [GO:0072160]; plasma membrane organization [GO:0007009]; renal tubule morphogenesis [GO:0061333]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_MTX1.1.1.m.43691,3.41724938641393e-05,0.0169196389943023,No,NA,NA,Q27HK4,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial sorting and assembly machinery complex [GO:0001401]; protein transport [GO:0015031],NA,NA,NA
CHOYP_MUC1.1.5.m.5910,-0.0232046844180967,0.0104819608885624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC21.1.1.m.41811,-0.0155873586023962,-0.00397519693758755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC4.1.1.m.41314,0.00959390971919166,0.0132703298207505,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5A.1.2.m.43407,0.0104988012061743,0.00123461046674885,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MUC5AC.1.2.m.17430,0.00541392178540409,0.00639370235280448,No,NA,NA,O35276,NA,NA,NA,axon [GO:0030424]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649],NA,NA,NA
CHOYP_MUC5B.1.1.m.15734,0,0,No,NA,NA,Q685J3,NA,NA,NA,apical plasma membrane [GO:0016324]; collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; extracellular matrix constituent; lubricant activity [GO:0030197]; PDZ domain binding [GO:0030165]; cellular homeostasis [GO:0019725]; O-glycan processing [GO:0016266]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_MUG2.1.1.m.55656,-0.00170956702160173,0.00759784973233166,No,NA,NA,Q6IE52,NA,NA,NA,extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_MUTA.1.1.m.31799,-0.00132154020481113,0.000675473160957969,No,NA,NA,P22033,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cobalamin binding [GO:0031419]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; methylmalonyl-CoA mutase activity [GO:0004494]; modified amino acid binding [GO:0072341]; protein homodimerization activity [GO:0042803]; cobalamin metabolic process [GO:0009235]; homocysteine metabolic process [GO:0050667]; positive regulation of GTPase activity [GO:0043547]; post-embryonic development [GO:0009791],NA,NA,NA
CHOYP_MVD1.1.1.m.28700,-0.0107238924687355,0.00890218447619511,No,NA,NA,Q99JF5,NA,NA,NA,cytosol [GO:0005829]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; ATP binding [GO:0005524]; diphosphomevalonate decarboxylase activity [GO:0004163]; Hsp70 protein binding [GO:0030544]; protein homodimerization activity [GO:0042803]; cholesterol biosynthetic process [GO:0006695]; isopentenyl diphosphate biosynthetic process; mevalonate pathway [GO:0019287]; isoprenoid biosynthetic process [GO:0008299]; positive regulation of cell proliferation [GO:0008284],NA,NA,NA
CHOYP_MVP.1.1.m.56230,0.000391262401238966,-0.000671976303524588,No,NA,NA,Q5EAJ7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634],NA,NA,NA
CHOYP_MYBA.1.1.m.48052,0.00319370486687439,0.0115839242225716,No,NA,NA,P10242,NA,NA,NA,nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; chromatin remodeling [GO:0006338]; mitotic cell cycle [GO:0000278]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of hepatic stellate cell proliferation [GO:1904899]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper cell differentiation [GO:0045624]; positive regulation of testosterone secretion [GO:2000845]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of transcription; DNA-templated [GO:0006355]; response to hypoxia [GO:0001666],NA,NA,NA
CHOYP_MYBPP.1.1.m.45264,-5.77862347024502e-05,0.00766684280904723,No,NA,NA,Q8TBZ2,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_MYBV.1.1.m.62683,0.00195534318973364,0.00127242483408115,No,NA,NA,Q54P70,NA,NA,NA,cysteine-type peptidase activity [GO:0008234],NA,NA,NA
CHOYP_MYBX.3.4.m.53061,-4.1051961968066e-05,0.0054466075014713,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYCB2.1.2.m.13017,0.00303591377321218,-0.00411859827072827,No,NA,NA,O75592,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein homodimerization activity [GO:0042803]; Ran GTPase binding [GO:0008536]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; branchiomotor neuron axon guidance [GO:0021785]; central nervous system projection neuron axonogenesis [GO:0021952]; negative regulation of protein catabolic process [GO:0042177]; neuromuscular process [GO:0050905]; protein ubiquitination [GO:0016567]; regulation of axon guidance [GO:1902667]; regulation of cytoskeleton organization [GO:0051493]; regulation of protein localization [GO:0032880],NA,NA,NA
CHOYP_MYCBP2.1.1.m.27070,-0.000635471556415197,-0.00302006307886326,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYD88.2.7.m.21423,-0.0125823781549518,-0.0155768645382262,No,NA,NA,A8QMS7,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_MYD88.4.7.m.31202,0.00596699999510219,0.00704687349025335,No,NA,NA,Q5XJ85,NA,NA,NA,cytoplasm [GO:0005737]; TIR domain binding [GO:0070976]; activation of innate immune response [GO:0002218]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; monocyte activation [GO:0042117]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; response to molecule of bacterial origin [GO:0002237],NA,NA,NA
CHOYP_MYD88.5.7.m.41603,0.00303490947502327,-0.00082011922326419,No,NA,NA,Q99836,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; death receptor binding [GO:0005123]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; TIR domain binding [GO:0070976]; 3'-UTR-mediated mRNA stabilization [GO:0070935]; apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to mechanical stimulus [GO:0071260]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; response to interleukin-1 [GO:0070555]; signal transduction [GO:0007165]; toll-like receptor 9 signaling pathway [GO:0034162]; toll-like receptor signaling pathway [GO:0002224]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_MYEF2.1.1.m.18999,-0.00273867704654102,-0.00253262616029831,No,NA,NA,Q8C854,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; ribonucleoprotein complex [GO:1990904]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; mRNA binding [GO:0003729]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of mRNA stability involved in response to oxidative stress [GO:2000815],NA,NA,NA
CHOYP_MYG1.1.1.m.4971,0.000361856258955307,-0.000298604891545483,No,NA,NA,Q9JK81,NA,NA,NA,mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; locomotory exploration behavior [GO:0035641],NA,NA,NA
CHOYP_MYO15.1.1.m.66281,-0.00784350093442988,0.00525240353034129,No,NA,NA,Q9UKN7,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; stereocilium [GO:0032420]; actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO16.4.4.m.65831,-2.95214891494391e-05,-0.00085226854663266,No,NA,NA,Q9Y6X6,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; motor activity [GO:0003774]; cerebellum development [GO:0021549]; negative regulation of cell proliferation [GO:0008285]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134],NA,NA,NA
CHOYP_MYO18.1.1.m.3952,0.00290661220460653,-0.00768384983256334,No,NA,NA,Q92614,NA,NA,NA,actomyosin [GO:0042641]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; myosin complex [GO:0016459]; trans-Golgi network [GO:0005802]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; actomyosin structure organization [GO:0031032]; asymmetric Golgi ribbon formation [GO:0090164]; cell migration [GO:0016477]; DNA metabolic process [GO:0006259]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; Golgi vesicle budding [GO:0048194]; negative regulation of apoptotic process [GO:0043066]; positive regulation of opsonization [GO:1903028]; positive regulation of protein secretion [GO:0050714]; regulation of macrophage activation [GO:0043030],NA,NA,NA
CHOYP_MYO1B.1.1.m.53598,-0.0121058289327427,0.000125347640739117,No,NA,NA,P46735,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; brush border [GO:0005903]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; filopodium [GO:0030175]; myosin complex [GO:0016459]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; actin filament bundle assembly [GO:0051017]; actin filament organization [GO:0007015]; actin filament-based movement [GO:0030048]; post-Golgi vesicle-mediated transport [GO:0006892]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_MYO1E.1.1.m.49109,-0.00691622596146188,-0.000877822278793991,No,NA,NA,Q12965,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; motor activity [GO:0003774]; phosphatidylinositol binding [GO:0035091]; actin filament-based movement [GO:0030048]; endocytosis [GO:0006897]; glomerular basement membrane development [GO:0032836]; glomerular filtration [GO:0003094]; glomerular visceral epithelial cell development [GO:0072015]; in utero embryonic development [GO:0001701]; nitrogen compound metabolic process [GO:0006807]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic hemopoiesis [GO:0035166]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_MYO22.2.2.m.24750,0.00439861059430229,-0.00298022018877418,No,NA,NA,Q9U1M8,NA,NA,NA,cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; membrane [GO:0016020]; myosin complex [GO:0016459]; phagocytic cup [GO:0001891]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; microtubule binding [GO:0008017]; motor activity [GO:0003774]; protein self-association [GO:0043621]; actin filament-based movement [GO:0030048]; cell morphogenesis [GO:0000902]; cell-substrate adhesion [GO:0031589]; filopodium assembly [GO:0046847]; phagocytosis [GO:0006909]; spore germination [GO:0009847],NA,NA,NA
CHOYP_MYO3.2.2.m.59993,0.00310701662131278,0.0221224492917866,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYO3AL.1.1.m.8123,-0.0145762070039165,-0.00443443089098246,No,NA,NA,Q1EG27,NA,NA,NA,cytoplasm [GO:0005737]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426]; actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine/threonine kinase activity [GO:0004674]; auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; response to stimulus [GO:0050896]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO5A.2.4.m.11575,0.00576916163693842,0.00346958209086765,No,NA,NA,Q9Y4I1,NA,NA,NA,actomyosin [GO:0042641]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium tip [GO:0032433]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; growth cone [GO:0030426]; insulin-responsive compartment [GO:0032593]; intermediate filament [GO:0005882]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule plus-end [GO:0035371]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; postsynapse [GO:0098794]; ruffle [GO:0001726]; smooth endoplasmic reticulum [GO:0005790]; unconventional myosin complex [GO:0016461]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; microfilament motor activity [GO:0000146]; Rab GTPase binding [GO:0017137]; RNA binding [GO:0003723]; actin filament-based movement [GO:0030048]; cellular response to insulin stimulus [GO:0032869]; chemical synaptic transmission [GO:0007268]; establishment of endoplasmic reticulum localization to postsynapse [GO:0099089]; exocytosis [GO:0006887]; hair follicle maturation [GO:0048820]; insulin secretion [GO:0030073]; locomotion involved in locomotory behavior [GO:0031987]; long-chain fatty acid biosynthetic process [GO:0042759]; melanin biosynthetic process [GO:0042438]; melanocyte differentiation [GO:0030318]; melanosome transport [GO:0032402]; myelination [GO:0042552]; odontogenesis [GO:0042476]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to plasma membrane [GO:0072659]; regulation of inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0031585]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; secretory granule localization [GO:0032252]; synapse organization [GO:0050808]; vesicle transport along actin filament [GO:0030050]; vesicle-mediated transport [GO:0016192]; visual perception [GO:0007601],NA,NA,NA
CHOYP_MYO6.1.1.m.4131,0.000484170183917877,-0.000680975745239876,No,NA,NA,Q9UM54,NA,NA,NA,actin filament [GO:0005884]; apical part of cell [GO:0045177]; cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle membrane [GO:0030665]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus [GO:0005902]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; RNA polymerase II; holoenzyme [GO:0016591]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; unconventional myosin complex [GO:0016461]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; minus-end directed microfilament motor activity [GO:0060001]; motor activity [GO:0003774]; actin filament-based movement [GO:0030048]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of secretion [GO:0051046]; response to drug [GO:0042493]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.1.3.m.59205,0.000776704248425719,-0.000599599239957945,No,NA,NA,Q17LW0,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYO7A.2.3.m.63360,0.0160531154472561,-0.00245877953634308,No,NA,NA,Q17LW0,NA,NA,NA,cytoplasm [GO:0005737]; myosin complex [GO:0016459]; actin filament binding [GO:0051015]; actin-dependent ATPase activity [GO:0030898]; ATP binding [GO:0005524]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; actin filament-based movement [GO:0030048]; antennal morphogenesis [GO:0048800]; chaeta morphogenesis [GO:0008407]; imaginal disc-derived wing hair organization [GO:0035317]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_MYOF.3.3.m.53228,-0.00218569958270035,0.00472900156417574,No,NA,NA,Q9ESD7,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; late endosome [GO:0005770]; membrane microdomain [GO:0098857]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; T-tubule [GO:0030315]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; microtubule binding [GO:0008017]; phospholipid binding [GO:0005543]; angiogenesis [GO:0001525]; cellular response to osmotic stress [GO:0071470]; cytokine secretion [GO:0050663]; fat cell differentiation [GO:0045444]; glycerol metabolic process [GO:0006071]; lipid storage [GO:0019915]; macrophage activation involved in immune response [GO:0002281]; monocyte activation involved in immune response [GO:0002280]; muscle fiber development [GO:0048747]; negative regulation of gene expression [GO:0010629]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of phagocytosis [GO:0050765]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein polyubiquitination [GO:1902915]; plasma membrane repair [GO:0001778]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; regulation of calcium ion import [GO:0090279]; skeletal muscle tissue regeneration [GO:0043403]; T-tubule organization [GO:0033292]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_MYPH.1.2.m.36560,0.00128449367093202,0.000172264235726716,No,NA,NA,Q24799,NA,NA,NA,,NA,NA,NA
CHOYP_MYS.1.7.m.433,-0.00134461863449326,-0.000391734932171202,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.1.7.m.435,-0.00191156595648693,0.00230331399659896,No,NA,NA,Q32LJ4,NA,NA,NA,calyx of Held [GO:0044305]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; regulation of synaptic transmission; glutamatergic [GO:0051966],NA,NA,NA
CHOYP_MYS.2.7.m.2064,0.00785092034380299,-0.00519379322347974,No,NA,NA,Q2VJ60,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; microtubule organizing center [GO:0005815]; postsynapse [GO:0098794]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_MYS.2.7.m.2069,0.00556597427247151,-0.0124085903179917,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2070,-0.000801286888242275,-0.000790022657918783,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.2.7.m.2075,-0.00299125198865169,0.0012847247875356,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.4.7.m.18188,0.000970097834721271,-0.000610434047244857,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.7.7.m.44341,-0.00122160822343613,-0.000725813961667668,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS.7.7.m.44342,0.000503539552933631,-0.00226911447567155,No,NA,NA,P24733,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYS3.1.2.m.31829,-0.0226034459665221,-0.0143847772168218,No,NA,NA,Q91ZR3,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; negative regulation of gene expression; epigenetic [GO:0045814]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of DNA-binding transcription factor activity [GO:0051090]; response to virus [GO:0009615]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_MYSP.1.9.m.1097,0.0107133913671726,-0.00568925403911787,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.1.9.m.1100,0.00286475586643098,-0.00412189302446779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_MYSP.4.9.m.2302,-0.00422023035041412,0.00406983334447635,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.5.9.m.28124,-0.0165330558298327,-0.033420364053397,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSP.8.9.m.44813,-0.00996165537787437,-0.00974245528473347,No,NA,NA,O96064,NA,NA,NA,myofibril [GO:0030016]; myosin filament [GO:0032982]; motor activity [GO:0003774],NA,NA,NA
CHOYP_MYSTI_04398.1.1.m.27734,-0.0188105217482935,-0.0119709696071186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_N2F1A.1.1.m.63063,0.0218864497712744,-0.0158124816746967,No,NA,NA,Q06725,NA,NA,NA,nucleus [GO:0005634]; nuclear receptor activity [GO:0004879]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; atrial cardiac muscle cell differentiation [GO:0055011]; cardiac atrium morphogenesis [GO:0003209]; endothelial cell proliferation [GO:0001935]; vasculature development [GO:0001944],NA,NA,NA
CHOYP_NAA15.1.1.m.34959,0.000507837507853389,-0.000757750155596275,No,NA,NA,Q9BXJ9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription; DNA-templated [GO:0045893]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NAA25.1.1.m.11255,0.000882707914460396,-0.00243442526656318,No,NA,NA,Q14CX7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416]; N-terminal peptidyl-methionine acetylation [GO:0017196],NA,NA,NA
CHOYP_NAA35.1.1.m.60092,-0.00617689577628925,-0.0171612613860247,No,NA,NA,Q5ZHV2,NA,NA,NA,cytoplasm [GO:0005737]; NatC complex [GO:0031417]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; smooth muscle cell proliferation [GO:0048659],NA,NA,NA
CHOYP_NACA.2.9.m.11875,0.000298433790879355,-0.00177386730224125,No,NA,NA,Q8AWF2,NA,NA,NA,nascent polypeptide-associated complex [GO:0005854]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NAEGRDRAFT_47557.1.1.m.11283,-0.0212983224403158,0.00929007698602987,No,NA,NA,Q0VD31,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NAEGRDRAFT_49892.1.1.m.10608,-7.10996463897338e-05,0.00943321217337967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAEGRDRAFT_71860.1.1.m.2556,-5.11341166114653e-05,0.00678426681126136,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NAF1.1.1.m.13716,0.00273538973897718,-0.000739180435699025,No,NA,NA,Q52KK4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; small nucleolar ribonucleoprotein complex [GO:0005732]; RNA binding [GO:0003723]; box H/ACA snoRNP assembly [GO:0000493]; pseudouridine synthesis [GO:0001522]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NAGLU.2.2.m.60267,-0.00150182497392868,0.00182514498440299,No,NA,NA,P54802,NA,NA,NA,extracellular exosome [GO:0070062]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; alpha-N-acetylglucosaminidase activity [GO:0004561]; cerebellar Purkinje cell layer development [GO:0021680]; glycosaminoglycan catabolic process [GO:0006027]; inner ear receptor cell development [GO:0060119]; locomotor rhythm [GO:0045475]; lysosome organization [GO:0007040]; middle ear morphogenesis [GO:0042474]; nervous system development [GO:0007399]; retinal rod cell development [GO:0046548],NA,NA,NA
CHOYP_NAGT1.1.1.m.8857,0.0114777500977075,-0.0208376556424559,No,NA,NA,Q8VCV9,NA,NA,NA,apical plasma membrane [GO:0016324]; integral component of membrane [GO:0016021]; glucose transmembrane transporter activity [GO:0005355]; symporter activity [GO:0015293]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_NAS13.1.1.m.30415,-0.0157092950548216,-0.00268645535756691,No,NA,NA,P42674,NA,NA,NA,cell cortex [GO:0005938]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NASP.2.4.m.13404,-0.00219346558024788,-0.00502707176413596,No,NA,NA,Q02508,NA,NA,NA,nucleus [GO:0005634]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NASP.4.4.m.56613,-0.0206684283236355,0.0275563761309072,No,NA,NA,P49321,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; histone binding [GO:0042393]; protein-containing complex binding [GO:0044877]; blastocyst development [GO:0001824]; cell proliferation [GO:0008283]; CENP-A containing nucleosome assembly [GO:0034080]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336]; G1/S transition of mitotic cell cycle [GO:0000082]; histone exchange [GO:0043486]; male gonad development [GO:0008584]; nucleosome assembly [GO:0006334]; protein transport [GO:0015031]; response to testosterone [GO:0033574],NA,NA,NA
CHOYP_NAV2.1.3.m.9737,0.00121982584885358,0.00084527099323979,No,NA,NA,Q8IVL1,NA,NA,NA,interstitial matrix [GO:0005614]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; heparin binding [GO:0008201]; glossopharyngeal nerve development [GO:0021563]; locomotory behavior [GO:0007626]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; optic nerve development [GO:0021554]; regulation of systemic arterial blood pressure by baroreceptor feedback [GO:0003025]; sensory perception of smell [GO:0007608]; sensory perception of sound [GO:0007605]; vagus nerve development [GO:0021564],NA,NA,NA
CHOYP_NBEL1.1.1.m.33217,0.00112455622250359,0.0064000294695126,No,NA,NA,Q6ZS30,NA,NA,NA,,NA,NA,NA
CHOYP_NC2A.1.1.m.22786,0,0,No,NA,NA,Q14919,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NCAH.1.5.m.8672,-0.00740229613429411,-0.00133821552906056,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCAH.3.5.m.51972,0.0214738059872795,0.0299010526252656,No,NA,NA,P42325,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NCBP2.1.1.m.60410,-0.0160419796913189,0.00299862678671875,No,NA,NA,B4KCD5,NA,NA,NA,nuclear cap binding complex [GO:0005846]; nucleus [GO:0005634]; RNA cap binding [GO:0000339]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of viral genome replication [GO:0045071]; primary miRNA processing [GO:0031053]; production of siRNA involved in RNA interference [GO:0030422],NA,NA,NA
CHOYP_NCDN.1.1.m.58381,-0.00996230204400415,0.0117282262474721,No,NA,NA,Q640K1,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_NCER_101848.1.1.m.63547,0.00145594966352133,0.00994995902025784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCKP1.1.4.m.24694,0.00137044635503989,0.0032870491090326,No,NA,NA,P28660,NA,NA,NA,filamentous actin [GO:0031941]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; postsynapse [GO:0098794]; ruffle [GO:0001726]; SCAR complex [GO:0031209]; protein-containing complex binding [GO:0044877]; apical protein localization [GO:0045176]; basal protein localization [GO:0045175]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell morphogenesis [GO:0000902]; cell projection assembly [GO:0030031]; cortical actin cytoskeleton organization [GO:0030866]; embryonic body morphogenesis [GO:0010172]; embryonic foregut morphogenesis [GO:0048617]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; establishment or maintenance of actin cytoskeleton polarity [GO:0030950]; in utero embryonic development [GO:0001701]; lamellipodium assembly [GO:0030032]; mesodermal cell migration [GO:0008078]; neural tube closure [GO:0001843]; neuron projection morphogenesis [GO:0048812]; notochord development [GO:0030903]; notochord morphogenesis [GO:0048570]; paraxial mesoderm development [GO:0048339]; paraxial mesoderm morphogenesis [GO:0048340]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; protein stabilization [GO:0050821]; Rac protein signal transduction [GO:0016601]; regulation of protein localization [GO:0032880]; somitogenesis [GO:0001756]; zygotic determination of anterior/posterior axis; embryo [GO:0007354],NA,NA,NA
CHOYP_NCLIV_053520.1.1.m.8896,-0.00236978582834205,-0.00212941663072412,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NCOA4.1.1.m.5549,0.00298888941090373,0.0170746530691857,No,NA,NA,Q13772,NA,NA,NA,autolysosome [GO:0044754]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; transcription coactivator activity [GO:0003713]; androgen receptor signaling pathway [GO:0030521]; cellular iron ion homeostasis [GO:0006879]; male gonad development [GO:0008584]; positive regulation of transcription; DNA-templated [GO:0045893]; protein targeting to lysosome [GO:0006622],NA,NA,NA
CHOYP_NCU02236.1.1.m.28628,-0.0171447672496659,0.0256682521023227,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ND1.2.5.m.36938,0.0020472033795584,-0.00281192794344542,No,NA,NA,Q61425,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; NAD+ binding [GO:0070403]; fatty acid beta-oxidation [GO:0006635]; negative regulation of insulin secretion [GO:0046676]; positive regulation of cold-induced thermogenesis [GO:0120162]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to insulin [GO:0032868],NA,NA,NA
CHOYP_ND1.4.5.m.42588,-0.000332634854048996,-0.00196406648209037,No,NA,NA,Q9ER88,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; structural constituent of ribosome [GO:0003735]; apoptotic mitochondrial changes [GO:0008637],NA,NA,NA
CHOYP_ND4.3.5.m.19536,0.000197673751383653,0.000514073963943522,No,NA,NA,F1LQ48,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; ribonucleoprotein complex [GO:1990904]; ribonucleoprotein granule [GO:0035770]; mRNA 3'-UTR binding [GO:0003730]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; transcription regulatory region DNA binding [GO:0044212]; cellular response to amino acid starvation [GO:0034198]; circadian rhythm [GO:0007623]; mRNA processing [GO:0006397]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to peptide [GO:1901652],NA,NA,NA
CHOYP_NDK7.1.1.m.64883,-0.00407136118114195,-0.00377558179763115,No,NA,NA,Q9Y5B8,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; nucleoside diphosphate kinase activity [GO:0004550]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_NDL1A.1.1.m.10230,-0.0026368372424187,-0.0210854220767761,No,NA,NA,Q9CZA6,NA,NA,NA,centrosome [GO:0005813]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; spindle [GO:0005819]; spindle pole centrosome [GO:0031616]; synapse [GO:0045202]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; centrosome localization [GO:0051642]; cerebral cortex development [GO:0021987]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; forebrain development [GO:0030900]; microtubule nucleation [GO:0007020]; microtubule organizing center organization [GO:0031023]; mitotic centrosome separation [GO:0007100]; neuroblast proliferation [GO:0007405]; neuron migration [GO:0001764]; regulation of microtubule motor activity [GO:2000574]; vesicle transport along microtubule [GO:0047496],NA,NA,NA
CHOYP_NDUA5.1.2.m.2750,-0.0103139107013163,-0.0166394907320252,No,NA,NA,Q18359,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_NDUFA7.2.2.m.57153,0.00170124498570479,-0.00144985645675234,No,NA,NA,Q9Z1P6,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; structural constituent of ribosome [GO:0003735]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_NDUFB7.1.1.m.27222,-0.0181302677497157,0.00887946515294512,No,NA,NA,P90789,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; respirasome [GO:0070469]; NADH dehydrogenase (ubiquinone) activity [GO:0008137],NA,NA,NA
CHOYP_NDUFB9.1.2.m.37494,-0.00844763834419773,0.0113456456638954,No,NA,NA,Q02369,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120]; mitochondrial respiratory chain complex I assembly [GO:0032981],NA,NA,NA
CHOYP_NDUFS4.1.1.m.66417,-0.000628325672934041,0.00172805450719093,No,NA,NA,P0CB96,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; brain development [GO:0007420]; cAMP-mediated signaling [GO:0019933]; cellular respiration [GO:0045333]; electron transport chain [GO:0022900]; mitochondrial respiratory chain complex I assembly [GO:0032981]; positive regulation of fibroblast proliferation [GO:0048146]; reactive oxygen species metabolic process [GO:0072593]; response to cAMP [GO:0051591],NA,NA,NA
CHOYP_NEC1.1.1.m.63094,-0.0093022963136393,-0.0169069302353215,No,NA,NA,P28840,NA,NA,NA,axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]; trans-Golgi network [GO:0005802]; transport vesicle [GO:0030133]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; insulin binding [GO:0043559]; protein-containing complex binding [GO:0044877]; serine-type endopeptidase activity [GO:0004252]; neurogenesis [GO:0022008]; pancreas development [GO:0031016]; peptide hormone processing [GO:0016486]; pituitary gland development [GO:0021983]; positive regulation of protein secretion [GO:0050714]; protein autoprocessing [GO:0016540]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to axon injury [GO:0048678]; response to calcium ion [GO:0051592]; response to chlorate [GO:0010157]; response to drug [GO:0042493]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to inorganic substance [GO:0010035]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NECA3.1.1.m.106,-0.00340157930263288,0.00601643795151079,No,NA,NA,Q9ESB5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; calcium ion binding [GO:0005509]; blastocyst hatching [GO:0001835]; regulation of amyloid precursor protein biosynthetic process [GO:0042984],NA,NA,NA
CHOYP_NECX.1.1.m.56979,-0.00140935356751821,-0.000272431687579165,No,NA,NA,Q16982,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NED4L.1.1.m.7792,-0.0047486919218821,0.00549241652633766,No,NA,NA,Q62940,NA,NA,NA,cytoplasm [GO:0005737]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; immune response [GO:0006955]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; neuromuscular junction development [GO:0007528]; neuron projection development [GO:0031175]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein targeting to lysosome [GO:0006622]; protein ubiquitination [GO:0016567]; receptor catabolic process [GO:0032801]; receptor internalization [GO:0031623]; regulation of dendrite morphogenesis [GO:0048814]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process at postsynapse; modulating synaptic transmission [GO:0099576]; regulation of synapse organization [GO:0050807]; response to denervation involved in regulation of muscle adaptation [GO:0014894]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEDD1.1.1.m.10741,0.000690232277553563,0.01826911349569,No,NA,NA,P33215,NA,NA,NA,apical part of cell [GO:0045177]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; gamma-tubulin ring complex; centrosomal [GO:0000924]; pericentriolar material [GO:0000242]; spindle pole [GO:0000922]; cell cycle [GO:0007049]; cell division [GO:0051301]; microtubule depolymerization [GO:0007019]; microtubule polymerization or depolymerization [GO:0031109]; protein localization to centrosome [GO:0071539]; regulation of establishment of protein localization [GO:0070201],NA,NA,NA
CHOYP_NEFH.1.2.m.59956,0.003345938600409,0.0117514986430489,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEK1.1.5.m.9137,-0.00761019399306401,-0.0125693447608523,No,NA,NA,P51954,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK1.4.5.m.32116,-0.00128356257285211,-0.0138269188646942,No,NA,NA,P51954,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cilium assembly [GO:0060271]; DNA damage response; detection of DNA damage [GO:0042769]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of DNA damage checkpoint [GO:2000001]; response to ionizing radiation [GO:0010212]; signal transduction by protein phosphorylation [GO:0023014]; spermatogenesis [GO:0007283]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEK9.1.1.m.19497,-0.00444352749765525,0.00607835546224238,No,NA,NA,Q8TD19,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic nuclear envelope disassembly [GO:0007077],NA,NA,NA
CHOYP_NELFB.1.2.m.9922,-0.00327120580592224,-0.0130899650942331,No,NA,NA,Q9Y113,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; RNA binding [GO:0003723]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NEMF.1.1.m.57807,0.00430053760069154,-0.00306772468105647,No,NA,NA,Q8CCP0,NA,NA,NA,nucleus [GO:0005634]; RQC complex [GO:1990112]; ribosomal large subunit binding [GO:0043023]; tRNA binding [GO:0000049]; nuclear export [GO:0051168]; rescue of stalled ribosome [GO:0072344]; ribosome-associated ubiquitin-dependent protein catabolic process [GO:1990116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.1.2.m.26774,-0.00475608223146977,0.00220608482863357,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G100691.2.2.m.65547,-0.000169474749181454,0.00210614815795916,No,NA,NA,F8WLE0,NA,NA,NA,intracellular [GO:0005622]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrial membrane [GO:0031966]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777]; cytoskeleton-dependent intracellular transport [GO:0030705]; microtubule-based movement [GO:0007018]; mitochondrion organization [GO:0007005]; organelle transport along microtubule [GO:0072384],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G106520.1.1.m.14881,-0.0116628554002539,0.00490329258082945,No,NA,NA,P50532,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein heterodimerization activity [GO:0046982]; cell division [GO:0051301]; mitotic chromosome condensation [GO:0007076],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G114289.1.1.m.17188,0.0248620506293481,-0.00166161833521467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120119.1.2.m.6082,0.00213107272737292,0.00173710490431691,No,NA,NA,P28825,NA,NA,NA,membrane [GO:0016020]; meprin A complex [GO:0017090]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G120526.4.5.m.36926,-0.0201596448734445,0.00470019564788873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122785.1.1.m.57840,-0.00622523849808778,0.00943523529563191,No,NA,NA,P33450,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell morphogenesis involved in differentiation [GO:0000904]; cell proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; peptide cross-linking [GO:0018149]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length; open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]; Wnt signaling pathway; planar cell polarity pathway [GO:0060071],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G122840.1.2.m.28819,0.0050515866942011,-0.0231772158823945,No,NA,NA,Q4R7T5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G135670.1.1.m.18689,-0.00225328678055397,-0.00470094600386047,No,NA,NA,Q52I78,NA,NA,NA,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; cytokine activity [GO:0005125]; nicotinamide phosphoribosyltransferase activity [GO:0047280]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; circadian regulation of gene expression [GO:0032922]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G140878.1.1.m.18069,-0.00326540239399411,0.00214702170089704,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G141380.2.4.m.8974,0.00266634989575546,-0.000720523898143867,No,NA,NA,P10079,NA,NA,NA,apical lamina of hyaline layer [GO:0032579]; cytoplasmic vesicle [GO:0031410]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154303.1.1.m.3521,-0.00552090402722607,0.00549045940067477,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G154974.1.1.m.44261,0.0149543655054548,-0.00137350369392757,No,NA,NA,Q9Y1A3,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; metal ion binding [GO:0046872]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; chaperone-mediated protein transport [GO:0072321]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157638.1.1.m.31214,-0.00678341070752286,0.00615552911764314,No,NA,NA,Q16820,NA,NA,NA,extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; meprin A complex [GO:0017090]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G157950.1.1.m.4584,0.00214318360133709,-1.34157542274944e-05,No,NA,NA,A2VD82,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G159364.1.1.m.22912,-0.00605260892954105,-0.0124246829784374,No,NA,NA,P79781,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic small ribosomal subunit [GO:0022627]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein tag [GO:0031386]; structural constituent of ribosome [GO:0003735]; ubiquitin protein ligase binding [GO:0031625]; DNA repair [GO:0006281]; modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G160170.1.1.m.66042,-0.0145025677784319,-0.00922939833481951,No,NA,NA,P0DJG4,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G162365.1.1.m.8038,0.00105876035732826,0.00229524817160785,No,NA,NA,Q7JZB4,NA,NA,NA,GTP binding [GO:0005525]; mannose-1-phosphate guanylyltransferase activity [GO:0004475]; GDP-mannose biosynthetic process [GO:0009298]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G163820.1.1.m.6391,0.00125268240609123,-0.028391407087836,No,NA,NA,Q5R5L3,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; oxidoreductase activity; acting on a sulfur group of donors; disulfide as acceptor [GO:0016671]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; protein folding in endoplasmic reticulum [GO:0034975]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.1.3.m.46942,0.00322722876510067,0.000622557993401318,No,NA,NA,P46209,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G164392.3.3.m.59979,0.00791624973883365,-0.0143718136946059,No,NA,NA,P46209,NA,NA,NA,hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G166546.1.1.m.10454,-0.0255383229213634,-0.00811003170502615,No,NA,NA,O35130,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; rRNA (pseudouridine) methyltransferase activity [GO:0070037]; rRNA binding [GO:0019843]; blastocyst development [GO:0001824]; nucleologenesis [GO:0017126]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167304.1.1.m.10864,0.0016872282962234,-3.69585381088052e-05,No,NA,NA,P49596,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; presynaptic active zone [GO:0048786]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; MAP kinase serine/threonine phosphatase activity [GO:1990439]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; ubiquitin protein ligase binding [GO:0031625]; cellular response to osmotic stress [GO:0071470]; negative regulation of axon extension [GO:0030517]; negative regulation of stress-activated MAPK cascade [GO:0032873]; positive regulation of synapse assembly [GO:0051965]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167758.1.1.m.66572,-0.00681128267025453,-0.00570918419286009,No,NA,NA,Q5PQQ6,NA,NA,NA,cytoplasm [GO:0005737]; manchette [GO:0002177]; motile cilium [GO:0031514]; sperm flagellum [GO:0036126]; calmodulin binding [GO:0005516]; cilium organization [GO:0044782]; sperm axoneme assembly [GO:0007288]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167835.1.1.m.6190,-0.00380913384323965,-0.00345311680743911,No,NA,NA,Q567Y6,NA,NA,NA,cell [GO:0005623]; intraciliary transport particle B [GO:0030992]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G167853.1.2.m.20047,-0.00936970355968254,-0.00323880691435585,No,NA,NA,A4FU69,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168076.2.2.m.56942,-0.00254104390824879,-6.72086741768604e-05,No,NA,NA,Q54271,NA,NA,NA,phosphonopyruvate decarboxylase activity [GO:0033980]; thiamine pyrophosphate binding [GO:0030976]; antibiotic biosynthetic process [GO:0017000]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168163.1.1.m.63148,0.00171901922360036,-0.00191820604816655,No,NA,NA,Q9Z2U1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G168923.1.1.m.29344,-0.00553940145774921,-0.000663090191529079,No,NA,NA,O95825,NA,NA,NA,cytosol [GO:0005829]; NADP binding [GO:0050661]; NADPH:quinone reductase activity [GO:0003960]; quinone metabolic process [GO:1901661],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169195.1.1.m.2476,0.000655335667847718,0.00156141980209532,No,NA,NA,P50174,NA,NA,NA,cytoplasm [GO:0005737]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; poly-hydroxybutyrate biosynthetic process [GO:0042619],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.1.2.m.18155,-0.0034914262993417,0.00473987919734472,No,NA,NA,O05218,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G169538.2.2.m.29703,0.00172437834420691,-0.00459197266404115,No,NA,NA,O05218,NA,NA,NA,glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione catabolic process [GO:0006751],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G171044.1.1.m.44527,0.0130948564567461,-0.00649978811498603,No,NA,NA,Q62356,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173323.2.2.m.55211,0.000190587519140473,-0.000309142581742599,No,NA,NA,P28075,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173435.1.1.m.37344,0.0020084100400015,0.0112622790703003,No,NA,NA,Q711T7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; glutaminase activity [GO:0004359]; NAD+ synthase (glutamine-hydrolyzing) activity [GO:0003952]; NAD+ synthase activity [GO:0008795]; NAD biosynthetic process [GO:0009435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13511,0.0022211095407363,-0.00763027876406367,No,NA,NA,O62742,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; lipid binding [GO:0008289]; propanoyl-CoA C-acyltransferase activity [GO:0033814]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G173950.1.1.m.13512,-0.000366068738185586,0.000751911329297481,No,NA,NA,Q6PAY8,NA,NA,NA,peroxisome [GO:0005777]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179696.1.1.m.40556,0.0316200455036965,0.00297622361850468,No,NA,NA,P18426,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G179716.1.1.m.55972,-0.000540227092624658,-0.000218549913300679,No,NA,NA,P15651,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; acyl-CoA dehydrogenase activity [GO:0003995]; butyryl-CoA dehydrogenase activity [GO:0004085]; fatty-acyl-CoA binding [GO:0000062]; flavin adenine dinucleotide binding [GO:0050660]; butyrate catabolic process [GO:0046359]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA dehydrogenase [GO:0033539]; protein homotetramerization [GO:0051289]; response to glucocorticoid [GO:0051384]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G180651.1.2.m.2808,-0.00167489553589377,-0.00287702331695031,No,NA,NA,P06797,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; lysosome [GO:0005764]; microvillus [GO:0005902]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; vacuole [GO:0005773]; aminopeptidase activity [GO:0004177]; cysteine-type carboxypeptidase activity [GO:0016807]; cysteine-type endopeptidase activity [GO:0004197]; histone binding [GO:0042393]; kininogen binding [GO:0030984]; peptide binding [GO:0042277]; protein-containing complex binding [GO:0044877]; autophagic cell death [GO:0048102]; cell communication [GO:0007154]; cellular response to starvation [GO:0009267]; decidualization [GO:0046697]; hair follicle morphogenesis [GO:0031069]; male gonad development [GO:0008584]; multicellular organism aging [GO:0010259]; negative regulation of keratinocyte proliferation [GO:0010839]; nerve development [GO:0021675]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to gonadotropin [GO:0034698]; response to organic cyclic compound [GO:0014070]; Sertoli cell differentiation [GO:0060008]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G181421.1.1.m.3106,-3.28471176420776e-05,-0.00175304285468953,No,NA,NA,P30837,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; ethanol oxidation [GO:0006069],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G182319.1.1.m.5048,-0.00169910094339084,0.00301025329061263,No,NA,NA,Q5ZIE6,NA,NA,NA,cytoplasm [GO:0005737]; NEDD8 activating enzyme activity [GO:0019781]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G183894.1.1.m.55454,-0.00371977164902247,0.000469164010605189,No,NA,NA,A5A6H9,NA,NA,NA,mitochondrial alpha-ketoglutarate dehydrogenase complex [GO:0005947]; 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO:0003863]; alpha-ketoacid dehydrogenase activity [GO:0003826]; metal ion binding [GO:0046872]; branched-chain amino acid catabolic process [GO:0009083],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G185623.1.1.m.62696,-0.000139999069413917,0.00372271114986687,No,NA,NA,Q54TR1,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; negative regulation of asexual reproduction [GO:1903665]; positive regulation of chemorepellent activity [GO:1903669]; protein localization to plasma membrane [GO:0072659]; proteolysis involved in cellular protein catabolic process [GO:0051603]; sorocarp morphogenesis [GO:0031288]; sporulation resulting in formation of a cellular spore [GO:0030435],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188927.1.1.m.17076,-0.00261419832950669,-0.00502633408330738,No,NA,NA,O05389,NA,NA,NA,oxidoreductase activity [GO:0016491]; NADPH regeneration [GO:0006740],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G188942.1.1.m.6629,0.00179889557186617,0.000413341114883603,No,NA,NA,Q9WUA2,NA,NA,NA,phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; phenylalanine-tRNA ligase activity [GO:0004826]; RNA binding [GO:0003723]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G191841.1.1.m.1745,-0.000992404035976177,-0.000319508372023563,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G192713.1.1.m.16224,-0.000976414164302027,0.00535872866648666,No,NA,NA,O88696,NA,NA,NA,endopeptidase Clp complex [GO:0009368]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP-dependent peptidase activity [GO:0004176]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; protein homooligomerization [GO:0051260]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G193373.1.2.m.19292,0.0052278220273666,-0.00949101995068429,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.1.2.m.11442,-0.003381699706633,-0.0023402042812661,No,NA,NA,Q8WPW2,NA,NA,NA,pyridoxal 5'-phosphate synthase (glutamine hydrolysing) activity [GO:0036381]; pyridoxal phosphate biosynthetic process [GO:0042823],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G194582.2.2.m.40726,-0.00972017477247427,-0.00917719689206682,No,NA,NA,P23606,NA,NA,NA,intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197278.1.1.m.45568,0.00511869638216783,0.00419175363237461,No,NA,NA,A6X391,NA,NA,NA,carboxylic ester hydrolase activity [GO:0052689]; deacetylase activity [GO:0019213]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G197314.1.2.m.61420,0.00635404383184771,-0.000882709167800688,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.1.15.m.3453,0.00240445601126319,-0.00436524806199976,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.12.15.m.51327,0.00717332496674777,-0.0130230466943496,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198667.14.15.m.61843,0.00885550534075462,0.00975771701856304,No,NA,NA,B3EWZ6,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198846.1.1.m.25649,-0.00717455640337979,0.00673175984953487,No,NA,NA,Q8R2L5,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.2.6.m.4748,0.00430528875152664,-0.00396923524681209,No,NA,NA,Q56R14,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G198897.4.6.m.52548,0.00616692751760081,0.00728298275109196,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G199721.1.1.m.64387,-0.0111369808108316,0.0330228875729071,No,NA,NA,Q9UGM1,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cholinergic synapse [GO:0098981]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic specialization membrane [GO:0099060]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; acetylcholine-gated cation-selective channel activity [GO:0022848]; calcium channel activity [GO:0005262]; transmembrane signaling receptor activity [GO:0004888]; chemical synaptic transmission [GO:0007268]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; inner ear morphogenesis [GO:0042472]; ion transmembrane transport [GO:0034220]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; nervous system process [GO:0050877]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; regulation of membrane potential [GO:0042391]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201445.4.5.m.54666,-0.0123923611983644,-0.00788646807627833,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.1.6.m.2876,0.00253404533324967,0.00299264234902543,No,NA,NA,Q04786,NA,NA,NA,beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G201552.4.6.m.22239,0.00297065818281933,-0.000802756688964673,No,NA,NA,P13670,NA,NA,NA,cell outer membrane [GO:0009279]; beta-N-acetylhexosaminidase activity [GO:0004563]; N-acetyl-beta-D-galactosaminidase activity [GO:0102148]; polysaccharide binding [GO:0030247]; chitin catabolic process [GO:0006032]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G202687.1.1.m.8886,-0.00484569888978467,-0.00491404696637784,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60812,-0.00320907153549242,0.00717096253617659,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G203842.1.1.m.60815,0.0113742900410219,-0.00658692094518033,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.1.2.m.15590,0.00259026049748525,-0.0093083143303539,No,NA,NA,Q9R013,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G204928.2.2.m.27972,0.00224309333882308,0.00285949273937557,No,NA,NA,Q9R013,NA,NA,NA,extracellular space [GO:0005615]; lysosome [GO:0005764]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206150.1.1.m.39762,-0.00441151691872315,-0.0203991648508633,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G206950.1.1.m.37574,0.00142048150441205,-0.000414234987527714,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G208725.1.1.m.36498,-0.0172565110231755,-0.0109820010177061,No,NA,NA,Q2KIR0,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212280.3.3.m.30224,0.0243642693726779,0.0144856911695449,No,NA,NA,E7FAM5,NA,NA,NA,P-body [GO:0000932]; miRNA binding [GO:0035198]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryonic body morphogenesis [GO:0010172]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA mediated inhibition of translation [GO:0035278]; miRNA metabolic process [GO:0010586]; neural tube development [GO:0021915]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein polyubiquitination [GO:0000209]; regulation of gene silencing by miRNA [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; stem cell proliferation [GO:0072089],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G212312.2.5.m.45586,0.00169339031341482,-0.0157766958154805,No,NA,NA,Q8K0U4,NA,NA,NA,ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.22.34.m.54623,0,0,No,NA,NA,Q9D9R9,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.25.34.m.55918,0.00556821437432622,0.00657591793107,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.29.34.m.57719,-0.00206997672936585,0.00904812562201791,No,NA,NA,Q6DFV8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214844.9.34.m.28637,-6.02853163964248e-05,0.00799841081331891,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G214960.1.1.m.2485,0.0170164196999912,0.0305182164292657,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G215851.2.2.m.18129,-0.00742059346335976,0.00356523717859093,No,NA,NA,Q49A92,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218264.11.14.m.51529,0.00296932134661489,-0.00080239543763951,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G218914.4.4.m.62116,0.00861848733564364,-0.0111920825247706,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221088.1.1.m.66380,-0.0143910526736459,-0.00915843039740707,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G221688.1.1.m.52819,-0.00240579344632588,-0.0113294273124721,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.3.5.m.31061,-0.0113012424030462,-0.0123869457160449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.4.5.m.31140,-0.0335454392199492,-0.012332905535716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224038.5.5.m.50649,0.0256498782599486,0.0138208246868501,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G224392.2.3.m.36325,-0.0100632086093429,0.0062491370795924,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G226328.1.1.m.11691,0.00161782744043548,0.00493414312041006,No,NA,NA,Q8IVN8,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular matrix structural constituent [GO:0005201]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]; immune response [GO:0006955],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G229510.4.4.m.47762,-0.00239654791026975,0.00599225115455625,No,NA,NA,Q03650,NA,NA,NA,ciliary pocket [GO:0020016]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G230495.1.1.m.61211,0.000803988117148816,0.00145051624384419,No,NA,NA,P52209,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; NADP binding [GO:0050661]; phosphogluconate dehydrogenase (decarboxylating) activity [GO:0004616]; D-gluconate metabolic process [GO:0019521]; oxidation-reduction process [GO:0055114]; pentose biosynthetic process [GO:0019322]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; oxidative branch [GO:0009051],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G232294.1.1.m.22465,0.000964350599292458,-0.000483857324204909,No,NA,NA,P16230,NA,NA,NA,sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233184.1.1.m.18285,-0.0193039657321119,0.011647189725138,No,NA,NA,Q5RC69,NA,NA,NA,dCMP deaminase activity [GO:0004132]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270]; nucleotide biosynthetic process [GO:0009165]; pyrimidine nucleotide metabolic process [GO:0006220],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.6.13.m.49823,-0.0117605461084436,-0.00203536609560893,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G233709.8.13.m.55781,0.0169510675576169,0.00801407694185612,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G234225.1.1.m.49490,0.002456970753116,-0.000448848124649284,No,NA,NA,O77834,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599]; glycerophospholipid catabolic process [GO:0046475]; hydrogen peroxide catabolic process [GO:0042744]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235461.1.1.m.28341,0.027243965903126,0.00138097329416437,No,NA,NA,Q8MP06,NA,NA,NA,extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N;N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19147,-0.00301842665980916,0.00258770362327972,No,NA,NA,Q9CQ62,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 2;4-dienoyl-CoA reductase (NADPH) activity [GO:0008670]; NADPH binding [GO:0070402]; fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235656.1.1.m.19149,-0.00600361275307465,-0.027414876786391,No,NA,NA,Q8CEI1,NA,NA,NA,mitochondrion [GO:0005739],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G235970.1.1.m.34141,-0.00667343341492758,0.00142862625320807,No,NA,NA,Q6DGA6,NA,NA,NA,allantoicase activity [GO:0004037]; allantoin catabolic process [GO:0000256]; purine nucleobase metabolic process [GO:0006144],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.1.2.m.46431,0.00879641003481568,-0.0253870502964254,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236573.2.2.m.47233,-0.00195505432803761,0.000631155113180072,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236653.1.1.m.59422,-0.00303860766757625,0.00412514314712942,No,NA,NA,Q8VBT9,NA,NA,NA,cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506]; glucose homeostasis [GO:0042593]; intracellular protein transport [GO:0006886]; positive regulation of protein modification process [GO:0031401]; regulation of glucose import [GO:0046324],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.3.6.m.24704,-0.000316776623911679,-0.00255791390225784,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.4.6.m.30181,-0.0263068124415843,0.02551593206301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G236658.5.6.m.34525,0.0117170077362553,-0.0249022293508585,No,NA,NA,O07552,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237029.1.1.m.64370,-0.000920945291787758,-0.00534252995696873,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237545.1.1.m.34853,0.0138704971855697,-0.0213463796162978,No,NA,NA,Q4KM33,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; actin cytoskeleton reorganization [GO:0031532]; cortical actin cytoskeleton organization [GO:0030866]; hematopoietic progenitor cell differentiation [GO:0002244]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; phosphatidylinositol metabolic process [GO:0046488]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of actin filament depolymerization [GO:0030836]; positive regulation of inositol-polyphosphate 5-phosphatase activity [GO:0010925]; positive regulation of integrin activation [GO:0033625]; positive regulation of platelet activation [GO:0010572]; protein kinase C signaling [GO:0070528]; protein secretion by platelet [GO:0070560]; regulation of cell diameter [GO:0060305]; ruffle organization [GO:0031529]; thrombin-activated receptor signaling pathway [GO:0070493]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237598.1.1.m.11619,-0.000779153044131874,0.00338335074360079,No,NA,NA,P38942,NA,NA,NA,transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237629.1.1.m.24486,0.0201720485811276,-0.00821180375847401,No,NA,NA,Q96PM5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; p53 binding [GO:0002039]; protein homodimerization activity [GO:0042803]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; error-free translesion synthesis [GO:0070987]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; protein autoubiquitination [GO:0051865]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237797.1.1.m.40688,0.00650061638215798,-0.0118017559610546,No,NA,NA,Q9BW85,NA,NA,NA,U2-type catalytic step 1 spliceosome [GO:0071006]; mRNA processing [GO:0006397]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G237881.1.1.m.10098,-0.00508837831099611,0.00393911268001261,No,NA,NA,Q5C9L6,NA,NA,NA,cytoplasm [GO:0005737]; (S)-coclaurine-N-methyltransferase activity [GO:0030794],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238062.3.6.m.5146,0.0029705803777386,0.00387122813000604,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238590.1.1.m.49168,0.007079686116343,-0.0091712623095919,No,NA,NA,Q9QUM7,NA,NA,NA,mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; synaptonemal complex [GO:0000795]; ATP binding [GO:0005524]; damaged DNA binding [GO:0003684]; DNA-dependent ATPase activity [GO:0008094]; mismatched DNA binding [GO:0030983]; chiasma assembly [GO:0051026]; female gamete generation [GO:0007292]; homologous chromosome segregation [GO:0045143]; meiosis I [GO:0007127]; mismatch repair [GO:0006298]; reciprocal meiotic recombination [GO:0007131]; synapsis [GO:0007129],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238593.1.1.m.8407,-7.90673568204683e-05,0.0104903356169644,No,NA,NA,Q6UPR8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; ovarian follicle development [GO:0001541],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G238894.7.11.m.61041,0.00883789992323189,-0.00506416401375136,No,NA,NA,Q6PDJ1,NA,NA,NA,voltage-gated calcium channel complex [GO:0005891]; voltage-gated calcium channel activity [GO:0005245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G239043.2.6.m.4886,-0.00249888848602968,-0.00277276648498585,No,NA,NA,B3EWZ5,NA,NA,NA,extracellular region [GO:0005576]; membrane [GO:0016020],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240471.1.1.m.10922,-0.019935618008719,-0.0126869780899699,No,NA,NA,Q8K4F6,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; rRNA base methylation [GO:0070475],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.1.3.m.5221,-0.00450941935841382,-0.00532539251449692,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240563.3.3.m.30812,-0.00347476115398004,0.00177816530485556,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G240887.2.2.m.37649,0.00507757429352878,-0.00137210559983609,No,NA,NA,Q9CPU4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; organelle membrane [GO:0031090]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241267.1.1.m.7467,0.00217796395322997,-0.000588548067189605,No,NA,NA,Q6PDZ2,NA,NA,NA,fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I transcription factor complex [GO:0000120]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; transcription by RNA polymerase I [GO:0006360],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.1.2.m.22601,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G241446.2.2.m.47394,-0.0125534829684883,-0.00798900557305847,No,NA,NA,Q5FVR2,NA,NA,NA,cytosol [GO:0005829]; phosphorylase activity [GO:0004645]; protein homodimerization activity [GO:0042803]; pyrimidine-nucleoside phosphorylase activity [GO:0016154]; thymidine phosphorylase activity [GO:0009032]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242065.1.1.m.21817,0.00297381220168525,0.000600886186643784,No,NA,NA,O17320,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.2.4.m.15572,-0.0341903802350304,0.0226772859373473,No,NA,NA,Q57951,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G242153.4.4.m.60071,0.00204212099031419,-0.00294274850866606,No,NA,NA,Q2FXL6,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G243463.1.1.m.49871,-0.0111193439928155,-0.0182480183802186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244077.1.1.m.14957,-0.00388827626545679,0.00527863348787937,No,NA,NA,Q17Q97,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244113.1.1.m.22167,-0.00992183675955602,0.0185568901946575,No,NA,NA,Q27802,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; dynein complex [GO:0030286]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; microtubule motor activity [GO:0003777]; cell projection organization [GO:0030030]; microtubule-based movement [GO:0007018]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244537.2.3.m.10401,-0.00117622185995895,-0.00700228365880343,No,NA,NA,P74148,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244727.1.1.m.35118,-0.000131048736033752,0.0163300358969063,No,NA,NA,Q9SKC3,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G244806.2.2.m.52012,0.00206273443135292,-0.00274382969549482,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245101.1.1.m.56451,0.00479309594458178,-0.0100798409509349,No,NA,NA,Q497B8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; histone demethylase activity (H3-K36 specific) [GO:0051864]; metal ion binding [GO:0046872]; peptidase activity [GO:0008233]; G2/M transition of mitotic cell cycle [GO:0000086]; histone H3-K36 demethylation [GO:0070544]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.11.11.m.63026,0.00464702523347962,0.00322907236555237,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.2.11.m.22482,0.00345958051339049,-0.014027778885308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245280.5.11.m.34248,0.00417995220528345,-0.0186636671123387,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245744.1.1.m.36806,-0.00773986380587832,-0.00492563022032137,No,NA,NA,A0JPI9,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G245969.1.2.m.347,0.0231481453473269,0.0146113188926283,No,NA,NA,Q8N6F8,NA,NA,NA,,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246111.1.2.m.45249,0.00266660530865579,-0.000720592918004641,No,NA,NA,A7SLZ2,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; cellular response to exogenous dsRNA [GO:0071360]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246422.1.1.m.1312,-0.0142184444329544,-0.00936773164328017,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G246686.1.1.m.53126,-0.0138425911073641,-0.0088093908104946,No,NA,NA,B3EWY7,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247177.1.1.m.63233,-0.00198818554499321,-0.000733231189033788,No,NA,NA,Q18786,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; U1 snRNP [GO:0005685]; U2 snRNP [GO:0005686]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G247395.1.8.m.5020,0.00698151748523342,-0.00908543604079018,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G248362.1.1.m.62940,0.00226684218640192,-0.00123157072949947,No,NA,NA,Q03958,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082]; chaperone-mediated protein complex assembly [GO:0051131]; protein folding [GO:0006457],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G52068.2.3.m.36345,-0.0128217384907452,0.0013454699688231,No,NA,NA,P49013,NA,NA,NA,extracellular space [GO:0005615]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G61368.1.1.m.42775,-5.13726351277525e-05,0.00681591247879511,No,NA,NA,P15253,NA,NA,NA,sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum lumen [GO:0033018]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G69851.3.4.m.5191,-0.00318649412041992,0.00432591035837914,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.1.2.m.17299,-0.00938497465111262,0.00769082770477409,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G73504.2.2.m.38500,-0.004018716586605,0.0031509792264133,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEMVEDRAFT_V1G79897.1.1.m.52661,0.00286142872926411,-0.00351985700660633,No,NA,NA,Q9Z1J2,NA,NA,NA,ciliary basal body [GO:0036064]; ciliary plasm [GO:0097014]; ciliary rootlet [GO:0035253]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; manganese ion binding [GO:0030145]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; mitotic cell cycle [GO:0000278]; positive regulation of transcription; DNA-templated [GO:0045893]; protein phosphorylation [GO:0006468]; regulation of cellular senescence [GO:2000772]; regulation of replicative cell aging [GO:1900062]; regulation of response to DNA damage stimulus [GO:2001020]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80221.1.1.m.12716,-0.00923783005129103,-0.00587893224119444,No,NA,NA,Q8BFR4,NA,NA,NA,lysosome [GO:0005764]; glycosaminoglycan binding [GO:0005539]; metal ion binding [GO:0046872]; N-acetylglucosamine-6-sulfatase activity [GO:0008449]; sulfate binding [GO:0043199]; sulfuric ester hydrolase activity [GO:0008484]; keratan sulfate catabolic process [GO:0042340],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G80846.1.1.m.24713,0.0114031273555072,0.0333658443451771,No,NA,NA,Q9DCG9,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G83869.3.3.m.30283,-0.010385501345766,-0.00660930741998862,No,NA,NA,Q5YLG1,NA,NA,NA,extracellular region [GO:0005576]; cellulase activity [GO:0008810]; cellulose binding [GO:0030248]; cellulose catabolic process [GO:0030245],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G86312.1.1.m.10844,-0.0101763215462077,0.00715950740610869,No,NA,NA,Q9Y6J8,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; pseudophosphatase activity [GO:0001691]; intracellular signal transduction [GO:0035556]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of stress granule assembly [GO:0062030]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; regulation of intrinsic apoptotic signaling pathway [GO:2001242],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G92762.1.1.m.1253,0.00462302081778468,0.00545966865635606,No,NA,NA,Q6ZHE5,NA,NA,NA,mitochondrion [GO:0005739]; D-cysteine desulfhydrase activity [GO:0019148],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G957.1.1.m.27284,0.00236979282669787,-0.000696358710504033,No,NA,NA,O11780,NA,NA,NA,extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; cell adhesion molecule binding [GO:0050839]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; cell adhesion [GO:0007155]; cell proliferation [GO:0008283]; extracellular matrix organization [GO:0030198],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G96234.1.1.m.27743,-0.00972569124717876,-0.00327562792507023,No,NA,NA,Q8WUA2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; regulation of phosphorylation of RNA polymerase II C-terminal domain [GO:1901407],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.1.2.m.34546,0.00799800172381214,0.00141234995943934,No,NA,NA,Q9GLK0,NA,NA,NA,membrane [GO:0016020]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; keratinization [GO:0031424]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63646,-0.0106551264135143,-0.00915684152520971,No,NA,NA,Q9JLF6,NA,NA,NA,cell-cell adherens junction [GO:0005913]; intrinsic component of membrane [GO:0031224]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; animal organ morphogenesis [GO:0009887]; keratinization [GO:0031424]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]; positive regulation of cell cycle [GO:0045787]; positive regulation of keratinocyte proliferation [GO:0010838]; protein metabolic process [GO:0019538],NA,NA,NA
CHOYP_NEMVEDRAFT_V1G97278.2.2.m.63648,-0.00344584522311349,0.0026077406390726,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NEO1.3.3.m.61836,0.00565585023816656,0.00667941363179045,No,NA,NA,P97798,NA,NA,NA,cell surface [GO:0009986]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; co-receptor binding [GO:0039706]; signaling receptor activity [GO:0038023]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; iron ion homeostasis [GO:0055072]; myoblast fusion [GO:0007520]; negative regulation of axon regeneration [GO:0048681]; negative regulation of neuron death [GO:1901215]; negative regulation of protein secretion [GO:0050709]; neuron migration [GO:0001764]; positive regulation of BMP signaling pathway [GO:0030513]; regulation of axon regeneration [GO:0048679]; regulation of neuron migration [GO:2001222]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_NEUL4.2.2.m.54340,-0.0174764689823284,-0.00779973368061678,No,NA,NA,A1L0Y2,NA,NA,NA,centriole [GO:0005814],NA,NA,NA
CHOYP_NF70.1.4.m.31159,0.0281088295105988,-0.00869684261317071,No,NA,NA,Q01240,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NF70.4.4.m.63507,-0.00509316935078755,-5.10077748433241e-05,No,NA,NA,Q01241,NA,NA,NA,intermediate filament [GO:0005882]; structural molecule activity [GO:0005198],NA,NA,NA
CHOYP_NFH.1.1.m.53607,-0.00150942852145475,-0.00405798643299803,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NFIL3.1.1.m.26076,-6.30087320103283e-05,0.00835974253051795,No,NA,NA,Q16649,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; cellular response to interleukin-4 [GO:0071353]; circadian rhythm [GO:0007623]; immune response [GO:0006955]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gene expression [GO:0010628]; regulation of transcription; DNA-templated [GO:0006355]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_NFKB.1.1.m.51558,-0.00604707003785236,0.00262621130663785,No,NA,NA,Q04861,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; NF-kappaB binding [GO:0051059]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_NFRKB.1.1.m.18027,0,0,No,NA,NA,Q6PIJ4,NA,NA,NA,Ino80 complex [GO:0031011]; nucleus [GO:0005634]; DNA binding [GO:0003677]; protease binding [GO:0002020]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_NFRKB.1.1.m.18028,-0.000802436028199763,0.00136666383349559,No,NA,NA,Q9DCH4,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; protein deubiquitination [GO:0016579]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_NFS1.1.1.m.1622,-0.0032617298461423,-0.00156837677149225,No,NA,NA,Q9Z1J3,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; [2Fe-2S] cluster assembly [GO:0044571]; iron incorporation into metallo-sulfur cluster [GO:0018283]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777],NA,NA,NA
CHOYP_NFX1.1.2.m.13487,-0.00364560786957478,0.00494919251365316,No,NA,NA,Q12986,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA binding [GO:0003723]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270]; inflammatory response [GO:0006954]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription by RNA polymerase II [GO:0006366]; viral process [GO:0016032],NA,NA,NA
CHOYP_NGAP.2.2.m.63455,-0.00116669511744583,0.00544828996495995,No,NA,NA,Q3UHC7,NA,NA,NA,AIP1-IRE1 complex [GO:1990597]; axon [GO:0030424]; cerebellar mossy fiber [GO:0044300]; climbing fiber [GO:0044301]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; neuronal cell body membrane [GO:0032809]; parallel fiber [GO:1990032]; plasma membrane [GO:0005886]; 14-3-3 protein binding [GO:0071889]; death receptor binding [GO:0005123]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; mitogen-activated protein kinase kinase binding [GO:0031434]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol-3-phosphate binding [GO:0032266]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; activation of JUN kinase activity [GO:0007257]; activation of MAPKKK activity [GO:0000185]; angiogenesis [GO:0001525]; cell cycle [GO:0007049]; cell motility involved in cerebral cortex radial glia guided migration [GO:0021814]; cellular protein catabolic process [GO:0044257]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; I-kappaB phosphorylation [GO:0007252]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; layer formation in cerebral cortex [GO:0021819]; negative regulation of angiogenesis [GO:0016525]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cellular protein catabolic process [GO:1903363]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of GTPase activity [GO:0034260]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; neuron projection morphogenesis [GO:0048812]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell cycle arrest [GO:0071158]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of synapse maturation [GO:0090129]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reelin-mediated signaling pathway [GO:0038026]; regulation of GTPase activity [GO:0043087]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of p38MAPK cascade [GO:1900744]; regulation of protein complex assembly [GO:0043254]; regulation of protein heterodimerization activity [GO:0043497]; response to unfolded protein [GO:0006986]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324],NA,NA,NA
CHOYP_NHP2.1.1.m.57624,-0.00530677722189421,-0.00565781599682717,No,NA,NA,Q6P8C4,NA,NA,NA,box H/ACA snoRNP complex [GO:0031429]; small nucleolar ribonucleoprotein complex [GO:0005732]; telomerase holoenzyme complex [GO:0005697]; box H/ACA snoRNA binding [GO:0034513]; RNA binding [GO:0003723]; cleavage involved in rRNA processing [GO:0000469]; maturation of LSU-rRNA [GO:0000470]; rRNA pseudouridine synthesis [GO:0031118]; snRNA pseudouridine synthesis [GO:0031120]; telomere maintenance via telomerase [GO:0007004]; translation [GO:0006412],NA,NA,NA
CHOYP_NID2.1.2.m.5776,-0.00575359138451834,-0.00297417343362963,No,NA,NA,P81439,NA,NA,NA,extracellular region [GO:0005576]; cysteine-type endopeptidase inhibitor activity [GO:0004869],NA,NA,NA
CHOYP_NIF3L.1.2.m.28817,0.0140179791553737,0.0127258062293972,No,NA,NA,Q9GZT8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription factor binding [GO:0008134]; negative regulation of nucleic acid-templated transcription [GO:1903507]; neuron differentiation [GO:0030182]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_NIPA.1.1.m.13987,0.00351061864060851,0.0157600950296401,No,NA,NA,Q80YV2,NA,NA,NA,nuclear membrane [GO:0031965]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_NIPLB.1.1.m.11155,-0.00122843787442172,-0.00199591291074576,No,NA,NA,Q6KCD5,NA,NA,NA,chromatin [GO:0000785]; integrator complex [GO:0032039]; nuclear chromatin [GO:0000790]; nuclear chromosome [GO:0000228]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; chromatin binding [GO:0003682]; chromo shadow domain binding [GO:0070087]; histone deacetylase binding [GO:0042826]; mediator complex binding [GO:0036033]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; brain development [GO:0007420]; cellular protein localization [GO:0034613]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to X-ray [GO:0071481]; cognition [GO:0050890]; cohesin loading [GO:0071921]; developmental growth [GO:0048589]; double-strand break repair [GO:0006302]; ear morphogenesis [GO:0042471]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic forelimb morphogenesis [GO:0035115]; embryonic viscerocranium morphogenesis [GO:0048703]; establishment of mitotic sister chromatid cohesion [GO:0034087]; establishment of protein localization to chromatin [GO:0071169]; external genitalia morphogenesis [GO:0035261]; eye morphogenesis [GO:0048592]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; forelimb morphogenesis [GO:0035136]; gall bladder development [GO:0061010]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; maintenance of mitotic sister chromatid cohesion [GO:0034088]; mitotic chromosome condensation [GO:0007076]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; outflow tract morphogenesis [GO:0003151]; positive regulation of histone deacetylation [GO:0031065]; positive regulation of mitotic cohesin loading [GO:1905406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of neuron migration [GO:2001224]; positive regulation of ossification [GO:0045778]; positive regulation of transcription by RNA polymerase II [GO:0045944]; rDNA condensation [GO:0070550]; regulation of developmental growth [GO:0048638]; regulation of embryonic development [GO:0045995]; regulation of hair cycle [GO:0042634]; regulation of transcription by RNA polymerase II [GO:0006357]; replication-born double-strand break repair via sister chromatid exchange [GO:1990414]; sensory perception of sound [GO:0007605]; stem cell population maintenance [GO:0019827]; transcriptional activation by promoter-enhancer looping [GO:0071733]; uterus morphogenesis [GO:0061038],NA,NA,NA
CHOYP_NIPSNAP3A.B.1.1.m.62397,-0.000839274123286672,0.0148906774920398,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NISCH.1.2.m.17955,-0.00213149724511173,-0.0115027080065796,No,NA,NA,Q9Y2I1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; membrane [GO:0016020]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; phosphatidylinositol binding [GO:0035091]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; glucose metabolic process [GO:0006006]; negative regulation of cell migration [GO:0030336]; norepinephrine secretion [GO:0048243]; Rac protein signal transduction [GO:0016601]; regulation of blood pressure [GO:0008217]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_NIT2B.1.1.m.18389,0.00362832620163403,-0.0024510786539795,No,NA,NA,Q6INI7,NA,NA,NA,cytoplasm [GO:0005737]; omega-amidase activity [GO:0050152]; nitrogen compound metabolic process [GO:0006807],NA,NA,NA
CHOYP_NKRF.1.1.m.61828,-0.0140695633512524,-0.00694706343508773,No,NA,NA,O15226,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_NKX23.1.1.m.25439,0.00333907194272273,0.00935556945993319,No,NA,NA,A6NCS4,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; atrial cardiac muscle cell development [GO:0055014]; cell differentiation [GO:0030154]; digestive tract development [GO:0048565]; embryonic heart tube development [GO:0035050]; hypothalamus development [GO:0021854]; negative regulation of apoptotic process [GO:0043066]; pericardium development [GO:0060039]; pharyngeal system development [GO:0060037]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tongue development [GO:0043586]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_NLRC3.1.1.m.57383,0.000857861154398233,-0.00986562517754565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NMT2.1.2.m.10421,-0.00397269797985076,0.00133360750819052,No,NA,NA,O60551,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; host cell [GO:0043657]; plasma membrane [GO:0005886]; glycylpeptide N-tetradecanoyltransferase activity [GO:0004379]; intracellular transport of virus [GO:0075733]; N-terminal peptidyl-glycine N-myristoylation [GO:0018008]; regulation of rhodopsin mediated signaling pathway [GO:0022400],NA,NA,NA
CHOYP_NNRE.2.2.m.27199,0,0,No,NA,NA,B7QDG3,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; NADHX epimerase activity [GO:0052856]; NADPHX epimerase activity [GO:0052857]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_NOC41.1.1.m.53790,-0.0197672349497206,0.0250969539988083,No,NA,NA,Q6NU91,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOG2.1.1.m.41399,-0.00755752460162248,-0.0184000716537881,No,NA,NA,Q99LH1,NA,NA,NA,nucleolus [GO:0005730]; GTP binding [GO:0005525]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL10.1.1.m.1606,-0.00902548051166819,0.0101431719164544,No,NA,NA,Q7T0Q5,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_NOL11.1.1.m.6423,0.00536123838315399,0.009750000144112,No,NA,NA,Q6INI5,NA,NA,NA,nucleolus [GO:0005730]; maturation of SSU-rRNA [GO:0030490]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838],NA,NA,NA
CHOYP_NOL5.1.1.m.49429,0.00197661433410103,-0.00108903221505656,No,NA,NA,Q4R779,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_NOL9.1.2.m.16473,-0.0011636482836496,0.00426702551309787,No,NA,NA,Q3TZX8,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; polynucleotide 5'-hydroxyl-kinase activity [GO:0051731]; RNA binding [GO:0003723]; cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000448]; maturation of 5.8S rRNA [GO:0000460],NA,NA,NA
CHOYP_NOLC1.3.3.m.66629,0.0100944366060699,0.0201743800615043,No,NA,NA,P41777,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; box H/ACA snoRNP complex [GO:0031429]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; box C/D snoRNA binding [GO:0034512]; box C/D snoRNP complex binding [GO:0062064]; box H/ACA snoRNA binding [GO:0034513]; box H/ACA snoRNP complex binding [GO:0062065]; DNA-binding transcription factor activity [GO:0003700]; GTP binding [GO:0005525]; nuclear localization sequence binding [GO:0008139]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; RNA polymerase I core binding [GO:0001042]; transcription factor binding [GO:0008134]; box H/ACA snoRNA metabolic process [GO:0033979]; neural crest cell development [GO:0014032]; neural crest formation [GO:0014029]; nucleolus organization [GO:0007000]; positive regulation of cell proliferation [GO:0008284]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of protein import into nucleus [GO:0042306]; regulation of translation [GO:0006417]; response to osmotic stress [GO:0006970],NA,NA,NA
CHOYP_NOMO1.2.2.m.46404,-0.00422941377410871,0.00426947340972521,No,NA,NA,Q15155,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_NOP56.1.1.m.55664,0.000839018952316998,-0.00190141160402725,No,NA,NA,O00567,NA,NA,NA,box C/D snoRNP complex [GO:0031428]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; pre-snoRNP complex [GO:0070761]; small nucleolar ribonucleoprotein complex [GO:0005732]; small-subunit processome [GO:0032040]; cadherin binding [GO:0045296]; histone methyltransferase binding [GO:1990226]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_NOSC.1.1.m.6346,-0.00228521810776427,0.00928689698927101,No,NA,NA,Q9Z0J4,NA,NA,NA,azurophil granule [GO:0042582]; calyx of Held [GO:0044305]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density; intracellular component [GO:0099092]; postsynaptic specialization; intracellular component [GO:0099091]; protein-containing complex [GO:0032991]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; sarcoplasmic reticulum membrane [GO:0033017]; synapse [GO:0045202]; T-tubule [GO:0030315]; vesicle membrane [GO:0012506]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; ion channel binding [GO:0044325]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; nitric-oxide synthase activity [GO:0004517]; oxidoreductase activity [GO:0016491]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080]; arginine catabolic process [GO:0006527]; behavioral response to cocaine [GO:0048148]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mechanical stimulus [GO:0071260]; establishment of protein localization [GO:0045184]; exogenous drug catabolic process [GO:0042738]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of heart contraction [GO:0045822]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of insulin secretion [GO:0046676]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of vasoconstriction [GO:0045906]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process [GO:0140196]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of histone acetylation [GO:0035066]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron death [GO:1901216]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of heart contraction [GO:0008016]; regulation of neurogenesis [GO:0050767]; regulation of sensory perception of pain [GO:0051930]; regulation of sodium ion transport [GO:0002028]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; retrograde trans-synaptic signaling by nitric oxide [GO:0098924]; striated muscle contraction [GO:0006941]; synaptic signaling by nitric oxide [GO:0099163]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_NOTC3.1.1.m.20877,-0.00411443160927194,0.00557188674210941,No,NA,NA,P07207,NA,NA,NA,adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; subapical complex [GO:0035003]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; transmembrane signaling receptor activity [GO:0004888]; actin filament organization [GO:0007015]; anterior/posterior pattern specification [GO:0009952]; asymmetric cell division [GO:0008356]; axon guidance [GO:0007411]; border follicle cell migration [GO:0007298]; cell adhesion [GO:0007155]; cell dedifferentiation [GO:0043697]; cell differentiation [GO:0030154]; cell fate specification [GO:0001708]; chaeta development [GO:0022416]; chaeta morphogenesis [GO:0008407]; compartment boundary maintenance [GO:0060289]; compound eye cone cell fate commitment [GO:0042676]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; compound eye retinal cell programmed cell death [GO:0046667]; crystal cell differentiation [GO:0042688]; defense response to insect [GO:0002213]; determination of adult lifespan [GO:0008340]; dorsal appendage formation [GO:0046843]; dorsal closure [GO:0007391]; dorsal/ventral axis specification [GO:0009950]; dorsal/ventral lineage restriction; imaginal disc [GO:0007451]; dorsal/ventral pattern formation; imaginal disc [GO:0007450]; ectoderm development [GO:0007398]; embryonic crystal cell differentiation [GO:0035165]; embryonic hemopoiesis [GO:0035162]; epithelial cell proliferation involved in Malpighian tubule morphogenesis [GO:0061331]; epithelial cell type specification; open tracheal system [GO:0035153]; establishment of ommatidial planar polarity [GO:0042067]; eye-antennal disc development [GO:0035214]; eye-antennal disc morphogenesis [GO:0007455]; female germ-line stem cell population maintenance [GO:0036099]; foregut morphogenesis [GO:0007440]; formation of a compartment boundary [GO:0060288]; germ-line stem cell population maintenance [GO:0030718]; germ-line stem-cell niche homeostasis [GO:0060250]; germarium-derived egg chamber formation [GO:0007293]; germarium-derived female germ-line cyst encapsulation [GO:0030708]; glial cell differentiation [GO:0010001]; glial cell fate determination [GO:0007403]; glial cell migration [GO:0008347]; hemocyte proliferation [GO:0035172]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived leg joint morphogenesis [GO:0016348]; imaginal disc-derived leg segmentation [GO:0036011]; imaginal disc-derived male genitalia morphogenesis [GO:0048803]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein specification [GO:0007474]; intestinal stem cell homeostasis [GO:0036335]; lamellocyte differentiation [GO:0035171]; larval lymph gland hemopoiesis [GO:0035167]; lateral inhibition [GO:0046331]; leg disc morphogenesis [GO:0007478]; long-term memory [GO:0007616]; lymph gland crystal cell differentiation [GO:0035170]; lymph gland development [GO:0048542]; Malpighian tubule tip cell differentiation [GO:0061382]; mesoderm development [GO:0007498]; morphogenesis of an epithelial fold [GO:0060571]; morphogenesis of follicular epithelium [GO:0016333]; motor neuron axon guidance [GO:0008045]; muscle cell fate determination [GO:0007521]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of compound eye photoreceptor development [GO:0045316]; negative regulation of gene expression [GO:0010629]; negative regulation of JNK cascade [GO:0046329]; negative regulation of lamellocyte differentiation [GO:0035204]; negative regulation of neurogenesis [GO:0050768]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process [GO:0050877]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; oocyte anterior/posterior axis specification [GO:0007314]; oocyte localization involved in germarium-derived egg chamber formation [GO:0030720]; oogenesis [GO:0048477]; ovarian follicle cell development [GO:0030707]; ovarian follicle cell migration [GO:0007297]; ovarian follicle cell stalk formation [GO:0030713]; peripheral nervous system development [GO:0007422]; positive regulation of cell proliferation [GO:0008284]; positive regulation of crystal cell differentiation [GO:0042691]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; R1/R6 cell differentiation [GO:0048052]; R3/R4 cell fate commitment [GO:0007464]; R7 cell differentiation [GO:0045466]; R8 cell development [GO:0045463]; R8 cell differentiation [GO:0045465]; R8 cell fate commitment [GO:0007460]; regulation of cardioblast cell fate specification [GO:0042686]; regulation of cell differentiation [GO:0045595]; regulation of crystal cell differentiation [GO:0042689]; regulation of filopodium assembly [GO:0051489]; regulation of glycolytic process [GO:0006110]; regulation of growth [GO:0040008]; regulation of mitotic cell cycle [GO:0007346]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of R8 cell spacing in compound eye [GO:0045468]; regulation of stem cell division [GO:2000035]; response to symbiont [GO:0009608]; retinal cell programmed cell death [GO:0046666]; second mitotic wave involved in compound eye morphogenesis [GO:0016330]; sensory organ development [GO:0007423]; sensory organ precursor cell fate determination [GO:0016360]; skeletal muscle tissue development [GO:0007519]; stem cell differentiation [GO:0048863]; ventral cord development [GO:0007419]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; wing disc proximal/distal pattern formation [GO:0007473],NA,NA,NA
CHOYP_NOV.1.2.m.27550,0.0302924299523332,0.0113731991957315,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NPC2.2.7.m.29742,0.00642310015900704,0.00689986467673809,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.4.7.m.30775,0.000242622981670848,0.00284354041005973,No,NA,NA,P61917,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPC2.5.7.m.30911,0.002905670371634,-0.00116762352269093,No,NA,NA,P79345,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; response to virus [GO:0009615],NA,NA,NA
CHOYP_NPC2.6.7.m.31030,0.00181847937051711,0.00334082807290276,No,NA,NA,P61917,NA,NA,NA,endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; cholesterol efflux [GO:0033344]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367],NA,NA,NA
CHOYP_NPL.1.3.m.4064,-0.00142626805230176,0.0094871552104863,No,NA,NA,Q66H59,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL.3.3.m.29352,-0.00435507923085903,-0.0173940065398984,No,NA,NA,Q9DCJ9,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; N-acetylneuraminate lyase activity [GO:0008747]; carbohydrate metabolic process [GO:0005975]; N-acetylneuraminate catabolic process [GO:0019262],NA,NA,NA
CHOYP_NPL4.1.1.m.62114,0.000504161060054479,-0.00460860954425692,No,NA,NA,P60670,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear outer membrane-endoplasmic reticulum membrane network [GO:0042175]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; Golgi organization [GO:0007030]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; retrograde protein transport; ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_NPTN.1.1.m.50315,0.00123129178523542,-0.00399969724187712,No,NA,NA,P35613,NA,NA,NA,acrosomal membrane [GO:0002080]; axon [GO:0030424]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cell-cell adhesion mediator activity [GO:0098632]; mannose binding [GO:0005537]; monocarboxylic acid transmembrane transporter activity [GO:0008028]; axon guidance [GO:0007411]; cell surface receptor signaling pathway [GO:0007166]; decidualization [GO:0046697]; dendrite self-avoidance [GO:0070593]; embryo implantation [GO:0007566]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; leukocyte migration [GO:0050900]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; pyruvate metabolic process [GO:0006090]; response to cAMP [GO:0051591]; response to mercury ion [GO:0046689]; response to peptide hormone [GO:0043434],NA,NA,NA
CHOYP_NR1AA.1.1.m.39226,0.00121249981817522,0.00806209358267785,No,NA,NA,Q9ULB1,NA,NA,NA,cell junction [GO:0030054]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic active zone membrane [GO:0099059]; neuronal cell body [GO:0043025]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; vesicle [GO:0031982]; acetylcholine receptor binding [GO:0033130]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; neuroligin family protein binding [GO:0097109]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; chemical synaptic transmission [GO:0007268]; gephyrin clustering involved in postsynaptic density assembly [GO:0097116]; learning [GO:0007612]; neuroligin clustering involved in postsynaptic membrane assembly [GO:0097118]; neuromuscular process controlling balance [GO:0050885]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission; glutamatergic [GO:0051968]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; prepulse inhibition [GO:0060134]; regulation of grooming behavior [GO:2000821]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle cycle [GO:0098693]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by endocannabinoid [GO:0099542]; vocal learning [GO:0042297]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_NRDC.1.1.m.28526,0.00467772756213469,0.0233258718940867,No,NA,NA,Q8BHG1,NA,NA,NA,mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; regulation of endopeptidase activity [GO:0052548],NA,NA,NA
CHOYP_NRG.1.1.m.10622,-0.00493230716082935,0.00604952776603784,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_NRP.2.4.m.39720,0.00338668478290602,0.00449391961884428,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_NRP.4.4.m.44647,0.00511778392784469,0.00203625655264801,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX3A.1.1.m.1705,0.00246901569125576,0.0146782509271832,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NRX4.1.1.m.8135,0.00662795173103086,0.00825730445589268,No,NA,NA,Q94887,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553],NA,NA,NA
CHOYP_NSF1C.1.1.m.62502,0.00120667870136424,-0.00227453101116141,No,NA,NA,Q9CZ44,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle pole centrosome [GO:0031616]; VCP-NSFL1C complex [GO:1990730]; ATPase binding [GO:0051117]; phospholipid binding [GO:0005543]; ubiquitin binding [GO:0043130]; autophagosome assembly [GO:0000045]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; membrane fusion [GO:0061025]; negative regulation of protein localization to centrosome [GO:1904780]; nuclear envelope reassembly [GO:0031468]; positive regulation of mitotic centrosome separation [GO:0046604]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_NSUN2.1.1.m.14138,-0.00158917894639207,-0.00761859009969553,No,NA,NA,Q08J23,NA,NA,NA,chromatoid body [GO:0033391]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; methyltransferase activity [GO:0008168]; RNA binding [GO:0003723]; tRNA (cytosine-5-)-methyltransferase activity [GO:0016428]; tRNA binding [GO:0000049]; cell division [GO:0051301]; hair follicle maturation [GO:0048820]; meiotic cell cycle checkpoint [GO:0033313]; spermatid development [GO:0007286]; tRNA methylation [GO:0030488]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_NT5M.1.1.m.6188,-0.0123354589072344,0.00364305247410952,No,NA,NA,Q9NPB1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotidase activity [GO:0008252]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; dUMP catabolic process [GO:0046079]; pyrimidine deoxyribonucleotide catabolic process [GO:0009223]; pyrimidine nucleoside catabolic process [GO:0046135],NA,NA,NA
CHOYP_NTF.2.1.1.m.38498,0.00163356747910337,0.00210575055788987,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_NTM1A.1.1.m.614,-0.00117635884187257,0.00304707099160887,No,NA,NA,Q6NWX7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; histone methyltransferase activity [GO:0042054]; N-terminal protein N-methyltransferase activity [GO:0071885]; protein methyltransferase activity [GO:0008276]; chromosome segregation [GO:0007059]; histone methylation [GO:0016571]; N-terminal peptidyl-glycine methylation [GO:0018013]; N-terminal peptidyl-proline dimethylation [GO:0018016]; N-terminal peptidyl-serine dimethylation [GO:0035572]; N-terminal peptidyl-serine trimethylation [GO:0035573]; spindle organization [GO:0007051],NA,NA,NA
CHOYP_NU107.1.2.m.46092,-0.000833795435429706,-0.00178683920471611,No,NA,NA,Q8BH74,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; female gonad development [GO:0008585]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NU160.1.1.m.46155,-0.00124018446127456,-0.00380744636563694,No,NA,NA,Q9Z0W3,NA,NA,NA,kinetochore [GO:0000776]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406],NA,NA,NA
CHOYP_NU188.2.2.m.51343,0.00503466088033489,0.00559589476971564,No,NA,NA,Q5SRE5,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUBP1.1.1.m.65721,-0.000708535284658359,-0.00189515264850238,No,NA,NA,Q6P298,NA,NA,NA,cytosol [GO:0005829]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226],NA,NA,NA
CHOYP_NUBPL.1.1.m.15123,0.00599074010675575,-0.0165677676108879,No,NA,NA,Q9CWD8,NA,NA,NA,mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; iron-sulfur cluster assembly [GO:0016226]; mitochondrial respiratory chain complex I assembly [GO:0032981]; mitochondrion morphogenesis [GO:0070584],NA,NA,NA
CHOYP_NUCB2.2.2.m.55289,0.000804932740515913,0.00267211569947421,No,NA,NA,Q9JI85,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi medial cisterna [GO:0005797]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; tumor necrosis factor receptor binding [GO:0005164]; insulin metabolic process [GO:1901142]; negative regulation of appetite [GO:0032099]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin receptor signaling pathway [GO:0046627]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of testosterone secretion [GO:2000845]; response to glucose [GO:0009749]; response to human chorionic gonadotropin [GO:0044752]; response to melanocyte-stimulating hormone [GO:1990680]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_NUCL.1.2.m.19135,-0.000352537297412524,0.00167006072047082,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUCL.2.2.m.21719,-0.00215446383662555,-0.00196329644907195,No,NA,NA,P20397,NA,NA,NA,nucleolus [GO:0005730]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_NUD16.1.2.m.10250,-0.00308554857628494,0.00300968314419043,No,NA,NA,P0DKY8,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; nucleotide metabolic process [GO:0009117],NA,NA,NA
CHOYP_NUD17.1.1.m.13156,-0.00911973726379678,0.00566259432280468,No,NA,NA,Q4V8V2,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872]; NADH pyrophosphatase activity [GO:0035529]; NAD catabolic process [GO:0019677]; NADH metabolic process [GO:0006734]; NADP catabolic process [GO:0006742],NA,NA,NA
CHOYP_NUDT14.1.1.m.64313,-0.00175893389785184,-0.00530624515646,No,NA,NA,Q05B60,NA,NA,NA,cytoplasm [GO:0005737]; ADP-ribose diphosphatase activity [GO:0047631]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UDP-sugar diphosphatase activity [GO:0008768]; nucleoside phosphate metabolic process [GO:0006753]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_NUFIP1.1.1.m.8979,-0.00256170620429702,0.00347771280457667,No,NA,NA,Q641W3,NA,NA,NA,cytosolic ribosome [GO:0022626]; fibrillar center [GO:0001650]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; perichromatin fibrils [GO:0005726]; pre-snoRNP complex [GO:0070761]; presynaptic active zone [GO:0048786]; transcription elongation factor complex [GO:0008023]; ATPase binding [GO:0051117]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; snoRNA binding [GO:0030515]; box C/D snoRNP assembly [GO:0000492]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein complex oligomerization [GO:0051259],NA,NA,NA
CHOYP_NUMB.1.1.m.19732,-0.00558000781600966,-0.0035090902627821,No,NA,NA,P16554,NA,NA,NA,basal cortex [GO:0045180]; basal part of cell [GO:0045178]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; Notch binding [GO:0005112]; asymmetric cell division [GO:0008356]; asymmetric neuroblast division [GO:0055059]; cell fate commitment [GO:0045165]; cell fate determination [GO:0001709]; central nervous system development [GO:0007417]; centrosome localization [GO:0051642]; embryonic heart tube development [GO:0035050]; glial cell migration [GO:0008347]; heart development [GO:0007507]; Malpighian tubule tip cell differentiation [GO:0061382]; muscle cell fate specification [GO:0042694]; negative regulation of gene expression [GO:0010629]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of Notch signaling pathway [GO:0045746]; neuroblast development [GO:0014019]; neuroblast fate determination [GO:0007400]; neuroblast proliferation [GO:0007405]; Notch signaling pathway [GO:0007219]; pericardial nephrocyte differentiation [GO:0061320]; positive regulation of endocytosis [GO:0045807]; protein localization [GO:0008104]; regulation of asymmetric cell division [GO:0009786]; regulation of nervous system development [GO:0051960]; regulation of neuroblast proliferation [GO:1902692]; regulation of neurogenesis [GO:0050767]; regulation of Notch signaling pathway [GO:0008593]; rhythmic behavior [GO:0007622]; sensory organ precursor cell division [GO:0045035]; sensory organ precursor cell fate determination [GO:0016360]; ventral cord development [GO:0007419],NA,NA,NA
CHOYP_NUP153.1.1.m.34857,0.000830864026433181,0.000782251018941649,No,NA,NA,Q640Z6,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; protein transport [GO:0015031],NA,NA,NA
CHOYP_NUP205.1.1.m.54932,-0.00544563936077032,0.00511003951249279,No,NA,NA,Q92621,NA,NA,NA,membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore inner ring [GO:0044611]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.2.3.m.20892,0.00314460153320847,-0.00227702988117354,No,NA,NA,P35658,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP214.3.3.m.52826,-0.00454674286715598,0.0025062244659845,No,NA,NA,P35658,NA,NA,NA,cytoplasmic side of nuclear pore [GO:1990876]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; nuclear export signal receptor activity [GO:0005049]; nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056]; mitotic cell cycle [GO:0000278]; mRNA export from nucleus [GO:0006406]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of cell cycle [GO:0051726]; regulation of mRNA stability [GO:0043488]; regulation of nucleocytoplasmic transport [GO:0046822]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP50.1.1.m.17104,0.000881697810249825,-0.0096668911870741,No,NA,NA,Q9UKX7,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; mRNA export from nucleus [GO:0006406]; positive regulation of GTPase activity [GO:0043547]; protein import into nucleus [GO:0006606]; viral process [GO:0016032],NA,NA,NA
CHOYP_NUP54.1.1.m.24886,-0.00759359446261911,0.0101723399918129,No,NA,NA,Q8BTS4,NA,NA,NA,nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; structural constituent of nuclear pore [GO:0017056]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; protein heterooligomerization [GO:0051291]; protein heterotetramerization [GO:0051290]; protein heterotrimerization [GO:0070208]; protein homooligomerization [GO:0051260]; protein localization to nuclear inner membrane [GO:0036228]; protein targeting [GO:0006605]; regulation of protein import into nucleus [GO:0042306],NA,NA,NA
CHOYP_NUP62L.1.1.m.15606,0.00268566891819291,-0.00131751911212814,No,NA,NA,P17955,NA,NA,NA,annulate lamellae [GO:0005642]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinesin binding [GO:0019894]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; receptor signaling complex scaffold activity [GO:0030159]; SH2 domain binding [GO:0042169]; structural constituent of nuclear pore [GO:0017056]; thyroid hormone receptor binding [GO:0046966]; ubiquitin binding [GO:0043130]; cell aging [GO:0007569]; cell death [GO:0008219]; cell surface receptor signaling pathway [GO:0007166]; centriole assembly [GO:0098534]; mitotic cell cycle [GO:0000278]; mitotic centrosome separation [GO:0007100]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of centriole replication [GO:0046601]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of transcription; DNA-templated [GO:0045893]; protein heterotrimerization [GO:0070208]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of protein import into nucleus [GO:0042306]; spermatogenesis [GO:0007283]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_NUP85.1.1.m.16167,0.00594853582822662,0.0029792187475154,No,NA,NA,Q6DBY0,NA,NA,NA,nuclear membrane [GO:0031965]; nuclear pore outer ring [GO:0031080]; structural constituent of nuclear pore [GO:0017056]; mRNA export from nucleus [GO:0006406]; positive regulation of transcription; DNA-templated [GO:0045893]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_NUP98.1.1.m.8689,-0.00483725773866031,0.00360800096026447,No,NA,NA,P49793,NA,NA,NA,kinetochore [GO:0000776]; nuclear body [GO:0016604]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; peptide binding [GO:0042277]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713]; DNA replication [GO:0006260]; mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398],NA,NA,NA
CHOYP_NUPL2.1.2.m.4693,0.0031303245659547,-0.00715006840647423,No,NA,NA,Q8CIC2,NA,NA,NA,cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; photoreceptor outer segment [GO:0001750]; metal ion binding [GO:0046872]; nuclear export signal receptor activity [GO:0005049]; mRNA transport [GO:0051028]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_NXF1.1.2.m.28017,-0.00545493733538322,0.0101456682412277,No,NA,NA,Q9UBU9,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032],NA,NA,NA
CHOYP_OAT.1.1.m.3069,-0.0017488984320752,-0.00174030643279603,No,NA,NA,Q9VW26,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ornithine-oxo-acid transaminase activity [GO:0004587]; pyridoxal phosphate binding [GO:0030170]; arginine catabolic process to glutamate [GO:0019544]; arginine catabolic process to proline via ornithine [GO:0010121]; L-proline biosynthetic process [GO:0055129]; ornithine metabolic process [GO:0006591],NA,NA,NA
CHOYP_OCDH.1.1.m.1284,0.00137155961855082,0.00017944474054415,No,NA,NA,Q9BHM6,NA,NA,NA,coenzyme binding [GO:0050662]; D-octopine dehydrogenase activity [GO:0047830]; nucleotide binding [GO:0000166],NA,NA,NA
CHOYP_OCTC.1.1.m.31819,0.0080815352447749,-0.00247066556417068,No,NA,NA,Q9UKG9,NA,NA,NA,cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; carnitine O-octanoyltransferase activity [GO:0008458]; signaling receptor binding [GO:0005102]; carnitine metabolic process [GO:0009437]; coenzyme A metabolic process [GO:0015936]; fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; fatty acid metabolic process [GO:0006631]; fatty acid transport [GO:0015908]; generation of precursor metabolites and energy [GO:0006091]; medium-chain fatty acid metabolic process [GO:0051791]; protein targeting to peroxisome [GO:0006625],NA,NA,NA
CHOYP_ODC1.1.1.m.12032,0.00477896757468396,-0.00866776056052723,No,NA,NA,Q04832,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ODH.1.2.m.1327,-0.00865112611151074,-0.00679595438027845,No,NA,NA,Q8N0N9,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODH.2.2.m.16624,-0.00433262366203351,-0.000685710033138968,No,NA,NA,Q8N0N9,NA,NA,NA,coenzyme binding [GO:0050662]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_ODO1.2.2.m.23540,-0.000829963623654662,0.00192929287198457,No,NA,NA,Q60HE2,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxoglutarate dehydrogenase complex [GO:0045252]; metal ion binding [GO:0046872]; oxoglutarate dehydrogenase (succinyl-transferring) activity [GO:0004591]; thiamine pyrophosphate binding [GO:0030976]; 2-oxoglutarate metabolic process [GO:0006103]; generation of precursor metabolites and energy [GO:0006091]; glycolytic process [GO:0006096]; histone succinylation [GO:0106077]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_ODPX.1.1.m.29097,-0.000724989010991263,0.00176776253570026,No,NA,NA,Q8BKZ9,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254]; pyruvate dehydrogenase (NAD+) activity [GO:0034604]; transferase activity; transferring acyl groups [GO:0016746]; mitochondrial acetyl-CoA biosynthetic process from pyruvate [GO:0061732],NA,NA,NA
CHOYP_ODPX.1.1.m.29098,-0.00341672344108928,0.0150303751770467,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OFD1.1.1.m.29513,-0.0040134760113618,-0.0058505220732539,No,NA,NA,O75665,NA,NA,NA,centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; gamma-tubulin binding [GO:0043015]; identical protein binding [GO:0042802]; ciliary basal body-plasma membrane docking [GO:0097711]; cilium assembly [GO:0060271]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; G2/M transition of mitotic cell cycle [GO:0000086]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_OFUT1.1.1.m.41737,-0.00109658161218606,0.000763065961984277,No,NA,NA,Q9V6X7,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; fucosyltransferase activity [GO:0008417]; Notch binding [GO:0005112]; peptide-O-fucosyltransferase activity [GO:0046922]; cell-cell adhesion [GO:0098609]; endocytosis [GO:0006897]; fucose metabolic process [GO:0006004]; negative regulation of Notch signaling pathway [GO:0045746]; Notch signaling pathway [GO:0007219]; O-glycan processing [GO:0016266]; positive regulation of Notch signaling pathway [GO:0045747]; protein catabolic process [GO:0030163]; protein O-linked fucosylation [GO:0036066]; protein O-linked glycosylation [GO:0006493]; regulation of Notch signaling pathway [GO:0008593]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_OGFD1.1.1.m.10563,-0.0189684380274641,-0.0120714671373688,No,NA,NA,Q5R4R3,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; nucleus [GO:0005634]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; peptidyl-proline 3-dioxygenase activity [GO:0031544]; peptidyl-proline dioxygenase activity [GO:0031543]; cell proliferation [GO:0008283]; protein hydroxylation [GO:0018126]; regulation of translational termination [GO:0006449]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_OGFRL1.1.1.m.44422,0.00240437522519238,-0.00902137853813956,No,NA,NA,Q5TC84,NA,NA,NA,membrane [GO:0016020]; opioid receptor activity [GO:0004985],NA,NA,NA
CHOYP_OGT1.3.3.m.54325,-0.00723279499907365,0.0067298102389502,No,NA,NA,P56558,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; histone acetyltransferase complex [GO:0000123]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; zymogen granule [GO:0042588]; monosaccharide binding [GO:0048029]; peptide binding [GO:0042277]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; protein domain specific binding [GO:0019904]; protein N-acetylglucosaminyltransferase activity [GO:0016262]; protein O-GlcNAc transferase activity [GO:0097363]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to toxic substance [GO:0097237]; circadian regulation of gene expression [GO:0032922]; forebrain development [GO:0030900]; glucosamine metabolic process [GO:0006041]; histone H3-K4 trimethylation [GO:0080182]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; intracellular distribution of mitochondria [GO:0048312]; negative regulation of cell death [GO:0060548]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein targeting to membrane [GO:0090315]; negative regulation of protein ubiquitination [GO:0031397]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 methylation [GO:0061087]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of proteolysis [GO:0045862]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein heterotrimerization [GO:0070208]; protein homotrimerization [GO:0070207]; protein O-linked glycosylation [GO:0006493]; protein processing [GO:0016485]; regulation of gluconeogenesis [GO:0006111]; regulation of glycolytic process [GO:0006110],NA,NA,NA
CHOYP_OLA1.2.2.m.28588,1.05044542118514e-05,0.000496104795267227,No,NA,NA,Q9NTK5,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; platelet alpha granule lumen [GO:0031093]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; ribosomal large subunit binding [GO:0043023]; ribosome binding [GO:0043022]; ATP metabolic process [GO:0046034]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_ONEC2.1.3.m.22857,-0.0265896855300215,0.0062129166586166,No,NA,NA,O95948,NA,NA,NA,actin cytoskeleton [GO:0015629]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cilium assembly [GO:0060271]; endocrine pancreas development [GO:0031018]; epithelial cell development [GO:0002064]; liver development [GO:0001889]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peripheral nervous system neuron development [GO:0048935]; positive regulation of cell migration [GO:0030335]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_ORC1.1.2.m.17178,-0.0100686534847781,-0.00753484730656848,No,NA,NA,Q5RDD2,NA,NA,NA,nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_OS11G0657400.1.2.m.24816,-0.0021641819312135,0.00409053344201541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_OSA.1.2.m.6579,-0.00255856696626317,-0.00223256061959298,No,NA,NA,Q8IN94,NA,NA,NA,brahma complex [GO:0035060]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; chromatin remodeling [GO:0006338]; imaginal disc-derived leg morphogenesis [GO:0007480]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing morphogenesis [GO:0007476]; imaginal disc-derived wing vein morphogenesis [GO:0008586]; negative regulation of neuroblast proliferation [GO:0007406]; neuroblast fate commitment [GO:0014017]; photoreceptor cell differentiation [GO:0046530]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; segment specification [GO:0007379]; wing disc dorsal/ventral pattern formation [GO:0048190]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_OSBL6.1.1.m.24967,0.00503224940516487,0.00951557939716288,No,NA,NA,Q9BZF3,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699],NA,NA,NA
CHOYP_OSBL8.1.2.m.7583,0.0081818005771422,-0.0148539166221948,No,NA,NA,B9EJ86,NA,NA,NA,cortical endoplasmic reticulum [GO:0032541]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; cholesterol binding [GO:0015485]; lipid binding [GO:0008289]; phosphatidylinositol-4-phosphate binding [GO:0070273]; phosphatidylserine binding [GO:0001786]; phospholipid transporter activity [GO:0005548]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; activation of protein kinase B activity [GO:0032148]; fat cell differentiation [GO:0045444]; negative regulation of cell migration [GO:0030336]; negative regulation of sequestering of triglyceride [GO:0010891]; phospholipid transport [GO:0015914]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein kinase B signaling [GO:0051897]; protein localization to nuclear pore [GO:0090204],NA,NA,NA
CHOYP_OSBL9.1.2.m.17667,-0.0185937819482374,0.00245628380931557,No,NA,NA,Q0IJ05,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; lipid binding [GO:0008289]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248],NA,NA,NA
CHOYP_OSBP1.1.1.m.12788,0.00462229418194986,0.00373163006095068,No,NA,NA,P22059,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]; lipid binding [GO:0008289]; oxysterol binding [GO:0008142]; phosphatidylinositol-4-phosphate binding [GO:0070273]; protein domain specific binding [GO:0019904]; sterol binding [GO:0032934]; sterol transporter activity [GO:0015248]; bile acid biosynthetic process [GO:0006699]; intracellular cholesterol transport [GO:0032367]; positive regulation of growth of symbiont in host [GO:0044128]; sterol transport [GO:0015918],NA,NA,NA
CHOYP_OSGEP.1.1.m.29582,-0.0100351277492366,0.00505334929481617,No,NA,NA,A7SXZ6,NA,NA,NA,cytoplasm [GO:0005737]; EKC/KEOPS complex [GO:0000408]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; N(6)-L-threonylcarbamoyladenine synthase activity [GO:0061711]; tRNA threonylcarbamoyladenosine modification [GO:0002949],NA,NA,NA
CHOYP_OSGI2.1.1.m.11055,-0.00285268519169921,0.00387273911503097,No,NA,NA,Q9Y236,NA,NA,NA,growth factor activity [GO:0008083]; meiotic cell cycle [GO:0051321]; negative regulation of cell growth [GO:0030308],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28852,0.00554843072600966,-0.00149934445649827,No,NA,NA,Q6R7L4,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28853,0,0,No,NA,NA,Q6R7L3,NA,NA,NA,,NA,NA,NA
CHOYP_OSHV1_GP010.1.2.m.28854,0.00693947514991242,-0.0125984964197937,No,NA,NA,Q6R7L5,NA,NA,NA,,NA,NA,NA
CHOYP_OST48.1.1.m.43513,0.000665404034740595,0.000851164663894387,No,NA,NA,Q5R501,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase complex [GO:0008250]; protein glycosylation [GO:0006486]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_OSTA.1.1.m.11011,0.00347161575512358,-0.000938129733356165,No,NA,NA,Q8R000,NA,NA,NA,basolateral plasma membrane [GO:0016323]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; bile acid transmembrane transporter activity [GO:0015125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transmembrane transporter activity [GO:0022857]; bile acid and bile salt transport [GO:0015721]; bile acid secretion [GO:0032782]; organic substance transport [GO:0071702],NA,NA,NA
CHOYP_OTER_1386.1.1.m.15303,0.00109761580908747,-0.00374456832005206,No,NA,NA,Q5EA79,NA,NA,NA,cytoplasm [GO:0005737]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_OTU6B.1.2.m.31547,-0.0146021535028711,-0.00545827471202932,No,NA,NA,Q7ZV00,NA,NA,NA,thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_OTUB1.1.1.m.29705,-0.0013501791902252,0.00132091342810168,No,NA,NA,B2RYG6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; NEDD8-specific protease activity [GO:0019784]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; adaptive immune response [GO:0002250]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; protein K48-linked deubiquitination [GO:0071108],NA,NA,NA
CHOYP_OTX5B.1.1.m.10054,-0.0108871050929491,-0.00692852680649452,No,NA,NA,Q9PT61,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; anterior/posterior pattern specification [GO:0009952]; eye photoreceptor cell fate commitment [GO:0042706]; positive regulation of rhodopsin gene expression [GO:0045872]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_OX2R.3.3.m.44161,-0.0060119770374387,-0.00132203810802754,No,NA,NA,O43614,NA,NA,NA,integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; neuropeptide receptor activity [GO:0008188]; orexin receptor activity [GO:0016499]; peptide hormone binding [GO:0017046]; chemical synaptic transmission [GO:0007268]; circadian sleep/wake cycle process [GO:0022410]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; regulation of circadian sleep/wake cycle; wakefulness [GO:0010840]; regulation of cytosolic calcium ion concentration [GO:0051480],NA,NA,NA
CHOYP_OXDD.1.4.m.2688,-0.00455283050789771,0.0113976071754138,No,NA,NA,P31228,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; cofactor binding [GO:0048037]; D-amino-acid oxidase activity [GO:0003884]; D-aspartate oxidase activity [GO:0008445]; FAD binding [GO:0071949]; signaling receptor binding [GO:0005102]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; D-amino acid catabolic process [GO:0019478]; D-amino acid metabolic process [GO:0046416],NA,NA,NA
CHOYP_OXSM.1.1.m.30217,0.00391486598281133,-0.00105790860499456,No,NA,NA,Q9NWU1,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; acyl-CoA metabolic process [GO:0006637]; medium-chain fatty acid biosynthetic process [GO:0051792]; short-chain fatty acid biosynthetic process [GO:0051790],NA,NA,NA
CHOYP_P121C.1.1.m.57092,-0.0019194549955638,0.00731440953053905,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_P20D2.1.2.m.9005,0.000360883708095631,-0.0025297183742023,No,NA,NA,A3KG59,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.1.2.m.9006,-0.0166586110381127,0.0210670264470141,No,NA,NA,Q8IYS1,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P20D2.2.2.m.47191,0.00640061886287485,-0.0116202122042919,No,NA,NA,Q8IYS1,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_P3A2.1.3.m.11560,-0.0079018717602259,0.0120493628731075,No,NA,NA,Q04073,NA,NA,NA,nucleus [GO:0005634]; core promoter sequence-specific DNA binding [GO:0001046]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_P4HA1.4.5.m.59821,-0.0228677584165979,-0.0145529850075987,No,NA,NA,Q10576,NA,NA,NA,cell [GO:0005623]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; peptidyl-proline 4-dioxygenase activity [GO:0031545]; procollagen-proline 4-dioxygenase activity [GO:0004656]; collagen and cuticulin-based cuticle development [GO:0040002]; cuticle development involved in collagen and cuticulin-based cuticle molting cycle [GO:0042338]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic body morphogenesis [GO:0010172]; macromolecule modification [GO:0043412]; oxidation-reduction process [GO:0055114]; peptidyl-proline hydroxylation [GO:0019511]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of multicellular organism growth [GO:0040018],NA,NA,NA
CHOYP_P4R3A.1.1.m.1043,-0.0111233854619433,0.00462602017289852,No,NA,NA,Q5SP90,NA,NA,NA,,NA,NA,NA
CHOYP_P66A.1.1.m.22279,-0.00344880209890294,-0.000287534053719777,No,NA,NA,Q86YP4,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein binding; bridging [GO:0030674]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]; DNA methylation [GO:0006306]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_PA1B2.1.2.m.10637,-0.0041654457117436,0.00296859945601344,No,NA,NA,O35264,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; plasma membrane [GO:0005886]; 1-alkyl-2-acetylglycerophosphocholine esterase activity [GO:0003847]; platelet-activating factor acetyltransferase activity [GO:0047179]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; brain development [GO:0007420]; lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PABP2.1.1.m.12768,-0.00507028848602698,0.00210445802022756,No,NA,NA,Q7KNF2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of polynucleotide adenylyltransferase activity [GO:1904247]; positive regulation of protein glycosylation [GO:0060050],NA,NA,NA
CHOYP_PABP4.4.6.m.38167,1.92555058231106e-05,-0.000578691372186851,No,NA,NA,Q13310,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; mRNA 3'-UTR binding [GO:0003730]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; blood coagulation [GO:0007596]; myeloid cell development [GO:0061515]; regulation of mRNA stability [GO:0043488]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; translation [GO:0006412],NA,NA,NA
CHOYP_PABP4.5.6.m.38922,-0.0126995084503693,-0.00808193582926581,No,NA,NA,Q9EPH8,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; messenger ribonucleoprotein complex [GO:1990124]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; synapse [GO:0045202]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; gene silencing by RNA [GO:0031047]; mRNA processing [GO:0006397]; negative regulation of nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PACN2.2.2.m.25018,-0.00236641847554397,-0.0022163870260306,No,NA,NA,Q9WVE8,NA,NA,NA,caveola [GO:0005901]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phosphatidic acid binding [GO:0070300]; phospholipid binding [GO:0005543]; actin cytoskeleton organization [GO:0030036]; caveola assembly [GO:0070836]; caveolin-mediated endocytosis [GO:0072584]; cell projection morphogenesis [GO:0048858]; cytoskeleton organization [GO:0007010]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of endocytosis [GO:0045806]; plasma membrane tubulation [GO:0097320]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PAGR1.1.1.m.18447,0.00178737323176825,-0.0156353191036265,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAK1.1.1.m.50796,0.0040046401534995,-0.0033895581601394,No,NA,NA,Q08E52,NA,NA,NA,actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; invadopodium [GO:0071437]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; ATP binding [GO:0005524]; collagen binding [GO:0005518]; protein serine/threonine kinase activity [GO:0004674]; Rac GTPase binding [GO:0048365]; actin cytoskeleton reorganization [GO:0031532]; activation of protein kinase activity [GO:0032147]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; exocytosis [GO:0006887]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; positive regulation of cell migration [GO:0030335]; positive regulation of cell proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098]; wound healing [GO:0042060],NA,NA,NA
CHOYP_PAK7.1.1.m.35662,-0.0017092817365454,-0.00636437247740434,No,NA,NA,Q5R8Z4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; learning [GO:0007612]; locomotory behavior [GO:0007626]; memory [GO:0007613],NA,NA,NA
CHOYP_PAN2.1.1.m.44690,0.000562394571098542,0.00122810164722161,No,NA,NA,A1Z7K9,NA,NA,NA,nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535]; mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],NA,NA,NA
CHOYP_PAN2.1.1.m.44693,-0.0197690857911443,0.0318773618600383,No,NA,NA,Q92193,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_PANG1.1.2.m.10756,-0.00539390438386865,0.010886429938766,No,NA,NA,P91943,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; repressing transcription factor binding [GO:0070491]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; canonical Wnt signaling pathway [GO:0060070]; embryonic pattern specification [GO:0009880]; heart development [GO:0007507]; imaginal disc-derived wing morphogenesis [GO:0007476]; mesodermal cell fate determination [GO:0007500]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; salivary gland morphogenesis [GO:0007435]; segment polarity determination [GO:0007367]; spiracle morphogenesis; open tracheal system [GO:0035277]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PAPOG.1.2.m.33182,-0.00713024910669469,-0.00155101184851065,No,NA,NA,Q6PCL9,NA,NA,NA,cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; polynucleotide adenylyltransferase activity [GO:0004652]; RNA binding [GO:0003723]; mRNA polyadenylation [GO:0006378]; RNA polyadenylation [GO:0043631],NA,NA,NA
CHOYP_PAPSS.1.1.m.53055,0.00157641954583666,-0.00339390548978457,No,NA,NA,Q27128,NA,NA,NA,adenylylsulfate kinase activity [GO:0004020]; ATP binding [GO:0005524]; nucleotidyltransferase activity [GO:0016779]; sulfate adenylyltransferase (ATP) activity [GO:0004781]; sulfate assimilation [GO:0000103],NA,NA,NA
CHOYP_PAR14.15.17.m.60687,0.00432531655004424,0.0047737030478945,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PAR15.2.6.m.21081,-0.0036341833030405,0.0194808021277594,No,NA,NA,O43734,NA,NA,NA,signaling receptor binding [GO:0005102]; B cell apoptotic process [GO:0001783]; humoral immune response [GO:0006959]; immunoglobulin secretion [GO:0048305]; intracellular signal transduction [GO:0035556]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_PAR15.5.6.m.60634,-0.00895812734483004,-0.00570093012924467,No,NA,NA,Q8BZH4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; cell division [GO:0051301]; kinetochore assembly [GO:0051382]; mitotic sister chromatid cohesion [GO:0007064]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_PARG.1.1.m.24813,0.000502161417057284,-0.00788230338801642,No,NA,NA,O02776,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; poly(ADP-ribose) glycohydrolase activity [GO:0004649]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate metabolic process [GO:0005975]; nucleotide-sugar metabolic process [GO:0009225]; regulation of DNA repair [GO:0006282],NA,NA,NA
CHOYP_PARN.1.1.m.19023,-0.00166789247050813,0.00334932012820289,No,NA,NA,Q90ZA1,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; poly(A)-specific ribonuclease activity [GO:0004535]; RNA binding [GO:0003723]; meiotic cell cycle [GO:0051321]; mRNA catabolic process [GO:0006402],NA,NA,NA
CHOYP_PARP12.1.2.m.42887,-0.00907756094417017,-0.0143438820961347,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PARP14.14.22.m.52621,0.00228797382178738,0.00192293538372384,No,NA,NA,Q460N5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; enzyme binding [GO:0019899]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; NAD+ binding [GO:0070403]; innate immune response [GO:0045087]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; positive regulation of interleukin-4-mediated signaling pathway [GO:1902216]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein ADP-ribosylation [GO:0006471]; protein poly-ADP-ribosylation [GO:0070212],NA,NA,NA
CHOYP_PARP16.1.1.m.1294,0.0078798988482021,0.00585530555409629,No,NA,NA,Q5U2Q4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum tubular network [GO:0071782]; integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; kinase binding [GO:0019900]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein serine/threonine kinase activator activity [GO:0043539]; endoplasmic reticulum unfolded protein response [GO:0030968]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PARP8.1.1.m.55346,-0.00249105594444474,0.00338179965383252,No,NA,NA,Q8N3A8,NA,NA,NA,intracellular [GO:0005622]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; protein ADP-ribosylation [GO:0006471],NA,NA,NA
CHOYP_PAT3.1.4.m.21678,-0.00529181068970954,0.00158831365186719,No,NA,NA,Q27874,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAT3.4.4.m.54228,0.00511931455184785,-0.00929402651640979,No,NA,NA,Q27874,NA,NA,NA,basal plasma membrane [GO:0009925]; basement membrane [GO:0005604]; cell surface [GO:0009986]; focal adhesion [GO:0005925]; integrin complex [GO:0008305]; lateral plasma membrane [GO:0016328]; M band [GO:0031430]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; striated muscle dense body [GO:0055120]; integrin binding [GO:0005178]; cell adhesion mediated by integrin [GO:0033627]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; integrin-mediated signaling pathway [GO:0007229]; mitochondrion organization [GO:0007005]; muscle cell cellular homeostasis [GO:0046716]; muscle cell development [GO:0055001]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; positive regulation of distal tip cell migration [GO:1903356]; positive regulation of locomotion [GO:0040017]; positive regulation of myosin II filament organization [GO:1904901]; positive regulation of ovulation [GO:0060279]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of smooth muscle contraction [GO:0045987]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of distal tip cell migration [GO:1903354]; regulation of vulval development [GO:0040028]; striated muscle cell development [GO:0055002]; vulval cell fate specification [GO:0072327],NA,NA,NA
CHOYP_PAX2A.1.2.m.10577,-0.0146068939783071,0.00928702116243319,No,NA,NA,Q02962,NA,NA,NA,centriolar satellite [GO:0034451]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; proximal promoter sequence-specific DNA binding [GO:0000987]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; aging [GO:0007568]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cell fate determination [GO:0001709]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose stimulus [GO:0071333]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to retinoic acid [GO:0071300]; cochlea development [GO:0090102]; cochlea morphogenesis [GO:0090103]; glial cell differentiation [GO:0010001]; inner ear morphogenesis [GO:0042472]; mesenchymal to epithelial transition [GO:0060231]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate specification [GO:0007501]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; metanephric distal convoluted tubule development [GO:0072221]; metanephric epithelium development [GO:0072207]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric mesenchyme development [GO:0072075]; metanephric nephron tubule formation [GO:0072289]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic process involved in metanephric collecting duct development [GO:1900215]; negative regulation of apoptotic process involved in metanephric nephron tubule development [GO:1900218]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytolysis [GO:0045918]; negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis [GO:0072305]; negative regulation of mesenchymal cell apoptotic process involved in metanephros development [GO:1900212]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription; DNA-templated [GO:0045892]; nephric duct formation [GO:0072179]; neural tube closure [GO:0001843]; optic chiasma development [GO:0061360]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; optic nerve development [GO:0021554]; optic nerve morphogenesis [GO:0021631]; optic nerve structural organization [GO:0021633]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of metanephric DCT cell differentiation [GO:2000594]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of optic nerve formation [GO:2000597]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; pronephric field specification [GO:0039003]; pronephros development [GO:0048793]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of metanephros size [GO:0035566]; response to nutrient levels [GO:0031667]; retinal pigment epithelium development [GO:0003406]; stem cell differentiation [GO:0048863]; transcription by RNA polymerase II [GO:0006366]; transcription; DNA-templated [GO:0006351]; ureter development [GO:0072189]; ureter maturation [GO:0035799]; urogenital system development [GO:0001655]; vestibulocochlear nerve formation [GO:0021650]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PAXB1.1.2.m.42816,0.00765181191375236,-0.00660719265648028,No,NA,NA,Q9Z1W9,NA,NA,NA,apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; activation of MAPK activity [GO:0000187]; activation of protein kinase activity [GO:0032147]; cellular hypotonic response [GO:0071476]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; maintenance of lens transparency [GO:0036438]; negative regulation of creatine transmembrane transporter activity [GO:1905408]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of blood pressure [GO:0008217]; regulation of inflammatory response [GO:0050727]; signal transduction by protein phosphorylation [GO:0023014]; signal transduction by trans-phosphorylation [GO:0023016]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PB1.2.6.m.11467,0.000478582427420658,-0.00251899661585479,No,NA,NA,Q90941,NA,NA,NA,RSC-type complex [GO:0016586]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; ATP-dependent chromatin remodeling [GO:0043044]; nucleosome disassembly [GO:0006337]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PC11X.1.2.m.24796,-0.0133554098789797,0.0131332504829901,No,NA,NA,Q8IW45,NA,NA,NA,mitochondrial matrix [GO:0005759]; ADP-dependent NAD(P)H-hydrate dehydratase activity [GO:0052855]; ATP binding [GO:0005524]; ATP-dependent NAD(P)H-hydrate dehydratase activity [GO:0047453]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356],NA,NA,NA
CHOYP_PC2.1.2.m.34944,-0.0110788033168579,0.0166704079751575,No,NA,NA,Q8JHV9,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_PC2.1.2.m.34945,-0.0129369399637539,0.0227553930895462,No,NA,NA,Q03333,NA,NA,NA,extracellular space [GO:0005615]; membrane [GO:0016020]; neuron projection [GO:0043005]; transport vesicle [GO:0030133]; serine-type endopeptidase activity [GO:0004252]; peptide hormone processing [GO:0016486]; protein processing [GO:0016485],NA,NA,NA
CHOYP_PCCA.2.2.m.45684,-0.000951246380845558,0.00161315322993652,No,NA,NA,Q91ZA3,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; propionyl-CoA carboxylase activity [GO:0004658],NA,NA,NA
CHOYP_PCCB.1.2.m.3057,-0.00918280895710807,0.00150087548041079,No,NA,NA,Q13231,NA,NA,NA,extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; chitin binding [GO:0008061]; chitinase activity [GO:0004568]; endochitinase activity [GO:0008843]; hydrolase activity; hydrolyzing O-glycosyl compounds [GO:0004553]; chitin catabolic process [GO:0006032]; immune response [GO:0006955]; neutrophil degranulation [GO:0043312]; polysaccharide catabolic process [GO:0000272]; polysaccharide digestion [GO:0044245]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_PCCB.1.2.m.3058,-5.97744917592423e-05,0.000331695807826825,No,NA,NA,P05166,NA,NA,NA,cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; propionyl-CoA carboxylase activity [GO:0004658]; biotin metabolic process [GO:0006768],NA,NA,NA
CHOYP_PCDH1.2.3.m.8055,-0.00218829905842082,0.0029707839419476,No,NA,NA,Q9HC56,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH1.3.3.m.63887,0.00572719271876788,0.00676366726606076,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCDH7.1.3.m.6236,0.00286852878641848,-0.000775158409036387,No,NA,NA,Q6KEQ9,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.2.5.m.34196,-0.0061664290698369,0.00156133054781365,No,NA,NA,Q6WYY1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PCDH9.4.5.m.58558,0.00679623871089981,-0.00226098274931411,No,NA,NA,Q9HC56,NA,NA,NA,cell-cell contact zone [GO:0044291]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PCDH9.5.5.m.59488,0.00755651178233185,0.018091931759162,No,NA,NA,O95453,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; 3'-5'-exoribonuclease activity [GO:0000175]; cation binding [GO:0043169]; metal ion binding [GO:0046872]; mRNA 3'-UTR binding [GO:0003730]; nuclease activity [GO:0004518]; poly(A)-specific ribonuclease activity [GO:0004535]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034]; box H/ACA snoRNA 3'-end processing [GO:0000495]; female gamete generation [GO:0007292]; miRNA catabolic process [GO:0010587]; ncRNA deadenylation [GO:0110008]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; polyadenylation-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of mRNA stability [GO:0043488]; regulation of telomerase RNA localization to Cajal body [GO:1904872]; RNA modification [GO:0009451]; RNA phosphodiester bond hydrolysis; exonucleolytic [GO:0090503]; telomerase RNA stabilization [GO:0090669],NA,NA,NA
CHOYP_PCF11.1.1.m.49191,0.00100079097230013,-0.00256626773562724,No,NA,NA,O94913,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; mRNA cleavage factor complex [GO:0005849]; nucleoplasm [GO:0005654]; mRNA binding [GO:0003729]; RNA polymerase II complex binding [GO:0000993]; mRNA 3'-end processing [GO:0031124]; mRNA cleavage [GO:0006379]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_PCH2.1.1.m.7113,0.00017427556119377,0.00319880511917505,No,NA,NA,Q6P4W8,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ATP binding [GO:0005524]; double-strand break repair [GO:0006302]; meiotic recombination checkpoint [GO:0051598]; oogenesis [GO:0048477]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130],NA,NA,NA
CHOYP_PCID2.1.1.m.28679,-0.00884006143764827,0.0213305182495561,No,NA,NA,Q5JVF3,NA,NA,NA,transcription export complex 2 [GO:0070390]; double-stranded DNA binding [GO:0003690]; RNA binding [GO:0003723]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity [GO:2000117]; nuclear retention of pre-mRNA at the site of transcription [GO:0071033]; poly(A)+ mRNA export from nucleus [GO:0016973]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of transcription; DNA-templated [GO:0045893]; posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; regulation of mRNA stability [GO:0043488]; spleen development [GO:0048536]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PCKG.1.2.m.43784,0.000304049997887746,-0.000940483909459126,No,NA,NA,P05153,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; DBD domain binding [GO:0050692]; epinephrine binding [GO:0051379]; GTP binding [GO:0005525]; inosine kinase activity [GO:0008906]; malate oxidase activity [GO:0019157]; manganese ion binding [GO:0030145]; mRNA binding [GO:0003729]; nucleoside diphosphate kinase activity [GO:0004550]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; protein-disulfide reductase activity [GO:0047134]; sequence-specific DNA binding [GO:0043565]; adult feeding behavior [GO:0008343]; aging [GO:0007568]; alanine metabolic process [GO:0006522]; aspartate metabolic process [GO:0006531]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to ethanol [GO:0071361]; cellular response to fructose stimulus [GO:0071332]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; cellular response to tumor necrosis factor [GO:0071356]; developmental growth [GO:0048589]; digestion [GO:0007586]; eggshell formation [GO:0030703]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic organ morphogenesis [GO:0048562]; gluconeogenesis [GO:0006094]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glycerol biosynthetic process from pyruvate [GO:0046327]; glycerol catabolic process [GO:0019563]; glycine metabolic process [GO:0006544]; hepatocyte differentiation [GO:0070365]; intestinal absorption [GO:0050892]; kidney interstitial fibroblast differentiation [GO:0072071]; lactate metabolic process [GO:0006089]; lipid catabolic process [GO:0016042]; malate transport [GO:0015743]; NADH regeneration [GO:0006735]; negative regulation of carbohydrate metabolic process [GO:0045912]; oviposition [GO:0018991]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of carbohydrate metabolic process [GO:0045913]; positive regulation of gluconeogenesis [GO:0045722]; proline metabolic process [GO:0006560]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; regulation of feeding behavior [GO:0060259]; regulation of gluconeogenesis [GO:0006111]; regulation of transcription by glucose [GO:0046015]; response to cAMP [GO:0051591]; response to cycloheximide [GO:0046898]; response to glucocorticoid [GO:0051384]; response to interleukin-6 [GO:0070741]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to methionine [GO:1904640]; response to starvation [GO:0042594]; serine family amino acid metabolic process [GO:0009069]; sexual reproduction [GO:0019953]; vitellogenesis [GO:0007296],NA,NA,NA
CHOYP_PCKG.1.2.m.43785,0.00160307387849924,0.000507163853790959,No,NA,NA,P29190,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCKG.2.2.m.50139,0.00109364363276001,-0.0107633371009548,No,NA,NA,P29190,NA,NA,NA,GTP binding [GO:0005525]; metal ion binding [GO:0046872]; phosphoenolpyruvate carboxykinase (GTP) activity [GO:0004613]; gluconeogenesis [GO:0006094],NA,NA,NA
CHOYP_PCP.1.1.m.59309,-0.00213095547271873,-0.00402997843197086,No,NA,NA,Q2TA14,NA,NA,NA,lysosome [GO:0005764]; carboxypeptidase activity [GO:0004180]; dipeptidyl-peptidase activity [GO:0008239]; serine-type peptidase activity [GO:0008236]; angiogenesis involved in wound healing [GO:0060055]; negative regulation of systemic arterial blood pressure [GO:0003085]; proteolysis [GO:0006508]; regulation of blood vessel endothelial cell migration [GO:0043535],NA,NA,NA
CHOYP_PCS.1.1.1.m.8305,0.00415627599970038,0.00490845503343482,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PCX1.1.1.m.55309,-0.00430122845648778,-0.00273729117218985,No,NA,NA,Q96RV3,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PCYB_062570.1.1.m.58917,0.00290426741533734,-0.000784816007337317,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDCD2L.1.1.m.43699,-0.00320854566132989,0.0136686681994724,No,NA,NA,Q5ZID2,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_PDCL3.1.1.m.7323,0.00207278419050943,0.0029503487982084,No,NA,NA,Q5RB77,NA,NA,NA,cytoplasm [GO:0005737]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; viral process [GO:0016032],NA,NA,NA
CHOYP_PDDC1.1.1.m.16484,0.00194168889496402,0.00696187952620149,No,NA,NA,Q8BFQ8,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_PDE11.1.3.m.8788,0.00328193403464068,0.00387587966556946,No,NA,NA,Q9VJ79,NA,NA,NA,cytosol [GO:0005829]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; metal ion binding [GO:0046872]; cAMP metabolic process [GO:0046058]; cGMP metabolic process [GO:0046068]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE2A.3.3.m.60225,-0.0133917724137596,0.00180970332507439,No,NA,NA,P14099,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; drug binding [GO:0008144]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to drug [GO:0035690]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; GMP catabolic process [GO:0046038]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of protein import into nucleus; translocation [GO:0033159]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of mitochondrion organization [GO:0010821]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PDE3A.1.3.m.22256,0.00490897093876672,0.002628487292091,No,NA,NA,Q14432,NA,NA,NA,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; 3';5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; metal ion binding [GO:0046872]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-mediated signaling [GO:0043951]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; response to drug [GO:0042493],NA,NA,NA
CHOYP_PDE6D.1.2.m.6439,-0.00617499469520892,0.00968933240670662,No,NA,NA,O55057,NA,NA,NA,cell projection [GO:0042995]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; phototransduction [GO:0007602]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PDHA.1.1.1.m.67024,-0.0161048060672077,0.0220377613402757,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PDHA1.1.1.m.42807,0.000944514972560889,0.000514435188106304,No,NA,NA,P52899,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase (acetyl-transferring) activity [GO:0004739]; acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096],NA,NA,NA
CHOYP_PDIA1.1.1.m.5297,0.000446910238367792,0.000520841063389109,No,NA,NA,P04785,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; melanosome [GO:0042470]; procollagen-proline 4-dioxygenase complex [GO:0016222]; enzyme binding [GO:0019899]; integrin binding [GO:0005178]; peptide disulfide oxidoreductase activity [GO:0015037]; procollagen-proline 4-dioxygenase activity [GO:0004656]; protein disulfide isomerase activity [GO:0003756]; protein heterodimerization activity [GO:0046982]; cell redox homeostasis [GO:0045454]; cellular response to hypoxia [GO:0071456]; cellular response to interleukin-7 [GO:0098761]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401]; positive regulation of viral entry into host cell [GO:0046598]; protein folding [GO:0006457]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA3.1.1.m.60223,0.000274908912302734,0.00227455805490887,No,NA,NA,Q8JG64,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; MHC class I peptide loading complex [GO:0042824]; myelin sheath [GO:0043209]; identical protein binding [GO:0042802]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; cellular response to interleukin-7 [GO:0098761]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein folding [GO:0006457]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA4.1.1.m.54958,0.00135872713434806,-0.000278198857407737,No,NA,NA,P13667,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; melanosome [GO:0042470]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; RNA binding [GO:0003723]; cell redox homeostasis [GO:0045454]; chaperone-mediated protein folding [GO:0061077]; protein folding [GO:0006457]; protein secretion [GO:0009306]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_PDIA6.1.2.m.9012,0.00145197109439566,0.000331032075568487,No,NA,NA,Q922R8,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; extracellular space [GO:0005615]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; peptide disulfide oxidoreductase activity [GO:0015037]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527],NA,NA,NA
CHOYP_PDIA6.2.2.m.58490,-0.0278297006089365,-0.0117842729945897,No,NA,NA,P38661,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; protein disulfide isomerase activity [GO:0003756]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_PDLI1.2.2.m.2094,0.00200709706652519,-0.000485510784039284,No,NA,NA,Q5E9E1,NA,NA,NA,cytoskeleton [GO:0005856]; transcription factor complex [GO:0005667]; Z disc [GO:0030018]; metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PDS5B.1.1.m.16690,-0.00223671770529154,0.00798785078672007,No,NA,NA,Q4VA53,NA,NA,NA,chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA binding [GO:0003677]; cell division [GO:0051301]; DNA repair [GO:0006281]; enteric nervous system development [GO:0048484]; lens development in camera-type eye [GO:0002088]; mitotic sister chromatid cohesion [GO:0007064]; negative regulation of cell proliferation [GO:0008285]; neuroblast migration [GO:0097402]; regulation of cell proliferation [GO:0042127],NA,NA,NA
CHOYP_PDXDC1.1.1.m.11298,-0.00390328857327899,0.0113022841330716,No,NA,NA,Q99K01,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; carboxylic acid metabolic process [GO:0019752]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665],NA,NA,NA
CHOYP_PDXK.1.1.m.14904,0.00230060706716619,-0.00369892477796505,No,NA,NA,P82197,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; pyridoxal kinase activity [GO:0008478]; pyridoxal 5'-phosphate salvage [GO:0009443],NA,NA,NA
CHOYP_PDZRN3.1.1.m.18229,0.00312783667758132,-0.000845230807583007,No,NA,NA,Q69ZS0,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neuromuscular junction development [GO:0007528]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PE2R3.2.2.m.61863,0.00392834514347626,0.0046392745558657,No,NA,NA,O75382,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; protein C-terminus binding [GO:0008022]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270]; nervous system development [GO:0007399]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PEAR1.10.16.m.42850,-0.00337325428497487,0.00457945161715742,No,NA,NA,O75095,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_PEAR1.6.16.m.37314,0.00443930708309576,0.00524270746181318,No,NA,NA,P59222,NA,NA,NA,integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157],NA,NA,NA
CHOYP_PECR.1.1.m.58859,-0.0025622345996608,-0.016386904345898,No,NA,NA,Q9WVK3,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; trans-2-enoyl-CoA reductase (NADPH) activity [GO:0019166]; fatty acid biosynthetic process [GO:0006633]; oxidation-reduction process [GO:0055114]; phytol metabolic process [GO:0033306],NA,NA,NA
CHOYP_PELO.1.1.m.14458,0.000934730120677968,0.00294379535428241,No,NA,NA,P48612,NA,NA,NA,cytoplasm [GO:0005737]; Dom34-Hbs1 complex [GO:1990533]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; compound eye morphogenesis [GO:0001745]; female germ-line stem cell asymmetric division [GO:0048132]; G2/MI transition of meiotic cell cycle [GO:0008315]; germ-line stem cell population maintenance [GO:0030718]; male meiosis I [GO:0007141]; meiotic cell cycle [GO:0051321]; meiotic nuclear envelope disassembly [GO:0051078]; meiotic spindle organization [GO:0000212]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process; no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process; non-stop decay [GO:0070481]; posttranscriptional gene silencing [GO:0016441]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; spermatocyte division [GO:0048137],NA,NA,NA
CHOYP_PEO1.1.1.m.14775,-0.00368810030988377,0.00500687926302059,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PEPM.1.1.m.14235,-0.000267785337873099,0.00143588963636285,No,NA,NA,P56839,NA,NA,NA,metal ion binding [GO:0046872]; phosphoenolpyruvate mutase activity [GO:0050188]; organic phosphonate biosynthetic process [GO:0032923],NA,NA,NA
CHOYP_PERMA_0370.1.1.m.41998,-0.00565426254481393,-0.00673530626204728,No,NA,NA,Q9VFD5,NA,NA,NA,ubiquitin-protein transferase activity [GO:0004842]; regulation of ubiquitin-protein transferase activity [GO:0051438],NA,NA,NA
CHOYP_PERQ2.2.2.m.40796,-0.00359417903646164,0.00119514335779239,No,NA,NA,O75420,NA,NA,NA,protein-containing complex [GO:0032991]; insulin-like growth factor receptor signaling pathway [GO:0048009],NA,NA,NA
CHOYP_PESC.1.1.m.16875,0.0025002261217175,0.0074404167493709,No,NA,NA,Q7ZY69,NA,NA,NA,nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; cell proliferation [GO:0008283]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_PEX2.2.2.m.26981,-0.00680946470666555,0.0253294503999522,No,NA,NA,P40855,NA,NA,NA,brush border membrane [GO:0031526]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; ATPase binding [GO:0051117]; peroxisome membrane class-1 targeting sequence binding [GO:0036105]; protein N-terminus binding [GO:0047485]; chaperone-mediated protein folding [GO:0061077]; chaperone-mediated protein transport [GO:0072321]; establishment of protein localization to peroxisome [GO:0072663]; negative regulation of lipid binding [GO:1900131]; peroxisome fission [GO:0016559]; peroxisome membrane biogenesis [GO:0016557]; peroxisome organization [GO:0007031]; protein import into peroxisome membrane [GO:0045046]; protein stabilization [GO:0050821]; protein targeting to peroxisome [GO:0006625]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_PF10_0308.1.1.m.43529,0.0227727163912793,0.0165669074587125,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFB0115W.2.2.m.65461,0.0071140301380479,0.00385087953321288,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PFD3.1.1.m.56418,0.00126122861725839,0.00132397764466321,No,NA,NA,Q5RCG9,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; prefoldin complex [GO:0016272]; protein folding [GO:0006457],NA,NA,NA
CHOYP_PGBM.2.3.m.44777,0.00977267130863002,0.00332244208803284,No,NA,NA,Q810U3,NA,NA,NA,axon [GO:0030424]; axon initial segment [GO:0043194]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; node of Ranvier [GO:0033268]; paranodal junction [GO:0033010]; paranode region of axon [GO:0033270]; plasma membrane [GO:0005886]; Schwann cell microvillus [GO:0097454]; septate junction [GO:0005918]; protein binding involved in heterotypic cell-cell adhesion [GO:0086080]; protein domain specific binding [GO:0019904]; axon guidance [GO:0007411]; clustering of voltage-gated sodium channels [GO:0045162]; paranodal junction assembly [GO:0030913]; peripheral nervous system development [GO:0007422]; protein localization to juxtaparanode region of axon [GO:0071205]; protein localization to paranode region of axon [GO:0002175]; protein localization to plasma membrane [GO:0072659]; synapse organization [GO:0050808]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_PGDH.3.5.m.36973,-0.00177980951567899,-0.008665331949342,No,NA,NA,Q8VCC1,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGDH.5.5.m.66725,-0.00124240822099316,0.00146484675248996,No,NA,NA,P15428,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; protein homodimerization activity [GO:0042803]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PGK1.1.1.m.27254,0.00138746222697222,-0.00132744454351949,No,NA,NA,Q3T0P6,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase activity [GO:0047134]; cellular response to hypoxia [GO:0071456]; chemical synaptic transmission [GO:0007268]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; myoblast fusion [GO:0007520]; negative regulation of angiogenesis [GO:0016525]; plasminogen activation [GO:0031639]; positive regulation of oxidative phosphorylation [GO:1903862]; response to hypoxia [GO:0001666]; somatic muscle development [GO:0007525],NA,NA,NA
CHOYP_PGM1.1.1.m.38482,0.000862585430112705,0.00165858631313155,No,NA,NA,P36871,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; tertiary granule lumen [GO:1904724]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; galactose catabolic process [GO:0019388]; gluconeogenesis [GO:0006094]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; glycolytic process [GO:0006096]; neutrophil degranulation [GO:0043312],NA,NA,NA
CHOYP_PGM2.1.1.m.65095,-0.000334318239963344,-0.000713723323468568,No,NA,NA,Q96G03,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; magnesium ion binding [GO:0000287]; phosphoglucomutase activity [GO:0004614]; phosphopentomutase activity [GO:0008973]; deoxyribose phosphate catabolic process [GO:0046386]; galactose catabolic process [GO:0019388]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycogen catabolic process [GO:0005980]; neutrophil degranulation [GO:0043312]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_PGPS1.1.1.m.10148,-0.00910568967595877,-0.00579483843251956,No,NA,NA,Q5ZHN9,NA,NA,NA,endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [GO:0008444]; cardiolipin biosynthetic process [GO:0032049],NA,NA,NA
CHOYP_PGRMC1.1.1.m.38547,-0.000113081705763594,0.0150032212192505,No,NA,NA,Q5XIU9,NA,NA,NA,integral component of membrane [GO:0016021]; nuclear envelope [GO:0005635]; steroid binding [GO:0005496],NA,NA,NA
CHOYP_PGTA.1.1.m.43418,0.0108455129823323,-0.00118612134291455,No,NA,NA,Q5EA80,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; Rab-protein geranylgeranyltransferase complex [GO:0005968]; Rab geranylgeranyltransferase activity [GO:0004663]; Rab GTPase binding [GO:0017137]; zinc ion binding [GO:0008270]; protein geranylgeranylation [GO:0018344],NA,NA,NA
CHOYP_PGTG_12376.1.2.m.43330,-0.00660075164603652,0.0121306906755846,No,NA,NA,P37167,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042],NA,NA,NA
CHOYP_PHATRDRAFT_43152.1.1.m.15003,0.00159523748124321,-0.00207697853927462,No,NA,NA,P25007,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PHC2.1.1.m.48379,-0.0071782114276344,-0.0020674413615796,No,NA,NA,Q8QHL5,NA,NA,NA,PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHF10.1.1.m.6981,0.0168933821832142,-0.00598737251269151,No,NA,NA,Q8WUB8,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleus [GO:0005634]; histone acetyltransferase activity [GO:0004402]; histone binding [GO:0042393]; metal ion binding [GO:0046872]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_PHF14.1.1.m.27257,0.00331228329795626,-0.00744195003516189,No,NA,NA,O94880,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; lung alveolus development [GO:0048286]; negative regulation of mesenchymal cell proliferation involved in lung development [GO:2000791]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHF5A.1.1.m.32389,-0.000484088183926329,0.00440410012820805,No,NA,NA,P83871,NA,NA,NA,nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PHLP.1.1.m.25742,-0.00771683882658725,0.0160038623311185,No,NA,NA,Q13371,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; protein-containing complex binding [GO:0044877]; cell projection organization [GO:0030030]; heterotrimeric G-protein complex assembly [GO:1902605]; negative regulation of protein refolding [GO:0061084]; positive regulation of smoothened signaling pathway [GO:0045880]; protein folding [GO:0006457]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; signal transduction [GO:0007165]; visual perception [GO:0007601],NA,NA,NA
CHOYP_PHOCN.1.1.m.40660,-0.00912653798482723,0.00267984948355443,No,NA,NA,Q9QYW3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; vesicle budding from membrane [GO:0006900],NA,NA,NA
CHOYP_PHR.1.1.m.7664,-0.0203575060888988,0.000668481724469207,No,NA,NA,Q28811,NA,NA,NA,deoxyribodipyrimidine photo-lyase activity [GO:0003904]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; protein-chromophore linkage [GO:0018298],NA,NA,NA
CHOYP_PHT4.1.1.m.18841,-0.0113826530002219,0.000825181317368833,No,NA,NA,O34371,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM009400.1.1.m.35298,-0.00977512008675131,0.00335671225066797,No,NA,NA,Q9U943,NA,NA,NA,extracellular region [GO:0005576]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_PHUM_PHUM035190.1.1.m.16675,0.00101128552971748,0.00209198065744232,No,NA,NA,Q9ERH3,NA,NA,NA,synaptic vesicle [GO:0008021]; hematopoietic progenitor cell differentiation [GO:0002244],NA,NA,NA
CHOYP_PHUM_PHUM049590.1.4.m.14204,-0.000114922528603223,0.0152474541135276,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM060390.1.1.m.12993,0.00337706592695021,-0.0165456074861396,No,NA,NA,Q642H7,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; G-protein alpha-subunit binding [GO:0001965]; GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; G protein-coupled receptor signaling pathway [GO:0007186],NA,NA,NA
CHOYP_PHUM_PHUM066670.2.3.m.42178,-0.00526410153972989,0.00814329528028303,No,NA,NA,P98160,NA,NA,NA,basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; amyloid-beta binding [GO:0001540]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; protein C-terminus binding [GO:0008022]; angiogenesis [GO:0001525]; brain development [GO:0007420]; cardiovascular system development [GO:0072358]; cell differentiation [GO:0030154]; cellular protein metabolic process [GO:0044267]; extracellular matrix organization [GO:0030198]; glycosaminoglycan biosynthetic process [GO:0006024]; glycosaminoglycan catabolic process [GO:0006027]; inflammatory response [GO:0006954]; lipid metabolic process [GO:0006629]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; receptor-mediated endocytosis [GO:0006898]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM068980.4.5.m.56739,0.0025860635585569,0.0100599125840967,No,NA,NA,Q8NFZ8,NA,NA,NA,integral component of membrane [GO:0016021]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM071280.1.1.m.25507,-0.000244607959644307,-0.00436991493465706,No,NA,NA,Q9Y6E0,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cadherin binding [GO:0045296]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cellular response to starvation [GO:0009267]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; MAPK cascade [GO:0000165]; negative regulation of cell migration [GO:0030336]; neuron projection morphogenesis [GO:0048812]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon regeneration [GO:0048679]; response to hydrogen peroxide [GO:0042542]; signal transduction [GO:0007165]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_PHUM_PHUM075600.1.1.m.35072,0.00389613089194091,0.0176066015488089,No,NA,NA,Q9U6M0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase activity; acting on NAD(P)H [GO:0016651]; innate immune response [GO:0045087]; regulation of oxidoreductase activity [GO:0051341],NA,NA,NA
CHOYP_PHUM_PHUM076810.1.1.m.24070,0.0154039328764681,0.00429901742160267,No,NA,NA,O75369,NA,NA,NA,actin cytoskeleton [GO:0015629]; brush border [GO:0005903]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; Z disc [GO:0030018]; actin binding [GO:0003779]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; actin cytoskeleton organization [GO:0030036]; cellular response to interferon-gamma [GO:0071346]; cytoskeletal anchoring at plasma membrane [GO:0007016]; epithelial cell morphogenesis [GO:0003382]; keratinocyte development [GO:0003334]; signal transduction [GO:0007165]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_PHUM_PHUM092120.1.1.m.33493,-0.000686734044654911,0.0108084557401774,No,NA,NA,Q5JWR5,NA,NA,NA,cytosol [GO:0005829]; endosome [GO:0005768]; Golgi membrane [GO:0000139]; trans-Golgi network [GO:0005802]; Golgi to endosome transport [GO:0006895]; protein transport [GO:0015031],NA,NA,NA
CHOYP_PHUM_PHUM122670.1.1.m.38346,0.00511360487700612,-0.00928366070105663,No,NA,NA,Q9BKZ9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; nucleus [GO:0005634]; amyloid-beta binding [GO:0001540]; transcription factor binding [GO:0008134]; embryo development ending in birth or egg hatching [GO:0009792]; feeding behavior [GO:0007631]; nematode larval development [GO:0002119]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_PHUM_PHUM125580.1.1.m.47466,-0.00470243570999036,0.00429793401330245,No,NA,NA,P04069,NA,NA,NA,extracellular region [GO:0005576]; metallocarboxypeptidase activity [GO:0004181]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PHUM_PHUM128460.1.7.m.3477,-0.0172069712035964,0.00651865373970073,No,NA,NA,Q8WV28,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.3.7.m.27983,-0.0176315632947167,0.0205387936235367,No,NA,NA,Q8WV28,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; intracellular [GO:0005622]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; B cell differentiation [GO:0030183]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.4.7.m.38295,0.00527687860083791,0.0194520940938758,No,NA,NA,Q9QUN3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM128460.6.7.m.60989,0.0023467567066053,-0.0238795936700359,No,NA,NA,Q9QUN3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; plasma membrane [GO:0005886]; SH3/SH2 adaptor activity [GO:0005070]; B cell activation [GO:0042113]; intracellular signal transduction [GO:0035556]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PHUM_PHUM135440.1.1.m.40573,-0.00231065673501173,0.00313689387988846,No,NA,NA,Q8IS64,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; peptide hormone processing [GO:0016486],NA,NA,NA
CHOYP_PHUM_PHUM137710.1.1.m.19548,-0.00141062488112443,0.0185511131657137,No,NA,NA,Q5ZJP5,NA,NA,NA,Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; sarcomere [GO:0030017],NA,NA,NA
CHOYP_PHUM_PHUM169900.2.2.m.61606,-0.0052958614322725,-0.00337027314274242,No,NA,NA,Q8C033,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; kinesin binding [GO:0019894]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; activation of GTPase activity [GO:0090630]; centrosome duplication [GO:0051298]; mitotic spindle assembly [GO:0090307]; myelination in peripheral nervous system [GO:0022011]; positive regulation of stress fiber assembly [GO:0051496]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_PHUM_PHUM174810.1.1.m.31029,-0.00353840328726999,-0.00978356675281841,No,NA,NA,Q8N5N7,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; mitochondrial translational elongation [GO:0070125]; mitochondrial translational termination [GO:0070126],NA,NA,NA
CHOYP_PHUM_PHUM174820.1.1.m.57391,0.00219543238359658,-0.000593268536008137,No,NA,NA,Q5SWW4,NA,NA,NA,mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; signaling receptor activity [GO:0038023]; thyroid hormone receptor binding [GO:0046966]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; androgen receptor signaling pathway [GO:0030521]; cholesterol homeostasis [GO:0042632]; intracellular steroid hormone receptor signaling pathway [GO:0030518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription initiation from RNA polymerase II promoter [GO:0006367]; triglyceride homeostasis [GO:0070328],NA,NA,NA
CHOYP_PHUM_PHUM176650.1.1.m.13332,-0.00759654156534864,-0.000791594239945567,No,NA,NA,Q6P9N1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; myelination [GO:0042552]; phosphatidylinositol phosphorylation [GO:0046854]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_PHUM_PHUM215460.1.1.m.33815,0.00206450373318513,0.00434698826126488,No,NA,NA,Q8JZP9,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytoskeletal adaptor activity [GO:0008093]; microtubule binding [GO:0008017]; thyroid hormone receptor binding [GO:0046966]; cell cycle arrest [GO:0007050]; cellular response to starvation [GO:0009267]; cellular response to thyroid hormone stimulus [GO:0097067]; microtubule bundle formation [GO:0001578]; negative regulation of cell growth [GO:0030308]; negative regulation of erythrocyte differentiation [GO:0045647]; negative regulation of gene expression [GO:0010629]; negative regulation of microtubule depolymerization [GO:0007026]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_PHUM_PHUM226120.1.7.m.673,0.00536894661724303,-0.00974722918868776,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_PHUM_PHUM226120.2.7.m.2274,0.00797741355006159,0.00556592426823486,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.3.7.m.20773,-0.00356227163635219,-0.00804346214038603,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.5.7.m.43551,-0.00585973191185419,-0.0130849424426562,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.6.7.m.48915,9.16434206192268e-05,5.83216466616444e-05,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM226120.7.7.m.54053,-0.00138771972496679,-0.00359843774638579,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_PHUM_PHUM228480.1.1.m.498,0.00264723110472601,-0.000715357454736622,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM229210.1.1.m.50089,0.0147285860267897,-0.0157242275990221,No,NA,NA,Q3T0L3,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_PHUM_PHUM233260.1.1.m.6315,-0.00236882078133109,0.00180168021662483,No,NA,NA,O08715,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; mitochondrial crista [GO:0030061]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; postsynaptic membrane [GO:0045211]; beta-tubulin binding [GO:0048487]; microtubule binding [GO:0008017]; protein kinase A regulatory subunit binding [GO:0034237]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; protein phosphatase binding [GO:0019903]; protein-containing complex scaffold activity [GO:0032947]; RNA binding [GO:0003723]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of protein dephosphorylation [GO:0035308]; negative regulation of protein import into nucleus [GO:0042308]; regulation of protein kinase A signaling [GO:0010738],NA,NA,NA
CHOYP_PHUM_PHUM234540.1.1.m.9211,0.0071074963042994,-0.00216064025295635,No,NA,NA,Q5ZHY5,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018]; chaperone binding [GO:0051087]; G protein-coupled receptor binding [GO:0001664]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; SMAD binding [GO:0046332]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579],NA,NA,NA
CHOYP_PHUM_PHUM241330.1.3.m.29132,-0.00369306519143423,-0.00364468384764958,No,NA,NA,Q16629,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; cellular response to leukemia inhibitory factor [GO:1990830]; mRNA 3'-end processing [GO:0031124]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA export from nucleus [GO:0006405]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PHUM_PHUM244880.1.2.m.691,-0.00718006278077356,-0.00456937422980527,No,NA,NA,Q9VB11,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM244880.2.2.m.41653,-0.004633748875634,0.00626730361462789,No,NA,NA,Q9VB11,NA,NA,NA,cation channel complex [GO:0034703]; cation channel activity [GO:0005261]; cation homeostasis [GO:0055080]; locomotor rhythm [GO:0045475],NA,NA,NA
CHOYP_PHUM_PHUM268120.1.1.m.23332,0.00664253126540506,-0.0183477827776821,No,NA,NA,Q4LDE5,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; chromatin binding [GO:0003682]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_PHUM_PHUM278110.1.1.m.17560,-2.38615704117481e-05,-0.00480187845623565,No,NA,NA,Q6GLE1,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44778,-0.00876624157187491,-0.00841963261894812,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_PHUM_PHUM289860.1.1.m.44779,0.00161920480267186,0.00151126101879396,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_PHUM_PHUM305910.1.2.m.58404,0.00520717387084609,0.00290127660629247,No,NA,NA,O35867,NA,NA,NA,actin cytoskeleton [GO:0015629]; cell junction [GO:0030054]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; dendritic spine neck [GO:0044326]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; growth cone lamellipodium [GO:1990761]; lamellipodium [GO:0030027]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; postsynaptic actin cytoskeleton [GO:0098871]; postsynaptic density [GO:0014069]; synapse [GO:0045202]; actin filament binding [GO:0051015]; GTPase binding [GO:0051020]; ion channel binding [GO:0044325]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein-containing complex binding [GO:0044877]; actin filament organization [GO:0007015]; aging [GO:0007568]; calcium-mediated signaling [GO:0019722]; cellular response to toxic substance [GO:0097237]; excitatory postsynaptic potential [GO:0060079]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of spontaneous neurotransmitter secretion [GO:1904049]; negative regulation of stress fiber assembly [GO:0051497]; neuron development [GO:0048666]; neuron projection development [GO:0031175]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein kinase activity [GO:0045860]; postsynaptic actin cytoskeleton organization [GO:0098974]; regulation of actin filament polymerization [GO:0030833]; regulation of dendritic spine morphogenesis [GO:0061001]; regulation of filopodium assembly [GO:0051489]; regulation of synapse assembly [GO:0051963]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM310360.1.1.m.21767,0.00778678309315142,-0.0141367692514925,No,NA,NA,Q5R7A4,NA,NA,NA,cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; symbiont-containing vacuole [GO:0020003]; trans-Golgi network [GO:0005802]; dynein complex binding [GO:0070840]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinesin binding [GO:0019894]; Rab GTPase binding [GO:0017137]; Golgi organization [GO:0007030]; mitochondrion organization [GO:0007005]; multi-organism toxin transport [GO:1990967]; negative regulation of neuron projection development [GO:0010977]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of receptor recycling [GO:0001921]; positive regulation of T cell receptor signaling pathway [GO:0050862]; protein localization to membrane [GO:0072657]; protein transport [GO:0015031]; response to bacterium [GO:0009617]; retrograde transport; endosome to Golgi [GO:0042147]; synapse assembly [GO:0007416]; T cell activation [GO:0042110]; viral RNA genome replication [GO:0039694],NA,NA,NA
CHOYP_PHUM_PHUM317840.1.2.m.29476,-0.0121454699174008,-0.0028532695230736,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM317840.2.2.m.36471,-0.00487975090241718,-0.0194584246280774,No,NA,NA,O60218,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; alditol:NADP+ 1-oxidoreductase activity [GO:0004032]; aldo-keto reductase (NADP) activity [GO:0004033]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; oxidoreductase activity [GO:0016491]; retinal dehydrogenase activity [GO:0001758]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],NA,NA,NA
CHOYP_PHUM_PHUM319040.1.1.m.54919,6.63330232912653e-05,-0.00381289700007187,No,NA,NA,Q5ZJ39,NA,NA,NA,mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of translation preinitiation complex [GO:0001731]; IRES-dependent viral translational initiation [GO:0075522]; ribosome disassembly [GO:0032790]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_PHUM_PHUM328150.1.1.m.8592,0.0158907436506369,-0.022919977056923,No,NA,NA,O76463,NA,NA,NA,bis(5'-adenosyl)-triphosphatase activity [GO:0047710]; hydrolase activity; acting on carbon-nitrogen (but not peptide) bonds [GO:0016810]; nucleotide binding [GO:0000166]; nucleobase-containing compound metabolic process [GO:0006139],NA,NA,NA
CHOYP_PHUM_PHUM332570.1.1.m.56283,-0.00703607400414026,-0.00976240241410443,No,NA,NA,Q9XYM0,NA,NA,NA,receptor tyrosine kinase binding [GO:0030971]; border follicle cell migration [GO:0007298]; ephrin receptor signaling pathway [GO:0048013]; imaginal disc fusion; thorax closure [GO:0046529]; myoblast fusion [GO:0007520]; phagocytosis; engulfment [GO:0006911]; positive regulation of JNK cascade [GO:0046330]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of GTPase activity [GO:0043087]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_PHUM_PHUM349810.1.2.m.7707,-0.00450392223083652,-0.00879502577150788,No,NA,NA,A7SMW7,NA,NA,NA,mitochondrion [GO:0005739]; (S)-2-hydroxy-acid oxidase activity [GO:0003973]; 2-hydroxyglutarate dehydrogenase activity [GO:0047545],NA,NA,NA
CHOYP_PHUM_PHUM350510.1.1.m.44180,-0.0055292618877511,0.010068430360486,No,NA,NA,Q9UI36,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; cell proliferation [GO:0008283]; development of primary female sexual characteristics [GO:0046545]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of nuclear cell cycle DNA replication [GO:0033262]; regulation of transcription; DNA-templated [GO:0006355]; respiratory gaseous exchange [GO:0007585]; suckling behavior [GO:0001967],NA,NA,NA
CHOYP_PHUM_PHUM353470.1.1.m.63458,0.000673404131306339,0.00283201569990185,No,NA,NA,A2TLM1,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; ribose-5-phosphate isomerase activity [GO:0004751]; D-ribose metabolic process [GO:0006014]; pentose-phosphate shunt; non-oxidative branch [GO:0009052],NA,NA,NA
CHOYP_PHUM_PHUM361660.1.1.m.63423,-0.0235847801005362,0.0349528924353015,No,NA,NA,Q7Z3K6,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone deacetylase binding [GO:0042826]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; histone deacetylation [GO:0016575]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_PHUM_PHUM370970.1.2.m.40102,-0.00212569934246189,0.000807857270568384,No,NA,NA,P49746,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; bone trabecula formation [GO:0060346]; cell-matrix adhesion [GO:0007160]; growth plate cartilage development [GO:0003417]; ossification involved in bone maturation [GO:0043931],NA,NA,NA
CHOYP_PHUM_PHUM375280.1.2.m.23797,0.00211406857094644,-0.00452541248583054,No,NA,NA,Q9W6Z2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-templated transcription; initiation [GO:0006352]; embryo development ending in birth or egg hatching [GO:0009792]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM377430.1.2.m.29459,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM378040.1.1.m.15341,-0.0074351495694592,-0.00473171083244683,No,NA,NA,Q9Y5B0,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; midbody [GO:0030496]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; phosphoprotein phosphatase activity [GO:0004721]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; Tat protein binding [GO:0030957]; TFIIF-class transcription factor complex binding [GO:0001096]; cell division [GO:0051301]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; exit from mitosis [GO:0010458]; negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; positive regulation by host of viral transcription [GO:0043923]; protein dephosphorylation [GO:0006470]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHUM_PHUM411900.1.1.m.50272,-0.00190734687010641,-0.00180956284245587,No,NA,NA,Q9WYG0,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PHUM_PHUM423190.1.1.m.18351,-0.00292636539230939,-0.00281864528983603,No,NA,NA,Q8C3P7,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity [GO:0016422]; mRNA (N6-adenosine)-methyltransferase activity [GO:0001734]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA methyltransferase activity [GO:0008173]; S-adenosyl-L-methionine binding [GO:1904047]; adenosine to inosine editing [GO:0006382]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; dosage compensation by inactivation of X chromosome [GO:0009048]; endothelial to hematopoietic transition [GO:0098508]; forebrain radial glial cell differentiation [GO:0021861]; gliogenesis [GO:0042063]; mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA methylation [GO:0080009]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of cap-independent translational initiation [GO:1903679]; primary miRNA methylation [GO:1990744]; primary miRNA processing [GO:0031053]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of meiotic cell cycle [GO:0051445]; regulation of T cell differentiation [GO:0045580]; RNA methylation [GO:0001510]; spermatogenesis [GO:0007283]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_PHUM_PHUM427190.1.1.m.57126,-0.00217659724519892,0.00295489783228745,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_PHUM_PHUM445570.1.1.m.18708,0.00338576094078161,0.000909890888216743,No,NA,NA,O15460,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; electron transfer activity [GO:0009055]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; oxidoreductase activity; acting on single donors with incorporation of molecular oxygen; incorporation of two atoms of oxygen [GO:0016702]; procollagen-proline 4-dioxygenase activity [GO:0004656]; peptidyl-proline hydroxylation to 4-hydroxy-L-proline [GO:0018401],NA,NA,NA
CHOYP_PHUM_PHUM450820.1.1.m.40803,-0.00493943241505114,0.00776748580742449,No,NA,NA,Q5R416,NA,NA,NA,actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; extrinsic component of postsynaptic membrane [GO:0098890]; extrinsic component of presynaptic membrane [GO:0098888]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density; intracellular component [GO:0099092]; presynaptic active zone cytoplasmic component [GO:0098831]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; structural molecule activity [GO:0005198]; axonogenesis [GO:0007409]; brain morphogenesis [GO:0048854]; cell-cell adhesion [GO:0098609]; dendrite morphogenesis [GO:0048813]; modification of postsynaptic actin cytoskeleton [GO:0098885]; prepulse inhibition [GO:0060134]; radial glia guided migration of Purkinje cell [GO:0021942]; regulation of synapse structural plasticity [GO:0051823],NA,NA,NA
CHOYP_PHUM_PHUM454570.1.1.m.28665,0.0014410438756892,0.000546310009305336,No,NA,NA,Q3UHU5,NA,NA,NA,apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; midbody [GO:0030496]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; microtubule bundle formation [GO:0001578]; positive regulation of microtubule motor activity [GO:2000576]; positive regulation of protein targeting to membrane [GO:0090314]; regulation of autophagy [GO:0010506],NA,NA,NA
CHOYP_PHUM_PHUM465390.1.1.m.21142,0.00368475386323373,0.00435159952040283,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM470230.1.1.m.29432,0.0017432418891456,-0.00334482876455694,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_PHUM_PHUM477110.1.1.m.53813,-0.00547308042778807,-0.0147115394838913,No,NA,NA,P20241,NA,NA,NA,bicellular tight junction [GO:0005923]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; septate junction [GO:0005918]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; axon ensheathment [GO:0008366]; axon extension [GO:0048675]; axonogenesis [GO:0007409]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell adhesion [GO:0098609]; central complex development [GO:0048036]; dendrite morphogenesis [GO:0048813]; establishment of glial blood-brain barrier [GO:0060857]; female courtship behavior [GO:0008050]; imaginal disc morphogenesis [GO:0007560]; male courtship behavior [GO:0008049]; melanotic encapsulation of foreign target [GO:0035011]; motor neuron axon guidance [GO:0008045]; mushroom body development [GO:0016319]; nerve maturation [GO:0021682]; neuron cell-cell adhesion [GO:0007158]; photoreceptor cell axon guidance [GO:0072499]; regulation of female receptivity [GO:0045924]; regulation of tube size; open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_PHUM_PHUM477570.1.1.m.2101,0.00290645706436686,-0.00217658806993756,No,NA,NA,P11240,NA,NA,NA,mitochondrial respiratory chain complex IV [GO:0005751]; myelin sheath [GO:0043209]; cytochrome-c oxidase activity [GO:0004129]; metal ion binding [GO:0046872]; mitochondrial electron transport; cytochrome c to oxygen [GO:0006123],NA,NA,NA
CHOYP_PHUM_PHUM477850.1.1.m.19067,-0.0022275179963632,0.00150215567893426,No,NA,NA,H2QII6,NA,NA,NA,annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; transferase activity [GO:0016740]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; positive regulation of GTPase activity [GO:0043547]; protein folding [GO:0006457]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_PHUM_PHUM479110.1.1.m.54103,0,0,No,NA,NA,O95822,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; identical protein binding [GO:0042802]; malonyl-CoA decarboxylase activity [GO:0050080]; signaling receptor binding [GO:0005102]; acetyl-CoA biosynthetic process [GO:0006085]; acyl-CoA metabolic process [GO:0006637]; fatty acid biosynthetic process [GO:0006633]; fatty acid oxidation [GO:0019395]; malonyl-CoA catabolic process [GO:2001294]; positive regulation of fatty acid oxidation [GO:0046321]; protein targeting to peroxisome [GO:0006625]; regulation of fatty acid beta-oxidation [GO:0031998]; regulation of glucose metabolic process [GO:0010906]; response to ischemia [GO:0002931],NA,NA,NA
CHOYP_PHUM_PHUM494500.1.1.m.9430,-0.000661986923786569,0.00256392021348706,No,NA,NA,Q09024,NA,NA,NA,axon [GO:0030424]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; cell-cell adhesion mediator activity [GO:0098632]; insulin binding [GO:0043559]; insulin-like growth factor binding [GO:0005520]; axon guidance [GO:0007411]; dendrite self-avoidance [GO:0070593]; determination of adult lifespan [GO:0008340]; entry into reproductive diapause [GO:0055116]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid storage [GO:0010888]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; positive regulation of insulin receptor signaling pathway [GO:0046628]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_PHUM_PHUM498110.1.1.m.60692,0.00144102085231123,-0.00164603577262449,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM498130.1.1.m.12138,-0.00630795524358194,0.000288983305752163,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM500930.1.1.m.21562,-0.000969166280944088,0.00672109898695377,No,NA,NA,P15215,NA,NA,NA,basement membrane [GO:0005604]; basement membrane assembly [GO:0070831]; cell adhesion mediated by integrin [GO:0033627]; endodermal digestive tract morphogenesis [GO:0061031]; extracellular matrix assembly [GO:0085029]; midgut development [GO:0007494]; salivary gland morphogenesis [GO:0007435]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_PHUM_PHUM516040.1.1.m.55603,-0.0116372960079193,-0.00584333062930267,No,NA,NA,Q5ZIJ9,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Notch signaling pathway [GO:0007219]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_PHUM_PHUM519460.1.1.m.3701,-0.0144404861565722,0.00879209425961099,No,NA,NA,Q9JHE7,NA,NA,NA,,NA,NA,NA
CHOYP_PHUM_PHUM536560.1.2.m.12360,-0.00299146032389466,-0.00122416010685733,No,NA,NA,P82808,NA,NA,NA,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; cellular response to insulin stimulus [GO:0032869]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; response to insulin [GO:0032868]; response to sucrose [GO:0009744]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_PHUM_PHUM536560.2.2.m.59367,0.00266555858369051,-0.00157940046060769,No,NA,NA,P47856,NA,NA,NA,amino acid binding [GO:0016597]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; glutamine-fructose-6-phosphate transaminase (isomerizing) activity [GO:0004360]; circadian regulation of gene expression [GO:0032922]; fructose 6-phosphate metabolic process [GO:0006002]; glucosamine biosynthetic process [GO:0006042]; glutamine metabolic process [GO:0006541]; negative regulation of glycogen biosynthetic process [GO:0045719]; protein homotetramerization [GO:0051289]; protein N-linked glycosylation [GO:0006487]; UDP-N-acetylglucosamine biosynthetic process [GO:0006048]; UDP-N-acetylglucosamine metabolic process [GO:0006047],NA,NA,NA
CHOYP_PHUM_PHUM537100.1.1.m.62217,0.000870584825374903,0.00246220004102524,No,NA,NA,Q80XC3,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; plasma membrane to endosome transport [GO:0048227]; positive regulation of GTPase activity [GO:0043547]; regulation of Golgi organization [GO:1903358]; retrograde transport; plasma membrane to Golgi [GO:0035526]; virion assembly [GO:0019068],NA,NA,NA
CHOYP_PHUM_PHUM538050.1.1.m.56205,-0.0144377694309316,0.00966556952390967,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PHUM_PHUM538580.1.1.m.43268,0.01128074122227,0.00600562601959168,No,NA,NA,Q9UBN7,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; caveola [GO:0005901]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; dendrite [GO:0030425]; histone deacetylase complex [GO:0000118]; inclusion body [GO:0016234]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; multivesicular body [GO:0005771]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; beta-catenin binding [GO:0008013]; beta-tubulin binding [GO:0048487]; dynein complex binding [GO:0070840]; enzyme binding [GO:0019899]; histone deacetylase activity [GO:0004407]; histone deacetylase binding [GO:0042826]; Hsp90 protein binding [GO:0051879]; microtubule binding [GO:0008017]; misfolded protein binding [GO:0051787]; NAD-dependent histone deacetylase activity (H3-K14 specific) [GO:0032041]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein deacetylase activity [GO:0033558]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; tau protein binding [GO:0048156]; tubulin deacetylase activity [GO:0042903]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; aggresome assembly [GO:0070842]; autophagy [GO:0006914]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to misfolded protein [GO:0071218]; cellular response to topologically incorrect protein [GO:0035967]; cilium assembly [GO:0060271]; collateral sprouting [GO:0048668]; dendritic spine morphogenesis [GO:0060997]; histone deacetylation [GO:0016575]; Hsp90 deacetylation [GO:0070846]; intracellular protein transport [GO:0006886]; lysosome localization [GO:0032418]; mitochondrion localization [GO:0051646]; negative regulation of hydrogen peroxide metabolic process [GO:0010727]; negative regulation of microtubule depolymerization [GO:0007026]; negative regulation of oxidoreductase activity [GO:0051354]; negative regulation of protein complex disassembly [GO:0043242]; negative regulation of proteolysis [GO:0045861]; negative regulation of transcription; DNA-templated [GO:0045892]; parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization [GO:0061734]; peptidyl-lysine deacetylation [GO:0034983]; polyubiquitinated misfolded protein transport [GO:0070845]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of hydrogen peroxide-mediated programmed cell death [GO:1901300]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein oligomerization [GO:0032461]; positive regulation of receptor biosynthetic process [GO:0010870]; positive regulation of signal transduction [GO:0009967]; protein deacetylation [GO:0006476]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein-containing complex disassembly [GO:0032984]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of establishment of protein localization [GO:0070201]; regulation of fat cell differentiation [GO:0045598]; regulation of gene expression; epigenetic [GO:0040029]; regulation of macroautophagy [GO:0016241]; regulation of microtubule-based movement [GO:0060632]; regulation of protein stability [GO:0031647]; regulation of signaling receptor activity [GO:0010469]; response to growth factor [GO:0070848]; response to misfolded protein [GO:0051788]; response to organic substance [GO:0010033]; response to toxic substance [GO:0009636]; tubulin deacetylation [GO:0090042]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PHUM_PHUM544530.1.1.m.38469,0.00128551274255722,0.00437812929331086,No,NA,NA,Q15428,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_PHUM_PHUM547410.1.1.m.10964,-0.0159606825996269,-0.0101573390076931,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PHUM_PHUM549040.1.1.m.10284,0.00025322791008003,-0.00139779544646376,No,NA,NA,O46036,NA,NA,NA,ISWI-type complex [GO:0031010]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; oxidoreductase activity; acting on the CH-OH group of donors; NAD or NADP as acceptor [GO:0016616]; protein homodimerization activity [GO:0042803]; repressing transcription factor binding [GO:0070491]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; ATP-dependent chromatin remodeling [GO:0043044]; chaeta development [GO:0022416]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; sensory organ precursor cell fate determination [GO:0016360]; wing disc development [GO:0035220],NA,NA,NA
CHOYP_PHUM_PHUM559420.1.1.m.8620,-0.00486538332085123,-0.00428818308436586,No,NA,NA,D2GXS7,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_PHUM_PHUM562900.1.1.m.43674,-0.00613388839738106,-0.00390359143468031,No,NA,NA,Q8QFV0,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; intracellular sodium activated potassium channel activity [GO:0005228]; outward rectifier potassium channel activity [GO:0015271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PHUM_PHUM563970.1.1.m.13515,0.00282929897546576,0.00799238053622138,No,NA,NA,O15381,NA,NA,NA,membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; preribosome binding [GO:1990275]; RNA binding [GO:0003723]; positive regulation of protein binding [GO:0032092]; positive regulation of telomerase activity [GO:0051973]; regulation of protein localization to nucleolus [GO:1904749]; ribosomal large subunit biogenesis [GO:0042273]; ribosome biogenesis [GO:0042254]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_PHUM_PHUM574190.1.1.m.24768,0.000180979710150575,-0.00541580119897004,No,NA,NA,Q05209,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; podosome [GO:0002102]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphoprotein phosphatase activity [GO:0004721]; protein tyrosine phosphatase activity [GO:0004725]; SH3 domain binding [GO:0017124]; cellular response to cytokine stimulus [GO:0071345]; cellular response to epidermal growth factor stimulus [GO:0071364]; ERBB2 signaling pathway [GO:0038128]; negative regulation of ERBB signaling pathway [GO:1901185]; negative regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000587]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; tissue regeneration [GO:0042246],NA,NA,NA
CHOYP_PHUM_PHUM574550.1.1.m.59401,-1.4723243478684e-05,0.00143575079292044,No,NA,NA,Q5XJK1,NA,NA,NA,cytosol [GO:0005829]; Golgi membrane [GO:0000139]; positive regulation of macroautophagy [GO:0016239]; regulation of protein complex stability [GO:0061635],NA,NA,NA
CHOYP_PHUM_PHUM579670.1.1.m.63016,-0.00100222696863058,0.000550512886817553,No,NA,NA,Q8R500,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; intrinsic component of mitochondrial outer membrane [GO:0031306]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Ras GTPase binding [GO:0017016]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to L-glutamate [GO:1905232]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to manganese ion [GO:0071287]; cellular response to mercaptoethanol [GO:0072705]; cellular response to oxygen-glucose deprivation [GO:0090650]; cellular response to testosterone stimulus [GO:0071394]; intracellular distribution of mitochondria [GO:0048312]; male gonad development [GO:0008584]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial fusion [GO:0008053]; mitochondrial membrane organization [GO:0007006]; mitochondrion localization [GO:0051646]; mitochondrion morphogenesis [GO:0070584]; mitochondrion organization [GO:0007005]; mitotic cell cycle [GO:0000278]; mitotic cell cycle arrest [GO:0071850]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of neuron death [GO:1901215]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of sarcomere organization [GO:0060299]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; positive regulation of cellular respiration [GO:1901857]; positive regulation of chromatin binding [GO:0035563]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of hydrogen peroxide biosynthetic process [GO:0010729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; protein targeting to mitochondrion [GO:0006626]; response to axon injury [GO:0048678]; response to cadmium ion [GO:0046686]; response to calcium ion [GO:0051592]; response to D-galactose [GO:1905377]; response to electrical stimulus [GO:0051602]; response to fatty acid [GO:0070542]; response to flavonoid [GO:1905395]; response to hypobaric hypoxia [GO:1990910]; response to L-arginine [GO:1903576]; response to muscle activity [GO:0014850]; response to nutrient levels [GO:0031667]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_PHUM_PHUM596890.1.1.m.10989,-0.000728947456364975,0.00448789307403927,No,NA,NA,Q9VGG5,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156],NA,NA,NA
CHOYP_PHUM_PHUM596940.1.1.m.2151,-0.00410555326505579,-0.00700909036053436,No,NA,NA,Q91YE8,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; stress fiber [GO:0001725]; Z disc [GO:0030018]; 14-3-3 protein binding [GO:0071889]; actin binding [GO:0003779]; alpha-actinin binding [GO:0051393]; filamin binding [GO:0031005]; muscle alpha-actinin binding [GO:0051371]; autophagosome assembly [GO:0000045]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of cell migration [GO:0030335]; regulation of Rho-dependent protein serine/threonine kinase activity [GO:2000298],NA,NA,NA
CHOYP_PHUM_PHUM600390.1.1.m.6641,-0.00621033648728566,0.00469261536780667,No,NA,NA,Q6DID3,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage factor complex [GO:0005849]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA polymerase binding [GO:0070063]; RNA polymerase core enzyme binding [GO:0043175]; RNA polymerase II complex binding [GO:0000993]; mRNA polyadenylation [GO:0006378]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380]; termination of RNA polymerase II transcription [GO:0006369]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PHUM_PHUM602670.1.1.m.52487,-0.0111961863569023,-0.00724890194635158,No,NA,NA,Q9NZ56,NA,NA,NA,cell cortex [GO:0005938]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; microvillus [GO:0005902]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; spindle [GO:0005819]; actin binding [GO:0003779]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hypoxia [GO:0071456]; establishment of meiotic spindle localization [GO:0051295]; formin-nucleated actin cable assembly [GO:0070649]; homologous chromosome movement towards spindle pole involved in homologous chromosome segregation [GO:0051758]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of protein catabolic process [GO:0042177]; oogenesis [GO:0048477]; polar body extrusion after meiotic divisions [GO:0040038]; positive regulation of double-strand break repair [GO:2000781]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_PHUM_PHUM616130.1.1.m.47653,-0.013535240384929,-0.0232860465281807,No,NA,NA,P92204,NA,NA,NA,chromosome [GO:0005694]; NELF complex [GO:0032021]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptional repressor complex [GO:0017053]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; positive regulation of transcription by RNA polymerase II [GO:0045944]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_PHYD1.1.2.m.17822,-0.00139297080222751,-0.00434336517123245,No,NA,NA,Q0IIB1,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PI3R4.1.1.m.14910,-0.0107948695379376,0.0189350237432634,No,NA,NA,Q99570,NA,NA,NA,autophagosome [GO:0005776]; axoneme [GO:0005930]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus-vacuole junction [GO:0071561]; phagocytic vesicle membrane [GO:0030670]; phosphatidylinositol 3-kinase complex; class III [GO:0035032]; phosphatidylinositol 3-kinase complex; class III; type I [GO:0034271]; phosphatidylinositol 3-kinase complex; class III; type II [GO:0034272]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; autophagy of peroxisome [GO:0030242]; cellular response to glucose starvation [GO:0042149]; late endosome to vacuole transport [GO:0045324]; macroautophagy [GO:0016236]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; protein phosphorylation [GO:0006468]; protein targeting to vacuole [GO:0006623]; receptor catabolic process [GO:0032801]; regulation of cytokinesis [GO:0032465]; toll-like receptor 9 signaling pathway [GO:0034162],NA,NA,NA
CHOYP_PI4KB.1.1.m.8669,-0.0134128154746236,0.00309321810816746,No,NA,NA,B1MTG7,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; rough endoplasmic reticulum membrane [GO:0030867]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; 14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; phosphatidylinositol-mediated signaling [GO:0048015],NA,NA,NA
CHOYP_PIDD.1.1.m.54294,-0.0171732239939635,-0.0109289973579083,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PIF.3.6.m.18904,0.0153286539116981,0.00808588638149598,No,NA,NA,C7G0B5,NA,NA,NA,extracellular region [GO:0005576]; chitin binding [GO:0008061]; chitin metabolic process [GO:0006030],NA,NA,NA
CHOYP_PIF.6.6.m.44699,0.00972258919932562,0.00211302787848449,No,NA,NA,Q99715,NA,NA,NA,collagen type XII trimer [GO:0005595]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]; growth plate cartilage chondrocyte morphogenesis [GO:0003429]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PIGS.1.1.m.18959,-0.000584104419569976,-0.00201434282242389,No,NA,NA,Q2HJ98,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; acetylpyruvate hydrolase activity [GO:0018773]; acylpyruvate hydrolase activity [GO:0047621]; fumarylpyruvate hydrolase activity [GO:0034545]; metal ion binding [GO:0046872]; oxaloacetate decarboxylase activity [GO:0008948],NA,NA,NA
CHOYP_PININ.1.1.m.56667,-0.00364742584498271,-0.0020302861036149,No,NA,NA,Q9H307,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; exon-exon junction complex [GO:0035145]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PIPNA.1.1.m.37750,-0.000654797228193859,0.00348501662219737,No,NA,NA,P53810,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; myelin sheath [GO:0043209]; fatty-acyl-CoA binding [GO:0000062]; lipid binding [GO:0008289]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine transporter activity [GO:0008525]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol transporter activity [GO:0008526]; phospholipid binding [GO:0005543]; stearic acid binding [GO:0070540]; axonogenesis [GO:0007409]; phospholipid transport [GO:0015914],NA,NA,NA
CHOYP_PIR.1.1.m.48663,0.000869724753504739,0.00837338731949608,No,NA,NA,O00625,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; quercetin 2;3-dioxygenase activity [GO:0008127]; transcription coregulator activity [GO:0003712]; digestion [GO:0007586]; monocyte differentiation [GO:0030224]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_PISD.2.2.m.30086,-0.01021152185349,-0.00649858730057003,No,NA,NA,P27465,NA,NA,NA,integral component of mitochondrial inner membrane [GO:0031305]; nucleus [GO:0005634]; phosphatidylserine decarboxylase activity [GO:0004609]; phosphatidylethanolamine biosynthetic process [GO:0006646]; protein autoprocessing [GO:0016540],NA,NA,NA
CHOYP_PK1IP.1.1.m.49466,0.0181615110498524,-0.00717320180191127,No,NA,NA,Q80VC6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA binding [GO:0000049]; selenocysteine incorporation [GO:0001514],NA,NA,NA
CHOYP_PK3C3.1.1.m.13959,-0.00226934154276119,0.0105557802099553,No,NA,NA,Q6AZN6,NA,NA,NA,midbody [GO:0030496]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; ATP binding [GO:0005524]; autophagy [GO:0006914]; cell cycle [GO:0007049]; cell division [GO:0051301]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_PK3CD.1.1.m.53039,0.00533017133685731,-0.0242835052167077,No,NA,NA,O00329,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mast cell granule [GO:0042629]; membrane [GO:0016020]; phosphatidylinositol 3-kinase complex [GO:0005942]; plasma membrane [GO:0005886]; 1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-4-phosphate 3-kinase activity [GO:0035005]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphatidylinositol 3-kinase activity [GO:0035004]; phosphatidylinositol-4;5-bisphosphate 3-kinase activity [GO:0046934]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; B cell activation [GO:0042113]; B cell chemotaxis [GO:0035754]; B cell receptor signaling pathway [GO:0050853]; cell migration [GO:0016477]; cytokine production [GO:0001816]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; mast cell chemotaxis [GO:0002551]; mast cell degranulation [GO:0043303]; mast cell differentiation [GO:0060374]; natural killer cell activation [GO:0030101]; natural killer cell chemotaxis [GO:0035747]; natural killer cell differentiation [GO:0001779]; negative regulation of gene expression [GO:0010629]; neutrophil chemotaxis [GO:0030593]; neutrophil extravasation [GO:0072672]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol phosphorylation [GO:0046854]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; phosphatidylinositol-mediated signaling [GO:0048015]; phosphorylation [GO:0016310]; platelet activation [GO:0030168]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; protein phosphorylation [GO:0006468]; respiratory burst involved in defense response [GO:0002679]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell chemotaxis [GO:0010818]; T cell differentiation [GO:0030217]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_PKH_082300.1.1.m.29388,-0.00366117467239131,0.0049703256433581,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKH_143120.1.1.m.6777,-0.0293834519127193,-0.00608808268907138,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PKHL1.3.3.m.42452,-0.0110695347985515,-0.0104023104248516,No,NA,NA,Q80ZA4,NA,NA,NA,cilium [GO:0005929]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_PLB1.1.1.m.16558,-0.00700735071686012,-0.0140798570162874,No,NA,NA,Q06HQ7,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; lysophospholipase activity [GO:0004622]; phospholipase A2 activity [GO:0004623]; phospholipase A2 activity (consuming 1;2-dipalmitoylphosphatidylcholine) [GO:0102567]; phospholipase A2 activity consuming 1;2-dioleoylphosphatidylethanolamine) [GO:0102568]; retinyl-palmitate esterase activity [GO:0050253]; lipid catabolic process [GO:0016042]; phospholipid metabolic process [GO:0006644],NA,NA,NA
CHOYP_PLC.2.5.m.5277,-0.00320565536222332,-0.00402194430615237,No,NA,NA,P82596,NA,NA,NA,carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLC.3.5.m.7658,-0.00428697641153506,0.0213860846374325,No,NA,NA,P86854,NA,NA,NA,extracellular region [GO:0005576]; carbohydrate binding [GO:0030246],NA,NA,NA
CHOYP_PLCB4.1.2.m.1637,-0.0146337068276211,-0.00548318741039463,No,NA,NA,Q15147,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic density [GO:0014069]; smooth endoplasmic reticulum [GO:0005790]; calcium ion binding [GO:0005509]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; G protein-coupled receptor signaling pathway [GO:0007186]; inositol phosphate metabolic process [GO:0043647]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PLCD1.1.1.m.63908,0.00555799061162762,0.00182357788014617,No,NA,NA,P10688,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; phospholipid binding [GO:0005543]; G protein-coupled receptor signaling pathway [GO:0007186]; intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of inositol trisphosphate biosynthetic process [GO:0032962]; positive regulation of norepinephrine secretion [GO:0010701]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of phospholipase C activity [GO:1900274]; response to aluminum ion [GO:0010044]; response to calcium ion [GO:0051592]; response to hyperoxia [GO:0055093]; response to organonitrogen compound [GO:0010243]; response to peptide hormone [GO:0043434]; response to prostaglandin F [GO:0034696],NA,NA,NA
CHOYP_PLCL2.1.1.m.62311,0.00443805107810613,-0.0123632225491018,No,NA,NA,Q9UPR0,NA,NA,NA,cytoplasm [GO:0005737]; GABA receptor binding [GO:0050811]; inositol 1;4;5 trisphosphate binding [GO:0070679]; phosphatidylinositol phospholipase C activity [GO:0004435]; B cell proliferation involved in immune response [GO:0002322]; B-1a B cell differentiation [GO:0002337]; gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; lipid metabolic process [GO:0006629]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cold-induced thermogenesis [GO:0120163]; positive regulation of receptor binding [GO:1900122]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of synaptic transmission; GABAergic [GO:0032228],NA,NA,NA
CHOYP_PLEKHA1.2.2.m.21816,-0.000567841661076437,-0.00554952142536076,No,NA,NA,Q9HB19,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; fibronectin binding [GO:0001968]; laminin binding [GO:0043236]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4-bisphosphate binding [GO:0043325]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of cell-matrix adhesion [GO:0001954],NA,NA,NA
CHOYP_PLIN2.1.1.m.23758,-0.000215565198726095,0.00366685378202624,No,NA,NA,Q4PLW0,NA,NA,NA,intracellular [GO:0005622]; lipid droplet [GO:0005811]; membrane [GO:0016020],NA,NA,NA
CHOYP_PLK1.1.2.m.26371,0.00287206305482977,0.00198734724270183,No,NA,NA,P62205,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278]; protein localization to chromatin [GO:0071168]; protein phosphorylation [GO:0006468]; signal transduction involved in G2 DNA damage checkpoint [GO:0072425],NA,NA,NA
CHOYP_PLMN.1.11.m.5524,-0.00574180488753768,0.00648478898209454,No,NA,NA,P00765,NA,NA,NA,extracellular space [GO:0005615]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]; digestion [GO:0007586],NA,NA,NA
CHOYP_PLMN.4.11.m.29150,0,0,No,NA,NA,P06867,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase activity [GO:0004252]; blood coagulation [GO:0007596]; fibrinolysis [GO:0042730]; interaction with symbiont via secreted substance involved in symbiotic interaction [GO:0052213]; tissue remodeling [GO:0048771],NA,NA,NA
CHOYP_PLOD3.1.1.m.41788,0.0168750959691631,0.00845746185718186,No,NA,NA,Q5U367,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802]; iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; basement membrane assembly [GO:0070831]; cellular response to hormone stimulus [GO:0032870]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311],NA,NA,NA
CHOYP_PLRG1.1.1.m.65600,-0.0132839610252845,0.0142232606841752,No,NA,NA,Q922V4,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; DNA replication factor A complex [GO:0005662]; fibrillar center [GO:0001650]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 2 spliceosome [GO:0071007]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein localization to nucleus [GO:0034504],NA,NA,NA
CHOYP_PLSP.4.5.m.44386,-7.63254070949718e-05,0.0101265448691516,No,NA,NA,H2A0M7,NA,NA,NA,extracellular region [GO:0005576]; heme binding [GO:0020037]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PLXA3.1.1.m.51322,-0.00968054665223322,-0.00151757137395985,No,NA,NA,O15031,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; semaphorin receptor complex [GO:0002116]; semaphorin receptor activity [GO:0017154]; brain development [GO:0007420]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell adhesion [GO:0007162]; neural tube closure [GO:0001843]; neuroblast proliferation [GO:0007405]; positive regulation of axonogenesis [GO:0050772]; positive regulation of neuron projection development [GO:0010976]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of GTPase activity [GO:0043087]; regulation of neuron migration [GO:2001222]; regulation of protein phosphorylation [GO:0001932]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287],NA,NA,NA
CHOYP_PLXB2.2.2.m.47843,-0.0155256134337435,0.0206916418324217,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PM20D2.1.1.m.27186,0.0197256903256551,0.0112964282018325,No,NA,NA,A3KG59,NA,NA,NA,nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268],NA,NA,NA
CHOYP_PMAA_001770.1.1.m.11519,0.0149586280084919,-0.00254728000926748,No,NA,NA,Q54RA4,NA,NA,NA,dioxygenase activity [GO:0051213]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_PMAR_PMAR003946.2.2.m.31102,-0.00127036073486389,0.000990795612916321,No,NA,NA,P55142,NA,NA,NA,cytoplasm [GO:0005737]; electron transfer activity [GO:0009055]; glutathione-disulfide reductase activity [GO:0004362]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular response to oxidative stress [GO:0034599],NA,NA,NA
CHOYP_PMAR_PMAR009545.1.1.m.28734,-9.58461359775118e-05,0.0127164758558493,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PMAR_PMAR019172.1.1.m.2563,-0.0102238488362489,-0.0134421539434953,No,NA,NA,B8DKP2,NA,NA,NA,magnesium ion binding [GO:0000287]; phosphonoacetaldehyde hydrolase activity [GO:0050194]; organic phosphonate catabolic process [GO:0019700],NA,NA,NA
CHOYP_PMS2.1.1.m.16450,0.0130682804129058,-0.00236345899092037,No,NA,NA,P54278,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; mismatch repair complex [GO:0032300]; MutLalpha complex [GO:0032389]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; single base insertion or deletion binding [GO:0032138]; mismatch repair [GO:0006298]; response to drug [GO:0042493]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_PMTR.1.1.m.46450,-0.0028400813192333,0.00385562839070652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PNCB.1.1.m.57201,-0.00911514846496973,0.00731948751380828,No,NA,NA,Q9VQX4,NA,NA,NA,cytosol [GO:0005829]; metal ion binding [GO:0046872]; nicotinate phosphoribosyltransferase activity [GO:0004516]; nicotinate-nucleotide diphosphorylase (carboxylating) activity [GO:0004514]; NAD biosynthetic process [GO:0009435]; NAD salvage [GO:0034355]; nicotinate nucleotide salvage [GO:0019358]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_PNO1.1.3.m.2044,-0.0203839210909348,0.00360821111706041,No,NA,NA,Q6VEU3,NA,NA,NA,nucleolus [GO:0005730]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_PNO1.2.3.m.47801,-7.01909140548378e-05,0.00931264525977101,No,NA,NA,Q8VCX6,NA,NA,NA,KICSTOR complex [GO:0140007]; lamellipodium [GO:0030027]; lysosomal membrane [GO:0005765]; postsynaptic actin cytoskeleton [GO:0098871]; stereocilium [GO:0032420]; actin filament binding [GO:0051015]; actin filament organization [GO:0007015]; cellular response to amino acid starvation [GO:0034198]; cellular response to glucose starvation [GO:0042149]; negative regulation of TORC1 signaling [GO:1904262]; protein localization to lysosome [GO:0061462],NA,NA,NA
CHOYP_PNP5B.1.1.m.21997,0.018184940411787,-0.0192706219690836,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_PO2F1.1.1.m.11428,-0.0138764255933605,0.0108240196044764,No,NA,NA,Q9UKI9,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; epidermis development [GO:0008544]; negative regulation by host of viral transcription [GO:0043922]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_POGLUT1.1.1.m.45796,0.0126429658224039,-0.027694797126788,No,NA,NA,G3V9D0,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; glucosyltransferase activity [GO:0046527]; protein xylosyltransferase activity [GO:0030158]; UDP-glucosyltransferase activity [GO:0035251]; UDP-xylosyltransferase activity [GO:0035252]; gastrulation [GO:0007369]; muscle tissue development [GO:0060537]; positive regulation of Notch signaling pathway [GO:0045747]; protein O-linked glycosylation [GO:0006493]; protein O-linked glycosylation via serine [GO:0018242]; regulation of gastrulation [GO:0010470],NA,NA,NA
CHOYP_POLD1.1.1.m.61169,0.002731982489286,-0.0214397793414567,No,NA,NA,P28340,NA,NA,NA,aggresome [GO:0016235]; cytosol [GO:0005829]; delta DNA polymerase complex [GO:0043625]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleotide-excision repair complex [GO:0000109]; nucleus [GO:0005634]; 3'-5'-exodeoxyribonuclease activity [GO:0008296]; 4 iron; 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; base-excision repair; gap-filling [GO:0006287]; cellular response to UV [GO:0034644]; DNA damage response; detection of DNA damage [GO:0042769]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA replication proofreading [GO:0045004]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-dependent DNA replication [GO:0006261]; fatty acid homeostasis [GO:0055089]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; response to UV [GO:0009411]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_POLR3K.1.1.m.8423,-0.0145351910484336,0.020920977396994,No,NA,NA,Q9Y2Y1,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; termination of RNA polymerase III transcription [GO:0006386]; transcription by RNA polymerase III [GO:0006383]; tRNA 3'-trailer cleavage [GO:0042779],NA,NA,NA
CHOYP_POMGNT1.1.1.m.33377,0.0054780231494671,-0.00994525573551181,No,NA,NA,Q5XIN7,NA,NA,NA,integral component of Golgi membrane [GO:0030173]; integral component of membrane [GO:0016021]; acetylglucosaminyltransferase activity [GO:0008375]; beta-1;3-galactosyl-O-glycosyl-glycoprotein beta-1;3-N-acetylglucosaminyltransferase activity [GO:0047223]; manganese ion binding [GO:0030145]; O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],NA,NA,NA
CHOYP_POPTRDRAFT_1091519.1.1.m.56854,0.00559895173055876,-0.010164799470884,No,NA,NA,Q8BWF0,NA,NA,NA,mitochondrion [GO:0005739]; carboxylic acid binding [GO:0031406]; NAD binding [GO:0051287]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; succinate-semialdehyde dehydrogenase [NAD(P)+] activity [GO:0009013]; acetate metabolic process [GO:0006083]; central nervous system development [GO:0007417]; galactosylceramide metabolic process [GO:0006681]; gamma-aminobutyric acid catabolic process [GO:0009450]; gamma-aminobutyric acid metabolic process [GO:0009448]; glucose metabolic process [GO:0006006]; glucosylceramide metabolic process [GO:0006678]; glutamate metabolic process [GO:0006536]; glutamine metabolic process [GO:0006541]; glutathione metabolic process [GO:0006749]; glycerophospholipid metabolic process [GO:0006650]; neurotransmitter catabolic process [GO:0042135]; oxidation-reduction process [GO:0055114]; post-embryonic development [GO:0009791]; protein homotetramerization [GO:0051289]; respiratory electron transport chain [GO:0022904]; short-chain fatty acid metabolic process [GO:0046459]; succinate metabolic process [GO:0006105],NA,NA,NA
CHOYP_POPTRDRAFT_655879.1.1.m.46190,0.00664847215268421,-0.00179660706937928,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PP1A.1.1.m.25950,0.00441879739079485,-0.00119408526472531,No,NA,NA,P62138,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PP1B.2.3.m.22075,0.0009586403811505,0.00250061442452813,No,NA,NA,Q5I085,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; metal ion binding [GO:0046872]; myosin-light-chain-phosphatase activity [GO:0050115]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; glycogen metabolic process [GO:0005977]; regulation of cell adhesion [GO:0030155]; regulation of circadian rhythm [GO:0042752],NA,NA,NA
CHOYP_PP1RA.1.1.m.9915,-0.00472496738437382,-0.0159334815631227,No,NA,NA,Q6GLQ4,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein phosphatase inhibitor activity [GO:0004864],NA,NA,NA
CHOYP_PP4C.1.1.m.10112,-0.00515959313996409,0.00804885460946594,No,NA,NA,Q5R6K8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; regulation of double-strand break repair via homologous recombination [GO:0010569],NA,NA,NA
CHOYP_PP4R1.1.1.m.11682,-0.000915505007813509,0.00229936630057815,No,NA,NA,Q8VI02,NA,NA,NA,protein phosphatase 4 complex [GO:0030289]; protein phosphatase regulator activity [GO:0019888]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PP6R3.1.1.m.43072,-0.00124792149940763,0.00332482710615573,No,NA,NA,Q5F471,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein phosphatase binding [GO:0019903]; regulation of phosphoprotein phosphatase activity [GO:0043666],NA,NA,NA
CHOYP_PPA5.1.1.m.36087,-0.00542753548888235,-0.0151855116985646,No,NA,NA,P09889,NA,NA,NA,extracellular region [GO:0005576]; lysosome [GO:0005764]; acid phosphatase activity [GO:0003993]; ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; bone morphogenesis [GO:0060349]; bone resorption [GO:0045453]; defense response to Gram-positive bacterium [GO:0050830]; ion transport [GO:0006811]; iron ion homeostasis [GO:0055072]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of superoxide anion generation [GO:0032929]; negative regulation of tumor necrosis factor production [GO:0032720]; ossification [GO:0001503]; response to cytokine [GO:0034097]; response to lipopolysaccharide [GO:0032496],NA,NA,NA
CHOYP_PPAC1.1.1.m.51347,-0.000320393636756442,0.00147724332391695,No,NA,NA,P82890,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; acid phosphatase activity [GO:0003993]; protein tyrosine phosphatase activity [GO:0004725]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPAL.2.2.m.32405,-0.00912227984009455,0.00396500448382773,No,NA,NA,Q0P5F0,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; acid phosphatase activity [GO:0003993]; lysosome organization [GO:0007040]; skeletal system development [GO:0001501],NA,NA,NA
CHOYP_PPAN.B.1.1.m.2112,-0.0116943921000573,0.0156160786097178,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPBT.1.4.m.5115,-0.00672780773331029,0.00948223540713678,No,NA,NA,Q29486,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; alkaline phosphatase activity [GO:0004035]; metal ion binding [GO:0046872]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PPIB.2.4.m.40019,-0.0172325172096142,-0.010966731413984,No,NA,NA,O94273,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; Golgi apparatus [GO:0005794]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein folding in endoplasmic reticulum [GO:0034975]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPID.1.1.m.55261,-0.0017793502225349,-0.000339007341696164,No,NA,NA,Q9CR16,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclosporin A binding [GO:0016018]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; FK506 binding [GO:0005528]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; apoptotic process [GO:0006915]; cellular response to UV-A [GO:0071492]; chaperone-mediated protein folding [GO:0061077]; lipid droplet organization [GO:0034389]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIE.1.1.m.18580,0.000320906381959075,-0.00494624859342146,No,NA,NA,Q5R723,NA,NA,NA,nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; mRNA binding [GO:0003729]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; poly(A) binding [GO:0008143]; mRNA splicing; via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413],NA,NA,NA
CHOYP_PPIG.1.1.m.63308,0.00650800436598053,0.00916750638771419,No,NA,NA,P30414,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_PPIH.1.1.m.18923,0.00129073174869432,0.00160637230694319,No,NA,NA,O43447,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ribonucleoprotein complex binding [GO:0043021]; unfolded protein binding [GO:0051082]; angiogenesis [GO:0001525]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026]; protein-containing complex assembly [GO:0065003],NA,NA,NA
CHOYP_PPIL2.1.1.m.55184,-0.00913820763597619,-0.00581553278200454,No,NA,NA,Q9D787,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein folding [GO:0006457]; protein localization to plasma membrane [GO:0072659]; protein peptidyl-prolyl isomerization [GO:0000413]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_PPM1H.1.1.m.24782,0.00670991010731192,-0.0322024914271524,No,NA,NA,Q5M821,NA,NA,NA,cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine phosphatase activity [GO:0004722],NA,NA,NA
CHOYP_PPME1.1.1.m.56260,-0.0138136794415152,-0.0222339208468572,No,NA,NA,Q8BVQ5,NA,NA,NA,protein C-terminal methylesterase activity [GO:0051722]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase binding [GO:0019903]; protein demethylation [GO:0006482],NA,NA,NA
CHOYP_PPN.2.4.m.44929,-0.00758993975853299,-0.00461912564290331,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPN.3.4.m.50209,-0.00974793516698226,-0.0224297452468889,No,NA,NA,Q868Z9,NA,NA,NA,basement membrane [GO:0005604]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; serine-type endopeptidase inhibitor activity [GO:0004867]; extracellular matrix organization [GO:0030198]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PPOX.1.1.m.45234,-0.0096503277165643,0.0161779496459007,No,NA,NA,P56602,NA,NA,NA,intrinsic component of mitochondrial inner membrane [GO:0031304]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491]; oxygen-dependent protoporphyrinogen oxidase activity [GO:0004729]; heme biosynthetic process [GO:0006783]; protoporphyrinogen IX biosynthetic process [GO:0006782],NA,NA,NA
CHOYP_PPP1CC.1.1.m.13937,0.000333272615032227,0.000802890441755403,No,NA,NA,P62138,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear chromosome; telomeric region [GO:0000784]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein phosphatase type 1 complex [GO:0000164]; PTW/PP1 phosphatase complex [GO:0072357]; cadherin binding involved in cell-cell adhesion [GO:0098641]; metal ion binding [GO:0046872]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; ribonucleoprotein complex binding [GO:0043021]; branching morphogenesis of an epithelial tube [GO:0048754]; cell cycle [GO:0007049]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen biosynthetic process [GO:0005979]; regulation of glycogen catabolic process [GO:0005981]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_PPP1R7.1.1.m.37778,0.00224744965731899,-0.000228155903155241,No,NA,NA,Q5HZV9,NA,NA,NA,nucleus [GO:0005634],NA,NA,NA
CHOYP_PPP6.1.1.m.16278,-0.00165729075996499,0.00597657558888318,No,NA,NA,Q64620,NA,NA,NA,cytoplasm [GO:0005737]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049]; innate immune response [GO:0045087]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PPR27.1.1.m.10278,0.000935332430677749,-0.00174149410720485,No,NA,NA,Q86WC6,NA,NA,NA,phosphatase binding [GO:0019902]; protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPR37.1.1.m.27483,-0.00678971126488197,0.00173172179625451,No,NA,NA,Q1L994,NA,NA,NA,protein phosphatase inhibitor activity [GO:0004864]; negative regulation of phosphatase activity [GO:0010923],NA,NA,NA
CHOYP_PPT2A.1.2.m.30339,-0.0124761723479378,0.0204536344672519,No,NA,NA,Q6PCJ9,NA,NA,NA,lysosome [GO:0005764]; palmitoyl-(protein) hydrolase activity [GO:0008474],NA,NA,NA
CHOYP_PPUTW619_2764.1.1.m.44946,0.0112477440669379,0.0115213140020122,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PPWD1.1.1.m.48713,0.00166281160287269,0.00347741451766401,No,NA,NA,Q29RZ2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA processing [GO:0006397]; protein peptidyl-prolyl isomerization [GO:0000413]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRB2.2.2.m.41331,-0.00262499203219556,-0.0119275744506836,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_PRCC.2.2.m.58572,0.00452202103836229,0.0112882912613937,No,NA,NA,Q92733,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mitotic cell cycle checkpoint [GO:0007093]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRG4.1.2.m.7441,0.00265433836031089,0.00313470531938839,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRIM.1.1.m.30784,-0.00641631200090681,-0.0040833251188056,No,NA,NA,Q6R7L6,NA,NA,NA,DNA primase activity [GO:0003896],NA,NA,NA
CHOYP_PRKAB1B.1.3.m.19788,-0.0163862346469007,-0.027230160064506,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB1B.2.3.m.31228,0.00695495341300752,0.00320838135522254,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PRKAB2.1.1.m.12513,0.00514915974973217,0.000476510981781423,No,NA,NA,O43741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; cell cycle arrest [GO:0007050]; fatty acid biosynthetic process [GO:0006633]; macroautophagy [GO:0016236]; positive regulation of cold-induced thermogenesis [GO:0120162]; protein phosphorylation [GO:0006468]; regulation of catalytic activity [GO:0050790]; regulation of fatty acid biosynthetic process [GO:0042304]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PRKCSH.1.1.m.28109,-0.00039171842860703,0.00275802489132915,No,NA,NA,P14314,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_PRKDC.1.1.m.47256,-0.00701120828106735,0.002562102050515,No,NA,NA,Q8QGX4,NA,NA,NA,nonhomologous end joining complex [GO:0070419]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-dependent protein kinase activity [GO:0004677]; kinase activity [GO:0016301]; protein serine/threonine kinase activity [GO:0004674]; cellular response to DNA damage stimulus [GO:0006974]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; double-strand break repair via nonhomologous end joining [GO:0006303]; immunoglobulin V(D)J recombination [GO:0033152]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; signal transduction involved in mitotic G1 DNA damage checkpoint [GO:0072431]; telomere maintenance [GO:0000723],NA,NA,NA
CHOYP_PRKN2.1.1.m.54903,0.00317583143707999,-0.000858200362426318,No,NA,NA,Q9JK66,NA,NA,NA,aggresome [GO:0016235]; axon [GO:0030424]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; Parkin-FBXW7-Cul1 ubiquitin ligase complex [GO:1990452]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; terminal bouton [GO:0043195]; ubiquitin ligase complex [GO:0000151]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; adult locomotory behavior [GO:0008344]; aggresome assembly [GO:0070842]; autophagy of mitochondrion [GO:0000422]; brain development [GO:0007420]; cellular protein modification process [GO:0006464]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to L-glutamate [GO:1905232]; cellular response to L-glutamine [GO:1904845]; cellular response to manganese ion [GO:0071287]; cellular response to toxic substance [GO:0097237]; mitochondrial fission [GO:0000266]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion localization [GO:0051646]; mitochondrion organization [GO:0007005]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of glucokinase activity [GO:0033132]; negative regulation of insulin secretion [GO:0046676]; negative regulation of JNK cascade [GO:0046329]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial fusion [GO:0010637]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of synaptic transmission; glutamatergic [GO:0051967]; neuron cellular homeostasis [GO:0070050]; positive regulation of apoptotic process [GO:0043065]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of DNA binding [GO:0043388]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of mitochondrial fusion [GO:0010636]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein localization to mitochondrion [GO:0070585]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of apoptotic process [GO:0042981]; regulation of autophagy [GO:0010506]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of gene expression [GO:0010468]; regulation of mitochondrion organization [GO:0010821]; response to corticosterone [GO:0051412]; response to curcumin [GO:1904643]; response to drug [GO:0042493]; response to endoplasmic reticulum stress [GO:0034976]; response to muscle activity [GO:0014850]; response to oxidative stress [GO:0006979]; response to unfolded protein [GO:0006986]; ubiquitin-dependent protein catabolic process [GO:0006511]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_PROF.2.2.m.41295,-0.0214455098384361,-0.0136478695232562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PROM1.3.3.m.58805,0.00278626517486362,-0.00174353578363042,No,NA,NA,O77302,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_PRP16.1.1.m.19094,0.000440891252618909,0.005588630959969,No,NA,NA,Q17R09,NA,NA,NA,spliceosomal complex [GO:0005681]; ATP binding [GO:0005524]; ATP-dependent 3'-5' RNA helicase activity [GO:0034459]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_PRP18.1.1.m.2214,-0.000413444691441501,-0.0242144014800846,No,NA,NA,Q2HJ41,NA,NA,NA,nuclear speck [GO:0016607]; U2-type post-spliceosomal complex [GO:0071021]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; generation of catalytic spliceosome for second transesterification step [GO:0000350]; nuclear retention of unspliced pre-mRNA at the site of transcription [GO:0071048],NA,NA,NA
CHOYP_PRP31.3.6.m.8812,-0.00142007134233546,0.00174844537835076,No,NA,NA,Q7SXM7,NA,NA,NA,Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690]; U4atac snRNA binding [GO:0030622]; mRNA splicing; via spliceosome [GO:0000398]; retina development in camera-type eye [GO:0060041]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP4B.1.1.m.28423,-0.00952090464569002,-0.00264131703214925,No,NA,NA,Q08DZ2,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; chromosome [GO:0005694]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; mRNA processing [GO:0006397]; protein phosphorylation [GO:0006468]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_PRP6.1.2.m.28600,-0.00361691024355931,0.00158378476831444,No,NA,NA,A1A5S1,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; androgen receptor binding [GO:0050681]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRP8.1.1.m.51584,-0.00645208794215761,2.72064475638615e-05,No,NA,NA,Q99PV0,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; pre-mRNA intronic binding [GO:0097157]; second spliceosomal transesterification activity [GO:0000386]; U1 snRNA binding [GO:0030619]; U2 snRNA binding [GO:0030620]; U5 snRNA binding [GO:0030623]; U6 snRNA binding [GO:0017070]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF3.1.1.m.736,-0.00158646257507042,-0.00230253119000688,No,NA,NA,Q5ZJ85,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal tri-snRNP complex assembly [GO:0000244],NA,NA,NA
CHOYP_PRPF4.1.1.m.62194,-0.00108529488580766,-0.00246220263708548,No,NA,NA,O43172,NA,NA,NA,Cajal body [GO:0015030]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; spliceosomal snRNP complex [GO:0097525]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 snRNP [GO:0071001]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4 snRNA binding [GO:0030621]; U6 snRNA binding [GO:0017070]; mRNA splicing; via spliceosome [GO:0000398]; RNA processing [GO:0006396]; RNA splicing [GO:0008380]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_PRPS1.1.1.m.10083,-0.00123311631545613,-0.00478960359726738,No,NA,NA,P60892,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; ribose phosphate diphosphokinase complex [GO:0002189]; ADP binding [GO:0043531]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; carbohydrate binding [GO:0030246]; GDP binding [GO:0019003]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; ribose phosphate diphosphokinase activity [GO:0004749]; 5-phosphoribose 1-diphosphate biosynthetic process [GO:0006015]; AMP biosynthetic process [GO:0006167]; animal organ regeneration [GO:0031100]; nucleoside metabolic process [GO:0009116]; nucleotide biosynthetic process [GO:0009165]; purine nucleotide biosynthetic process [GO:0006164]; ribose phosphate metabolic process [GO:0019693],NA,NA,NA
CHOYP_PRRC1.1.1.m.6820,0.0011843948248319,-0.00228015199221949,No,NA,NA,A6H8J1,NA,NA,NA,Golgi apparatus [GO:0005794],NA,NA,NA
CHOYP_PRRT1.2.5.m.28553,-0.0127741754867569,-0.00812945374690841,No,NA,NA,Q6MG82,NA,NA,NA,cell junction [GO:0030054]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020],NA,NA,NA
CHOYP_PRS4.1.1.m.45626,0.00115264390023889,-0.00123053581798128,No,NA,NA,P48601,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; TBP-class protein binding [GO:0017025]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PRS6B.1.1.m.66735,-0.000285284722759764,-0.00239458780874298,No,NA,NA,Q4R7L3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; blastocyst development [GO:0001824]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRS7.1.1.m.31825,-0.000113718000071602,-0.000852774819672899,No,NA,NA,Q4R4R0,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; proteasome-activating ATPase activity [GO:0036402]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_PRS8.1.1.m.40757,-0.000128108170861759,-0.00135260391572916,No,NA,NA,P54814,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATP binding [GO:0005524]; proteasome-activating ATPase activity [GO:0036402]; protein catabolic process [GO:0030163],NA,NA,NA
CHOYP_PRTG.2.3.m.27411,0.00383670667637415,-0.00696547422995069,No,NA,NA,Q2EY13,NA,NA,NA,integral component of membrane [GO:0016021]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_PRUN2.1.1.m.38759,-0.0038303240548618,-0.0154331149419069,No,NA,NA,Q5BJR4,NA,NA,NA,cytoplasm [GO:0005737]; exopolyphosphatase activity [GO:0004309]; apoptotic process [GO:0006915]; polyphosphate catabolic process [GO:0006798],NA,NA,NA
CHOYP_PSA.1.1.m.27259,0.000804701237620102,-0.000233490296974039,No,NA,NA,Q11011,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270]; cellular response to hypoxia [GO:0071456]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSA1.1.1.m.44276,0.00193854513462305,-0.00485657273401518,No,NA,NA,P25786,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; polysome [GO:0005844]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; immune system process [GO:0002376]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSA2.1.1.m.57091,0.00141008055576389,-0.000120082797027948,No,NA,NA,P25787,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; secretory granule lumen [GO:0034774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; response to virus [GO:0009615],NA,NA,NA
CHOYP_PSA4.1.1.m.19303,0.00281862633798732,-0.00223108185869635,No,NA,NA,P25789,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; post-translational protein modification [GO:0043687]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; viral process [GO:0016032],NA,NA,NA
CHOYP_PSA6.1.1.m.30357,6.50317526152362e-05,-0.00328427906209616,No,NA,NA,P60901,NA,NA,NA,cytoplasm [GO:0005737]; myofibril [GO:0030016]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; polysome [GO:0005844]; proteasome core complex [GO:0005839]; proteasome core complex; alpha-subunit complex [GO:0019773]; sarcomere [GO:0030017]; endopeptidase activity [GO:0004175]; NF-kappaB binding [GO:0051059]; RNA binding [GO:0003723]; threonine-type endopeptidase activity [GO:0004298]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; proteolysis involved in cellular protein catabolic process [GO:0051603],NA,NA,NA
CHOYP_PSB1.2.2.m.63827,0.00140527539827866,0.000530791339042567,No,NA,NA,Q2TBX6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSD7.1.1.m.19729,0.00124298490346015,0.000938509289462941,No,NA,NA,P26270,NA,NA,NA,cytosol [GO:0005829]; dendrite [GO:0030425]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161],NA,NA,NA
CHOYP_PSDE.1.1.m.38562,0.000646407445364802,-0.00208222736741786,No,NA,NA,Q9V3H2,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; lid subcomplex [GO:0008541]; Lys63-specific deubiquitinase activity [GO:0061578]; metal ion binding [GO:0046872]; metallopeptidase activity [GO:0008237]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_PSIP1.1.1.m.61157,-0.0159431953963587,0.0221589437570946,No,NA,NA,Q9Y3E1,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; cell proliferation [GO:0008283]; microtubule polymerization [GO:0046785]; negative regulation of microtubule depolymerization [GO:0007026]; neuron projection development [GO:0031175],NA,NA,NA
CHOYP_PSMB2.1.1.m.62965,0.000775292228051362,0.000521102079995803,No,NA,NA,P40307,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome core complex [GO:0005839]; proteasome core complex; beta-subunit complex [GO:0019774]; endopeptidase activity [GO:0004175]; threonine-type endopeptidase activity [GO:0004298]; proteasomal protein catabolic process [GO:0010498]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; response to organic cyclic compound [GO:0014070]; response to organonitrogen compound [GO:0010243],NA,NA,NA
CHOYP_PSMC6.1.1.m.13888,0.00131196611376893,0.000668057300719112,No,NA,NA,P62334,NA,NA,NA,cytosolic proteasome complex [GO:0031597]; inclusion body [GO:0016234]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle; base subcomplex [GO:0008540]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; proteasome-activating ATPase activity [GO:0036402]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of RNA polymerase II transcriptional preinitiation complex assembly [GO:0045899]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_PSMD1.1.1.m.21682,-0.000672808510035495,0.00252565533524598,No,NA,NA,Q99460,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; ubiquitin protein ligase binding [GO:0031625]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD1.1.1.m.21683,-0.00392575283769283,0.0046213192731799,No,NA,NA,Q99805,NA,NA,NA,endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; protein localization to membrane [GO:0072657],NA,NA,NA
CHOYP_PSMD2.1.3.m.13362,0.0251118185455351,-0.0105521804407393,No,NA,NA,P56701,NA,NA,NA,nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; enzyme regulator activity [GO:0030234]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD2.3.3.m.59657,-0.00445241732739528,0.0117551355283669,No,NA,NA,Q5VUA4,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]; meiotic cell cycle [GO:0051321]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_PSMD2.3.3.m.59658,-0.000939800739766093,0.000218471957659998,No,NA,NA,Q13200,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; regulation of protein catabolic process [GO:0042176],NA,NA,NA
CHOYP_PSMD6.1.1.m.60839,-0.00450697041791331,0.00520115190248873,No,NA,NA,Q15008,NA,NA,NA,cytosol [GO:0005829]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; secretory granule lumen [GO:0034774]; ATPase activity [GO:0016887]; enzyme regulator activity [GO:0030234]; neutrophil degranulation [GO:0043312]; post-translational protein modification [GO:0043687]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_PSMD9.1.1.m.5055,-0.0205763640311426,0.000562435014896796,No,NA,NA,Q3SZ19,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; proteasome regulatory particle; base subcomplex [GO:0008540]; proteasome regulatory particle assembly [GO:0070682],NA,NA,NA
CHOYP_PSME4.1.1.m.18992,-0.0027658939100609,-0.000528425872141499,No,NA,NA,Q6NRP2,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; spermatoproteasome complex [GO:1990111]; lysine-acetylated histone binding [GO:0070577]; peptidase activator activity [GO:0016504]; proteasome binding [GO:0070628]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; spermatogenesis; exchange of chromosomal proteins [GO:0035093],NA,NA,NA
CHOYP_PSMG2.1.1.m.66279,4.2424612434134e-06,0.00823318098391109,No,NA,NA,Q1LXS2,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; proteasome assembly [GO:0043248],NA,NA,NA
CHOYP_PSTA_4372.1.1.m.39115,0.00966433767161857,0.00705205603064972,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.1.2.m.4739,0.00312550054964805,-0.00237096792953533,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTA.2.2.m.9655,-0.0116228007062795,0.000142778435281473,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PSTPIP1.1.1.m.39114,0.0102817670104536,-0.0165907220309087,No,NA,NA,O43586,NA,NA,NA,actin filament [GO:0005884]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; uropod [GO:0001931]; actin filament binding [GO:0051015]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; actin filament polymerization [GO:0030041]; cell adhesion [GO:0007155]; endocytosis [GO:0006897]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTCD3.1.1.m.24655,-0.0184376392785735,-0.00975314086387449,No,NA,NA,Q5R8W8,NA,NA,NA,mitochondrion [GO:0005739]; ribosome [GO:0005840]; ribosomal small subunit binding [GO:0043024]; rRNA binding [GO:0019843]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_PTEN.1.1.m.5408,-0.016667121770813,0.0126580593650257,No,NA,NA,P60484,NA,NA,NA,apical plasma membrane [GO:0016324]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; myelin sheath adaxonal region [GO:0035749]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; postsynaptic membrane [GO:0045211]; Schmidt-Lanterman incisure [GO:0043220]; anaphase-promoting complex binding [GO:0010997]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; inositol-1;3;4;5-tetrakisphosphate 3-phosphatase activity [GO:0051717]; ionotropic glutamate receptor binding [GO:0035255]; lipid binding [GO:0008289]; PDZ domain binding [GO:0030165]; phosphatidylinositol-3;4;5-trisphosphate 3-phosphatase activity [GO:0016314]; phosphatidylinositol-3;4-bisphosphate 3-phosphatase activity [GO:0051800]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphoprotein phosphatase activity [GO:0004721]; platelet-derived growth factor receptor binding [GO:0005161]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; ubiquitin-specific protease binding [GO:1990381]; adult behavior [GO:0030534]; aging [GO:0007568]; angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; brain morphogenesis [GO:0048854]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue development [GO:0048738]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; cellular response to electrical stimulus [GO:0071257]; cellular response to ethanol [GO:0071361]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to leptin stimulus [GO:0044320]; cellular response to nerve growth factor stimulus [GO:1990090]; central nervous system development [GO:0007417]; central nervous system myelin maintenance [GO:0032286]; central nervous system neuron axonogenesis [GO:0021955]; dendritic spine morphogenesis [GO:0060997]; dentate gyrus development [GO:0021542]; endothelial cell migration [GO:0043542]; forebrain morphogenesis [GO:0048853]; heart development [GO:0007507]; inositol phosphate dephosphorylation [GO:0046855]; inositol phosphate metabolic process [GO:0043647]; learning or memory [GO:0007611]; locomotor rhythm [GO:0045475]; locomotory behavior [GO:0007626]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; male mating behavior [GO:0060179]; maternal behavior [GO:0042711]; memory [GO:0007613]; multicellular organismal response to stress [GO:0033555]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of keratinocyte migration [GO:0051548]; negative regulation of myelination [GO:0031642]; negative regulation of organ growth [GO:0046621]; negative regulation of phagocytosis [GO:0050765]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of potassium ion transmembrane transporter activity [GO:1901017]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of ribosome biogenesis [GO:0090071]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of synaptic vesicle clustering [GO:2000808]; negative regulation of vascular smooth muscle cell proliferation [GO:1904706]; negative regulation of wound healing; spreading of epidermal cells [GO:1903690]; neuron-neuron synaptic transmission [GO:0007270]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of TRAIL-activated apoptotic signaling pathway [GO:1903984]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; postsynaptic density assembly [GO:0097107]; prepulse inhibition [GO:0060134]; presynaptic membrane assembly [GO:0097105]; prostate gland growth [GO:0060736]; protein dephosphorylation [GO:0006470]; protein deubiquitination [GO:0016579]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; regulation of B cell apoptotic process [GO:0002902]; regulation of cellular component size [GO:0032535]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of myeloid cell apoptotic process [GO:0033032]; regulation of neuron projection development [GO:0010975]; regulation of protein stability [GO:0031647]; regulation of synaptic transmission; GABAergic [GO:0032228]; response to activity [GO:0014823]; response to arsenic-containing substance [GO:0046685]; response to ATP [GO:0033198]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to zinc ion [GO:0010043]; rhythmic synaptic transmission [GO:0060024]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; synapse maturation [GO:0060074]; transcription initiation from RNA polymerase II promoter [GO:0006367],NA,NA,NA
CHOYP_PTER.1.2.m.28985,0.00269436350842493,-0.0001854030010855,No,NA,NA,Q7SZS2,NA,NA,NA,hydrolase activity; acting on ester bonds [GO:0016788]; zinc ion binding [GO:0008270]; catabolic process [GO:0009056],NA,NA,NA
CHOYP_PTGR1.1.1.m.29812,0.0230141625435607,-0.00588922659486889,No,NA,NA,Q3SZJ4,NA,NA,NA,cytoplasm [GO:0005737]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; 2-alkenal reductase [NAD(P)] activity [GO:0032440],NA,NA,NA
CHOYP_PTH1R.4.4.m.65130,0.00295812972916063,0.00266690033858461,No,NA,NA,P25107,NA,NA,NA,integral component of plasma membrane [GO:0005887]; parathyroid hormone receptor activity [GO:0004991]; peptide hormone binding [GO:0017046]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; cell surface receptor signaling pathway [GO:0007166],NA,NA,NA
CHOYP_PTHB1.1.1.m.35678,-0.00871861636274967,0.0213766996122401,No,NA,NA,Q6AX60,NA,NA,NA,BBSome [GO:0034464]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815],NA,NA,NA
CHOYP_PTN11.4.4.m.62827,0.0015114386823742,0.00348195581437236,No,NA,NA,Q90687,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphotyrosine residue binding [GO:0001784]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; SH3/SH2 adaptor activity [GO:0005070]; abortive mitotic cell cycle [GO:0033277]; activation of MAPK activity [GO:0000187]; atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; DNA damage checkpoint [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; face morphogenesis [GO:0060325]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; multicellular organismal reproductive process [GO:0048609]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of multicellular organism growth [GO:0040014]; regulation of protein complex assembly [GO:0043254]; regulation of protein export from nucleus [GO:0046825]; triglyceride metabolic process [GO:0006641],NA,NA,NA
CHOYP_PTN11.4.4.m.62828,-0.0332026739678176,-0.0185589515178519,No,NA,NA,Q20191,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_PTP10.3.3.m.46720,-4.48549111750112e-05,0.00595116734916809,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPA.1.1.m.18579,-0.00355769160484487,0.00986314740713538,No,NA,NA,Q2KJ44,NA,NA,NA,calcium channel complex [GO:0034704]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; protein homodimerization activity [GO:0042803]; protein phosphatase 2A binding [GO:0051721]; protein tyrosine phosphatase activator activity [GO:0008160]; signaling receptor binding [GO:0005102]; mitotic spindle organization [GO:0007052]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphoprotein phosphatase activity [GO:0032516],NA,NA,NA
CHOYP_PTPN23.1.1.m.16408,0.000734817121604341,0.00893041949660808,No,NA,NA,Q6PB44,NA,NA,NA,ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; cilium assembly [GO:0060271]; early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; negative regulation of epithelial cell migration [GO:0010633]; positive regulation of adherens junction organization [GO:1903393]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of homophilic cell adhesion [GO:1903387]; positive regulation of Wnt protein secretion [GO:0061357]; protein transport [GO:0015031]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],NA,NA,NA
CHOYP_PTPRA.19.22.m.59233,-0.00695629365757135,-0.00442696811217016,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRA.2.22.m.3118,-0.00278544858257744,0.00378146025717956,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46545,0.00412644566898977,-0.00749149033092176,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRA.9.22.m.46547,0.0059003982083454,0.00696821849345678,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PTPRB.1.4.m.21615,0.00802924633046042,0.00481611130339821,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.3.4.m.52977,0.00218528745922147,0.00867941569864463,No,NA,NA,B2RU80,NA,NA,NA,integral component of membrane [GO:0016021]; receptor complex [GO:0043235]; protein tyrosine phosphatase activity [GO:0004725]; angiogenesis [GO:0001525]; dephosphorylation [GO:0016311],NA,NA,NA
CHOYP_PTPRB.4.4.m.66782,0.00165237020216114,-0.000446517623637158,No,NA,NA,P35992,NA,NA,NA,apical part of cell [GO:0045177]; axon [GO:0030424]; integral component of membrane [GO:0016021]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; branching involved in open tracheal system development [GO:0060446]; central nervous system development [GO:0007417]; long-term memory [GO:0007616]; motor neuron axon guidance [GO:0008045]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; open tracheal system development [GO:0007424]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRC.5.14.m.34957,0.00797849657810203,-0.0144848217484896,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRE.7.19.m.34309,-0.00698345041013547,-0.00444425060246592,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPREA.1.2.m.4823,0.00556011152845871,-0.0050631860284541,No,NA,NA,B9EKR1,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; filopodium [GO:0030175]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; integral component of postsynaptic density membrane [GO:0099061]; intrinsic component of plasma membrane [GO:0031226]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; perineuronal net [GO:0072534]; postsynaptic membrane [GO:0045211]; ruffle membrane [GO:0032587]; synapse [GO:0045202]; fibroblast growth factor binding [GO:0017134]; phosphatase activity [GO:0016791]; protein tyrosine phosphatase activity [GO:0004725]; axonal fasciculation [GO:0007413]; axonogenesis [GO:0007409]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of dendrite development [GO:2000171]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of cell migration [GO:0030335]; positive regulation of dendrite development [GO:1900006]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Schwann cell migration [GO:1900149]; protein dephosphorylation [GO:0006470]; regulation of dendrite morphogenesis [GO:0048814]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRF.2.6.m.17540,0,0,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRF.3.6.m.28841,0.00625580959212592,0.00451622433677782,No,NA,NA,P16621,NA,NA,NA,axon [GO:0030424]; basal plasma membrane [GO:0009925]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725]; SAM domain binding [GO:0032093]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon extension [GO:0048675]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; cell adhesion [GO:0007155]; centripetally migrating follicle cell migration [GO:0060269]; motor neuron axon guidance [GO:0008045]; negative regulation of homophilic cell adhesion [GO:1903386]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; peptidyl-tyrosine dephosphorylation [GO:0035335]; photoreceptor cell morphogenesis [GO:0008594]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of plasma membrane bounded cell projection assembly [GO:0120034]; R7 cell development [GO:0045467]; regulation of axon extension involved in axon guidance [GO:0048841]; retinal ganglion cell axon guidance [GO:0031290]; spermatogenesis [GO:0007283]; synaptic growth at neuromuscular junction [GO:0051124],NA,NA,NA
CHOYP_PTPRG.1.3.m.56419,-0.00829936766796373,-0.000383126276412873,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.2.3.m.61939,0.00193203662023778,0.00177449057414491,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRG.3.3.m.65311,-0.00215022881388207,0.00291910066277855,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.10.20.m.31769,-0.00683885696273158,-0.00435223168946488,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.13.20.m.40023,0.00852378356357458,-0.000857918710594058,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRK.17.20.m.60780,-0.00220436836803738,0.00983297143656765,No,NA,NA,Q15262,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRK.18.20.m.62712,0.00771128220766403,0.00501527294983523,No,NA,NA,P23471,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRK.4.20.m.2624,0.0101028974993854,-0.00407926939327861,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.6.20.m.6291,0.0043389162138742,0.00230412503195186,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRK.8.20.m.8333,0.00246626872445362,0.00859076813737177,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRM.11.15.m.52054,-1.40369802487779e-05,0.00224332673324949,No,NA,NA,P23469,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; negative regulation of insulin receptor signaling pathway [GO:0046627]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_PTPRM.14.15.m.57240,0.00477810947823235,-0.00867457464065595,No,NA,NA,Q15262,NA,NA,NA,adherens junction [GO:0005912]; axon [GO:0030424]; cell junction [GO:0030054]; cell surface [GO:0009986]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; leading edge membrane [GO:0031256]; neuronal cell body [GO:0043025]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; beta-catenin binding [GO:0008013]; gamma-catenin binding [GO:0045295]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV [GO:0034644]; focal adhesion assembly [GO:0048041]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription; DNA-templated [GO:0045892]; neuron projection development [GO:0031175]; protein dephosphorylation [GO:0006470]; protein localization to cell surface [GO:0034394]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_PTPRQ.6.8.m.45809,-4.22098403592715e-08,0.00353855002297919,No,NA,NA,P0C5E4,NA,NA,NA,integral component of membrane [GO:0016021]; stereocilium bundle [GO:0032421]; protein tyrosine phosphatase activity [GO:0004725]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear morphogenesis [GO:0042472]; neuromuscular process controlling balance [GO:0050885]; regulation of fat cell differentiation [GO:0045598]; vestibular receptor cell morphogenesis [GO:0060116],NA,NA,NA
CHOYP_PTPRT.11.45.m.39468,0.00721452322654109,-0.00062056754323879,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.12.45.m.39573,0.00227031573267833,-0.00502326680001418,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.17.45.m.42361,0.00961996014019811,0.00601822469414115,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.22.45.m.47112,0.00813408204769523,0.0286144642610051,No,NA,NA,O14522,NA,NA,NA,cell surface [GO:0009986]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cell adhesion [GO:0007155]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.26.45.m.52045,-0.00744414768896076,-0.00104400628136581,No,NA,NA,P28828,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRT.30.45.m.53464,-0.00614868340586626,-0.0022092641991414,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.38.45.m.60044,0.00238559070933114,-0.00531649666246386,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRT.40.45.m.61584,0.00316053268091812,0.00373250778993168,No,NA,NA,P18433,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; integral component of synaptic membrane [GO:0099699]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685]; protein tyrosine phosphatase activity [GO:0004725]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axon guidance [GO:0007411]; insulin receptor signaling pathway [GO:0008286]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804],NA,NA,NA
CHOYP_PTPRT.6.45.m.24275,0.00413496288980341,-0.00750695319714855,No,NA,NA,Q99M80,NA,NA,NA,cell surface [GO:0009986]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; alpha-actinin binding [GO:0051393]; alpha-catenin binding [GO:0045294]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; delta-catenin binding [GO:0070097]; gamma-catenin binding [GO:0045295]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine phosphatase activity [GO:0004725]; STAT family protein binding [GO:0097677]; thiolester hydrolase activity [GO:0016790]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; cellular response to interleukin-6 [GO:0071354]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of cell migration [GO:0030336]; negative regulation of STAT cascade [GO:1904893]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity [GO:1990264]; protein dephosphorylation [GO:0006470]; regulation of synapse organization [GO:0050807]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_PTPRU.2.2.m.58388,0.0022381603028062,-0.00495038705251239,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PTPRZ.1.9.m.12735,0.0192530702569835,-0.028929451904034,No,NA,NA,P23471,NA,NA,NA,integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; cytokine-mediated signaling pathway [GO:0019221]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; protein dephosphorylation [GO:0006470]; regulation of oligodendrocyte progenitor proliferation [GO:0070445],NA,NA,NA
CHOYP_PTPRZ.4.9.m.21524,-0.00723332490292345,0.00210043144787312,No,NA,NA,P28827,NA,NA,NA,cell-cell adherens junction [GO:0005913]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; neuron projection development [GO:0031175]; positive regulation of blood vessel diameter [GO:0097755]; protein dephosphorylation [GO:0006470]; response to drug [GO:0042493]; retina layer formation [GO:0010842]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_PUA1A.1.1.m.6287,-0.00111619060840646,-0.000417540234338814,No,NA,NA,Q561L1,NA,NA,NA,cytoplasm [GO:0005737]; adenylosuccinate synthase activity [GO:0004019]; GTP binding [GO:0005525]; magnesium ion binding [GO:0000287]; 'de novo' AMP biosynthetic process [GO:0044208],NA,NA,NA
CHOYP_PUM1.1.1.m.8674,-0.00518677629049082,0.00936971076144136,No,NA,NA,Q80U58,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; perinuclear region of cytoplasm [GO:0048471]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; positive regulation of gene silencing by miRNA [GO:2000637]; positive regulation of RIG-I signaling pathway [GO:1900246]; posttranscriptional regulation of gene expression [GO:0010608]; production of miRNAs involved in gene silencing by miRNA [GO:0035196]; regulation of chromosome segregation [GO:0051983]; regulation of mRNA stability [GO:0043488]; regulation of translation [GO:0006417]; stress granule assembly [GO:0034063],NA,NA,NA
CHOYP_PUR2.1.1.m.17810,0.00903409894525037,0.00105777365769527,No,NA,NA,Q64737,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; phosphoribosylamine-glycine ligase activity [GO:0004637]; phosphoribosylformylglycinamidine cyclo-ligase activity [GO:0004641]; phosphoribosylglycinamide formyltransferase activity [GO:0004644]; 'de novo' IMP biosynthetic process [GO:0006189]; adenine biosynthetic process [GO:0046084]; brainstem development [GO:0003360]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; glycine metabolic process [GO:0006544]; purine nucleotide biosynthetic process [GO:0006164]; response to inorganic substance [GO:0010035]; response to organic substance [GO:0010033]; ribonucleoside monophosphate biosynthetic process [GO:0009156]; tetrahydrofolate biosynthetic process [GO:0046654],NA,NA,NA
CHOYP_PUR8.1.1.m.2748,-0.00219986913694985,-0.00801213610093506,No,NA,NA,P21265,NA,NA,NA,cytosol [GO:0005829]; (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [GO:0070626]; N6-(1;2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [GO:0004018]; 'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189],NA,NA,NA
CHOYP_PUS3.1.1.m.9880,-0.00759097112638606,-0.0033627391069795,No,NA,NA,Q9BZE2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; tRNA pseudouridine synthase activity [GO:0106029]; mRNA pseudouridine synthesis [GO:1990481]; tRNA modification [GO:0006400]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PUS7.1.1.m.53798,0.00767684162576037,-0.00946168541073166,No,NA,NA,Q96PZ0,NA,NA,NA,nucleus [GO:0005634]; enzyme binding [GO:0019899]; pseudouridine synthase activity [GO:0009982]; RNA binding [GO:0003723]; mRNA pseudouridine synthesis [GO:1990481]; negative regulation of translation [GO:0017148]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of mesoderm development [GO:2000380]; tRNA pseudouridine synthesis [GO:0031119],NA,NA,NA
CHOYP_PVX_111155.1.1.m.25208,0.0232570691217613,0.00182597573710211,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PWP2.1.1.m.7530,-0.00976879813195628,-0.00522763481016849,No,NA,NA,Q5RFQ3,NA,NA,NA,nucleolus [GO:0005730],NA,NA,NA
CHOYP_PXK.1.1.m.27815,0.0066134146878916,-0.00956094881027483,No,NA,NA,Q8BX57,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; actin binding [GO:0003779]; ATP binding [GO:0005524]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein kinase activity [GO:0004672]; inflammatory response [GO:0006954]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of ATPase activity [GO:0032780]; negative regulation of ion transport [GO:0043271]; regulation of membrane potential [GO:0042391],NA,NA,NA
CHOYP_PY03350.1.1.m.8097,-0.00291879724445339,0.00442043123858023,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY03697.1.1.m.58980,-0.0022043924993542,0.00109055125227402,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PY04960.1.1.m.26352,-0.00692670948869414,-0.00440814082012478,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_PYR1.1.1.m.61565,-0.00298523570614449,-0.00104343721441368,No,NA,NA,Q91437,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; aspartate carbamoyltransferase activity [GO:0004070]; ATP binding [GO:0005524]; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity [GO:0004088]; dihydroorotase activity [GO:0004151]; zinc ion binding [GO:0008270]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; glutamine metabolic process [GO:0006541],NA,NA,NA
CHOYP_PYRD2.1.1.m.26691,-0.00125338739272929,-0.014308845761515,No,NA,NA,Q68FT3,NA,NA,NA,oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_PYRG1.1.1.m.13552,-0.00729019754413073,0.00150573937624012,No,NA,NA,Q6PEI7,NA,NA,NA,cytoophidium [GO:0097268]; cytoplasm [GO:0005737]; ATP binding [GO:0005524]; CTP synthase activity [GO:0003883]; identical protein binding [GO:0042802]; 'de novo' CTP biosynthetic process [GO:0044210]; CTP biosynthetic process [GO:0006241]; glutamine metabolic process [GO:0006541]; pyrimidine nucleobase biosynthetic process [GO:0019856],NA,NA,NA
CHOYP_QARS.2.2.m.18038,-0.000691269494269612,-0.000405524358219285,No,NA,NA,P47897,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of transcription; DNA-templated [GO:0045892]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_QCR2.1.1.m.35612,-0.00353885004794018,0.00405771535604708,No,NA,NA,P22695,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial respiratory chain complex IV [GO:0005751]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; protein-containing complex binding [GO:0044877]; aerobic respiration [GO:0009060]; oxidative phosphorylation [GO:0006119]; protein processing involved in protein targeting to mitochondrion [GO:0006627],NA,NA,NA
CHOYP_QCR2.1.1.m.35613,-0.0036277295192621,0.00146906224197901,No,NA,NA,Q8VIG3,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; meiotic spindle [GO:0072687]; motile cilium [GO:0031514]; outer dense fiber [GO:0001520]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_QPCT.1.1.m.38977,0.00673379988835299,-0.0234850721878851,No,NA,NA,Q16769,NA,NA,NA,extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]; glutaminyl-peptide cyclotransferase activity [GO:0016603]; zinc ion binding [GO:0008270]; cellular protein modification process [GO:0006464]; neutrophil degranulation [GO:0043312]; peptidyl-pyroglutamic acid biosynthetic process; using glutaminyl-peptide cyclotransferase [GO:0017186],NA,NA,NA
CHOYP_QTRTD1.1.1.m.19041,0.00496834412900344,-0.00850270711420683,No,NA,NA,Q28DX0,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; metal ion binding [GO:0046872]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; queuine tRNA-ribosyltransferase activity [GO:0008479]; tRNA-guanine transglycosylation [GO:0101030],NA,NA,NA
CHOYP_R3HDM1.1.1.m.36018,0.00295976448767798,0.0029450310268332,No,NA,NA,Q15032,NA,NA,NA,RNA binding [GO:0003723],NA,NA,NA
CHOYP_RAB1A.1.3.m.10036,-0.000980887924876839,0.00212769790710191,No,NA,NA,Q05974,NA,NA,NA,endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein transport [GO:0015031]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_RAB21.1.1.m.56542,0.00150817427531993,0.0118099026396349,No,NA,NA,P35282,NA,NA,NA,axon cytoplasm [GO:1904115]; cleavage furrow [GO:0032154]; cytoplasmic side of early endosome membrane [GO:0098559]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle membrane [GO:0030659]; early endosome [GO:0005769]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi cisterna membrane [GO:0032580]; neuron projection [GO:0043005]; synapse [GO:0045202]; trans-Golgi network [GO:0005802]; vesicle membrane [GO:0012506]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; anterograde axonal transport [GO:0008089]; intracellular protein transport [GO:0006886]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of receptor-mediated endocytosis [GO:0048260]; Rab protein signal transduction [GO:0032482]; regulation of axon extension [GO:0030516]; regulation of exocytosis [GO:0017157],NA,NA,NA
CHOYP_RAB35.1.1.m.8277,0.00324453461966676,-0.00569770685249068,No,NA,NA,Q5U316,NA,NA,NA,anchored component of synaptic vesicle membrane [GO:0098993]; cell projection membrane [GO:0031253]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intercellular bridge [GO:0045171]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; antigen processing and presentation [GO:0019882]; cellular response to nerve growth factor stimulus [GO:1990090]; endocytic recycling [GO:0032456]; endosomal transport [GO:0016197]; intracellular protein transport [GO:0006886]; mitotic cytokinesis [GO:0000281]; neuron projection development [GO:0031175]; plasma membrane to endosome transport [GO:0048227]; protein localization to endosome [GO:0036010]; Rab protein signal transduction [GO:0032482],NA,NA,NA
CHOYP_RAB35.1.1.m.8278,0.00239612972853017,-0.000325353970997803,No,NA,NA,P62282,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; osteoblast differentiation [GO:0001649]; translation [GO:0006412],NA,NA,NA
CHOYP_RAB4B.1.1.m.55402,-0.00617156496390473,-0.0261201397610951,No,NA,NA,Q68EK7,NA,NA,NA,endosome [GO:0005768]; insulin-responsive compartment [GO:0032593]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; intracellular protein transport [GO:0006886]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100],NA,NA,NA
CHOYP_RAB7A.1.2.m.23789,0.000677415102646709,-0.00317571576655575,No,NA,NA,Q5D013,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; methyltransferase activity [GO:0008168]; protein-lysine N-methyltransferase activity [GO:0016279]; peptidyl-lysine methylation [GO:0018022],NA,NA,NA
CHOYP_RAB7A.1.2.m.23790,0.000388058241728319,0.000102645384167377,No,NA,NA,H9BW96,NA,NA,NA,cytosol [GO:0005829]; endosome membrane [GO:0010008]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; early endosome to late endosome transport [GO:0045022]; endosome to lysosome transport [GO:0008333]; lipid catabolic process [GO:0016042]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of viral process [GO:0048524]; protein targeting to lysosome [GO:0006622]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAB8A.2.3.m.33866,-0.00926186115090268,0.0232431757319009,No,NA,NA,Q4R5P1,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; midbody [GO:0030496]; non-motile cilium [GO:0097730]; phagocytic vesicle [GO:0045335]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin V binding [GO:0031489]; Rab GTPase binding [GO:0017137]; autophagy [GO:0006914]; axonogenesis [GO:0007409]; cellular response to insulin stimulus [GO:0032869]; cilium assembly [GO:0060271]; Golgi vesicle fusion to target membrane [GO:0048210]; protein localization to plasma membrane [GO:0072659]; protein transport [GO:0015031]; regulation of autophagy [GO:0010506]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_RABGAP1.1.1.m.50532,-0.00132180209466088,-0.00137438324134653,No,NA,NA,A2AWA9,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cell cycle [GO:0007049]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RABP2.1.1.m.29597,0.0218978866581986,0.00183481745336781,No,NA,NA,P22935,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; cyclin binding [GO:0030332]; retinal binding [GO:0016918]; retinoic acid binding [GO:0001972]; retinol binding [GO:0019841]; embryonic forelimb morphogenesis [GO:0035115]; positive regulation of collateral sprouting [GO:0048672]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573],NA,NA,NA
CHOYP_RABX5.1.2.m.26033,-0.0120255921803097,-0.00195357847240216,No,NA,NA,O18973,NA,NA,NA,early endosome [GO:0005769]; recycling endosome [GO:0055037]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAC1.1.3.m.20870,0.0182753408957704,0.0119821653762296,No,NA,NA,Q9QX22,NA,NA,NA,cytoplasm [GO:0005737]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; drug metabolic process [GO:0017144],NA,NA,NA
CHOYP_RAC1.1.3.m.20871,-0.00105060321900567,-0.0136023186148911,No,NA,NA,Q6RUV5,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RAC1.2.3.m.23406,-0.0126616974194729,-0.00805787298253932,No,NA,NA,Q6RUV5,NA,NA,NA,actin filament [GO:0005884]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; lamellipodium [GO:0030027]; melanosome [GO:0042470]; membrane [GO:0016020]; recycling endosome membrane [GO:0055038]; ruffle membrane [GO:0032587]; trans-Golgi network [GO:0005802]; ATPase binding [GO:0051117]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; histone deacetylase binding [GO:0042826]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; Rab GTPase binding [GO:0017137]; Rho GDP-dissociation inhibitor binding [GO:0051022]; thioesterase binding [GO:0031996]; actin cytoskeleton organization [GO:0030036]; actin filament organization [GO:0007015]; bone resorption [GO:0045453]; cell motility [GO:0048870]; cell projection assembly [GO:0030031]; cell proliferation [GO:0008283]; cellular response to mechanical stimulus [GO:0071260]; chemotaxis [GO:0006935]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; lamellipodium assembly [GO:0030032]; localization within membrane [GO:0051668]; mast cell chemotaxis [GO:0002551]; negative regulation of interleukin-23 production [GO:0032707]; neuron migration [GO:0001764]; neuron projection morphogenesis [GO:0048812]; positive regulation of DNA replication [GO:0045740]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; Rac protein signal transduction [GO:0016601]; regulation of cell migration [GO:0030334]; regulation of cell size [GO:0008361]; regulation of nitric oxide biosynthetic process [GO:0045428]; regulation of respiratory burst [GO:0060263]; Rho protein signal transduction [GO:0007266]; ruffle assembly [GO:0097178]; semaphorin-plexin signaling pathway [GO:0071526]; substrate adhesion-dependent cell spreading [GO:0034446],NA,NA,NA
CHOYP_RADI.1.2.m.2373,0.00118492939883926,0.000598061360468942,No,NA,NA,P26043,NA,NA,NA,apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; cell periphery [GO:0071944]; cell tip [GO:0051286]; cell-cell adherens junction [GO:0005913]; cleavage furrow [GO:0032154]; cortical actin cytoskeleton [GO:0030864]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; microvillus [GO:0005902]; midbody [GO:0030496]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; stereocilium [GO:0032420]; T-tubule [GO:0030315]; actin binding [GO:0003779]; ATPase binding [GO:0051117]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; apical protein localization [GO:0045176]; barbed-end actin filament capping [GO:0051016]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to thyroid hormone stimulus [GO:0097067]; establishment of endothelial barrier [GO:0061028]; establishment of protein localization [GO:0045184]; microvillus assembly [GO:0030033]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of homotypic cell-cell adhesion [GO:0034111]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of protein localization to early endosome [GO:1902966]; protein localization to plasma membrane [GO:0072659]; regulation of actin filament bundle assembly [GO:0032231]; regulation of cell shape [GO:0008360]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of organelle assembly [GO:1902115]; regulation of ruffle assembly [GO:1900027],NA,NA,NA
CHOYP_RADI.2.2.m.22446,-0.0102588596959265,-0.000989947319053862,No,NA,NA,E1BBQ2,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_RAEL1.1.1.m.40419,-0.00085003685066195,0.00167413409831894,No,NA,NA,A5GFN6,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; mitotic spindle pole [GO:0097431]; nuclear pore [GO:0005643]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to organic cyclic compound [GO:0071407]; mRNA export from nucleus [GO:0006406]; regulation of mitotic spindle organization [GO:0060236]; transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000972],NA,NA,NA
CHOYP_RAGP1.1.1.m.64037,-0.00341686808467823,-0.000641318787073112,No,NA,NA,P46060,NA,NA,NA,aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RALA.1.4.m.8443,-0.00218393961099376,-0.0271259120544015,No,NA,NA,P48555,NA,NA,NA,cleavage furrow [GO:0032154]; Flemming body [GO:0090543]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; PDZ domain binding [GO:0030165]; border follicle cell migration [GO:0007298]; defense response to Gram-negative bacterium [GO:0050829]; dorsal closure [GO:0007391]; innate immune response [GO:0045087]; negative regulation of innate immune response [GO:0045824]; negative regulation of JNK cascade [GO:0046329]; R3/R4 cell fate commitment [GO:0007464]; Ras protein signal transduction [GO:0007265]; regulation of cell morphogenesis [GO:0022604]; regulation of Notch signaling pathway [GO:0008593],NA,NA,NA
CHOYP_RALA.4.4.m.26414,-0.000208021470685965,-0.0190371940528779,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RAN.1.3.m.3468,-0.00493604802680833,-0.00144835455106526,No,NA,NA,H9D1R1,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; electron transfer activity [GO:0009055]; protein-disulfide reductase (glutathione) activity [GO:0019153]; cell redox homeostasis [GO:0045454]; defense response to virus [GO:0051607]; oxidation-reduction process [GO:0055114]; viral process [GO:0016032],NA,NA,NA
CHOYP_RAN.3.3.m.59027,-0.0117643918421735,0.00325494972453476,No,NA,NA,A0MZ67,NA,NA,NA,axon [GO:0030424]; axonal growth cone [GO:0044295]; cell leading edge [GO:0031252]; cytosol [GO:0005829]; filopodium [GO:0030175]; growth cone [GO:0030426]; lamellipodium [GO:0030027]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; actin filament binding [GO:0051015]; cell adhesion molecule binding [GO:0050839]; actin filament bundle retrograde transport [GO:0061573]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cytoplasmic actin-based contraction involved in cell motility [GO:0060327]; endoplasmic reticulum polarization [GO:0061163]; netrin-activated signaling pathway [GO:0038007]; positive regulation of axon extension [GO:0045773]; positive regulation of neuron migration [GO:2001224]; Ras protein signal transduction [GO:0007265]; regulation of establishment of cell polarity [GO:2000114]; substrate-dependent cell migration; cell extension [GO:0006930],NA,NA,NA
CHOYP_RANB9.1.2.m.40766,-0.000829533067280513,0.000226256501653895,No,NA,NA,A1L252,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RANGRF.1.2.m.18930,-0.00912507004298763,0.00369293949016401,No,NA,NA,A3KPP3,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; guanyl-nucleotide exchange factor activity [GO:0005085]; heart contraction [GO:0060047]; heart looping [GO:0001947]; protein transport [GO:0015031],NA,NA,NA
CHOYP_RAS.1.1.m.57089,-0.0147433179562779,-0.021742523298981,No,NA,NA,P23175,NA,NA,NA,host cell plasma membrane [GO:0020002]; membrane [GO:0016020]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RAS3.1.1.m.15706,0.000296951372772029,-0.00330290466403011,No,NA,NA,Q640R7,NA,NA,NA,cell junction [GO:0030054]; cytosol [GO:0005829]; plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; Rap protein signal transduction [GO:0032486],NA,NA,NA
CHOYP_RAVR1.1.1.m.62572,-0.0197062491733444,0.00135656700468525,No,NA,NA,Q9HCJ3,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RB3GP.1.2.m.53902,0.00103473730380992,-0.00169518885559816,No,NA,NA,Q642R9,NA,NA,NA,cytoplasm [GO:0005737]; GTPase activator activity [GO:0005096],NA,NA,NA
CHOYP_RB6I2.2.2.m.65652,-0.00918000648843926,-0.00439804578759294,No,NA,NA,Q99MI1,NA,NA,NA,cytoplasm [GO:0005737]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; IkappaB kinase complex [GO:0008385]; membrane [GO:0016020]; postsynaptic density [GO:0014069]; presynaptic active zone cytoplasmic component [GO:0098831]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; PDZ domain binding [GO:0030165]; Rab GTPase binding [GO:0017137]; structural constituent of presynaptic active zone [GO:0098882]; voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels [GO:0099635]; I-kappaB phosphorylation [GO:0007252]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147]; synaptic vesicle priming [GO:0016082],NA,NA,NA
CHOYP_RBBP4.1.1.m.62913,-3.63419755078312e-05,0.000542655591263745,No,NA,NA,Q60972,NA,NA,NA,CAF-1 complex [GO:0033186]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; NURF complex [GO:0016589]; protein-containing complex [GO:0032991]; DNA-dependent ATPase activity [GO:0008094]; histone deacetylase binding [GO:0042826]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cell cycle [GO:0007049]; chromatin assembly [GO:0031497]; chromatin remodeling [GO:0006338]; DNA replication [GO:0006260]; DNA replication-dependent nucleosome assembly [GO:0006335]; DNA replication-independent nucleosome assembly [GO:0006336],NA,NA,NA
CHOYP_RBCC1.1.2.m.7288,-0.00343031400364132,0.00154899666807834,No,NA,NA,Q9ESK9,NA,NA,NA,Atg1/ULK1 kinase complex [GO:1990316]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of peroxisome [GO:0030242]; cell cycle [GO:0007049]; glycophagy [GO:0061723]; heart development [GO:0007507]; liver development [GO:0001889]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; piecemeal microautophagy of the nucleus [GO:0034727]; positive regulation of cell size [GO:0045793]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; reticulophagy [GO:0061709],NA,NA,NA
CHOYP_RBEL1.1.1.m.174,-0.00144943209389815,0.00659460680087111,No,NA,NA,Q3YEC7,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; GTP binding [GO:0005525],NA,NA,NA
CHOYP_RBM10.2.2.m.59955,-0.0163515901079682,-0.00622022547589586,No,NA,NA,A4IGK4,NA,NA,NA,nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; positive regulation of apoptotic process [GO:0043065]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RBM19.1.2.m.28228,-0.00495328598793688,-0.00522169935781931,No,NA,NA,Q9Y4C8,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; multicellular organism development [GO:0007275]; positive regulation of embryonic development [GO:0040019]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RBM20.1.2.m.2222,-0.00101307640556662,-0.00222946236072198,No,NA,NA,Q8K310,NA,NA,NA,cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; zinc ion binding [GO:0008270]; activation of innate immune response [GO:0002218]; blastocyst formation [GO:0001825]; heart valve development [GO:0003170]; innate immune response [GO:0045087]; posttranscriptional regulation of gene expression [GO:0010608]; ventricular septum development [GO:0003281],NA,NA,NA
CHOYP_RBM22.1.1.m.43645,-0.00177761558336829,-0.00296097614752881,No,NA,NA,Q5ZM16,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007]; metal ion binding [GO:0046872]; pre-mRNA binding [GO:0036002]; U6 snRNA binding [GO:0017070]; cellular response to drug [GO:0035690]; mRNA cis splicing; via spliceosome [GO:0045292]; positive regulation of RNA splicing [GO:0033120]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RBM25.1.2.m.41094,-0.00501721957504832,0.000524477962418462,No,NA,NA,B2RY56,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; mRNA binding [GO:0003729]; apoptotic process [GO:0006915]; mRNA processing [GO:0006397]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; regulation of apoptotic process [GO:0042981]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBM39.1.1.m.19427,-0.000316531266655545,-0.00252608450760924,No,NA,NA,Q5RC80,NA,NA,NA,nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RBMX.1.1.m.26723,0.000270931627094326,0.00106316283909991,No,NA,NA,Q7ZWA3,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; commitment complex [GO:0000243]; extracellular exosome [GO:0070062]; nuclear euchromatin [GO:0005719]; nucleus [GO:0005634]; supraspliceosomal complex [GO:0044530]; chromatin binding [GO:0003682]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; cellular response to interleukin-1 [GO:0071347]; membrane protein ectodomain proteolysis [GO:0006509]; mRNA splicing; via spliceosome [GO:0000398]; multicellular organism development [GO:0007275]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein homooligomerization [GO:0051260]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RBP6.1.2.m.6061,0.0106837944998419,0.0105000517970866,No,NA,NA,Q9VVE5,NA,NA,NA,cytoplasm [GO:0005737]; polysome [GO:0005844]; ribonucleoprotein complex [GO:1990904]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; stem cell development [GO:0048864],NA,NA,NA
CHOYP_RBSK.1.1.m.17187,0.00464469208173843,-0.000879262844555636,No,NA,NA,Q9H477,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; ribokinase activity [GO:0004747]; carbohydrate phosphorylation [GO:0046835]; D-ribose catabolic process [GO:0019303]; pentose-phosphate shunt [GO:0006098],NA,NA,NA
CHOYP_RBX1A.1.1.m.63168,-0.0049495858179866,-0.000791665193765143,No,NA,NA,P62878,NA,NA,NA,anaphase-promoting complex [GO:0005680]; Cul2-RING ubiquitin ligase complex [GO:0031462]; Cul3-RING ubiquitin ligase complex [GO:0031463]; Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; Cul4B-RING E3 ubiquitin ligase complex [GO:0031465]; Cul5-RING ubiquitin ligase complex [GO:0031466]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cullin-RING ubiquitin ligase complex [GO:0031461]; cytosol [GO:0005829]; nuclear SCF ubiquitin ligase complex [GO:0043224]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; VCB complex [GO:0030891]; cullin family protein binding [GO:0097602]; eukaryotic initiation factor 4E binding [GO:0008190]; NEDD8 transferase activity [GO:0019788]; protein-containing complex binding [GO:0044877]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; DNA repair [GO:0006281]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein monoubiquitination [GO:0006513]; protein neddylation [GO:0045116]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RCC1.1.1.m.15249,0.000254215272341985,-0.000874220196835933,No,NA,NA,P18754,NA,NA,NA,chromatin [GO:0000785]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; Ran GTPase binding [GO:0008536]; Ran guanyl-nucleotide exchange factor activity [GO:0005087]; sulfate binding [GO:0043199]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic spindle organization [GO:0007052]; protein heterotetramerization [GO:0051290]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032],NA,NA,NA
CHOYP_RCL1.1.1.m.7474,-7.57679084317747e-05,0.0100525782118845,No,NA,NA,Q9JJT0,NA,NA,NA,nucleolus [GO:0005730]; endoribonuclease activity [GO:0004521]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RD23B.1.1.m.38952,-0.00385646535706842,0.00300119908244213,No,NA,NA,P54727,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; XPC complex [GO:0071942]; damaged DNA binding [GO:0003684]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; single-stranded DNA binding [GO:0003697]; ubiquitin binding [GO:0043130]; cellular response to interleukin-7 [GO:0098761]; embryonic organ development [GO:0048568]; global genome nucleotide-excision repair [GO:0070911]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA damage recognition [GO:0000715]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; protein folding [GO:0006457]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RDH13.1.3.m.10433,-0.0108316924750198,0.0173297416153736,No,NA,NA,Q8NBN7,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; NADP-retinol dehydrogenase activity [GO:0052650]; eye photoreceptor cell development [GO:0042462]; response to high light intensity [GO:0009644]; retina layer formation [GO:0010842]; retinal metabolic process [GO:0042574],NA,NA,NA
CHOYP_RED.1.2.m.8931,-0.00349168326162746,0.0175928137724318,No,NA,NA,Q9Z1M8,NA,NA,NA,cytoplasm [GO:0005737]; mitotic spindle pole [GO:0097431]; nuclear chromosome [GO:0000228]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; identical protein binding [GO:0042802]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA splicing; via spliceosome [GO:0000398]; protein localization to kinetochore [GO:0034501],NA,NA,NA
CHOYP_RED1.1.2.m.60684,-0.0142034542815443,0.00225588978773981,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RED1.2.2.m.61084,-0.00169184356957983,-0.00722962801494159,No,NA,NA,Q91ZS8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded RNA adenosine deaminase activity [GO:0003726]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; tRNA-specific adenosine deaminase activity [GO:0008251]; adenosine to inosine editing [GO:0006382]; base conversion or substitution editing [GO:0016553]; facial nerve morphogenesis [GO:0021610]; hypoglossal nerve morphogenesis [GO:0021618]; innervation [GO:0060384]; motor behavior [GO:0061744]; motor neuron apoptotic process [GO:0097049]; mRNA modification [GO:0016556]; mRNA processing [GO:0006397]; multicellular organism growth [GO:0035264]; muscle tissue morphogenesis [GO:0060415]; negative regulation of cell migration [GO:0030336]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity by regulation of protein phosphorylation [GO:0044387]; neuromuscular process controlling posture [GO:0050884]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of mRNA processing [GO:0050685]; positive regulation of viral genome replication [GO:0045070]; regulation of cell cycle [GO:0051726]; RNA processing [GO:0006396]; spinal cord ventral commissure morphogenesis [GO:0021965],NA,NA,NA
CHOYP_RELN.3.4.m.48195,0.0028486433180234,-0.00207561842538134,No,NA,NA,P58751,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; cellular response to dexamethasone stimulus [GO:0071549]; central nervous system development [GO:0007417]; cerebral cortex development [GO:0021987]; cerebral cortex tangential migration [GO:0021800]; dentate gyrus development [GO:0021542]; glial cell differentiation [GO:0010001]; hypothalamus development [GO:0021854]; locomotory behavior [GO:0007626]; memory [GO:0007613]; midgut development [GO:0007494]; neuron migration [GO:0001764]; orbitofrontal cortex development [GO:0021769]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to corticosterone [GO:0051412]; response to drug [GO:0042493]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to hormone [GO:0009725]; response to insecticide [GO:0017085]; response to lithium ion [GO:0010226]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to pain [GO:0048265]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; social behavior [GO:0035176]; spinal cord patterning [GO:0021511],NA,NA,NA
CHOYP_RENT1.1.1.m.44133,-0.00173008930958569,-0.00185976902377445,No,NA,NA,Q9EPU0,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; supraspliceosomal complex [GO:0044530]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; chromatin binding [GO:0003682]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; zinc ion binding [GO:0008270]; 3'-UTR-mediated mRNA destabilization [GO:0061158]; cell cycle phase transition [GO:0044770]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; dosage compensation by inactivation of X chromosome [GO:0009048]; histone mRNA catabolic process [GO:0071044]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process; endonucleolytic cleavage-dependent decay [GO:0000294]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of mRNA catabolic process [GO:0061014]; regulation of telomere maintenance [GO:0032204]; regulation of translational termination [GO:0006449]; telomere maintenance via semi-conservative replication [GO:0032201],NA,NA,NA
CHOYP_RENT2.1.1.m.50589,0.00502911911144367,-0.00112138388974972,No,NA,NA,Q9HAU5,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; polysome [GO:0005844]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_REPS1.1.2.m.35334,0.0072397305091472,0.00598698484896986,No,NA,NA,O54916,NA,NA,NA,clathrin-coated pit [GO:0005905]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; SH3 domain binding [GO:0017124]; receptor-mediated endocytosis [GO:0006898],NA,NA,NA
CHOYP_RER1.1.1.m.49089,-0.0288174516209453,0.0338962654963492,No,NA,NA,A5PJ65,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of Golgi membrane [GO:0030173]; protein retention in ER lumen [GO:0006621]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RFA1.1.1.m.16020,-0.00153723046327516,0.00194193717811941,No,NA,NA,P27694,NA,NA,NA,DNA replication factor A complex [GO:0005662]; nuclear chromosome; telomeric region [GO:0000784]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; damaged DNA binding [GO:0003684]; G-rich strand telomeric DNA binding [GO:0098505]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; single-stranded telomeric DNA binding [GO:0043047]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; DNA damage response; detection of DNA damage [GO:0042769]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; DNA unwinding involved in DNA replication [GO:0006268]; DNA-dependent DNA replication [GO:0006261]; double-strand break repair via homologous recombination [GO:0000724]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; G1/S transition of mitotic cell cycle [GO:0000082]; interstrand cross-link repair [GO:0036297]; meiotic cell cycle [GO:0051321]; mismatch repair [GO:0006298]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; nucleotide-excision repair; preincision complex assembly [GO:0006294]; nucleotide-excision repair; preincision complex stabilization [GO:0006293]; protein localization to chromosome [GO:0034502]; regulation of cellular response to heat [GO:1900034]; telomere maintenance [GO:0000723]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFA2.1.1.m.6290,0.00143198857338591,-0.00788545854408399,No,NA,NA,Q62193,NA,NA,NA,chromatin [GO:0000785]; chromosome; telomeric region [GO:0000781]; condensed nuclear chromosome [GO:0000794]; DNA replication factor A complex [GO:0005662]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; site of double-strand break [GO:0035861]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; G-rich strand telomeric DNA binding [GO:0098505]; protein N-terminus binding [GO:0047485]; protein phosphatase binding [GO:0019903]; sequence-specific DNA binding [GO:0043565]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; base-excision repair [GO:0006284]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; DNA unwinding involved in DNA replication [GO:0006268]; double-strand break repair via homologous recombination [GO:0000724]; heteroduplex formation [GO:0030491]; mismatch repair [GO:0006298]; mitotic G1 DNA damage checkpoint [GO:0031571]; mitotic recombination [GO:0006312]; nucleotide-excision repair [GO:0006289]; positive regulation of helicase activity [GO:0051096]; protein localization to chromosome [GO:0034502]; reciprocal meiotic recombination [GO:0007131]; regulation of DNA damage checkpoint [GO:2000001]; regulation of double-strand break repair via homologous recombination [GO:0010569]; telomere maintenance [GO:0000723]; telomere maintenance via recombination [GO:0000722]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_RFC1.1.3.m.8918,0.00533971744933755,0.0215634919229322,No,NA,NA,P35251,NA,NA,NA,cytoplasm [GO:0005737]; DNA replication factor C complex [GO:0005663]; Elg1 RFC-like complex [GO:0031391]; extracellular exosome [GO:0070062]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA clamp loader activity [GO:0003689]; DNA clamp unloader activity [GO:0061860]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein domain specific binding [GO:0019904]; sequence-specific DNA binding [GO:0043565]; DNA clamp unloading [GO:0090618]; DNA damage response; detection of DNA damage [GO:0042769]; DNA-dependent DNA replication [GO:0006261]; error-free translesion synthesis [GO:0070987]; error-prone translesion synthesis [GO:0042276]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleotide-excision repair; DNA gap filling [GO:0006297]; nucleotide-excision repair; DNA incision [GO:0033683]; nucleotide-excision repair; DNA incision; 5'-to lesion [GO:0006296]; positive regulation of transcription; DNA-templated [GO:0045893]; telomere maintenance via semi-conservative replication [GO:0032201]; telomere maintenance via telomerase [GO:0007004]; transcription-coupled nucleotide-excision repair [GO:0006283]; translesion synthesis [GO:0019985],NA,NA,NA
CHOYP_RFC2.1.2.m.12862,-0.0172797120415675,0.0105389534706444,No,NA,NA,Q6DGR4,NA,NA,NA,,NA,NA,NA
CHOYP_RFC2.1.2.m.12863,-0.01667423097193,-0.00108467848499114,No,NA,NA,Q641W4,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA clamp loader activity [GO:0003689]; enzyme binding [GO:0019899]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264],NA,NA,NA
CHOYP_RFC3.1.1.m.48357,-0.00957372381709429,-0.00114889516028851,No,NA,NA,Q8R323,NA,NA,NA,Ctf18 RFC-like complex [GO:0031390]; DNA replication factor C complex [GO:0005663]; nucleus [GO:0005634]; DNA clamp loader activity [GO:0003689]; single-stranded DNA-dependent ATPase activity [GO:0043142]; DNA replication [GO:0006260]; DNA-dependent DNA replication [GO:0006261]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; response to organophosphorus [GO:0046683],NA,NA,NA
CHOYP_RFIP4.1.2.m.976,0.014653136096485,0.0303047002769829,No,NA,NA,Q3LGD4,NA,NA,NA,cleavage furrow [GO:0032154]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; midbody [GO:0030496]; recycling endosome membrane [GO:0055038]; ADP-ribosylation factor binding [GO:0030306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; Rab GTPase binding [GO:0017137]; cell cycle [GO:0007049]; cell division [GO:0051301]; endocytic recycling [GO:0032456]; eye morphogenesis [GO:0048592]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465],NA,NA,NA
CHOYP_RFX3.1.1.m.55790,-0.00152432181124394,-0.00494586400337956,No,NA,NA,Q0V9K5,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription regulatory region DNA binding [GO:0044212]; cell differentiation [GO:0030154]; cilium-dependent cell motility [GO:0060285]; endocrine pancreas development [GO:0031018]; epithelial cilium movement involved in determination of left/right asymmetry [GO:0060287]; regulation of insulin secretion [GO:0050796]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_RGD1309762.1.1.m.47917,0.00852340378498293,-0.000176707143775744,No,NA,NA,Q9Y4D8,NA,NA,NA,integral component of membrane [GO:0016021]; ubiquitin-protein transferase activity [GO:0004842]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RGD1310712.1.1.m.16487,0.0112193466175122,0.0223251328116361,No,NA,NA,Q7ZUV7,NA,NA,NA,nucleus [GO:0005634]; chromatin organization [GO:0006325]; DNA repair [GO:0006281]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_RGD1561408.1.2.m.4308,0.00217247048038666,0.00201116397628329,No,NA,NA,P15941,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nuclear chromatin [GO:0000790]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; p53 binding [GO:0002039]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage response; signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response; signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; O-glycan processing [GO:0016266]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],NA,NA,NA
CHOYP_RGN.1.1.m.30406,-0.00514357290092882,-0.00210534945187374,No,NA,NA,Q6DF62,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; enzyme regulator activity [GO:0030234]; gluconolactonase activity [GO:0004341]; zinc ion binding [GO:0008270]; cellular calcium ion homeostasis [GO:0006874]; L-ascorbic acid biosynthetic process [GO:0019853]; positive regulation of ATPase activity [GO:0032781]; regulation of calcium-mediated signaling [GO:0050848],NA,NA,NA
CHOYP_RGPA1.1.1.m.50924,-0.00155169230665768,0.006533025240996,No,NA,NA,Q2PPJ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; protein heterodimerization activity [GO:0046982]; activation of GTPase activity [GO:0090630]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_RHDF1.2.3.m.45435,0.00295485883279241,0.0034896122663545,No,NA,NA,Q6PIX5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; cell migration [GO:0016477]; cell proliferation [GO:0008283]; negative regulation of protein secretion [GO:0050709]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHDF1.3.3.m.54744,-0.002865761754106,-0.00610780308016215,No,NA,NA,Q6PJF5,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; growth factor binding [GO:0019838]; negative regulation of protein secretion [GO:0050709]; protein transport [GO:0015031]; proteolysis [GO:0006508]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of protein secretion [GO:0050708],NA,NA,NA
CHOYP_RHG07.1.1.m.14019,-0.0136061459403266,-0.00216383016961319,No,NA,NA,Q923Q2,NA,NA,NA,lipid droplet [GO:0005811]; mitochondrial membrane [GO:0031966]; GTPase activator activity [GO:0005096]; lipid binding [GO:0008289]; cell cycle [GO:0007049]; endothelial cell migration [GO:0043542]; endothelial tube lumen extension [GO:0097498]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of sprouting angiogenesis [GO:1903671]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHG17.1.2.m.32099,-0.00119311736182272,0.000827277578671482,No,NA,NA,Q9CYH6,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; endoplasmic reticulum [GO:0005783]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; 5S rRNA binding [GO:0008097]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; hematopoietic progenitor cell differentiation [GO:0002244]; mitotic metaphase plate congression [GO:0007080]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_RHG18.1.1.m.24618,-0.00373614246457515,-0.0196116038036832,No,NA,NA,Q8K0Q5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of actin filament polymerization [GO:0030833]; regulation of cell motility [GO:2000145]; regulation of cell shape [GO:0008360]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHG44.1.1.m.982,-0.000648419935514424,-0.00342374868618679,No,NA,NA,Q68EM7,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; actin filament organization [GO:0007015]; calcium ion regulated exocytosis [GO:0017156]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RHO.1.1.m.2313,-0.00712173660835457,0.0105158097099406,No,NA,NA,P01122,NA,NA,NA,plasma membrane [GO:0005886]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_RHO1.3.3.m.44337,0.00150250322867536,-0.000836007382522178,No,NA,NA,Q5ZIN1,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; unfolded protein binding [GO:0051082]; cell cycle [GO:0007049]; cell division [GO:0051301]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_RHOM172_0471.1.1.m.60636,0.00966880126632517,-0.0125518164533563,No,NA,NA,Q96C23,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; aldose 1-epimerase activity [GO:0004034]; carbohydrate binding [GO:0030246]; galactose catabolic process via UDP-galactose [GO:0033499]; galactose metabolic process [GO:0006012]; glucose metabolic process [GO:0006006],NA,NA,NA
CHOYP_RIF1.1.1.m.13682,-0.00686779558389789,-0.00286538572245074,No,NA,NA,E1C2U2,NA,NA,NA,chromosome; telomeric region [GO:0000781]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; female pronucleus [GO:0001939]; male pronucleus [GO:0001940]; nuclear body [GO:0016604]; nuclear chromatin [GO:0000790]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; spindle midzone [GO:0051233]; cell cycle [GO:0007049]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to leukemia inhibitory factor [GO:1990830]; chromatin silencing at telomere [GO:0006348]; DNA repair [GO:0006281]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of isotype switching [GO:0045830]; stem cell population maintenance [GO:0019827]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247],NA,NA,NA
CHOYP_RIMB2.3.5.m.17363,-0.0164644914098842,0.0068191519236598,No,NA,NA,O15034,NA,NA,NA,cell junction [GO:0030054]; plasma membrane [GO:0005886]; synapse [GO:0045202]; negative regulation of phosphatase activity [GO:0010923]; neuromuscular synaptic transmission [GO:0007274],NA,NA,NA
CHOYP_RINT1.1.1.m.9402,-0.00941083050354843,0.000784978322933323,No,NA,NA,Q6NUQ1,NA,NA,NA,cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; cell cycle [GO:0007049]; Golgi organization [GO:0007030]; protein transport [GO:0015031]; regulation of ER to Golgi vesicle-mediated transport [GO:0060628]; regulation of signal transduction involved in mitotic G2 DNA damage checkpoint [GO:1902504]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890],NA,NA,NA
CHOYP_RIOK3.1.1.m.54195,-0.00712968724944921,0.00472532924348373,No,NA,NA,Q9DBU3,NA,NA,NA,cytosol [GO:0005829]; preribosome; small subunit precursor [GO:0030688]; ATP binding [GO:0005524]; caspase binding [GO:0089720]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; cellular response to dsDNA [GO:1990786]; cellular response to dsRNA [GO:0071359]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; maturation of SSU-rRNA [GO:0030490]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of MDA-5 signaling pathway [GO:0039534]; negative regulation of protein homooligomerization [GO:0032463]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728],NA,NA,NA
CHOYP_RIPL1.1.1.m.59984,0.0206612079950456,-0.00261068721301918,No,NA,NA,D3ZUQ0,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; dynein light intermediate chain binding [GO:0051959]; protein dimerization activity [GO:0046983]; small GTPase binding [GO:0031267]; cilium assembly [GO:0060271]; epithelial cell morphogenesis [GO:0003382]; protein transport from ciliary membrane to plasma membrane [GO:1903445]; regulation of neuron death [GO:1901214],NA,NA,NA
CHOYP_RIR1.2.2.m.30556,-0.00251937886041948,-0.00267415953787934,No,NA,NA,P07742,NA,NA,NA,cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; neuronal cell body [GO:0043025]; nuclear envelope [GO:0005635]; ribonucleoside-diphosphate reductase complex [GO:0005971]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; identical protein binding [GO:0042802]; purine nucleotide binding [GO:0017076]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; cell proliferation in forebrain [GO:0021846]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260]; male gonad development [GO:0008584]; mitotic cell cycle [GO:0000278]; protein complex oligomerization [GO:0051259]; protein heterotetramerization [GO:0051290]; pyrimidine nucleobase metabolic process [GO:0006206]; response to ionizing radiation [GO:0010212]; retina development in camera-type eye [GO:0060041],NA,NA,NA
CHOYP_RIR2.1.1.m.19831,-0.0151352561049951,0.0106918729050269,No,NA,NA,P07201,NA,NA,NA,metal ion binding [GO:0046872]; ribonucleoside-diphosphate reductase activity; thioredoxin disulfide as acceptor [GO:0004748]; deoxyribonucleotide biosynthetic process [GO:0009263]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_RL10.1.3.m.11695,0.000725902324140532,-0.000397265612246057,No,NA,NA,O61231,NA,NA,NA,cytoplasm [GO:0005737]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; neuronal cell body [GO:0043025]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_RL10A.1.2.m.7633,-0.00675815781440947,0.000216160474076239,No,NA,NA,Q9N4I4,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; maturation of LSU-rRNA [GO:0000470]; translation [GO:0006412],NA,NA,NA
CHOYP_RL11.2.7.m.12991,0.00173624677805979,-0.00125742262931029,No,NA,NA,P62914,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; synapse [GO:0045202]; peroxisome proliferator activated receptor binding [GO:0042975]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL14.2.9.m.10151,0.00224055262895078,-0.00146480609628206,No,NA,NA,O46160,NA,NA,NA,ribosome [GO:0005840]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL17.2.7.m.34420,0.00780172320881442,-0.00221441209589984,No,NA,NA,Q8TBZ5,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; positive regulation by host of viral process [GO:0044794]; positive regulation by host of viral release from host cell [GO:0044791],NA,NA,NA
CHOYP_RL17.7.7.m.57535,-0.00147096479536925,0.00118795206575491,No,NA,NA,Q09JW2,NA,NA,NA,large ribosomal subunit [GO:0015934]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL18A.1.8.m.12900,0.00153116434417673,0.00208740279235497,No,NA,NA,Q02543,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL18A.6.8.m.61646,0.00126043901158905,-0.00624510915148371,No,NA,NA,Q02543,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; membrane [GO:0016020]; polysomal ribosome [GO:0042788]; postsynaptic density [GO:0014069]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; response to antineoplastic agent [GO:0097327]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RL21.1.4.m.19435,0.00063224973038467,-0.00515550699986147,No,NA,NA,P49666,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; endoplasmic reticulum [GO:0005783]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL22.4.4.m.37418,0.00120890207189164,-0.00279139108476756,No,NA,NA,P67985,NA,NA,NA,cytoplasmic side of rough endoplasmic reticulum membrane [GO:0098556]; cytosolic large ribosomal subunit [GO:0022625]; glutamatergic synapse [GO:0098978]; large ribosomal subunit [GO:0015934]; presynapse [GO:0098793]; heparin binding [GO:0008201]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; alpha-beta T cell differentiation [GO:0046632]; regulation of translation at presynapse; modulating synaptic transmission [GO:0099577]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23.1.11.m.2901,0.0035854967580252,-0.00550320956765884,No,NA,NA,P48159,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; large ribosomal subunit rRNA binding [GO:0070180]; myosin binding [GO:0017022]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL23.4.11.m.13922,0.00716442980825912,-0.00107910090391336,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL23A.3.6.m.31005,0.00473953406556008,-0.00286707069787639,No,NA,NA,P62752,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL23A.6.6.m.63333,0.00962706750103667,0.0113693190577543,No,NA,NA,P62752,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleus [GO:0005634]; large ribosomal subunit rRNA binding [GO:0070180]; structural constituent of ribosome [GO:0003735]; TORC2 complex binding [GO:1904841]; cell proliferation [GO:0008283]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RL24.6.9.m.43123,0.00418877940007466,0.00574402370859107,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL24.6.9.m.43124,-0.000145764948672481,0.0193395010817922,No,NA,NA,Q9DFQ7,NA,NA,NA,ribosome [GO:0005840],NA,NA,NA
CHOYP_RL39.1.2.m.5372,-0.00127233314395919,0.00369420282730847,No,NA,NA,Q9D1L0,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mitochondrion organization [GO:0007005]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cellular response to hypoxia [GO:1900037],NA,NA,NA
CHOYP_RL39.2.2.m.64898,0.00358303155948446,0.00423146809653043,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4480,-0.00591303898388385,0.00202408368423652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL4.2.6.m.4481,0.000579494308360068,0.000187764831873914,No,NA,NA,P49165,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL4.6.6.m.66341,-0.00214411355016696,-0.00536695434014862,No,NA,NA,P49165,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL40.1.7.m.3623,0.000682985470564282,0.00133173258946182,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RL44.1.2.m.28788,0.0095602162149307,0.00611989007476196,No,NA,NA,P90702,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RL7A.2.6.m.5689,0.00115919037978757,-5.07178896633872e-05,No,NA,NA,Q9ESD1,NA,NA,NA,anchored component of plasma membrane [GO:0046658]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; serine-type endopeptidase activity [GO:0004252]; sodium channel regulator activity [GO:0017080]; positive regulation of sodium ion transmembrane transport [GO:1902307]; positive regulation of sodium ion transport [GO:0010765]; transepithelial transport [GO:0070633],NA,NA,NA
CHOYP_RL8.3.10.m.22753,0.0025144121861159,-0.00807259928684999,No,NA,NA,Q90YV7,NA,NA,NA,cytoplasm [GO:0005737]; nucleolus [GO:0005730]; ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; protein localization to nucleus [GO:0034504]; translation [GO:0006412],NA,NA,NA
CHOYP_RL9.4.6.m.43062,0.00458566286195711,-0.000834561637588568,No,NA,NA,P50882,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RL9.5.6.m.63453,0.00211951175891236,0.000408963911884791,No,NA,NA,P50882,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RLA0.3.7.m.42195,-0.00190304676761566,0.0055334049375693,No,NA,NA,O75689,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; GTPase activator activity [GO:0005096]; inositol 1;3;4;5 tetrakisphosphate binding [GO:0043533]; metal ion binding [GO:0046872]; phosphatidylinositol bisphosphate binding [GO:1902936]; phosphatidylinositol-3;4;5-trisphosphate binding [GO:0005547]; cell surface receptor signaling pathway [GO:0007166]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_RLA0.3.7.m.42196,0.000766252053892412,-0.000771302822316582,No,NA,NA,Q9DG68,NA,NA,NA,ribosome [GO:0005840]; ribosome biogenesis [GO:0042254],NA,NA,NA
CHOYP_RLA0.5.7.m.56220,0.0103494920378713,-0.00299522376250346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RLA1.3.12.m.12071,-3.34932065326593e-05,-0.00242685690616942,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLA1.8.12.m.25631,0.00453654119866464,-0.010339960889762,No,NA,NA,O01359,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translational elongation [GO:0006414],NA,NA,NA
CHOYP_RLP24.2.2.m.51354,-0.0201638220333574,0.00855368883270234,No,NA,NA,Q7ZTZ2,NA,NA,NA,cytosolic large ribosomal subunit [GO:0022625]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; assembly of large subunit precursor of preribosome [GO:1902626]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM10.1.2.m.26850,0.0103343634696008,-0.0126691588587633,No,NA,NA,Q29NV5,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; ribonucleoprotein complex [GO:1990904]; structural constituent of ribosome [GO:0003735]; ribosome biogenesis [GO:0042254]; translation [GO:0006412],NA,NA,NA
CHOYP_RM11.1.1.m.9390,-0.0132510069226632,-0.0107103381591528,No,NA,NA,Q9VFJ2,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; large ribosomal subunit rRNA binding [GO:0070180]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; gene silencing by RNA [GO:0031047]; mitochondrial translation [GO:0032543]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],NA,NA,NA
CHOYP_RM22.1.1.m.63127,0.00379032412111775,0.0112189342109958,No,NA,NA,Q0VFH6,NA,NA,NA,large ribosomal subunit [GO:0015934]; mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; ribosome assembly [GO:0042255]; translation [GO:0006412],NA,NA,NA
CHOYP_RM23.1.1.m.173,-0.0131593085277006,-0.00837455146346974,No,NA,NA,Q5TUE9,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RM37.1.1.m.14517,-0.0150554766274109,-0.00635320209738732,No,NA,NA,Q6AXT0,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM49.1.1.m.1644,-0.00928915242118443,-0.00744225934071011,No,NA,NA,Q9CQ40,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RM51.1.1.m.12099,0.00371019358562313,0.0257374463434137,No,NA,NA,Q22438,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrial ribosome [GO:0005761]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RMI1.1.1.m.17246,0.00327324596983918,-0.00088452455153265,No,NA,NA,Q9H9A7,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; RecQ helicase-Topo III complex [GO:0031422]; nucleotide binding [GO:0000166]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; glucose homeostasis [GO:0042593]; multicellular organism growth [GO:0035264]; reduction of food intake in response to dietary excess [GO:0002023]; resolution of meiotic recombination intermediates [GO:0000712]; response to glucose [GO:0009749],NA,NA,NA
CHOYP_RN19A.1.1.m.35894,-0.00690002015643195,-0.00094874081087435,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RN213.11.13.m.59720,-0.00352457780773776,0.00238350136143059,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.12.13.m.60577,-0.00399230573545799,0.0022695724997223,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.4.13.m.27716,0.00234608521153287,0.0231410065056187,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.6.13.m.42268,0.00211257846439687,0.00153571595897459,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45975,-0.00258349388866035,-0.00164412913342691,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.7.13.m.45976,0.00418096852378144,-0.00759047562534976,No,NA,NA,E9Q555,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; angiogenesis [GO:0001525]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein autoubiquitination [GO:0051865]; protein homooligomerization [GO:0051260]; protein ubiquitination [GO:0016567]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN213.8.13.m.52889,0.00386529264446221,-0.00701737155775053,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RN45S.2.5.m.14111,0.0297432373992339,0.00795313341175489,No,NA,NA,Q04832,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_RN45S.4.5.m.43162,0.000542941075326336,0.00024758740803939,No,NA,NA,Q7M3Y3,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RNF17.1.1.m.17312,-0.0143110692145247,-0.00910752912146031,No,NA,NA,Q99MV7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; multicellular organism development [GO:0007275]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_RNF213.1.4.m.3458,0,0,No,NA,NA,A0A0R4IBK5,NA,NA,NA,cytosol [GO:0005829]; ATPase activity [GO:0016887]; metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]; blood circulation [GO:0008015]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_RNOY.1.3.m.4495,-0.0243506554587081,-0.00213505354339253,No,NA,NA,Q7M456,NA,NA,NA,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RNOY.3.3.m.58342,-0.0113032003177559,0.0200802496185668,No,NA,NA,Q7M456,NA,NA,NA,extracellular region [GO:0005576]; ribonuclease T2 activity [GO:0033897]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RNP1B.1.1.m.59888,0.00440252292572318,-0.0299720231806583,No,NA,NA,Q3KPW1,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; RNA binding [GO:0003723]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_RNZ1.1.1.m.29553,0.00188915999097771,-0.00534739978662847,No,NA,NA,Q9H777,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; 3'-tRNA processing endoribonuclease activity [GO:0042781]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_RO60.1.6.m.24126,-0.0167434733494878,-0.0120475469172314,No,NA,NA,O08848,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; metal ion binding [GO:0046872]; misfolded RNA binding [GO:0034336]; RNA binding [GO:0003723]; U2 snRNA binding [GO:0030620]; cilium assembly [GO:0060271]; immune system development [GO:0002520]; response to UV [GO:0009411]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_ROAA.3.6.m.39522,-0.0308393670931153,-0.00523975862216072,No,NA,NA,Q99020,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_ROCK2.1.1.m.26830,0.00374371607940704,0.00158333025993978,No,NA,NA,Q28021,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; Rho GTPase binding [GO:0017048]; actin cytoskeleton organization [GO:0030036]; positive regulation of centrosome duplication [GO:0010825]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of circadian rhythm [GO:0042752]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_RORA.1.2.m.59037,0.00292822568904733,-0.00667012212011129,No,NA,NA,P28699,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_RPA1.1.2.m.3320,-0.00727376852091823,0.00648378796803881,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPA1.2.2.m.6583,0.00523579644085105,-0.00246184104471933,No,NA,NA,O35134,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; RNA polymerase I activity [GO:0001054]; zinc ion binding [GO:0008270]; negative regulation of protein localization to nucleolus [GO:1904750]; rRNA transcription [GO:0009303],NA,NA,NA
CHOYP_RPA12.1.1.m.48818,-0.0012148592194375,-0.00202313983728053,No,NA,NA,Q9DCG9,NA,NA,NA,nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; protein heterodimerization activity [GO:0046982]; protein methyltransferase activity [GO:0008276]; rRNA (guanine) methyltransferase activity [GO:0016435]; peptidyl-glutamine methylation [GO:0018364]; positive regulation of rRNA processing [GO:2000234]; rRNA (guanine-N7)-methylation [GO:0070476]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_RPAB1.1.1.m.11586,-0.0038802959564136,-0.00046914208881234,No,NA,NA,B0BNE2,NA,NA,NA,nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAB3.2.4.m.30639,-0.000579917403265939,0.000157123932019222,No,NA,NA,Q923G2,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; RNA polymerase I complex [GO:0005736]; RNA polymerase II; core complex [GO:0005665]; RNA polymerase III complex [GO:0005666]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; single-stranded DNA binding [GO:0003697]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase II [GO:0006366]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPAC1.1.1.m.36389,-0.000334805877592933,-0.0100674870843526,No,NA,NA,P52432,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase I complex [GO:0005736]; RNA polymerase III complex [GO:0005666]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase I [GO:0006360]; transcription by RNA polymerase III [GO:0006383],NA,NA,NA
CHOYP_RPB1.1.1.m.36612,-0.00532317391715133,0.00708214809745718,No,NA,NA,P04052,NA,NA,NA,nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPB2.1.1.m.38872,-0.000651092667671498,-0.00254547974691015,No,NA,NA,P30876,NA,NA,NA,membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; metal ion binding [GO:0046872]; ribonucleoside binding [GO:0032549]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene silencing by miRNA [GO:0060964]; RNA metabolic process [GO:0016070]; snRNA transcription by RNA polymerase II [GO:0042795]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; transcription initiation from RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283],NA,NA,NA
CHOYP_RPB3.1.1.m.45705,-0.00471689489097955,-0.0141955729314188,No,NA,NA,P97760,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II; core complex [GO:0005665]; DNA binding [GO:0003677]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; protein dimerization activity [GO:0046983]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_RPC1.1.1.m.16568,-0.00226773733902523,-0.00129297484376893,No,NA,NA,Q15637,NA,NA,NA,nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; identical protein binding [GO:0042802]; pre-mRNA branch point binding [GO:0045131]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_RPF2.2.2.m.27891,0.000938515539747168,0.00340573579025992,No,NA,NA,Q9JJ80,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; 5S rRNA binding [GO:0008097]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; rRNA binding [GO:0019843]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463]; protein localization to nucleolus [GO:1902570]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_RPGRB.1.1.m.59104,0.00631183058816041,0.0121788295505885,No,NA,NA,Q9N1T2,NA,NA,NA,centrosome [GO:0005813]; ciliary basal body [GO:0036064]; Golgi apparatus [GO:0005794]; sperm flagellum [GO:0036126]; guanyl-nucleotide exchange factor activity [GO:0005085]; cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; response to stimulus [GO:0050896]; visual perception [GO:0007601],NA,NA,NA
CHOYP_RPL36.1.1.m.57199,0.00291132029670275,-0.00125251641937608,No,NA,NA,P15771,NA,NA,NA,nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; DNA binding [GO:0003677]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_RPOC1.1.1.m.34397,-0.00775214026744428,0.00229805502243224,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RPS24.1.8.m.571,0.0183379718480953,-0.0237335277382609,No,NA,NA,O42387,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RPS27L.1.1.m.21535,-0.00480231407116973,0.00663221312221486,No,NA,NA,O01369,NA,NA,NA,mitochondrial respiratory chain complex III [GO:0005750]; mitochondrial electron transport; ubiquinol to cytochrome c [GO:0006122],NA,NA,NA
CHOYP_RPZ3.1.1.m.26308,-0.0268730965358061,-0.0238083864703592,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RRAGA.1.1.m.41224,-0.00109138228419468,-0.000897072624260251,No,NA,NA,Q63486,NA,NA,NA,cytoplasm [GO:0005737]; EGO complex [GO:0034448]; GATOR1 complex [GO:1990130]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to starvation [GO:0009267]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of autophagy [GO:0010506]; regulation of TORC1 signaling [GO:1903432]; response to amino acid [GO:0043200],NA,NA,NA
CHOYP_RREB1.1.1.m.11945,-0.00829985564010844,-0.00244142927755402,No,NA,NA,O57415,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_RRP1B.1.1.m.21811,0.00685799226929297,0.00334074056016385,No,NA,NA,Q14684,NA,NA,NA,cytosol [GO:0005829]; euchromatin [GO:0000791]; granular component [GO:0001652]; heterochromatin [GO:0000792]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; preribosome; small subunit precursor [GO:0030688]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; apoptotic process [GO:0006915]; cellular response to virus [GO:0098586]; mRNA processing [GO:0006397]; negative regulation of GTPase activity [GO:0034260]; negative regulation of phosphatase activity [GO:0010923]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of apoptotic process [GO:0043065]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of RNA splicing [GO:0043484]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RRP5.1.1.m.7375,-0.0118949497740635,0.0194759959671121,No,NA,NA,Q14690,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; transcription factor binding [GO:0008134]; mRNA processing [GO:0006397]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_RS14.3.6.m.23056,-0.00426662119577399,0.000235405433774592,No,NA,NA,Q920P5,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ATP metabolic process [GO:0046034]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142],NA,NA,NA
CHOYP_RS15A.5.11.m.18785,0.00300883929534049,0.0013425566403674,No,NA,NA,Q6XIM8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS15A.6.11.m.23616,-0.0240897682128979,-0.0153306690254509,No,NA,NA,Q6XIM8,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS16.1.5.m.29365,0.000642204373362314,-0.00263123900701047,No,NA,NA,Q98TR7,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS17.10.11.m.58728,0.000482988435149412,-0.0204602029780248,No,NA,NA,Q94519,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; respirasome [GO:0070469]; acyl binding [GO:0000035]; acyl carrier activity [GO:0000036]; phosphopantetheine binding [GO:0031177]; fatty acid biosynthetic process [GO:0006633]; lipid A biosynthetic process [GO:0009245]; mitochondrial electron transport; NADH to ubiquinone [GO:0006120],NA,NA,NA
CHOYP_RS19.3.12.m.15295,0.00146995838650838,-0.000182006500475963,No,NA,NA,Q8ITC3,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.2.10.m.5562,0.00122155475631916,0.000270194165957444,No,NA,NA,Q90YS3,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS2.7.10.m.39920,0.00366389897565297,-0.000990090151538355,No,NA,NA,Q90YS3,NA,NA,NA,small ribosomal subunit [GO:0015935]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS21.1.4.m.13400,0.00179577391765448,0.000448931762096566,No,NA,NA,O14463,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; antioxidant activity [GO:0016209]; protein disulfide oxidoreductase activity [GO:0015035]; cell redox homeostasis [GO:0045454]; cellular detoxification of hydrogen peroxide [GO:0061692]; cellular response to reactive oxygen species [GO:0034614]; glycerol ether metabolic process [GO:0006662]; hydrogen peroxide catabolic process [GO:0042744]; L-methionine salvage from methionine sulphoxide [GO:1990355]; positive regulation of cellular response to oxidative stress [GO:1900409]; sulfate assimilation; phosphoadenylyl sulfate reduction by phosphoadenylyl-sulfate reductase (thioredoxin) [GO:0019379],NA,NA,NA
CHOYP_RS23.1.9.m.12948,-0.00108432103445606,0.00186429834249064,No,NA,NA,Q86FP7,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; polysomal ribosome [GO:0042788]; rough endoplasmic reticulum [GO:0005791]; structural constituent of ribosome [GO:0003735]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_RS23.4.9.m.24810,0.00159345574641653,-0.013509028776213,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS27L.1.4.m.9354,0.00362320995770413,-0.0006914751068101,No,NA,NA,Q3T0B7,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RS27L.3.4.m.33064,-6.90778119124143e-05,0.00916496339054526,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS3.2.7.m.23037,0.00113958204075575,0.000189417963811646,No,NA,NA,P62909,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; dendrite [GO:0030425]; endomembrane system [GO:0012505]; mitochondrial inner membrane [GO:0005743]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; spindle [GO:0005819]; class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; kinase binding [GO:0019900]; oxidized purine DNA binding [GO:0032357]; oxidized purine nucleobase lesion DNA N-glycosylase activity [GO:0008534]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; apoptotic process [GO:0006915]; cell cycle [GO:0007049]; cell division [GO:0051301]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to nerve growth factor stimulus [GO:1990090]; DNA repair [GO:0006281]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of DNA repair [GO:0045739]; regulation of apoptotic process [GO:0042981]; regulation of translation [GO:0006417]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3.4.7.m.42801,0.00950860670895697,-0.011531634732918,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS32.1.1.m.57158,-0.00763362724038209,0.000605865251022512,No,NA,NA,P14314,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; glucosidase II complex [GO:0017177]; intracellular [GO:0005622]; intracellular membrane-bounded organelle [GO:0043231]; calcium ion binding [GO:0005509]; ion channel binding [GO:0044325]; phosphoprotein binding [GO:0051219]; protein kinase C binding [GO:0005080]; cellular protein metabolic process [GO:0044267]; intracellular signal transduction [GO:0035556]; N-glycan processing [GO:0006491]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_RS3A.14.15.m.57763,0.00825775046343131,0.00975219086268575,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.2.15.m.2682,0.00836423548318192,0.00987794693163255,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.4.15.m.15366,0.00347648368457649,-0.00093944518693219,No,NA,NA,Q8VE97,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; hematopoietic progenitor cell differentiation [GO:0002244]; mRNA cis splicing; via spliceosome [GO:0045292]; negative regulation of mRNA splicing; via spliceosome [GO:0048025]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_RS3A.4.15.m.15367,-0.0141365633057057,-0.0187867621973064,No,NA,NA,P49395,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS3A.8.15.m.27207,-0.00427461281760817,0.0163423415715154,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.10.11.m.60432,-0.00369654362114535,-0.00106526502732517,No,NA,NA,Q4PMB3,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS4.11.11.m.63584,-0.00353932018098725,-0.00346302845865121,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RS4.3.11.m.15465,0.00482044122687149,-0.00721591312043174,No,NA,NA,Q4PMB3,NA,NA,NA,ribosome [GO:0005840]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS5.1.2.m.146,0.00356249350014857,0.0024583842239567,No,NA,NA,P46782,NA,NA,NA,cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translational fidelity [GO:0006450]; ribosomal small subunit assembly [GO:0000028]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; translation [GO:0006412]; translational initiation [GO:0006413],NA,NA,NA
CHOYP_RS6.10.12.m.44863,0.00141030337045778,0.00120744815827447,No,NA,NA,Q9BMX5,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.5.12.m.23146,0,0,No,NA,NA,O01727,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS6.8.12.m.36342,-0.000496738429714884,-0.00347380133277227,No,NA,NA,O61462,NA,NA,NA,ribosome [GO:0005840]; metal ion binding [GO:0046872]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS7.5.9.m.38700,-0.0129312902064946,-0.00822944116671412,No,NA,NA,Q969G6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; riboflavin kinase activity [GO:0008531]; apoptotic process [GO:0006915]; FMN biosynthetic process [GO:0009398]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; reactive oxygen species metabolic process [GO:0072593]; riboflavin biosynthetic process [GO:0009231]; riboflavin metabolic process [GO:0006771],NA,NA,NA
CHOYP_RS7.6.9.m.44704,0.00214343194315753,-0.00276224781053745,No,NA,NA,P02362,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS8.12.14.m.59492,0.00438770618205688,-0.00615241973581925,No,NA,NA,Q6ZQ03,NA,NA,NA,nuclear speck [GO:0016607],NA,NA,NA
CHOYP_RS8.8.14.m.44842,0.00867648226629934,-0.018966366805688,No,NA,NA,Q8WQI5,NA,NA,NA,ribosome [GO:0005840]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.11.13.m.49921,0.00213455513847262,0.000506891213650835,No,NA,NA,B4PEU8,NA,NA,NA,nuclear chromosome [GO:0000228]; nucleolus [GO:0005730]; small ribosomal subunit [GO:0015935]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.8.13.m.41198,0.0012700879542958,0.00168046987137582,No,NA,NA,P29314,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; nucleolus [GO:0005730]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; 5.8S rRNA binding [GO:1990932]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182]; positive regulation of cell proliferation [GO:0008284]; positive regulation of translational fidelity [GO:0045903]; translation [GO:0006412],NA,NA,NA
CHOYP_RS9.9.13.m.44486,0.0244809232629939,0.015789836107215,No,NA,NA,P86954,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_RSMB.1.2.m.12400,6.13273675518552e-05,0.00060946042321706,No,NA,NA,Q9N1Q0,NA,NA,NA,cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; SMN-Sm protein complex [GO:0034719]; U1 snRNP [GO:0005685]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U7 snRNP [GO:0005683]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RSPH4A.1.1.m.15217,0.0063131034063506,0.0033839435430087,No,NA,NA,Q8BYM7,NA,NA,NA,axoneme [GO:0005930]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; radial spoke [GO:0001534]; axoneme assembly [GO:0035082]; cilium movement [GO:0003341],NA,NA,NA
CHOYP_RSRC2.1.1.m.14844,0.00144210933118355,-0.0220512033200535,No,NA,NA,Q7ZYR8,NA,NA,NA,,NA,NA,NA
CHOYP_RSSA.1.10.m.2054,0.000840396272885373,0.00135166939821794,No,NA,NA,A3RLT6,NA,NA,NA,cytosolic small ribosomal subunit [GO:0022627]; structural constituent of ribosome [GO:0003735]; ribosomal small subunit assembly [GO:0000028]; translation [GO:0006412],NA,NA,NA
CHOYP_RSSA.3.10.m.22114,0.0135695655195893,0.00439673654311413,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_RSU1.1.1.m.44138,7.72464605840906e-06,-0.000531720112098628,No,NA,NA,Q15404,NA,NA,NA,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_RT10.2.4.m.12766,-0.00919387881620722,0.022038052512219,No,NA,NA,Q9VFB2,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543]; translation [GO:0006412],NA,NA,NA
CHOYP_RT16.1.1.m.16545,0.0120543709956798,0.0103484349949216,No,NA,NA,P82915,NA,NA,NA,cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial small ribosomal subunit [GO:0005763]; structural constituent of ribosome [GO:0003735]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_RTCB.1.2.m.27510,-0.00516374930470432,0.00540485764850482,No,NA,NA,Q6NZS4,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; tRNA-splicing ligase complex [GO:0072669]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; RNA ligase (ATP) activity [GO:0003972]; tRNA exon ligation utilizing 2';3' cyclic phosphate of 5'-exon as source of linkage phosphate [GO:0000971]; tRNA splicing; via endonucleolytic cleavage and ligation [GO:0006388],NA,NA,NA
CHOYP_RTEL1.1.1.m.16665,-0.00841260563487688,0.0140464844151669,No,NA,NA,Q5RJZ1,NA,NA,NA,chromosome; telomeric region [GO:0000781]; nucleus [GO:0005634]; 4 iron; 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182]; metal ion binding [GO:0046872]; DNA duplex unwinding [GO:0032508]; DNA repair [GO:0006281]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of DNA recombination [GO:0045910]; negative regulation of t-circle formation [GO:1904430]; negative regulation of telomere maintenance in response to DNA damage [GO:1904506]; positive regulation of telomeric loop disassembly [GO:1904535]; regulation of double-strand break repair via homologous recombination [GO:0010569]; replication fork processing [GO:0031297]; strand displacement [GO:0000732]; telomere maintenance [GO:0000723]; telomere maintenance in response to DNA damage [GO:0043247]; telomeric loop disassembly [GO:0090657],NA,NA,NA
CHOYP_RTF1.1.1.m.10685,-0.00272826777467677,-0.00332657088310611,No,NA,NA,A2AQ19,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; nucleolus [GO:0005730]; RNA polymerase II C-terminal domain phosphoserine binding [GO:1990269]; single-stranded DNA binding [GO:0003697]; blastocyst growth [GO:0001832]; endodermal cell fate commitment [GO:0001711]; histone H3-K4 trimethylation [GO:0080182]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; stem cell population maintenance [GO:0019827]; transcription elongation from RNA polymerase II promoter [GO:0006368]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_RTTN.1.3.m.9025,-0.00595382812586699,0.0101264474895165,No,NA,NA,Q86VV8,NA,NA,NA,centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; ciliary basal body organization [GO:0032053]; determination of left/right symmetry [GO:0007368],NA,NA,NA
CHOYP_RTTN.1.3.m.9026,0.00217081874754335,-0.000260355940285541,No,NA,NA,Q5I0P2,NA,NA,NA,glycine cleavage complex [GO:0005960]; mitochondrion [GO:0005739]; aminomethyltransferase activity [GO:0004047]; enzyme binding [GO:0019899]; glycine decarboxylation via glycine cleavage system [GO:0019464]; protein lipoylation [GO:0009249],NA,NA,NA
CHOYP_RU1C.1.2.m.50387,-0.00240333592081505,-0.000790538161566965,No,NA,NA,C3Z1P5,NA,NA,NA,commitment complex [GO:0000243]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; mRNA binding [GO:0003729]; pre-mRNA 5'-splice site binding [GO:0030627]; U1 snRNA binding [GO:0030619]; zinc ion binding [GO:0008270]; mRNA 5'-splice site recognition [GO:0000395]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_RU2A.1.1.m.20848,-0.00898741017065887,0.00770653961680782,No,NA,NA,P57784,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type catalytic step 2 spliceosome [GO:0071007]; U2-type precatalytic spliceosome [GO:0071005]; U2 snRNA binding [GO:0030620]; mRNA splicing; via spliceosome [GO:0000398]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_RUNX1.1.1.m.49526,0.00559062156956561,-0.00174792800903004,No,NA,NA,Q01196,NA,NA,NA,core-binding factor complex [GO:0016513]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; hematopoietic stem cell proliferation [GO:0071425]; hemopoiesis [GO:0030097]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive; alpha-beta T cell differentiation [GO:0043371]; negative regulation of gene expression [GO:0010629]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; peripheral nervous system neuron development [GO:0048935]; positive regulation of angiogenesis [GO:0045766]; positive regulation of CD8-positive; alpha-beta T cell differentiation [GO:0043378]; positive regulation of granulocyte differentiation [GO:0030854]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of B cell receptor signaling pathway [GO:0050855]; regulation of bicellular tight junction assembly [GO:2000810]; regulation of cytokine-mediated signaling pathway [GO:0001959]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of keratinocyte differentiation [GO:0045616]; regulation of megakaryocyte differentiation [GO:0045652]; regulation of myeloid cell differentiation [GO:0045637]; regulation of regulatory T cell differentiation [GO:0045589]; regulation of Wnt signaling pathway [GO:0030111],NA,NA,NA
CHOYP_RUVB1.1.1.m.25669,0.00135470579916919,-0.000763566971099674,No,NA,NA,Q9DE26,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RUVB2.1.1.m.19005,-0.000973247181634417,0.00248341268149696,No,NA,NA,Q9DE27,NA,NA,NA,Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NuA4 histone acetyltransferase complex [GO:0035267]; R2TP complex [GO:0097255]; Swr1 complex [GO:0000812]; ATP binding [GO:0005524]; ATP-dependent 5'-3' DNA helicase activity [GO:0043141]; DNA recombination [GO:0006310]; DNA repair [GO:0006281],NA,NA,NA
CHOYP_RXR.1.2.m.45987,0.000123762097312895,-0.00489496777726009,No,NA,NA,Q5I7G2,NA,NA,NA,cytoplasm [GO:0005737]; growth cone [GO:0030426]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; retinal binding [GO:0016918]; sequence-specific DNA binding [GO:0043565]; steroid hormone receptor activity [GO:0003707]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_S12A2.1.2.m.32137,0.00415195085237341,-1.80674553448075e-05,No,NA,NA,P55013,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S12A2.2.2.m.39394,0.00857204782197635,0.0117292115851667,No,NA,NA,P55013,NA,NA,NA,integral component of membrane [GO:0016021]; cation:chloride symporter activity [GO:0015377]; potassium ion transport [GO:0006813]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_S26A5.2.2.m.9883,0.0241641268097791,0.00562250019531528,No,NA,NA,P58743,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; anion:anion antiporter activity [GO:0015301]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; oxalate transmembrane transporter activity [GO:0019531]; protein homodimerization activity [GO:0042803]; secondary active sulfate transmembrane transporter activity [GO:0008271]; spectrin binding [GO:0030507]; sulfate transmembrane transporter activity [GO:0015116]; transcription factor binding [GO:0008134]; cochlea development [GO:0090102]; fructose transmembrane transport [GO:0015755]; negative regulation of ion transmembrane transport [GO:0034766]; positive regulation of cell motility [GO:2000147]; positive regulation of cell size [GO:0045793]; protein tetramerization [GO:0051262]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; response to auditory stimulus [GO:0010996]; response to ischemia [GO:0002931]; response to potassium ion [GO:0035864]; response to salicylic acid [GO:0009751]; response to salt [GO:1902074]; response to thyroid hormone [GO:0097066]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_S28A3.2.3.m.7477,-0.00290359995985248,0.00394185982093067,No,NA,NA,Q9UA35,NA,NA,NA,integral component of plasma membrane [GO:0005887]; nucleoside transmembrane transporter activity [GO:0005337],NA,NA,NA
CHOYP_S30BP.1.1.m.62845,-0.00430906425818306,-0.000260882896551613,No,NA,NA,Q9UHR5,NA,NA,NA,intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; apoptotic process [GO:0006915]; positive regulation of cell death [GO:0010942]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_S4A10.3.4.m.28397,0.0197510275403719,0.00182731405936719,No,NA,NA,Q8JZR6,NA,NA,NA,integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; anion:anion antiporter activity [GO:0015301]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_S4A8.1.1.m.28334,0.00260657566583528,0.00307829880593112,No,NA,NA,Q80ZA5,NA,NA,NA,integral component of plasma membrane [GO:0005887]; antiporter activity [GO:0015297]; inorganic anion exchanger activity [GO:0005452]; sodium:bicarbonate symporter activity [GO:0008510]; bicarbonate transport [GO:0015701]; regulation of intracellular pH [GO:0051453],NA,NA,NA
CHOYP_SAC1.1.1.m.40164,-0.00574952757128891,-0.0171973264430907,No,NA,NA,Q6GM29,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; phosphatase activity [GO:0016791]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; phosphatidylinositol dephosphorylation [GO:0046856],NA,NA,NA
CHOYP_SACS.11.17.m.53250,-0.00377494339919359,-0.00308585549930862,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.12.17.m.53659,-0.00276251409242414,0.0107979571254481,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.14.17.m.61817,-0.00154730774007049,0.000968898071522945,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.4.17.m.32398,0.00173044973865374,-0.00314160139867886,No,NA,NA,Q9NZJ4,NA,NA,NA,axon [GO:0030424]; cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; proteasome binding [GO:0070628]; negative regulation of inclusion body assembly [GO:0090084]; protein folding [GO:0006457],NA,NA,NA
CHOYP_SACS.6.17.m.35149,-0.00448815635194542,-0.00126637694440677,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SACS.9.17.m.52781,0.00143746373591554,0.00221247938187911,No,NA,NA,Q9JLC8,NA,NA,NA,cytoplasm [GO:0005737]; low-density lipoprotein particle receptor binding [GO:0050750],NA,NA,NA
CHOYP_SAE1.1.1.m.46861,-0.0010932626162491,0.00565093236557129,No,NA,NA,Q8JGT5,NA,NA,NA,SUMO activating enzyme complex [GO:0031510]; ubiquitin-like modifier activating enzyme activity [GO:0008641]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAE2.1.1.m.59765,0.000920855858871927,-0.00581499034566706,No,NA,NA,Q28GH3,NA,NA,NA,cytoplasm [GO:0005737]; SUMO activating enzyme complex [GO:0031510]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; SUMO activating enzyme activity [GO:0019948]; transferase activity [GO:0016740]; protein modification by small protein conjugation [GO:0032446]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_SAFB2.2.3.m.30765,-0.00191263216297924,0.00110811745954978,No,NA,NA,Q14151,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAFB2.3.3.m.33384,-0.00416712567642883,-0.0114882812193663,No,NA,NA,Q14151,NA,NA,NA,cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of mRNA processing [GO:0050684]; regulation of transcription by RNA polymerase II [GO:0006357]; Sertoli cell differentiation [GO:0060008],NA,NA,NA
CHOYP_SAHH3.2.2.m.51221,0.000631126378221792,0.0298261152087783,No,NA,NA,Q96HN2,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; neuron projection [GO:0043005]; hydrolase activity [GO:0016787]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine cycle [GO:0033353],NA,NA,NA
CHOYP_SAHHA.1.1.m.62610,0.00124821617217319,7.22767339366017e-07,No,NA,NA,P51893,NA,NA,NA,adenosylhomocysteinase activity [GO:0004013]; NAD binding [GO:0051287]; one-carbon metabolic process [GO:0006730]; S-adenosylhomocysteine catabolic process [GO:0019510],NA,NA,NA
CHOYP_SALIVA_1456.1.1.m.19330,-0.00814809678086846,-0.00140560489669552,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SAM9L.1.2.m.51914,-0.00260466867317693,0.00353603765380771,No,NA,NA,Q5K651,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_SAMD15.1.1.m.27733,0.0023517768709041,-0.0156546712796379,No,NA,NA,Q95JY5,NA,NA,NA,,NA,NA,NA
CHOYP_SAMH1.10.12.m.55275,-0.0154973067211164,0.00948796996531822,No,NA,NA,Q9Y3Z3,NA,NA,NA,intracellular [GO:0005622]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; nucleic acid binding [GO:0003676]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; immune response [GO:0006955]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; somatic hypermutation of immunoglobulin genes [GO:0016446]; type I interferon signaling pathway [GO:0060337],NA,NA,NA
CHOYP_SAMH1.12.12.m.66249,-0.00424157463426766,-0.00161514322103486,No,NA,NA,Q6INN8,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; dGTP binding [GO:0032567]; dGTPase activity [GO:0008832]; GTP binding [GO:0005525]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; triphosphoric monoester hydrolase activity [GO:0016793]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; dATP catabolic process [GO:0046061]; defense response to virus [GO:0051607]; deoxyribonucleotide catabolic process [GO:0009264]; dGTP catabolic process [GO:0006203]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair via homologous recombination [GO:0000724]; innate immune response [GO:0045087]; negative regulation of type I interferon-mediated signaling pathway [GO:0060339]; protein homotetramerization [GO:0051289]; regulation of innate immune response [GO:0045088]; RNA phosphodiester bond hydrolysis [GO:0090501]; somatic hypermutation of immunoglobulin genes [GO:0016446],NA,NA,NA
CHOYP_SAP.1.2.m.13958,0.000577572689459614,0.00119356644841471,No,NA,NA,Q12959,NA,NA,NA,apical plasma membrane [GO:0016324]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell projection membrane [GO:0031253]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; immunological synapse [GO:0001772]; intercalated disc [GO:0014704]; lateral loop [GO:0043219]; lateral plasma membrane [GO:0016328]; membrane raft [GO:0045121]; microtubule [GO:0005874]; MPP7-DLG1-LIN7 complex [GO:0097025]; myelin sheath abaxonal region [GO:0035748]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; node of Ranvier [GO:0033268]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; sarcolemma [GO:0042383]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; guanylate kinase activity [GO:0004385]; ion channel binding [GO:0044325]; ionotropic glutamate receptor binding [GO:0035255]; L27 domain binding [GO:0097016]; mitogen-activated protein kinase kinase binding [GO:0031434]; phosphatase binding [GO:0019902]; phosphoprotein phosphatase activity [GO:0004721]; potassium channel regulator activity [GO:0015459]; protein C-terminus binding [GO:0008022]; protein kinase binding [GO:0019901]; protein-containing complex scaffold activity [GO:0032947]; Ras guanyl-nucleotide exchange factor activity [GO:0005088]; structural constituent of postsynaptic density [GO:0098919]; actin filament organization [GO:0007015]; activation of protein kinase activity [GO:0032147]; amyloid precursor protein metabolic process [GO:0042982]; astral microtubule organization [GO:0030953]; bicellular tight junction assembly [GO:0070830]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cellular protein-containing complex localization [GO:0034629]; chemical synaptic transmission [GO:0007268]; cortical actin cytoskeleton organization [GO:0030866]; cortical microtubule organization [GO:0043622]; embryonic skeletal system morphogenesis [GO:0048704]; endothelial cell proliferation [GO:0001935]; establishment of centrosome localization [GO:0051660]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; hard palate development [GO:0060022]; immunological synapse formation [GO:0001771]; lens development in camera-type eye [GO:0002088]; MAPK cascade [GO:0000165]; membrane raft organization [GO:0031579]; mitotic cell cycle checkpoint [GO:0007093]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; peristalsis [GO:0030432]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell proliferation [GO:0008284]; positive regulation of potassium ion transport [GO:0043268]; positive regulation of protein localization to plasma membrane [GO:1903078]; protein localization to plasma membrane [GO:0072659]; receptor clustering [GO:0043113]; receptor localization to synapse [GO:0097120]; regulation of cell shape [GO:0008360]; regulation of membrane potential [GO:0042391]; regulation of myelination [GO:0031641]; regulation of potassium ion export across plasma membrane [GO:1903764]; regulation of potassium ion import [GO:1903286]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of ventricular cardiac muscle cell action potential [GO:0098911]; regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization [GO:1903760]; reproductive structure development [GO:0048608]; smooth muscle tissue development [GO:0048745]; T cell activation [GO:0042110]; T cell cytokine production [GO:0002369]; viral process [GO:0016032],NA,NA,NA
CHOYP_SARM1.1.1.m.377,-0.00499189903667743,0.00453332119975133,No,NA,NA,Q6IDD9,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; signaling adaptor activity [GO:0035591]; innate immune response [GO:0045087]; negative regulation of MyD88-independent toll-like receptor signaling pathway [GO:0034128]; regulation of neuron death [GO:1901214]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SARNP.1.1.m.46095,-0.00162935417256516,0.00014020898828929,No,NA,NA,Q9D1J3,NA,NA,NA,cytoplasmic ribonucleoprotein granule [GO:0036464]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; transcription export complex [GO:0000346]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RS domain binding [GO:0050733]; mRNA export from nucleus [GO:0006406]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_SART1.1.1.m.14398,0.00272391715984423,-0.00728764145175353,No,NA,NA,O43290,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; RNA binding [GO:0003723]; maturation of 5S rRNA [GO:0000481]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; spliceosomal snRNP assembly [GO:0000387],NA,NA,NA
CHOYP_SASB.2.3.m.37538,0.00283546122867259,-0.000766222610457555,No,NA,NA,Q8N0W4,NA,NA,NA,asymmetric; glutamatergic; excitatory synapse [GO:0098985]; cell junction [GO:0030054]; cell surface [GO:0009986]; dendrite [GO:0030425]; excitatory synapse [GO:0060076]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; spanning component of membrane [GO:0089717]; symmetric; GABA-ergic; inhibitory synapse [GO:0098983]; synapse [GO:0045202]; cell adhesion molecule binding [GO:0050839]; chloride ion binding [GO:0031404]; neurexin family protein binding [GO:0042043]; protein homodimerization activity [GO:0042803]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; adult behavior [GO:0030534]; brainstem development [GO:0003360]; cell-cell junction organization [GO:0045216]; cerebellum development [GO:0021549]; learning [GO:0007612]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of excitatory postsynaptic potential [GO:0090394]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; organ growth [GO:0035265]; postsynaptic membrane assembly [GO:0097104]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; social behavior [GO:0035176]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; vocalization behavior [GO:0071625],NA,NA,NA
CHOYP_SASB.3.3.m.51787,0.00126490546516937,0.00864842041759937,No,NA,NA,P23953,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity; acting on ester bonds [GO:0016788]; methyl indole-3-acetate esterase activity [GO:0080030]; sterol esterase activity [GO:0004771]; triglyceride lipase activity [GO:0004806]; lipid catabolic process [GO:0016042]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_SBDS.1.1.m.27786,-0.000624586616187021,-0.0199788259733334,No,NA,NA,P70122,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle pole [GO:0000922]; microtubule binding [GO:0008017]; ribosome binding [GO:0043022]; rRNA binding [GO:0019843]; bone marrow development [GO:0048539]; bone mineralization [GO:0030282]; cell proliferation [GO:0008283]; inner cell mass cell proliferation [GO:0001833]; leukocyte chemotaxis [GO:0030595]; mature ribosome assembly [GO:0042256]; mitotic spindle organization [GO:0007052]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SBNO1.1.1.m.7257,-0.00817021379911206,0.00257816726489503,No,NA,NA,A3KN83,NA,NA,NA,nucleus [GO:0005634]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_SBP1.1.2.m.2083,0.00575607614943431,0.00408426070180585,No,NA,NA,Q569D5,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SBP1.2.2.m.49372,0.0193572746474582,-0.0155840223925813,No,NA,NA,Q569D5,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; methanethiol oxidase activity [GO:0018549]; selenium binding [GO:0008430]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SC22B.1.1.m.62900,0.000199506486308534,0.000201172332145932,No,NA,NA,Q6P7L4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; melanosome [GO:0042470]; SNARE complex [GO:0031201]; SNAP receptor activity [GO:0005484]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; protein transport [GO:0015031]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_SC24B.1.2.m.95,-0.0026862661852608,0.00479207028282444,No,NA,NA,O95487,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],NA,NA,NA
CHOYP_SC24B.2.2.m.54667,-0.00894096019402344,0.0130580571541009,No,NA,NA,O95487,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; aorta morphogenesis [GO:0035909]; auditory receptor cell stereocilium organization [GO:0060088]; cargo loading into COPII-coated vesicle [GO:0090110]; cochlear nucleus development [GO:0021747]; COPII vesicle coating [GO:0048208]; coronary artery morphogenesis [GO:0060982]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; lung lobe morphogenesis [GO:0060463]; neural tube closure [GO:0001843]; outflow tract morphogenesis [GO:0003151]; pulmonary artery morphogenesis [GO:0061156]; regulation of cargo loading into COPII-coated vesicle [GO:1901301]; regulation of establishment of planar polarity involved in neural tube closure [GO:0090178],NA,NA,NA
CHOYP_SC24C.1.1.m.9387,0.000785714263652757,0.00201061634273207,No,NA,NA,P53992,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; SNARE binding [GO:0000149]; zinc ion binding [GO:0008270]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8240,-0.000154864954247298,0.00017742931404721,No,NA,NA,Q5F3X8,NA,NA,NA,COPII vesicle coat [GO:0030127]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; structural molecule activity [GO:0005198]; cargo loading into COPII-coated vesicle [GO:0090110]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum organization [GO:0007029]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_SC31A.1.2.m.8241,-0.002503716071901,-0.000115558670890714,No,NA,NA,O57521,NA,NA,NA,aryl hydrocarbon receptor complex [GO:0034751]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; ATP binding [GO:0005524]; protein dimerization activity [GO:0046983]; protein kinase binding [GO:0019901]; unfolded protein binding [GO:0051082]; blood vessel development [GO:0001568]; leukocyte migration [GO:0050900]; muscle organ development [GO:0007517]; negative regulation of cell cycle arrest [GO:0071157]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of transforming growth factor beta activation [GO:1901389]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; regulation of cellular protein localization [GO:1903827]; response to estrogen [GO:0043627],NA,NA,NA
CHOYP_SC5A9.3.5.m.27017,-6.30544924479979e-05,0.0083658138394429,No,NA,NA,A8WHP3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glucose:sodium symporter activity [GO:0005412],NA,NA,NA
CHOYP_SC6A5.3.7.m.20491,0.00198936656338457,7.66956005420317e-05,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.5.7.m.49357,0.00667865726594841,-0.0121249860884857,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SC6A5.7.7.m.62985,0.00280019590851115,-0.000756692913701526,No,NA,NA,A7Y2W8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SC6A6.2.2.m.37040,-0.0012772691979463,0.00906959411301245,No,NA,NA,P31646,NA,NA,NA,integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; gamma-aminobutyric acid:sodium symporter activity [GO:0005332]; neurotransmitter binding [GO:0042165]; neurotransmitter transport [GO:0006836],NA,NA,NA
CHOYP_SC6A9.4.6.m.26535,0.017605059747559,0.0035624654554901,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SC6A9.6.6.m.57818,0.00268157871459243,-0.000724639159959282,No,NA,NA,A7Y2W8,NA,NA,NA,integral component of plasma membrane [GO:0005887]; amino acid:sodium symporter activity [GO:0005283]; neurotransmitter:sodium symporter activity [GO:0005328],NA,NA,NA
CHOYP_SCAM1.1.1.m.5509,-0.00891207323088757,0.00579894959379866,No,NA,NA,Q8K021,NA,NA,NA,clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; recycling endosome membrane [GO:0055038]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588]; zymogen granule membrane [GO:0042589]; protein domain specific binding [GO:0019904]; endocytosis [GO:0006897]; exocytosis [GO:0006887]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SCAPER.1.1.m.34551,-0.00467177701714576,-0.00184815820504284,No,NA,NA,Q9BY12,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_SCMH1.1.1.m.1166,-0.00600390733525445,-0.00633711627744466,No,NA,NA,Q96GD3,NA,NA,NA,chromocenter [GO:0010369]; nucleoplasm [GO:0005654]; anterior/posterior pattern specification [GO:0009952]; chromatin remodeling [GO:0006338]; gene silencing [GO:0016458]; negative regulation of transcription; DNA-templated [GO:0045892]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SCN1.1.2.m.28878,-0.0053892913813957,-0.0110722225771605,No,NA,NA,P15390,NA,NA,NA,axon [GO:0030424]; plasma membrane [GO:0005886]; voltage-gated sodium channel complex [GO:0001518]; voltage-gated ion channel activity [GO:0005244]; voltage-gated sodium channel activity [GO:0005248]; cation transport [GO:0006812]; choline transport [GO:0015871]; membrane depolarization during action potential [GO:0086010]; neuronal action potential [GO:0019228]; potassium ion transport [GO:0006813]; regulation of ion transmembrane transport [GO:0034765]; sodium ion transmembrane transport [GO:0035725]; sodium ion transport [GO:0006814],NA,NA,NA
CHOYP_SCOT1.1.1.m.59655,-0.000158858941541805,0.000415498649022792,No,NA,NA,B2GV06,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; 3-oxoacid CoA-transferase activity [GO:0008260]; protein homodimerization activity [GO:0042803]; adipose tissue development [GO:0060612]; brain development [GO:0007420]; cellular ketone body metabolic process [GO:0046950]; heart development [GO:0007507]; ketone body catabolic process [GO:0046952]; ketone catabolic process [GO:0042182]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; response to activity [GO:0014823]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to hormone [GO:0009725]; response to nutrient [GO:0007584]; response to starvation [GO:0042594],NA,NA,NA
CHOYP_SCP.3.12.m.27952,-0.00564001848697252,0.00167709040238987,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.6.12.m.50694,0.00404217620702637,-0.00109231146381328,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.8.12.m.57173,0.00676606088468515,0.00373426370629895,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCP.9.12.m.62606,0.0088034310564123,0.00491342385558892,No,NA,NA,P02637,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SCPDL.1.1.m.55687,-0.0125353053245743,0.00220867700292708,No,NA,NA,Q8NBX0,NA,NA,NA,extracellular region [GO:0005576]; lipid droplet [GO:0005811]; membrane [GO:0016020]; midbody [GO:0030496]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; oxidoreductase activity [GO:0016491]; glycolipid biosynthetic process [GO:0009247]; platelet degranulation [GO:0002576],NA,NA,NA
CHOYP_SDA1.1.1.m.12704,0.00128783649102248,0.010336365510123,No,NA,NA,Q9NVU7,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; actin cytoskeleton organization [GO:0030036]; ribosomal large subunit biogenesis [GO:0042273]; ribosomal large subunit export from nucleus [GO:0000055],NA,NA,NA
CHOYP_SDHC.1.1.m.31276,-0.0159767104889198,0.000983960574108901,No,NA,NA,P70097,NA,NA,NA,integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrial respiratory chain complex II; succinate dehydrogenase complex (ubiquinone) [GO:0005749]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; succinate dehydrogenase activity [GO:0000104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SDR16C5.1.1.m.7423,0.014534271840621,0.00918202360854835,No,NA,NA,Q8N3Y7,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcriptional repressor complex [GO:0017053]; activating transcription factor binding [GO:0033613]; DNA-binding transcription factor activity [GO:0003700]; retinol dehydrogenase activity [GO:0004745]; transcription factor binding [GO:0008134]; keratinocyte proliferation [GO:0043616]; negative regulation of histone acetylation [GO:0035067]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone deacetylation [GO:0031065]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572],NA,NA,NA
CHOYP_SEC13.1.1.m.20714,0.000348330930384968,0.0026523104091138,No,NA,NA,Q5XFW8,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear pore [GO:0005643]; nuclear pore outer ring [GO:0031080]; protein-containing complex [GO:0032991]; structural molecule activity [GO:0005198]; COPII-coated vesicle budding [GO:0090114]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; mRNA transport [GO:0051028]; positive regulation of TORC1 signaling [GO:1904263]; protein exit from endoplasmic reticulum [GO:0032527]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SEC23B.1.1.m.12147,0.000247456965167589,0.00204287808725974,No,NA,NA,Q7SZE5,NA,NA,NA,COPII vesicle coat [GO:0030127]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; extrinsic component of membrane [GO:0019898]; Golgi membrane [GO:0000139]; perinuclear region of cytoplasm [GO:0048471]; GTPase activator activity [GO:0005096]; zinc ion binding [GO:0008270]; cargo loading into COPII-coated vesicle [GO:0090110]; cartilage development [GO:0051216]; embryonic neurocranium morphogenesis [GO:0048702]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; macroautophagy [GO:0016236]; pectoral fin morphogenesis [GO:0035138]; regulation of cell shape [GO:0008360]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_SEC23IP.1.1.m.41425,-0.00526858040991566,0.00590934888137779,No,NA,NA,Q6NZC7,NA,NA,NA,cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum exit site [GO:0070971]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; metal ion binding [GO:0046872]; phospholipase activity [GO:0004620]; acrosome assembly [GO:0001675]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; single fertilization [GO:0007338]; spermatid development [GO:0007286],NA,NA,NA
CHOYP_SEH1.1.1.m.55025,0.00192761490325434,-0.00484376732273731,No,NA,NA,Q6TGU2,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; lysosomal membrane [GO:0005765]; nuclear pore outer ring [GO:0031080]; Seh1-associated complex [GO:0035859]; structural molecule activity [GO:0005198]; attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; cellular protein-containing complex localization [GO:0034629]; cellular response to amino acid starvation [GO:0034198]; mitotic metaphase plate congression [GO:0007080]; mRNA transport [GO:0051028]; nuclear pore organization [GO:0006999]; positive regulation of TORC1 signaling [GO:1904263]; protein transport [GO:0015031],NA,NA,NA
CHOYP_SELD.1.2.m.8600,-0.000140987990542497,0.00329013904451264,No,NA,NA,P62716,NA,NA,NA,chromosome; centromeric region [GO:0000775]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein phosphatase type 2A complex [GO:0000159]; spindle pole [GO:0000922]; metal ion binding [GO:0046872]; phosphoprotein phosphatase activity [GO:0004721]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein serine/threonine phosphatase activity [GO:0004722]; apoptotic mitochondrial changes [GO:0008637]; negative regulation of Ras protein signal transduction [GO:0046580]; positive regulation of microtubule binding [GO:1904528]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein dephosphorylation [GO:0006470]; regulation of gene expression [GO:0010468]; response to endoplasmic reticulum stress [GO:0034976]; response to hydrogen peroxide [GO:0042542]; response to lead ion [GO:0010288],NA,NA,NA
CHOYP_SELJ.1.1.m.21559,-0.00645570034724024,-0.0138991381584611,No,NA,NA,P40821,NA,NA,NA,structural constituent of eye lens [GO:0005212],NA,NA,NA
CHOYP_SEM1A.1.2.m.57703,0.00190910391234997,0.0125225938938115,No,NA,NA,Q26473,NA,NA,NA,integral component of membrane [GO:0016021]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEM2A.1.1.m.43497,0.000400677054015274,-0.00347370839301962,No,NA,NA,Q9XZC8,NA,NA,NA,extracellular region [GO:0005576]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SEP11.1.2.m.19430,0.00188383284568813,-0.000414796234747439,No,NA,NA,P54359,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; septin complex [GO:0031105]; septin ring [GO:0005940]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein homodimerization activity [GO:0042803]; protein-containing complex scaffold activity [GO:0032947]; cellularization [GO:0007349]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; growth of a germarium-derived egg chamber [GO:0007295]; imaginal disc development [GO:0007444]; mitotic cytokinesis [GO:0000281]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_SEPT2.1.1.m.40428,0.00157413199090699,-0.00749506644353167,No,NA,NA,Q63ZQ1,NA,NA,NA,ciliary membrane [GO:0060170]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; midbody [GO:0030496]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell division [GO:0051301]; cilium assembly [GO:0060271]; smoothened signaling pathway [GO:0007224],NA,NA,NA
CHOYP_SEPT5.1.2.m.11458,0.00253021702266973,-0.0056731857292314,No,NA,NA,Q99719,NA,NA,NA,microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; septin complex [GO:0031105]; septin ring [GO:0005940]; synaptic vesicle [GO:0008021]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein-containing complex scaffold activity [GO:0032947]; structural molecule activity [GO:0005198]; cilium assembly [GO:0060271]; cytoskeleton-dependent cytokinesis [GO:0061640]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; synaptic vesicle targeting [GO:0016080],NA,NA,NA
CHOYP_SEPT7.1.1.m.59134,-0.00649533367725067,-0.00123531126347351,No,NA,NA,Q5R481,NA,NA,NA,axoneme [GO:0005930]; cleavage furrow [GO:0032154]; condensed chromosome kinetochore [GO:0000777]; midbody [GO:0030496]; motile cilium [GO:0031514]; septin complex [GO:0031105]; spindle [GO:0005819]; GTP binding [GO:0005525]; cell cycle [GO:0007049]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cilium assembly [GO:0060271]; regulation of embryonic cell shape [GO:0016476]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SERB.1.1.m.7242,0.00622857226171845,0.00715417828400215,No,NA,NA,Q2KHU0,NA,NA,NA,cytoplasm [GO:0005737]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; phosphoserine phosphatase activity [GO:0004647]; protein homodimerization activity [GO:0042803]; dephosphorylation [GO:0016311]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563],NA,NA,NA
CHOYP_SETD2.1.1.m.25547,0.00335547657195088,-0.00738123405626148,No,NA,NA,Q9BYW2,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; alpha-tubulin binding [GO:0043014]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone-lysine N-methyltransferase activity [GO:0018024]; metal ion binding [GO:0046872]; protein-lysine N-methyltransferase activity [GO:0016279]; angiogenesis [GO:0001525]; cell migration involved in vasculogenesis [GO:0035441]; coronary vasculature morphogenesis [GO:0060977]; defense response to virus [GO:0051607]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic placenta morphogenesis [GO:0060669]; endodermal cell differentiation [GO:0035987]; forebrain development [GO:0030900]; histone H3-K36 dimethylation [GO:0097676]; histone H3-K36 trimethylation [GO:0097198]; mesoderm morphogenesis [GO:0048332]; microtubule cytoskeleton organization involved in mitosis [GO:1902850]; mismatch repair [GO:0006298]; morphogenesis of a branching structure [GO:0001763]; neural tube closure [GO:0001843]; nucleosome organization [GO:0034728]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; pericardium development [GO:0060039]; positive regulation of interferon-alpha production [GO:0032727]; regulation of cytokinesis [GO:0032465]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of mRNA export from nucleus [GO:0010793]; regulation of protein localization to chromatin [GO:1905634]; regulation of transcription; DNA-templated [GO:0006355]; response to type I interferon [GO:0034340]; stem cell development [GO:0048864]; stem cell differentiation [GO:0048863]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SETD3.1.1.m.42582,0.00304207999188959,0.0070820550742095,No,NA,NA,B1MTJ4,NA,NA,NA,nucleus [GO:0005634]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; transcription coactivator activity [GO:0003713]; histone H3-K36 methylation [GO:0010452]; peptidyl-lysine dimethylation [GO:0018027]; peptidyl-lysine monomethylation [GO:0018026]; peptidyl-lysine trimethylation [GO:0018023]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_SETD6.1.1.m.14704,0.00104646756399621,0.00595756465218203,No,NA,NA,Q9CWY3,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; NF-kappaB binding [GO:0051059]; protein-lysine N-methyltransferase activity [GO:0016279]; histone lysine methylation [GO:0034968]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; peptidyl-lysine monomethylation [GO:0018026]; regulation of inflammatory response [GO:0050727]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_SF3A1.1.3.m.41531,-0.00398912310817493,0.00109830765424621,No,NA,NA,Q15459,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684]; RNA binding [GO:0003723]; mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3A3.1.1.m.50392,0.000796586206615635,0.00271085148426149,No,NA,NA,Q9D554,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B1.1.3.m.24001,-0.00190478898835371,0.00377210177723746,No,NA,NA,O57683,NA,NA,NA,spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SF3B3.1.1.m.45473,-0.00154046204723272,0.00129883134398108,No,NA,NA,Q15393,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; small nuclear ribonucleoprotein complex [GO:0030532]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2-type precatalytic spliceosome [GO:0071005]; nucleic acid binding [GO:0003676]; protein-containing complex binding [GO:0044877]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein catabolic process [GO:0042177]; RNA splicing; via transesterification reactions [GO:0000375],NA,NA,NA
CHOYP_SF3B4.1.1.m.14985,0.00137345890520185,-0.000367464601196555,No,NA,NA,O14102,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U2 snRNP [GO:0005686]; U2-type prespliceosome [GO:0071004]; RNA binding [GO:0003723]; mRNA cis splicing; via spliceosome [GO:0045292]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_SF3B5.1.1.m.12205,-0.00880445383782962,-0.000819482114675523,No,NA,NA,Q9VHI4,NA,NA,NA,precatalytic spliceosome [GO:0071011]; SAGA complex [GO:0000124]; U2 snRNP [GO:0005686]; mRNA splicing; via spliceosome [GO:0000398]; regulation of gene expression [GO:0010468]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SGPL1.1.1.m.42223,-0.005744040325371,-0.00804869915568281,No,NA,NA,Q8CHN6,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; carboxy-lyase activity [GO:0016831]; pyridoxal phosphate binding [GO:0030170]; sphinganine-1-phosphate aldolase activity [GO:0008117]; ameboidal-type cell migration [GO:0001667]; androgen metabolic process [GO:0008209]; apoptotic signaling pathway [GO:0097190]; ceramide metabolic process [GO:0006672]; estrogen metabolic process [GO:0008210]; face morphogenesis [GO:0060325]; fatty acid metabolic process [GO:0006631]; fibroblast migration [GO:0010761]; hemopoiesis [GO:0030097]; kidney development [GO:0001822]; Leydig cell differentiation [GO:0033327]; luteinization [GO:0001553]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; post-embryonic development [GO:0009791]; regulation of multicellular organism growth [GO:0040014]; roof of mouth development [GO:0060021]; skeletal system morphogenesis [GO:0048705]; spermatogenesis [GO:0007283]; sphingolipid catabolic process [GO:0030149]; sphingolipid metabolic process [GO:0006665]; vasculogenesis [GO:0001570],NA,NA,NA
CHOYP_SGPP1.1.1.m.5606,-0.00800965427144675,0.0133163586413281,No,NA,NA,Q99P55,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; hydrolase activity [GO:0016787],NA,NA,NA
CHOYP_SH3KBP1.1.1.m.30545,-0.00304901354538716,-0.0008764288212813,No,NA,NA,Q96B97,NA,NA,NA,cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; focal adhesion [GO:0005925]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]; SH3 domain binding [GO:0017124]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; cell migration [GO:0016477]; cell-cell signaling [GO:0007267]; cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; membrane organization [GO:0061024]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SH3L1.2.5.m.9176,-0.0104025862431941,0.0172199157026025,No,NA,NA,Q9NFP5,NA,NA,NA,SH3 domain binding [GO:0017124],NA,NA,NA
CHOYP_SHD.1.1.m.20907,0.00934807879023582,-0.00614158348656489,No,NA,NA,Q8CG80,NA,NA,NA,phosphotyrosine residue binding [GO:0001784]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHEP.1.1.m.27990,0.000191993486285766,-0.000584143770359093,No,NA,NA,Q5RBD3,NA,NA,NA,cytoplasm [GO:0005737]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_SHLB1.2.2.m.54016,-0.00622632076734238,0.00568884148191526,No,NA,NA,Q5ZIR1,NA,NA,NA,Golgi membrane [GO:0000139]; mitochondrial outer membrane [GO:0005741]; lipid binding [GO:0008289]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_SHMT2.1.1.m.10572,-0.00216874744646549,0.000620147192793745,No,NA,NA,P34897,NA,NA,NA,BRISC complex [GO:0070552]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule cytoskeleton [GO:0015630]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; amino acid binding [GO:0016597]; chromatin binding [GO:0003682]; cobalt ion binding [GO:0050897]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; L-allo-threonine aldolase activity [GO:0008732]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; zinc ion binding [GO:0008270]; cellular response to tetrahydrofolate [GO:1904482]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine biosynthetic process [GO:0006564]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; one-carbon metabolic process [GO:0006730]; positive regulation of cell proliferation [GO:0008284]; protein homotetramerization [GO:0051289]; protein K63-linked deubiquitination [GO:0070536]; protein tetramerization [GO:0051262]; regulation of aerobic respiration [GO:1903715]; regulation of mitochondrial translation [GO:0070129]; regulation of oxidative phosphorylation [GO:0002082]; response to type I interferon [GO:0034340]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],NA,NA,NA
CHOYP_SHROOM3.1.1.m.15543,0.00746146878489595,0.00686217133780289,No,NA,NA,Q27IV2,NA,NA,NA,adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; microtubule [GO:0005874]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; apical protein localization [GO:0045176]; cell morphogenesis [GO:0000902]; cellular pigment accumulation [GO:0043482]; epithelial cell development [GO:0002064]; neural tube closure [GO:0001843]; pattern specification process [GO:0007389]; regulation of cell shape [GO:0008360],NA,NA,NA
CHOYP_SI_CH211.197G15.10.6.7.m.50389,-0.00235915788289414,0.00105089937846252,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.197G15.7.3.3.m.61063,0.020524907650966,-0.00186162368871008,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_CH211.250G4.3.1.2.m.7118,0.000556804216254638,-0.00175110364563943,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.21N12.1.1.1.m.65205,-0.00793444498524461,-0.00205306927715099,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEY.5N18.1.1.2.m.5489,-0.0182804991534487,0.0147036659454633,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI_DKEYP.75B4.10.2.2.m.54469,-0.00681996746818036,-0.00710777380542562,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SI1L1.1.2.m.7671,-0.00489254630485522,2.87721371971743e-05,No,NA,NA,Q80TE4,NA,NA,NA,GTPase activator activity [GO:0005096]; regulation of small GTPase mediated signal transduction [GO:0051056],NA,NA,NA
CHOYP_SIK3.1.1.m.8214,0.00615360207828494,-0.00639062290329513,No,NA,NA,Q6P4S6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; tau-protein kinase activity [GO:0050321]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; endochondral ossification [GO:0001958]; intracellular signal transduction [GO:0035556]; limb morphogenesis [GO:0035108]; microtubule cytoskeleton organization [GO:0000226]; multicellular organism growth [GO:0035264]; protein phosphorylation [GO:0006468]; regulation of protein localization [GO:0032880]; skeletal system morphogenesis [GO:0048705],NA,NA,NA
CHOYP_SIP.1.1.m.5724,-0.000957611344558521,-0.00454947171587087,No,NA,NA,Q3T168,NA,NA,NA,beta-catenin destruction complex [GO:0030877]; cytosol [GO:0005829]; nuclear envelope lumen [GO:0005641]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SCF ubiquitin ligase complex [GO:0019005]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; cellular response to leukemia inhibitory factor [GO:1990830]; heart development [GO:0007507],NA,NA,NA
CHOYP_SIRT1.1.1.m.9844,0.00405750631972978,0.0270334322726391,No,NA,NA,Q923E4,NA,NA,NA,axon [GO:0030424]; chromatin [GO:0000785]; chromatin silencing complex [GO:0005677]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ESC/E(Z) complex [GO:0035098]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; nuclear chromatin [GO:0000790]; nuclear envelope [GO:0005635]; nuclear euchromatin [GO:0005719]; nuclear heterochromatin [GO:0005720]; nuclear inner membrane [GO:0005637]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; rDNA heterochromatin [GO:0033553]; bHLH transcription factor binding [GO:0043425]; deacetylase activity [GO:0019213]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; histone binding [GO:0042393]; histone deacetylase activity [GO:0004407]; HLH domain binding [GO:0043398]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; metal ion binding [GO:0046872]; mitogen-activated protein kinase binding [GO:0051019]; NAD+ binding [GO:0070403]; NAD-dependent histone deacetylase activity [GO:0017136]; NAD-dependent histone deacetylase activity (H3-K9 specific) [GO:0046969]; NAD-dependent protein deacetylase activity [GO:0034979]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein C-terminus binding [GO:0008022]; protein deacetylase activity [GO:0033558]; protein domain specific binding [GO:0019904]; protein kinase B binding [GO:0043422]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; angiogenesis [GO:0001525]; behavioral response to starvation [GO:0042595]; cellular glucose homeostasis [GO:0001678]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to starvation [GO:0009267]; cellular response to tumor necrosis factor [GO:0071356]; cellular triglyceride homeostasis [GO:0035356]; cholesterol homeostasis [GO:0042632]; chromatin organization [GO:0006325]; chromatin silencing at rDNA [GO:0000183]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA synthesis involved in DNA repair [GO:0000731]; energy homeostasis [GO:0097009]; establishment of chromatin silencing [GO:0006343]; fatty acid homeostasis [GO:0055089]; histone deacetylation [GO:0016575]; histone H3 deacetylation [GO:0070932]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; leptin-mediated signaling pathway [GO:0033210]; macrophage cytokine production [GO:0010934]; macrophage differentiation [GO:0030225]; maintenance of chromatin silencing [GO:0006344]; muscle organ development [GO:0007517]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP-dependent protein kinase activity [GO:2000480]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cellular response to testosterone stimulus [GO:2000655]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of gene expression [GO:0010629]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of helicase activity [GO:0051097]; negative regulation of histone H3-K14 acetylation [GO:0071441]; negative regulation of histone H3-K9 trimethylation [GO:1900113]; negative regulation of histone H4-K16 acetylation [GO:2000619]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of peptidyl-lysine acetylation [GO:2000757]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of tumor necrosis factor production [GO:0032720]; ovulation from ovarian follicle [GO:0001542]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine deacetylation [GO:0034983]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel diameter [GO:0097755]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular senescence [GO:2000774]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of chromatin silencing [GO:0031937]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA repair [GO:0045739]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of heart rate [GO:0010460]; positive regulation of histone H3-K9 methylation [GO:0051574]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of macroautophagy [GO:0016239]; positive regulation of macrophage apoptotic process [GO:2000111]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of thyroid-stimulating hormone secretion [GO:2000614]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deacetylation [GO:0006476]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; pyrimidine dimer repair by nucleotide-excision repair [GO:0000720]; regulation of apoptotic process [GO:0042981]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell proliferation [GO:0042127]; regulation of endodeoxyribonuclease activity [GO:0032071]; regulation of glucose metabolic process [GO:0010906]; regulation of lipid storage [GO:0010883]; regulation of mitotic cell cycle [GO:0007346]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; regulation of protein import into nucleus; translocation [GO:0033158]; regulation of protein serine/threonine kinase activity [GO:0071900]; regulation of smooth muscle cell apoptotic process [GO:0034391]; response to ethanol [GO:0045471]; response to hydrogen peroxide [GO:0042542]; response to insulin [GO:0032868]; response to leptin [GO:0044321]; response to oxidative stress [GO:0006979]; rRNA processing [GO:0006364]; single strand break repair [GO:0000012]; spermatogenesis [GO:0007283]; stress-induced premature senescence [GO:0090400]; transforming growth factor beta receptor signaling pathway [GO:0007179]; triglyceride mobilization [GO:0006642]; UV-damage excision repair [GO:0070914]; white fat cell differentiation [GO:0050872],NA,NA,NA
CHOYP_SIX1.1.2.m.49270,-0.0104819007001185,-0.00667065573113818,No,NA,NA,Q27350,NA,NA,NA,nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anatomical structure development [GO:0048856]; Bolwig's organ morphogenesis [GO:0001746]; circadian rhythm [GO:0007623]; compound eye development [GO:0048749]; compound eye morphogenesis [GO:0001745]; entrainment of circadian clock [GO:0009649]; eye-antennal disc morphogenesis [GO:0007455]; glial cell migration [GO:0008347]; negative regulation of transcription; DNA-templated [GO:0045892]; optic lobe placode formation [GO:0001744]; positive regulation of transcription by RNA polymerase II [GO:0045944]; ring gland development [GO:0035271]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SK2L2.1.1.m.35679,-0.000719200519917466,-0.000958645549169861,No,NA,NA,P42285,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAMP complex [GO:0031499]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; maturation of 5.8S rRNA [GO:0000460]; mRNA splicing; via spliceosome [GO:0000398]; RNA catabolic process [GO:0006401]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_SKAP2.1.1.m.63022,0.0148730518157223,-0.010286729736766,No,NA,NA,Q6PG29,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; B cell activation [GO:0042113],NA,NA,NA
CHOYP_SKIV2L.3.4.m.25390,-0.00560099936801148,0.00531634017879086,No,NA,NA,Q15477,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay [GO:0043928]; nuclear-transcribed mRNA catabolic process; 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SLAI2.1.2.m.8777,-0.0116615056206252,-0.00883613224949646,No,NA,NA,Q3MHV6,NA,NA,NA,cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630]; cytoplasmic microtubule organization [GO:0031122]; microtubule nucleation [GO:0007020]; positive regulation of microtubule polymerization [GO:0031116],NA,NA,NA
CHOYP_SLC31.5.5.m.57886,-0.00311433148098561,0.00196087975484008,No,NA,NA,Q91WV7,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; mitochondrial inner membrane [GO:0005743]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC34A2.1.2.m.9501,0.000767019863701389,-0.000269668441703984,No,NA,NA,Q9DBP0,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; vesicle [GO:0031982]; phosphate ion binding [GO:0042301]; protein domain specific binding [GO:0019904]; sodium ion binding [GO:0031402]; sodium-dependent phosphate transmembrane transporter activity [GO:0015321]; sodium:phosphate symporter activity [GO:0005436]; cellular phosphate ion homeostasis [GO:0030643]; in utero embryonic development [GO:0001701]; phosphate ion transport [GO:0006817]; response to estrogen [GO:0043627]; sodium-dependent phosphate transport [GO:0044341],NA,NA,NA
CHOYP_SLC3A1.1.1.m.14892,-0.00196586669446336,-0.00163996557566275,No,NA,NA,Q64319,NA,NA,NA,brush border membrane [GO:0031526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774]; catalytic activity [GO:0003824]; protein heterodimerization activity [GO:0046982]; amino acid transport [GO:0006865]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_SLC40A1.1.1.m.55100,-1.35184477888123e-05,0.00380004915981844,No,NA,NA,Q9JHI9,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; synaptic vesicle [GO:0008021]; ferrous iron transmembrane transporter activity [GO:0015093]; identical protein binding [GO:0042802]; iron channel activity [GO:0097689]; iron ion transmembrane transporter activity [GO:0005381]; peptide hormone binding [GO:0017046]; cellular iron ion homeostasis [GO:0006879]; endothelium development [GO:0003158]; iron ion export across plasma membrane [GO:1903988]; iron ion homeostasis [GO:0055072]; iron ion transmembrane transport [GO:0034755]; iron ion transport [GO:0006826]; lymphocyte homeostasis [GO:0002260]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of apoptotic process [GO:0043066]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription from RNA polymerase II promoter in response to iron [GO:0034395]; spleen development [GO:0048536]; spleen trabecula formation [GO:0060345],NA,NA,NA
CHOYP_SLC6A14.1.1.m.43828,-0.0106978505980121,0.004462554490801,No,NA,NA,Q9Y345,NA,NA,NA,glycinergic synapse [GO:0098690]; integral component of membrane [GO:0016021]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]; glycine:sodium symporter activity [GO:0015375]; metal ion binding [GO:0046872]; chemical synaptic transmission [GO:0007268]; glycine import across plasma membrane [GO:1903804]; synaptic transmission; glycinergic [GO:0060012],NA,NA,NA
CHOYP_SLK.1.1.m.59382,-0.00041623904349164,0.00118297906273388,No,NA,NA,Q7SY52,NA,NA,NA,cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activity [GO:0004674]; activation of protein kinase activity [GO:0032147]; cell cycle [GO:0007049]; protein autophosphorylation [GO:0046777]; regulation of lymphocyte migration [GO:2000401]; signal transduction by protein phosphorylation [GO:0023014]; stress-activated protein kinase signaling cascade [GO:0031098],NA,NA,NA
CHOYP_SLMAP.2.8.m.897,-0.00963429821938011,-0.00737407810435519,No,NA,NA,Q14BN4,NA,NA,NA,integral component of plasma membrane [GO:0005887]; microtubule organizing center [GO:0005815]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; muscle contraction [GO:0006936]; protein localization to plasma membrane [GO:0072659]; regulation of membrane depolarization during cardiac muscle cell action potential [GO:1900825]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of voltage-gated sodium channel activity [GO:1905150],NA,NA,NA
CHOYP_SLX4.1.1.m.278,0.00369472594469123,-0.00670771068139046,No,NA,NA,Q8IY92,NA,NA,NA,cell junction [GO:0030054]; chromosome; telomeric region [GO:0000781]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; Slx1-Slx4 complex [GO:0033557]; 5'-flap endonuclease activity [GO:0017108]; endodeoxyribonuclease activity [GO:0004520]; enzyme activator activity [GO:0008047]; DNA double-strand break processing involved in repair via single-strand annealing [GO:0010792]; DNA repair [GO:0006281]; DNA replication [GO:0006260]; double-strand break repair via homologous recombination [GO:0000724]; interstrand cross-link repair [GO:0036297]; meiotic DNA double-strand break processing [GO:0000706]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; nucleotide-excision repair [GO:0006289]; positive regulation of t-circle formation [GO:1904431]; resolution of meiotic recombination intermediates [GO:0000712]; response to intra-S DNA damage checkpoint signaling [GO:0072429]; t-circle formation [GO:0090656]; telomeric D-loop disassembly [GO:0061820],NA,NA,NA
CHOYP_SMAD1.2.2.m.60397,-0.0207903774327406,0.00182102189163196,No,NA,NA,Q5R6H7,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; transcription factor complex [GO:0005667]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac muscle contraction [GO:0060048]; cartilage development [GO:0051216]; cellular response to organic cyclic compound [GO:0071407]; embryonic pattern specification [GO:0009880]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast fate commitment [GO:0002051]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; protein phosphorylation [GO:0006468]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD3.1.1.m.51679,0.00266045215229155,-0.0194871861000541,No,NA,NA,P84025,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear chromatin [GO:0000790]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription factor complex [GO:0005667]; beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; enzyme binding [GO:0019899]; glucocorticoid receptor binding [GO:0035259]; mineralocorticoid receptor binding [GO:0031962]; phosphatase binding [GO:0019902]; primary miRNA binding [GO:0070878]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; proximal promoter sequence-specific DNA binding [GO:0000987]; R-SMAD binding [GO:0070412]; RNA polymerase II activating transcription factor binding [GO:0001102]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; SMAD binding [GO:0046332]; transcription coregulator activity [GO:0003712]; transcription factor binding [GO:0008134]; transforming growth factor beta receptor binding [GO:0005160]; transforming growth factor beta receptor; pathway-specific cytoplasmic mediator activity [GO:0030618]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:0097296]; adrenal gland development [GO:0030325]; cell cycle arrest [GO:0007050]; cell-cell junction organization [GO:0045216]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; evasion or tolerance of host defenses by virus [GO:0019049]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; protein stabilization [GO:0050821]; regulation of binding [GO:0051098]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],NA,NA,NA
CHOYP_SMAD4.3.4.m.13408,0.00269721883826374,0.016840217678033,No,NA,NA,Q1HE26,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872]; transforming growth factor beta receptor signaling pathway [GO:0007179],NA,NA,NA
CHOYP_SMARCA5.1.1.m.31708,-0.0104668242484058,0.008660521878783,No,NA,NA,O60264,NA,NA,NA,chromatin silencing complex [GO:0005677]; condensed chromosome [GO:0000793]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NURF complex [GO:0016589]; RSF complex [GO:0031213]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; helicase activity [GO:0004386]; nucleosome binding [GO:0031491]; ATP-dependent chromatin remodeling [GO:0043044]; cellular response to leukemia inhibitory factor [GO:1990830]; CENP-A containing nucleosome assembly [GO:0034080]; chromatin remodeling [GO:0006338]; chromatin silencing at rDNA [GO:0000183]; DNA-templated transcription; initiation [GO:0006352]; nucleosome assembly [GO:0006334]; nucleosome positioning [GO:0016584]; positive regulation of gene expression; epigenetic [GO:0045815]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMC.3.5.m.51502,0.00591008704841803,-0.0107296602281375,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMC2.1.4.m.17836,-0.00644436264752242,0.004223944624571,No,NA,NA,P50533,NA,NA,NA,chromosome [GO:0005694]; cytosol [GO:0005829]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome condensation [GO:0030261],NA,NA,NA
CHOYP_SMC2.1.4.m.17837,0.00262958048937583,-0.00071058775433196,No,NA,NA,Q6Q0C0,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; intracellular membrane-bounded organelle [GO:0043231]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; activation of MAPKKK activity [GO:0000185]; apoptotic process [GO:0006915]; Notch signaling pathway [GO:0007219]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of MAPK cascade [GO:0043410]; protein ubiquitination [GO:0016567]; ribosomal large subunit assembly [GO:0000027],NA,NA,NA
CHOYP_SMC3.1.1.m.65133,-0.0053457507381769,-0.00291718604695146,No,NA,NA,O93309,NA,NA,NA,chromatin [GO:0000785]; chromosome; centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; regulation of DNA replication [GO:0006275],NA,NA,NA
CHOYP_SMCA4.1.1.m.54020,-0.00312701647040471,-0.00105989995328097,No,NA,NA,A7Z019,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; chromatin binding [GO:0003682]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; ATP-dependent chromatin remodeling [GO:0043044]; nervous system development [GO:0007399]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_SMG1.1.1.m.46694,0.00556282782623039,0.00441828376771371,No,NA,NA,Q8BKX6,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162]; DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; peptidyl-serine phosphorylation [GO:0018105]; phosphatidylinositol phosphorylation [GO:0046854]; protein autophosphorylation [GO:0046777]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of telomere maintenance [GO:0032204],NA,NA,NA
CHOYP_SMG5.1.1.m.21320,0.00423371862839357,0.00224709108063983,No,NA,NA,Q6ZPY2,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; histone deacetylase binding [GO:0042826]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; ubiquitin protein ligase binding [GO:0031625]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of dephosphorylation [GO:0035303]; regulation of RNA stability [GO:0043487]; regulation of telomere maintenance [GO:0032204]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG7.1.1.m.21983,-0.00771466715538027,-0.00400808443985458,No,NA,NA,Q5RJH6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; telomerase holoenzyme complex [GO:0005697]; protein phosphatase 2A binding [GO:0051721]; ribonuclease activity [GO:0004540]; ribonucleoprotein complex binding [GO:0043021]; telomerase RNA binding [GO:0070034]; telomeric DNA binding [GO:0042162]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of RNA stability [GO:0043487]; telomere maintenance via telomerase [GO:0007004],NA,NA,NA
CHOYP_SMG9.1.1.m.2906,0.00306601108227413,-0.000828523765867771,No,NA,NA,B5X165,NA,NA,NA,nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184],NA,NA,NA
CHOYP_SMHD1.1.1.m.47344,0.00758928714826551,0.00372690946778666,No,NA,NA,Q6P5D8,NA,NA,NA,Barr body [GO:0001740]; nuclear chromosome; telomeric region [GO:0000784]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; dosage compensation by inactivation of X chromosome [GO:0009048]; double-strand break repair [GO:0006302]; heterochromatin organization involved in chromatin silencing [GO:0070868]; inactivation of X chromosome by DNA methylation [GO:0060821]; inactivation of X chromosome by heterochromatin assembly [GO:0060820]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],NA,NA,NA
CHOYP_SMOX.1.2.m.3830,-0.00378041286220013,0.00752577277197115,No,NA,NA,Q99K82,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity [GO:0052895]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208],NA,NA,NA
CHOYP_SMP_001000.1.1.m.39561,-0.0143594946867001,-0.0129040846067169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_005500.1.1.m.34627,-0.0025865682060068,0.00351146488026297,No,NA,NA,Q95ZJ1,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653]; protein O-linked glycosylation via threonine [GO:0018243],NA,NA,NA
CHOYP_SMP_006860.2.1.4.m.8660,0.00346615269168927,-0.00164607327054537,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_006860.2.2.4.m.24582,0.00685447475055478,-0.0128858556757134,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_006860.2.3.4.m.63036,-0.00552714111880425,0.0020954033529342,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_012720.1.2.m.31152,0.011064310201429,-0.0335416560067794,No,NA,NA,Q9WUM3,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_012720.2.2.m.34968,0.00340486049489618,-0.001584438922661,No,NA,NA,Q9WUM3,NA,NA,NA,actin filament [GO:0005884]; cell leading edge [GO:0031252]; cell periphery [GO:0071944]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; lamellipodium [GO:0030027]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; stress fiber [GO:0001725]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament bundle assembly [GO:0051017]; cell migration [GO:0016477]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; endothelial cell chemotaxis [GO:0035767]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; negative regulation of lamellipodium morphogenesis [GO:2000393]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; positive regulation of lamellipodium morphogenesis [GO:2000394]; protein kinase C signaling [GO:0070528]; protein localization to cell leading edge [GO:1902463]; ruffle organization [GO:0031529]; wound healing [GO:0042060],NA,NA,NA
CHOYP_SMP_039300.1.1.m.1202,0.00055122229646309,-0.00355871182335686,No,NA,NA,F7H9X2,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; regulation of neuron apoptotic process [GO:0043523],NA,NA,NA
CHOYP_SMP_043120.1.1.m.12494,-0.0136767693812634,-0.0282354589688516,No,NA,NA,Q49YE0,NA,NA,NA,cytoplasm [GO:0005737],NA,NA,NA
CHOYP_SMP_045300.1.1.m.927,-0.000982968835023561,-0.000103323919809778,No,NA,NA,A1ZA47,NA,NA,NA,actin cytoskeleton [GO:0015629]; apical part of cell [GO:0045177]; basal part of cell [GO:0045178]; basolateral plasma membrane [GO:0016323]; cell leading edge [GO:0031252]; focal adhesion [GO:0005925]; muscle tendon junction [GO:0005927]; stress fiber [GO:0001725]; Z disc [GO:0030018]; zonula adherens [GO:0005915]; actin binding [GO:0003779]; actinin binding [GO:0042805]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; muscle structure development [GO:0061061]; myofibril assembly [GO:0030239]; regulation of cell-matrix adhesion [GO:0001952],NA,NA,NA
CHOYP_SMP_048560.1.2.m.58825,-0.0300160788130121,0.012561824263233,No,NA,NA,O35115,NA,NA,NA,M band [GO:0031430]; nucleus [GO:0005634]; Z disc [GO:0030018]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; transcription factor binding [GO:0008134]; atrial cardiac muscle cell development [GO:0055014]; heart trabecula formation [GO:0060347]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; response to hormone [GO:0009725]; ventricular cardiac muscle cell development [GO:0055015],NA,NA,NA
CHOYP_SMP_051990.1.7.m.327,0.000544307521545863,-0.00326157360755117,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.2.7.m.611,0.00164701222194692,-0.00134308639518607,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_051990.4.7.m.9424,0.00209465202374,0.000923925490017736,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.5.7.m.43424,-0.000324558445932407,0.00055818671510177,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_051990.7.7.m.57569,0.00223431810149774,-0.000225358969656123,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_076400.2.2.m.49169,-0.010520278463867,0.0042147094355381,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_078690.3.5.m.2272,0.00234247652807237,-0.000380192967809891,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_SMP_078690.4.5.m.41580,-0.00425595206112917,-0.0201980834839641,No,NA,NA,P37801,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_078690.5.5.m.64878,0.00396537677567554,-0.00463748947183281,No,NA,NA,P37397,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; microtubule [GO:0005874]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; actin binding [GO:0003779]; calmodulin binding [GO:0005516]; microtubule binding [GO:0008017]; protein binding; bridging [GO:0030674]; actomyosin structure organization [GO:0031032]; epithelial cell differentiation [GO:0030855]; negative regulation of ATPase activity [GO:0032780],NA,NA,NA
CHOYP_SMP_082940.1.1.m.3343,-0.00878946765826466,0.000832918163841568,No,NA,NA,Q9N2W7,NA,NA,NA,mitochondrial respiratory chain complex I [GO:0005747]; mitochondrion [GO:0005739]; electron transfer activity [GO:0009055]; NADH dehydrogenase (ubiquinone) activity [GO:0008137]; response to oxidative stress [GO:0006979],NA,NA,NA
CHOYP_SMP_087250.2.2.m.25167,0.00273020904146254,-0.00163295307098761,No,NA,NA,P97314,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_SMP_089460.1.1.1.m.34779,0.000281042622178575,0.00099438237688377,No,NA,NA,Q9VT65,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_SMP_102490.1.2.m.22219,0.0101945221482789,0.00898611403772209,No,NA,NA,P0C2C1,NA,NA,NA,mitochondrial large ribosomal subunit [GO:0005762]; mitochondrion [GO:0005739]; structural constituent of ribosome [GO:0003735]; translation [GO:0006412],NA,NA,NA
CHOYP_SMP_105540.1.1.m.40275,-0.00787916057179443,0.0133566049387381,No,NA,NA,Q8JZW5,NA,NA,NA,cell junction [GO:0030054]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211],NA,NA,NA
CHOYP_SMP_137640.1.2.m.40559,0.0213857291028571,0.0127120864117626,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_SMP_140370.1.1.m.35365,-0.033851030288925,0.026662236367116,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_143090.1.1.m.6805,-0.00479419181837274,0.00165987766017624,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_147320.1.1.m.27463,-8.3336176981612e-05,0.0110567053298226,No,NA,NA,Q96M20,NA,NA,NA,cytosol [GO:0005829]; cAMP binding [GO:0030552]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148160.1.1.m.11635,-0.0277875204788709,0.0217398548024329,No,NA,NA,Q9NWH7,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SMP_148530.1.1.m.18051,0.00613348304293116,0.00206814442450046,No,NA,NA,P12812,NA,NA,NA,,NA,NA,NA
CHOYP_SMP_149390.1.1.m.8819,-0.0103213179148313,-0.00143885601049519,No,NA,NA,Q8C419,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor signaling pathway [GO:0007186]; protein localization to plasma membrane [GO:0072659],NA,NA,NA
CHOYP_SMP_149990.1.1.1.m.44960,-0.00344644513805743,0.00738152224057383,No,NA,NA,Q0E908,NA,NA,NA,cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_SMP_158990.1.1.m.28205,-0.0257434954051734,-0.0123132524440917,No,NA,NA,P36609,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_SMP_159010.1.1.1.m.56000,-0.00233193278255767,-0.00417958210070059,No,NA,NA,P26818,NA,NA,NA,ATP binding [GO:0005524]; beta-adrenergic receptor kinase activity [GO:0047696]; G protein-coupled receptor kinase activity [GO:0004703]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_SMP_159780.1.2.m.41665,0.00508569142434501,0.00644113995863716,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_168770.1.1.m.18618,-0.0216730414696392,0.00947247820231496,No,NA,NA,Q9VF08,NA,NA,NA,TIM23 mitochondrial import inner membrane translocase complex [GO:0005744]; instar larval development [GO:0002168]; protein import into mitochondrial matrix [GO:0030150],NA,NA,NA
CHOYP_SMP_171550.1.1.m.44645,-0.0305070311115414,0.0225106480965166,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SMP_173720.2.3.m.52988,0.00150400902491813,-0.0166599117420951,No,NA,NA,Q8CIR4,NA,NA,NA,apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; integral component of membrane [GO:0016021]; ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; metal ion transport [GO:0030001]; protein tetramerization [GO:0051262]; response to toxic substance [GO:0009636],NA,NA,NA
CHOYP_SMP_176410.1.1.m.18565,0.00392340151430025,-0.000315390660051563,No,NA,NA,Q9UJT9,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; ubiquitin ligase complex [GO:0000151]; ubiquitin-protein transferase activity [GO:0004842]; cell division [GO:0051301]; cell proliferation [GO:0008283]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; post-translational protein modification [GO:0043687]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF complex assembly [GO:0010265]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SMP_194720.1.1.m.53496,0.00265301094355773,-9.53772929765482e-05,No,NA,NA,O02485,NA,NA,NA,,NA,NA,NA
CHOYP_SMRC2.2.2.m.49912,-0.00128713428027575,-0.00316841270008764,No,NA,NA,Q8TAQ2,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SMRD1.1.2.m.1725,-0.00077191874089356,-0.0107648288744505,No,NA,NA,Q61466,NA,NA,NA,intracellular membrane-bounded organelle [GO:0043231]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SWI/SNF complex [GO:0016514]; chromatin binding [GO:0003682]; protein-containing complex scaffold activity [GO:0032947]; signaling receptor binding [GO:0005102]; cellular response to fatty acid [GO:0071398]; chromatin remodeling [GO:0006338]; chromatin-mediated maintenance of transcription [GO:0048096]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337],NA,NA,NA
CHOYP_SMU1.1.1.m.58635,-0.00492208053998169,-0.000172407369447217,No,NA,NA,Q6NRT3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SMYD5.1.1.m.27234,0.0199877446093588,-0.00779352129523821,No,NA,NA,Q5ZIZ2,NA,NA,NA,metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168],NA,NA,NA
CHOYP_SNF1A.1.1.m.52779,-0.00227615874542696,-0.000132787649985347,No,NA,NA,P54646,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; [acetyl-CoA carboxylase] kinase activity [GO:0050405]; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity [GO:0047322]; AMP-activated protein kinase activity [GO:0004679]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; histone serine kinase activity [GO:0035174]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; cell cycle arrest [GO:0007050]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to glucose starvation [GO:0042149]; cellular response to glucose stimulus [GO:0071333]; cellular response to nutrient levels [GO:0031669]; cellular response to oxidative stress [GO:0034599]; cellular response to prostaglandin E stimulus [GO:0071380]; cholesterol biosynthetic process [GO:0006695]; energy homeostasis [GO:0097009]; fatty acid biosynthetic process [GO:0006633]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; intracellular signal transduction [GO:0035556]; lipid biosynthetic process [GO:0008610]; macroautophagy [GO:0016236]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of TOR signaling [GO:0032007]; negative regulation of tubulin deacetylation [GO:1904428]; positive regulation of autophagy [GO:0010508]; positive regulation of cellular protein localization [GO:1903829]; positive regulation of glycolytic process [GO:0045821]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-lysine acetylation [GO:2000758]; protein phosphorylation [GO:0006468]; regulation of circadian rhythm [GO:0042752]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of macroautophagy [GO:0016241]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of stress granule assembly [GO:0062028]; response to muscle activity [GO:0014850]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_SNUT2.1.1.m.19264,-0.00771254075265673,0.00389623532741436,No,NA,NA,Q3TIX9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398]; protein deubiquitination [GO:0016579]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SNW1.2.2.m.19563,-0.000932579509565618,0.00180768743291072,No,NA,NA,Q5R7R9,NA,NA,NA,nuclear matrix [GO:0016363]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; nuclear hormone receptor binding [GO:0035257]; retinoic acid receptor binding [GO:0042974]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; vitamin D receptor binding [GO:0042809]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of vitamin D receptor signaling pathway [GO:0070562]; retinoic acid receptor signaling pathway [GO:0048384],NA,NA,NA
CHOYP_SNX2.1.1.m.25425,-0.000796587567951305,8.16301148081266e-05,No,NA,NA,O60749,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer; tubulation complex [GO:0030905]; cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459]; early endosome to Golgi transport [GO:0034498]; endocytosis [GO:0006897]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; protein complex oligomerization [GO:0051259]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_SODM.1.2.m.45531,0.000880180840231456,0.000906508156977129,No,NA,NA,P41976,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; manganese ion binding [GO:0030145]; metal ion binding [GO:0046872]; superoxide dismutase activity [GO:0004784]; age-dependent response to reactive oxygen species [GO:0001315]; aging [GO:0007568]; regulation of transcription by RNA polymerase II [GO:0006357]; superoxide metabolic process [GO:0006801],NA,NA,NA
CHOYP_SODM.2.2.m.62946,0.0306706107428036,0.0256736093313765,No,NA,NA,Q28709,NA,NA,NA,cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intrinsic component of plasma membrane [GO:0031226]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; multivesicular body membrane [GO:0032585]; multivesicular body; internal vesicle [GO:0097487]; cell migration [GO:0016477]; cell-matrix adhesion [GO:0007160]; endosome to melanosome transport [GO:0035646]; pigment granule maturation [GO:0048757]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; regulation of vascular endothelial growth factor signaling pathway [GO:1900746],NA,NA,NA
CHOYP_SON.1.3.m.26634,0.00191775875548673,0.00975675767049396,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_04G037735.1.1.m.52863,0.00544447205632638,0.00174249946763397,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SORBIDRAFT_06G032450.1.1.m.16356,0.00452816016860542,0.0145059726209889,No,NA,NA,Q7XR46,NA,NA,NA,peroxisome [GO:0005777]; flavin adenine dinucleotide binding [GO:0050660]; norspermine:oxygen oxidoreductase activity [GO:0052894]; oxidoreductase activity [GO:0016491]; polyamine oxidase activity [GO:0046592]; spermine:oxygen oxidoreductase (spermidine-forming) activity [GO:0052901]; polyamine catabolic process [GO:0006598]; spermine catabolic process [GO:0046208]; thermospermine catabolic process [GO:1903602],NA,NA,NA
CHOYP_SORL.1.3.m.4531,0.000282754413140254,0.0178443065030091,No,NA,NA,P98158,NA,NA,NA,apical plasma membrane [GO:0016324]; axon [GO:0030424]; brush border [GO:0005903]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; endosome [GO:0005768]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; protein-containing complex [GO:0032991]; calcium ion binding [GO:0005509]; drug binding [GO:0008144]; hemoglobin binding [GO:0030492]; hormone binding [GO:0042562]; low-density lipoprotein particle receptor binding [GO:0050750]; PDZ domain binding [GO:0030165]; protein-containing complex binding [GO:0044877]; SH3 domain binding [GO:0017124]; signaling receptor activity [GO:0038023]; steroid hormone receptor binding [GO:0035258]; aging [GO:0007568]; animal organ regeneration [GO:0031100]; coronary artery morphogenesis [GO:0060982]; endocytic hemoglobin import [GO:0020028]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; folate import across plasma membrane [GO:1904447]; hormone secretion [GO:0046879]; male gonad development [GO:0008584]; metal ion transport [GO:0030001]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of endopeptidase activity [GO:0010951]; neural tube closure [GO:0001843]; neuron projection arborization [GO:0140058]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endocytosis [GO:0045807]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of neurogenesis [GO:0050769]; positive regulation of oligodendrocyte progenitor proliferation [GO:0070447]; pulmonary artery morphogenesis [GO:0061156]; receptor-mediated endocytosis [GO:0006898]; response to drug [GO:0042493]; response to retinoic acid [GO:0032526]; response to vitamin D [GO:0033280]; response to X-ray [GO:0010165]; secondary heart field specification [GO:0003139]; sensory perception of sound [GO:0007605]; transcytosis [GO:0045056]; vagina development [GO:0060068]; ventricular compact myocardium morphogenesis [GO:0003223]; vitamin metabolic process [GO:0006766],NA,NA,NA
CHOYP_SORL.3.3.m.58779,0.00278436831032749,0.00401339499553285,No,NA,NA,O88307,NA,NA,NA,early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; integral component of membrane [GO:0016021]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; multivesicular body [GO:0005771]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; cell migration [GO:0016477]; cholesterol metabolic process [GO:0008203]; endocytosis [GO:0006897]; lipid transport [GO:0006869]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein oligomerization [GO:0032460]; negative regulation of tau-protein kinase activity [GO:1902948]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],NA,NA,NA
CHOYP_SOS1.1.1.m.52801,0.00993579886044799,-0.0130190054190487,No,NA,NA,Q07890,NA,NA,NA,cytosol [GO:0005829]; nucleosome [GO:0000786]; DNA binding [GO:0003677]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein heterodimerization activity [GO:0046982]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase mediated signal transduction [GO:0007264],NA,NA,NA
CHOYP_SOSB1.1.2.m.1668,-0.0107922652930668,-0.013521372919836,No,NA,NA,Q3SWT1,NA,NA,NA,nucleus [GO:0005634]; SOSS complex [GO:0070876]; single-stranded DNA binding [GO:0003697]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair via homologous recombination [GO:0000724]; mitotic cell cycle checkpoint [GO:0007093]; response to ionizing radiation [GO:0010212],NA,NA,NA
CHOYP_SOX2.1.2.m.31411,-0.0178096947882093,0.0141285870009391,No,NA,NA,P48430,NA,NA,NA,cell [GO:0005623]; cytosol [GO:0005829]; nuclear transcription factor complex [GO:0044798]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; miRNA binding [GO:0035198]; sequence-specific DNA binding [GO:0043565]; transcription regulatory region DNA binding [GO:0044212]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; central nervous system development [GO:0007417]; endodermal cell fate specification [GO:0001714]; eye development [GO:0001654]; forebrain development [GO:0030900]; inner ear development [GO:0048839]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; pituitary gland development [GO:0021983]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043281]; regulation of transcription; DNA-templated [GO:0006355]; response to growth factor [GO:0070848]; response to wounding [GO:0009611]; sensory organ precursor cell fate determination [GO:0016360]; somatic stem cell population maintenance [GO:0035019],NA,NA,NA
CHOYP_SP3.1.1.m.9839,-0.00295748365767725,0.00929976334973887,No,NA,NA,Q02446,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SPAG16.1.1.m.51927,-0.00826653744452194,-0.00421981738884616,No,NA,NA,Q8N0X2,NA,NA,NA,axonemal central apparatus [GO:1990716]; axoneme [GO:0005930]; sperm flagellum [GO:0036126]; axoneme assembly [GO:0035082]; cilium assembly [GO:0060271]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_SPAG7.1.1.m.66661,0.00359800753543896,-0.000972284402400596,No,NA,NA,Q7SYJ9,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_SPAT6.1.1.m.11699,0.00233734783388929,-0.000598456818518742,No,NA,NA,Q3U6K5,NA,NA,NA,extracellular region [GO:0005576]; sperm connecting piece [GO:0097224]; myosin light chain binding [GO:0032027]; cell differentiation [GO:0030154]; motile cilium assembly [GO:0044458]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPB3.1.1.m.31072,-0.0101978672216097,0.00278043990761734,No,NA,NA,Q5BIR5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; serine-type endopeptidase inhibitor activity [GO:0004867]; epithelial cell-cell adhesion [GO:0090136]; negative regulation of endopeptidase activity [GO:0010951],NA,NA,NA
CHOYP_SPCA.1.1.m.6746,0.00287279419941677,0.00339269604549026,No,NA,NA,P98194,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; trans-Golgi network [GO:0005802]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calcium-transporting ATPase activity [GO:0005388]; manganese ion binding [GO:0030145]; manganese-transporting ATPase activity [GO:0015410]; metal ion binding [GO:0046872]; proton-exporting ATPase activity; phosphorylative mechanism [GO:0008553]; actin cytoskeleton reorganization [GO:0031532]; ATP hydrolysis coupled cation transmembrane transport [GO:0099132]; calcium ion transmembrane transport [GO:0070588]; calcium ion transport [GO:0006816]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular calcium ion homeostasis [GO:0006874]; cellular manganese ion homeostasis [GO:0030026]; epidermis development [GO:0008544]; Golgi calcium ion homeostasis [GO:0032468]; Golgi calcium ion transport [GO:0032472]; manganese ion transport [GO:0006828]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_SPCS.1.1.m.65784,-0.00470253109043735,-0.0156902879510619,No,NA,NA,Q803A7,NA,NA,NA,cytoplasm [GO:0005737]; transferase activity; transferring selenium-containing groups [GO:0016785]; tRNA binding [GO:0000049]; selenocysteinyl-tRNA(Sec) biosynthetic process [GO:0097056]; translation [GO:0006412],NA,NA,NA
CHOYP_SPF45.1.1.m.22111,-0.00334467855647808,-0.0171435938559824,No,NA,NA,Q96I25,NA,NA,NA,nucleoplasm [GO:0005654]; spliceosomal complex [GO:0005681]; RNA binding [GO:0003723]; alternative mRNA splicing; via spliceosome [GO:0000380]; DNA repair [GO:0006281]; mRNA splicing; via spliceosome [GO:0000398]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_SPH127.1.1.m.56840,0.0169470546801272,0.015990394069365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.16.37.m.16200,0.00173277601684074,-0.00495422789031346,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.25.37.m.28547,-0.00589824879383082,0.00934702277468078,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.29.37.m.30551,0.00128649789555652,0.00433440185017636,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.30.37.m.30616,-0.0348964430535506,-0.0130945997737773,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPI2.8.37.m.4837,-0.00166772456271644,0.00544206215156483,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SPR.1.3.m.17978,-0.0108379460492983,0.0231390059147685,No,NA,NA,B0BML7,NA,NA,NA,cytoplasm [GO:0005737]; sepiapterin reductase activity [GO:0004757]; tetrahydrobiopterin biosynthetic process [GO:0006729],NA,NA,NA
CHOYP_SPR.2.3.m.21888,-3.84821048709463e-05,0.0154156663212006,No,NA,NA,Q8SWR3,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; G protein-coupled peptide receptor activity [GO:0008528]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of female receptivity; post-mating [GO:0045434]; regulation of post-mating oviposition [GO:0048042],NA,NA,NA
CHOYP_SPT20.1.1.m.35908,0.00127491823089821,9.36269489037814e-05,No,NA,NA,Q8TB22,NA,NA,NA,extracellular region [GO:0005576]; catalytic activity [GO:0003824]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SPT4H.1.1.m.40744,-0.00286497916375426,0.000467594483269684,No,NA,NA,Q6DGQ0,NA,NA,NA,DSIF complex [GO:0032044]; RNA polymerase II complex binding [GO:0000993]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription; elongation [GO:0032786],NA,NA,NA
CHOYP_SPT5H.1.1.m.60053,-0.00156636999169395,0.0013764137386582,No,NA,NA,O00267,NA,NA,NA,DSIF complex [GO:0032044]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; enzyme binding [GO:0019899]; mRNA binding [GO:0003729]; protein heterodimerization activity [GO:0046982]; RNA binding [GO:0003723]; 7-methylguanosine mRNA capping [GO:0006370]; negative regulation of DNA-templated transcription; elongation [GO:0032785]; negative regulation of mRNA polyadenylation [GO:1900364]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; positive regulation of macroautophagy [GO:0016239]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368],NA,NA,NA
CHOYP_SPT6H.1.1.m.55595,-0.00133937163484113,-0.00159821658830715,No,NA,NA,Q7KZ85,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023]; transcriptionally active chromatin [GO:0035327]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; histone binding [GO:0042393]; nucleosome binding [GO:0031491]; RNA binding [GO:0003723]; blastocyst formation [GO:0001825]; chromatin maintenance [GO:0070827]; chromatin remodeling [GO:0006338]; mRNA processing [GO:0006397]; mRNA transcription by RNA polymerase II [GO:0042789]; mRNA transport [GO:0051028]; negative regulation of histone H3-K27 methylation [GO:0061086]; nucleosome organization [GO:0034728]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968]; regulation of isotype switching [GO:0045191]; regulation of mRNA export from nucleus [GO:0010793]; regulation of mRNA processing [GO:0050684]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription; DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; transcription by RNA polymerase II [GO:0006366]; transcription elongation from RNA polymerase II promoter [GO:0006368]; viral process [GO:0016032],NA,NA,NA
CHOYP_SPTCA.1.2.m.1905,-0.00464137860752227,-0.00989029446794727,No,NA,NA,P13395,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SPTCA.2.2.m.25615,-0.00791509317541944,-0.00719349568876579,No,NA,NA,P13395,NA,NA,NA,basolateral plasma membrane [GO:0016323]; cell cortex [GO:0005938]; fusome [GO:0045169]; Golgi apparatus [GO:0005794]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; spectrin [GO:0008091]; spectrosome [GO:0045170]; actin binding [GO:0003779]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; cytoskeletal protein binding [GO:0008092]; microtubule binding [GO:0008017]; actin filament capping [GO:0051693]; axon midline choice point recognition [GO:0016199]; central nervous system development [GO:0007417]; fusome organization [GO:0045478]; germ-line cyst formation [GO:0048134]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; long-term strengthening of neuromuscular junction [GO:0042062]; maintenance of presynaptic active zone structure [GO:0048790]; negative regulation of microtubule depolymerization [GO:0007026]; neuromuscular synaptic transmission [GO:0007274]; oocyte construction [GO:0007308]; ovarian follicle cell development [GO:0030707]; plasma membrane organization [GO:0007009]; regulation of cell shape [GO:0008360]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_SQPA.2.2.m.61080,0.00251676053730848,-0.00570518900753888,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SR140.1.2.m.11983,-0.000252586241945245,-0.00676373241665345,No,NA,NA,Q6NV83,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA binding [GO:0003723]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_SRA1.1.1.m.56432,0.00379327691712234,-0.00102505176661736,No,NA,NA,Q80VJ2,NA,NA,NA,cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; microtubule cytoskeleton [GO:0015630]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; steroid hormone aporeceptor complex [GO:0005831]; transcription factor complex [GO:0005667]; DNA binding [GO:0003677]; nuclear receptor binding [GO:0016922]; nuclear receptor transcription coactivator activity [GO:0030374]; steroid receptor RNA activator RNA binding [GO:0002153]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; apoptotic process [GO:0006915]; cell differentiation [GO:0030154]; cell proliferation [GO:0008283]; cellular response to estrogen stimulus [GO:0071391]; negative regulation of myoblast differentiation [GO:0045662]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_SRAP.10.18.m.43353,-0.00304271020400619,0.00712540982116687,No,NA,NA,Q9Y4F5,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874],NA,NA,NA
CHOYP_SRAP.14.18.m.50950,-0.00310167120058344,-0.000812985400347829,No,NA,NA,Q9BRZ2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; RNA binding [GO:0003723]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; regulation of type I interferon production [GO:0032479]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_SRAP.16.18.m.58654,0.0205865093934224,0.0138958730407626,No,NA,NA,Q8K561,NA,NA,NA,anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226],NA,NA,NA
CHOYP_SRC.1.2.m.2503,0.00152065629808774,0.00126168463221811,No,NA,NA,Q9W596,NA,NA,NA,axon [GO:0030424]; cell projection [GO:0042995]; cytosol [GO:0005829]; dendrite [GO:0030425]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; microtubule cytoskeleton [GO:0015630]; neuronal cell body [GO:0043025]; synapse [GO:0045202]; actin binding [GO:0003779]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; tubulin binding [GO:0015631]; axo-dendritic transport [GO:0008088]; axonogenesis [GO:0007409]; compound eye development [GO:0048749]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; nervous system development [GO:0007399]; neurofilament cytoskeleton organization [GO:0060052]; neuromuscular junction development [GO:0007528]; olfactory learning [GO:0008355]; regulation of microtubule depolymerization [GO:0031114]; regulation of synaptic growth at neuromuscular junction [GO:0008582],NA,NA,NA
CHOYP_SRC1.1.1.m.63625,0.00742018677080352,-0.0134712200053557,No,NA,NA,P09324,NA,NA,NA,actin filament [GO:0005884]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; Golgi apparatus [GO:0005794]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; signaling receptor binding [GO:0005102]; cell differentiation [GO:0030154]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of glucose transmembrane transport [GO:0010827]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRC2.1.1.m.6537,0.00876140687488084,0.0103469961278027,No,NA,NA,Q9V9J3,NA,NA,NA,adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102]; actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure; spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion; thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic growth at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sevenless signaling pathway [GO:0045874]; protein phosphorylation [GO:0006468]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_SRCR12.1.1.m.53668,-8.3997738528158e-06,0.00159900152549783,No,NA,NA,Q9NR16,NA,NA,NA,external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; scavenger receptor activity [GO:0005044],NA,NA,NA
CHOYP_SREC2.7.9.m.44662,0.00491680529627927,0.00580662056771031,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SREC2.9.9.m.66799,0.00410148458937916,0.00389105877866365,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SRFB1.1.2.m.18320,-0.00291403726379195,0.00395602926217834,No,NA,NA,Q5XGC9,NA,NA,NA,90S preribosome [GO:0030686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; maturation of SSU-rRNA [GO:0030490],NA,NA,NA
CHOYP_SRP54.1.2.m.21986,-0.000725355914137807,-0.000967080425742523,No,NA,NA,P14576,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; drug binding [GO:0008144]; endoplasmic reticulum signal peptide binding [GO:0030942]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; ribonucleoprotein complex binding [GO:0043021]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP68.1.1.m.61852,-0.00140403132020388,0.00259106269273709,No,NA,NA,Q9UHB9,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; nucleolus [GO:0005730]; ribosome [GO:0005840]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; endoplasmic reticulum signal peptide binding [GO:0030942]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614],NA,NA,NA
CHOYP_SRP72.1.1.m.60789,-0.000747587876996181,-0.00133058608511687,No,NA,NA,O76094,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; signal recognition particle [GO:0048500]; signal recognition particle; endoplasmic reticulum targeting [GO:0005786]; 7S RNA binding [GO:0008312]; RNA binding [GO:0003723]; signal recognition particle binding [GO:0005047]; TPR domain binding [GO:0030911]; response to drug [GO:0042493]; SRP-dependent cotranslational protein targeting to membrane [GO:0006614]; SRP-dependent cotranslational protein targeting to membrane; translocation [GO:0006616],NA,NA,NA
CHOYP_SRPK2.1.1.m.5002,-0.000213871606430569,-0.000838896505620009,No,NA,NA,O70551,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; cell differentiation [GO:0030154]; chromosome segregation [GO:0007059]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of gene expression [GO:0010468]; regulation of mRNA processing [GO:0050684]; spliceosomal complex assembly [GO:0000245],NA,NA,NA
CHOYP_SRPX2.1.1.m.37317,-0.0027984368373172,-0.00899579608461604,No,NA,NA,Q8TER0,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_SRSF4.6.6.m.44673,-0.00564507142312695,-0.0276921387201226,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_SSPO.1.14.m.962,0.00151101786397043,0.00476220020793554,No,NA,NA,Q8CG65,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSPO.11.14.m.53093,-0.0178857596718985,0.00204576691084998,No,NA,NA,Q06852,NA,NA,NA,cell wall [GO:0005618]; extracellular region [GO:0005576]; S-layer [GO:0030115]; carbohydrate binding [GO:0030246]; polysaccharide catabolic process [GO:0000272],NA,NA,NA
CHOYP_SSPO.12.14.m.53188,-0.00617440899558552,-0.00426462406765388,No,NA,NA,Q9Y493,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; binding of sperm to zona pellucida [GO:0007339]; cell-cell adhesion [GO:0098609],NA,NA,NA
CHOYP_SSPO.2.14.m.3787,0.00288849011086031,0.00418700520845451,No,NA,NA,Q28178,NA,NA,NA,cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; sarcoplasmic reticulum [GO:0016529]; calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986],NA,NA,NA
CHOYP_SSPO.6.14.m.26542,-0.0143605223843017,-0.0150441111134273,No,NA,NA,Q8CG65,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; extracellular matrix structural constituent [GO:0005201]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; nervous system development [GO:0007399],NA,NA,NA
CHOYP_SSRB.1.2.m.5816,-0.0061034322771611,0.00402743587818861,No,NA,NA,Q5E9E4,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_SSRP1.1.1.m.19377,-0.0142234318181392,0.0104078994207445,No,NA,NA,Q04678,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; DNA binding [GO:0003677]; DNA repair [GO:0006281]; DNA replication [GO:0006260],NA,NA,NA
CHOYP_SSSCA1.1.2.m.25666,0.00169293914939557,-0.00611544914585998,No,NA,NA,O60232,NA,NA,NA,identical protein binding [GO:0042802]; cell division [GO:0051301]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_SSU72.1.1.m.2079,-0.000816011410936715,0.00196063436441931,No,NA,NA,Q5ZJQ7,NA,NA,NA,cytoplasm [GO:0005737]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO:0008420]; dephosphorylation of RNA polymerase II C-terminal domain [GO:0070940]; mRNA polyadenylation [GO:0006378]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_ST1C1.1.1.m.45503,-0.00273573058085761,-0.0316424415132991,No,NA,NA,O75897,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST1C4.2.3.m.14628,-0.0160853777721131,-0.022866658137742,No,NA,NA,O75897,NA,NA,NA,cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; ethanol catabolic process [GO:0006068]; sulfation [GO:0051923],NA,NA,NA
CHOYP_ST5.1.1.m.54184,0.00435623514372339,-0.00790866912502326,No,NA,NA,P78524,NA,NA,NA,Rab guanyl-nucleotide exchange factor activity [GO:0017112]; positive regulation of ERK1 and ERK2 cascade [GO:0070374],NA,NA,NA
CHOYP_STAB2.1.1.m.64132,0.00146653118281163,-0.000467563370799307,No,NA,NA,Q8R4U0,NA,NA,NA,cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyaluronic acid binding [GO:0005540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]; cell adhesion [GO:0007155]; defense response to bacterium [GO:0042742]; defense response to Gram-positive bacterium [GO:0050830]; endocytosis [GO:0006897],NA,NA,NA
CHOYP_STAR5.2.2.m.39352,0.00357493398730202,0.000412273870302736,No,NA,NA,A1A4M6,NA,NA,NA,bile acid binding [GO:0032052]; cholesterol binding [GO:0015485]; cholesterol transporter activity [GO:0017127]; cholesterol import [GO:0070508],NA,NA,NA
CHOYP_STAT1.1.2.m.1003,0.0015284760765124,0.00034071063622693,No,NA,NA,P42232,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; double-stranded DNA binding [GO:0003690]; glucocorticoid receptor binding [GO:0035259]; protein dimerization activity [GO:0046983]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; acute-phase response [GO:0006953]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hormone stimulus [GO:0032870]; cytokine-mediated signaling pathway [GO:0019221]; development of secondary female sexual characteristics [GO:0046543]; development of secondary male sexual characteristics [GO:0046544]; female pregnancy [GO:0007565]; JAK-STAT cascade [GO:0007259]; JAK-STAT cascade involved in growth hormone signaling pathway [GO:0060397]; lactation [GO:0007595]; lipid storage [GO:0019915]; liver development [GO:0001889]; luteinization [GO:0001553]; mast cell migration [GO:0097531]; natural killer cell differentiation [GO:0001779]; negative regulation of apoptotic process [GO:0043066]; negative regulation of erythrocyte differentiation [GO:0045647]; Peyer's patch development [GO:0048541]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of cell proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-2 biosynthetic process [GO:0045086]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone metabolic process [GO:0042448]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; regulation of multicellular organism growth [GO:0040014]; regulation of steroid metabolic process [GO:0019218]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to interleukin-15 [GO:0070672]; response to interleukin-2 [GO:0070669]; response to interleukin-4 [GO:0070670]; response to lipopolysaccharide [GO:0032496]; response to peptide hormone [GO:0043434]; sex differentiation [GO:0007548]; T cell differentiation in thymus [GO:0033077]; T cell homeostasis [GO:0043029]; taurine metabolic process [GO:0019530]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_STERM_3136.1.1.m.53971,-0.0118910902098088,-0.00215111329171968,No,NA,NA,Q5UR67,NA,NA,NA,hydrolase activity; acting on glycosyl bonds [GO:0016798]; metabolic process [GO:0008152],NA,NA,NA
CHOYP_STIM1.1.1.m.13316,0.00423558667683657,0.0200996336441504,No,NA,NA,P84903,NA,NA,NA,endoplasmic reticulum [GO:0005783]; growth cone [GO:0030426]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of plasma membrane [GO:0005887]; microtubule [GO:0005874]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum membrane [GO:0033017]; calcium channel regulator activity [GO:0005246]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; microtubule plus-end binding [GO:0051010]; store-operated calcium channel activity [GO:0015279]; activation of store-operated calcium channel activity [GO:0032237]; cellular calcium ion homeostasis [GO:0006874]; detection of calcium ion [GO:0005513]; enamel mineralization [GO:0070166]; myotube differentiation [GO:0014902]; positive regulation of adenylate cyclase activity [GO:0045762]; regulation of calcium ion transport [GO:0051924]; regulation of store-operated calcium entry [GO:2001256]; store-operated calcium entry [GO:0002115],NA,NA,NA
CHOYP_STING.3.3.m.61083,-0.000923659053288357,-0.0101158905500647,No,NA,NA,Q86WV6,NA,NA,NA,cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; peroxisome [GO:0005777]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; cyclic-di-GMP binding [GO:0035438]; cyclic-GMP-AMP binding [GO:0061507]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; activation of innate immune response [GO:0002218]; apoptotic process [GO:0006915]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to organic cyclic compound [GO:0071407]; cytoplasmic pattern recognition receptor signaling pathway in response to virus [GO:0039528]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; neutrophil degranulation [GO:0043312]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus; translocation [GO:0033160]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type I interferon production [GO:0032481]; regulation of inflammatory response [GO:0050727]; regulation of type I interferon production [GO:0032479]; viral process [GO:0016032],NA,NA,NA
CHOYP_STIP1.1.2.m.12856,-0.000264932385758316,-0.00032286756900043,No,NA,NA,P31948,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STIP1.2.2.m.54723,0.00191982449800813,0.000859929644945935,No,NA,NA,P31948,NA,NA,NA,chaperone complex [GO:0101031]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; myelin sheath [GO:0043209]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; chaperone binding [GO:0051087]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; cellular response to interleukin-7 [GO:0098761],NA,NA,NA
CHOYP_STK17A.1.1.m.24446,0.00927690817367407,0.00217435747613279,No,NA,NA,Q9UEE5,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; apoptotic process [GO:0006915]; intracellular signal transduction [GO:0035556]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fibroblast apoptotic process [GO:2000271]; protein phosphorylation [GO:0006468]; regulation of reactive oxygen species metabolic process [GO:2000377],NA,NA,NA
CHOYP_STK31.1.1.m.16297,-0.00330845370013342,0.000458398172828972,No,NA,NA,Q9BXU1,NA,NA,NA,acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; nuclease activity [GO:0004518]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_STK33.1.1.m.8044,-0.0163091117815699,-0.00596304410414633,No,NA,NA,Q924X7,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; mitotic DNA damage checkpoint [GO:0044773]; protein autophosphorylation [GO:0046777]; signal transduction in response to DNA damage [GO:0042770],NA,NA,NA
CHOYP_STRN.MLCK.2.3.m.9348,0.00205148630815486,-0.000554370195034628,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_STRN3.3.5.m.25133,-0.00148357976134583,-0.0023136311197468,No,NA,NA,A5D7H2,NA,NA,NA,cytoplasm [GO:0005737]; dendrite [GO:0030425]; FAR/SIN/STRIPAK complex [GO:0090443]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; armadillo repeat domain binding [GO:0070016]; calmodulin binding [GO:0005516]; DNA-binding transcription factor activity [GO:0003700]; protein phosphatase 2A binding [GO:0051721]; protein-containing complex binding [GO:0044877]; Rho GTPase binding [GO:0017048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944],NA,NA,NA
CHOYP_STRUM.1.1.m.42335,-0.00550251099487357,0.00309208091819232,No,NA,NA,Q5R5P0,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; WASH complex [GO:0071203]; protein transport [GO:0015031],NA,NA,NA
CHOYP_STT3A.1.1.m.40532,-0.0129214334969637,0.00658401923276032,No,NA,NA,Q2KJI2,NA,NA,NA,integral component of membrane [GO:0016021]; oligosaccharyltransferase III complex [GO:0035000]; dolichyl-diphosphooligosaccharide-protein glycotransferase activity [GO:0004579]; metal ion binding [GO:0046872]; co-translational protein modification [GO:0043686]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_STX.1.1.m.30392,0.00359005413865333,-0.000970135167424125,No,NA,NA,Q16932,NA,NA,NA,cell [GO:0005623]; integral component of membrane [GO:0016021]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; intracellular protein transport [GO:0006886]; neurotransmitter transport [GO:0006836]; regulation of exocytosis [GO:0017157]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_STX12.1.1.m.34092,-0.0114631104439351,-0.00729509519000131,No,NA,NA,Q86Y82,NA,NA,NA,early endosome membrane [GO:0031901]; endomembrane system [GO:0012505]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of synaptic vesicle membrane [GO:0030285]; membrane raft [GO:0045121]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; autophagosome assembly [GO:0000045]; cholesterol efflux [GO:0033344]; intracellular protein transport [GO:0006886]; protein stabilization [GO:0050821]; vesicle docking [GO:0048278]; vesicle fusion [GO:0006906],NA,NA,NA
CHOYP_STXB1.1.1.m.56878,-0.00254796006740453,0.00434629017208644,No,NA,NA,P61765,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; postsynapse [GO:0098794]; presynapse [GO:0098793]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein N-terminus binding [GO:0047485]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; axon target recognition [GO:0007412]; cellular response to interferon-gamma [GO:0071346]; developmental process involved in reproduction [GO:0003006]; long-term synaptic depression [GO:0060292]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of SNARE complex assembly [GO:0035544]; negative regulation of synaptic transmission; GABAergic [GO:0032229]; neuromuscular synaptic transmission [GO:0007274]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutamate secretion; neurotransmission [GO:1903296]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of vesicle docking [GO:0106022]; presynaptic dense core vesicle exocytosis [GO:0099525]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; protein transport [GO:0015031]; regulation of synaptic vesicle priming [GO:0010807]; regulation of vesicle fusion [GO:0031338]; response to estradiol [GO:0032355]; synaptic vesicle maturation [GO:0016188]; synaptic vesicle priming [GO:0016082]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_STXB5.1.2.m.50466,0.00308004137505016,-0.00323756994029712,No,NA,NA,Q5T5C0,NA,NA,NA,acetylcholine-gated channel complex [GO:0005892]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; extrinsic component of presynaptic membrane [GO:0098888]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; Schaffer collateral - CA1 synapse [GO:0098685]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075]; exocytosis [GO:0006887]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; synaptic vesicle cycle [GO:0099504],NA,NA,NA
CHOYP_SUCB1.1.1.m.41299,0.000681340683800893,0.00112866587426507,No,NA,NA,Q9Z2I9,NA,NA,NA,mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase activity [GO:0004774]; succinate metabolic process [GO:0006105]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUCB2.1.1.m.7164,-0.000779352478160542,0.00121033806500637,No,NA,NA,P53590,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; metal ion binding [GO:0046872]; succinate-CoA ligase (GDP-forming) activity [GO:0004776]; succinyl-CoA metabolic process [GO:0006104]; tricarboxylic acid cycle [GO:0006099],NA,NA,NA
CHOYP_SUDX.1.1.m.4577,-0.00359561633660738,-0.00582633447313726,No,NA,NA,Q8BZZ3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; lung development [GO:0030324]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of protein catabolic process [GO:0045732]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; T cell differentiation [GO:0030217]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_SUIS.2.2.m.16063,-6.79599840522601e-05,0.00901665453229376,No,NA,NA,O43451,NA,NA,NA,apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; tertiary granule membrane [GO:0070821]; alpha-1;4-glucosidase activity [GO:0004558]; amylase activity [GO:0016160]; carbohydrate binding [GO:0030246]; catalytic activity [GO:0003824]; glucan 1;4-alpha-glucosidase activity [GO:0004339]; maltose alpha-glucosidase activity [GO:0032450]; neutrophil degranulation [GO:0043312]; polysaccharide digestion [GO:0044245]; starch catabolic process [GO:0005983],NA,NA,NA
CHOYP_SUOX.1.1.m.32255,-0.000149754349425306,0.00134762792442917,No,NA,NA,Q9VWP4,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; heme binding [GO:0020037]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; sulfite oxidase activity [GO:0008482]; nitrate assimilation [GO:0042128]; sulfur compound metabolic process [GO:0006790],NA,NA,NA
CHOYP_SUV3.1.1.m.14574,0.008598329083756,-0.0048618967173062,No,NA,NA,Q9VN03,NA,NA,NA,mitochondrial degradosome [GO:0045025]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; DNA duplex unwinding [GO:0032508]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA processing [GO:0000963]; mitochondrial tRNA processing [GO:0090646]; oxidative phosphorylation [GO:0006119]; positive regulation of mitochondrial translation [GO:0070131]; regulation of mitochondrial mRNA stability [GO:0044528]; respiratory electron transport chain [GO:0022904]; RNA catabolic process [GO:0006401],NA,NA,NA
CHOYP_SVEP1.2.8.m.26503,0.0258800516314826,0.00621411195548978,No,NA,NA,P0C6B8,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155],NA,NA,NA
CHOYP_SYAC.2.2.m.18500,0.000619518367484375,-0.000373634638830498,No,NA,NA,Q8BGQ7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; alanine-tRNA ligase activity [GO:0004813]; amino acid binding [GO:0016597]; aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; Ser-tRNA(Ala) hydrolase activity [GO:0002196]; translation regulator activity [GO:0045182]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270]; alanyl-tRNA aminoacylation [GO:0006419]; cerebellar Purkinje cell layer development [GO:0021680]; negative regulation of neuron apoptotic process [GO:0043524]; neuromuscular process [GO:0050905]; neuromuscular process controlling balance [GO:0050885]; regulation of cytoplasmic translational fidelity [GO:0140018]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_SYB.1.3.m.25801,-0.00989272921644651,-0.00700603795850775,No,NA,NA,P35589,NA,NA,NA,cell junction [GO:0030054]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synaptic vesicle membrane [GO:0030672]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_SYCC.1.1.m.11415,0.000346045076214393,0.000389942608646512,No,NA,NA,Q9ER72,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; cysteine-tRNA ligase activity [GO:0004817]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]; cysteinyl-tRNA aminoacylation [GO:0006423],NA,NA,NA
CHOYP_SYCP2.1.2.m.47476,-0.0082991990150953,0.00486131024728041,No,NA,NA,Q9CUU3,NA,NA,NA,lateral element [GO:0000800]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795]; DNA binding [GO:0003677]; protein heterodimerization activity [GO:0046982]; animal organ morphogenesis [GO:0009887]; cell division [GO:0051301]; female meiotic nuclear division [GO:0007143]; fertilization [GO:0009566]; male genitalia morphogenesis [GO:0048808]; male meiotic nuclear division [GO:0007140]; negative regulation of apoptotic process [GO:0043066],NA,NA,NA
CHOYP_SYFA.1.1.m.53256,0.00166225778036772,-0.00178588887523614,No,NA,NA,Q1JPX3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; phenylalanine-tRNA ligase complex [GO:0009328]; ATP binding [GO:0005524]; phenylalanine-tRNA ligase activity [GO:0004826]; tRNA binding [GO:0000049]; phenylalanyl-tRNA aminoacylation [GO:0006432]; protein heterotetramerization [GO:0051290],NA,NA,NA
CHOYP_SYFA.1.1.m.53257,-0.0181563527999692,0.0106701191449788,No,NA,NA,Q08BI9,NA,NA,NA,calcium channel complex [GO:0034704]; integral component of mitochondrial inner membrane [GO:0031305]; mitochondrial inner membrane [GO:0005743]; uniplex complex [GO:1990246]; calcium channel activity [GO:0005262]; identical protein binding [GO:0042802]; uniporter activity [GO:0015292]; actin filament organization [GO:0007015]; calcium import into the mitochondrion [GO:0036444]; calcium-mediated signaling [GO:0019722]; chordate embryonic development [GO:0043009]; convergent extension involved in gastrulation [GO:0060027]; glucose homeostasis [GO:0042593]; mitochondrial calcium ion homeostasis [GO:0051560]; mitochondrial calcium ion transmembrane transport [GO:0006851]; positive regulation of insulin secretion [GO:0032024]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; protein complex oligomerization [GO:0051259]; regulation of heart contraction [GO:0008016],NA,NA,NA
CHOYP_SYHC.1.1.m.65924,0.000994412696112359,0.00103104822954087,No,NA,NA,Q61035,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; ATP binding [GO:0005524]; histidine-tRNA ligase activity [GO:0004821]; identical protein binding [GO:0042802]; histidyl-tRNA aminoacylation [GO:0006427]; mitochondrial translation [GO:0032543],NA,NA,NA
CHOYP_SYMC.1.1.m.18367,0.00399456337825331,-0.00138434566227288,No,NA,NA,P56192,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to starvation [GO:0009267]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418],NA,NA,NA
CHOYP_SYMPK.1.1.m.1791,-0.00249300385308006,0.00156967846267409,No,NA,NA,Q92797,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; cell adhesion [GO:0007155]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing; via spliceosome [GO:0000398]; negative regulation of protein binding [GO:0032091]; positive regulation of protein dephosphorylation [GO:0035307]; termination of RNA polymerase II transcription [GO:0006369],NA,NA,NA
CHOYP_SYNE1.1.1.m.51183,0.0024498013323594,0.000201152649702545,No,NA,NA,Q8NF91,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; meiotic nuclear membrane microtubule tethering complex [GO:0034993]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; postsynaptic membrane [GO:0045211]; sarcomere [GO:0030017]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; cytoskeletal anchoring at nuclear membrane [GO:0090286]; Golgi organization [GO:0007030]; muscle cell differentiation [GO:0042692]; nuclear matrix anchoring at nuclear membrane [GO:0090292]; nucleus organization [GO:0006997]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_SYNJ1.1.1.m.42275,0.0138327666633993,-0.0198878955309163,No,NA,NA,Q8CHC4,NA,NA,NA,clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane coat [GO:0030117]; neuron projection [GO:0043005]; parallel fiber to Purkinje cell synapse [GO:0098688]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; synaptic membrane [GO:0097060]; terminal bouton [GO:0043195]; vesicle membrane [GO:0012506]; EH domain binding [GO:1990175]; inositol-1;4;5-trisphosphate 5-phosphatase activity [GO:0052658]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-3-phosphatase activity [GO:0004438]; phosphatidylinositol-4;5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein C-terminus binding [GO:0008022]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; brain development [GO:0007420]; inositol phosphate dephosphorylation [GO:0046855]; learning [GO:0007612]; neurotransmitter transport [GO:0006836]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of endosome organization [GO:1904980]; positive regulation of gliogenesis [GO:0014015]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of synaptic vesicle recycling [GO:1903423]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; response to cytokine [GO:0034097]; response to retinoic acid [GO:0032526]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]; synaptic vesicle uncoating [GO:0016191],NA,NA,NA
CHOYP_SYPL1.1.1.m.49654,-0.00117474131790562,0.00740040939157418,No,NA,NA,Q16563,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of synaptic vesicle membrane [GO:0030285]; melanosome [GO:0042470]; secretory granule [GO:0030141]; chemical synaptic transmission [GO:0007268],NA,NA,NA
CHOYP_SYRC.1.2.m.36309,-0.000218321595677268,-0.00204923666950881,No,NA,NA,P37880,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; arginine-tRNA ligase activity [GO:0004814]; ATP binding [GO:0005524]; arginyl-tRNA aminoacylation [GO:0006420],NA,NA,NA
CHOYP_SYTC.1.1.m.35709,0.00162635191648521,0.000504087674865029,No,NA,NA,Q9D0R2,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; threonine-tRNA ligase activity [GO:0004829]; threonyl-tRNA aminoacylation [GO:0006435],NA,NA,NA
CHOYP_SYWC.3.5.m.26200,0.0275056301128092,0.0113385270628707,No,NA,NA,P23381,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; angiogenesis [GO:0001525]; negative regulation of cell proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; translation [GO:0006412]; tRNA aminoacylation for protein translation [GO:0006418]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYWC.4.5.m.36166,0.00562357074400868,-0.00943440550024924,No,NA,NA,P17248,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; regulation of protein ADP-ribosylation [GO:0010835]; tryptophanyl-tRNA aminoacylation [GO:0006436],NA,NA,NA
CHOYP_SYYC.1.2.m.23460,-0.00294887895569641,0.00303469032449612,No,NA,NA,Q6TGS6,NA,NA,NA,aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; methionyl glutamyl tRNA synthetase complex [GO:0017102]; ATP binding [GO:0005524]; tRNA binding [GO:0000049]; tyrosine-tRNA ligase activity [GO:0004831]; cellular response to DNA damage stimulus [GO:0006974]; tRNA aminoacylation for protein translation [GO:0006418]; tyrosyl-tRNA aminoacylation [GO:0006437],NA,NA,NA
CHOYP_T23O.5.6.m.52216,0.0110186266290776,-0.00714624295829404,No,NA,NA,Q5U4U6,NA,NA,NA,heme binding [GO:0020037]; metal ion binding [GO:0046872]; tryptophan 2;3-dioxygenase activity [GO:0004833]; protein homotetramerization [GO:0051289]; tryptophan catabolic process to kynurenine [GO:0019441],NA,NA,NA
CHOYP_T24B8.5.1.2.m.5660,-0.0140501943140448,-0.00131683228620565,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T24B8.5.2.2.m.46909,-0.0130687679035991,0.00553265922242908,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_T3HPD.1.2.m.24627,0.0134596553624458,-0.0100298044661625,No,NA,NA,Q66II5,NA,NA,NA,hydro-lyase activity [GO:0016836]; trans-L-3-hydroxyproline dehydratase activity [GO:0050346],NA,NA,NA
CHOYP_TAB3.1.1.m.25766,0.00257994811092849,0.00178882744545836,No,NA,NA,Q99K90,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; metal ion binding [GO:0046872]; heart development [GO:0007507]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of protein kinase activity [GO:0045860],NA,NA,NA
CHOYP_TACC1.2.2.m.53512,0.00233303710981678,0.00399805531995808,No,NA,NA,Q6Y685,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; protein domain specific binding [GO:0019904]; cell division [GO:0051301]; cell proliferation [GO:0008283]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; microtubule cytoskeleton organization [GO:0000226]; mitotic spindle organization [GO:0007052]; neurogenesis [GO:0022008]; regulation of microtubule-based process [GO:0032886],NA,NA,NA
CHOYP_TACC3.3.3.m.16099,0.0029252257043775,0.0125666817456827,No,NA,NA,Q9PTG8,NA,NA,NA,cytoplasm [GO:0005737]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; translation initiation factor binding [GO:0031369]; cell division [GO:0051301]; mitotic spindle organization [GO:0007052]; negative regulation of translation [GO:0017148],NA,NA,NA
CHOYP_TAD2A.1.1.m.27478,-0.00418291511766802,0.005678628345737,No,NA,NA,Q5M823,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; spindle pole [GO:0000922]; unfolded protein binding [GO:0051082]; developmental process [GO:0032502]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TAF1.1.1.m.31656,0.00161425127795046,0.00668409010459339,No,NA,NA,P21675,NA,NA,NA,MLL1 complex [GO:0071339]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; transcription factor TFIID complex [GO:0005669]; ATP binding [GO:0005524]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; kinase activity [GO:0016301]; lysine-acetylated histone binding [GO:0070577]; nuclear hormone receptor binding [GO:0035257]; p53 binding [GO:0002039]; protein heterodimerization activity [GO:0046982]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II general transcription initiation factor activity [GO:0016251]; RNA polymerase II sequence-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; TBP-class protein binding [GO:0017025]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]; ubiquitin conjugating enzyme activity [GO:0061631]; cell cycle [GO:0007049]; cellular response to ATP [GO:0071318]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; DNA-templated transcription; initiation [GO:0006352]; midbrain development [GO:0030901]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of protein autoubiquitination [GO:1905524]; negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903026]; negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage [GO:0010768]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of androgen receptor activity [GO:2000825]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation from RNA polymerase II promoter [GO:0060261]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; protein polyubiquitination [GO:0000209]; protein stabilization [GO:0050821]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of transcription initiation from RNA polymerase II promoter [GO:0060260]; regulation of transcription; DNA-templated [GO:0006355]; RNA polymerase II preinitiation complex assembly [GO:0051123]; transcription by RNA polymerase II [GO:0006366]; transcription factor catabolic process [GO:0036369]; transcription initiation from RNA polymerase II promoter [GO:0006367]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_TAF13.1.3.m.20331,-0.00224812155672909,-0.0199753650160924,No,NA,NA,Q5R9W6,NA,NA,NA,nucleus [GO:0005634]; protein heterodimerization activity [GO:0046982]; transcription by RNA polymerase II [GO:0006366],NA,NA,NA
CHOYP_TAF9.1.1.m.10395,-0.00239520751994588,0.0111003922518298,No,NA,NA,A5PJA1,NA,NA,NA,Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_TAGL3.1.1.m.31031,0.00193659840013747,-0.00370517954567644,No,NA,NA,P37805,NA,NA,NA,actin filament binding [GO:0051015],NA,NA,NA
CHOYP_TALDO.2.2.m.43331,0.000780548436690996,0.00151906115355255,No,NA,NA,P37837,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; monosaccharide binding [GO:0048029]; sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [GO:0004801]; carbohydrate metabolic process [GO:0005975]; fructose 6-phosphate metabolic process [GO:0006002]; interleukin-12-mediated signaling pathway [GO:0035722]; pentose-phosphate shunt [GO:0006098]; pentose-phosphate shunt; non-oxidative branch [GO:0009052]; xylulose biosynthetic process [GO:0005999],NA,NA,NA
CHOYP_TBA.1.6.m.12217,-0.0184638836439349,0.00346619789089863,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBA.3.6.m.29937,-0.0281529483547829,-0.0179164668378463,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TBA.5.6.m.37448,0.0158092524487432,-0.0239129645537281,No,NA,NA,P02553,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBA1.2.9.m.9962,-0.00265205806821718,0.0055739604094973,No,NA,NA,P06605,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; perinuclear region of cytoplasm [GO:0048471]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; myosin binding [GO:0017022]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic cytokinesis [GO:0000281],NA,NA,NA
CHOYP_TBA1.7.9.m.44107,-0.00858972066844157,0.0116612051398664,No,NA,NA,P06603,NA,NA,NA,astral microtubule [GO:0000235]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; antimicrobial humoral response [GO:0019730]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094],NA,NA,NA
CHOYP_TBA2.1.1.m.955,-0.00396676790526921,-0.000948177242076927,No,NA,NA,P68370,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytoplasmic ribonucleoprotein granule [GO:0036464]; membrane raft [GO:0045121]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; recycling endosome [GO:0055037]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; regulation of synapse organization [GO:0050807],NA,NA,NA
CHOYP_TBA3.1.1.m.5111,0.00170016083019672,0.00261149865330763,No,NA,NA,Q68FR8,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB.2.7.m.37919,0.0016310834363255,0.0016184117335593,No,NA,NA,P02554,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; neuron migration [GO:0001764],NA,NA,NA
CHOYP_TBB.5.7.m.60062,0.00215712441833912,0.00406161604345242,No,NA,NA,P38552,NA,NA,NA,extracellular space [GO:0005615]; carbohydrate binding [GO:0030246]; galactoside binding [GO:0016936],NA,NA,NA
CHOYP_TBB2.1.2.m.45096,-0.00241228855130568,0.00525064674542831,No,NA,NA,P41937,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53000,0.00308455112939196,-0.000833533816140009,No,NA,NA,P41387,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB2.2.2.m.53001,0.00541614836001037,0.00639633188013479,No,NA,NA,P41937,NA,NA,NA,axonemal microtubule [GO:0005879]; cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule cytoskeleton organization [GO:0000226]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_TBB2.2.2.m.53003,-9.73566226563859e-05,0.0129168810906205,No,NA,NA,P41386,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4.1.1.m.40048,-0.0167434973195686,-0.0106555203630974,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.1.7.m.12262,0.000735732652209425,0.000294866563320426,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBB4B.3.7.m.22777,-0.00267063514742034,0.00362559220606834,No,NA,NA,P43006,NA,NA,NA,axolemma [GO:0030673]; axon [GO:0030424]; cell surface [GO:0009986]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; anion transmembrane transporter activity [GO:0008509]; glutamate:sodium symporter activity [GO:0015501]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-glutamate transmembrane transporter activity [GO:0005313]; metal ion binding [GO:0046872]; adult behavior [GO:0030534]; anion transmembrane transport [GO:0098656]; cellular response to extracellular stimulus [GO:0031668]; D-aspartate import across plasma membrane [GO:0070779]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; nervous system development [GO:0007399]; neurotransmitter reuptake [GO:0098810]; positive regulation of glucose import [GO:0046326]; protein homotrimerization [GO:0070207]; response to amino acid [GO:0043200]; response to drug [GO:0042493]; response to light stimulus [GO:0009416]; response to wounding [GO:0009611]; telencephalon development [GO:0021537]; visual behavior [GO:0007632],NA,NA,NA
CHOYP_TBB4B.7.7.m.63980,-0.00251473666366237,-0.00121960721960577,No,NA,NA,P11833,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; structural constituent of cytoskeleton [GO:0005200]; microtubule-based process [GO:0007017],NA,NA,NA
CHOYP_TBC13.1.1.m.24396,0.00648614445061403,-0.00221665556562491,No,NA,NA,Q9NVG8,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBC15.1.1.m.4226,-0.00146287550415335,0.0138003761854325,No,NA,NA,Q9CXF4,NA,NA,NA,cytoplasm [GO:0005737]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886]; regulation of GTPase activity [GO:0043087],NA,NA,NA
CHOYP_TBC1D22A.1.1.m.24510,-0.00784349471587355,-0.00211505072372727,No,NA,NA,Q9NU19,NA,NA,NA,cell [GO:0005623]; 14-3-3 protein binding [GO:0071889]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TBCA.1.1.m.12075,0.00114777689860002,0.00174426391199582,No,NA,NA,O75347,NA,NA,NA,cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; nucleolus [GO:0005730]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; RNA binding [GO:0003723]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD.1.2.m.35202,-0.00560697793919335,-0.000738655687741901,No,NA,NA,Q9BTW9,NA,NA,NA,adherens junction [GO:0005912]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; beta-tubulin binding [GO:0048487]; chaperone binding [GO:0051087]; GTPase activator activity [GO:0005096]; adherens junction assembly [GO:0034333]; bicellular tight junction assembly [GO:0070830]; cell morphogenesis involved in neuron differentiation [GO:0048667]; microtubule cytoskeleton organization [GO:0000226]; mitotic cell cycle [GO:0000278]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of microtubule polymerization [GO:0031115]; post-chaperonin tubulin folding pathway [GO:0007023]; protein folding [GO:0006457]; tubulin complex assembly [GO:0007021],NA,NA,NA
CHOYP_TBCD1.1.1.m.14806,0.00118161464704026,0.0167636315124586,No,NA,NA,O60343,NA,NA,NA,cytosol [GO:0005829]; vesicle [GO:0031982]; GTPase activator activity [GO:0005096]; Rab GTPase binding [GO:0017137]; activation of GTPase activity [GO:0090630]; cellular response to insulin stimulus [GO:0032869]; intracellular protein transport [GO:0006886]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_TBCE.1.1.m.14005,0.00240899875796807,-0.016281270860829,No,NA,NA,Q5U508,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; post-chaperonin tubulin folding pathway [GO:0007023],NA,NA,NA
CHOYP_TBCEL.2.2.m.26805,-0.00982342597266934,-0.00279669731156001,No,NA,NA,Q5QJ74,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856],NA,NA,NA
CHOYP_TBG1.1.1.m.28190,-0.0190472723588606,-0.00100548436754169,No,NA,NA,P23258,NA,NA,NA,apical part of cell [GO:0045177]; cell leading edge [GO:0031252]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; gamma-tubulin complex [GO:0000930]; microtubule [GO:0005874]; non-motile cilium [GO:0097730]; nucleus [GO:0005634]; pericentriolar material [GO:0000242]; polar microtubule [GO:0005827]; recycling endosome [GO:0055037]; spindle [GO:0005819]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; structural constituent of cytoskeleton [GO:0005200]; ciliary basal body-plasma membrane docking [GO:0097711]; cytoplasmic microtubule organization [GO:0031122]; G2/M transition of mitotic cell cycle [GO:0000086]; meiotic spindle organization [GO:0000212]; microtubule cytoskeleton organization [GO:0000226]; microtubule nucleation [GO:0007020]; microtubule-based process [GO:0007017]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; regulation of G2/M transition of mitotic cell cycle [GO:0010389],NA,NA,NA
CHOYP_TBL2.1.1.m.29917,0.00606121202172241,0.01499424077018,No,NA,NA,Q9Y4P3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; integral component of endoplasmic reticulum membrane [GO:0030176]; phosphoprotein binding [GO:0051219]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation initiation factor binding [GO:0031369]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; endoplasmic reticulum unfolded protein response [GO:0030968],NA,NA,NA
CHOYP_TBRG4.1.1.m.48213,-0.0136981959592956,0.0179265756007941,No,NA,NA,Q6PA48,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; protein kinase activity [GO:0004672]; cellular respiration [GO:0045333]; mitochondrial mRNA processing [GO:0090615]; mRNA metabolic process [GO:0016071]; regulation of mitochondrial mRNA stability [GO:0044528],NA,NA,NA
CHOYP_TC1DB.1.1.m.22354,-0.0333338538086197,-0.0131990452723088,No,NA,NA,A2VDD2,NA,NA,NA,,NA,NA,NA
CHOYP_TCF25.1.1.m.28509,-5.98954810792929e-05,0.00794668904751684,No,NA,NA,Q8R3L2,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; negative regulation of transcription by RNA polymerase II [GO:0000122],NA,NA,NA
CHOYP_TCFAP2B.2.2.m.11727,-0.0119941502059286,-0.00763304758367016,No,NA,NA,P34056,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227]; protein dimerization activity [GO:0046983]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II distal enhancer sequence-specific DNA binding [GO:0000980]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; transcription regulatory region DNA binding [GO:0044212]; transcription regulatory region sequence-specific DNA binding [GO:0000976]; anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of cell differentiation [GO:0045595]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transcription; DNA-templated [GO:0006355]; response to lipopolysaccharide [GO:0032496]; roof of mouth development [GO:0060021]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; trigeminal nerve development [GO:0021559],NA,NA,NA
CHOYP_TCPB.1.1.m.6398,-0.000314661292675334,-0.000669486270249451,No,NA,NA,Q3ZBH0,NA,NA,NA,cell body [GO:0044297]; chaperonin-containing T-complex [GO:0005832]; microtubule [GO:0005874]; myelin sheath [GO:0043209]; zona pellucida receptor complex [GO:0002199]; ATP binding [GO:0005524]; protein binding involved in protein folding [GO:0044183]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; binding of sperm to zona pellucida [GO:0007339]; chaperone mediated protein folding independent of cofactor [GO:0051086]; chaperone-mediated protein complex assembly [GO:0051131]; positive regulation of establishment of protein localization to telomere [GO:1904851]; positive regulation of telomerase activity [GO:0051973]; positive regulation of telomerase RNA localization to Cajal body [GO:1904874]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein stabilization [GO:0050821]; scaRNA localization to Cajal body [GO:0090666]; toxin transport [GO:1901998],NA,NA,NA
CHOYP_TCPD.1.1.m.13556,0.000680137596060648,-0.000994534736641793,No,NA,NA,Q2T9X2,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; cilium [GO:0005929]; melanosome [GO:0042470]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPG.1.1.m.30926,-0.00895336529708792,-0.00584058650123338,No,NA,NA,P48605,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; unfolded protein binding [GO:0051082]; lumen formation; open tracheal system [GO:0035149]; protein folding [GO:0006457]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_TCPH.1.1.m.7312,-0.00135763904205314,-0.000504419952679671,No,NA,NA,Q5ZJK8,NA,NA,NA,chaperonin-containing T-complex [GO:0005832]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCPQ.1.1.m.57792,0.000487009826722677,0.000492399837317562,No,NA,NA,Q6EE31,NA,NA,NA,cell projection [GO:0042995]; chaperonin-containing T-complex [GO:0005832]; microtubule organizing center [GO:0005815]; ATP binding [GO:0005524]; unfolded protein binding [GO:0051082]; protein folding [GO:0006457],NA,NA,NA
CHOYP_TCRG1.1.1.m.1150,-0.00153538954266149,3.28272894321484e-05,No,NA,NA,Q8CGF7,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; identical protein binding [GO:0042802]; proline-rich region binding [GO:0070064]; RNA polymerase binding [GO:0070063]; RNA polymerase II repressing transcription factor binding [GO:0001103]; transcription corepressor activity [GO:0003714]; negative regulation of transcription by RNA polymerase II [GO:0000122]; transcription; DNA-templated [GO:0006351],NA,NA,NA
CHOYP_TDRD1.1.1.m.34821,0.00191492039599885,-0.000517466184973207,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TDRD3.1.2.m.3301,0.00195870670338927,-0.0182333237013821,No,NA,NA,Q5ZMS6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; chromatin binding [GO:0003682]; methylated histone binding [GO:0035064]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; chromatin organization [GO:0006325]; mRNA processing [GO:0006397],NA,NA,NA
CHOYP_TDRD3.2.2.m.8522,-0.00430486923067662,0.00584419041513798,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEFF2.1.1.m.26857,0.00114715134161982,-0.000586206288506813,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEKT3.1.1.m.37281,-0.00601337277402271,-0.00193308776005047,No,NA,NA,A6H782,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60031,-0.000591341081001697,-0.00704234509520315,No,NA,NA,A6H782,NA,NA,NA,acrosomal membrane [GO:0002080]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEKT5.1.1.m.60033,-0.00650011613499705,0.00144032337908253,No,NA,NA,Q9BXF9,NA,NA,NA,acrosomal membrane [GO:0002080]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; outer acrosomal membrane [GO:0002081]; sperm flagellum [GO:0036126]; cilium assembly [GO:0060271]; cilium movement involved in cell motility [GO:0060294]; flagellated sperm motility [GO:0030317]; regulation of brood size [GO:0060378],NA,NA,NA
CHOYP_TEMPT.1.3.m.4934,0.0112159670856857,0.00109119078610637,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TEMPT.2.3.m.39578,0.0278675318071758,0.00263104915935651,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TEN2.1.2.m.44821,-0.00194965798895186,0.00717795820128738,No,NA,NA,O61307,NA,NA,NA,cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; integral component of plasma membrane [GO:0005887]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cell adhesion [GO:0007155]; chaeta development [GO:0022416]; compound eye corneal lens development [GO:0048058]; compound eye morphogenesis [GO:0001745]; compound eye photoreceptor development [GO:0042051]; cytoplasmic microtubule organization [GO:0031122]; maintenance of alignment of postsynaptic density and presynaptic active zone [GO:0099559]; maintenance of presynaptic active zone structure [GO:0048790]; motor neuron axon guidance [GO:0008045]; neuromuscular synaptic transmission [GO:0007274]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of locomotion [GO:0040017]; postsynaptic membrane organization [GO:0001941]; postsynaptic spectrin-associated cytoskeleton organization [GO:0099190]; presynaptic membrane organization [GO:0097090]; R7 cell development [GO:0045467]; regulation of homotypic cell-cell adhesion [GO:0034110]; regulation of terminal button organization [GO:2000331]; synapse organization [GO:0050808]; synaptic growth at neuromuscular junction [GO:0051124]; synaptic target attraction [GO:0016200]; synaptic target recognition [GO:0008039]; synaptic vesicle membrane organization [GO:0048499],NA,NA,NA
CHOYP_TENA.5.5.m.43448,0.00726477318825278,0.0085795102455208,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TENS3.2.4.m.45659,0.0212734957461623,0.0171230554572944,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.3.4.m.52970,0.00134765364913237,-0.000660288607362153,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TENS3.4.4.m.60095,0.0121490459274248,-0.0178668588094228,No,NA,NA,Q9HBL0,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; focal adhesion [GO:0005925]; actin binding [GO:0003779]; RNA binding [GO:0003723]; cell-substrate junction assembly [GO:0007044]; fibroblast migration [GO:0010761],NA,NA,NA
CHOYP_TERA.1.1.m.29200,0.000384858910163075,-0.0017252419200666,No,NA,NA,P23787,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; lipid binding [GO:0008289]; protein-containing complex binding [GO:0044877]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to heat [GO:0034605]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; macroautophagy [GO:0016236]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein hexamerization [GO:0034214]; protein N-linked glycosylation via asparagine [GO:0018279]; protein ubiquitination [GO:0016567]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_TEX10.2.3.m.28279,0.00591819690384159,-0.0107443835295848,No,NA,NA,Q803M3,NA,NA,NA,MLL1 complex [GO:0071339]; nucleolus [GO:0005730]; Rix1 complex [GO:0097344],NA,NA,NA
CHOYP_TFCP2.1.2.m.11029,-0.00627438913455569,-0.00312011075787702,No,NA,NA,Q12800,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; DNA binding [GO:0003677]; DNA-binding transcription activator activity; RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; protein C-terminus binding [GO:0008022]; proximal promoter sequence-specific DNA binding [GO:0000987]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription factor binding [GO:0008134]; mRNA transcription by RNA polymerase II [GO:0042789]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TFG.1.1.m.8487,0.0034105946108495,-0.00106338754456814,No,NA,NA,Q92734,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; Golgi membrane [GO:0000139]; identical protein binding [GO:0042802]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123],NA,NA,NA
CHOYP_TFP11.1.1.m.65838,0.00343570688867679,0.00405748145030503,No,NA,NA,Q66J74,NA,NA,NA,spliceosomal complex [GO:0005681]; nucleic acid binding [GO:0003676]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_TGM1.1.2.m.5148,0.00665581721578811,0.0011649964535363,No,NA,NA,P52183,NA,NA,NA,plasma membrane [GO:0005886]; metal ion binding [GO:0046872]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; peptide cross-linking [GO:0018149],NA,NA,NA
CHOYP_TGME49_066610.1.1.m.2678,-0.00225855707217894,-0.0206644036735227,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_THERJR_2510.1.1.m.38407,-0.00101102657869214,0.0271878168568253,No,NA,NA,Q4R4Z9,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ligase activity [GO:0016874]; fatty acid metabolic process [GO:0006631],NA,NA,NA
CHOYP_THIKA.1.1.m.13333,0.00227766605566229,-0.00275860016110119,No,NA,NA,P21775,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; acetyl-CoA C-acyltransferase activity [GO:0003988]; palmitoyl-CoA oxidase activity [GO:0016401]; fatty acid beta-oxidation [GO:0006635]; phenylacetate catabolic process [GO:0010124]; response to drug [GO:0042493]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545],NA,NA,NA
CHOYP_THNS1.1.1.m.28661,0.00335062094461749,0.00193519431651645,No,NA,NA,Q5R5P3,NA,NA,NA,,NA,NA,NA
CHOYP_THNS2.1.1.m.27131,0.0158739416625699,-0.00333180304610318,No,NA,NA,Q5RFE6,NA,NA,NA,lyase activity [GO:0016829],NA,NA,NA
CHOYP_THOC1.1.1.m.62740,-0.00339528812432347,-0.000115491578207484,No,NA,NA,Q8R3N6,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nuclear chromosome; telomeric region [GO:0000784]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex [GO:0000347]; THO complex part of transcription export complex [GO:0000445]; transcription export complex [GO:0000346]; DNA binding [GO:0003677]; RNA binding [GO:0003723]; apoptotic process [GO:0006915]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; negative regulation of isotype switching to IgA isotypes [GO:0048297]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; regulation of DNA recombination [GO:0000018]; regulation of DNA-templated transcription; elongation [GO:0032784]; replication fork processing [GO:0031297]; RNA splicing [GO:0008380]; signal transduction [GO:0007165]; viral mRNA export from host cell nucleus [GO:0046784],NA,NA,NA
CHOYP_THOC2.1.2.m.9631,-0.000347463265530168,0.00266337678395651,No,NA,NA,B2KI97,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC2.2.2.m.19049,-0.000172055100062025,-0.000838506784834242,No,NA,NA,B2KI97,NA,NA,NA,nuclear speck [GO:0016607]; THO complex [GO:0000347]; RNA binding [GO:0003723]; generation of neurons [GO:0048699]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; neuron development [GO:0048666]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC5.1.1.m.12880,0.000536558285517681,9.7561699640124e-05,No,NA,NA,Q5ZJK1,NA,NA,NA,cytoplasm [GO:0005737]; nuclear chromosome [GO:0000228]; THO complex part of transcription export complex [GO:0000445]; mRNA binding [GO:0003729]; cell differentiation [GO:0030154]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; negative regulation of DNA damage checkpoint [GO:2000002]; positive regulation of DNA-templated transcription; elongation [GO:0032786]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOC7.1.1.m.6771,-0.00095714987374996,0.00125121714523793,No,NA,NA,Q6DGZ3,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; THO complex part of transcription export complex [GO:0000445]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; mRNA processing [GO:0006397]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_THOP1.1.1.m.18269,0.0007461393564166,0.00115305643275435,No,NA,NA,Q8C1A5,NA,NA,NA,mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; peptide binding [GO:0042277]; intracellular signal transduction [GO:0035556]; peptide metabolic process [GO:0006518]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_THSD4.1.2.m.36522,-0.007021391743375,0.00978488565301937,No,NA,NA,Q6ZMP0,NA,NA,NA,collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; microfibril [GO:0001527]; extracellular matrix structural constituent [GO:0005201]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THSD4.2.2.m.57001,0.00621971184224377,0.0189587460143559,No,NA,NA,Q3UTY6,NA,NA,NA,extracellular matrix [GO:0031012]; microfibril [GO:0001527]; peptidase activity [GO:0008233]; elastic fiber assembly [GO:0048251],NA,NA,NA
CHOYP_THTR.1.1.m.25923,-0.000273549441097652,0.00290963859212858,No,NA,NA,P25324,NA,NA,NA,mitochondrial matrix [GO:0005759]; 5S rRNA binding [GO:0008097]; thiosulfate sulfurtransferase activity [GO:0004792]; rRNA import into mitochondrion [GO:0035928]; rRNA transport [GO:0051029],NA,NA,NA
CHOYP_THUM1.1.1.m.47876,0,0,No,NA,NA,Q24K03,NA,NA,NA,RNA binding [GO:0003723]; tRNA modification [GO:0006400],NA,NA,NA
CHOYP_THUM3.1.1.m.17928,0.0113813060233653,0.00690604788890333,No,NA,NA,Q9BV44,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; RNA binding [GO:0003723]; tRNA (guanine) methyltransferase activity [GO:0016423]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TIAP2.12.13.m.62840,-5.66414992293202e-05,0.00751496395804371,No,NA,NA,Q8JHV9,NA,NA,NA,cytoplasm [GO:0005737]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; metal ion binding [GO:0046872]; transferase activity [GO:0016740]; multicellular organism development [GO:0007275]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; protein autoubiquitination [GO:0051865],NA,NA,NA
CHOYP_TIF1A.3.8.m.12841,-9.3932391421317e-05,0.0124625680045321,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.4.8.m.23900,-0.0114459232510548,-0.00371127384914855,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIF1A.5.8.m.32570,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIM8A.1.1.m.4787,-0.0142126030165589,0.0245322597596207,No,NA,NA,Q90YI5,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; metal ion binding [GO:0046872]; chaperone-mediated protein transport [GO:0072321],NA,NA,NA
CHOYP_TIMP2B.1.1.m.29629,-0.00880895333230022,-0.025041095705919,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.4.9.m.28669,-0.0300343699316025,0.000978657481773457,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TIMP3.5.9.m.39776,0.00166695832327883,0.0017044015620528,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.1.19.m.2116,0.00181135686280111,0.00213916585693629,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TITIN.19.19.m.66288,0.014491061887751,0.0125326124254823,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.4.19.m.19569,0.00650932784373076,-0.00848187266046097,No,NA,NA,P20273,NA,NA,NA,cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; neuronal cell body membrane [GO:0032809]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; carbohydrate binding [GO:0030246]; CD4 receptor binding [GO:0042609]; IgM binding [GO:0001791]; protein phosphatase binding [GO:0019903]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]; B cell activation [GO:0042113]; cell adhesion [GO:0007155]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of calcium-mediated signaling [GO:0050849]; negative regulation of immunoglobulin secretion [GO:0051025]; regulation of B cell proliferation [GO:0030888]; regulation of endocytosis [GO:0030100]; regulation of immune response [GO:0050776],NA,NA,NA
CHOYP_TITIN.6.19.m.31591,0.0238082828960632,-0.00401178521261853,No,NA,NA,Q8WZ42,NA,NA,NA,condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; muscle filament sliding [GO:0030049]; platelet degranulation [GO:0002576]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_TITIN.8.19.m.35861,-0.0196103708814782,-0.01927716217684,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TLE4.1.1.m.19069,-0.00457918694465193,-0.00194540726024357,No,NA,NA,Q62441,NA,NA,NA,beta-catenin-TCF complex [GO:1990907]; nucleus [GO:0005634]; transcription factor complex [GO:0005667]; chromatin binding [GO:0003682]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; repressing transcription factor binding [GO:0070491]; transcription corepressor activity [GO:0003714]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_TLN1.4.4.m.33719,0.00166952052247918,-0.00097854990095042,No,NA,NA,Q9Y490,NA,NA,NA,cell surface [GO:0009986]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; integrin binding [GO:0005178]; LIM domain binding [GO:0030274]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; structural constituent of cytoskeleton [GO:0005200]; vinculin binding [GO:0017166]; cell-cell junction assembly [GO:0007043]; cell-substrate junction assembly [GO:0007044]; cortical actin cytoskeleton organization [GO:0030866]; cytoskeletal anchoring at plasma membrane [GO:0007016]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; IRE1-mediated unfolded protein response [GO:0036498]; muscle contraction [GO:0006936]; platelet aggregation [GO:0070527]; platelet degranulation [GO:0002576]; viral process [GO:0016032],NA,NA,NA
CHOYP_TLN2.1.2.m.5591,-0.00112322321497365,0.00114194438925503,No,NA,NA,Q9Y4G6,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; synapse [GO:0045202]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cell adhesion [GO:0007155]; cell-cell junction assembly [GO:0007043]; cytoskeletal anchoring at plasma membrane [GO:0007016],NA,NA,NA
CHOYP_TLR1.1.3.m.1564,-0.00553577134897062,-0.0110795565510876,No,NA,NA,Q9Y2C9,NA,NA,NA,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; Toll-like receptor 2-Toll-like receptor 6 protein complex [GO:0035355]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; lipopeptide binding [GO:0071723]; protein heterodimerization activity [GO:0046982]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; Toll-like receptor 2 binding [GO:0035663]; transmembrane signaling receptor activity [GO:0004888]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; cell activation [GO:0001775]; cellular response to amyloid-beta [GO:1904646]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; defense response to bacterium [GO:0042742]; detection of diacyl bacterial lipopeptide [GO:0042496]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1 beta secretion [GO:0050702]; microglial cell activation [GO:0001774]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of interleukin-8 secretion [GO:2000483]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; nitric oxide metabolic process [GO:0046209]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-6 biosynthetic process [GO:0045410]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; signal transduction [GO:0007165]; toll-like receptor 6 signaling pathway [GO:0034150]; toll-like receptor signaling pathway [GO:0002224]; toll-like receptor TLR6:TLR2 signaling pathway [GO:0038124]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666],NA,NA,NA
CHOYP_TM9S4.1.1.m.23520,-0.00947411067296243,0.0151697765500582,No,NA,NA,Q8BH24,NA,NA,NA,early endosome [GO:0005769]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; cell adhesion [GO:0007155]; phagocytosis [GO:0006909]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to cell surface [GO:2000010]; protein localization to membrane [GO:0072657]; regulation of intracellular pH [GO:0051453]; response to hypoxia [GO:0001666]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072],NA,NA,NA
CHOYP_TMC3.1.1.m.4078,-0.00555764996833865,0.00167124530455384,No,NA,NA,Q7TQ69,NA,NA,NA,integral component of plasma membrane [GO:0005887]; ion channel activity [GO:0005216]; mechanosensitive ion channel activity [GO:0008381],NA,NA,NA
CHOYP_TMCO4.1.1.m.378,-0.012240132080391,0.00615582637569194,No,NA,NA,Q91WU4,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TMED7.1.3.m.6189,0.00116440190876667,0.00759896256478237,No,NA,NA,D3ZTX0,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMED7.2.3.m.28259,0.0234717842785822,0.0128672467057945,No,NA,NA,D3ZTX0,NA,NA,NA,COPI-coated vesicle membrane [GO:0030663]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_TMEDA.1.2.m.42794,0.00501586895593519,0.00181220869204322,No,NA,NA,Q9D1D4,NA,NA,NA,cis-Golgi network [GO:0005801]; COPI-coated vesicle [GO:0030137]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network transport vesicle [GO:0030140]; transport vesicle membrane [GO:0030658]; zymogen granule membrane [GO:0042589]; protein-containing complex binding [GO:0044877]; syntaxin binding [GO:0019905]; COPI-coated vesicle budding [GO:0035964]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; intracellular protein transport [GO:0006886]; kidney development [GO:0001822]; protein complex oligomerization [GO:0051259]; regulated exocytosis [GO:0045055]; regulation of amyloid-beta formation [GO:1902003]; response to alkaloid [GO:0043279]; retrograde vesicle-mediated transport; Golgi to endoplasmic reticulum [GO:0006890]; vesicle targeting; to; from or within Golgi [GO:0048199],NA,NA,NA
CHOYP_TMEDA.1.2.m.42795,-0.0211007667803222,-0.00371988945519705,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEL_0889.1.2.m.168,0.0238227061482523,-0.0126895821873575,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TMEM16.2.2.m.41752,0.00310718197157376,0.0113266592430851,No,NA,NA,A2AHL1,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; phospholipid scramblase activity [GO:0017128]; protein dimerization activity [GO:0046983]; calcium activated galactosylceramide scrambling [GO:0061591]; calcium activated phosphatidylcholine scrambling [GO:0061590]; detection of mechanical stimulus [GO:0050982]; detection of temperature stimulus [GO:0016048],NA,NA,NA
CHOYP_TMEM2.1.4.m.6314,-0.0127335981045625,0.00819000711929353,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.2.4.m.8174,-0.0138600166758303,0.0112133377073888,No,NA,NA,Q5FWI3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.3.4.m.10491,-0.0224055682205768,-0.0138221585583823,No,NA,NA,Q5FWI3,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; hyaluronan catabolic process [GO:0030214]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMEM2.4.4.m.28440,0.00740531952831903,-0.00484461139309748,No,NA,NA,A3KPQ7,NA,NA,NA,integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; hyalurononglucosaminidase activity [GO:0004415]; angiogenesis [GO:0001525]; atrioventricular valve formation [GO:0003190]; cardiac muscle tissue morphogenesis [GO:0055008]; cell migration involved in heart formation [GO:0060974]; cell migration to the midline involved in heart development [GO:0003318]; embryonic heart tube morphogenesis [GO:0003143]; endocardial cushion development [GO:0003197]; heart looping [GO:0001947]; hyaluronan catabolic process [GO:0030214]; muscle attachment [GO:0016203]; muscle tissue morphogenesis [GO:0060415]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TMM98.1.1.m.51750,0.0075141364673646,-0.0136417840451707,No,NA,NA,Q6INX1,NA,NA,NA,integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_TNNC.1.1.m.66691,0.000305101788572591,0.000576421429065655,No,NA,NA,Q9BLG0,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_TNNC2.1.1.m.32533,0.0206914999925888,-0.0310809014713698,No,NA,NA,P02595,NA,NA,NA,calcium ion binding [GO:0005509],NA,NA,NA
CHOYP_TNNI.3.3.m.56962,0.00061270493493649,0.00581914433611915,No,NA,NA,Q7M3Y3,NA,NA,NA,troponin complex [GO:0005861]; actin binding [GO:0003779]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_TNPO1.1.1.m.8874,-0.000595292815499063,0.00257136671111207,No,NA,NA,Q92973,NA,NA,NA,cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nucleus [GO:0005634]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; intraciliary transport involved in cilium assembly [GO:0035735]; NLS-bearing protein import into nucleus [GO:0006607]; protein import into nucleus; translocation [GO:0000060]; regulation of mRNA stability [GO:0043488]; ribosomal protein import into nucleus [GO:0006610]; viral process [GO:0016032],NA,NA,NA
CHOYP_TNPO3.1.1.m.11099,-0.00391354557260871,0.00400213061249908,No,NA,NA,Q9Y5L0,NA,NA,NA,cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; signaling receptor activity [GO:0038023]; protein import into nucleus [GO:0006606],NA,NA,NA
CHOYP_TNRC6A.1.2.m.16253,-0.00423724566242264,-0.00549467988506161,No,NA,NA,Q9HCJ0,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TNRC6A.2.2.m.59802,0.00254228506589386,-0.000418894758462923,No,NA,NA,Q9HCJ0,NA,NA,NA,cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; RNA binding [GO:0003723]; gene silencing by miRNA [GO:0035195]; miRNA mediated inhibition of translation [GO:0035278]; negative regulation of gene expression [GO:0010629]; positive regulation of gene expression [GO:0010628]; positive regulation of nuclear-transcribed mRNA catabolic process; deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; posttranscriptional gene silencing by RNA [GO:0035194]; regulation of megakaryocyte differentiation [GO:0045652]; Wnt signaling pathway; calcium modulating pathway [GO:0007223],NA,NA,NA
CHOYP_TOL2_C08810.1.1.m.6377,-0.00598350345459291,0.000779787368076238,No,NA,NA,C5BMZ8,NA,NA,NA,carboxyl-O-methyltransferase activity [GO:0010340]; malonyl-CoA methyltransferase activity [GO:0102130]; methyl indole-3-acetate esterase activity [GO:0080030]; biotin biosynthetic process [GO:0009102],NA,NA,NA
CHOYP_TOLIP.1.1.m.57590,0.00314745680896811,-0.00304597099651003,No,NA,NA,Q9H0E2,NA,NA,NA,azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; interleukin-1 receptor complex [GO:0045323]; interleukin-18 receptor complex [GO:0045092]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; specific granule lumen [GO:0035580]; interleukin-1; type I receptor binding [GO:0005150]; kinase binding [GO:0019900]; SUMO binding [GO:0032183]; Toll-like receptor binding [GO:0035325]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase binding [GO:0031625]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; epithelial cell differentiation [GO:0030855]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; leukocyte activation [GO:0045321]; neutrophil degranulation [GO:0043312]; phosphorylation [GO:0016310]; positive regulation of protein sumoylation [GO:0033235]; protein localization to endosome [GO:0036010]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TOLL.1.1.1.m.37581,-0.00253240230488047,0.0190636421334792,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TOM20.1.1.m.11207,0.00176165310923458,0.00214065047585265,No,NA,NA,Q6DFM9,NA,NA,NA,integral component of mitochondrial outer membrane [GO:0031307]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion targeting sequence binding [GO:0030943]; P-P-bond-hydrolysis-driven protein transmembrane transporter activity [GO:0015450]; mitochondrial outer membrane translocase complex assembly [GO:0070096]; protein import into mitochondrial matrix [GO:0030150]; tRNA import into mitochondrion [GO:0016031],NA,NA,NA
CHOYP_TOMM70A.1.1.m.42370,0.00400705304802305,0.00301556904816235,No,NA,NA,O94826,NA,NA,NA,extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrial outer membrane translocase complex [GO:0005742]; mitochondrion [GO:0005739]; protein transmembrane transporter activity [GO:0008320]; protein targeting to mitochondrion [GO:0006626],NA,NA,NA
CHOYP_TONSL.1.1.m.18360,-0.00378270466940536,0.00300450259915472,No,NA,NA,Q8TAQ2,NA,NA,NA,nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; SWI/SNF complex [GO:0016514]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; transcription coactivator activity [GO:0003713]; ATP-dependent chromatin remodeling [GO:0043044]; chromatin remodeling [GO:0006338]; negative regulation of transcription; DNA-templated [GO:0045892]; nervous system development [GO:0007399]; nucleosome disassembly [GO:0006337]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_TOP1.5.5.m.61515,-0.00848060248273494,0.0014052169711341,No,NA,NA,P11387,NA,NA,NA,DNA topoisomerase complex (ATP-hydrolyzing) [GO:0009330]; fibrillar center [GO:0001650]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; perikaryon [GO:0043204]; protein-DNA complex [GO:0032993]; replication fork protection complex [GO:0031298]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase type I activity [GO:0003917]; double-stranded DNA binding [GO:0003690]; protein domain specific binding [GO:0019904]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; chromatin remodeling [GO:0006338]; chromosome segregation [GO:0007059]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; DNA replication [GO:0006260]; DNA topological change [GO:0006265]; embryonic cleavage [GO:0040016]; peptidyl-serine phosphorylation [GO:0018105]; phosphorylation [GO:0016310]; programmed cell death [GO:0012501]; response to drug [GO:0042493]; viral process [GO:0016032],NA,NA,NA
CHOYP_TOP2B.1.1.m.6674,-0.00187646795149487,0.00889284702823923,No,NA,NA,Q64511,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; viral integration complex [GO:0019035]; ATP binding [GO:0005524]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type II (ATP-hydrolyzing) activity [GO:0003918]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; metal ion binding [GO:0046872]; protein C-terminus binding [GO:0008022]; protein heterodimerization activity [GO:0046982]; protein kinase C binding [GO:0005080]; ribonucleoprotein complex binding [GO:0043021]; axonogenesis [GO:0007409]; cell aging [GO:0007569]; cellular response to ATP [GO:0071318]; cellular response to hydrogen peroxide [GO:0070301]; DNA topological change [GO:0006265]; forebrain development [GO:0030900]; mitotic DNA integrity checkpoint [GO:0044774]; neuron migration [GO:0001764]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; positive regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045870]; resolution of meiotic recombination intermediates [GO:0000712]; sister chromatid segregation [GO:0000819],NA,NA,NA
CHOYP_TOP3B.1.1.m.1654,-0.0124493696102709,-0.00607025520972565,No,NA,NA,O95985,NA,NA,NA,condensed chromosome [GO:0000793]; nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA topoisomerase activity [GO:0003916]; DNA topoisomerase type I activity [GO:0003917]; RNA binding [GO:0003723]; chromosome segregation [GO:0007059]; DNA topological change [GO:0006265],NA,NA,NA
CHOYP_TPC2.1.2.m.19378,-0.00782251725914612,0.00497294758038949,No,NA,NA,A0JMD4,NA,NA,NA,integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; NAADP-sensitive calcium-release channel activity [GO:0072345]; voltage-gated calcium channel activity [GO:0005245]; calcium-mediated signaling [GO:0019722]; regulation of ion transmembrane transport [GO:0034765]; regulation of myotome development [GO:2000290]; skeletal myofibril assembly [GO:0014866]; smooth muscle contraction [GO:0006939],NA,NA,NA
CHOYP_TPM.18.19.m.66023,-0.0346153157408235,0.00212786253319911,No,NA,NA,Q9GZ71,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.19.19.m.66623,0.0213454673008047,0.026167381841725,No,NA,NA,P43689,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.6.19.m.12415,0.0033488880779159,-0.00400695781118596,No,NA,NA,O02389,NA,NA,NA,,NA,NA,NA
CHOYP_TPM.7.19.m.15554,-0.0171167576298137,0.0218030035385167,No,NA,NA,Q99020,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynaptic cytosol [GO:0099523]; ribonucleoprotein complex [GO:1990904]; RNA polymerase II transcription factor complex [GO:0090575]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; epithelial to mesenchymal transition [GO:0001837]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893],NA,NA,NA
CHOYP_TPM2.8.8.m.50799,0.00350647620694384,0.0169041588912807,No,NA,NA,Q25145,NA,NA,NA,,NA,NA,NA
CHOYP_TPP2.1.1.m.24017,0.00213585418005693,-0.00153940553982726,No,NA,NA,P29144,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; aminopeptidase activity [GO:0004177]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; tripeptidyl-peptidase activity [GO:0008240]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_TPPC3.1.1.m.58563,-0.000919992110409705,0.00431670107668768,No,NA,NA,Q5ZI57,NA,NA,NA,cis-Golgi network membrane [GO:0033106]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; TRAPP complex [GO:0030008]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intra-Golgi vesicle-mediated transport [GO:0006891],NA,NA,NA
CHOYP_TPPC8.1.1.m.6302,0.013253964549619,0.00539525108800533,No,NA,NA,Q9Y2L5,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; phagophore assembly site [GO:0000407]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072]; Rab guanyl-nucleotide exchange factor activity [GO:0017112]; autophagosome assembly [GO:0000045]; autophagy of peroxisome [GO:0030242]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; protein localization by the Cvt pathway [GO:0032258]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_TPR.1.2.m.29645,0.0129887547145292,-0.0135544825724096,No,NA,NA,Q5EE04,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TPR.2.2.m.46877,-0.000388587547954288,0.000879568862696732,No,NA,NA,F1MA98,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; extrinsic component of membrane [GO:0019898]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; heat shock protein binding [GO:0031072]; mitogen-activated protein kinase binding [GO:0051019]; mRNA binding [GO:0003729]; protein homodimerization activity [GO:0042803]; structural constituent of nuclear pore [GO:0017056]; tubulin binding [GO:0015631]; cell division [GO:0051301]; cellular response to heat [GO:0034605]; cellular response to interferon-alpha [GO:0035457]; mitotic spindle assembly checkpoint [GO:0007094]; mRNA export from nucleus in response to heat stress [GO:0031990]; negative regulation of RNA export from nucleus [GO:0046832]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translational initiation [GO:0045947]; nuclear pore organization [GO:0006999]; positive regulation of heterochromatin assembly [GO:0031453]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090267]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein import into nucleus [GO:0042307]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; regulation of mitotic sister chromatid separation [GO:0010965]; regulation of mitotic spindle assembly [GO:1901673]; response to epidermal growth factor [GO:0070849]; RNA export from nucleus [GO:0006405]; RNA import into nucleus [GO:0006404],NA,NA,NA
CHOYP_TR12A.1.2.m.32633,0.00446313112435583,0.00527084304165633,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRA2A.1.1.m.21305,-0.00669447122867356,0.0111070037982891,No,NA,NA,P62997,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; response to reactive oxygen species [GO:0000302],NA,NA,NA
CHOYP_TRAP1.1.1.m.60651,-0.000944456557206741,0.00311163621109676,No,NA,NA,Q5XHZ0,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; negative regulation of cellular respiration [GO:1901856]; negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide [GO:1903751]; protein folding [GO:0006457]; translational attenuation [GO:0009386],NA,NA,NA
CHOYP_TRD7B.1.1.m.56981,-0.00421533535721676,-0.000998889270974372,No,NA,NA,Q5M7P8,NA,NA,NA,cytoplasm [GO:0005737]; ribonucleoprotein granule [GO:0035770]; mRNA binding [GO:0003729]; lens fiber cell differentiation [GO:0070306]; lens morphogenesis in camera-type eye [GO:0002089]; posttranscriptional regulation of gene expression [GO:0010608]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_TRI10.1.1.m.35702,-0.012327462515519,-0.0120843696074231,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI33.5.8.m.56889,0.0219631451652495,-0.0170396483778176,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI45.13.23.m.35793,0.0030623382509507,0.00361654269423939,No,NA,NA,Q80VI1,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; interferon-beta production [GO:0032608]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral release from host cell [GO:1902187]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRI45.18.23.m.48495,-8.56748810269367e-05,0.0113669950793573,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRI46.2.3.m.61659,-0.00745647846053566,-0.00789739018414353,No,NA,NA,Q6PFY8,NA,NA,NA,cytosol [GO:0005829]; intercellular bridge [GO:0045171]; nucleoplasm [GO:0005654]; zinc ion binding [GO:0008270]; bone development [GO:0060348],NA,NA,NA
CHOYP_TRI56.4.4.m.61739,-0.0219219444577902,0.0132104824960506,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIADDRAFT_19804.1.1.m.8993,0.00756564988753171,-0.00407963234794886,No,NA,NA,A6H603,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524],NA,NA,NA
CHOYP_TRIADDRAFT_21078.2.2.m.64279,0.00248496509015729,-0.000671508542956722,No,NA,NA,Q89YT0,NA,NA,NA,deoxyribonuclease IV (phage-T4-induced) activity [GO:0008833]; DNA binding [GO:0003677]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; phosphoric diester hydrolase activity [GO:0008081]; zinc ion binding [GO:0008270]; base-excision repair [GO:0006284],NA,NA,NA
CHOYP_TRIADDRAFT_21752.1.1.m.62548,-0.00964408989062564,-0.00166283124383081,No,NA,NA,P91119,NA,NA,NA,3';5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3';5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; metal ion binding [GO:0046872]; chemosensory behavior [GO:0007635]; chemotaxis [GO:0006935]; determination of adult lifespan [GO:0008340]; microvillus organization [GO:0032528]; negative regulation of cGMP-mediated signaling [GO:0010754]; phototransduction [GO:0007602]; positive regulation of gene expression [GO:0010628]; response to alkaline pH [GO:0010446]; response to hydrogen peroxide [GO:0042542],NA,NA,NA
CHOYP_TRIADDRAFT_23075.1.1.m.48886,0.0148218641084648,-0.0288419844833177,No,NA,NA,Q9Z223,NA,NA,NA,cytosol [GO:0005829]; molybdopterin synthase complex [GO:0019008]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; molybdopterin synthase activity [GO:0030366]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],NA,NA,NA
CHOYP_TRIADDRAFT_25769.1.1.m.25945,-0.0158078754582589,-0.0104257924405638,No,NA,NA,Q5ZKX1,NA,NA,NA,cytosol [GO:0005829]; ESCRT III complex [GO:0000815]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; endosome transport via multivesicular body sorting pathway [GO:0032509]; late endosome to vacuole transport [GO:0045324]; protein transport [GO:0015031],NA,NA,NA
CHOYP_TRIADDRAFT_26208.1.1.m.10460,-0.00049081061753927,0.000169039838894929,No,NA,NA,P31029,NA,NA,NA,mitochondrial matrix [GO:0005759]; peroxisomal matrix [GO:0005782]; alanine-glyoxylate transaminase activity [GO:0008453]; amino acid binding [GO:0016597]; protein homodimerization activity [GO:0042803]; protein self-association [GO:0043621]; pyridoxal phosphate binding [GO:0030170]; serine-pyruvate transaminase activity [GO:0004760]; signaling receptor binding [GO:0005102]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; L-alanine catabolic process [GO:0042853]; L-cysteine catabolic process [GO:0019448]; Notch signaling pathway [GO:0007219]; oxalic acid secretion [GO:0046724],NA,NA,NA
CHOYP_TRIADDRAFT_26518.1.1.m.16475,0.000122202779985347,0.00335124821170481,No,NA,NA,P83088,NA,NA,NA,Golgi cisterna membrane [GO:0032580]; integral component of membrane [GO:0016021]; alpha-(1->3)-fucosyltransferase activity [GO:0046920]; fucosyltransferase activity [GO:0008417]; fucosylation [GO:0036065]; protein glycosylation [GO:0006486],NA,NA,NA
CHOYP_TRIADDRAFT_26633.4.6.m.50465,-0.0107069399654137,0.0198295002064086,No,NA,NA,A2RUV0,NA,NA,NA,integral component of membrane [GO:0016021]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; signaling receptor activity [GO:0038023]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cilium assembly [GO:0060271]; Notch signaling involved in heart development [GO:0061314]; regulation of developmental process [GO:0050793]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_TRIADDRAFT_29967.1.1.m.56654,-0.00299190508110395,-0.00719127416183395,No,NA,NA,Q55G11,NA,NA,NA,extracellular region [GO:0005576]; ceramidase activity [GO:0102121]; N-acylsphingosine amidohydrolase activity [GO:0017040]; ceramide catabolic process [GO:0046514]; ceramide metabolic process [GO:0006672]; long-chain fatty acid biosynthetic process [GO:0042759]; sphingosine biosynthetic process [GO:0046512],NA,NA,NA
CHOYP_TRIADDRAFT_29994.1.1.m.48948,-0.0307819006704909,0.00694135961758165,No,NA,NA,P16273,NA,NA,NA,defense response [GO:0006952]; response to biotic stimulus [GO:0009607],NA,NA,NA
CHOYP_TRIADDRAFT_32712.2.4.m.28430,-0.0167852702791542,-0.0106821045714618,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.3.4.m.44104,-0.0344677988421115,-0.0107170482856495,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_32712.4.4.m.44519,0.0214810572848333,0.0154235337939817,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_37121.1.1.m.51940,-0.0176359983484014,-0.0118271588172363,No,NA,NA,Q8BYK4,NA,NA,NA,intracellular [GO:0005622]; photoreceptor inner segment [GO:0001917]; retinol dehydrogenase activity [GO:0004745]; response to stimulus [GO:0050896]; retinol metabolic process [GO:0042572]; visual perception [GO:0007601],NA,NA,NA
CHOYP_TRIADDRAFT_38448.1.1.m.27929,0.005168977067185,0.00161147629076984,No,NA,NA,Q7Z0T3,NA,NA,NA,extracellular region [GO:0005576]; pheromone activity [GO:0005186],NA,NA,NA
CHOYP_TRIADDRAFT_49883.1.1.m.29857,-0.0296305457085046,-0.00588025667398177,No,NA,NA,Q9QY94,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; glutamate-ammonia ligase activity [GO:0004356]; metal ion binding [GO:0046872]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; angiogenesis [GO:0001525]; glutamine biosynthetic process [GO:0006542]; protein palmitoylation [GO:0018345]; regulation of endothelial cell migration [GO:0010594]; regulation of sprouting angiogenesis [GO:1903670],NA,NA,NA
CHOYP_TRIADDRAFT_50333.1.1.m.59774,-0.00646003859563146,0.00372526120730882,No,NA,NA,Q8BHW2,NA,NA,NA,basal plasma membrane [GO:0009925],NA,NA,NA
CHOYP_TRIADDRAFT_51343.2.2.m.65118,5.74333404626928e-05,0.00305776651956394,No,NA,NA,Q75JP5,NA,NA,NA,,NA,NA,NA
CHOYP_TRIADDRAFT_52608.1.2.m.25467,-0.00497322165292632,-0.00912331472940973,No,NA,NA,Q9UGM3,NA,NA,NA,cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; phagocytic vesicle membrane [GO:0030670]; zymogen granule membrane [GO:0042589]; calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; heparan sulfate binding [GO:1904399]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; pattern recognition receptor activity [GO:0038187]; scavenger receptor activity [GO:0005044]; signaling pattern recognition receptor activity [GO:0008329]; zymogen binding [GO:0035375]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular protein metabolic process [GO:0044267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; epithelial cell differentiation [GO:0030855]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; multicellular organism development [GO:0007275]; protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]; viral process [GO:0016032],NA,NA,NA
CHOYP_TRIADDRAFT_53531.1.2.m.12127,-0.00891430307295226,-0.00203417895233517,No,NA,NA,P86734,NA,NA,NA,extracellular region [GO:0005576]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_TRIADDRAFT_53596.1.1.m.47642,-0.00449463705827829,0.00141968088517304,No,NA,NA,Q9NTG1,NA,NA,NA,integral component of membrane [GO:0016021]; membrane [GO:0016020]; calcium channel activity [GO:0005262]; calcium ion binding [GO:0005509]; acrosome reaction [GO:0007340]; detection of mechanical stimulus [GO:0050982],NA,NA,NA
CHOYP_TRIADDRAFT_53677.1.1.m.35290,-0.00386949587961017,0.00395819455197169,No,NA,NA,Q8WWZ7,NA,NA,NA,Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; lipid transporter activity [GO:0005319]; cholesterol efflux [GO:0033344]; high-density lipoprotein particle remodeling [GO:0034375]; lipid transport [GO:0006869]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; reverse cholesterol transport [GO:0043691]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_TRIADDRAFT_55241.1.1.m.41679,-0.00354420531457703,-0.0022555235133783,No,NA,NA,Q9TU34,NA,NA,NA,axon [GO:0030424]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; integral component of endoplasmic reticulum membrane [GO:0030176]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; rough endoplasmic reticulum [GO:0005791]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]; secretory granule membrane [GO:0030667]; transport vesicle membrane [GO:0030658]; calcium ion binding [GO:0005509]; calcium-release channel activity [GO:0015278]; inositol 1;4;5 trisphosphate binding [GO:0070679]; inositol 1;4;5-trisphosphate-sensitive calcium-release channel activity [GO:0005220]; phosphatidylinositol binding [GO:0035091]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; release of sequestered calcium ion into cytosol [GO:0051209],NA,NA,NA
CHOYP_TRIADDRAFT_55525.1.1.m.53631,-0.00633427647430413,0.00163933046324487,No,NA,NA,P00491,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; intracellular [GO:0005622]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; drug binding [GO:0008144]; nucleoside binding [GO:0001882]; phosphate ion binding [GO:0042301]; purine nucleobase binding [GO:0002060]; purine-nucleoside phosphorylase activity [GO:0004731]; immune response [GO:0006955]; inosine catabolic process [GO:0006148]; interleukin-2 secretion [GO:0070970]; NAD biosynthesis via nicotinamide riboside salvage pathway [GO:0034356]; neutrophil degranulation [GO:0043312]; nicotinamide riboside catabolic process [GO:0006738]; nucleobase-containing compound metabolic process [GO:0006139]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of T cell proliferation [GO:0042102]; purine nucleotide catabolic process [GO:0006195]; purine-containing compound salvage [GO:0043101]; response to drug [GO:0042493]; urate biosynthetic process [GO:0034418],NA,NA,NA
CHOYP_TRIADDRAFT_55768.1.2.m.4473,0.00037315636447842,-0.0142617076302739,No,NA,NA,Q8IZJ3,NA,NA,NA,extracellular space [GO:0005615]; plasma membrane [GO:0005886]; serine-type endopeptidase inhibitor activity [GO:0004867]; eye development [GO:0001654],NA,NA,NA
CHOYP_TRIADDRAFT_55768.2.2.m.14361,0.00151292006584624,0.00356779167724458,No,NA,NA,Q6YHK3,NA,NA,NA,anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]; hair follicle development [GO:0001942]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of wound healing [GO:0061045]; osteoclast fusion [GO:0072675]; platelet degranulation [GO:0002576]; regulation of keratinocyte differentiation [GO:0045616],NA,NA,NA
CHOYP_TRIADDRAFT_57018.1.2.m.10706,-0.00250313983114796,-0.00219326556012474,No,NA,NA,Q05927,NA,NA,NA,anchored component of membrane [GO:0031225]; plasma membrane [GO:0005886]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide catabolic process [GO:0009166],NA,NA,NA
CHOYP_TRIADDRAFT_57086.1.1.m.25271,-0.00142755611249221,0.00177095814784601,No,NA,NA,Q6C0Y0,NA,NA,NA,actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; actin binding [GO:0003779]; actin filament depolymerization [GO:0030042]; cell cycle [GO:0007049]; cell division [GO:0051301],NA,NA,NA
CHOYP_TRIADDRAFT_57945.3.3.m.55640,-0.00327504836672987,0.0099141224090826,No,NA,NA,Q55E58,NA,NA,NA,actomyosin [GO:0042641]; ATP binding [GO:0005524]; GTP binding [GO:0005525]; phosphoprotein phosphatase activity [GO:0004721]; protein serine/threonine kinase activity [GO:0004674]; cheating during chimeric sorocarp development [GO:0099139]; mitotic cytokinesis [GO:0000281]; protein dephosphorylation [GO:0006470],NA,NA,NA
CHOYP_TRIADDRAFT_60787.1.1.m.6621,0.00498774863687292,-0.00905517088641311,No,NA,NA,Q32N22,NA,NA,NA,RNA polymerase I core factor complex [GO:0070860]; metal ion binding [GO:0046872]; RNA polymerase I CORE element sequence-specific DNA binding [GO:0001164]; RNA polymerase I preinitiation complex assembly [GO:0001188],NA,NA,NA
CHOYP_TRIADDRAFT_61434.1.1.m.8434,0.00270551653856777,0.0124837622660604,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.1.2.m.5483,0.0200058933311632,0.0102627872337022,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_62546.2.2.m.56798,0.0139106198437961,-0.00712929546151577,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_63204.1.2.m.30701,0.00124574953347962,-0.000926398235444941,No,NA,NA,Q9BYV1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63204.2.2.m.38038,0.00278641761544197,0.00183861867820797,No,NA,NA,Q9BYV1,NA,NA,NA,mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; (R)-3-amino-2-methylpropionate-pyruvate transaminase activity [GO:0047305]; alanine-glyoxylate transaminase activity [GO:0008453]; pyridoxal phosphate binding [GO:0030170]; glycine biosynthetic process; by transamination of glyoxylate [GO:0019265]; glyoxylate catabolic process [GO:0009436]; glyoxylate metabolic process [GO:0046487]; L-alanine catabolic process; by transamination [GO:0019481]; positive regulation of nitric oxide biosynthetic process [GO:0045429],NA,NA,NA
CHOYP_TRIADDRAFT_63666.3.3.m.57696,-0.00247775675816353,0.00265892143091241,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64314.1.2.m.9124,-0.00071637548675878,0.00491802844949827,No,NA,NA,Q93T20,NA,NA,NA,NAD(P)H dehydrogenase (quinone) activity [GO:0003955],NA,NA,NA
CHOYP_TRIADDRAFT_64314.2.2.m.54695,0.000332740372632216,-0.00171484621559904,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIADDRAFT_64367.1.1.m.42126,0,0,No,NA,NA,Q1JPJ2,NA,NA,NA,cytosol [GO:0005829]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815],NA,NA,NA
CHOYP_TRIB2.1.1.m.226,0.00914413107803528,-0.00520140821391755,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.16.59.m.31979,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM2.42.59.m.43682,-0.000458333108051827,-0.0167521274166541,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM33.1.1.m.36639,0.00266729350905051,0.00911951152682771,No,NA,NA,Q9UPN9,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634]; co-SMAD binding [GO:0070410]; DNA binding [GO:0003677]; R-SMAD binding [GO:0070412]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892]; protein ubiquitination [GO:0016567]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015],NA,NA,NA
CHOYP_TRIM5.1.2.m.60878,0.00406902632739212,-0.0010995671332295,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TRIM56.2.2.m.59948,-0.0100115038321008,0.0010142416218161,No,NA,NA,E1BD59,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; defense response to virus [GO:0051607]; interferon-beta production [GO:0032608]; protein K63-linked ubiquitination [GO:0070534]; response to type I interferon [GO:0034340],NA,NA,NA
CHOYP_TRIO.1.1.m.49282,-0.0033804757270197,0.00719154215512728,No,NA,NA,Q0KL02,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; negative regulation of fat cell differentiation [GO:0045599]; regulation of Rho protein signal transduction [GO:0035023],NA,NA,NA
CHOYP_TRIPC.1.1.m.6424,-0.00273623847734155,-0.0028594394822123,No,NA,NA,G5E870,NA,NA,NA,nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; thyroid hormone receptor binding [GO:0046966]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; regulation of embryonic development [GO:0045995]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_TRM13.1.1.m.16853,-0.00291612329722502,0.00395886121268413,No,NA,NA,Q8BYH3,NA,NA,NA,metal ion binding [GO:0046872]; tRNA 2'-O-methyltransferase activity [GO:0106050]; tRNA methyltransferase activity [GO:0008175]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRM5.1.1.m.24347,-0.00953593510672817,-0.00606864556260671,No,NA,NA,Q3MHN8,NA,NA,NA,cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; nucleus [GO:0005634]; tRNA (guanine(37)-N(1))-methyltransferase activity [GO:0052906]; tRNA (guanine-N1-)-methyltransferase activity [GO:0009019]; tRNA methyltransferase activity [GO:0008175]; mitochondrial tRNA methylation [GO:0070901]; tRNA methylation [GO:0030488]; tRNA N1-guanine methylation [GO:0002939],NA,NA,NA
CHOYP_TRMT2A.1.1.m.17768,-0.000517717100068429,0.00050080294762637,No,NA,NA,Q8IZ69,NA,NA,NA,RNA binding [GO:0003723]; RNA methyltransferase activity [GO:0008173]; RNA processing [GO:0006396],NA,NA,NA
CHOYP_TRMT6.1.1.m.8062,-0.00194345993284438,0.00615655330484857,No,NA,NA,Q8CE96,NA,NA,NA,nucleus [GO:0005634]; tRNA (m1A) methyltransferase complex [GO:0031515]; mRNA methylation [GO:0080009]; tRNA methylation [GO:0030488],NA,NA,NA
CHOYP_TRNT1.1.1.m.1512,0.00592270041847538,-0.0107525595820621,No,NA,NA,Q8K1J6,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity [GO:0052929]; CTP:3'-cytidine-tRNA cytidylyltransferase activity [GO:0052928]; CTP:tRNA cytidylyltransferase activity [GO:0052927]; tRNA binding [GO:0000049]; tRNA nucleotidyltransferase activity [GO:0009022]; mitochondrial tRNA 3'-end processing [GO:1990180]; tRNA 3'-terminal CCA addition [GO:0001680]; tRNA processing [GO:0008033],NA,NA,NA
CHOYP_TRPM3.1.7.m.9000,-0.00194921846675891,-0.00922348134818029,No,NA,NA,A8DYE2,NA,NA,NA,cation channel complex [GO:0034703]; divalent inorganic cation transmembrane transporter activity [GO:0072509]; intracellular phosphatidylinositol-3;5-bisphosphate-sensitive cation channel activity [GO:0097682]; zinc ion transmembrane transporter activity [GO:0005385]; cation transmembrane transport [GO:0098655]; divalent metal ion transport [GO:0070838]; magnesium ion homeostasis [GO:0010960]; protein tetramerization [GO:0051262]; zinc ion homeostasis [GO:0055069],NA,NA,NA
CHOYP_TRPM3.3.7.m.16169,0.00415201454447691,0.00249577046545536,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRPM3.7.7.m.59826,-1.60096078750425e-06,0.00900726508467592,No,NA,NA,Q9HCF6,NA,NA,NA,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium activated cation channel activity [GO:0005227]; calcium channel activity [GO:0005262]; cation channel activity [GO:0005261]; calcium ion transmembrane transport [GO:0070588]; cation transport [GO:0006812]; detection of temperature stimulus [GO:0016048]; protein tetramerization [GO:0051262]; sensory perception of temperature stimulus [GO:0050951],NA,NA,NA
CHOYP_TRRAP.1.2.m.339,0.00514616162153908,0.0286626568052688,No,NA,NA,Q8I8U7,NA,NA,NA,cytoplasm [GO:0005737]; histone acetyltransferase complex [GO:0000123]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleus [GO:0005634]; polytene chromosome [GO:0005700]; polytene chromosome puff [GO:0005703]; SAGA complex [GO:0000124]; transcription coregulator activity [GO:0003712]; DNA repair [GO:0006281]; histone acetylation [GO:0016573]; histone exchange [GO:0043486]; histone H3 acetylation [GO:0043966]; mitotic cytokinesis [GO:0000281]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of transcription; DNA-templated [GO:0006355]; transcription; DNA-templated [GO:0006351]; wing disc pattern formation [GO:0035222],NA,NA,NA
CHOYP_TRXR2.1.1.m.10443,0.002204023338275,0.0101502531973159,No,NA,NA,Q9JLT4,NA,NA,NA,axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; protein homodimerization activity [GO:0042803]; thioredoxin-disulfide reductase activity [GO:0004791]; cell redox homeostasis [GO:0045454]; heart development [GO:0007507]; hemopoiesis [GO:0030097]; response to oxygen radical [GO:0000305],NA,NA,NA
CHOYP_TS101.4.4.m.57290,-0.00491979695794259,-0.00747218224264144,No,NA,NA,Q61187,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; microtubule organizing center [GO:0005815]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; calcium-dependent protein binding [GO:0048306]; nuclear receptor transcription coactivator activity [GO:0030374]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790]; cell cycle arrest [GO:0007050]; cell differentiation [GO:0030154]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; negative regulation of cell proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; positive regulation of viral process [GO:0048524]; positive regulation of viral release from host cell [GO:1902188]; protein monoubiquitination [GO:0006513]; protein transport [GO:0015031]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; regulation of viral budding via host ESCRT complex [GO:1903772]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755],NA,NA,NA
CHOYP_TSC1.1.1.m.5136,0.00400036677969984,0.0109451670226006,No,NA,NA,Q9Z136,NA,NA,NA,actin filament [GO:0005884]; cell cortex [GO:0005938]; cell projection [GO:0042995]; chaperone complex [GO:0101031]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; TSC1-TSC2 complex [GO:0033596]; ATPase inhibitor activity [GO:0042030]; chaperone binding [GO:0051087]; GTPase activating protein binding [GO:0032794]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; protein N-terminus binding [GO:0047485]; activation of GTPase activity [GO:0090630]; adaptive immune response [GO:0002250]; adult locomotory behavior [GO:0008344]; cardiac muscle cell differentiation [GO:0055007]; cell projection organization [GO:0030030]; cell-matrix adhesion [GO:0007160]; cellular response to oxygen-glucose deprivation [GO:0090650]; cerebral cortex development [GO:0021987]; glucose import [GO:0046323]; hippocampus development [GO:0021766]; kidney development [GO:0001822]; memory T cell differentiation [GO:0043379]; myelination [GO:0042552]; negative regulation of ATPase activity [GO:0032780]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cell size [GO:0045792]; negative regulation of GTPase activity [GO:0034260]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of macroautophagy [GO:0016242]; negative regulation of neuron projection development [GO:0010977]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of TOR signaling [GO:0032007]; negative regulation of translation [GO:0017148]; neural tube closure [GO:0001843]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of macroautophagy [GO:0016239]; positive regulation of stress fiber assembly [GO:0051496]; potassium ion transport [GO:0006813]; protein heterooligomerization [GO:0051291]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of focal adhesion assembly [GO:0051893]; regulation of neuron death [GO:1901214]; regulation of phosphoprotein phosphatase activity [GO:0043666]; regulation of protein kinase activity [GO:0045859]; response to insulin [GO:0032868]; rRNA export from nucleus [GO:0006407]; synapse organization [GO:0050808],NA,NA,NA
CHOYP_TSIB_0893.1.1.m.10314,0.00119853742384197,0.00746172535499534,No,NA,NA,P0AGF9,NA,NA,NA,L-serine ammonia-lyase activity [GO:0003941]; L-threonine ammonia-lyase activity [GO:0004794]; nucleotide binding [GO:0000166]; pyridoxal phosphate binding [GO:0030170]; L-threonine catabolic process to propionate [GO:0070689],NA,NA,NA
CHOYP_TSN3.1.1.m.57074,-0.00375360574222598,0.00509580791551154,No,NA,NA,Q6NWG0,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; cell surface receptor signaling pathway [GO:0007166]; multicellular organism development [GO:0007275]; pigmentation [GO:0043473],NA,NA,NA
CHOYP_TSP_00320.1.1.m.7280,0.00546711041232971,-0.0145611073849007,No,NA,NA,Q2HJC9,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; neuronal ribonucleoprotein granule [GO:0071598]; nuclear speck [GO:0016607]; double-stranded DNA binding [GO:0003690]; ribonucleoprotein complex binding [GO:0043021]; activation of innate immune response [GO:0002218]; alternative mRNA splicing; via spliceosome [GO:0000380]; cellular response to exogenous dsRNA [GO:0071360]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; neuron projection development [GO:0031175]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of type I interferon production [GO:0032481]; regulation of dendrite morphogenesis [GO:0048814]; regulation of RNA splicing [GO:0043484],NA,NA,NA
CHOYP_TSP_02835.1.1.m.26375,-0.0244461463359114,0.00337559987881182,No,NA,NA,O01814,NA,NA,NA,nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; fatty acid binding [GO:0005504],NA,NA,NA
CHOYP_TSP_03740.1.1.m.61194,0.00995811256097681,0.00366424300163057,No,NA,NA,P24367,NA,NA,NA,endoplasmic reticulum lumen [GO:0005788]; melanosome [GO:0042470]; protein-containing complex [GO:0032991]; cyclosporin A binding [GO:0016018]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; unfolded protein binding [GO:0051082]; chaperone-mediated protein folding [GO:0061077]; negative regulation of collagen fibril organization [GO:1904027]; protein peptidyl-prolyl isomerization [GO:0000413]; protein refolding [GO:0042026],NA,NA,NA
CHOYP_TSP_06726.1.1.m.7470,-0.00740954370913365,0.0107644444819616,No,NA,NA,Q3ZBG5,NA,NA,NA,axon [GO:0030424]; chaperone complex [GO:0101031]; dendritic microtubule [GO:1901588]; adenyl-nucleotide exchange factor activity [GO:0000774]; chaperone binding [GO:0051087]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; ion channel binding [GO:0044325]; tau protein binding [GO:0048156]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of protein binding [GO:0032091]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein processing [GO:0010954]; protein metabolic process [GO:0019538]; protein stabilization [GO:0050821],NA,NA,NA
CHOYP_TSP_07884.1.1.m.41175,0.0036875571129215,0.00435491008616914,No,NA,NA,Q96KE9,NA,NA,NA,cytosol [GO:0005829]; neurogenesis [GO:0022008]; post-translational protein modification [GO:0043687],NA,NA,NA
CHOYP_TSP_10783.1.2.m.5651,0.00761956914625163,-0.0138331952396476,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSP_10831.1.1.m.47028,-0.0140176687417444,-0.00892080978483771,No,NA,NA,Q18206,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]; molting cycle; collagen and cuticulin-based cuticle [GO:0018996]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_TSP1.1.1.m.43967,0.00459660393630261,-0.00124213367183372,No,NA,NA,P30151,NA,NA,NA,eukaryotic translation elongation factor 1 complex [GO:0005853]; translation elongation factor activity [GO:0003746],NA,NA,NA
CHOYP_TSPAN18A.2.2.m.50689,0.01430068799337,0.0115900577173674,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TSSC1.1.1.m.66470,-0.0095099552864288,0.00245504674147099,No,NA,NA,Q6DUZ9,NA,NA,NA,,NA,NA,NA
CHOYP_TT30A.1.1.m.28332,-0.00397671947268702,-1.85883059753863e-05,No,NA,NA,Q6INU8,NA,NA,NA,axonemal microtubule [GO:0005879]; cilium [GO:0005929]; transporter activity [GO:0005215]; intraciliary transport [GO:0042073]; protein polyglutamylation [GO:0018095],NA,NA,NA
CHOYP_TT39C.1.1.m.6317,0.0039558114794399,0.00467171159205398,No,NA,NA,Q8N584,NA,NA,NA,,NA,NA,NA
CHOYP_TTC1.1.2.m.53162,-0.00724912887063287,0.0253012223650938,No,NA,NA,Q3ZBR5,NA,NA,NA,cytosol [GO:0005829],NA,NA,NA
CHOYP_TTC12.1.1.m.14571,-0.00495176584460391,0.00672240222323625,No,NA,NA,Q9H892,NA,NA,NA,centrosome [GO:0005813],NA,NA,NA
CHOYP_TTC14.1.1.m.54084,0.00183367386595723,0.00181377248116336,No,NA,NA,Q9CSP9,NA,NA,NA,nucleic acid binding [GO:0003676],NA,NA,NA
CHOYP_TTC28.1.1.m.51607,0.00514103058232768,-0.00494729890897502,No,NA,NA,Q96AY4,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922]; kinase binding [GO:0019900]; cell cycle [GO:0007049]; cell division [GO:0051301]; regulation of mitotic cell cycle [GO:0007346],NA,NA,NA
CHOYP_TTC38.1.1.m.27111,0.000674307474223071,0.00188182483770166,No,NA,NA,A3KPN8,NA,NA,NA,,NA,NA,NA
CHOYP_TTC4.1.1.m.16365,0.000638007817483318,0.00803151131815108,No,NA,NA,O95801,NA,NA,NA,,NA,NA,NA
CHOYP_TTC8.1.1.m.35457,-0.00812650172261017,-0.0171780821575536,No,NA,NA,Q8TAM2,NA,NA,NA,BBSome [GO:0034464]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary membrane [GO:0060170]; cilium [GO:0005929]; cytosol [GO:0005829]; non-motile cilium [GO:0097730]; RNA polymerase II repressing transcription factor binding [GO:0001103]; cilium assembly [GO:0060271]; establishment of anatomical structure orientation [GO:0048560]; non-motile cilium assembly [GO:1905515]; protein transport [GO:0015031]; sensory processing [GO:0050893],NA,NA,NA
CHOYP_TTHERM_00599920.1.1.m.38926,0.00506764704628363,0.00598476079398844,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TTL11.1.1.m.51011,-0.00241199547014293,0.00327446899141929,No,NA,NA,Q6DIB5,NA,NA,NA,cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; complement component C1q binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast migration [GO:0051451]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841],NA,NA,NA
CHOYP_TTL12.1.1.m.6226,0.00235718779478459,-2.31946141250206e-05,No,NA,NA,Q3UDE2,NA,NA,NA,ATP binding [GO:0005524]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_TTN.2.9.m.17508,0.00516347814861996,-0.00937420475810659,No,NA,NA,A2ASS6,NA,NA,NA,A band [GO:0031672]; condensed nuclear chromosome [GO:0000794]; I band [GO:0031674]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; myofibril [GO:0030016]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein kinase binding [GO:0019901]; protein self-association [GO:0043621]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of muscle [GO:0008307]; telethonin binding [GO:0031433]; adult heart development [GO:0007512]; cardiac muscle contraction [GO:0060048]; cardiac muscle fiber development [GO:0048739]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; forward locomotion [GO:0043056]; heart development [GO:0007507]; heart growth [GO:0060419]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; regulation of catalytic activity [GO:0050790]; regulation of protein kinase activity [GO:0045859]; regulation of relaxation of cardiac muscle [GO:1901897]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; somitogenesis [GO:0001756]; striated muscle cell development [GO:0055002]; striated muscle myosin thick filament assembly [GO:0071688]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TUT4.2.2.m.35505,-0.000766165146061495,-0.0160812881749474,No,NA,NA,Q5TAX3,NA,NA,NA,cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; RNA uridylyltransferase activity [GO:0050265]; zinc ion binding [GO:0008270]; miRNA catabolic process [GO:0010587]; miRNA metabolic process [GO:0010586]; negative regulation of transposition; RNA-mediated [GO:0010526]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; oocyte maturation [GO:0001556]; polyuridylation-dependent mRNA catabolic process [GO:1990074]; pre-miRNA processing [GO:0031054]; RNA 3' uridylation [GO:0071076]; RNA 3'-end processing [GO:0031123]; stem cell population maintenance [GO:0019827],NA,NA,NA
CHOYP_TVAG_008910.1.4.m.27225,-8.76372662040583e-05,0.0116273563706108,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_008910.2.4.m.37672,-0.00269442270561508,0.00365788564221051,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_012450.7.8.m.63509,-4.82400208722116e-05,0.00640028994858034,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_020440.14.21.m.33137,0.00221972637452643,-0.000599833466242579,No,NA,NA,P16157,NA,NA,NA,axolemma [GO:0030673]; axon initial segment [GO:0043194]; basolateral plasma membrane [GO:0016323]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; sarcolemma [GO:0042383]; sarcoplasmic reticulum [GO:0016529]; spectrin-associated cytoskeleton [GO:0014731]; Z disc [GO:0030018]; ATPase binding [GO:0051117]; cytoskeletal adaptor activity [GO:0008093]; enzyme binding [GO:0019899]; ion channel binding [GO:0044325]; protein phosphatase binding [GO:0019903]; spectrin binding [GO:0030507]; structural constituent of cytoskeleton [GO:0005200]; structural molecule activity [GO:0005198]; cytoskeleton organization [GO:0007010]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; positive regulation of organelle organization [GO:0010638]; protein localization to plasma membrane [GO:0072659]; signal transduction [GO:0007165],NA,NA,NA
CHOYP_TVAG_087170.4.8.m.31291,0.00241407726207835,0.00200479786948294,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087170.6.8.m.41156,-0.0104127412999405,0.00899408822428492,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.3.4.m.52917,0.00733812704213225,0.00866613925988907,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_087500.4.4.m.60594,0.00433482361900148,-0.00117139315312708,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_098350.1.1.m.14015,0.00234087020248574,-0.00424980913226421,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_106580.1.1.m.44429,0.0040995305308333,0.00715821738445429,No,NA,NA,H2A0M0,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_TVAG_110290.2.8.m.6221,-0.00249438895528462,-0.00555852065190337,No,NA,NA,Q14980,NA,NA,NA,cell cortex [GO:0005938]; cell cortex region [GO:0099738]; centrosome [GO:0005813]; chromosome [GO:0005694]; cortical microtubule [GO:0055028]; cytoplasm [GO:0005737]; cytoplasmic microtubule bundle [GO:1905720]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extrinsic component of plasma membrane [GO:0019897]; Golgi membrane [GO:0000139]; lateral cell cortex [GO:0097575]; lateral plasma membrane [GO:0016328]; microtubule bundle [GO:0097427]; microtubule minus-end [GO:0036449]; microtubule plus-end [GO:0035371]; mitotic spindle [GO:0072686]; mitotic spindle astral microtubule [GO:0061673]; mitotic spindle midzone [GO:1990023]; mitotic spindle pole [GO:0097431]; neuronal cell body [GO:0043025]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; spindle pole centrosome [GO:0031616]; disordered domain specific binding [GO:0097718]; dynein complex binding [GO:0070840]; microtubule binding [GO:0008017]; microtubule minus-end binding [GO:0051011]; microtubule plus-end binding [GO:0051010]; phosphatidylinositol binding [GO:0035091]; protein C-terminus binding [GO:0008022]; protein domain specific binding [GO:0019904]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]; tubulin binding [GO:0015631]; anastral spindle assembly [GO:0055048]; astral microtubule organization [GO:0030953]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; establishment of mitotic spindle orientation [GO:0000132]; meiotic cell cycle [GO:0051321]; microtubule bundle formation [GO:0001578]; nucleus organization [GO:0006997]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chromosome segregation [GO:0051984]; positive regulation of chromosome separation [GO:1905820]; positive regulation of hair follicle development [GO:0051798]; positive regulation of intracellular transport [GO:0032388]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of mitotic spindle elongation [GO:1902846]; positive regulation of protein localization to cell cortex [GO:1904778]; positive regulation of protein localization to spindle pole body [GO:1902365]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236],NA,NA,NA
CHOYP_TVAG_117920.1.1.m.65694,0.00416361587288613,0.00323870038724396,No,NA,NA,Q4UMH6,NA,NA,NA,guanosine tetraphosphate metabolic process [GO:0015969],NA,NA,NA
CHOYP_TVAG_127540.1.10.m.21803,0.00310978596935157,-0.000840352990654831,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_166520.1.2.m.37665,-0.00244181474331832,-0.0124983863021169,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_168130.1.2.m.10205,-0.0107225210092508,-0.00682378590190234,No,NA,NA,O00461,NA,NA,NA,cis-Golgi network [GO:0005801]; endocytic vesicle [GO:0030139]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; transport vesicle [GO:0030133],NA,NA,NA
CHOYP_TVAG_193760.1.4.m.10065,0.000156139891757748,0.00281827384487469,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_199400.1.1.m.52426,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_216960.2.4.m.29368,-0.0240993769662605,0.0107862422753112,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_268110.1.13.m.574,0.00704337635036559,0.00631688001522392,No,NA,NA,Q96SN8,NA,NA,NA,cell junction [GO:0030054]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule plus-end [GO:0035371]; mitotic spindle pole [GO:0097431]; pericentriolar material [GO:0000242]; perinuclear region of cytoplasm [GO:0048471]; spindle pole [GO:0000922]; calmodulin binding [GO:0005516]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; transcription regulatory region DNA binding [GO:0044212]; tubulin binding [GO:0015631]; brain development [GO:0007420]; centriole replication [GO:0007099]; centrosome cycle [GO:0007098]; chromosome segregation [GO:0007059]; ciliary basal body-plasma membrane docking [GO:0097711]; establishment of mitotic spindle orientation [GO:0000132]; G2/M transition of mitotic cell cycle [GO:0000086]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; microtubule organizing center organization [GO:0031023]; negative regulation of centriole replication [GO:0046600]; negative regulation of neuron differentiation [GO:0045665]; neurogenesis [GO:0022008]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of mitotic cell cycle spindle assembly checkpoint [GO:0090266]; regulation of neuron differentiation [GO:0045664],NA,NA,NA
CHOYP_TVAG_283050.1.1.m.65542,0.000146245048777801,0.00202269058165613,No,NA,NA,O75832,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; transcription factor binding [GO:0008134]; apoptotic process [GO:0006915]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response; signal transduction by p53 class mediator [GO:0043518]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; post-translational protein modification [GO:0043687]; proteasome regulatory particle assembly [GO:0070682]; protein deubiquitination [GO:0016579],NA,NA,NA
CHOYP_TVAG_286470.1.2.m.41541,-0.00180020817715275,0.016069755745897,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_313830.1.4.m.32667,-0.00164723906802671,0.00223625347413618,No,NA,NA,Q9VCA8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; M band [GO:0031430]; Z disc [GO:0030018]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; antimicrobial humoral response [GO:0019730]; compound eye photoreceptor cell differentiation [GO:0001751]; flight [GO:0060361]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy of mitochondrion [GO:1903147]; sarcomere organization [GO:0045214]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],NA,NA,NA
CHOYP_TVAG_355490.1.22.m.8202,0.010750079847777,-0.00827582366782652,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.12.22.m.45126,-0.00308834887564282,0.00419267065513095,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.16.22.m.50235,0.00104137012146674,0.00297503053390366,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.19.22.m.56184,-0.00222662621845605,-0.019334022639106,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.2.22.m.9582,-0.00489221936992988,-0.00155238724343836,No,NA,NA,P49454,NA,NA,NA,axoneme [GO:0005930]; centrosome [GO:0005813]; chromosome; centromeric region [GO:0000775]; ciliary basal body [GO:0036064]; ciliary transition fiber [GO:0097539]; condensed chromosome outer kinetochore [GO:0000940]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; pronucleus [GO:0045120]; spindle [GO:0005819]; spindle pole [GO:0000922]; chromatin binding [GO:0003682]; dynein complex binding [GO:0070840]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; transcription factor binding [GO:0008134]; cell differentiation [GO:0030154]; cell division [GO:0051301]; cell proliferation [GO:0008283]; chromosome segregation [GO:0007059]; DNA biosynthetic process [GO:0071897]; kidney development [GO:0001822]; kinetochore assembly [GO:0051382]; metaphase plate congression [GO:0051310]; mitotic cell cycle [GO:0000278]; mitotic spindle assembly checkpoint [GO:0007094]; muscle organ development [GO:0007517]; negative regulation of transcription; DNA-templated [GO:0045892]; protein transport [GO:0015031]; regulation of cell cycle [GO:0051726]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of striated muscle tissue development [GO:0016202]; response to drug [GO:0042493]; ventricular system development [GO:0021591],NA,NA,NA
CHOYP_TVAG_355490.3.22.m.9919,0.00432364299549097,-0.00784949864686041,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.4.22.m.10865,-0.00682199330291205,0.00633092041173868,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.5.22.m.11608,-0.0130102185674989,0.00609875596174188,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.6.22.m.13410,-0.0194077756172996,0.00493920081789842,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_355490.7.22.m.16997,0.00499676949245975,-0.0218914435155406,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.1.3.m.7885,0.0029203277810324,-0.00530180428622546,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_399490.2.3.m.26257,0.00207712600888352,-0.00947240955823096,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.2.4.m.6401,-0.00250921391308234,-0.00431982068893282,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_407710.4.4.m.62673,0.00991656534061369,0.000731732707445774,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_410100.4.6.m.41037,-0.0126368772497123,0.00809125648544984,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_417100.1.2.m.19129,0.00135305051930459,0.00699682748113308,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TVAG_480920.2.3.m.38258,0.00413024776130063,0.0141847887902079,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_TWF1.1.1.m.62154,0.00066080669967629,-0.00193993896081724,No,NA,NA,Q91YR1,NA,NA,NA,actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; myofibril [GO:0030016]; perinuclear region of cytoplasm [GO:0048471]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; phosphatidylinositol-4;5-bisphosphate binding [GO:0005546]; protein tyrosine kinase activity [GO:0004713]; protein-containing complex binding [GO:0044877]; actin filament depolymerization [GO:0030042]; barbed-end actin filament capping [GO:0051016]; negative regulation of actin filament polymerization [GO:0030837]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of neuron projection development [GO:0010976]; regulation of actin phosphorylation [GO:0043538]; regulation of lamellipodium assembly [GO:0010591]; sequestering of actin monomers [GO:0042989],NA,NA,NA
CHOYP_TXN4A.1.2.m.59542,0.0164732590544987,0.0063105762459686,No,NA,NA,P83877,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; cell cycle [GO:0007049]; cell division [GO:0051301]; mRNA splicing; via spliceosome [GO:0000398],NA,NA,NA
CHOYP_TXND3.1.4.m.3505,-0.0200514833194382,0.00762641152794086,No,NA,NA,Q95YJ5,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXND3.4.4.m.64014,0.0177872643113252,0.0157585397296996,No,NA,NA,P90666,NA,NA,NA,cell [GO:0005623]; nucleoside diphosphate kinase activity [GO:0004550]; cell differentiation [GO:0030154]; cell redox homeostasis [GO:0045454]; CTP biosynthetic process [GO:0006241]; GTP biosynthetic process [GO:0006183]; multicellular organism development [GO:0007275]; spermatogenesis [GO:0007283]; UTP biosynthetic process [GO:0006228],NA,NA,NA
CHOYP_TXNDC9.1.1.m.22863,-0.00254915909095175,-0.00157103802186666,No,NA,NA,O18883,NA,NA,NA,cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; cell redox homeostasis [GO:0045454],NA,NA,NA
CHOYP_TYRO.1.1.m.38876,0.00586426322024469,0.00322598591898548,No,NA,NA,P86952,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.2.6.m.42960,-0.00756950488483227,0.0284965548252067,No,NA,NA,H2A0L1,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.5.6.m.44175,0.00258092004917808,-0.000697438313550578,No,NA,NA,H2A0L0,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_TYRO1.6.6.m.44318,0.017501725773282,0.0170749903785183,No,NA,NA,H2A0L0,NA,NA,NA,extracellular region [GO:0005576]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491],NA,NA,NA
CHOYP_U2AF2.1.1.m.30416,0.000388241740293877,-0.000715328881009197,No,NA,NA,Q24562,NA,NA,NA,commitment complex [GO:0000243]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U2-type prespliceosome [GO:0071004]; U2AF [GO:0089701]; mRNA binding [GO:0003729]; poly-pyrimidine tract binding [GO:0008187]; pre-mRNA 3'-splice site binding [GO:0030628]; RNA binding [GO:0003723]; mRNA splicing; via spliceosome [GO:0000398]; nuclear export [GO:0051168]; positive regulation of RNA export from nucleus [GO:0046833]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_U520.1.1.m.7087,-0.00141530416300567,0.0035521572595098,No,NA,NA,O75643,NA,NA,NA,catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; post-mRNA release spliceosomal complex [GO:0071014]; spliceosomal complex [GO:0005681]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682]; ATP binding [GO:0005524]; ATP-dependent helicase activity [GO:0008026]; ATP-dependent RNA helicase activity [GO:0004004]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing; via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388],NA,NA,NA
CHOYP_U5S1.1.1.m.49230,-0.00365493285712971,0.00268427769439209,No,NA,NA,Q15029,NA,NA,NA,Cajal body [GO:0015030]; catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681]; U2-type catalytic step 2 spliceosome [GO:0071007]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; RNA binding [GO:0003723]; U5 snRNA binding [GO:0030623]; cellular response to drug [GO:0035690]; mRNA processing [GO:0006397]; mRNA splicing; via spliceosome [GO:0000398]; response to cocaine [GO:0042220]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_UAFA.3.8.m.34702,-0.00461681151743789,-0.0206157440654268,No,NA,NA,P11137,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UAFA.6.8.m.45002,-0.0100072867033652,0.0106162460993445,No,NA,NA,P11137,NA,NA,NA,apical distal dendrite [GO:0150014]; axon hillock [GO:0043203]; axon initial segment [GO:0043194]; basal dendrite [GO:0097441]; CA3 pyramidal cell dendrite [GO:0097442]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendrite cytoplasm [GO:0032839]; dendritic branch [GO:0044307]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; dendritic shaft [GO:0043198]; distal dendrite [GO:0150002]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nuclear periphery [GO:0034399]; nucleolus [GO:0005730]; postsynaptic density [GO:0014069]; primary dendrite [GO:0150001]; proximal dendrite [GO:1990635]; proximal neuron projection [GO:1990769]; calmodulin binding [GO:0005516]; dystroglycan binding [GO:0002162]; microtubule binding [GO:0008017]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; axonogenesis [GO:0007409]; cellular response to organic substance [GO:0071310]; central nervous system neuron development [GO:0021954]; dendrite development [GO:0016358]; dendrite morphogenesis [GO:0048813]; establishment of cell polarity [GO:0030010]; microtubule bundle formation [GO:0001578]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of axon extension [GO:0030517]; negative regulation of microtubule binding [GO:1904527]; negative regulation of microtubule motor activity [GO:2000575]; negative regulation of microtubule polymerization [GO:0031115]; neuron projection development [GO:0031175]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of anterograde synaptic vesicle transport [GO:1903744]; regulation of cellular protein localization [GO:1903827]; regulation of microtubule polymerization [GO:0031113]; regulation of organelle transport along microtubule [GO:1902513],NA,NA,NA
CHOYP_UB2D2.1.1.m.56387,0.00967232570341586,0.0214807911543052,No,NA,NA,P62840,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UB2G2.1.1.m.7534,-0.0146551270054794,-0.0208707664111549,No,NA,NA,Q5RF84,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin-protein transferase activity [GO:0004842]; protein K48-linked ubiquitination [GO:0070936]; protein N-linked glycosylation via asparagine [GO:0018279]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UB2R2.1.1.m.18979,-0.00917892160169161,-0.0167470948548996,No,NA,NA,Q8CFI2,NA,NA,NA,cytosol [GO:0005829]; nuclear speck [GO:0016607]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; cell cycle [GO:0007049]; cellular response to interferon-beta [GO:0035458]; negative regulation of cAMP-mediated signaling [GO:0043951]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of neuron apoptotic process [GO:0043525]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA1.2.2.m.30036,0.000429787007446255,-0.00245273088595101,No,NA,NA,Q5U300,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; desmosome [GO:0030057]; endosome membrane [GO:0010008]; heterochromatin [GO:0000792]; lysosomal membrane [GO:0005765]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; rough endoplasmic reticulum membrane [GO:0030867]; ATP binding [GO:0005524]; ubiquitin activating enzyme activity [GO:0004839]; cellular response to DNA damage stimulus [GO:0006974]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBA3.1.1.m.59856,0.000333874542174235,0.00119251129562655,No,NA,NA,Q8C878,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; acid-amino acid ligase activity [GO:0016881]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; nuclear receptor binding [GO:0016922]; protein heterodimerization activity [GO:0046982]; endomitotic cell cycle [GO:0007113]; mitotic cell cycle [GO:0000278]; negative regulation of transcription; DNA-templated [GO:0045892]; protein modification by small protein conjugation [GO:0032446]; protein neddylation [GO:0045116]; regulation of cell cycle [GO:0051726],NA,NA,NA
CHOYP_UBA5.1.2.m.8624,-0.00102012481011043,0.00137930688921371,No,NA,NA,A7MAZ3,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; UFM1 activating enzyme activity [GO:0071566]; neuromuscular process [GO:0050905]; protein K69-linked ufmylation [GO:1990592]; protein modification by small protein conjugation [GO:0032446]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; response to endoplasmic reticulum stress [GO:0034976],NA,NA,NA
CHOYP_UBA6.3.4.m.53927,0.00283640001230075,0.000142141627642441,No,NA,NA,Q8C7R4,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBA6.4.4.m.63770,0.000334275045727557,0.00330753176157601,No,NA,NA,A0AVT1,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; ATP binding [GO:0005524]; FAT10 activating enzyme activity [GO:0019780]; ubiquitin activating enzyme activity [GO:0004839]; amygdala development [GO:0021764]; dendritic spine development [GO:0060996]; hippocampus development [GO:0021766]; learning [GO:0007612]; locomotory behavior [GO:0007626]; protein modification by small protein conjugation [GO:0032446]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC12.1.1.m.51806,-0.00188550555070225,0.0054138792067565,No,NA,NA,Q6P8D9,NA,NA,NA,ATP binding [GO:0005524]; NEDD8 transferase activity [GO:0019788]; ubiquitin-protein transferase activity [GO:0004842]; cellular protein modification process [GO:0006464]; protein neddylation [GO:0045116],NA,NA,NA
CHOYP_UBC2.1.3.m.24138,0.0170458752180829,-0.00412698877012555,No,NA,NA,P35129,NA,NA,NA,chromosome [GO:0005694]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBC9B.1.1.m.10688,0.000411621592947193,-0.00686364852871551,No,NA,NA,Q9DDJ0,NA,NA,NA,nucleus [GO:0005634]; ATP binding [GO:0005524]; SUMO conjugating enzyme activity [GO:0061656]; cell cycle [GO:0007049]; cell division [GO:0051301]; chromosome segregation [GO:0007059]; definitive hemopoiesis [GO:0060216]; embryonic heart tube elongation [GO:0036306]; heart looping [GO:0001947]; protein sumoylation [GO:0016925],NA,NA,NA
CHOYP_UBCD1.1.2.m.50237,-0.000666956317793345,-0.000125587099692961,No,NA,NA,P62840,NA,NA,NA,ATP binding [GO:0005524]; transferase activity [GO:0016740]; protein ubiquitination [GO:0016567],NA,NA,NA
CHOYP_UBCD2.1.1.m.54558,-0.0224745157351308,0.00593503442921724,No,NA,NA,P52485,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; lipid storage [GO:0019915]; protein polyubiquitination [GO:0000209],NA,NA,NA
CHOYP_UBCP1.1.1.m.7721,-0.00820870611093836,0.00167246437522214,No,NA,NA,Q641F1,NA,NA,NA,nucleus [GO:0005634]; phosphoprotein phosphatase activity [GO:0004721],NA,NA,NA
CHOYP_UBD2A.1.1.m.63050,0.00550608106153163,0.00650254008706912,No,NA,NA,Q6IP57,NA,NA,NA,,NA,NA,NA
CHOYP_UBE2A.1.1.m.48761,0.00268626140615408,0.0267834501794106,No,NA,NA,Q9Z255,NA,NA,NA,chromatin [GO:0000785]; HULC complex [GO:0033503]; nuclear chromatin [GO:0000790]; XY body [GO:0001741]; ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; blastocyst hatching [GO:0001835]; DNA repair [GO:0006281]; histone H2A ubiquitination [GO:0033522]; in utero embryonic development [GO:0001701]; maternal process involved in female pregnancy [GO:0060135]; positive regulation of cell proliferation [GO:0008284]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to UV [GO:0009411],NA,NA,NA
CHOYP_UBE2C.1.1.m.55757,-0.0132414272774845,0.00957697398031407,No,NA,NA,P56616,NA,NA,NA,anaphase-promoting complex [GO:0005680]; ATP binding [GO:0005524]; transferase activity [GO:0016740]; anaphase-promoting complex-dependent catabolic process [GO:0031145]; cell division [GO:0051301]; exit from mitosis [GO:0010458]; free ubiquitin chain polymerization [GO:0010994]; protein K11-linked ubiquitination [GO:0070979]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2H.1.1.m.49863,-0.0305615271925448,-0.011228770543522,No,NA,NA,P62257,NA,NA,NA,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2N.1.1.m.62056,0.000348883807547157,0.00128956447862495,No,NA,NA,Q5R7J6,NA,NA,NA,cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; UBC13-MMS2 complex [GO:0031372]; UBC13-UEV1A complex [GO:0035370]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; histone ubiquitination [GO:0016574]; positive regulation of DNA repair [GO:0045739]; positive regulation of histone modification [GO:0031058]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; regulation of histone ubiquitination [GO:0033182]; T cell receptor signaling pathway [GO:0050852]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE2Z.1.1.m.61760,-0.0106977558755671,-0.00680802543195839,No,NA,NA,Q66KB0,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ATP binding [GO:0005524]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; ubiquitin conjugating enzyme activity [GO:0061631]; apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBE4A.2.2.m.59113,0.00340794090387695,0.00593830448518442,No,NA,NA,A5PKG6,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ubiquitin-ubiquitin ligase activity [GO:0034450]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBE4B.1.1.m.11223,0.00190490168006993,-0.00172537299814496,No,NA,NA,Q9ES00,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; enzyme binding [GO:0019899]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; unfolded protein binding [GO:0051082]; cellular protein catabolic process [GO:0044257]; granzyme-mediated apoptotic signaling pathway [GO:0008626]; neuron projection development [GO:0031175]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein folding [GO:0006457]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; response to endoplasmic reticulum stress [GO:0034976]; response to UV [GO:0009411]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular trabecula myocardium morphogenesis [GO:0003222],NA,NA,NA
CHOYP_UBL4A.2.2.m.18059,0.00336282975413212,-0.00433119902230579,No,NA,NA,A4QND0,NA,NA,NA,BAT3 complex [GO:0071818]; cytosol [GO:0005829]; nucleus [GO:0005634]; tail-anchored membrane protein insertion into ER membrane [GO:0071816],NA,NA,NA
CHOYP_UBL5.3.5.m.41673,-0.0124409241588553,-0.0167258816965899,No,NA,NA,Q791B0,NA,NA,NA,cytoplasm [GO:0005737]; cellular protein modification process [GO:0006464],NA,NA,NA
CHOYP_UBP10.1.1.m.10603,-0.00281049035413895,0.00219671368438955,No,NA,NA,Q6DIJ4,NA,NA,NA,cytoplasm [GO:0005737]; early endosome [GO:0005769]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; ion channel binding [GO:0044325]; p53 binding [GO:0002039]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; autophagy [GO:0006914]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to interleukin-1 [GO:0071347]; DNA damage response; signal transduction by p53 class mediator [GO:0030330]; DNA repair [GO:0006281]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; protein deubiquitination [GO:0016579]; regulation of autophagy [GO:0010506]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP15.4.4.m.56615,0.000998941785627844,0.000787106593969644,No,NA,NA,Q9R085,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; BMP signaling pathway [GO:0030509]; histone H2B conserved C-terminal lysine deubiquitination [GO:0035616]; monoubiquitinated protein deubiquitination [GO:0035520]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; protein deubiquitination [GO:0016579]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP19.1.1.m.55642,-0.00640952305620515,0.000788075456871978,No,NA,NA,O94966,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBP20.2.2.m.51412,-0.0114220398678309,0.0172616351734893,No,NA,NA,Q9Y2K6,NA,NA,NA,centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; cysteine-type endopeptidase activity [GO:0004197]; G protein-coupled receptor binding [GO:0001664]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; zinc ion binding [GO:0008270]; endocytosis [GO:0006897]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP24.1.1.m.54945,0.00164997026095258,0.0157096289358844,No,NA,NA,Q9UPU5,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP25.1.1.m.61531,-0.00277788129168728,0.012667756458266,No,NA,NA,P57080,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; ATPase binding [GO:0051117]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of ERAD pathway [GO:1904293]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP32.1.1.m.56373,0.000374924249813693,0.00493036131391169,No,NA,NA,Q8NFA0,NA,NA,NA,cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP34.1.1.m.55124,-0.00888492062870127,0.00337307467811514,No,NA,NA,Q70CQ2,NA,NA,NA,cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; regulation of protein stability [GO:0031647]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_UBP47.1.2.m.66121,-0.0137210316657162,0.00423399566269176,No,NA,NA,Q8BY87,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; SCF ubiquitin ligase complex [GO:0019005]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitinyl hydrolase activity [GO:0101005]; WD40-repeat domain binding [GO:0071987]; base-excision repair [GO:0006284]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to UV [GO:0034644]; monoubiquitinated protein deubiquitination [GO:0035520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of G2/M transition of mitotic cell cycle [GO:0010972]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of transcription; DNA-templated [GO:0045892]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; protein deubiquitination [GO:0016579]; regulation of protein stability [GO:0031647]; response to drug [GO:0042493]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBP47.2.2.m.66754,-0.000632791647394188,0.00183274613478535,No,NA,NA,A4II09,NA,NA,NA,eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex; eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex; eIF3m [GO:0071541]; multi-eIF complex [GO:0043614]; mRNA binding [GO:0003729]; translation initiation factor activity [GO:0003743]; formation of cytoplasmic translation initiation complex [GO:0001732]; translation reinitiation [GO:0002188],NA,NA,NA
CHOYP_UBP48.1.1.m.25564,-0.00504483578179134,0.00828485308203406,No,NA,NA,Q86UV5,NA,NA,NA,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; protein deubiquitination [GO:0016579]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UBQL4.1.1.m.37426,-0.00142145596397266,0.00394119976158107,No,NA,NA,Q8R317,NA,NA,NA,aggresome [GO:0016235]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; identical protein binding [GO:0042802]; intermediate filament binding [GO:0019215]; kinase binding [GO:0019900]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; signaling receptor binding [GO:0005102]; aggrephagy [GO:0035973]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; cellular response to hypoxia [GO:0071456]; macroautophagy [GO:0016236]; negative regulation of store-operated calcium channel activity [GO:1901340]; negative regulation of toll-like receptor 3 signaling pathway [GO:0034140]; positive regulation of ER-associated ubiquitin-dependent protein catabolic process [GO:1903071]; positive regulation of protein ubiquitination [GO:0031398]; regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902175]; regulation of protein ubiquitination [GO:0031396]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBQL4.1.1.m.37429,-0.00786842173392303,-0.0032091476923591,No,NA,NA,Q6DEB4,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; phosphatase inhibitor activity [GO:0019212]; protein kinase binding [GO:0019901]; protein phosphatase 2A binding [GO:0051721]; protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; cell division [GO:0051301]; G2/M transition of mitotic cell cycle [GO:0000086]; mitotic cell cycle [GO:0000278],NA,NA,NA
CHOYP_UBR2.2.2.m.54412,-0.0084039589915,0.00549580482465352,No,NA,NA,Q6WKZ8,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151]; leucine binding [GO:0070728]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cellular response to leucine [GO:0071233]; chromatin silencing [GO:0006342]; histone H2A ubiquitination [GO:0033522]; male meiosis I [GO:0007141]; male meiotic nuclear division [GO:0007140]; negative regulation of TOR signaling [GO:0032007]; negative regulation of transposition [GO:0010529]; protein ubiquitination [GO:0016567]; reciprocal meiotic recombination [GO:0007131]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR3.1.1.m.43346,-0.00265479263054475,0.00133504802425564,No,NA,NA,Q5U430,NA,NA,NA,cytoplasm [GO:0005737]; integral component of membrane [GO:0016021]; ubiquitin ligase complex [GO:0000151]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; embryo development ending in birth or egg hatching [GO:0009792]; in utero embryonic development [GO:0001701]; olfactory behavior [GO:0042048]; protein ubiquitination [GO:0016567]; sensory perception of smell [GO:0007608]; suckling behavior [GO:0001967]; ubiquitin-dependent protein catabolic process [GO:0006511]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],NA,NA,NA
CHOYP_UBR4.1.1.m.34997,-0.00211624113939439,-0.00353117158272349,No,NA,NA,Q5T4S7,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; ficolin-1-rich granule membrane [GO:0101003]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; calmodulin binding [GO:0005516]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; neutrophil degranulation [GO:0043312]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral process [GO:0016032],NA,NA,NA
CHOYP_UBR5.1.1.m.44200,-0.0101764379124768,0.00233968472158742,No,NA,NA,Q80TP3,NA,NA,NA,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270]; cellular response to DNA damage stimulus [GO:0006974]; DNA repair [GO:0006281]; negative regulation of double-strand break repair [GO:2000780]; negative regulation of histone H2A K63-linked ubiquitination [GO:1901315]; negative regulation of interleukin-17 secretion [GO:1905077]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of protein import into nucleus; translocation [GO:0033160]; progesterone receptor signaling pathway [GO:0050847]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of protein stability [GO:0031647],NA,NA,NA
CHOYP_UBR7.1.1.m.7300,-0.00298904563571401,-0.0039277691028652,No,NA,NA,Q8N806,NA,NA,NA,cytoplasm [GO:0005737]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_UBS3B.1.1.m.43636,-0.00266429944445934,0.016827444104187,No,NA,NA,Q8TF42,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; phosphatase activity [GO:0016791]; phosphoprotein binding [GO:0051219]; protein tyrosine phosphatase activity [GO:0004725]; ubiquitin protein ligase binding [GO:0031625]; collagen-activated signaling pathway [GO:0038065]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; negative regulation of bone resorption [GO:0045779]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of signal transduction [GO:0009968]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet aggregation [GO:0070527]; regulation of osteoclast differentiation [GO:0045670]; regulation of protein binding [GO:0043393]; regulation of release of sequestered calcium ion into cytosol [GO:0051279],NA,NA,NA
CHOYP_UBXN4.1.1.m.22642,0.00574051853906733,-0.0012733118807765,No,NA,NA,Q5R4I3,NA,NA,NA,endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; response to unfolded protein [GO:0006986]; ubiquitin-dependent ERAD pathway [GO:0030433],NA,NA,NA
CHOYP_UBXN7.1.1.m.64349,-0.0202718564864043,-0.0179232002096807,No,NA,NA,Q5REY7,NA,NA,NA,nuclear body [GO:0016604]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; transcription factor binding [GO:0008134]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625],NA,NA,NA
CHOYP_UCHL.1.1.m.29303,0.000637609466243438,0.000472257000660601,No,NA,NA,O01391,NA,NA,NA,cytoplasm [GO:0005737]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCHL5.2.2.m.46419,0.000196004193063853,-0.00124133002708762,No,NA,NA,Q9WUP7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic proteasome complex [GO:0031597]; Ino80 complex [GO:0031011]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; endopeptidase inhibitor activity [GO:0004866]; proteasome binding [GO:0070628]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; forebrain morphogenesis [GO:0048853]; lateral ventricle development [GO:0021670]; midbrain development [GO:0030901]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; protein deubiquitination [GO:0016579]; regulation of proteasomal protein catabolic process [GO:0061136]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UCK2.1.1.m.6328,-0.00455587602230965,0.00213955645885669,No,NA,NA,B1H116,NA,NA,NA,cytosol [GO:0005829]; ATP binding [GO:0005524]; uridine kinase activity [GO:0004849]; CMP salvage [GO:0006238]; CTP salvage [GO:0044211]; UMP salvage [GO:0044206],NA,NA,NA
CHOYP_UFC1.1.2.m.6917,0.00112745008137003,-1.44343594396835e-05,No,NA,NA,A7SM54,NA,NA,NA,UFM1 transferase activity [GO:0071568]; protein K69-linked ufmylation [GO:1990592],NA,NA,NA
CHOYP_UFD1L.1.1.m.43606,-0.00171953699811461,-0.00204349381435828,No,NA,NA,Q92890,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; ATPase binding [GO:0051117]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; ER-associated misfolded protein catabolic process [GO:0071712]; error-free translesion synthesis [GO:0070987]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein deubiquitination [GO:0016579]; retrograde protein transport; ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UFL1.1.1.m.20000,0.00597871698005659,0.000349837755607081,No,NA,NA,Q4R367,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; UFM1 transferase activity [GO:0071568]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of protein ubiquitination [GO:0031397]; protein K69-linked ufmylation [GO:1990592]; protein ufmylation [GO:0071569]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UFSP2.1.1.m.36906,-0.000893949943241116,0.00768813721539427,No,NA,NA,Q9NUQ7,NA,NA,NA,cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; thiolester hydrolase activity [GO:0016790]; UFM1 hydrolase activity [GO:0071567]; proteolysis [GO:0006508]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146],NA,NA,NA
CHOYP_UGGG1.1.1.m.59266,-0.00156088593290129,0.0037315529364183,No,NA,NA,Q9JLA3,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; UDP-glucose:glycoprotein glucosyltransferase activity [GO:0003980]; unfolded protein binding [GO:0051082]; 'de novo' posttranslational protein folding [GO:0051084]; ER-associated misfolded protein catabolic process [GO:0071712]; protein folding [GO:0006457]; protein N-linked glycosylation via asparagine [GO:0018279],NA,NA,NA
CHOYP_UGPA.1.1.m.49579,0.00244194737834822,0.00294391848669906,No,NA,NA,Q07130,NA,NA,NA,cytoplasm [GO:0005737]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; UTP:glucose-1-phosphate uridylyltransferase activity [GO:0003983]; glycogen metabolic process [GO:0005977]; UDP-glucose metabolic process [GO:0006011],NA,NA,NA
CHOYP_UHRF1.1.1.m.10935,0.00629420895413929,-0.00677508860518411,No,NA,NA,B6CHA3,NA,NA,NA,euchromatin [GO:0000791]; heterochromatin [GO:0000792]; nuclear chromatin [GO:0000790]; replication fork [GO:0005657]; hemi-methylated DNA-binding [GO:0044729]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; cell cycle [GO:0007049]; histone ubiquitination [GO:0016574]; maintenance of DNA methylation [GO:0010216]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein autoubiquitination [GO:0051865]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UN45B.1.1.m.19072,-0.0047485605080824,-0.00354479740829186,No,NA,NA,D7REX8,NA,NA,NA,cytosol [GO:0005829]; Z disc [GO:0030018]; Hsp90 protein binding [GO:0051879]; cardiac muscle tissue development [GO:0048738]; chaperone-mediated protein folding [GO:0061077]; lens development in camera-type eye [GO:0002088]; muscle fiber development [GO:0048747]; myofibril assembly [GO:0030239]; skeletal muscle tissue development [GO:0007519],NA,NA,NA
CHOYP_UNC.89.1.2.m.1625,-7.17771658440682e-06,0.00169579551728232,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC22.2.2.m.50516,0.00206476134820671,0.00182269479303444,No,NA,NA,Q23551,NA,NA,NA,A band [GO:0031672]; M band [GO:0031430]; sarcomere [GO:0030017]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; muscle alpha-actinin binding [GO:0051371]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; structural constituent of muscle [GO:0008307]; adult locomotory behavior [GO:0008344]; behavioral response to nicotine [GO:0035095]; muscle contraction [GO:0006936]; negative regulation of cell division [GO:0051782]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of locomotion [GO:0040017]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of striated muscle contraction [GO:0045989]; sarcomere organization [GO:0045214]; striated muscle myosin thick filament assembly [GO:0071688],NA,NA,NA
CHOYP_UNC89.1.19.m.7848,-0.00991140850453812,0.00346690573880116,No,NA,NA,A8T6P4,NA,NA,NA,cortical actin cytoskeleton [GO:0030864]; perinuclear region of cytoplasm [GO:0048471]; transport vesicle [GO:0030133]; actin binding [GO:0003779]; metal ion binding [GO:0046872]; myosin binding [GO:0017022]; Rab GTPase binding [GO:0017137]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_UNC89.15.19.m.55545,0.00995107008429266,-0.00636541793979549,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_UNC89.16.19.m.57422,-0.00567183761543068,-0.00360954345761262,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_URIC.1.2.m.35940,-0.00466765601196911,0.0063367013176434,No,NA,NA,P09118,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_URIC.2.2.m.54754,-0.00237596904053335,0.0103382431109403,No,NA,NA,P09118,NA,NA,NA,peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; urate oxidase activity [GO:0004846]; purine nucleobase catabolic process [GO:0006145]; urate catabolic process [GO:0019628],NA,NA,NA
CHOYP_USH1C.1.1.m.30582,0.0150464732170173,-0.0235871654831517,No,NA,NA,Q9Y6N9,NA,NA,NA,apical part of cell [GO:0045177]; brush border [GO:0005903]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; microvillus [GO:0005902]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; actin filament binding [GO:0051015]; spectrin binding [GO:0030507]; actin filament bundle assembly [GO:0051017]; brush border assembly [GO:1904970]; cellular protein-containing complex assembly [GO:0034622]; equilibrioception [GO:0050957]; G2/M transition of mitotic cell cycle [GO:0000086]; inner ear auditory receptor cell differentiation [GO:0042491]; inner ear morphogenesis [GO:0042472]; inner ear receptor cell stereocilium organization [GO:0060122]; parallel actin filament bundle assembly [GO:0030046]; photoreceptor cell maintenance [GO:0045494]; protein localization to microvillus [GO:1904106]; regulation of microvillus length [GO:0032532]; retinal cone cell development [GO:0046549]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],NA,NA,NA
CHOYP_USO1.1.11.m.6354,0.00184547529750273,0.00201079087698751,No,NA,NA,Q9Z1Z0,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; ER to Golgi transport vesicle membrane [GO:0012507]; fibrillar center [GO:0001650]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi stack [GO:0005795]; perinuclear region of cytoplasm [GO:0048471]; protein transporter activity [GO:0008565]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; Golgi vesicle docking [GO:0048211]; intracellular protein transport [GO:0006886]; membrane fusion [GO:0061025]; transcytosis [GO:0045056]; vesicle fusion with Golgi apparatus [GO:0048280],NA,NA,NA
CHOYP_USO1.11.11.m.64787,0.00279956688602783,0.003306216472186,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USO1.2.11.m.12785,-0.00621750102642028,-0.000531565805411597,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_USP36.1.2.m.17402,0.00205830902071306,-0.000556213886838232,No,NA,NA,B1AQJ2,NA,NA,NA,cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; cysteine-type endopeptidase activity [GO:0004197]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; histone deubiquitination [GO:0016578]; negative regulation of macroautophagy [GO:0016242]; nucleolus organization [GO:0007000]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of protein stability [GO:0031647]; regulation of rRNA processing [GO:2000232]; ubiquitin-dependent protein catabolic process [GO:0006511],NA,NA,NA
CHOYP_UT14A.1.1.m.44047,0.00990252822081847,-0.0224693553969649,No,NA,NA,Q3T0Q8,NA,NA,NA,nucleolus [GO:0005730]; small-subunit processome [GO:0032040]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UTP20.2.4.m.1508,-0.00521505950261356,-0.00331885099416584,No,NA,NA,O75691,NA,NA,NA,90S preribosome [GO:0030686]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; preribosome; small subunit precursor [GO:0030688]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000480]; endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000447]; endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000472]; negative regulation of cell proliferation [GO:0008285]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_UUR10_0415.1.1.m.64919,0.0209154509637619,0.0101020845829998,No,NA,NA,B8I6E7,NA,NA,NA,cytoplasm [GO:0005737]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; translation initiation factor activity [GO:0003743],NA,NA,NA
CHOYP_VA0D1.1.2.m.31117,-0.00566166848631071,-0.010193215788206,No,NA,NA,Q9W4P5,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V0 domain [GO:0000220]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; regulation of Notch signaling pathway [GO:0008593]; terminal branching; open tracheal system [GO:0007430]; vacuolar acidification [GO:0007035],NA,NA,NA
CHOYP_VAC14.1.1.m.31290,0.000608549218186908,0.00723963602891711,No,NA,NA,Q66L58,NA,NA,NA,endosome membrane [GO:0010008]; extrinsic component of vacuolar membrane [GO:0000306]; PAS complex [GO:0070772]; phosphatidylinositol biosynthetic process [GO:0006661],NA,NA,NA
CHOYP_VASP.1.1.m.15245,0.00202871331877601,0.00233012573678962,No,NA,NA,Q2TA49,NA,NA,NA,bicellular tight junction [GO:0005923]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; lamellipodium membrane [GO:0031258]; actin binding [GO:0003779]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_VATA.1.1.m.44460,0.000147527184306,0.000530982660368075,No,NA,NA,P38606,NA,NA,NA,apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; lysosomal membrane [GO:0005765]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting two-sector ATPase complex [GO:0016469]; proton-transporting V-type ATPase; V1 domain [GO:0033180]; vacuolar membrane [GO:0005774]; ATP binding [GO:0005524]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; cellular iron ion homeostasis [GO:0006879]; cellular response to increased oxygen levels [GO:0036295]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572],NA,NA,NA
CHOYP_VATB.1.2.m.33785,0.00152393584270923,0.000682974363363343,No,NA,NA,P31401,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; ATP binding [GO:0005524]; hydrolase activity [GO:0016787]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034],NA,NA,NA
CHOYP_VATB.2.2.m.62084,-0.00989067763455977,0.00462241318045152,No,NA,NA,Q8IYT3,NA,NA,NA,,NA,NA,NA
CHOYP_VATC1.1.1.m.38693,-0.00186494871400253,-0.00232854100063387,No,NA,NA,Q5XH14,NA,NA,NA,proton-transporting V-type ATPase; V1 domain [GO:0033180]; proton transmembrane transporter activity [GO:0015078]; ATP hydrolysis coupled proton transport [GO:0015991],NA,NA,NA
CHOYP_VATD.2.2.m.64245,-0.00747389865655586,0.0219783568804525,No,NA,NA,Q5RCS8,NA,NA,NA,centrosome [GO:0005813]; cilium [GO:0005929]; proton-transporting V-type ATPase complex [GO:0033176]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; cilium assembly [GO:0060271]; ion transport [GO:0006811]; protein localization to cilium [GO:0061512],NA,NA,NA
CHOYP_VATE.1.1.m.21420,-0.000628780039240844,-0.00170562301775373,No,NA,NA,P54611,NA,NA,NA,plasma membrane [GO:0005886]; plasma membrane proton-transporting V-type ATPase complex [GO:0033181]; vacuolar proton-transporting V-type ATPase; V1 domain [GO:0000221]; proton-transporting ATPase activity; rotational mechanism [GO:0046961]; apical protein localization [GO:0045176]; ATP hydrolysis coupled proton transport [GO:0015991]; liquid clearance; open tracheal system [GO:0035002]; terminal branching; open tracheal system [GO:0007430],NA,NA,NA
CHOYP_VATG.1.2.m.4407,0.0013743682022341,-0.00525951234293821,No,NA,NA,Q25532,NA,NA,NA,apical plasma membrane [GO:0016324]; vacuolar proton-transporting V-type ATPase complex [GO:0016471]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; proton transmembrane transport [GO:1902600],NA,NA,NA
CHOYP_VAV2.1.3.m.40262,-0.00964825248294942,-0.0261095301456973,No,NA,NA,P52735,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VAV2.3.3.m.62875,0.00436009779844775,0.00269512472219251,No,NA,NA,P52735,NA,NA,NA,cytosol [GO:0005829]; plasma membrane [GO:0005886]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; angiogenesis [GO:0001525]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; G protein-coupled receptor signaling pathway [GO:0007186]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of apoptotic process [GO:0043065]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],NA,NA,NA
CHOYP_VDE.1.1.m.30310,-0.00572149212608829,-0.014388379888993,No,NA,NA,Q40251,NA,NA,NA,chloroplast thylakoid membrane [GO:0009535]; violaxanthin de-epoxidase activity [GO:0046422],NA,NA,NA
CHOYP_VIGLN.1.2.m.34766,0.00159220153657792,-0.000898795908455282,No,NA,NA,Q00341,NA,NA,NA,cytosol [GO:0005829]; high-density lipoprotein particle [GO:0034364]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; lipid binding [GO:0008289]; RNA binding [GO:0003723]; cholesterol metabolic process [GO:0008203]; high-density lipoprotein particle clearance [GO:0034384]; lipid transport [GO:0006869],NA,NA,NA
CHOYP_VIGLN.2.2.m.61191,-0.00569692055544456,0.00631966739972068,No,NA,NA,Q61733,NA,NA,NA,mitochondrial small ribosomal subunit [GO:0005763]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; protein domain specific binding [GO:0019904]; structural constituent of ribosome [GO:0003735],NA,NA,NA
CHOYP_VIP2.1.1.m.54883,0,0,No,NA,NA,Q9VR59,NA,NA,NA,cytosol [GO:0005829]; 5-diphosphoinositol pentakisphosphate 3-kinase activity [GO:0102092]; ATP binding [GO:0005524]; diphosphoinositol-pentakisphosphate kinase activity [GO:0033857]; inositol heptakisphosphate kinase activity [GO:0000829]; inositol hexakisphosphate 1-kinase activity [GO:0052723]; inositol hexakisphosphate 3-kinase activity [GO:0052724]; inositol hexakisphosphate 5-kinase activity [GO:0000832]; inositol hexakisphosphate kinase activity [GO:0000828]; inositol-1;3;4;5;6-pentakisphosphate kinase activity [GO:0000827]; inositol metabolic process [GO:0006020]; inositol phosphate biosynthetic process [GO:0032958],NA,NA,NA
CHOYP_VIR.1.1.m.51105,0.000977433881919426,1.73908062102589e-05,No,NA,NA,A2AIV2,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA N6-methyladenosine methyltransferase complex [GO:0036396]; mRNA alternative polyadenylation [GO:0110104]; mRNA methylation [GO:0080009]; mRNA processing [GO:0006397]; multicellular organism development [GO:0007275]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_VMA5A.1.1.m.24860,0.0024227036991671,-0.000654683736800739,No,NA,NA,O00534,NA,NA,NA,nucleoplasm [GO:0005654]; nucleus [GO:0005634],NA,NA,NA
CHOYP_VMP1.1.1.m.34831,-7.69767793197612e-05,0.0102129662891204,No,NA,NA,Q6INE8,NA,NA,NA,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; vacuolar membrane [GO:0005774],NA,NA,NA
CHOYP_VOLCADRAFT_121426.1.1.m.43175,-0.000324714499260904,0.00147480506766507,No,NA,NA,Q9Y6K8,NA,NA,NA,cytosol [GO:0005829]; microtubule organizing center [GO:0005815]; adenylate kinase activity [GO:0004017]; ATP binding [GO:0005524]; nucleoside diphosphate kinase activity [GO:0004550]; nucleoside kinase activity [GO:0019206]; ADP biosynthetic process [GO:0006172]; ATP metabolic process [GO:0046034]; dADP biosynthetic process [GO:0006173]; nucleobase-containing small molecule interconversion [GO:0015949]; nucleoside diphosphate phosphorylation [GO:0006165]; nucleoside triphosphate biosynthetic process [GO:0009142]; pyrimidine ribonucleotide biosynthetic process [GO:0009220],NA,NA,NA
CHOYP_VOLCADRAFT_93060.1.2.m.3949,0.00371663113560498,-0.00305386275695795,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VOLCADRAFT_93060.2.2.m.26741,-0.00506058550756518,-0.00482474675430242,No,NA,NA,O96790,NA,NA,NA,extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819],NA,NA,NA
CHOYP_VP13D.2.3.m.58593,0.0050325687139282,-0.0091365409566443,No,NA,NA,Q96GQ7,NA,NA,NA,chromosome [GO:0005694]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; helicase activity [GO:0004386]; RNA binding [GO:0003723]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_VP33.1.2.m.1058,0.00661902741097528,-0.00328218871263806,No,NA,NA,Q16943,NA,NA,NA,cell junction [GO:0030054]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; neuron projection [GO:0043005]; synapse [GO:0045202],NA,NA,NA
CHOYP_VP33A.1.1.m.58311,-0.00250552381542923,-0.00450408449829043,No,NA,NA,Q63615,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; protein-containing complex binding [GO:0044877]; protein transport [GO:0015031]; regulation of lysosomal lumen pH [GO:0035751]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPP1.2.2.m.13421,-0.005558358621801,-0.00158664791732459,No,NA,NA,Q8C2P3,NA,NA,NA,flavin adenine dinucleotide binding [GO:0050660]; tRNA dihydrouridine synthase activity [GO:0017150],NA,NA,NA
CHOYP_VPRBP.1.1.m.15849,-0.00293711144872828,0.0113172036362683,No,NA,NA,Q9Y4B6,NA,NA,NA,Cul4-RING E3 ubiquitin ligase complex [GO:0080008]; cytoplasm [GO:0005737]; fibrillar center [GO:0001650]; nucleus [GO:0005634]; ATP binding [GO:0005524]; estrogen receptor binding [GO:0030331]; histone kinase activity (H2A-T120 specific) [GO:1990244]; B cell differentiation [GO:0030183]; cell competition in a multicellular organism [GO:0035212]; histone H2A-T120 phosphorylation [GO:1990245]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein ubiquitination [GO:0016567]; V(D)J recombination [GO:0033151]; viral process [GO:0016032],NA,NA,NA
CHOYP_VPS11.3.3.m.17579,-0.0107817891564669,0.027044332685512,No,NA,NA,Q9H270,NA,NA,NA,autophagosome [GO:0005776]; clathrin-coated vesicle [GO:0030136]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; protein binding; bridging [GO:0030674]; protein domain specific binding [GO:0019904]; syntaxin binding [GO:0019905]; autophagy [GO:0006914]; endosomal vesicle fusion [GO:0034058]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of early endosome to late endosome transport [GO:2000643]; positive regulation of protein targeting to mitochondrion [GO:1903955]; regulation of organelle assembly [GO:1902115]; regulation of protein stability [GO:0031647]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS18.1.1.m.38708,0.001008902573115,0.0215390584179695,No,NA,NA,P59015,NA,NA,NA,endosome [GO:0005768]; HOPS complex [GO:0030897]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; metal ion binding [GO:0046872]; protein binding; bridging [GO:0030674]; apical protein localization [GO:0045176]; bile acid and bile salt transport [GO:0015721]; endosome organization [GO:0007032]; endosome to lysosome transport [GO:0008333]; endosome to pigment granule transport [GO:0043485]; eye pigmentation [GO:0048069]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; notochord cell vacuolation [GO:0060036]; optokinetic behavior [GO:0007634]; pigment granule maturation [GO:0048757]; regulation of SNARE complex assembly [GO:0035542]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS25.1.1.m.66093,0.00355166857676093,-0.0068877148578838,No,NA,NA,Q6NWF4,NA,NA,NA,ESCRT II complex [GO:0000814]; protein homodimerization activity [GO:0042803]; structural molecule activity [GO:0005198]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS35.1.1.m.55447,0.000796257969552748,0.000159918671703243,No,NA,NA,Q2HJG5,NA,NA,NA,cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; mitochondrion-derived vesicle [GO:0099073]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; retromer complex [GO:0030904]; retromer; cargo-selective complex [GO:0030906]; tubular endosome [GO:0097422]; D1 dopamine receptor binding [GO:0031748]; protein transporter activity [GO:0008565]; intracellular protein transport [GO:0006886]; lysosome organization [GO:0007040]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrion to lysosome transport [GO:0099074]; negative regulation of cellular protein localization [GO:1903828]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of late endosome to lysosome transport [GO:1902823]; negative regulation of lysosomal protein catabolic process [GO:1905166]; negative regulation of neuron death [GO:1901215]; negative regulation of protein homooligomerization [GO:0032463]; neurotransmitter receptor transport; endosome to postsynaptic membrane [GO:0098887]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of dopamine biosynthetic process [GO:1903181]; positive regulation of dopamine receptor signaling pathway [GO:0060161]; positive regulation of gene expression [GO:0010628]; positive regulation of locomotion involved in locomotory behavior [GO:0090326]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of Wnt protein secretion [GO:0061357]; protein destabilization [GO:0031648]; protein localization to organelle [GO:0033365]; regulation of dendritic spine maintenance [GO:1902950]; regulation of terminal button organization [GO:2000331]; retrograde transport; endosome to Golgi [GO:0042147]; retrograde transport; endosome to plasma membrane [GO:1990126]; synapse assembly [GO:0007416]; transcytosis [GO:0045056]; vesicle-mediated transport in synapse [GO:0099003]; voluntary musculoskeletal movement [GO:0050882],NA,NA,NA
CHOYP_VPS36.1.1.m.27030,-0.0038909203945065,-0.0197369940883003,No,NA,NA,A5PK00,NA,NA,NA,endosome [GO:0005768]; ESCRT II complex [GO:0000814]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; phosphatidylinositol-3-phosphate binding [GO:0032266]; ubiquitin binding [GO:0043130]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328],NA,NA,NA
CHOYP_VPS45.1.1.m.8023,-8.34050882385092e-05,0.00927166036068534,No,NA,NA,P97390,NA,NA,NA,endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; synaptic vesicle [GO:0008021]; protein transport [GO:0015031]; vesicle docking involved in exocytosis [GO:0006904],NA,NA,NA
CHOYP_VPS4B.2.2.m.30053,0.00583514634347176,-0.00292525802651819,No,NA,NA,Q0VD48,NA,NA,NA,centrosome [GO:0005813]; cytosol [GO:0005829]; Flemming body [GO:0090543]; late endosome membrane [GO:0031902]; nucleus [GO:0005634]; spindle pole [GO:0000922]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ATPase activity; coupled [GO:0042623]; protein C-terminus binding [GO:0008022]; protein homodimerization activity [GO:0042803]; cholesterol transport [GO:0030301]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; late endosomal microautophagy [GO:0061738]; midbody abscission [GO:0061952]; mitotic metaphase plate congression [GO:0007080]; multivesicular body assembly [GO:0036258]; negative regulation of cell death [GO:0060548]; negative regulation of exosomal secretion [GO:1903542]; nucleus organization [GO:0006997]; positive regulation of centriole elongation [GO:1903724]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of viral release from host cell [GO:1902188]; potassium ion transport [GO:0006813]; protein depolymerization [GO:0051261]; protein transport [GO:0015031]; regulation of mitotic spindle assembly [GO:1901673]; response to lipid [GO:0033993]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; vacuole organization [GO:0007033]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],NA,NA,NA
CHOYP_VPS51.1.1.m.43266,-0.00698529634275972,0.00925622811875997,No,NA,NA,Q155U0,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; GARP complex [GO:0000938]; membrane [GO:0016020]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; ADP-ribosylation factor binding [GO:0030306]; endocytic recycling [GO:0032456]; Golgi organization [GO:0007030]; Golgi vesicle transport [GO:0048193]; lipid digestion [GO:0044241]; lipid transport [GO:0006869]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; regulation of phospholipase activity [GO:0010517]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS53.1.1.m.51625,-0.000660103047486192,-0.00127200836085206,No,NA,NA,Q5ZLD7,NA,NA,NA,cytosol [GO:0005829]; EARP complex [GO:1990745]; endosome membrane [GO:0010008]; GARP complex [GO:0000938]; perinuclear region of cytoplasm [GO:0048471]; recycling endosome [GO:0055037]; trans-Golgi network [GO:0005802]; endocytic recycling [GO:0032456]; lysosomal transport [GO:0007041]; protein transport [GO:0015031]; retrograde transport; endosome to Golgi [GO:0042147],NA,NA,NA
CHOYP_VPS8.1.1.m.51272,-0.000665990416449118,0.0037133153753809,No,NA,NA,Q0P5W1,NA,NA,NA,CORVET complex [GO:0033263]; early endosome [GO:0005769]; metal ion binding [GO:0046872]; endosomal vesicle fusion [GO:0034058],NA,NA,NA
CHOYP_VRK1.1.1.m.10917,-0.0104468380036729,0.0287407899407139,No,NA,NA,Q32PI1,NA,NA,NA,cytoplasm [GO:0005737]; Golgi stack [GO:0005795]; nucleus [GO:0005634]; spindle [GO:0005819]; ATP binding [GO:0005524]; protein serine/threonine kinase activity [GO:0004674]; cell cycle [GO:0007049]; cell division [GO:0051301]; Golgi disassembly [GO:0090166]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468],NA,NA,NA
CHOYP_VRP.2.4.m.18914,-0.00396065333168415,0.015698697251389,No,NA,NA,H2A0K6,NA,NA,NA,extracellular region [GO:0005576],NA,NA,NA
CHOYP_VTA1.1.1.m.36056,0.00152839169040507,0.00056015140244986,No,NA,NA,Q32L63,NA,NA,NA,endosome membrane [GO:0010008]; protein transport [GO:0015031],NA,NA,NA
CHOYP_VWA8.2.3.m.28001,-0.00438216228289903,-0.000353569933776647,No,NA,NA,B0R0T1,NA,NA,NA,mitochondrion [GO:0005739]; ATP binding [GO:0005524]; ATPase activity [GO:0016887],NA,NA,NA
CHOYP_VWCE.1.3.m.5007,0.00727336106804644,-0.0109496943624645,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_VWDE.5.13.m.28163,0.00578390305649209,-0.00499298394855528,No,NA,NA,Q8N2E2,NA,NA,NA,cell surface [GO:0009986]; extracellular region [GO:0005576]; signaling receptor binding [GO:0005102]; anatomical structure development [GO:0048856],NA,NA,NA
CHOYP_VWDE.8.13.m.38775,0.000143528580803372,0.00400020704388784,No,NA,NA,O46581,NA,NA,NA,mitochondrial inner membrane [GO:0005743]; cytochrome-c oxidase activity [GO:0004129],NA,NA,NA
CHOYP_WASP.1.1.m.35786,0.0154118203540104,0.0123987510496412,No,NA,NA,P42768,NA,NA,NA,actin cortical patch [GO:0030479]; actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; cell-cell junction [GO:0005911]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; phagocytic vesicle [GO:0045335]; site of double-strand break [GO:0035861]; vesicle membrane [GO:0012506]; actin filament binding [GO:0051015]; GTPase regulator activity [GO:0030695]; identical protein binding [GO:0042802]; phospholipase binding [GO:0043274]; protein kinase binding [GO:0019901]; Rac GTPase binding [GO:0048365]; SH3 domain binding [GO:0017124]; small GTPase binding [GO:0031267]; actin cortical patch assembly [GO:0000147]; actin cortical patch localization [GO:0051666]; actin filament polymerization [GO:0030041]; actin filament-based movement [GO:0030048]; actin polymerization or depolymerization [GO:0008154]; blood coagulation [GO:0007596]; Cdc42 protein signal transduction [GO:0032488]; cellular response to interferon-gamma [GO:0071346]; defense response [GO:0006952]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; epidermis development [GO:0008544]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; immune response [GO:0006955]; negative regulation of cell motility [GO:2000146]; negative regulation of stress fiber assembly [GO:0051497]; positive regulation of actin nucleation [GO:0051127]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of actin polymerization or depolymerization [GO:0008064]; regulation of lamellipodium assembly [GO:0010591]; regulation of stress fiber assembly [GO:0051492]; regulation of T cell antigen processing and presentation [GO:0002625]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WBP11.1.1.m.12849,0.00033501209536642,-0.0108879633202116,No,NA,NA,Q923D5,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein phosphatase regulator activity [GO:0019888]; WW domain binding [GO:0050699]; mRNA cis splicing; via spliceosome [GO:0045292]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDHD1.1.1.m.23505,-0.00904343324158357,-0.00140028075710236,No,NA,NA,O13046,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677],NA,NA,NA
CHOYP_WDR1.1.1.m.29076,0.000661427148016797,-0.00186431793787567,No,NA,NA,Q9VU68,NA,NA,NA,actomyosin; actin portion [GO:0042643]; cortical actin cytoskeleton [GO:0030864]; cytoskeleton [GO:0005856]; actin binding [GO:0003779]; actin filament binding [GO:0051015]; actin filament depolymerization [GO:0030042]; border follicle cell migration [GO:0007298]; establishment of planar polarity [GO:0001736]; imaginal disc-derived wing hair organization [GO:0035317]; locomotion [GO:0040011]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; positive regulation of actin filament depolymerization [GO:0030836]; regulation of actin filament depolymerization [GO:0030834]; regulation of actin filament polymerization [GO:0030833]; sarcomere organization [GO:0045214],NA,NA,NA
CHOYP_WDR11.2.2.m.58625,-0.00707393064233243,0.0109119839218115,No,NA,NA,Q9BZH6,NA,NA,NA,axoneme [GO:0005930]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nucleus [GO:0005634]; trans-Golgi network [GO:0005802]; cilium assembly [GO:0060271]; head development [GO:0060322]; heart development [GO:0007507]; intracellular protein transport [GO:0006886]; multicellular organism growth [GO:0035264]; regulation of smoothened signaling pathway [GO:0008589]; vesicle tethering to Golgi [GO:0099041],NA,NA,NA
CHOYP_WDR12.1.1.m.13380,-0.00181022316101538,-0.000841214861505507,No,NA,NA,B7PY76,NA,NA,NA,nucleoplasm [GO:0005654]; PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687]; ribonucleoprotein complex binding [GO:0043021]; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000466]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA; 5.8S rRNA; LSU-rRNA) [GO:0000463],NA,NA,NA
CHOYP_WDR17.1.1.m.17546,-0.00601078502570895,0.0046803118197313,No,NA,NA,Q8IZU2,NA,NA,NA,,NA,NA,NA
CHOYP_WDR26.1.1.m.43030,-0.00147545656089333,-0.000342932964066226,No,NA,NA,Q28D01,NA,NA,NA,mitochondrion [GO:0005739]; nucleus [GO:0005634],NA,NA,NA
CHOYP_WDR31.2.2.m.65613,-7.48635030689398e-05,0.00993258538334646,No,NA,NA,Q9JHB4,NA,NA,NA,,NA,NA,NA
CHOYP_WDR37.1.1.m.57561,-0.00115999451868571,0.00985223210598962,No,NA,NA,Q9Y2I8,NA,NA,NA,PeBoW complex [GO:0070545]; preribosome; large subunit precursor [GO:0030687],NA,NA,NA
CHOYP_WDR5.2.3.m.6293,-0.00463982248781529,-0.0193121068946351,No,NA,NA,Q5M786,NA,NA,NA,histone acetyltransferase complex [GO:0000123]; MLL1 complex [GO:0071339]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188]; histone binding [GO:0042393]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982],NA,NA,NA
CHOYP_WDR52.1.1.m.21751,-0.00844443725875453,-0.000819361412040016,No,NA,NA,Q96MT7,NA,NA,NA,cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; motile cilium [GO:0031514]; cilium-dependent cell motility [GO:0060285]; sperm axoneme assembly [GO:0007288],NA,NA,NA
CHOYP_WDR59.4.5.m.55404,0.00272562762634693,-0.00267404900011481,No,NA,NA,Q5ZLG9,NA,NA,NA,GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; cellular response to amino acid starvation [GO:0034198]; positive regulation of TOR signaling [GO:0032008],NA,NA,NA
CHOYP_WDR61.1.2.m.7565,-0.00078246710276383,-0.00504129713339371,No,NA,NA,Q6P5M2,NA,NA,NA,Cdc73/Paf1 complex [GO:0016593]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ski complex [GO:0055087]; transcriptionally active chromatin [GO:0035327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation from RNA polymerase II promoter [GO:0032968],NA,NA,NA
CHOYP_WDR63.1.1.m.21743,-0.00776123860362532,-0.00152822223900789,No,NA,NA,Q8IWG1,NA,NA,NA,dynein complex [GO:0030286]; dynein heavy chain binding [GO:0045504]; dynein light chain binding [GO:0045503]; microtubule-based movement [GO:0007018],NA,NA,NA
CHOYP_WDR70.1.1.m.7199,0.0144876330524222,-0.00636716143685581,No,NA,NA,Q0VA16,NA,NA,NA,nucleus [GO:0005634]; site of double-strand break [GO:0035861]; regulation of DNA double-strand break processing [GO:1903775]; regulation of histone H2B conserved C-terminal lysine ubiquitination [GO:2001173],NA,NA,NA
CHOYP_WDR74.1.1.m.19017,-0.00371907586206173,-0.00841780903057436,No,NA,NA,Q6RFH5,NA,NA,NA,nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; blastocyst formation [GO:0001825]; ribosomal large subunit biogenesis [GO:0042273]; RNA metabolic process [GO:0016070]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR75.1.1.m.9234,-0.000473218017388874,-0.0191300357982797,No,NA,NA,Q6DFC6,NA,NA,NA,nucleolus [GO:0005730]; rRNA processing [GO:0006364],NA,NA,NA
CHOYP_WDR89.1.1.m.30861,0.0123534890892698,0.00653522724857392,No,NA,NA,Q5RBZ3,NA,NA,NA,,NA,NA,NA
CHOYP_WDR92.1.1.m.12560,-0.00444182963306318,0.00218818648046098,No,NA,NA,Q29RZ9,NA,NA,NA,ubiquitin binding [GO:0043130]; apoptotic process [GO:0006915],NA,NA,NA
CHOYP_WFIKKN1.1.1.m.28942,-0.0204940789993313,-0.0130423812858428,No,NA,NA,P84875,NA,NA,NA,extracellular region [GO:0005576]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],NA,NA,NA
CHOYP_WHITE.1.1.m.38819,0.00757616047874268,-0.0137543875588958,No,NA,NA,P10090,NA,NA,NA,cytoplasmic vesicle [GO:0031410]; integral component of pigment granule membrane [GO:0090740]; pigment granule [GO:0048770]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; 3';5'-cyclic GMP transmembrane-transporting ATPase activity [GO:1905948]; amine transmembrane transporter activity [GO:0005275]; ATP binding [GO:0005524]; ATPase activity; coupled to transmembrane movement of substances [GO:0042626]; eye pigment precursor transporter activity [GO:0005395]; guanine-transporting ATPase activity [GO:0008558]; pigment binding [GO:0031409]; aminergic neurotransmitter loading into synaptic vesicle [GO:0015842]; cellular biogenic amine biosynthetic process [GO:0042401]; cGMP transport [GO:0070731]; compound eye pigmentation [GO:0048072]; eye pigment metabolic process [GO:0042441]; eye pigment precursor transport [GO:0006856]; gravitaxis [GO:0042332]; histamine uptake [GO:0051615]; male courtship behavior [GO:0008049]; memory [GO:0007613]; ommochrome biosynthetic process [GO:0006727]; transmembrane transport [GO:0055085],NA,NA,NA
CHOYP_WHSC1.1.1.m.15308,-0.000205045138340279,-0.00286148963124007,No,NA,NA,O88491,NA,NA,NA,chromatin [GO:0000785]; histone methyltransferase complex [GO:0035097]; nucleus [GO:0005634]; androgen receptor binding [GO:0050681]; chromatin binding [GO:0003682]; estrogen receptor binding [GO:0030331]; histone methyltransferase activity [GO:0042054]; histone methyltransferase activity (H3-K36 specific) [GO:0046975]; histone methyltransferase activity (H4-K20 specific) [GO:0042799]; retinoic acid receptor binding [GO:0042974]; retinoid X receptor binding [GO:0046965]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; thyroid hormone receptor binding [GO:0046966]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; gastrulation with mouth forming second [GO:0001702]; histone methylation [GO:0016571]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription; DNA-templated [GO:0045893]; regulation of histone H3-K36 methylation [GO:0000414]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_WIBG.1.1.m.11521,-0.00855756499777185,-0.012485473909213,No,NA,NA,Q640E9,NA,NA,NA,cytoplasm [GO:0005737]; exon-exon junction complex [GO:0035145]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribosome binding [GO:0043022]; exon-exon junction complex disassembly [GO:1903259]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; positive regulation of translation [GO:0045727],NA,NA,NA
CHOYP_WIPI2.1.2.m.9192,-0.0069243585274417,-0.0136583969970136,No,NA,NA,Q5ZHN3,NA,NA,NA,autophagosome [GO:0005776]; cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; nucleoplasm [GO:0005654]; phagophore assembly site membrane [GO:0034045]; protein-containing complex [GO:0032991]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein lipidation involved in autophagosome assembly [GO:0061739]; protein localization to phagophore assembly site [GO:0034497]; xenophagy [GO:0098792],NA,NA,NA
CHOYP_WIPI3.1.1.m.13956,-0.000618778650644647,-0.00350290988228873,No,NA,NA,Q5ZL16,NA,NA,NA,cytosol [GO:0005829]; extrinsic component of membrane [GO:0019898]; lysosome [GO:0005764]; phagophore assembly site [GO:0000407]; phagophore assembly site membrane [GO:0034045]; phosphatidylinositol-3;5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; TSC1-TSC2 complex binding [GO:0062078]; autophagosome assembly [GO:0000045]; autophagy of mitochondrion [GO:0000422]; cellular response to starvation [GO:0009267]; protein lipidation [GO:0006497]; protein localization to phagophore assembly site [GO:0034497],NA,NA,NA
CHOYP_WKK_06610.2.2.m.50131,-6.16201673175628e-05,0.00817551340944022,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_WN10A.1.1.m.28564,-0.00324341268669932,0.00440318168107649,No,NA,NA,Q98SN7,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; camera-type eye photoreceptor cell differentiation [GO:0060219]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cell proliferation [GO:0008283]; cornea development in camera-type eye [GO:0061303]; embryonic camera-type eye formation [GO:0060900]; embryonic forelimb morphogenesis [GO:0035115]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; limb development [GO:0060173]; morphogenesis of an epithelial sheet [GO:0002011]; negative regulation of glial cell differentiation [GO:0045686]; negative regulation of neuron differentiation [GO:0045665]; neural retina development [GO:0003407]; neuron differentiation [GO:0030182]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of fibroblast growth factor production [GO:0090270]; retina layer formation [GO:0010842]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WNK2.1.2.m.38552,0.00499660788289467,0.00286073422850721,No,NA,NA,P83741,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; ATP binding [GO:0005524]; chloride channel inhibitor activity [GO:0019869]; magnesium ion binding [GO:0000287]; phosphatase binding [GO:0019902]; potassium channel inhibitor activity [GO:0019870]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase inhibitor activity [GO:0030291]; cellular response to calcium ion [GO:0071277]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; intracellular signal transduction [GO:0035556]; ion homeostasis [GO:0050801]; ion transport [GO:0006811]; lymphocyte migration into lymph node [GO:0097022]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of kinase activity [GO:0033673]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of phosphatase activity [GO:0010923]; negative regulation of sodium ion transport [GO:0010766]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of ion transmembrane transporter activity [GO:0032414]; positive regulation of potassium ion import across plasma membrane [GO:1903288]; positive regulation of sodium ion transmembrane transporter activity [GO:2000651]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of cellular process [GO:0050794]; regulation of sodium ion transport [GO:0002028]; signal transduction by trans-phosphorylation [GO:0023016]; T cell receptor signaling pathway [GO:0050852],NA,NA,NA
CHOYP_WNT7B.1.2.m.36042,-0.00388061376403053,0.0125027601178194,No,NA,NA,Q3L254,NA,NA,NA,extracellular space [GO:0005615]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; lens fiber cell development [GO:0070307]; neuron differentiation [GO:0030182]; positive regulation of JNK cascade [GO:0046330]; stem cell proliferation [GO:0072089]; Wnt signaling pathway [GO:0016055],NA,NA,NA
CHOYP_WRI_006090.1.1.m.34650,0,0,No,NA,NA,Q8N7Z5,NA,NA,NA,,NA,NA,NA
CHOYP_XCASPASE.7.1.4.m.26576,-0.00127179514769014,0.000429601621758949,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XDH.1.3.m.46824,-0.011912139665602,0.00659057330460843,No,NA,NA,P47990,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.2.3.m.53113,0.00135508860438673,0.0055000998121828,No,NA,NA,P47990,NA,NA,NA,cytosol [GO:0005829]; peroxisome [GO:0005777]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; iron ion binding [GO:0005506]; molybdenum ion binding [GO:0030151]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; urate biosynthetic process [GO:0034418]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XDH.3.3.m.55146,-0.00106289585844731,-0.000656434257882432,No,NA,NA,P47989,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron; 2 sulfur cluster binding [GO:0051537]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; purine nucleotide catabolic process [GO:0006195]; xanthine catabolic process [GO:0009115],NA,NA,NA
CHOYP_XFIN.1.4.m.606,0.00271330702298188,-0.00492596170119144,No,NA,NA,Q99KE8,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; multicellular organism development [GO:0007275]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mRNA splicing; via spliceosome [GO:0048026]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of gene expression [GO:0010468],NA,NA,NA
CHOYP_XIAP.1.7.m.6021,-0.0246666157200536,-0.0022141296013521,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_XPO1.1.1.m.31560,-0.00086812200918834,0.00267673486318042,No,NA,NA,Q80U96,NA,NA,NA,annulate lamellae [GO:0005642]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; nuclear export signal receptor activity [GO:0005049]; protein domain specific binding [GO:0019904]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; mRNA transport [GO:0051028]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein export from nucleus [GO:0006611]; protein localization to nucleus [GO:0034504]; regulation of centrosome duplication [GO:0010824]; regulation of protein catabolic process [GO:0042176]; regulation of protein export from nucleus [GO:0046825]; response to drug [GO:0042493]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056],NA,NA,NA
CHOYP_XPO2.1.1.m.50289,-0.00183823081413516,0.00341729129384353,No,NA,NA,Q8AY73,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; Ran GTPase binding [GO:0008536]; body fluid secretion [GO:0007589]; intracellular protein transport [GO:0006886],NA,NA,NA
CHOYP_XPO5.1.1.m.14207,-0.00899061532912498,0.0255195568142572,No,NA,NA,Q9HAV4,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; micro-ribonucleoprotein complex [GO:0035068]; nuclear RNA export factor complex [GO:0042272]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA nuclear export complex [GO:0042565]; mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; RNA binding [GO:0003723]; tRNA binding [GO:0000049]; miRNA metabolic process [GO:0010586]; positive regulation of RNA interference [GO:1900370]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; regulation of protein export from nucleus [GO:0046825],NA,NA,NA
CHOYP_XPO6.1.1.m.15288,-0.0013634347454534,0.00558180879938426,No,NA,NA,Q96QU8,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_XPO7.1.1.m.50167,-0.0133731047104475,0.0234295661818956,No,NA,NA,Q5ZLT0,NA,NA,NA,cytoplasm [GO:0005737]; nuclear pore [GO:0005643]; nuclear export signal receptor activity [GO:0005049]; Ran GTPase binding [GO:0008536]; protein export from nucleus [GO:0006611],NA,NA,NA
CHOYP_XPP1.1.2.m.16748,0.00122467294757035,0.000611678259346815,No,NA,NA,Q9NQW7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XPP1.2.2.m.38696,-0.00395650408280262,-0.000691831300760855,No,NA,NA,Q9NQW7,NA,NA,NA,cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803]; bradykinin catabolic process [GO:0010815]; proteolysis [GO:0006508],NA,NA,NA
CHOYP_XRN2.1.1.m.13943,-0.00412742505439138,0.00342948147699659,No,NA,NA,Q5ZIP4,NA,NA,NA,aggresome [GO:0016235]; nucleolus [GO:0005730]; 5'-3' exonuclease activity [GO:0008409]; 5'-3' exoribonuclease activity [GO:0004534]; metal ion binding [GO:0046872]; transcription termination site sequence-specific DNA binding [GO:0001147]; DNA catabolic process; exonucleolytic [GO:0000738]; DNA-templated transcription; termination [GO:0006353]; mRNA processing [GO:0006397]; spermatogenesis [GO:0007283],NA,NA,NA
CHOYP_Y003.1.1.m.31014,0.0153386926310359,0.00540571721203026,No,NA,NA,Q6R7B4,NA,NA,NA,,NA,NA,NA
CHOYP_Y022.1.1.m.30669,0.00241613500092098,0.00844372865897002,No,NA,NA,Q6R7K1,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0417.2.2.m.29395,-0.00133887441712409,0.00199011568118305,No,NA,NA,F1LNI5,NA,NA,NA,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; magnesium-dependent protein serine/threonine phosphatase activity [GO:0004724]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; cell cycle [GO:0007049],NA,NA,NA
CHOYP_Y045.1.1.m.43767,0.00753243431717339,-0.00281454544388759,No,NA,NA,Q502K3,NA,NA,NA,,NA,NA,NA
CHOYP_Y054.1.1.m.9666,-0.000929876186595965,0.000611129888624123,No,NA,NA,Q6R7G0,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y061.1.1.m.29896,0.0055095497607239,-0.00113281071202485,No,NA,NA,Q6R7G4,NA,NA,NA,,NA,NA,NA
CHOYP_Y071.1.1.m.29248,0.00811401179476492,-0.0147308472670011,No,NA,NA,Q6R7F6,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y077.1.1.m.27629,-4.80470499050191e-05,0.00637468734478051,No,NA,NA,Q6R7F2,NA,NA,NA,host cell membrane [GO:0033644]; integral component of membrane [GO:0016021],NA,NA,NA
CHOYP_Y0777.3.3.m.60141,0.00614673971190953,-0.00390717517600511,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_Y1004.1.1.m.18927,-0.00046344629110973,0.000442725612368174,No,NA,NA,P34501,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_Y118.1.1.m.30002,0.00824173971669602,-0.0149627350873901,No,NA,NA,Q6R796,NA,NA,NA,metal ion binding [GO:0046872],NA,NA,NA
CHOYP_Y7557.3.3.m.42713,0.0281698844448691,-0.0114709435747013,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YAHB.1.1.m.25422,0.00141069048303777,-0.00376166231703172,No,NA,NA,P42297,NA,NA,NA,,NA,NA,NA
CHOYP_YAP.1.2.m.23386,-0.00376937293019815,0.00507923411193805,No,NA,NA,Q1L8J7,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YAP.2.2.m.62060,0.0158573293873367,0.0133047497652285,No,NA,NA,Q1L8J7,NA,NA,NA,chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; blood vessel morphogenesis [GO:0048514]; brain development [GO:0007420]; cartilage development [GO:0051216]; cilium assembly [GO:0060271]; dorsal/ventral axis specification [GO:0009950]; embryonic hemopoiesis [GO:0035162]; endoderm development [GO:0007492]; fin regeneration [GO:0031101]; heart formation [GO:0060914]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; pancreas development [GO:0031016]; positive regulation of glutamate-ammonia ligase activity [GO:1905480]; posterior lateral line development [GO:0048916]; pronephric duct development [GO:0039022]; regulation of organ growth [GO:0046620]; retinal pigment epithelium development [GO:0003406],NA,NA,NA
CHOYP_YDJC.1.1.m.4244,0.00107126893527894,0.0121995745066459,No,NA,NA,A2BIR6,NA,NA,NA,hydrolase activity [GO:0016787]; magnesium ion binding [GO:0000287]; carbohydrate metabolic process [GO:0005975],NA,NA,NA
CHOYP_YETS2.1.1.m.302,-0.00960853890063503,0.00117299459885665,No,NA,NA,Q9ULM3,NA,NA,NA,Ada2/Gcn5/Ada3 transcription activator complex [GO:0005671]; mitotic spindle [GO:0072686]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; histone binding [GO:0042393]; modification-dependent protein binding [GO:0140030]; TBP-class protein binding [GO:0017025]; histone H3 acetylation [GO:0043966]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_YG31B.1.3.m.6174,0.00174251280742899,0.00501106642660434,No,NA,NA,Q7LHG5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; retrotransposon nucleocapsid [GO:0000943]; aspartic-type endopeptidase activity [GO:0004190]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; peptidase activity [GO:0008233]; ribonuclease activity [GO:0004540]; RNA binding [GO:0003723]; RNA-directed DNA polymerase activity [GO:0003964]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; zinc ion binding [GO:0008270]; DNA integration [GO:0015074]; DNA recombination [GO:0006310]; transposition; RNA-mediated [GO:0032197],NA,NA,NA
CHOYP_YG31B.2.3.m.9011,-0.00615720799624527,-0.00165269754311954,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL086.1.1.m.33481,0,0,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YL58.1.1.m.35411,0.00357338945662699,-0.000965631894363803,No,NA,NA,A5D7H5,NA,NA,NA,cytoplasmic stress granule [GO:0010494]; dendrite [GO:0030425]; exon-exon junction complex [GO:0035145]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; intracellular mRNA localization [GO:0008298]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; nuclear-transcribed mRNA catabolic process; nonsense-mediated decay [GO:0000184]; regulation of translation [GO:0006417]; RNA splicing [GO:0008380],NA,NA,NA
CHOYP_YL8A.1.1.m.29604,-0.0226235990581083,0.0263833976082186,No,NA,NA,Q9UTA8,NA,NA,NA,cytosol [GO:0005829]; nucleus [GO:0005634]; trans-aconitate 3-methyltransferase activity [GO:0046547]; cellular detoxification [GO:1990748],NA,NA,NA
CHOYP_YLPM1.1.2.m.17086,-0.0112340671746969,0.00438115403341023,No,NA,NA,P0CB49,NA,NA,NA,nuclear speck [GO:0016607]; nucleus [GO:0005634]; DNA-binding transcription repressor activity; RNA polymerase II-specific [GO:0001227],NA,NA,NA
CHOYP_YMS5.1.1.m.5494,-0.0055755041840804,0.0218511046520197,No,NA,NA,P34501,NA,NA,NA,cell-matrix adhesion [GO:0007160],NA,NA,NA
CHOYP_YNY5.2.4.m.50761,0.00954470535505642,0.00608118952790702,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_YQK4.2.2.m.31850,-0.00209631301139464,-0.00151525746778232,No,NA,NA,Q09288,NA,NA,NA,defense response to Gram-negative bacterium [GO:0050829]; regulation of antimicrobial humoral response [GO:0002759]; response to bacterium [GO:0009617],NA,NA,NA
CHOYP_YS11.1.1.m.30657,-0.00950241355048189,0.0136411216586848,No,NA,NA,Q9W0Y2,NA,NA,NA,gamma-glutamylaminecyclotransferase activity [GO:0061929]; transferase activity; transferring acyl groups [GO:0016746]; cellular modified amino acid catabolic process [GO:0042219],NA,NA,NA
CHOYP_YTDC1.1.2.m.56405,0.00288036852030513,-0.00522925894348199,No,NA,NA,Q9H2Y7,NA,NA,NA,cytosol [GO:0005829]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; insulin receptor signaling pathway [GO:0008286],NA,NA,NA
CHOYP_ZADH2.1.3.m.13137,-0.000792611525067607,0.000750202522387919,No,NA,NA,Q8BGC4,NA,NA,NA,mitochondrion [GO:0005739]; peroxisome [GO:0005777]; 13-prostaglandin reductase activity [GO:0036132]; 15-oxoprostaglandin 13-oxidase activity [GO:0047522]; zinc ion binding [GO:0008270]; negative regulation of fat cell differentiation [GO:0045599],NA,NA,NA
CHOYP_ZBTB5.4.4.m.42642,0.0116628850718694,-0.00294113037397942,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZC11A.1.1.m.60722,0.00693307345560932,-0.00901255041996491,No,NA,NA,Q6NZF1,NA,NA,NA,cell [GO:0005623]; metal ion binding [GO:0046872]; mRNA binding [GO:0003729]; poly(A)+ mRNA export from nucleus [GO:0016973],NA,NA,NA
CHOYP_ZC3H18.1.1.m.8085,-0.0050078134568142,-0.00272981426578192,No,NA,NA,Q86VM9,NA,NA,NA,nuclear speck [GO:0016607]; protein-containing complex [GO:0032991]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZC3H4.1.1.m.57516,0,0,No,NA,NA,P61129,NA,NA,NA,nucleus [GO:0005634]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; negative regulation of transcription; DNA-templated [GO:0045892],NA,NA,NA
CHOYP_ZC3HA.1.1.m.27569,0,0,No,NA,NA,Q8R205,NA,NA,NA,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; posttranscriptional regulation of gene expression [GO:0010608]; regulation of alternative mRNA splicing; via spliceosome [GO:0000381],NA,NA,NA
CHOYP_ZC3HDC1L.1.1.m.44413,-0.00586827694238927,0.00703439291614045,No,NA,NA,Q9H0J9,NA,NA,NA,nucleus [GO:0005634]; metal ion binding [GO:0046872]; NAD+ ADP-ribosyltransferase activity [GO:0003950]; RNA binding [GO:0003723],NA,NA,NA
CHOYP_ZC3HF.1.1.m.39867,-0.00389291959628848,0.00571085524464763,No,NA,NA,Q8WU90,NA,NA,NA,cytosol [GO:0005829]; nucleolus [GO:0005730]; cadherin binding [GO:0045296]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; cytokine-mediated signaling pathway [GO:0019221]; cytoplasmic translation [GO:0002181],NA,NA,NA
CHOYP_ZCCHC8.1.1.m.18098,-0.0195461406726609,0.00631892641835138,No,NA,NA,Q5F3D1,NA,NA,NA,nucleoplasm [GO:0005654]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270],NA,NA,NA
CHOYP_ZDHHC17.1.1.m.29726,0,0,No,NA,NA,Q8IUH5,NA,NA,NA,aggresome [GO:0016235]; cell junction [GO:0030054]; cytoplasmic vesicle membrane [GO:0030659]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; magnesium ion transmembrane transporter activity [GO:0015095]; palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]; lipoprotein transport [GO:0042953]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; protein palmitoylation [GO:0018345],NA,NA,NA
CHOYP_ZEB2.1.1.m.29733,-0.00242835816221223,0.00329668260187597,No,NA,NA,Q9UDV7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; zinc ion binding [GO:0008270]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.3.10.m.29555,0.0028198975647052,-0.000762016863924048,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_BBOX_RING_.1.5.10.m.34434,0.0254628360528163,-0.0187058815417455,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZF_U1LIKE_.10.1.1.m.18971,-0.00910716606072674,-0.015337337738916,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZFP37.1.4.m.10878,-0.0209580687390645,-0.00789679969736079,No,NA,NA,Q6GQR8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFP37.3.4.m.48467,0.00527757565708023,0.00845416309379143,No,NA,NA,A2T812,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZFR.1.1.m.57469,0.00118403114710785,-0.00159745075118917,No,NA,NA,Q96KR1,NA,NA,NA,chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; DNA binding [GO:0003677]; double-stranded RNA binding [GO:0003725]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; zinc ion binding [GO:0008270]; multicellular organism development [GO:0007275],NA,NA,NA
CHOYP_ZFY27.1.1.m.31417,-7.84424932157445e-05,0.0104074312529895,No,NA,NA,Q6P7B7,NA,NA,NA,axon [GO:0030424]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum tubular network [GO:0071782]; growth cone membrane [GO:0032584]; integral component of endoplasmic reticulum membrane [GO:0030176]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; recycling endosome membrane [GO:0055038]; metal ion binding [GO:0046872]; protein self-association [GO:0043621]; endoplasmic reticulum tubular network formation [GO:0071787]; neuron projection development [GO:0031175]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of axon extension [GO:0045773]; protein localization to plasma membrane [GO:0072659]; vesicle-mediated transport [GO:0016192],NA,NA,NA
CHOYP_ZGC_113208.1.1.m.15618,0.000909890181909092,0.00988118704438137,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZGC_113625.1.2.m.2855,-0.00959114668789335,0.0030874162916598,No,NA,NA,Q8NHV1,NA,NA,NA,cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; GTP metabolic process [GO:0046039],NA,NA,NA
CHOYP_ZGC_136858.1.1.m.51274,0.0256364689299667,0.00847303080944803,No,NA,NA,Q9USY1,NA,NA,NA,cytoplasm [GO:0005737]; ATP binding [GO:0005524]; hydrolase activity; acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; pseudouridine kinase activity [GO:0050225]; pseudouridylate synthase activity [GO:0004730]; pseudouridine synthesis [GO:0001522]; pyrimidine nucleoside metabolic process [GO:0006213],NA,NA,NA
CHOYP_ZGC_171566.1.1.m.22181,-0.0136312750985417,0.00190762446333303,No,NA,NA,Q9Z0L8,NA,NA,NA,cytosol [GO:0005829]; extracellular space [GO:0005615]; lysosome [GO:0005764]; melanosome [GO:0042470]; vacuole [GO:0005773]; gamma-glutamyl-peptidase activity [GO:0034722]; response to drug [GO:0042493]; response to ethanol [GO:0045471]; response to insulin [GO:0032868]; response to zinc ion [GO:0010043]; tetrahydrofolylpolyglutamate metabolic process [GO:0046900],NA,NA,NA
CHOYP_ZGC_73273.1.1.m.18633,-0.00269013989316895,0.00307207079139004,No,NA,NA,Q9QY93,NA,NA,NA,cytosol [GO:0005829]; dCTP diphosphatase activity [GO:0047840]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside-triphosphate diphosphatase activity [GO:0047429]; pyrimidine deoxyribonucleotide binding [GO:0032556]; pyrophosphatase activity [GO:0016462]; dCTP catabolic process [GO:0006253]; DNA protection [GO:0042262]; nucleoside triphosphate catabolic process [GO:0009143]; protein homotetramerization [GO:0051289],NA,NA,NA
CHOYP_ZGC_92203.1.1.m.55468,0.0106070538652561,0.0134078650213203,No,NA,NA,Q9HCU5,NA,NA,NA,endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; integral component of endoplasmic reticulum membrane [GO:0030176]; membrane [GO:0016020]; nucleus [GO:0005634]; DNA binding [GO:0003677]; GTPase activator activity [GO:0005096]; GTPase binding [GO:0051020]; guanyl-nucleotide exchange factor activity [GO:0005085]; Sar guanyl-nucleotide exchange factor activity [GO:0005090]; COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; IRE1-mediated unfolded protein response [GO:0036498]; protein exit from endoplasmic reticulum [GO:0032527]; protein secretion [GO:0009306]; regulation of COPII vesicle coating [GO:0003400],NA,NA,NA
CHOYP_ZIP.1.1.m.15785,0.00352539540307349,-0.0132205862182716,No,NA,NA,Q99323,NA,NA,NA,actomyosin contractile ring [GO:0005826]; apical cortex [GO:0045179]; cell cortex [GO:0005938]; cell leading edge [GO:0031252]; cell-cell contact zone [GO:0044291]; cilium [GO:0005929]; cleavage furrow [GO:0032154]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; myosin complex [GO:0016459]; myosin II complex [GO:0016460]; unconventional myosin complex [GO:0016461]; Z disc [GO:0030018]; actin binding [GO:0003779]; ATP binding [GO:0005524]; ATPase activity; coupled [GO:0042623]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; motor activity [GO:0003774]; myosin light chain binding [GO:0032027]; anterior midgut development [GO:0007496]; border follicle cell migration [GO:0007298]; cellular response to mechanical stimulus [GO:0071260]; compartment boundary maintenance [GO:0060289]; cuticle pattern formation [GO:0035017]; dorsal closure [GO:0007391]; dorsal closure; amnioserosa morphology change [GO:0046664]; dorsal closure; leading edge cell differentiation [GO:0046663]; dorsal closure; spreading of leading edge cells [GO:0007395]; establishment of neuroblast polarity [GO:0045200]; establishment of planar polarity [GO:0001736]; eye-antennal disc morphogenesis [GO:0007455]; head involution [GO:0008258]; imaginal disc-derived wing hair organization [GO:0035317]; left/right axis specification [GO:0070986]; maintenance of protein location in cell [GO:0032507]; Malpighian tubule morphogenesis [GO:0007443]; mitotic cytokinesis [GO:0000281]; morphogenesis of an epithelial fold [GO:0060571]; muscle contraction [GO:0006936]; myofibril assembly [GO:0030239]; myosin II filament assembly [GO:0031036]; ommatidial rotation [GO:0016318]; ovarian follicle cell migration [GO:0007297]; positive regulation of border follicle cell migration [GO:1903688]; protein complex oligomerization [GO:0051259]; regulation of myoblast fusion [GO:1901739]; regulation of tube length; open tracheal system [GO:0035159]; salivary gland morphogenesis [GO:0007435]; sarcomere organization [GO:0045214]; spiracle morphogenesis; open tracheal system [GO:0035277]; wound healing [GO:0042060],NA,NA,NA
CHOYP_ZMY11.1.1.m.3621,-0.00094268076662416,0.0052172162328415,No,NA,NA,Q8R5C8,NA,NA,NA,chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; double-stranded DNA binding [GO:0003690]; histone binding [GO:0042393]; methylated histone binding [GO:0035064]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270]; chromatin organization [GO:0006325]; defense response to virus [GO:0051607]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of JNK cascade [GO:0046329]; regulation of transcription elongation from RNA polymerase II promoter [GO:0034243],NA,NA,NA
CHOYP_ZN207.1.1.m.6909,-0.00199645958851751,-0.0113749314313678,No,NA,NA,Q7ZXV8,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytoplasm [GO:0005737]; kinetochore [GO:0000776]; microtubule [GO:0005874]; nucleus [GO:0005634]; spindle [GO:0005819]; spindle matrix [GO:1990047]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; nucleic acid binding [GO:0003676]; attachment of spindle microtubules to kinetochore [GO:0008608]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule polymerization [GO:0046785]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly [GO:0090307]; mitotic spindle assembly checkpoint [GO:0007094]; protein stabilization [GO:0050821]; regulation of chromosome segregation [GO:0051983],NA,NA,NA
CHOYP_ZN330.1.2.m.7843,0.000965207375668533,0.00142274441364694,No,NA,NA,Q9VAU9,NA,NA,NA,chromosome; centromeric region [GO:0000775]; midbody [GO:0030496]; nucleolus [GO:0005730]; zinc ion binding [GO:0008270]; larval lymph gland hemopoiesis [GO:0035167],NA,NA,NA
CHOYP_ZN521.2.3.m.13584,-8.06293744993216e-08,0.00220175348882333,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZN568.1.1.m.61611,0.00270270161466634,-0.000730347170871724,No,NA,NA,P08043,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZN609.1.1.m.44387,-0.00189909494440157,0.00257816715834693,No,NA,NA,O15014,NA,NA,NA,integrator complex [GO:0032039]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; muscle organ development [GO:0007517]; positive regulation of neuron migration [GO:2001224]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of myoblast proliferation [GO:2000291]; regulation of transcription by RNA polymerase II [GO:0006357],NA,NA,NA
CHOYP_ZN622.1.1.m.2103,-0.00231754456472118,-0.00267552340655289,No,NA,NA,Q91VY9,NA,NA,NA,cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleus [GO:0005634]; preribosome; large subunit precursor [GO:0030687]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; positive regulation of apoptotic process [GO:0043065]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; ribosomal large subunit biogenesis [GO:0042273],NA,NA,NA
CHOYP_ZN706.1.2.m.11926,-0.000941849556114823,0.00525902944361148,No,NA,NA,Q5ZMM5,NA,NA,NA,cytoplasm [GO:0005737]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription; DNA-templated [GO:0045892]; regulation of translation [GO:0006417],NA,NA,NA
CHOYP_ZN729.1.1.m.13702,0.000398034578765449,-0.00195516481266504,No,NA,NA,P52740,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF184.1.1.m.59420,-0.0167773032189714,-0.00867367549954463,No,NA,NA,Q76KX8,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF259.1.1.m.10424,-0.000792617332973582,0.00255724083379866,No,NA,NA,Q62384,NA,NA,NA,axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; Gemini of coiled bodies [GO:0097504]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; SMN complex [GO:0032797]; receptor tyrosine kinase binding [GO:0030971]; translation initiation factor binding [GO:0031369]; zinc ion binding [GO:0008270]; apoptotic process involved in development [GO:1902742]; axon development [GO:0061564]; Cajal body organization [GO:0030576]; cellular response to epidermal growth factor stimulus [GO:0071364]; DNA endoreduplication [GO:0042023]; inner cell mass cell proliferation [GO:0001833]; microtubule cytoskeleton organization [GO:0000226]; mRNA processing [GO:0006397]; negative regulation of motor neuron apoptotic process [GO:2000672]; positive regulation of gene expression [GO:0010628]; positive regulation of growth [GO:0045927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of RNA splicing [GO:0033120]; positive regulation of transcription involved in G1/S transition of mitotic cell cycle [GO:0071931]; pre-mRNA catabolic process [GO:1990261]; regulation of myelination [GO:0031641]; RNA splicing [GO:0008380]; spinal cord development [GO:0021510]; trophectodermal cell proliferation [GO:0001834],NA,NA,NA
CHOYP_ZNF382.1.1.m.21527,-0.00289353415465441,-0.0245700062457741,No,NA,NA,Q5T5D7,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF43.1.1.m.6773,-0.00332237481617136,0.00451037883283453,No,NA,NA,A8MTY0,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF510.1.1.m.10853,0.00262804887019637,0.00310365810787301,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CHOYP_ZNF624.1.1.m.45743,-0.00436146940147132,-0.0118708426728877,No,NA,NA,Q6ZNA1,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; DNA-binding transcription factor activity; RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872],NA,NA,NA
CHOYP_ZNF85.1.1.m.65738,0.00073606792495196,0.00648022334124571,No,NA,NA,Q8BIQ3,NA,NA,NA,nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; regulation of transcription; DNA-templated [GO:0006355],NA,NA,NA
CHOYP_ZNRD1.1.2.m.7107,-0.00999858426829909,-0.0105588456380863,No,NA,NA,Q6MFY5,NA,NA,NA,RNA polymerase I complex [GO:0005736]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; nucleic acid binding [GO:0003676]; zinc ion binding [GO:0008270]; mRNA cleavage [GO:0006379]; termination of RNA polymerase I transcription [GO:0006363],NA,NA,NA
CHOYP_ZW10.1.1.m.35287,-0.00081469750936847,0.00871995689348948,No,NA,NA,O54692,NA,NA,NA,condensed chromosome kinetochore [GO:0000777]; cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922]; cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; mitotic cell cycle checkpoint [GO:0007093]; mitotic metaphase plate congression [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of exit from mitosis [GO:0007096],NA,NA,NA
CHOYP_ZYRO0F11880G.1.1.m.7082,-0.00819661031289054,0.00644217549628789,No,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
